Citrus Sinensis ID: 041249

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------79
Protein Sequence
ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP
Secondary Structure (PSIPRED)
cEEEcccccEEccccccccccccccEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEccccccccccEEEccccccccccHHHHHccccccEEEccccccccccccccccccccHHHHccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEcccccccccHHHHHHHHHHHcccccccccEEEEcccccccccEEEEEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccEEEcccHHHHHcccccccccEEEEEccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHcccccccccEEcccccccccccccccccccccEEEcccccccccccHHcccccccccccccccEEccccccccccccccccEEcccccccccccHHHHccccccEEEEccccccccccHHHHHccccccccccccccccccccccHHccccccEEEccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHccccEEEccccEEEEccHHHccccccccEEEccccEEEEEccHHHHcccccEEEEcccccccccEEEEEccccccccccHHHcccccccEEEEccccccccccccHccccccEEEEccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHccccccccHHHHHHHHccccHHcEEEccccEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHHHcHHHHHEEcccccccccccEEEEEEEcccccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccEEccHHHcEcEEEEEEEcEccccHHHcccccEcccccHHHHHHHHHHHHccccccccccccccEEHHHHEcccccccEEEEcccHccccccHHHHHHHHHHHHHHcccccccccccccccccccEEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHccccEEEccccEEEEccHHHccccccccEEEccccEEcccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHcccccEEEccccccccccc
Coil and Loop (DISEMBL)
ilaldsnrlsgnippsignlkklvepyvsdnflkgsipsslglceSLTTIglfnnnlsgtippqlmgLTSLVALdlsrnqfrgsfptevGNLINLETLtvsgnilqgeipstlgsCIKLEILEMQgnvfqgltildlsrnklsgeipeFLVGLKVIENLNlsyndlegmvptegvfknASAISVLgnnklcggisefklppcglkksteWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRkrkeqsnpnsLINSLLNLSYqnlhnatdgfssanligtgsfgsvykgvldegrtTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAcsgvdyqgndFKALVYEFMQNgsleewlypvnredevdkaprnLNLLQRLNIAIDVASALDylhhdcqpitthcdlkpsnilldeemvshvgdfglarflppthvqtssigvkgsigyiapeyglgsevstngdvysYGILMLELIIrkkpsdimfegdmnlhnfarmalpdhvmDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIgskaqkvtiLDLESLKLAGsilphignlsfLKILnlennsftheipseigrlrrlqvpdlnnnsiggeipvnlsscsNLIRIGLAknqlmgkipsdfgslsKIEVLSLGFnnligsippplgnlsslRKISLAINNLAGSIPFTLSKLKNLVILYLGVnrlsgivpssifnissiaefdvgenkiqgnipldygftlqnlqyfsigtnritgaippsisnaSKLEVFQALNnkltgevp
Flexible Loop (DISEMBL)
ilaldsnrlsgnippsignLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIisnqrqrqirVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALnnkltgevp
Low Complexity Region (SEG)
ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQsnpnslinsllnlsyqnlhnATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP
Disordered region (IsUnstruct)
*****************GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKR*******SLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI*****LEVF************
Disordered Region (DISOPRED)
ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISE*********************LVIAIVSGLMGLALTLSISFL********************NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR*****KAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT****SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP
Disordered Region (DISEMBL)
ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP
Disordered Region (DISPRO)
ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQ*NPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN********PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	789	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.697	0.544	0.449	1e-138
C0LGT6	1031	LRR receptor-like serine/	no	no	0.638	0.488	0.467	1e-128
Q9SD62	1025	Putative receptor-like pr	no	no	0.678	0.521	0.453	1e-121
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.628	0.506	0.371	3e-82
Q9FL28	1173	LRR receptor-like serine/	no	no	0.675	0.454	0.347	3e-75
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.589	0.464	0.344	1e-72
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.642	0.460	0.328	2e-71
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.605	0.401	0.358	4e-71
C0LGX3	993	LRR receptor-like serine/	no	no	0.612	0.486	0.35	8e-71
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.628	0.450	0.349	5e-70

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  492 bits (1266), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 269/598 (44%), Positives = 382/598 (63%), Gaps = 48/598 (8%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L+L SNRLSG IP  IGN+  L    +S+N  +G +P+SLG C  L  + + +N L+GTI
Sbjct: 414 LSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTI 473

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P ++M +  L+ LD+S N   GS P ++G L NL TL++  N L G++P TLG+C+ +E 
Sbjct: 474 PLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMES 533

Query: 122 LEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
           L ++GN+F G          +  +DLS N LSG IPE+      +E LNLS+N+LEG VP
Sbjct: 534 LFLEGNLFYGDIPDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVP 593

Query: 172 TEGVFKNASAISVLGNNKLCGGISEFKLPPC-----GLKKSTEWRLTFELKLVIAIVSGL 226
            +G+F+NA+ +S++GNN LCGGI  F+L PC      + K    RL    K+VI +  G+
Sbjct: 594 VKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK---KVVIGVSVGI 650

Query: 227 MGLALTLSISF-LCWVRKRKEQSNPNSLINSLL-----NLSYQNLHNATDGFSSANLIGT 280
             L L    S  L W+RKRK+    N+   S L      +SY +L NAT+GFSS+N++G+
Sbjct: 651 TLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGS 710

Query: 281 GSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD 340
           GSFG+VYK +L   +  V VKV N+    A +SF+AEC +L+ IRHRNLVK+ TACS +D
Sbjct: 711 GSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSID 770

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           +QGN+F+AL+YEFM NGSL+ WL+P   E E+ +  R L LL+RLNIAIDVAS LDYLH 
Sbjct: 771 FQGNEFRALIYEFMPNGSLDMWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHV 829

Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL-----PPTHVQTSSIGVKGSIGYIA 455
            C     HCDLKPSN+LLD+++ +HV DFGLAR L          Q SS GV+G+IGY A
Sbjct: 830 HCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAA 889

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDS 515
           PEYG+G + S NGDVYS+GIL+LE+   K+P++ +F G+  L+++ + ALP+ ++DIVD 
Sbjct: 890 PEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDE 949

Query: 516 TLLNDVEDLAIISNQRQRQIRVN-NIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572
           ++L                +RV   ++ECL  +  +G +  + + ++    +LA SI+
Sbjct: 950 SIL-------------HIGLRVGFPVVECLTMVFEVGLRCCEESPMN----RLATSIV 990

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  460 bits (1183), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 248/530 (46%), Positives = 332/530 (62%), Gaps = 26/530 (4%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           ++ L SN +SG IP   GN+ +L + +++ N   G IP SLG C  L  + +  N L+GT
Sbjct: 421 VVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGT 480

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           IP +++ + SL  +DLS N   G FP EVG L  L  L  S N L G++P  +G C+ +E
Sbjct: 481 IPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSME 540

Query: 121 ILEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
            L MQGN F G          L  +D S N LSG IP +L  L  + NLNLS N  EG V
Sbjct: 541 FLFMQGNSFDGAIPDISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRV 600

Query: 171 PTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWR--LTFELKLVIAIVSGLMG 228
           PT GVF+NA+A+SV GN  +CGG+ E +L PC ++ S   R  L+   K+V  I  G+  
Sbjct: 601 PTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIAS 660

Query: 229 LALTLSISFLCWVRKRKEQSNP---NSLINSLLNL-----SYQNLHNATDGFSSANLIGT 280
           L L + ++ LCW  KRK+++N    N   ++ L +     SY+ LH+AT  FSS NLIG+
Sbjct: 661 LLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGS 720

Query: 281 GSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD 340
           G+FG+V+KG+L      V VKV NL  H A++SF+AEC   + IRHRNLVK+ T CS +D
Sbjct: 721 GNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLD 780

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
            +GNDF+ALVYEFM  GSL+ WL   + E  V+   R+L   ++LNIAIDVASAL+YLH 
Sbjct: 781 SEGNDFRALVYEFMPKGSLDMWLQLEDLE-RVNDHSRSLTPAEKLNIAIDVASALEYLHV 839

Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIA 455
            C     HCD+KPSNILLD+++ +HV DFGLA+ L          Q SS GV+G+IGY A
Sbjct: 840 HCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAA 899

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
           PEYG+G + S  GDVYS+GIL+LE+   KKP+D  F GD NLH++ +  L
Sbjct: 900 PEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  436 bits (1120), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 260/573 (45%), Positives = 344/573 (60%), Gaps = 38/573 (6%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
           L SN LSG IP S+GN+  L   Y+ +N  +GSIPSSLG C  L  + L  N L+G+IP 
Sbjct: 432 LYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPH 491

Query: 64  QLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILE 123
           +LM L SLV L++S N   G    ++G L  L  L VS N L G+IP TL +C+ LE L 
Sbjct: 492 ELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLL 551

Query: 124 MQGNVF----------QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTE 173
           +QGN F           GL  LDLS+N LSG IPE++     ++NLNLS N+ +G VPTE
Sbjct: 552 LQGNSFVGPIPDIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTE 611

Query: 174 GVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTL 233
           GVF+N SA+SV GN  LCGGI   +L PC ++         ++  +         L L L
Sbjct: 612 GVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCL 671

Query: 234 SISFLCWVRKRKEQSNPN--------SLINSLL-NLSYQNLHNATDGFSSANLIGTGSFG 284
            + +LCW + R +    N        S + S    +SY  L+  T GFSS+NLIG+G+FG
Sbjct: 672 CVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFG 731

Query: 285 SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344
           +V+KG L      V +KV NL    A++SFIAEC AL  IRHRNLVK+ T CS  D++GN
Sbjct: 732 AVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGN 791

Query: 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQP 404
           DF+ALVYEFM NG+L+ WL+P +  +E     R L L  RLNIAIDVASAL YLH  C  
Sbjct: 792 DFRALVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHN 850

Query: 405 ITTHCDLKPSNILLDEEMVSHVGDFGLARFL-----PPTHVQTSSIGVKGSIGYIAPEYG 459
              HCD+KPSNILLD+++ +HV DFGLA+ L        H+Q SS GV+G+IGY APEYG
Sbjct: 851 PIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYG 910

Query: 460 LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD-HVMDIVDSTLL 518
           +G   S  GDVYS+GI++LE+   K+P++ +F   + LH+F + AL     +DI D T+L
Sbjct: 911 MGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL 970

Query: 519 NDVEDLAIISNQRQRQIRVNNIIECLISMLRIG 551
                       R    +  N++ECL  + R+G
Sbjct: 971 ------------RGAYAQHFNMVECLTLVFRVG 991

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  306 bits (785), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 206/554 (37%), Positives = 298/554 (53%), Gaps = 58/554 (10%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L +  N LSG+IP S GNL +L    +  N L G++P SLG C +L  + L +NNL+GT
Sbjct: 373 LLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGT 432

Query: 61  IPPQLMG-LTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
           IP +++  L +L + L+LS N   G  P E+  +  + ++ +S N L G+IP  LGSCI 
Sbjct: 433 IPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIA 492

Query: 119 LEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           LE L +  N F             L  LD+S N+L+G IP        +++LN S+N L 
Sbjct: 493 LEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLS 552

Query: 168 GMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLM 227
           G V  +G F   +  S LG++ LCG I   +      KK  ++       L+  I + ++
Sbjct: 553 GNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ----ACKKKHKYPSVLLPVLLSLIATPVL 608

Query: 228 -------------GLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSS 274
                        G  LT+         +++ Q++P         +SYQ L  AT GF++
Sbjct: 609 CVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPK-----YPRISYQQLIAATGGFNA 663

Query: 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVF 333
           ++LIG+G FG VYKGVL    T V VKV +       S SF  EC+ L+  RHRNL+++ 
Sbjct: 664 SSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRII 722

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
           T CS        F ALV   M NGSLE  LYP       + + +NL+L+Q +NI  DVA 
Sbjct: 723 TTCSKPG-----FNALVLPLMPNGSLERHLYPG------EYSSKNLDLIQLVNICSDVAE 771

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS-----SIG-- 446
            + YLHH       HCDLKPSNILLD+EM + V DFG++R +       S     S G  
Sbjct: 772 GIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGST 831

Query: 447 ---VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + GS+GYIAPEYG+G   ST+GDVYS+G+L+LE++  ++P+D++     +LH F + 
Sbjct: 832 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKS 891

Query: 504 ALPDHVMDIVDSTL 517
             PD +  I++  L
Sbjct: 892 HYPDSLEGIIEQAL 905

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  283 bits (725), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 209/601 (34%), Positives = 314/601 (52%), Gaps = 68/601 (11%)

Query: 2    LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLF----NNNL 57
            L+L  N+ +G+IP S+ +L  L    +SDN L G+IP  L    SL  + L+    NN L
Sbjct: 580  LSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLL 637

Query: 58   SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
            +GTIP +L  L  +  +DLS N F GS P  +    N+ TL  S N L G IP  +   +
Sbjct: 638  TGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGM 697

Query: 118  KLEI-LEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
             + I L +  N F G           L  LDLS N L+GEIPE L  L  +++L L+ N+
Sbjct: 698  DMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNN 757

Query: 166  LEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLK-KSTEWRLTFELKLVIAIVS 224
            L+G VP  GVFKN +A  ++GN  LCG  S+  L PC +K KS+ +     + L+I   +
Sbjct: 758  LKGHVPESGVFKNINASDLMGNTDLCG--SKKPLKPCTIKQKSSHFSKRTRVILIILGSA 815

Query: 225  GLMGLALTLSISFLCW------VRKRKEQSNPNSLINSLLNLSY---QNLHNATDGFSSA 275
              + L L L +   C       +    E S P+  ++S L L     + L  ATD F+SA
Sbjct: 816  AALLLVLLLVLILTCCKKKEKKIENSSESSLPD--LDSALKLKRFEPKELEQATDSFNSA 873

Query: 276  NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRSFIAECRALRSIRHRNLVKVF 333
            N+IG+ S  +VYKG L++G T + VKV NL    A   + F  E + L  ++HRNLVK+ 
Sbjct: 874  NIIGSSSLSTVYKGQLEDG-TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL 932

Query: 334  TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                G  ++    KALV  FM+NG+LE+ ++          AP   +LL+++++ + +AS
Sbjct: 933  ----GFAWESGKTKALVLPFMENGNLEDTIHG-------SAAPIG-SLLEKIDLCVHIAS 980

Query: 394  ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR---FLPPTHVQTSSIGVKGS 450
             +DYLH        HCDLKP+NILLD + V+HV DFG AR   F        S+   +G+
Sbjct: 981  GIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGT 1040

Query: 451  IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG--DMNLHNFAR------ 502
            IGY+APE+    +V+T  DV+S+GI+M+EL+ +++P+ +  E   DM L           
Sbjct: 1041 IGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNG 1100

Query: 503  ---------MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSK 553
                     M L D ++ +     + D   L +     + + R  ++ E L  ++++  K
Sbjct: 1101 RKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRP-DMNEILTHLMKLRGK 1159

Query: 554  A 554
            A
Sbjct: 1160 A 1160

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  275 bits (702), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 190/551 (34%), Positives = 270/551 (49%), Gaps = 86/551 (15%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL L SN+L+G +PP++ +  +L+      NFL GSIP SLG CESLT I +  N L+G+
Sbjct: 363 ILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGS 422

Query: 61  IPPQLMGLTSLVALDL-------------------------SRNQFRGSFPTEVGNLINL 95
           IP +L GL  L  ++L                         S NQ  GS P  +GNL  +
Sbjct: 423 IPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGV 482

Query: 96  ETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSG 144
           + L + GN   G IP  +G   +L  L+   N+F G           LT +DLSRN+LSG
Sbjct: 483 QKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSG 542

Query: 145 EIPEFLVGLKVIENLNLS------------------------YNDLEGMVPTEGVFKNAS 180
           +IP  L G+K++  LNLS                        YN+L G+VP+ G F   +
Sbjct: 543 DIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFN 602

Query: 181 AISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCW 240
             S +GN+ LCG      L PCG  K T       L     ++  L  L  ++  + +  
Sbjct: 603 YTSFVGNSHLCGPY----LGPCG--KGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAI 656

Query: 241 VRKRKEQSNPNSLINSLLNLSYQNLH----NATDGFSSANLIGTGSFGSVYKGVLDEGRT 296
           ++ R  ++   +    L   ++Q L     +  D     N+IG G  G VYKG + +G  
Sbjct: 657 IKARSLRNASEAKAWRLT--AFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDL 714

Query: 297 TVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQ 355
               ++  + H  +    F AE + L  IRHR++V++   CS      ++   LVYE+M 
Sbjct: 715 VAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-----HETNLLVYEYMP 769

Query: 356 NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN 415
           NGSL E L+         K   +L+   R  IA++ A  L YLHHDC P+  H D+K +N
Sbjct: 770 NGSLGEVLH--------GKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNN 821

Query: 416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGI 475
           ILLD    +HV DFGLA+FL  +        + GS GYIAPEY    +V    DVYS+G+
Sbjct: 822 ILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGV 881

Query: 476 LMLELIIRKKP 486
           ++LELI  KKP
Sbjct: 882 VLLELITGKKP 892

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  271 bits (692), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 192/585 (32%), Positives = 296/585 (50%), Gaps = 78/585 (13%)

Query: 2    LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
            + L  NR  G+IP  +GN   L    ++DN   G +P  +G+   L T+ + +N L+G +
Sbjct: 486  IELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEV 545

Query: 62   PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
            P ++     L  LD+  N F G+ P+EVG+L  LE L +S N L G IP  LG+  +L  
Sbjct: 546  PSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTE 605

Query: 122  LEMQGNVFQG--------LT----ILDLSRNKLSGEIPEFLVGLKVIE------------ 157
            L+M GN+F G        LT     L+LS NKL+GEIP  L  L ++E            
Sbjct: 606  LQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGE 665

Query: 158  ------------NLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGI--SEFKLPPCG 203
                          N SYN L G +P   + +N S  S +GN  LCG       +  P  
Sbjct: 666  IPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFA 722

Query: 204  LKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKR--------KEQSNPNSLIN 255
              +ST          +IAI + ++G    + I+ + ++ +R         +   P+ +  
Sbjct: 723  PSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSL 782

Query: 256  SLL-----NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---- 306
             +        ++Q+L  ATD F  + ++G G+ G+VYK VL  G T    K+ + H    
Sbjct: 783  DIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGN 842

Query: 307  HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
            ++    SF AE   L +IRHRN+VK+   C   ++QG++   L+YE+M  GSL E L+  
Sbjct: 843  NNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEILH-- 895

Query: 367  NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
                       NL+  +R  IA+  A  L YLHHDC+P   H D+K +NILLD++  +HV
Sbjct: 896  -------DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 948

Query: 427  GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            GDFGLA+ +   H ++ S  + GS GYIAPEY    +V+   D+YSYG+++LEL+  K P
Sbjct: 949  GDFGLAKVIDMPHSKSMS-AIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAP 1007

Query: 487  SDIMFEGDMNLHNFARMALPDHVMD--IVDSTLLNDVEDLAIISN 529
               + +G  ++ N+ R  +    +   ++D+ L   +ED  I+S+
Sbjct: 1008 VQPIDQGG-DVVNWVRSYIRRDALSSGVLDARL--TLEDERIVSH 1049

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  270 bits (689), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 199/555 (35%), Positives = 274/555 (49%), Gaps = 77/555 (13%)

Query: 1    ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            I  L  NRLSG IP  +G    LVE  +S+N L G IP+SL    +LT + L  N L+G+
Sbjct: 584  IFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGS 643

Query: 61   IP-----------------------PQLMGLT-SLVALDLSRNQFRGSFPTEVGNLINLE 96
            IP                       P+  GL  SLV L+L++N+  G  P  +GNL  L 
Sbjct: 644  IPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELT 703

Query: 97   TLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGE 145
             + +S N L GE+ S L +  KL  L ++ N F G           L  LD+S N LSGE
Sbjct: 704  HMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGE 763

Query: 146  IPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLK 205
            IP  + GL  +E LNL+ N+L G VP++GV ++ S   + GN +LCG +        G K
Sbjct: 764  IPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTK 823

Query: 206  KSTEW-----RLTFELKLVIAIVSGLMGLALTLSIS----------------------FL 238
              + W      L F + +V   V  L   A+T  +                       FL
Sbjct: 824  LRSAWGIAGLMLGFTI-IVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFL 882

Query: 239  CWVRKRKEQS-NPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTT 297
               R R+  S N       LL +   ++  ATD FS  N+IG G FG+VYK  L  G  T
Sbjct: 883  SGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACL-PGEKT 941

Query: 298  VTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNG 357
            V VK  +    + +R F+AE   L  ++H NLV +   CS      ++ K LVYE+M NG
Sbjct: 942  VAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCS-----FSEEKLLVYEYMVNG 996

Query: 358  SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417
            SL+ WL       EV      L+  +RL IA+  A  L +LHH   P   H D+K SNIL
Sbjct: 997  SLDHWLRNQTGMLEV------LDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNIL 1050

Query: 418  LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
            LD +    V DFGLAR +       S++ + G+ GYI PEYG  +  +T GDVYS+G+++
Sbjct: 1051 LDGDFEPKVADFGLARLISACESHVSTV-IAGTFGYIPPEYGQSARATTKGDVYSFGVIL 1109

Query: 478  LELIIRKKPSDIMFE 492
            LEL+  K+P+   F+
Sbjct: 1110 LELVTGKEPTGPDFK 1124

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  269 bits (687), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 182/520 (35%), Positives = 269/520 (51%), Gaps = 37/520 (7%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           + +  N+LSG +P     L        ++N L+GSIP S+     L+ + +  NN SG I
Sbjct: 416 IRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVI 475

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P +L  L  L  +DLSRN F GS P+ +  L NLE + +  N+L GEIPS++ SC +L  
Sbjct: 476 PVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTE 535

Query: 122 LEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
           L +  N  +G           L  LDLS N+L+GEIP  L+ LK +   N+S N L G +
Sbjct: 536 LNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLK-LNQFNVSDNKLYGKI 594

Query: 171 PTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLA 230
           P+ G  ++    S LGN  LC    +  + PC  K+ T + L   +  ++A+   L+ L 
Sbjct: 595 PS-GFQQDIFRPSFLGNPNLCAPNLD-PIRPCRSKRETRYILPISILCIVALTGALVWLF 652

Query: 231 LTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGV 290
           +     F     KRK +      I   +  + ++++      +  N+IG+G  G VY+  
Sbjct: 653 IKTKPLF-----KRKPKRTNKITIFQRVGFTEEDIYPQ---LTEDNIIGSGGSGLVYRVK 704

Query: 291 LDEGRTTVTVKVFNLHHHRASRS--FIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348
           L  G+T    K++     +      F +E   L  +RH N+VK+   C+     G +F+ 
Sbjct: 705 LKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCN-----GEEFRF 759

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LVYEFM+NGSL + L+     ++  +A   L+   R +IA+  A  L YLHHD  P   H
Sbjct: 760 LVYEFMENGSLGDVLH----SEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVH 815

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTH----VQTSSIGVKGSIGYIAPEYGLGSEV 464
            D+K +NILLD EM   V DFGLA+ L           S   V GS GYIAPEYG  S+V
Sbjct: 816 RDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKV 875

Query: 465 STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
           +   DVYS+G+++LELI  K+P+D  F  + ++  FA  A
Sbjct: 876 NEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEA 915

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  266 bits (680), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 192/550 (34%), Positives = 280/550 (50%), Gaps = 54/550 (9%)

Query: 2    LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
            L L +N  +G IPP IGNL K+V   +S N L G IP  LG C ++  + L  N  SG I
Sbjct: 504  LRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYI 563

Query: 62   PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +L  L  L  L LS N+  G  P   G+L  L  L + GN+L   IP  LG    L+I
Sbjct: 564  AQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQI 623

Query: 122  -LEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
             L +  N   G           L IL L+ NKLSGEIP  +  L  +   N+S N+L G 
Sbjct: 624  SLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGT 683

Query: 170  VPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTF-----ELKLVIAIVS 224
            VP   VF+   + +  GN+ LC        P   L   ++ +L +     + + ++ I  
Sbjct: 684  VPDTAVFQRMDSSNFAGNHGLCNSQRSHCQP---LVPHSDSKLNWLINGSQRQKILTITC 740

Query: 225  GLMGLALTLSISFLCWVRKRKE--------QSNPNSLINSLL---NLSYQNLHNATDGFS 273
             ++G    ++   LCW  KR+E        Q+ P+ + +        +YQ L +AT  FS
Sbjct: 741  IVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFS 800

Query: 274  SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVK 331
               ++G G+ G+VYK  +  G   + VK  N     AS   SF AE   L  IRHRN+VK
Sbjct: 801  EDVVLGRGACGTVYKAEMSGGEV-IAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVK 859

Query: 332  VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN--LNLLQRLNIAI 389
            ++  C    Y  N    L+YE+M  GSL E         ++ +  +N  L+   R  IA+
Sbjct: 860  LYGFC----YHQNS-NLLLYEYMSKGSLGE---------QLQRGEKNCLLDWNARYRIAL 905

Query: 390  DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
              A  L YLHHDC+P   H D+K +NILLDE   +HVGDFGLA+ +  ++ ++ S  V G
Sbjct: 906  GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAG 964

Query: 450  SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509
            S GYIAPEY    +V+   D+YS+G+++LELI  K P   + +G  +L N+ R ++ + +
Sbjct: 965  SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMI 1023

Query: 510  --MDIVDSTL 517
              +++ D+ L
Sbjct: 1024 PTIEMFDARL 1033

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	789
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.989	0.410	0.458	0.0
255581223	1015	receptor-kinase, putative [Ricinus commu	0.689	0.535	0.575	1e-176
359486510	965	PREDICTED: probable LRR receptor-like se	0.695	0.568	0.556	1e-171
255585471	963	serine-threonine protein kinase, plant-t	0.642	0.526	0.572	1e-163
224119022	1021	predicted protein [Populus trichocarpa]	0.688	0.531	0.539	1e-162
359482058	1040	PREDICTED: probable LRR receptor-like se	0.693	0.525	0.535	1e-160
224097752	1025	predicted protein [Populus trichocarpa]	0.694	0.534	0.536	1e-160
224119098	768	predicted protein [Populus trichocarpa]	0.680	0.699	0.524	1e-159
224113117	1006	predicted protein [Populus trichocarpa]	0.695	0.545	0.521	1e-159
224119106	919	predicted protein [Populus trichocarpa]	0.680	0.584	0.519	1e-158

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  717 bits (1850), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/900 (45%), Positives = 537/900 (59%), Gaps = 119/900 (13%)

Query: 4    LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
            L  N+LSG+IP S+GN+ +L   ++ +N L G IPSS G    L  + L  N+L+GTIP 
Sbjct: 463  LSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPE 522

Query: 64   QLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEIL 122
            ++M L SL ++L+L+RNQ  G  P+EV  L NL  L VS N L GEIP  LGSC+ LE L
Sbjct: 523  KVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHL 582

Query: 123  EMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
             M+GN F+G           L  LDLSRN LSG+IPEFL  L  + NLNLS+N+ EG +P
Sbjct: 583  HMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLP 641

Query: 172  TEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLAL 231
            T+GVF NA++ SV GNNKLCGGI E  LP C + K         LKL+I +++G +GL L
Sbjct: 642  TKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVL 701

Query: 232  TLSISFLCWVRKRKEQSNPNSLINS--LLNLSYQNLHNATDGFSSANLIGTGSFGSVYKG 289
             +S+  +  +R+ K + +  S  +   +LN+SY  L  AT GFSSANLIGTG FGSVYKG
Sbjct: 702  IMSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKG 761

Query: 290  VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349
             L +  T V VKV  LH   A +SF AEC ALR+IRHRNLVKV T CS VDYQGNDFKAL
Sbjct: 762  XLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKAL 821

Query: 350  VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC 409
            VYEFM NGSLE WL+PV   DE++   R L+L QRLNIAIDVASALDYLHH C     HC
Sbjct: 822  VYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHC 881

Query: 410  DLKPSNILLDEEMVSHVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLGSEV 464
            DLKPSNILLD +M +HVGDFGLARF+P         Q+SSIG+KG+IGY APEYG+G++V
Sbjct: 882  DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 941

Query: 465  STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLN----- 519
            S  GD YSYGIL+LE+   K+P++ MF   +NLHNF +MALP+ + DI+D   L+     
Sbjct: 942  SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 1001

Query: 520  ------DVEDLAIISNQRQ-----------------------------------RQIRVN 538
                  D  +LA +  ++                                    R+I + 
Sbjct: 1002 EETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1061

Query: 539  NIIE----------------CLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLK 582
            N I                 C    +    + Q+VT+L+L SL L GSI P IGNLSFL+
Sbjct: 1062 NGITDAPLRAMSSWNDSLHFCQWQGVSCSGRHQRVTVLNLHSLGLVGSIPPLIGNLSFLR 1121

Query: 583  ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGK 642
             +NL NNSF  E+P  +    R+Q+ +L NN + G+IP NLS CSN+  +GL  N   G+
Sbjct: 1122 TINLSNNSFQGEVPPVV----RMQILNLTNNWLEGQIPANLSXCSNMRILGLGNNNFWGE 1177

Query: 643  IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
            +PS+ GSLS +  L + +N+L G+I P  GNLSSLR +  A N L GSIP +L +L++LV
Sbjct: 1178 VPSELGSLSNMLQLFIDYNSLTGTIAPTFGNLSSLRVLVAASNELNGSIPHSLGRLQSLV 1237

Query: 703  ILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQ-------------- 748
             L L  N+LSG +P SI N++S+ +F V  N+++G++PLD   TL               
Sbjct: 1238 TLVLSTNQLSGTIPPSISNLTSLTQFGVAFNQLKGSLPLDLWSTLSKLRLFSVHQLKILF 1297

Query: 749  -------------------NLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
                                LQ+ S   N+I+G IP  I N + L       N+ TG +P
Sbjct: 1298 LSDNNFGGVLPNSLGNLSTQLQWLSFAANQISGNIPTGIGNLANLIALDMHKNQFTGSIP 1357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  625 bits (1613), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 327/568 (57%), Positives = 400/568 (70%), Gaps = 24/568 (4%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L  N+LSG IP S+GNL  L+     DN L+G IPSSL  CE+L  + L  NNLSG+
Sbjct: 421 VLHLFGNKLSGTIPSSLGNLTMLLTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGS 480

Query: 61  IPPQLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           IP Q+ GL+SL +ALDLS N F G  P EVGNL +LE L +S N+L G IP +LGSCIKL
Sbjct: 481 IPLQVFGLSSLSIALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKL 540

Query: 120 EILEMQGNVF-----------QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           E+L +QGN F           +GL +LD S N LSGEIPEFL    ++E+LNLSYN+ EG
Sbjct: 541 EVLALQGNFFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEG 600

Query: 169 MVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228
            VP EG+F+NAS   V+GN+KLCGGI EF L  C  K     +LT  LK+VI+ +  L+G
Sbjct: 601 RVPVEGIFRNASTTLVMGNDKLCGGIPEFHLAKCNAKSPK--KLTLLLKIVISTICSLLG 658

Query: 229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYK 288
           L+  L  +   W+RK+KE+   +   + LLN+S+Q+L  ATDGFSSANLIG GSFG VYK
Sbjct: 659 LSFILIFALTFWLRKKKEEPTSDPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYK 718

Query: 289 GVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348
           G LDEG  T+ VKV NL HH AS SFIAEC ALR+IRHRNLVKV TACSG+DYQGNDFKA
Sbjct: 719 GFLDEGNVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKA 778

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LVYE+M NGSLEEWL+P+ R +EV+  PR+LNLLQRLNIAIDVASALDYLH+ C     H
Sbjct: 779 LVYEYMVNGSLEEWLHPIPRTEEVE-PPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVH 837

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLGSE 463
           CDLKPSN+LLD EM  HV DFGLA+ L  +       Q+SSIGV+G++G+  PEYG+GS 
Sbjct: 838 CDLKPSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSN 897

Query: 464 VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           VST GDVYSYGIL+LEL   K+P+D MF+ D+NLHNFA +A  D + ++ D  LL +   
Sbjct: 898 VSTYGDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQETAV 957

Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIG 551
                N R+ Q     + ECL SMLRIG
Sbjct: 958 RETRLNSRKCQ----RLEECLFSMLRIG 981

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  607 bits (1566), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 316/568 (55%), Positives = 402/568 (70%), Gaps = 19/568 (3%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L  N+LSG +P S+GNL+ L++  +  N+ +G IPSSLG C++L  + L  NNLSGT
Sbjct: 356 VLMLIKNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGT 415

Query: 61  IPPQLMGLTSLVALDLSR-NQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           IPPQ++ L+SL        N+  G+ P EVGNL NL  L VS N+L G IPS++GSC  L
Sbjct: 416 IPPQVVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSL 475

Query: 120 EILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           E L M+GN FQG           + ILDLS N LSG+IPEFL  +   + +NLSYND EG
Sbjct: 476 EYLSMKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIH-FQLVNLSYNDFEG 534

Query: 169 MVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228
           ++PTEGVFKN SA S++GN+KLCGGI EF+LP C L++  +  L+  LK++IA VSGL+ 
Sbjct: 535 ILPTEGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLA 594

Query: 229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYK 288
           +   LS     W+RK+K +   +S   SLL +SYQ+L  ATDGFSS+NLIG GSFGSVYK
Sbjct: 595 ITCVLSFLIFLWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYK 654

Query: 289 GVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348
           G+LD   T + VKV NL    AS+SFIAEC ALR+IRHRNLVKV TACSGVDYQGNDFKA
Sbjct: 655 GILDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKA 714

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           +VYEFM NGSLE+WL+P     E    PR LN LQRLNIAIDVA ALDYLHH CQ    H
Sbjct: 715 VVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVH 774

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPT-----HVQTSSIGVKGSIGYIAPEYGLGSE 463
           CDLKPSN+LLD EM  HVGDFG+A+FLP        +Q+SSIG++G+IGY APEYG+GSE
Sbjct: 775 CDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSE 834

Query: 464 VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           VST+GDVYS+GIL+LE+   K+P++ MF+  +N+HNF + A+P+ V +I D  LL +  +
Sbjct: 835 VSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVE 894

Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIG 551
           +   ++QR R    ++  ECLIS+  IG
Sbjct: 895 MDNTTSQR-RMASSHDAQECLISIFGIG 921

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  583 bits (1502), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 303/529 (57%), Positives = 373/529 (70%), Gaps = 22/529 (4%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +LAL+SN LSG+IP S+GNL  L++  V DN L G IPS LG C+++  + L  NN SG+
Sbjct: 428 VLALNSNMLSGHIPSSLGNLTNLIQLLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGS 487

Query: 61  IPPQLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           IPP+++ ++SL + LDLS+N   G+ P EVGNL +L    VSGN L GEIP TLGSCI L
Sbjct: 488 IPPEVISISSLSIYLDLSQNNLTGTLPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISL 547

Query: 120 EILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNA 179
           EIL M GN FQGL             IP  L  L+ ++ L+LS N L GMVP++G+FKNA
Sbjct: 548 EILNMAGNNFQGL-------------IPSSLSSLRALQILDLSNNHLSGMVPSKGIFKNA 594

Query: 180 SAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLC 239
           SA SV GNN LCGGI EF+LP C   +  + RLT  LK VI+ +SG+  L L L   +L 
Sbjct: 595 SATSVEGNNMLCGGIPEFQLPVCNSARHKKNRLTPVLKTVISAISGMAFLILML---YLF 651

Query: 240 WVRKRK-EQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTV 298
           W R++K  ++  +     ++ LSYQNLH ATDGFSSAN+IG GSFGSVYKG LD   T +
Sbjct: 652 WFRQKKVNETTADFSEKKIMELSYQNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTLI 711

Query: 299 TVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGS 358
            VKVFNL      +SF+AEC ALR+IRHRNL+KV TACS +DY GNDFKALVYEFM NGS
Sbjct: 712 AVKVFNLMRRGGFKSFLAECEALRNIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNGS 771

Query: 359 LEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418
           LEEWL+P    +E +   R LN LQRLNIAIDVASAL YLHH C+P   HCDLKPSNILL
Sbjct: 772 LEEWLHPPVATNEAELETRKLNFLQRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILL 831

Query: 419 DEEMVSHVGDFGLARFLPPT----HVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYG 474
           DEE+  HVGDFGLARFL       + Q+SSIGV+G++GY  PEYG+ SEVST GDVYSYG
Sbjct: 832 DEELTGHVGDFGLARFLLDATQNHYTQSSSIGVRGTVGYAPPEYGMSSEVSTYGDVYSYG 891

Query: 475 ILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           IL+LE+   K+P D MF+   NLHNF + ALP+ V++IVD  LL ++E+
Sbjct: 892 ILLLEMFTGKRPMDDMFKDGFNLHNFVKAALPNQVVEIVDPNLLPEIEE 940

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa]

 Score =  578 bits (1490), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 306/567 (53%), Positives = 387/567 (68%), Gaps = 24/567 (4%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L LD N LSG IP S+GNL KL+  Y+ DN L+GSIPSSLG C+ L  + L  NNLSG I
Sbjct: 420 LVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDI 479

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           PP L G+ SL+ +  S+N F GS P E+G LINLE L VSGN+L GEIPS+LG CI LE 
Sbjct: 480 PPGLFGIFSLLYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLED 539

Query: 122 LEMQGNVF-----------QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
           L M  N F           +G+   + S N LSG+IPEF  G   +E L+LSYN+ EGM+
Sbjct: 540 LYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMI 599

Query: 171 PTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLA 230
           P EG+FKN++A+SV+GN++LCGG +E  LP C + +    RL  +LK+ I  ++ L+ LA
Sbjct: 600 PDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPK--RLKLKLKIAIFAITVLLALA 657

Query: 231 LTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGV 290
           L ++  FLC  R+++ +   +S+ N LL +SYQ L  AT+GFSS+NL+G GSFGSVYKG+
Sbjct: 658 LVVTCLFLCSSRRKRREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGM 717

Query: 291 LDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350
           LD+    + VKV NL    ASRSFIAEC ALR+IRHRNLVKV TACS +DY GNDFKA+V
Sbjct: 718 LDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIV 777

Query: 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD 410
           YEFM NGSLE+WL+P             LNLLQRLNIAIDVA AL+YLHH C+    HCD
Sbjct: 778 YEFMANGSLEDWLHPTGTGGGTTLT---LNLLQRLNIAIDVACALEYLHHHCEMPIAHCD 834

Query: 411 LKPSNILLDEEMVSHVGDFGLARFLP------PTHVQTSSIGVKGSIGYIAPEYGLGSEV 464
           LKPSN+LLD+E+  HVGDFGLA+FL       PT+ +++SIGV+G+IGY  PEYG+G EV
Sbjct: 835 LKPSNVLLDDELTGHVGDFGLAKFLSGASLDYPTN-ESTSIGVRGTIGYAPPEYGVGGEV 893

Query: 465 STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDL 524
           S  GD YSYGIL+LE+   K+P+D MF    NLHNF + A+P+ V  I D TLL + E  
Sbjct: 894 SAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQE-EPT 952

Query: 525 AIISNQRQRQIRVNNIIECLISMLRIG 551
                     +R +  +ECL S+LRIG
Sbjct: 953 GDDDKHEISSMRNSRPLECLNSILRIG 979

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 305/570 (53%), Positives = 384/570 (67%), Gaps = 23/570 (4%)

Query: 4    LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
            L  N+LSG+IP S+GN+ +L   ++ +N L G IPSS G    L  + L  N+L+GTIP 
Sbjct: 432  LSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPE 491

Query: 64   QLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEIL 122
            ++M L SL ++L+L+RNQ  G  P+EV  L NL  L VS N L GEIP  LGSC+ LE L
Sbjct: 492  KVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHL 551

Query: 123  EMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
             M+GN F+G           L  LDLSRN LSG+IPEFL  L  + NLNLS+N+ EG +P
Sbjct: 552  HMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLP 610

Query: 172  TEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLAL 231
            T+GVF NA++ SV GNNKLCGGI E  LP C + K         LKL+I +++G +GL L
Sbjct: 611  TKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVL 670

Query: 232  TLSISFLCWVRKRKEQSNPNSLINS--LLNLSYQNLHNATDGFSSANLIGTGSFGSVYKG 289
             +S+  +  +R+ K + +  S  +   +LN+SY  L  AT GFSSANLIGTG FGSVYKG
Sbjct: 671  IMSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKG 730

Query: 290  VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349
            +L +  T V VKV  LH   A +SF AEC ALR+IRHRNLVKV T CS VDYQGNDFKAL
Sbjct: 731  ILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKAL 790

Query: 350  VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC 409
            VYEFM NGSLE WL+PV   DE++   R L+L QRLNIAIDVASALDYLHH C     HC
Sbjct: 791  VYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHC 850

Query: 410  DLKPSNILLDEEMVSHVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLGSEV 464
            DLKPSNILLD +M +HVGDFGLARF+P         Q+SSIG+KG+IGY APEYG+G++V
Sbjct: 851  DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 910

Query: 465  STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLND---V 521
            S  GD YSYGIL+LE+   K+P++ MF   +NLHNF +MALP+ + DI+D   L+     
Sbjct: 911  SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 970

Query: 522  EDLAIISNQRQRQIRVNNIIECLISMLRIG 551
            E+     +     ++   + ECLIS+LRIG
Sbjct: 971  EETTAADSSNLAHMKREKMHECLISILRIG 1000

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 305/569 (53%), Positives = 401/569 (70%), Gaps = 21/569 (3%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +LAL  N++SGNIP S+GN+  L+E Y+S N L+G IPSSLG C++L  + L  NNLSG+
Sbjct: 423 VLALGGNKISGNIPSSMGNITSLLEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGS 482

Query: 61  IPPQLMGL-TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           IP +++ + +S   L LS NQ  GS P EVG L NL    +S N L GEIP TLGSC+ L
Sbjct: 483 IPKEVISIPSSSRILVLSENQLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSL 542

Query: 120 EILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           E L M+GN+FQG           L IL+LS N LSGEIP+FL  LK++ +L+LS+N+LEG
Sbjct: 543 EFLYMEGNLFQGPIPESLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEG 602

Query: 169 MVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228
            VP +G+F  AS  S+LGN KLCGG+ +  L  C  KKS + + + +LKL+IAI  G +G
Sbjct: 603 EVPVQGIFARASGFSMLGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVG 662

Query: 229 LALTLSISFLCWVRKRKEQSNPNSLINSLLN-LSYQNLHNATDGFSSANLIGTGSFGSVY 287
           + L +S     +++++K +    S   S    ++Y++L  AT+GFS ANLIG GSFGSVY
Sbjct: 663 IILVVSYMLFFFLKEKKSRPASGSPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVY 722

Query: 288 KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347
           KG+L      V VKVFNL    AS+SF+AEC AL +IRHRNLVKV TACSG+D+QGNDFK
Sbjct: 723 KGILRSDGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFK 782

Query: 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT 407
           ALVYEFM NGSLEEWL+P    DE  +  R+L+LLQRLNIAIDVASALDYLH+ CQ    
Sbjct: 783 ALVYEFMVNGSLEEWLHPAQISDEAHRR-RDLSLLQRLNIAIDVASALDYLHNHCQIAIV 841

Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHV----QTSSIGVKGSIGYIAPEYGLGS 462
           HCDLKPSN+LLD ++ +HVGDFGLAR LP  +H     QTSSIG+KG+IGY APEYGLGS
Sbjct: 842 HCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGS 901

Query: 463 EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVE 522
           EVS  GDVYSYGIL+LE+   ++P+D +F+  +NLHNFA+ ALP  V +++D  L+ + E
Sbjct: 902 EVSPYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAE 961

Query: 523 DLAIISNQRQRQIRVNNIIECLISMLRIG 551
           + +   +  +R   + N +ECL +++++G
Sbjct: 962 ETS--GDASRRMSHIGNHMECLAAIVKVG 988

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119098|ref|XP_002331324.1| predicted protein [Populus trichocarpa] gi|222873907|gb|EEF11038.1| predicted protein [Populus trichocarpa]

 Score =  570 bits (1469), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 298/568 (52%), Positives = 383/568 (67%), Gaps = 31/568 (5%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL L  N  SG+IP S+GNL KL+  Y++D  ++GSIPSSL  C  L  + L  N ++G+
Sbjct: 184 ILGLALNNFSGHIPSSLGNLTKLIGLYLNDINVQGSIPSSLANCNKLLELDLSGNYITGS 243

Query: 61  IPPQLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           +PP + GL+SL + LDLSRN   GS P EVGNL NLE   +SGN++ G+IPS+L  CI L
Sbjct: 244 MPPGIFGLSSLTINLDLSRNHLSGSLPKEVGNLENLEIFAISGNMISGKIPSSLAHCISL 303

Query: 120 EILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           + L +  N F+G           +   + S N LSG+IPEF    + +E L+LSYN+ EG
Sbjct: 304 QFLYLDANFFEGSVPSSLSTLRGIQEFNFSHNNLSGKIPEFFQDFRSLEILDLSYNNFEG 363

Query: 169 MVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228
           MVP  G+FKNA+A SV+GN+KLCGG  +F+LPPC  K     RL+ ++K+ I ++S L+ 
Sbjct: 364 MVPFRGIFKNATATSVIGNSKLCGGTPDFELPPCNFKHPK--RLSLKMKITIFVISLLLA 421

Query: 229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYK 288
           +A+ ++  FL W RK++ +  P+S  N LL +SYQ+L  AT+GFSS NLIGTGSFGSVYK
Sbjct: 422 VAVLITGLFLFWSRKKRREFTPSSDGNVLLKVSYQSLLKATNGFSSINLIGTGSFGSVYK 481

Query: 289 GVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348
           G LD     V VKV NL    AS+SF+AEC ALR++RHRNLVKV TACSGVDY GNDFKA
Sbjct: 482 GTLDHNGIAVAVKVLNLTRQGASKSFMAECEALRNVRHRNLVKVVTACSGVDYHGNDFKA 541

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LVYEFM NGSLE WL+P    DEV      L+L QRLNIAIDVA ALDYLHH C+    H
Sbjct: 542 LVYEFMVNGSLETWLHPSPATDEVRGI---LDLSQRLNIAIDVAHALDYLHHQCEKQIVH 598

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSE 463
           CDLKP N+LLD+EMV HVGDFGLA+FL    +      +SSIG++G+IGY  PEYG G+E
Sbjct: 599 CDLKPGNVLLDDEMVGHVGDFGLAKFLLEDTLHHSTNPSSSIGIRGTIGYAPPEYGAGNE 658

Query: 464 VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           VS  GDVYSYGIL+LE+   K+P+D +F G +NLH++ +  LP+ V+ I D TL      
Sbjct: 659 VSAYGDVYSYGILLLEMFTGKRPTDDLFNG-LNLHSYVKTFLPEKVLQIADPTLPQ---- 713

Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIG 551
                N     I  N ++ECL+S+   G
Sbjct: 714 ----INFEGNSIEQNRVLECLVSVFTTG 737

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  567 bits (1461), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 296/568 (52%), Positives = 397/568 (69%), Gaps = 19/568 (3%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L  N++SGNIP S+GN+  LVE Y+S N L+G IPSSL  C++L ++ L  NNLSG +
Sbjct: 405 LTLVENKISGNIPSSLGNVTSLVELYLSANNLQGGIPSSLANCQNLMSLKLAQNNLSGPL 464

Query: 62  PPQLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
             Q++G+ SL V+LDLS NQ  G  P+EVG L+NL  L VS N L GEIP +LGSCI LE
Sbjct: 465 TKQVIGMASLSVSLDLSHNQLIGPLPSEVGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLE 524

Query: 121 ILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
            L ++GN  QG           L  L+LS N L+G+IP FL   ++++ L+LS+N LEG 
Sbjct: 525 YLHLEGNFLQGSIPELLSSLRALQYLNLSYNNLTGQIPRFLADFQLLQRLDLSFNHLEGE 584

Query: 170 VPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGL 229
           +PT+ VF N SA+SVLGN+KLCGGIS+  L  C   +  + + + +LKLVI+I  G +  
Sbjct: 585 MPTQRVFGNVSAVSVLGNDKLCGGISQLNLSRCTSNELRKPKFSTKLKLVISIPCGFIIA 644

Query: 230 ALTLSISFL-CWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYK 288
            L +S   +  W + + E ++  S   S   ++Y+ L+ AT GFSS+N IG GSFGSVYK
Sbjct: 645 LLLISSLLIHSWRKTKNEPASGASWEVSFRRVTYEELYQATGGFSSSNFIGGGSFGSVYK 704

Query: 289 GVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348
            +L      V VKVFNL    AS+S++AEC AL +IRHRNLVK+ TACS +D++GNDFKA
Sbjct: 705 AILAPDGMIVAVKVFNLLRKGASKSYMAECAALINIRHRNLVKILTACSSLDFRGNDFKA 764

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LVYEFM NGSLEEWL+PV+  DE ++   NLNL+QRLN+AIDVASALDYLH+ CQ    H
Sbjct: 765 LVYEFMVNGSLEEWLHPVHTSDE-EREQGNLNLIQRLNVAIDVASALDYLHYHCQMAVVH 823

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSE 463
           CDLKPSN+LLD +M +HVGDFGLARF P   V     Q SSIG+KG++GY APEYG+G+E
Sbjct: 824 CDLKPSNVLLDGDMTAHVGDFGLARFRPEASVQLSSNQNSSIGLKGTVGYAAPEYGIGNE 883

Query: 464 VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           VST GDVYSYGIL+LE++  K P+D  F+  +NLH + +MALPD V+++VD  LL ++E 
Sbjct: 884 VSTYGDVYSYGILLLEILTGKTPTDGSFKEGLNLHKYVKMALPDRVVEVVDPILLREIEQ 943

Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIG 551
            +  ++   ++I  + ++ECL+S++ +G
Sbjct: 944 TSANASDGMKRIGNDKVLECLVSIMEVG 971

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119106|ref|XP_002331326.1| predicted protein [Populus trichocarpa] gi|222873909|gb|EEF11040.1| predicted protein [Populus trichocarpa]

 Score =  566 bits (1458), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 295/568 (51%), Positives = 382/568 (67%), Gaps = 31/568 (5%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL L  N  SG+IP S+GNL  L+  Y++D  ++GSIPSSL  C  L  + L  N ++G+
Sbjct: 335 ILGLALNNFSGDIPSSLGNLTNLIGLYLNDINVQGSIPSSLANCNKLLELDLSGNYITGS 394

Query: 61  IPPQLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           +PP + GL+SL + LDLSRN   GS P EVGNL NLE   +SGN++ G+IPS+L  CI L
Sbjct: 395 MPPGIFGLSSLTINLDLSRNHLSGSLPKEVGNLENLEIFAISGNMISGKIPSSLAHCISL 454

Query: 120 EILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           + L +  N F+G           +   + S N LSG+IPEF    K +E L+LSYN+ EG
Sbjct: 455 QFLYLDANFFEGSVPSSLSTLRGIQEFNFSHNNLSGKIPEFFQDFKSLEILDLSYNNFEG 514

Query: 169 MVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228
           MVP  G+FKNA+A SV+GN+KLCGG  +F+LPPC  K     RL+ ++K+ I ++S L+ 
Sbjct: 515 MVPFRGIFKNATATSVIGNSKLCGGTPDFELPPCNFKHPK--RLSLKMKITIFVISLLLA 572

Query: 229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYK 288
           +A+ ++  FL W RK++ +  P+S  N LL +SYQ+L  AT+GFSS NLIGTGSFGSVYK
Sbjct: 573 VAVLITGLFLFWSRKKRREFTPSSDGNVLLKVSYQSLLKATNGFSSINLIGTGSFGSVYK 632

Query: 289 GVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348
           G+LD   T V VKV NL    AS+SF+AEC AL ++RHRNLVKV TACSGVDY GNDFKA
Sbjct: 633 GILDHNGTAVAVKVLNLTRQGASKSFMAECEALPNVRHRNLVKVVTACSGVDYHGNDFKA 692

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LVYEFM NGSLE WL+P    DEV      L+L QRL+IAIDVA ALDY HH C+    H
Sbjct: 693 LVYEFMVNGSLETWLHPSRATDEVRGI---LDLTQRLSIAIDVAHALDYFHHQCEKQIVH 749

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSE 463
           CDLKP N+LLD+EMV HVGDFGLA+FL    +      +SSIG++G+IGY  PEYG G+E
Sbjct: 750 CDLKPGNVLLDDEMVGHVGDFGLAKFLLEDTLHHSTNPSSSIGIRGTIGYAPPEYGAGNE 809

Query: 464 VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           VS  GDVYSYGIL+LE+   K+P+D +F G +NLH++ +  LP+ V+ I D TL      
Sbjct: 810 VSAYGDVYSYGILLLEMFTGKRPTDDLFNG-LNLHSYVKTFLPEKVLQIADPTLPQ---- 864

Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIG 551
                N     I  N +++CL+S+   G
Sbjct: 865 ----INFEGNSIEQNRVLQCLVSIFTTG 888

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	789
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.655	0.512	0.460	2.2e-121
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.637	0.498	0.440	7.3e-114
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.680	0.523	0.444	2.9e-112
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.638	0.498	0.417	4.3e-109
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.698	0.537	0.409	7.5e-105
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.619	0.474	0.439	1.6e-104
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.462	0.727	0.452	7.4e-82
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.637	0.513	0.378	6.2e-78
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.480	0.466	0.431	7.5e-73
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.615	0.414	0.365	1.4e-72

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
 Identities = 248/539 (46%), Positives = 336/539 (62%)

Query:     2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L L SNR SG IP  IGNL +LV+ Y+S+N  +G +P SLG C  +  + +  N L+GTI
Sbjct:   415 LILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTI 474

Query:    62 PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
             P ++M + +LV L++  N   GS P ++G L NL  L +  N L G +P TLG C+ +E+
Sbjct:   475 PKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEV 534

Query:   122 LEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
             + +Q N F G          +  +DLS N LSG I E+      +E LNLS N+ EG VP
Sbjct:   535 IYLQENHFDGTIPDIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVP 594

Query:   172 TEGVFKNASAISVLGNNKLCGGISEFKLPPC-GLKKSTEWRLTFELKLVIAIVSGLMGLA 230
             TEG+F+NA+ +SV GN  LCG I E KL PC       E R    LK V   VS  + L 
Sbjct:   595 TEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALL 654

Query:   231 LTLSISFLCWVRKRKEQXXXXXXXXXXXXXXXXXXXX-----ATDGFSSANLIGTGSFGS 285
             L L I  L W +KRK                           ATDGFSS+N++G+GSFG+
Sbjct:   655 LLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGT 714

Query:   286 VYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345
             V+K +L      V VKV N+    A +SF+AEC +L+ IRHRNLVK+ TAC+ +D+QGN+
Sbjct:   715 VFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNE 774

Query:   346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPI 405
             F+AL+YEFM NGSL++WL+P   E E+ +  R L LL+RLNIAIDVAS LDYLH  C   
Sbjct:   775 FRALIYEFMPNGSLDKWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 833

Query:   406 TTHCDLKPSNILLDEEMVSHVGDFGLARFL-----PPTHVQTSSIGVKGSIGYIAPEYGL 460
               HCDLKPSNILLD+++ +HV DFGLAR L          Q SS GV+G+IGY APEYG+
Sbjct:   834 IAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGM 893

Query:   461 GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
             G + S +GDVYS+G+L+LE+   K+P++ +F G+  L+++ + ALP+ V+DI D ++L+
Sbjct:   894 GGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILH 952

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
 Identities = 234/531 (44%), Positives = 332/531 (62%)

Query:     2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L L +N   G +P S+GN   L+E ++ DN L G+IP  +   + L  + +  N+L G++
Sbjct:   438 LDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSL 497

Query:    62 PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
             P  +  L +L  L L  N+  G  P  +GN + +E+L + GN+  G+IP           
Sbjct:   498 PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP----------- 546

Query:   122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASA 181
              +++G V  G+  +DLS N LSG IPE+      +E LNLS+N+LEG VP +G+F+NA+ 
Sbjct:   547 -DLKGLV--GVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATT 603

Query:   182 ISVLGNNKLCGGISEFKLPPC-GLKKSTEWRLTFELKLVIAIVS-GLMGLALTLSISF-L 238
             +S++GNN LCGGI  F+L PC     S   + +  LK V+  VS G+  L L    S  L
Sbjct:   604 VSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTL 663

Query:   239 CWVRKRKEQXXX-----XXXXXXXXXXXXXXXXXATDGFSSANLIGTGSFGSVYKGVLDE 293
              W+RKRK+                          AT+GFSS+N++G+GSFG+VYK +L  
Sbjct:   664 IWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLT 723

Query:   294 GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEF 353
              +  V VKV N+    A +SF+AEC +L+ IRHRNLVK+ TACS +D+QGN+F+AL+YEF
Sbjct:   724 EKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEF 783

Query:   354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP 413
             M NGSL+ WL+P   E E+ +  R L LL+RLNIAIDVAS LDYLH  C     HCDLKP
Sbjct:   784 MPNGSLDMWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKP 842

Query:   414 SNILLDEEMVSHVGDFGLARFL-----PPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468
             SN+LLD+++ +HV DFGLAR L          Q SS GV+G+IGY APEYG+G + S NG
Sbjct:   843 SNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSING 902

Query:   469 DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
             DVYS+GIL+LE+   K+P++ +F G+  L+++ + ALP+ ++DIVD ++L+
Sbjct:   903 DVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH 953

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
 Identities = 253/569 (44%), Positives = 348/569 (61%)

Query:     1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
             +LA ++N LSG+IP +IGNL +L    +  N   G IP +L    +L ++GL  NNLSG 
Sbjct:   429 LLAYENN-LSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGP 487

Query:    61 IPPQLMGLTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
             IP +L  + +L + +++S+N   GS P E+G+L NL       N L G+IP+TLG C  L
Sbjct:   488 IPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLL 547

Query:   120 EILEMQGNVF-----------QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
               L +Q N+            +GL  LDLS N LSG+IP  L  + ++ +LNLS+N   G
Sbjct:   548 RYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVG 607

Query:   169 MVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228
              VPT G F  AS IS+ GN KLCGGI +  LP C      E R  F + L I+ VS    
Sbjct:   608 EVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCC--PLLENRKHFPV-LPIS-VSLAAA 663

Query:   229 LALTLSISFLC-WVRKRKEQXXXXXXXXXXXXXXXXXXXXATDGFSSANLIGTGSFGSVY 287
             LA+  S+  L  W ++ K+                     ATDGF+  NL+G+GSFGSVY
Sbjct:   664 LAILSSLYLLITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVY 723

Query:   288 KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347
             KG L+  +  V VKV  L + +A +SF AEC ALR++RHRNLVK+ T CS +D +GNDFK
Sbjct:   724 KGKLNI-QDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFK 782

Query:   348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH-HDCQPIT 406
             A+VY+FM NGSLE+W++P    D+ D+  R+LNL +R+ I +DVA ALDYLH H  +P+ 
Sbjct:   783 AIVYDFMPNGSLEDWIHP-ETNDQADQ--RHLNLHRRVTILLDVACALDYLHRHGPEPVV 839

Query:   407 THCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQ--TSSIGVKGSIGYIAPEYGLGS 462
              HCD+K SN+LLD +MV+HVGDFGLAR L    + +Q  TSS+G  G+IGY APEYG+G 
Sbjct:   840 -HCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGL 898

Query:   463 EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVE 522
               ST+GD+YSYGIL+LE++  K+P+D  F  D+ L  +  + L   V D+VD+ L+ D E
Sbjct:   899 IASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSE 958

Query:   523 DLAIISNQRQRQIRVNNIIECLISMLRIG 551
             +    +N          I EC++ +LR+G
Sbjct:   959 NWLNSTNNSP----CRRITECIVWLLRLG 983

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
 Identities = 222/532 (41%), Positives = 322/532 (60%)

Query:     1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
             IL L +N   G +PPS+G    +++  +  N L G+IP  +    +L  + +  N+LSG+
Sbjct:   438 ILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGS 497

Query:    61 IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
             +P  +  L +LV L L  N+F G  P  +GN + +E L + GN   G IP+  G      
Sbjct:   498 LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG------ 551

Query:   121 ILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNAS 180
                       G+  +DLS N LSG IPE+      +E LNLS N+  G VP++G F+N++
Sbjct:   552 --------LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNST 603

Query:   181 AISVLGNNKLCGGISEFKLPPC-GLKKSTEWRLTFELKLVIAIVSGLMGLALTLSIS--F 237
              + V GN  LCGGI + KL PC   +   E + +  LK V  +VS  + L L L I+   
Sbjct:   604 IVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMV 663

Query:   238 LCWVRKRKEQXXX-----XXXXXXXXXXXXXXXXXATDGFSSANLIGTGSFGSVYKGVLD 292
             LCW RKR++                          AT+GFSS+N++G+GSFG+V+K +L 
Sbjct:   664 LCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLP 723

Query:   293 EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352
                  V VKV N+    A +SF+AEC +L+  RHRNLVK+ TAC+  D+QGN+F+AL+YE
Sbjct:   724 TESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYE 783

Query:   353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK 412
             ++ NGS++ WL+P   E E+ + PR L LL+RLNI IDVAS LDYLH  C     HCDLK
Sbjct:   784 YLPNGSVDMWLHPEEVE-EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLK 842

Query:   413 PSNILLDEEMVSHVGDFGLARFL----PPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTN 467
             PSN+LL++++ +HV DFGLAR L      + + Q SS GV+G+IGY APEYG+G + S +
Sbjct:   843 PSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIH 902

Query:   468 GDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
             GDVYS+G+L+LE+   K+P+D +F G++ LH++ ++ALP+ V +I D  +L+
Sbjct:   903 GDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILH 954

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
 Identities = 245/598 (40%), Positives = 334/598 (55%)

Query:     2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L L +N   G+IP S+G+   L++  +  N L GSIP  L    SL  + +  N L G +
Sbjct:   454 LYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPL 513

Query:    62 PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
                +  L  L+ALD+S N+  G  P  + N ++LE L + GN   G IP   G       
Sbjct:   514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG------- 566

Query:   122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASA 181
                      GL  LDLS+N LSG IPE++     ++NLNLS N+ +G VPTEGVF+N SA
Sbjct:   567 -------LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSA 619

Query:   182 ISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG--LALTLSISFLC 239
             +SV GN  LCGGI   +L PC ++     R +   K++   VS +M   L L L + +LC
Sbjct:   620 MSVFGNINLCGGIPSLQLQPCSVELPR--RHSSVRKIITICVSAVMAALLLLCLCVVYLC 677

Query:   240 WVRKR---------KEQXXXXXXXXXXXXXXXXXXXXATDGFSSANLIGTGSFGSVYKGV 290
             W + R         +                       T GFSS+NLIG+G+FG+V+KG 
Sbjct:   678 WYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGF 737

Query:   291 LDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350
             L      V +KV NL    A++SFIAEC AL  IRHRNLVK+ T CS  D++GNDF+ALV
Sbjct:   738 LGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALV 797

Query:   351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD 410
             YEFM NG+L+ WL+P +  +E     R L L  RLNIAIDVASAL YLH  C     HCD
Sbjct:   798 YEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCD 856

Query:   411 LKPSNILLDEEMVSHVGDFGLARFL-----PPTHVQTSSIGVKGSIGYIAPEYGLGSEVS 465
             +KPSNILLD+++ +HV DFGLA+ L        H+Q SS GV+G+IGY APEYG+G   S
Sbjct:   857 IKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPS 916

Query:   466 TNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH-VMDIVDSTLLNDVEDL 524
               GDVYS+GI++LE+   K+P++ +F   + LH+F + AL     +DI D T+L      
Sbjct:   917 IMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL------ 970

Query:   525 AIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLK 582
                   R    +  N++ECL  + R+G    + + ++  S+  A S L  I   SF +
Sbjct:   971 ------RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRE-SFFR 1021

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
 Identities = 228/519 (43%), Positives = 306/519 (58%)

Query:     2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L L+SN   G IP S+G  + L++ ++  N L G+IP  +    SL  I L NN L+G  
Sbjct:   446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHF 505

Query:    62 PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
             P ++  L  LV L  S N+  G  P  +G  +++E L + GN   G IP  +   + L+ 
Sbjct:   506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLK- 563

Query:   122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASA 181
                  NV       D S N LSG IP +L  L  + NLNLS N  EG VPT GVF+NA+A
Sbjct:   564 -----NV-------DFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATA 611

Query:   182 ISVLGNNKLCGGISEFKLPPCGLKKSTEWR--LTFELKLVIAIVSGLMGLALTLSISFLC 239
             +SV GN  +CGG+ E +L PC ++ S   R  L+   K+V  I  G+  L L + ++ LC
Sbjct:   612 VSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLC 671

Query:   240 WVRKRKEQXXXXXXXXXXXXX--------XXXXXXXATDGFSSANLIGTGSFGSVYKGVL 291
             W  KRK++                            AT  FSS NLIG+G+FG+V+KG+L
Sbjct:   672 WFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLL 731

Query:   292 DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351
                   V VKV NL  H A++SF+AEC   + IRHRNLVK+ T CS +D +GNDF+ALVY
Sbjct:   732 GPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVY 791

Query:   352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411
             EFM  GSL+ WL   + E  V+   R+L   ++LNIAIDVASAL+YLH  C     HCD+
Sbjct:   792 EFMPKGSLDMWLQLEDLE-RVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDI 850

Query:   412 KPSNILLDEEMVSHVGDFGLARFL----PPTHV-QTSSIGVKGSIGYIAPEYGLGSEVST 466
             KPSNILLD+++ +HV DFGLA+ L      + + Q SS GV+G+IGY APEYG+G + S 
Sbjct:   851 KPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSI 910

Query:   467 NGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
              GDVYS+GIL+LE+   KKP+D  F GD NLH++ +  L
Sbjct:   911 QGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
 Identities = 178/393 (45%), Positives = 240/393 (61%)

Query:   126 GNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN--------DLEGMVPTEGVFK 177
             G   + +T LDL   KLSG I   +  L  + +LNL  N        + EG VPT+GVF+
Sbjct:    69 GRKQERVTSLDLGGFKLSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQ 128

Query:   178 NASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISF 237
             N + +SV GN  LCGG+ E +L PC   +S   +  F L   +A+  G+  L L + ++ 
Sbjct:   129 NGTTVSVFGNENLCGGVIEMQLKPC--IESPRQKKPFSLGEKVAVGVGVALLFLFIIVAS 186

Query:   238 LCWVRKRKEQXXXXXXXXXXXXXXXXXXXXATDGFSSANLIGTGSFGSVYKGVLDEGRTT 297
             L W +K+ ++                    AT GFSS+NLIG+G+F  V+KG+L      
Sbjct:   187 LSWFKKKNDKISYEELYN------------ATSGFSSSNLIGSGNFSDVFKGLLGLEEKL 234

Query:   298 VTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNG 357
             V VKV NL  H A++SFIAEC + + IRHRNL K+ T CS +D QGNDF+ALVYEFM  G
Sbjct:   235 VAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKG 294

Query:   358 SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417
             SL+ WL P + E   +   R+L   +++NIAIDVASAL+YLH  C     HCD+KPSN+L
Sbjct:   295 SLDMWLQPEDLES-ANNHSRSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVL 353

Query:   418 LDEEMVSHVGDFGLARFL----PPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYS 472
             LD+++ +HV DFGLAR L      T + Q SS GV+G+IGY APEYG+GS+ S  GDVYS
Sbjct:   354 LDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYS 413

Query:   473 YGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
             +G+L+LE+   KKP+D  F G  NLH + +  L
Sbjct:   414 FGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVL 446

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
 Identities = 207/547 (37%), Positives = 291/547 (53%)

Query:     1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
             +L +  N LSG+IP S GNL +L    +  N L G++P SLG C +L  + L +NNL+GT
Sbjct:   373 LLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGT 432

Query:    61 IPPQLMG-LTSL-VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
             IP +++  L +L + L+LS N   G  P E+  +  + ++ +S N L G+IP  LGSCI 
Sbjct:   433 IPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIA 492

Query:   119 LEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             LE L +  N F             L  LD+S N+L+G IP        +++LN S+N L 
Sbjct:   493 LEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLS 552

Query:   168 GMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLK-KSTEWRLTFELKLVIAIVSGL 226
             G V  +G F   +  S LG++ LCG I   +   C  K K     L   L L+   V  +
Sbjct:   553 GNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYPSVLLPVLLSLIATPVLCV 610

Query:   227 MGLALTLSISF---LCWVRKRK--EQXXXXXXXXXXXXXXXXXXXXATDGFSSANLIGTG 281
              G  L     F   L    K +  ++                    AT GF++++LIG+G
Sbjct:   611 FGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSG 670

Query:   282 SFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVD 340
              FG VYKGVL    T V VKV +       S SF  EC+ L+  RHRNL+++ T CS   
Sbjct:   671 RFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK-- 727

Query:   341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
               G  F ALV   M NGSLE  LYP       + + +NL+L+Q +NI  DVA  + YLHH
Sbjct:   728 -PG--FNALVLPLMPNGSLERHLYPG------EYSSKNLDLIQLVNICSDVAEGIAYLHH 778

Query:   401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH--VQTS---SIG-----VKGS 450
                    HCDLKPSNILLD+EM + V DFG++R +      V T    S G     + GS
Sbjct:   779 YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGS 838

Query:   451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM 510
             +GYIAPEYG+G   ST+GDVYS+G+L+LE++  ++P+D++     +LH F +   PD + 
Sbjct:   839 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLE 898

Query:   511 DIVDSTL 517
              I++  L
Sbjct:   899 GIIEQAL 905

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 736 (264.1 bits), Expect = 7.5e-73, P = 7.5e-73
 Identities = 174/403 (43%), Positives = 234/403 (58%)

Query:     2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L +D+N+L G++P +IGNL +L    V  N   G+IPS+LG    L  I L +NN  G I
Sbjct:   403 LTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQI 462

Query:    62 PPQLMGLTSLVA-LDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
             P ++  + +L   LD+S N   GS P E+G L N+       N L GE PST+G C  L+
Sbjct:   463 PIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQ 522

Query:   121 ILEMQGNVF-----------QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
              L +Q N             +GL  LDLS N LSG+IP  L  + ++ +LNLS+N   G 
Sbjct:   523 HLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGE 582

Query:   170 VPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLK--KSTEWRLTFELKLVIAIVSGLM 227
             VPT GVF NAS I + GN  +CGGI E  LP C LK  K  + ++   L +VI +VS L 
Sbjct:   583 VPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILL-LVVVICLVSTLA 641

Query:   228 GLALTLSISFLCWVRKRKEQXXXXXXXXXXXXXXXXXXXXATDGFSSANLIGTGSFGSVY 287
               +L L +   C  R++KE                     ATDGFSS++L+G+GSFGSVY
Sbjct:   642 VFSL-LYMLLTCHKRRKKE-VPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVY 699

Query:   288 KGVLD--EGRTT--VTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343
             KG  D  +G  T  V V+V  L   +A +SF AEC  LR+ RHRNLVK+ T CS +D +G
Sbjct:   700 KGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRG 759

Query:   344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             NDFKA+VY+FM NGSLE+WL+P    D+ ++  R+L L QR++
Sbjct:   760 NDFKAIVYDFMPNGSLEDWLHP-ETNDQAEQ--RHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 740 (265.6 bits), Expect = 1.4e-72, P = 1.4e-72
 Identities = 196/536 (36%), Positives = 286/536 (53%)

Query:     2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLF----NNNL 57
             L+L  N+ +G+IP S+ +L  L    +SDN L G+IP  L    SL  + L+    NN L
Sbjct:   580 LSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLL 637

Query:    58 SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
             +GTIP +L  L  +  +DLS N F GS P  +    N+ TL  S N L G IP  +   +
Sbjct:   638 TGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGM 697

Query:   118 KLEI-LEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
              + I L +  N F G           L  LDLS N L+GEIPE L  L  +++L L+ N+
Sbjct:   698 DMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNN 757

Query:   166 LEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLK-KSTEWRLTFELKLVIAIVS 224
             L+G VP  GVFKN +A  ++GN  LCG  S+  L PC +K KS+ +     + L+I   +
Sbjct:   758 LKGHVPESGVFKNINASDLMGNTDLCG--SKKPLKPCTIKQKSSHFSKRTRVILIILGSA 815

Query:   225 GLMGLALTLSISFLCWVRKRKEQXXXXXXXXXXXXXXXXXXXX-------ATDGFSSANL 277
               + L L L +   C  +K K+                            ATD F+SAN+
Sbjct:   816 AALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANI 875

Query:   278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS--FIAECRALRSIRHRNLVKVFTA 335
             IG+ S  +VYKG L++G T + VKV NL    A     F  E + L  ++HRNLVK+   
Sbjct:   876 IGSSSLSTVYKGQLEDG-TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL-- 932

Query:   336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
               G  ++    KALV  FM+NG+LE+ ++          AP   +LL+++++ + +AS +
Sbjct:   933 --GFAWESGKTKALVLPFMENGNLEDTIHG-------SAAPIG-SLLEKIDLCVHIASGI 982

Query:   396 DYLHHDCQ-PITTHCDLKPSNILLDEEMVSHVGDFGLARFL---PPTHVQTSSIGVKGSI 451
             DYLH     PI  HCDLKP+NILLD + V+HV DFG AR L          S+   +G+I
Sbjct:   983 DYLHSGYGFPIV-HCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTI 1041

Query:   452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG--DMNLHNFARMAL 505
             GY+APE+    +V+T  DV+S+GI+M+EL+ +++P+ +  E   DM L      ++
Sbjct:  1042 GYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSI 1097

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00029263001 SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (886 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	789
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-53
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-42
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-31
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-29
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-29
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-23
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-16
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-07
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.001
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.001
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.001
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.001
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.001
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.001
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.002
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.002
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.003
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.004
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.004
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  198 bits (505), Expect = 6e-53
 Identities = 167/581 (28%), Positives = 259/581 (44%), Gaps = 74/581 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L SN L G IP S+G  + L    + DN   G +PS       +  + + NNNL G I
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Query: 62  P-----------------------PQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETL 98
                                   P   G   L  LDLSRNQF G+ P ++G+L  L  L
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504

Query: 99  TVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGEIP 147
            +S N L GEIP  L SC KL  L++  N   G           L+ LDLS+N+LSGEIP
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564

Query: 148 EFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCG-LKK 206
           + L  ++ +  +N+S+N L G +P+ G F   +A +V GN  LCGG +   LPPC  ++K
Sbjct: 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK 624

Query: 207 STEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSN---PNSLINSLLNLSYQ 263
           +  W       L   +V  L+               KR E  +        +S ++ S  
Sbjct: 625 TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI- 683

Query: 264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS 323
            +++        N+I  G  G+ YKG   +      VK  N   +    S IA+   +  
Sbjct: 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGK 739

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           ++H N+VK+   C     +      L++E+++  +L E L             RNL+  +
Sbjct: 740 LQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVL-------------RNLSWER 781

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           R  IAI +A AL +LH  C P     +L P  I++D +   H+      R   P  + T 
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTD 835

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
           +     S  Y+APE     +++   D+Y +G++++EL+  K P+D  F    ++  +AR 
Sbjct: 836 TKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY 894

Query: 504 ALPDHVMDI-VDSTLLNDVEDLAIISNQRQRQIRVNNIIEC 543
              D  +D+ +D ++  DV       NQ +    +N  + C
Sbjct: 895 CYSDCHLDMWIDPSIRGDVS-----VNQNEIVEVMNLALHC 930

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  167 bits (424), Expect = 1e-42
 Identities = 92/230 (40%), Positives = 144/230 (62%), Gaps = 3/230 (1%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           L+L +    GSI P  G++  L+ L+L NN  + EIP++IG    L+V DL  N + G+I
Sbjct: 123 LNLSNNNFTGSI-PR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRK 679
           P +L++ ++L  + LA NQL+G+IP + G +  ++ + LG+NNL G IP  +G L+SL  
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 680 ISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNI 739
           + L  NNL G IP +L  LKNL  L+L  N+LSG +P SIF++  +   D+ +N + G I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 740 PLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           P +    LQNL+   + +N  TG IP ++++  +L+V Q  +NK +GE+P
Sbjct: 301 P-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  158 bits (400), Expect = 8e-40
 Identities = 93/235 (39%), Positives = 136/235 (57%), Gaps = 4/235 (1%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRL-RRLQVPDLNNNS 614
           +V  +DL    ++G I   I  L +++ +NL NN  +  IP +I      L+  +L+NN+
Sbjct: 70  RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
             G IP    S  NL  + L+ N L G+IP+D GS S ++VL LG N L+G IP  L NL
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187

Query: 675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK 734
           +SL  ++LA N L G IP  L ++K+L  +YLG N LSG +P  I  ++S+   D+  N 
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247

Query: 735 IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           + G IP   G  L+NLQY  +  N+++G IPPSI +  KL      +N L+GE+P
Sbjct: 248 LTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  140 bits (355), Expect = 6e-38
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G FG+VY     +    V +K+             + E   L+ + H N+VK++   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            GV ++  +   LV E+ + GSL++ L          +    L+  + L I + +   L+
Sbjct: 58  -GV-FEDENHLYLVMEYCEGGSLKDLL---------KENEGKLSEDEILRILLQILEGLE 106

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           YLH     I  H DLKP NILLD +     + DFGL++ L        +I   G+  Y+A
Sbjct: 107 YLHS--NGI-IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMA 161

Query: 456 PEYGLG-SEVSTNGDVYSYGILMLEL 480
           PE  LG    S   D++S G+++ EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  136 bits (346), Expect = 4e-36
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 27/251 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVKVFT 334
             +G GSFG VY     +    V +KV      +  R   + E + L+ ++H N+V+++ 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                 ++  D   LV E+ + G L + L          K    L+  +       + SA
Sbjct: 65  V-----FEDEDKLYLVMEYCEGGDLFDLL----------KKRGRLSEDEARFYLRQILSA 109

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           L+YLH   + I  H DLKP NILLDE+    + DFGLAR L P    T+ +   G+  Y+
Sbjct: 110 LEYLH--SKGIV-HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYM 163

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN-FARMALPDHVMDIV 513
           APE  LG       D++S G+++ EL+  K P    F GD  L   F ++  P       
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPP 219

Query: 514 DSTLLNDVEDL 524
           +  +  + +DL
Sbjct: 220 EWDISPEAKDL 230

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  132 bits (334), Expect = 1e-34
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG VYKG L    +   T V VK             F+ E   ++ + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C+    QG     +V E+M  G L ++L          K    L L   L +A+ +A
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQIA 112

Query: 393 SALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             ++YL   +      H DL   N L+ E +V  + DFGL+R +          G K  I
Sbjct: 113 KGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            ++APE     + ++  DV+S+G+L+ E+ 
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  141 bits (356), Expect = 2e-34
 Identities = 78/231 (33%), Positives = 124/231 (53%), Gaps = 1/231 (0%)

Query: 559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           +LDL    L G I   + NL+ L+ L L +N    +IP E+G+++ L+   L  N++ GE
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227

Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
           IP  +   ++L  + L  N L G IPS  G+L  ++ L L  N L G IPP + +L  L 
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287

Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
            + L+ N+L+G IP  + +L+NL IL+L  N  +G +P ++ ++  +    +  NK  G 
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347

Query: 739 IPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           IP + G    NL    + TN +TG IP  + ++  L      +N L GE+P
Sbjct: 348 IPKNLG-KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  131 bits (331), Expect = 4e-34
 Identities = 70/250 (28%), Positives = 107/250 (42%), Gaps = 23/250 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G+GSFG+VYK         V VK+        +  ++   E R LR + H N+V++   
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                   +    LV E+ + G L ++L               L+  +   IA+ +   L
Sbjct: 65  --DAFEDKDHL-YLVMEYCEGGDLFDYL----------SRGGPLSEDEAKKIALQILRGL 111

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YLH     I  H DLKP NILLDE  V  + DFGLA+ L      +S     G+  Y+A
Sbjct: 112 EYLHS--NGII-HRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMA 166

Query: 456 PE-YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD 514
           PE    G+      DV+S G+++ EL+  K P       D        +  P    +   
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW 226

Query: 515 STLLNDVEDL 524
           S+   + +DL
Sbjct: 227 SSGSEEAKDL 236

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  126 bits (319), Expect = 2e-32
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)

Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
             +G G+FG VYKG L   D   T V VK          R  F+ E R ++ + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 332 VFTACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           +   C+  +  Y       LV E+M+ G L ++L   +R          L+L   L+ AI
Sbjct: 61  LLGVCTEEEPLY-------LVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
            +A  ++YL    +    H DL   N L+ E++V  + DFGL+R +          G K 
Sbjct: 113 QIAKGMEYLAS--KKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            I ++APE       ++  DV+S+G+L+ E+
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  126 bits (318), Expect = 2e-32
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G+FG VYKG L    D     V VK             F+ E R +R + H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C+  +        +V E+M  G L ++L            P+ L+L   L+ A+ +A
Sbjct: 67  LGVCTEEEPL-----MIVMEYMPGGDLLDYL--------RKNRPKELSLSDLLSFALQIA 113

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
             ++YL    +    H DL   N L+ E +V  + DFGL+R L          G K  I 
Sbjct: 114 RGMEYLES--KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIR 169

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           ++APE     + ++  DV+S+G+L+ E+
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (306), Expect = 7e-31
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 25/209 (11%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G+FG VYKG L     + +  V VK             F+ E R +R + H N+VK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR-NLNLLQRLNIAIDV 391
              C+  +        +V E+M+ G L  +L          +  R  L+L   L+ A+ +
Sbjct: 67  LGVCTEEEPL-----YIVMEYMEGGDLLSYL----------RKNRPKLSLSDLLSFALQI 111

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A  ++YL    +    H DL   N L+ E +V  + DFGL+R L          G K  I
Sbjct: 112 ARGMEYLES--KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPI 167

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            ++APE     + ++  DV+S+G+L+ E+
Sbjct: 168 RWMAPESLKEGKFTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  126 bits (317), Expect = 1e-29
 Identities = 82/235 (34%), Positives = 126/235 (53%), Gaps = 2/235 (0%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
           QK+  LDL    L+G I   +  L  L+IL+L +N+FT +IP  +  L RLQV  L +N 
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
             GEIP NL   +NL  + L+ N L G+IP    S   +  L L  N+L G IP  LG  
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403

Query: 675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK 734
            SLR++ L  N+ +G +P   +KL  +  L +  N L G + S  +++ S+    +  NK
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463

Query: 735 IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
             G +P  +G   + L+   +  N+ +GA+P  + + S+L   +   NKL+GE+P
Sbjct: 464 FFGGLPDSFG--SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  124 bits (314), Expect = 3e-29
 Identities = 83/261 (31%), Positives = 126/261 (48%), Gaps = 26/261 (9%)

Query: 553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDL-- 610
           + Q + IL L S    G I   + +L  L++L L +N F+ EIP  +G+   L V DL  
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365

Query: 611 NN----------------------NSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFG 648
           NN                      NS+ GEIP +L +C +L R+ L  N   G++PS+F 
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425

Query: 649 SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV 708
            L  +  L +  NNL G I     ++ SL+ +SLA N   G +P      K L  L L  
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSR 484

Query: 709 NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI 768
           N+ SG VP  + ++S + +  + ENK+ G IP +   + + L    +  N+++G IP S 
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS-SCKKLVSLDLSHNQLSGQIPASF 543

Query: 769 SNASKLEVFQALNNKLTGEVP 789
           S    L       N+L+GE+P
Sbjct: 544 SEMPVLSQLDLSQNQLSGEIP 564

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  118 bits (296), Expect = 4e-27
 Identities = 81/231 (35%), Positives = 109/231 (47%), Gaps = 3/231 (1%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           LDL    L G I   +GNL  L+ L L  N  +  IP  I  L++L   DL++NS+ GEI
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRK 679
           P  +    NL  + L  N   GKIP    SL +++VL L  N   G IP  LG  ++L  
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 680 ISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNI 739
           + L+ NNL G IP  L    NL  L L  N L G +P S+    S+    + +N   G +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 740 PLDYGFTLQNLQYF-SIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           P    FT   L YF  I  N + G I     +   L++     NK  G +P
Sbjct: 421 P--SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  117 bits (295), Expect = 5e-27
 Identities = 78/194 (40%), Positives = 100/194 (51%), Gaps = 13/194 (6%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L  N L G IP S+ NL  L    ++ N L G IP  LG  +SL  I L  NNLSG 
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           IP ++ GLTSL  LDL  N   G  P+ +GNL NL+ L +  N L G IP ++ S     
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS----- 282

Query: 121 ILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNAS 180
                    Q L  LDLS N LSGEIPE ++ L+ +E L+L  N+  G +P         
Sbjct: 283 --------LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334

Query: 181 AISVLGNNKLCGGI 194
            +  L +NK  G I
Sbjct: 335 QVLQLWSNKFSGEI 348

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  116 bits (293), Expect = 9e-27
 Identities = 81/236 (34%), Positives = 117/236 (49%), Gaps = 5/236 (2%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
            +  L L S +L G I   +G +  LK + L  N+ + EIP EIG L  L   DL  N++
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
            G IP +L +  NL  + L +N+L G IP    SL K+  L L  N+L G IP  +  L 
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
           +L  + L  NN  G IP  L+ L  L +L L  N+ SG +P ++   +++   D+  N +
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368

Query: 736 QGNIP--LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            G IP  L     L  L  FS   N + G IP S+     L   +  +N  +GE+P
Sbjct: 369 TGEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421

Length = 968

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 24/204 (11%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            IG G FG V  G    G+  V VK        A+++F+AE   + ++RH NLV++    
Sbjct: 13  TIGKGEFGDVMLGDY-RGQK-VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLL--- 66

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            GV  QGN    +V E+M  GSL ++L   +R   V      + L Q+L  A+DV   ++
Sbjct: 67  -GVVLQGNPL-YIVTEYMAKGSLVDYLR--SRGRAV------ITLAQQLGFALDVCEGME 116

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL  + +    H DL   N+L+ E++V+ V DFGLA+              K  + + AP
Sbjct: 117 YL--EEKNFV-HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAP 168

Query: 457 EYGLGSEVSTNGDVYSYGILMLEL 480
           E     + ST  DV+S+GIL+ E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 4e-25
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 29/209 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS---FIAECRALRSIRHRNLVKVFT 334
           +G G FG V+ G  + G T V VK         + S   F+ E + ++ +RH  LV+++ 
Sbjct: 14  LGAGQFGEVWMGTWN-GTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 335 ACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
            CS  +  Y       +V E+M  GSL ++L    +  E     + L L Q +++A  +A
Sbjct: 69  VCSEEEPIY-------IVTEYMSKGSLLDFL----KSGE----GKKLRLPQLVDMAAQIA 113

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
             + YL         H DL   NIL+ E +V  + DFGLAR +      T+  G K  I 
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIK 169

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + APE       +   DV+S+GIL+ E++
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  103 bits (258), Expect = 2e-24
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 20/214 (9%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVF 333
            L+G GSFGSVY  +  +    + VK   L         +   E R L S++H N+V+ +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 334 TACSGVDYQ-GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               G +     +   +  E++  GSL   L    +  E         ++++      + 
Sbjct: 66  ----GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--------PVIRKY--TRQIL 111

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
             L YLH     +  H D+K +NIL+D + V  + DFG A+ L        +  V+G+  
Sbjct: 112 EGLAYLH-SNGIV--HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           ++APE   G E     D++S G  ++E+   K P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  102 bits (257), Expect = 2e-24
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVFTAC 336
           +G GS G VYK           +K  ++      R  +  E + LRS     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G  Y+  +  ++V E+M  GSL + L  V +  E   A           IA  +   LD
Sbjct: 65  YGAFYKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLA----------YIARQILKGLD 113

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YLH     I  H D+KPSN+L++ +    + DFG+++ L  T  Q ++    G++ Y++P
Sbjct: 114 YLHTKRHII--HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSP 169

Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           E   G   S   D++S G+ +LE  + K P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V++G+ +   T V VK            F+AE + ++ +RH  L++++  C+
Sbjct: 14  LGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 338 GVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             +  Y       +V E M+ GSL E+L           A R L L Q +++A  VAS +
Sbjct: 72  LEEPIY-------IVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQVASGM 116

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            YL         H DL   N+L+ E  +  V DFGLAR +    +  +  G K  I + A
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTA 172

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELI 481
           PE  L +  S   DV+S+GIL+ E++
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  106 bits (266), Expect = 1e-23
 Identities = 72/208 (34%), Positives = 119/208 (57%), Gaps = 2/208 (0%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           L L S  L G I   +G    L+ + L++NSF+ E+PSE  +L  +   D++NN++ G I
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRK 679
                   +L  + LA+N+  G +P  FGS  ++E L L  N   G++P  LG+LS L +
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQ 503

Query: 680 ISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNI 739
           + L+ N L+G IP  LS  K LV L L  N+LSG +P+S   +  +++ D+ +N++ G I
Sbjct: 504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI 563

Query: 740 PLDYGFTLQNLQYFSIGTNRITGAIPPS 767
           P + G  +++L   +I  N + G++P +
Sbjct: 564 PKNLG-NVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (262), Expect = 5e-23
 Identities = 86/255 (33%), Positives = 114/255 (44%), Gaps = 62/255 (24%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L  N+LSG IPPSI +L+KL+   +SDN L G IP  +   ++L  + LF+NN +G I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL---------------ETLTVSGNI-- 104
           P  L  L  L  L L  N+F G  P  +G   NL               E L  SGN+  
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384

Query: 105 -------LQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGEI 146
                  L+GEIP +LG+C  L  + +Q N F G           +  LD+S N L G I
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Query: 147 P-----------------EFLVGL------KVIENLNLSYNDLEGMVPTEGVFKNASAIS 183
                             +F  GL      K +ENL+LS N   G VP +    + S + 
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK--LGSLSELM 502

Query: 184 V--LGNNKLCGGISE 196
              L  NKL G I +
Sbjct: 503 QLKLSENKLSGEIPD 517

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 71/231 (30%), Positives = 112/231 (48%), Gaps = 31/231 (13%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    +G+G FG V++G L + R  V +K+         + F  E +AL+ +RH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 332 VFTACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           +F  CS  +  Y       ++ E M+ GSL  +L    R  E     + L +   +++A 
Sbjct: 67  LFAVCSVGEPVY-------IITELMEKGSLLAFL----RSPE----GQVLPVASLIDMAC 111

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS--IGV 447
            VA  + YL  + Q    H DL   NIL+ E++V  V DFGLAR +      +S   I  
Sbjct: 112 QVAEGMAYL--EEQNSI-HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY 168

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
           K    + APE       ST  DV+S+GIL+ E+    +   + + G MN H
Sbjct: 169 K----WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ---VPYPG-MNNH 211

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 95.7 bits (239), Expect = 5e-22
 Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 20/215 (9%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F     IG G FG VYK         V +KV  L         I E + L+  +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
            + +     Y   D   +V EF   GSL         +D +    + L   Q   +  ++
Sbjct: 62  YYGS-----YLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKEL 107

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
              L+YL H    I  H D+K +NILL  +    + DFGL+  L  T  + + +   G+ 
Sbjct: 108 LKGLEYL-HSNGII--HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTP 161

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            ++APE   G       D++S GI  +EL   K P
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =   99 bits (249), Expect = 2e-21
 Identities = 67/170 (39%), Positives = 88/170 (51%), Gaps = 13/170 (7%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L  N L+G IP S+GNLK L   ++  N L G IP S+   + L ++ L +N+LSG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  ++ L +L  L L  N F G  P  + +L  L+ L +  N   GEIP  LG       
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK------ 354

Query: 122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
                N    LT+LDLS N L+GEIPE L     +  L L  N LEG +P
Sbjct: 355 ---HNN----LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 3e-21
 Identities = 71/206 (34%), Positives = 104/206 (50%), Gaps = 16/206 (7%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSL-GLCESLTTIGLFNNNLSGT 60
           + L    +SG I  +I  L  +    +S+N L G IP  +     SL  + L NNN +G+
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           IP     + +L  LDLS N   G  P ++G+  +L+ L + GN+L G+IP++L +   LE
Sbjct: 134 IPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191

Query: 121 ILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
            L +  N   G           L  + L  N LSGEIP  + GL  + +L+L YN+L G 
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251

Query: 170 VPTE-GVFKNASAISVLGNNKLCGGI 194
           +P+  G  KN   +  L  NKL G I
Sbjct: 252 IPSSLGNLKNLQYL-FLYQNKLSGPI 276

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.4 bits (245), Expect = 5e-21
 Identities = 71/185 (38%), Positives = 90/185 (48%), Gaps = 14/185 (7%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCES--LTTIGLFNNNLS 58
           +L L SN+ SG IP ++G    L    +S N L G IP   GLC S  L  + LF+N+L 
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE--GLCSSGNLFKLILFSNSLE 393

Query: 59  GTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
           G IP  L    SL  + L  N F G  P+E   L  +  L +S N LQG I S       
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453

Query: 119 LEILEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           L++L +  N F G          L  LDLSRN+ SG +P  L  L  +  L LS N L G
Sbjct: 454 LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG 513

Query: 169 MVPTE 173
            +P E
Sbjct: 514 EIPDE 518

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 95.2 bits (235), Expect = 7e-21
 Identities = 89/403 (22%), Positives = 144/403 (35%), Gaps = 44/403 (10%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH-RNLVKV 332
            +G GSFG VY       R  V +KV         +    F+ E + L S+ H  N+VK+
Sbjct: 7   KLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +       +Q      LV E++  GSLE+ L       +       L+  + L I   + 
Sbjct: 64  YDF-----FQDEGSLYLVMEYVDGGSLEDLL-------KKIGRKGPLSESEALFILAQIL 111

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLP----PTHVQTSSIGV 447
           SAL+YLH        H D+KP NILLD +  V  + DFGLA+ LP     + +       
Sbjct: 112 SALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168

Query: 448 KGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
            G+ GY+APE  LG      S++ D++S GI + EL+    P    FEG+ N        
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSA----- 219

Query: 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLES 564
                       +L                  ++     L+  L       +++     S
Sbjct: 220 -----TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Query: 565 LKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLS 624
             L   +     +LS L   +          PS    +  L    ++ + +  +      
Sbjct: 275 HDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSK 334

Query: 625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSI 667
             +         N     + +     S +  +S   +    S 
Sbjct: 335 ELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSPSSLSS 377

Length = 384

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 8e-21
 Identities = 70/233 (30%), Positives = 106/233 (45%), Gaps = 31/233 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFTAC 336
           +G+G FG V+ G   + R  + V +  +     S   FI E + +  + H NLV+++  C
Sbjct: 12  LGSGQFGVVHLG---KWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           +    Q   F  +V E+M NG L  +L    RE         L     L++  DV  A++
Sbjct: 69  T---KQRPIF--IVTEYMANGCLLNYL----RER-----KGKLGTEWLLDMCSDVCEAME 114

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL  +      H DL   N L+ E+ V  V DFGLAR++      TSS G K  + +  P
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAPP 170

Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509
           E    S  S+  DV+S+G+LM E         +  EG M    F+   + + V
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWE---------VFSEGKMPYERFSNSEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 9e-21
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 14  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L          +  + L L Q +++A  +AS + Y
Sbjct: 72  ------EEPIYIVTEYMSKGSLLDFLK--------GEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 173

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  SF+ E + ++ +RH  LV+++   S
Sbjct: 14  LGNGQFGEVWMGTWN-GNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L         D   R L L   +++A  VA+ + Y
Sbjct: 72  ------EEPIYIVTEYMSKGSLLDFLK--------DGEGRALKLPNLVDMAAQVAAGMAY 117

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ + +V  + DFGLAR +      T+  G K  I + APE
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPE 173

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL+ + +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           + +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C+    +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA+
Sbjct: 71  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 117

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YL         H DL   N L+ E  +  V DFGL+R +      T+  G K  I + A
Sbjct: 118 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 173

Query: 456 PEYGLGSEVSTNGDVYSYGILMLEL 480
           PE    ++ S   DV+++G+L+ E+
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 276 NLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V +G L   G+  + V +  L      +    F+ E   +    H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      ++ E+M+NGSL+++L    RE++         + Q + +   +
Sbjct: 70  L----EGVVTKSRPV-MIITEYMENGSLDKFL----REND-----GKFTVGQLVGMLRGI 115

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           AS + YL         H DL   NIL++  +V  V DFGL+R L  +    ++ G K  I
Sbjct: 116 ASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE     + ++  DV+S+GI+M E++
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 32/226 (14%)

Query: 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHR 327
            F    +IG G+FG V      + +    +K  N        + R+ + E R L+ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
            LV ++ +     +Q  +   LV + +  G L    Y ++++ +  +             
Sbjct: 61  FLVNLWYS-----FQDEENMYLVVDLLLGGDLR---YHLSQKVKFSEEQVKF-------W 105

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
             ++  AL+YLH   + I  H D+KP NILLDE+   H+ DF +A  + P    T +   
Sbjct: 106 ICEIVLALEYLHS--KGII-HRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTST 159

Query: 448 KGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489
            G+ GY+APE     G    V    D +S G+   E +  K+P   
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 71/247 (28%), Positives = 102/247 (41%), Gaps = 33/247 (13%)

Query: 276 NLIGTGSFGSVYKGVLD--EGRTT--VTVKVFNLHHHRASRS-FIAECRALRSIRHRNLV 330
             +G G FG V     D     T   V VK  N       RS F  E   LR++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K    C      G     L+ E++ +GSL ++L   +R+         +NL + L  +  
Sbjct: 70  KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYL-QRHRD--------QINLKRLLLFSSQ 117

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +   +DYL    + I  H DL   NIL++ E +  + DFGLA+ LP             S
Sbjct: 118 ICKGMDYLG-SQRYI--HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH---NFARMALP 506
            I + APE    S+ S+  DV+S+G+ + EL            GD +      F RM   
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY---------GDPSQSPPAEFLRMIGI 225

Query: 507 DHVMDIV 513
                IV
Sbjct: 226 AQGQMIV 232

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.1 bits (234), Expect = 1e-19
 Identities = 69/182 (37%), Positives = 95/182 (52%), Gaps = 15/182 (8%)

Query: 2   LALDSNRLSGNIPP-SIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           L L +N  +G+IP  SI NL+ L    +S+N L G IP+ +G   SL  + L  N L G 
Sbjct: 123 LNLSNNNFTGSIPRGSIPNLETL---DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           IP  L  LTSL  L L+ NQ  G  P E+G + +L+ + +  N L GEIP  +G    L 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 121 ILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
            L++  N   G           L  L L +NKLSG IP  +  L+ + +L+LS N L G 
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 170 VP 171
           +P
Sbjct: 300 IP 301

Length = 968

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 20/203 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G FG V+ G   E +  V +K        +   FI E + +  + H  LV+++  C+
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                      LV+EFM++G L ++L    R      +   L     L + +DV   + Y
Sbjct: 70  E-----RSPICLVFEFMEHGCLSDYL----RAQRGKFSQETL-----LGMCLDVCEGMAY 115

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +PE
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPE 171

Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               S+ S+  DV+S+G+LM E+
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 2e-19
 Identities = 52/136 (38%), Positives = 76/136 (55%), Gaps = 1/136 (0%)

Query: 559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           +L L   K  G  LP       L+ L+L  N F+  +P ++G L  L    L+ N + GE
Sbjct: 456 MLSLARNKFFGG-LPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514

Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
           IP  LSSC  L+ + L+ NQL G+IP+ F  +  +  L L  N L G IP  LGN+ SL 
Sbjct: 515 IPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574

Query: 679 KISLAINNLAGSIPFT 694
           +++++ N+L GS+P T
Sbjct: 575 QVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 276 NLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKV 332
           N IG G+FG VY  V LD G   + VK   +     +  +    E + L  ++H NLVK 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 333 FTACSGVDYQGNDFKALVYEFM---QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           +    GV+         VY FM     G+LEE L      DE        ++++     +
Sbjct: 65  Y----GVEVHREK----VYIFMEYCSGGTLEELLEHGRILDE--------HVIRVY--TL 106

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGV 447
            +   L YLH     I  H D+KP+NI LD   V  +GDFG A  L    T +      +
Sbjct: 107 QLLEGLAYLHS--HGIV-HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163

Query: 448 KGSIGYIAPEYGLGSEVSTNG---DVYSYGILMLELIIRKKP 486
            G+  Y+APE   G +   +G   D++S G ++LE+   K+P
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNL 329
           +   +LIG G+FG VYKG+  E    V +K  +L   +    +S + E   L++++H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR--EDEVDKAPRNLNLLQRLNI 387
           VK   +      + +D   ++ E+ +NGSL + +       E  V               
Sbjct: 62  VKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ--------- 107

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              V   L YLH   Q +  H D+K +NIL  ++ V  + DFG+A  L       +S  V
Sbjct: 108 ---VLQGLAYLHE--QGV-IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--V 159

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+  ++APE    S  ST  D++S G  ++EL+    P
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 34/217 (15%)

Query: 277 LIGTGSFGSVYKGVLDE-GRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK- 331
           +IG G FG V +G L   G+  + V +  L   +  +  R F++E   +    H N++  
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 332 --VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
             V T    V         ++ EFM+NG+L+ +L    R+++         ++Q + +  
Sbjct: 71  EGVVTKSRPV--------MIITEFMENGALDSFL----RQND-----GQFTVIQLVGMLR 113

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----PTHVQTSS 444
            +A+ + YL    +    H DL   NIL++  +V  V DFGL+RFL      PT+  TSS
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSS 168

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +G K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.9 bits (215), Expect = 6e-19
 Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 35/224 (15%)

Query: 257 LLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA 316
           LLNL    L           +IG G FG+V +G      T   V V N+     +++F+ 
Sbjct: 2   LLNLQKLTL---------GEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDVTAQAFLE 48

Query: 317 ECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAP 376
           E   +  + H+NLV++      + + G     +V E M  G+L  +L    R        
Sbjct: 49  ETAVMTKLHHKNLVRLLGV---ILHNG---LYIVMELMSKGNLVNFLRTRGRA------- 95

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
             ++++Q L  ++DVA  ++YL         H DL   NIL+ E+ V+ V DFGLAR + 
Sbjct: 96  -LVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VG 150

Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
              V  S + VK    + APE     + S+  DV+SYG+L+ E+
Sbjct: 151 SMGVDNSKLPVK----WTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V  G  D     V VK   + +   +++F+AE   +  +RH NLV++     
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLL---- 65

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
           GV  +      +V E+M  GSL ++L    R          L     L  ++DV  A++Y
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 117

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L  +      H DL   N+L+ E+ V+ V DFGL +    T   T  + VK    + APE
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK----WTAPE 169

Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
                + ST  DV+S+GIL+ E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K           +F+ E + ++ +RH  LV ++   S
Sbjct: 14  LGQGCFGEVWMGTWN-GTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V EFM  GSL ++L       E D   + L L Q +++A  +A  + Y
Sbjct: 72  ------EEPIYIVTEFMGKGSLLDFL------KEGDG--KYLKLPQLVDMAAQIADGMAY 117

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ + +V  + DFGLAR +      T+  G K  I + APE
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPE 173

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL+ + +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 90.3 bits (224), Expect = 2e-18
 Identities = 64/167 (38%), Positives = 93/167 (55%), Gaps = 14/167 (8%)

Query: 19  NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLT-SLVALDLS 77
           N  ++V   +S   + G I S++     + TI L NN LSG IP  +   + SL  L+LS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 78  RNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG------ 131
            N F GS P   G++ NLETL +S N+L GEIP+ +GS   L++L++ GNV  G      
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 132 -----LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTE 173
                L  L L+ N+L G+IP  L  +K ++ + L YN+L G +P E
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.9 bits (223), Expect = 2e-18
 Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 7/195 (3%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
           +K   V  LD+ +  L G I     ++  L++L+L  N F   +P   G  +RL+  DL+
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLS 483

Query: 612 NNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
            N   G +P  L S S L+++ L++N+L G+IP +  S  K+  L L  N L G IP   
Sbjct: 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS----IFNISSIAE 727
             +  L ++ L+ N L+G IP  L  +++LV + +  N L G +PS+      N S++A 
Sbjct: 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG 603

Query: 728 FDV--GENKIQGNIP 740
                G +   G  P
Sbjct: 604 NIDLCGGDTTSGLPP 618

Length = 968

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + +  + H  LV+++  C+
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   +  +V E+M NG L  +L    RE       +     Q L +  DV   + Y
Sbjct: 70  K---QRPIY--IVTEYMSNGCLLNYL----REHG-----KRFQPSQLLEMCKDVCEGMAY 115

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    Q I  H DL   N L+D++    V DFGL+R++      TSS+G K  + +  PE
Sbjct: 116 LESK-QFI--HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE 171

Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             L S+ S+  DV+++G+LM E+
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 5e-18
 Identities = 65/248 (26%), Positives = 98/248 (39%), Gaps = 48/248 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVF--------NLHHHRASRSFIAECRALRSIRHRNL 329
           +G GSFG V   V    R   T K++         +   +     + E   L  I H  +
Sbjct: 1   LGKGSFGKVLL-V----RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR--EDEVDKAPRNLNLLQRLNI 387
           VK+  A     +Q  +   LV E+   G L   L    R  E+             R   
Sbjct: 56  VKLHYA-----FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-----------RFYA 99

Query: 388 AIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           A ++  AL+YLH         + DLKP NILLD +    + DFGLA+ L     +T++  
Sbjct: 100 A-EIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF- 153

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-----MNLHNFA 501
             G+  Y+APE  LG       D +S G+L+ E++  K P    F  +            
Sbjct: 154 -CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP----FYAEDRKEIYEKILKD 208

Query: 502 RMALPDHV 509
            +  P+ +
Sbjct: 209 PLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 30/219 (13%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG V+ G       +  +  V VK       + A + F  E   L + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYP----VNREDEVDKAPRNLNLLQRLNI 387
            +  C+    +G D   +V+E+M++G L ++L             D     L L Q L I
Sbjct: 73  FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 388 AIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           A+ +AS + YL   H       H DL   N L+  ++V  +GDFG++R +      T   
Sbjct: 128 AVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDV----YTTDYY 178

Query: 446 GVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            V G     I ++ PE  +  + +T  DV+S+G+++ E+
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 26/212 (12%)

Query: 277 LIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVKV 332
           +IG G FG V++G+L   GR  V V +  L   +  +  + F++E   +    H N++++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL-NLLQRLNIAIDV 391
                GV  +      ++ E+M+NG+L+++L    R+ + + +   L  +L+ +   +  
Sbjct: 72  ----EGVVTKFKPA-MIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKY 122

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
            S ++Y+H D         L   NIL++  +   V DFGL+R L   P    T+S G K 
Sbjct: 123 LSDMNYVHRD---------LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS-GGKI 172

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + APE     + ++  DV+S+GI+M E++
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 31/237 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRNLVKVFTAC 336
           +G G FG V+ G  + G T V +K  +L     S  +F+AE   ++ ++H  LV+++   
Sbjct: 14  LGAGQFGEVWMGYYN-GHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           +       +   ++ E+M+NGSL ++L    +  E  K    L + + +++A  +A  + 
Sbjct: 71  T------QEPIYIITEYMENGSLVDFL----KTPEGIK----LTINKLIDMAAQIAEGMA 116

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           ++    +    H DL+ +NIL+ E +   + DFGLAR +      T+  G K  I + AP
Sbjct: 117 FIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAP 172

Query: 457 E---YGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPD 507
           E   YG     +   DV+S+GIL+ E++   +   P     E   NL    RM  PD
Sbjct: 173 EAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 24/221 (10%)

Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+       + ++ +  V VK        A + F  E   L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV-----DKAPRNLNLLQRLNI 387
           +  C+           +V+E+M++G L  +L     + ++     D AP  L L Q L I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 388 AIDVASALDYL---HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           A  +AS + YL   H        H DL   N L+ + +V  +GDFG++R +  T      
Sbjct: 128 ASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
                 I ++ PE  L  + +T  D++S+G+++ E+    K
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 64/229 (27%), Positives = 90/229 (39%), Gaps = 45/229 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR------HRNLVK 331
           IG G++G VYK         V +K   L       S      ALR I+      H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFE----SEGIPKTALREIKLLKELNHPNIIK 62

Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              VF     +         LV+EFM            +    +    R L      +  
Sbjct: 63  LLDVFRHKGDL--------YLVFEFMDT----------DLYKLIKDRQRGLPESLIKSYL 104

Query: 389 IDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIG 446
             +   L + H H       H DLKP N+L++ E V  + DFGLAR F  P    T  + 
Sbjct: 105 YQLLQGLAFCHSHGI----LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            +    Y APE  LG +  ST  D++S G +  EL+ R+     +F G 
Sbjct: 161 TR---WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGK 202

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 278 IGTGSFGSVYKGV-LDEGRTT---VTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKV 332
           +G+G+FG+VYKGV + EG      V +KV        A++  + E   + S+ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C     Q      L+ + M  G L +  Y  N +D       N+     LN  + +A
Sbjct: 75  LGICLSSQVQ------LITQLMPLGCLLD--YVRNHKD-------NIGSQYLLNWCVQIA 119

Query: 393 SALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
             + YL           H DL   N+L+       + DFGLA+ L     +  + G K  
Sbjct: 120 KGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           I ++A E  L    +   DV+SYG+ + EL+
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 277 LIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK- 331
           +IG G FG V  G L   G+  + V +  L   +  +  R F++E   +    H N++  
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 332 --VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
             V T    V         +V E+M+NGSL+ +L          K      ++Q + +  
Sbjct: 71  EGVVTKSKPV--------MIVTEYMENGSLDAFL---------RKHDGQFTVIQLVGMLR 113

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGV 447
            +AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G 
Sbjct: 114 GIASGMKYLS-DMGYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-GG 169

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 78.3 bits (194), Expect = 5e-16
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 34/227 (14%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
             IG GSFG VY            +K  +L +         + E + L+ + H N++K +
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWL---YPVNR---EDEVDKAPRNLNLLQRLNI 387
                  ++      +V E+   G L + +       +   E+++            L+ 
Sbjct: 66  E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI------------LDW 108

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
            + +  AL YLH   + I  H D+KP NI L    +  +GDFG+++ L  T     +  V
Sbjct: 109 FVQLCLALKYLHS--RKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--V 163

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G+  Y++PE       +   D++S G ++ EL   K P    FEG+
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 25/221 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFTAC 336
           +G+G FG V+ G   + R  + V +  ++    S   FI E + +  + H  LV+++  C
Sbjct: 12  LGSGQFGVVHLG---KWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           +    Q      +V EFM+NG L  +L    R+ +   +   L     L++  DV   ++
Sbjct: 69  T----QQKPL-YIVTEFMENGCLLNYL----RQRQGKLSKDML-----LSMCQDVCEGME 114

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL  +      H DL   N L+    V  V DFG+ R++      TSS G K  + +  P
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170

Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL 497
           E    S+ S+  DV+S+G+LM E+    K   + FE   N 
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGK---MPFEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)

Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V    Y    D     V VK       + + S +  E   L+++ H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDV 391
              CS    QG     L+ E++  GSL ++L            P++ LNL Q L  A  +
Sbjct: 72  KGCCSE---QGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFAQQI 116

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV--QTSSIGVKG 449
              + YLH        H DL   N+LLD + +  +GDFGLA+ +P  H   +    G   
Sbjct: 117 CEGMAYLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG-DS 172

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS 487
            + + A E    ++ S   DV+S+G+ + EL+      
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 69/208 (33%), Positives = 97/208 (46%), Gaps = 27/208 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTA 335
            IG G+FG VYKGVL +G T V VK           R F+ E   L+   H N+VK+   
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C  V  Q      +V E +  GSL  +L          K    L + + L +++D A+ +
Sbjct: 61  C--VQKQP---IYIVMELVPGGSLLTFL---------RKKKNRLTVKKLLQMSLDAAAGM 106

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-SIGYI 454
           +YL         H DL   N L+ E  V  + DFG++R      + T S G+K   I + 
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWT 162

Query: 455 APE---YGLGSEVSTNGDVYSYGILMLE 479
           APE   YG     ++  DV+SYGIL+ E
Sbjct: 163 APEALNYG---RYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           +G G+FG VYKG L         T+V +K    +     +  F  E   +  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY------PVNREDEVDKAPRNLNLLQRL 385
           +   C+           +++E++ +G L E+L        V  E   +    +L+    L
Sbjct: 73  LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 386 NIAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT---HV 440
           +IAI +A+ ++YL  HH       H DL   N L+ E +   + DFGL+R +       V
Sbjct: 128 HIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           Q+ S+     + ++ PE  L  + +T  D++S+G+++ E+
Sbjct: 183 QSKSL---LPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 30/217 (13%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRAS----RSFIAECRALRSIRHRN 328
           +G GSFG VY+G+       E  T V +K  N     AS      F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 329 LVKVFTACSGVDYQGNDFKALV-YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           +V++     GV   G     LV  E M  G L+ +L     E E +       L + + +
Sbjct: 71  VVRLL----GVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 388 AIDVASALDYLH--HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           A ++A  + YL           H DL   N ++ E++   +GDFG+ R +  T       
Sbjct: 125 AAEIADGMAYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTRDIYET--DYYRK 177

Query: 446 GVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           G KG   + ++APE       +T  DV+S+G+++ E+
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 15/219 (6%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNL--HHHRASRSFIAECRALRSIRH 326
                ++G G FGSV +G L +   +   V VK   L  H +     F++E   ++   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 327 RNLVKVFTAC-SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
            N++K+   C      Q      ++  FM++G L  +L            P  L L   L
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG----LPEKLPLQTLL 116

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
              +D+A  ++YL +    I  H DL   N +L E+M   V DFGL++ +          
Sbjct: 117 KFMVDIALGMEYLSNR-NFI--HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173

Query: 446 GVKGSIGYIAPEYGLGSEVST-NGDVYSYGILMLELIIR 483
             K  + +IA E  L   V T   DV+++G+ M E+  R
Sbjct: 174 IAKMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.2 bits (186), Expect = 8e-15
 Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 45/229 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVK---V 332
           +G G++G VYK    +    V +K   L +       + + E   L+ ++H N+VK   V
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
                           LV+E+     L+++L         DK P  L+     +I   + 
Sbjct: 67  IH--------TERKLYLVFEYCDM-DLKKYL---------DKRPGPLSPNLIKSIMYQLL 108

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPP----TH-VQTSSIG 446
             L Y H        H DLKP NIL++ + V  + DFGLAR F  P    TH V T    
Sbjct: 109 RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT---- 161

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
               + Y APE  LGS+  ST  D++S G +  E+ I  KP   +F GD
Sbjct: 162 ----LWYRAPEILLGSKHYSTAVDIWSVGCIFAEM-ITGKP---LFPGD 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+    ++  T V VK           +F+AE   +++++H  LVK+    +
Sbjct: 14  LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   ++ EFM  GSL ++L    + DE  K P    L + ++ +  +A  + +
Sbjct: 72  ------KEPIYIITEFMAKGSLLDFL----KSDEGSKQP----LPKLIDFSAQIAEGMAF 117

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    Q    H DL+ +NIL+   +V  + DFGLAR +      T+  G K  I + APE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 173

Query: 458 YGLGSEVSTNGDVYSYGILMLELI 481
                  +   DV+S+GIL++E++
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 23/210 (10%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTT---VTVKVFNLHHHRASRSFIAE-CRALRSIRHRNLVK 331
           L+G+G FG+V+KG+ + EG +    V +K       R +   I +   A+ S+ H  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C G   Q      LV +    GSL + +    R+      P+ L     LN  + +
Sbjct: 74  LLGICPGASLQ------LVTQLSPLGSLLDHV----RQHRDSLDPQRL-----LNWCVQI 118

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A  + YL         H +L   NILL  + +  + DFG+A  L P   +      K  I
Sbjct: 119 AKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            ++A E  L    +   DV+SYG+ + E++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 42/231 (18%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVFT 334
           N IG+G+ G+VYK +         +KV   +H    R  I  E   LR + H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C  +     + + L+ EFM  GSLE     +  E                ++A  + S 
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADE------------QFLADVARQILSG 180

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSIGY 453
           + YLH   +    H D+KPSN+L++      + DFG++R L  T     SS+   G+I Y
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAY 234

Query: 454 IAPEYGLGSEVSTN----------GDVYSYGILMLELIIRKKPSDIMFEGD 494
           ++PE      ++T+          GD++S G+ +LE  + + P  +  +GD
Sbjct: 235 MSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280

Length = 353

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 66/255 (25%), Positives = 119/255 (46%), Gaps = 30/255 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  +   T V VK        + ++F+ E   +++++H  LV+++   +
Sbjct: 14  LGAGQFGEVWMGYYNNS-TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 338 GVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             +  Y       ++ E+M  GSL ++L    + DE  K    + L + ++ +  +A  +
Sbjct: 72  KEEPIY-------IITEYMAKGSLLDFL----KSDEGGK----VLLPKLIDFSAQIAEGM 116

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            Y+    +    H DL+ +N+L+ E ++  + DFGLAR +      T+  G K  I + A
Sbjct: 117 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTA 172

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK-PSDIMFEGDM--NLHNFARMA----LPDH 508
           PE       +   DV+S+GIL+ E++   K P   M   D+   L    RM      PD 
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232

Query: 509 VMDIVDSTLLNDVED 523
           + DI+ +      E+
Sbjct: 233 LYDIMKTCWKEKAEE 247

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.6 bits (186), Expect = 4e-14
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)

Query: 73  ALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGL 132
            L L     RG  P ++  L +L+++ +SGN ++G IP +LGS                L
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-------------ITSL 468

Query: 133 TILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTE--GVFKNASAISVLGNNKL 190
            +LDLS N  +G IPE L  L  +  LNL+ N L G VP    G   + ++ +   N  L
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528

Query: 191 CGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRK 243
           CG      L  CG        L+   K+ IA     +     +  +   W R+
Sbjct: 529 CGIPG---LRACGP------HLSVGAKIGIAF-GVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.6 bits (186), Expect = 4e-14
 Identities = 36/82 (43%), Positives = 49/82 (59%)

Query: 33  LKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNL 92
           L+G IP+ +     L +I L  N++ G IPP L  +TSL  LDLS N F GS P  +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 93  INLETLTVSGNILQGEIPSTLG 114
            +L  L ++GN L G +P+ LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRSFIAECRALRSIRHRNLVK---V 332
           IG G++G VYK    +    V +K   + + +     + I E + L+ +RH N+V+   +
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 333 FTACSGVDYQGNDFKALVYEFMQ---NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
            T+      +G+ +  +V+E+M     G L+        E ++ K       +++L    
Sbjct: 67  VTSKG----KGSIY--MVFEYMDHDLTGLLDSPEVKFT-ESQI-KC-----YMKQL---- 109

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
                L YLH     +  H D+K SNIL++ + V  + DFGLAR     +    +  V  
Sbjct: 110 --LEGLQYLHS-NGIL--HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163

Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRK 484
           ++ Y  PE  LG+       D++S G ++ EL + K
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 36/88 (40%), Positives = 57/88 (64%)

Query: 632 IGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI 691
           +GL    L G IP+D   L  ++ ++L  N++ G+IPP LG+++SL  + L+ N+  GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 692 PFTLSKLKNLVILYLGVNRLSGIVPSSI 719
           P +L +L +L IL L  N LSG VP+++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTT---VTVKVFN-LHHHRASRSFIAECRALRSIRHRNLVK 331
           ++G+G+FG+VYKG+ + EG T    V +K+ N     +A+  F+ E   + S+ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C     Q      LV + M +G L ++         V +   N+     LN  + +
Sbjct: 74  LLGVCLSPTIQ------LVTQLMPHGCLLDY---------VHEHKDNIGSQLLLNWCVQI 118

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A  + YL    +    H DL   N+L+       + DFGLAR L     + ++ G K  I
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            ++A E     + +   DV+SYG+ + EL+    KP D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 55/233 (23%), Positives = 82/233 (35%), Gaps = 55/233 (23%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVF---NLHHHRASRS----FIAECRALRSIRHRNLV 330
           IG GSFG+V K      R     K+     + +   +       ++E   LR ++H N+V
Sbjct: 8   IGKGSFGTVRKV-----RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 331 K---------------VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
           +               V   C G D      K       +   +EE        + +   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC----KKERKYIEE--------EFI--- 107

Query: 376 PRNLNLLQRLNIAIDVASALDYLHH--DCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
                      I   +  AL   H+  D      H DLKP+NI LD      +GDFGLA+
Sbjct: 108 ---------WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158

Query: 434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            L        +    G+  Y++PE           D++S G L+ EL     P
Sbjct: 159 ILGHDSSFAKTY--VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 53/278 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRAL-RSIRHRNLVKV 332
           +IG GSF +V      E      +K+ +       +  +    E   L R   H  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +       +Q  +    V E+  NG L +++              +L+       A ++ 
Sbjct: 68  YYT-----FQDEENLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFYAAEIL 112

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            AL+YL H    I  H DLKP NILLD++M   + DFG A+ L P     S+ G   +I 
Sbjct: 113 LALEYL-HSKGII--HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 453 ------------------YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                             Y++PE         + D+++ G ++ +++  K P    F G 
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGS 225

Query: 495 MNLHNFAR-MAL--------PDHVMDIVDSTLLNDVED 523
                F + + L        P    D+++  L+ D +D
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQD 263

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 33/222 (14%)

Query: 276 NLIGTGSFGSVYKGVL--DEGRTTVTVKVFNLHHHRAS-RSFIAECRAL-RSIRHRNLVK 331
           ++IG G+FG V K  +  D  R    +K    +  +   R F  E   L +   H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-------PRNLNLLQR 384
           +  AC   +++G  +  L  E+  +G+L ++L   +R  E D A          L+  Q 
Sbjct: 73  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 126

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L+ A DVA  +DYL    Q    H DL   NIL+ E  V+ + DFGL+R           
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175

Query: 445 IGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G     ++A E    S  +TN DV+SYG+L+ E++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 18/217 (8%)

Query: 278 IGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V     Y    ++ +  V VK        A + F  E   L +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA----PRNLNLLQRLNIA 388
           +  C     +G+    +V+E+M++G L ++L   +  D V  A    P  L   Q L+IA
Sbjct: 73  YGVC----VEGDPL-IMVFEYMKHGDLNKFLR-AHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +A+ + YL         H DL   N L+ E ++  +GDFG++R +  T          
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
             I ++ PE  +  + +T  DV+S G+++ E+    K
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 28/213 (13%)

Query: 277 LIGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLV 330
            +G G+FGSV    Y  + D     V VK   L H  A   R F  E   L+S++H N+V
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 331 KVFTACSGVDYQ-GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           K      GV Y  G     LV E++  GSL ++L      + +D   + L    ++   +
Sbjct: 69  KY----KGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLD-HRKLLLYASQICKGM 121

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGV 447
           +   +  Y+H D         L   NIL++ E    +GDFGL + LP    + +    G 
Sbjct: 122 EYLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG- 171

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           +  I + APE    S+ S   DV+S+G+++ EL
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 32/210 (15%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           L+G G+FG V+KG L + +T V VK    +L      + F++E R L+   H N+VK+  
Sbjct: 2   LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C+         +  +Y  M+     ++L  + ++ +       L   Q +  A+D A+ 
Sbjct: 60  VCTQ--------RQPIYIVMELVPGGDFLSFLRKKKD------ELKTKQLVKFALDAAAG 105

Query: 395 LDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-SIG 452
           + YL   +C     H DL   N L+ E  V  + DFG++R         SS G+K   I 
Sbjct: 106 MAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIK 159

Query: 453 YIAPE---YGLGSEVSTNGDVYSYGILMLE 479
           + APE   YG     S+  DV+SYGIL+ E
Sbjct: 160 WTAPEALNYG---RYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 3e-13
 Identities = 36/87 (41%), Positives = 54/87 (62%)

Query: 609 DLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP 668
            L+N  + G IP ++S   +L  I L+ N + G IP   GS++ +EVL L +N+  GSIP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Query: 669 PPLGNLSSLRKISLAINNLAGSIPFTL 695
             LG L+SLR ++L  N+L+G +P  L
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)

Query: 278 IGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V     Y     + +  V VK        A + F  E   L +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE--VDKAPRN----LNLLQRLN 386
           +  C   D    D   +V+E+M++G L ++L     +    VD  PR     L L Q L+
Sbjct: 73  YGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           IA  +AS + YL         H DL   N L+   ++  +GDFG++R +  T        
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
               I ++ PE  +  + +T  DV+S+G+++ E+    K
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 25/219 (11%)

Query: 276 NLIGTGSFGSVYKGVL------DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRN 328
           N +G+G+FG VY+G          G   V VK          +  F+ E   + +  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNI 387
           +VK+   C  +    N+ + ++ E M+ G L  +L    R+  V++     L L + L+I
Sbjct: 61  IVKLLGVC--LL---NEPQYIIMELMEGGDLLSYL----RDARVERFGPPLLTLKELLDI 111

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-----MVSHVGDFGLARFLPPTHVQT 442
            +DVA    YL    Q    H DL   N L+ E+      V  +GDFGLAR +  +    
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                   + ++APE  L  + +T  DV+S+G+LM E++
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVF 333
           +G G+FGSV KGV          V VK     H  A +  F+ E   +  + H  +V++ 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C     +G     LV E    G L ++L          K  R + +     +A  VA 
Sbjct: 63  GVC-----KGEPL-MLVMELAPLGPLLKYL----------KKRREIPVSDLKELAHQVAM 106

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQTSSIGVKGSI 451
            + YL      +  H DL   N+LL     + + DFG++R L     + + ++ G +  +
Sbjct: 107 GMAYLE-SKHFV--HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG-RWPL 162

Query: 452 GYIAPE---YGLGSEVSTNGDVYSYGILMLE 479
            + APE   YG   + S+  DV+SYG+ + E
Sbjct: 163 KWYAPECINYG---KFSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVKVFT 334
           IG G FG V  G ++ G T   V V  L    +      F+ E +  RS++H NL++   
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 335 ACSGV-DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            C+ V  Y       LV EF   G L+ +L    + + +   P     LQR+  A ++A 
Sbjct: 63  QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPT---TLQRM--ACEIAL 111

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA--RFLPPTHVQTSSIGVKGSI 451
            L +LH +      H DL   N LL  ++   +GD+GL+  ++    +V    + V   +
Sbjct: 112 GLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PL 166

Query: 452 GYIAPEYGLGSEVSTN---------GDVYSYGILMLEL 480
            +IAPE  L  EV  N          +V+S G+ + EL
Sbjct: 167 RWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 277 LIGTGSFGSVYK-GVLDEGRTTVTVKVFNLHH----------HRASRSFIAECRALR-SI 324
            +G+G+FG VYK    + G+  + +K  N+H+           ++    ++E   ++  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+V+ +       +  ND   +V + ++   L E    +  + +           + 
Sbjct: 67  RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ------RFTEERI 115

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
            NI + +  AL YLH + + +  H DL P+NI+L E+    + DFGLA+   P    TS 
Sbjct: 116 WNIFVQMVLALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS- 172

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             V G+I Y  PE           DV+++G ++ ++   + P
Sbjct: 173 --VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVFTAC 336
           +G G+ G V K +       + VK   L  + A +  I  E   L       +V  + A 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
               Y   D  ++  E+M  GSL++ L       EV        +L +  IA+ V   L 
Sbjct: 69  ----YNNGDI-SICMEYMDGGSLDKIL------KEVQG-RIPERILGK--IAVAVLKGLT 114

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---Y 453
           YLH   + I  H D+KPSNIL++      + DFG++  L       +S+  K  +G   Y
Sbjct: 115 YLHEKHKII--HRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLA-KTFVGTSSY 165

Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           +APE   G++ S   D++S G+ ++EL   + P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 31/215 (14%)

Query: 278 IGTGSFGSVYKGVLD-EGRTT---VTVKVF---NLHHHRASRSFIAECRALRSIRHRNLV 330
           +G G FG V     D EG  T   V VK     +  +H A      E   LR++ H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENIV 69

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN---LNLLQRLNI 387
           K    C+  +  GN  K L+ EF+ +GSL+E+L            PRN   +NL Q+L  
Sbjct: 70  KYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL------------PRNKNKINLKQQLKY 114

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP-THVQTSSIG 446
           A+ +   +DYL    Q +  H DL   N+L++ E    +GDFGL + +       T    
Sbjct: 115 AVQICKGMDYLGSR-QYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +   + + APE  + S+     DV+S+G+ + EL+
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 71/240 (29%), Positives = 99/240 (41%), Gaps = 39/240 (16%)

Query: 259 NLSYQNLHNATDG---FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF- 314
           +     L +  D    F+    IG GSFG+VY          V +K  +    +++  + 
Sbjct: 1   DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ 60

Query: 315 --IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV 372
             I E R L+ +RH N ++ +  C    Y       LV E+   GS  + L       EV
Sbjct: 61  DIIKEVRFLQQLRHPNTIE-YKGC----YLREHTAWLVMEYCL-GSASDIL-------EV 107

Query: 373 DKAPRNLNLLQRLNIAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429
            K P     LQ + IA         L YLH        H D+K  NILL E     + DF
Sbjct: 108 HKKP-----LQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADF 159

Query: 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNG--DVYSYGILMLELIIRKKP 486
           G A  + P +   S +G      ++APE  L   E   +G  DV+S GI  +EL  RK P
Sbjct: 160 GSASLVSPAN---SFVGTP---YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 55/218 (25%), Positives = 106/218 (48%), Gaps = 16/218 (7%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHHRASRS----FIAECRALRS 323
           D  + ++L+  G+FG ++ G+L + +     +VF   +  H AS       + E   L  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYG 64

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           + H+N++ +   C     +  +   ++Y +M  G+L+ +L    R  E +  P+ L+  Q
Sbjct: 65  LSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANN-PQALSTQQ 118

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
            +++AI +A  + YLH   +    H D+   N ++DEE+   + D  L+R L P      
Sbjct: 119 LVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                  + ++A E  +  E S+  DV+S+G+L+ EL+
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.5 bits (171), Expect = 7e-13
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 40/222 (18%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-----RSFIAECRALRSIRHRN-- 328
             +G G++  VYK    E    V +K   L   + +      + + E + L+ ++H N  
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRL 385
            L+ VF   S ++        LV+EFM+   LE+    V ++  +   P ++   +L  L
Sbjct: 66  GLLDVFGHKSNIN--------LVFEFME-TDLEK----VIKDKSIVLTPADIKSYMLMTL 112

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTS 443
                    L+YLH     +  H DLKP+N+L+  + V  + DFGLAR    P   +   
Sbjct: 113 R-------GLEYLH-SNWIL--HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRK 484
            +    +  Y APE   G+     G D++S G +  EL++R 
Sbjct: 163 VV----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 35/221 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVFTAC 336
           IG G+   VY  +       V +K  +L   + S   +  E +A+    H N+VK +   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY--T 66

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWL---YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
           S V     D   LV  ++  GSL + +   YP    DE   A           +  +V  
Sbjct: 67  SFVV---GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA----------TVLKEVLK 113

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG- 452
            L+YLH + Q    H D+K  NILL E+    + DFG++  L       +    K  +G 
Sbjct: 114 GLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGT 169

Query: 453 --YIAPE-----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             ++APE     +G   +     D++S+GI  +EL     P
Sbjct: 170 PCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G+      DE  T V +K  N       R  F+ E   ++     ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  QG     ++ E M  G L+ +L  +  E E +      +L + + +A ++
Sbjct: 74  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T       G KG  
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 183

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + +++PE       +T  DV+S+G+++ E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 32/224 (14%)

Query: 278 IGTGSFGSVYK----GVL-DEGRTTVTVKVFNLHHHRAS----RSFIAECRALRSIRHRN 328
           IG G+FG V++    G+L  E  T V VK+       AS      F  E   +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEV---------DKAP 376
           +VK+   C+     G     L++E+M  G L E+L    P  +                P
Sbjct: 70  IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
             L+  ++L IA  VA+ + YL    +    H DL   N L+ E MV  + DFGL+R + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
                 +S      I ++ PE    +  +T  DV++YG+++ E+
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 277 LIGTGSFGSVYKG-VLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVF 333
           ++G G++G V K      G   V +K F          ++ + E + LR +RH N+V + 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEI-VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 334 TAC--SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
            A    G  Y       LV+E+++   LE           ++ +P  L      +    +
Sbjct: 67  EAFRRKGRLY-------LVFEYVERTLLEL----------LEASPGGLPPDAVRSYIWQL 109

Query: 392 ASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVK 448
             A+ Y H H+      H D+KP NIL+ E  V  + DFG AR L   P    T  +  +
Sbjct: 110 LQAIAYCHSHNI----IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR 165

Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
               Y APE  +G        DV++ G +M EL+
Sbjct: 166 ---WYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-------SFIAECRALRSI 324
           F   N IG G++G VY+      R T + ++  L   R          S + E   L ++
Sbjct: 9   FEKLNRIGEGTYGIVYRA-----RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63

Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQN--GSLEEWLYPVNREDEVDKAPRNLNLL 382
           RH N+V++     G   +  D   LV E+ +    SL            +D  P   +  
Sbjct: 64  RHPNIVELKEVVVG---KHLDSIFLVMEYCEQDLASL------------LDNMPTPFSES 108

Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           Q   + + +   L YLH +      H DLK SN+LL ++    + DFGLAR +  P    
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRK 484
           T  +    ++ Y APE  LG    T   D+++ G ++ EL+  K
Sbjct: 166 TPKV---VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)

Query: 278 IGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRNLVK 331
           +G G FG V K          G TTV VK+   +   +  R  ++E   L+ + H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------------YPVNREDEVDKAP--R 377
           ++ ACS      +    L+ E+ + GSL  +L               NR       P  R
Sbjct: 68  LYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FL 435
            L +   ++ A  ++  + YL    +    H DL   N+L+ E     + DFGL+R  + 
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 436 PPTHVQTSS--IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             ++V+ S   I VK    ++A E       +T  DV+S+G+L+ E++
Sbjct: 180 EDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 24/234 (10%)

Query: 269 TDGFSSANLIGTGSFGSVYKGV-LDEGRTTV--TVKVFNLHHHRASRSFIAECRALRSIR 325
              F     IG G F  VYK + L +GR      V++F +   +A +  + E   L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N++K   +     +  N+   +V E    G L   +    ++       R +      
Sbjct: 61  HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQK------RLIPERTIW 109

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
              + + SAL+++H        H D+KP+N+ +    V  +GD GL RF         S+
Sbjct: 110 KYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-MNLH 498
              G+  Y++PE    +  +   D++S G L+ E+   + P    F GD MNL+
Sbjct: 167 --VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 22/209 (10%)

Query: 277 LIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHHHR---ASRSFIAECRALRSIRHRNLVKV 332
            +G GSFG V +G     G   + V V  L   +       F+ E   + S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +    GV         +V E    GSL + L           A  +  +    + A+ +A
Sbjct: 62  Y----GVVLT--HPLMMVTELAPLGSLLDRLR--------KDALGHFLISTLCDYAVQIA 107

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH-VQTSSIGVKGSI 451
           + + YL         H DL   NILL  +    +GDFGL R LP           +K   
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + APE       S   DV+ +G+ + E+
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 36/213 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G++G VYK         V +KV  L           E   L+  RH N+V  F +  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V E+   GSL++ +Y V R          L+ LQ   +  +    L Y
Sbjct: 69  ---YLRRDKLWIVMEYCGGGSLQD-IYQVTR--------GPLSELQIAYVCRETLKGLAY 116

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS-IG---Y 453
           LH   +    H D+K +NILL E+    + DFG++  L      T++I  + S IG   +
Sbjct: 117 LHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYW 167

Query: 454 IAPEYGLGSEVSTNG------DVYSYGILMLEL 480
           +APE    + V   G      D+++ GI  +EL
Sbjct: 168 MAPEV---AAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 12/211 (5%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS----FIAECRALRSIRHRNLVKVF 333
           +G G FGSV +G L++  + + V V  +     +RS    F++E   ++   H N++++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 334 TAC-SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             C   V+ +G     ++  FM++G L  +L      D     P+ L     +    D+A
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC----PQYLPTQMLVKFMTDIA 122

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           S ++YL         H DL   N +L+E M   V DFGL++ +            K  + 
Sbjct: 123 SGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           +IA E       +T  DV+S+G+ M E+  R
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 69.2 bits (169), Expect = 3e-12
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 10/209 (4%)

Query: 562 LESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRL-RRLQVPDLNNNSIGGEIP 620
             +L    S +  +  L+ L  L+L+NN+ T +IP  IG L   L+  DL++N I   +P
Sbjct: 99  DLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156

Query: 621 VNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKI 680
             L +  NL  + L+ N L   +P    +LS +  L L   N I  +PP +  LS+L ++
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS-GNKISDLPPEIELLSALEEL 214

Query: 681 SLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP 740
            L+ NN    +  +LS LKNL  L L  N+L  + P SI N+S++   D+  N+I     
Sbjct: 215 DLS-NNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISS--- 269

Query: 741 LDYGFTLQNLQYFSIGTNRITGAIPPSIS 769
           +    +L NL+   +  N ++ A+P    
Sbjct: 270 ISSLGSLTNLRELDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 68.0 bits (167), Expect = 3e-12
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFT 334
           +GTGSFG V             +K+ +       +     + E R L+SIRH  LV ++ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
           +     +Q +    LV E++  G L   L    R  E   A        R   A  V  A
Sbjct: 69  S-----FQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-PVA--------RFYAA-QVVLA 113

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           L+YLH     +  + DLKP N+LLD +    + DFG A+ +     +T ++   G+  Y+
Sbjct: 114 LEYLHS-LDIV--YRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLC--GTPEYL 165

Query: 455 APEY----GLGSEVSTNGDVYSYGILMLELII 482
           APE     G G  V    D ++ GIL+ E++ 
Sbjct: 166 APEIILSKGYGKAV----DWWALGILIYEMLA 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 37/214 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVF-----NLHHHRASRSFIA--ECRALRSIRHRNLV 330
           IG GS+G V+K    E    V +K F     +    +     IA  E R L+ ++H NLV
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-----IALREIRMLKQLKHPNLV 63

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +        ++      LV+E+  +  L          +E++K PR +       I   
Sbjct: 64  NLIEV-----FRRKRKLHLVFEYCDHTVL----------NELEKNPRGVPEHLIKKIIWQ 108

Query: 391 VASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL-PPTHVQTSSIGVK 448
              A+++ H H+C     H D+KP NIL+ ++    + DFG AR L  P    T  +  +
Sbjct: 109 TLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164

Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELI 481
               Y APE  +G ++     DV++ G +  EL+
Sbjct: 165 ---WYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G+FG V+ G L    T V VK             F+ E R L+   H N+V++   C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           +    Q      +V E +Q G    +L          + PR L + + + +  + A+ ++
Sbjct: 63  T----QKQPI-YIVMELVQGGDFLTFLR--------TEGPR-LKVKELIQMVENAAAGME 108

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-SIGYIA 455
           YL         H DL   N L+ E+ V  + DFG++R      V  S+ G+K   + + A
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTA 164

Query: 456 PE---YGLGSEVSTNGDVYSYGILMLE 479
           PE   YG     S+  DV+S+GIL+ E
Sbjct: 165 PEALNYG---RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRT--TVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           IG G+ G VYK    +  T   V +K   L         I E   ++  +H N+V  + +
Sbjct: 27  IGEGASGEVYKAT--DRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDS 83

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y   D   +V E+M  GSL + +               +N  Q   +  +V   L
Sbjct: 84  -----YLVGDELWVVMEYMDGGSLTDIITQNFVR---------MNEPQIAYVCREVLQGL 129

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YLH   Q +  H D+K  NILL ++    + DFG A  L     + +S+ V G+  ++A
Sbjct: 130 EYLHS--QNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-V-GTPYWMA 184

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELI 481
           PE     +     D++S GI+ +E+ 
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 20/224 (8%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRS-FIAECRALRSIRHRNL 329
           F   N IG GSFG V+K V    +    +K  +L   +R  R   I E R L  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           ++ +   S +D        +V E+ +NG L + L            P   + + R  I I
Sbjct: 62  IRYYE--SFLDKG---KLNIVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQI 110

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
            +   L +LH        H D+K  N+ LD      +GD G+A+ L       ++I   G
Sbjct: 111 LLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VG 163

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
           +  Y++PE       +   DV++ G+++ E    K P D   +G
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 276 NLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRAS------RSFIAECRALRSIRHRN 328
             IG G++G+VYK   L+ GR  V +K   +            R  IA  + L S  H N
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRF-VALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPN 62

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAP-RNLNLLQRLNI 387
           +V++   C G          LV+E +    L  +L          K P   L      ++
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL---------SKCPKPGLPPETIKDL 112

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              +   +D+LH        H DLKP NIL+  +    + DFGLAR        TS   V
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---V 166

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK 484
             ++ Y APE  L S  +T  D++S G +  EL  R+
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 62/238 (26%), Positives = 95/238 (39%), Gaps = 62/238 (26%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVK-----VFNLHHHRASRSFIAECRALRSI 324
           D + + + +G+G++G V      +    V +K       +  H  A R++  E R L+ +
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTY-RELRLLKHM 71

Query: 325 RHRN---LVKVFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            H N   L+ VFT  S +     DF+   LV   M                       +L
Sbjct: 72  DHENVIGLLDVFTPASSL----EDFQDVYLVTHLMG---------------------ADL 106

Query: 380 NLL---QRLN------IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430
           N +   Q+L+      +   +   L Y+ H    I  H DLKPSNI ++E+    + DFG
Sbjct: 107 NNIVKCQKLSDDHIQFLVYQILRGLKYI-HSAGII--HRDLKPSNIAVNEDCELKILDFG 163

Query: 431 LAR---FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRK 484
           LAR        +V T          Y APE  L         D++S G +M EL+  K
Sbjct: 164 LARHTDDEMTGYVATR--------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 35/226 (15%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG VYKG+ +  +  V +K+ +L          AE   +  I+    + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 332 VFTACSG---VDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L P   E+              
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA---------- 104

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E+    + DFG+A  L  T ++ ++
Sbjct: 105 -TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP-SDI 489
               G+  ++APE    S      D++S GI  +EL   + P SD+
Sbjct: 161 F--VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L          AE   +  I+    + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 332 VFTACSG---VDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L    R    D+        Q 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDE-------FQI 103

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             +  ++   LDYLH + +    H D+K +N+LL E+    + DFG+A  L  T ++ ++
Sbjct: 104 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
               G+  ++APE    S   +  D++S GI  +EL   + P+  M
Sbjct: 161 F--VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 71/260 (27%), Positives = 106/260 (40%), Gaps = 64/260 (24%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH------HRASRSFIAECRALRSIRHRNLVK 331
           IG G+ G V+K    E   TV +K   L        ++A R    E +AL++ +H  +VK
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63

Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              VF   SG          LV E+M +      L  V R++E     R L   Q  +  
Sbjct: 64  LLDVFPHGSGF--------VLVMEYMPSD-----LSEVLRDEE-----RPLPEAQVKSYM 105

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +   + Y+H        H DLKP+N+L+  + V  + DFGLAR       +  S  V 
Sbjct: 106 RMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV- 161

Query: 449 GSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507
            +  Y APE   G+     G D+++ G +  EL +   P   +F G+             
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAEL-LNGSP---LFPGE------------- 204

Query: 508 HVMDIVDSTLLNDVEDLAII 527
                      ND+E LAI+
Sbjct: 205 -----------NDIEQLAIV 213

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +G GS+GSVYK +  E    V +KV  +      +  I E   L+      +VK     
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK----- 62

Query: 337 SGVDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               Y G+ FK     +V E+   GS+          D +    + L   +   I     
Sbjct: 63  ----YYGSYFKNTDLWIVMEYCGAGSV---------SDIMKITNKTLTEEEIAAILYQTL 109

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
             L+YLH        H D+K  NILL+EE  + + DFG++  L  T  + ++  V G+  
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPF 164

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           ++APE       +   D++S GI  +E+
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 33/222 (14%)

Query: 276 NLIGTGSFGSVYKGVL--DEGRTTVTVKVFN-LHHHRASRSFIAECRALRSI-RHRNLVK 331
           ++IG G+FG V + ++  D  +    +K+          R F  E   L  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-------PRNLNLLQR 384
           +  AC    Y       +  E+   G+L ++L   +R  E D A          L   Q 
Sbjct: 68  LLGACENRGYL-----YIAIEYAPYGNLLDFLRK-SRVLETDPAFAKEHGTASTLTSQQL 121

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L  A DVA+ + YL  + Q I  H DL   N+L+ E + S + DFGL+R           
Sbjct: 122 LQFASDVATGMQYLS-EKQFI--HRDLAARNVLVGENLASKIADFGLSR--------GEE 170

Query: 445 IGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G     ++A E    S  +T  DV+S+G+L+ E++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 34/222 (15%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L               +  I+    + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE---------IEDIQQE--IT 54

Query: 332 VFTACSG---VDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L P          P  L+  Q 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQI 103

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E     + DFG+A  L  T ++ ++
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               G+  ++APE    S   +  D++S GI  +EL   + P
Sbjct: 161 F--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 24/235 (10%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVK---VFNLHHHRASRSFIAECRALRSIRHRN 328
           F     IG G F  VY+         V +K   +F+L   +A    I E   L+ + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++K + +      + N+   +V E    G L   +          K  R +         
Sbjct: 64  VIKYYASF----IEDNELN-IVLELADAGDLSRMI------KHFKKQKRLIPEKTVWKYF 112

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
           + + SAL+++H        H D+KP+N+ +    V  +GD GL RF   +   T++  + 
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-MNLHNFAR 502
           G+  Y++PE    +  +   D++S G L+ E+   + P    F GD MNL++  +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 70/237 (29%), Positives = 104/237 (43%), Gaps = 41/237 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTA 335
           IG G++G VYKG   +    V +K   L         + I E   L+ ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL--- 64

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              V  Q +    L++EF+    L+++L         D  P+   +        D     
Sbjct: 65  -QDVLMQESRL-YLIFEFLSM-DLKKYL---------DSLPKGQYM--------DAELVK 104

Query: 396 DYLHHDCQPIT-------THCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
            YL+   Q I         H DLKP N+L+D + V  + DFGLAR F  P  V T  +  
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV-- 162

Query: 448 KGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
             ++ Y APE  LGS   ST  D++S G +  E+   KKP   +F GD  +    R+
Sbjct: 163 -VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGDSEIDQLFRI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 42/228 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTA 335
           IG G++G VYK         V +K   L         + I E   L+ + H N+V++   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD- 65

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              V +  N    LV+EF+ +  L++++         D +P            +D     
Sbjct: 66  ---VVHSENKL-YLVFEFL-DLDLKKYM---------DSSP---------LTGLDPPLIK 102

Query: 396 DYLHHDCQPIT-------THCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
            YL+   Q I         H DLKP N+L+D E    + DFGLAR F  P    T  +  
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV-- 160

Query: 448 KGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             ++ Y APE  LGS + ST  D++S G +  E+ + ++P   +F GD
Sbjct: 161 -VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEM-VNRRP---LFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 49/250 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFT 334
           ++G G+FG V+       +  V +K   +         +   EC+ L+ + H N+++ + 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                ++  +    +V E+   G+L E++                   +R N  +D  + 
Sbjct: 67  -----NFLEDKALMIVMEYAPGGTLAEYIQ------------------KRCNSLLDEDTI 103

Query: 395 LDY-------LHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLARFLPPTHVQTSSIG 446
           L +       LHH    +  H DLK  NILLD+ +MV  +GDFG+++ L     ++ +  
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYT 160

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506
           V G+  YI+PE   G   +   D+++ G ++ EL   K+     FE            LP
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA----FEAA---------NLP 207

Query: 507 DHVMDIVDST 516
             V+ I+  T
Sbjct: 208 ALVLKIMSGT 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVFT 334
           L+G GS+G V K    E    V +K F           IA  E R L+ +RH NLV +  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                  +      LV+EF+ +  L          D+++K P  L+  +       +   
Sbjct: 68  VFR----RKKRLY-LVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQILRG 112

Query: 395 LDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGVKGSIG 452
           +++ H H+      H D+KP NIL+ +  V  + DFG AR L  P  V T  +  +    
Sbjct: 113 IEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---W 165

Query: 453 YIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL 497
           Y APE  +G ++     D+++ G L+ E++      + +F GD ++
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLT----GEPLFPGDSDI 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 36/243 (14%)

Query: 277 LIGTGSFGSVYKGV---LDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
            IG G FG VY+GV    +  +  V VK        + R  F+ E   +R   H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               +       +   +V E    G L  +L  VN+         +L+L   +  +  ++
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYL-QVNKY--------SLDLASLILYSYQLS 117

Query: 393 SALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           +AL YL          H D+   N+L+       +GDFGL+R+L       +S G K  I
Sbjct: 118 TALAYLESKRF----VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPI 172

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKP------SDIMFEGDMNLHNFARMA 504
            ++APE       ++  DV+ +G+ M E+++   KP      +D++      + N  R+ 
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GRIENGERLP 228

Query: 505 LPD 507
           +P 
Sbjct: 229 MPP 231

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 45/238 (18%)

Query: 260 LSYQNLHNATDGFSSANLIGTGSFGSVY----KGVLDEG-RTTVTVKVFNLHHHRASRS- 313
               NL   T        +G G FG V+    KG+ +EG  T V VK          +S 
Sbjct: 2   FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54

Query: 314 FIAECRALRSIRHRNLVKVFTACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDE 371
           F  E    R + H+N+V++   C   +  Y       ++ E+   G L+++L     +DE
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLCREAEPHY-------MILEYTDLGDLKQFLRATKSKDE 107

Query: 372 VDKAPRNLNLLQRLNIAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429
             K P  L+  Q++ +   +A  +D+L           H DL   N L+  +    V   
Sbjct: 108 KLK-PPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLL 161

Query: 430 GLAR-------FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            L++       +                + ++APE     + ST  DV+S+G+LM E+
Sbjct: 162 SLSKDVYNSEYYK---LRNA-----LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)

Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N +        F+ E   ++   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    +V  +M++G L  ++    R +       N  +   +   + V
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFI----RSET-----HNPTVKDLIGFGLQV 107

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-------FLPPTHVQTSS 444
           A  ++YL         H DL   N +LDE     V DFGLAR       +    H     
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT---- 160

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G K  + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 161 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 36/248 (14%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL--HHHRASRSFIAECRALRSIRHRNL 329
           F     IG G++G VYK         V +K   L         + I E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 330 VKVFTACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           VK+      +D    + K  LV+EF+ +  L++++      D    +   L L++  +  
Sbjct: 62  VKL------LDVIHTENKLYLVFEFL-HQDLKKFM------DASPLSGIPLPLIK--SYL 106

Query: 389 IDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIG 446
             +   L + H H       H DLKP N+L++ E    + DFGLAR F  P    T  + 
Sbjct: 107 FQLLQGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV- 161

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN----FA 501
              ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +      F 
Sbjct: 162 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFR 215

Query: 502 RMALPDHV 509
            +  PD V
Sbjct: 216 TLGTPDEV 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.3 bits (155), Expect = 1e-10
 Identities = 73/277 (26%), Positives = 113/277 (40%), Gaps = 59/277 (21%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTV---KVFNLHHH-----RASRSFIAECRALRSIRHR 327
             IG+G++G V   V D+ RT   V   K+ N+        R  R    E + LR +RH 
Sbjct: 6   KPIGSGAYGVVCSAV-DK-RTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHE 59

Query: 328 NLVK---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           N++    +    S  D+  ND   +V E M+   L + +          K+P+ L     
Sbjct: 60  NIIGLLDILRPPSPEDF--NDV-YIVTELMET-DLHKVI----------KSPQPLTDDHI 105

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
                 +   L YLH     I  H DLKPSNIL++      + DFGLAR      V    
Sbjct: 106 QYFLYQILRGLKYLH-SANVI--HRDLKPSNILVNSNCDLKICDFGLARG-----VDPDE 157

Query: 445 IGVKGSIGYI------APEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNL 497
                   Y+      APE  L S   T   D++S G +  EL+ RK     +F G   +
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK----PLFPGRDYI 213

Query: 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
                    + +++++ +      EDL  I++++ R 
Sbjct: 214 DQL------NLIVEVLGTP---SEEDLKFITSEKARN 241

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 272 FSSANLIGTGSFGSVYKGV-LDEG---RTTVTVKVF-NLHHHRASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG   +  V +K        +A++  + E   + S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L +++    RE + +   + L     LN
Sbjct: 69  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV----REHKDNIGSQYL-----LN 113

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL    +    H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 27/221 (12%)

Query: 277 LIGTGSFGSVYKGVL-----DEGRTTVTVKVF--NLHHHRASRSFIAECRALRSI-RHRN 328
            +G G+FG V K            +TV VK+   +      S   ++E   ++ I +H+N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKN 77

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEVDKAPRNL--NLLQ 383
           ++ +   C+    +G  +  +V E+  +G+L ++L    P   E      PR     L Q
Sbjct: 78  IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPG-EYASPDDPRPPEETLTQ 131

Query: 384 R--LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
           +  ++ A  VA  +++L         H DL   N+L+ E+ V  + DFGLAR +      
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTN-GDVYSYGILMLELI 481
             +   +  + ++APE  L   V T+  DV+S+G+L+ E+ 
Sbjct: 189 RKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 27/233 (11%)

Query: 278 IGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSF-----IAECRALRSIRHRNLVK 331
           IG G++G V+K   L  G   V +K   +              +A  R L +  H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAID 390
           +F  C+           LV+E +    L  +L         DK P      + + ++   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---------DKVPEPGVPTETIKDMMFQ 118

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +   LD+LH        H DLKP NIL+       + DFGLAR       Q +   V  +
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 172

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
           + Y APE  L S  +T  D++S G +  E+  R+KP   +F G  ++    ++
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKP---LFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 65/259 (25%), Positives = 110/259 (42%), Gaps = 40/259 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G GS G V+  V  +    V VK   L   ++ +  + E + +R + H N+VKV+    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS---- 393
                  +    + E          +Y V    E D A    N+L++  ++ + A     
Sbjct: 73  PSGSDLTEDVGSLTELNS-------VYIVQEYMETDLA----NVLEQGPLSEEHARLFMY 121

Query: 394 ----ALDYLHHDCQPITTHCDLKPSNILLD-EEMVSHVGDFGLARFLPP--THVQTSSIG 446
                L Y+H        H DLKP+N+ ++ E++V  +GDFGLAR + P  +H    S G
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 447 VKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
           +  +  Y +P   L     T   D+++ G +  E++  K     +F G    H   +M L
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGA---HELEQMQL 230

Query: 506 PDHVMDIVDSTLLNDVEDL 524
                 I++S  +   ED 
Sbjct: 231 ------ILESVPVVREEDR 243

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 13/218 (5%)

Query: 272 FSSANLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRH 326
           F+   ++G G FGSV +  L   D     V VK+       +S    F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 327 RNLVKVFTACSGVDYQGN-DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
            N++K+         +G      ++  FM++G L  +L      +E    P  L L   +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE----PFTLPLQTLV 116

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
              ID+AS ++YL         H DL   N +L+E M   V DFGL++ +          
Sbjct: 117 RFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
             K  + ++A E    +  +T+ DV+++G+ M E++ R
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF-IAECRALRSIRHRNLVKVFTAC 336
           +G G++ +VYKG        V +K  +L     + S  I E   ++ ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                   +   LV+E+M    L++++       +       L+     +    +   + 
Sbjct: 68  -----HTENKLMLVFEYMDK-DLKKYM-------DTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGYIA 455
           + H   +    H DLKP N+L+++     + DFGLAR F  P  V T S  V  ++ Y A
Sbjct: 115 FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVV-TLWYRA 168

Query: 456 PEYGLGSEV-STNGDVYSYGILMLELI 481
           P+  LGS   ST+ D++S G +M E+I
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 34/240 (14%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHR 327
           D F     IG G++G VYK    +    V +K   L + +      A  E + LR + HR
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 328 NLVKVFTACSGVDYQGNDFKA------LVYEFMQN---GSLEEWLYPVNREDEVDKAPRN 378
           N+V +    +       DFK       LV+E+M +   G LE  L   + +         
Sbjct: 67  NIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-------HI 118

Query: 379 LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438
            + +++L         L+Y H   +    H D+K SNILL+ +    + DFGLAR     
Sbjct: 119 KSFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 439 HVQTSSIGVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNL 497
             +  +  V  ++ Y  PE  LG E      DV+S G ++ EL  +K     +F+ +  L
Sbjct: 170 ESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP----IFQANQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 25/216 (11%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRN 328
           +     + +G G+ GSV K  L        +K      +    +  + E    +S +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +VK + A   +D   +     + E+ + GSL+  +Y      +V K    +       IA
Sbjct: 61  IVKYYGAF--LDESSSSIGIAM-EYCEGGSLDS-IY-----KKVKKRGGRIGEKVLGKIA 111

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG----LARFLPPTHVQTSS 444
             V   L YLH        H D+KPSNILL  +    + DFG    L   L  T   TS 
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF 168

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
                   Y+APE   G   S   DV+S G+ +LE+
Sbjct: 169 --------YMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 24/224 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK---VFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG G F  VY+      R  V +K   +F +   +A +  + E   L+ + H N++K   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
           +     +  ++   +V E    G L + +          K  R +         + + SA
Sbjct: 70  S-----FIEDNELNIVLELADAGDLSQMI------KYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           ++++H        H D+KP+N+ +    V  +GD GL RF   +   T++  + G+  Y+
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYM 173

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-MNL 497
           +PE    +  +   D++S G L+ E+   + P    F GD MNL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKVFNL-----HHHRASRSFIAECRALRSIRHRNLV 330
           L+G G+FG VY    +D GR  + VK            +   +   E + L++++H  +V
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIA 388
           + +        + ++  ++  E+M  GS+++ L  Y    E    K  R           
Sbjct: 68  QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ---------- 112

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI-GV 447
             +   ++YLH +   +  H D+K +NIL D      +GDFG ++ L       + +  V
Sbjct: 113 --ILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+  +++PE   G       DV+S G  ++E++  K P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.8 bits (151), Expect = 3e-10
 Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 43/216 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR---SIR----HRNLV 330
           +G G+FGSVY     E    V +K       +   S+  EC  LR   S+R    H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHPNIV 61

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K+        ++ ND    V+E+M     E  LY + +    D+  +  +     +I   
Sbjct: 62  KLKEV-----FRENDELYFVFEYM-----EGNLYQLMK----DRKGKPFSESVIRSIIYQ 107

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL---PP--THVQTSSI 445
           +   L ++H        H DLKP N+L+    V  + DFGLAR +   PP   +V T   
Sbjct: 108 ILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-- 162

Query: 446 GVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLEL 480
                  Y APE  L S   S+  D+++ G +M EL
Sbjct: 163 ------WYRAPEILLRSTSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 48/231 (20%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL----------HHHRASRSFIAECR 319
           D       +GTG+FG V+            +KV  +          H H        E R
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-------EKR 53

Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            L+ + H  ++++F            F  ++ E++  G L  +L          +     
Sbjct: 54  VLKEVSHPFIIRLFWT-----EHDQRFLYMLMEYVPGGELFSYL----------RNSGRF 98

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +    L  A ++  AL+YLH   + I  + DLKP NILLD+E    + DFG A+ L    
Sbjct: 99  SNSTGLFYASEIVCALEYLHS--KEIV-YRDLKPENILLDKEGHIKLTDFGFAKKL---R 152

Query: 440 VQTSSIGVKGSIGYIAPEY----GLGSEVSTNGDVYSYGILMLELIIRKKP 486
            +T ++   G+  Y+APE     G    V    D ++ GIL+ E+++   P
Sbjct: 153 DRTWTLC--GTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALRSIRHRNLVKV 332
           IG G++G+VYK         V +K   +  +      ++   +A  + L +  H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR-NLNLLQRLNIAIDV 391
              C+           LV+E +    L  +L         DK P   L      ++    
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---------DKVPPPGLPAETIKDLMRQF 117

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
              LD+LH +C     H DLKP NIL+       + DFGLAR       Q +   V  ++
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTL 171

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            Y APE  L S  +T  D++S G +  E+  R+KP   +F G+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP---LFCGN 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 33/222 (14%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS---RSFIAECRALRSI-RHRNLVK 331
           ++IG G+FG V K  + +    +   +  +  + +    R F  E   L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-------PRNLNLLQR 384
           +  AC     +   +  L  E+  +G+L ++L   +R  E D A          L+  Q 
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 114

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L+ A DVA  +DYL    Q    H DL   NIL+ E  V+ + DFGL+R           
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 163

Query: 445 IGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G     ++A E    S  +TN DV+SYG+L+ E++
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 67/218 (30%), Positives = 90/218 (41%), Gaps = 36/218 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG GSFG+VY          V VK  +      +   +  I E + L+ ++H N ++ + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-YK 87

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C    Y       LV E+   GS  + L       EV K P     LQ + IA     A
Sbjct: 88  GC----YLKEHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQEVEIAAITHGA 130

Query: 395 LD---YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           L    YLH        H D+K  NILL E     + DFG A    P +         G+ 
Sbjct: 131 LQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTP 181

Query: 452 GYIAPEYGLG-SEVSTNG--DVYSYGILMLELIIRKKP 486
            ++APE  L   E   +G  DV+S GI  +EL  RK P
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 19/212 (8%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           +G G FG V    +         K  N   L   +     + E R L  +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-- 58

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
           A +   +Q      LV   M  G L   +Y V+ E+     PR             + S 
Sbjct: 59  AYA---FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY------TAQIISG 109

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           L++LH   Q    + DLKP N+LLD +    + D GLA  L     Q+ + G  G+ G++
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGTPGFM 164

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE   G E   + D ++ G+ + E+I  + P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 35/232 (15%)

Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y + R 
Sbjct: 75  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            +     ++L     ++    VA  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 130 PDEQMTFKDL-----VSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 180

Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 6e-10
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 31/219 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTT--VTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVKV 332
           IG G++G VYK     G+      +K F     +    S+S   E   LR ++H N+V +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 333 FTACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAPRNL--NLL-QRLNIA 388
                 V  +  D    L++++ ++      +   +R+ +    P ++  +LL Q LN  
Sbjct: 68  ----VEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQILN-- 119

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGDFGLAR-FLPPTHVQTS 443
                 + YLH        H DLKP+NIL+     E  V  +GD GLAR F  P      
Sbjct: 120 -----GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
              V  +I Y APE  LG+   T   D+++ G +  EL+
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 11/107 (10%)

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           IA+ +  AL+YLH     I  H D+KPSN+L++      + DFG++ +L  +  +T   G
Sbjct: 108 IAVSIVKALEYLHSKLSVI--HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 447 VKGSIGYIAPEYGLGSEVSTNG-----DVYSYGILMLELIIRKKPSD 488
            K    Y+APE  +  E++  G     DV+S GI M+EL   + P D
Sbjct: 166 CK---PYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 72/225 (32%), Positives = 99/225 (44%), Gaps = 38/225 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF---IAECRALRSIRHRN 328
           FS    IG GSFG+VY          V +K  +    +++  +   I E R L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            ++ +  C    Y       LV E+   GS  + L       EV K P     LQ + IA
Sbjct: 77  TIQ-YRGC----YLREHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQEVEIA 118

Query: 389 IDVASALD---YLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
                AL    YLH H+      H D+K  NILL E  +  +GDFG A  + P +     
Sbjct: 119 AVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----- 169

Query: 445 IGVKGSIGYIAPEYGLG-SEVSTNG--DVYSYGILMLELIIRKKP 486
               G+  ++APE  L   E   +G  DV+S GI  +EL  RK P
Sbjct: 170 -XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 75/258 (29%), Positives = 108/258 (41%), Gaps = 58/258 (22%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKVFNL-----HHHRASRSFIAECRALRSIRHRNLV 330
           L+G+GSFGSVY+G+ LD+G     VK  +L         A +    E   L  ++H N+V
Sbjct: 7   LLGSGSFGSVYEGLNLDDG-DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 331 KVF-TACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNI 387
           +   T          D   +  E +  GSL + L  Y    E  +    R +        
Sbjct: 66  QYLGTEREE------DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI-------- 111

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI-- 445
                  L+YLH      T H D+K +NIL+D   V  + DFG+A+      V   S   
Sbjct: 112 ----LLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAK 159

Query: 446 GVKGSIGYIAPE-------YGLGSEVSTNGDVYSYGILMLELIIRKKP-SDIMFEGDMNL 497
             KGS  ++APE       YGL +      D++S G  +LE+   K P S    EG   +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPPWSQ--LEGVAAV 211

Query: 498 HNFARM----ALPDHVMD 511
               R      +PDH+ D
Sbjct: 212 FKIGRSKELPPIPDHLSD 229

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 24/218 (11%)

Query: 277 LIGTGSFGSVYKGV-LDEG---RTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVK 331
           ++G+G+FG+VYKG+ + +G   +  V +KV   +   +A++  + E   +  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C     Q      LV + M  G L +++    RE++     ++L     LN  + +
Sbjct: 74  LLGICLTSTVQ------LVTQLMPYGCLLDYV----RENKDRIGSQDL-----LNWCVQI 118

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A  + YL    +    H DL   N+L+       + DFGLAR L     +  + G K  I
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 46/225 (20%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRH---RNLVKV 332
           LIG G++G+VY+G        V +K+ NL       S I  E   L  +R     N+ K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 333 F-------TACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           +            ++Y +G   + L    M+ G + E               + ++++ R
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTL----MKAGPIAE---------------KYISVIIR 108

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
                +V  AL Y+H     +  H D+K +NIL+       + DFG+A  L     Q SS
Sbjct: 109 -----EVLVALKYIHKV--GV-IHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSS 156

Query: 445 --IGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELIIRKKP 486
                 G+  ++APE    G    T  D++S GI + E+     P
Sbjct: 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKV-FNLHHHRASRSFIA-EC--RALRSIRHRNLVK 331
           L+G G+FG VY    +D GR     +V F+      S+   A EC  + L++++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAI 389
            +  C  +  +      +  E+M  GS+++ L  Y    E    K  R            
Sbjct: 69  YY-GC--LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ----------- 114

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI-GVK 448
            +   + YLH +   +  H D+K +NIL D      +GDFG ++ L    +  + I  V 
Sbjct: 115 -ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  +++PE   G       DV+S G  ++E++  K P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 18/211 (8%)

Query: 278 IGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G        E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 74  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 183

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 37/233 (15%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIR 325
           D +   N I  G++G VY+    + +T   V +  L   +    F    + E   L  ++
Sbjct: 5   DEYEKLNRIEEGTYGVVYRAR--DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQN---GSLEEWLYPVNREDEVDKAPRNLNLL 382
           H N+V V     G +    D   +V E++++     +E    P   + EV        L+
Sbjct: 63  HPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPF-LQSEVK------CLM 112

Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
            +L       S + +LH +      H DLK SN+LL+   +  + DFGLAR +  P    
Sbjct: 113 LQL------LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163

Query: 442 TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
           T  + V  ++ Y APE  LG  E ST  D++S G +  EL + KKP   +F G
Sbjct: 164 TQLV-V--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL-LTKKP---LFPG 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 25/219 (11%)

Query: 278 IGTGSFGSVYKGV---LDEGRTT--VTVKVFNLHHHRASRSF---IAECRALRSI-RHRN 328
           +G G FG V       +D+ +    VTV V  L      +     ++E   ++ I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEVD--KAP-RNLNLL 382
           ++ +  AC+    Q      LV E+   G+L E+L    P   +   D  K P   L   
Sbjct: 80  IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 383 QRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             ++ A  VA  ++YL    C     H DL   N+L+ E+ V  + DFGLAR +      
Sbjct: 135 DLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             +   +  + ++APE       +   DV+S+G+L+ E+
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 277 LIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHHRAS------RSFIAECRALRSIRHRNL 329
           ++GTG FG + +G L    +  + V +  L   RA       R F+AE   L    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++     GV  +GN    +V E+M NG+L+ +L    R+ E       L   Q + +  
Sbjct: 69  VRL----EGVITRGNTM-MIVTEYMSNGALDSFL----RKHE-----GQLVAGQLMGMLP 114

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGV 447
            +AS + YL    +    H  L    +L++ ++V  +  F   R L     +   +++  
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSG 168

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           K  + + APE       S+  DV+S+GI+M E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 53/218 (24%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G  +FG +YKG L     D  +      + ++++ +    F  E   +  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN-------REDEVDKAPRNLNLLQRL 385
                GV  Q      +++E++  G L E+L   +         DE      +L+    L
Sbjct: 73  L----GVVTQEQPV-CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT---HVQT 442
           +IAI +A+ ++YL         H DL   NIL+ E++   + D GL+R +       VQ 
Sbjct: 128 HIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            S+     I ++ PE  +  + S++ D++S+G+++ E+
Sbjct: 185 KSL---LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D +     +G GS+ +VYKG        V +KV  L     +  + I E   L+ ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +            +   LV+E++    L +++         DK P  L+        
Sbjct: 65  IVLLHDII-----HTKETLTLVFEYVHT-DLCQYM---------DKHPGGLHPENVKLFL 109

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGV 447
             +   L Y+H   Q    H DLKP N+L+ +     + DFGLAR    P+H  ++ +  
Sbjct: 110 FQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV-- 164

Query: 448 KGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
             ++ Y  P+  LGS E ST  D++  G + +E+I
Sbjct: 165 -VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 3e-09
 Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 36/218 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLV 330
           F+    IG GSFG VYK +       V +KV +L         I  E + L   R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 331 KVFTACSGVDYQG---NDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
           K         Y G      K  ++ E+   GS  + L P  + DE               
Sbjct: 63  K---------YYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDET-------------Y 99

Query: 387 IAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           IA    +V   L+YLH +      H D+K +NILL EE    + DFG++  L  T   + 
Sbjct: 100 IAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSK 154

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                G+  ++APE    S      D++S GI  +EL 
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 68/235 (28%), Positives = 98/235 (41%), Gaps = 49/235 (20%)

Query: 272 FSSANLIGTGSFGSVY----KGVLDEGR---------TTVTVKVFNLHHHRASRSFIAEC 318
           F    ++GTG++G V+     G  D G+          T+  K     H R  R  +   
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN--REDEVDKAP 376
           R     R   LV +  A     +Q +    L+ +++  G L   LY      E EV    
Sbjct: 62  R-----RCPFLVTLHYA-----FQTDTKLHLILDYVNGGELFTHLYQREHFTESEV---- 107

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLAR- 433
                  R+ IA ++  ALD+LH   Q    + D+K  NILLD E   HV   DFGL++ 
Sbjct: 108 -------RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSE--GHVVLTDFGLSKE 154

Query: 434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG--DVYSYGILMLELIIRKKP 486
           FL     +  S    G+I Y+APE   G     +   D +S G+L  EL+    P
Sbjct: 155 FLAEEEERAYSFC--GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 29/221 (13%)

Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++    L
Sbjct: 86  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEE---QL 137

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +    ++ A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 138 SFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 194

Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               +   +  + ++APE       +   DV+S+G+L+ E+
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 37/217 (17%)

Query: 278 IGTGSFGSVYK----GVLDEGRT-TVTVKVFNLHHHRASR-SFIAECRALRSI-RHRNLV 330
           +G G+FG V +    G+        V VK+     H + R + ++E + +  +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 331 KVFTAC--SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            +  AC   G          ++ E+   G L  +L          K    L L   L+ +
Sbjct: 103 NLLGACTIGGPIL-------VITEYCCYGDLLNFLR--------RKRESFLTLEDLLSFS 147

Query: 389 IDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
             VA  + +L   +C     H DL   N+LL    +  + DFGLAR +    +  S+  V
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI----MNDSNYVV 199

Query: 448 KGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           KG+    + ++APE       +   DV+SYGIL+ E+
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)

Query: 278 IGTGSFGSVYKGV---LDEGRT--TVTVKVFNLHHHRASRSF---IAECRALRSI-RHRN 328
           +G G FG V +     +D+ R   TVTV V  L  +   +     I+E   ++ I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEVD--KAPRN-LNLL 382
           ++ +   C+    Q      +V E+   G+L E+L    P   +   D  K P   L+  
Sbjct: 80  IINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 383 QRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             ++ A  VA  ++YL    C     H DL   N+L+ E+ V  + DFGLAR +      
Sbjct: 135 DLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             +   +  + ++APE       +   DV+S+GILM E+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 64/247 (25%), Positives = 107/247 (43%), Gaps = 45/247 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA----ECRALRSIRHRN---LV 330
           +G+G++G+V   +  + RT   V +  L+    S  F      E R L+ ++H N   L+
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            VFT    +D + +DF  LV  FM        L  + + +++ +      + Q L     
Sbjct: 81  DVFTPDLSLD-RFHDF-YLVMPFMGTD-----LGKLMKHEKLSEDRIQFLVYQMLK---- 129

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
               L Y+H        H DLKP N+ ++E+    + DFGLAR        +   G   +
Sbjct: 130 ---GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178

Query: 451 IGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509
             Y APE  L     +   D++S G +M E++  K     +F+G  +L         D +
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL---------DQL 225

Query: 510 MDIVDST 516
           M+I+  T
Sbjct: 226 MEIMKVT 232

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 30/219 (13%)

Query: 276 NLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNL 329
             +G G+FG VY+G+      D     V VK           S F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V+      GV ++    + ++ E M  G L+ +L   NR       P +L +   L  A 
Sbjct: 72  VR----LIGVSFERLP-RFILLELMAGGDLKSFLRE-NRPRPER--PSSLTMKDLLFCAR 123

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIG 446
           DVA    YL  +      H D+   N LL       V+ + DFG+AR      +  +S  
Sbjct: 124 DVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYY 175

Query: 447 VKGS-----IGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            KG      I ++ PE  L    ++  DV+S+G+L+ E+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 57.6 bits (140), Expect = 5e-09
 Identities = 57/212 (26%), Positives = 82/212 (38%), Gaps = 34/212 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFT 334
           +G G FG V    +     T  +K     H           +E   L    H  +VK++ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                 ++   +  ++ E+   G L   L      DE   A        R  IA  V  A
Sbjct: 61  T-----FKDKKYIYMLMEYCLGGELWTILRDRGLFDE-YTA--------RFYIAC-VVLA 105

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-----G 449
            +YLH+  + I    DLKP N+LLD      + DFG A+ L          G K     G
Sbjct: 106 FEYLHN--RGIIYR-DLKPENLLLDSNGYVKLVDFGFAKKL--------KSGQKTWTFCG 154

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +  Y+APE  L      + D +S GIL+ EL+
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 39/227 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTA 335
           IG G++G VYK        T+ +K   L         + I E   L+ ++H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ-- 67

Query: 336 CSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAP---RNLNLLQRLNIAIDV 391
               D   ++ +  LV+E++           ++ +  +D +P   +N  L++     I  
Sbjct: 68  ----DVVHSEKRLYLVFEYLD----------LDLKKHMDSSPDFAKNPRLIKTYLYQI-- 111

Query: 392 ASALDYLH-HDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLAR-FLPPTHVQTSSIGVK 448
              + Y H H       H DLKP N+L+D    +  + DFGLAR F  P    T  +   
Sbjct: 112 LRGIAYCHSHR----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV--- 164

Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            ++ Y APE  LGS   ST  D++S G +  E+ + +KP   +F GD
Sbjct: 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM-VNQKP---LFPGD 207

Length = 294

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 34/224 (15%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNL------HHHRASRSFIAECRA----LRSIRH 326
           LIG G++G VY  +       + VK   L       H    +  +   R+    L+ + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V       G +    ++ ++  E++  GS+   L    R +E           ++  
Sbjct: 68  LNIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEE----QLVRFFTEQ-- 116

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
               V   L YLH   + I  H DLK  N+L+D + +  + DFG+++     +    ++ 
Sbjct: 117 ----VLEGLAYLHS--KGIL-HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 447 VKGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           ++GS+ ++APE    Y  G   S   D++S G ++LE+   ++P
Sbjct: 170 MQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 17/161 (10%)

Query: 329 LVKV---FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           L KV   F       ++  D   LV   M  G L+  +Y V                + +
Sbjct: 47  LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE--------PGFPEARAI 98

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A  +   L++LH   Q    + DLKP N+LLD+     + D GLA  L          
Sbjct: 99  FYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G  G+ GY+APE   G     + D ++ G  + E+I  + P
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 6e-09
 Identities = 29/67 (43%), Positives = 38/67 (56%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           + L  N + GNIPPS+G++  L    +S N   GSIP SLG   SL  + L  N+LSG +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 62  PPQLMGL 68
           P  L G 
Sbjct: 507 PAALGGR 513

Length = 623

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 56/258 (21%), Positives = 94/258 (36%), Gaps = 41/258 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS----RSFIAECRALRSIRHRNLVKVF 333
           I  G+FGSVY       +   T   F +   + S    ++ +   +A R+I        +
Sbjct: 4   ISKGAFGSVYLA-----KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            A     +Q  D+  LV E++  G     +          K    L          +V  
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLI----------KTLGGLPEDWAKQYIAEVVL 108

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKGSI 451
            ++ LH        H D+KP N+L+D+     + DFGL+R        V        G+ 
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV--------GTP 157

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP-----SDIMFE----GDMNLHNFAR 502
            Y+APE  LG       D +S G ++ E +    P      D +F+      +N     +
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK 217

Query: 503 MALPDHVMDIVDSTLLND 520
                  +D+++  L  D
Sbjct: 218 EFCSPEAVDLINRLLCMD 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 7e-09
 Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 6/135 (4%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           L L++  L G I   I  L  L+ +NL  NS    IP  +G +  L+V DL+ NS  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG--SIP--PPLG-NL 674
           P +L   ++L  + L  N L G++P+  G    +   S  F +  G   IP     G +L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIPGLRACGPHL 541

Query: 675 SSLRKISLAINNLAG 689
           S   KI +A      
Sbjct: 542 SVGAKIGIAFGVSVA 556

Length = 623

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 35/219 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS------FIAECRALRSIRHRNLVK 331
           IG G FG V  G    G +   V V  L   RAS +      F+ E +  R + H N+++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKEL---RASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 332 VFTAC-SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
               C   + Y       LV EF   G L+ +L                 +LQR+  A +
Sbjct: 60  CLGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKD---VLQRM--ACE 108

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA--RFLPPTHVQTSSIGVK 448
           VAS L +LH   Q    H DL   N  L  ++   +GD+GLA  ++ P  +  T      
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY-PEDYYITKDCHAV 164

Query: 449 GSIGYIAPEYG-------LGSEVSTNGDVYSYGILMLEL 480
             + ++APE         L  + +   +++S G+ M EL
Sbjct: 165 -PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 60/239 (25%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSF----IAECRALRSIRHRNLV 330
           IG G+FG V+K      R   T ++  L           F    + E + L+ ++H N+V
Sbjct: 20  IGQGTFGEVFKA-----RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 331 KVFTACSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
            +   C       N +K    LV+EF                 E D A     LL   N+
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFC----------------EHDLA----GLLSNKNV 114

Query: 388 AIDVA----------SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
              ++          + L Y+H +      H D+K +NIL+ ++ +  + DFGLAR    
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR---A 168

Query: 438 THVQTSSIGVKGS-----IGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490
             +  +S   + +     + Y  PE  LG  +     D++  G +M E+  R   S IM
Sbjct: 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR---SPIM 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 78/266 (29%), Positives = 112/266 (42%), Gaps = 51/266 (19%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRH 326
           F+    IG GSFG+VY     + RT   V +  + +     +   +  I E + L+ I+H
Sbjct: 27  FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N ++ +  C    Y       LV E+   GS  + L       EV K P     LQ + 
Sbjct: 85  PNSIE-YKGC----YLREHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQEVE 126

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           IA     AL  L +       H D+K  NILL E     + DFG A    P +       
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------S 180

Query: 447 VKGSIGYIAPEYGLG-SEVSTNG--DVYSYGILMLELIIRKKPSDIMFEGDMN----LHN 499
             G+  ++APE  L   E   +G  DV+S GI  +EL  RK P   +F  +MN    L++
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMNAMSALYH 235

Query: 500 FARMALP--------DHVMDIVDSTL 517
            A+   P        D+  + VDS L
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCL 261

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 73/300 (24%), Positives = 111/300 (37%), Gaps = 72/300 (24%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTV---KVFN---LHHHRASRSFIAECRALRS 323
           D F    +IG G+FG V+   L   + T  V   KV     +          AE   L  
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNL 381
                +VK++ +     +Q  +   LV E+M  G L   L    V  E+           
Sbjct: 58  ADSPWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA--------- 103

Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLA------- 432
             R  IA ++  ALD +H   +    H D+KP NIL+D +   H+   DFGL        
Sbjct: 104 --RFYIA-ELVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAK 155

Query: 433 ------------RFLPPTHVQTSSIGVK--------GSIGYIAPEYGLGSEVSTNGDVYS 472
                        F     V+      +        G+  YIAPE   G+      D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215

Query: 473 YGILMLELIIRKKP--SDIMFEGDMNLHNFAR-MALPDHV------MDIVDSTLLNDVED 523
            G+++ E++    P  SD + E    + N+   +  P         +D++   LL D ED
Sbjct: 216 LGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPED 274

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 36/223 (16%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKV-FNLHHHRASRSFIA-EC--RALRSIRHRNLVK 331
           L+G G+FG VY     D GR     +V F+      S+   A EC  + L+++RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAI 389
            +      D +       V E+M  GS+++ L  Y    E+   +  R +  LQ      
Sbjct: 69  YYGCLR--DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQ------ 117

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT---SSIG 446
                + YLH +   +  H D+K +NIL D      +GDFG ++      +QT   S  G
Sbjct: 118 ----GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTG 165

Query: 447 VKGSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           +K   G   +++PE   G       DV+S    ++E++  K P
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.8 bits (138), Expect = 2e-08
 Identities = 69/239 (28%), Positives = 106/239 (44%), Gaps = 61/239 (25%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHR--ASRSFIAECRALRSIR-HRNLVKVF 333
           +G G++G V+K +    +  V +K +F+   +   A R+F  E   L+ +  H N+VK+ 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73

Query: 334 TACSGVDYQGNDFKA-------LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
                     N  KA       LV+E+M     E  L+ V R           N+L+ ++
Sbjct: 74  ----------NVIKAENDKDIYLVFEYM-----ETDLHAVIRA----------NILEDVH 108

Query: 387 ---IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
              I   +  AL Y+H     I  H DLKPSNILL+ +    + DFGLAR      +   
Sbjct: 109 KRYIMYQLLKALKYIH-SGNVI--HRDLKPSNILLNSDCRVKLADFGLAR-----SLSEL 160

Query: 444 SIGVKGSI--------GYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEG 493
               +  +         Y APE  LGS   T G D++S G ++ E+ +  KP   +F G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM-LLGKP---LFPG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 278 IGTGSFGSVYKGV--LDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVKVFT 334
           +G+G+FG V KGV  + + +  V +KV    + ++ R   + E   +  + +  +V++  
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C            LV E    G L ++L    ++DE+  +    N+++ ++    V+  
Sbjct: 63  VCEAEALM------LVMEMASGGPLNKFL--SGKKDEITVS----NVVELMH---QVSMG 107

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQTSSIGVKGSIG 452
           + YL         H DL   N+LL  +  + + DFGL++ L    ++ +  S G K  + 
Sbjct: 108 MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPLK 163

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLE 479
           + APE     + S+  DV+SYGI M E
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 48/238 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVKV- 332
           IG+G++G V   +       V +K     F++    A R+   E + LR  +H N++ + 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAKRTL-RELKILRHFKHDNIIAIR 70

Query: 333 --FTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
                       G DFK   +V + M++  L   ++  + +   ++  R   L Q L   
Sbjct: 71  DILRP------PGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEEHIRYF-LYQLLR-- 118

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
                 L Y+H        H DLKPSN+L++E+    +GDFG+AR L      +S    K
Sbjct: 119 -----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL-----SSSPTEHK 165

Query: 449 G-------SIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                   +  Y APE  L   E +T  D++S G +  E++ R++    +F G   +H
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPGKNYVH 219

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 14/122 (11%)

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++A ALD+LH        + DLKP NILLDEE    + DFGL++       +  +    G
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 160

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-----MNLHNFARMA 504
           ++ Y+APE       + + D +S+G+LM E++    P    F+G      M +   A++ 
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLG 216

Query: 505 LP 506
           +P
Sbjct: 217 MP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G+ G+VY  +       V +K  NL         I E   +R  +H N+V    +  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V E++  GSL +    V  E  +D+        Q   +  +   AL++
Sbjct: 85  ---YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALEF 130

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH + Q I  H D+K  NILL  +    + DFG    + P   + S++   G+  ++APE
Sbjct: 131 LHSN-QVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                      D++S GI+ +E++  + P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 27/210 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G+ G+VYK      R  + VKV  L       +  ++E   L       ++  + A 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA- 67

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
               +   +  ++  EFM  GSL          D   K P ++  L R  IA+ V   L 
Sbjct: 68  ----FFVENRISICTEFMDGGSL----------DVYRKIPEHV--LGR--IAVAVVKGLT 109

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL         H D+KPSN+L++      + DFG++  L    V + +    G+  Y+AP
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAP 162

Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           E   G +   + DV+S GI  +EL + + P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.8 bits (137), Expect = 5e-08
 Identities = 50/194 (25%), Positives = 74/194 (38%), Gaps = 30/194 (15%)

Query: 298 VTVKVFNLHH----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEF 353
           V +K+         H+ +R F  E      + H N+V +    SG           V+E+
Sbjct: 6   VAIKLLRTDAPEEEHQRAR-FRRETALCARLYHPNIVALLD--SGE--APPGLLFAVFEY 60

Query: 354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP 413
           +   +L E L      D    A     L+            LD L         H DLKP
Sbjct: 61  VPGRTLREVL----AADGALPAGETGRLM---------LQVLDALACAHNQGIVHRDLKP 107

Query: 414 SNILL---DEEMVSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVS 465
            NI++        + V DFG+   LP          T +  V G+  Y APE   G  V+
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167

Query: 466 TNGDVYSYGILMLE 479
            N D+Y++G++ LE
Sbjct: 168 PNSDLYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 42/233 (18%)

Query: 272 FSSANL-----IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH 326
           F++ +L     IG G+FG+V K +     T + VK          RS + E    R +  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--------RSTVDEKEQKRLLMD 52

Query: 327 RNLVKVFTACSG-VDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
            ++V   + C   V + G  F+     +  E M + SL++  Y    E      P  +  
Sbjct: 53  LDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEI-- 108

Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
           L +  IA+    AL+YL  + + I  H D+KPSNILLD      + DFG++  L  +  +
Sbjct: 109 LGK--IAVATVKALNYLKEELKII--HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNG--------DVYSYGILMLELIIRKKP 486
           T   G +    Y+APE      +  +         DV+S GI + E+   K P
Sbjct: 165 TRDAGCR---PYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 72/297 (24%), Positives = 114/297 (38%), Gaps = 93/297 (31%)

Query: 262 YQNLHNATDGFSSANLIGTGSFGSV---YKGVLDEGRTTVTVKVFN------LHHHRASR 312
           YQNL            IG+G+ G V   Y  V  +    V +K  +       H  RA R
Sbjct: 18  YQNLK----------PIGSGAQGIVCAAYDTVTGQ---NVAIKKLSRPFQNVTHAKRAYR 64

Query: 313 SFIAECRALRSIRHRN---LVKVFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVN 367
             +     ++ + H+N   L+ VFT    ++    +F+   LV E M             
Sbjct: 65  ELVL----MKLVNHKNIIGLLNVFTPQKSLE----EFQDVYLVMELM------------- 103

Query: 368 REDEVDKAPRNLNLLQRLNIAID----------VASALDYLHHDCQPITTHCDLKPSNIL 417
                     + NL Q + + +D          +   + +LH        H DLKPSNI+
Sbjct: 104 ----------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 150

Query: 418 LDEEMVSHVGDFGLAR-----FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYS 472
           +  +    + DFGLAR     F+   +V T          Y APE  LG     N D++S
Sbjct: 151 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--------YRAPEVILGMGYKENVDIWS 202

Query: 473 YGILMLELIIRKKPSDIMFEGDMNLHNFARMAL-----PDHVMDIVDSTLLNDVEDL 524
            G +M E+I       ++F G  ++  + ++        D  M  +  T+ N VE+ 
Sbjct: 203 VGCIMGEMIRGT----VLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR 255

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 19/205 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G GS+G V             +K  NL +   R  ++   E + L  ++H N+V    +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             G D        +V  F + G L   L    +E +    P N    Q +   + +A AL
Sbjct: 68  WEGEDGL----LYIVMGFCEGGDLYHKL----KEQKGKLLPEN----QVVEWFVQIAMAL 115

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            YLH   +    H DLK  N+ L    +  VGD G+AR L       S++   G+  Y++
Sbjct: 116 QYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGTPYYMS 170

Query: 456 PEYGLGSEVSTNGDVYSYGILMLEL 480
           PE       +   DV++ G  + E+
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 65/226 (28%), Positives = 93/226 (41%), Gaps = 26/226 (11%)

Query: 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASR-SFIAECRALRSIRHRN 328
            F     +G GS+GSVYK           +K  +L    +  R   + E R L S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NI 387
           ++    A       GN    +V E+   G L + +    R     K  R L   Q +  I
Sbjct: 61  IISYKEAF----LDGNKL-CIVMEYAPFGDLSKAI--SKR-----KKKRKLIPEQEIWRI 108

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
            I +   L  LH   Q I  H DLK +NILL    +  +GD G+++ L     +T     
Sbjct: 109 FIQLLRGLQALHE--QKI-LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----Q 161

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
            G+  Y+APE   G   S   D++S G L+ E+     P    FE 
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 61/239 (25%), Positives = 92/239 (38%), Gaps = 39/239 (16%)

Query: 265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI 324
           L + T  F    +IG G++G VYK    +    V +K+ ++           E   LR  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59

Query: 325 -RHRNLVKVFTACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
             H N+   + A    +  GND +  LV E    GS+             D         
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV------------TDLVKGLRKKG 107

Query: 383 QRLN------IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
           +RL       I  +    L YLH   +    H D+K  NILL +     + DFG++  L 
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL- 163

Query: 437 PTHVQTSSIGVKGS-IG---YIAPE-----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                 S++G + + IG   ++APE         +      DV+S GI  +EL   K P
Sbjct: 164 -----DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 278 IGTGSFGSVYKGVL-----DEGR-----TTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           +G G+F ++YKGVL      +        +V +KV     HR S +F      +  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           +LVK++  C   +        +V E+++ G L+ +L+         +   N++L  +L++
Sbjct: 62  HLVKLYGVCVRDENI------MVEEYVKFGPLDVFLH---------REKNNVSLHWKLDV 106

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILL--DEEMVSHVGDFGLARFLPPTHVQTSSI 445
           A  +ASAL YL  D + +  H ++   NIL+        +V    L+    P  V +   
Sbjct: 107 AKQLASALHYL-EDKKLV--HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163

Query: 446 GVKGSIGYIAPEY--GLGSEVSTNGDVYSYGILMLEL 480
            V+  I +IAPE      + ++   D +S+G  +LE+
Sbjct: 164 RVE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 9/98 (9%)

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           + + +  AL YL      I  H D+KPSNILLD      + DFG++  L  +  +T S  
Sbjct: 119 MTVAIVKALHYLKEKHGVI--HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174

Query: 447 VKGSIGYIAPEY----GLGSEVSTNGDVYSYGILMLEL 480
             G   Y+APE         +     DV+S GI ++EL
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 29/215 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF---IAECRALRSIRHRNLVKVFT 334
           I  G++G V+            +KV               + E   L   +   +VK++ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
           +     +QG     LV E++  G L   L  V   DE          + R+ IA ++  A
Sbjct: 61  S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDED---------VARIYIA-EIVLA 105

Query: 395 LDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF------LPPTHVQTSSIGV 447
           L+YLH +       H DLKP NIL+D      + DFGL++       +     +     +
Sbjct: 106 LEYLHSNGI----IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII 482
            G+  YIAPE  LG   S   D +S G ++ E ++
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G+ G+VY  +       V +K  NL         I E   +R  ++ N+V    +  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V E++  GSL +    V  E  +D+        Q   +  +   ALD+
Sbjct: 85  ---YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALDF 130

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH + Q I  H D+K  NILL  +    + DFG    + P   + S++   G+  ++APE
Sbjct: 131 LHSN-QVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                      D++S GI+ +E++  + P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 8e-08
 Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 35/267 (13%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHRASRSFIAECRALRSIRHRNLV 330
           + + + IG G++G V           V +K +    H    +  + E + LR  +H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 331 KVFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            +        ++   F    +V E M     E  LY + +   +        L Q L   
Sbjct: 67  GILDIIRPPSFE--SFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQILR-- 117

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-V 447
                 L Y+H     +  H DLKPSN+LL+      + DFGLAR   P H  T  +   
Sbjct: 118 -----GLKYIH-SANVL--HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 448 KGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506
             +  Y APE  L S   +   D++S G ++ E++  +     +F G   LH        
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP----LFPGKDYLHQL------ 219

Query: 507 DHVMDIVDSTLLNDVEDLAIISNQRQR 533
           + ++ ++ +      EDL  I + R R
Sbjct: 220 NLILGVLGTP---SQEDLNCIISLRAR 243

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 22/218 (10%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRN 328
           D F   + +G G+ G V K         +  K+ +L    A R+  I E + L       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  +    G  Y   +  ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 65  IVGFY----GAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPE--------EILGKVSIA 111

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    Q    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 112 --VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 163

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++EL I + P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 64/257 (24%), Positives = 103/257 (40%), Gaps = 24/257 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V           V VK  +L   +       E   +R   H N+V ++ +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL Y
Sbjct: 88  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLSVLRALSY 133

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH+       H D+K  +ILL  +    + DFG    +     +  S+   G+  ++APE
Sbjct: 134 LHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPE 188

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD-ST 516
                   T  D++S GI+++E+I  + P     E  +      R  LP  V D    S+
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246

Query: 517 LLNDVEDLAIISNQRQR 533
           +L    DL ++    QR
Sbjct: 247 VLRGFLDLMLVREPSQR 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 25/72 (34%), Positives = 45/72 (62%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
           SK + +  ++L    + G+I P +G+++ L++L+L  NSF   IP  +G+L  L++ +LN
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498

Query: 612 NNSIGGEIPVNL 623
            NS+ G +P  L
Sbjct: 499 GNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 29/225 (12%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH------HHRASRSFIAECRALRSIR 325
           ++   ++G G++G+VY G+ ++G+  + VK   L         +       E   L+S++
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V+    C       N   ++  EF+  GS+   L       E         +L   
Sbjct: 61  HVNIVQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-- 113

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTS 443
                    + YLH++C     H D+K +N++L    +  + DFG AR L     H   S
Sbjct: 114 --------GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162

Query: 444 SI--GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           ++   + G+  ++APE    S      D++S G  + E+   K P
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV---KVFT 334
           +G G++G VYK    +G+      +  +     S S   E   LR ++H N++   KVF 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 335 ACSGVDYQGNDFKA-LVYEFMQNGSLEEW-LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           + S       D K  L++++ ++   + W +   +R  + +K P  L      ++   + 
Sbjct: 69  SHS-------DRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 393 SALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
             + YLH +      H DLKP+NIL+     E     + D G AR F  P         V
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
             +  Y APE  LG+   T   D+++ G +  EL+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 22/218 (10%)

Query: 272 FSSANLIGTGSFGSVYK-GVLDEGRTTVTVKVFN--LHHHRASRSFIAECRALRSIRHRN 328
           F    ++G G FG V    V   G+     K+    +   +     + E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +  A     Y+  D   LV   M  G L+  +Y +      +         + +  A
Sbjct: 62  VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG--------RAVFYA 108

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            ++   L+ LH   Q    + DLKP NILLD+     + D GLA  +P    QT   G  
Sbjct: 109 AEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIK-GRV 162

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G++GY+APE       + + D ++ G L+ E+I  + P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 18/148 (12%)

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPV-NREDEVDKAPRNLNLLQRLNIAIDVASALDYLH 399
           Y+  D   LV   M  G L+  +Y + N   E ++A         L  A ++   L+ LH
Sbjct: 69  YETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA---------LFYAAEILCGLEDLH 119

Query: 400 HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI-GVKGSIGYIAPEY 458
              +  T + DLKP NILLD+     + D GLA  +P    +  SI G  G++GY+APE 
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP----EGESIRGRVGTVGYMAPEV 172

Query: 459 GLGSEVSTNGDVYSYGILMLELIIRKKP 486
                 + + D +  G L+ E+I  + P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 39/231 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA----ECRALRSIRHR 327
           ++S   +G+G++GSV   +  + RT   V +  L     S  F      E   L+ ++H 
Sbjct: 17  YTSLKQVGSGAYGSVCSAI--DKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 328 N---LVKVFT-ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           N   L+ VFT A SG ++Q  DF  LV  +MQ   L++ +     ED+V          Q
Sbjct: 75  NVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQT-DLQKIMGHPLSEDKV----------Q 120

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
            L     +   L Y+H        H DLKP N+ ++E+    + DFGLAR     H    
Sbjct: 121 YL--VYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAE 170

Query: 444 SIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             G   +  Y APE  L     +   D++S G +M E++  K     +F+G
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 30/228 (13%)

Query: 278 IGTGSFGSVY--KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           IG GSFG +Y  K   D     +          +   +   E   L  ++H N+V  F +
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                +Q N    +V E+   G L   +  +NR+  V       +  Q L+  + ++  L
Sbjct: 68  -----FQENGRLFIVMEYCDGGDL---MKRINRQRGV-----LFSEDQILSWFVQISLGL 114

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTH--VQTSSIGVKGSIG 452
            ++H        H D+K  NI L +  MV+ +GDFG+AR L  +     T      G+  
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV----GTPY 167

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           Y++PE       +   D++S G ++ EL   K P    FEG+ NLH  
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 16/177 (9%)

Query: 309 RASRSFIAECRALRSIRHRNLVKVFTACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPV 366
           RA R F +  R  +S + R   +     S VD   +      L   F  + S      P 
Sbjct: 104 RAKREFFSPYRE-KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS--TNPP 160

Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSH 425
              D++ K+P  L +   +  +  VA  +++L    C     H DL   NILL E  V  
Sbjct: 161 QETDDLWKSP--LTMEDLICYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVK 214

Query: 426 VGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + DFGLAR  +  P +V+  S   +  + ++APE       +T  DV+S+G+L+ E+
Sbjct: 215 ICDFGLARDIYKDPDYVRKGS--ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 31/247 (12%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKV-FNLHHHRASRSFIA-EC--RALRSIRHRNLVK 331
           L+G G+FG VY     D GR     +V F+      S+   A EC  + L+++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAI 389
            +      D       ++  E M  GS+++ L  Y    E+   K  R            
Sbjct: 69  YYGCLR--DPMERTL-SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ----------- 114

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI-GVK 448
            +   + YLH +   +  H D+K +NIL D      +GDFG ++ L    +  + +  V 
Sbjct: 115 -ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM----A 504
           G+  +++PE   G       D++S G  ++E++  K P    FE    +   A       
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW-AEFEAMAAIFKIATQPTNPV 229

Query: 505 LPDHVMD 511
           LP HV D
Sbjct: 230 LPPHVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 14/223 (6%)

Query: 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL 321
           + +  + +D +     IG G++G V+K +  +  +   VK+ +   H       AE   L
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNIL 68

Query: 322 RSIR-HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           +++  H N+VK +      D +  D   LV E    GS+          D V    +   
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT---------DLVKGFLKRGE 119

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT-H 439
            ++   IA  +  AL  L H     T H D+K +NILL  E    + DFG++  L  T  
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 440 VQTSSIGVKGSIG--YIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + +S+G    +    IA E  L S      DV+S GI  +EL
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G+ G+V+  +       V +K  NL         I E   ++ +++ N+V    +  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              +   D   +V E++  GSL +    V  E  +D+A       Q   +  +   AL++
Sbjct: 85  ---FLVGDELFVVMEYLAGGSLTD----VVTETCMDEA-------QIAAVCRECLQALEF 130

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH + Q I  H D+K  N+LL  +    + DFG    + P   + S++   G+  ++APE
Sbjct: 131 LHAN-QVI--HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                      D++S GI+ +E++  + P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.9 bits (127), Expect = 5e-07
 Identities = 36/127 (28%), Positives = 64/127 (50%), Gaps = 8/127 (6%)

Query: 658 LGFNN--LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIV 715
           LG +N  L G IP  +  L  L+ I+L+ N++ G+IP +L  + +L +L L  N  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 716 PSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIP------PSIS 769
           P S+  ++S+   ++  N + G +P   G  L +   F+   N     IP      P +S
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542

Query: 770 NASKLEV 776
             +K+ +
Sbjct: 543 VGAKIGI 549

Length = 623

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 47/208 (22%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 278 IGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG+    +   TV VK+    ++  +     + E   ++ + +  +V++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G L ++L          +  +++       +   V+ 
Sbjct: 63  GICEAESWM------LVMELAELGPLNKFL----------QKNKHVTEKNITELVHQVSM 106

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 107 GMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPV 162

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLE 479
            + APE     + S+  DV+S+G+LM E
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 32/210 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++ +V+KG        V +K   L H   A  + I E   L++++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--- 69

Query: 337 SGVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI---DVA 392
              D    +    LV+E++ +  L+++L                NL+   N+ I    + 
Sbjct: 70  ---DIIHTERCLTLVFEYLDS-DLKQYLDNCG------------NLMSMHNVKIFMFQLL 113

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGVKGSI 451
             L Y H        H DLKP N+L++E+    + DFGLAR    PT   ++ +    ++
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV---VTL 167

Query: 452 GYIAPEYGLGS-EVSTNGDVYSYGILMLEL 480
            Y  P+  LGS E ST  D++  G ++ E+
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.9 bits (127), Expect = 6e-07
 Identities = 65/258 (25%), Positives = 101/258 (39%), Gaps = 66/258 (25%)

Query: 277 LIGTGSFGSVYKGVLDE--GRTTVTVKV------FNLHHHRASRSFIAECRALRSIRHRN 328
           LIG G  G VY    D    R     K+        L   R    F+ E +    + H  
Sbjct: 9   LIGKGGMGEVYLA-YDPVCSRRVALKKIREDLSENPLLKKR----FLREAKIAADLIHPG 63

Query: 329 LVKVFTACSGVDYQGNDFKALVY---EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           +V V++ CS  D         VY    +++  +L+  L  V +++ + K          L
Sbjct: 64  IVPVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSK---------EL 106

Query: 386 NIAIDVASALDYLHHDCQPI-------TTHCDLKPSNILLD--EEMVSHVGDFGLARF-- 434
                V + L   H  C  I         H DLKP NILL    E+V  + D+G A F  
Sbjct: 107 AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV--ILDWGAAIFKK 164

Query: 435 ----------LPPTHVQTSSIGVKGSI----GYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
                     +   ++  SS+ + G I     Y+APE  LG   S + D+Y+ G+++ ++
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Query: 481 II------RKKPSDIMFE 492
           +       RKK   I + 
Sbjct: 225 LTLSFPYRRKKGRKISYR 242

Length = 932

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 56/235 (23%)

Query: 261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECR 319
           +Y+ L            +G GS+ +VYKG        V +K   L H   A  + I E  
Sbjct: 6   TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS 55

Query: 320 ALRSIRHRNLVK----VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
            L+ ++H N+V     + T  +           LV+E++    L++++         D  
Sbjct: 56  LLKDLKHANIVTLHDIIHTKKTLT---------LVFEYLDT-DLKQYM---------DDC 96

Query: 376 PRNLN-------LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
              L+       L Q L         L Y H   + +  H DLKP N+L+ E     + D
Sbjct: 97  GGGLSMHNVRLFLFQLLR-------GLAYCHQ--RRVL-HRDLKPQNLLISERGELKLAD 146

Query: 429 FGLARFLP-PTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
           FGLAR    P+   ++ +    ++ Y  P+  LGS E ST+ D++  G +  E+ 
Sbjct: 147 FGLARAKSVPSKTYSNEV---VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA 198

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V    +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V E++  GSL +    V  E  +D+        Q   +  +   AL++
Sbjct: 86  ---YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALEF 131

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH + Q I  H D+K  NILL  +    + DFG    + P   + S++   G+  ++APE
Sbjct: 132 LHSN-QVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 186

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                      D++S GI+ +E+I  + P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 38/119 (31%), Positives = 60/119 (50%), Gaps = 14/119 (11%)

Query: 368 REDEVDKAP-RNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSH 425
            +DE D      L+L   L  +  VA  +D+L   +C     H D+   N+LL +  V+ 
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAK 252

Query: 426 VGDFGLARFLPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + DFGLAR +    +  S+  VKG+    + ++APE       +   DV+SYGIL+ E+
Sbjct: 253 ICDFGLARDI----MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 27/219 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS------RSFIAECRALRSIRHRNLV 330
            +GTG+F S Y+    +  T + VK      + +S       +   E R +  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           +      G   + + F   V E+M  GS+   L                 ++  +N    
Sbjct: 67  R----MLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGAFKEAVI--INYTEQ 111

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVK- 448
           +   L YLH + Q I  H D+K +N+L+D       + DFG A  L            + 
Sbjct: 112 LLRGLSYLH-ENQII--HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168

Query: 449 -GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+I ++APE   G +   + DV+S G +++E+   K P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A ++   L +LH        + DLK  NILLD +    + DFG+ +       +T +   
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC- 157

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+  YIAPE  LG + +T+ D +S+G+L+ E++I + P
Sbjct: 158 -GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 31/223 (13%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNL--------HHHRASRSFIA-ECRALRSIRHR 327
           LIG+GSFGSVY G+       + VK   L           R+    +A E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+V+   +    D+  N F     E++  GS+   L      +E          L R N 
Sbjct: 67  NIVQYLGSSLDADHL-NIF----LEYVPGGSVAALLNNYGAFEET---------LVR-NF 111

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG- 446
              +   L+YLH+       H D+K +NIL+D +    + DFG+++ L    + T + G 
Sbjct: 112 VRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168

Query: 447 ---VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              ++GS+ ++APE    +  +   D++S G L++E++  K P
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 9e-07
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++ +V+KG        V +K   L H   A  + I E   L+ ++H N+V +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                  +    LV+E++ +  L++++      D+        N++   N+ I +   L 
Sbjct: 74  -----HTDKSLTLVFEYL-DKDLKQYM------DDCG------NIMSMHNVKIFLYQILR 115

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGVKGSIGYIA 455
            L +  +    H DLKP N+L++E     + DFGLAR    PT   ++ +    ++ Y  
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV---VTLWYRP 172

Query: 456 PEYGLG-SEVSTNGDVYSYGILMLEL 480
           P+  LG SE ST  D++  G +  E+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 3/106 (2%)

Query: 374 KAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
              R L L Q   +A  + SA+DY+H   + I  H D+K  N+L++      +GDFG A 
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIH--GEGII-HRDIKTENVLVNGPEDICLGDFGAAC 308

Query: 434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE 479
           F   +       G+ G++   APE   G   + + D++S G+++ E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 26/215 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       K+  +        F+ E   L   +H N+V ++ A  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 338 GVDYQGNDFKALVY-EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                  + K  +  EF   G+L+           + +  R L   Q   +   +  AL+
Sbjct: 73  ------YENKLWILIEFCDGGALD---------SIMLELERGLTEPQIRYVCRQMLEALN 117

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           +LH        H DLK  NILL  +    + DFG++     T  +  +    G+  ++AP
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAP 172

Query: 457 EYGLGSEVSTN-----GDVYSYGILMLELIIRKKP 486
           E         N      D++S GI ++EL   + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV---KVFT 334
           +G G++G VYK    +G+      +  +     S S   E   LR ++H N++   KVF 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 335 ACSGVDYQGNDFKA-LVYEFMQNGSLEEW-LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           + +       D K  L++++ ++   + W +   +R  + +K P  L      ++   + 
Sbjct: 69  SHA-------DRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118

Query: 393 SALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
             + YLH +      H DLKP+NIL+     E     + D G AR F  P         V
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
             +  Y APE  LG+   T   D+++ G +  EL+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++ +VYKG        V +K   L H   A  + I E   L+ ++H N+V +    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                       LV+E++ +  L+++L      D+        N +   N+ + +   L 
Sbjct: 74  -----HTEKSLTLVFEYL-DKDLKQYL------DDCG------NSINMHNVKLFLFQLLR 115

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGVKGSIGYIA 455
            L++  +    H DLKP N+L++E     + DFGLAR    PT   ++ +    ++ Y  
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV---VTLWYRP 172

Query: 456 PEYGLGS-EVSTNGDVYSYGILMLELI 481
           P+  LGS + ST  D++  G +  E+ 
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMS 199

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)

Query: 278 IGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           +G G+F  ++KG+  E        +T V +KV +  H   S SF      +  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL-NLLQRLNIAI 389
             +  C   D        +V E+++ GSL+ +L          K  +NL N+  +L +A 
Sbjct: 63  LNYGVCVCGDES-----IMVQEYVKFGSLDTYL----------KKNKNLINISWKLEVAK 107

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEE 421
            +A AL +L        TH ++   N+LL  E
Sbjct: 108 QLAWALHFLEDKG---LTHGNVCAKNVLLIRE 136

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 31/274 (11%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           D F    +IG G+FG V    +        +K+ N       R+  A  R  R++     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGD 59

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRLNI 387
            +  T      +Q  ++  LV ++   G L   L         D+ P ++    +  + +
Sbjct: 60  CQWITTLH-YAFQDENYLYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVL 113

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           AI     L Y+H D         +KP N+LLD      + DFG    +       SS+ V
Sbjct: 114 AIHSIHQLHYVHRD---------IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164

Query: 448 KGSIGYIAPEY------GLGSEVSTNGDVYSYGILMLELIIRKKP--SDIMFEGDMNLHN 499
            G+  YI+PE       G+G +     D +S G+ M E++  + P  ++ + E    + N
Sbjct: 165 -GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Query: 500 F-ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQ 532
              R   P H+ D+ +     D+    I S +R+
Sbjct: 223 HEERFQFPSHITDVSEEA--KDLIQRLICSRERR 254

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 11/108 (10%)

Query: 388 AIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           A ++   L +LH         + DLK  N+LLD E    + DFG+ +      V TS+  
Sbjct: 102 AAEIVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             G+  YIAPE           D ++ G+L+ E++  + P    FEGD
Sbjct: 158 --GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 28/141 (19%)

Query: 352 EFMQNGSLEEWLYPVNREDEVDK--APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC 409
           EFM  GSL          D + K   P  + +L +  IA+ V   L YL++  + +  H 
Sbjct: 83  EFMDCGSL----------DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHRIM--HR 128

Query: 410 DLKPSNILLDEEMVSHVGDFG----LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVS 465
           D+KPSNIL++      + DFG    L   +  T V TS+        Y++PE   G + +
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST--------YMSPERIQGGKYT 180

Query: 466 TNGDVYSYGILMLELIIRKKP 486
              DV+S GI ++EL + K P
Sbjct: 181 VKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 22/218 (10%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R+  I E + L       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  +    G  Y   +  ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 65  IVGFY----GAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 111

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 112 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 163

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ I + P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 39/106 (36%), Positives = 54/106 (50%), Gaps = 14/106 (13%)

Query: 408 HCDLKPSNILLDEE-MVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EV 464
           H DLKP N+L+D++  +  + D GL R F  P    T  I    ++ Y APE  LGS   
Sbjct: 133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI---VTLWYRAPEVLLGSTHY 189

Query: 465 STNGDVYSYGILMLELIIRKKPSDIMFEGDMN----LHNFARMALP 506
           ST  D++S G +  E+  RK+P   +F GD      LH F  +  P
Sbjct: 190 STPVDIWSVGCIFAEM-SRKQP---LFPGDSELQQLLHIFKLLGTP 231

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 25/201 (12%)

Query: 313 SFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV 372
            F+ E + L  +   N+ ++   C+      +    ++ E+M+NG L ++L       E 
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCT-----VDPPLCMIMEYMENGDLNQFLQ--KHVAET 117

Query: 373 DKAPRNLNLLQR---LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429
                N   L     L +A  +AS + YL         H DL   N L+ +     + DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADF 174

Query: 430 GLARFLPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELII--R 483
           G++R L      +    V+G     I ++A E  L  + +T  DV+++G+ + E++   R
Sbjct: 175 GMSRNL----YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230

Query: 484 KKPSDIMFEGDM--NLHNFAR 502
           ++P + + +  +  N  +F R
Sbjct: 231 EQPYEHLTDQQVIENAGHFFR 251

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A ++   L +LH        + DLK  N+LLD++    + DFG+ +       + S+   
Sbjct: 102 AAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC- 157

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G+  YIAPE   G + + + D +S+G+L+ E++I + P    F G+
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 34/222 (15%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRN 328
           F     +GTGSFG V             +K          +  +    E   L  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +   CS   +Q  +    + EF+  G L   L          KA R  N + +   A
Sbjct: 80  IVNMM--CS---FQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFYHA 125

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            ++  A +YLH     I  + DLKP N+LLD +    V DFG A+      V   +  + 
Sbjct: 126 -ELVLAFEYLH-SKDII--YRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC 176

Query: 449 GSIGYIAPEY----GLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y+APE     G G  V    D ++ G+L+ E I    P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 21/209 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V           V VK+ +L   +       E   +R  +H+N+V+++ +  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS-- 86

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   +   ++ EF+Q G+L + +      +E           Q   +   V  AL Y
Sbjct: 87  ---YLVGEELWVLMEFLQGGALTDIVSQTRLNEE-----------QIATVCESVLQALCY 132

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH        H D+K  +ILL  +    + DFG    +     +  S+   G+  ++APE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPE 187

Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               +   T  D++S GI+++E++  + P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 28/210 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV +         ++ E   L S  H N+VK+  A  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y  N+   L+ EF   G+++  +  + R          L   Q   +      AL+Y
Sbjct: 72  ---YYENNLWILI-EFCAGGAVDAVMLELERP---------LTEPQIRVVCKQTLEALNY 118

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGYIAP 456
           LH +      H DLK  NIL   +    + DFG+ A+       + S IG      ++AP
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP---YWMAP 172

Query: 457 EYGLGSEVSTN------GDVYSYGILMLEL 480
           E  +  E S +       DV+S GI ++E+
Sbjct: 173 EVVM-CETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 35/115 (30%), Positives = 60/115 (52%), Gaps = 8/115 (6%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIG 446
           A ++  AL++LH   +    + DLK  N+LLD +    + D+G+ +  L P    ++  G
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG-DMNLHNF 500
                 YIAPE   G E   + D ++ G+LM E++  + P DI+ +  DMN  ++
Sbjct: 159 TPN---YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 28/217 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           ++G G++G VY       +  + +K       R  +    E      ++HRN+V+   + 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           S      N F  +  E +  GSL   L            P   N    +     +   L 
Sbjct: 75  S-----ENGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 397 YLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           YLH     I  H D+K  N+L++    V  + DFG ++ L   +  T +    G++ Y+A
Sbjct: 123 YLHD--NQI-VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMA 177

Query: 456 PEY------GLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE       G G+      D++S G  ++E+   K P
Sbjct: 178 PEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 54/236 (22%), Positives = 107/236 (45%), Gaps = 35/236 (14%)

Query: 278 IGTGSFGSVY----KGV---LDEGRTT-------VTVKVFNLHHHRASRS-FIAECRALR 322
           +G G FG V+    +G+   L EG          V VK+      + +R+ F+ E + + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            +++ N++++   C       +D   ++ E+M+NG L ++L     E     A  N+  +
Sbjct: 73  RLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHA-NNIPSV 126

Query: 383 QRLNI---AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT- 438
              N+   A+ +AS + YL         H DL   N L+       + DFG++R L    
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 439 --HVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDIM 490
              +Q  ++     I ++A E  L  + +T  DV+++G+ + E+    +++P  ++
Sbjct: 184 YYRIQGRAV---LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 44/228 (19%)

Query: 278 IGTGSFGSV---YKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G V   Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 25  IGSGAQGIVCAAYDAVLDR---NVAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 77

Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 78  IISLLNVFTPQKSLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 129

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 130 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 180 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 67/272 (24%), Positives = 109/272 (40%), Gaps = 59/272 (21%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G+G++GSV        R  V VK  +      +H  R  R    E R L+ ++H N++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHMKHENVI- 77

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLN--- 386
                            L+  F    S+E +  +Y V      D    N+   Q+L+   
Sbjct: 78  ----------------GLLDVFTPATSIENFNEVYLVTNLMGADL--NNIVKCQKLSDEH 119

Query: 387 ---IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
              +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR          
Sbjct: 120 VQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDE 171

Query: 444 SIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             G   +  Y APE  L     +   D++S G +M EL+  K     +F G+  +    R
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGNDYIDQLKR 227

Query: 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
                 +M++V +      E L  IS++  R+
Sbjct: 228 ------IMEVVGTP---SPEVLKKISSEHARK 250

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 15/174 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L+ NRL  NI   +  L  L    + +N +    P    L  +L  + L +N +  +
Sbjct: 97  SLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-S 154

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           +P  L  L +L  LDLS N      P  + NL NL  L +SGN +  ++P  +     LE
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 121 ILEMQGN----------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
            L++  N            + L+ L+LS NKL  ++PE +  L  +E L+LS N
Sbjct: 213 ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN 265

Length = 394

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 23/148 (15%)

Query: 373 DKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431
           D     L  L  L+    VA  +++L   +C     H DL   N+LL +  +  + DFGL
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGL 283

Query: 432 ARFLPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS 487
           AR +    +  S+   KGS    + ++APE    +  +T  DV+SYGIL+ E+       
Sbjct: 284 ARDI----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF---SLG 336

Query: 488 DIMFEG---DMNLHNFA----RMALPDH 508
              + G   D   +N      RMA PDH
Sbjct: 337 GTPYPGMIVDSTFYNKIKSGYRMAKPDH 364

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
           R L + Q L I   +   L YLH        H D+K  NI +++     +GD G A+F  
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-- 206

Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           P  V  + +G+ G++   APE     + ++  D++S GI++ E++
Sbjct: 207 PV-VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 30/227 (13%)

Query: 277 LIGTGSFGSVY--KGVLDEGRT-TVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           LIG G FG VY  +   D         K+ NL     + + + E     +I   + + ++
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYDIDKIALW 74

Query: 334 TACSGVDYQG-------NDFK--ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
                +D+ G         FK   + Y F+    L E L    +E       +N  L++ 
Sbjct: 75  KNIHNIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIK- 129

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF--LPPTHVQT 442
            NI  D+ + L+Y+H       +H D+KP NI++D     ++ D+G+A    +   H++ 
Sbjct: 130 -NIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185

Query: 443 SSIGV---KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           S       +G++ Y   +   G+ V+  GD+ S G  ML+    K P
Sbjct: 186 SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
           DE+ K P  L L   ++ +  VA  +++L    C     H DL   NILL E  V  + D
Sbjct: 163 DELYKEP--LTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICD 216

Query: 429 FGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE---LIIR 483
           FGLAR  +  P +V+      +  + ++APE       +T  DV+S+G+L+ E   L   
Sbjct: 217 FGLARDIYKDPDYVRKGD--ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 274

Query: 484 KKPSDIMFEGDMN-LHNFARMALPDHVMDIVDSTLL 518
             P   + E     L    RM  P++    + S +L
Sbjct: 275 PYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 36/213 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTAC 336
           +G GS+ +VYKG+       V +KV ++        + I E   L+ ++H N+V +    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                   +    V+E+M    L +++          + P  L+          +   L 
Sbjct: 73  -----HTKETLTFVFEYMHT-DLAQYM---------IQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVG-----DFGLARF--LPPTHVQTSSIGVKG 449
           Y+H   Q I  H DLKP N+L     +S++G     DFGLAR   +P    QT S  V  
Sbjct: 118 YIHG--QHIL-HRDLKPQNLL-----ISYLGELKLADFGLARAKSIP---SQTYSSEVV- 165

Query: 450 SIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
           ++ Y  P+  LG+ + S+  D++  G + +E++
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 19/154 (12%)

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           +Q  +    V EF+  G L   ++ +  +   D       L +    A ++   L +LH 
Sbjct: 65  FQTKEHLFFVMEFLNGGDL---MFHIQDKGRFD-------LYRATFYAAEIVCGLQFLHS 114

Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL 460
                  + DLK  N++LD +    + DFG+ +          +    G+  YIAPE   
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 461 GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           G + + + D +S+G+L+ E++I + P    F GD
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 44/197 (22%)

Query: 306 HHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEW--L 363
           H  RA R  +     L+ + H+N++                  L+  F    SLEE+  +
Sbjct: 63  HAKRAYRELVL----LKCVNHKNIIS-----------------LLNVFTPQKSLEEFQDV 101

Query: 364 YPVNREDEVDKAPRNLNLLQRLNIAID--VASALDY-----LHHDCQPITTHCDLKPSNI 416
           Y V    E+  A    NL Q +++ +D    S L Y     + H       H DLKPSNI
Sbjct: 102 YLVM---ELMDA----NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154

Query: 417 LLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGIL 476
           ++  +    + DFGLAR      + T  +  +    Y APE  LG     N D++S G +
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCI 211

Query: 477 MLELIIRKKPSDIMFEG 493
           M EL+       ++F+G
Sbjct: 212 MGELV----KGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 56/235 (23%)

Query: 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFI 315
           YQNL          + +G+G++GSV      +    V VK  +      +H  R  R   
Sbjct: 19  YQNL----------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR--- 65

Query: 316 AECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVD 373
            E R L+ ++H N++                  L+  F    SLEE+  +Y V      D
Sbjct: 66  -ELRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVTHLMGAD 107

Query: 374 KAPRNLNLLQRLN------IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427
               N+   Q+L       +   +   L Y+H        H DLKPSN+ ++E+    + 
Sbjct: 108 L--NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162

Query: 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELI 481
           DFGLAR     H      G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 163 DFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 56/173 (32%), Positives = 85/173 (49%), Gaps = 12/173 (6%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L  N++S ++PP I  L  L E  +S+N +   + SSL   ++L+ + L NN L   +
Sbjct: 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL 247

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  +  L++L  LDLS NQ   S  + +G+L NL  L +SGN L   +P      + LE+
Sbjct: 248 PESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305

Query: 122 LE----MQGNVFQGLTILDLSRNKLSGE---IPEFLVGLKVIENLNLSYNDLE 167
           L         +   L  + L+ N LS      PE L  L+ + NL    N L+
Sbjct: 306 LLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 48.1 bits (115), Expect = 9e-06
 Identities = 55/231 (23%), Positives = 89/231 (38%), Gaps = 46/231 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR------ASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VYK    +    V +K   +H+ +      A R    E + L+ ++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 332 ----VFTACSGVDYQGNDFKALVYEFMQ---NGSLEEWLYPVNREDEVDKAPR-NLNLLQ 383
                         +      +V  +M    +G LE               P   L   Q
Sbjct: 72  LIDMAVERPDKSKRKRGSV-YMVTPYMDHDLSGLLEN--------------PSVKLTESQ 116

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQ 441
                + +   ++YLH     I  H D+K +NIL+D + +  + DFGLAR    PP + +
Sbjct: 117 IKCYMLQLLEGINYLH--ENHIL-HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Query: 442 TSSIGVKGSIG-------YIAPEYGLG-SEVSTNGDVYSYGILMLELIIRK 484
               G             Y  PE  LG    +T  D++  G +  E+  R+
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 3/96 (3%)

Query: 696 SKLKNLVILYLGVNR--LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYF 753
           S      I  LG++   L G +P+ I  +  +   ++  N I+GNIP   G ++ +L+  
Sbjct: 413 STKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVL 471

Query: 754 SIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            +  N   G+IP S+   + L +     N L+G VP
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 29/213 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL  
Sbjct: 86  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLKALSV 131

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH        H D+K  +ILL  +    + DFG    +     +  S+   G+  ++APE
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPE 186

Query: 458 Y----GLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  G EV    D++S GI+++E++  + P
Sbjct: 187 LISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 48/237 (20%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNL----HHHRASRSFIAEC----------RAL 321
             +G G++G V K         V +K   +    +     R  +  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 322 RSIRHRNLVKVFTACSGVD-YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
             I+H N++ +      VD Y   DF  LV + M    L++    V+R+  + ++     
Sbjct: 75  NEIKHENIMGL------VDVYVEGDFINLVMDIMA-SDLKK---VVDRKIRLTESQVKCI 124

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           LLQ LN        L+ LH   +    H DL P+NI ++ + +  + DFGLAR +  P +
Sbjct: 125 LLQILN-------GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Query: 440 VQTSSIGVKGS-----------IGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRK 484
             T S                 + Y APE  +G+E      D++S G +  EL+  K
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 26/209 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV           ++ E   L +  H  +VK+     
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---- 75

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
           G  Y       ++ EF   G+++  +       E+D   R L   Q   I   +  AL Y
Sbjct: 76  GAFYWDGKLWIMI-EFCPGGAVDAIML------ELD---RGLTEPQIQVICRQMLEALQY 125

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGYIAP 456
           LH        H DLK  N+LL  +    + DFG+ A+ +     + S IG      ++AP
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP---YWMAP 179

Query: 457 EYGL-----GSEVSTNGDVYSYGILMLEL 480
           E  +      +      D++S GI ++E+
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 22/229 (9%)

Query: 260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECR 319
           L  ++L + TD +     IG G++G VYK    +  +   VK+ +           AE  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYN 70

Query: 320 ALRSI-RHRNLVKVFTACSGVDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDK 374
            L+S+  H N+VK +    G+ Y+ +        LV E    GS+ E +  +    +   
Sbjct: 71  ILQSLPNHPNVVKFY----GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ--- 123

Query: 375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
                  L    I+  +  AL  L H       H D+K +NILL  E    + DFG++  
Sbjct: 124 ------RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 435 LPPTHV-QTSSIGVKGSIG--YIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           L  T + + +S+G    +    IA E           DV+S GI  +EL
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 7/89 (7%)

Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS--IGVKGSIGYIAPEYGLG-SEV 464
           H DLKP N+L++ +    + DFGLAR       + +        +  Y APE  L     
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Query: 465 STNGDVYSYGILMLELIIRKKPSDIMFEG 493
           +   DV+S G ++ EL+ RK     +F+G
Sbjct: 188 TKAIDVWSVGCILAELLGRKP----VFKG 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH 326
           N  + F     IG+G++G VYK           +KV  L           E   ++  +H
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V  F +     Y   D   +  EF   GSL++ +Y V         P  L+  Q   
Sbjct: 66  SNIVAYFGS-----YLRRDKLWICMEFCGGGSLQD-IYHVT-------GP--LSESQIAY 110

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           ++ +    L YLH   +    H D+K +NILL +     + DFG++  +  T  +  S  
Sbjct: 111 VSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF- 166

Query: 447 VKGSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKPSDIMFE 492
             G+  ++APE    + V   G      D+++ GI  +EL   + P   MF+
Sbjct: 167 -IGTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 7/106 (6%)

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVK 448
           +++ AL+YLH   +    + DLK  N+LLD E    + D+G+ +  L P    ++  G  
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
               YIAPE   G +   + D ++ G+LM E++  + P DI+   D
Sbjct: 161 N---YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 31/211 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH----HHRASRSFIAECRALRSIRHRNLVKV- 332
           IG GSFG V      + R   T +++ L      H  SRS +    A R++    L +V 
Sbjct: 1   IGKGSFGKVM-----QVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTV----LAQVN 51

Query: 333 --FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
             F       +Q  +   LV  F+  G L    + + RE   D +       + L     
Sbjct: 52  CPFIVPLKFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAELL----- 103

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
              AL+ LH   +    + DLKP NILLD +    + DFGL +       +T++    G+
Sbjct: 104 --CALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GT 156

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             Y+APE  LG   +   D ++ G+L+ E++
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 16/99 (16%)

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG----- 452
           +HH       H D+K +NILL    +  +GDFG ++    T        V   +G     
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT--------VSDDVGRTFCG 207

Query: 453 ---YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
              Y+APE       S   D++S G+L+ EL+  K+P D
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH 326
           N    +     +G+G++G VYK           VK+  L           E   ++  +H
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V  F +     Y   +   +  E+   GSL++ +Y V         P  L+ LQ   
Sbjct: 66  CNIVAYFGS-----YLSREKLWICMEYCGGGSLQD-IYHVT-------GP--LSELQIAY 110

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +    L YLH   +    H D+K +NILL +     + DFG+A  +  T  +  S  
Sbjct: 111 VCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF- 166

Query: 447 VKGSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKPSDIMFE 492
             G+  ++APE    + V  NG      D+++ GI  +EL   + P   MF+
Sbjct: 167 -IGTPYWMAPEV---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 35/225 (15%)

Query: 270 DGFSSANLIGTGSFGSV----YKGVLDEGRTTVTVKVF---NLHHHRASRSFIAECRALR 322
           + F+    +GTGSFG V    YK   +E    V +K F    +   +      +E + L 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYK---NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86

Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            I H   V ++ +     ++   +  LV EF+  G    +L    R ++  + P ++   
Sbjct: 87  YINHPFCVNLYGS-----FKDESYLYLVLEFVIGGEFFTFL----RRNK--RFPNDVGCF 135

Query: 383 QRLNIAIDVASALDYLHHDCQPIT-THCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
               I +      +YL    Q +   + DLKP N+LLD++    + DFG A+      V 
Sbjct: 136 YAAQIVL----IFEYL----QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VD 182

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           T +  + G+  YIAPE  L        D ++ GI + E+++   P
Sbjct: 183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           Y+  D   LV   M  G L+  +Y        +      +  + +  A ++   L+ LH 
Sbjct: 69  YETKDALCLVLTLMNGGDLKFHIY--------NMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI-GVKGSIGYIAPEYG 459
           +      + DLKP NILLD+     + D GLA  +P    +  +I G  G++GY+APE  
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP----EGETIRGRVGTVGYMAPEVV 173

Query: 460 LGSEVSTNGDVYSYGILMLELIIRKKP 486
                + + D +  G L+ E+I  K P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 276 NLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV-- 332
           N+IG GSFG VY+ + +D        KV     ++     I     ++++ H N++ +  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI-----MKNLNHINIIFLKD 126

Query: 333 --FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
             +T C   + + N F  +V EF+   ++ +++    R +        L L      +  
Sbjct: 127 YYYTECFKKN-EKNIFLNVVMEFIPQ-TVHKYMKHYARNNH------ALPLFLVKLYSYQ 178

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTHVQTSSIGVKG 449
           +  AL Y+H        H DLKP N+L+D    +  + DFG A+ L       S I    
Sbjct: 179 LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI---C 232

Query: 450 SIGYIAPEYGLGS-EVSTNGDVYSYGILMLELII 482
           S  Y APE  LG+   +T+ D++S G ++ E+I+
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266

Length = 440

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 24/217 (11%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSFIAECRALRS-IRHRNLVK 331
           +G   FG VYKG L      E    V +K          R        +RS ++H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY------PVNREDEVDKAPRNLNLLQRL 385
           +     GV  +     ++++ +  +  L E+L        V   D+       L     +
Sbjct: 73  LL----GVVTKEQPL-SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 386 NIAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           +I   +A+ +++L  HH       H DL   N+L+ +++   + D GL R +        
Sbjct: 128 HIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
                  I +++PE  +  + S + D++SYG+++ E+
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 48/229 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTT---VTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G +G V+   L + + T   V +K      L      R  + E   L + +   LVK
Sbjct: 9   VGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ----RLNI 387
           +  A     +Q +++  L  E++  G     L              NL +L     R  +
Sbjct: 66  LLYA-----FQDDEYLYLAMEYVPGGDFRTLL-------------NNLGVLSEDHARFYM 107

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSI 445
           A ++  A+D LH   +    H DLKP N L+D     H+   DFGL+       + T + 
Sbjct: 108 A-EMFEAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLS-----KGIVTYAN 156

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            V GS  Y+APE   G       D +S G ++ E +    P    F G 
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGS 201

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 13/101 (12%)

Query: 385 LNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           L+ +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR +       S
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIR----NDS 268

Query: 444 SIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           +  VKG+    + ++APE       +   DV+SYGIL+ E+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 25/173 (14%)

Query: 317 ECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE--DEVDK 374
           E R L  +  R     F       Y+  D   LV   M  G L+  +Y +     DE   
Sbjct: 50  EKRILEKVNSR-----FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE--- 101

Query: 375 APRNLNLLQR-LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
                   QR +  A ++   L+ L  +      + DLKP NILLD+     + D GLA 
Sbjct: 102 --------QRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV 150

Query: 434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            +P        +   G++GY+APE     + + + D +  G L+ E+I  + P
Sbjct: 151 QIPEGETVRGRV---GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 63/256 (24%), Positives = 97/256 (37%), Gaps = 27/256 (10%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           + F    +IG G+FG V    L        +K+ N       R+  A  R  R +     
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGD 59

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRLNI 387
            +  T      +Q  +   LV ++   G L   L         D+ P ++    L  + I
Sbjct: 60  NQWITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVI 113

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           AID    L Y+H D         +KP NIL+D      + DFG    L       SS+ V
Sbjct: 114 AIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 164

Query: 448 KGSIGYIAPEYGLGSE-----VSTNGDVYSYGILMLELIIRKKP--SDIMFEGDMNLHNF 500
            G+  YI+PE     E          D +S G+ M E++  + P  ++ + E    + N 
Sbjct: 165 -GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223

Query: 501 A-RMALPDHVMDIVDS 515
             R   P  V D+ + 
Sbjct: 224 KERFQFPAQVTDVSED 239

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 16/128 (12%)

Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVST 466
           H DLKPSN+LL+      + DFGLAR         +   V  +  Y APE  L  SE +T
Sbjct: 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPELLLNCSEYTT 188

Query: 467 NGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAI 526
             DV+S G +  EL+ RK     +F G   +H   ++ L   + +++ S      EDL  
Sbjct: 189 AIDVWSVGCIFAELLGRKP----LFPGKDYVH---QLKL---ITELLGSP---SEEDLGF 235

Query: 527 ISNQRQRQ 534
           I N++ R+
Sbjct: 236 IRNEKARR 243

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 46/229 (20%)

Query: 278 IGTGSFGSV---YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG+G+ G V   Y  +L+     V +K       + SR F  +  A R+ R   L+K   
Sbjct: 32  IGSGAQGIVCAAYDAILER---NVAIK-------KLSRPFQNQTHAKRAYRELVLMKC-- 79

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               V+++  +   L+  F    SLEE+  +Y V    E+  A    NL Q + + +D  
Sbjct: 80  ----VNHK--NIIGLLNVFTPQKSLEEFQDVYIVM---ELMDA----NLCQVIQMELD-H 125

Query: 393 SALDYL--------HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             + YL         H       H DLKPSNI++  +    + DFGLAR    + + T  
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 185

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
           +  +    Y APE  LG     N D++S G +M E+I       ++F G
Sbjct: 186 VVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPG 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 21/155 (13%)

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH- 399
           +Q  D    V E++  G L   ++ + R  + D+             A +V  AL +LH 
Sbjct: 65  FQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF-------YAAEVTLALMFLHR 114

Query: 400 HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYG 459
           H       + DLK  NILLD E    + DFG+ +      V T++    G+  YIAPE  
Sbjct: 115 HG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDYIAPEIL 168

Query: 460 LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
              E   + D ++ G+LM E++  + P    FE D
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP----FEAD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 12/131 (9%)

Query: 356 NGSLEEWLYPVNREDEV---DKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDL 411
           +G +EE       E+E    D   + L L   +  +  VA  +++L    C     H DL
Sbjct: 150 SGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDL 205

Query: 412 KPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGD 469
              NILL E  V  + DFGLAR  +  P +V+      +  + ++APE       +   D
Sbjct: 206 AARNILLSENNVVKICDFGLARDIYKDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSD 263

Query: 470 VYSYGILMLEL 480
           V+S+G+L+ E+
Sbjct: 264 VWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 50/204 (24%), Positives = 100/204 (49%), Gaps = 26/204 (12%)

Query: 298 VTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN 356
           V VK+     ++ +R+ F+ E + L  ++  N++++   C  VD    D   ++ E+M+N
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC--VD---EDPLCMITEYMEN 103

Query: 357 GSLEEWLYPVNREDEV----DKAPRNLNLL-----QRLNIAIDVASALDYLHHDCQPITT 407
           G L ++L   + +D+     D  P    L        L++A+ +AS + YL         
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160

Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPT---HVQTSSIGVKGSIGYIAPEYGLGSEV 464
           H DL   N L+ E +   + DFG++R L       +Q  ++     I ++A E  L  + 
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAV---LPIRWMAWECILMGKF 217

Query: 465 STNGDVYSYGILMLELII--RKKP 486
           +T  DV+++G+ + E+++  +++P
Sbjct: 218 TTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 28/108 (25%), Positives = 54/108 (50%), Gaps = 13/108 (12%)

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQTSSIG 446
             + SA+ Y+H   +    H D+K  NI L +  +  +GDFG+++ L    +  +T    
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---- 160

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           V G+  Y++PE   G + +   D+++ G ++ EL+  K+     F+  
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR----TFDAT 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 58/259 (22%), Positives = 98/259 (37%), Gaps = 66/259 (25%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF---------NLHHHRASRSFIAECRA 320
           D F S  +IG G+FG V      +      +K+           + H RA R  + E   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
                   +VK+F +     +Q      L+ EF+  G +   L    ++D + +      
Sbjct: 61  AW------VVKMFYS-----FQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFY 106

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL----- 435
           + + + +AID    L ++H D         +KP N+LLD +    + DFGL   L     
Sbjct: 107 IAETV-LAIDAIHQLGFIHRD---------IKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156

Query: 436 ----------PPTHVQTSSIGVK------------------GSIGYIAPEYGLGSEVSTN 467
                     PP+     ++  K                  G+  YIAPE  + +  +  
Sbjct: 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216

Query: 468 GDVYSYGILMLELIIRKKP 486
            D +S G++M E++I   P
Sbjct: 217 CDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 9/99 (9%)

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           L YLH        H D+KP N+L++   V  + DFGLAR   P   +  +  V     Y 
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171

Query: 455 APEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFE 492
           APE  +GS   T+  D++S G +  EL+ R+    I+F+
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQ 206

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 31/209 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V           V VK  +L   +       E   +R  +H N+V+++++  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL +
Sbjct: 85  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLAVLKALSF 130

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-----GSIG 452
           LH   Q +  H D+K  +ILL  +    + DFG          Q S    +     G+  
Sbjct: 131 LH--AQGVI-HRDIKSDSILLTSDGRVKLSDFGFC-------AQVSKEVPRRKSLVGTPY 180

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++APE        T  D++S GI+++E++
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 29/229 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIR-HRNLVKV 332
           ++G GSFG V    L E      VKV     +         + E R L   R H  L ++
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +  C    +Q  D    V EF+  G L   ++ + +    D+A            A ++ 
Sbjct: 62  Y-CC----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-------YAAEIT 106

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           SAL +LH        + DLK  N+LLD E    + DFG+ +        TS+    G+  
Sbjct: 107 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPD 161

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP-----SDIMFEGDMN 496
           YIAPE         + D ++ G+L+ E++    P      D +FE  +N
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 24/139 (17%)

Query: 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411
           E M  GSL++ L    R  E        N+L +++IA  V   L YL    + +  H D+
Sbjct: 79  EHMDGGSLDQVLKKAGRIPE--------NILGKISIA--VLRGLTYLREKHKIM--HRDV 126

Query: 412 KPSNILLDEEMVSHVGDFG----LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           KPSNIL++      + DFG    L   +  + V T S        Y++PE   G+  +  
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--------YMSPERLQGTHYTVQ 178

Query: 468 GDVYSYGILMLELIIRKKP 486
            D++S G+ ++E+ I + P
Sbjct: 179 SDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 27/208 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G++G+V+K    E    V +K   L         S + E   L+ ++H+N+V+++  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65

Query: 336 CSGVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
               D   +D K  LV+E+     L+++    N   ++D       + Q L         
Sbjct: 66  ----DVLHSDKKLTLVFEYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLK-------G 111

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGY 453
           L + H        H DLKP N+L+++     + DFGLAR F  P  V+  S  V  ++ Y
Sbjct: 112 LAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCYSAEVV-TLWY 165

Query: 454 IAPEYGLGSEV-STNGDVYSYGILMLEL 480
             P+   G+++ ST+ D++S G +  EL
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 52/188 (27%), Positives = 78/188 (41%), Gaps = 37/188 (19%)

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRLNIAIDVASALDYL 398
           +Q  +   LV ++   G L   L         D+ P ++    L  + +AID    L Y+
Sbjct: 70  FQDENNLYLVMDYYVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 399 HHDCQPITTHCDLKPSNILLDEEMVSHV--GDFG-LARFLPPTHVQTSSIGVKGSIGYIA 455
           H D         +KP N+LLD     H+   DFG   R L    VQ S++ V G+  YI+
Sbjct: 125 HRD---------IKPDNVLLD--KNGHIRLADFGSCLRLLADGTVQ-SNVAV-GTPDYIS 171

Query: 456 PEY------GLGSEVSTNGDVYSYGILMLELIIRKKP--SDIMFE--GD-MNLHNFARMA 504
           PE       G G       D +S G+ M E++  + P  ++ + E  G  MN        
Sbjct: 172 PEILQAMEDGKGR-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--HFQ 228

Query: 505 LPDHVMDI 512
            P  V D+
Sbjct: 229 FPPDVTDV 236

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 8/100 (8%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A ++   L+++H+       + DLKP+NILLDE     + D GLA          S    
Sbjct: 103 ATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156

Query: 448 KGSIGYIAPE-YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+ GY+APE    G+   ++ D +S G ++ +L+    P
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.3 bits (107), Expect = 8e-05
 Identities = 40/113 (35%), Positives = 57/113 (50%), Gaps = 17/113 (15%)

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVK 448
           ++  AL++LH   +    + D+K  NILLD E    + DFGL++ FL     +T S    
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167

Query: 449 GSIGYIAPEY-----GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN 496
           G+I Y+APE      G G  V    D +S GIL+ EL+    P     EG+ N
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP--FTLEGERN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 37/120 (30%), Positives = 52/120 (43%), Gaps = 7/120 (5%)

Query: 375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
           A RN+ +   L I   V  A+ YLH +      H D+K  NI ++      +GDFG A F
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF 231

Query: 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            P         G  G+I   APE           D++S GI++ E+       D +FE D
Sbjct: 232 -PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM---ATCHDSLFEKD 287

Length = 391

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 17/142 (11%)

Query: 379 LNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
           L+ +  +  +  VA+ +++L   +C     H DL   N+L+ E  +  + DFGLAR +  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI-- 289

Query: 438 THVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELII---RKKPSDIM 490
             ++ S+   KGS    + ++APE    +  +T  DV+S+GIL+ E+        P   M
Sbjct: 290 --MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347

Query: 491 FEGDMN-LHNFARMALPDHVMD 511
            E   N +    RMA P H  D
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASD 369

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 56/204 (27%), Positives = 82/204 (40%), Gaps = 16/204 (7%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GSFG V             VKV         +       A R++  +N+   F    
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              +Q  D    V +++  G L    + + RE    + PR      R   A ++ASAL Y
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPE-PR-----ARF-YAAEIASALGY 111

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH     I  + DLKP NILLD +    + DFGL +        TS+    G+  Y+APE
Sbjct: 112 LH-SLNII--YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEYLAPE 166

Query: 458 YGLGSEVSTNGDVYSYGILMLELI 481
                      D +  G ++ E++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 18/60 (30%), Positives = 31/60 (51%)

Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
            ++  ++ +IA  +A  L  LH     +  H DL P NIL+D+  +  + D+  A + PP
Sbjct: 82  EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 39/235 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +IG GS+G V   +       V +K    VF  H   A+R  + E + LR +RH ++V++
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATR-ILREIKLLRLLRHPDIVEI 64

Query: 333 FTACSGVDYQGNDFKAL--VYEFMQNGSLEEWLYPVNR-EDEVDKAPRNLNLLQRLNIAI 389
                 +     +FK +  V+E M     E  L+ V +  D++        L Q L    
Sbjct: 65  KHIM--LPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR--- 114

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL----PPTHVQTSSI 445
               AL Y+H        H DLKP NIL + +    + DFGLAR      P     T  +
Sbjct: 115 ----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 446 GVKGSIGYIAPEY--GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
             +    Y APE      S+ +   D++S G +  E+ +  KP   +F G   +H
Sbjct: 168 ATR---WYRAPELCGSFFSKYTPAIDIWSIGCIFAEV-LTGKP---LFPGKNVVH 215

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 14/138 (10%)

Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LV   M  G L+  +Y V          R L + + ++ +  +   + +LH        +
Sbjct: 70  LVMSLMNGGDLKYHIYNVGE--------RGLEMERVIHYSAQITCGILHLH---SMDIVY 118

Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468
            D+KP N+LLD++    + D GLA  L      T   G     GY+APE       S   
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN---GYMAPEILKEEPYSYPV 175

Query: 469 DVYSYGILMLELIIRKKP 486
           D ++ G  + E++  + P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 9e-05
 Identities = 40/128 (31%), Positives = 51/128 (39%), Gaps = 44/128 (34%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MVSHVGDFGLARFLPPTHVQTSS 444
           A +V  AL+YLH     I  + DLKP NILL E    M+S   DF L++         S 
Sbjct: 109 AAEVLLALEYLH--LLGIV-YRDLKPENILLHESGHIMLS---DFDLSKQSDVEPPPVSK 162

Query: 445 IGVKGSIG---------------------------YIAPE----YGLGSEVSTNGDVYSY 473
              KGS                             YIAPE     G GS V    D ++ 
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTL 218

Query: 474 GILMLELI 481
           GIL+ E++
Sbjct: 219 GILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 9e-05
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRAL-RSIRHRNLVKV 332
           +IG GSFG V             VKV     + + +  +  +AE   L ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             +     +Q  +    V +F+  G L    + + RE    + PR      R   A ++A
Sbjct: 62  HYS-----FQTTEKLYFVLDFVNGGEL---FFHLQRERSFPE-PR-----ARFYAA-EIA 106

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           SAL YLH        + DLKP NILLD +    + DFGL +         ++    G+  
Sbjct: 107 SALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPE 161

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           Y+APE           D +  G ++ E++
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 1e-04
 Identities = 41/125 (32%), Positives = 61/125 (48%), Gaps = 8/125 (6%)

Query: 666 SIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI 725
           SI  PL  LS+    S  +    G    T +    +V + L    +SG + S+IF +  I
Sbjct: 40  SINDPLKYLSNWNS-SADVCLWQG---ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYI 95

Query: 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP-SISNASKLEVFQALNNKL 784
              ++  N++ G IP D   T  +L+Y ++  N  TG+IP  SI N   LE     NN L
Sbjct: 96  QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN---LETLDLSNNML 152

Query: 785 TGEVP 789
           +GE+P
Sbjct: 153 SGEIP 157

Length = 968

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 46/205 (22%)

Query: 298 VTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNG 357
           V  K   L+  R +    +E   L +  H  +VK F      D++ +D   L+ E+   G
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYGSGG 150

Query: 358 SLEEWLYPVNREDEVDKAPRNLNLLQRLN------------IAIDVASALDYLHHDCQPI 405
            L                  N  + QRL             +   +  ALD +H      
Sbjct: 151 DL------------------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM-- 190

Query: 406 TTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG----YIAPEYGLG 461
             H DLK +NI L    +  +GDFG ++     +  + S+ V  S      Y+APE    
Sbjct: 191 -MHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVASSFCGTPYYLAPELWER 245

Query: 462 SEVSTNGDVYSYGILMLELIIRKKP 486
              S   D++S G+++ EL+   +P
Sbjct: 246 KRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 18/115 (15%)

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK--GSI 451
           AL++LH   Q I  + DLKP NILLD +    + DFGL +      +   ++     G+I
Sbjct: 112 ALEHLHQ--QGII-YRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTI 164

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELII---------RKKPSDIMFEGDMNL 497
            Y+APE  + S      D +S G LM +++          RKK  D + +G +NL
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 26/175 (14%)

Query: 315 IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK 374
           + E R L++ RH      F       +Q  D    V E++  G L    + ++RE     
Sbjct: 43  LTESRVLKNTRHP-----FLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRE----- 89

Query: 375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
             R  +  +      ++ SALDYLH        + DLK  N++LD++    + DFGL + 
Sbjct: 90  --RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK- 143

Query: 435 LPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  T +  +K   G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 144 ----EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 40/190 (21%), Positives = 88/190 (46%), Gaps = 18/190 (9%)

Query: 298 VTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN 356
           V VK+     ++ +R+ F+ E + +  ++  N++++   C  +    +D   ++ E+M+N
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC--IT---SDPLCMITEYMEN 103

Query: 357 GSLEEWLYPVN-REDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN 415
           G L ++L     +E         ++    + +A  +AS + YL         H DL   N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160

Query: 416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVY 471
            L+ +     + DFG++R L           ++G     I +++ E  L  + +T  DV+
Sbjct: 161 CLVGKNYTIKIADFGMSRNL----YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216

Query: 472 SYGILMLELI 481
           ++G+ + E++
Sbjct: 217 AFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 56/259 (21%), Positives = 97/259 (37%), Gaps = 66/259 (25%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF---------NLHHHRASRSFIAECRA 320
           + F S  +IG G+FG V      +      +K+           + H RA R  + E  +
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L       +VK+F +     +Q      L+ EF+  G +   L    ++D + +      
Sbjct: 61  LW------VVKMFYS-----FQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFY 106

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH- 439
           + + + +AID    L ++H D         +KP N+LLD +    + DFGL   L   H 
Sbjct: 107 IAETV-LAIDSIHQLGFIHRD---------IKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156

Query: 440 --------------------------------VQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
                                            +  +    G+  YIAPE  + +  +  
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216

Query: 468 GDVYSYGILMLELIIRKKP 486
            D +S G++M E++I   P
Sbjct: 217 CDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 33/218 (15%)

Query: 278 IGTGSFGSVYKGVLD------------EGRTTVTVKVFNLHHHRASRSFIAECRALRSIR 325
           +G G+   +Y G+L+            E    V +KV +  H   S +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H+++V ++  C  V    N    +V EF++ G L+ +++   R+ +V   P       + 
Sbjct: 63  HKHIVLLYGVC--VRDVEN---IMVEEFVEFGPLDLFMH---RKSDVLTTP------WKF 108

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV-SHVGDF-GLARFLPPTHVQTS 443
            +A  +ASAL YL         H ++   NILL  E +    G F  L+    P  V + 
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 444 SIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLEL 480
              V+  I +IAPE    S+  S   D +S+G  + E+
Sbjct: 166 QECVE-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 56/220 (25%), Positives = 86/220 (39%), Gaps = 33/220 (15%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFI--AECRALRSIRHRNLVKV-- 332
           +IG G FG VY       R   T K++ +      R  +   E  AL      +LV    
Sbjct: 1   IIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 333 --FTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIA 388
             F  C    +   D  + + + M  G L   L  + V  E E+               A
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM------------RFYA 103

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            ++   L+++H+       + DLKP+NILLDE     + D GLA          S     
Sbjct: 104 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 156

Query: 449 GSIGYIAPE-YGLGSEVSTNGDVYSYGILMLELIIRKKPS 487
           G+ GY+APE    G    ++ D +S G ++ +L+    P 
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 36/111 (32%), Positives = 51/111 (45%), Gaps = 21/111 (18%)

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           L Y+H        H DLKPSNIL++E     + DFGLAR        T  +  +    Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTR---YYR 172

Query: 455 APEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           APE  L       EV    D++S G +  E+ +  KP   +F G  +++ F
Sbjct: 173 APEIMLTWQKYDVEV----DIWSAGCIFAEM-LEGKP---LFPGKDHVNQF 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR---SFIAECRALRSIRHRNLVKVFT 334
           IG G FG V    +        V V  L  + +S+    F+ +    R ++H N+++   
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 335 AC-SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            C   + Y       LV+E+ + G L+ +L     +++  +    L LLQR+  A ++A+
Sbjct: 63  QCVEAIPY------LLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRM--ACEIAA 110

Query: 394 ALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG--- 449
            + ++H H+      H DL   N  L  ++   VGD+G+     P+  +   I  +    
Sbjct: 111 GVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIG----PSRYKEDYIETEDDKC 162

Query: 450 -SIGYIAPEYG-------LGSEVSTNGDVYSYGILMLEL 480
             + ++APE         + +E +   +V++ G+ + EL
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 62/245 (25%), Positives = 101/245 (41%), Gaps = 47/245 (19%)

Query: 272 FSSANLIGTGSFGSVY--KGVL--DEGR---------TTVTVKVFNLHHHRASRSFIAEC 318
           F    ++GTG++G V+  + V   D G+          T+  K     H R  R      
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER------ 55

Query: 319 RALRSIRHRN-LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
           + L  IR    LV +  A     +Q +    L+ +++  G L   L    R  E      
Sbjct: 56  QVLEHIRQSPFLVTLHYA-----FQTDTKLHLILDYINGGELFTHLSQRERFKE------ 104

Query: 378 NLNLLQRLNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FL 435
                Q + I   ++  AL++LH   +    + D+K  NILLD      + DFGL++ F 
Sbjct: 105 -----QEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156

Query: 436 PPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG--DVYSYGILMLELIIRKKPSDIMFEG 493
                +  S    G+I Y+AP+   G +   +   D +S G+LM EL+    P  +  +G
Sbjct: 157 EDEVERAYSFC--GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DG 212

Query: 494 DMNLH 498
           + N  
Sbjct: 213 EKNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 71/309 (22%), Positives = 126/309 (40%), Gaps = 42/309 (13%)

Query: 241 VRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTV 300
           +RK K   N  +     +N   ++L    + +    +IG G+FG V        R    +
Sbjct: 15  LRKNKNIDNFLNRYKDTIN-KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 73

Query: 301 KVFNLHH--HRASRSFIAECRALRSIRHRN-LVKVFTACSGVDYQGNDFKALVYEFMQNG 357
           K+ +      R+  +F  E R + +  +   +V++F A     +Q + +  +V E+M  G
Sbjct: 74  KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGG 128

Query: 358 SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417
            L      VN     D   +      R   A +V  ALD +H        H D+KP N+L
Sbjct: 129 DL------VNLMSNYDVPEK----WARFYTA-EVVLALDAIH---SMGFIHRDVKPDNML 174

Query: 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY----GLGSEVSTNGDVYSY 473
           LD+     + DFG    +    +      V G+  YI+PE     G         D +S 
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233

Query: 474 GILMLELIIRKKP--SDIM---FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIIS 528
           G+ + E+++   P  +D +   +   MN  N   +  PD      D+ +  + ++L I +
Sbjct: 234 GVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPD------DNDISKEAKNL-ICA 284

Query: 529 NQRQRQIRV 537
               R++R+
Sbjct: 285 FLTDREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHRNL 329
           F    ++G G++G V K    E +  V +K F  +  +     + + E + LR+++  N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++  A     ++      LV+E+++   LE           +++ P  +   +  +   
Sbjct: 63  VELKEA-----FRRRGKLYLVFEYVEKNMLEL----------LEEMPNGVPPEKVRSYIY 107

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
            +  A+ + H +      H D+KP N+L+    V  + DFG AR L        +  V  
Sbjct: 108 QLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-A 163

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           +  Y +PE  LG+      D++S G ++ EL
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 40/130 (30%), Positives = 56/130 (43%), Gaps = 27/130 (20%)

Query: 388 AIDVASALDYLHHD---CQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           A ++  ALD LH +   C+      DL P+NILLD       G   L  F   + V+ S 
Sbjct: 91  AAEMVVALDALHREGIVCR------DLNPNNILLD-----DRGHIQLTYFSRWSEVEDSC 139

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL-----IIRKKPSDIMFEGDMNLHN 499
            G      Y APE G  SE +   D +S G ++ EL     ++   PS I      N H 
Sbjct: 140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTH- 192

Query: 500 FARMALPDHV 509
              + +P+ V
Sbjct: 193 -TTLNIPEWV 201

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 5e-04
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 35/188 (18%)

Query: 315 IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK 374
           + E R L++ RH  L  +  +     +Q +D    V E+   G L    + ++RE  V  
Sbjct: 43  LTESRVLQNTRHPFLTALKYS-----FQTHDRLCFVMEYANGGEL---FFHLSRE-RVFS 93

Query: 375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
             R      R   A ++ SAL YLH  C  +  + DLK  N++LD++    + DFGL + 
Sbjct: 94  EDRA-----RFYGA-EIVSALGYLH-SCDVV--YRDLKLENLMLDKDGHIKITDFGLCK- 143

Query: 435 LPPTHVQTSSIGVK-----GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP--- 486
                 +  S G       G+  Y+APE    ++     D +  G++M E++  + P   
Sbjct: 144 ------EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Query: 487 --SDIMFE 492
              + +FE
Sbjct: 198 QDHEKLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 5e-04
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           + +++ AL++LH   +    + DLK  N+LLD E    + D+G+ +        TS+   
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC- 157

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
            G+  YIAPE   G +   + D ++ G+LM E++  + P DI+
Sbjct: 158 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.8 bits (101), Expect = 5e-04
 Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 9/103 (8%)

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSI 445
           A ++A  L +LH   + I  + DLK  N++LD E    + DFG+ +         +T   
Sbjct: 107 AAEIAIGLFFLHS--KGII-YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC- 162

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
              G+  YIAPE         + D +++G+L+ E++  + P D
Sbjct: 163 ---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 34/190 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---------LHHHRASRSFIAECRALRSIRHR 327
           +IG GSFG V         +   VKV            +H  A R+ +     L++++H 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-----LKNLKHP 56

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
            LV +  +     +Q  +    V +++  G L    + + RE      PR      R   
Sbjct: 57  FLVGLHYS-----FQTAEKLYFVLDYVNGGEL---FFHLQRERCF-LEPR-----ARF-Y 101

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A +VASA+ YLH     I  + DLKP NILLD +    + DFGL +        TS+   
Sbjct: 102 AAEVASAIGYLH--SLNII-YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC- 157

Query: 448 KGSIGYIAPE 457
            G+  Y+APE
Sbjct: 158 -GTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 26/208 (12%)

Query: 281 GSFGSVYKGVL--DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSG 338
           GS G V+      DE R  V VK          ++   E   L++I HR ++ +  A   
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYR- 156

Query: 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL 398
                  +K+ V   M     + + Y V+R       P  L   Q + I   +  AL YL
Sbjct: 157 -------WKSTVCMVMPKYKCDLFTY-VDR-----SGPLPLE--QAITIQRRLLEALAYL 201

Query: 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY 458
           H        H D+K  NI LDE   + +GDFG A  L          G  G++   +PE 
Sbjct: 202 HGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPEL 258

Query: 459 GLGSEVSTNGDVYSYGILMLELIIRKKP 486
                     D++S G+++ E+ ++   
Sbjct: 259 LALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.1 bits (99), Expect = 8e-04
 Identities = 77/282 (27%), Positives = 113/282 (40%), Gaps = 46/282 (16%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLHHHRASR--SFIAECRALRSIR 325
             F   +L+G G FG V   V+ E  T     +KV       A    SF  E R + SI 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 326 HR----NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR-EDEVDKAPRNLN 380
           +      L   F        Q  D   LV E+   G L   L  +NR ED+ D+      
Sbjct: 59  NSPWIPQLQYAF--------QDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFY 107

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
           L + L +AI     + Y+H          D+KP N+L+D      + DFG A  L    +
Sbjct: 108 LAE-LVLAIHSVHQMGYVHR---------DIKPENVLIDRTGHIKLADFGSAARLTANKM 157

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKP--SDIMFE 492
             S + V G+  YIAPE          G      D +S G++  E+I  + P       +
Sbjct: 158 VNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216

Query: 493 GDMNLHNFAR-MALPDHVMDIVDSTLLNDVEDLAIISNQRQR 533
              N+ NF R +  P+     V S  L+ ++ L  +  Q++R
Sbjct: 217 TYNNIMNFQRFLKFPEDPK--VSSDFLDLIQSL--LCGQKER 254

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 22/184 (11%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +IG GSFG V             VKV     +   +  +  ++E    R++  +N+   F
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNVKHPF 57

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                  +Q  D    V +++  G L    Y + RE      PR      R   A ++AS
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRE-RCFLEPR-----ARF-YAAEIAS 107

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YLH        + DLKP NILLD +    + DFGL +     +  TS+    G+  Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC--GTPEY 162

Query: 454 IAPE 457
           +APE
Sbjct: 163 LAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           +Q  D    V E++  G L   +Y + +  +  K P      Q +  A +++  L +LH 
Sbjct: 70  FQTVDRLYFVMEYVNGGDL---MYHIQQVGKF-KEP------QAVFYAAEISVGLFFLH- 118

Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL 460
             +    + DLK  N++LD E    + DFG+ +      V T +    G+  YIAPE   
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--GTPDYIAPEIIA 174

Query: 461 GSEVSTNGDVYSYGILMLELIIRKKPSD 488
                 + D ++YG+L+ E++  + P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 35/221 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++GSVYK +      T+ +K   L    +     I E   L    H+ +       
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61

Query: 337 SGVDYQGNDF-KALVY---EFMQNGSLEEWLYPVNREDE-VDKAPRNLNLLQRLNIAIDV 391
             VD+ G  F +  VY   E+M  GSL++ LY      E + +     ++L+R  I   V
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPE-----DVLRR--ITYAV 111

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
              L +L  +   I  H D+KP+N+L++      + DFG++  L  +  +T +IG +   
Sbjct: 112 VKGLKFLKEEHNII--HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQ--- 165

Query: 452 GYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKP 486
            Y+APE       + N       DV+S G+ +LE+ + + P
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 37/181 (20%)

Query: 315 IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK 374
           + E R L++ RH      F       +Q +D    V E+   G L    + ++RE     
Sbjct: 43  LTENRVLQNSRHP-----FLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE----- 89

Query: 375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
             R  +  +      ++ SALDYLH +   +  + DLK  N++LD++    + DFGL + 
Sbjct: 90  --RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKE 145

Query: 435 LPPTHVQTSSIGVK---------GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
                      G+K         G+  Y+APE    ++     D +  G++M E++  + 
Sbjct: 146 -----------GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194

Query: 486 P 486
           P
Sbjct: 195 P 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 64/271 (23%), Positives = 107/271 (39%), Gaps = 35/271 (12%)

Query: 225 GLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNL--SYQNLHNATDGFSSANLIGTGS 282
           GL  L L L    L   RK K   N ++ +N    +    + L    + +    +IG G+
Sbjct: 2   GLNSLVLDLDFPAL---RKNK---NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGA 55

Query: 283 FGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN-LVKVFTACSGV 339
           FG V        +    +K+ +      R+  +F  E R + +  +   +V++F A    
Sbjct: 56  FGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA---- 111

Query: 340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH 399
            +Q + +  +V E+M  G L      VN     D   +            +V  ALD +H
Sbjct: 112 -FQDDKYLYMVMEYMPGGDL------VNLMSNYDVPEKWAKFY-----TAEVVLALDAIH 159

Query: 400 HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY- 458
                   H D+KP N+LLD+     + DFG    +  T +      V G+  YI+PE  
Sbjct: 160 ---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVL 215

Query: 459 ---GLGSEVSTNGDVYSYGILMLELIIRKKP 486
              G         D +S G+ + E+++   P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 31/222 (13%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTV-TVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           LI      S+YKG+ +     + T K F+  H         E + LR I   N++K++  
Sbjct: 27  LIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY-- 84

Query: 336 CSGVDYQGND---FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             G      D     +L+ E+   G L E L             ++L+   +L++AID  
Sbjct: 85  --GFIIDIVDDLPRLSLILEYCTRGYLREVLD----------KEKDLSFKTKLDMAIDCC 132

Query: 393 SALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL---PPTHVQTSSIGVK 448
             L  L+ +  +P   + +L   + L+ E     +   GL + L   P  +V        
Sbjct: 133 KGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSY 189

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
             +  I  EY +        D+YS G+++ E+   K P + +
Sbjct: 190 KMLNDIFSEYTIKD------DIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 61/252 (24%)

Query: 256 SLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFI 315
           SL ++    L +    F    ++G G++G VYKG   +      +KV ++          
Sbjct: 2   SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIK 60

Query: 316 AECRALRSI-RHRNLVKVFTACSGVDYQGNDFKA-LVYEFMQNGSL-------------E 360
            E   L+    HRN+   + A       G+D +  LV EF   GS+             E
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120

Query: 361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLD 419
           +W+  + RE                     +   L +LH H       H D+K  N+LL 
Sbjct: 121 DWIAYICRE---------------------ILRGLAHLHAHK----VIHRDIKGQNVLLT 155

Query: 420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-----------STNG 468
           E     + DFG++  L  T      +G + +  +I   Y +  EV               
Sbjct: 156 ENAEVKLVDFGVSAQLDRT------VGRRNT--FIGTPYWMAPEVIACDENPDATYDYRS 207

Query: 469 DVYSYGILMLEL 480
           D++S GI  +E+
Sbjct: 208 DIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 76/331 (22%), Positives = 117/331 (35%), Gaps = 105/331 (31%)

Query: 270 DGFSSANLIGTGSFGSVYKGV--LDEGR-----TTVTVKVF---NLHHHRASRSFIAECR 319
           + F +  +IG G+FG V + V   D G+     T +  ++F    L H +A R  +AE  
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPR 377
           +        +V ++ +     +Q   +  L+ EF+  G L   L  Y    ED       
Sbjct: 60  SPW------VVSLYYS-----FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED------- 101

Query: 378 NLNLLQRLNIA-----IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432
               + R  +A     I+    L ++H D         +KP NIL+D      + DFGL+
Sbjct: 102 ----VTRFYMAECVLAIEAVHKLGFIHRD---------IKPDNILIDRGGHIKLSDFGLS 148

Query: 433 RFLPPTH-----------------------VQTSSIGVK--------------------- 448
                 H                       V   SI +                      
Sbjct: 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST 208

Query: 449 -GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP--SDIMFEGDMNLHNFAR-MA 504
            G+  YIAPE  L        D +S G +M E +I   P  S+   E    + N+   + 
Sbjct: 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY 268

Query: 505 LPDHVMDIVDSTLLNDVEDL--AIISNQRQR 533
            PD      D  L  + EDL   +I+N   R
Sbjct: 269 FPD------DIHLSVEAEDLIRRLITNAENR 293

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.9 bits (95), Expect = 0.001
 Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 47/229 (20%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLV 330
           F    L+G G++G VYKG   +      +KV ++           E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66

Query: 331 KVFTACSGVDYQGNDFKA-LVYEFMQNGSL-------------EEWLYPVNREDEVDKAP 376
             + A    +  G D +  LV EF   GS+             EEW+  + RE       
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE------- 119

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
                         +   L +LH   Q    H D+K  N+LL E     + DFG++  L 
Sbjct: 120 --------------ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162

Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSE-----VSTNGDVYSYGILMLEL 480
            T  + ++    G+  ++APE     E          D++S GI  +E+
Sbjct: 163 RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 16/42 (38%), Positives = 25/42 (59%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLG 42
           +L L  N  +G+IP S+G L  L    ++ N L G +P++LG
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 24/209 (11%)

Query: 278 IGTGSFGSVY----KGVLDEGRTTV--TVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG+VY    K  + E R  V   + V  L+ +   ++   E + L  + H  +VK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +     +   D   ++ E+ +   L+  L      +E+    + L+  Q     I +
Sbjct: 67  FHAS-----FLERDAFCIITEYCEGRDLDCKL------EELKHTGKTLSENQVCEWFIQL 115

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
              + Y+H   Q    H DLK  NI L   ++  +GDFG++R L  +    ++    G+ 
Sbjct: 116 LLGVHYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTF--TGTP 169

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            Y++PE        +  D++S G ++ E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 47/220 (21%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G+FG VY+    + R    +KV       + +  +A+     +I  RN++      +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL----VRT 50

Query: 338 GVD-----------YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            +D           +Q +    LV ++M  G L   L    R  E D+A        +  
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-DRA--------KFY 101

Query: 387 IAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           IA ++  AL++LH +D      + DLKP NILLD      + DFGL++     +  T++ 
Sbjct: 102 IA-ELVLALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156

Query: 446 GVKGSIGYIAPEY-----GLGSEVSTNGDVYSYGILMLEL 480
              G+  Y+APE      G    V    D +S G+L+ E+
Sbjct: 157 C--GTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 30/177 (16%)

Query: 315 IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED--EV 372
           + E R L++ RH  L  +  A     +Q +D    V E+   G L    + ++RE     
Sbjct: 43  VTESRVLQNTRHPFLTALKYA-----FQTHDRLCFVMEYANGGEL---FFHLSRERVFTE 94

Query: 373 DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432
           ++A        R   A ++ SAL+YLH        + D+K  N++LD++    + DFGL 
Sbjct: 95  ERA--------RFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 142

Query: 433 RFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           +        +    +K   G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 143 K-----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 2/63 (3%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
            N I   I    +GS    + +LDL      GSI   +G L+ L+ILNL  NS +  +P+
Sbjct: 451 GNSIRGNIP-PSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508

Query: 598 EIG 600
            +G
Sbjct: 509 ALG 511

Length = 623

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 40.1 bits (94), Expect = 0.004
 Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 62/244 (25%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-------HRASRSFIAECR 319
            A D F    +IG G+FG V + V    R   + +V+ +          R+  +F  E R
Sbjct: 41  KAED-FDVIKVIGRGAFGEV-QLV----RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 320 ALRSIRHRN---LVKVFTACSGVDYQGNDFKALVYEFMQNGSL----------EEWLYPV 366
            + +  H N   +V++  A     +Q + +  +V E+M  G L          E+W    
Sbjct: 95  DIMA--HANSEWIVQLHYA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW---- 143

Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
                            R   A +V  ALD +H        H D+KP N+LLD+     +
Sbjct: 144 ----------------ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKL 183

Query: 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY----GLGSEVSTNGDVYSYGILMLELII 482
            DFG    +    +      V G+  YI+PE     G         D +S G+ + E+++
Sbjct: 184 ADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242

Query: 483 RKKP 486
              P
Sbjct: 243 GDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 25/79 (31%), Positives = 36/79 (45%), Gaps = 2/79 (2%)

Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H D+K  NI L +     +GDFG AR L  T     +    G+  Y+ PE       +  
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPYNNK 180

Query: 468 GDVYSYGILMLELIIRKKP 486
            D++S G ++ EL   K P
Sbjct: 181 SDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 36/203 (17%), Positives = 55/203 (27%), Gaps = 47/203 (23%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV--KVFTA 335
           +  G+    Y  V       V +K+       A+     E   LR +    +   +V   
Sbjct: 5   LSGGASNRTYL-VGTGDGRYV-LKLA--PPAEAAEELRRELALLRHLAAAGIPVPRVLAG 60

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID----- 390
            +     G  F  L+ E +    L   L P  R   ++   R L  L  +          
Sbjct: 61  GTDGGGLGLPF--LLMEGLPGEVLTRPLDPAERGALLEALARLLARLHSVPPEALPLARR 118

Query: 391 ------------------------------VASALDYLH---HDCQPITTHCDLKPSNIL 417
                                             L  L         +  H DL P N+L
Sbjct: 119 LRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLL 178

Query: 418 LDEEM-VSHVGDFGLARFLPPTH 439
           +D    V+ V DF  A    P +
Sbjct: 179 VDPGGRVTGVIDFEDAGLGDPAY 201

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	789
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.98
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.98
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.98
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.98
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.98
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.98
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.98
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.98
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.98
PTZ00267	478	NIMA-related protein kinase; Provisional	99.98
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.98
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.98
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.98
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.98
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.98
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.98
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.98
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.98
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.98
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.98
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.98
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.88
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.88
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.87
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.87
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.87
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.87
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.85
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.85
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.84
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.83
PLN00181	793	protein SPA1-RELATED; Provisional	99.82
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.81
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.81
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.76
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.75
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.74
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.72
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.71
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.71
PRK12274	218	serine/threonine protein kinase; Provisional	99.7
PRK10345	210	hypothetical protein; Provisional	99.67
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.65
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.64
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.64
smart00090	237	RIO RIO-like kinase.	99.6
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.59
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.59
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.58
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.58
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.57
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.56
PRK14879	211	serine/threonine protein kinase; Provisional	99.56
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.52
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.49
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.46
PLN03150	623	hypothetical protein; Provisional	99.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.42
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.35
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.35
PLN03150	623	hypothetical protein; Provisional	99.31
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.29
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.26
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.26
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.18
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.15
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.15
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.14
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.12
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.06
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.04
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.04
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.96
KOG1243	690	consensus Protein kinase [General function predict	98.96
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.95
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.91
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.86
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.76
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.76
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.75
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.73
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.7
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.68
KOG3087	229	consensus Serine/threonine protein kinase [General	98.66
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.46
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.45
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.45
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.42
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.41
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.26
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.23
COG4248	637	Uncharacterized protein with protein kinase and he	98.2
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.18
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.08
PF13306	129	LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_	98.04

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-61  Score=597.17  Aligned_cols=520  Identities=28%  Similarity=0.434  Sum_probs=391.7

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQF   81 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l   81 (789)
                      |+|++|+++|.+|+.+..++.|+.|++++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+|++|++
T Consensus       409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l  487 (968)
T PLN00113        409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQF  487 (968)
T ss_pred             EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCcc
Confidence            4555566655566666666666666666666666666555566666666666666666666544 346788888888888


Q ss_pred             CCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCc-----------cceeecCCcccCCCchhhh
Q 041249           82 RGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFL  150 (789)
Q Consensus        82 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~-----------l~~l~ls~N~l~~~~p~~~  150 (789)
                      ++.+|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|++.+           |+.|||++|+++|.+|..+
T Consensus       488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  567 (968)
T PLN00113        488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL  567 (968)
T ss_pred             CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence            88888889999999999999999999999999999999999999998753           8899999999999999999


Q ss_pred             cCcccccEEecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHH
Q 041249          151 VGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLA  230 (789)
Q Consensus       151 ~~~~~l~~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~  230 (789)
                      ..+++|+.|++++|++++.+|..+.+.......+.||+.+|++.+....+.|.....   ...  +.+++++++++++++
T Consensus       568 ~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~--~~~~~~~~~~~~~~~  642 (968)
T PLN00113        568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPS--WWFYITCTLGAFLVL  642 (968)
T ss_pred             hcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---cce--eeeehhHHHHHHHHH
Confidence            999999999999999999999988888888889999999998776555566643211   111  222333333333333


Q ss_pred             HHHHHHHHHHHHhcccCCCC---Cc-------cc-cccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEE
Q 041249          231 LTLSISFLCWVRKRKEQSNP---NS-------LI-NSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVT  299 (789)
Q Consensus       231 ~~~~~~~~~~~~~~k~~~~~---~~-------~~-~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~va  299 (789)
                      +++++++++++++++.+...   ..       +. .....+++.++.   ..|...+.||+|+||.||+|++..+++.||
T Consensus       643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~va  719 (968)
T PLN00113        643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFV  719 (968)
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEE
Confidence            33333333444332211110   00       00 112234555544   457788999999999999999988899999


Q ss_pred             EEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCC
Q 041249          300 VKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL  379 (789)
Q Consensus       300 vK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l  379 (789)
                      ||.++....    ....|++.+++++||||++++|+|....     ..++||||+++|+|.++++             .+
T Consensus       720 vK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~-------------~l  777 (968)
T PLN00113        720 VKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLSEVLR-------------NL  777 (968)
T ss_pred             EEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHHHHHh-------------cC
Confidence            999864332    2235688999999999999999997765     7899999999999999983             36


Q ss_pred             CHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccC
Q 041249          380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYG  459 (789)
Q Consensus       380 ~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~  459 (789)
                      +|.++..|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+......      ....++..|+|||+.
T Consensus       778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~  850 (968)
T PLN00113        778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETR  850 (968)
T ss_pred             CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccc
Confidence            899999999999999999998777789999999999999999988875 5554433211      123578999999999


Q ss_pred             CCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc-hhhhccCCcccChhhHHHhhhhhhhhhhhc
Q 041249          460 LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH-VMDIVDSTLLNDVEDLAIISNQRQRQIRVN  538 (789)
Q Consensus       460 ~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~  538 (789)
                      ....++.|+|||||||++|||+||+.||+..+......+.|++...... ..+.+|+.+.....                
T Consensus       851 ~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------  914 (968)
T PLN00113        851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----------------  914 (968)
T ss_pred             cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----------------
Confidence            9999999999999999999999999999876667778889988776544 55567776643211                


Q ss_pred             hhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       539 ~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      ...++..++.+++..|++.+|.+||++.++...+..+
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            1224556778999999999999999999886655443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=426.94  Aligned_cols=284  Identities=36%  Similarity=0.599  Sum_probs=245.6

Q ss_pred             ccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeee
Q 041249          256 SLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA  335 (789)
Q Consensus       256 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  335 (789)
                      ....|++.|+..||++|+..+.||+|+||+||+|... +++.||||++........++|..|++++++++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            5678999999999999999999999999999999998 459999998865543314569999999999999999999999


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      |.+..    ..+++|||||++|+|.++++..       ... .++|.+|++||.++|+||+|||+.+.++||||||||+|
T Consensus       140 C~e~~----~~~~LVYEym~nGsL~d~L~~~-------~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN  207 (361)
T KOG1187|consen  140 CLEGG----EHRLLVYEYMPNGSLEDHLHGK-------KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN  207 (361)
T ss_pred             EecCC----ceEEEEEEccCCCCHHHHhCCC-------CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence            98765    1489999999999999999865       111 78999999999999999999999999999999999999


Q ss_pred             eecCCCCceeeCcccccccCCC-CCCccceeee-cccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccc-c
Q 041249          416 ILLDEEMVSHVGDFGLARFLPP-THVQTSSIGV-KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF-E  492 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~-~  492 (789)
                      ||+|+++++||+|||+|+..+. ...   .... .||.+|+|||+...+..++|+|||||||+|.|++||+.|.+... .
T Consensus       208 ILLD~~~~aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~  284 (361)
T KOG1187|consen  208 ILLDEDFNAKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR  284 (361)
T ss_pred             eeECCCCCEEccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence            9999999999999999977765 221   1112 79999999999999999999999999999999999999998654 4


Q ss_pred             CCccHHHHHHHhCCCc-hhhhccCCcc-cChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          493 GDMNLHNFARMALPDH-VMDIVDSTLL-NDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~-~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      +...++.|++..+.+. +.+++|+.+. +.+.                 ..++..++..++..|.+.++..||.|.++..
T Consensus       285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~-----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYP-----------------DEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccccHHHHHHHHHHCcchhheeCCCccCCCCC-----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            5567999998888875 9999999987 3321                 1146677899999999999999999998754


Q ss_pred             cc
Q 041249          571 IL  572 (789)
Q Consensus       571 ~l  572 (789)
                      .+
T Consensus       348 ~L  349 (361)
T KOG1187|consen  348 EL  349 (361)
T ss_pred             HH
Confidence            44

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.3e-48  Score=478.21  Aligned_cols=455  Identities=31%  Similarity=0.481  Sum_probs=322.8

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|||++|+++|.+|.  +.+++|++|+|++|.+++.+|..++.+++|++|+|++|.+++.+|..++++++|++|+|++|+
T Consensus       122 ~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~  199 (968)
T PLN00113        122 YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ  199 (968)
T ss_pred             EEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCC
Confidence            489999999999996  468999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCC-----------ccceeecCCcccCCCchhh
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ-----------GLTILDLSRNKLSGEIPEF  149 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~-----------~l~~l~ls~N~l~~~~p~~  149 (789)
                      +++.+|..++.+++|++|+|++|++++.+|..++++++|++|++++|++.           .|+.|++++|++++.+|..
T Consensus       200 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~  279 (968)
T PLN00113        200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS  279 (968)
T ss_pred             CcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh
Confidence            99999999999999999999999999999999999999999999999764           3899999999999999999


Q ss_pred             hcCcccccEEecccCCCCCCCCCc-ccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHH
Q 041249          150 LVGLKVIENLNLSYNDLEGMVPTE-GVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG  228 (789)
Q Consensus       150 ~~~~~~l~~l~ls~N~~~~~~~~~-~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~  228 (789)
                      +..+++|+.|++++|.+++.+|.. ...+.+..+.+.+|..... .+.                                
T Consensus       280 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~~~--------------------------------  326 (968)
T PLN00113        280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK-IPV--------------------------------  326 (968)
T ss_pred             HhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc-CCh--------------------------------
Confidence            999999999999999999887764 3345555555555532100 000                                


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc
Q 041249          229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH  308 (789)
Q Consensus       229 v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~  308 (789)
                                                                                                      
T Consensus       327 --------------------------------------------------------------------------------  326 (968)
T PLN00113        327 --------------------------------------------------------------------------------  326 (968)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHH
Q 041249          309 RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA  388 (789)
Q Consensus       309 ~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  388 (789)
                              .+..+     +++..+ ..                            ..+                      
T Consensus       327 --------~~~~l-----~~L~~L-~L----------------------------~~n----------------------  342 (968)
T PLN00113        327 --------ALTSL-----PRLQVL-QL----------------------------WSN----------------------  342 (968)
T ss_pred             --------hHhcC-----CCCCEE-EC----------------------------cCC----------------------
Confidence                    00000     000000 00                            000                      


Q ss_pred             HHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccc
Q 041249          389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG  468 (789)
Q Consensus       389 ~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~  468 (789)
                                   .   +                                                              
T Consensus       343 -------------~---l--------------------------------------------------------------  344 (968)
T PLN00113        343 -------------K---F--------------------------------------------------------------  344 (968)
T ss_pred             -------------C---C--------------------------------------------------------------
Confidence                         0   0                                                              


Q ss_pred             cchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHH
Q 041249          469 DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISML  548 (789)
Q Consensus       469 DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  548 (789)
                                   +|..|                                                              
T Consensus       345 -------------~~~~p--------------------------------------------------------------  349 (968)
T PLN00113        345 -------------SGEIP--------------------------------------------------------------  349 (968)
T ss_pred             -------------cCcCC--------------------------------------------------------------
Confidence                         00000                                                              


Q ss_pred             hhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCC
Q 041249          549 RIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSN  628 (789)
Q Consensus       549 ~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~  628 (789)
                      .....+.+++.+++..+.+....+..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..|..+++
T Consensus       350 ~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~  429 (968)
T PLN00113        350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL  429 (968)
T ss_pred             hHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCC
Confidence            00001123344444555555455555566666666666666666666666666666666666666666666666666666


Q ss_pred             CcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccC
Q 041249          629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV  708 (789)
Q Consensus       629 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  708 (789)
                      |+.|++++|++++.+|..+..+++|+.|+|++|++.+..|..+ ..++|+.|+|++|++++..|..|.++++|+.|+|++
T Consensus       430 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~  508 (968)
T PLN00113        430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE  508 (968)
T ss_pred             CCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcC
Confidence            6666666666666666666666666666666666666666544 346666666666666666666666666666666666


Q ss_pred             ccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccC
Q 041249          709 NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV  788 (789)
Q Consensus       709 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  788 (789)
                      |++++.+|..+..+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+
T Consensus       509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  587 (968)
T PLN00113        509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS-EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL  587 (968)
T ss_pred             CcceeeCChHHcCccCCCEEECCCCcccccCChhHh-CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeC
Confidence            666666666666666666666666666666666554 6666666666666666666666666666666666666666665


Q ss_pred             C
Q 041249          789 P  789 (789)
Q Consensus       789 P  789 (789)
                      |
T Consensus       588 p  588 (968)
T PLN00113        588 P  588 (968)
T ss_pred             C
Confidence            5

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=359.83  Aligned_cols=258  Identities=31%  Similarity=0.424  Sum_probs=205.0

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceE-EEEEEeccccchh--hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTT-VTVKVFNLHHHRA--SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ..+++...+.||.|+||+||+|.|+  |+. ||||.+.......  .+.|.+|+.++.+++|||||+++|+|.....   
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---  113 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---  113 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence            3344555667999999999999998  555 9999997653322  5689999999999999999999999976531   


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V  423 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~  423 (789)
                       ..++|||||++|+|.++++..        ....+++..++.|+.|||+||.|||+.+.  ||||||||+|||++.++ +
T Consensus       114 -~~~iVtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~  182 (362)
T KOG0192|consen  114 -SLCIVTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKT  182 (362)
T ss_pred             -ceEEEEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCE
Confidence             479999999999999999753        34789999999999999999999998864  99999999999999998 9


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCC--CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL--GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      +||+|||+++......  ...+...||..|||||.+.  ..+|+.|+|||||||++|||+||+.||.....     .+.+
T Consensus       183 ~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~  255 (362)
T KOG0192|consen  183 LKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVA  255 (362)
T ss_pred             EEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence            9999999999876543  2233467999999999999  56899999999999999999999999984322     1111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      ...        .....+                  ......|...+..++..||+.++..||+..+....+..
T Consensus       256 ~~v--------~~~~~R------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  256 SAV--------VVGGLR------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             HHH--------HhcCCC------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            110        000011                  00111366677788889999999999999887554443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-41  Score=340.42  Aligned_cols=200  Identities=31%  Similarity=0.518  Sum_probs=182.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      -.+|...+.||+|.|++||+|.++.++..||||.+...  .....+-+..|+.+++.++|||||++++.+...+     .
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-----~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-----F   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----e
Confidence            36888888999999999999999999999999999766  4555677899999999999999999999998877     9


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-----
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-----  421 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-----  421 (789)
                      .|+|||||.+|+|.+|++..          +.+++.+...++.|+|.||++||+.+   ||||||||+|||++..     
T Consensus        84 i~lVMEyC~gGDLs~yi~~~----------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~  150 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRR----------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDT  150 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCC
Confidence            99999999999999999765          57899999999999999999999998   9999999999999865     


Q ss_pred             -CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 -MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                       -.+||+|||+|+.+.+..   .....+|++.|||||++...+|+.|+|+||.|+++||+++|+.||+.
T Consensus       151 ~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  151 SPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence             467999999999998665   23346799999999999999999999999999999999999999983

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=328.54  Aligned_cols=255  Identities=23%  Similarity=0.276  Sum_probs=208.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +......||+|..|+||++.++.+++-+|+|++... .....+++.+|++++++.+||+||++||.|....   . ...+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~---~-~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG---E-EISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---c-eEEe
Confidence            445678999999999999999999999999999655 4455789999999999999999999999998654   1 4899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||.+|+|+.++...          +++++...-+|+.+|++||.|||+ .+   ||||||||+|||++..+++||+|
T Consensus       156 ~mEYMDgGSLd~~~k~~----------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRV----------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             ehhhcCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecc
Confidence            99999999999999644          668999999999999999999996 66   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.++.+-...    .....||..|||||-+.+..|+.++||||||++++|+.+|+-|+....+...+..+.......+.
T Consensus       223 FGVS~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p  298 (364)
T KOG0581|consen  223 FGVSGILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP  298 (364)
T ss_pred             ccccHHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence            99999876652    34467999999999999999999999999999999999999999754222223322222111110


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                           .|.+..                     ..|..++...+..|.+.++-.|++..+...++
T Consensus       299 -----pP~lP~---------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  299 -----PPRLPE---------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             -----CCCCCc---------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                 111110                     03666777889999999999999998765543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=344.00  Aligned_cols=249  Identities=29%  Similarity=0.439  Sum_probs=203.7

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      ...+.||+|-||+||.|.|+ +...||+|.++... -....|.+|+++|.+|+|+|||+++|+|...+     ..+||||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE  281 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTE  281 (468)
T ss_pred             HHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEE
Confidence            34578999999999999998 55699999997653 23467889999999999999999999998765     7899999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      ||+.|+|.++++..        .+..+...+.+.++.|||+||+||++++   +|||||.++|||++++..+||+|||+|
T Consensus       282 ~m~~GsLl~yLr~~--------~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTR--------EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             ecccCcHHHHhhhc--------CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence            99999999999753        4678899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMD  511 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  511 (789)
                      +...++.. .......-...|+|||.+..++++.|||||||||+||||+| |+.|+..     +...+.++         
T Consensus       351 r~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-----msn~ev~~---------  415 (468)
T KOG0197|consen  351 RLIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-----MSNEEVLE---------  415 (468)
T ss_pred             cccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-----CCHHHHHH---------
Confidence            95444432 12222223457999999999999999999999999999999 9999862     22222222         


Q ss_pred             hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .++...+                  ......|+..+.+++..||+.++-+||+.......+
T Consensus       416 ~le~GyR------------------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l  458 (468)
T KOG0197|consen  416 LLERGYR------------------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVL  458 (468)
T ss_pred             HHhccCc------------------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHH
Confidence            2222222                  223346888999999999999999999998654433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-39  Score=359.44  Aligned_cols=269  Identities=24%  Similarity=0.354  Sum_probs=220.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      ..+....+.||+|.||+||+|...     .....||||.++..... .+.+|++|+++++.++|||||+++|.|.+.+  
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~--  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD--  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC--
Confidence            446667789999999999999974     23567999999988766 6889999999999999999999999999877  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCC----CCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA----PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                         ..++|+|||..|||.+||...+-.......    +..++..+.+.||.|||.||+||-++.   +|||||-.+|+|+
T Consensus       563 ---P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV  636 (774)
T KOG1026|consen  563 ---PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV  636 (774)
T ss_pred             ---eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence               899999999999999999865433332222    334999999999999999999999887   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +++..+||+|||+++..-..+.........-..+|||||.+..+++|++||||||||||||+++ |+.|++....+  ..
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--EV  714 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--EV  714 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--HH
Confidence            9999999999999998766654433323344579999999999999999999999999999998 99999854322  11


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccccC
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGN  577 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~  577 (789)
                      ++.++           +..+                   .....+|+.++.+++..||+..+.+||+.+++...+..+..
T Consensus       715 Ie~i~-----------~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECIR-----------AGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHH-----------cCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            22211           1111                   12234799999999999999999999999998777665544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=319.69  Aligned_cols=201  Identities=29%  Similarity=0.373  Sum_probs=183.4

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ..++|...++||+|+||+||.++-+++++.+|+|+++..   .....+...+|..++.+++||.||+++..|+...    
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~----   98 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE----   98 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC----
Confidence            457999999999999999999999999999999999654   3345678999999999999999999999999877    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++|+||+.+|.|..++.+.          ..+++..+.-++.+|+.||.|||+.+   ||||||||+|||+|++|++
T Consensus        99 -kLylVld~~~GGeLf~hL~~e----------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   99 -KLYLVLDYLNGGELFYHLQRE----------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             -eEEEEEeccCCccHHHHHHhc----------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcE
Confidence             899999999999999999765          67899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +|+|||+++..-....  .+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.
T Consensus       165 ~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             EEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence            9999999996544432  2334789999999999999999999999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-39  Score=311.88  Aligned_cols=254  Identities=23%  Similarity=0.301  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .+|.+.++||.|.||+||+++...+|..||.|.+...  .....+.+.+|+.+++.++|||||++++.....+   ..-.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~---~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED---NEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc---chhh
Confidence            3577788999999999999999999999999998744  4445678999999999999999999998533222   2237


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC-CCceecCCCCCceecCCCCceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ-PITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .+||||+..|+|...++..+      ...+.+++.++.+++.|++.||.++|+..+ ..|+||||||.||++++.+.+||
T Consensus        96 nivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence            89999999999999997652      345789999999999999999999998432 24999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||+++++......  .....||+-||+||.+....|+.|+||||+||++|||+.-++||..     .++.+..+..-.
T Consensus       170 GDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-----~n~~~L~~KI~q  242 (375)
T KOG0591|consen  170 GDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-----DNLLSLCKKIEQ  242 (375)
T ss_pred             ccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-----ccHHHHHHHHHc
Confidence            999999998766532  3346799999999999999999999999999999999999999973     255555443322


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      -....+.|                          .-....+.+++..|..+++-.||+.
T Consensus       243 gd~~~~p~--------------------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  243 GDYPPLPD--------------------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCCCcH--------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence            11111111                          1233455577788888999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-37  Score=331.95  Aligned_cols=200  Identities=28%  Similarity=0.397  Sum_probs=182.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ..|...++||+|||+.+|.++..++|+.||+|++...   +....+...+||++.+.++|||||+++++|.+..     +
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-----n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-----N   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-----c
Confidence            4688999999999999999999889999999999653   4455677899999999999999999999998877     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+|.|+|.+|+|.++++.+          +.+++.++..+..||+.||.|||+.+   |+|||||-.|+|+++++++||
T Consensus        93 VYivLELC~~~sL~el~Krr----------k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKI  159 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRR----------KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKI  159 (592)
T ss_pred             eEEEEEecCCccHHHHHHhc----------CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEe
Confidence            99999999999999999744          78999999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+|.....++..  ....+||+.|+|||++.....+..+||||+|||||-|++|++||+.
T Consensus       160 gDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet  220 (592)
T KOG0575|consen  160 GDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET  220 (592)
T ss_pred             cccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence            999999998765432  3347899999999999988899999999999999999999999973

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-37  Score=315.03  Aligned_cols=254  Identities=20%  Similarity=0.223  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      +-|-..+.+|+|+||.|-+|..+.+++.||||+++.....       ......+|+++|++++|||||++.+++...+  
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d--  249 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD--  249 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC--
Confidence            4566789999999999999999999999999999644211       2234579999999999999999999998877  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-  421 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-  421 (789)
                         ..||||||+.+|+|.+++-..          +.+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+ 
T Consensus       250 ---s~YmVlE~v~GGeLfd~vv~n----------k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  250 ---SSYMVLEYVEGGELFDKVVAN----------KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDA  313 (475)
T ss_pred             ---ceEEEEEEecCccHHHHHHhc----------cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCC
Confidence               679999999999999999665          44555566889999999999999999   9999999999999766 


Q ss_pred             --CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--c-CccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          422 --MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--V-STNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       422 --~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                        ..+||+|||+|+......   .+...+||+.|.|||++.+..  + ..|+||||+|||||-+++|..||.+......-
T Consensus       314 e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             cceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence              788999999999987443   344578999999999998754  3 34889999999999999999999865443222


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..+..+..++..            ..                ...+-..+..+++.+...++|-.|++..++..++
T Consensus       391 ~eQI~~G~y~f~------------p~----------------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  391 KEQILKGRYAFG------------PL----------------QWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             HHHHhcCccccc------------Ch----------------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            233322222211            00                0112234556788889999999999999886544

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=327.90  Aligned_cols=205  Identities=24%  Similarity=0.420  Sum_probs=183.5

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      +...||..++.||+|+|++|++|+...+++++|||++...   +....+....|-.+|.+| .||.|++++..|++..  
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--  147 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--  147 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence            3457899999999999999999999999999999998543   334456677888999999 8999999999999877  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..|+|+||+++|+|.+++++.          ..|++.....++++|+.||+|||+.|   ||||||||+|||+|.++
T Consensus       148 ---sLYFvLe~A~nGdll~~i~K~----------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dm  211 (604)
T KOG0592|consen  148 ---SLYFVLEYAPNGDLLDLIKKY----------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDG  211 (604)
T ss_pred             ---ceEEEEEecCCCcHHHHHHHh----------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCC
Confidence               899999999999999999865          67899999999999999999999999   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCc---------cce--eeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          423 VSHVGDFGLARFLPPTHVQ---------TSS--IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++||+|||.|+.+++....         ...  ....||..|.+||++.++..++.+|||+|||++|+|+.|++||.+
T Consensus       212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra  289 (604)
T KOG0592|consen  212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA  289 (604)
T ss_pred             cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence            9999999999998765421         111  347799999999999999999999999999999999999999964

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=333.94  Aligned_cols=205  Identities=19%  Similarity=0.203  Sum_probs=187.5

Q ss_pred             ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      |..|++|+.|.|..|.|+..-.+.|..+.++++|+|+.|+++..-.+.+.+++.|+.|+||+|.|..+.++.+...++|+
T Consensus       241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~  320 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK  320 (873)
T ss_pred             hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence            55788889999999999988888999999999999999999988888899999999999999999988899999899999


Q ss_pred             EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCC---ccccCCCCccEEEcc
Q 041249          655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP---SSIFNISSIAEFDVG  731 (789)
Q Consensus       655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls  731 (789)
                      +|+|++|+|+...+++|..+..|++|+|++|+|+.....+|..+++|++|||++|.|+..+.   ..|.+|++|+.|+|.
T Consensus       321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~  400 (873)
T KOG4194|consen  321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT  400 (873)
T ss_pred             eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence            99999999998889999999999999999999998888899999999999999999986553   568889999999999


Q ss_pred             CCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccC
Q 041249          732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN  781 (789)
Q Consensus       732 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  781 (789)
                      +|+|. .||...|.++++|++|||.+|.|..+-|.+|..+ .|++|.+..
T Consensus       401 gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  401 GNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             Cceee-ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            99998 9999999999999999999999998999999999 888888754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=328.42  Aligned_cols=262  Identities=27%  Similarity=0.373  Sum_probs=208.4

Q ss_pred             ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeec
Q 041249          260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACS  337 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  337 (789)
                      .+..++++-.+.+...+.||+|.||+||+|.|.   -.||||+++...  .+..+.|+.|++++++-+|.||+-++|+|.
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            344666667777788899999999999999997   469999997663  445688999999999999999999999998


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ...      .+||..||++-+|..+++-.         ...|+..+.++||.|||+||.|||.++   |||||||+.|||
T Consensus       459 ~p~------~AIiTqwCeGsSLY~hlHv~---------etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIF  520 (678)
T KOG0193|consen  459 NPP------LAIITQWCEGSSLYTHLHVQ---------ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIF  520 (678)
T ss_pred             CCc------eeeeehhccCchhhhhccch---------hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceE
Confidence            654      49999999999999999854         367889999999999999999999998   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD  494 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~  494 (789)
                      +.+++++||+|||++....--..........|..-|||||++..   .+|++.+||||||+|+|||++|.-||.....+.
T Consensus       521 l~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq  600 (678)
T KOG0193|consen  521 LHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ  600 (678)
T ss_pred             EccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence            99999999999999986553332222333458889999998764   569999999999999999999999997332210


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           .+.. ..++   ..-|.+                   ......|..+|.++...|+..++.+||.......
T Consensus       601 -----Iifm-VGrG---~l~pd~-------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  601 -----IIFM-VGRG---YLMPDL-------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -----eEEE-eccc---ccCccc-------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                 0000 0000   000000                   1122368889999999999999999999887643

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=324.13  Aligned_cols=216  Identities=18%  Similarity=0.157  Sum_probs=201.0

Q ss_pred             cccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCC
Q 041249          572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS  651 (789)
Q Consensus       572 l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  651 (789)
                      ...|++|++|+.|+|..|+|.-+---.|.+|++|+.|.|..|.|+..-.++|..|.++++|+|+.|+++..-.+++.+++
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt  293 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT  293 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence            34577899999999999999944456799999999999999999988899999999999999999999988899999999


Q ss_pred             CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEcc
Q 041249          652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG  731 (789)
Q Consensus       652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  731 (789)
                      +|+.|+|++|.|..+.++++.-+++|++|+|+.|+|+...+++|..|..|++|+|++|+|+.....+|..+++|++|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            99999999999999999999999999999999999998888999999999999999999998888999999999999999


Q ss_pred             CCcccccCCcc--cccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          732 ENKIQGNIPLD--YGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       732 ~N~l~~~ip~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      +|.|+..|.+.  .|.+|+.|+.|+|.+|+|..+...+|.++..|+.|||.+|.|-..
T Consensus       374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSI  431 (873)
T KOG4194|consen  374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASI  431 (873)
T ss_pred             CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceee
Confidence            99999877653  667899999999999999988889999999999999999988653

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.6e-39  Score=324.75  Aligned_cols=178  Identities=30%  Similarity=0.478  Sum_probs=123.1

Q ss_pred             EcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCC
Q 041249            3 ALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFR   82 (789)
Q Consensus         3 ~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   82 (789)
                      |+++|++. .+|++++.+-.+..|+..+|+++ +.|+.+..+.+|..+++.+|.++ .+|+..-.++.|++||..+|.|+
T Consensus       120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~  196 (565)
T KOG0472|consen  120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE  196 (565)
T ss_pred             hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh
Confidence            34444444 44444444444444444444444 44444444445555555555554 33333334666777777777775


Q ss_pred             CCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCC-----------ccceeecCCcccCCCchhhhc
Q 041249           83 GSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ-----------GLTILDLSRNKLSGEIPEFLV  151 (789)
Q Consensus        83 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~-----------~l~~l~ls~N~l~~~~p~~~~  151 (789)
                       .+|++++.+.+|+.|+|.+|+|. .+| +|.+|+.|++|+++.|++.           ++.+|||.+|+++ ++|+.++
T Consensus       197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c  272 (565)
T KOG0472|consen  197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC  272 (565)
T ss_pred             -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHH
Confidence             78888888888888888888887 677 6888888888888888663           3778999999999 7999999


Q ss_pred             CcccccEEecccCCCCCCCCCcccccCCccccccCCC
Q 041249          152 GLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNN  188 (789)
Q Consensus       152 ~~~~l~~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~  188 (789)
                      -+++|++||+|+|.|++.+++.|.. .+..+.+.|||
T Consensus       273 lLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  273 LLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             HhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            9999999999999999998887655 55555666664

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=290.11  Aligned_cols=198  Identities=25%  Similarity=0.339  Sum_probs=181.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.+|.|+||.|..++.+.++..+|+|+++...   ....+...+|..+++.+.||.++++++.|.+..     .
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-----~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-----N  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----e
Confidence            57888999999999999999999999999999997553   333456788999999999999999999998877     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||.++|-|..++++.          +++++.....+|+||+.|++|||+.+   |++||+||+|||+|.+|++||
T Consensus       119 lymvmeyv~GGElFS~Lrk~----------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKi  185 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKS----------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKI  185 (355)
T ss_pred             EEEEEeccCCccHHHHHHhc----------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEE
Confidence            99999999999999999765          68999999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +|||.|+.....     +-..+||+.|+|||.+....|...+|.|||||++|||+.|.+||.+.
T Consensus       186 tDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  186 TDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             EeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            999999987654     34578999999999999999999999999999999999999999843

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=315.53  Aligned_cols=252  Identities=20%  Similarity=0.260  Sum_probs=208.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ..|+....||+|..|.||.|....+++.||||++....+...+-..+|+.+|+..+|+|||.++..+...+     ..|.
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEE
Confidence            46778889999999999999999999999999999988888888999999999999999999999988776     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |||||++|+|.+.+...           .+++.++..|+.++++||+|||.++   |+|||||++|||++.++.+||+||
T Consensus       348 VMEym~ggsLTDvVt~~-----------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-----------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             EEeecCCCchhhhhhcc-----------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeee
Confidence            99999999999998654           5899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |++..+.....  ......||+.|||||+.....|++|+||||+|++++||+-|++||-.   +. .+..... ...++.
T Consensus       414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~-PlrAlyL-Ia~ng~  486 (550)
T KOG0578|consen  414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---EN-PLRALYL-IATNGT  486 (550)
T ss_pred             eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CC-hHHHHHH-HhhcCC
Confidence            99998876653  23346799999999999999999999999999999999999999862   11 1111111 111111


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .++-.+                         ..-...+.+...+|.+.+...|++..+...++
T Consensus       487 P~lk~~-------------------------~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  487 PKLKNP-------------------------EKLSPELKDFLDRCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             CCcCCc-------------------------cccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence            111111                         11123444667789999999999998775543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=318.64  Aligned_cols=244  Identities=21%  Similarity=0.323  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .....+-+|.|+.|.||.|+++  ++.||||.++.-       -+.+|..|++|+|+||+.+.|+|....     -.|||
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIi  190 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCII  190 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEe
Confidence            3445678999999999999997  889999987533       245788999999999999999998766     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      ||||..|-|.+.++..          +.++......|..+||.||.|||.+.   |||||||+-||||+.+..+||+|||
T Consensus       191 MEfCa~GqL~~VLka~----------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG----------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             eeccccccHHHHHhcc----------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecccc
Confidence            9999999999999754          67888899999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchh
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM  510 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  510 (789)
                      -++...+..   ....+.||..|||||++.+.++++|+||||||||||||+||..||.+....     .   ..|.-+  
T Consensus       258 TS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----A---IIwGVG--  324 (904)
T KOG4721|consen  258 TSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----A---IIWGVG--  324 (904)
T ss_pred             chHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----e---eEEecc--
Confidence            999887653   234578999999999999999999999999999999999999999732111     0   011100  


Q ss_pred             hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                         .-                  .+-.-...+|..-+.=++-.|++..+-+||+...+..+++.+
T Consensus       325 ---sN------------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 ---SN------------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ---CC------------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence               00                  000112234555555667789999999999998876655433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=308.62  Aligned_cols=259  Identities=27%  Similarity=0.369  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .++...+.||+|.||.||.+....+|...|||..........+.+.+|+.+|++++|||||+++|......   ....++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeEe
Confidence            46777899999999999999999889999999997764444677999999999999999999999744332   125889


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~D  428 (789)
                      .|||+++|+|.+++...        .+ .+++..+..+..||++||+|||+++   |||+||||+|||++. ++.+||+|
T Consensus        94 ~mEy~~~GsL~~~~~~~--------g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRY--------GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             eeeccCCCcHHHHHHHc--------CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEecc
Confidence            99999999999999765        33 7999999999999999999999998   999999999999999 79999999


Q ss_pred             ccccccCCCCC-CccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          429 FGLARFLPPTH-VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       429 fgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      ||.++...... .........||+.|||||+...+. ...++|||||||++.||+||+.||....+..   ....+....
T Consensus       162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~~ig~~  238 (313)
T KOG0198|consen  162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALLLIGRE  238 (313)
T ss_pred             CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHHHHhcc
Confidence            99998776411 122233577999999999998654 4469999999999999999999998531111   111111111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...+.+.+.                           ......+....|...++..||+..+...++-
T Consensus       239 ~~~P~ip~~---------------------------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  239 DSLPEIPDS---------------------------LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCCCCCCcc---------------------------cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            111111111                           1122336677899999999999988755543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=343.34  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=207.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc-----eEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR-----TTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++-...+.||+|.||+||+|++..-.     ..||||.++.. +.+...+|.+|..+|++++|||||+++|+|....  
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~--  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG--  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence            345556789999999999999996443     34999998655 4566789999999999999999999999998755  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++++|||.+|+|..|+++.+...   .....++....+.++.|||+|+.||+++.   +|||||.++|+|+++..
T Consensus       769 ---~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r  839 (1025)
T KOG1095|consen  769 ---PPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERR  839 (1025)
T ss_pred             ---CcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccC
Confidence               7899999999999999998763222   23677899999999999999999999887   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~  501 (789)
                      .+||+|||+|+.+.............-...|||||.+.++.++.|+|||||||++||++| |..||..... ...+..+.
T Consensus       840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~~  918 (1025)
T KOG1095|consen  840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDVL  918 (1025)
T ss_pred             cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHHH
Confidence            999999999995544432211111123358999999999999999999999999999999 9999863211 00111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      +.                          +     |......|...+.+++..||+.++-+||+........
T Consensus       919 ~g--------------------------g-----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~  958 (1025)
T KOG1095|consen  919 EG--------------------------G-----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD  958 (1025)
T ss_pred             hC--------------------------C-----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence            10                          0     2334557889999999999999999999998775533

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=332.94  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=212.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCc---eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ....++++||.|.||+||.|.++-.+   ..||||.++... ....++|..|+.+|.++.||||+++-|+.....     
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-----  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-----  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----
Confidence            45567899999999999999997554   569999998664 445678999999999999999999999987655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..+||.|||++|+|+.||+.+        + ..+++.+..-++++||.||.||-+++   +|||||.++|||++.+..+|
T Consensus       704 PvMIiTEyMENGsLDsFLR~~--------D-GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCK  771 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQN--------D-GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCK  771 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhc--------C-CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEE
Confidence            789999999999999999765        3 45999999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCC-CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          426 VGDFGLARFLPPTH-VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       426 l~Dfgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ++|||+++.+.++. ....+.+-.-..+|.|||.+.-.++|..+|||||||||||.++ |+.||.+...     .+    
T Consensus       772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----Qd----  842 (996)
T KOG0196|consen  772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QD----  842 (996)
T ss_pred             eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----HH----
Confidence            99999999886665 2223333344578999999999999999999999999999886 9999874321     11    


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG  576 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~  576 (789)
                           +...+...+                  |....+.|...+.+++..||+.+.-.||........++.+.
T Consensus       843 -----VIkaIe~gy------------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  843 -----VIKAIEQGY------------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             -----HHHHHHhcc------------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                 111111111                  12345689999999999999999999999988876665443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.3e-36  Score=291.43  Aligned_cols=273  Identities=21%  Similarity=0.265  Sum_probs=203.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .|....++|+|+||.||+++.+++|+.||||.+...  .....+...+||++++.++|+|+|.++.+|....     ..+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-----klh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-----KLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-----eeE
Confidence            466677899999999999999999999999999644  3344677899999999999999999999986543     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+...-|.++=          ..+..++.....+++.|+++|+.|+|.++   ++||||||+|||++..+.+||+|
T Consensus        78 LVFE~~dhTvL~eLe----------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELE----------RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             EEeeecchHHHHHHH----------hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEecc
Confidence            999999986555543          23466889999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH--HHhC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA--RMAL  505 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~--~~~~  505 (789)
                      ||.|+.+.....  ..+....|..|+|||.+.+ -+|+..+||||.||++.||++|.+-|.    +..++.+..  +..+
T Consensus       145 FGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P----G~SDiDQLy~I~ktL  218 (396)
T KOG0593|consen  145 FGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP----GRSDIDQLYLIRKTL  218 (396)
T ss_pred             chhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC----CcchHHHHHHHHHHH
Confidence            999999884332  2233457899999999988 579999999999999999999998875    334444443  3332


Q ss_pred             CC---chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PD---HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .+   ....+.........-.   +..+......-.....-...+++++-.|.+.+|.+|.++.....
T Consensus       219 G~L~prhq~iF~~N~~F~Gv~---lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  219 GNLIPRHQSIFSSNPFFHGVR---LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cccCHHHHHHhccCCceeeee---cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11   1111111110000000   00000000001112233457788999999999999999987644

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-35  Score=306.72  Aligned_cols=204  Identities=28%  Similarity=0.388  Sum_probs=180.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+.|...+.||+|+||.||+|+...+++.||+|.++.+.  ........+||.+|+++.||||+++.+...+..   ...
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---Cce
Confidence            356777889999999999999999999999999998775  455677899999999999999999999987652   237


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+|+|||+. +|.-++..         .+-.|+..++..++.|++.||+|+|+.+   |+|||||.+|||||.++.+||
T Consensus       193 iYlVFeYMdh-DL~GLl~~---------p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKi  259 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSS---------PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKI  259 (560)
T ss_pred             EEEEEecccc-hhhhhhcC---------CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEe
Confidence            8999999997 78877753         3567999999999999999999999999   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+|+++....... .+...-|..|+|||++.+.. |+...|+||.|||+.||++|++.|..
T Consensus       260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G  322 (560)
T KOG0600|consen  260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG  322 (560)
T ss_pred             ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence            9999999988776443 34455799999999999865 99999999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-34  Score=278.67  Aligned_cols=273  Identities=23%  Similarity=0.304  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|...+.+|+|.||.||+|++..+++.||||.++.....  ......+||..++.++|+||+.++++|...+     ..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence            3577788999999999999999999999999999766333  3567889999999999999999999998876     88


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      .+|+|||+. +|+..++..         ...++...+..++.++.+|++|||.+.   |+||||||.|+|++.++.+|++
T Consensus        77 ~lVfEfm~t-dLe~vIkd~---------~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiA  143 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDK---------NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIA  143 (318)
T ss_pred             EEEEEeccc-cHHHHhccc---------ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEee
Confidence            999999996 899988654         567899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC-
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL-  505 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-  505 (789)
                      |||+|+.+.+......  ...-|..|+|||.+.+.+ |+..+||||.||++.||+-|.+-|.    ++.++.+...... 
T Consensus       144 DFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~  217 (318)
T KOG0659|consen  144 DFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRA  217 (318)
T ss_pred             cccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHH
Confidence            9999999987764322  225788999999999865 9999999999999999999986654    4556666544331 


Q ss_pred             -CCchhhh-ccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 -PDHVMDI-VDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 -~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                       .-...+. -+-.-..++-++......    ........+.....++........|..|-++.+...
T Consensus       218 LGTP~~~~WP~~~~lpdY~~~~~~P~~----~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  218 LGTPTPDQWPEMTSLPDYVKIQQFPKP----PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cCCCCcccCccccccccHHHHhcCCCC----ccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence             1111111 010111111111111000    001122233444567777777777777777776643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=296.46  Aligned_cols=263  Identities=21%  Similarity=0.229  Sum_probs=210.0

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ..++|...+.||.|..++||+|.....+..||||++..++-. ..+.+.+|+..|+.++||||++++..|....     .
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----E   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----e
Confidence            457889999999999999999999989999999999877443 3589999999999999999999999998776     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+||.||..|++.++++..        .+..+++..+..|.+++++||.|||.+|   .||||+|+.||||+.+|.+||
T Consensus        99 LWvVmpfMa~GS~ldIik~~--------~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkL  167 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTY--------YPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKL  167 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHH--------ccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEE
Confidence            99999999999999999765        4556999999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccce--eeecccccccCcccC-CC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSS--IGVKGSIGYIAPEYG-LG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~--~~~~gt~~y~aPE~~-~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~  502 (789)
                      +|||.+..+.+.......  ....||+.|||||.+ .. ..|+.|+||||||++..||.+|..||..+..-     +..-
T Consensus       168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl  242 (516)
T KOG0582|consen  168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLL  242 (516)
T ss_pred             cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence            999998888766532222  345799999999994 33 35999999999999999999999999843221     1111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ..+........ ...                 +..+........+.+++..|.+-++-.||+.....
T Consensus       243 ~tLqn~pp~~~-t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl  291 (516)
T KOG0582|consen  243 LTLQNDPPTLL-TSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL  291 (516)
T ss_pred             HHhcCCCCCcc-ccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            11111100000 000                 01122234455777889999999999999998664

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=303.59  Aligned_cols=210  Identities=30%  Similarity=0.434  Sum_probs=185.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|.||.||||+-+.+.+.||+|.+.....  ...+.+.+|++++++++||||+.++.+|....     +.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-----~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-----HL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-----eE
Confidence            467788899999999999999999999999999965533  34577999999999999999999999987665     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      |+|.||+.+ +|..++..          +..+++..+..+++|+..||.|||+..   |.|||+||.|||++..+++|++
T Consensus        77 ~vVte~a~g-~L~~il~~----------d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~Klc  142 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQ----------DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLC  142 (808)
T ss_pred             EEEehhhhh-hHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeec
Confidence            999999997 99999964          478999999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |||+|+.+....  ...+.+.||+-|||||...+..|+..+|.||+||++||+.+|++||..     .++.+.++...
T Consensus       143 dFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~  213 (808)
T KOG0597|consen  143 DFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSIL  213 (808)
T ss_pred             hhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHh
Confidence            999999887644  234567899999999999999999999999999999999999999972     34455555443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=308.54  Aligned_cols=247  Identities=23%  Similarity=0.281  Sum_probs=201.0

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc----cc-hhhHHHHHHHHHHhcCC-CCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH----HH-RASRSFIAECRALRSIR-HRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  341 (789)
                      ....|...+.||+|+||.|+.|....+++.||+|++...    .. ...+...+|+.++++++ ||||++++.++.... 
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-   93 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-   93 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence            456899999999999999999999989999999987543    12 23556778999999998 999999999998776 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...          .++.+.+...++.|++.|++|+|+.+   |+||||||+||+++.+
T Consensus        94 ----~~~ivmEy~~gGdL~~~i~~~----------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~  156 (370)
T KOG0583|consen   94 ----KIYIVMEYCSGGDLFDYIVNK----------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGN  156 (370)
T ss_pred             ----eEEEEEEecCCccHHHHHHHc----------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCC
Confidence                799999999999999999643          67788999999999999999999998   9999999999999999


Q ss_pred             -CceeeCcccccccCC-CCCCccceeeecccccccCcccCCCCC-cC-ccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249          422 -MVSHVGDFGLARFLP-PTHVQTSSIGVKGSIGYIAPEYGLGSE-VS-TNGDVYSYGILMLELIIRKKPSDIMFEGDMNL  497 (789)
Q Consensus       422 -~~~kl~Dfgla~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~  497 (789)
                       +++||+|||++.... .+.   .....+||+.|+|||.+.+.. |+ .++||||+||+||.|++|+.||++     .+.
T Consensus       157 ~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~  228 (370)
T KOG0583|consen  157 EGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNV  228 (370)
T ss_pred             CCCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccH
Confidence             999999999999884 222   234567999999999999877 85 779999999999999999999984     233


Q ss_pred             HHHHHHhCCCc--hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          498 HNFARMALPDH--VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       498 ~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ....+......  +.+.++                             ......+..+|...++..|.+...+.
T Consensus       229 ~~l~~ki~~~~~~~p~~~~-----------------------------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  229 PNLYRKIRKGEFKIPSYLL-----------------------------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHHHhcCCccCCCCcC-----------------------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            33333321111  111111                             23344667788888888888888775

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-34  Score=313.93  Aligned_cols=268  Identities=22%  Similarity=0.270  Sum_probs=200.7

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      .+.++|...+.||+|+||.||+|.+.     .+++.||||+++.... .....+.+|++++.++ +||||++++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34678999999999999999999852     3456899999875432 3356789999999999 899999999988643


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCc-------------------------------------------------
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED-------------------------------------------------  370 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------  370 (789)
                      .    ...++||||+++|+|.+++.......                                                 
T Consensus        84 ~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          84 N----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             C----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            2    25789999999999999986531100                                                 


Q ss_pred             ---cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeee
Q 041249          371 ---EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV  447 (789)
Q Consensus       371 ---~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  447 (789)
                         ........+++.++..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++..............
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence               00001245888999999999999999999888   999999999999999999999999999876543322222234


Q ss_pred             cccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHH
Q 041249          448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAI  526 (789)
Q Consensus       448 ~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  526 (789)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+........        .+..         
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~--------~~~~---------  298 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGT--------RMRA---------  298 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCC--------CCCC---------
Confidence            46678999999999999999999999999999997 99998742211 11111111000        0000         


Q ss_pred             hhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          527 ISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                                   ...+...+.+++..|++.++..||+...+...+
T Consensus       299 -------------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l  331 (338)
T cd05102         299 -------------PENATPEIYRIMLACWQGDPKERPTFSALVEIL  331 (338)
T ss_pred             -------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                         012334567889999999999999998775433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=275.00  Aligned_cols=203  Identities=23%  Similarity=0.353  Sum_probs=182.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      -++|..++.||+|-||.||.|+.+.++-.||+|++...   .....+++++|+++-+.++||||+++|+++.+..     
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-----   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-----   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-----
Confidence            36899999999999999999999999999999998544   3445688999999999999999999999998877     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..|+++||..+|.+...+...        ....+++.....+..|+|.|+.|+|..+   ++||||||+|+|++-++..|
T Consensus        96 riyLilEya~~gel~k~L~~~--------~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk  164 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEG--------RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK  164 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhc--------ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence            899999999999999999743        4467888899999999999999999877   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF  491 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~  491 (789)
                      ++|||.+-..+...    ....+||+-|.|||+..+...+.++|+|++||..||+++|.+||+...
T Consensus       165 iAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  165 IADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             ccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            99999998776333    234679999999999999999999999999999999999999998543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=305.66  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=206.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ...+.++||+|-||+|+.+... ++..||||+++...... ..+|.+|+++|.+++||||++++|+|...+     ..++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Picm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHH
Confidence            4457889999999999999997 57999999998876555 489999999999999999999999998877     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ++|||++|+|.+|+...        ....+....-..|+.|||.||+||.+..   +||||+.++|+|++.++++||+||
T Consensus       613 I~EYmEnGDLnqFl~ah--------eapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAH--------ELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             HHHHHhcCcHHHHHHhc--------cCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence            99999999999999765        2223455667789999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCCccccCCccHHHHHHHhCCC
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |+++.+-............-..+|||+|.+..+++++++|||+|||++||+++  ...||+...++  ..++-....++.
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~  759 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRD  759 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCC
Confidence            99997766554332233344579999999999999999999999999999865  88998743222  122222222221


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .        -+..+               .....-|...+.+++..|++.+...||+.......+
T Consensus       760 ~--------~~~~~---------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l  801 (807)
T KOG1094|consen  760 Q--------GRQVV---------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL  801 (807)
T ss_pred             C--------Cccee---------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence            1        11000               112235778888999999999999999998765443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=301.94  Aligned_cols=249  Identities=24%  Similarity=0.273  Sum_probs=206.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .-|+..+.||.|.||.||+|.+..+++.||+|++...... ......+|+.+++.++++||.++||.+....     ..|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence            4577789999999999999999999999999999877544 4678999999999999999999999987766     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      ++|||+.+|++.+.+...          ..+.+..+.-|.+++..|+.|+|+++   .+|||||+.||++..++.+|++|
T Consensus        88 iiMey~~gGsv~~lL~~~----------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~D  154 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSG----------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLAD  154 (467)
T ss_pred             HHHHHhcCcchhhhhccC----------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEe
Confidence            999999999999999654          44577788889999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.+..+......  .....||+.|||||++....|+.|+||||+|++.+||++|.+|+....              |.+
T Consensus       155 fgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h--------------Pmr  218 (467)
T KOG0201|consen  155 FGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH--------------PMR  218 (467)
T ss_pred             cceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC--------------cce
Confidence            9999887655432  245679999999999998889999999999999999999999997321              222


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      +.-.+.+.-.                  +.....+...+.+.+..|.+.+|-+||+......
T Consensus       219 vlflIpk~~P------------------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  219 VLFLIPKSAP------------------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             EEEeccCCCC------------------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1111221111                  1112255666778899999999999999986643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.4e-34  Score=298.96  Aligned_cols=205  Identities=23%  Similarity=0.343  Sum_probs=180.4

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ..++|.....||+|+||+||.|+-+.+|+.+|+|+++..   ........+.|-++|....+|.||++|..|++.+    
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~----  214 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE----  214 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC----
Confidence            458999999999999999999999999999999999755   3444567888999999999999999999999888    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..|+||||+++|++..+|...          ..|++.....++.+++.|++-+|..|   +|||||||+|+|||..|++
T Consensus       215 -~LYLiMEylPGGD~mTLL~~~----------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHi  280 (550)
T KOG0605|consen  215 -YLYLIMEYLPGGDMMTLLMRK----------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHI  280 (550)
T ss_pred             -eeEEEEEecCCccHHHHHHhc----------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCE
Confidence             899999999999999999755          67899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCC----------------------Cc-----------------------cceeeecccccccCcccC
Q 041249          425 HVGDFGLARFLPPTH----------------------VQ-----------------------TSSIGVKGSIGYIAPEYG  459 (789)
Q Consensus       425 kl~Dfgla~~~~~~~----------------------~~-----------------------~~~~~~~gt~~y~aPE~~  459 (789)
                      ||+|||++.-+...+                      ..                       .......||+-|||||++
T Consensus       281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence            999999986432100                      00                       001123499999999999


Q ss_pred             CCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          460 LGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       460 ~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .+..|+..+|.||+|||||||++|-+||...
T Consensus       361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             hcCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999999999843

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-33  Score=301.72  Aligned_cols=267  Identities=20%  Similarity=0.311  Sum_probs=199.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC----------------CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCcccee
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE----------------GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKV  332 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l  332 (789)
                      ++|...+.||+|+||.||+|.+..                ++..||+|.+..... .....+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999998642                345799999876533 335679999999999999999999


Q ss_pred             eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccc---------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 041249          333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV---------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQ  403 (789)
Q Consensus       333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~  403 (789)
                      ++++....     ..++||||+.+|+|.+++.........         ......+++.++..++.|++.||+|||+.+ 
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-  158 (304)
T cd05096          85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-  158 (304)
T ss_pred             EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence            99987655     789999999999999998653211110         112345788999999999999999999988 


Q ss_pred             CCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-
Q 041249          404 PITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-  482 (789)
Q Consensus       404 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-  482 (789)
                        |+||||||+||++++++.+||+|||+++...............++..|+|||+...+.++.++||||||+++|||++ 
T Consensus       159 --ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 --FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             --ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence              99999999999999999999999999987654432222223345788999999988899999999999999999987 


Q ss_pred             -hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEec
Q 041249          483 -RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILD  561 (789)
Q Consensus       483 -G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~  561 (789)
                       |..||....  .......+............                       ......|...+.+++..|++.++.+
T Consensus       237 ~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~  291 (304)
T cd05096         237 CKEQPYGELT--DEQVIENAGEFFRDQGRQVY-----------------------LFRPPPCPQGLYELMLQCWSRDCRE  291 (304)
T ss_pred             cCCCCCCcCC--HHHHHHHHHHHhhhcccccc-----------------------ccCCCCCCHHHHHHHHHHccCCchh
Confidence             556765321  11122222111111000000                       0011134456778999999999999


Q ss_pred             cCcccccc
Q 041249          562 LESLKLAG  569 (789)
Q Consensus       562 l~s~~~~~  569 (789)
                      ||+...+.
T Consensus       292 RPs~~~i~  299 (304)
T cd05096         292 RPSFSDIH  299 (304)
T ss_pred             CcCHHHHH
Confidence            99998764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-35  Score=278.13  Aligned_cols=268  Identities=18%  Similarity=0.185  Sum_probs=214.2

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +..+.|.+.+.+|+|||+.||.++.-.+++.+|+|++..+..++.+...+|++..++++|||++++++++.....++...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            45678999999999999999999998899999999999888888899999999999999999999999987776667778


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|++++|...|+|.+.+...      ...+..+++.+.+.|+.+|++||++||... ++++||||||.||++.+.+.+++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~------k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERL------KIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             EEEEeehhccccHHHHHHHH------hhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEE
Confidence            99999999999999999655      234567899999999999999999999985 57999999999999999999999


Q ss_pred             CcccccccCCCCCC-------ccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          427 GDFGLARFLPPTHV-------QTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       427 ~Dfgla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                      .|||.+...+-...       -..+....-|.+|+|||...-   ...++++|||||||++|+|+.|..||+..++.+.+
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            99999886652210       111222347889999998753   45799999999999999999999999854442222


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      +.-.           +..+.+.                +|.  .......+.+++.+|.+++|..||+..+...
T Consensus       251 laLA-----------v~n~q~s----------------~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~  295 (302)
T KOG2345|consen  251 LALA-----------VQNAQIS----------------IPN--SSRYSEALHQLIKSMLQVDPNQRPTIPELLS  295 (302)
T ss_pred             EEEe-----------eeccccc----------------cCC--CCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1111           1111110                000  1113456778899999999999999877643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=297.38  Aligned_cols=274  Identities=23%  Similarity=0.240  Sum_probs=208.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|...+.||.|+||.||+|+-.+++..||||.++..- .-....-.+|+..+++++ ||||+++..++.+.+    +..
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceE
Confidence            46677889999999999999999999999999986553 233445678999999998 999999999987654    379


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|||||.. +|.++++.+         .+.|++..+..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+
T Consensus        86 ~fVfE~Md~-NLYqLmK~R---------~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKia  152 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR---------NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIA  152 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc---------CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEec
Confidence            999999997 899999754         578999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCC-CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh--
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA--  504 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~--  504 (789)
                      |||+||........   +....|..|+|||++. .+.|+.+.||||+|||++|+.+-++-|..    ...+.+..+..  
T Consensus       153 DFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG----~sE~Dqi~KIc~V  225 (538)
T KOG0661|consen  153 DFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG----ASEIDQIYKICEV  225 (538)
T ss_pred             ccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC----CcHHHHHHHHHHH
Confidence            99999988766533   2345889999999875 56799999999999999999999887753    33344444433  


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhh----hchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR----VNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ++....+.++...     .+......+.++..    .....++..+.++++..|...++..||+..+...++
T Consensus       226 LGtP~~~~~~eg~-----~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  226 LGTPDKDSWPEGY-----NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hCCCccccchhHH-----HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1111111111100     00000000000000    112334667777888999999999999998876543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-33  Score=297.79  Aligned_cols=200  Identities=25%  Similarity=0.378  Sum_probs=173.6

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|...+.||+|+||+||+|....+++.||+|.+....   ......+.+|++++++++|++|+++++++...+     ..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----AL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eE
Confidence            3677889999999999999999899999999986442   223346788999999999999999999987655     79


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+
T Consensus        76 ~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNM--------GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             EEEEEecCCCcHHHHHHhh--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence            9999999999999887543        2245889999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++........   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  203 (285)
T cd05631         145 DLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             eCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence            9999987643321   2234689999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-34  Score=308.98  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=203.8

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCce---E-EEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRT---T-VTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      +..-++....+.||+|.||+||+|.+...+.   . ||||..+..   ......+|.+|+++|..++|||||++||++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3344555666999999999999999975422   3 899999853   35567889999999999999999999999987


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      ..     ..++|||+|.+|+|.+++...         +..++..+++.++.+.|.||+|||..+   ++||||-++|+|+
T Consensus       233 ~~-----Pl~ivmEl~~gGsL~~~L~k~---------~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~  295 (474)
T KOG0194|consen  233 EE-----PLMLVMELCNGGSLDDYLKKN---------KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLY  295 (474)
T ss_pred             CC-----ccEEEEEecCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHhee
Confidence            76     789999999999999999865         236899999999999999999999988   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +.++.+||+|||+++........  .....-...|+|||++..+.|++++|||||||++||+.+ |..||.....  ...
T Consensus       296 ~~~~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v  371 (474)
T KOG0194|consen  296 SKKGVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEV  371 (474)
T ss_pred             cCCCeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHH
Confidence            99999999999998876411110  001124468999999999999999999999999999998 8989873211  122


Q ss_pred             HHHH-HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249          498 HNFA-RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG  576 (789)
Q Consensus       498 ~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~  576 (789)
                      ..++ ...++...                              .......+..+...|+..++-+|+++..+...+..+.
T Consensus       372 ~~kI~~~~~r~~~------------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  372 KAKIVKNGYRMPI------------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             HHHHHhcCccCCC------------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            2222 11111110                              0123445557777999999999999998876665544

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-33  Score=305.39  Aligned_cols=204  Identities=24%  Similarity=0.301  Sum_probs=171.7

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||+|+||.||+|....+++.||||.+...  .......+.+|++++++++||||+++++++...........++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            67788999999999999999989999999998643  2233456889999999999999999999886554333346899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+. ++|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        82 v~e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          82 VFELME-SDLHQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             EEecCC-CCHHHHHHhc----------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence            999996 6898888543          45899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCC-ccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+++....... ........|+..|+|||++..  ..++.++|||||||++|||++|+.||..
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            99986543321 112234568999999998765  6789999999999999999999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=299.21  Aligned_cols=197  Identities=26%  Similarity=0.372  Sum_probs=173.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ......+.+|++++++++||||+++++++.+..     .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-----F   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-----e
Confidence            47888999999999999999999899999999986432   233456889999999999999999998876654     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl  142 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS----------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKL  142 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEE
Confidence            89999999999999998643          46888999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++......     ....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         143 TDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             EecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999998764322     234589999999999888899999999999999999999999963

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.6e-33  Score=294.17  Aligned_cols=257  Identities=19%  Similarity=0.269  Sum_probs=197.7

Q ss_pred             cccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh---hHHHHHHHHHHhcCCCCccceee
Q 041249          257 LLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVKVF  333 (789)
Q Consensus       257 ~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~  333 (789)
                      ...++..++     +......||+|+++.||+|.+  +++.||||+++......   .+.+.+|++++++++||||++++
T Consensus        12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            445555555     233346899999999999998  48999999997553332   46788999999999999999999


Q ss_pred             eeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCC
Q 041249          334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLK  412 (789)
Q Consensus       334 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk  412 (789)
                      |++.+.. .+....++||||+.+|+|.+++...          +.+++.....++.|++.||+|||.. +   ++|||||
T Consensus        85 g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlk  150 (283)
T PHA02988         85 GFIIDIV-DDLPRLSLILEYCTRGYLREVLDKE----------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLT  150 (283)
T ss_pred             eeEEecc-cCCCceEEEEEeCCCCcHHHHHhhC----------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCC
Confidence            9986521 1223679999999999999999643          4688999999999999999999974 5   7899999


Q ss_pred             CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |+||++++++.+|++|||+++......     ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||...
T Consensus       151 p~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        151 SVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             hhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999998764332     12347889999999876  67999999999999999999999999732


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           ...++........    ..+.+                      ...|...+.+++..|++.++..||+...+..
T Consensus       226 -----~~~~~~~~i~~~~----~~~~~----------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        226 -----TTKEIYDLIINKN----NSLKL----------------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -----CHHHHHHHHHhcC----CCCCC----------------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                 1122211111000    00000                      1134456778889999999999999987743

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-33  Score=309.20  Aligned_cols=264  Identities=21%  Similarity=0.324  Sum_probs=199.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  341 (789)
                      -++|...+.||+|+||.||+|.+..     +++.||+|+++.... .....+.+|+++++.+ +|+||++++++|.... 
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~-  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG-  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence            3578899999999999999998643     345799999975433 3346688999999999 8999999999987765 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCC----------------------------------------------------
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNRE----------------------------------------------------  369 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  369 (789)
                          ..++||||+.+|+|.+++......                                                    
T Consensus       116 ----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         116 ----PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             ----CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence                789999999999999988542100                                                    


Q ss_pred             --------ccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCc
Q 041249          370 --------DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ  441 (789)
Q Consensus       370 --------~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  441 (789)
                              .........+++.++..|+.|++.||+|||+.+   ++||||||+||++++++++||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                    001112345889999999999999999999888   999999999999999999999999999876544322


Q ss_pred             cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccC
Q 041249          442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLND  520 (789)
Q Consensus       442 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  520 (789)
                      .......++..|+|||++....++.++|||||||++|||++ |+.||.....+. .+...........     .+.    
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~-----~~~----  338 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMS-----RPD----  338 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCcc-----CCC----
Confidence            22222335678999999998899999999999999999997 999997432211 1111111110000     000    


Q ss_pred             hhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          521 VEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                                           .....+.+++..|++.++.+||+...+...
T Consensus       339 ---------------------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         339 ---------------------FAPPEIYSIMKMCWNLEPTERPTFSQISQL  368 (374)
T ss_pred             ---------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 112346678889999999999999877544

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-33  Score=303.37  Aligned_cols=196  Identities=24%  Similarity=0.323  Sum_probs=174.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|++++++++||||+++++++...+     .
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-----R   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----E
Confidence            57888999999999999999999899999999986432   233467889999999999999999999987765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  159 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA----------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKV  159 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEE
Confidence            99999999999999998643          45788889999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +|||+++......     ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       160 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  216 (329)
T PTZ00263        160 TDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF  216 (329)
T ss_pred             eeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence            9999998765432     23468999999999998889999999999999999999999996

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-33  Score=305.67  Aligned_cols=202  Identities=25%  Similarity=0.325  Sum_probs=175.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|....+++.||+|+++...   ......+..|++++.+++|++|+++++.+.+..     .
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----N   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----e
Confidence            47889999999999999999999889999999996432   223456888999999999999999999987765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL  142 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKK----------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKL  142 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEE
Confidence            99999999999999998643          46889999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCc---------------------------------cceeeecccccccCcccCCCCCcCccccchhh
Q 041249          427 GDFGLARFLPPTHVQ---------------------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSY  473 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sf  473 (789)
                      +|||+++........                                 .......||..|+|||++.+..++.++|||||
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl  222 (363)
T cd05628         143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL  222 (363)
T ss_pred             eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence            999999865422100                                 00123469999999999998899999999999


Q ss_pred             HHHHHHHHHhcCCCCc
Q 041249          474 GILMLELIIRKKPSDI  489 (789)
Q Consensus       474 Gvvl~elltG~~P~~~  489 (789)
                      ||++|||++|+.||..
T Consensus       223 Gvil~ell~G~~Pf~~  238 (363)
T cd05628         223 GVIMYEMLIGYPPFCS  238 (363)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-33  Score=300.48  Aligned_cols=194  Identities=24%  Similarity=0.284  Sum_probs=169.3

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||++....+++.||+|+++...   ......+..|++++++++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEe
Confidence            46999999999999999899999999987542   233456788999999999999999999987765     8999999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a  142 (323)
T cd05571          76 YANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence            99999999988643          46889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         143 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             cccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence            75432221  12345699999999999998999999999999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-33  Score=297.78  Aligned_cols=191  Identities=25%  Similarity=0.312  Sum_probs=167.7

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||+|+||.||+|....+++.||+|+++..   .......+..|++++.+++||||+++++++....     ..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence            69999999999999989999999998643   2334566888999999999999999999987655     889999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      ++|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          76 NGGELFHHLQRE----------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            999999998643          45889999999999999999999888   99999999999999999999999999986


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       143 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         143 NMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             CccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence            433221  1234568999999999999899999999999999999999999996

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4e-33  Score=306.47  Aligned_cols=263  Identities=21%  Similarity=0.287  Sum_probs=199.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEE-----cCCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||.||+|++     ..++..||||+++... ....+.+.+|++++..+ +||||++++++|...+ 
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence            45788899999999999999975     2356789999987543 33456788999999999 8999999999997766 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCcc--------------------------------------------------
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDE--------------------------------------------------  371 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  371 (789)
                          ..++||||+++|+|.+++........                                                  
T Consensus       113 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         113 ----PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ----cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence                78999999999999999865321000                                                  


Q ss_pred             ---------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC
Q 041249          372 ---------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP  436 (789)
Q Consensus       372 ---------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  436 (789)
                                     .......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence                           0011235889999999999999999999888   9999999999999999999999999998765


Q ss_pred             CCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccC
Q 041249          437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDS  515 (789)
Q Consensus       437 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  515 (789)
                      ............++..|+|||.+....++.++|||||||++|||++ |..||.....+ ..+..++.......     .+
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~  339 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRML-----SP  339 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCC-----CC
Confidence            4432222222335667999999999999999999999999999998 88898643211 12222222111100     00


Q ss_pred             CcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          516 TLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                                               .....++.+++..|++.++-.||++..+..
T Consensus       340 -------------------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         340 -------------------------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             -------------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                     011234668889999999999999987743

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=302.28  Aligned_cols=197  Identities=24%  Similarity=0.327  Sum_probs=174.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++...   ......+..|++++..++||||+++++++....     .
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----Y   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----E
Confidence            36888999999999999999999889999999996542   233466888999999999999999999987765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL  142 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNL----------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKL  142 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEE
Confidence            99999999999999998543          46788999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++.....     ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  200 (333)
T cd05600         143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG  200 (333)
T ss_pred             EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence            99999986544     12235689999999999988999999999999999999999999973

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-33  Score=277.32  Aligned_cols=202  Identities=26%  Similarity=0.358  Sum_probs=176.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh--hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|.+.+.|++|+||.||+|+++.+++.||+|.++......  .-...+||.++.+.+|||||.+-.+.....   .+..
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~i  152 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDKI  152 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---ccee
Confidence            56778899999999999999999999999999998765322  334678999999999999999988876654   3468


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      |+||||++. +|...+..         .++++...+...+..|+++|++|||+.+   |+|||||++|+|+.+.|.+||+
T Consensus       153 y~VMe~~Eh-DLksl~d~---------m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKia  219 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMET---------MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIA  219 (419)
T ss_pred             eeeHHHHHh-hHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEec
Confidence            999999997 88888854         4578999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||+|+.+.....  ..+...-|..|+|||.+.+.+ |++..|+||+|||+.|++++++-|..
T Consensus       220 DFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G  280 (419)
T KOG0663|consen  220 DFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG  280 (419)
T ss_pred             ccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence            9999999876642  234556789999999998865 99999999999999999999988863

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8e-33  Score=298.17  Aligned_cols=194  Identities=24%  Similarity=0.294  Sum_probs=168.8

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||++....+++.||+|+++...   ......+..|++++++++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEe
Confidence            46999999999999999899999999997542   233456778999999999999999999987665     8999999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~  142 (323)
T cd05595          76 YANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHh
Confidence            99999999888543          46889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.......  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  197 (323)
T cd05595         143 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             ccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence            76432221  12235689999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-32  Score=291.18  Aligned_cols=263  Identities=21%  Similarity=0.354  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCc-----eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGR-----TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ++|...+.||+|+||.||+|.....+     ..||+|.++.... .....+.+|++.+++++||||+++++++....   
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ---   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence            47888999999999999999986444     6899999865433 33567899999999999999999999987655   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccc------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEV------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                        ..+++|||+.+|+|.+++.......+.      ......+++.++..++.|++.||+|||+.+   ++|+||||+||+
T Consensus        82 --~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil  156 (283)
T cd05048          82 --PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCL  156 (283)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEE
Confidence              789999999999999999754221110      111256889999999999999999999988   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN  496 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~  496 (789)
                      +++++.+||+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |..||......  .
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~  234 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E  234 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence            99999999999999987654432222333456788999999998999999999999999999998 99998743211  1


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      +...++.....   .                           ....+..++.+++..|++.++..||+..++...+
T Consensus       235 ~~~~i~~~~~~---~---------------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l  280 (283)
T cd05048         235 VIEMIRSRQLL---P---------------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL  280 (283)
T ss_pred             HHHHHHcCCcC---C---------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            11111111000   0                           0113456677899999999999999998875544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2e-36  Score=305.74  Aligned_cols=222  Identities=23%  Similarity=0.363  Sum_probs=167.6

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccC-----------------
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE-----------------  618 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-----------------  618 (789)
                      ++..+|+.++++. ..|+.+.-+++|+.||+++|.|+ ..|.+++++ .|+.|-+.+|.+.++                 
T Consensus       253 ~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLr  329 (565)
T KOG0472|consen  253 SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLR  329 (565)
T ss_pred             cceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHH
Confidence            3445666667665 66888888999999999999999 577778888 899998888877520                 


Q ss_pred             ---------------------CCccC---cCCCCCcEEEcccCCCCCCCCc-ccCCCC--CCcEEEccCCCCC-------
Q 041249          619 ---------------------IPVNL---SSCSNLIRIGLAKNQLMGKIPS-DFGSLS--KIEVLSLGFNNLI-------  664 (789)
Q Consensus       619 ---------------------~p~~~---~~l~~L~~L~l~~N~l~~~~~~-~~~~l~--~L~~L~L~~N~l~-------  664 (789)
                                           .+..|   ..+.+.++|++++-+++ .+|+ .|....  -.+..+++.|++.       
T Consensus       330 s~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~  408 (565)
T KOG0472|consen  330 SKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLV  408 (565)
T ss_pred             HhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhhhhH
Confidence                                 11111   12345666666666666 3333 232211  1444555555442       


Q ss_pred             ----------------ccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249          665 ----------------GSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF  728 (789)
Q Consensus       665 ----------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  728 (789)
                                      +.+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+|++. .+|..+..+..++.+
T Consensus       409 ~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtl  486 (565)
T KOG0472|consen  409 ELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETL  486 (565)
T ss_pred             HHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHH
Confidence                            255666778889999999999987 78888999999999999999998 888888888888888


Q ss_pred             EccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      -.++|++. .+|.+-..+|.+|+.|||.+|.|. .+|..+++|++|++|++++|+|.
T Consensus       487 las~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  487 LASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             Hhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            88889997 777773338999999999999999 78999999999999999999998

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.9e-33  Score=292.90  Aligned_cols=201  Identities=23%  Similarity=0.327  Sum_probs=172.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|++..+++.||+|+++...  ....+.+.+|++++++++||||+++++++...+     ..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EE
Confidence            46888999999999999999999899999999986542  233567889999999999999999999987655     88


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.++.+..+...          ...+++..+..++.|++.||+|||..+   ++||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~  142 (287)
T cd07848          76 YLVFEYVEKNMLELLEEM----------PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLC  142 (287)
T ss_pred             EEEEecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence            999999998877655421          245889999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++......... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~  203 (287)
T cd07848         143 DFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             eccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence            99999876543321 12234588999999999988899999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.6e-33  Score=297.68  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=197.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCce----EEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .+|+..+.||+|+||.||+|.+..+++    .||+|.++... ....+.+..|+.+++.++||||++++|+|...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            578999999999999999999865554    48999986543 34456789999999999999999999998653     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++|+||+..|+|.+++...         ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcE
Confidence             467999999999999998653         245788999999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||+....  ..+..+...
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~  226 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK  226 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhC
Confidence            9999999998765443222223335678999999999999999999999999999998 9999863211  011111110


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...          .                    .....|...+.+++..|++.++-.||+.......
T Consensus       227 ~~~----------~--------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         227 GER----------L--------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCC----------C--------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            000          0                    0011234456688899999999999999877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-33  Score=285.20  Aligned_cols=205  Identities=23%  Similarity=0.340  Sum_probs=172.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------------hhHHHHHHHHHHhcCCCCccceeee
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------------ASRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      -+.|...+.||+|.||.|-+|....+++.||||++......              ..+...+||++|++++|||||+++.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            46899999999999999999999999999999998543111              1247889999999999999999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      +..+..   ....|||+|||..|.+...=          .....++..+..+|+.++..||+|||.++   ||||||||+
T Consensus       176 vLDDP~---s~~~YlVley~s~G~v~w~p----------~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs  239 (576)
T KOG0585|consen  176 VLDDPE---SDKLYLVLEYCSKGEVKWCP----------PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS  239 (576)
T ss_pred             eecCcc---cCceEEEEEeccCCccccCC----------CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence            876543   44799999999998765422          22233999999999999999999999999   999999999


Q ss_pred             ceecCCCCceeeCcccccccCCCCC---CccceeeecccccccCcccCCCCC----cCccccchhhHHHHHHHHHhcCCC
Q 041249          415 NILLDEEMVSHVGDFGLARFLPPTH---VQTSSIGVKGSIGYIAPEYGLGSE----VSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       415 Nill~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      |+|++.++++||+|||.+...+...   .........||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999999999999999999775433   223344567999999999987743    467899999999999999999999


Q ss_pred             Cc
Q 041249          488 DI  489 (789)
Q Consensus       488 ~~  489 (789)
                      -+
T Consensus       320 ~~  321 (576)
T KOG0585|consen  320 FD  321 (576)
T ss_pred             cc
Confidence            63

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=280.74  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhc--CCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS--IRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .....+.||+|.||+||+|.|+  |+.||||+|...   +.+.+.+|.++...  ++|+||+.+++.-.... ..-...|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLw  285 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLW  285 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEE
Confidence            4556789999999999999998  999999999532   33445555555554  59999999998743222 2223589


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-----CCCCceecCCCCCceecCCCCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-----CQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivH~dlk~~Nill~~~~~  423 (789)
                      +|.+|.+.|+|.+|+...           .++....++++.-+|.||+|||..     |.|.|+|||||+.|||+..++.
T Consensus       286 LvTdYHe~GSL~DyL~r~-----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence            999999999999999754           688899999999999999999964     6788999999999999999999


Q ss_pred             eeeCcccccccCCCCC--CccceeeecccccccCcccCCCCC------cCccccchhhHHHHHHHHHh----------cC
Q 041249          424 SHVGDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSE------VSTNGDVYSYGILMLELIIR----------KK  485 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~sfGvvl~elltG----------~~  485 (789)
                      +-|+|+|+|-......  .........||.+|||||++...-      .-..+||||||.|+||+..+          +.
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            9999999999887664  233444567999999999987532      23469999999999999654          35


Q ss_pred             CCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCc
Q 041249          486 PSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLES  564 (789)
Q Consensus       486 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s  564 (789)
                      ||++....+.++.+..+                     ..+....+++...+|...+++..+.+++..||...+..|-+
T Consensus       435 Pyyd~Vp~DPs~eeMrk---------------------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRK---------------------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             CcccCCCCCCCHHHHhc---------------------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence            66554444444443322                     22222333444446666788899999999999977755433

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-33  Score=304.57  Aligned_cols=202  Identities=23%  Similarity=0.298  Sum_probs=173.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||++....+++.||||++....   ......+..|+++++.++||||+++++++....     .
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----Y   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----e
Confidence            47888999999999999999999999999999985432   233456888999999999999999999988765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          +.+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|+
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl  142 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY----------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKL  142 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEE
Confidence            99999999999999998643          46788889999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCc---------------------------------------------cceeeecccccccCcccCCC
Q 041249          427 GDFGLARFLPPTHVQ---------------------------------------------TSSIGVKGSIGYIAPEYGLG  461 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~  461 (789)
                      +|||+++........                                             .......||..|+|||++..
T Consensus       143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  222 (377)
T cd05629         143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ  222 (377)
T ss_pred             eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence            999999643211000                                             00012458999999999988


Q ss_pred             CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          462 SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       462 ~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ..++.++|||||||++|||++|+.||..
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~~  250 (377)
T cd05629         223 QGYGQECDWWSLGAIMFECLIGWPPFCS  250 (377)
T ss_pred             CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence            8899999999999999999999999963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=283.31  Aligned_cols=200  Identities=31%  Similarity=0.440  Sum_probs=167.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHh--cCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR--SIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .....++||+|+||.||+|++.  ++.||||++...   ....|..|-++.+  .++|+||++++++-....-. ....+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cccee
Confidence            3444578999999999999997  699999999643   3445666666555  45899999999986554433 44789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC------CCCceecCCCCCceecCCCC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC------QPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivH~dlk~~Nill~~~~  422 (789)
                      +|+||.+.|+|.+|+...           .++|....+|+.-+++||+|||+.-      .|+|+|||||++|||+..++
T Consensus       285 LVt~fh~kGsL~dyL~~n-----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            999999999999999754           6899999999999999999999864      56799999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC------cCccccchhhHHHHHHHHHhcCCC
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE------VSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      ++.|+|||+|..+.+.......-+..||.+|||||++.+..      .=.+.||||+|.|||||+++..-+
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            99999999999999887666566688999999999987643      123699999999999999986555

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-32  Score=295.54  Aligned_cols=194  Identities=24%  Similarity=0.310  Sum_probs=169.0

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||++....+++.||+|++...   .......+..|+++++.++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEe
Confidence            4689999999999999989999999999644   2233467888999999999999999999987665     8999999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+.+|+|..++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 y~~~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~  142 (328)
T cd05593          76 YVNGGELFFHLSRE----------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLC  142 (328)
T ss_pred             CCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCC
Confidence            99999999888543          46889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         143 KEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             ccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence            76432221  12235689999999999988999999999999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.3e-35  Score=311.53  Aligned_cols=359  Identities=23%  Similarity=0.363  Sum_probs=297.2

Q ss_pred             EEcCCCCCC-ccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            2 LALDSNRLS-GNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         2 l~l~~n~~~-~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|+++|.|+ +.+|..+..++++++|.|..-+|. .+|+.++.|.+|++|.+++|++. .+-..+..|+.|+.+++..|+
T Consensus        12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~   89 (1255)
T KOG0444|consen   12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN   89 (1255)
T ss_pred             ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence            589999999 589999999999999999999999 99999999999999999999999 666789999999999999999


Q ss_pred             CC-CCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhh-hcCcccccE
Q 041249           81 FR-GSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEF-LVGLKVIEN  158 (789)
Q Consensus        81 l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~-~~~~~~l~~  158 (789)
                      |. .-+|..+.++..|+.||||+|+++ +.|..+..-+++-+|+||+|+             |. .||.. +-++.-|-+
T Consensus        90 LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~-------------Ie-tIPn~lfinLtDLLf  154 (1255)
T KOG0444|consen   90 LKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN-------------IE-TIPNSLFINLTDLLF  154 (1255)
T ss_pred             cccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc-------------cc-cCCchHHHhhHhHhh
Confidence            96 458999999999999999999999 889888777776665555554             55 44433 556777888


Q ss_pred             EecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHHH
Q 041249          159 LNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFL  238 (789)
Q Consensus       159 l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~~  238 (789)
                      ||||+|++...||..-.+..++.+.+.+||.                                                 
T Consensus       155 LDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL-------------------------------------------------  185 (1255)
T KOG0444|consen  155 LDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL-------------------------------------------------  185 (1255)
T ss_pred             hccccchhhhcCHHHHHHhhhhhhhcCCChh-------------------------------------------------
Confidence            8888888876655321010011000000000                                                 


Q ss_pred             HHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHH
Q 041249          239 CWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAEC  318 (789)
Q Consensus       239 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~  318 (789)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (1255)
T KOG0444|consen  186 --------------------------------------------------------------------------------  185 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 041249          319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL  398 (789)
Q Consensus       319 ~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L  398 (789)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (1255)
T KOG0444|consen  186 --------------------------------------------------------------------------------  185 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHH
Q 041249          399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILML  478 (789)
Q Consensus       399 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~  478 (789)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (1255)
T KOG0444|consen  186 --------------------------------------------------------------------------------  185 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceee
Q 041249          479 ELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVT  558 (789)
Q Consensus       479 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~  558 (789)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (1255)
T KOG0444|consen  186 --------------------------------------------------------------------------------  185 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             EeccCcccccccccccccCccccchhcccCCccc-ccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccC
Q 041249          559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFT-HEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKN  637 (789)
Q Consensus       559 ~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N  637 (789)
                               ....+..+..+++|++|.+++.+-+ ..+|.++..+.+|..+|||.|.+. .+|..+.++++|+.|+||+|
T Consensus       186 ---------~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N  255 (1255)
T KOG0444|consen  186 ---------NHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGN  255 (1255)
T ss_pred             ---------hHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcC
Confidence                     0000111234567788888886543 358889999999999999999999 89999999999999999999


Q ss_pred             CCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCcc-CCccccCCCCCCeeeccCccccccCC
Q 041249          638 QLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS-IPFTLSKLKNLVILYLGVNRLSGIVP  716 (789)
Q Consensus       638 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p  716 (789)
                      +|+ .+........+|++|+||.|+++ .+|.++.++++|+.|++.+|+++-. +|+.++.|.+|+++..++|.+. ..|
T Consensus       256 ~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVP  332 (1255)
T KOG0444|consen  256 KIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVP  332 (1255)
T ss_pred             cee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCc
Confidence            999 56556777889999999999999 8999999999999999999998733 7899999999999999999998 999


Q ss_pred             ccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249          717 SSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       717 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  761 (789)
                      +.+..+.+|+.|.|++|.+- ++|..+. -++.|+.|||..|.=-
T Consensus       333 EglcRC~kL~kL~L~~NrLi-TLPeaIH-lL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  333 EGLCRCVKLQKLKLDHNRLI-TLPEAIH-LLPDLKVLDLRENPNL  375 (1255)
T ss_pred             hhhhhhHHHHHhccccccee-echhhhh-hcCCcceeeccCCcCc
Confidence            99999999999999999998 9999998 7999999999999844

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-33  Score=302.92  Aligned_cols=226  Identities=24%  Similarity=0.398  Sum_probs=189.0

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEeccc----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ...+||+|.|-+||+|.+..+|-+||=-.++..    .....++|..|+++|+.|+||||+++|.+..+..   +...-+
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~  120 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF  120 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence            356899999999999999988888875443322    3334578999999999999999999999876654   235778


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~D  428 (789)
                      |.|.|..|+|+.|.++.          +..+......|++||++||.|||++ .|||+|||||..|||++.+ |.+||+|
T Consensus       121 iTEL~TSGtLr~Y~kk~----------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKH----------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             eeecccCCcHHHHHHHh----------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence            99999999999999765          6678889999999999999999998 6899999999999999754 8999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      +|+|.....+..    ..+.||+.|||||+.. ..|++.+||||||+.|+||+|+..||.........|.......-|..
T Consensus       190 LGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  190 LGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA  264 (632)
T ss_pred             hhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence            999999876652    2478999999999877 78999999999999999999999999876666666666666556666


Q ss_pred             hhhhccCCcc
Q 041249          509 VMDIVDSTLL  518 (789)
Q Consensus       509 ~~~~~d~~~~  518 (789)
                      +..+-||.++
T Consensus       265 l~kV~dPevr  274 (632)
T KOG0584|consen  265 LSKVKDPEVR  274 (632)
T ss_pred             hhccCCHHHH
Confidence            6667676654

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-32  Score=302.69  Aligned_cols=202  Identities=24%  Similarity=0.342  Sum_probs=174.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|....+++.||||+++...   ......+..|++++..++||||+++++++....     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----Y   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----e
Confidence            47889999999999999999999899999999996432   233456788999999999999999999988766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl  142 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKK----------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKL  142 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEE
Confidence            99999999999999998643          45899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCcc------------------------------------ceeeecccccccCcccCCCCCcCccccc
Q 041249          427 GDFGLARFLPPTHVQT------------------------------------SSIGVKGSIGYIAPEYGLGSEVSTNGDV  470 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV  470 (789)
                      +|||+++.........                                    ......||+.|+|||++....++.++||
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  222 (364)
T cd05599         143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW  222 (364)
T ss_pred             eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence            9999987654321100                                    0012358999999999998899999999


Q ss_pred             hhhHHHHHHHHHhcCCCCc
Q 041249          471 YSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       471 ~sfGvvl~elltG~~P~~~  489 (789)
                      |||||++|||++|+.||..
T Consensus       223 wSlG~il~el~~G~~Pf~~  241 (364)
T cd05599         223 WSLGVIMYEMLVGYPPFCS  241 (364)
T ss_pred             ecchhHHHHhhcCCCCCCC
Confidence            9999999999999999973

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.98  E-value=3.8e-32  Score=294.04  Aligned_cols=200  Identities=25%  Similarity=0.341  Sum_probs=176.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      -++|...+.||+|+||.||++....++..||+|.+..... .....+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EE
Confidence            4689999999999999999999998999999999976532 33567999999999999999999999987655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+.+  .|+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~  146 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA----------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC  146 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence            9999999999999998643          45788999999999999999999752  39999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++.......    .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       147 Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999998664432    2234589999999999988999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-33  Score=295.75  Aligned_cols=263  Identities=23%  Similarity=0.366  Sum_probs=217.2

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      +.+++....+.....+||.|-||+||.|.|+.-...||||.++.+... ..+|.+|+++|+.++|||+|+++|+|.... 
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~Ep-  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCC-
Confidence            356666667778888999999999999999988999999999765443 568999999999999999999999998776 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..|||.|||..|+|.+|++++        ....++....+.+|.||+.||+||....   +|||||.++|+|++++
T Consensus       337 ----PFYIiTEfM~yGNLLdYLRec--------nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEn  401 (1157)
T KOG4278|consen  337 ----PFYIITEFMCYGNLLDYLREC--------NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN  401 (1157)
T ss_pred             ----CeEEEEecccCccHHHHHHHh--------chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhcccccc
Confidence                789999999999999999887        3445677788999999999999999888   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      ..+|++|||+++++..+.... ..+..=...|.|||.+.-..++.|+|||+|||+|||+.| |-.||..     .++.+.
T Consensus       402 hiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----idlSqV  475 (1157)
T KOG4278|consen  402 HIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDLSQV  475 (1157)
T ss_pred             ceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----ccHHHH
Confidence            999999999999987654221 112222357999999999999999999999999999998 9999862     223322


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                               .+.+...++                  -+....|...+.+++..||+..+-|||+..++....+.
T Consensus       476 ---------Y~LLEkgyR------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  476 ---------YGLLEKGYR------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             ---------HHHHhcccc------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence                     233333333                  22345899999999999999999999999887654443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.98  E-value=1.6e-32  Score=302.71  Aligned_cols=201  Identities=22%  Similarity=0.307  Sum_probs=172.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|...+.||+|+||+||+|....+++.||+|++....   ......+..|++++++++|+||+++++++.+.+     ..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----NL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----EE
Confidence            5778899999999999999999899999999996442   233467889999999999999999999998765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+++|+|.+++...          ..+++..+..++.|++.||+|||..+   |+||||||+|||++.++++||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~  143 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM----------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLT  143 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEe
Confidence            9999999999999998643          45788899999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCC---------------------------------------------ccceeeecccccccCcccCCCC
Q 041249          428 DFGLARFLPPTHV---------------------------------------------QTSSIGVKGSIGYIAPEYGLGS  462 (789)
Q Consensus       428 Dfgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~  462 (789)
                      |||+++.......                                             ........||..|+|||.+...
T Consensus       144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (381)
T cd05626         144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK  223 (381)
T ss_pred             eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence            9999764321100                                             0001124699999999999888


Q ss_pred             CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          463 EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       463 ~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .++.++|||||||++|||++|+.||..
T Consensus       224 ~~~~~~DiwSlG~il~elltG~~Pf~~  250 (381)
T cd05626         224 GYTQLCDWWSVGVILFEMLVGQPPFLA  250 (381)
T ss_pred             CCCCccceeehhhHHHHHHhCCCCCcC
Confidence            899999999999999999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=3.2e-32  Score=289.16  Aligned_cols=204  Identities=28%  Similarity=0.387  Sum_probs=168.9

Q ss_pred             CCCCCCcccccCCccEEEEEEc-CCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~  344 (789)
                      +|...+.||+|+||+||+|... .+++.||+|.++....  .....+.+|+++++.+   +||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888999999999999999985 3578899999865432  2234566677776665   69999999999865443334


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++|+||+. ++|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence            46899999997 6899888643        2345889999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||.++......   ......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence            999999998765432   22345689999999999888999999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.98  E-value=1.2e-32  Score=298.32  Aligned_cols=198  Identities=25%  Similarity=0.378  Sum_probs=173.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc-eEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR-TTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      -++|...+.||+|+||.||+|.+..++ ..||+|++...   .......+..|+++++.++||||+++++++....    
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----  104 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES----  104 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----
Confidence            357888999999999999999976554 68999998643   2233456888999999999999999999997765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++
T Consensus       105 -~~~lv~Ey~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426        105 -YLYLVLEFVIGGEFFTFLRRN----------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             -EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCE
Confidence             899999999999999998644          46889999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence            999999998764322     235689999999999988899999999999999999999999973

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.98  E-value=1.1e-32  Score=288.73  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=196.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|++.   ..+..||+|+++.... .....+.+|++.+.+++||||+++++++...+    
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC----
Confidence            457888999999999999999875   3467899999876532 33567899999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+++|+|.+++...         ...+++.+++.++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~  146 (266)
T cd05064          80 -TMMIVTEYMSNGALDSFLRKH---------EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC  146 (266)
T ss_pred             -CcEEEEEeCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcE
Confidence             789999999999999998643         246899999999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |++|||.+......... ......++..|+|||.+....++.++|||||||++||+++ |+.||......  .....+..
T Consensus       147 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~  223 (266)
T cd05064         147 KISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED  223 (266)
T ss_pred             EECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC
Confidence            99999987664332211 1112335678999999999999999999999999999875 99999632111  11111110


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...        ..                      ....+...+.+++..|++.++..||+......
T Consensus       224 ~~~--------~~----------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         224 GFR--------LP----------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCC--------CC----------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            000        00                      01134456778889999999999999876643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.98  E-value=2.7e-32  Score=293.11  Aligned_cols=194  Identities=24%  Similarity=0.359  Sum_probs=165.3

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|....+++.||+|+++...   ......+..|..++... .||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999889999999997542   22334455666777654 8999999999987655     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|..++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~gg~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~  142 (316)
T cd05592          76 EYLNGGDLMFHIQSS----------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGM  142 (316)
T ss_pred             cCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcC
Confidence            999999999988543          46888999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++......  .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence            98654332  122345689999999999988999999999999999999999999973

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.98  E-value=4.1e-33  Score=290.77  Aligned_cols=246  Identities=29%  Similarity=0.438  Sum_probs=189.3

Q ss_pred             CCcccccCCccEEEEEEc----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          275 ANLIGTGSFGSVYKGVLD----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .+.||.|.||.||+|.+.    ..+..|+||+++.... ...+.+.+|++.+++++||||++++|+|....     ..++
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~l   78 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLFL   78 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cccc
Confidence            468999999999999998    4578899999966533 34788999999999999999999999998554     6899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||++.|+|.+++...        ....+++.++..|+.|+|.||+|||+.+   ++|++|+++||+++.++.+||+||
T Consensus        79 v~e~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f  147 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSK--------NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDF  147 (259)
T ss_dssp             EEE--TTEBHHHHHHHT--------CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEEST
T ss_pred             ccccccccccccccccc--------cccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999999754        3467899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |++....................|+|||.+....++.++||||||+++||+++ |+.||...     +..++........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~  222 (259)
T PF07714_consen  148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQ  222 (259)
T ss_dssp             TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccc
Confidence            99988743332222223446789999999999999999999999999999999 78888632     1122211111100


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      ..                           .....+...+.+++..|++.+|.+||++...
T Consensus       223 ~~---------------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i  255 (259)
T PF07714_consen  223 RL---------------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI  255 (259)
T ss_dssp             ET---------------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred             cc---------------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence            00                           0111344567789999999999999998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=297.54  Aligned_cols=201  Identities=24%  Similarity=0.347  Sum_probs=176.4

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (789)
                      .-++|....+||+|.||.|+.+..+.+++.+|||+++..   ...+.+....|-+++... +||.++.++..++..+   
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~---  442 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE---  442 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC---
Confidence            447899999999999999999999999999999999755   334455666777777666 6999999999998877   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        +.++||||..+|++..+.+           .+.+++..+..||++|+.||+|||+++   |||||||-+|||+|.+|+
T Consensus       443 --~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  443 --HLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             --eEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCc
Confidence              9999999999999544443           357899999999999999999999999   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +||+|||+++.--...  ..+...+||+.|||||++.+..|+..+|.|||||+||||++|..||..
T Consensus       507 ~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  507 VKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             EEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999754222  245568899999999999999999999999999999999999999974

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=2.2e-32  Score=288.28  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=199.1

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .++++|+..+.||+|+||.||+|.+.     ..+..||+|++.... ......+.+|+++++.++|+||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45788999999999999999999875     235779999986432 234556889999999999999999999987655


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+++|+|.+++...+...........+++.++..++.|++.||+|||+.+   ++||||||+||++++
T Consensus        83 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~  154 (277)
T cd05062          83 -----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  154 (277)
T ss_pred             -----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcC
Confidence                 789999999999999998654211111112345688899999999999999999887   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~  499 (789)
                      ++.+|++|||+++...............++..|+|||++..+.++.++|||||||++|||++ |+.||....     ...
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~  229 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQ  229 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHH
Confidence            99999999999986654332211222345778999999998889999999999999999999 788886321     111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ..+........+                           ....+...+.+++..|.+.++.+||+.....
T Consensus       230 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l  272 (277)
T cd05062         230 VLRFVMEGGLLD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII  272 (277)
T ss_pred             HHHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            111111100000                           0112344567889999999999999887663

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.3e-32  Score=294.83  Aligned_cols=197  Identities=25%  Similarity=0.366  Sum_probs=176.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      -|.-++.||+|+.|.|..|++..+|+.+|||++...   .......++.||.+|+-+.|||++++|++.....     +.
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-----~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-----HL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-----eE
Confidence            466788999999999999999999999999999655   3334567899999999999999999999865544     99


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      |+|.||+++|-|.+++-..          ..+++.+..+++.||..|+.|+|..+   |+|||+||+|+|+|+++.+||+
T Consensus        88 ylvlEyv~gGELFdylv~k----------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRK----------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             EEEEEecCCchhHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeee
Confidence            9999999999999999654          67899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |||+|....++..   ...-+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||+
T Consensus       155 DFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd  213 (786)
T KOG0588|consen  155 DFGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD  213 (786)
T ss_pred             ccceeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence            9999998877652   223569999999999999998 578999999999999999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.98  E-value=2.4e-32  Score=291.96  Aligned_cols=201  Identities=25%  Similarity=0.388  Sum_probs=170.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||.||+|....+++.||+|+++.... .....+.+|+++++.++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eE
Confidence            4789999999999999999999998899999999865432 23456788999999999999999999987655     79


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+. +++.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~  145 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKH---------PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLA  145 (303)
T ss_pred             EEEEECCC-cCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEC
Confidence            99999996 6787777532         245788899999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||+++.......  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       146 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         146 DFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             CCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999876543221  1223457899999998765 4589999999999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=1.9e-32  Score=310.17  Aligned_cols=253  Identities=19%  Similarity=0.203  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCCccEEEEEEcCC-ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEG-RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .|...+.||.|++|.||+|....+ ++.||+|.+..........+..|+++++.++||||+++++++...+     ..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEE
Confidence            377889999999999999998766 7889999876555555667888999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+|+|.+++....      .....+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       143 v~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             EEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeC
Confidence            999999999999885431      12346889999999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...     +............ 
T Consensus       214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~~~~~~~~~~~-  287 (478)
T PTZ00267        214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQREIMQQVLYGK-  287 (478)
T ss_pred             cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCC-
Confidence            9998775543322233456999999999999989999999999999999999999999632     1122221111100 


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                         .++.                       ...+...+.+++..|++.++-.|++.....
T Consensus       288 ---~~~~-----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l  321 (478)
T PTZ00267        288 ---YDPF-----------------------PCPVSSGMKALLDPLLSKNPALRPTTQQLL  321 (478)
T ss_pred             ---CCCC-----------------------CccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence               0000                       001223456778889999999999987664

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=6e-33  Score=309.85  Aligned_cols=211  Identities=21%  Similarity=0.279  Sum_probs=176.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeee-eccCCCCC-Cce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTA-CSGVDYQG-NDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~~~~~~-~~~  346 (789)
                      -..++.+.|.+|||+.||.|+....+..||+|++-.......+.+.+||++|++|+ |+|||.|++. .......+ ..+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            34556789999999999999999777999999998777788899999999999996 9999999994 33322223 356


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      ..+.||||.+|.|-+++..+        -..+|++.++++|+.|+|+|+++||.. .+||+|||||.+||||+.+++.||
T Consensus       117 vllLmEyC~gg~Lvd~mn~R--------lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTR--------LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             EEeehhhccCCcHHHHHHHH--------HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence            78999999999999999754        224499999999999999999999987 688999999999999999999999


Q ss_pred             CcccccccCCCCCCc-------cceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQ-------TSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||||.|...-.....       ........|+.|+|||++.   +..+++|+||||+||+||-|+....||+.
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~  260 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE  260 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence            999988755433210       1111244899999999864   45689999999999999999999999984

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.8e-32  Score=310.43  Aligned_cols=266  Identities=21%  Similarity=0.245  Sum_probs=206.8

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .....++|...+.||+|+||+||+|....+++.||||+++...  ......+.+|+..+..++|+||+++...+...+..
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3345679999999999999999999998899999999986542  33456788999999999999999988776543311


Q ss_pred             ---CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          343 ---GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       343 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                         .....++||||+.+|+|.+++...      ......+++..+..++.|++.||.|||+.+   |+||||||+||+++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~------~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~  177 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSR------AKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC  177 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHh------hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence               112368999999999999998643      123356899999999999999999999887   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                      .++.+||+|||+++...............||..|+|||++....++.++|||||||++|||++|+.||...     ....
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~  252 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEE  252 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHH
Confidence            99999999999998776543333333456999999999999999999999999999999999999999632     2222


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ++........ ....                          ..+...+.+++..|++.++-.||+......+
T Consensus       253 ~~~~~~~~~~-~~~~--------------------------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 VMHKTLAGRY-DPLP--------------------------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHhcCCC-CCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            2222211100 0000                          1223456678889999999999999876544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.98  E-value=3.8e-32  Score=288.19  Aligned_cols=200  Identities=24%  Similarity=0.378  Sum_probs=170.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||.|+||.||+|....+++.||+|.++.... .....+.+|++++++++||||+++++++....     ..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eEE
Confidence            568889999999999999999998999999999875432 33456789999999999999999999987654     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+. |+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNC---------GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             EEEeCCC-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECc
Confidence            9999998 4898887543         245788899999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++.......  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       147 fG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         147 FGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             CcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999986543321  1223457899999998865 5689999999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.98  E-value=3e-32  Score=293.65  Aligned_cols=194  Identities=27%  Similarity=0.338  Sum_probs=167.4

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|....+++.||+|+++...   ......+..|++++..+ +||||+++++++....     ..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEE
Confidence            46999999999999999889999999986542   23345677888888876 7999999999987665     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|..++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~  142 (321)
T cd05591          76 EYVNGGDLMFQIQRS----------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGM  142 (321)
T ss_pred             eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccc
Confidence            999999999888543          46889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......|+..|+|||++....++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         143 CKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             ceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence            876433221  12235689999999999988999999999999999999999999973

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.98  E-value=1.9e-32  Score=300.13  Aligned_cols=207  Identities=22%  Similarity=0.317  Sum_probs=176.8

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccC
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGV  339 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  339 (789)
                      .++....++|...+.||+|+||.||++....+++.||+|++...   .......+.+|+++++.++||||+++++++...
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34445668999999999999999999999989999999998642   223345688999999999999999999998765


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      .     ..++||||+++|+|.+++...           .+++.++..++.|++.||+|||+.+   |+||||||+|||++
T Consensus       116 ~-----~~~lv~Ey~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~  176 (370)
T cd05621         116 K-----YLYMVMEYMPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLD  176 (370)
T ss_pred             C-----EEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEC
Confidence            5     899999999999999998532           4788899999999999999999988   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .++.+||+|||++......... ......||..|+|||.+...    .++.++|||||||++|||++|+.||..
T Consensus       177 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         177 KHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             CCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            9999999999999876543321 12245699999999998653    378999999999999999999999973

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.5e-32  Score=277.30  Aligned_cols=198  Identities=23%  Similarity=0.363  Sum_probs=178.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|.+.+.+|+|.||.|-+|..+..|+.||||.++..   ..++.-.+++||++|+.++||||+.+|.+|...+     ..
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-----KI  128 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-----KI  128 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-----eE
Confidence            455667899999999999999889999999999755   3344556889999999999999999999987766     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      .+||||..+|.|.+|+.++          +.+++.+..++++||..|+.|+|.+.   +||||||-+|||+|+++++||+
T Consensus       129 vivMEYaS~GeLYDYiSer----------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIA  195 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISER----------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIA  195 (668)
T ss_pred             EEEEEecCCccHHHHHHHh----------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeee
Confidence            9999999999999999765          78999999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++.++....   ..+.++|++-|.+||+..+.+| .+.+|-||+||+||-|+.|.-||+.
T Consensus       196 DFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  196 DFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             ccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence            999999987765   3345779999999999998887 6889999999999999999999974

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.98  E-value=5.2e-32  Score=292.17  Aligned_cols=199  Identities=23%  Similarity=0.299  Sum_probs=170.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCC-ccceeeeeeccCCCCCCce
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHR-NLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~~~~  346 (789)
                      +|...+.||+|+||.||+|....+++.||+|+++..   .......+..|++++..+.|+ +|+++++++...+     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----R   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----E
Confidence            577889999999999999999988999999998644   223456678899999999765 5778888776655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||..+   |+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL  142 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV----------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKI  142 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEE
Confidence            99999999999999988643          45788999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         143 ADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             eecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            99999875432221  23345689999999999998999999999999999999999999973

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=5.1e-32  Score=292.60  Aligned_cols=194  Identities=25%  Similarity=0.319  Sum_probs=167.8

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|....+++.||+|+++..   .......+..|+.++.++ +||||+++++++....     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEE
Confidence            4799999999999999989999999999754   223345677888888877 8999999999987665     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|..++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~  142 (329)
T cd05618          76 EYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            999999999888543          46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         143 CKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            876432221  12335689999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.98  E-value=1.9e-32  Score=286.03  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=205.5

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++..+|...+.||.|+||.||+|.+.. ++.||+|.+..........+..|+++++.++|+||+++++++....     .
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   76 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----P   76 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----C
Confidence            456789999999999999999999985 8999999998766656778999999999999999999999987665     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...        .+..+++.++..++.|++.|++|||+.+   ++|+||||+||++++++.+|+
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl  145 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSP--------EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKV  145 (261)
T ss_pred             eEEEEeecccCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEE
Confidence            89999999999999999754        3456899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||.+.........  .....++..|+|||......++.++||||||+++|+|++ |+.||....  .......+....
T Consensus       146 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~  221 (261)
T cd05148         146 ADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAGY  221 (261)
T ss_pred             ccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCC
Confidence            999999877544321  113345678999999988889999999999999999998 899986321  111111111100


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..                              .....+...+.+++..|++.++.+||+.......+
T Consensus       222 ~~------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L  258 (261)
T cd05148         222 RM------------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL  258 (261)
T ss_pred             cC------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            00                              00113345677889999999999999998765433

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=5.7e-32  Score=295.44  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=190.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||++..... .....+.+|++++++++|+||+++++++....     ..+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eEE
Confidence            456667899999999999999998899999999865433 33567899999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|....              ..++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|
T Consensus       149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D  211 (353)
T PLN00034        149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIAD  211 (353)
T ss_pred             EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcc
Confidence            999999999886532              2356678899999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+++.......  ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....+  ........
T Consensus       212 fG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~  287 (353)
T PLN00034        212 FGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCA  287 (353)
T ss_pred             cccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHH
Confidence            999987653321  1223468999999998743     22457899999999999999999999732111  11111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .....     .+.                      ....+..++.+++..|++.++.+|++..++..++
T Consensus       288 ~~~~~-----~~~----------------------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        288 ICMSQ-----PPE----------------------APATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             HhccC-----CCC----------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            10000     000                      0112234566788899999999999998775543

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.98  E-value=4.1e-32  Score=292.29  Aligned_cols=194  Identities=26%  Similarity=0.344  Sum_probs=167.3

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|....+++.||+|+++..   .......+..|++++... +||||+++++++...+     ..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEE
Confidence            4699999999999999989999999998643   223345677888888877 7999999999987665     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        76 Ey~~~g~L~~~i~~~----------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~  142 (320)
T cd05590          76 EFVNGGDLMFHIQKS----------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM  142 (320)
T ss_pred             cCCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCC
Confidence            999999999988643          46889999999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         143 CKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             CeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            876432221  12335689999999999988999999999999999999999999973

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.98  E-value=6.9e-32  Score=292.11  Aligned_cols=201  Identities=24%  Similarity=0.344  Sum_probs=175.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ..++|...+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|++++++++|+||++++++|....     .
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~   77 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----E   77 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----E
Confidence            3478999999999999999999999899999999987653 234567899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++.....++.|++.||+|||+.+  .++||||||+||+++.++.+||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL  145 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKL  145 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEE
Confidence            99999999999999998643          45788899999999999999999742  2999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++.......    .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       146 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         146 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             eeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999987654332    1234588999999999888899999999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.98  E-value=3.3e-32  Score=287.34  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=194.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||+||+|.+..+++    .|++|.+..... ....++..|+..++++.||||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-----   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-----   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence            578888999999999999999976665    477788754322 2345778888899999999999999987532     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++++||+++|+|.+++...         ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQH---------RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcE
Confidence             467899999999999999643         246899999999999999999999887   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||.++...+...........++..|+|||....+.++.++|||||||++||+++ |+.||.....  ..+.+++..
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~  226 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEK  226 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC
Confidence            9999999987655443222334557789999999998999999999999999999998 9999863211  111222211


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....     ..+                         ..|...+.+++..|+..++-.||+..+...
T Consensus       227 ~~~~-----~~~-------------------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         227 GERL-----AQP-------------------------QICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCcC-----CCC-------------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1000     000                         012334557788999999999999987643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.98  E-value=4.8e-32  Score=292.29  Aligned_cols=199  Identities=23%  Similarity=0.301  Sum_probs=170.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +|...+.||+|+||.||+|....+++.||+|+++...   .........|.+++..+ .|++|+++++++...+     .
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----R   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----E
Confidence            5788899999999999999999889999999987542   22334566788888777 5899999998887655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL  142 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV----------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEE
Confidence            99999999999999988643          45788999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++.......  ......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus       143 ~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~  203 (323)
T cd05616         143 ADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             ccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence            99999876433221  12345689999999999999999999999999999999999999973

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.6e-32  Score=298.10  Aligned_cols=202  Identities=25%  Similarity=0.333  Sum_probs=176.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|....+++.||||+++...   ......+..|++++..++|+||+++++++....     .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----H   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----e
Confidence            46888999999999999999999899999999986442   234567889999999999999999999887655     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||..+   |+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL  142 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK----------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKL  142 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEe
Confidence            99999999999999998643          46889999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCC---------------------------CccceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249          427 GDFGLARFLPPTH---------------------------VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE  479 (789)
Q Consensus       427 ~Dfgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e  479 (789)
                      +|||++.......                           .........||..|+|||++.+..++.++|||||||++||
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  222 (350)
T cd05573         143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE  222 (350)
T ss_pred             ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence            9999998765433                           0111223568999999999999999999999999999999


Q ss_pred             HHHhcCCCCc
Q 041249          480 LIIRKKPSDI  489 (789)
Q Consensus       480 lltG~~P~~~  489 (789)
                      |++|+.||..
T Consensus       223 ll~g~~Pf~~  232 (350)
T cd05573         223 MLYGFPPFYS  232 (350)
T ss_pred             hccCCCCCCC
Confidence            9999999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.98  E-value=3.5e-32  Score=300.41  Aligned_cols=201  Identities=21%  Similarity=0.298  Sum_probs=171.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|...+.||+|+||+||+|....+++.||+|++....   ......+.+|+++++.++|+||+++++.+...+     ..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----EE
Confidence            5778899999999999999999899999999986432   233467889999999999999999999998765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+++|+|.+++...          ..+++.....++.|++.||+|||+.+   ||||||||+|||++.++++||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~  143 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM----------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLT  143 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999998643          45788889999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCC---------------------------------------------ccceeeecccccccCcccCCCC
Q 041249          428 DFGLARFLPPTHV---------------------------------------------QTSSIGVKGSIGYIAPEYGLGS  462 (789)
Q Consensus       428 Dfgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~  462 (789)
                      |||++........                                             ........||..|+|||++.+.
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (382)
T cd05625         144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT  223 (382)
T ss_pred             ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence            9999753321000                                             0001124589999999999988


Q ss_pred             CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          463 EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       463 ~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .++.++|||||||++|||++|+.||..
T Consensus       224 ~~~~~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         224 GYTQLCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence            999999999999999999999999973

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.98  E-value=2.6e-32  Score=294.63  Aligned_cols=194  Identities=24%  Similarity=0.293  Sum_probs=167.9

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||++....+++.||+|+++...   ......+..|++++..++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEe
Confidence            46899999999999999899999999996542   233456788999999999999999999887665     8999999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      |+.+|+|.+++...          ..+++.++..++.|++.||+|||+ .+   |+||||||+||+++.++.+||+|||+
T Consensus        76 ~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~  142 (325)
T cd05594          76 YANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGL  142 (325)
T ss_pred             CCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCC
Confidence            99999999888543          468999999999999999999997 66   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~  198 (325)
T cd05594         143 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             CeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence            875432221  12234689999999999998999999999999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=275.76  Aligned_cols=281  Identities=21%  Similarity=0.212  Sum_probs=211.4

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEec--cccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN--LHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ....|...+.||+|+||.|..+....+++.||||.+.  .......++..+|++.++.++|+||+.+++++.....+..+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666889999999999999999999999999997  55666788899999999999999999999999875555666


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+|+|+ -+|...++..          +.++.....-+..|+++||.|+|+.+   |+|||+||+|++++.+-..|
T Consensus       100 DvYiV~elMe-tDL~~iik~~----------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lK  165 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQ----------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLK  165 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcC----------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEE
Confidence            8999999996 4899988654          55888999999999999999999999   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH--HH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF--AR  502 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~--~~  502 (789)
                      ++|||+|+...........+....|..|.|||.+.. ..|+...||||.||++.||++|++-|..    ...+.+.  +.
T Consensus       166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG----~d~v~Ql~lI~  241 (359)
T KOG0660|consen  166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG----KDYVHQLQLIL  241 (359)
T ss_pred             eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC----CchHHHHHHHH
Confidence            999999999875433334455668999999998865 5699999999999999999999998852    2222222  11


Q ss_pred             HhCCCc----hhhhccCCcccChhhHHHhhhh-hhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          503 MALPDH----VMDIVDSTLLNDVEDLAIISNQ-RQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       503 ~~~~~~----~~~~~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...+-.    +..+-....+.     ...+.+ ..+..+.....+.....+++..++...+|.+|.+..++..+
T Consensus       242 ~~lGtP~~e~l~~i~s~~ar~-----yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  242 ELLGTPSEEDLQKIRSEKARP-----YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhcCCCCHHHHHHhccHHHHH-----HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            112111    11111011100     000000 11112222333455566677778888888888888877544

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=2.6e-32  Score=300.94  Aligned_cols=202  Identities=22%  Similarity=0.296  Sum_probs=172.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+|...+.||+|+||.||+|....+++.||||++....   ......+..|++++.+++|+||+++++.+....     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----N   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----E
Confidence            36888999999999999999999899999999986432   223456888999999999999999999987655     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL  142 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRL----------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL  142 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEE
Confidence            99999999999999998643          45788888999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCC-----------------------------------------ccceeeecccccccCcccCCCCCcC
Q 041249          427 GDFGLARFLPPTHV-----------------------------------------QTSSIGVKGSIGYIAPEYGLGSEVS  465 (789)
Q Consensus       427 ~Dfgla~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~  465 (789)
                      +|||++........                                         ........||..|+|||++....++
T Consensus       143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  222 (376)
T cd05598         143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT  222 (376)
T ss_pred             EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence            99999753321000                                         0001134699999999999988999


Q ss_pred             ccccchhhHHHHHHHHHhcCCCCc
Q 041249          466 TNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       466 ~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .++|||||||++|||++|+.||..
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~~  246 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFLA  246 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCCC
Confidence            999999999999999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=7.2e-32  Score=291.56  Aligned_cols=194  Identities=25%  Similarity=0.328  Sum_probs=168.3

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|....+++.||+|+++...   ....+.+..|+.++.++ +||||+++++++....     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEE
Confidence            46899999999999999899999999997542   23345688899999998 7999999999987665     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~  142 (329)
T cd05588          76 EFVSGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcc
Confidence            999999999888543          46899999999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++......  .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         143 CKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            87532222  122345689999999999998999999999999999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=3.4e-32  Score=298.50  Aligned_cols=208  Identities=22%  Similarity=0.305  Sum_probs=178.4

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      +.++..+.++|...+.||+|+||.||++....+++.||+|++...   .......+.+|+.+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            456667789999999999999999999999999999999998643   22334567889999999999999999999876


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      ..     ..++||||+++|+|.+++...           .++...+..++.|++.||+|||+.+   |+||||||+||++
T Consensus       115 ~~-----~~~lv~Ey~~gg~L~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll  175 (371)
T cd05622         115 DR-----YLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLL  175 (371)
T ss_pred             CC-----EEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEE
Confidence            55     899999999999999998532           4788889999999999999999988   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.++++||+|||+++........ ......||+.|+|||++...    .++.++|||||||++|||++|+.||..
T Consensus       176 ~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         176 DKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             CCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            99999999999999876543321 12345699999999998653    378999999999999999999999973

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=6.6e-32  Score=291.37  Aligned_cols=197  Identities=24%  Similarity=0.336  Sum_probs=167.1

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHH---hcCCCCccceeeeeeccCCCCCCc
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRAL---RSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      |...+.||+|+||.||+|.+..+++.||||+++...   ....+.+..|++++   +.++||||+++++++....     
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-----   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-----   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence            566789999999999999999899999999996442   22234566666554   5678999999999987665     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|..++..           ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~k  141 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-----------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVK  141 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEE
Confidence            89999999999999988743           35899999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++.......  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       142 L~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         142 IADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             eCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            999999875432221  12345689999999999988999999999999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=6.8e-32  Score=282.80  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|+..+.||+|+||.||+|.+..+   ...||||.++.... .....+..|+..+++++||||+++++.+....    
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR----   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC----
Confidence            46799999999999999999998643   46899999875433 34567899999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...         ...+++.++..++.|++.|++|||+.+   |+|+||||+||++++++.+
T Consensus        79 -~~~iv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~  145 (266)
T cd05033          79 -PVMIITEYMENGSLDKFLREN---------DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC  145 (266)
T ss_pred             -ceEEEEEcCCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCE
Confidence             789999999999999998643         236899999999999999999999887   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |++|||++................++..|+|||......++.++||||||+++|||++ |..||.....  ..+...+..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~  223 (266)
T cd05033         146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVED  223 (266)
T ss_pred             EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHHc
Confidence            9999999998763332222223345678999999998899999999999999999998 9999863211  111111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....       +                       ....+...+.+++..|++.++-.||+...+...+
T Consensus       224 ~~~~-------~-----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l  262 (266)
T cd05033         224 GYRL-------P-----------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL  262 (266)
T ss_pred             CCCC-------C-----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            1000       0                       0112334567889999999999999988774433

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=6.5e-32  Score=291.17  Aligned_cols=194  Identities=24%  Similarity=0.306  Sum_probs=165.9

Q ss_pred             CcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.||+|+||.||++...   .+++.||+|+++...    ......+..|+++++.++||||+++++++....     ..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eEE
Confidence            57999999999999874   468899999986432    223456788999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...          ..+.+..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D  143 (323)
T cd05584          77 LILEYLSGGELFMHLERE----------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTD  143 (323)
T ss_pred             EEEeCCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEee
Confidence            999999999999998643          45778888999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++.......  ......|+..|+|||++....++.++|||||||++|||++|+.||..
T Consensus       144 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         144 FGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             CcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence            999875433221  12234689999999999988899999999999999999999999973

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-32  Score=286.67  Aligned_cols=200  Identities=26%  Similarity=0.376  Sum_probs=173.0

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +|...+.||+|+||+||++....+++.||+|.+....   ......+.+|++++++++||||+++++.+...+     ..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eE
Confidence            4777889999999999999998889999999986432   222345778999999999999999999987655     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~  144 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEe
Confidence            9999999999999887543        2346899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++........   .....|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~  203 (285)
T cd05605         145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ  203 (285)
T ss_pred             eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence            9999987643321   1234688999999999888899999999999999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=7.1e-32  Score=282.15  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ..+|...+.||+|++|.||+|.+...++.||+|.+... ......+.+|++.+++++|+||+++++++....     ..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcE
Confidence            35678889999999999999999988999999998643 333567889999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+++|.+++...        ....+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d  147 (263)
T cd05052          79 IITEFMTYGNLLDYLREC--------NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD  147 (263)
T ss_pred             EEEEeCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCC
Confidence            999999999999998654        2356899999999999999999999887   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.+......... ......++..|+|||......++.++|||||||++|||++ |..||...     +...+.+.....
T Consensus       148 f~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~~~~  221 (263)
T cd05052         148 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKG  221 (263)
T ss_pred             Cccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHCC
Confidence            9999876543311 1112234568999999988899999999999999999998 99998632     112221111100


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                               ....                  ....+...+.+++.+|++.++-+||+.......+
T Consensus       222 ---------~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l  259 (263)
T cd05052         222 ---------YRME------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAF  259 (263)
T ss_pred             ---------CCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence                     0000                  0112344567888999999999999998775433

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=9.2e-32  Score=288.88  Aligned_cols=194  Identities=25%  Similarity=0.393  Sum_probs=166.3

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|.+..+++.||+|+++...   ......+..|.+++... +||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEE
Confidence            46899999999999999889999999987542   23344566777888764 8999999999987765     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        76 ey~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05619          76 EYLNGGDLMFHIQSC----------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM  142 (316)
T ss_pred             eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCc
Confidence            999999999998643          45788999999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (316)
T cd05619         143 CKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             ceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            875432221  12345689999999999988999999999999999999999999973

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=3.2e-32  Score=300.24  Aligned_cols=267  Identities=22%  Similarity=0.307  Sum_probs=201.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCC-CCccceeeeeeccCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIR-HRNLVKVFTACSGVD  340 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  340 (789)
                      ..++|...+.||+|+||.||+|++..     .+..||||+++.... ...+.+..|+++++++. ||||++++++|....
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35688899999999999999999742     235799999975433 33467899999999995 999999999997655


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCcc-------------------------------------------------
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDE-------------------------------------------------  371 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------  371 (789)
                           ..++||||+++|+|.+++........                                                 
T Consensus       115 -----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         115 -----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             -----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence                 78999999999999998865311000                                                 


Q ss_pred             -------------------------------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          372 -------------------------------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       372 -------------------------------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                                                           .......+++.++..++.|++.||+|||+.+   ++||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence                                                 0011245889999999999999999999988   999999999


Q ss_pred             ceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccC
Q 041249          415 NILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEG  493 (789)
Q Consensus       415 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~  493 (789)
                      ||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999999999999987654432222233446788999999998899999999999999999997 99998632211


Q ss_pred             CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      . .+...++....        +                      .....+...+.+++..|++.++.+||+...+...+.
T Consensus       347 ~-~~~~~~~~~~~--------~----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         347 S-TFYNKIKSGYR--------M----------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             H-HHHHHHhcCCC--------C----------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence            0 01111110000        0                      001123455678899999999999999887655443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=7.5e-32  Score=290.80  Aligned_cols=193  Identities=27%  Similarity=0.336  Sum_probs=163.6

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|....+++.||+|++....   ......+..|.. +++.++||||+++++++....     ..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEE
Confidence            46999999999999999899999999986432   222334444444 567889999999999987655     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~  142 (323)
T cd05575          76 DYVNGGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGL  142 (323)
T ss_pred             cCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCC
Confidence            999999999988643          46788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  197 (323)
T cd05575         143 CKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (323)
T ss_pred             CcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence            875432221  2234568999999999999899999999999999999999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=8.3e-32  Score=284.37  Aligned_cols=196  Identities=26%  Similarity=0.367  Sum_probs=168.0

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||+|+||+||++....+++.||+|.+.....   .....+..|++++++++|+||+++.+++....     ..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence            6999999999999998999999999864322   22356778999999999999999998886654     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      ++|+|..++....      .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+..
T Consensus        76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            9999998875431      12356899999999999999999999888   99999999999999999999999999987


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .......  .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       147 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  199 (280)
T cd05608         147 LKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             cCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            6543321  2235689999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=3.3e-32  Score=294.87  Aligned_cols=268  Identities=21%  Similarity=0.249  Sum_probs=200.9

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVD  340 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  340 (789)
                      ..+.|...+.||+|+||.||+|....     +++.||+|+++... ....+.+..|++++.++ +|+||++++++|...+
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            34678899999999999999997532     35789999987543 23345678899999999 8999999999886543


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCc--------------------------------------------------
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNRED--------------------------------------------------  370 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------  370 (789)
                          ...++++||+++|+|.+++......-                                                  
T Consensus        85 ----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          85 ----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence                26789999999999999986431100                                                  


Q ss_pred             -cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecc
Q 041249          371 -EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG  449 (789)
Q Consensus       371 -~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  449 (789)
                       ........+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++.+.............+
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~  237 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  237 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence             00001236899999999999999999999888   99999999999999999999999999987754433222333456


Q ss_pred             cccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhh
Q 041249          450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIIS  528 (789)
Q Consensus       450 t~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  528 (789)
                      +..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+....+.....    .                
T Consensus       238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~----~----------------  296 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRM----R----------------  296 (337)
T ss_pred             CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccCCC----C----------------
Confidence            778999999999999999999999999999998 99998642211 1111111110000    0                


Q ss_pred             hhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          529 NQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                                ....+..++.+++..|++.++.+||+..++...+.
T Consensus       297 ----------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~  331 (337)
T cd05054         297 ----------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG  331 (337)
T ss_pred             ----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                      01123345678899999999999999988755443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=8.2e-32  Score=285.69  Aligned_cols=266  Identities=23%  Similarity=0.343  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||.|+||.||++...     .++..+|+|.++.........+..|++++++++||||+++++++....   
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC---
Confidence            467889999999999999999852     345679999987666566678999999999999999999999987655   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCcc---ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDE---VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                        ..++|+||+.+|+|.+++...+....   .......+++.+++.++.|++.||+|||+.+   ++||||||+||++++
T Consensus        81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~  155 (288)
T cd05093          81 --PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGE  155 (288)
T ss_pred             --ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEcc
Confidence              78999999999999999864421110   1122345899999999999999999999888   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~  499 (789)
                      ++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||......  .+..
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~  233 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIE  233 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence            99999999999986654332222223335678999999988889999999999999999999 89998632211  1111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      .+....   ...                           ....+..++.+++..|++.++.+||+...+...+..
T Consensus       234 ~i~~~~---~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         234 CITQGR---VLQ---------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HHHcCC---cCC---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            111000   000                           001223457789999999999999999887544433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=7.2e-32  Score=285.34  Aligned_cols=262  Identities=20%  Similarity=0.296  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEc----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLD----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||.||+|.+.    ..++.|++|.+.... ......+.+|++++++++||||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ----   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence            46778899999999999999863    356789999997443 233467889999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCc-------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNRED-------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                       ..++||||+.+|+|.+++.......       ........+++.+.+.++.|++.||+|||+.+   ++||||||+||+
T Consensus        81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil  156 (283)
T cd05090          81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL  156 (283)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence             7899999999999999985331110       00111345889999999999999999999888   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN  496 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~  496 (789)
                      +++++.+|++|||+++...............++..|+|||++....++.++|||||||++|||++ |..||....  ...
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~  234 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQE  234 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence            99999999999999987654432222233445678999999988889999999999999999998 999986321  111


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      +...+.......                              ....+...+.+++..|++.++..||+...+...
T Consensus       235 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         235 VIEMVRKRQLLP------------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcCCcCC------------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            111111110000                              001233456678889999999999998876443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=3.3e-32  Score=294.63  Aligned_cols=202  Identities=23%  Similarity=0.264  Sum_probs=174.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||++....+++.||+|+++...   ......+.+|+++++.++|+||+++++++....     .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----N   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----e
Confidence            47888999999999999999999899999999997542   234567889999999999999999999887655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL  143 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRY---------EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKL  143 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEe
Confidence            89999999999999998643         246889999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCC------CCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL------GSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++......... ......||..|+|||++.      ...++.++|||||||++|||++|+.||..
T Consensus       144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            999999876544322 222346899999999986      45688999999999999999999999963

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=5.6e-32  Score=282.55  Aligned_cols=254  Identities=22%  Similarity=0.397  Sum_probs=199.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|++|.||+|... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+....     ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PI   76 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----Cc
Confidence            3467889999999999999999976 66789999976433 23567899999999999999999999887654     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++++||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+|++
T Consensus        77 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~  145 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIA  145 (261)
T ss_pred             EEEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEEC
Confidence            9999999999999998643        2456788999999999999999999887   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.+......... ......++..|+|||+...+.++.++|||||||++|||++ |+.||....  .......+....+
T Consensus       146 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~  222 (261)
T cd05072         146 DFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGYR  222 (261)
T ss_pred             CCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCCC
Confidence            99999876543321 1122345678999999988889999999999999999998 999986321  1112222111111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .       +                       ....+...+.+++.+|++.++-+||+.......+
T Consensus       223 ~-------~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  258 (261)
T cd05072         223 M-------P-----------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL  258 (261)
T ss_pred             C-------C-----------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            0       0                       0012234566889999999999999998775443

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-33  Score=303.53  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=209.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCc----eEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGR----TTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ....++||+|+||+||+|.|-..+    -+||||++... ..+...++.+|+-.|++++|||+++++|+|...      .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence            345679999999999999995444    35899998654 445578899999999999999999999999865      3


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      ..||.+||+.|.|.++++..         ...+-....+.|..|||+||.|||.+.   +|||||-++|||+..-.++|+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h---------r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvki  839 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH---------RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKI  839 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh---------hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEE
Confidence            78999999999999999764         356778889999999999999999887   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      .|||+++...++..+.......-.+.|||-|.+....|+.++|||||||++||++| |..|++...-+            
T Consensus       840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------  907 (1177)
T KOG1025|consen  840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------  907 (1177)
T ss_pred             EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------
Confidence            99999999998887665555556678999999999999999999999999999998 99999732110            


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG  576 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~  576 (789)
                        .+.+.+...-                  |....+.|...+..++.+||..+...||..++.......+.
T Consensus       908 --eI~dlle~ge------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  908 --EIPDLLEKGE------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             --HhhHHHhccc------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence              1122211111                  12234578889999999999999999999988765544443

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=1.1e-31  Score=288.41  Aligned_cols=194  Identities=24%  Similarity=0.350  Sum_probs=166.2

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|.+..+++.||+|.++...   .........|+.++... +||||+++++++...+     ..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEE
Confidence            46999999999999999899999999996542   23345567777887755 8999999999987655     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05620          76 EFLNGGDLMFHIQDK----------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGM  142 (316)
T ss_pred             CCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCC
Confidence            999999999988543          46788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++......  .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~  198 (316)
T cd05620         143 CKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             CeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            87543222  122345689999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=8.6e-32  Score=283.82  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=199.1

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ++++|...+.||+|++|.||+|.+..     .+..||+|.+.... ......+..|+.++++++|+||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence            56789999999999999999999986     67889999986543 333467899999999999999999999887655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...+...   .....+++.+++.++.||+.||+|||+.+   ++||||||+||+++.+
T Consensus        83 ----~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~  152 (277)
T cd05036          83 ----PRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK  152 (277)
T ss_pred             ----CcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEecc
Confidence                6799999999999999987552111   12346899999999999999999999988   9999999999999865


Q ss_pred             C---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          422 M---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       422 ~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +   .+|++|||.++................+..|+|||++.+..+++++|||||||++|||++ |+.||+....     
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----  227 (277)
T cd05036         153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----  227 (277)
T ss_pred             CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            4   689999999987643322111112233568999999999999999999999999999997 9999863211     


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .............+                           ....+...+.+++..|++.++.+||+...+..
T Consensus       228 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~  273 (277)
T cd05036         228 QEVMEFVTGGGRLD---------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILE  273 (277)
T ss_pred             HHHHHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11111111100000                           01123345678889999999999999987643

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=3.8e-32  Score=297.60  Aligned_cols=202  Identities=26%  Similarity=0.328  Sum_probs=174.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||++....+++.||+|+++..   .......+..|++++..++|++|+++++.+....     .
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----N   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence            4788899999999999999999989999999998643   2233467888999999999999999999987665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++++||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL  142 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK----------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKL  142 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEE
Confidence            99999999999999998643          46889999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCc---------------------------------cceeeecccccccCcccCCCCCcCccccchhh
Q 041249          427 GDFGLARFLPPTHVQ---------------------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSY  473 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sf  473 (789)
                      +|||+++........                                 .......||..|+|||++.+..++.++|||||
T Consensus       143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl  222 (360)
T cd05627         143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL  222 (360)
T ss_pred             eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence            999998755322100                                 00113468999999999999899999999999


Q ss_pred             HHHHHHHHHhcCCCCc
Q 041249          474 GILMLELIIRKKPSDI  489 (789)
Q Consensus       474 Gvvl~elltG~~P~~~  489 (789)
                      ||++|||++|+.||..
T Consensus       223 Gvilyel~tG~~Pf~~  238 (360)
T cd05627         223 GVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cceeeecccCCCCCCC
Confidence            9999999999999963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=4.3e-32  Score=297.73  Aligned_cols=205  Identities=22%  Similarity=0.306  Sum_probs=174.7

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      .....++|...+.||+|+||.||++....+++.||+|+++..   .......+..|+.+++.++||||+++++++.... 
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~-  116 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK-  116 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence            344567899999999999999999999989999999998643   2233456788999999999999999999887655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+++|+|.+++..           ..++...+..++.|++.||+|||+.+   |+||||||+|||++.+
T Consensus       117 ----~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~  178 (370)
T cd05596         117 ----YLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS  178 (370)
T ss_pred             ----EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCC
Confidence                89999999999999998853           24678888999999999999999988   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.+||+|||.+......... ......||+.|+|||.+...    .++.++|||||||++|||++|+.||..
T Consensus       179 ~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         179 GHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            99999999999876543211 12235689999999987653    478999999999999999999999973

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=2.3e-31  Score=280.58  Aligned_cols=244  Identities=20%  Similarity=0.243  Sum_probs=190.5

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||+|+||+||++....+++.||+|.+....   ......+..|++++++++||||+++++++....     ..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-----HLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-----eEEEEEecC
Confidence            699999999999999899999999986432   222345667999999999999999999887655     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      .+|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        76 ~g~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~  144 (277)
T cd05607          76 NGGDLKYHIYNV--------GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVE  144 (277)
T ss_pred             CCCCHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeee
Confidence            999999888543        2345889999999999999999999888   99999999999999999999999999987


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhcc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD  514 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d  514 (789)
                      ......   .....|+..|+|||++.+..++.++|||||||++|||++|+.||....+. .......+......      
T Consensus       145 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~------  214 (277)
T cd05607         145 LKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE------  214 (277)
T ss_pred             cCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc------
Confidence            654321   22346889999999999888999999999999999999999999643211 11122222111110      


Q ss_pred             CCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          515 STLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                        +...                   ......++.+++..|.+.++..|++..+.
T Consensus       215 --~~~~-------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~  247 (277)
T cd05607         215 --VKFE-------------------HQNFTEESKDICRLFLAKKPEDRLGSREK  247 (277)
T ss_pred             --cccc-------------------cccCCHHHHHHHHHHhccCHhhCCCCccc
Confidence              0000                   00123345688889999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=1.2e-31  Score=278.93  Aligned_cols=250  Identities=21%  Similarity=0.268  Sum_probs=200.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|++|.||+|....+++.|++|.+...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEE
Confidence            577788999999999999999989999999998643  3445678999999999999999999999987655     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+++|.+++...        ....+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+|++|
T Consensus        76 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~d  144 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--------RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGD  144 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcc
Confidence            999999999999998643        2356889999999999999999999887   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.++........  .....|+..|+|||+..+..++.++|||||||++|||++|+.||.....     ....+......
T Consensus       145 f~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~  217 (256)
T cd08529         145 LGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRGV  217 (256)
T ss_pred             cccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence            9998876544321  2234578899999999999999999999999999999999999963221     11111110000


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...     +.                      ......+.+++.+|++.++.+||++.....
T Consensus       218 ~~~-----~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         218 FPP-----VS----------------------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCC-----Cc----------------------cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            000     00                      022345668888999999999999876643

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-31  Score=280.24  Aligned_cols=254  Identities=28%  Similarity=0.410  Sum_probs=198.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|++++++++|+||+++++++....     ..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PI   76 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Ce
Confidence            4567888999999999999999986 56789999986543 23567889999999999999999999987655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+++|.+++...        .+..+++.++..++.|++.|+.|||+.+   ++||||||+||++++++.+||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~  145 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGG--------AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVA  145 (261)
T ss_pred             eeeeecccCCcHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEEC
Confidence            9999999999999998654        2456899999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||+++........ .......+..|+|||+.....++.++||||||+++|||++ |+.||.....  ......+.....
T Consensus       146 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~  222 (261)
T cd05068         146 DFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGYR  222 (261)
T ss_pred             CcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC
Confidence            99999887643211 1112223457999999998899999999999999999999 9999863211  011111110000


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                              .                      .....+...+.+++.+|++.++.+||+.......+
T Consensus       223 --------~----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l  258 (261)
T cd05068         223 --------M----------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL  258 (261)
T ss_pred             --------C----------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence                    0                      00112334567888999999999999998765433

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1e-31  Score=289.50  Aligned_cols=199  Identities=24%  Similarity=0.319  Sum_probs=169.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +|...+.||+|+||+||+|....+++.||+|+++...   ......+..|++++..+. |++|+++.+++...+     .
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-----R   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-----E
Confidence            4777889999999999999999899999999986442   233456778888998885 577778888876655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL  142 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV----------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEE
Confidence            89999999999999998643          46899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++.......  ......||..|+|||++....++.++|||||||++|||++|+.||..
T Consensus       143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (323)
T cd05615         143 ADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             eccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence            99999886433321  12235589999999999988899999999999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=8.8e-32  Score=284.12  Aligned_cols=261  Identities=25%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++|...+.||+|+||.||+|....     +++.||||.++..... ..+.+.+|++++++++|+||+++++++....  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence            4568888999999999999998753     3578999999765444 4578999999999999999999999987765  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCcc----ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDE----VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                         ..++||||+++|+|.+++........    .......+++.++..++.|++.|++|||+.+   ++||||||+||++
T Consensus        82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili  155 (280)
T cd05049          82 ---PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLV  155 (280)
T ss_pred             ---CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEE
Confidence               78999999999999999975421100    0123456899999999999999999999888   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +.++.+||+|||.++...............++..|+|||++....+++++|||||||++|||++ |+.||.....  ...
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~  233 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEV  233 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHH
Confidence            9999999999999986543332222223345678999999999999999999999999999999 9999863211  112


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ...++.....    ..                          ...+...+.+++..|++.++..|++..++.
T Consensus       234 ~~~~~~~~~~----~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil  275 (280)
T cd05049         234 IECITQGRLL----QR--------------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIH  275 (280)
T ss_pred             HHHHHcCCcC----CC--------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            2222110000    00                          002234566888999999999999887663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=9.5e-32  Score=279.25  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=191.1

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      +.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||++++++|....     ..++|+||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence            46899999999999998889999999876443 334567999999999999999999999987655     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      .+++|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|++|||.+..
T Consensus        76 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          76 QGGDFLTFLRTE---------GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             cCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcc
Confidence            999999998533         245789999999999999999999888   99999999999999999999999999886


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV  513 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (789)
                      ..............++..|+|||.+.++.++.++||||||+++|||++ |..||......  .......           
T Consensus       144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~-----------  210 (252)
T cd05084         144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIE-----------  210 (252)
T ss_pred             cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHH-----------
Confidence            543321111111223467999999999899999999999999999998 88888632110  0111111           


Q ss_pred             cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                       .....                  .....+...+.+++.+|.+.++..||+...+.
T Consensus       211 -~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  247 (252)
T cd05084         211 -QGVRL------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVH  247 (252)
T ss_pred             -cCCCC------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence             00000                  00112344567888999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.9e-31  Score=280.31  Aligned_cols=261  Identities=22%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             CCCCCcccccCCccEEEEEEcCC---ceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      |...+.||+|+||.||+|....+   +..||+|.++...  ......+..|++.++.++|+||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            55678999999999999998643   3789999987543  3335678999999999999999999998866542 2233


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++++||+.+|+|..++.....    ......+++.+...++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRL----GGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhc----cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEE
Confidence            47999999999999999854311    123357899999999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.....  ....++....
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~  231 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHG  231 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence            999999987765443222223345678999999988889999999999999999999 8888863211  1111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..        +.                      ....+..++.+++.+|++.++-+||+...+...
T Consensus       232 ~~--------~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         232 NR--------LK----------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CC--------CC----------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00        00                      011234466788889999999999998876443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.2e-31  Score=281.29  Aligned_cols=258  Identities=19%  Similarity=0.217  Sum_probs=201.2

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      |++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++....   
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   78 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG---   78 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC---
Confidence            45678889999999999999999999998889999999987776666778999999999999999999999987765   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCC--CHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL--NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-  420 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-  420 (789)
                        ..++|+||+.+++|.+++...         ...+  ++..+..++.|++.||+|||+.+   ++||||||+||+++. 
T Consensus        79 --~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~  144 (268)
T cd06624          79 --FFKIFMEQVPGGSLSALLRSK---------WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTY  144 (268)
T ss_pred             --EEEEEEecCCCCCHHHHHHHh---------cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCC
Confidence              789999999999999998643         1233  77888999999999999999887   999999999999986 


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                      .+.+||+|||.+........  ......|+..|+|||+.....  ++.++||||||+++|||++|+.||......  ...
T Consensus       145 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~--~~~  220 (268)
T cd06624         145 SGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP--QAA  220 (268)
T ss_pred             CCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh--hhh
Confidence            67999999999886643321  112235788999999987654  789999999999999999999998632111  111


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .+......      ..+.+                      ...+...+.+++..|++.++-+||+..+...
T Consensus       221 ~~~~~~~~------~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         221 MFKVGMFK------IHPEI----------------------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             Hhhhhhhc------cCCCC----------------------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            11100000      00000                      0122334567788999999999999877644

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=294.10  Aligned_cols=206  Identities=29%  Similarity=0.405  Sum_probs=177.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l  349 (789)
                      |...+.||+|+||.||+|+.+.+|+.||||+++... ....+..-+|++++++++|+|||+++++-.... +.-.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345678999999999999999999999999997653 344667888999999999999999998854432 111446789


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC--CCC--cee
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--EEM--VSH  425 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~k  425 (789)
                      |||||.+|+|+..+.+.       .....|++.+.+.++.+++.||.|||.++   ||||||||.||++-  .++  .-|
T Consensus        95 vmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             EEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEe
Confidence            99999999999999765       45678999999999999999999999998   99999999999994  334  349


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |+|||.|+.+++..   ......||..|.|||+... ..|+.-+|.|||||++|+.+||..||-..
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99999999998776   4567889999999999985 78999999999999999999999999743

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1.5e-31  Score=284.02  Aligned_cols=266  Identities=23%  Similarity=0.348  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .+|...+.||+|+||.||+|.+.     .+...|++|.++.......+.+.+|++.+++++|+||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD----   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence            45777889999999999999864     235679999987666666678999999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                       ..++||||+.+++|.+++.......      ........+++.+++.++.|++.|++|||+.+   ++||||||+||++
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~  156 (291)
T cd05094          81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV  156 (291)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence             7899999999999999996542110      00112345899999999999999999999888   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +.++.+||+|||++................++..|+|||+.....++.++|||||||++|||+| |+.||......  ..
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~  234 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EV  234 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999987654432222233446788999999998899999999999999999999 99998632111  11


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      .+......   ..+                           ....+...+.+++..|++.++..||+...+...+..+
T Consensus       235 ~~~~~~~~---~~~---------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         235 IECITQGR---VLE---------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHHHhCCC---CCC---------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            11111000   000                           0012334567899999999999999998886555443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=1.6e-31  Score=288.00  Aligned_cols=194  Identities=26%  Similarity=0.323  Sum_probs=163.5

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|+...+++.||+|++....   ......+..|+. +++.++||||+++++++...+     ..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999899999999986432   222334555554 678889999999999887655     889999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|...+...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  142 (321)
T cd05603          76 DYVNGGELFFHLQRE----------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGL  142 (321)
T ss_pred             cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCC
Confidence            999999998887543          45788889999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++......  .......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         143 CKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             CccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence            87542222  122345689999999999888899999999999999999999999963

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=1.4e-31  Score=287.90  Aligned_cols=194  Identities=24%  Similarity=0.312  Sum_probs=167.1

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|.+..+++.||+|+++...   ......+..|++++..+ +||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999889999999987442   23345677888888888 7999999999987655     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|..++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~  142 (318)
T cd05570          76 EYVNGGDLMFHIQRS----------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGM  142 (318)
T ss_pred             cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCC
Confidence            999999999888543          46899999999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       143 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~  198 (318)
T cd05570         143 CKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             CeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence            875332221  12234589999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=1.2e-31  Score=283.63  Aligned_cols=263  Identities=18%  Similarity=0.242  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .+|...+.||+|+||.||+|.+..     .++.||+|+++..... ....+.+|+.+++.++||||+++++++....   
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~---   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ---   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence            346677899999999999999753     3578999999755433 3466889999999999999999999987665   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                        ..++++||+.+++|.+++.......      ........+++..+..++.|++.||+|+|+.+   ++||||||+||+
T Consensus        82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil  156 (283)
T cd05091          82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVL  156 (283)
T ss_pred             --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheE
Confidence              7899999999999999985321110      01112345889999999999999999999888   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN  496 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~  496 (789)
                      +++++.+||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..||....     
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----  231 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----  231 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence            99999999999999887654432222233446778999999988899999999999999999998 888886321     


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..++...........     +                      ...|...+.+++..|++.++..||+...+...+
T Consensus       232 ~~~~~~~i~~~~~~~-----~----------------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l  280 (283)
T cd05091         232 NQDVIEMIRNRQVLP-----C----------------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL  280 (283)
T ss_pred             HHHHHHHHHcCCcCC-----C----------------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence            112222111111000     0                      013445577889999999999999998775443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=8.4e-32  Score=285.90  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=199.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +|...+.||+|+||.||+|....     +...|++|.+..... .....+..|++++++++||||+++++.|...+    
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG----   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence            46778999999999999998742     236799998865433 33467889999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCc--------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecC
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNRED--------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD  410 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~d  410 (789)
                       ..++|+||+.+|+|.+++.......              ........+++.++..++.|++.||+|||+.+   ++|||
T Consensus        77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~d  152 (290)
T cd05045          77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRD  152 (290)
T ss_pred             -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhh
Confidence             6899999999999999986532111              01122356899999999999999999999888   99999


Q ss_pred             CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249          411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDI  489 (789)
Q Consensus       411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~  489 (789)
                      |||+||++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999987654432222223345678999999988889999999999999999999 9999863


Q ss_pred             cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ...  ..+.++....            ....                  ....+...+.+++..|++.++-.||+...+.
T Consensus       233 ~~~--~~~~~~~~~~------------~~~~------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         233 IAP--ERLFNLLKTG------------YRME------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             CCH--HHHHHHHhCC------------CCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            211  1111111111            0000                  0112334567888999999999999998875


Q ss_pred             cccc
Q 041249          570 SILP  573 (789)
Q Consensus       570 ~~l~  573 (789)
                      ..+.
T Consensus       281 ~~l~  284 (290)
T cd05045         281 KELE  284 (290)
T ss_pred             HHHH
Confidence            4443

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=1.6e-31  Score=288.48  Aligned_cols=194  Identities=25%  Similarity=0.315  Sum_probs=168.4

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|....+++.||+|+++...   ....+.+..|+.++.++ +||+|+++++.+....     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEE
Confidence            46999999999999999899999999997542   23345688899999888 6999999999887655     799999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|..++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (327)
T cd05617          76 EYVNGGDLMFHMQRQ----------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGM  142 (327)
T ss_pred             eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccc
Confidence            999999999888543          46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++......  .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            87533222  112345689999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.5e-32  Score=286.94  Aligned_cols=253  Identities=21%  Similarity=0.246  Sum_probs=209.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.+|+|+||.++..+.+..++.+|+|.+.....  ...+...+|+.++++++|||||.+.+.+.+.+    ...
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceE
Confidence            578888999999999999999999999999999986643  33457899999999999999999999987655    238


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|||+|+++|++.+.+...        .+..+++.++..|+.|++.|+.|||...   |+|||||++|||++.+..+||+
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~--------k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLg  148 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQ--------KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLG  148 (426)
T ss_pred             EEEEeecCCCCHHHHHHHH--------hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeec
Confidence            9999999999999999866        3577999999999999999999999776   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+|+.+.+...  ....+.||+-||+||.+.+.+|..|+||||+||++|||++-+++|..     .+....+....+.
T Consensus       149 DfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-----~~m~~Li~ki~~~  221 (426)
T KOG0589|consen  149 DFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-----SNMSELILKINRG  221 (426)
T ss_pred             chhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-----cchHHHHHHHhhc
Confidence            9999999987652  23357799999999999999999999999999999999999999973     2333333322221


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          ..+|...                       ....++..++..|++..+-.||+.......
T Consensus       222 ----~~~Plp~-----------------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 ----LYSPLPS-----------------------MYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----cCCCCCc-----------------------cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1222221                       223445577788899999999998877554

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=1.1e-31  Score=283.41  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCce----EEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||+|+||+||+|.+..+++    .||+|+++... ......+..|+..++.+.|+||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            4678889999999999999999876665    48999986543 33456788999999999999999999998642    


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++++||+++|+|.+++...         ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~  147 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVREN---------KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNH  147 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence              467999999999999998643         246899999999999999999999888   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||+...  ...+..++.
T Consensus       148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~  225 (279)
T cd05109         148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLE  225 (279)
T ss_pred             EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH
Confidence            99999999987754432222222345678999999988899999999999999999998 899986321  112222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ......                              ....+...+.+++..|++.++..||+......
T Consensus       226 ~~~~~~------------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         226 KGERLP------------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCcCC------------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            111000                              01123445668888999999999999988743

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=1.4e-31  Score=278.83  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=193.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|+..+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|++++++++||||+++++++....     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEE
Confidence            56888899999999999999987 56789999876332 23467889999999999999999999987655     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+|++||
T Consensus        77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          77 VTEFMENGCLLNYLRQR---------QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCC
Confidence            99999999999998643         135789999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.++........ ......++..|+|||......++.++||||||+++|||++ |+.||....  .......+.....  
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~~--  219 (256)
T cd05114         145 GMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGFR--  219 (256)
T ss_pred             CCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCC--
Confidence            999876433211 1122335668999999988889999999999999999999 899986321  1111111111100  


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                         ...+.                         .....+.+++.+|++.++..||+.....
T Consensus       220 ---~~~~~-------------------------~~~~~~~~li~~c~~~~p~~Rps~~~l~  252 (256)
T cd05114         220 ---LYRPK-------------------------LASMTVYEVMYSCWHEKPEGRPTFAELL  252 (256)
T ss_pred             ---CCCCC-------------------------CCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence               00000                         1123567889999999999999988763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=8.4e-32  Score=273.01  Aligned_cols=209  Identities=26%  Similarity=0.380  Sum_probs=176.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCc-cceeeeeeccCCC-CCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRN-LVKVFTACSGVDY-QGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~-~~~~  345 (789)
                      ..|...++||+|+||+||+|+...+|+.||+|.++....  .......+|+.+++.++|+| |+++++++..... +...
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            456667889999999999999999999999999987755  24567789999999999999 9999999876542 3333


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+.. +|..++.....      ....++...+..++.|++.||+|||+++   |+||||||+||++++.+.+|
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~------~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lK  160 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPK------KPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLK  160 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEe
Confidence            67899999986 99999976521      1145777899999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |+|||+|+...-+...  .+...+|..|+|||.+.+. .|++..||||+||++.||++++.-|...
T Consensus       161 laDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~  224 (323)
T KOG0594|consen  161 LADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD  224 (323)
T ss_pred             eeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence            9999999977643321  3345689999999999987 5999999999999999999988887643

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=7.6e-32  Score=312.83  Aligned_cols=212  Identities=24%  Similarity=0.356  Sum_probs=175.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|++++++++||||+++++++...+     .
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----P   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----E
Confidence            46888999999999999999999889999999986542   223567899999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccc-cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEV-DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      .++||||+++|+|.+++......... ......+++..++.++.|+++||+|||+.+   |+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEE
Confidence            89999999999999998643111111 112345678889999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCC----------------ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHV----------------QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++.......                ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999987622110                0011124589999999999999999999999999999999999999964

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=1.3e-31  Score=290.19  Aligned_cols=200  Identities=25%  Similarity=0.326  Sum_probs=169.4

Q ss_pred             CCCCCCcccccCCccEEEEEEc---CCceEEEEEEeccc----cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLH----HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      +|...+.||+|+||.||++...   .+++.||+|++...    .....+.+..|++++..+ .|++|+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence            5778899999999999998864   46889999998643    222345688899999999 5999999998887655  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        79 ---~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~  142 (332)
T cd05614          79 ---KLHLILDYVSGGEMFTHLYQR----------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEG  142 (332)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCC
Confidence               789999999999999998643          46889999999999999999999988   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .+||+|||+++........ ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus       143 ~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             CEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            9999999999865433321 122456999999999987654 78999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=1.8e-31  Score=288.02  Aligned_cols=193  Identities=26%  Similarity=0.328  Sum_probs=162.7

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHH-HHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAEC-RALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|....+++.||+|++....   ......+..|. .+++.++|+||+++++++...+     ..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEE
Confidence            46999999999999999889999999986432   12223344444 4567889999999999987665     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          76 DYINGGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             eCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCC
Confidence            999999999988643          45778888899999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  197 (325)
T cd05602         143 CKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             CcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence            875432221  1234568999999999999899999999999999999999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=1.4e-31  Score=280.43  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|+...+++.||||.++..   .......+.+|++++++++||||+++++++...+     .
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence            5788999999999999999999889999999987543   2333457889999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+++|+|.+++...      ......++...+..++.|++.||+|||+.+   ++|+||||+||+++.++.+++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYF------KKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHh------hhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEE
Confidence            89999999999999888532      112345788999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.+........  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....   .....+......
T Consensus       148 ~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~  222 (267)
T cd08228         148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQKIEQ  222 (267)
T ss_pred             CccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHHHhc
Confidence            99999987654332  1123458889999999988889999999999999999999999986321   122222221111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..     .+..                     ........+.+++.+|++.++..||+..++...+
T Consensus       223 ~~-----~~~~---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~  262 (267)
T cd08228         223 CD-----YPPL---------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA  262 (267)
T ss_pred             CC-----CCCC---------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence            00     0000                     0012234566888899999999999998875433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=278.85  Aligned_cols=251  Identities=20%  Similarity=0.282  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-----hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-----RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|++|.||+|....+++.||+|.+.....     .....+.+|++++++++||||+++++++...+    
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE----   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence            579999999999999999999988899999999864321     12356888999999999999999999987765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++|+||+++++|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+
T Consensus        78 -~~~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~  143 (263)
T cd06625          78 -TLSIFMEYMPGGSVKDQLKAY----------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV  143 (263)
T ss_pred             -eEEEEEEECCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence             899999999999999988643          45788899999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccc-eeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTS-SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+++.......... .....++..|+|||...+..++.++||||||+++|||++|+.||....    ......+.
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~  219 (263)
T cd06625         144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----AMAAIFKI  219 (263)
T ss_pred             EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----hHHHHHHH
Confidence            9999999987654321111 123457789999999999889999999999999999999999986321    11111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      .....     .+.+                      ...+...+.++...|++.++..||+.....
T Consensus       220 ~~~~~-----~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll  258 (263)
T cd06625         220 ATQPT-----NPQL----------------------PSHVSPDARNFLRRTFVENAKKRPSAEELL  258 (263)
T ss_pred             hccCC-----CCCC----------------------CccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            10000     0000                      012233456788899999999999877653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=288.52  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=206.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC----CceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE----GRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +.....++||.|-||.||+|.+..    ..-.||||+.+.+ .....+.|..|.-+|+.++||||++++|+|.+.     
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-----  463 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-----  463 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-----
Confidence            444567789999999999999852    2346899999865 445577899999999999999999999999864     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..|+|||.++-|-|++|+..+         ...++..+...++.|++.||+|||+..   +|||||.++|||+....-+
T Consensus       464 -P~WivmEL~~~GELr~yLq~n---------k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQN---------KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             -ceeEEEecccchhHHHHHHhc---------cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCccee
Confidence             489999999999999999865         456888999999999999999999877   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |++|||+++.+.++...... ...-...|||||.+.-.+++..+|||-|||.+||+++ |..||......          
T Consensus       531 KLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------  599 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------  599 (974)
T ss_pred             eecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------
Confidence            99999999999887754333 2223457999999999999999999999999999987 99999743221          


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                             |++-.               ....-|.....+|...+..++.+||..+|.+||........+..
T Consensus       600 -------DVI~~---------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  600 -------DVIGH---------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             -------ceEEE---------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence                   11100               00011123345899999999999999999999999877655443

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-33  Score=274.00  Aligned_cols=199  Identities=25%  Similarity=0.349  Sum_probs=177.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +-|++.+++|+|+||.||+|.++++|+.||||.+...  .+.+++.+|+.++.+...|++|++||.+.-..     ..|+
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEe
Confidence            3577788999999999999999999999999998543  45678999999999999999999999976555     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |||||..|+..+.++.+         .+.+++.++..++.+.++||+|||...   -+|||||+.|||++.++++||+||
T Consensus       106 VMEYCGAGSiSDI~R~R---------~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR---------RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             ehhhcCCCcHHHHHHHh---------cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhc
Confidence            99999999999998654         478999999999999999999999776   899999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.|..+.+...  ....+.||+.|||||++..-.|+.++||||+|++..||.-|++||.+
T Consensus       174 GVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  174 GVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             cccchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence            99887654432  12346799999999999999999999999999999999999999974

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=1.4e-31  Score=285.79  Aligned_cols=255  Identities=21%  Similarity=0.287  Sum_probs=197.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||.||+|.+.     ..+..||+|.++... ....+.+.+|+++++++ +|+||+++++++.... 
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG-  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence            467999999999999999999862     345689999987543 33356789999999999 7999999999987665 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   ++|+||||+||+++++
T Consensus       113 ----~~~lv~e~~~~~~L~~~i~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~  177 (302)
T cd05055         113 ----PILVITEYCCYGDLLNFLRRK--------RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHG  177 (302)
T ss_pred             ----ceEEEEEcCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCC
Confidence                789999999999999998643        1234899999999999999999999887   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      +.+|++|||.++...............++..|+|||.+....++.++|||||||++|||++ |+.||...... ..+...
T Consensus       178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~  256 (302)
T cd05055         178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKL  256 (302)
T ss_pred             CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHH
Confidence            9999999999987654432222222345678999999999999999999999999999998 99998632111 111111


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....++..        .                      .......+.+++.+|++.++.+||+..++..
T Consensus       257 ~~~~~~~~--------~----------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         257 IKEGYRMA--------Q----------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHcCCcCC--------C----------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            11110000        0                      0011234667888999999999999987744

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-31  Score=288.77  Aligned_cols=201  Identities=24%  Similarity=0.293  Sum_probs=172.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||++....+++.||+|+++..   .......+.+|+.++..++|+||+++++++....     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----N   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----e
Confidence            4788899999999999999999988999999998642   2233456889999999999999999999987665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl  143 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRL  143 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEE
Confidence            99999999999999998542         246888999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +|||++......... ......||+.|+|||++..     ..++.++|||||||++|||++|+.||.
T Consensus       144 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         144 ADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             EECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            999998766543321 1122458999999999863     457899999999999999999999996

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=2.3e-31  Score=281.78  Aligned_cols=199  Identities=26%  Similarity=0.372  Sum_probs=172.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ......+..|++++++++|++|+++.+.+...+     ..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----ALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EEE
Confidence            666789999999999999999899999999986442   223455788999999999999999998887655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+|+|.+++...        ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEec
Confidence            999999999999888543        2346899999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||++........   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       146 fg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         146 LGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             CCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            999976543321   1234689999999999988999999999999999999999999973

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.5e-32  Score=277.61  Aligned_cols=201  Identities=29%  Similarity=0.397  Sum_probs=169.0

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      |...+++|.|+||.||+|...++++.||||....+..    .--.|+++|+++.|||||++..+|......+.-...+||
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            4557899999999999999999999999999854433    334689999999999999999888765533223467899


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeCccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFG  430 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg  430 (789)
                      |||+. +|.+.++..      ....+.++...+.-+..|+.+||+|||+.+   |+||||||+|+|+|.+ +.+||+|||
T Consensus       102 eymP~-tL~~~~r~~------~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHY------TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             HhchH-HHHHHHHHH------hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence            99996 888888642      123467888889999999999999999988   9999999999999987 889999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .|+.+......   ....-|..|+|||.+.+.+ |+.+.||||.|||+.||+-|++-|..
T Consensus       172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG  228 (364)
T KOG0658|consen  172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG  228 (364)
T ss_pred             cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence            99998777643   2344678899999999865 99999999999999999999998863

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-31  Score=280.34  Aligned_cols=261  Identities=21%  Similarity=0.323  Sum_probs=200.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++|...+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+++++.++|+||+++++++....  
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ--   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence            46788899999999999999998643     4789999986443 233567889999999999999999999987655  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++.......+.......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        83 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~  156 (277)
T cd05032          83 ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL  156 (277)
T ss_pred             ---CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence               789999999999999999754221111122345789999999999999999999887   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~  501 (789)
                      .+||+|||+++...............++..|+|||....+.++.++|||||||++||+++ |+.||....  ...+..+.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~  234 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKFV  234 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHHHH
Confidence            999999999987654432222223346788999999988889999999999999999998 999986321  11111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      .   ......     .                      ...+...+.+++..|++.++-.||+.....
T Consensus       235 ~---~~~~~~-----~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  272 (277)
T cd05032         235 I---DGGHLD-----L----------------------PENCPDKLLELMRMCWQYNPKMRPTFLEIV  272 (277)
T ss_pred             h---cCCCCC-----C----------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            1   000000     0                      012345677889999999999999887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=3.5e-31  Score=278.32  Aligned_cols=260  Identities=23%  Similarity=0.373  Sum_probs=195.5

Q ss_pred             CCCCCcccccCCccEEEEEEcCCce--EEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  346 (789)
                      |...+.||+|+||.||+|++..++.  .||+|.++..  .......+..|++.++.++|+||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999976654  6999998654  23445678899999999999999999998754321 22235


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++++||+.+|+|.+++.....    ......+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRL----GDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcc----cCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEE
Confidence            7899999999999988753311    123356899999999999999999999887   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+++...............++..|+|||......++.++||||||+++|||++ |+.||....  ...+...++.. 
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~-  230 (272)
T cd05075         154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYLRQG-  230 (272)
T ss_pred             CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcC-
Confidence            99999987754432211222346678999999998899999999999999999999 788886321  11111111110 


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                        ....                           ....+...+.+++..|++.++.+||+......
T Consensus       231 --~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         231 --NRLK---------------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             --CCCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              0000                           00123344668889999999999999887643

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.3e-31  Score=289.66  Aligned_cols=201  Identities=22%  Similarity=0.292  Sum_probs=173.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||++....+++.||+|++...   .......+.+|+.++..++|++|+++++++...+     .
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----Y   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence            4788899999999999999999989999999998642   2233456888999999999999999999987665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl  143 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRL  143 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEE
Confidence            99999999999999999642         245788899999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +|||+++........ ......|+..|+|||++..     +.++.++|||||||++|||++|+.||.
T Consensus       144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         144 ADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             EeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            999999876543321 1223469999999998865     568899999999999999999999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=1.9e-31  Score=280.29  Aligned_cols=259  Identities=20%  Similarity=0.246  Sum_probs=199.8

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC-C
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG-N  344 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~-~  344 (789)
                      .+++.|+..+.||+|+||+||+|.+..+++.||+|.+.... .....+..|++++.++ +|+||+++++++......+ .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            46778899999999999999999999889999999986543 3345788999999999 7999999999987644322 2


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+.+|+|.+++...        ....+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence            3689999999999999998643        2346889999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                      ||+|||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|+.||+....    ...
T Consensus       151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~  224 (272)
T cd06637         151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRA  224 (272)
T ss_pred             EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHH
Confidence            9999999886543221  123356889999999886     34588899999999999999999999963211    111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..... ........+                          ..+...+.++..+|++.++.+||+...+..
T Consensus       225 ~~~~~-~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         225 LFLIP-RNPAPRLKS--------------------------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHh-cCCCCCCCC--------------------------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11100 000000000                          112334567888999999999999876643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=1.6e-31  Score=284.63  Aligned_cols=250  Identities=20%  Similarity=0.265  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .+|...+.||+|++|.||+|....+++.||+|.+..........+..|+++++.++|+|++++++.+....     ..++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEE
Confidence            57888899999999999999998889999999998766666678999999999999999999999987655     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+++++|.+++..           ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+||
T Consensus        95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             eecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECcc
Confidence            9999999999998843           24788899999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |.+.........  .....|+..|+|||......++.++|||||||++|||++|+.||.....    ...+.. ......
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~-~~~~~~  233 (296)
T cd06654         161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYL-IATNGT  233 (296)
T ss_pred             ccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHH-HhcCCC
Confidence            998876543311  1234588899999999888899999999999999999999999963221    111111 000000


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .....+                         ......+.+++.+|+..++..||+......
T Consensus       234 ~~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 PELQNP-------------------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCc-------------------------cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            000000                         011234557778999999999999876644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=293.28  Aligned_cols=194  Identities=24%  Similarity=0.374  Sum_probs=172.6

Q ss_pred             cccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCC
Q 041249          277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN  356 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  356 (789)
                      ++|+|.||+||-|++..+...+|||-+.....+..+-+.+||+..+.++|.|||+++|.|.+..     +.-|.||..++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEeecCCC
Confidence            7999999999999999999999999998777777888999999999999999999999987655     88899999999


Q ss_pred             CChhhhccCCCCCccccCCCCCC--CHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCcccccc
Q 041249          357 GSLEEWLYPVNREDEVDKAPRNL--NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLAR  433 (789)
Q Consensus       357 g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~  433 (789)
                      |+|..++...         +.++  ++.++-.+.+||++||.|||...   |||||||-.|||++. .|.+||+|||-++
T Consensus       657 GSLSsLLrsk---------WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsK  724 (1226)
T KOG4279|consen  657 GSLSSLLRSK---------WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSK  724 (1226)
T ss_pred             CcHHHHHHhc---------cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccch
Confidence            9999999754         4555  78889999999999999999888   999999999999975 5788999999998


Q ss_pred             cCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       434 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .+.--.+  .+....||..|||||++..|+  |+..+|||||||++.||.||++||..
T Consensus       725 RLAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E  780 (1226)
T KOG4279|consen  725 RLAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE  780 (1226)
T ss_pred             hhccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence            7653332  234467999999999998876  89999999999999999999999973

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.9e-31  Score=283.58  Aligned_cols=268  Identities=20%  Similarity=0.323  Sum_probs=203.6

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      +..+.++|+..+.||+|+||.||++.+...     ...||+|.+.... ......+.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            344567888899999999999999998643     3789999987542 23446688999999999 8999999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      ...     ..+++|||+.+|+|.+++.......+      .......+++..++.++.|++.||+|||+.+   ++||||
T Consensus        87 ~~~-----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dl  158 (293)
T cd05053          87 QEG-----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDL  158 (293)
T ss_pred             CCC-----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence            655     78999999999999999865311100      0123457899999999999999999999887   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM  490 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~  490 (789)
                      ||+||++++++.+|++|||.++...............++..|+|||...+..++.++|||||||++||+++ |..||...
T Consensus       159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999999999997765432222222335678999999988899999999999999999997 99998632


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           ...+..+.....         ..                  ......+...+.+++..|++.++-.||+......
T Consensus       239 -----~~~~~~~~~~~~---------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~  286 (293)
T cd05053         239 -----PVEELFKLLKEG---------YR------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE  286 (293)
T ss_pred             -----CHHHHHHHHHcC---------Cc------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                 111111111000         00                  0001123446778999999999999999987754


Q ss_pred             cc
Q 041249          571 IL  572 (789)
Q Consensus       571 ~l  572 (789)
                      .+
T Consensus       287 ~l  288 (293)
T cd05053         287 DL  288 (293)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.7e-31  Score=292.68  Aligned_cols=195  Identities=24%  Similarity=0.326  Sum_probs=168.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ..+|...+.||+|+||.||++....+++.||+|...      ...+.+|++++++++||||+++++++....     ..+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeE
Confidence            367999999999999999999999999999999743      235678999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+|++. ++|.+++...          ..+++.+++.++.|++.||+|||+.+   ||||||||+||+++.++.+||+|
T Consensus       160 lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAK----------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             EEEecCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEe
Confidence            9999986 6888887533          45789999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.|+..
T Consensus       226 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        226 FGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             CCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            999976433221 112235699999999999988999999999999999999999988753

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.8e-31  Score=282.38  Aligned_cols=266  Identities=22%  Similarity=0.311  Sum_probs=196.8

Q ss_pred             CCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      |...+.||+|+||+||.+.+    ..+++.||+|+++.... .....+.+|++++++++||||+++++++....   ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---GKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---Cce
Confidence            37788999999999988764    34578899999875532 34567889999999999999999999876532   235


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++..           ..+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l  148 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKI  148 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEE
Confidence            7999999999999999853           24899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccc-eeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTS-SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+++.......... .....++..|+|||......++.++||||||+++|||++|+.|+............+.....
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05080         149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM  228 (283)
T ss_pred             eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc
Confidence            99999987754332111 11223556799999998888999999999999999999999998643211111111100000


Q ss_pred             CC-chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PD-HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .. ...+..+.....                  .....+..++.+++..|++.++-+||+...+...+
T Consensus       229 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l  278 (283)
T cd05080         229 TVVRLIELLERGMRL------------------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL  278 (283)
T ss_pred             chhhhhhhhhcCCCC------------------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            00 011111111100                  00123456778899999999999999998775433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.1e-31  Score=288.80  Aligned_cols=194  Identities=27%  Similarity=0.326  Sum_probs=167.4

Q ss_pred             CcccccCCccEEEEEE---cCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      +.||+|+||.||++..   ..+++.||+|+++....  .....+..|++++++++||||+++++++....     ..++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEE
Confidence            5799999999999876   34689999999965422  23455778999999999999999999987655     88999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      |||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        77 ~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          77 LDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             EcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeecc
Confidence            9999999999988543          46899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +++.......  ......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       144 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         144 LSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             CCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence            9886544321  22345689999999999888899999999999999999999999973

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=2.4e-31  Score=280.95  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=199.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ..+|...+.||+|+||.||++...     .++..+|+|.+..........+..|++.+++++|+||+++++++....   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR---   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC---
Confidence            356778899999999999999753     346789999987666666778999999999999999999999987655   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCC-----ccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNRE-----DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                        ..++|+||+.+|+|.+++......     .........+++.+++.++.|++.|++|||+.+   ++||||||+||++
T Consensus        81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~  155 (280)
T cd05092          81 --PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLV  155 (280)
T ss_pred             --ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEE
Confidence              789999999999999998654211     001112246899999999999999999999888   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      ++++.+||+|||++................++..|+|||+.....++.++|||||||++|||++ |+.||.....  ...
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~  233 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEA  233 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHH
Confidence            9999999999999986654332211222335678999999998899999999999999999998 8999863211  111


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ........+.                              .....+...+.+++..|++.+|.+||+...+..
T Consensus       234 ~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         234 IECITQGREL------------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHcCccC------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1111100000                              000123345668889999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=2.7e-31  Score=281.73  Aligned_cols=264  Identities=20%  Similarity=0.308  Sum_probs=199.0

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .++++|.+.+.||+|+||.||+|..+.     .+..||+|.++... ......+.+|+..+++++||||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            467889999999999999999997652     35689999986443 233456788999999999999999999987655


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+.+|+|.+++................++..+..++.|++.||.|||+.+   ++||||||+||++++
T Consensus        83 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~  154 (288)
T cd05061          83 -----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH  154 (288)
T ss_pred             -----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence                 689999999999999999653211111122345677889999999999999999887   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~  499 (789)
                      ++.+|++|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |+.||....     ..+
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~  229 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQ  229 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHH
Confidence            99999999999987654432222222335678999999998899999999999999999999 788886321     111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      +...........                           ....+...+.+++..|.+.++..||+......
T Consensus       230 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  273 (288)
T cd05061         230 VLKFVMDGGYLD---------------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN  273 (288)
T ss_pred             HHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            211111100000                           00122346778899999999999999887643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=2.4e-31  Score=278.74  Aligned_cols=199  Identities=24%  Similarity=0.324  Sum_probs=173.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||.||+|....+++.||+|++..........+.+|+.++++++||||+++++++....     ..++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEEE
Confidence            57999999999999999999998889999999997665555667889999999999999999999987655     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+|||++|+||+++.++.+|++||
T Consensus        84 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          84 CMEYCGGGSLQDIYHVT----------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             EEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcC
Confidence            99999999999988533          45789999999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |.+........  ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||.
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         151 GVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             ccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence            99987643321  112345888999999874   3457889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=2.3e-31  Score=288.03  Aligned_cols=201  Identities=23%  Similarity=0.286  Sum_probs=172.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||++....+++.||+|++...   .......+.+|+.++..++|++|+++++.+....     .
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----N   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----E
Confidence            4788899999999999999999988999999998532   2223455888999999999999999999987665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL  143 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL  143 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEE
Confidence            99999999999999999642         245888899999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +|||++......... ......||..|+|||++.     ...++.++|||||||++|||++|+.||.
T Consensus       144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         144 ADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             eecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence            999998765433211 122346899999999886     3468999999999999999999999997

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=2.3e-31  Score=281.70  Aligned_cols=200  Identities=25%  Similarity=0.390  Sum_probs=172.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|...+.||+|+||+||++.+..+++.||+|.+....   ......+.+|++++++++|++++++++.+...+     ..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----AL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EE
Confidence            3677889999999999999999999999999986442   222356778999999999999999999987655     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+|+|.+++...        ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++++
T Consensus        76 ~lv~e~~~g~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~  144 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHM--------GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRIS  144 (285)
T ss_pred             EEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence            9999999999999988543        2345889999999999999999999887   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++........   .....|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         145 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             eccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            9999876543321   1234689999999999988999999999999999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=2.3e-31  Score=277.14  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=193.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|++|.||.|.+. ++..||+|.++... .....+.+|++++.+++||||+++++++....     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEE
Confidence            46778889999999999999886 45679999986433 23467899999999999999999999987655     6799


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+|+|.+++...         ...+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+|++||
T Consensus        77 v~e~~~~~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          77 VTEYMSNGCLLNYLREH---------GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCC
Confidence            99999999999998643         236899999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.++........ ......++..|+|||......++.++|||||||++|||++ |+.||.....  ......+...... 
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~-  220 (256)
T cd05113         145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVSQGLRL-  220 (256)
T ss_pred             ccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHhcCCCC-
Confidence            999876543311 1122345678999999988889999999999999999998 9999863211  1111111100000 


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                            +.                       .......+.+++..|++.++.+||+.....
T Consensus       221 ------~~-----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll  252 (256)
T cd05113         221 ------YR-----------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLL  252 (256)
T ss_pred             ------CC-----------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence                  00                       001234566888899999999999987653

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=4.9e-31  Score=279.65  Aligned_cols=204  Identities=28%  Similarity=0.406  Sum_probs=169.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCCc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .|...+.||+|+||+||+|....+++.||+|.++....  .....+.+|+++++++   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            37778899999999999999999999999999875422  2234566777777665   699999999998765444445


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+. +++.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV--------PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            6899999998 4888887543        2345899999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.++.......   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~  209 (288)
T cd07863         149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  209 (288)
T ss_pred             ECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence            999999987653321   1234578899999999988999999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-32  Score=277.16  Aligned_cols=202  Identities=25%  Similarity=0.353  Sum_probs=181.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      -+.|+.-++||+||||+||-++.+.+|+.+|.|.+...   ..........|-+++.+++.+.||.+-..+...+     
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-----  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-----  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence            36788899999999999999999999999999998543   4445567888999999999999999977776665     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..|+|+..|.+|+|.-+++..        ....+++.....++++|+.||++||...   ||+||+||+|||+|+.|+++
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~--------g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNH--------GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             ceEEEEEeecCCceeEEeecc--------CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeE
Confidence            899999999999999999765        4467999999999999999999999887   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|+|+|..++.....   .+..||.+|||||++.++.|+..+|.||+||++|||+.|+.||-.
T Consensus       328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            9999999999877643   345799999999999999999999999999999999999999963

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=2.3e-31  Score=281.69  Aligned_cols=273  Identities=25%  Similarity=0.322  Sum_probs=200.3

Q ss_pred             cCCCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .+|...+.||+|+||.||++.+    ..+++.||+|.+........+.+.+|++++++++||||+++++++...+   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence            4678889999999999999985    3468899999987666666678999999999999999999999875432   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+++|+|.+++...         ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~  148 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---------RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK  148 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEE
Confidence            579999999999999998643         235899999999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccce-eeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSS-IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|||+++..+........ ....++..|+|||...+..++.++|||||||++|||++|..|+.....      .+.+..
T Consensus       149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~  222 (284)
T cd05081         149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMM  222 (284)
T ss_pred             ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhc
Confidence            9999999987654322111 112244569999999888899999999999999999999877642211      111100


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ............+.    +  ..    ....+......+...+.+++..|++.++-.||+...+...++
T Consensus       223 ~~~~~~~~~~~~~~----~--~~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         223 GNDKQGQMIVYHLI----E--LL----KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             ccccccccchHHHH----H--HH----hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            00000000000000    0  00    000001111234556788999999999999999988755433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=2e-31  Score=281.55  Aligned_cols=266  Identities=21%  Similarity=0.352  Sum_probs=204.4

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcC----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDE----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ...++|...+.||+|+||.||+|.+..    +++.|++|++.... ......+..|+..+++++|+||+++++++.... 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG-   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence            346788899999999999999999975    36889999986543 334567889999999999999999999876532 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                         ...++++||+..|+|.+++.......  ...+..+++.++..++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        82 ---~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~  153 (280)
T cd05043          82 ---EPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEE  153 (280)
T ss_pred             ---CCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCC
Confidence               26789999999999999986541111  112357899999999999999999999887   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      +.+|++|||+++.+.+...........++..|+|||++....++.++||||||+++||+++ |+.||...  ....+..+
T Consensus       154 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~  231 (280)
T cd05043         154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAY  231 (280)
T ss_pred             CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHH
Confidence            9999999999987654432222223346778999999988889999999999999999999 99999632  11122222


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .......                              .....+..++.+++..|++.++-.||+...+...+.
T Consensus       232 ~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         232 LKDGYRL------------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             HHcCCCC------------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            2211110                              001123345678899999999999999988754433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=4.8e-31  Score=274.90  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=190.8

Q ss_pred             cccccCCccEEEEEEc--CCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          277 LIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      .||+|+||.||+|.++  .+++.||+|+++....  ...+.+..|+.+++++.|+||+++++++...      ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CcEEEEe
Confidence            5899999999999763  4578999999864432  3356789999999999999999999987532      4689999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+++|+|.+++...          ..+++..+..++.|++.||+|||..+   ++||||||+||++++++.+||+|||.+
T Consensus        76 ~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~  142 (257)
T cd05116          76 LAELGPLNKFLQKN----------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLS  142 (257)
T ss_pred             cCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccc
Confidence            99999999998543          45789999999999999999999888   999999999999999999999999999


Q ss_pred             ccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchh
Q 041249          433 RFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVM  510 (789)
Q Consensus       433 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  510 (789)
                      +......... ......++..|+|||.+....++.++|||||||++|||++ |+.||.....  ......++....   .
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~---~  217 (257)
T cd05116         143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGER---M  217 (257)
T ss_pred             cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC---C
Confidence            8775443211 1112234578999999988889999999999999999998 9999974211  112222211100   0


Q ss_pred             hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      +     .                      ...+...+.+++..|++.++-+||++..+...+.
T Consensus       218 ~-----~----------------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         218 E-----C----------------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             C-----C----------------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence            0     0                      0123345668899999999999999988755444

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=2.1e-31  Score=293.59  Aligned_cols=269  Identities=19%  Similarity=0.275  Sum_probs=201.6

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCC-CCccceeeeee
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIR-HRNLVKVFTAC  336 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~  336 (789)
                      +.....++|...+.||+|+||.||+|.+..     .++.||+|+++.... ...+.+..|++++.++. ||||++++++|
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            355566788899999999999999999752     356899999975432 23457889999999997 99999999999


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCc----------------------------------------------
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED----------------------------------------------  370 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------------------------------------  370 (789)
                      ....     ..++|+||+.+|+|.++++..+...                                              
T Consensus       111 ~~~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (401)
T cd05107         111 TKGG-----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE  185 (401)
T ss_pred             ccCC-----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence            7755     7899999999999999997542100                                              


Q ss_pred             ------------------------------------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCcee
Q 041249          371 ------------------------------------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH  408 (789)
Q Consensus       371 ------------------------------------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH  408 (789)
                                                                ........+++.....++.|++.||+|||+.+   ++|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH  262 (401)
T cd05107         186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVH  262 (401)
T ss_pred             ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCc
Confidence                                                      00012245788889999999999999999887   999


Q ss_pred             cCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCC
Q 041249          409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPS  487 (789)
Q Consensus       409 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~  487 (789)
                      |||||+||++++++.+|++|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||
T Consensus       263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987643332111223346788999999998889999999999999999998 89998


Q ss_pred             CccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccc
Q 041249          488 DIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKL  567 (789)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~  567 (789)
                      ....... .....+.....        +.                      ....+...+.+++..|++.++-.||+...
T Consensus       343 ~~~~~~~-~~~~~~~~~~~--------~~----------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~e  391 (401)
T cd05107         343 PELPMNE-QFYNAIKRGYR--------MA----------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQ  391 (401)
T ss_pred             CCCCchH-HHHHHHHcCCC--------CC----------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            6321110 00111110000        00                      00123345678888999999999999987


Q ss_pred             cccc
Q 041249          568 AGSI  571 (789)
Q Consensus       568 ~~~~  571 (789)
                      ....
T Consensus       392 ll~~  395 (401)
T cd05107         392 LVHL  395 (401)
T ss_pred             HHHH
Confidence            7443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=3.8e-31  Score=285.55  Aligned_cols=193  Identities=27%  Similarity=0.336  Sum_probs=164.2

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|....+++.||+|++....   ......+..|.. +++.++||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEE
Confidence            46999999999999999899999999986442   223344555554 567789999999999887655     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|..++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~  142 (325)
T cd05604          76 DFVNGGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGL  142 (325)
T ss_pred             cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCC
Confidence            999999999888543          46889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++.......  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~  197 (325)
T cd05604         143 CKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             cccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence            875432221  1234568999999999999999999999999999999999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=5.9e-31  Score=275.63  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|++|.||+|....+++.||+|.++..   .......+.+|++++++++|+|++++++++....     .
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----E   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----e
Confidence            6788999999999999999999989999999998643   2233567899999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...      ......+++.++..++.+++.||+|||+.+   ++||||+|+||+++.++.+++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHF------KKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHh------cccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEE
Confidence            89999999999999988543      122356889999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.+.........  .....++..|+|||...+..++.++|||||||++|+|++|+.||...   .....++......
T Consensus       148 ~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~  222 (267)
T cd08224         148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSLCKKIEK  222 (267)
T ss_pred             eccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHHHhhhhc
Confidence            999998876543321  22345888999999998888999999999999999999999998632   1222222211110


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...    .+ .                     ........+.+++..|++.++..||+...+...
T Consensus       223 ~~~----~~-~---------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~  261 (267)
T cd08224         223 CDY----PP-L---------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQV  261 (267)
T ss_pred             CCC----CC-C---------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            000    00 0                     001233456688889999999999999876443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=3.1e-31  Score=278.05  Aligned_cols=255  Identities=22%  Similarity=0.368  Sum_probs=198.1

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCce---EEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .+++|+..+.||+|+||.||+|....+++   .+|+|.++... ......+..|++++++++|+|++++.+++...+   
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   79 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK---   79 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC---
Confidence            35678889999999999999999875544   79999986542 334567899999999999999999999987665   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+++|.+++...         ...+++.++..++.|++.|++|||+.+   ++|+||||+||+++.++.
T Consensus        80 --~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~  145 (268)
T cd05063          80 --PAMIITEYMENGALDKYLRDH---------DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLE  145 (268)
T ss_pred             --CcEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCc
Confidence              789999999999999998543         245899999999999999999999888   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccce-eeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSS-IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~  501 (789)
                      +|++|||.+............ .....+..|+|||+.....++.++|||||||++||+++ |+.||.....     ..+.
T Consensus       146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~  220 (268)
T cd05063         146 CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVM  220 (268)
T ss_pred             EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHH
Confidence            999999999876543322111 11223457999999988889999999999999999998 9999863211     1111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      +.....         ..                  ......+...+.+++..|++.++.+||++..+...
T Consensus       221 ~~i~~~---------~~------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~  263 (268)
T cd05063         221 KAINDG---------FR------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL  263 (268)
T ss_pred             HHHhcC---------CC------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            111000         00                  00011234556788999999999999999877443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=7.9e-31  Score=274.75  Aligned_cols=204  Identities=23%  Similarity=0.367  Sum_probs=173.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .+|...+.||+|+||.||+|....+++.||+|.+....     ......+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence            47899999999999999999998889999999986432     223456889999999999999999999876432   2


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++++||+++++|.+++...          ..+++.....++.|++.||+|||+.+   ++||||+|+||+++.++.+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~  145 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY----------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNV  145 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence            3678999999999999998543          35788999999999999999999887   9999999999999999999


Q ss_pred             eeCcccccccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++....... ........++..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence            9999999986643221 1112234588899999999888899999999999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=5.6e-31  Score=274.85  Aligned_cols=250  Identities=27%  Similarity=0.443  Sum_probs=195.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|++|.||+|... ++..||+|.++.... ..+.+.+|++++++++|+|++++++++.. .     ..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~-----~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-E-----PIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-C-----CcE
Confidence            457888999999999999999887 667799999875433 34578999999999999999999988743 2     578


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      ++|||+.+++|.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+|++|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~d  145 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIAD  145 (260)
T ss_pred             EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCC
Confidence            999999999999998643        2346899999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.+......... ......++..|+|||.....+++.++||||||+++|||++ |+.||....  ............+.
T Consensus       146 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~  222 (260)
T cd05070         146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVERGYRM  222 (260)
T ss_pred             ceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCC
Confidence            9999876543311 1112335678999999988899999999999999999999 899986321  11111111110000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                              .                      ....+...+.+++.+|++.++..||+......
T Consensus       223 --------~----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 --------P----------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             --------C----------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                    0                      00123345778899999999999999876543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=6.2e-31  Score=274.04  Aligned_cols=245  Identities=22%  Similarity=0.332  Sum_probs=189.0

Q ss_pred             cccccCCccEEEEEEc--CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeec
Q 041249          277 LIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEF  353 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  353 (789)
                      .||+|+||.||+|.+.  .++..||+|++..... ...+.+.+|++++++++|+||+++++.+.. .     ..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~-----~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-E-----ALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-C-----CeEEEEEe
Confidence            3899999999999875  4456799999875533 335679999999999999999999998753 2     57999999


Q ss_pred             cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccc
Q 041249          354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR  433 (789)
Q Consensus       354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  433 (789)
                      +++|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|++|||.+.
T Consensus        76 ~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          76 ASGGPLNKFLSGK---------KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccc
Confidence            9999999998643         246899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249          434 FLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMD  511 (789)
Q Consensus       434 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  511 (789)
                      ......... ......++..|+|||......++.++|||||||++||+++ |+.||.....  ......+....+.    
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~----  217 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGKRL----  217 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCCC----
Confidence            665443211 1112223568999999988889999999999999999996 9999863211  1111111111000    


Q ss_pred             hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                                                .....+..++.+++..|+..++-+||+...+...
T Consensus       218 --------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         218 --------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      0011334566688999999999999998877443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=4.7e-31  Score=290.34  Aligned_cols=204  Identities=24%  Similarity=0.305  Sum_probs=171.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|+||.||++....+++.||||.+...  .....+.+.+|+++++.++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            578899999999999999999889999999998643  223446788999999999999999999998765433333689


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+. ++|.+.+...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D  146 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----------QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD  146 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence            9999997 5787777433          56899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  207 (372)
T cd07853         147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA  207 (372)
T ss_pred             ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence            9999876543321 12234578899999998774 479999999999999999999999974

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=5.6e-31  Score=281.57  Aligned_cols=268  Identities=20%  Similarity=0.328  Sum_probs=203.5

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEc-------CCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLD-------EGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      ...++|...+.||+|+||.||+|++.       ..+..||+|.+.... ....+.+..|+..++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34578889999999999999999852       234579999986442 34456789999999999 8999999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      ...     ..++||||+.+|+|.+++........      .......+++.++..++.|++.||+|||+.+   ++||||
T Consensus        92 ~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dl  163 (304)
T cd05101          92 QDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDL  163 (304)
T ss_pred             cCC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence            655     78999999999999999975421110      0112346889999999999999999999988   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM  490 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~  490 (789)
                      ||+||++++++.+||+|||.++...............++..|+|||...+..++.++||||||+++|||++ |..||...
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987765443222233345678999999988889999999999999999998 78887522


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           ....+.+........                           .....+...+.+++..|++..+..||++..+..
T Consensus       244 -----~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         244 -----PVEELFKLLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             -----CHHHHHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                 222222211110000                           001134456678888999999999999988755


Q ss_pred             cccc
Q 041249          571 ILPH  574 (789)
Q Consensus       571 ~l~~  574 (789)
                      .+..
T Consensus       292 ~l~~  295 (304)
T cd05101         292 DLDR  295 (304)
T ss_pred             HHHH
Confidence            4443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.2e-31  Score=273.99  Aligned_cols=246  Identities=25%  Similarity=0.335  Sum_probs=192.7

Q ss_pred             CcccccCCccEEEEEEcCCc---eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|.+...+   ..||+|.+..... ...+.+..|+++++++.|+||+++++++.. +     ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-----~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-E-----PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-C-----ceEEEE
Confidence            47999999999999886544   7899999875543 345678999999999999999999998753 2     579999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||.
T Consensus        75 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          75 ELAPLGPLLKYLKKR----------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             EeCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccc
Confidence            999999999999654          36889999999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCch
Q 041249          432 ARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       432 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      ++......... ......++..|+|||......++.++||||||+++|||++ |+.||....  ...+..++....+.. 
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~-  218 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGERLP-  218 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCCcCC-
Confidence            98775443221 1112224568999999998899999999999999999998 999986321  112222222111100 


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                                                   ....+...+.+++..|++.++..||+.......+
T Consensus       219 -----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l  252 (257)
T cd05060         219 -----------------------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF  252 (257)
T ss_pred             -----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence                                         0012334567889999999999999988775443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=8.1e-31  Score=279.20  Aligned_cols=268  Identities=18%  Similarity=0.284  Sum_probs=198.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC----------------CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCcccee
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE----------------GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKV  332 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  332 (789)
                      ++|+..+.||+|+||.||++.+..                ++..||+|+++... ......+.+|++.+++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568889999999999999986542                34579999987553 3345678999999999999999999


Q ss_pred             eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCcc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE-VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      ++++...+     ..++||||+.+|+|.+++........ .......+++.++..++.|++.||+|||+.+   ++|+||
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl  156 (296)
T cd05095          85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL  156 (296)
T ss_pred             EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence            99987665     68999999999999999875422111 1223346888999999999999999999988   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCCc
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDI  489 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~~  489 (789)
                      ||+||+++.++.+|++|||.++.+.............++..|+|||....+.++.++|||||||++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999987654432222222334678999999888899999999999999999998  6788763


Q ss_pred             cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ....  .........+.........+                       ....|...+.+++..|++.++..||+...+.
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~  291 (296)
T cd05095         237 LSDE--QVIENTGEFFRDQGRQVYLP-----------------------KPALCPDSLYKLMLSCWRRNAKERPSFQEIH  291 (296)
T ss_pred             cChH--HHHHHHHHHHhhccccccCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            2111  11110000000000000000                       0112345677899999999999999988764


Q ss_pred             c
Q 041249          570 S  570 (789)
Q Consensus       570 ~  570 (789)
                      .
T Consensus       292 ~  292 (296)
T cd05095         292 A  292 (296)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=3.3e-31  Score=277.69  Aligned_cols=258  Identities=20%  Similarity=0.272  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||.|++|.||+|....+++.||||.+...   .......+.+|+++++.++|+||+++++++...+     .
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence            4678889999999999999999888999999987543   2233467889999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .+++|||+++++|.+++...      ......+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHF------KKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHh------hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEE
Confidence            89999999999999988632      112356899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.+.........  .....++..|+|||...+..++.++||||||+++|||++|..||.....   ....+.+..  
T Consensus       148 ~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~--  220 (267)
T cd08229         148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKI--  220 (267)
T ss_pred             CcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhh--
Confidence            999998876543321  1234588899999999888899999999999999999999999863211   111111111  


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                         .....+...                     ...+...+.+++..|++.++..||++..+....
T Consensus       221 ---~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~  262 (267)
T cd08229         221 ---EQCDYPPLP---------------------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVA  262 (267)
T ss_pred             ---hcCCCCCCC---------------------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence               000001010                     012334566788899999999999998764433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=6.2e-31  Score=278.96  Aligned_cols=262  Identities=24%  Similarity=0.337  Sum_probs=199.9

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ..++|...+.||+|+||.||+|....     +++.||+|.+..... .....+..|+++++++.||||+++++++...+ 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-
Confidence            45789999999999999999998742     578899999875432 33567899999999999999999999987765 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCcc------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceec
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDE------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC  409 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~  409 (789)
                          ..++|+||+.+|+|.+++........            .......+++.+++.++.|++.||+|||..+   ++||
T Consensus        82 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~  154 (288)
T cd05050          82 ----PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHR  154 (288)
T ss_pred             ----ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence                78999999999999999964321100            1122346889999999999999999999887   9999


Q ss_pred             CCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249          410 DLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSD  488 (789)
Q Consensus       410 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~  488 (789)
                      ||||+||++++++.+|++|||.+.................+..|+|||......++.++|||||||++|||++ |..||.
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999886543322111222234567999999988899999999999999999998 888885


Q ss_pred             ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      ..     ...++.+.........     .                      ...+..++.+++.+|++.++..||+..++
T Consensus       235 ~~-----~~~~~~~~~~~~~~~~-----~----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         235 GM-----AHEEVIYYVRDGNVLS-----C----------------------PDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             CC-----CHHHHHHHHhcCCCCC-----C----------------------CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            22     1122222111110000     0                      01234567788999999999999998876


Q ss_pred             c
Q 041249          569 G  569 (789)
Q Consensus       569 ~  569 (789)
                      .
T Consensus       283 ~  283 (288)
T cd05050         283 N  283 (288)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=3.8e-31  Score=277.21  Aligned_cols=199  Identities=25%  Similarity=0.331  Sum_probs=173.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||.||+|....+++.||+|.++.........+.+|+.+++.++||||+++++++...+     ..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEEE
Confidence            57778889999999999999998889999999997665555567889999999999999999999987665     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+++++|.+++...          ..+++.++..++.|++.|+.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          84 CMEFCGGGSLQDIYHVT----------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             EEeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcc
Confidence            99999999999998543          46889999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |.+........  ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||.
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         151 GVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             eeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence            99876543221  122346889999999874   4568999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.3e-31  Score=275.08  Aligned_cols=248  Identities=26%  Similarity=0.356  Sum_probs=193.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .+|+..+.||+|+||.||+|.++ ++..+|+|.+.... .....+.+|++++++++||||+++++++....     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEE
Confidence            46888999999999999999987 56789999985432 23456888999999999999999999987655     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+++++|.+++...         ...+++.++..++.|++.|++|||+.+   ++||||||+||++++++.+|++||
T Consensus        77 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          77 VTEYMANGCLLNYLRER---------KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             EEecCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCc
Confidence            99999999999998643         236899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.++........ ......++..|+|||......++.++||||||+++||+++ |+.||+.....  .....+....+  
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--  219 (256)
T cd05059         145 GLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYR--  219 (256)
T ss_pred             ccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCc--
Confidence            999876533211 1112234467999999998899999999999999999999 89998632111  11111110000  


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                            .                      .....+..++.+++..|++.++..||+...+.
T Consensus       220 ------~----------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l  252 (256)
T cd05059         220 ------L----------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL  252 (256)
T ss_pred             ------C----------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence                  0                      00112345677899999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=9.7e-31  Score=278.57  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=200.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc----------------eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR----------------TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVK  331 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  331 (789)
                      ..+|...+.||+|+||.||+|.....+                ..||+|.+.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467889999999999999999876433                568999987553 334567899999999999999999


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccc-cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV-DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD  410 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~d  410 (789)
                      +++++....     ..++|+||+.+++|.+++......... ......+++..+..++.|++.||+|||+.+   ++|+|
T Consensus        84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~d  155 (296)
T cd05051          84 LLGVCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRD  155 (296)
T ss_pred             EEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence            999987654     789999999999999998654211000 112346899999999999999999999888   99999


Q ss_pred             CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCC
Q 041249          411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSD  488 (789)
Q Consensus       411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~  488 (789)
                      |||+||+++.++.++++|||.++...............++..|+|||+.....++.++|||||||++|||++  |..||.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999987654433222333456778999999988899999999999999999998  677775


Q ss_pred             ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      ...  ...........+.........+                       ....+..++.+++..|++.++..||+...+
T Consensus       236 ~~~--~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         236 HLT--DQQVIENAGHFFRDDGRQIYLP-----------------------RPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             CcC--hHHHHHHHHhccccccccccCC-----------------------CccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence            321  1111111111111000000000                       011233467789999999999999998876


Q ss_pred             c
Q 041249          569 G  569 (789)
Q Consensus       569 ~  569 (789)
                      .
T Consensus       291 ~  291 (296)
T cd05051         291 H  291 (296)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.4e-30  Score=278.91  Aligned_cols=198  Identities=25%  Similarity=0.343  Sum_probs=173.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||.||++.+..++..+|+|.+..... .....+.+|++++.+++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEE
Confidence            478899999999999999999998899999999865432 33456889999999999999999999998766     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|+||+++++|.+++...          ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.+|++
T Consensus        76 lv~ey~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~  142 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLC  142 (308)
T ss_pred             EEeeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEc
Confidence            999999999999998643          457889999999999999999997 45   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++.......    .....|+..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus       143 dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         143 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             cCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            999987654332    1234588899999999888899999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=4e-31  Score=281.66  Aligned_cols=251  Identities=21%  Similarity=0.248  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .+|...+.||+|++|.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++....     ..++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEEE
Confidence            57888999999999999999998889999999997766666677899999999999999999999987655     8899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+++++|.+++..           ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+|++||
T Consensus        94 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             eecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcC
Confidence            9999999999998853           24788899999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |.+.........  .....++..|+|||...+..++.++|||||||++|++++|+.||........... .    .... 
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~----~~~~-  231 (297)
T cd06656         160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I----ATNG-  231 (297)
T ss_pred             ccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-e----ccCC-
Confidence            999876544321  1234578899999999988899999999999999999999999963211100000 0    0000 


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          .+.+.                    ........+.+++.+|++.++..|++...+...
T Consensus       232 ----~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         232 ----TPELQ--------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ----CCCCC--------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00000                    000112334577789999999999998877554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.8e-31  Score=269.18  Aligned_cols=204  Identities=24%  Similarity=0.324  Sum_probs=177.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +.|...+.||.|.-|+||.+..+.++..+|+|++....   .....+...|-++|+.+.||.+..+|+.+....     .
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-----~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-----Y  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-----e
Confidence            45666789999999999999999889999999996553   333456788999999999999999999998877     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+|||||++|+|..+.+..        .++.+++..+..++++|+.||+|||..|   ||+|||||+|||+-++|++-|
T Consensus       152 ~cl~meyCpGGdL~~LrqkQ--------p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIML  220 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQ--------PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIML  220 (459)
T ss_pred             eEEEEecCCCccHHHHHhhC--------CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEe
Confidence            99999999999999998766        6788999999999999999999999999   999999999999999999999


Q ss_pred             CcccccccCCCCC---------------------------------C---------------------ccceeeeccccc
Q 041249          427 GDFGLARFLPPTH---------------------------------V---------------------QTSSIGVKGSIG  452 (789)
Q Consensus       427 ~Dfgla~~~~~~~---------------------------------~---------------------~~~~~~~~gt~~  452 (789)
                      +||.++...+..-                                 .                     ........||-.
T Consensus       221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE  300 (459)
T KOG0610|consen  221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE  300 (459)
T ss_pred             eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence            9999876432100                                 0                     011223458999


Q ss_pred             ccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       453 y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.|||++.+..-+..+|.|+|||++|||+.|..||..
T Consensus       301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG  337 (459)
T KOG0610|consen  301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG  337 (459)
T ss_pred             cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence            9999999999999999999999999999999999974

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=2e-30  Score=273.72  Aligned_cols=195  Identities=26%  Similarity=0.365  Sum_probs=170.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||.||+|.+..+++.||+|.+... .......+..|++++++++||||+++++++....     ..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEE
Confidence            3677889999999999999999889999999998654 2334567889999999999999999999988765     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++|++..+.              .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~d  138 (279)
T cd06619          76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCD  138 (279)
T ss_pred             EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEee
Confidence            999999999886542              3577888999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ||++.......    .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       139 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         139 FGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             CCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence            99998664432    22346889999999999888999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=6.9e-31  Score=279.01  Aligned_cols=269  Identities=24%  Similarity=0.231  Sum_probs=206.3

Q ss_pred             ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeecc
Q 041249          260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSG  338 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  338 (789)
                      +++.++..++++|...+.||+|+||.||++....+++.+|+|++.... .....+.+|++++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            556778888999999999999999999999998899999999986432 2345678899999999 89999999999876


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      .+.......++|+||+.+|+|.+++...      ......+++..+..++.|++.||+|||..+   ++||||||+||++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili  161 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGL------LICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILL  161 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHh------hhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence            5433334689999999999999988542      112356899999999999999999999887   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-----CcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----EVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      +.++.+||+|||.+.........  .....|+..|+|||.+...     .++.++|||||||++|||++|+.||......
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             cCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            99999999999998876543211  1234578899999987643     3689999999999999999999998632110


Q ss_pred             CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                       ..+..+.+..    ...+.+                         .......+.+++.+|++.++..||+......
T Consensus       240 -~~~~~~~~~~----~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 -KTLFKIPRNP----PPTLLH-------------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHHHHhcCC----CCCCCc-------------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1111111000    000000                         0112235678889999999999999887644

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1e-30  Score=278.38  Aligned_cols=267  Identities=19%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCC--------------ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeee
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEG--------------RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      ++|...+.||+|+||.||++.....              ...||+|.++... ......+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788899999999999999987532              2358999987543 233467899999999999999999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCc--cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED--EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      ++....     ..++||||+.+++|.+++.......  ........+++.+++.++.|++.||+|||+.+   ++|||||
T Consensus        85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk  156 (295)
T cd05097          85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA  156 (295)
T ss_pred             EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence            987655     7899999999999999985431110  00111234788999999999999999999988   9999999


Q ss_pred             CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCCcc
Q 041249          413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDIM  490 (789)
Q Consensus       413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~~~  490 (789)
                      |+||++++++.+|++|||++................++..|+|||....+.++.++|||||||++|||++  |..||...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999999987654432222223345678999999988899999999999999999998  56677632


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ..+  .........+........                       ......+...+.+++..|+..++-+||++..+.
T Consensus       237 ~~~--~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~  290 (295)
T cd05097         237 SDE--QVIENTGEFFRNQGRQIY-----------------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH  290 (295)
T ss_pred             ChH--HHHHHHHHhhhhcccccc-----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            111  111111111100000000                       000011234677899999999999999998763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=8.4e-31  Score=280.90  Aligned_cols=200  Identities=24%  Similarity=0.369  Sum_probs=170.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||+|+...+++.||+|.++.... .....+.+|++++++++||||+++++++...+     ..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEE
Confidence            578889999999999999999998899999999875432 33456788999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+ ++.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDC---------GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             EEEeCCCC-CHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECc
Confidence            99999985 888877533         245788899999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||.++........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       148 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  207 (309)
T cd07872         148 FGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG  207 (309)
T ss_pred             cccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999865433211  123457889999998865 4689999999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.8e-30  Score=272.58  Aligned_cols=201  Identities=25%  Similarity=0.378  Sum_probs=163.4

Q ss_pred             CcccccCCccEEEEEEcC--CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||+|.+..  ++..+|+|.++.... .....+.+|++++++++||||+++++++.+..     ..++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence            368999999999998753  346799998865543 33457889999999999999999999987655     6899999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+++|+|.+++....     .......++..+..++.|++.|++|||+.+   ++|+||||+||+++.++++|++|||.+
T Consensus        76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          76 FCPLGDLKGYLRSCR-----KAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             CCCCCcHHHHHHHhh-----hcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccc
Confidence            999999999986531     012235677788899999999999999888   999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCCC-------CcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-------EVSTNGDVYSYGILMLELII-RKKPSDI  489 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~sfGvvl~ellt-G~~P~~~  489 (789)
                      ................++..|+|||+....       .++.++||||||+++|||++ |+.||..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  212 (269)
T cd05087         148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH  212 (269)
T ss_pred             ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            765443322222334577889999987542       35889999999999999996 9999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=9.8e-31  Score=277.08  Aligned_cols=270  Identities=21%  Similarity=0.246  Sum_probs=205.9

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      .+.++.+.+++++|...+.||+|+||.||++....+++.+|+|.++... .....+..|+.+++++ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            4566778889999999999999999999999999889999999986432 2345688899999999 6999999999986


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ..........++||||+++|+|.+++....      .....+++..+..++.|++.||.|||+.+   ++||||||+||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil  156 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL  156 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence            544334447899999999999999875320      12346788999999999999999999887   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      ++.++.+|++|||.+........  ......|+..|+|||++..     ..++.++|||||||++|||++|+.||.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999999999887654321  1223458899999998753     4478999999999999999999999863211


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                          ...+.+.. ........++.                         .+...+.+++.+|++.++-+||+...+..
T Consensus       235 ----~~~~~~~~-~~~~~~~~~~~-------------------------~~~~~~~~li~~~l~~~p~~Rps~~ell~  282 (286)
T cd06638         235 ----MRALFKIP-RNPPPTLHQPE-------------------------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ  282 (286)
T ss_pred             ----hHHHhhcc-ccCCCcccCCC-------------------------CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                11111100 00000000110                         12234567888999999999999877643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=3.5e-31  Score=296.46  Aligned_cols=205  Identities=25%  Similarity=0.366  Sum_probs=166.2

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---CCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY---QGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~~  344 (789)
                      ...+|...+.||+|+||.||+|....+++.||||.+....    ....+|+.+++.++||||+++++++.....   ...
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999998889999999885332    234579999999999999999887654321   112


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V  423 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~  423 (789)
                      ...++||||+++ ++.+++...      ......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHY------ARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHH------hhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCc
Confidence            246799999985 676666432      123456899999999999999999999988   99999999999999665 7


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +||+|||+|+.......   .....||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       210 vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             eeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999987654332   1234578999999988664 689999999999999999999999964

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=5.6e-31  Score=273.94  Aligned_cols=250  Identities=24%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|++|.||+|.+..+++.|++|.++....  ...+.+|++.+++++|+||+++++++....     ..++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEE
Confidence            678899999999999999999998889999999865533  678999999999999999999999987765     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ++||+.+++|.+++...         ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+||
T Consensus        76 ~~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          76 VMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             EEecCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEccc
Confidence            99999999999998543         356899999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |.+........  ......++..|+|||++.+..++.++|||||||++|||++|+.||.......    .... . ..  
T Consensus       144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~~-~-~~--  213 (256)
T cd06612         144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIFM-I-PN--  213 (256)
T ss_pred             ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhhh-h-cc--
Confidence            99987754431  1223447889999999988889999999999999999999999997421110    0000 0 00  


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                        ...+...                    ........+.++...|++.+|..|++...+..
T Consensus       214 --~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 --KPPPTLS--------------------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             --CCCCCCC--------------------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence              0000000                    00112234567788999999999999876643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.2e-30  Score=277.94  Aligned_cols=260  Identities=21%  Similarity=0.305  Sum_probs=196.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCce--EEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||.||+|....++.  .+++|.++.. .....+.+..|++++.++ +||||+++++++....     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-----   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence            678899999999999999999876654  4788888643 233456789999999999 7999999999987655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      ..++|+||+++|+|.+++........      .......+++.++..++.|++.||+|||+.+   ++||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEEC
Confidence            78999999999999999965421110      0112346899999999999999999999887   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHH
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLH  498 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~  498 (789)
                      +++.+||+|||++........   ......+..|+|||+.....++.++|||||||++|||++ |..||...     ...
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~-----~~~  225 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-----TCA  225 (297)
T ss_pred             CCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHH
Confidence            999999999999875322111   111123457999999988889999999999999999998 99998632     112


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ++......         ....                  .....+...+.+++..|++.++..||+...+...+
T Consensus       226 ~~~~~~~~---------~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  272 (297)
T cd05089         226 ELYEKLPQ---------GYRM------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL  272 (297)
T ss_pred             HHHHHHhc---------CCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            22111110         0000                  00112334566888999999999999998875443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=1.7e-30  Score=270.56  Aligned_cols=252  Identities=21%  Similarity=0.276  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|++|.||++....+++.||+|.+....  ....+.+.+|++++++++|+|++++.+.+...+    ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEE
Confidence            5778899999999999999999889999999986542  334567899999999999999999988764322    2578


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++++|.+++...        ....+++.++..++.+++.|++|||+.+   ++||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             EEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEec
Confidence            999999999999998643        2346899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||++........  ......++..|+|||...+..++.++||||||+++|||++|+.||+..     +............
T Consensus       146 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~~  218 (257)
T cd08223         146 LGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRIIEGK  218 (257)
T ss_pred             ccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcC
Confidence            999987643321  122345788999999999999999999999999999999999998632     1222221111100


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .     +.+                      .......+.+++..|.+.++.+||+......+
T Consensus       219 ~-----~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 L-----PPM----------------------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             C-----CCC----------------------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0     000                      01223456688899999999999998776443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=6.2e-31  Score=285.99  Aligned_cols=266  Identities=22%  Similarity=0.250  Sum_probs=196.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||.||+|.+.     .+++.||||+++.... .....+.+|++++.++ +|+||++++++|.... 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence            367999999999999999999853     3578899999975432 3346788999999999 6899999999886433 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCc---------------------------------------------------
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNRED---------------------------------------------------  370 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  370 (789)
                         ...++||||+.+|+|.+++.......                                                   
T Consensus        85 ---~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          85 ---GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             ---CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence               25789999999999999986431100                                                   


Q ss_pred             ------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccce
Q 041249          371 ------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS  444 (789)
Q Consensus       371 ------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  444 (789)
                            ........+++.++..++.|++.||+|||+.+   |+||||||+||++++++++|++|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                  00001235788999999999999999999888   999999999999999999999999999876443322222


Q ss_pred             eeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhh
Q 041249          445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED  523 (789)
Q Consensus       445 ~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  523 (789)
                      ....++..|+|||.+....++.++||||||+++|||++ |..||...... ......+.........             
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~-------------  304 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAP-------------  304 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCCCCC-------------
Confidence            22345678999999988889999999999999999997 99998632111 0111111100000000             


Q ss_pred             HHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          524 LAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                                       ......+.+++..|++.++..||+...+...+
T Consensus       305 -----------------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l  336 (343)
T cd05103         305 -----------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  336 (343)
T ss_pred             -----------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                             01123466788899999999999998875433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=6.5e-31  Score=275.82  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=195.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCce---EEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .+|...+.||+|+||.||+|.+..+++   .||||.++.. .......+..|++.++.++||||+++++++....     
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-----   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----
Confidence            357778999999999999999976554   6999998654 3334568999999999999999999999987655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+.+|+|.+++...         ...+++.++..++.|++.|++|||+.+   ++|+||||+||+++.++.+|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEE
Confidence            789999999999999998643         245899999999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccc-eeeec--ccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249          426 VGDFGLARFLPPTHVQTS-SIGVK--GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~  501 (789)
                      ++|||.+........... .....  .+..|+|||+.....++.++|||||||++||+++ |..||....  ......++
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i  224 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAI  224 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHH
Confidence            999999887654332111 11111  2457999999999999999999999999999886 999986321  11222222


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ....+.                              .....+...+.+++..|++.++.+||+...+.
T Consensus       225 ~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  262 (269)
T cd05065         225 EQDYRL------------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIV  262 (269)
T ss_pred             HcCCcC------------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            111100                              00113344566888899999999999998664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=5.8e-31  Score=280.17  Aligned_cols=199  Identities=22%  Similarity=0.364  Sum_probs=176.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .+|...+.||.|++|.||+|....+++.|++|.+..........+.+|++.++.++||||+++++++....     ..++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEE
Confidence            46888899999999999999998899999999997666556678899999999999999999999987655     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+.+++|.+++..           ..+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+||
T Consensus        94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccC
Confidence            9999999999998843           24789999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |++.........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~  217 (296)
T cd06655         160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             ccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            998876543321  1234588899999999988899999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=1.3e-30  Score=271.32  Aligned_cols=248  Identities=19%  Similarity=0.214  Sum_probs=197.0

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +|...+.||+|+||.||++.+..+++.+|+|.++.. .....+.+.+|++++++++|+||+++.+.+....     ..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEE
Confidence            467789999999999999999989999999998643 3334567889999999999999999999987665     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+++|++.+++...        ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++++||
T Consensus        76 v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--------RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEccc
Confidence            99999999999988543        2345788999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |.+........  ......|+..|+|||......++.++||||||+++|+|++|+.||...     +.............
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~  217 (255)
T cd08219         145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQGSY  217 (255)
T ss_pred             Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhcCCC
Confidence            99987654332  122345888999999998888999999999999999999999999732     11111111111100


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      .. ..                          ......+.+++.+|++.+|..||+....
T Consensus       218 ~~-~~--------------------------~~~~~~~~~li~~~l~~~P~~Rp~~~~i  249 (255)
T cd08219         218 KP-LP--------------------------SHYSYELRSLIKQMFKRNPRSRPSATTI  249 (255)
T ss_pred             CC-CC--------------------------cccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence            00 00                          0122345577889999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=6.6e-32  Score=260.06  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=200.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcC-CCCccceeeeeeccCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSI-RHRNLVKVFTACSGVD  340 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  340 (789)
                      ..|...+.+|.|..+.|.++..+.++++.|+|++......        -.++..+|+.+++++ .||+|+++.+.+....
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4677889999999999999999999999999998643211        135677899999999 6999999999988766


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           +.++|+|.|+.|-|.+++.+.          -.+++.+...|+.|+..|++|||...   ||||||||+|||+++
T Consensus        97 -----F~FlVFdl~prGELFDyLts~----------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd  158 (411)
T KOG0599|consen   97 -----FVFLVFDLMPRGELFDYLTSK----------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD  158 (411)
T ss_pred             -----hhhhhhhhcccchHHHHhhhh----------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence                 899999999999999999654          56889999999999999999999988   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCC------CCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG------SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD  494 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~  494 (789)
                      +.++||+|||.|..++++.   .....+||++|.|||.+..      ..|+..+|+||.||+||-|+.|.+||....  .
T Consensus       159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Q  233 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--Q  233 (411)
T ss_pred             ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--H
Confidence            9999999999999988776   3445789999999998754      248899999999999999999999996310  0


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      +-+...           ++...+                +++..+..+......+++.+|.++++..|-+.++...++
T Consensus       234 mlMLR~-----------ImeGky----------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  234 MLMLRM-----------IMEGKY----------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             HHHHHH-----------HHhccc----------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            001111           111111                111122223334455777888888888887777665443

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=8.7e-31  Score=274.56  Aligned_cols=253  Identities=24%  Similarity=0.355  Sum_probs=196.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc---eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ..+|...+.||+|+||.||+|.+..++   ..+|+|.++... ....+.+..|+.++++++||||+++++++...+    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK----   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            357888999999999999999986443   479999986543 334567899999999999999999999987654    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+++|+|.+++...         ...+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+
T Consensus        79 -~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  145 (267)
T cd05066          79 -PVMIVTEYMENGSLDAFLRKH---------DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVC  145 (267)
T ss_pred             -ccEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeE
Confidence             789999999999999998643         245899999999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccc-eeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTS-SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      |++|||++........... .....++..|+|||+.....++.++||||||+++||+++ |+.||.....  ......+.
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~  223 (267)
T cd05066         146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIE  223 (267)
T ss_pred             EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHh
Confidence            9999999988765432111 112223568999999998899999999999999999886 9999863211  11112111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .....       +                       ....+...+.+++..|++.++..||++..+..
T Consensus       224 ~~~~~-------~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         224 EGYRL-------P-----------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCcC-------C-----------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            11000       0                       00123345668888999999999999887643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=7e-31  Score=305.87  Aligned_cols=263  Identities=20%  Similarity=0.273  Sum_probs=200.3

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .+.....++|.+.+.||+|+||+||+|.+..+++.||+|.+...  .......+..|+.+++.++||||+++++++....
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            33444567899999999999999999999989999999998644  2334567899999999999999999999875432


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC----CCceecCCCCCce
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ----PITTHCDLKPSNI  416 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~ivH~dlk~~Ni  416 (789)
                         ....++||||+.+|+|.+++....      .....+++..++.|+.||+.||+|||..+.    .+||||||||+||
T Consensus        86 ---~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI  156 (1021)
T PTZ00266         86 ---NQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI  156 (1021)
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence               236899999999999999986431      123468999999999999999999998652    3499999999999


Q ss_pred             ecCC-----------------CCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--CCcCccccchhhHHHH
Q 041249          417 LLDE-----------------EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILM  477 (789)
Q Consensus       417 ll~~-----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl  477 (789)
                      |++.                 ...+||+|||++........   .....||+.|+|||++..  ..+++++|||||||++
T Consensus       157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII  233 (1021)
T ss_pred             EeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence            9964                 34589999999987654321   223468999999998854  4589999999999999


Q ss_pred             HHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhcccccee
Q 041249          478 LELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKV  557 (789)
Q Consensus       478 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l  557 (789)
                      |||++|+.||...    .....++......       +.+.                     .......+.+++..|++.
T Consensus       234 YELLTGk~PF~~~----~~~~qli~~lk~~-------p~lp---------------------i~~~S~eL~dLI~~~L~~  281 (1021)
T PTZ00266        234 YELCSGKTPFHKA----NNFSQLISELKRG-------PDLP---------------------IKGKSKELNILIKNLLNL  281 (1021)
T ss_pred             HHHHHCCCCCCcC----CcHHHHHHHHhcC-------CCCC---------------------cCCCCHHHHHHHHHHhcC
Confidence            9999999999632    1222222211110       0000                     001123456788899999


Q ss_pred             eEeccCcccccc
Q 041249          558 TILDLESLKLAG  569 (789)
Q Consensus       558 ~~l~l~s~~~~~  569 (789)
                      ++..||+.....
T Consensus       282 dPeeRPSa~QlL  293 (1021)
T PTZ00266        282 SAKERPSALQCL  293 (1021)
T ss_pred             ChhHCcCHHHHh
Confidence            999999987764

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=7.5e-31  Score=280.41  Aligned_cols=255  Identities=24%  Similarity=0.357  Sum_probs=197.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||+|+||.||+|.+..++.    .||+|.+..... .....+.+|+.++++++||||++++|+|...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            4678889999999999999999876665    578888865433 2345788999999999999999999998643    


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++++||+++|++.+++...         ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~  147 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHEH---------KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNH  147 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCc
Confidence              357899999999999998643         235788999999999999999999888   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+++...............++..|+|||+..+..++.++|||||||++||+++ |+.||....  .....++++
T Consensus       148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~  225 (303)
T cd05110         148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLE  225 (303)
T ss_pred             eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH
Confidence            99999999987754443222333446778999999988889999999999999999998 999986321  111222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .....                              .....+...+.+++..|+..++-.||+.......+.
T Consensus       226 ~~~~~------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         226 KGERL------------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11000                              000123345668888999999999999988755443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.1e-30  Score=289.20  Aligned_cols=198  Identities=24%  Similarity=0.278  Sum_probs=169.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC--CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ...|...+.||+|+||.||++....  .++.||+|.+...     ....+|++++++++||||+++++++....     .
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----T  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----E
Confidence            3578899999999999999998643  4678999987533     24568999999999999999999887655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|||++. +++.+++..          ...+++.++..++.|++.||+|||+.+   ||||||||+|||++.++.+||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l  226 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDR----------SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVL  226 (392)
T ss_pred             EEEEehhcC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEE
Confidence            899999987 688888732          256899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +|||++................||..|+|||++....++.++|||||||++|||++|+.||...
T Consensus       227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            9999998766544333333466999999999999999999999999999999999999999643

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1e-30  Score=280.88  Aligned_cols=266  Identities=22%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEc-------CCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeecc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLD-------EGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSG  338 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  338 (789)
                      ..++|...+.||+|+||.||+++..       .....||+|.++... ......+..|+++++++ +||||++++++|..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            4467888999999999999999863       234679999987543 23456788999999999 69999999999876


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      ..     ..++|+||+.+|+|.+++.......      ........+++.++..++.|++.||.|||+.+   ++|||||
T Consensus        90 ~~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlk  161 (314)
T cd05099          90 EG-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLA  161 (314)
T ss_pred             CC-----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence            54     6899999999999999996542110      01112346899999999999999999999888   9999999


Q ss_pred             CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccc
Q 041249          413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMF  491 (789)
Q Consensus       413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~  491 (789)
                      |+||++++++.+||+|||.++...............++..|+|||.+....++.++|||||||++|||++ |+.||... 
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-  240 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-  240 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-
Confidence            9999999999999999999987654332211122234567999999988889999999999999999999 89998632 


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          ...............+                           ....+..++.+++.+|++.++-.||+.......
T Consensus       241 ----~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         241 ----PVEELFKLLREGHRMD---------------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             ----CHHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                1111111110000000                           011234456688899999999999998876543


Q ss_pred             cc
Q 041249          572 LP  573 (789)
Q Consensus       572 l~  573 (789)
                      +.
T Consensus       290 l~  291 (314)
T cd05099         290 LD  291 (314)
T ss_pred             HH
Confidence            33

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=271.50  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=197.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||.|++|.||+|...  ++.||+|.++.... ..+.+..|+.++++++|+||+++++++....     ..+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN-----PLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC-----CeE
Confidence            468889999999999999999985  78999999976644 5678999999999999999999999987654     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+++++|.+++...        ....+++..+..++.|++.|+.|||+.+   ++|+||||+||++++++.+||+|
T Consensus        77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d  145 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSR--------GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSD  145 (256)
T ss_pred             EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcc
Confidence            999999999999998654        2236899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.++.......     ...++..|+|||++..+.++.++||||||+++||+++ |+.||.....  ..+..........
T Consensus       146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~  218 (256)
T cd05039         146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYRM  218 (256)
T ss_pred             cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCCC
Confidence            999987743321     2335568999999998899999999999999999997 9999863211  1111111111000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .                              ....+...+.+++..|++.++..||+......
T Consensus       219 ~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         219 E------------------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             C------------------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            0                              00122345667888999999999999876643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=3.3e-30  Score=268.33  Aligned_cols=249  Identities=19%  Similarity=0.268  Sum_probs=199.1

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|+..+.||.|+||.||.+....+++.|++|.+...  .....+.+.+|++++++++|+||+++++++.+..     ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEE
Confidence            477889999999999999999989999999998654  3344567889999999999999999999987755     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      ++|||+++|+|.+++...        .+..+++.++..++.|++.|++|||+.+   ++|+||+|+||++++++.+|++|
T Consensus        76 ~~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d  144 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQ--------KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGD  144 (256)
T ss_pred             EEEEecCCCcHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECc
Confidence            999999999999998643        2356899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.+........  ......++..|+|||...+..++.++||||||+++|||++|+.||+..     ...+.........
T Consensus       145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~  217 (256)
T cd08221         145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQGN  217 (256)
T ss_pred             CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCC
Confidence            999987654432  123355889999999998888999999999999999999999998632     1112211111110


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ....                           ...+...+.+++..|++.++.+|++.....
T Consensus       218 ~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll  251 (256)
T cd08221         218 YTPV---------------------------VSVYSSELISLVHSLLQQDPEKRPTADEVL  251 (256)
T ss_pred             CCCC---------------------------ccccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence            0000                           012234456778889999999999877653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=1.2e-30  Score=278.83  Aligned_cols=260  Identities=23%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCce--EEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|.+..++.  .+++|.++... ......+.+|++++.++ +|+||+++++++....    
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~----   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----
Confidence            4678889999999999999999876665  45777765432 33456788999999999 8999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccc------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEV------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                       ..++|+||+++|+|.+++.......+.      ......+++.++..++.|++.|++|||+.+   ++||||||+||++
T Consensus        82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili  157 (303)
T cd05088          82 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV  157 (303)
T ss_pred             -CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEe
Confidence             789999999999999999754221110      112346899999999999999999999888   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +.++.+||+|||++.......   ......++..|+|||+.....++.++|||||||++|||+| |..||.....     
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  229 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----  229 (303)
T ss_pred             cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----
Confidence            999999999999986432111   1111224567999999988889999999999999999998 9999863211     


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .+..... +..        ...                  .....+...+.+++..|++.++..||+.......
T Consensus       230 ~~~~~~~-~~~--------~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         230 AELYEKL-PQG--------YRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHHHHH-hcC--------CcC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1111111 000        000                  0001223456688899999999999999876443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.9e-30  Score=270.24  Aligned_cols=246  Identities=26%  Similarity=0.352  Sum_probs=192.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      -++|...+.||+|+||.||++...  ++.||+|.++...  ..+.+..|+.++++++|+|++++++++....    ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceE
Confidence            357888999999999999999875  7889999986432  3467899999999999999999999764332    2679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|++|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d  145 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSD  145 (256)
T ss_pred             EEEECCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecC
Confidence            999999999999998643        2345789999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.++.......     ...++..|+|||+.....++.++||||||+++|||++ |+.||...     ...+........
T Consensus       146 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~  215 (256)
T cd05082         146 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKG  215 (256)
T ss_pred             CccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcC
Confidence            999886543321     2234568999999988889999999999999999998 99998621     222222111000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...+                           ....+...+.+++..|++.++.+||+......
T Consensus       216 ~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         216 YKMD---------------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCCC---------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0000                           00123445668888999999999999887643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-30  Score=269.92  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=198.5

Q ss_pred             CcccccCCccEEEEEEcCC---ceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|.....   +..|++|.++...... .+.+.+|++.+..++|+|++++++++....     ..++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE-----PLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC-----ceEEEE
Confidence            4799999999999999865   8999999997664443 678999999999999999999999987644     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+++|.+++....... .......+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.+|++|||.
T Consensus        76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence            9999999999986531100 0011367899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchh
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVM  510 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  510 (789)
                      +................++..|+|||......++.++||||+|+++|||++ |+.||....  ...+.+.......    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~----  225 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKGYR----  225 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC----
Confidence            998876543223334567889999999988899999999999999999999 699987431  1111111111000    


Q ss_pred             hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                                                ......+..++.+++..|++.++.+||+.....
T Consensus       226 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~  258 (262)
T cd00192         226 --------------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELV  258 (262)
T ss_pred             --------------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence                                      001112345667888899999999999887653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=259.53  Aligned_cols=200  Identities=25%  Similarity=0.383  Sum_probs=174.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++.|+.-+.||+|.|+.||++....+|+.+|+|.++..  .....+.+.+|+++.+.++||||+++.....+..     .
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-----~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-----e
Confidence            46788888999999999999999999999999998644  4446678999999999999999999998877665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---Cc
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MV  423 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~~  423 (789)
                      .++|+|+|.+|+|..-+-.+          ..+++...-++..||+.||.|+|+++   |||||+||+|+++..+   --
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R----------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~  151 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAA  151 (355)
T ss_pred             eEEEEecccchHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCc
Confidence            99999999999976655322          45677788899999999999999998   9999999999999532   35


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +||+|||+|......   ....+..||++|||||+....+|+..+|||+.||+||-|+.|..||.+
T Consensus       152 vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  152 VKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             eeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            699999999998833   245567899999999999999999999999999999999999999974

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=1e-30  Score=273.31  Aligned_cols=252  Identities=26%  Similarity=0.422  Sum_probs=195.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .+.|...+.||+|+||.||+|.+.. ...||+|.++.... ....+..|++++++++|+||+++++.+.. .     ..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~-----~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-----PIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-C-----CcE
Confidence            3568889999999999999999874 45699999875332 34578999999999999999999987643 2     468


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...        .+..+++..+..++.|+++||+|+|+.+   ++|+||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             EEEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEecc
Confidence            999999999999999643        2346789999999999999999999887   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.++........ ......++..|+|||+.....++.++||||||+++|||++ |+.||.....     ......... 
T Consensus       146 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~~~~~~~~~-  218 (262)
T cd05071         146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVER-  218 (262)
T ss_pred             CCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----HHHHHHHhc-
Confidence            9999876544321 1122346678999999998999999999999999999999 8888863211     011110000 


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                              ...                  ......+...+.+++..|++.++-.||+.......+
T Consensus       219 --------~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l  257 (262)
T cd05071         219 --------GYR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL  257 (262)
T ss_pred             --------CCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence                    000                  000113445677899999999999999988765443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.3e-30  Score=272.01  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=195.8

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|+||.||+|..+ +++.||+|.+..... ....+..|++++++++|+||+++++++.. +     ..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~   75 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E-----PI   75 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C-----Cc
Confidence            3467888999999999999999976 678899999864433 34678899999999999999999988642 2     57


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++++||+.+|+|.+++...        .+..+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++++
T Consensus        76 ~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05067          76 YIITEYMENGSLVDFLKTP--------EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIA  144 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEc
Confidence            9999999999999998643        3356899999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.+......... ......++..|+|||++....++.++||||||+++||+++ |+.||....  ...+........+
T Consensus       145 dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~  221 (260)
T cd05067         145 DFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGYR  221 (260)
T ss_pred             cCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCCC
Confidence            99999876533211 1122345678999999998899999999999999999999 999996321  1111111111100


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..        .                      ...+..++.+++.+|.+.++.+||+......
T Consensus       222 ~~--------~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 MP--------R----------------------PDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CC--------C----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            00        0                      0012345678888999999999999876643

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=275.20  Aligned_cols=253  Identities=22%  Similarity=0.252  Sum_probs=199.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|.+.+.||.|++|.||+|.+..+++.||+|+++.......+.+..|++++++++|+||+++++++....     ..+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEE
Confidence            467888999999999999999998889999999998766666678999999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+++++|.+++...         ...+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|
T Consensus        79 lv~e~~~~~~L~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d  146 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL---------ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLAD  146 (280)
T ss_pred             EEeeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEcc
Confidence            999999999999998543         246899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||.+........  ......++..|+|||.+.     ...++.++||||||+++|||++|+.||.....     ......
T Consensus       147 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~  219 (280)
T cd06611         147 FGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLK  219 (280)
T ss_pred             Cccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHH
Confidence            998876543322  123455889999999874     34478899999999999999999999863211     111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .....     .+.+.                    ....+...+.+++..|++.++..|++...+..
T Consensus       220 ~~~~~-----~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         220 ILKSE-----PPTLD--------------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HhcCC-----CCCcC--------------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            10000     00000                    00012234557788899999999999887644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.3e-30  Score=275.60  Aligned_cols=251  Identities=22%  Similarity=0.262  Sum_probs=195.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      |...+.||+|+||.||+|....++..+++|.+..........+..|+++++.++|||++++++++....     ..++|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEEE
Confidence            456788999999999999999889999999997665556677899999999999999999999987655     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|++..++...         ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+|++|||+
T Consensus        82 e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~  149 (282)
T cd06643          82 EFCAGGAVDAVMLEL---------ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV  149 (282)
T ss_pred             EecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccc
Confidence            999999999887532         246899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +........  ......++..|+|||++.     ...++.++|||||||++|||++|+.||..... ........+...+
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~  226 (282)
T cd06643         150 SAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPP  226 (282)
T ss_pred             ccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcCCC
Confidence            876543221  122345889999999874     34578899999999999999999999863211 0011111110000


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          ....+                         ..+...+.+++..|++.++.+|++.......
T Consensus       227 ----~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 ----TLAQP-------------------------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----CCCCc-------------------------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00000                         0122345678889999999999998766443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=9e-31  Score=280.40  Aligned_cols=266  Identities=21%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC-------CceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      .++|...+.||+|+||.||++.+..       ....+|+|.++... ......+..|++++.++ +|+||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678999999999999999998742       23579999997543 33456788899999999 799999999998766


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP  413 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~  413 (789)
                      .     ..++||||+.+|+|.+++.......      ........+++.+++.++.|++.||+|||+.+   ++||||||
T Consensus        97 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp  168 (307)
T cd05098          97 G-----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAA  168 (307)
T ss_pred             C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccH
Confidence            5     7899999999999999997542110      00112345899999999999999999999887   99999999


Q ss_pred             CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcccc
Q 041249          414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFE  492 (789)
Q Consensus       414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~  492 (789)
                      +||++++++.+||+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...  
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--  246 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--  246 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence            999999999999999999987654332111222234568999999988889999999999999999998 88888532  


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                         ...+..+........                           .....+..++.+++..|++.++-.||++..+...+
T Consensus       247 ---~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l  296 (307)
T cd05098         247 ---PVEELFKLLKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  296 (307)
T ss_pred             ---CHHHHHHHHHcCCCC---------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence               122222111000000                           00112344566788899999999999998875544


Q ss_pred             cc
Q 041249          573 PH  574 (789)
Q Consensus       573 ~~  574 (789)
                      ..
T Consensus       297 ~~  298 (307)
T cd05098         297 DR  298 (307)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=273.03  Aligned_cols=249  Identities=24%  Similarity=0.272  Sum_probs=198.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||.|++|.||+|....+++.||+|++.... ......+.+|+++++.++|+||+++++++.+..     ..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEE
Confidence            36778899999999999999999899999999987553 344567889999999999999999999987665     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+++|.+++..           ..+++.++..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|
T Consensus        76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d  141 (274)
T cd06609          76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLAD  141 (274)
T ss_pred             EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcc
Confidence            99999999999999853           26889999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.++.......  ......++..|+|||++.+..++.++||||||+++|||++|+.||......  .....+....+  
T Consensus       142 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~--  215 (274)
T cd06609         142 FGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKNNP--  215 (274)
T ss_pred             cccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhcCC--
Confidence            999988765431  122345788999999999888999999999999999999999999632211  01110110100  


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                            +.+..                     ..+...+.+++..|+..++.+|++......
T Consensus       216 ------~~~~~---------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         216 ------PSLEG---------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ------CCCcc---------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  01000                     002234557778899999999998877644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-30  Score=274.90  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||+|+||.||+|.+..+++    .||+|....... .....+.+|++.+++++|+||++++++|.. .   
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~---   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S---   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C---
Confidence            3567888999999999999999875544    589998865543 345678899999999999999999999875 3   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++|+||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.
T Consensus        82 --~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~  147 (279)
T cd05057          82 --QVQLITQLMPLGCLLDYVRNH---------KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQH  147 (279)
T ss_pred             --ceEEEEecCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCe
Confidence              689999999999999998643         235899999999999999999999887   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||.++...............++..|+|||......++.++||||||+++||+++ |+.||+....  ..+.+.+.
T Consensus       148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~  225 (279)
T cd05057         148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLE  225 (279)
T ss_pred             EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHh
Confidence            99999999987764432222222234568999999988889999999999999999998 9999873211  11122211


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .....                              .....+...+.+++..|+..++..||+.......+
T Consensus       226 ~~~~~------------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l  265 (279)
T cd05057         226 KGERL------------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF  265 (279)
T ss_pred             CCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            10000                              00011234456778899999999999888764433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=2.6e-30  Score=271.27  Aligned_cols=201  Identities=25%  Similarity=0.341  Sum_probs=160.9

Q ss_pred             CcccccCCccEEEEEEcC--CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||+|....  ....+|+|.+.... ......+.+|++.++.++|+||+++++++....     ..++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEE
Confidence            358999999999997643  24578888876443 233567889999999999999999999987665     7899999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+.+|+|.+++....     .......++.....++.|++.||+|||+.+   |+||||||+||++++++.+|++|||++
T Consensus        76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          76 FCPLGDLKNYLRSNR-----GMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eCCCCcHHHHHHhcc-----ccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccc
Confidence            999999999986541     111234567888999999999999999888   999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCC-------CCcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLG-------SEVSTNGDVYSYGILMLELII-RKKPSDI  489 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~sfGvvl~ellt-G~~P~~~  489 (789)
                      ................++..|+|||+...       ..++.++|||||||++|||++ |..||..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            76544332212223345678999998642       357889999999999999999 7888863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=4.3e-30  Score=273.11  Aligned_cols=252  Identities=20%  Similarity=0.222  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|.+.+.||+|+||.||+|....+++.|++|.+........+.+..|+++++.++|+||+++++.+....     ..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEE
Confidence            57888999999999999999999889999999998766666778999999999999999999999987655     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.++++..++...         ...+++..+..++.|+++|++|||+.+   ++||||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL---------DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             EEecCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccC
Confidence            99999999998887533         245899999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |.+........  ......++..|+|||++.     ...++.++|||||||++|||++|+.||.....     .......
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~  227 (292)
T cd06644         155 GVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKI  227 (292)
T ss_pred             ccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHH
Confidence            98876433221  122345788999999875     34578899999999999999999999863211     1111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .........+                         ...+...+.+++..|++.++..||+...+..
T Consensus       228 ~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         228 AKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             hcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000000                         0012234557788899999999998876643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=1.7e-30  Score=281.65  Aligned_cols=266  Identities=21%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCC-------ceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEG-------RTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      ....+|...+.||+|+||.||+|.+...       ...||+|.++... ....+.+.+|+++++++ +||||++++++|.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3345788899999999999999986422       3468999887543 33456789999999999 8999999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      ...     ..++++||+.+|+|.+++.......      ........+++.+++.++.|++.||+|||..+   ++||||
T Consensus        89 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dl  160 (334)
T cd05100          89 QDG-----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL  160 (334)
T ss_pred             cCC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence            655     7899999999999999987541100      00112346889999999999999999999988   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM  490 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~  490 (789)
                      ||+||++++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999987654332222222334567999999999899999999999999999998 88888632


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           ....+.+........+.                           ...+...+.+++..|++.++..||+..+...
T Consensus       241 -----~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~  288 (334)
T cd05100         241 -----PVEELFKLLKEGHRMDK---------------------------PANCTHELYMIMRECWHAVPSQRPTFKQLVE  288 (334)
T ss_pred             -----CHHHHHHHHHcCCCCCC---------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                 22222222111100000                           1123345668889999999999999987754


Q ss_pred             cc
Q 041249          571 IL  572 (789)
Q Consensus       571 ~l  572 (789)
                      .+
T Consensus       289 ~l  290 (334)
T cd05100         289 DL  290 (334)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=3.2e-30  Score=271.07  Aligned_cols=255  Identities=18%  Similarity=0.272  Sum_probs=195.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc----------hhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH----------RASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .|...+.||.|++|.||+|....+++.||+|.++....          ...+.+..|+.++++++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            36678899999999999999988899999998854211          11346788999999999999999999987655


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++|+||+.+|+|.+++...          ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.
T Consensus        82 -----~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~  143 (272)
T cd06629          82 -----YLSIFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDA  143 (272)
T ss_pred             -----ceEEEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcC
Confidence                 789999999999999998643          46888999999999999999999887   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                      ++.+|++|||.+................|+..|+|||......  ++.++||||||+++||+++|+.||....    ...
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~  219 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIA  219 (272)
T ss_pred             CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHH
Confidence            9999999999998765433222233456889999999987654  8999999999999999999999986211    111


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .+.. ..........++..                      ..+....+.+++..|++.++..||++..+..
T Consensus       220 ~~~~-~~~~~~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 AMFK-LGNKRSAPPIPPDV----------------------SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHH-hhccccCCcCCccc----------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111 11100000111111                      0123345667788999999999999876644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.6e-30  Score=281.30  Aligned_cols=202  Identities=25%  Similarity=0.324  Sum_probs=170.1

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~  344 (789)
                      ..++|...+.||+|+||.||+|....+++.||||.+....  ......+.+|++++++++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999998889999999986432  2234567789999999999999999998754331 122


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++++|++ +++|.+++..           ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-----------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence            3578999987 5788887742           35889999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++......     ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         158 RILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             EEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999998764332     23458899999999876 5689999999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.97  E-value=3.2e-33  Score=295.39  Aligned_cols=355  Identities=28%  Similarity=0.402  Sum_probs=288.3

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCC-CCcccccCCCCCCEEEccCCc
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG-TIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      |.|..-++. .+|++++.|.+|++|.+++|+|. .+-+.++.|+.|+.+++.+|++.. .+|+.+..+..|+.||||+|+
T Consensus        37 LkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq  114 (1255)
T KOG0444|consen   37 LKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ  114 (1255)
T ss_pred             EEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhh
Confidence            445556666 89999999999999999999999 788889999999999999999973 488899999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCcc-ccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEE
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPST-LGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENL  159 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l  159 (789)
                      |+ .+|..+-.-.++-+|+||+|+|. .||.. |-+++.|-.             ||||+|++. .+|..+..+..|++|
T Consensus       115 L~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf-------------LDLS~NrLe-~LPPQ~RRL~~LqtL  178 (1255)
T KOG0444|consen  115 LR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLF-------------LDLSNNRLE-MLPPQIRRLSMLQTL  178 (1255)
T ss_pred             hh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhh-------------hccccchhh-hcCHHHHHHhhhhhh
Confidence            99 99999999999999999999998 67754 566655544             555556666 566678889999999


Q ss_pred             ecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHHHH
Q 041249          160 NLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLC  239 (789)
Q Consensus       160 ~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~~~  239 (789)
                      +||+|++...--     +.++                    +.                                     
T Consensus       179 ~Ls~NPL~hfQL-----rQLP--------------------sm-------------------------------------  196 (1255)
T KOG0444|consen  179 KLSNNPLNHFQL-----RQLP--------------------SM-------------------------------------  196 (1255)
T ss_pred             hcCCChhhHHHH-----hcCc--------------------cc-------------------------------------
Confidence            999999864410     0000                    00                                     


Q ss_pred             HHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHH
Q 041249          240 WVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECR  319 (789)
Q Consensus       240 ~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~  319 (789)
                                                                                                      
T Consensus       197 --------------------------------------------------------------------------------  196 (1255)
T KOG0444|consen  197 --------------------------------------------------------------------------------  196 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh
Q 041249          320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH  399 (789)
Q Consensus       320 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH  399 (789)
                                                                                               .+|+-||
T Consensus       197 -------------------------------------------------------------------------tsL~vLh  203 (1255)
T KOG0444|consen  197 -------------------------------------------------------------------------TSLSVLH  203 (1255)
T ss_pred             -------------------------------------------------------------------------hhhhhhh
Confidence                                                                                     0011122


Q ss_pred             cCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249          400 HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE  479 (789)
Q Consensus       400 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e  479 (789)
                      -.+.                                            ..|                             
T Consensus       204 ms~T--------------------------------------------qRT-----------------------------  210 (1255)
T KOG0444|consen  204 MSNT--------------------------------------------QRT-----------------------------  210 (1255)
T ss_pred             cccc--------------------------------------------cch-----------------------------
Confidence            1110                                            000                             


Q ss_pred             HHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeE
Q 041249          480 LIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTI  559 (789)
Q Consensus       480 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~  559 (789)
                                                                                                      
T Consensus       211 --------------------------------------------------------------------------------  210 (1255)
T KOG0444|consen  211 --------------------------------------------------------------------------------  210 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             eccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCC
Q 041249          560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQL  639 (789)
Q Consensus       560 l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l  639 (789)
                              ....|..+..+.+|..+|||.|.+. .+|+++..+.+|+.|+||+|+|+ .+....+...+|++|+||+|++
T Consensus       211 --------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL  280 (1255)
T KOG0444|consen  211 --------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQL  280 (1255)
T ss_pred             --------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchh
Confidence                    0012334556889999999999999 89999999999999999999999 6667778889999999999999


Q ss_pred             CCCCCcccCCCCCCcEEEccCCCCCc-cCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCcc
Q 041249          640 MGKIPSDFGSLSKIEVLSLGFNNLIG-SIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS  718 (789)
Q Consensus       640 ~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  718 (789)
                      + .+|+++..+++|+.|.+.+|+++- -+|+.++++.+|+.+..++|++. ..|+.++.|.+|+.|.|++|++. .+|++
T Consensus       281 t-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPea  357 (1255)
T KOG0444|consen  281 T-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEA  357 (1255)
T ss_pred             c-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhh
Confidence            9 899999999999999999999862 36888999999999999999998 89999999999999999999999 89999


Q ss_pred             ccCCCCccEEEccCCcccccCCcccccCCCCccEEEcc
Q 041249          719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG  756 (789)
Q Consensus       719 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  756 (789)
                      +.-++.|+.|||..|.-. ..|+.-...-+.|+.-+++
T Consensus       358 IHlL~~l~vLDlreNpnL-VMPPKP~da~~~lefYNID  394 (1255)
T KOG0444|consen  358 IHLLPDLKVLDLRENPNL-VMPPKPNDARKKLEFYNID  394 (1255)
T ss_pred             hhhcCCcceeeccCCcCc-cCCCCcchhhhcceeeecc
Confidence            999999999999999976 5655432223456655444

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.9e-30  Score=270.56  Aligned_cols=200  Identities=26%  Similarity=0.429  Sum_probs=171.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      |.....||+|++|.||+|....+++.||+|.+......         ..+.+..|++++++++||||+++++++....  
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   79 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD--   79 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence            66778999999999999999888999999988644221         1256888999999999999999999987655  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++|+||+++++|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~  143 (267)
T cd06628          80 ---HLNIFLEYVPGGSVAALLNNY----------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKG  143 (267)
T ss_pred             ---ccEEEEEecCCCCHHHHHHhc----------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCC
Confidence               789999999999999999543          45788899999999999999999888   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCc----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          423 VSHVGDFGLARFLPPTHVQ----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .+||+|||.++........    .......|+..|+|||.+....++.++|||||||++|+|++|+.||..
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            9999999999877633211    111224578899999999988899999999999999999999999973

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.1e-30  Score=285.58  Aligned_cols=194  Identities=22%  Similarity=0.344  Sum_probs=166.1

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ....+|...+.||+|+||.||+|....+++.||+|+....      ....|+.++++++|+||+++++++....     .
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----I  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-----e
Confidence            3456899999999999999999999988999999985322      2356899999999999999999987765     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+|++. |++.+++...         ...+++.++..|+.|++.||+|||..+   ||||||||+||+++.++.+||
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl  198 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKR---------SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCI  198 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence            899999986 6888887533         356899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      +|||.++......   ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       199 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        199 GDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9999997543221   122456899999999999999999999999999999999965554

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=3e-30  Score=273.13  Aligned_cols=201  Identities=26%  Similarity=0.358  Sum_probs=170.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||.|++|.||+|....+++.||+|.++...  ......+.+|+.++.+++||||+++++++....     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEE
Confidence            5778899999999999999998889999999986543  223467889999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+. +++.+++...       .....+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        76 ~v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSL-------PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEEecCC-CCHHHHHhcC-------CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECc
Confidence            9999998 6888888543       12356899999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||++........  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       145 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         145 FGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             ccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999986543321  11223468899999987654 478999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.4e-30  Score=267.55  Aligned_cols=253  Identities=23%  Similarity=0.261  Sum_probs=200.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||.|++|.||+|....+++.+++|++........+.+.+|++++++++||||+++++++....     ..++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEE
Confidence            57888999999999999999998888999999998766666788999999999999999999999887655     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      +|||+.+++|.+++...         ...+++.++..++.|++.||+|||+.+   ++|+||+|+||++++++.+|++||
T Consensus        78 ~~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---------RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECcc
Confidence            99999999999988543         246889999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCC---CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS---EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |.+........  ......++..|+|||.....   .++.++||||||+++|||++|+.||....... ......+...+
T Consensus       146 g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~~~~~~~~~~  222 (262)
T cd06613         146 GVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-ALFLISKSNFP  222 (262)
T ss_pred             ccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC
Confidence            99886654321  11234578899999998776   78999999999999999999999997422110 01111110000


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                             .+.+.                    ........+.+++..|++.++..||+...+.
T Consensus       223 -------~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  258 (262)
T cd06613         223 -------PPKLK--------------------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLL  258 (262)
T ss_pred             -------Ccccc--------------------chhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence                   00000                    0112234566888999999999999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=2.1e-30  Score=269.89  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=193.7

Q ss_pred             CcccccCCccEEEEEEcC-Cc--eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDE-GR--TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|++|.||+|.+.. ++  ..||+|.++.... ...+.+..|++.+++++||||+++++++.. .     ..++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-----~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-----PLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-----eEEEEE
Confidence            468999999999999864 33  3699999987655 567789999999999999999999999875 3     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...        ....+++..+..++.|++.||+|||..+   ++|+||||+||+++.++.+||+|||.
T Consensus        75 e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          75 ELAPLGSLLDRLRKD--------ALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             EecCCCcHHHHHHhc--------ccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccc
Confidence            999999999998654        1146899999999999999999999888   99999999999999999999999999


Q ss_pred             cccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCch
Q 041249          432 ARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       432 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      ++........ .......++..|+|||+.....++.++|||||||++|||++ |+.||....     ..+..+...... 
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~-  217 (257)
T cd05040         144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKIDKEG-  217 (257)
T ss_pred             cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcC-
Confidence            9987654321 11223457789999999988899999999999999999999 999986321     111111111000 


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           ....                    ....+...+.+++..|++.++.+||+...+..
T Consensus       218 -----~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         218 -----ERLE--------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----CcCC--------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                 0000                    00112345668888999999999999887643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.1e-30  Score=276.55  Aligned_cols=258  Identities=23%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             CCCCCCcccccCCccEEEEEEc----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLD----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .|.+.+.||+|+||.||.+.+.    .+++.||+|.++... ......+.+|++++++++|||++++.+++....   ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CC
Confidence            4677899999999999999853    467899999987553 334567999999999999999999999886542   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+++++|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---------KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEE
Confidence            579999999999999998543         235899999999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC----------C
Q 041249          426 VGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG----------D  494 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~----------~  494 (789)
                      |+|||+++........ .......++..|+|||...+..++.++|||||||++|||++++.|.......          .
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd05079         150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ  229 (284)
T ss_pred             ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence            9999999877544321 1122344677899999998888999999999999999999988775432110          0


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .....+..         .....                  .+......+...+.+++..|.+.++.+||+......
T Consensus       230 ~~~~~~~~---------~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         230 MTVTRLVR---------VLEEG------------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             ccHHHHHH---------HHHcC------------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            00000000         00000                  001111234567889999999999999999887644

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.2e-30  Score=270.65  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=185.6

Q ss_pred             CcccccCCccEEEEEEcC---CceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|.+..   ....||+|.+... .......+.+|+.+++.++||||+++++++...+    ...++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence            468999999999999753   3467999998543 3344567889999999999999999999875432    2578999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...         ....++..++.++.|++.||+|||..+   ++||||||+||++++++.+|++|||+
T Consensus        77 e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          77 PYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             ecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccc
Confidence            999999999998643         234677888999999999999999887   99999999999999999999999999


Q ss_pred             cccCCCCCCc--cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHh-cCCCCccccCCccHHHHHHHhCCCc
Q 041249          432 ARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       432 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ++........  .......++..|+|||+.....++.++|||||||++|||++| ..||...     +.....+......
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~~  219 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQGR  219 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcCC
Confidence            9865433211  111233467789999999888999999999999999999995 5555421     1111111111000


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                           .+.                      ....+...+.+++..|++.++.+||+...+...
T Consensus       220 -----~~~----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 -----RLL----------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -----CCC----------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                 000                      000123356688999999999999999877443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.2e-30  Score=275.96  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||.||+|.+..    +++.||||.++..... ....+.+|++.++++.|+||+++++++....   .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~---~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG---G   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC---C
Confidence            456777899999999999999753    3789999999765443 5678999999999999999999999876522   3


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+++++|.+++...         ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~  148 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---------RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLV  148 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---------ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCE
Confidence            3689999999999999999654         235899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |++|||.+.......... ......++..|+|||......++.++||||||+++|||++|+.|+.........   ++..
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~  225 (284)
T cd05038         149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGI  225 (284)
T ss_pred             EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccc
Confidence            999999999876443211 111233556799999998889999999999999999999999998643221100   0000


Q ss_pred             hCCCc----hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          504 ALPDH----VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       504 ~~~~~----~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .....    ..+.+....                  +......|..++.+++..|++.++.+||++..+...+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         226 AQGQMIVTRLLELLKEGE------------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             ccccccHHHHHHHHHcCC------------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence            00000    001111000                  01112234567888999999999999999987755443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=3.3e-30  Score=267.32  Aligned_cols=243  Identities=26%  Similarity=0.343  Sum_probs=189.3

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ++||+|+||.||+|... +++.||+|.++.... .....+.+|++.+++++||||+++++++....     ..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECC
Confidence            47899999999999976 688999999865432 33456889999999999999999999987655     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      ++|+|.+++...         ...+++.++..++.|++.||.|+|..+   ++||||||+||++++++.+|++|||++..
T Consensus        75 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          75 PGGDFLSFLRKK---------KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcccee
Confidence            999999988543         235789999999999999999999888   99999999999999999999999999876


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV  513 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (789)
                      ....... ......++..|+|||+...+.++.++||||||+++||+++ |..||......  .....+.....       
T Consensus       143 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-------  212 (250)
T cd05085         143 EDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYR-------  212 (250)
T ss_pred             ccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCC-------
Confidence            5433211 1112234568999999998999999999999999999998 99998632111  11111110000       


Q ss_pred             cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                                             ......+...+.+++.+|++.++.+||+...+.
T Consensus       213 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  245 (250)
T cd05085         213 -----------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ  245 (250)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence                                   000112334567889999999999999988764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3e-30  Score=273.11  Aligned_cols=256  Identities=21%  Similarity=0.265  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||++.+..+++.||+|++.... ......+..|+++++.++||||+++++++....     ..+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EEE
Confidence            56778899999999999999999889999999986543 344578899999999999999999999988765     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|+||+++|+|.+++...          ..+++.....++.+++.||.|||+ .+   ++||||+|+||++++++.++|+
T Consensus        80 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~  146 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKG----------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLC  146 (284)
T ss_pred             EEEecCCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEc
Confidence            999999999999988543          458899999999999999999996 45   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCC------ccHHHHH
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD------MNLHNFA  501 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~------~~~~~~~  501 (789)
                      |||++.......    .....|+..|+|||++.+..++.++|||||||++||+++|+.||+......      .....+.
T Consensus       147 d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd06620         147 DFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL  222 (284)
T ss_pred             cCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence            999987653322    123458899999999988899999999999999999999999997543210      1111222


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      +......     .+.+.                     ...+...+.+++..|.+.++..||+..++...+.
T Consensus       223 ~~~~~~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         223 QQIVQEP-----PPRLP---------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             HHHhhcc-----CCCCC---------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            2111110     00000                     0123445678888999999999999988765443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=2.3e-30  Score=270.28  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=192.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|++|.||+|.+.. +..||+|.+.... ...+.+.+|++++++++|+|++++++++.. .     ..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E-----PIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C-----CcEE
Confidence            568888999999999999999874 4569999876433 234678899999999999999999988642 2     5789


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          78 VTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             EEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCC
Confidence            99999999999999643        2345789999999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.+......... ......++..|+|||......++.++|||||||++|||++ |+.||.....  .....+....... 
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~-  222 (260)
T cd05069         147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGYRM-  222 (260)
T ss_pred             ccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC-
Confidence            999876443211 1122346678999999988899999999999999999999 8999863211  1111111111100 


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                             ..                      .......+.+++..|++.++..||+...+..
T Consensus       223 -------~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -------PC----------------------PQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -------CC----------------------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                   00                      0112345667888999999999998876543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=1.4e-30  Score=274.57  Aligned_cols=247  Identities=23%  Similarity=0.292  Sum_probs=196.2

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      |+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+..|++.+++++||||+++++.+....     ..++|
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv   80 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-----KLWII   80 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-----ceEEE
Confidence            455678999999999999998889999999987543 344567899999999999999999999987654     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      +||+++++|.+++..           ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.+|++|||
T Consensus        81 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          81 MEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             EEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccc
Confidence            999999999998842           35788999999999999999999887   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchh
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM  510 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  510 (789)
                      ++........  ......++..|+|||++.+..++.++|||||||++|||++|+.|+......  ....+.    ..   
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~----~~---  215 (277)
T cd06642         147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLFLI----PK---  215 (277)
T ss_pred             ccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHhhh----hc---
Confidence            9987654321  112345788999999999888999999999999999999999998632211  000000    00   


Q ss_pred             hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       ...+.+.                      ..+...+.+++..|++.++..||++..+..+
T Consensus       216 -~~~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         216 -NSPPTLE----------------------GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -CCCCCCC----------------------cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             0011110                      1233456688889999999999999877543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=9.5e-31  Score=286.17  Aligned_cols=202  Identities=22%  Similarity=0.264  Sum_probs=170.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .++|...+.||+|+||.||++....+++.||||.+...  .......+.+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999999888999999998643  23335677889999999999999999998765432 2233


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+ ++.+.+.            ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+|
T Consensus        96 ~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~k  159 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEE
Confidence            57999999975 5666553            23788889999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         160 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             EeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999987544321   2234588999999999888899999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=3.5e-30  Score=268.07  Aligned_cols=250  Identities=20%  Similarity=0.237  Sum_probs=198.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|+..+.||+|+||.||++....+++.||+|.+...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-----NLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-----eEE
Confidence            477889999999999999999989999999998644  2334567899999999999999999999987655     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+++|.+++...        ....+++.++..++.|++.|++|||+.+   ++|+||+|+||+++.++.++++|
T Consensus        76 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d  144 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--------RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGD  144 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEee
Confidence            999999999999988643        2345788999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.+.........  .....|+..|+|||...+..++.++|||||||++|+|++|+.||...     .....+.......
T Consensus       145 ~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~  217 (256)
T cd08218         145 FGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGS  217 (256)
T ss_pred             ccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCC
Confidence            9999876543211  12245788999999998888999999999999999999999998631     1112211111110


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...                           ........+.+++..|++.++..||++..+..
T Consensus       218 ~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 YPP---------------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCC---------------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            000                           01122345668888999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.8e-30  Score=273.07  Aligned_cols=266  Identities=21%  Similarity=0.227  Sum_probs=204.0

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      ..+..++..+.+.|+..+.||+|+||.||+|....+++.||+|++.... .....+..|+.+++++ +|+||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            3466677778889999999999999999999998889999999986543 2345688899999999 7999999999986


Q ss_pred             cCCC-CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCce
Q 041249          338 GVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI  416 (789)
Q Consensus       338 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Ni  416 (789)
                      .... ......+++|||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++|+||+|+||
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~ni  152 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--------KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNV  152 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence            4322 1234789999999999999998643        2345788889999999999999999988   99999999999


Q ss_pred             ecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccc
Q 041249          417 LLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMF  491 (789)
Q Consensus       417 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~  491 (789)
                      ++++++.++|+|||.+........  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....
T Consensus       153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            999999999999999886543221  122345888999999875     3468889999999999999999999996321


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ..    ......      .....+.+.                     ...+...+.+++..|++.++.+||+..+..
T Consensus       231 ~~----~~~~~~------~~~~~~~~~---------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell  277 (282)
T cd06636         231 PM----RALFLI------PRNPPPKLK---------------------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLL  277 (282)
T ss_pred             HH----hhhhhH------hhCCCCCCc---------------------ccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence            10    000000      000000000                     012344567888899999999999987654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=3.3e-30  Score=268.36  Aligned_cols=198  Identities=28%  Similarity=0.380  Sum_probs=172.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .|...+.||+|++|.||+|....+++.|++|.+....     .+..+.+..|++++++++|+||+++++++....     
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-----   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence            3667889999999999999998889999999986543     234567899999999999999999999987655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+++++|.+++...          ..+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~k  142 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY----------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVK  142 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence            789999999999999998543          35789999999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.+.......   ......|+..|+|||...... ++.++||||||+++|+|++|+.||..
T Consensus       143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            99999988764433   122355888999999987766 89999999999999999999999974

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=4e-30  Score=270.00  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=190.1

Q ss_pred             CcccccCCccEEEEEEcCCce--EEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||.||+|....++.  .+++|.++... ......+..|++++.++ +||||+++++++....     ..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEE
Confidence            468999999999999986665  56888886433 34456788999999999 8999999999987655     689999


Q ss_pred             eccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          352 EFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ||+++|+|.+++........      .......+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEE
Confidence            99999999999875421110      1122346889999999999999999999887   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ++|||++.......   .......+..|+|||+.....++.++|||||||++|||++ |..||...     +.....+..
T Consensus       153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~-----~~~~~~~~~  224 (270)
T cd05047         153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEKL  224 (270)
T ss_pred             ECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc-----CHHHHHHHH
Confidence            99999986432111   1111223567999999988889999999999999999997 99998632     111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...         ..                  ......+...+.+++..|++.++..||+...+...
T Consensus       225 ~~~---------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         225 PQG---------YR------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             hCC---------CC------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            000         00                  00011233456788999999999999999877443

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=2.9e-30  Score=278.92  Aligned_cols=199  Identities=21%  Similarity=0.197  Sum_probs=166.0

Q ss_pred             CCccccc--CCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          275 ANLIGTG--SFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       275 ~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .++||+|  +|++||++....+++.||+|.++...  ......+.+|+++++.++||||+++++++...+     ..++|
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~lv   77 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWVV   77 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEEE
Confidence            5689999  67899999999999999999997553  233467888999999999999999999998765     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      +||+.+|++.+++...        ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+
T Consensus        78 ~e~~~~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          78 TSFMAYGSAKDLICTH--------FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             EeccCCCcHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccc
Confidence            9999999999998643        2245889999999999999999999988   9999999999999999999999998


Q ss_pred             ccccCCCCCC-----ccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          431 LARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       431 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .+........     ........++..|+|||++..  ..++.++|||||||++|||++|+.||..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            6544322111     011122346778999999876  3589999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=282.73  Aligned_cols=192  Identities=26%  Similarity=0.289  Sum_probs=160.8

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      ||+|+||+||+|....+++.||+|++....   .........|..++...   .||||+++++++....     ..++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence            699999999999999899999999986432   12233445566666655   6999999999887665     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (330)
T cd05586          76 DYMSGGELFWHLQKE----------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGL  142 (330)
T ss_pred             cCCCCChHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCc
Confidence            999999999888543          46889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.......  ......||..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         143 SKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             CcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence            876433221  12345689999999998765 489999999999999999999999963

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=3e-30  Score=270.09  Aligned_cols=200  Identities=24%  Similarity=0.400  Sum_probs=170.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +|...+.||+|+||+||+|... +++.+|+|.++....      .....+.+|++.+++++|+||+++++++.+.+    
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence            4778899999999999999875 788999999864421      22356889999999999999999999987765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++|+||+++++|.+++...          ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+
T Consensus        76 -~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~  141 (265)
T cd06631          76 -TISIFMEFVPGGSISSILNRF----------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGII  141 (265)
T ss_pred             -eEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeE
Confidence             899999999999999998543          35788899999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCC----CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTH----VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |++|||.+.......    .........|+..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus       142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            999999988654221    11112234588999999999988899999999999999999999999963

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=280.50  Aligned_cols=193  Identities=30%  Similarity=0.399  Sum_probs=167.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      |...+.||.|+||.||-|.+..+.+.||||.+.-...   +....+.+|+..+.+++|||++.+-|.|.-..     ..|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence            4556789999999999999999999999999865433   33567999999999999999999999876544     689


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|||||-+ +-.+++.         .-.+++-+-++..|..+.+.||+|||+.+   .||||||+.|||+++.+.+||+|
T Consensus       103 LVMEYClG-SAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             HHHHHHhc-cHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeecc
Confidence            99999985 5555542         12467888999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||.|....+..      .+.||+.|||||++.   .|+|+-|+||||+|++..||.-+++|..
T Consensus       170 FGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  170 FGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             ccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence            99999887765      356999999999864   5889999999999999999999999975

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.8e-30  Score=273.56  Aligned_cols=253  Identities=21%  Similarity=0.226  Sum_probs=195.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||.||++.+..+++.||+|.++.. .......+.+|++++++++|+||+++++.+....     ..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEE
Confidence            4677889999999999999999988999999998654 2333467889999999999999999999887655     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|+||+++++|..++...       .....+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.+|++
T Consensus        76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~  145 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLC  145 (286)
T ss_pred             EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEe
Confidence            999999999999988643       1234689999999999999999999963 5   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC------CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      |||.+........    ....++..|+|||.+.+.      .++.++|||||||++|||++|+.||.....  .......
T Consensus       146 dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~  219 (286)
T cd06622         146 DFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQL  219 (286)
T ss_pred             ecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHH
Confidence            9999886643321    223578899999988554      358899999999999999999999963211  1111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      +......     .+.+                      ...+...+.+++.+|++.++..|++......
T Consensus       220 ~~~~~~~-----~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 SAIVDGD-----PPTL----------------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHhhcC-----CCCC----------------------CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1000000     0000                      1123345567888999999999999876644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.5e-30  Score=285.50  Aligned_cols=202  Identities=22%  Similarity=0.248  Sum_probs=170.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .++|...+.||+|+||.||++.....++.||||++...  .......+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46899999999999999999999888999999998643  23345678889999999999999999998765431 2223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+ ++.+.+.            ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       103 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence            57999999975 6666653            23678889999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            99999998764432   12234588999999999998999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=3.1e-30  Score=274.05  Aligned_cols=203  Identities=23%  Similarity=0.380  Sum_probs=170.2

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++++|...+.||+|+||.||+|....+++.||+|++..... .....+.+|+++++.++|+||+++.+++....     .
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----T   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----e
Confidence            56889999999999999999999988899999999865533 23346788999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+. +++.+++...         ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l  144 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQH---------PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKL  144 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEE
Confidence            899999996 6777766432         234678888999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +|||+++........  .....++..|+|||...+. .++.++|||||||++|||++|+.||+..
T Consensus       145 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         145 ADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             eccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            999998765332211  1233478899999998764 4789999999999999999999999743

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-30  Score=270.23  Aligned_cols=252  Identities=25%  Similarity=0.424  Sum_probs=197.0

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .-++|...+.||+|++|.||+|... +++.||||.+.... .....+.+|+..+++++|+||+++++++....     ..
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ce
Confidence            4468889999999999999999986 56889999987543 23467899999999999999999999987654     68


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+++|.+++...        ....+++.++..++.|++.|++|||..+   ++|+||||+||++++++.+|++
T Consensus        77 ~~v~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSG--------EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             EEEEeccCCCCHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEEC
Confidence            9999999999999999654        3356899999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.+......... ......++..|+|||...+..+++++||||||+++||+++ |+.||.....  ....+.......
T Consensus       146 d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~  222 (261)
T cd05034         146 DFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYR  222 (261)
T ss_pred             ccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence            99999877543211 1112234568999999998889999999999999999999 9999863211  111111111000


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..                              ....+...+.+++.+|.+.++..||+......
T Consensus       223 ~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         223 MP------------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CC------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            00                              00112345668888999999999998876543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2e-30  Score=289.15  Aligned_cols=196  Identities=26%  Similarity=0.334  Sum_probs=169.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ..+|...+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++|+||+++++++....     ..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEE
Confidence            457999999999999999999999899999999642      234578999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|||++. ++|.+++...         ...+++.++..|+.|++.||+|||+.+   ||||||||+|||++.++.+||+|
T Consensus       237 lv~e~~~-~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGAR---------LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EEEEccC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcc
Confidence            9999995 6888887533         246899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            999987654332222234569999999999999999999999999999999999887664

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=2.4e-30  Score=272.23  Aligned_cols=235  Identities=22%  Similarity=0.287  Sum_probs=180.4

Q ss_pred             cccccCCccEEEEEEcCC------------------------ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcccee
Q 041249          277 LIGTGSFGSVYKGVLDEG------------------------RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV  332 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  332 (789)
                      .||+|+||.||+|.+..+                        ...|++|++..........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999986321                        24589999876655556778899999999999999999


Q ss_pred             eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      +++|....     ..++||||+.+|+|..++...         ...+++..++.++.|+++||+|||+.+   ++|||||
T Consensus        82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlk  144 (274)
T cd05076          82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKE---------KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVC  144 (274)
T ss_pred             EEEEEeCC-----ceEEEEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCC
Confidence            99998765     789999999999999988542         246789999999999999999999887   9999999


Q ss_pred             CCceecCCCC-------ceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHH-Hh
Q 041249          413 PSNILLDEEM-------VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELI-IR  483 (789)
Q Consensus       413 ~~Nill~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~ell-tG  483 (789)
                      |+||+++..+       .+|++|||.+.......      ...++..|+|||.+.. ..++.++|||||||++||++ +|
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g  218 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG  218 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999997643       47999999886543221      2346788999998865 56899999999999999995 68


Q ss_pred             cCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccC
Q 041249          484 KKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLE  563 (789)
Q Consensus       484 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~  563 (789)
                      +.||......  ....+.....          ....                      .....+.+++..|++.++-+||
T Consensus       219 ~~p~~~~~~~--~~~~~~~~~~----------~~~~----------------------~~~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         219 EVPLKERTPS--EKERFYEKKH----------RLPE----------------------PSCKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             CCCccccChH--HHHHHHHhcc----------CCCC----------------------CCChHHHHHHHHHcccChhhCc
Confidence            9998632111  1111111100          0000                      0112456788899999999999


Q ss_pred             ccccc
Q 041249          564 SLKLA  568 (789)
Q Consensus       564 s~~~~  568 (789)
                      ++..+
T Consensus       265 s~~~i  269 (274)
T cd05076         265 SFRTI  269 (274)
T ss_pred             CHHHH
Confidence            88765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3.7e-30  Score=269.02  Aligned_cols=236  Identities=21%  Similarity=0.307  Sum_probs=181.8

Q ss_pred             CcccccCCccEEEEEEcC------------CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          276 NLIGTGSFGSVYKGVLDE------------GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      +.||+|+||.||+|.+..            ....|++|++..........+.+|+..++.++||||+++++++....   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~---   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV---   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            468999999999998642            23468999987666666678899999999999999999999987655   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|..++...         ...+++.++..++.|+++||+|||+.+   ++||||||+||+++.++.
T Consensus        78 --~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          78 --ENIMVEEFVEFGPLDLFMHRK---------SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGI  143 (262)
T ss_pred             --CCEEEEecccCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCc
Confidence              679999999999999887532         245899999999999999999999887   999999999999986654


Q ss_pred             -------eeeCcccccccCCCCCCccceeeecccccccCcccCC-CCCcCccccchhhHHHHHHHH-HhcCCCCccccCC
Q 041249          424 -------SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGD  494 (789)
Q Consensus       424 -------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~sfGvvl~ell-tG~~P~~~~~~~~  494 (789)
                             +|++|||.+.......      ...++..|+|||.+. ...++.++|||||||++|||+ +|+.|+....   
T Consensus       144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---  214 (262)
T cd05077         144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT---  214 (262)
T ss_pred             cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc---
Confidence                   8999999987653322      234778999999886 456899999999999999998 4888875321   


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                        .....+.. ... ....                           ......+.+++..|++.++.+||+....
T Consensus       215 --~~~~~~~~-~~~-~~~~---------------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~i  257 (262)
T cd05077         215 --LAEKERFY-EGQ-CMLV---------------------------TPSCKELADLMTHCMNYDPNQRPFFRAI  257 (262)
T ss_pred             --hhHHHHHH-hcC-ccCC---------------------------CCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence              11110000 000 0000                           0112345678889999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=3e-30  Score=279.96  Aligned_cols=281  Identities=20%  Similarity=0.227  Sum_probs=201.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +++|...+.||+|++|.||+|.+..+++.||+|.++.. .......+.+|++++++++|+||+++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            57899999999999999999999989999999998643 23345668889999999999999999998876655455568


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+.+ ++...+..           ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+
T Consensus        84 ~lv~e~~~~-~l~~~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-----------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             EEEehhccc-CHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence            999999984 77776642           35889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCc-cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          428 DFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       428 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |||++......... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....  .......+....
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~--~~~~~~~~~~~~  226 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--YLHQLNLILGVL  226 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHc
Confidence            99999876543321 11223468889999998755 468999999999999999999999996321  111111111111


Q ss_pred             CCc----hhhhccCCcccChhhHHHhhhhhhhhh-hhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDH----VMDIVDSTLLNDVEDLAIISNQRQRQI-RVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~----~~~~~d~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...    ...+.+........     ........ ..........++.+++..|++.++..|++......+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIK-----SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHh-----hcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111    11111111110000     00000000 000011224556788999999999999998876543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=5.1e-30  Score=268.73  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=196.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +|+..+.||+|++|.||+|....+++.||+|+++....      ...+.+..|++.+++++|+||+++++++.+.+    
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS----   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence            47888999999999999999988999999999864331      23467899999999999999999999987665    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V  423 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~  423 (789)
                       ..++|+||+.+++|.+++...          ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++ .
T Consensus        77 -~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~  142 (268)
T cd06630          77 -HFNLFVEWMAGGSVSHLLSKY----------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQR  142 (268)
T ss_pred             -eEEEEEeccCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence             889999999999999998643          45788999999999999999999998   99999999999998776 5


Q ss_pred             eeeCcccccccCCCCCCc--cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      +||+|||.+.........  .......++..|+|||...+..++.++||||+|+++|+|++|+.||......  ......
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~  220 (268)
T cd06630         143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI  220 (268)
T ss_pred             EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH
Confidence            899999999877654311  1122345888999999998888999999999999999999999998632111  111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .......    ..+..                      .......+.++...|.+.++..|++......
T Consensus       221 ~~~~~~~----~~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 FKIASAT----TAPSI----------------------PEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHhccC----CCCCC----------------------chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            1000000    00000                      0112345567888999999999998876643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=5.8e-30  Score=269.86  Aligned_cols=248  Identities=23%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+..|+++++++.|+||+++++++....     ..++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEEE
Confidence            5677889999999999999998889999999987543 344567899999999999999999999987765     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+++|+|.+++..           ..+++.+...++.|++.||+|+|+.+   ++|+||+|+||+++.++.++++||
T Consensus        80 v~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             EEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccc
Confidence            9999999999998853           24788899999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |.+........  ......++..|+|||++.+..++.++|||||||++|||++|+.||......     ...... .   
T Consensus       146 g~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~-~---  214 (277)
T cd06640         146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLI-P---  214 (277)
T ss_pred             ccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhh-h---
Confidence            99987654332  122345788999999998888999999999999999999999998632111     000000 0   


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       ....+.+                      ...+...+.+++..|++.++..||+...+...
T Consensus       215 -~~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 -KNNPPTL----------------------TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -cCCCCCC----------------------chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             0000111                      11344566788899999999999999877443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=3.1e-30  Score=292.04  Aligned_cols=203  Identities=23%  Similarity=0.308  Sum_probs=165.6

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC------Cccceeeeee
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH------RNLVKVFTAC  336 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~  336 (789)
                      +++...+++|.+.+.||+|+||+||+|.+..+++.||||+++... ...+....|+++++.++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            445567789999999999999999999998889999999986432 223445667777776654      4588888887


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCc
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSN  415 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~N  415 (789)
                      ....    ...++|||++ +++|.+++...          ..+++..+..|+.||+.||+|||+ .+   ||||||||+|
T Consensus       201 ~~~~----~~~~iv~~~~-g~~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~N  262 (467)
T PTZ00284        201 QNET----GHMCIVMPKY-GPCLLDWIMKH----------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPEN  262 (467)
T ss_pred             EcCC----ceEEEEEecc-CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence            6432    3689999988 56888887543          468999999999999999999997 47   9999999999


Q ss_pred             eecCCCC----------------ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249          416 ILLDEEM----------------VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE  479 (789)
Q Consensus       416 ill~~~~----------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e  479 (789)
                      ||++.++                .+||+|||.+......     .....||..|+|||++.+..++.++|||||||++||
T Consensus       263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e  337 (467)
T PTZ00284        263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE  337 (467)
T ss_pred             EEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence            9998665                4899999987643322     223568999999999999999999999999999999


Q ss_pred             HHHhcCCCCc
Q 041249          480 LIIRKKPSDI  489 (789)
Q Consensus       480 lltG~~P~~~  489 (789)
                      |++|+.||+.
T Consensus       338 lltG~~pf~~  347 (467)
T PTZ00284        338 LYTGKLLYDT  347 (467)
T ss_pred             HHhCCCCCCC
Confidence            9999999974

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=3e-30  Score=272.82  Aligned_cols=253  Identities=22%  Similarity=0.235  Sum_probs=190.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHH-HhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRA-LRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+..|+.. ++...||||+++++++....     ..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence            47888999999999999999999899999999987543 2233455556664 56668999999999987655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      ++|+||++ |+|.+++....      .....+++.++..++.|++.||+|||+. +   ++||||||+||+++.++.+||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999997 68887775431      1235689999999999999999999986 6   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~  502 (789)
                      +|||.+........   .....++..|+|||.+..    ..++.++|||||||++|||++|+.||.........+.....
T Consensus       146 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (283)
T cd06617         146 CDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE  222 (283)
T ss_pred             eecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence            99999987643321   123457889999998764    34689999999999999999999998632221111111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .         ..+.+.                     ...+...+.+++..|...++.+|++...+..
T Consensus       223 ~---------~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 E---------PSPQLP---------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             c---------CCCCCC---------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         001110                     0012334667888899999999999977644

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=3.7e-30  Score=274.80  Aligned_cols=200  Identities=25%  Similarity=0.383  Sum_probs=169.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||.|+||.||+|....+++.||+|.++.... .....+.+|++.+++++||||+++++++....     ..+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eEE
Confidence            568889999999999999999998899999999875432 33456788999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+. ++|.+++...         ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d  147 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDC---------GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLAD  147 (301)
T ss_pred             EEEeccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECc
Confidence            9999998 5888887543         245788999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||++.........  .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       148 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         148 FGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             CcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999865433211  1233468899999987654 478999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=6.2e-30  Score=267.77  Aligned_cols=204  Identities=23%  Similarity=0.357  Sum_probs=172.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||.||.|....+++.||+|.+....     ......+..|++++++++||||+++++++.+..   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence            57888999999999999999999889999999985432     123457888999999999999999999875532   1


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++|+||+++|+|.+++...          ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~  145 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY----------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNV  145 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCE
Confidence            2578999999999999998543          34788889999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||.++....... ........|+..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus       146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            9999999986543221 1112234588999999999888899999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=3.8e-30  Score=269.96  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=190.9

Q ss_pred             CcccccCCccEEEEEEcCCc------eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          276 NLIGTGSFGSVYKGVLDEGR------TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.||+|+||.||+|++....      +.||+|.+.... ......+.+|++.+++++||||+++++++...+     ..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence            46899999999999986433      689999886443 234567899999999999999999999987655     689


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-----c
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-----V  423 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-----~  423 (789)
                      +||||+++|+|.+++.......   .....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.+.     .
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcc
Confidence            9999999999999996531110   12345789999999999999999999887   99999999999999877     8


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +|++|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||....  .......+.
T Consensus       150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~  227 (269)
T cd05044         150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVT  227 (269)
T ss_pred             eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHh
Confidence            99999999987654432222222345678999999999999999999999999999998 999986321  111111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ..   .       .+                    .....+...+.+++..|+..++..||+...+.
T Consensus       228 ~~---~-------~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  264 (269)
T cd05044         228 AG---G-------RL--------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ  264 (269)
T ss_pred             cC---C-------cc--------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            00   0       00                    00012234566888899999999999988763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=6.3e-30  Score=270.77  Aligned_cols=200  Identities=25%  Similarity=0.333  Sum_probs=171.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|+..+.||+|++|.||+|....+++.||+|++....  ....+.+.+|++++++++|+|++++++++....     ..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EE
Confidence            46888899999999999999999889999999986442  223466889999999999999999999987655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||++++.+..+....          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++++||+
T Consensus        76 ~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~  142 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP----------RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLC  142 (286)
T ss_pred             EEEEeccCccHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEEC
Confidence            9999999998888876432          45899999999999999999999987   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++.........  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       143 dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~  203 (286)
T cd07847         143 DFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG  203 (286)
T ss_pred             ccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999877554321  123457789999999866 4579999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=9.8e-30  Score=269.60  Aligned_cols=263  Identities=22%  Similarity=0.212  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||.|++|.||++....+++.||+|.+..... .....+.+|++++++++||||++++++|....   ....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence            467888999999999999999988899999999875433 34567899999999999999999999986543   23579


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+++++|.+++...      ......++...+..++.|++.||+|||+.+   ++|+||+|+||++++++.++++|
T Consensus        78 lv~e~~~~~~L~~~l~~~------~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKV------KKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             EEEEecCCCCHHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence            999999999999887532      112356888999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcccc---CCccHHHHHHHhC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE---GDMNLHNFARMAL  505 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~---~~~~~~~~~~~~~  505 (789)
                      ||++........    ....++..|+|||...+..++.++||||||+++|||++|+.||+....   .......+.....
T Consensus       149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            999876543321    124577899999999988999999999999999999999999975422   1112222222111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .....+..+.                        .......+.+++..|++.++..||+..++...+
T Consensus       225 ~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         225 NPELKDEPGN------------------------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             chhhccCCCC------------------------CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            1001000000                        001234566889999999999999998775544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=8.5e-30  Score=266.75  Aligned_cols=259  Identities=22%  Similarity=0.250  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|+..+.||.|++|+||+|....++..||+|++.... ....+.+.+|++.++.++|+||+++++.+....     ..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEE
Confidence            47889999999999999999998889999999986543 335678999999999999999999999887655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+|++.+++|.+++...       .....+++.....++.|++.||+|||+.+   ++||||+|+||++++++.+|++|
T Consensus        76 iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSS-------YPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             EEEeccCCCcHHHHHHHh-------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence            999999999999998643       11246889999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCcc--ceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          429 FGLARFLPPTHVQT--SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       429 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      ||++..........  ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+....+.. 
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-  223 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-  223 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-
Confidence            99998776554221  22334588899999998877 7899999999999999999999999733111 1111111110 


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                              ++.+....                 ........+.++...|.+.++..||+......
T Consensus       224 --------~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 --------PPSLETGA-----------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --------CCCcCCcc-----------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    00010000                 00123345668888999999999998876644

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=1.4e-29  Score=265.70  Aligned_cols=199  Identities=23%  Similarity=0.358  Sum_probs=158.2

Q ss_pred             CcccccCCccEEEEEEcCC--ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      +.||+|+||.||+|....+  ...+++|.++... ....+.+.+|+..++.++||||+++++.|....     ..++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEe
Confidence            3699999999999986533  2356677765443 344678999999999999999999999987655     7899999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA  432 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  432 (789)
                      |+.+|+|.+++....      ......++.....++.|++.||+|||+.+   ++||||||+||+++.++.+|++|||++
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          76 YCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             cCCCCcHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccc
Confidence            999999999986531      11234677788899999999999999887   999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeecccccccCcccCCC-------CCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249          433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLG-------SEVSTNGDVYSYGILMLELII-RKKPSD  488 (789)
Q Consensus       433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~sfGvvl~ellt-G~~P~~  488 (789)
                      ................++..|+|||+...       ..++.++|||||||++|||++ |..||.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            65332221112223557889999998743       245789999999999999997 567775

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=3.6e-30  Score=270.33  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=195.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      -++|...+.||+|+||.||+|.+...   ...||||...... ....+.+.+|++++++++||||+++++++...     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-----   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-----
Confidence            35678889999999999999998643   3568999986554 34456899999999999999999999988642     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+++|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~  146 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---------KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCV  146 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCe
Confidence             468999999999999999643         235899999999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |++|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |+.||......  ........
T Consensus       147 ~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~  223 (270)
T cd05056         147 KLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIEN  223 (270)
T ss_pred             EEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHc
Confidence            999999998765443211 112234568999999888889999999999999999996 99999633211  11111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....                              .....+...+.+++.+|+..+|..||+.......+
T Consensus       224 ~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l  262 (270)
T cd05056         224 GERL------------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL  262 (270)
T ss_pred             CCcC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            0000                              00113344667888899999999999887764433

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=5.8e-30  Score=267.48  Aligned_cols=258  Identities=21%  Similarity=0.261  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||.|+||.||++....+++.||+|.+...  .....+.+..|++++++++|+||+++++++....   ....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence            477788999999999999999989999999998643  2334567889999999999999999999875432   23679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--CCCceecCCCCCceecCCCCceee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--QPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      +++||+.+++|.+++...      ......+++.++..++.|++.||+|||..+  ...++|+||+|+||++++++.+|+
T Consensus        78 ~~~e~~~~~~L~~~l~~~------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKC------KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             EEehhccCCCHHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence            999999999999998643      123457899999999999999999999333  334999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.+.........  .....++..|+|||......++.++||||||+++|+|++|+.||....     ...+.+....
T Consensus       152 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~  224 (265)
T cd08217         152 GDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKE  224 (265)
T ss_pred             ecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhc
Confidence            999999987654421  223458899999999998889999999999999999999999997421     1122111110


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...     +.+.                      .+....+.+++..|.+.++.+||++..+..+
T Consensus       225 ~~~-----~~~~----------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 GKF-----RRIP----------------------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCC-----CCCc----------------------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            000     0010                      1223456688889999999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.7e-30  Score=270.88  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=196.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhh--HHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||+|+||+||++....+++.||+|.+........  .....|+..+++++||||+++++++....     ..++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccc
Confidence            3456789999999999999999999999999976644332  23456999999999999999999998755     8899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+++|.+++..          ...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+||
T Consensus        76 v~~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Df  142 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----------NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDF  142 (260)
T ss_dssp             EEEEETTEBHHHHHHH----------HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSG
T ss_pred             cccccccccccccccc----------ccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            9999999999999962          256799999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCC-CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.+......  ........++..|+|||... ...++.++||||+|+++|+|++|+.||....  ..+............
T Consensus       143 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~  218 (260)
T PF00069_consen  143 GSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKRP  218 (260)
T ss_dssp             TTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHTH
T ss_pred             ccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhccccc
Confidence            999865211  12233456889999999998 7889999999999999999999999998430  001111111110000


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                                              ..............+.++...|.+.++-+||+......
T Consensus       219 ------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  219 ------------------------LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ------------------------HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ------------------------ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                    00000001111256778888999999999999877644

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.2e-30  Score=267.55  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=193.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      -++|...+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|++++++++|+||+++.+.+.. .     ..+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-----~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-----PIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C-----CeE
Confidence            467888999999999999999876 56779999886432 234678899999999999999999998765 3     679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      ++|||+.+|+|.+++...        ....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+|++|
T Consensus        77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d  145 (260)
T cd05073          77 IITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD  145 (260)
T ss_pred             EEEEeCCCCcHHHHHHhC--------CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECC
Confidence            999999999999998653        2346788999999999999999999887   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.+......... ......++..|+|||++..+.++.++|||||||++|++++ |+.||....  ......+.......
T Consensus       146 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~  222 (260)
T cd05073         146 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRM  222 (260)
T ss_pred             CcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCC
Confidence            9999876543321 1222345678999999988889999999999999999999 899986321  11122222111110


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      .        .                      ......++.+++.+|++.++-.||+.....
T Consensus       223 ~--------~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  254 (260)
T cd05073         223 P--------R----------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQ  254 (260)
T ss_pred             C--------C----------------------cccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            0        0                      001223466788899999999999877653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=4.3e-30  Score=268.82  Aligned_cols=254  Identities=22%  Similarity=0.252  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|+..+.||.|++|.||++....+++.||+|.+.... ......+.+|++.+++++||||+++++.+....     ..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEE
Confidence            46778889999999999999999889999999986553 344567889999999999999999999987665     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|+||+.+++|.+++...         ...+++..+..++.|++.||+|+|+ .+   ++|+||||+||++++++.+||+
T Consensus        76 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~  143 (265)
T cd06605          76 ICMEYMDGGSLDKILKEV---------QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLC  143 (265)
T ss_pred             EEEEecCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEe
Confidence            999999999999998643         1568889999999999999999998 77   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||.+.........    ...++..|+|||...+..++.++||||||+++|+|++|+.||...........+..+.....
T Consensus       144 d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         144 DFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             ecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence            99998766433211    15688899999999888999999999999999999999999974432222333333222111


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..     +.+.                     .......+.+++..|+..++..||+......
T Consensus       220 ~~-----~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 PP-----PRLP---------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CC-----CCCC---------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            00     0000                     0013345668888999999999999876643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=9.5e-30  Score=264.69  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|++|.||++....+++.+|+|.+...  .......+..|++++++++|||++++++.+....     ..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-----ALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-----EEE
Confidence            477788999999999999999889999999998654  2334567899999999999999999999876554     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~  427 (789)
                      +|+||+++++|.+++...        .+..+++..+..++.++++||+|||+.+   ++|+||+|+||+++++ +.+|++
T Consensus        76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~  144 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKR--------CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIG  144 (256)
T ss_pred             EEEecCCCCCHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEc
Confidence            999999999999999653        2345889999999999999999999988   9999999999999865 467999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||.+........   .....++..|+|||......++.++||||||+++|+|++|+.||...     +....+......
T Consensus       145 d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-----~~~~~~~~~~~~  216 (256)
T cd08220         145 DFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----NLPALVLKIMSG  216 (256)
T ss_pred             cCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-----chHHHHHHHHhc
Confidence            9999987754432   12245788999999998888999999999999999999999998632     111111111100


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....+.                           ..+...+.++...|++.++..||+......
T Consensus       217 ~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 TFAPIS---------------------------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCC---------------------------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            000000                           012334567888999999999999887643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=3.6e-30  Score=273.74  Aligned_cols=200  Identities=24%  Similarity=0.365  Sum_probs=175.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .+.|...+.||+|+||.||+|....+++.||+|.+........+.+..|++++++++|||++++++++....     ..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence            367888999999999999999998889999999987665555677899999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++++|.+++..           ..+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|
T Consensus        93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~d  158 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD  158 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEcc
Confidence            99999999999999853           24688899999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||++....+....  .....++..|+|||.+....++.++|||||||++||+++|+.||..
T Consensus       159 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~  217 (293)
T cd06647         159 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (293)
T ss_pred             Ccceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9998866544321  2234588899999999888899999999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.7e-30  Score=265.14  Aligned_cols=244  Identities=27%  Similarity=0.332  Sum_probs=190.5

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      +.||+|++|.||++.... ++.||+|.++..... ....+.+|+++++++.|+||+++++++....     ..++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence            478999999999999986 999999998765443 4567999999999999999999999987665     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      .+++|.+++...         ...+++..+..++.+++.|++|||+.+   ++||||||+||+++.++.+||+|||.+..
T Consensus        75 ~~~~l~~~l~~~---------~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~  142 (251)
T cd05041          75 PGGSLLTFLRKK---------KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRE  142 (251)
T ss_pred             CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccc
Confidence            999999998543         235788999999999999999999988   99999999999999999999999999986


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV  513 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (789)
                      ..............++..|+|||...++.++.++|||||||++|||++ |..||......  ............      
T Consensus       143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~~------  214 (251)
T cd05041         143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYRM------  214 (251)
T ss_pred             ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCCC------
Confidence            653222111112234567999999988899999999999999999999 88888632211  111111110000      


Q ss_pred             cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                                              .....+...+.+++..|.+.++..||+.....
T Consensus       215 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell  246 (251)
T cd05041         215 ------------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY  246 (251)
T ss_pred             ------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence                                    00012234567888899999999999887653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=9.1e-30  Score=272.33  Aligned_cols=249  Identities=21%  Similarity=0.242  Sum_probs=193.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||++....+++.||+|.+....   ......+.+|+++++.++||||+++++.+....     .
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-----H   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-----E
Confidence            47888999999999999999999899999999986543   233457889999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|+
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l  142 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNI----------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKL  142 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEE
Confidence            89999999999999998543          45788999999999999999999887   999999999999999999999


Q ss_pred             CcccccccCCCCCC-------------ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          427 GDFGLARFLPPTHV-------------QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       427 ~Dfgla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      +|||.++.......             ........++..|+|||.+....++.++||||||+++|||++|+.||...   
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---  219 (305)
T cd05609         143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---  219 (305)
T ss_pred             eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence            99999874221110             00111234778899999998888999999999999999999999998632   


Q ss_pred             CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                        ...++........   ...+..                      ...+...+.+++.+|++.++..|++..
T Consensus       220 --~~~~~~~~~~~~~---~~~~~~----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         220 --TPEELFGQVISDD---IEWPEG----------------------DEALPADAQDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             --CHHHHHHHHHhcc---cCCCCc----------------------cccCCHHHHHHHHHHhccChhhccCcc
Confidence              1122222111110   000000                      001234456888999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=4.3e-30  Score=272.94  Aligned_cols=197  Identities=26%  Similarity=0.355  Sum_probs=172.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .|.....||+|+||.||++....+++.||||.+........+.+..|+..++.++|+||+++++.+...+     ..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEE
Confidence            3444567999999999999998889999999987665566677899999999999999999999987655     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      |||+++++|.+++..           ..+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        98 ~e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658          98 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             EeCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCc
Confidence            999999999998742           24788999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++.........  .....|+..|+|||+.....++.++|||||||++|||++|+.||.
T Consensus       164 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  219 (292)
T cd06658         164 FCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF  219 (292)
T ss_pred             chhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            98865443321  223458899999999988889999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.1e-30  Score=270.16  Aligned_cols=237  Identities=22%  Similarity=0.307  Sum_probs=182.8

Q ss_pred             CcccccCCccEEEEEEcCCce-------EEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          276 NLIGTGSFGSVYKGVLDEGRT-------TVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.||+|+||.||+|.....+.       .||+|.+........+.+.+|+.+++.+.|||++++++++....     ..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence            468999999999999865443       48889886555555678899999999999999999999988655     689


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc-----
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV-----  423 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~-----  423 (789)
                      +||||+.+|+|.+++...         ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.     
T Consensus        76 lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~  143 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---------KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGN  143 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCC
Confidence            999999999999999654         235789999999999999999999888   999999999999987765     


Q ss_pred             ---eeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhc-CCCCccccCCccHH
Q 041249          424 ---SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMNLH  498 (789)
Q Consensus       424 ---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~-~P~~~~~~~~~~~~  498 (789)
                         +|++|||.+.......      ...++..|+|||.+.+. .++.++|||||||++|||++|. .|+.....  ....
T Consensus       144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~  215 (258)
T cd05078         144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKL  215 (258)
T ss_pred             CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHH
Confidence               5899999887654322      24578899999999875 4799999999999999999985 55542110  0001


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ......          ..+.                      .....++.+++..|++.++..||+.....
T Consensus       216 ~~~~~~----------~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il  254 (258)
T cd05078         216 QFYEDR----------HQLP----------------------APKWTELANLINQCMDYEPDFRPSFRAII  254 (258)
T ss_pred             HHHHcc----------ccCC----------------------CCCcHHHHHHHHHHhccChhhCCCHHHHH
Confidence            110000          0000                      01123456888899999999999988763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=1.2e-29  Score=265.02  Aligned_cols=253  Identities=24%  Similarity=0.287  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|++|.||+|+...+++.|++|.+..... .....+..|++.+.+++|+|++++++.+....     ..+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEE
Confidence            468888999999999999999998899999999876644 45678999999999999999999999987765     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|+||+.+++|.+++...          ..+++..+..++.|++.|++|||+ .+   ++||||+|+||+++.++.++|+
T Consensus        76 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~  142 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV----------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIA  142 (264)
T ss_pred             EEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEc
Confidence            999999999999998643          568899999999999999999998 87   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||.+..........  ....++..|+|||...+..++.++||||||+++|||++|+.||.....  ....+..+.....
T Consensus       143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~  218 (264)
T cd06623         143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG  218 (264)
T ss_pred             cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC
Confidence            999998775444221  234578899999999988999999999999999999999999974432  1111111111111


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .     .+....                     ..+...+.++...|++.++..|++......
T Consensus       219 ~-----~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         219 P-----PPSLPA---------------------EEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             C-----CCCCCc---------------------ccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0     000000                     002345667788899999999998876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=280.09  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=202.0

Q ss_pred             CCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          273 SSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ...+.||+|.||.|++|.|...   .-.||||.++..... ....|..|+.+|.+|+|+|++++||+..+.      ...
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hhh
Confidence            3457899999999999999633   346899999877554 568899999999999999999999998752      578


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+|.++.|+|.+.+++.        ....|-......++.|||.||+||..+.   +||||+-++|+++...-.+||+|
T Consensus       187 MV~ELaplGSLldrLrka--------~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~D  255 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKA--------KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICD  255 (1039)
T ss_pred             HHhhhcccchHHHHHhhc--------cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeec
Confidence            999999999999999763        3456788889999999999999999887   99999999999999999999999


Q ss_pred             ccccccCCCCCCcccee-eecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          429 FGLARFLPPTHVQTSSI-GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      ||+.+.++.....+.+. ...-.+.|+|||.+...+++-++|||+|||++|||+| |+.||-...     -.+       
T Consensus       256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~q-------  323 (1039)
T KOG0199|consen  256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQ-------  323 (1039)
T ss_pred             ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHH-------
Confidence            99999988766443222 3344568999999999999999999999999999998 899986211     111       


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                        +.+.+|..-+                  ......|...+++++..||.-.+.||++....
T Consensus       324 --IL~~iD~~er------------------LpRPk~csedIY~imk~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  324 --ILKNIDAGER------------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI  365 (1039)
T ss_pred             --HHHhcccccc------------------CCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence              2222331111                  22345789999999999999999999998765

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=9.3e-30  Score=267.60  Aligned_cols=262  Identities=23%  Similarity=0.255  Sum_probs=201.2

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC-CCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY-QGN  344 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~~  344 (789)
                      .++++|...+.||+|++|.||+|....+++.+++|++..... ..+.+..|+++++++ .|+||+++++++..... ...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            467899999999999999999999988899999999875543 346789999999999 79999999999876543 234


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+.+++|.+++...      ......+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGL------RKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHH------hhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeE
Confidence            4689999999999999988643      112356899999999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                      |++|||.+........  ......|+..|+|||.+..     ..++.++|||||||++|||++|+.||...... ..+..
T Consensus       153 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~  229 (275)
T cd06608         153 KLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK  229 (275)
T ss_pred             EECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH
Confidence            9999999886643321  1223458889999998753     34788999999999999999999999632110 11111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..+    .     ..+.+.                    ........+.+++.+|...++..||+......
T Consensus       230 ~~~----~-----~~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPR----N-----PPPTLK--------------------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhc----c-----CCCCCC--------------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            100    0     000000                    00112345667888999999999999877644

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=5.4e-30  Score=267.04  Aligned_cols=199  Identities=28%  Similarity=0.394  Sum_probs=174.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +|...+.||.|+||.||+|....+++.||+|++....   ....+.+.+|++++++++||||+++++.+....     ..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-----NM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-----eE
Confidence            4777889999999999999998889999999996442   234578999999999999999999999886655     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+.+++|.+++...          ..+++.++..++.|+++||.|||+.+   ++|+||+|+||++++++.++++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~  142 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK----------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHIT  142 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEe
Confidence            9999999999999998532          46889999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |||.+........   .....|+..|+|||......++.++||||||+++|+|++|+.||...
T Consensus       143 d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  202 (258)
T cd05578         143 DFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH  202 (258)
T ss_pred             ecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence            9999887755431   22355888999999998888999999999999999999999999743

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-29  Score=265.19  Aligned_cols=204  Identities=23%  Similarity=0.367  Sum_probs=172.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .+|...+.||+|++|.||+|....+++.||+|.+...     .......+.+|++++++++|+||+++++++....   .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence            5788999999999999999999888999999987532     1233467889999999999999999999876532   2


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++|+||+++++|.+++...          ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~  145 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY----------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNV  145 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCE
Confidence            2578999999999999988543          34788899999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|+|||.++....... ........++..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            9999999986543211 1112234588999999999888899999999999999999999999963

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.5e-30  Score=274.97  Aligned_cols=204  Identities=25%  Similarity=0.326  Sum_probs=174.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|++|.||+|....+++.||+|.+.....   ...+.+..|++.++.++|+||+++++.+....     .
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----Y   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----E
Confidence            368888999999999999999998899999999865432   24567889999999999999999999987655     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++...        ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l  144 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIML  144 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEE
Confidence            89999999999999998643        2356899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCc---------------------------cceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249          427 GDFGLARFLPPTHVQ---------------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE  479 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e  479 (789)
                      +|||.+.........                           .......|+..|+|||+..+..++.++||||||+++|+
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence            999998866433211                           01112357889999999998889999999999999999


Q ss_pred             HHHhcCCCCc
Q 041249          480 LIIRKKPSDI  489 (789)
Q Consensus       480 lltG~~P~~~  489 (789)
                      |++|+.||..
T Consensus       225 l~~g~~pf~~  234 (316)
T cd05574         225 MLYGTTPFKG  234 (316)
T ss_pred             HhhCCCCCCC
Confidence            9999999963

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=2e-29  Score=263.61  Aligned_cols=201  Identities=29%  Similarity=0.441  Sum_probs=174.6

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .|...+.||+|++|.||+|....+++.|++|.++....  ...+.+..|++++++++|+||+++++.+...+     ..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEE
Confidence            36778899999999999999988899999999876544  35678999999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++++|.+++...          ..+++..+..++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|
T Consensus        76 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d  142 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG----------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD  142 (264)
T ss_pred             EEEecCCCCcHHHHHhhc----------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence            999999999999998543          45788899999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccc--eeeecccccccCcccCCCCC---cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTS--SIGVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||.+...........  .....++..|+|||++....   ++.++||||||+++||+++|+.||..
T Consensus       143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence            999988765442211  12345788999999988766   89999999999999999999999963

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=1.1e-29  Score=278.22  Aligned_cols=202  Identities=23%  Similarity=0.254  Sum_probs=169.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .++|...+.||+|+||.||++....+++.||+|.+...  .......+.+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            36889999999999999999999989999999998643  23345678899999999999999999998864431 1223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+ ++.+.+.            ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence            57999999985 5555542            23678889999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99999997653322   12234588999999999998999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=2e-29  Score=264.22  Aligned_cols=250  Identities=18%  Similarity=0.240  Sum_probs=191.9

Q ss_pred             cHHHHHHhhcCCCCCCcc--cccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          261 SYQNLHNATDGFSSANLI--GTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~i--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      +..+.....++|...+.+  |+|+||.||++....+++.+|+|.+........     |+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            445556666788887877  999999999999998999999999864422211     22222222 7999999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ..+     ..++||||+++|+|.+++...          ..+++.++..++.|+++||+|||+.+   ++||||||+||+
T Consensus        80 ~~~-----~~~iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil  141 (267)
T PHA03390         80 TLK-----GHVLIMDYIKDGDLFDLLKKE----------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVL  141 (267)
T ss_pred             cCC-----eeEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEE
Confidence            765     899999999999999999643          37899999999999999999999988   999999999999


Q ss_pred             cCCCC-ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          418 LDEEM-VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       418 l~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                      ++.++ .++++|||.++......      ...++..|+|||++....++.++|||||||++|||++|+.||....++..+
T Consensus       142 ~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T PHA03390        142 YDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD  215 (267)
T ss_pred             EeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence            99998 99999999988765332      235889999999999888999999999999999999999999854443333


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc-ccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL-KLA  568 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~-~~~  568 (789)
                      ...+.+.. .... ..                           .......+.++...|.+.++..|++. ...
T Consensus       216 ~~~~~~~~-~~~~-~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  259 (267)
T PHA03390        216 LESLLKRQ-QKKL-PF---------------------------IKNVSKNANDFVQSMLKYNINYRLTNYNEI  259 (267)
T ss_pred             HHHHHHhh-cccC-Cc---------------------------ccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence            33333322 1000 00                           00123345567778888888888753 443

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-29  Score=269.77  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=169.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||.|++|.||+|..+.+++.||+|.+..... .....+.+|++++++++|+||+++++++...+     ..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eEE
Confidence            578889999999999999999988899999999865432 22355778999999999999999999987655     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+. ++|.+++...         ...+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~L~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EEEecCC-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECc
Confidence            9999998 4899887543         236789999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++........  .....++..|+|||+..+ ..++.++||||||+++|||++|+.||..
T Consensus       147 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         147 FGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             cccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9998765322211  122346788999998865 4589999999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=1.2e-29  Score=264.10  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|+||.||+|..+.++..||+|.+....  ....+.+.+|++++++++|+||+++++.+....     ..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEE
Confidence            4677889999999999999999899999999986542  234567889999999999999999999987655     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~  427 (789)
                      +|+||+.+++|.+++...        ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++ .+|++
T Consensus        76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--------RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEec
Confidence            999999999999998643        2345789999999999999999999888   99999999999999885 56999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||.+.........  .....|+..|+|||......++.++||||||+++|||++|+.||...     ...+++......
T Consensus       145 d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~  217 (257)
T cd08225         145 DFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQG  217 (257)
T ss_pred             ccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcc
Confidence            99999876543321  12245888999999998888999999999999999999999998632     223333322211


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..... .+                          .....+.+++.+|++.++..||+...+..
T Consensus       218 ~~~~~-~~--------------------------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 YFAPI-SP--------------------------NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             cCCCC-CC--------------------------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11111 11                          11234557778899999999999877643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=1.9e-29  Score=265.23  Aligned_cols=261  Identities=22%  Similarity=0.336  Sum_probs=194.9

Q ss_pred             CCCCCcccccCCccEEEEEEcC---CceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC-Cc
Q 041249          272 FSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG-ND  345 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~-~~  345 (789)
                      |...+.||+|+||.||+|.+..   +++.||||++....  ....+.+.+|++.+++++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5667899999999999999753   46899999986542  334567889999999999999999999876543221 12


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++++||+.+|++.+++......    .....+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEE
Confidence            357889999999999887533111    12245789999999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ++|||.++...............++..|++||......++.++||||||+++|||++ |+.||.....  ..+..+....
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~  231 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG  231 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC
Confidence            999999987654332212222345678999999988889999999999999999999 8888863211  1111111110


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..        ..                      ....+...+.+++..|++.++-+||+...+...
T Consensus       232 ~~--------~~----------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         232 NR--------LK----------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             Cc--------CC----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00        00                      001233467788999999999999998876443

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=273.63  Aligned_cols=200  Identities=27%  Similarity=0.362  Sum_probs=178.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---hhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---ASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~  344 (789)
                      .+.|...+.||.|.||.||+++.+.+|+.+|+|++......   ......+|+++|+.+. |||||.+.+.+....    
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~----  109 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD----  109 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence            45677889999999999999999999999999999766443   3468999999999997 999999999998876    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---  421 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---  421 (789)
                       ..++|||++.+|.|.+.+...           .+++.....++.|++.|+.|||+.+   +||||+||+|+|+...   
T Consensus       110 -~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~  174 (382)
T KOG0032|consen  110 -SVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEG  174 (382)
T ss_pred             -eEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCC
Confidence             899999999999999998532           3899999999999999999999988   9999999999999644   


Q ss_pred             -CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          422 -MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       422 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                       +.+|++|||++.....   ........||+.|+|||.+....|+..+||||.||++|.|++|..||...
T Consensus       175 ~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~  241 (382)
T KOG0032|consen  175 SGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE  241 (382)
T ss_pred             CCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence             4799999999999877   23455678999999999999999999999999999999999999999854

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=1.8e-29  Score=262.79  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=195.7

Q ss_pred             CCCCCcccccCCccEEEEEEcCCc----eEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGR----TTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      |...+.||.|+||.||++.+...+    ..||+|+++..... ..+.+..|++.+..++|+||+++++++....     .
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----P   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----e
Confidence            356789999999999999998665    89999999765443 5678999999999999999999999987765     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .+++|||+++++|.+++...        ....+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+++
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l  144 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKN--------RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKI  144 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhh--------hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEE
Confidence            89999999999999998654        1122899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||.+............ ...++..|+|||......++.++||||+|+++|||++ |+.||...     +.....+...
T Consensus       145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~  218 (258)
T smart00219      145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLK  218 (258)
T ss_pred             cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHh
Confidence            999999887655322111 2336789999999988889999999999999999998 78887631     1111111111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      .....                           .....+...+.+++.+|.+.++..||+....
T Consensus       219 ~~~~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (258)
T smart00219      219 KGYRL---------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSEL  254 (258)
T ss_pred             cCCCC---------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            10000                           0011234456688889999999999987654

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=6e-30  Score=270.73  Aligned_cols=198  Identities=23%  Similarity=0.372  Sum_probs=166.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .|...+.||+|++|.||+|.+..+++.||+|.++...  ......+.+|++++++++|+||+++++++.+..     ..+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-----KLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-----ceE
Confidence            3677789999999999999999899999999986542  223456788999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+. +++.+++...         ...+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d  142 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSC---------NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLAD  142 (284)
T ss_pred             EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECc
Confidence            9999997 5787776532         245899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||+++........  .....++..|+|||.+.+.. ++.++|||||||++|||++|+.|+.
T Consensus       143 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         143 FGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             cchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            9999865433211  12345788999999887654 7999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=1.9e-29  Score=264.65  Aligned_cols=252  Identities=21%  Similarity=0.345  Sum_probs=194.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcC-CceEEEEEEecccc----------chhhHHHHHHHHHHhc-CCCCccceeeeeecc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHH----------HRASRSFIAECRALRS-IRHRNLVKVFTACSG  338 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  338 (789)
                      +|+..+.||+|+||.||+|.+.. +++.+|+|.+....          ......+..|++++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            57888999999999999999986 67899999885331          1223457788888875 699999999999876


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCcee
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNIL  417 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nil  417 (789)
                      ..     ..++||||+.+++|.+++...      ......+++..+..++.|++.||.|||+ .+   ++|+||+|+||+
T Consensus        81 ~~-----~~~lv~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil  146 (269)
T cd08528          81 ND-----RLYIVMDLIEGAPLGEHFNSL------KEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIM  146 (269)
T ss_pred             CC-----eEEEEEecCCCCcHHHHHHHH------HhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEE
Confidence            65     899999999999999887432      1223568999999999999999999996 55   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL  497 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~  497 (789)
                      ++.++.+||+|||.+.......   ......|+..|+|||......++.++||||||+++|||++|+.||...     ..
T Consensus       147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~  218 (269)
T cd08528         147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NM  218 (269)
T ss_pred             ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CH
Confidence            9999999999999998765443   223456888999999999888999999999999999999999998632     11


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ................                          ...+...+.+++.+|++.++..||+..++..
T Consensus       219 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~  265 (269)
T cd08528         219 LSLATKIVEAVYEPLP--------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSA  265 (269)
T ss_pred             HHHHHHHhhccCCcCC--------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence            1111111110000000                          0012234567888999999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=8.1e-30  Score=271.51  Aligned_cols=196  Identities=25%  Similarity=0.353  Sum_probs=171.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      |.....||+|+||.||+|....+++.||+|++..........+.+|+..++.+.|||++++++.+....     ..++|+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEE
Confidence            334557999999999999998889999999997665555677889999999999999999999987655     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++++|..++..           ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        98 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~  163 (297)
T cd06659          98 EFLQGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGF  163 (297)
T ss_pred             ecCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechh
Confidence            99999999987742           35789999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +.........  .....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         164 CAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             Hhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            8765443321  223558899999999988889999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.96  E-value=1.6e-29  Score=268.32  Aligned_cols=197  Identities=28%  Similarity=0.352  Sum_probs=174.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|++|.||++.+..+++.||+|++....   ......+..|+++++++.||||+++++++....     .
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----N   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----e
Confidence            46888899999999999999999889999999986432   233567889999999999999999999987665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++...          ..++...+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl  142 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS----------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKI  142 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEE
Confidence            89999999999999998643          56889999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++.......     ....++..|+|||...+...+.++||||||+++|+|++|+.||..
T Consensus       143 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         143 TDFGFAKRVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             eeCCCccccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999998765542     234588999999999888899999999999999999999999863

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=2.1e-29  Score=271.16  Aligned_cols=206  Identities=22%  Similarity=0.321  Sum_probs=162.9

Q ss_pred             CCcccccCCccEEEEEEcC--CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          275 ANLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      ...||+|+||+||+|....  +++.||+|.++...  ....+.+|++++++++||||+++++++....   ....++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEe
Confidence            3589999999999999753  45789999986432  2346788999999999999999999885432   236799999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCceeeCc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGD  428 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D  428 (789)
                      |+.+ ++.+++....... .......+++..+..++.|++.||+|||+.+   ++||||||+||++    ++++++||+|
T Consensus        81 ~~~~-~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          81 YAEH-DLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeCC-cHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            9885 7777664321111 1122346889999999999999999999988   9999999999999    5667999999


Q ss_pred             ccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          429 FGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       429 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ||+++........ .......||..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9999877544321 122335688999999998764 5899999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.1e-29  Score=264.73  Aligned_cols=189  Identities=28%  Similarity=0.452  Sum_probs=161.2

Q ss_pred             CcccccCCccEEEEEEcCCc----------eEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          276 NLIGTGSFGSVYKGVLDEGR----------TTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      +.||+|+||.||+|.+..++          ..|++|.+...... ...+.+|++++++++||||+++++++.. .     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D-----   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence            46899999999999998665          45888887654433 6788999999999999999999999876 4     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC---
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---  422 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~---  422 (789)
                      ..++|+||+.+|+|.+++...         ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++   
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~  141 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHRE---------KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNE  141 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCcccc
Confidence            579999999999999998654         226889999999999999999999887   99999999999999888   


Q ss_pred             ----ceeeCcccccccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249          423 ----VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELII-RKKPSDI  489 (789)
Q Consensus       423 ----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~ellt-G~~P~~~  489 (789)
                          .+|++|||.+.......      ...++..|+|||++...  .++.++||||||+++|||++ |..|+..
T Consensus       142 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         142 GYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             CCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence                79999999998764421      23466789999998876  78999999999999999999 5777753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=6.2e-30  Score=270.86  Aligned_cols=199  Identities=25%  Similarity=0.369  Sum_probs=170.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||.||+|.+..+++.||+|.+.....  ...+.+.+|+++++.++||||+++++++....     ..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-----RL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-----eE
Confidence            467888999999999999999988899999999854322  23567889999999999999999999987654     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+.++++.++....          ..+++.++..++.|++.||+|||+.+   ++|+||+|+||++++++.+|++
T Consensus        76 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~  142 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYP----------NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC  142 (286)
T ss_pred             EEEEecCCccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEE
Confidence            9999999999888876432          34899999999999999999999887   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |||++.........  .....++..|+|||+..+ ..++.++||||||+++|||++|+.||.
T Consensus       143 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~  202 (286)
T cd07846         143 DFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             eeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence            99999876543311  223457889999998865 447889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=1.2e-29  Score=267.05  Aligned_cols=259  Identities=20%  Similarity=0.309  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ++|...+.||+|+||+||+|+...     +.+.|++|.+...... ....+..|++++++++|+||+++++++....   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE---   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence            578889999999999999999753     3467999998655444 4577999999999999999999999987655   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+++|+|.+++....... .......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        82 --~~~lv~e~~~~~~L~~~i~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          82 --PHYMILEYTDLGDLKQFLRATKSKD-EKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             --cceEEEEecCCCcHHHHHHhccccc-ccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCc
Confidence              7899999999999999997541110 0111236899999999999999999999988   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      ++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....  ..+.....
T Consensus       156 ~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~  232 (275)
T cd05046         156 VKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQ  232 (275)
T ss_pred             EEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHH
Confidence            99999999875543221 11223346778999999988889999999999999999999 7888853211  11111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ..   ... ..                         ....+...+.+++..|++.++..|++.....
T Consensus       233 ~~---~~~-~~-------------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l  270 (275)
T cd05046         233 AG---KLE-LP-------------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELV  270 (275)
T ss_pred             cC---CcC-CC-------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            00   000 00                         0012344677889999999999999887653

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=1.4e-29  Score=267.09  Aligned_cols=192  Identities=23%  Similarity=0.306  Sum_probs=158.7

Q ss_pred             cccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHh---cCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALR---SIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .||+|+||.||++....+++.||+|.+.....   .....+..|..++.   ...|++|+.+++++...+     ..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEE
Confidence            48999999999999988899999999864421   22233444444333   347999999999887655     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      |||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|++|||
T Consensus        76 ~e~~~~~~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          76 LDLMNGGDLHYHLSQH----------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCC
Confidence            9999999999988543          46899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ++........    ....|+..|+|||...+ ..++.++|||||||++|||++|+.||...
T Consensus       143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         143 LACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             cceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            9876543321    23458999999999875 45899999999999999999999999743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=9.8e-30  Score=264.74  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=193.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ..+|+..+.||+|+||.||+|.+. .++.+|+|.++.... ....+.+|++++++++|||++++++++....     ..+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PIC   75 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceE
Confidence            356788899999999999999986 467899998864322 3457899999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+|+|.+++...         ...+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d  143 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQ---------RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSD  143 (256)
T ss_pred             EEEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECC
Confidence            999999999999998643         235789999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.++........ ......++..|+|||....+.++.++||||||+++|||++ |+.||....     .....+.....
T Consensus       144 ~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~  217 (256)
T cd05112         144 FGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETINAG  217 (256)
T ss_pred             CcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHhCC
Confidence            9998876543211 1112335578999999998899999999999999999998 999986321     11222111000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                        ....++..                         ....+.+++..|++.++..||+...+.
T Consensus       218 --~~~~~~~~-------------------------~~~~~~~l~~~~l~~~p~~Rp~~~~~l  252 (256)
T cd05112         218 --FRLYKPRL-------------------------ASQSVYELMQHCWKERPEDRPSFSLLL  252 (256)
T ss_pred             --CCCCCCCC-------------------------CCHHHHHHHHHHcccChhhCCCHHHHH
Confidence              00011111                         123566889999999999999987663

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=1.4e-29  Score=274.47  Aligned_cols=284  Identities=19%  Similarity=0.227  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|++|.||+|....+++.||+|++....  ......+..|+.++++++||||+++.+++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            378999999999999999999999899999999986542  234567788999999999999999999876543 22336


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+. |+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl  148 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD----------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRI  148 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEe
Confidence            899999996 6898888543          45899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCc--cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||.+.........  .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....  .......+..
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~--~~~~~~~~~~  226 (334)
T cd07855         149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN--YVHQLKLILS  226 (334)
T ss_pred             cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC--hHHHHHHHHH
Confidence            999999876443311  11123468889999998765 458999999999999999999999996321  1111112222


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhh-hchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR-VNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .......+..+............ ........+ ..........+.+++..|.+.++.+|++...+..
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11111111111100000000000 000000000 0001123566778999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=3.1e-29  Score=265.46  Aligned_cols=248  Identities=20%  Similarity=0.238  Sum_probs=196.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .|...+.||+|++|.||++....+++.|++|.+........+.+.+|+.+++.++|||++++++++...+     ..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEE
Confidence            5666789999999999999998889999999987655555667889999999999999999999987655     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      +||+.+++|.+++..           ..+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.++++|||
T Consensus        95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648          95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccc
Confidence            999999999998843           35788999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchh
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM  510 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  510 (789)
                      .+.........  .....|+..|+|||...+..++.++|||||||++|||++|+.||...     +.....+.....   
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~~---  230 (285)
T cd06648         161 FCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRDN---  230 (285)
T ss_pred             cchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHhc---
Confidence            88765443221  12345888999999998888999999999999999999999998631     111111111110   


Q ss_pred             hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                        ..+.+.                    ........+.+++..|++.++-+||+.....
T Consensus       231 --~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il  267 (285)
T cd06648         231 --LPPKLK--------------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELL  267 (285)
T ss_pred             --CCCCCc--------------------ccccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence              000000                    0011234566888899999999999887664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.9e-29  Score=263.48  Aligned_cols=248  Identities=21%  Similarity=0.262  Sum_probs=194.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC---CCccceeeeeeccCCCCCCce
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR---HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|++++++++   |||++++++++....     .
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----R   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----E
Confidence            4677889999999999999998889999999986543 334567888999999996   999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++..           ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+++
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEE
Confidence            8999999999999998742           25789999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||.+.........  .....|+..|+|||+..++. ++.++|||||||++|+|++|+.||.....     ..+... .
T Consensus       143 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-~  214 (277)
T cd06917         143 CDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML-I  214 (277)
T ss_pred             ccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc-c
Confidence            999999877654321  22345888999999987654 68999999999999999999999973211     111100 0


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .    ....+.+..+                     .....+.+++..|++.++..|++......
T Consensus       215 ~----~~~~~~~~~~---------------------~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         215 P----KSKPPRLEDN---------------------GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             c----cCCCCCCCcc---------------------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0    0001111100                     12345667888999999999999877643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=2e-29  Score=262.11  Aligned_cols=242  Identities=25%  Similarity=0.363  Sum_probs=189.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||.||+|..  .++.||+|.++...  ....+.+|++++++++|||++++++++...      ..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEE
Confidence            5688899999999999999975  57889999986432  346788999999999999999999987542      4689


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+|+|.+++...        ....+++.++..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        76 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Df  144 (254)
T cd05083          76 VMELMSKGNLVNFLRTR--------GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDF  144 (254)
T ss_pred             EEECCCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCC
Confidence            99999999999998654        2345789999999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.+.......     .....+..|+|||++..+.++.++|||||||++|||++ |+.||....     ...+..... ..
T Consensus       145 g~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~-~~  213 (254)
T cd05083         145 GLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVE-KG  213 (254)
T ss_pred             ccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHh-CC
Confidence            9987653321     11234567999999988899999999999999999998 999986321     111111110 00


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                              .+.                  .....+...+.+++..|++.++-.||+.....
T Consensus       214 --------~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  248 (254)
T cd05083         214 --------YRM------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLR  248 (254)
T ss_pred             --------CCC------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence                    000                  00012234566888899999999999887653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.3e-29  Score=268.28  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=169.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|+..+.||.|++|.||+|....+++.||||.++...  ......+.+|++++++++||||+++++++...+     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-----cEE
Confidence            5788899999999999999998889999999986543  223457889999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+. +++.+++...        ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+|++|
T Consensus        76 ~v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~d  143 (284)
T cd07860          76 LVFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLAD  143 (284)
T ss_pred             EEeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEee
Confidence            9999996 6888888543        2356899999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++........  .....++..|+|||...+.. ++.++|||||||++|||+||+.||..
T Consensus       144 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         144 FGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             ccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9998866543211  12234678899999886654 68899999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-29  Score=268.14  Aligned_cols=201  Identities=25%  Similarity=0.333  Sum_probs=172.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.++..  .......+.+|++++++++|+||+++++++...+     ..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EE
Confidence            3678889999999999999999988999999998654  2334577899999999999999999999987655     79


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+.++.+..+....          ..+++.++..++.|++.|++|||..+   ++|+||+|+||++++++.+||+
T Consensus        76 ~iv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~  142 (288)
T cd07833          76 YLVFEYVERTLLELLEASP----------GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLC  142 (288)
T ss_pred             EEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEE
Confidence            9999999987777655322          45789999999999999999999888   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.+.......... .....++..|+|||+.... .++.++||||||+++|||++|+.||..
T Consensus       143 d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         143 DFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             eeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999998776544211 1234578889999999888 789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=2.5e-29  Score=265.09  Aligned_cols=248  Identities=23%  Similarity=0.298  Sum_probs=195.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      -|+..+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|++.+++++||||+++++++....     ..++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEEE
Confidence            3667889999999999999998889999999986443 233467889999999999999999999987665     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+.+++|.+++..           ..+++..+..++.|++.|++|||..+   ++|+||+|+||+++.++.++++||
T Consensus        80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeec
Confidence            9999999999998842           35789999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |++........  ......++..|+|||...+..++.++|||||||++|+|++|..||.....     ..+.... ....
T Consensus       146 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~-~~~~  217 (277)
T cd06641         146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLI-PKNN  217 (277)
T ss_pred             ccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHH-hcCC
Confidence            99887644321  11224578899999999888899999999999999999999999863211     1111110 0000


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          .+.+.                      ..+...+.+++..|++.++..||++.....+
T Consensus       218 ----~~~~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 ----PPTLE----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----CCCCC----------------------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                00000                      1123445678889999999999998876553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=253.37  Aligned_cols=201  Identities=23%  Similarity=0.293  Sum_probs=178.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|+..+++|+|.||.|-.++.+.+++.+|+|+++..   ..........|-+++...+||.+..+-..|+..+     .
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-----r  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-----R  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-----e
Confidence            6899999999999999999999999999999999765   2333445677999999999999999988888777     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+||||..+|.|.-++...          +.+++.....+..+|..||.|||+.+   ||.||+|-+|.|+|.++++||
T Consensus       243 lCFVMeyanGGeLf~HLsre----------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRE----------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             EEEEEEEccCceEeeehhhh----------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEe
Confidence            99999999999999988654          67888888899999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +|||+++.--...  ..+...+||+.|.|||++.+..|+..+|.|..|||||||++|+.||...
T Consensus       310 tDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  310 TDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             eecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            9999998643332  2344578999999999999999999999999999999999999999743

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=3.9e-29  Score=269.05  Aligned_cols=206  Identities=22%  Similarity=0.312  Sum_probs=163.6

Q ss_pred             CCcccccCCccEEEEEEc--CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          275 ANLIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      .+.||+|+||+||+|...  .+++.||+|.+....  ....+.+|++++++++||||+++++++....   ....++|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence            468999999999999975  356889999986432  2345788999999999999999999875432   236899999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCceeeCc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGD  428 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D  428 (789)
                      |+.+ ++.+++....... .......+++..+..++.|++.||+|||+.+   |+||||||+|||+    +..+.+||+|
T Consensus        81 ~~~~-~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          81 YAEH-DLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             ccCC-CHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            9874 7877765331111 1122346899999999999999999999988   9999999999999    4567999999


Q ss_pred             ccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          429 FGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       429 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9999876544321 122345689999999998764 5899999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=292.24  Aligned_cols=208  Identities=24%  Similarity=0.302  Sum_probs=185.4

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecc---ccchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      ..++....+||.+.++||.|+||+|..++.+.+++.+|+|+++.   -+.....-|+.|-++|..-..+=|+.+...|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            35666678999999999999999999999999999999999975   345556789999999999999999999888888


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      ..     +.|+|||||++|+|-.++...          ..+++..+..++++|.-||.-+|..|   +|||||||.|||+
T Consensus       147 ~~-----~LYlVMdY~pGGDlltLlSk~----------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLl  208 (1317)
T KOG0612|consen  147 ER-----YLYLVMDYMPGGDLLTLLSKF----------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLL  208 (1317)
T ss_pred             cc-----ceEEEEecccCchHHHHHhhc----------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEe
Confidence            76     899999999999999999755          27899999999999999999999988   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |..|++||+|||.+-.+..++.- ......||+-|++||++..     +.|++.+|.||+||++|||+.|..||+
T Consensus       209 d~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  209 DKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             cccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            99999999999999888755532 2345679999999998752     679999999999999999999999998

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=3.4e-29  Score=269.39  Aligned_cols=248  Identities=26%  Similarity=0.272  Sum_probs=192.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|...+.||+|+||.||+|.+..+++.||+|.+....   ......+..|++++++++|+|++++++++....     ..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eE
Confidence            3667889999999999999998889999999986432   223456888999999999999999999987765     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+. |++.+.+...         ...+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.+|++
T Consensus       101 ~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~  167 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA  167 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEe
Confidence            99999997 5777766432         345899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |||++.......      ...|+..|+|||++.   .+.++.++|||||||++|||++|+.||..... ......+....
T Consensus       168 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~  240 (317)
T cd06635         168 DFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNE  240 (317)
T ss_pred             cCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhcc
Confidence            999987654332      235788999999874   45689999999999999999999999863210 00111111110


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .+         ..                     ........+.+++.+|++.++..|++...+...+-
T Consensus       241 ~~---------~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         241 SP---------TL---------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             CC---------CC---------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            00         00                     00122334567888999999999999887755443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=3.8e-29  Score=264.95  Aligned_cols=253  Identities=22%  Similarity=0.248  Sum_probs=201.3

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ..+++|...+.||+|++|.||+|.+..+++.|++|++..... ....+..|++.+++++|+|++++++++....     .
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   89 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----E   89 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----E
Confidence            356788899999999999999999988899999999976544 5567889999999999999999999987765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+.+++|.+++...         ...+++..+..++.|++.||+|||..+   ++|+||+|+||+++.++.+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l  157 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKL  157 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEE
Confidence            99999999999999999654         147899999999999999999999887   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.+........  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+..    
T Consensus       158 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~----  230 (286)
T cd06614         158 ADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITT----  230 (286)
T ss_pred             Cccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----
Confidence            99999876654321  112234778999999998888999999999999999999999998632110 00111100    


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      .......                         ....+...+.+++..|++.++..|++...+.
T Consensus       231 ~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il  268 (286)
T cd06614         231 KGIPPLK-------------------------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL  268 (286)
T ss_pred             cCCCCCc-------------------------chhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence            0000000                         0011334566888999999999999887664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=4.6e-29  Score=267.16  Aligned_cols=247  Identities=26%  Similarity=0.263  Sum_probs=192.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ..|...+.||+|+||+||+|....+++.||+|.+....   ....+.+.+|+++++.++||||+++.++|....     .
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence            45888899999999999999998889999999986432   223456889999999999999999999998765     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+. |++.+++...         ...+++.++..++.|++.||.|||+.+   ++||||+|+||++++++.+||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL  156 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVH---------KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKL  156 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEE
Confidence            899999997 5777766432         245899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||.+.......      ...++..|+|||.+.   ...++.++||||||+++|||++|+.||....     .......
T Consensus       157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~  225 (307)
T cd06607         157 ADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYH  225 (307)
T ss_pred             eecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHH
Confidence            9999987664332      235778999999874   4568999999999999999999999986321     1111000


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....     .+.+.                     ...+...+.++...|++.++-.||++..+...
T Consensus       226 ~~~~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 IAQND-----SPTLS---------------------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HhcCC-----CCCCC---------------------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000     00000                     01233456788889999999999998877543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=4.2e-29  Score=266.29  Aligned_cols=198  Identities=25%  Similarity=0.381  Sum_probs=169.0

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-----hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      +|...+.||+|++|.||+|....+++.||||.++.....     ....+..|++++++++|+||+++++++....     
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-----   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence            367788999999999999999888999999999755332     3456778999999999999999999987754     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+ .|+|.+++...         ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~  142 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLK  142 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEE
Confidence            889999999 89999998643         136899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |+|||+++........  .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.
T Consensus       143 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~  204 (298)
T cd07841         143 LADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             EccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence            9999999877554321  122346778999998865 457899999999999999999977775

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=3.6e-29  Score=260.32  Aligned_cols=203  Identities=27%  Similarity=0.415  Sum_probs=177.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|++|.||+|....+++.|++|++.....  ...+.+.+|++.+++++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            46778899999999999999998899999999865543  45678999999999999999999999987652   12789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|
T Consensus        78 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d  144 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF----------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLAD  144 (260)
T ss_pred             EEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcc
Confidence            999999999999998644          37899999999999999999999987   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||.+................++..|+|||......++.++||||||+++|+|++|+.||..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  205 (260)
T cd06606         145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE  205 (260)
T ss_pred             cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999987765432122345688899999999888899999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=3.3e-29  Score=271.89  Aligned_cols=205  Identities=26%  Similarity=0.310  Sum_probs=171.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+.|...+.||+|+||+||+|....+++.||||.++..  .......+..|+++++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35788899999999999999999989999999998643  2333456778999999999999999999886554333345


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+. ++|.+++...          ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS----------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence            899999997 6888887543          46899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++........  ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus       150 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         150 CDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            99999987654321  1223457889999998765 4689999999999999999999999963

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=4e-29  Score=263.51  Aligned_cols=193  Identities=25%  Similarity=0.365  Sum_probs=166.5

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||+|+||+||++....+++.||+|.+....   ......+..|++++++++||||+++++++...+     ..++|+||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence            689999999999998889999999986432   223455678999999999999999999987655     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      ++++|.+++...        ....+++.++..++.|++.||.|||..+   ++||||+|+||++++++.+|++|||.+..
T Consensus        76 ~~~~L~~~l~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~  144 (277)
T cd05577          76 NGGDLKYHIYNV--------GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVE  144 (277)
T ss_pred             CCCcHHHHHHHc--------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhh
Confidence            999999998654        2246899999999999999999999888   99999999999999999999999999887


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .....   ......++..|+|||...+..++.++|||||||++|+|++|+.||..
T Consensus       145 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         145 LKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             hccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            64422   12234577899999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=4.6e-29  Score=264.18  Aligned_cols=199  Identities=26%  Similarity=0.330  Sum_probs=171.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||.|++|.||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeE
Confidence            4677889999999999999998889999999987553  334567999999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+ +++|.+++...         ...+++.++..++.|+++||+|||+.+   ++|+||||+||+++.++.++++|
T Consensus        76 ~v~e~~-~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~d  142 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDE---------ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIAD  142 (286)
T ss_pred             EEeccc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEee
Confidence            999999 99999998643         256899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||.+........ .......++..|+|||...+.+ ++.++||||+|+++|||++|+.||.
T Consensus       143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence            999987765432 1122345888999999986554 6899999999999999999977775

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=2.8e-29  Score=266.26  Aligned_cols=258  Identities=22%  Similarity=0.210  Sum_probs=192.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||++....+++.||+|.+.... ......+.+|+..+.++. |+||+++++++....     ..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cE
Confidence            35666789999999999999999899999999986543 344567889999999996 999999999887654     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      +++|||+.. ++.++....     .......+++.....++.+++.||+|||+. +   ++||||||+||+++.++.+||
T Consensus        79 ~~~~e~~~~-~l~~l~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl  149 (288)
T cd06616          79 WICMELMDI-SLDKFYKYV-----YEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKL  149 (288)
T ss_pred             EEEEecccC-CHHHHHHHH-----HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEE
Confidence            999999874 444432110     001235689999999999999999999974 6   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCC---CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS---EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||+++.......   .....|+..|+|||.+...   .++.++|||||||++|||++|+.||....    ........
T Consensus       150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~  222 (288)
T cd06616         150 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQ  222 (288)
T ss_pred             eecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhh
Confidence            99999976543321   1223578899999998776   68999999999999999999999986321    11111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....     .+.+..                  .....+...+.+++..|++.++.+||+...+...
T Consensus       223 ~~~~~-----~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         223 VVKGD-----PPILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hcCCC-----CCcCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11100     011110                  0011244567788889999999999999876543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-31  Score=295.02  Aligned_cols=227  Identities=22%  Similarity=0.330  Sum_probs=166.6

Q ss_pred             hhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCc-CCC
Q 041249          549 RIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLS-SCS  627 (789)
Q Consensus       549 ~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~  627 (789)
                      +....|.+++.++...+.+ ...+..+...++|+.|++..|.++ -+|....+++.|++|||..|+|. .+|..|- -+.
T Consensus       258 ~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~  334 (1081)
T KOG0618|consen  258 EWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLN  334 (1081)
T ss_pred             HHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhh
Confidence            4456788888888888888 466777888899999999999998 46666788999999999999998 5555443 333


Q ss_pred             C-CcEEEcccCCCCCCCCc-ccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeee
Q 041249          628 N-LIRIGLAKNQLMGKIPS-DFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILY  705 (789)
Q Consensus       628 ~-L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  705 (789)
                      . |..|+.+.|+++ ..|. .=..++.|+.|++.+|.++...-..+.+.++|+.|+|++|+|.......+.+++.|++|+
T Consensus       335 ~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~  413 (1081)
T KOG0618|consen  335 ASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELN  413 (1081)
T ss_pred             HHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHh
Confidence            2 677777778877 4442 112345688888888888777767777778888888888888733334567788888888


Q ss_pred             ccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCc
Q 041249          706 LGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK  783 (789)
Q Consensus       706 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  783 (789)
                      ||+|+++ .+|.++..++.|++|...+|+|. ..| ++. .+++|+.+|||.|.|+...-..-...++|++|||++|.
T Consensus       414 LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~-~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  414 LSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA-QLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             cccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh-hcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            8888887 67788888888888888888887 777 444 67888888888888775433232334678888888875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.7e-29  Score=265.46  Aligned_cols=253  Identities=18%  Similarity=0.204  Sum_probs=198.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..-|.+.+.||.||.+.||++... +.+.+|+|.+...  +.+....|..|++.|.+| .|.+|+++++|-...+     
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~-----  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG-----  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-----
Confidence            456888999999999999999987 4556666665433  445578899999999999 5999999999977655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..||||||-.. +|..+++..         +...+...+..+..|++.|+.++|.++   |||.||||.|+|+.. |.+|
T Consensus       434 ~lYmvmE~Gd~-DL~kiL~k~---------~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LK  499 (677)
T KOG0596|consen  434 YLYMVMECGDI-DLNKILKKK---------KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLK  499 (677)
T ss_pred             eEEEEeecccc-cHHHHHHhc---------cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEE
Confidence            89999998774 999999765         233343378899999999999999999   999999999999964 7899


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCC-----------CcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----------EVSTNGDVYSYGILMLELIIRKKPSDIMFEGD  494 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~  494 (789)
                      |+|||+|..++.+..........||+.||+||.+...           +++.++||||+||+||+|+.|++||..     
T Consensus       500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-----  574 (677)
T KOG0596|consen  500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-----  574 (677)
T ss_pred             eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----
Confidence            9999999999999888888888999999999987542           367899999999999999999999972     


Q ss_pred             ccHH-HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          495 MNLH-NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       495 ~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                        +. .|.+      +..+.||.-.=.+++           +      ..-+++++++-.|...++-.|++......+
T Consensus       575 --~~n~~aK------l~aI~~P~~~Iefp~-----------~------~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  575 --IINQIAK------LHAITDPNHEIEFPD-----------I------PENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHHHHH------HHhhcCCCccccccC-----------C------CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              23 2222      234444422111110           0      011236788899999999999999876543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=5.3e-29  Score=264.49  Aligned_cols=245  Identities=21%  Similarity=0.261  Sum_probs=193.5

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ...||+|+||.||++....+++.||||.+..........+..|+.+++.++|+|++++++++...+     ..++||||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecC
Confidence            357999999999999998899999999987655556677999999999999999999999987765     899999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      ++++|.+++..           ..+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++++|||.+..
T Consensus       100 ~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~  165 (292)
T cd06657         100 EGGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ  165 (292)
T ss_pred             CCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEccccccee
Confidence            99999998742           24788999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhcc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD  514 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d  514 (789)
                      .......  .....|+..|+|||......++.++|||||||++|||++|+.||...  .........+...+.....   
T Consensus       166 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~---  238 (292)
T cd06657         166 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKN---  238 (292)
T ss_pred             ccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccCC---
Confidence            6543211  22345788999999998888999999999999999999999998631  1111112222111111000   


Q ss_pred             CCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          515 STLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                                               .......+.++...|.+.++.+|++...+..
T Consensus       239 -------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 -------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                                     0011223456777899999999999877643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=5.2e-29  Score=260.25  Aligned_cols=192  Identities=26%  Similarity=0.346  Sum_probs=168.4

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||.|++|.||++....+++.||+|++....   ....+.+.+|++++++++||||+++++.+....     ..++|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence            689999999999999889999999986442   234567999999999999999999999987655     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      ++++|.+++...          ..+++..+..++.|++.||+|+|+.+   ++|+||+|+||+++.++.+||+|||.+..
T Consensus        76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~  142 (262)
T cd05572          76 LGGELWTILRDR----------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKK  142 (262)
T ss_pred             CCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence            999999999643          35889999999999999999999887   99999999999999999999999999987


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .....   ......++..|+|||......++.++||||||+++|||++|+.||...
T Consensus       143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  195 (262)
T cd05572         143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED  195 (262)
T ss_pred             cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence            76543   112345788999999998888999999999999999999999999743

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-30  Score=258.89  Aligned_cols=272  Identities=20%  Similarity=0.267  Sum_probs=222.5

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeee
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTA  335 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~  335 (789)
                      .+|+....+.++....+-+|.||+||.|.|++.     .+.|-+|+++.+..+. ...+..|.-.+....|||+.++.|+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            467777778888889999999999999988633     4568888887665443 4678889999999999999999999


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      +.+..    ...+..+.++.-|+|..|+..++  .+.+...+.++..+...++.|++.||+|||.++   +||.||.++|
T Consensus       356 ~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr--~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRN  426 (563)
T KOG1024|consen  356 SIEDY----ATPFVLYPATGVGNLKSFLQICR--GDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARN  426 (563)
T ss_pred             Eeecc----CcceEEEeccCcchHHHHHHHhc--cCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhc
Confidence            87643    36788999999999999998664  334456778899999999999999999999998   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCC
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGD  494 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~  494 (789)
                      .+|++..++||+|=.+++.+.+.+......+......||+||.+.+..|+..+|||||||+||||+| |+.|+.+-... 
T Consensus       427 CvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-  505 (563)
T KOG1024|consen  427 CVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-  505 (563)
T ss_pred             ceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-
Confidence            9999999999999999999988887666667778889999999999999999999999999999998 99998732110 


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                       .+..+.++.                              -|.....+|+.++..++.-||.+.+.+||+..+...-+..
T Consensus       506 -Em~~ylkdG------------------------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  506 -EMEHYLKDG------------------------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -HHHHHHhcc------------------------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence             011111111                              0133455899999999999999999999999877544433

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1.3e-28  Score=254.97  Aligned_cols=198  Identities=30%  Similarity=0.431  Sum_probs=177.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      +|...+.||+|++|.||++....+++.|++|++..........+.+|++.+++++|++++++++.+....     ..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEE
Confidence            4777899999999999999998889999999997766556678999999999999999999999987655     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      +||+++++|.+++...         ...+++..+..++.+++.|++|||..+   ++||||+|+||++++++.++|+|||
T Consensus        76 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          76 MEFCSGGSLKDLLKST---------NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             EecCCCCcHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecc
Confidence            9999999999998643         256899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      .+........   .....++..|+|||+.....++.++||||||+++|+|++|+.||.
T Consensus       144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  198 (253)
T cd05122         144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS  198 (253)
T ss_pred             cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9988765542   234568889999999988889999999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=3.4e-29  Score=271.88  Aligned_cols=203  Identities=26%  Similarity=0.371  Sum_probs=169.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+++++++ +|+||++++++|....   ..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---DK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---Cc
Confidence            46788899999999999999999888999999988532  223345677899999999 9999999999886533   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+. ++|.+++..           ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             eEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence            5799999998 588888742           25788899999999999999999888   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc---cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQ---TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.+.........   .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            9999999877544321   12233458889999998765 4578999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=5.5e-29  Score=267.65  Aligned_cols=208  Identities=24%  Similarity=0.331  Sum_probs=171.0

Q ss_pred             CCCCCCcccccCCccEEEEEEcC--CceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .|...+.||+|++|.||+|....  +++.||+|.+....   ......+.+|++++++++||||+++++++....   ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence            36778899999999999999987  78999999997643   334567788999999999999999999997652   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC----C
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE----E  421 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~----~  421 (789)
                      ..++||||+.+ ++.+++....     ......+++..+..++.|++.||+|||+.+   ++||||||+||+++.    +
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHR-----QAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhc-----cCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCcc
Confidence            78999999985 6666664321     112246889999999999999999999888   999999999999999    9


Q ss_pred             CceeeCcccccccCCCCCC-ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          422 MVSHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +.+|++|||++........ ........++..|+|||...+. .++.++|||||||++|||++|+.||...
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            9999999999987654432 1122345678899999987664 5799999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=4.5e-29  Score=265.37  Aligned_cols=202  Identities=25%  Similarity=0.343  Sum_probs=170.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||.|++|.||+|.+..+++.||+|.++....  .....+.+|++++.+++||||+++++++....   ....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            578889999999999999999998899999999975432  22345678999999999999999999886542   2378


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+. ++|.+++...         ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~-~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETM---------KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             EEEehhcC-cCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEe
Confidence            99999998 4898888543         236899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.+.........  .....++..|+|||...+.. ++.++||||||+++|||++|+.||..
T Consensus       149 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         149 DFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             ecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999877654211  12344778999999887644 68999999999999999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=3.6e-29  Score=271.15  Aligned_cols=195  Identities=29%  Similarity=0.358  Sum_probs=169.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-C-----CccceeeeeeccCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-H-----RNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~~  344 (789)
                      .|.+.++||+|+||.|.+|.+..+++.||||+++.... ..++...|+.+|+.++ |     -|+|+++++|....    
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~----  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN----  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----
Confidence            67889999999999999999999999999999976543 3456678999999986 4     57999999998766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC--
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM--  422 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~--  422 (789)
                       +.|||+|.+.. +|.++++.+        .-..++...+..++.||+.||.+||..+   |||.||||+|||+.+..  
T Consensus       262 -HlciVfELL~~-NLYellK~n--------~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  262 -HLCIVFELLST-NLYELLKNN--------KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             -ceeeeehhhhh-hHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcC
Confidence             99999999985 999999876        3456899999999999999999999888   99999999999998654  


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      .+||+|||.|.+......     ...-+..|+|||++.+.+|+.+.||||||||+.||.+|.+-|.
T Consensus       329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             ceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            779999999998765442     2235678999999999999999999999999999999966654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=8.5e-29  Score=261.09  Aligned_cols=192  Identities=23%  Similarity=0.304  Sum_probs=159.1

Q ss_pred             cccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHH---HHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAEC---RALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .||+|+||.||+|....+++.||+|.+.....   .....+..|.   +.++...||+|+++.+++...+     ..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEE
Confidence            48999999999999988899999999864321   1122233443   3444567999999999887665     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      +||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        76 ~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          76 LDLMNGGDLHYHLSQH----------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             EecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999988533          46899999999999999999999888   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ++........    ....|+..|+|||...++ .++.++|||||||++|||++|+.||...
T Consensus       143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         143 LACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             CccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            9876543321    224588999999998765 5899999999999999999999999743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=6.9e-29  Score=262.50  Aligned_cols=199  Identities=27%  Similarity=0.376  Sum_probs=168.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||.|++|.||+|.+..+++.||+|++....  ......+.+|++.++.++|||++++++++...+     ..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~-----~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-----KLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC-----eEEE
Confidence            567789999999999999998899999999987543  223456888999999999999999999987655     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ++||+. ++|.+++...        ....+++.++..++.|+++||+|||+.+   ++||||+|+||+++.++.+||+||
T Consensus        76 v~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          76 VFEFLD-LDLKKYMDSS--------PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             EEeccC-cCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeec
Confidence            999995 6899988654        2246899999999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.+.........  .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       144 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         144 GLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             ccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999865433211  1223467899999987654 478999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=9.3e-29  Score=261.83  Aligned_cols=201  Identities=25%  Similarity=0.364  Sum_probs=170.0

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||.|++|.||+|.+..+++.||+|.+....  ......+..|+++++.++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            556788999999999999999889999999997653  334567889999999999999999999987651   237899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+.+ ++.+++...         ...+++.++..++.|++.||+|||+.+   ++|+||+|+||++++++.+|++||
T Consensus        78 v~e~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~  144 (287)
T cd07840          78 VFEYMDH-DLTGLLDSP---------EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADF  144 (287)
T ss_pred             Eeccccc-cHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccc
Confidence            9999984 888887543         246899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         145 GLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             cceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999877654321 1223456788999998765 4579999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=8.3e-29  Score=257.52  Aligned_cols=252  Identities=22%  Similarity=0.245  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|+..+.||+|++|.||++....+++.+|+|.+...  .......+.+|++.+++++|+||+++.+++....     ..+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-----KLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC-----EEE
Confidence            477889999999999999999888999999998654  2334567788999999999999999998887654     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++++|.+++...      ......+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+|++|
T Consensus        76 ~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          76 IVMEYAPFGDLSKAISKR------KKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             EEehhcCCCCHHHHHHHH------HhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEee
Confidence            999999999999998643      122356899999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.+.......    .....++..|+|||...+..++.++||||||+++|||++|+.||....     ............
T Consensus       147 ~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~  217 (256)
T cd08530         147 LGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKVQRGK  217 (256)
T ss_pred             ccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC
Confidence            99998876552    123457889999999988889999999999999999999999997321     111111110000


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....                           .......+.++...|.+.++.+||+.......|
T Consensus       218 ~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         218 YPPI---------------------------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             CCCC---------------------------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence            0000                           012334567888899999999999988765443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=8.1e-29  Score=265.53  Aligned_cols=207  Identities=23%  Similarity=0.341  Sum_probs=169.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC---CC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ---GN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---~~  344 (789)
                      ++|...+.||+|+||.||+|....+++.||||.+....  ......+.+|++++++++||||++++++|......   ..
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57888999999999999999999899999999986442  22234567899999999999999999998765421   12


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++|+||+.+ ++.+.+...         ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNK---------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL  158 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence            346999999974 777776432         246899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCc--cceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||.+.........  .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999876543321  1122345778899999886654 78999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=9.3e-29  Score=261.59  Aligned_cols=202  Identities=24%  Similarity=0.374  Sum_probs=170.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +|+..+.||.|++|.||+|+...+++.||||.++.... .....+.+|++++++++|+||+++++++....     ..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence            57888999999999999999998899999999876533 23466788999999999999999999988765     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+.+ ++.+++...       .....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+|++||
T Consensus        76 v~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          76 VFEYMDK-DLKKYMDTH-------GVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             EEecCCc-cHHHHHHhc-------CCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeec
Confidence            9999984 888887543       11246899999999999999999999888   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |++........  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         145 GLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             chhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99986543321  11223467899999987654 4789999999999999999999999743

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=5.4e-29  Score=264.80  Aligned_cols=261  Identities=20%  Similarity=0.233  Sum_probs=182.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccchhh-----------HHHHHHHHHHhcCCCCccceeee
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHHRAS-----------RSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      .+.|...+.||+|+||.||+|.+..+   ...+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46789999999999999999999866   66778887543322111           11233445566778999999998


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      .+.... ......++++|+... ++.+.+...          ...++..+..|+.|++.||+|||+.+   ++||||||+
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~  155 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKRI----------KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPE  155 (294)
T ss_pred             eeeEec-CCceEEEEEEehhcc-CHHHHHHhh----------ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence            764432 111245778887654 555554322          23467788999999999999999887   999999999


Q ss_pred             ceecCCCCceeeCcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          415 NILLDEEMVSHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       415 Nill~~~~~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++.++.+||+|||+|+.......     ........||..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999987653321     1112234699999999999999999999999999999999999999974


Q ss_pred             cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      .... .......+..+..   .+..+.+                     ...++...+.++...|+++++.+||+.....
T Consensus       236 ~~~~-~~~~~~~~~~~~~---~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~  290 (294)
T PHA02882        236 FGHN-GNLIHAAKCDFIK---RLHEGKI---------------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI  290 (294)
T ss_pred             cccc-hHHHHHhHHHHHH---Hhhhhhh---------------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence            3211 1111111100000   0000000                     1123445677888899999999999887653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4e-29  Score=288.31  Aligned_cols=271  Identities=22%  Similarity=0.348  Sum_probs=210.5

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcC-------CceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeee
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFT  334 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~  334 (789)
                      .++...++....+.+|+|.||.|++|....       ....||||+++.... ...+.+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            455666777777899999999999998641       256799999976543 4567899999999999 7999999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCC------CCCCHHHHHHHHHHHHHHHhhhhcCCCCCcee
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAP------RNLNLLQRLNIAIDVASALDYLHHDCQPITTH  408 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH  408 (789)
                      +|....     ..++|.||+..|+|.++++..+........+      ..++....+.++.|||.||+||++..   +||
T Consensus       370 ~~t~~~-----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vH  441 (609)
T KOG0200|consen  370 ACTQDG-----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVH  441 (609)
T ss_pred             eeccCC-----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccc
Confidence            998744     7899999999999999998874111111111      34899999999999999999999776   999


Q ss_pred             cCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecc--cccccCcccCCCCCcCccccchhhHHHHHHHHH-hcC
Q 041249          409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKK  485 (789)
Q Consensus       409 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~  485 (789)
                      ||+-++|||+.++..+|++|||+|+...+........ -.|  ...|||||.+....|+.|+|||||||+|||++| |..
T Consensus       442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~  520 (609)
T KOG0200|consen  442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT  520 (609)
T ss_pred             hhhhhhhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence            9999999999999999999999999876655332111 112  235999999999999999999999999999998 999


Q ss_pred             CCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          486 PSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       486 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      ||.... ...++.++.+...                              |......|..++.+++..|++.++.+||+.
T Consensus       521 PYp~~~-~~~~l~~~l~~G~------------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F  569 (609)
T KOG0200|consen  521 PYPGIP-PTEELLEFLKEGN------------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTF  569 (609)
T ss_pred             CCCCCC-cHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence            986311 0111122222111                              122334677888899999999999999999


Q ss_pred             ccccccccc
Q 041249          566 KLAGSILPH  574 (789)
Q Consensus       566 ~~~~~~l~~  574 (789)
                      .+.......
T Consensus       570 ~~~~~~~~~  578 (609)
T KOG0200|consen  570 SECVEFFEK  578 (609)
T ss_pred             HHHHHHHHH
Confidence            887654443

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=3.1e-29  Score=268.71  Aligned_cols=203  Identities=27%  Similarity=0.359  Sum_probs=178.6

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .-...|....+||+|.|++|..|....++..||||.++...-  .....+.+|+++|..++|||||+++.+.....    
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~----  128 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA----  128 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc----
Confidence            345689999999999999999999999999999999865532  22345889999999999999999999987766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||..+|.+++++...          .+..+.....++.|+..|++|||+++   |||||||++|||++.++++
T Consensus       129 -~lylV~eya~~ge~~~yl~~~----------gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mni  194 (596)
T KOG0586|consen  129 -TLYLVMEYASGGELFDYLVKH----------GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNI  194 (596)
T ss_pred             -eeEEEEEeccCchhHHHHHhc----------ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccce
Confidence             899999999999999999765          34455778889999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCcc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ||+|||++.++....   .....+|++.|.|||+..+.+| ++++|+||+|+++|-|+.|..||+..
T Consensus       195 kIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  195 KIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             eeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence            999999999987554   2334679999999999998876 78899999999999999999999843

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=9.4e-29  Score=263.12  Aligned_cols=209  Identities=22%  Similarity=0.313  Sum_probs=171.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||.|+||.||+|.+..+++.||+|.++....  .....+.+|+++++++. |+||+++++++...+..+...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468889999999999999999998999999999865432  23467888999999995 699999999987665434445


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCcee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~k  425 (789)
                      .++||||+.+ ++.+++....+     .....+++.++..++.||++||+|||+.+   ++||||+|+||+++. ++.+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEE
Confidence            8999999985 88888764311     11346899999999999999999999888   999999999999998 88999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++|||.++........  .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999998865433211  122346788999998765 4579999999999999999999999863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.4e-28  Score=267.51  Aligned_cols=208  Identities=22%  Similarity=0.318  Sum_probs=170.8

Q ss_pred             cHHHHHHhh----cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeee
Q 041249          261 SYQNLHNAT----DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       261 ~~~~~~~~~----~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      +.+|+..++    ++|...+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|++++++++||||+++++
T Consensus         2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~   81 (342)
T cd07879           2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD   81 (342)
T ss_pred             chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence            445555554    78999999999999999999998889999999986432  223456889999999999999999999


Q ss_pred             eeccCCC-CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249          335 ACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP  413 (789)
Q Consensus       335 ~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~  413 (789)
                      ++..... ......++|+||+.. ++..+..            ..+++..+..++.|++.||+|||..+   ++||||||
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp  145 (342)
T cd07879          82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKP  145 (342)
T ss_pred             eecccccCCCCceEEEEeccccc-CHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence            8865431 122356899999974 6665542            34788999999999999999999988   99999999


Q ss_pred             CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +||+++.++.+||+|||+++......     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       146 ~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         146 GNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             HHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999988654322     23457888999999876 4689999999999999999999999973

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-28  Score=256.48  Aligned_cols=238  Identities=20%  Similarity=0.234  Sum_probs=182.5

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHH-hcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRAL-RSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|++|.||+|....+++.||+|+++....   .....+..|...+ ....|+|++++++++...+     ..++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEE
Confidence            468999999999999988899999999864321   2223344555544 4458999999999987655     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+++|.+++...          ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||.
T Consensus        77 e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  143 (260)
T cd05611          77 EYLNGGDCASLIKTL----------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGL  143 (260)
T ss_pred             eccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccc
Confidence            999999999998643          45788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD  511 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  511 (789)
                      ++.....      ....++..|+|||...+..++.++||||||+++|||++|..||.....     ............  
T Consensus       144 ~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--  210 (260)
T cd05611         144 SRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRI--  210 (260)
T ss_pred             ceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhccc--
Confidence            8765431      224578899999999888899999999999999999999999963211     111111100000  


Q ss_pred             hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                          ...                  ......+...+.+++..|++.++..|++..
T Consensus       211 ----~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         211 ----NWP------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             ----CCC------------------CcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence                000                  000112345567888999999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=2.2e-28  Score=254.39  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||.|++|.||++.+..+++.|++|++.....  .....+.+|+++++.++|+|++++.+.+...+     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-----~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-----KLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC-----EEE
Confidence            47778899999999999999998899999999976533  55677899999999999999999999887654     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+++++|.+++....      .....+++.++..++.+++.||+|||+.+   ++|+||+|+||++++++.++++|
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECC
Confidence            9999999999999986531      12467899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.+........  ......|+..|+|||......++.++||||||+++|+|++|+.||+...     ..+.........
T Consensus       147 ~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~  219 (258)
T cd08215         147 FGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ  219 (258)
T ss_pred             ccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC
Confidence            999987765431  1223458889999999988889999999999999999999999986321     222222211111


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...     +.                      ..+...+.+++..|++.++..||+......
T Consensus       220 ~~~-----~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPP-----IP----------------------SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCC-----CC----------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000     00                      022344567888999999999999877643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.5e-28  Score=263.45  Aligned_cols=203  Identities=28%  Similarity=0.370  Sum_probs=169.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||.|+||.||+|.+..+++.||+|.++....  .....+.+|++++++++|+||+++++++....   ...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence            4689999999999999999999998899999999865432  22345678999999999999999999986532   225


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+.+ +|.+++...         ...+++.++..++.|+++||+|||+.+   ++||||||+||++++++.+||
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL  149 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNM---------PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKI  149 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            7999999974 788887543         256899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||.+.........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       150 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         150 ADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             CccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999877543211  122335778999999865 4579999999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=1.1e-28  Score=262.80  Aligned_cols=253  Identities=19%  Similarity=0.205  Sum_probs=190.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      -++|...+.||+|++|.||+|.+..+++.||||.++.... .....+..|++.+.+. .|+||++++++|....     .
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----D   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----e
Confidence            4678889999999999999999998899999999965432 3345566777777676 5999999999997765     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCcee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      .++||||+. +++..++...         ...+++..+..++.|+++||+|||+ .+   ++||||+|+||++++++.+|
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~k  155 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRI---------QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVK  155 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEE
Confidence            999999986 4676666432         2468999999999999999999997 46   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCC----cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE----VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      |+|||.+.........   ....++..|+|||.+....    ++.++||||||+++|||++|+.||.....+    .+..
T Consensus       156 L~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~  228 (296)
T cd06618         156 LCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVL  228 (296)
T ss_pred             ECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHH
Confidence            9999999876543321   1234778999999987553    889999999999999999999998632111    1111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..........     +..                    ...+..++.+++..|.+.++..||+...+...
T Consensus       229 ~~~~~~~~~~-----~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         229 TKILQEEPPS-----LPP--------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHhcCCCCC-----CCC--------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111110000     000                    00123456678889999999999998776443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=2e-28  Score=258.75  Aligned_cols=272  Identities=19%  Similarity=0.178  Sum_probs=192.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||+|+||.||+|....+++.||+|.++... ........+|+..+.++. |+|++++++++.+..   ....++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            556788999999999999998889999999986542 223334567899999985 999999999987651   126899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+. |++.+++...         ...+++.++..++.|++.||+|||+.+   ++||||+|+||+++. +.+||+||
T Consensus        78 v~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          78 VFELMD-MNLYELIKGR---------KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             EEecCC-ccHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEec
Confidence            999997 5888877543         246899999999999999999999888   999999999999999 99999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.++........   ....++..|+|||.... ..++.++|||||||++|||++|+.||....  ......+........
T Consensus       144 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--~~~~~~~~~~~~~~~  218 (282)
T cd07831         144 GSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--ELDQIAKIHDVLGTP  218 (282)
T ss_pred             ccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--HHHHHHHHHHHcCCC
Confidence            999876543321   12347889999997654 557899999999999999999999996421  112222222222111


Q ss_pred             hhh---hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMD---IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~---~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..+   ...+.-....   ..... ....+ ..........+.+++.+|.+.+|..|++...+..
T Consensus       219 ~~~~~~~~~~~~~~~~---~~~~~-~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLKKFRKSRHMNY---NFPSK-KGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHHhhcccccccc---cCccc-ccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000   0000000000   00000 00000 0001234567789999999999999999876643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=295.53  Aligned_cols=203  Identities=27%  Similarity=0.397  Sum_probs=175.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      -++....+||.|.||.||.|...++|...|+|.++....  ...+...+|+.++..++|||+|++||+-.+.+     ..
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KV 1309 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HH
Confidence            367788899999999999999999999999999976643  33467889999999999999999999976655     67


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +|.||||.+|+|.+.+..          ++..++.....+..|++.|++|||.+|   ||||||||.||+++.++.+|++
T Consensus      1310 ~IFMEyC~~GsLa~ll~~----------gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----------GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh----------cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEee
Confidence            899999999999999853          356777778889999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCC--CccceeeecccccccCcccCCCCC---cCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          428 DFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       428 Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |||.|..+....  .........||+.|||||.+.+..   -..++||||+|||+.||+||+.||...
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence            999999887553  223344567999999999988754   356799999999999999999999844

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.6e-28  Score=265.82  Aligned_cols=205  Identities=25%  Similarity=0.313  Sum_probs=174.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||.|++|.||+|....+++.||||.+....  ....+.+.+|+++++.++|+||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998889999999986543  34457799999999999999999999998765433344689


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+. +++.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|
T Consensus        81 lv~e~~~-~~l~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          81 IVTELME-TDLHKVIKSP----------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             EEecchh-hhHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence            9999998 4888888543          37899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||.+......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~  209 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG  209 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence            9999987655311 112234578899999999887 789999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-29  Score=245.55  Aligned_cols=207  Identities=23%  Similarity=0.326  Sum_probs=175.3

Q ss_pred             cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      +|.|+-+-|     .+.+|+|+|+.|..+..-.+++++|||++.........+..+|++++... .|+||++++.+|.+.
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            355665555     36899999999999999999999999999877666677888999999999 599999999999877


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      .     ..|+|||-|.+|.|..++.+.          +-+++.+...+..+||.||.|||+.|   |.|||+||+|||..
T Consensus       149 ~-----~FYLVfEKm~GGplLshI~~~----------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~  210 (463)
T KOG0607|consen  149 T-----RFYLVFEKMRGGPLLSHIQKR----------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCE  210 (463)
T ss_pred             c-----eEEEEEecccCchHHHHHHHh----------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeec
Confidence            6     899999999999999999765          67899999999999999999999998   99999999999997


Q ss_pred             CCC---ceeeCcccccccCCCCC-----CccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCC
Q 041249          420 EEM---VSHVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       420 ~~~---~~kl~Dfgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      ...   -+||+||.+..-+....     .........|+..|||||+..-     -.|+.++|.||+|||+|-|++|..|
T Consensus       211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP  290 (463)
T KOG0607|consen  211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP  290 (463)
T ss_pred             CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence            655   45999998877554222     1222334668999999997542     3489999999999999999999999


Q ss_pred             CCcc
Q 041249          487 SDIM  490 (789)
Q Consensus       487 ~~~~  490 (789)
                      |-..
T Consensus       291 FvG~  294 (463)
T KOG0607|consen  291 FVGH  294 (463)
T ss_pred             ccCc
Confidence            9643

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-29  Score=258.14  Aligned_cols=201  Identities=23%  Similarity=0.351  Sum_probs=175.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .=|+.++.||+|-|..|-.|++--+|..||||++...+-  .....+.+|++.|+-++|||||++|.+.....     ..
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-----Kl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-----KL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-----eE
Confidence            347788999999999999999999999999999965532  33567889999999999999999999876554     79


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-Cceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl  426 (789)
                      |+|+|.-.+|+|.+|+.+.         ...+++.-..+++.||+.|+.|+|...   +|||||||+||.+.+. +-+||
T Consensus        93 yLiLELGD~GDl~DyImKH---------e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKL  160 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKH---------EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKL  160 (864)
T ss_pred             EEEEEecCCchHHHHHHhh---------hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEe
Confidence            9999999999999999754         356888899999999999999999665   9999999999988765 68899


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcC-ccccchhhHHHHHHHHHhcCCCCcc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .|||++..+.++..   ....+|+..|-|||++.+..|+ +.+||||+||+||-|++|+.||...
T Consensus       161 TDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA  222 (864)
T KOG4717|consen  161 TDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA  222 (864)
T ss_pred             eeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence            99999998877763   2345799999999999999985 6799999999999999999999744

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.2e-28  Score=269.34  Aligned_cols=202  Identities=22%  Similarity=0.255  Sum_probs=170.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .++|...+.||+|+||.||+|....+++.||+|.+...  .......+.+|+.++++++|+||+++++++..... ....
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46799999999999999999999989999999998533  23334567789999999999999999998764432 2223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+. +++.+.+..            .++..++..++.|++.||+|||..+   ++||||||+||+++.++.+|
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence            5799999997 478777632            2788889999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus       159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            999999987654321   2234578899999999988999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=3e-28  Score=257.94  Aligned_cols=203  Identities=27%  Similarity=0.367  Sum_probs=168.7

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      |+..+.||+|++|.||+|.+..+++.||+|+++....  .....+.+|++++.++   +|+|++++++++...+..+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999988899999999974422  2234566787776655   6999999999998776434445


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .+++|||+.+ ++.+++...        ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~--------~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC--------PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEE
Confidence            8999999984 888887543        2235899999999999999999999888   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||.+........   .....++..|+|||......++.++|||||||++|||++|+.||..
T Consensus       149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~  208 (287)
T cd07838         149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG  208 (287)
T ss_pred             eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence            99999987754432   1223478899999999988999999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.7e-28  Score=264.99  Aligned_cols=202  Identities=25%  Similarity=0.318  Sum_probs=170.1

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ++...+++|...+.||.|+||.||+|....+++.||+|.+...  .....+.+..|++++.+++||||+++.+++.... 
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-   82 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-   82 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence            4455788999999999999999999999989999999987543  2233567889999999999999999999875422 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                         ...++|+||+. ++|.+++..           ..+++.....++.|+++||+|||+.+   ++||||+|+||+++++
T Consensus        83 ---~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~  144 (328)
T cd07856          83 ---EDIYFVTELLG-TDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINEN  144 (328)
T ss_pred             ---CcEEEEeehhc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCC
Confidence               26789999985 688887743           24678888899999999999999988   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.+|++|||.+.......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       145 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         145 CDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             CCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999988654322     12346788999998766 5689999999999999999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=2.2e-28  Score=255.60  Aligned_cols=193  Identities=26%  Similarity=0.385  Sum_probs=167.2

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||+|+||.||++.+..+++.|++|.+.....   .....+.+|++.+++++|+||+++++.+....     ..++|+||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-----NLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc-----EEEEEEecC
Confidence            6899999999999998899999999865433   34567889999999999999999998876554     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      .+++|.+++...          ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+|++|||++..
T Consensus        76 ~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          76 PGGDLASLLENV----------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             CCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            999999998643          36899999999999999999999888   99999999999999999999999999886


Q ss_pred             CCCCCC------ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          435 LPPTHV------QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       435 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ......      ........++..|+|||......++.++||||||+++||+++|+.||.
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  202 (265)
T cd05579         143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH  202 (265)
T ss_pred             cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            554321      112233457889999999988889999999999999999999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=3.2e-28  Score=257.22  Aligned_cols=275  Identities=22%  Similarity=0.204  Sum_probs=198.7

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||.|++|.||+|....+++.+++|.++....  .....+..|++++++++|+||+++++++....     ..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-----DLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC-----CEEE
Confidence            5567889999999999999988899999999865533  34567889999999999999999999987655     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+.+ ++.+++...         ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+|++||
T Consensus        76 v~e~~~~-~l~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df  142 (283)
T cd05118          76 VFEFMDT-DLYKLIKDR---------QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADF  142 (283)
T ss_pred             EEeccCC-CHHHHHHhh---------cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeee
Confidence            9999985 888877543         246899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      |.+........  ......++..|+|||...+. .++.++||||||+++|+|++|+.||.....  .....-........
T Consensus       143 ~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~  218 (283)
T cd05118         143 GLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTP  218 (283)
T ss_pred             eeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCC
Confidence            99987765431  11224577889999998776 689999999999999999999999863211  11111111111111


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhh-hhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQR-QIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..+..........  .......... ........+....+.+++..|++.++..||+......
T Consensus       219 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         219 DPEVWPKFTSLAR--NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             chHhcccchhhhh--hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000000000  0000000000 0000111245667889999999999999999887643

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=1.7e-28  Score=258.73  Aligned_cols=202  Identities=25%  Similarity=0.424  Sum_probs=175.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|++|.||+|....+++.||+|++...   .....+.+..|++++.++. |+||+++++.+...+     
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE-----   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-----
Confidence            4688889999999999999999989999999998643   2333567889999999998 999999999887655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+++|.+++...          ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~  142 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK  142 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence            789999999999999998643          36899999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc------------------cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          426 VGDFGLARFLPPTHVQ------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      ++|||++.........                  .......++..|+|||......++.++||||||++++++++|+.||
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            9999999876544321                  1222345788999999998888999999999999999999999999


Q ss_pred             Cc
Q 041249          488 DI  489 (789)
Q Consensus       488 ~~  489 (789)
                      ..
T Consensus       223 ~~  224 (280)
T cd05581         223 RG  224 (280)
T ss_pred             CC
Confidence            73

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=3.9e-28  Score=259.32  Aligned_cols=210  Identities=26%  Similarity=0.349  Sum_probs=172.0

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCC---
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVD---  340 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  340 (789)
                      +.+.++|+..+.||+|++|.||+|....+++.||+|.++...  ......+..|++++++++||||+++++++....   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999999889999999997543  223456788999999999999999999886543   


Q ss_pred             --CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          341 --YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       341 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                        .......++|+||+.+ ++...+...         ...+++..+..++.|++.||+|||+.+   ++||||||+||++
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili  149 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG---------LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILL  149 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence              1122368999999986 666666432         246899999999999999999999888   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++++.+||+|||.+......... ......++..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         150 NNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             CCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999876544321 11223457789999987654 478999999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.3e-28  Score=264.77  Aligned_cols=209  Identities=22%  Similarity=0.308  Sum_probs=173.2

Q ss_pred             cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      .-.++...+++|...+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|++++.+++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34567778899999999999999999999998889999999986432  2234567889999999999999999998764


Q ss_pred             CCC-CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          339 VDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       339 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ... ......+++++++ +++|.+++..           ..+++..+..++.|+++||+|||+.+   ++||||||+||+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl  152 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA  152 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEE
Confidence            332 1222467888876 6788887742           35789999999999999999999988   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +++++.+||+|||++.......     ....++..|+|||...+ ..++.++|||||||++|||++|+.||..
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999988654322     23457889999998766 4688999999999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=1.7e-28  Score=262.86  Aligned_cols=248  Identities=26%  Similarity=0.283  Sum_probs=191.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +.|+..+.||+|++|.||+|....+++.||+|.+...   .......+.+|+++++.++|+|++++++++....     .
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----e
Confidence            4477788999999999999999888999999998643   2233456788999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+. |++.+.+...         ...+++.++..++.|++.|+.|||+.+   ++||||+|+||+++.++.+|+
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~---------~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl  156 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL  156 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEE
Confidence            899999997 6887776432         245789999999999999999999887   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||++.......      ...++..|+|||.+.   .+.++.++|||||||++|||++|+.||...... .....+.+.
T Consensus       157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~  229 (308)
T cd06634         157 GDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN  229 (308)
T ss_pred             CCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhc
Confidence            9999988764322      245788999999874   356899999999999999999999998632100 000111110


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..         +..                     ....+...+.+++.+|++..+..||+...+...+
T Consensus       230 ~~---------~~~---------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         230 ES---------PAL---------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CC---------CCc---------------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            00         000                     0012234456788899999999999988765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=2.6e-28  Score=259.69  Aligned_cols=201  Identities=26%  Similarity=0.344  Sum_probs=166.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||.|++|+||+|....+++.||+|.+.....  ...+.+..|++++++++|+||+++++++....     ..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eE
Confidence            468888999999999999999988899999999865432  23467889999999999999999999987655     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl  426 (789)
                      ++||||+. +++.+++...        ....+++.....++.|++.||+|||+.+   ++|+||+|+||+++. ++.+|+
T Consensus        77 ~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl  144 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSS--------PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKL  144 (294)
T ss_pred             EEEEeccc-ccHHHHHHhC--------CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEE
Confidence            99999996 5787777543        2234577888899999999999999887   999999999999985 557899


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++.........  .....++..|+|||.+.+. .++.++|||||||++|+|+||+.||..
T Consensus       145 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        145 ADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             cccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999866443211  1223467899999988664 579999999999999999999999964

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.3e-28  Score=251.76  Aligned_cols=198  Identities=30%  Similarity=0.427  Sum_probs=174.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|...+.||+|++|.||++....+++.|++|.+.....  .....+.+|++++++++|+|++++++++....     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Confidence            46778899999999999999988899999999976543  45578999999999999999999999987654     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+++|.+++...          ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d  142 (254)
T cd06627          76 IILEYAENGSLRQIIKKF----------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLAD  142 (254)
T ss_pred             EEEecCCCCcHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEec
Confidence            999999999999998543          46899999999999999999999888   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||.+.........  .....++..|+|||......++.++||||||+++|+|++|+.||.
T Consensus       143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~  200 (254)
T cd06627         143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY  200 (254)
T ss_pred             cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            9999987654432  223458889999999888789999999999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=4.1e-28  Score=257.56  Aligned_cols=199  Identities=24%  Similarity=0.323  Sum_probs=167.8

Q ss_pred             CCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      +|...+.||+|+||.||.+...   .+++.||+|+++...    ....+.+..|++++.++ .|+||+++++.+....  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence            4677889999999999999874   368999999986432    23346788899999999 5999999998876654  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++|+||+++++|.+++...          ..+++.++..++.|++.||.|||..+   ++||||+|+||+++.++
T Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~  142 (290)
T cd05613          79 ---KLHLILDYINGGELFTHLSQR----------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNG  142 (290)
T ss_pred             ---eEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCC
Confidence               789999999999999998643          45788899999999999999999888   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCC
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++||+|||+++........ ......|+..|+|||.....  .++.++||||||+++|+|++|+.||.
T Consensus       143 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  209 (290)
T cd05613         143 HVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT  209 (290)
T ss_pred             CEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence            9999999999876543321 11234588899999998753  47889999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-29  Score=267.70  Aligned_cols=199  Identities=25%  Similarity=0.361  Sum_probs=174.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      -|.+...||.|+||.||+|..++++...|-|++.....+....|.-||++++...||+||++++.|....     ..||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence            3455677999999999999999888889999998888888899999999999999999999999887655     89999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      .|||.+|-....+..-         ++.+++.++.-+++|++.||.|||+..   |+|||||+.|||++-+|.++|+|||
T Consensus       108 iEFC~GGAVDaimlEL---------~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFG  175 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLEL---------GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFG  175 (1187)
T ss_pred             EeecCCchHhHHHHHh---------ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccc
Confidence            9999999998887643         578999999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      .+......  ......+.||+.|||||+...     .+|+.++||||||++|.||..+.+|..
T Consensus       176 VSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh  236 (1187)
T KOG0579|consen  176 VSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH  236 (1187)
T ss_pred             ccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence            87654321  122345779999999998654     469999999999999999999999976

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=3.5e-28  Score=263.29  Aligned_cols=204  Identities=23%  Similarity=0.283  Sum_probs=166.6

Q ss_pred             CCCCCCcccccCCccEEEEEEcCC--ceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      +|...+.||+|+||.||++....+  ++.||+|.+...  .....+.+.+|++++.++ .||||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            467788999999999999999877  889999998643  222346678899999999 5999999998754321 1223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++++||+. ++|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG----------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEE
Confidence            5788889887 6898888533          56889999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc--cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.++........  .......|+..|+|||...+ ..++.++|||||||++|+|++|+.||..
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            9999999876543321  11223458899999998765 4689999999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=3.3e-28  Score=263.00  Aligned_cols=199  Identities=23%  Similarity=0.283  Sum_probs=162.9

Q ss_pred             Cccccc--CCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTG--SFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      ..||.|  +||+||++.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+     ..++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEE
Confidence            356776  88999999998899999999987543  233467889999999999999999999998765     789999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+..|++.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|++||+.
T Consensus        79 e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226          79 PFMAYGSANSLLKTY--------FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             ecccCCCHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHH
Confidence            999999999988654        2345889999999999999999999887   99999999999999999999999986


Q ss_pred             cccCCCCCCc-----cceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          432 ARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       432 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +.........     .......++..|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            5433221110     011112355679999998764  4789999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.3e-28  Score=256.33  Aligned_cols=198  Identities=26%  Similarity=0.336  Sum_probs=167.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||.|++|+||+|....+++.|+||.+..... .......+|++.+.+++ |+|++++++++....     ..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-----~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND-----ELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC-----cEEE
Confidence            5667899999999999999988899999999865432 22334567999999998 999999999987754     8899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+ +|++.+++...        .+..+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          76 VFEYM-EGNLYQLMKDR--------KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             EEecC-CCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeec
Confidence            99999 78999888654        2356899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.+.........   ....++..|+|||.... ..++.++||||||+++|||++|+.||..
T Consensus       144 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~  201 (283)
T cd07830         144 GLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG  201 (283)
T ss_pred             ccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence            999876543321   12347889999998754 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=4.3e-28  Score=260.54  Aligned_cols=192  Identities=23%  Similarity=0.215  Sum_probs=159.4

Q ss_pred             CCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCCh
Q 041249          282 SFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSL  359 (789)
Q Consensus       282 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L  359 (789)
                      +++.||.++...+++.||+|+++..  .....+.+..|++.+++++|+||+++++++....     ..+++|||+.+|++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEeccCCCCH
Confidence            4556666666668999999998754  3445678999999999999999999999987655     78999999999999


Q ss_pred             hhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC
Q 041249          360 EEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH  439 (789)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  439 (789)
                      .+++...        ....+++.....++.|+++||+|||+.+   |+||||||+||+++.++.+|++|||.+.......
T Consensus        87 ~~~l~~~--------~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          87 EDLLKTH--------FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             HHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            9998643        2345788999999999999999999988   9999999999999999999999999887654322


Q ss_pred             C-----ccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          440 V-----QTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       440 ~-----~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .     ........++..|+|||.+...  .++.++|||||||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~  212 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD  212 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            1     1122234577889999998763  588999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=9.1e-28  Score=257.75  Aligned_cols=193  Identities=30%  Similarity=0.373  Sum_probs=164.3

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      |...+.||+|+||+||+|....+++.|++|.+.....   .....+..|+++++.++|||++++++++.+..     ..+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence            5556789999999999999988899999999864322   23356788999999999999999999988765     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+. |++.+++...         ...+++.++..++.|++.|++|||+.+   ++|+||+|+||++++++.+||+|
T Consensus        98 lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~d  164 (313)
T cd06633          98 LVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLAD  164 (313)
T ss_pred             EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEee
Confidence            9999996 5777776432         345899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||.+......      ....|+..|+|||++.   .+.++.++|||||||++|||++|..||.
T Consensus       165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         165 FGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             cCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9998654322      2345788999999974   4568999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=3.7e-28  Score=264.16  Aligned_cols=205  Identities=23%  Similarity=0.339  Sum_probs=168.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC-------
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ-------  342 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-------  342 (789)
                      .+|...+.||.|+||.||+|....+++.||+|.+........+.+.+|++++++++||||+++++.+......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788899999999999999999989999999999776666667889999999999999999999876543211       


Q ss_pred             --CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          343 --GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       343 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                        .....++|+||+. ++|.+++..           ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~  149 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-----------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT  149 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence              1125789999998 588887742           35788999999999999999999988   999999999999984


Q ss_pred             -CCceeeCcccccccCCCCCCc-cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          421 -EMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       421 -~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                       ++.+|++|||.++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             567899999999866433211 11122357889999997654 4588999999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=9.5e-29  Score=229.50  Aligned_cols=221  Identities=24%  Similarity=0.286  Sum_probs=179.6

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      ++...++......||.|++|.|-+-++..+|+..|+|.++.. ..+.+++...|+++..+- .+|.+|.+||......  
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--  118 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--  118 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--
Confidence            556667777788999999999999999999999999999755 345567778888877666 7999999999865544  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..|+.||.|.. ++..+-.+.      ...+..+++.-.-+||..|..||.|||++-  .++|||+||+|||++.++
T Consensus       119 ---dvwIcME~M~t-Sldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G  186 (282)
T KOG0984|consen  119 ---DVWICMELMDT-SLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG  186 (282)
T ss_pred             ---cEEEeHHHhhh-hHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence               79999999985 666655322      234677888999999999999999999864  599999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCC----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                      ++|++|||.+..+.++..   .+...|-..|||||.+..    ..|+.|+||||+|+++.||.+++.||+.......-+.
T Consensus       187 qVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk  263 (282)
T KOG0984|consen  187 QVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK  263 (282)
T ss_pred             cEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence            999999999988876542   233458889999998764    3589999999999999999999999986544444444


Q ss_pred             HHHH
Q 041249          499 NFAR  502 (789)
Q Consensus       499 ~~~~  502 (789)
                      +.+.
T Consensus       264 qvVe  267 (282)
T KOG0984|consen  264 QVVE  267 (282)
T ss_pred             HHhc
Confidence            4433

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=6.9e-28  Score=261.45  Aligned_cols=201  Identities=23%  Similarity=0.313  Sum_probs=166.3

Q ss_pred             cCCC-CCCcccccCCccEEEEEEcCCceEEEEEEeccccchh--------------hHHHHHHHHHHhcCCCCccceeee
Q 041249          270 DGFS-SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--------------SRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       270 ~~f~-~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      +.|. ..+.||.|+||+||+|....+++.||||.++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3577999999999999998889999999986442221              125778999999999999999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      ++....     ..++||||+. |++.+++...          ..+++.....++.|++.||+|||..+   ++|+||+|+
T Consensus        88 ~~~~~~-----~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~  148 (335)
T PTZ00024         88 VYVEGD-----FINLVMDIMA-SDLKKVVDRK----------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPA  148 (335)
T ss_pred             EEecCC-----cEEEEEeccc-cCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHH
Confidence            987655     7899999997 6899888543          45889999999999999999999888   999999999


Q ss_pred             ceecCCCCceeeCcccccccCCCCCC------------ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHH
Q 041249          415 NILLDEEMVSHVGDFGLARFLPPTHV------------QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI  481 (789)
Q Consensus       415 Nill~~~~~~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~ell  481 (789)
                      ||+++.++.+|++|||.+.....+..            ........++..|+|||.+.+. .++.++|||||||++|||+
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999987652210            0111223467889999998764 4799999999999999999


Q ss_pred             HhcCCCCc
Q 041249          482 IRKKPSDI  489 (789)
Q Consensus       482 tG~~P~~~  489 (789)
                      +|+.||..
T Consensus       229 tg~~p~~~  236 (335)
T PTZ00024        229 TGKPLFPG  236 (335)
T ss_pred             hCCCCCCC
Confidence            99999974

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=6.7e-29  Score=243.66  Aligned_cols=207  Identities=25%  Similarity=0.330  Sum_probs=174.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCC----ceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEG----RTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ..|.....||.|.||.||+|.-.++    .+.+|||.++..++  ......-+|++.++.++|||++.+..++...+   
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d---  100 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD---  100 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---
Confidence            4678888999999999999976533    34789999976643  23566788999999999999999999987643   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC--
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--  421 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--  421 (789)
                       ...++++||.+. +|.+.++-.+.     ...+.++......|+.||+.|+.|||++.   |+||||||+|||+..+  
T Consensus       101 -~~v~l~fdYAEh-DL~~II~fHr~-----~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgp  170 (438)
T KOG0666|consen  101 -KKVWLLFDYAEH-DLWHIIKFHRA-----SKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGP  170 (438)
T ss_pred             -ceEEEEehhhhh-hHHHHHHHhcc-----chhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCC
Confidence             378999999997 78888765422     23467899999999999999999999999   9999999999999877  


Q ss_pred             --CceeeCcccccccCCCCCC-ccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 --MVSHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 --~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                        |.+||+|+|+++.+...-. -.....+.-|+.|+|||.+.+.+ ||...||||.||+..||+|-++-|..
T Consensus       171 erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  171 ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence              8999999999999876653 33455677899999999999876 99999999999999999999988864

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=6.2e-28  Score=255.95  Aligned_cols=199  Identities=25%  Similarity=0.339  Sum_probs=167.4

Q ss_pred             CCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      +|...+.||+|++|.||++...   .+++.||||+++...    ....+.+..|++++.++ .|+||+++++.+....  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence            4677889999999999999864   356889999986432    23346688999999999 5999999998876655  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++...          ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++
T Consensus        79 ---~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~  142 (288)
T cd05583          79 ---KLHLILDYVNGGELFTHLYQR----------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEG  142 (288)
T ss_pred             ---EEEEEEecCCCCcHHHHHhhc----------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCC
Confidence               789999999999999988543          45788999999999999999999887   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCC
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      .++++|||+++........ ......|+..|+|||...+..  .+.++||||||+++|||++|..||.
T Consensus       143 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  209 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT  209 (288)
T ss_pred             CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence            9999999998876543321 122345888999999987665  7899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=9.9e-29  Score=257.02  Aligned_cols=194  Identities=26%  Similarity=0.381  Sum_probs=171.1

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE  352 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  352 (789)
                      .+++|+|-||+||-|.++.+|+.||||++...  .......+++|++++.++.||.||.+-.-|...+     ..+.|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence            68999999999999999999999999999644  2334578999999999999999999988887666     8899999


Q ss_pred             ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCceeeCcc
Q 041249          353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVSHVGDF  429 (789)
Q Consensus       353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df  429 (789)
                      -+.+.-|+-.+..         ...++++.....++.||+.||.|||..+   |||.||||+|||+..   -..+||+||
T Consensus       644 Kl~GDMLEMILSs---------EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  644 KLHGDMLEMILSS---------EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             hhcchHHHHHHHh---------hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccc
Confidence            9986555555543         4577999999999999999999999998   999999999999953   358899999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |.|++++....   ...+.||+.|.|||++.+..|...-|+||.||++|.-++|.-||.
T Consensus       712 GfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  712 GFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             cceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence            99999987763   345789999999999999999999999999999999999999996

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=6.5e-28  Score=258.66  Aligned_cols=208  Identities=23%  Similarity=0.329  Sum_probs=169.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---CC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDY---QG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~  343 (789)
                      .++|...+.||.|++|.||+|.+..+++.||+|.+.....  .....+.+|++++++++|+||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999998899999999865432  223467789999999999999999988755431   11


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                      ....++|+||+.. ++...+...         ...+++.++..++.|+++||+|||+.+   ++|+||||+||++++++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---------SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI  153 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            2357999999885 666666432         346899999999999999999999988   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCc---------cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQ---------TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|++|||+++........         .......++..|+|||..... .++.++|||||||++|||++|+.||..
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            999999999876543311         111234567889999987654 589999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=4.8e-28  Score=275.27  Aligned_cols=204  Identities=20%  Similarity=0.259  Sum_probs=158.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCce-EEEEEE--------------ec---cccchhhHHHHHHHHHHhcCCCCccc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRT-TVTVKV--------------FN---LHHHRASRSFIAECRALRSIRHRNLV  330 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~-~vavK~--------------~~---~~~~~~~~~~~~e~~~l~~l~h~niv  330 (789)
                      .++|...+.||+|+||+||++.++.... .+++|.              +.   .........+.+|++++++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999988753322 122221              10   01122345688999999999999999


Q ss_pred             eeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecC
Q 041249          331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD  410 (789)
Q Consensus       331 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~d  410 (789)
                      ++++++...+     ..++|+|++. +++.+++.....     .........+...|+.|++.||+|||+.+   |||||
T Consensus       227 ~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrD  292 (501)
T PHA03210        227 KIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRD  292 (501)
T ss_pred             cEeEEEEECC-----eeEEEEeccc-cCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9999987765     7899999886 577777653311     11122345667889999999999999988   99999


Q ss_pred             CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      |||+|||++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus       293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999999877543321 122356899999999999989999999999999999999987543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=7.3e-28  Score=261.94  Aligned_cols=202  Identities=24%  Similarity=0.320  Sum_probs=169.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~  344 (789)
                      .+++|...+.||+|++|.||+|....+++.||+|++...  .......+.+|++++++++|+|++++.+++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            357899999999999999999999988999999998643  22334567789999999999999999987765442 222


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++|+||+. ++|.+++..           ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        93 ~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          93 QDVYLVTHLMG-ADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             ccEEEEEecCC-CCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence            34899999984 689888843           35899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||.+.......     ....++..|+|||.... ..++.++|||||||++||+++|+.||..
T Consensus       158 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         158 KILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             EEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999999998764331     22357888999998765 3678999999999999999999999963

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=1.4e-27  Score=249.15  Aligned_cols=250  Identities=19%  Similarity=0.216  Sum_probs=190.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      |...+.||+|+||.||++.+...+..+++|+++..     .......+..|+.++++++||||+++++++....     .
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   76 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-----A   76 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----c
Confidence            67788999999999999999877777777776432     2223445778999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+.+++|.+++...      ......+++.++..++.|++.|+.|||+.+   ++|+||+|+||++++ ..+|+
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l  146 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEEL------KHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKI  146 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHH------hhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEee
Confidence            89999999999999888542      112356899999999999999999999888   999999999999976 56999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.++.......  ......|+..|+|||......++.++||||||+++|+|++|..||...     ...........
T Consensus       147 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~  219 (260)
T cd08222         147 GDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVE  219 (260)
T ss_pred             cccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHc
Confidence            99999887644321  122345788999999988888899999999999999999999998632     11122111111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .     ..+..                      ...+..++.+++.+|++.++-.||+......
T Consensus       220 ~-----~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 G-----PTPSL----------------------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C-----CCCCC----------------------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            0     01111                      0123345667888999999999998876643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-27  Score=251.72  Aligned_cols=198  Identities=28%  Similarity=0.380  Sum_probs=170.2

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |+..+.||.|++|.||+|+...+++.||+|++....  ....+.+..|++++++++|+|++++++++....     ..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER-----KLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC-----ceEE
Confidence            456788999999999999999889999999997653  334567888999999999999999999987654     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |+||+. ++|.+++...         ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+||
T Consensus        76 v~e~~~-~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~  142 (282)
T cd07829          76 VFEYCD-MDLKKYLDKR---------PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADF  142 (282)
T ss_pred             EecCcC-cCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecC
Confidence            999998 5899998643         146899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.++........  .....++..|+|||..... .++.++|||||||++||+++|+.||..
T Consensus       143 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         143 GLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             CcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999876544321  1223456789999998776 789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.1e-27  Score=258.19  Aligned_cols=203  Identities=23%  Similarity=0.302  Sum_probs=169.8

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QG  343 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~  343 (789)
                      ...++|...+.||+|+||.||+|....+++.||||.+....  ......+..|++++++++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34678999999999999999999998899999999985432  2234568899999999999999999998865431 12


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                      ....++|+||+ ++++.+++..           ..+++.++..++.|++.||+|||..+   |+||||||+||+++.++.
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~  156 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE  156 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence            23468999998 5688887742           35789999999999999999999888   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|++|||.+.......     ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||..
T Consensus       157 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         157 LKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             EEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999998654332     23457889999998876 4589999999999999999999999973

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.7e-27  Score=245.33  Aligned_cols=192  Identities=29%  Similarity=0.360  Sum_probs=167.6

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      ||.|++|.||++....+++.+|+|.++....   .....+..|++++++++|+||+++++.+....     ..++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-----KLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC-----eeEEEEecC
Confidence            6899999999999988899999999865432   24567899999999999999999999887655     899999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      .+++|.+++...          ..+++.....++.|++.|+.|+|+.+   ++|+||+|+||+++.++.++++|||.+..
T Consensus        76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~  142 (250)
T cd05123          76 PGGELFSHLSKE----------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE  142 (250)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCccee
Confidence            999999998643          35899999999999999999999887   99999999999999999999999999987


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ......  ......++..|+|||.......+.++||||||+++||+++|+.||..
T Consensus       143 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         143 LSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             cccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            654321  12345578899999999888899999999999999999999999963

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=235.91  Aligned_cols=250  Identities=19%  Similarity=0.188  Sum_probs=189.9

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ......||.|.-|.|++++++.+++..|||..... ..+..+++...++++.+- ..|.||+-+|+|....     ..++
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~I  168 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVFI  168 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHHH
Confidence            34456799999999999999999999999998644 445566777777777666 4899999999997655     6788


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      .||.|.. =++.++..         ..+.+++.-.-++..-+.+||.||.+..  .|+|||+||+|||+|+.+++|++||
T Consensus       169 cMelMs~-C~ekLlkr---------ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  169 CMELMST-CAEKLLKR---------IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             HHHHHHH-HHHHHHHH---------hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence            8998863 23333321         2355788888899999999999998865  4999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |++..+-++..   .+...|-+.|||||-+.-   .+|+.++||||||++++||.||+.||....-+...+..... .. 
T Consensus       237 GIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e-  311 (391)
T KOG0983|consen  237 GISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE-  311 (391)
T ss_pred             cccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC-
Confidence            99988766553   344568899999998864   46999999999999999999999999753323222222222 11 


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                             .|.+++..                    .+.....+....|...+.-+||.......
T Consensus       312 -------PP~L~~~~--------------------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 -------PPLLPGHM--------------------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -------CCCCCccc--------------------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                   13333211                    23445667788999999999998876644

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=237.77  Aligned_cols=203  Identities=23%  Similarity=0.283  Sum_probs=171.8

Q ss_pred             hhcCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          268 ATDGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       268 ~~~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      -|++|++. ++||-|-.|.|-.+..+.+++.+|+|++.+.     ...++|++..=.. .|||||.+++++... +.+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            36777764 5899999999999999999999999998644     3456777766555 699999999998654 34555


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---C
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---M  422 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~  422 (789)
                      -..+|||.|++|.|...+.+.        ..+.+++.+...|..||+.|+.|||+.+   |+||||||+|+|....   -
T Consensus       133 cLLiVmE~meGGeLfsriq~~--------g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDR--------GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             eeEeeeecccchHHHHHHHHc--------ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence            678999999999999999765        5678999999999999999999999998   9999999999999643   4


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ..||+|||.|+......   .....+=|+.|.|||++-..+|+..+|+||+||++|-|++|.+||+..
T Consensus       202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence            67999999999865432   223355688999999999999999999999999999999999999743

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-29  Score=242.97  Aligned_cols=253  Identities=23%  Similarity=0.246  Sum_probs=188.0

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      ....||.|.||+|++-.++..|+..|||.++.... ..++++..|.+...+- +.||||++||.+..+.     ..|+.|
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiCM  142 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWICM  142 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeeeH
Confidence            34579999999999999999999999999986644 5567788888865555 7999999999987766     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      |.|.- ++..+-+..     -......+++.-.-+|..-...||.||...-  .|+|||+||+|||++..|.+||+|||+
T Consensus       143 ELMd~-SlDklYk~v-----y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGI  214 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRV-----YSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGI  214 (361)
T ss_pred             HHHhh-hHHHHHHHH-----HHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccc
Confidence            99985 544433211     0012346778878888888999999997643  599999999999999999999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      +..+..+.   ..+...|-.+|||||-+...  .|+.++||||+|++|||+.||+-|+.....   .+.+..+-.     
T Consensus       215 cGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv-----  283 (361)
T KOG1006|consen  215 CGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVV-----  283 (361)
T ss_pred             hHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHH-----
Confidence            88765543   23445688999999988653  399999999999999999999999863211   112221111     


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                        .-||.+...                ..+-.+....+...+..|.-.+.-+||.....
T Consensus       284 --~gdpp~l~~----------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~L  324 (361)
T KOG1006|consen  284 --IGDPPILLF----------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDL  324 (361)
T ss_pred             --cCCCCeecC----------------cccccccCHHHHHHHHHHhhcccccCcchhhh
Confidence              112211111                11112345667788889999999898887654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.95  E-value=2e-30  Score=287.31  Aligned_cols=224  Identities=25%  Similarity=0.359  Sum_probs=187.1

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEc
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      .++..+++..+...... +.+..+.+|+.|+..+|+++ .+|..+....+|+.|++.+|.++ -+|....+++.|++|+|
T Consensus       241 ~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL  317 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL  317 (1081)
T ss_pred             ccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence            34556666666666544 78888999999999999997 78888889999999999999998 77888888999999999


Q ss_pred             ccCCCCCCCCccc-CCCC-CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc
Q 041249          635 AKNQLMGKIPSDF-GSLS-KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       635 ~~N~l~~~~~~~~-~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      ..|+|. ..|+.| .-+. .|..|+.+.|++.......=..++.|+.|++.+|.++...-..+.+.++|++|+|++|+|.
T Consensus       318 ~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~  396 (1081)
T KOG0618|consen  318 QSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN  396 (1081)
T ss_pred             hhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence            999998 566544 3333 3888888999887333212234678999999999999887778999999999999999999


Q ss_pred             ccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          713 GIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       713 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ......+.++..|++|+||+|+++ .+|..+. +++.|+.|...+|+|. ..| .+..++.|+.+|++.|.++-
T Consensus       397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva-~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVA-NLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             cCCHHHHhchHHhHHHhcccchhh-hhhHHHH-hhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            555567789999999999999999 9998887 8999999999999999 567 88999999999999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=215.59  Aligned_cols=198  Identities=24%  Similarity=0.370  Sum_probs=169.6

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +|+..++||+|.||+||+|+..++++.||+|.++...  ........+|+.+++.++|+|||++++...+..     ...
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-----klt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-----eeE
Confidence            4666789999999999999999999999999997653  344677899999999999999999999877655     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.. +|..+....         ...++......++.|+++|+.|+|++.   +.|||+||.|.+|+.+++.|++|
T Consensus        78 lvfe~cdq-dlkkyfdsl---------ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelklad  144 (292)
T KOG0662|consen   78 LVFEFCDQ-DLKKYFDSL---------NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLAD  144 (292)
T ss_pred             EeHHHhhH-HHHHHHHhc---------CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecc
Confidence            99999985 788887644         356788889999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHH-hcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELII-RKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~ellt-G~~P~~  488 (789)
                      ||+++..+-+..  ......-|..|.+|+.+.+.+ |++..|+||-||++.|+.- |++-|.
T Consensus       145 fglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  145 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             cchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence            999998765431  122345788999999999876 8999999999999999997 554443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-27  Score=261.31  Aligned_cols=270  Identities=21%  Similarity=0.209  Sum_probs=212.7

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      .+.++.+..-++.|.+.++||+|.+|.||+++...+++.+|+|+..... ....+.+.|..++..+ .|||++.++|++.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            4445556667889999999999999999999999999999999986554 3346788899999998 6999999999998


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      -.+....+..|+|||||.+|+..++++..        .+.++.|..+.-|+++++.|+.|||...   ++|||+|=.|||
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~--------~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiL  155 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNT--------KGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVL  155 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhh--------cccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEE
Confidence            88877788899999999999999999876        2678999999999999999999999887   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-----CcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----EVSTNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      +++++.+|+.|||.+.-....-  ....-..||+.|||||++...     .|+.++|+||+|++..||.-|.+|+.+...
T Consensus       156 LT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  156 LTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            9999999999999988654322  112234599999999998764     478899999999999999999999974322


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      -    ...+.      +...-.|.+.                    ....-..++.+.+..|...+...||.......++
T Consensus       234 m----raLF~------IpRNPPPkLk--------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  234 M----RALFL------IPRNPPPKLK--------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             h----hhhcc------CCCCCCcccc--------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence            1    01100      0011111111                    1112234556777888888888888887665543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=7.6e-28  Score=273.97  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=188.9

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC---
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ---  342 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  342 (789)
                      +.-++|...+.||+||||.||+++.+-+|+.+|||.+.... ........+|+..+++++|||||+|+....+....   
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45578889999999999999999999999999999997664 33346688899999999999999998764332200   


Q ss_pred             ----------------------------------------------------------C---------------------
Q 041249          343 ----------------------------------------------------------G---------------------  343 (789)
Q Consensus       343 ----------------------------------------------------------~---------------------  343 (789)
                                                                                +                     
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                      0                     


Q ss_pred             ------------------------C--------ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHH
Q 041249          344 ------------------------N--------DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV  391 (789)
Q Consensus       344 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  391 (789)
                                              .        ...||=||||+.-++++++..++...         ......+++++|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---------~~d~~wrLFreI  706 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---------QRDEAWRLFREI  706 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---------hhHHHHHHHHHH
Confidence                                    0        12466678888877777776552111         244567899999


Q ss_pred             HHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC-----------CC-----CCccceeeecccccccC
Q 041249          392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----------PT-----HVQTSSIGVKGSIGYIA  455 (789)
Q Consensus       392 a~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~-----------~~-----~~~~~~~~~~gt~~y~a  455 (789)
                      ++||+|+|++|   ||||||||.|||++++..+||+|||+|....           +.     ......+...||..|+|
T Consensus       707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            99999999998   9999999999999999999999999999821           00     01223456779999999


Q ss_pred             cccCCCC---CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhh
Q 041249          456 PEYGLGS---EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQ  532 (789)
Q Consensus       456 PE~~~~~---~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  532 (789)
                      ||.+.+.   +|+.|+|+||+|||++||+.   ||...++....+.+..+..+|.. .+..|+...              
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~~--------------  845 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEHP--------------  845 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccch--------------
Confidence            9998764   49999999999999999985   46655554444444433333332 222333222              


Q ss_pred             hhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          533 RQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       533 ~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                                   .-..++.+..+-+|-+||+..+.
T Consensus       846 -------------~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  846 -------------EEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             -------------HHHHHHHHHhcCCCccCCCHHHH
Confidence                         11244556667788888887654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=4.8e-27  Score=275.31  Aligned_cols=146  Identities=28%  Similarity=0.397  Sum_probs=130.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||+++...   ......+..|+++++.++|+||+++++.+....     .
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-----N   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----E
Confidence            57888999999999999999999899999999986442   223467889999999999999999998887655     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++...          ..+++..+..|+.||+.||+|||..+   ||||||||+|||++.++++||
T Consensus        79 ~~lVmEy~~g~~L~~li~~~----------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL  145 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIY----------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKL  145 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEE
Confidence            99999999999999998643          35788889999999999999999987   999999999999999999999


Q ss_pred             Ccccccc
Q 041249          427 GDFGLAR  433 (789)
Q Consensus       427 ~Dfgla~  433 (789)
                      +|||+++
T Consensus       146 ~DFGls~  152 (669)
T cd05610         146 TDFGLSK  152 (669)
T ss_pred             EeCCCCc
Confidence            9999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.6e-28  Score=244.32  Aligned_cols=203  Identities=23%  Similarity=0.294  Sum_probs=172.2

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      +...+|....+||+|+||.|-.|.-+.+.+.+|||+++..-   ..+.+-...|-++++-- +-|.++++-..++..+  
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD--  423 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--  423 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh--
Confidence            34458999999999999999999999889999999997552   22222344566677666 5677888777777766  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|--.++..          ..+.+..+..+|++||-||-+||+.+   |++||||-.|||++.++
T Consensus       424 ---RLyFVMEyvnGGDLMyhiQQ~----------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eG  487 (683)
T KOG0696|consen  424 ---RLYFVMEYVNGGDLMYHIQQV----------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEG  487 (683)
T ss_pred             ---heeeEEEEecCchhhhHHHHh----------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCC
Confidence               899999999999999988765          45677889999999999999999998   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++||+|||+++.--.+.  ..+...+||+-|+|||++...+|+..+|.|||||+||||+.|++||+.
T Consensus       488 HiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  488 HIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             ceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999998654333  234457899999999999999999999999999999999999999984

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=256.26  Aligned_cols=243  Identities=21%  Similarity=0.182  Sum_probs=192.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++.|.....+|.|+|+.|..+....+++..++|++...    .....+|+.++... .||||+++.+.+.+..     +.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~-----~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGK-----EI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCc-----ee
Confidence            56788888899999999999999999999999999655    23345677676666 7999999999987766     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec-CCCCceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL-DEEMVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl  426 (789)
                      ++|||.+.+|-+.+.+...          +.+. .++..|+.+++.|+.|||.+|   +||||+||+|||+ +..++++|
T Consensus       392 ~~v~e~l~g~ell~ri~~~----------~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrl  457 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSK----------PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRL  457 (612)
T ss_pred             eeeehhccccHHHHHHHhc----------chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEE
Confidence            9999999999887777543          2233 778899999999999999998   9999999999999 69999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.++....+     ....+=|..|.|||.+....|++.+||||||++||+|++|+.||.....+    .+.......
T Consensus       458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~  528 (612)
T KOG0603|consen  458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQM  528 (612)
T ss_pred             EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcC
Confidence            999999988766     22344678999999999889999999999999999999999999743332    111111111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ..+.+                              .-.....++...+.+++|..|+++.....++-
T Consensus       529 ~~~s~------------------------------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  529 PKFSE------------------------------CVSDEAKDLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             Ccccc------------------------------ccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence            11111                              11223346677899999999999998866543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=9e-27  Score=239.53  Aligned_cols=180  Identities=23%  Similarity=0.201  Sum_probs=154.1

Q ss_pred             cCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChh
Q 041249          281 GSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLE  360 (789)
Q Consensus       281 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  360 (789)
                      |.+|.||++....+++.||+|.++...     .+..|...+....||||+++++++...+     ..++||||+.+|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence            889999999999999999999986543     2334555555667999999999987655     889999999999999


Q ss_pred             hhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCC
Q 041249          361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV  440 (789)
Q Consensus       361 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  440 (789)
                      +++...          ..+++..+..++.|++.||+|||..+   ++||||||+||+++.++.++++|||.+....... 
T Consensus        74 ~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-  139 (237)
T cd05576          74 SHISKF----------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-  139 (237)
T ss_pred             HHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence            998543          35899999999999999999999887   9999999999999999999999999876654322 


Q ss_pred             ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       441 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                          ....++..|+|||......++.++||||+|+++|||++|+.|+.
T Consensus       140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence                12345678999999988889999999999999999999998875

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-27  Score=242.20  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=170.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .|-...++|.|||++||+|.+-...+.||||+....+.       ...+..-+|.++.+.+.||.||++|+++.-..   
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt---  540 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT---  540 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc---
Confidence            34446689999999999999988889999999754321       11344667899999999999999999986432   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC--
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--  421 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--  421 (789)
                       ...|-|+||+++.+|.-|++..          +.+++.+...|+.||+.||.||... .+||+|-||||.|||+...  
T Consensus       541 -dsFCTVLEYceGNDLDFYLKQh----------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  541 -DSFCTVLEYCEGNDLDFYLKQH----------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             -ccceeeeeecCCCchhHHHHhh----------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence             3579999999999999999765          6789999999999999999999887 6889999999999999654  


Q ss_pred             -CceeeCcccccccCCCCCCc-----cceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 -MVSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 -~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                       +.+||.|||+++.+.++...     ..+....||..|.+||.+.-+    +++.|+||||.||+.|+.+.|+.||..
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence             68899999999999866522     233346799999999987654    478999999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=263.51  Aligned_cols=269  Identities=21%  Similarity=0.257  Sum_probs=204.0

Q ss_pred             CCCCCcccccCCc-cEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFG-SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+++|+|..| .||+|.+.  +++||||++-..   ......+|++.+..- +|||||++++.-.+..     +.|+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q-----F~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ-----FLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCc-----eEEE
Confidence            4456789999987 68999996  889999998433   234567899999888 7999999998866555     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---C--Cce
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---E--MVS  424 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~  424 (789)
                      ..|.|.. +|.+++.....+.+      .........+..|+++||+|||+.+   ||||||||.||||+.   +  .+|
T Consensus       581 alELC~~-sL~dlie~~~~d~~------~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra  650 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLDVE------MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRA  650 (903)
T ss_pred             EehHhhh-hHHHHHhccccchh------hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeE
Confidence            9999986 99999976411111      1111456778899999999999987   999999999999976   2  588


Q ss_pred             eeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHh-cCCCCccccCCccHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG-~~P~~~~~~~~~~~~~~~~  502 (789)
                      +|+|||+++.++.+..+ .......||-+|+|||++....-+..+||||+|||+|+.++| .+||.+..+.+.++..-  
T Consensus       651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~--  728 (903)
T KOG1027|consen  651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG--  728 (903)
T ss_pred             EecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC--
Confidence            99999999999877633 234567899999999999998888999999999999999995 99998543332221110  


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccccCccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLK  582 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~  582 (789)
                          +.-..-                        .....+|  ...+++..+.+.+|..||+...+..+|-.+..-..|+
T Consensus       729 ----~~~L~~------------------------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~  778 (903)
T KOG1027|consen  729 ----NYTLVH------------------------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLS  778 (903)
T ss_pred             ----ccceee------------------------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHH
Confidence                000000                        0011122  4557888999999999999999998888777777777


Q ss_pred             hhcccCCccc
Q 041249          583 ILNLENNSFT  592 (789)
Q Consensus       583 ~L~L~~N~l~  592 (789)
                      .|.=..+++.
T Consensus       779 Fl~dvSDRvE  788 (903)
T KOG1027|consen  779 FLRDVSDRVE  788 (903)
T ss_pred             HHHhhhhhhh
Confidence            7755555554

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=6.1e-27  Score=248.57  Aligned_cols=213  Identities=21%  Similarity=0.279  Sum_probs=177.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .-|...+.||-|+||+|..+.-..+...+|.|.++..+   .......+.|.++|+.-..+=||++|..|++.+     .
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----n  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----N  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----c
Confidence            45778899999999999999988888899999997552   222345778999999999999999999999887     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+||+|+++|++-.+|-+.          ..|++.-...+++++.+|+++.|..|   +|||||||.|||||.+|++||
T Consensus       704 LYFVMdYIPGGDmMSLLIrm----------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRM----------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHh----------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence            99999999999998888543          67888888999999999999999999   999999999999999999999


Q ss_pred             CcccccccCCCCCC----------------------------------------ccceeeecccccccCcccCCCCCcCc
Q 041249          427 GDFGLARFLPPTHV----------------------------------------QTSSIGVKGSIGYIAPEYGLGSEVST  466 (789)
Q Consensus       427 ~Dfgla~~~~~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~  466 (789)
                      +|||++.-+...+.                                        ....-...||..|+|||++....|+.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            99999875432110                                        00001234999999999999999999


Q ss_pred             cccchhhHHHHHHHHHhcCCCCcccc--CCccHHHH
Q 041249          467 NGDVYSYGILMLELIIRKKPSDIMFE--GDMNLHNF  500 (789)
Q Consensus       467 k~DV~sfGvvl~elltG~~P~~~~~~--~~~~~~~~  500 (789)
                      -+|.||.|||||||+.|+.||.+...  ....+.+|
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence            99999999999999999999976533  23344455

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=9e-27  Score=245.71  Aligned_cols=197  Identities=21%  Similarity=0.334  Sum_probs=171.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--------chhhHHHHHHHHHHhcCC---CCccceeeeeecc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--------HRASRSFIAECRALRSIR---HRNLVKVFTACSG  338 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  338 (789)
                      .+|+..+.+|.|+||.|+.|.++.+...|+||++...+        ........-||++|+.++   |+||++++.+|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            47899999999999999999999999999999986542        111234667999999997   9999999999988


Q ss_pred             CCCCCCceEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          339 VDYQGNDFKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      .+     ..++++|-... .+|.+++..          ..++++.+..-|+.||+.|+++||+++   |||||||-+||.
T Consensus       641 dd-----~yyl~te~hg~gIDLFd~IE~----------kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvi  702 (772)
T KOG1152|consen  641 DD-----YYYLETEVHGEGIDLFDFIEF----------KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVI  702 (772)
T ss_pred             CC-----eeEEEecCCCCCcchhhhhhc----------cCccchHHHHHHHHHHHhccccccccC---ceecccccccEE
Confidence            77     88999986554 489999853          477899999999999999999999999   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCC
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++.+|-+||+|||.|.+...+.    .....||..|.|||.+.+.+| ...-|||++|++||-++..+.||+
T Consensus       703 vd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999999998876554    334679999999999999887 566999999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.7e-25  Score=249.03  Aligned_cols=217  Identities=18%  Similarity=0.246  Sum_probs=158.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEc----------------CCceEEEEEEeccccchhhHHH--------------HHH
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLD----------------EGRTTVTVKVFNLHHHRASRSF--------------IAE  317 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e  317 (789)
                      ..++|+..++||+|+||+||+|.+.                ..++.||||.+........+.|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999999752                2356799999876544333333              346


Q ss_pred             HHHHhcCCCCcc-----ceeeeeeccCCCC---CCceEEEEeeccCCCChhhhccCCCCC--------------ccccCC
Q 041249          318 CRALRSIRHRNL-----VKVFTACSGVDYQ---GNDFKALVYEFMQNGSLEEWLYPVNRE--------------DEVDKA  375 (789)
Q Consensus       318 ~~~l~~l~h~ni-----v~l~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~~~~  375 (789)
                      +.++.+++|.++     ++++++|.....+   .....++||||+.+|+|.++++.....              ......
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     6778887643211   123579999999999999998753110              000011


Q ss_pred             CCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccC
Q 041249          376 PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA  455 (789)
Q Consensus       376 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  455 (789)
                      ...+++..+..++.|++.||.|+|..+   |+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            234678889999999999999999887   999999999999999999999999999765433211 1112234789999


Q ss_pred             cccCCCCCc----------------------CccccchhhHHHHHHHHHhcC-CCC
Q 041249          456 PEYGLGSEV----------------------STNGDVYSYGILMLELIIRKK-PSD  488 (789)
Q Consensus       456 PE~~~~~~~----------------------~~k~DV~sfGvvl~elltG~~-P~~  488 (789)
                      ||.+.....                      ..+.||||+||++|||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            998754321                      235799999999999999875 765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=7.3e-26  Score=258.75  Aligned_cols=213  Identities=22%  Similarity=0.198  Sum_probs=145.4

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCC----ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEG----RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQ  342 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  342 (789)
                      +.++|...+.||+|+||.||+|.+..+    +..||+|.+......  .....|  .+....+.++..++..+.... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            568999999999999999999999888    899999987533211  111111  112222333333332221111 12


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCc----cc------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNRED----EV------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      .....++|+||+.+++|.+++.......    ..      ...........+..++.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            2346899999999999999986431100    00      000111223446689999999999999887   9999999


Q ss_pred             CCceecCC-CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----------------------CcCcccc
Q 041249          413 PSNILLDE-EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----------------------EVSTNGD  469 (789)
Q Consensus       413 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D  469 (789)
                      |+|||+++ ++.+||+|||+|+........ ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 579999999999866433221 12234688999999964322                      2345679


Q ss_pred             chhhHHHHHHHHHhcCCCC
Q 041249          470 VYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       470 V~sfGvvl~elltG~~P~~  488 (789)
                      ||||||++|||+++..|++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999877754

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4e-27  Score=244.67  Aligned_cols=200  Identities=22%  Similarity=0.323  Sum_probs=175.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++.....+|-||||.|=....+.....+|+|.++..   ....+.....|-.+|-..+.|.||++|..|.+.+     .
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-----y  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-----Y  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-----h
Confidence            4666777899999999999999855555888888644   3344556778999999999999999999987766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+.||-|-+|.+...+..+          ..++..+...++..+.+|++|||..+   ||+|||||+|.+++.++-+||
T Consensus       495 vYmLmEaClGGElWTiLrdR----------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KL  561 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDR----------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKL  561 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhc----------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEE
Confidence            99999999999999999654          67888899999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .|||.|+.+.....   +-..+||+.|.|||++.+...+..+|.||+|+++|||++|++||...
T Consensus       562 VDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  562 VDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             eehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999877652   23477999999999999999999999999999999999999999743

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.2e-25  Score=231.18  Aligned_cols=238  Identities=28%  Similarity=0.314  Sum_probs=189.1

Q ss_pred             CCccEEEEEEcCCceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChh
Q 041249          282 SFGSVYKGVLDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLE  360 (789)
Q Consensus       282 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  360 (789)
                      +||.||+|.+..+++.||+|++....... .+.+.+|++.+++++|+|++++++.+....     ..++++||+.+++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence            58999999999889999999997665444 688999999999999999999999987655     789999999999999


Q ss_pred             hhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCC
Q 041249          361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV  440 (789)
Q Consensus       361 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  440 (789)
                      +++...          ..+++..+..++.+++.|+.|||..+   ++|+||+|+||++++++.++++|||.+....... 
T Consensus        76 ~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-  141 (244)
T smart00220       76 DLLKKR----------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-  141 (244)
T ss_pred             HHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence            998644          22789999999999999999999987   9999999999999999999999999999876543 


Q ss_pred             ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccC
Q 041249          441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLND  520 (789)
Q Consensus       441 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  520 (789)
                        ......++..|+|||......++.++||||||+++|++++|..||+... +.....++.......    ...      
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~----~~~------  208 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPP----FPP------  208 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCC----Ccc------
Confidence              1223457889999999988889999999999999999999999987321 111111111110000    000      


Q ss_pred             hhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          521 VEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                                        ........+.+++..|...++.+||+.....
T Consensus       209 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~  239 (244)
T smart00220      209 ------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEAL  239 (244)
T ss_pred             ------------------ccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence                              0000234566888899999999999887654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.6e-27  Score=225.98  Aligned_cols=207  Identities=22%  Similarity=0.357  Sum_probs=171.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC---C
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG---N  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~---~  344 (789)
                      ..|....+||+|.||+||+|+..++++.||+|.+-..  +........+|++++..++|+|++.++..|....-..   .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3556677899999999999999999999999876432  3333456788999999999999999999997654222   2


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||.+++. +|..++..         ...+++..++.+++.++..||.|+|...   |+|||+||+|+||+.++..
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn---------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN---------RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC---------ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence            247999999997 78777743         3477999999999999999999999887   9999999999999999999


Q ss_pred             eeCcccccccCCCCCC--ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHV--QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.+..+..  ....+...-|..|.+||.+.+. +|+++.|||+-|||+.||.||.+-+..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence            9999999987765542  1222344468999999998875 599999999999999999999988863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=2.6e-26  Score=216.35  Aligned_cols=207  Identities=22%  Similarity=0.394  Sum_probs=172.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ..++|.+.+.+|.|.+++||.|..-.+.++++||+++..+   .+.+.+|+.++..++ ||||++++++..+..   ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence            3578999999999999999999988789999999997554   456789999999996 999999999987654   335


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-cee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~k  425 (789)
                      ..+++||..+.++..+-             +.++...+.-+..++++||.|+|++|   |+|||+||.|++||... ..+
T Consensus       110 paLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLr  173 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLR  173 (338)
T ss_pred             chhHhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceee
Confidence            78999999998877665             34677788899999999999999999   99999999999999765 679


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~  502 (789)
                      ++|+|+|.++.+....   .-...+.-|.-||.+.+-+ |+..-|+|||||++..|+..+.||.   .+..++.+.++
T Consensus       174 lIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF---hG~dN~DQLVk  245 (338)
T KOG0668|consen  174 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF---HGHDNYDQLVK  245 (338)
T ss_pred             eeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc---CCCCCHHHHHH
Confidence            9999999999877632   1223455678899987754 8999999999999999999999985   34445555543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.2e-26  Score=223.89  Aligned_cols=212  Identities=24%  Similarity=0.314  Sum_probs=180.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .+|+..++||.|+|+.|..+.+..+.+.+|+|+++..   ..++.+-...|-.+...- +||.+|.+-..++..+     
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes-----  324 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES-----  324 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-----
Confidence            5899999999999999999999999999999998754   334444455666666665 7999999988887766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|.||.++|+|--+++..          +.++++.+..+..+|+-||.|||+.|   |++||+|-.|||+|.++++|
T Consensus       325 rlffvieyv~ggdlmfhmqrq----------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             eEEEEEEEecCcceeeehhhh----------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence            899999999999998888654          67899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc--ccCCccHHHHH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM--FEGDMNLHNFA  501 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~--~~~~~~~~~~~  501 (789)
                      ++|+|+++.--.+.  ..+...+||+.|+|||++.+..|...+|.|++||+|+||+.|+.||+..  ...+++..++.
T Consensus       392 ltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl  467 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL  467 (593)
T ss_pred             ecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence            99999998654333  2344578999999999999999999999999999999999999999864  22344444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=6.4e-25  Score=223.22  Aligned_cols=199  Identities=30%  Similarity=0.448  Sum_probs=172.8

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      |+..+.||.|++|.||++....+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++....     ..+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEE
Confidence            45678899999999999999977899999999766554 6678999999999999999999999987655     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCC-CCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      +|++.+++|.+++...          .. +++.....++.+++.++.|||..+   ++|+|++|+||+++.++.++++||
T Consensus        76 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~  142 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----------GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADF  142 (225)
T ss_pred             EeccCCCCHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeC
Confidence            9999999999998654          22 788999999999999999999887   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccC-CCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYG-LGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.+......... ......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus       143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999987655311 12334577889999998 556688899999999999999999999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-26  Score=222.24  Aligned_cols=203  Identities=24%  Similarity=0.319  Sum_probs=170.4

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      |....+.||.|.||.||-.++..+|+.||.|.+...  .-...+.+-+|++++..++|.|++..+++.+....+-..+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            566789999999999999999999999999987433  233457788999999999999999999987765543334567


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      .+.|.|.. +|...+-          .++.++...+.-+++||++||.|||+.+   |.||||||.|.|++.+-..||+|
T Consensus       134 V~TELmQS-DLHKIIV----------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD  199 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIV----------SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD  199 (449)
T ss_pred             HHHHHHHh-hhhheec----------cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence            78888875 6777663          4577888888899999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||+++....+.... ++...-|..|.|||++.+.+ |+...||||.||+..|++-++.-|.
T Consensus       200 FGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ  259 (449)
T KOG0664|consen  200 FGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ  259 (449)
T ss_pred             cccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence            99999887665332 33344677899999999865 9999999999999999999988875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-25  Score=224.50  Aligned_cols=199  Identities=25%  Similarity=0.317  Sum_probs=166.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-C-Cc----cceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-H-RN----LVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~l~~~~~~~~~~  342 (789)
                      ++.|.+...+|+|.||.|-.+.++.++..||||+++... ...++...|++++.++. + |+    ++.+.+++....  
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg--  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG--  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC--
Confidence            678999999999999999999999899999999997543 23456778999999993 2 22    556655554333  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---  419 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~---  419 (789)
                         +.|+|+|.+.. ++.+++..+        .-.+++...+..|+.|++++++|||+.+   ++|.||||+||++.   
T Consensus       165 ---hiCivfellG~-S~~dFlk~N--------~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  165 ---HICIVFELLGL-STFDFLKEN--------NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE  229 (415)
T ss_pred             ---ceEEEEeccCh-hHHHHhccC--------CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence               78999998864 899999765        4467899999999999999999999988   99999999999993   


Q ss_pred             -----------------CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249          420 -----------------EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII  482 (789)
Q Consensus       420 -----------------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt  482 (789)
                                       ....+|++|||.|.+....+     .....|.-|.|||++.+-.++.++||||+||||+|+.|
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence                             13467999999999876554     33567889999999999999999999999999999999


Q ss_pred             hcCCCCcc
Q 041249          483 RKKPSDIM  490 (789)
Q Consensus       483 G~~P~~~~  490 (789)
                      |..-|...
T Consensus       305 G~~LFqtH  312 (415)
T KOG0671|consen  305 GETLFQTH  312 (415)
T ss_pred             cceecccC
Confidence            99988643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-24  Score=209.81  Aligned_cols=209  Identities=21%  Similarity=0.312  Sum_probs=167.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.|++.+.+|+|.||.+-.+.++.+.+.+++|-+... ....++|.+|.-.---+ .|.||+.-|....+..    +..+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceEE
Confidence            5799999999999999999999999999999987433 23456788887665556 5999999887754433    2678


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC--CCCceee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--EEMVSHV  426 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl  426 (789)
                      +++||++.|+|.+.+...           .+-+.....++.|++.|+.|||+..   +||||||.+|||+.  +..++|+
T Consensus        99 F~qE~aP~gdL~snv~~~-----------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA-----------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             EeeccCccchhhhhcCcc-----------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEe
Confidence            899999999999988543           4556677889999999999999988   99999999999994  4469999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC---C--CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---S--EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      +|||+++..+.-     .....-+..|.|||....   +  ++.+.+|||.||++++..+||+.||....-.+..+.+|.
T Consensus       165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            999998865432     123445678999997654   2  358899999999999999999999985555566666665


Q ss_pred             H
Q 041249          502 R  502 (789)
Q Consensus       502 ~  502 (789)
                      +
T Consensus       240 ~  240 (378)
T KOG1345|consen  240 Q  240 (378)
T ss_pred             H
Confidence            4

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=2.9e-24  Score=230.63  Aligned_cols=199  Identities=27%  Similarity=0.364  Sum_probs=174.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|.....+|.|.||.||++++..+++.+|+|+++.....+.....+|+-+++..+|+||+.++|.+...+     ..|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence            368899999999999999999999999999999999998888888899999999999999999999987655     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +.|||+.+|+|++.-+-          ...+++.++....++..+|++|||+.+   -+|||||=.||++++.+.+|+.|
T Consensus        89 icMEycgggslQdiy~~----------TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaD  155 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLAD  155 (829)
T ss_pred             EEEEecCCCcccceeee----------cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecc
Confidence            99999999999987653          478999999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      ||.+..+..-..  ......||+.|||||+..   .+.|.+++|||+.|++..|+---+.|.
T Consensus       156 fgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  156 FGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             cCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            998876654321  123467999999999754   567999999999999999985444443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-24  Score=219.46  Aligned_cols=198  Identities=23%  Similarity=0.248  Sum_probs=156.8

Q ss_pred             ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      |..|++|++|+|++|+|+.+-+.+|.++.+++.|.|..|+|..+....|.++..|++|+|.+|+|+...|.+|..+..|.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            88999999999999999999999999999999999999999977788999999999999999999999999999999999


Q ss_pred             EEEccCCCCC------------------ccCCcCCCCCCCCCEEEccCCcCCc---cCCccc---------cCCCCCC-e
Q 041249          655 VLSLGFNNLI------------------GSIPPPLGNLSSLRKISLAINNLAG---SIPFTL---------SKLKNLV-I  703 (789)
Q Consensus       655 ~L~L~~N~l~------------------~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~---------~~l~~L~-~  703 (789)
                      +|+|-.|.+.                  |..|  -++-..++.+.++++.+..   ..|+..         ..++.+. +
T Consensus       350 ~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tV  427 (498)
T KOG4237|consen  350 TLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTV  427 (498)
T ss_pred             eeehccCcccCccchHHHHHHHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhh
Confidence            9999988761                  1111  1223356677777766542   122222         1233343 3


Q ss_pred             eeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249          704 LYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       704 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                      ...|++.++ .+|..+..  ..++|++.+|.++ .+|.+.   +.+| .+||++|+|.......|.++++|.+|-++.|
T Consensus       428 vRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~~~---~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  428 VRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPDEL---LRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             Hhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCHHH---Hhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            445666665 66655432  5789999999999 999984   5677 8999999999888888999999999998876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.88  E-value=4.8e-22  Score=199.15  Aligned_cols=184  Identities=30%  Similarity=0.520  Sum_probs=160.0

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCC
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN  356 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  356 (789)
                      ||+|.+|.||++....+++.+++|++...... ....+.+|++.++.++|++++++++++....     ..++++||+.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-----HLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----eEEEEEecCCC
Confidence            68999999999999878999999999765433 3567999999999999999999999987654     78999999999


Q ss_pred             CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCcccccccC
Q 041249          357 GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLARFL  435 (789)
Q Consensus       357 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~  435 (789)
                      ++|.+++...         ...+++..+..++.+++++++|||..+   ++|+||+|.||++++ +..++++|||.+...
T Consensus        76 ~~l~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          76 GSLKDLLKEN---------EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            9999998543         145789999999999999999999988   999999999999999 899999999999877


Q ss_pred             CCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHH
Q 041249          436 PPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLEL  480 (789)
Q Consensus       436 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~el  480 (789)
                      .....  ......+...|++||..... .++.++|+|++|++++++
T Consensus       144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            65432  12234577899999998877 789999999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.87  E-value=5.1e-23  Score=204.03  Aligned_cols=210  Identities=22%  Similarity=0.286  Sum_probs=171.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~  347 (789)
                      .|.-...+|.|.. .|..+.+.-.++.||+|.....  .....++...|...+..++|+||++++.++.... .......
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555677888888 7888888778999999987433  3344577888999999999999999999986543 2223357


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|||+|.. ++.+.+.-            .++-.++..|..|+++|++|||+.+   |+||||||+||++..+..+|+.
T Consensus        97 y~v~e~m~~-nl~~vi~~------------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   97 YLVMELMDA-NLCQVILM------------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             HHHHHhhhh-HHHHHHHH------------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence            999999985 77777652            3567788999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |||+|+.....   ...+....|..|.|||.+.+..+.+.+||||.||++.||++|+.-|.    ++..+.+|.+..
T Consensus       161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~  230 (369)
T KOG0665|consen  161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKII  230 (369)
T ss_pred             cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHH
Confidence            99999976655   23444567889999999999889999999999999999999998775    556677776544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.7e-22  Score=207.67  Aligned_cols=136  Identities=25%  Similarity=0.415  Sum_probs=116.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-----C---CccceeeeeeccCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-----H---RNLVKVFTACSGVDY  341 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~~~  341 (789)
                      ..|-..++||+|-|++||.+.+..+.+.||+|+.+.. +...+....||.++++++     |   ..||+++++|....+
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            4677889999999999999999999999999998643 334567788999999883     2   469999999987775


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      .|. +.|||+|++.. +|..++...        .-+.++...+.+|+.||+.||.|||..+  .|+|.||||+|||+
T Consensus       157 NG~-HVCMVfEvLGd-nLLklI~~s--------~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQ-HVCMVFEVLGD-NLLKLIKYS--------NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCc-EEEEEehhhhh-HHHHHHHHh--------CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            554 89999999976 777777544        4567899999999999999999999987  69999999999999

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.87  E-value=2.8e-22  Score=206.41  Aligned_cols=210  Identities=26%  Similarity=0.368  Sum_probs=171.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC---CceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  344 (789)
                      .+.|...++||.|.|+.||++++..   ..+.||+|.+....  .......|++++..+ .+.||+++.+.+...+    
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd----  108 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND----  108 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC----
Confidence            4678899999999999999999987   78899999986442  335688999999999 5999999999877666    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V  423 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~  423 (789)
                       ..++|+||++.-...++..             .++...+..+++.+.+||+++|..|   ||||||||+|++.+... .
T Consensus       109 -~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  109 -QVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             -eeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCC
Confidence             8999999999999988874             3578889999999999999999999   99999999999998764 5


Q ss_pred             eeeCcccccccC-----------------CC-CC------------------------CccceeeecccccccCcccCCC
Q 041249          424 SHVGDFGLARFL-----------------PP-TH------------------------VQTSSIGVKGSIGYIAPEYGLG  461 (789)
Q Consensus       424 ~kl~Dfgla~~~-----------------~~-~~------------------------~~~~~~~~~gt~~y~aPE~~~~  461 (789)
                      -.|.|||+|...                 .+ ..                        .........||++|.|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            589999999821                 11 00                        0001112459999999999876


Q ss_pred             -CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          462 -SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       462 -~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                       +..+++.||||-||++.-+++++.||.....+...+...+
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~  292 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIA  292 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccccchHHHHH
Confidence             4579999999999999999999999976555544444443

>PLN03210 Resistant to P

Probab=99.87  E-value=8.6e-21  Score=235.09  Aligned_cols=172  Identities=23%  Similarity=0.293  Sum_probs=138.2

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCc-------cCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCC
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG-------GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS  651 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~-------~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  651 (789)
                      ++|++|+|++|.++ .+|..+ .+++|++|++.++...       ...+..+...++|+.|+|++|.....+|..+.+++
T Consensus       725 ~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~  802 (1153)
T PLN03210        725 TNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLH  802 (1153)
T ss_pred             CCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCC
Confidence            45778889999988 566654 6888999999875432       12222334457899999999987778999999999


Q ss_pred             CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEcc
Q 041249          652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG  731 (789)
Q Consensus       652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  731 (789)
                      +|+.|++++|..-+.+|..+ ++++|++|+|++|..-..+|..   .++|+.|+|++|.|+ .+|.++..+++|+.|+|+
T Consensus       803 ~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~  877 (1153)
T PLN03210        803 KLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMN  877 (1153)
T ss_pred             CCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECC
Confidence            99999999976444777766 7899999999998654466653   358999999999998 789999999999999999


Q ss_pred             C-CcccccCCcccccCCCCccEEEccCCc
Q 041249          732 E-NKIQGNIPLDYGFTLQNLQYFSIGTNR  759 (789)
Q Consensus       732 ~-N~l~~~ip~~~~~~l~~L~~L~L~~N~  759 (789)
                      + |++. .+|..+. .+++|+.|+++++.
T Consensus       878 ~C~~L~-~l~~~~~-~L~~L~~L~l~~C~  904 (1153)
T PLN03210        878 GCNNLQ-RVSLNIS-KLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCcC-ccCcccc-cccCCCeeecCCCc
Confidence            8 5666 7888876 79999999999986

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.86  E-value=3.9e-21  Score=221.35  Aligned_cols=123  Identities=24%  Similarity=0.255  Sum_probs=82.9

Q ss_pred             ccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEcc
Q 041249          580 FLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLG  659 (789)
Q Consensus       580 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  659 (789)
                      +|++|+|++|+|++ +|..   ..+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|+ .+|..   .++|+.|+++
T Consensus       343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS  410 (788)
T PRK15387        343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVS  410 (788)
T ss_pred             ccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence            46778888888884 4543   245777788888887 35543   246777888888877 35533   2467777777


Q ss_pred             CCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccc
Q 041249          660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSI  719 (789)
Q Consensus       660 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  719 (789)
                      +|+|++ +|..+   .+|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..+
T Consensus       411 ~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        411 GNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            777773 45432   35667777777777 567777777777777777777776666655

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=3.1e-21  Score=206.16  Aligned_cols=176  Identities=22%  Similarity=0.180  Sum_probs=136.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC-CceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ..++|...+.||+|+||+||+|.+.. +++.||||++...     .......+.+|++++++++|+|+++.+..+   . 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~-   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G-   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-
Confidence            45789999999999999999999875 6778899987533     122356799999999999999998643221   1 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC-CCCceecCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL-KPSNILLDE  420 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl-k~~Nill~~  420 (789)
                          ..++||||+.+++|... ...          .      ...++.++++||+|||+.+   |+|||| ||+|||++.
T Consensus        92 ----~~~LVmE~~~G~~L~~~-~~~----------~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~  147 (365)
T PRK09188         92 ----KDGLVRGWTEGVPLHLA-RPH----------G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGP  147 (365)
T ss_pred             ----CcEEEEEccCCCCHHHh-Ccc----------c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcC
Confidence                46999999999999632 111          0      1467889999999999988   999999 999999999


Q ss_pred             CCceeeCcccccccCCCCCCccc------eeeecccccccCcccCCCCC------cCccccch
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTS------SIGVKGSIGYIAPEYGLGSE------VSTNGDVY  471 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~k~DV~  471 (789)
                      ++.+||+|||+|+..........      .....+++.|+|||++...+      .+..+|-|
T Consensus       148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999999999998876552211      13456888999999987643      23446766

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.85  E-value=6.5e-21  Score=219.53  Aligned_cols=140  Identities=24%  Similarity=0.313  Sum_probs=105.8

Q ss_pred             hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCC
Q 041249          583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNN  662 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  662 (789)
                      .|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..   ..+|+.|++++|+|+ .+|..   ..+|+.|+|++|+
T Consensus       326 ~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~  393 (788)
T PRK15387        326 KLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNR  393 (788)
T ss_pred             ccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCc
Confidence            34455666663 4431   247899999999999 45543   357888999999998 46653   3578999999999


Q ss_pred             CCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcc
Q 041249          663 LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD  742 (789)
Q Consensus       663 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~  742 (789)
                      |++ +|..   .++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++.++..
T Consensus       394 Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~  464 (788)
T PRK15387        394 LTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA  464 (788)
T ss_pred             ccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence            984 5543   357899999999998 466543   46788999999998 78888999999999999999998776664


Q ss_pred             c
Q 041249          743 Y  743 (789)
Q Consensus       743 ~  743 (789)
                      +
T Consensus       465 L  465 (788)
T PRK15387        465 L  465 (788)
T ss_pred             H
Confidence            4

>PLN03210 Resistant to P

Probab=99.85  E-value=3.8e-20  Score=229.38  Aligned_cols=131  Identities=17%  Similarity=0.244  Sum_probs=111.7

Q ss_pred             ccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCC
Q 041249          599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR  678 (789)
Q Consensus       599 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  678 (789)
                      +...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|..-...|..   ..+|+
T Consensus       774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~  849 (1153)
T PLN03210        774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNIS  849 (1153)
T ss_pred             hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccC
Confidence            3445789999999998887899999999999999999985444777765 7899999999998655455543   36899


Q ss_pred             EEEccCCcCCccCCccccCCCCCCeeeccC-ccccccCCccccCCCCccEEEccCCcc
Q 041249          679 KISLAINNLAGSIPFTLSKLKNLVILYLGV-NRLSGIVPSSIFNISSIAEFDVGENKI  735 (789)
Q Consensus       679 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l  735 (789)
                      .|+|++|.|+ .+|..+..+++|+.|+|++ |+++ .+|..+..+++|+.|++++|.-
T Consensus       850 ~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~~  905 (1153)
T PLN03210        850 DLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCGA  905 (1153)
T ss_pred             EeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCcc
Confidence            9999999998 7899999999999999999 5666 6788889999999999999863

syringae 6; Provisional

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.84  E-value=6.1e-22  Score=206.82  Aligned_cols=200  Identities=23%  Similarity=0.267  Sum_probs=167.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC------CCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR------HRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~  342 (789)
                      .+.|.+.-..|+|-|++|..|.+...++.||||+++... ...+.=.+|+++|++|.      .-|.++++..|....  
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn--  507 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN--  507 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc--
Confidence            456777788899999999999999889999999997442 22345577999999995      367899988887655  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         +.|+|||-+.. +|.+.++..       ...-.|....+..++.|+.-||..|...+   |+|.||||.|||+++..
T Consensus       508 ---HLClVFE~Lsl-NLRevLKKy-------G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  508 ---HLCLVFEPLSL-NLREVLKKY-------GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK  573 (752)
T ss_pred             ---eeEEEehhhhc-hHHHHHHHh-------CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence               99999998875 899999876       23345778889999999999999999888   99999999999999875


Q ss_pred             -ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          423 -VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       423 -~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                       ..||||||.|.........    ..--+..|.|||++.+-.|+...|+||.||+||||.||+.-|..
T Consensus       574 ~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence             5599999999887665421    11234689999999999999999999999999999999998864

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.83  E-value=1e-22  Score=206.67  Aligned_cols=230  Identities=20%  Similarity=0.216  Sum_probs=206.0

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccC-CCCccCCCccCcCCCCCcEEEc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNN-NSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      ..+.+++..|.+....+..|+.+++|+.|||++|+|+.+.|++|.++++|..|-+.+ |+|+.+....|+++..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            356788889999999999999999999999999999999999999999988776655 9999777789999999999999


Q ss_pred             ccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC--------------------------
Q 041249          635 AKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA--------------------------  688 (789)
Q Consensus       635 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------------  688 (789)
                      .-|++.-+..++|..+++|..|.+.+|.+..+....|..+..++.+.++.|.+.                          
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            999999888889999999999999999998555558999999999988888720                          


Q ss_pred             -----------------------------------ccC-CccccCCCCCCeeeccCccccccCCccccCCCCccEEEccC
Q 041249          689 -----------------------------------GSI-PFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE  732 (789)
Q Consensus       689 -----------------------------------~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  732 (789)
                                                         ++. ...|..|++|+.|+|++|+|+.+-+.+|.++..+++|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence                                               011 13467899999999999999999999999999999999999


Q ss_pred             CcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       733 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      |+|. .+...+|.++.+|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|++..
T Consensus       308 N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C  360 (498)
T KOG4237|consen  308 NKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC  360 (498)
T ss_pred             chHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence            9999 9999999999999999999999999999999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.82  E-value=7.7e-21  Score=228.67  Aligned_cols=153  Identities=18%  Similarity=0.290  Sum_probs=115.1

Q ss_pred             cCCC-CccceeeeeeccCCCCC--CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh
Q 041249          323 SIRH-RNLVKVFTACSGVDYQG--NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH  399 (789)
Q Consensus       323 ~l~h-~niv~l~~~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH  399 (789)
                      .++| +||++++++|......+  ....+.++||+ .++|.+++...         ...+++.+++.++.||+.||+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH   97 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---------DRSVDAFECFHVFRQIVEIVNAAH   97 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---------cccccHHHHHHHHHHHHHHHHHHH
Confidence            4556 68888888874333222  12456678887 45999999532         355899999999999999999999


Q ss_pred             cCCCCCceecCCCCCceecCC-------------------CCceeeCcccccccCCCCCC--------------ccceee
Q 041249          400 HDCQPITTHCDLKPSNILLDE-------------------EMVSHVGDFGLARFLPPTHV--------------QTSSIG  446 (789)
Q Consensus       400 ~~~~~~ivH~dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~  446 (789)
                      +.+   ||||||||+|||++.                   ++.+|++|||+++.......              ......
T Consensus        98 ~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (793)
T PLN00181         98 SQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL  174 (793)
T ss_pred             hCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence            988   999999999999954                   45567777777764321100              000111


Q ss_pred             ecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       447 ~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ..||+.|||||++.+..++.++|||||||+||||++|..|+.
T Consensus       175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            347888999999999999999999999999999999988865

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.81  E-value=3.8e-22  Score=180.24  Aligned_cols=164  Identities=28%  Similarity=0.547  Sum_probs=100.0

Q ss_pred             CccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEE
Q 041249          601 RLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKI  680 (789)
Q Consensus       601 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  680 (789)
                      .+.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            4455555566666665 55555666666666666666665 45555666666666666666665 556666666666666


Q ss_pred             EccCCcCCc-cCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCc
Q 041249          681 SLAINNLAG-SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNR  759 (789)
Q Consensus       681 ~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~  759 (789)
                      ||+.|++.. .+|+.|..|+.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.++. .+.+|++|++.+|+
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig-~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIG-DLTRLRELHIQGNR  184 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHH-HHHHHHHHhcccce
Confidence            666665542 35666666666666666666666 56666666666666666666666 6666665 56666666666666


Q ss_pred             ccccCcccccCC
Q 041249          760 ITGAIPPSISNA  771 (789)
Q Consensus       760 l~~~~~~~~~~l  771 (789)
                      ++ .+|..++++
T Consensus       185 l~-vlppel~~l  195 (264)
T KOG0617|consen  185 LT-VLPPELANL  195 (264)
T ss_pred             ee-ecChhhhhh
Confidence            66 455555443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.81  E-value=3.2e-20  Score=181.36  Aligned_cols=165  Identities=21%  Similarity=0.159  Sum_probs=120.3

Q ss_pred             CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC
Q 041249          357 GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP  436 (789)
Q Consensus       357 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  436 (789)
                      |+|.+++...         +..+++.++..|+.|++.||+|||+.+         ||+||++++++.+|+  ||.++...
T Consensus         1 GsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEVR---------GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeec
Confidence            6788888532         356999999999999999999999876         999999999999999  99998765


Q ss_pred             CCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCC
Q 041249          437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDST  516 (789)
Q Consensus       437 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  516 (789)
                      ...       ..|+..|+|||++.+..++.|+|||||||++|||++|+.||.....-...+..+.....+..      +.
T Consensus        61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~  127 (176)
T smart00750       61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PR  127 (176)
T ss_pred             ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------cc
Confidence            432       24889999999999999999999999999999999999999643222222222222111110      00


Q ss_pred             cccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          517 LLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      -+...                 ........+.+++..|++.++..||+......+
T Consensus       128 ~~~~~-----------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~  165 (176)
T smart00750      128 DRSNL-----------------ESVSAARSFADFMRVCASRLPQRREAANHYLAH  165 (176)
T ss_pred             ccccH-----------------HHHHhhhhHHHHHHHHHhcccccccCHHHHHHH
Confidence            00000                 000011246788889999999999998876443

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=4e-19  Score=190.83  Aligned_cols=202  Identities=24%  Similarity=0.307  Sum_probs=164.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCc-eEEEEEEeccccchhhHHHHHHHHHHhcCCC----Cccceeeeeec-cCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGR-TTVTVKVFNLHHHRASRSFIAECRALRSIRH----RNLVKVFTACS-GVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~~-~~~~~~~  344 (789)
                      .|...+.||+|+||.||.+....++ ..+|+|............+..|+.++..+..    +++..+++... ..     
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~-----   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE-----   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----
Confidence            7999999999999999999987553 6899999866544433378889999999863    57888877763 33     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---  421 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---  421 (789)
                      ...++||+.... +|.++....        ..+.++..+.+.|+.|+..+|+++|+.|   ++||||||+|++++..   
T Consensus        94 ~~~~iVM~l~G~-sL~dl~~~~--------~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~  161 (322)
T KOG1164|consen   94 DFNFIVMSLLGP-SLEDLRKRN--------PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRS  161 (322)
T ss_pred             ceeEEEEeccCc-cHHHHHHhC--------CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCc
Confidence            378999987764 898877544        2578999999999999999999999999   9999999999999865   


Q ss_pred             --CceeeCcccccccCC--CCCCc------cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 --MVSHVGDFGLARFLP--PTHVQ------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 --~~~kl~Dfgla~~~~--~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                        ..+.+.|||+++...  .....      .......||..|+++..+.+.+.+.+.|+||++.++.|+..|..||..
T Consensus       162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence              468999999999332  22210      112234599999999999999999999999999999999999999963

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=5.2e-21  Score=172.94  Aligned_cols=183  Identities=33%  Similarity=0.518  Sum_probs=162.6

Q ss_pred             cccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCC
Q 041249          572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS  651 (789)
Q Consensus       572 l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  651 (789)
                      ...+.+++..+.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++
T Consensus        26 ~~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p  102 (264)
T KOG0617|consen   26 LPGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFP  102 (264)
T ss_pred             cccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCc
Confidence            345667888999999999999 67777999999999999999999 88999999999999999999998 8999999999


Q ss_pred             CCcEEEccCCCCC-ccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEc
Q 041249          652 KIEVLSLGFNNLI-GSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDV  730 (789)
Q Consensus       652 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  730 (789)
                      -|+.|||.+|++. ...|+.|..|..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|.+
T Consensus       103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi  180 (264)
T KOG0617|consen  103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI  180 (264)
T ss_pred             hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence            9999999999996 457899999999999999999998 88989999999999999999998 89999999999999999


Q ss_pred             cCCcccccCCcccccCCC---CccEEEccCCccc
Q 041249          731 GENKIQGNIPLDYGFTLQ---NLQYFSIGTNRIT  761 (789)
Q Consensus       731 s~N~l~~~ip~~~~~~l~---~L~~L~L~~N~l~  761 (789)
                      .+|+++ .+|.++. .+.   +=+.+.+.+|...
T Consensus       181 qgnrl~-vlppel~-~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  181 QGNRLT-VLPPELA-NLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             ccceee-ecChhhh-hhhhhhhHHHHhhhhCCCC
Confidence            999999 9998876 321   1223455555543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=3.5e-19  Score=169.76  Aligned_cols=202  Identities=22%  Similarity=0.322  Sum_probs=167.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC-CccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH-RNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ...|...+.||.|+||.+|.|..-..|.+||||+-+...  ...++.-|..+...++| ..|..+..+..+..     ..
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-----yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD-----YN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccc-----cc
Confidence            457899999999999999999999899999999975443  33567778888888865 55666665555444     67


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---Cce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~  424 (789)
                      .+||+.... +|++++.-+         .+.++..+.+-++-|+..-++|+|..+   ++||||||+|.|.+-+   ..+
T Consensus        87 vlVMdLLGP-sLEdLfnfC---------~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl  153 (341)
T KOG1163|consen   87 VLVMDLLGP-SLEDLFNFC---------SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKL  153 (341)
T ss_pred             eeeeeccCc-cHHHHHHHH---------hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceE
Confidence            899998864 888888655         467899999999999999999999998   9999999999999754   466


Q ss_pred             eeCcccccccCCCCC-----CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          425 HVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       425 kl~Dfgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .++|||+|+.+.+..     +........||.+|.+--.+.+.+.+.+-|.=|.|.+|.+.-.|..||...
T Consensus       154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            899999999887654     223334567999999998888888899999999999999999999999743

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-18  Score=173.68  Aligned_cols=200  Identities=21%  Similarity=0.320  Sum_probs=171.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      -.|.+.++||+|.||+++.|+.--+++.||||.-...  ....+++.|.+..+.| ..++|..+|.+-++..     +..
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-----~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-----YNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccc-----hhh
Confidence            4899999999999999999999889999999986433  3346788899999988 4689988887766555     678


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-----CCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-----EMV  423 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-----~~~  423 (789)
                      +|+|.+.. +|+++..-+         ++.|+..+...+|.|+..-++|+|++.   +|.|||||+|+||+.     ...
T Consensus       101 LVidLLGP-SLEDLFD~C---------gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~  167 (449)
T KOG1165|consen  101 LVIDLLGP-SLEDLFDLC---------GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANV  167 (449)
T ss_pred             hhhhhhCc-CHHHHHHHh---------cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCce
Confidence            99998864 888887543         688999999999999999999999998   999999999999973     346


Q ss_pred             eeeCcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.++|||+|+.+.+...     ........||.+||+--++.+.+-+.+-|.=|+|-|..+.+-|..||..
T Consensus       168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            79999999999987662     2233345699999999999999999999999999999999999999974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.5e-19  Score=174.82  Aligned_cols=243  Identities=20%  Similarity=0.297  Sum_probs=177.8

Q ss_pred             cccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      +|.+.-.|+.|+|+|.  |..++.|+++..  .....+.|.+|.-.++-+.||||.+++|.|....     ...++..||
T Consensus       197 kl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~isq~m  269 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIISQYM  269 (448)
T ss_pred             hhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEeeeec
Confidence            5677888999999997  666777776533  4455678999999999999999999999998765     889999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      +-|+|...+++.        ..-..+..+..+++.++|+|++|||+.. +.|----+.+..|++|++.+++|+= +-+++
T Consensus       270 p~gslynvlhe~--------t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf  339 (448)
T KOG0195|consen  270 PFGSLYNVLHEQ--------TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF  339 (448)
T ss_pred             cchHHHHHHhcC--------ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee
Confidence            999999999865        3345677889999999999999999985 3344457899999999999998741 11111


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCc---CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEV---STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD  511 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  511 (789)
                            +...-+..-.+.||+||.+...+-   -..+|+|||.+++||+.|++.||.+...-+..+.-.     .+++..
T Consensus       340 ------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----leglrv  408 (448)
T KOG0195|consen  340 ------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----LEGLRV  408 (448)
T ss_pred             ------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----hccccc
Confidence                  111112334578999999987654   356999999999999999999998542211111000     011112


Q ss_pred             hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      -+.|.+                          ...+..++.-|.+-++-.||..+.+..+++
T Consensus       409 ~ippgi--------------------------s~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  409 HIPPGI--------------------------SRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             cCCCCc--------------------------cHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence            222222                          334557778899999999999987765443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.76  E-value=8.3e-19  Score=174.22  Aligned_cols=174  Identities=11%  Similarity=0.115  Sum_probs=133.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHH---------HHHHHHHHhcCCCCccceeeeeeccC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS---------FIAECRALRSIRHRNLVKVFTACSGV  339 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~~  339 (789)
                      .+.|...+++|.|+||.||....  ++..+|||+++.........         +.+|++.+.++.|++|..+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999655  46689999997654333332         78999999999999999998875543


Q ss_pred             CCC---CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCce
Q 041249          340 DYQ---GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI  416 (789)
Q Consensus       340 ~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Ni  416 (789)
                      ...   .....++||||+++.+|.++..              ++.    ....+++.++..+|..+   ++|||++|+||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Ni  166 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNF  166 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHE
Confidence            211   1235799999999999987631              111    34669999999999998   99999999999


Q ss_pred             ecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHH
Q 041249          417 LLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL  480 (789)
Q Consensus       417 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~el  480 (789)
                      ++++++ ++++|||.......+....              .+.....+..++||||||+++...
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHH
Confidence            999988 9999999887664332110              122333467899999999997655

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.75  E-value=3.9e-18  Score=167.80  Aligned_cols=142  Identities=15%  Similarity=0.111  Sum_probs=108.9

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccch--h-------h-----------------HHHHHHHHHHhcCCCCc
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--A-------S-----------------RSFIAECRALRSIRHRN  328 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~n  328 (789)
                      ...||+|++|.||+|... +|+.||||+++.....  .       .                 .....|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999754221  1       0                 12245999999998877


Q ss_pred             cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh-hcCCCCCce
Q 041249          329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITT  407 (789)
Q Consensus       329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~iv  407 (789)
                      +.....+..  .     ..++||||++++++......          ...++..+...++.|++.+|.|+ |..+   |+
T Consensus        81 v~~p~~~~~--~-----~~~iVmE~i~g~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~l~H~~g---ii  140 (190)
T cd05147          81 IPCPEPILL--K-----SHVLVMEFIGDDGWAAPRLK----------DAPLSESKARELYLQVIQIMRILYQDCR---LV  140 (190)
T ss_pred             CCCCcEEEe--c-----CCEEEEEEeCCCCCcchhhh----------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            643222211  1     34899999998776544321          23578889999999999999999 6777   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPT  438 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  438 (789)
                      ||||||+||+++ ++.++++|||+|.....+
T Consensus       141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         141 HADLSEYNLLYH-DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             cCCCCHHHEEEE-CCcEEEEEccccccCCCc
Confidence            999999999998 478999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.74  E-value=1.5e-17  Score=178.85  Aligned_cols=200  Identities=34%  Similarity=0.510  Sum_probs=167.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---hhHHHHHHHHHHhcCCCC-ccceeeeeeccCCCCCCceE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---ASRSFIAECRALRSIRHR-NLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~  347 (789)
                      |...+.||.|+|+.||++...   ..+++|.+......   ....+.+|+..++.+.|+ ++++++..+....     ..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence            556778999999999999987   88999998655333   367899999999999988 7999999985433     47


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl  426 (789)
                      +++++++.++++.+++....       ....++......+..|++.+++|+|..+   ++|||+||+||+++... .+++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l  143 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIG-------RKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKL  143 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcc-------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEE
Confidence            99999999999997765430       0036888999999999999999999998   99999999999999988 7999


Q ss_pred             CcccccccCCCCCCcc----ceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQT----SSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .|||.++.........    ......|+..|+|||....   ..++...|+||+|++++++++|..||..
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~  213 (384)
T COG0515         144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG  213 (384)
T ss_pred             eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9999998665544221    2355679999999999987   5789999999999999999999999663

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.72  E-value=3.3e-17  Score=161.85  Aligned_cols=142  Identities=18%  Similarity=0.108  Sum_probs=110.3

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchh--------------------------hHHHHHHHHHHhcCCCCc
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--------------------------SRSFIAECRALRSIRHRN  328 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~n  328 (789)
                      ...||+|++|.||+|... +|+.||||+++......                          ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999987552110                          122467899999999988


Q ss_pred             cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCce
Q 041249          329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITT  407 (789)
Q Consensus       329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~iv  407 (789)
                      +.....+...       ..++||||++++++......          ...++..+...++.+++.++.++|+ .+   |+
T Consensus        81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~----------~~~~~~~~~~~i~~~l~~~l~~lH~~~g---iv  140 (190)
T cd05145          81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLK----------DVPLEEEEAEELYEQVVEQMRRLYQEAG---LV  140 (190)
T ss_pred             CCCceEEEec-------CCEEEEEEecCCCchhhhhh----------hccCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence            7433322211       24899999998754433211          1346778899999999999999999 88   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPT  438 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  438 (789)
                      ||||||+||+++ ++.++++|||++...+..
T Consensus       141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         141 HGDLSEYNILYH-DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             cCCCChhhEEEE-CCCEEEEEcccceecCCC
Confidence            999999999999 889999999999877654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.71  E-value=3.4e-17  Score=190.23  Aligned_cols=202  Identities=24%  Similarity=0.429  Sum_probs=109.9

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      +...+++....+.. .|..+  .+.|+.|+|++|+|+ .+|..+.  ++|++|++++|+|+ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lts-LP~~I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLTT-IPACI--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcCc-CCccc--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            34556665555442 23323  246777777777777 3454443  46777777777777 4455443  357777777


Q ss_pred             cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccC
Q 041249          636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIV  715 (789)
Q Consensus       636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  715 (789)
                      +|++. .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..+.  ++|+.|++++|+++ .+
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~L  319 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-AL  319 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cC
Confidence            77776 4555443  36777777777776 3455443  36777777777776 3444332  24555555555555 23


Q ss_pred             CccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          716 PSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       716 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      |..+.  ++|+.|++++|.++ .+|..+.   ++|+.|+|++|+|+ .+|..+.  ++|+.|++++|+|+
T Consensus       320 P~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        320 PETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             Ccccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence            33222  34555555555554 4444332   34555555555554 2333332  34555555555544

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.71  E-value=1.4e-17  Score=193.46  Aligned_cols=206  Identities=24%  Similarity=0.385  Sum_probs=117.6

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      .++.+++..+.+... +..+  .++|++|+|++|+|+ .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+++
T Consensus       200 ~L~~L~Ls~N~LtsL-P~~l--~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        200 QITTLILDNNELKSL-PENL--QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF  270 (754)
T ss_pred             CCcEEEecCCCCCcC-Chhh--ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence            456666767666532 3322  246777777777777 3454443  35777777777776 5555543  467777777


Q ss_pred             cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCC-------------------CCCCCCEEEccCCcCCccCCcccc
Q 041249          636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG-------------------NLSSLRKISLAINNLAGSIPFTLS  696 (789)
Q Consensus       636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------------------~l~~L~~L~L~~N~l~~~~~~~~~  696 (789)
                      +|+|+ .+|+.+.  ++|+.|+|++|+|++ +|..+.                   -.++|+.|++++|.++ .+|..+.
T Consensus       271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~  345 (754)
T PRK15370        271 HNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP  345 (754)
T ss_pred             CCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCccccCCccccccceeccccCCccc-cCChhhc
Confidence            77776 4555442  366777777776663 333221                   0134555555555555 2444332


Q ss_pred             CCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccc----cCCC
Q 041249          697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI----SNAS  772 (789)
Q Consensus       697 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~  772 (789)
                        ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.   ..|+.|++++|+|+ .+|..+    ..++
T Consensus       346 --~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~---~sL~~LdLs~N~L~-~LP~sl~~~~~~~~  415 (754)
T PRK15370        346 --PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP---AALQIMQASRNNLV-RLPESLPHFRGEGP  415 (754)
T ss_pred             --CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH---HHHHHHhhccCCcc-cCchhHHHHhhcCC
Confidence              45666666666665 4454442  45666666666666 5665543   24666666666666 334333    2345


Q ss_pred             CCCeeeccCCcCc
Q 041249          773 KLEVFQALNNKLT  785 (789)
Q Consensus       773 ~L~~L~l~~N~l~  785 (789)
                      ++..|++.+|+|+
T Consensus       416 ~l~~L~L~~Npls  428 (754)
T PRK15370        416 QPTRIIVEYNPFS  428 (754)
T ss_pred             CccEEEeeCCCcc
Confidence            6667777777765

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=7e-17  Score=156.82  Aligned_cols=190  Identities=16%  Similarity=0.052  Sum_probs=138.4

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch----hhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----ASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +.....|+.|+||+||.+..  .+.+++.+.+.....-    ....+.+|+++++++. |+++.+++++.         .
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------G   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------C
Confidence            34577899999999996655  5788888887655331    1235889999999995 58899888761         5


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC-CCCceecCCCCcee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL-KPSNILLDEEMVSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl-k~~Nill~~~~~~k  425 (789)
                      .+++|||+.+.+|.+....                 ....+..|++.+|+++|..|   |||||| ||+||+++.++.++
T Consensus        73 ~~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~  132 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPA  132 (218)
T ss_pred             EEEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEE
Confidence            6899999998888654311                 12357789999999999998   999999 79999999999999


Q ss_pred             eCcccccccCCCCCCc----c-------ceeeecccccccCcccCCC-CCcC-ccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          426 VGDFGLARFLPPTHVQ----T-------SSIGVKGSIGYIAPEYGLG-SEVS-TNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~-~~~~-~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      |+|||+|....+....    .       .......+..|++|+...- ...+ ...+.++-|.-+|.++||+.|.....+
T Consensus       133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            9999999976554420    0       0001223445555543221 1223 557888999999999999999864433

>PRK10345 hypothetical protein; Provisional

Probab=99.67  E-value=3.3e-16  Score=155.43  Aligned_cols=142  Identities=18%  Similarity=0.288  Sum_probs=109.6

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-----CCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-----RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+..+.||+|++|.||.  +++++.. +||++........+.+.+|+++++.+     .||||++++|++....  +...
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            45578999999999996  6556555 69988766555667899999999999     5799999999987643  1123


Q ss_pred             -EEEEeec--cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHH-hhhhcCCCCCceecCCCCCceecCC--
Q 041249          347 -KALVYEF--MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL-DYLHHDCQPITTHCDLKPSNILLDE--  420 (789)
Q Consensus       347 -~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivH~dlk~~Nill~~--  420 (789)
                       ..+|+||  +..|+|.+++...           .+++.  ..++.+++.++ +|||+.+   ||||||||+||+++.  
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~  142 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRIS  142 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccC
Confidence             3478999  5589999999532           23433  35678888887 9999998   999999999999974  


Q ss_pred             --CCceeeCc-cccccc
Q 041249          421 --EMVSHVGD-FGLARF  434 (789)
Q Consensus       421 --~~~~kl~D-fgla~~  434 (789)
                        +..++|+| ||....
T Consensus       143 ~~~~~~~LiDg~G~~~~  159 (210)
T PRK10345        143 ESEVIPVVCDNIGESTF  159 (210)
T ss_pred             CCCCcEEEEECCCCcce
Confidence              34899999 555444

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.67  E-value=3.1e-18  Score=184.35  Aligned_cols=230  Identities=23%  Similarity=0.264  Sum_probs=157.1

Q ss_pred             eeEeccCccccccc----ccccccCccccchhcccCCcccc------cCcccccCccceeeecccCCCCccCCCccCcCC
Q 041249          557 VTILDLESLKLAGS----ILPHIGNLSFLKILNLENNSFTH------EIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSC  626 (789)
Q Consensus       557 l~~l~l~s~~~~~~----~l~~l~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l  626 (789)
                      ++.+++..+.+...    ....+...+.|++|+++++.+.+      .++..|..+++|+.|++++|.+.+..+..+..+
T Consensus        25 L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l  104 (319)
T cd00116          25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESL  104 (319)
T ss_pred             ccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHH
Confidence            66666666665322    23445567778888888887762      234556677888888888888876666655555


Q ss_pred             CC---CcEEEcccCCCCC----CCCcccCCC-CCCcEEEccCCCCCcc----CCcCCCCCCCCCEEEccCCcCCcc----
Q 041249          627 SN---LIRIGLAKNQLMG----KIPSDFGSL-SKIEVLSLGFNNLIGS----IPPPLGNLSSLRKISLAINNLAGS----  690 (789)
Q Consensus       627 ~~---L~~L~l~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----  690 (789)
                      .+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++..+..+++|++|+|++|.+++.    
T Consensus       105 ~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~  184 (319)
T cd00116         105 LRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRA  184 (319)
T ss_pred             hccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHH
Confidence            54   8888888888873    223344556 7888888888888732    334466677888888888888742    


Q ss_pred             CCccccCCCCCCeeeccCcccccc----CCccccCCCCccEEEccCCcccccCCcccccC----CCCccEEEccCCcccc
Q 041249          691 IPFTLSKLKNLVILYLGVNRLSGI----VPSSIFNISSIAEFDVGENKIQGNIPLDYGFT----LQNLQYFSIGTNRITG  762 (789)
Q Consensus       691 ~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~----l~~L~~L~L~~N~l~~  762 (789)
                      ++..+..+++|++|+|++|.+++.    ++..+..+++|++|++++|.+++.....+...    .+.|++|++++|.+++
T Consensus       185 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~  264 (319)
T cd00116         185 LAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITD  264 (319)
T ss_pred             HHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCc
Confidence            333455667888888888888643    33456677888888888888874322222222    3688888888888862


Q ss_pred             ----cCcccccCCCCCCeeeccCCcCcc
Q 041249          763 ----AIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       763 ----~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                          .+...+..+++|+.+++++|.++.
T Consensus       265 ~~~~~l~~~~~~~~~L~~l~l~~N~l~~  292 (319)
T cd00116         265 DGAKDLAEVLAEKESLLELDLRGNKFGE  292 (319)
T ss_pred             HHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence                233455666788888888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=4e-17  Score=186.30  Aligned_cols=202  Identities=24%  Similarity=0.330  Sum_probs=161.7

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEecc-----ccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL-----HHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ...+.+|.|.+|.|+........+..+.|.++.     ..... ...+..|..+-.+++|+|++..+..+.+.+     .
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence            457789999999888777764555555554431     11111 122566777788899999999888877665     3


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      ..-+|||++. +|..++...          ..+...++-.+..|+..|+.|+|+.|   +.|||+|++|++++.++.+|+
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~----------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki  461 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN----------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKI  461 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc----------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEE
Confidence            3334999999 999998643          46788889999999999999999999   999999999999999999999


Q ss_pred             CcccccccCCCCCCc--cceeeecccccccCcccCCCCCcCcc-ccchhhHHHHHHHHHhcCCCCccccC
Q 041249          427 GDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTN-GDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k-~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      +|||.+.....+...  ....+..|+-+|+|||.....+|++. .||||.|+++..|++|+.||......
T Consensus       462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence            999999987655543  45567889999999999999999876 99999999999999999999765443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=2e-16  Score=183.66  Aligned_cols=202  Identities=18%  Similarity=0.192  Sum_probs=161.6

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC---CCccceeeeeeccC
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR---HRNLVKVFTACSGV  339 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  339 (789)
                      .+.+...+.|.+...||+|+||.||+|...+ ++.||+|+-+....-   +|..-.+++.+|+   -+.|+.+.......
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            3555567889999999999999999999985 999999997654332   3333344444554   34455554444333


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      +     ...+|+||.+-|+|.+++...          +.++|.-.+.++.|++.-+++||..+   ||||||||.|.+|.
T Consensus       767 ~-----~S~lv~ey~~~Gtlld~~N~~----------~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  767 N-----ASVLVSEYSPYGTLLDLINTN----------KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLR  828 (974)
T ss_pred             C-----cceeeeeccccccHHHhhccC----------CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEee
Confidence            3     568999999999999999744          67889999999999999999999999   99999999999994


Q ss_pred             -------CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249          420 -------EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       420 -------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                             +...++|+|||.+.-+..-.......++++|-.+-++|+..+..++..+|.|.+..+++-|+.|+.-
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence                   3346799999999866533333456678899999999999999999999999999999999999743

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.64  E-value=1.5e-17  Score=179.13  Aligned_cols=235  Identities=21%  Similarity=0.252  Sum_probs=175.7

Q ss_pred             hhccccceeeEeccCccccc------ccccccccCccccchhcccCCcccccCcccccCccc---eeeecccCCCCcc--
Q 041249          549 RIGSKAQKVTILDLESLKLA------GSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRR---LQVPDLNNNSIGG--  617 (789)
Q Consensus       549 ~i~~~c~~l~~l~l~s~~~~------~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~i~~--  617 (789)
                      +....+..++.+++..+...      ......+..+++|+.|++++|.+.+..+..|..+.+   |+.|++++|++++  
T Consensus        45 ~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~  124 (319)
T cd00116          45 SALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRG  124 (319)
T ss_pred             HHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHH
Confidence            33344555666666665544      223356677899999999999998777777777666   9999999999983  


Q ss_pred             --CCCccCcCC-CCCcEEEcccCCCCCC----CCcccCCCCCCcEEEccCCCCCcc----CCcCCCCCCCCCEEEccCCc
Q 041249          618 --EIPVNLSSC-SNLIRIGLAKNQLMGK----IPSDFGSLSKIEVLSLGFNNLIGS----IPPPLGNLSSLRKISLAINN  686 (789)
Q Consensus       618 --~~p~~~~~l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~  686 (789)
                        .+...+..+ ++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|++|+|++|.
T Consensus       125 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  204 (319)
T cd00116         125 LRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG  204 (319)
T ss_pred             HHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence              233455667 8999999999999843    344567788999999999999842    33445566899999999999


Q ss_pred             CCcc----CCccccCCCCCCeeeccCccccccCCcccc-----CCCCccEEEccCCcccc----cCCcccccCCCCccEE
Q 041249          687 LAGS----IPFTLSKLKNLVILYLGVNRLSGIVPSSIF-----NISSIAEFDVGENKIQG----NIPLDYGFTLQNLQYF  753 (789)
Q Consensus       687 l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~ip~~~~~~l~~L~~L  753 (789)
                      +++.    +...+..+++|++|++++|.+++.....+.     ..++|+.|++++|.+++    .+...+. .+++|++|
T Consensus       205 i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~-~~~~L~~l  283 (319)
T cd00116         205 LTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLA-EKESLLEL  283 (319)
T ss_pred             cChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHh-cCCCccEE
Confidence            9744    344567889999999999999863333332     24799999999999961    2333333 56899999


Q ss_pred             EccCCccccc----CcccccCC-CCCCeeeccCCcC
Q 041249          754 SIGTNRITGA----IPPSISNA-SKLEVFQALNNKL  784 (789)
Q Consensus       754 ~L~~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l  784 (789)
                      ++++|.++..    ....+... +.|++|++.+|++
T Consensus       284 ~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         284 DLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             ECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            9999999965    44445555 6899999999975

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.64  E-value=3.6e-16  Score=170.10  Aligned_cols=216  Identities=25%  Similarity=0.331  Sum_probs=159.1

Q ss_pred             HhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc
Q 041249          321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH  400 (789)
Q Consensus       321 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~  400 (789)
                      |+.+.|.|+.+++|.+....     ..+.|.+|+..|+|.+.+..         ....++|.-...+.+++++||+|+|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence            35678999999999998775     88999999999999999964         35678999999999999999999997


Q ss_pred             CCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC-------cCccccchhh
Q 041249          401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-------VSTNGDVYSY  473 (789)
Q Consensus       401 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~DV~sf  473 (789)
                      ..  ...|+.++++|.+++..|.+|++|||+....................-|.|||.+....       .+.++|||||
T Consensus        67 s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   67 SP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             Cc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence            54  23999999999999999999999999998875421111111223456799999987641       4778999999


Q ss_pred             HHHHHHHHHhcCCCCccccCCc--cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhc
Q 041249          474 GILMLELIIRKKPSDIMFEGDM--NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIG  551 (789)
Q Consensus       474 Gvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  551 (789)
                      |++++|+++.+.||+.......  .+...++....    ....|.+.                    ...+....+..++
T Consensus       145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~----~~~rP~i~--------------------~~~e~~~~l~~l~  200 (484)
T KOG1023|consen  145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGS----NPFRPSIE--------------------LLNELPPELLLLV  200 (484)
T ss_pred             HHHHHHHHhccCccccccccCChHHHHHHHHhcCC----CCcCcchh--------------------hhhhcchHHHHHH
Confidence            9999999999999986433222  23333332000    11111111                    0012333677888


Q ss_pred             cccceeeEeccCccccccccccccc
Q 041249          552 SKAQKVTILDLESLKLAGSILPHIG  576 (789)
Q Consensus       552 ~~c~~l~~l~l~s~~~~~~~l~~l~  576 (789)
                      ..|+.-.|..||+...+......+.
T Consensus       201 ~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  201 ARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             HHhcccChhhCccHHHHHhhhhhhc
Confidence            9999999999999988766554443

>smart00090 RIO RIO-like kinase

Probab=99.60  E-value=3.8e-15  Score=151.70  Aligned_cols=146  Identities=18%  Similarity=0.137  Sum_probs=112.3

Q ss_pred             CCCCCCcccccCCccEEEEE-EcCCceEEEEEEeccccch------------------------hhHHHHHHHHHHhcCC
Q 041249          271 GFSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHR------------------------ASRSFIAECRALRSIR  325 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  325 (789)
                      .|...+.||+|++|.||+|. ...+++.||+|+++.....                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57788999999999999998 5558999999998754210                        1123678999999997


Q ss_pred             CC--ccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 041249          326 HR--NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ  403 (789)
Q Consensus       326 h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~  403 (789)
                      +.  .+.+++++.         ..++||||+.++++.......          ..+...+...++.|++.++++||..+ 
T Consensus       109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~g-  168 (237)
T smart00090      109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKD----------VEPEEEEEFELYDDILEEMRKLYKEG-  168 (237)
T ss_pred             hcCCCCCeeeEec---------CceEEEEEecCCccccccccc----------CCcchHHHHHHHHHHHHHHHHHHhcC-
Confidence            53  344444321         348999999998887654222          23455667899999999999999775 


Q ss_pred             CCceecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249          404 PITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT  438 (789)
Q Consensus       404 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  438 (789)
                       .++||||||+||+++ +++++++|||.+......
T Consensus       169 -~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      169 -ELVHGDLSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             -CEEeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence             499999999999999 889999999998865543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.59  E-value=6.9e-15  Score=146.52  Aligned_cols=149  Identities=18%  Similarity=0.134  Sum_probs=114.9

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch----------------------hhHHHHHHHH
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----------------------ASRSFIAECR  319 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~  319 (789)
                      .+++.+....|...+.||+|+||.||++... +++.||||+++.....                      ....+..|..
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   85 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA   85 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence            3455556656888999999999999999986 7999999997643211                      1123677888


Q ss_pred             HHhcCCCCc--cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 041249          320 ALRSIRHRN--LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY  397 (789)
Q Consensus       320 ~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~  397 (789)
                      .+.++.|++  +.+.++.         ...++||||+.++++......                .....++.+++.++.+
T Consensus        86 ~l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~  140 (198)
T cd05144          86 ALKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVK  140 (198)
T ss_pred             HHHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHH
Confidence            898887774  4444432         145899999999988765420                2346788999999999


Q ss_pred             hhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC
Q 041249          398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH  439 (789)
Q Consensus       398 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  439 (789)
                      +|..+   ++||||||+||++++++.++|+|||.+.......
T Consensus       141 lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~~~  179 (198)
T cd05144         141 AYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDHPN  179 (198)
T ss_pred             HHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCCCcc
Confidence            99987   9999999999999999999999999997655443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.59  E-value=3.5e-16  Score=169.71  Aligned_cols=187  Identities=25%  Similarity=0.263  Sum_probs=153.9

Q ss_pred             cccccCCccEEEEEE---cCCceEEEEEEeccccch--hhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEEE
Q 041249          277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      ++|+|.||.|+.+.-   ...++.+|.|+.+.....  .......|..++...+ ||.++++-..++...     ..+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence            368899998886543   334677888887654222  2235667888888886 999999977776655     78999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      +++..+|.+...+...          ..++......+...+|-|++++|..+   ++|||+|++||+++.+|++++.|||
T Consensus        76 ld~~rgg~lft~l~~~----------~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfg  142 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKE----------VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFG  142 (612)
T ss_pred             hhhcccchhhhccccC----------CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCch
Confidence            9999999999888654          55677788889999999999999888   9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +++..-.....      +||..|||||+..  .....+|-||||++++||+||-.||..
T Consensus       143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            99976544322      7899999999987  567889999999999999999999974

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.58  E-value=7e-16  Score=175.16  Aligned_cols=197  Identities=22%  Similarity=0.248  Sum_probs=144.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHH--HhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRA--LRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++.-.+.+|.+.|=.|.+|++++ |. |+||++-... ....+.|+++++.  ...++|||.+++.-......     ..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~k-----AA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDK-----AA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhH-----HH
Confidence            56667889999999999999983 44 9999985443 3334444444333  44558999999865533222     44


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|=+|..+ +|.+.+.-          ...+...+...|+.|+.+|+..+|..+   |+|||||.+|||++.-.=+.|+
T Consensus        97 ylvRqyvkh-nLyDRlST----------RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~Lt  162 (1431)
T KOG1240|consen   97 YLVRQYVKH-NLYDRLST----------RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLT  162 (1431)
T ss_pred             HHHHHHHhh-hhhhhhcc----------chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhh
Confidence            566677765 78887743          356788899999999999999999998   9999999999999988888999


Q ss_pred             cccccc--cCCCCCCccceee---ecccccccCcccCCC----------CC-cCccccchhhHHHHHHHHH-hcCCCC
Q 041249          428 DFGLAR--FLPPTHVQTSSIG---VKGSIGYIAPEYGLG----------SE-VSTNGDVYSYGILMLELII-RKKPSD  488 (789)
Q Consensus       428 Dfgla~--~~~~~~~~~~~~~---~~gt~~y~aPE~~~~----------~~-~~~k~DV~sfGvvl~ellt-G~~P~~  488 (789)
                      ||..=+  +++.+.+...+-.   -..-..|+|||-+..          .. .+++.||||.|||+.||++ |++||+
T Consensus       163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            996544  2333333222221   122346999996543          12 6789999999999999998 899997

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.58  E-value=1.1e-16  Score=170.04  Aligned_cols=184  Identities=27%  Similarity=0.456  Sum_probs=166.3

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      .++.-...||+.|++. ++|..+..+..|+.|.|.+|.|. .+|..+.++..|++|||+.|+++ .+|..+..|+ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            4666678999999999 89999999999999999999999 88999999999999999999999 7887777765 9999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      -+++|+++ .+|..++.++.|..|+.+.|.|. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+|+
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis  224 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS  224 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence            99999998 88889999999999999999998 78889999999999999999999 678888765 6999999999999


Q ss_pred             ccCCcccccCCCCccEEEccCCcccccCcccccCC
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNA  771 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  771 (789)
                       .||..+- +|..|++|-|.+|.++ ..|..++..
T Consensus       225 -~iPv~fr-~m~~Lq~l~LenNPLq-SPPAqIC~k  256 (722)
T KOG0532|consen  225 -YLPVDFR-KMRHLQVLQLENNPLQ-SPPAQICEK  256 (722)
T ss_pred             -ecchhhh-hhhhheeeeeccCCCC-CChHHHHhc
Confidence             9999987 8999999999999999 566666543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.57  E-value=2.5e-15  Score=153.93  Aligned_cols=206  Identities=21%  Similarity=0.249  Sum_probs=131.3

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCC-----------Cccceeeeeecc
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH-----------RNLVKVFTACSG  338 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-----------~niv~l~~~~~~  338 (789)
                      ...+.||.|+++.||.+++.++++++|+|++.....   ...+.+++|.-....+.+           .-++++--.-..
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            346789999999999999999999999999854432   234566666655555432           222222111111


Q ss_pred             CCC-----C-CCc-----eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCce
Q 041249          339 VDY-----Q-GND-----FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT  407 (789)
Q Consensus       339 ~~~-----~-~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv  407 (789)
                      .+.     . +..     ..+++|+-+. ++|.+++..-.   ........+....++.+..|+.+.+++||+.|   +|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~---~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALF---SRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHH---HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHh---hcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            110     0 001     2356777664 57777753210   00011233455667888899999999999999   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--------CCcCccccchhhHHHHHH
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--------SEVSTNGDVYSYGILMLE  479 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~sfGvvl~e  479 (789)
                      |+||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|++|+++|.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            9999999999999999999999887765432211     234467899997543        247999999999999999


Q ss_pred             HHHhcCCCCcc
Q 041249          480 LIIRKKPSDIM  490 (789)
Q Consensus       480 lltG~~P~~~~  490 (789)
                      |.+|+.||+..
T Consensus       243 lWC~~lPf~~~  253 (288)
T PF14531_consen  243 LWCGRLPFGLS  253 (288)
T ss_dssp             HHHSS-STCCC
T ss_pred             HHHccCCCCCC
Confidence            99999999854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.56  E-value=1.6e-14  Score=165.78  Aligned_cols=147  Identities=20%  Similarity=0.241  Sum_probs=114.3

Q ss_pred             ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEe--ccccc------hhhHHHHHHHHHHhcCCCCccce
Q 041249          260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHH------RASRSFIAECRALRSIRHRNLVK  331 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~--~~~~~------~~~~~~~~e~~~l~~l~h~niv~  331 (789)
                      .++.........|...+.||+|+||+||+|.+...  .+++|+.  +....      .....+..|+++++.++|++++.
T Consensus       323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             eeeccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            34444444455667789999999999999998633  3444432  11111      12356889999999999999988


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      ...++....     ..++||||+++++|.+++.                  ....++.+++.+|.|||..+   ++|||+
T Consensus       401 p~~~~~~~~-----~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~g---iiHrDl  454 (535)
T PRK09605        401 PVIYDVDPE-----EKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKAG---IVHGDL  454 (535)
T ss_pred             eEEEEEeCC-----CCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhCC---CccCCC
Confidence            766665433     5689999999999998773                  35678999999999999988   999999


Q ss_pred             CCCceecCCCCceeeCcccccccC
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFL  435 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~  435 (789)
                      ||+||++ +++.++++|||+++..
T Consensus       455 kp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        455 TTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999 6789999999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.56  E-value=1.6e-14  Score=145.52  Aligned_cols=135  Identities=21%  Similarity=0.265  Sum_probs=110.2

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.||+|++|.||+|.+  .+..|++|........        ....+..|++.+..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999988  4778999986543211        1245788999999999998876655554333     57


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+++++|.+++...             .+ ++..++.+++.+|.++|..+   ++|||++|.||+++ ++.++++
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~li  136 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLI  136 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEE
Confidence            8999999999999988532             12 78899999999999999888   99999999999999 7889999


Q ss_pred             cccccccC
Q 041249          428 DFGLARFL  435 (789)
Q Consensus       428 Dfgla~~~  435 (789)
                      |||.+...
T Consensus       137 Df~~a~~~  144 (211)
T PRK14879        137 DFGLAEFS  144 (211)
T ss_pred             ECCcccCC
Confidence            99998763

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=2.6e-16  Score=167.28  Aligned_cols=194  Identities=24%  Similarity=0.373  Sum_probs=172.8

Q ss_pred             hhcccCCcccccCcc-cc-cCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          583 ILNLENNSFTHEIPS-EI-GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~-~~-~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      .|.|++-++.. .|. ++ ..+..-...||+.|++. ++|..+..+..|+.|.|.+|.|. .+|..+.++..|++|||+.
T Consensus        54 ~l~Ls~rrlk~-fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~  130 (722)
T KOG0532|consen   54 RLLLSGRRLKE-FPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS  130 (722)
T ss_pred             ccccccchhhc-CCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence            45566666663 332 22 35667788999999999 89999999999999999999998 8999999999999999999


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |+++ ..|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|.|. .+|..+..+.+|+.|.+..|.+. .+|
T Consensus       131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp  205 (722)
T KOG0532|consen  131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP  205 (722)
T ss_pred             chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence            9998 7888888887 999999999999 89999999999999999999999 78999999999999999999999 999


Q ss_pred             cccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          741 LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       741 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      .++. . -.|..||+|.|+|+ .+|..|.+|+.|++|-|.+|++...
T Consensus       206 ~El~-~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP  249 (722)
T KOG0532|consen  206 EELC-S-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP  249 (722)
T ss_pred             HHHh-C-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence            9986 4 46899999999999 7899999999999999999999763

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.52  E-value=4.2e-14  Score=141.06  Aligned_cols=131  Identities=21%  Similarity=0.255  Sum_probs=103.1

Q ss_pred             cccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .||+|++|.||+|.+  ++..|++|........        ....+..|++++..+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            489999999999996  4788999986433211        1255778999999998876544333333322     468


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+++++|.+++...          .       ..++.+++.+|.++|..+   ++|||++|.||+++ ++.++++|
T Consensus        74 lv~e~~~g~~l~~~~~~~----------~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liD  132 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----------N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLID  132 (199)
T ss_pred             EEEEEECCccHHHHHhhc----------H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEE
Confidence            999999999999887432          0       078999999999999888   99999999999999 88999999


Q ss_pred             ccccccC
Q 041249          429 FGLARFL  435 (789)
Q Consensus       429 fgla~~~  435 (789)
                      ||.+...
T Consensus       133 fg~a~~~  139 (199)
T TIGR03724       133 FGLGKYS  139 (199)
T ss_pred             CCCCcCC
Confidence            9998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=5.4e-14  Score=143.64  Aligned_cols=150  Identities=25%  Similarity=0.282  Sum_probs=111.9

Q ss_pred             CCCccceeeeeeccCC----------------------CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHH
Q 041249          325 RHRNLVKVFTACSGVD----------------------YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL  382 (789)
Q Consensus       325 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~  382 (789)
                      +|||||++.+.|.++-                      +.+....|+||.-... +|++++...           ..+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----------~~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----------HRSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----------CCchH
Confidence            5999999999876542                      1234457888876664 899988643           34666


Q ss_pred             HHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec--CCCC--ceeeCcccccccCCCCC---Ccccee-eeccccccc
Q 041249          383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL--DEEM--VSHVGDFGLARFLPPTH---VQTSSI-GVKGSIGYI  454 (789)
Q Consensus       383 ~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfgla~~~~~~~---~~~~~~-~~~gt~~y~  454 (789)
                      ...-|+.|+++|+.|||.+|   |.|||+|+.|||+  +++.  ...++|||.+-.-..-.   ...... ...|...-|
T Consensus       342 ~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            77889999999999999999   9999999999999  3443  55889999876433211   111111 233666789


Q ss_pred             CcccCCCC--C----cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          455 APEYGLGS--E----VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       455 aPE~~~~~--~----~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||+....  +    --.|+|.|+.|.+.||++....||+.
T Consensus       419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            99987652  2    24789999999999999999999985

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.49  E-value=2.5e-14  Score=158.74  Aligned_cols=196  Identities=28%  Similarity=0.455  Sum_probs=125.4

Q ss_pred             hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCC-CCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249          583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCS-NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN  661 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  661 (789)
                      .+++..|.+.. ....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            46666666642 3333455566777777777777 5555555553 7777777777776 45455666777777777777


Q ss_pred             CCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCc
Q 041249          662 NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL  741 (789)
Q Consensus       662 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~  741 (789)
                      +++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|++. ..+..+..+.++..|.+++|++. .++.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            776 44444446667777777777776 55555455556777777777544 45566667777777777777776 4444


Q ss_pred             ccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccC
Q 041249          742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV  788 (789)
Q Consensus       742 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  788 (789)
                      .+. .+++++.|++++|.++...+  +..+.+++.|++++|.++...
T Consensus       250 ~~~-~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~  293 (394)
T COG4886         250 SIG-NLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNAL  293 (394)
T ss_pred             hhc-cccccceecccccccccccc--ccccCccCEEeccCccccccc
Confidence            444 56667777777777774332  666777777777777666543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.46  E-value=2e-14  Score=153.28  Aligned_cols=130  Identities=28%  Similarity=0.478  Sum_probs=111.4

Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++.|+++...+|.+++...       .....-++.....++.|++.|+.|   ++   .+|+|+||.||+...+...|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr-------~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRR-------RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCC-------CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhh
Confidence            468999999999999999755       234566888999999999999999   55   89999999999999999999


Q ss_pred             eCcccccccCCCCC----CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249          426 VGDFGLARFLPPTH----VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSD  488 (789)
Q Consensus       426 l~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~  488 (789)
                      |+|||+........    .....+...||..||+||.+.+..|+.|+||||+|++++|+++ =..+++
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e  464 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE  464 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence            99999998876555    2334445669999999999999999999999999999999988 455543

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=2.3e-13  Score=157.88  Aligned_cols=111  Identities=38%  Similarity=0.632  Sum_probs=64.9

Q ss_pred             CCEEEccCCcCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhh
Q 041249           71 LVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFL  150 (789)
Q Consensus        71 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~  150 (789)
                      ++.|+|++|.|+|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.             |||++|+++|.+|+.+
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~-------------LdLs~N~lsg~iP~~l  486 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-------------LDLSYNSFNGSIPESL  486 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE-------------EECCCCCCCCCCchHH
Confidence            556666666666666666666666666666666666666666655555443             3333444555666666


Q ss_pred             cCcccccEEecccCCCCCCCCCc--ccccCCccccccCCCccccCC
Q 041249          151 VGLKVIENLNLSYNDLEGMVPTE--GVFKNASAISVLGNNKLCGGI  194 (789)
Q Consensus       151 ~~~~~l~~l~ls~N~~~~~~~~~--~~~~~~~~~~~~~n~~~~~~~  194 (789)
                      ..+++|+.|+|++|+++|.+|..  ........+.+.+|+.+|+.+
T Consensus       487 ~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             hcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            66666666666666666666543  112233445666777778643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=5.8e-14  Score=159.83  Aligned_cols=167  Identities=27%  Similarity=0.364  Sum_probs=122.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .+||..+++|..|+||.||...++.+.+.+|+|+=+ +.    ..            -+||..+.+           ..+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~----li------------lRnilt~a~-----------npf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN----LI------------LRNILTFAG-----------NPF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc----hh------------hhccccccC-----------Ccc
Confidence            369999999999999999999999889999995421 11    00            012332222           112


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      .|      |+-...++..          ..++        .+++.+++|+|+.+   |||||+||+|.+|+.-+++|++|
T Consensus       134 vv------gDc~tllk~~----------g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTD  186 (1205)
T KOG0606|consen  134 VV------GDCATLLKNI----------GPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTD  186 (1205)
T ss_pred             ee------chhhhhcccC----------CCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccc
Confidence            22      3333333221          1111        22378999999888   99999999999999999999999


Q ss_pred             ccccccCCCCC------------C-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          429 FGLARFLPPTH------------V-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       429 fgla~~~~~~~------------~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ||+++......            . +.....+.||+.|+|||++....|...+|.|++|+++||.+.|+.||+..
T Consensus       187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence            99988653221            1 11222457999999999999999999999999999999999999999743

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.42  E-value=5.9e-13  Score=131.36  Aligned_cols=138  Identities=20%  Similarity=0.176  Sum_probs=97.2

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchh--hHH----------------------HHHHHHHHhcCCCCc--
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRS----------------------FIAECRALRSIRHRN--  328 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--  328 (789)
                      .+.||+|+||.||+|... +++.||||+++......  ...                      ...|.+.+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 78999999986542211  111                      134555555553332  


Q ss_pred             cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCce
Q 041249          329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITT  407 (789)
Q Consensus       329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~iv  407 (789)
                      +.+.++..         ..++||||++++++.......        .  . ...+...++.+++.++.++|. .+   ++
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~--------~--~-~~~~~~~~~~~~~~~l~~lh~~~~---iv  137 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKD--------V--R-LLEDPEELYDQILELMRKLYREAG---LV  137 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhh--------h--h-hcccHHHHHHHHHHHHHHHhhccC---cC
Confidence            33333321         358999999996543221110        0  0 015578899999999999998 77   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPP  437 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  437 (789)
                      |+||||+||+++ ++.++++|||.+.....
T Consensus       138 H~Dl~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         138 HGDLSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             cCCCChhhEEEE-CCcEEEEECcccccccC
Confidence            999999999999 89999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.41  E-value=1.4e-12  Score=123.44  Aligned_cols=136  Identities=22%  Similarity=0.253  Sum_probs=112.0

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC--CccceeeeeeccCCCCCCceEEEEe
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH--RNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.+.||+|.++.||++...  ++.+++|.......  ...+..|++.+..++|  ..+.+++++.....     ..++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~-----~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG-----WSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----ccEEEE
Confidence            3567999999999999986  37899999865433  4678999999999976  58888888765433     689999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.++.+..+                 +......++.+++.+++++|.....+++|+|++|+||++++.+.+++.|||.
T Consensus        73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~  135 (155)
T cd05120          73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY  135 (155)
T ss_pred             EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence            99998655432                 4556788899999999999987556699999999999999989999999999


Q ss_pred             cccC
Q 041249          432 ARFL  435 (789)
Q Consensus       432 a~~~  435 (789)
                      +...
T Consensus       136 ~~~~  139 (155)
T cd05120         136 AGYG  139 (155)
T ss_pred             ccCC
Confidence            8754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=1.2e-13  Score=153.35  Aligned_cols=186  Identities=34%  Similarity=0.518  Sum_probs=150.8

Q ss_pred             cccCccccchhcccCCcccccCcccccCcc-ceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLR-RLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSK  652 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  652 (789)
                      .+..++.++.|++.+|.++ .++.....++ +|+.|++++|.|. .+|..+..+++|+.|++++|++. .+|.....+++
T Consensus       111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~  187 (394)
T COG4886         111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN  187 (394)
T ss_pred             hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhh
Confidence            4445578899999999999 4566566664 8999999999998 66677889999999999999998 56655557889


Q ss_pred             CcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccC
Q 041249          653 IEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE  732 (789)
Q Consensus       653 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  732 (789)
                      |+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.+++++..|.+++|++. .++..+..+++++.|++++
T Consensus       188 L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~  264 (394)
T COG4886         188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN  264 (394)
T ss_pred             hhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccc
Confidence            999999999998 66665555667999999999654 56777888999999999999998 5578888888999999999


Q ss_pred             CcccccCCcccccCCCCccEEEccCCcccccCcccc
Q 041249          733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI  768 (789)
Q Consensus       733 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~  768 (789)
                      |.++ .++. +. .+.+|+.|++++|.+....|...
T Consensus       265 n~i~-~i~~-~~-~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         265 NQIS-SISS-LG-SLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             cccc-cccc-cc-ccCccCEEeccCccccccchhhh
Confidence            9998 7777 44 78999999999998876554443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.35  E-value=5.7e-12  Score=128.69  Aligned_cols=141  Identities=17%  Similarity=0.126  Sum_probs=106.0

Q ss_pred             CCccc-ccCCccEEEEEEcCCceEEEEEEecccc-------------chhhHHHHHHHHHHhcCCCCcc--ceeeeeecc
Q 041249          275 ANLIG-TGSFGSVYKGVLDEGRTTVTVKVFNLHH-------------HRASRSFIAECRALRSIRHRNL--VKVFTACSG  338 (789)
Q Consensus       275 ~~~ig-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~  338 (789)
                      ...|| .||.|+||.....  +..++||.+....             ......+.+|++++.++.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45787 8999999999885  7789998874311             1223567889999999998885  566666433


Q ss_pred             CCCCCCceEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          339 VDYQGNDFKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      .. ......++|+|++++ .+|.+++...           .++..    .+.+++.++.+||..|   |+||||||.|||
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-----------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NIL  174 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQEA-----------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNIL  174 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhcC-----------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEE
Confidence            21 111124699999997 6888887432           23332    3578999999999998   999999999999


Q ss_pred             cCCCCceeeCcccccccCC
Q 041249          418 LDEEMVSHVGDFGLARFLP  436 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~  436 (789)
                      ++.++.++++|||.+....
T Consensus       175 v~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        175 LDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             EcCCCCEEEEECCCcccCC
Confidence            9998999999999988754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=2.9e-13  Score=154.84  Aligned_cols=218  Identities=25%  Similarity=0.281  Sum_probs=172.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC-CceEEEEEEecccc--chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHH--HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..|...+.||+|.|+.|-...... ....+|+|.+....  .........|..+=..+. |+|++.+++......     
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-----   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-----   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-----
Confidence            356667789999999999888742 34456666664443  223344555777777775 999999998866555     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh-cCCCCCceecCCCCCceecCCCC-c
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEM-V  423 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH~dlk~~Nill~~~~-~  423 (789)
                      ..+++.||..+|++.+.+...        .....+....-.+..|+..|+.|+| ..+   ++|+|+||+|.+++..+ .
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~--------~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~  163 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHP--------DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSA  163 (601)
T ss_pred             ccccccCcccccccccccccC--------CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCc
Confidence            789999999999998877311        1224566677889999999999999 777   99999999999999999 9


Q ss_pred             eeeCcccccccCCC-CCCccceeeecc-cccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249          424 SHVGDFGLARFLPP-THVQTSSIGVKG-SIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       424 ~kl~Dfgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~  500 (789)
                      .|++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|
T Consensus       164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~  243 (601)
T KOG0590|consen  164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW  243 (601)
T ss_pred             ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence            99999999999988 565555666778 9999999998884 56888999999999999999999999776666666666


Q ss_pred             HHH
Q 041249          501 ARM  503 (789)
Q Consensus       501 ~~~  503 (789)
                      ...
T Consensus       244 ~~~  246 (601)
T KOG0590|consen  244 KSN  246 (601)
T ss_pred             ccc
Confidence            554

>PLN03150 hypothetical protein; Provisional

Probab=99.31  E-value=3.4e-12  Score=148.22  Aligned_cols=107  Identities=35%  Similarity=0.573  Sum_probs=97.0

Q ss_pred             cCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEecc
Q 041249           22 KLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVS  101 (789)
Q Consensus        22 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  101 (789)
                      .++.|+|++|.+.|.+|+.++.+++|++|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++.+++|++|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            58889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcCCccccCC-cccccccccCCC
Q 041249          102 GNILQGEIPSTLGSC-IKLEILEMQGNV  128 (789)
Q Consensus       102 ~N~l~~~~p~~~~~l-~~L~~l~l~~N~  128 (789)
                      +|+++|.+|..+..+ .++..+++++|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~  526 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNA  526 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCc
Confidence            999999999988764 244455555553

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.29  E-value=4.3e-13  Score=132.27  Aligned_cols=132  Identities=23%  Similarity=0.319  Sum_probs=102.1

Q ss_pred             CCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249          649 SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF  728 (789)
Q Consensus       649 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  728 (789)
                      ...-|++|||++|.|+ .+.++..-+|.++.|++|+|.|+ .+. .++.+++|..||||+|.++ .+.++-..+.+++.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            3456888888888887 66677777888888888888887 333 3888888888888888888 666777788888888


Q ss_pred             EccCCcccccCCcccccCCCCccEEEccCCccccc-CcccccCCCCCCeeeccCCcCccc
Q 041249          729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA-IPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      .|++|.|. .+. ++. .+-+|..||+++|+|... .-..+++++.|+.+.|.+|++.+.
T Consensus       358 ~La~N~iE-~LS-GL~-KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  358 KLAQNKIE-TLS-GLR-KLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             ehhhhhHh-hhh-hhH-hhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            88888886 332 233 577788888988888743 235678888889999999988764

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.26  E-value=2.9e-12  Score=122.27  Aligned_cols=137  Identities=26%  Similarity=0.357  Sum_probs=37.8

Q ss_pred             ccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccC-CCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC
Q 041249          610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFG-SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA  688 (789)
Q Consensus       610 Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  688 (789)
                      |..+.|. .. ..+.+..++++|+|++|+|+. +. .+. .+.+|+.|+|++|.|+.+  +.+..++.|++|++++|+|+
T Consensus         4 lt~~~i~-~~-~~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    4 LTANMIE-QI-AQYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---
T ss_pred             ccccccc-cc-ccccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC
Confidence            4445555 22 234445566777777777763 32 343 466777777777777633  24666777777777777776


Q ss_pred             ccCCccc-cCCCCCCeeeccCccccccC-CccccCCCCccEEEccCCcccccCCc---ccccCCCCccEEE
Q 041249          689 GSIPFTL-SKLKNLVILYLGVNRLSGIV-PSSIFNISSIAEFDVGENKIQGNIPL---DYGFTLQNLQYFS  754 (789)
Q Consensus       689 ~~~~~~~-~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip~---~~~~~l~~L~~L~  754 (789)
                      . +.+.+ ..+++|++|+|++|+|...- -..+..+++|+.|+|.+|+++ ..+.   .+...+|+|+.||
T Consensus        78 ~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   78 S-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred             c-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence            3 33333 35667777777777776321 134455666666666666666 3222   1222456666554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.26  E-value=3.9e-12  Score=121.42  Aligned_cols=121  Identities=25%  Similarity=0.322  Sum_probs=30.3

Q ss_pred             ceeeecccCCCCccCCCccCc-CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCC-CCCCCCCEEE
Q 041249          604 RLQVPDLNNNSIGGEIPVNLS-SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKIS  681 (789)
Q Consensus       604 ~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~  681 (789)
                      ++++|+|++|.|+.+  +.++ .+.+|+.|+|++|.|+. ++ .+..++.|++|++++|+|+.+ .+.+ ..+++|++|+
T Consensus        20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred             ccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEE
Confidence            455555555555522  2333 34555555555555552 22 244555555555555555522 2222 2345555555


Q ss_pred             ccCCcCCccCC-ccccCCCCCCeeeccCccccccC---CccccCCCCccEEE
Q 041249          682 LAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIV---PSSIFNISSIAEFD  729 (789)
Q Consensus       682 L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~  729 (789)
                      |++|+|..... ..+..+++|+.|+|.+|.++...   ...+..+|+|+.||
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            55555542111 23444555555555555555221   01334455555554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.20  E-value=2e-12  Score=143.68  Aligned_cols=197  Identities=28%  Similarity=0.365  Sum_probs=100.9

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+..+++|+.|++.+|+|..+ ...+..+.+|++|+|++|.|+.+  ..+..++.|+.|++++|.|+. +. .|..++.|
T Consensus        90 ~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~-~~-~~~~l~~L  164 (414)
T KOG0531|consen   90 HLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISD-IS-GLESLKSL  164 (414)
T ss_pred             ccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchh-cc-CCccchhh
Confidence            345556666666666666632 22245556666666666666543  334455556666666666652 22 34445566


Q ss_pred             cEEEccCCCCCccCC-cCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCC--ccEEEc
Q 041249          654 EVLSLGFNNLIGSIP-PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISS--IAEFDV  730 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L  730 (789)
                      +.+++++|+++.+.+ . ...+.+|+.+++.+|.+.  ....+..+..+..+++..|+++..-+  +..+..  |+.+++
T Consensus       165 ~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l  239 (414)
T KOG0531|consen  165 KLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYL  239 (414)
T ss_pred             hcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhc
Confidence            666666666653333 1 344555666666666655  22234444455555666666652211  122222  566666


Q ss_pred             cCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcC
Q 041249          731 GENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL  784 (789)
Q Consensus       731 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  784 (789)
                      ++|.+. .++..+. .+.++..|++.+|++...  ..+.....+..+.+..|++
T Consensus       240 ~~n~i~-~~~~~~~-~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~  289 (414)
T KOG0531|consen  240 SGNRIS-RSPEGLE-NLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKL  289 (414)
T ss_pred             ccCccc-ccccccc-ccccccccchhhcccccc--ccccccchHHHhccCcchh
Confidence            666665 4433332 455566666666665533  2233344444455554444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.18  E-value=2.4e-12  Score=126.99  Aligned_cols=131  Identities=24%  Similarity=0.314  Sum_probs=110.1

Q ss_pred             CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCee
Q 041249          625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVIL  704 (789)
Q Consensus       625 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  704 (789)
                      ....|++||||+|.|+ .+.+...-+++++.|++++|.|+.+  ..+..+++|+.||||+|.++ .+.+.=..+-+++.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            3567999999999998 6777888889999999999999833  34888999999999999998 666666778899999


Q ss_pred             eccCccccccCCccccCCCCccEEEccCCcccccCCc--ccccCCCCccEEEccCCccccc
Q 041249          705 YLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL--DYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       705 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~--~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      .|+.|.|...  ..+..+-+|..||+++|+|. .+..  .++ ++|-|+.|.|.+|+|.+.
T Consensus       358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG-~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIE-ELDEVNHIG-NLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             ehhhhhHhhh--hhhHhhhhheeccccccchh-hHHHhcccc-cccHHHHHhhcCCCcccc
Confidence            9999999833  45788889999999999998 5433  355 799999999999999854

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.15  E-value=4e-12  Score=132.05  Aligned_cols=186  Identities=23%  Similarity=0.260  Sum_probs=116.8

Q ss_pred             cccCccccchhcccCCccccc--CcccccCccceeeecccCCCCccCCCccC-cCCCCCcEEEcccCCCCCC-CCcccCC
Q 041249          574 HIGNLSFLKILNLENNSFTHE--IPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLMGK-IPSDFGS  649 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~l~~N~l~~~-~~~~~~~  649 (789)
                      ....|++++.|||+.|-+..-  +-+...+|++|+.|+|+.|++.--..... ..++.|+.|.|+.|.++-- +......
T Consensus       141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~  220 (505)
T KOG3207|consen  141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT  220 (505)
T ss_pred             hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence            455677788888888876633  23345677888888888888762221111 2456778888888877621 1222445


Q ss_pred             CCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC--ccccCCCCCCeeeccCcccccc-CCcc-----ccC
Q 041249          650 LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP--FTLSKLKNLVILYLGVNRLSGI-VPSS-----IFN  721 (789)
Q Consensus       650 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----~~~  721 (789)
                      +++|+.|+|+.|+...+-.....-+..|+.|+|++|++- ..+  ...+.++.|+.|+++.+.|+.+ .|+.     -..
T Consensus       221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~  299 (505)
T KOG3207|consen  221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT  299 (505)
T ss_pred             CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence            677888888888533333334445667888888888775 333  3456777778888888877743 2332     245


Q ss_pred             CCCccEEEccCCcccccCCc--ccccCCCCccEEEccCCcccc
Q 041249          722 ISSIAEFDVGENKIQGNIPL--DYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       722 l~~L~~L~Ls~N~l~~~ip~--~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      +++|+.|+++.|+|. ..+.  .+. .+++|+.|....|.|+.
T Consensus       300 f~kL~~L~i~~N~I~-~w~sl~~l~-~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  300 FPKLEYLNISENNIR-DWRSLNHLR-TLENLKHLRITLNYLNK  340 (505)
T ss_pred             cccceeeecccCccc-cccccchhh-ccchhhhhhcccccccc
Confidence            677888888888875 3332  222 46677777777777764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=4.9e-11  Score=119.68  Aligned_cols=161  Identities=24%  Similarity=0.362  Sum_probs=125.7

Q ss_pred             HHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 041249          319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL  398 (789)
Q Consensus       319 ~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L  398 (789)
                      ..+-.+-|.||+++-.|..+.++.+.....++.|||..|++..++++.      ......+......+|+-||..||.||
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt------~~~~~a~~~~~wkkw~tqIlsal~yL  192 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRT------KKNQKALFQKAWKKWCTQILSALSYL  192 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHH------HHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence            344455799999998888877776777889999999999999999754      34456788888899999999999999


Q ss_pred             hcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC--CccceeeecccccccCcccCCCCCcCccccchhhHHH
Q 041249          399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGIL  476 (789)
Q Consensus       399 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvv  476 (789)
                      |+. .|+|+|+++...-|++..++-+|++--.-....+.-.  .........+-++|.|||+-..-..+..+|||+||+.
T Consensus       193 hs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             hcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            987 7899999999999999999988875432222111111  1111222335678999999888888999999999999


Q ss_pred             HHHHHHhcCC
Q 041249          477 MLELIIRKKP  486 (789)
Q Consensus       477 l~elltG~~P  486 (789)
                      ..||..|..-
T Consensus       272 AlemailEiq  281 (458)
T KOG1266|consen  272 ALEMAILEIQ  281 (458)
T ss_pred             HHHHHHheec
Confidence            9999888654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.14  E-value=1.2e-10  Score=129.39  Aligned_cols=144  Identities=20%  Similarity=0.193  Sum_probs=101.0

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhh----------------------------------------HHH
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS----------------------------------------RSF  314 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  314 (789)
                      .+.||.|++|.||+|+.+ +|+.||||+.+.......                                        -.|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            468999999999999997 789999999865421110                                        024


Q ss_pred             HHHHHHHhcC----CCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHH
Q 041249          315 IAECRALRSI----RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID  390 (789)
Q Consensus       315 ~~e~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  390 (789)
                      ..|++.+.++    +|.+-+.+-..+.+..    ...++||||++++++.++....         ....   .+..++..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~---------~~~~---~~~~ia~~  264 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALD---------EAGL---DRKALAEN  264 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHH---------hcCC---CHHHHHHH
Confidence            4455555555    2333334333333221    2469999999999998875321         0011   24456666


Q ss_pred             HHH-HHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249          391 VAS-ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT  438 (789)
Q Consensus       391 ia~-gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  438 (789)
                      ++. .+..+|..|   ++|+|++|.||++++++++++.|||++..+++.
T Consensus       265 ~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       265 LARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             HHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            666 477889888   999999999999999999999999999877543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.12  E-value=3.8e-12  Score=141.51  Aligned_cols=197  Identities=26%  Similarity=0.302  Sum_probs=110.0

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      .+..++.+++..|.|.. .-..+..+++|+.|++.+|+|+++ ...+..+++|++|++++|+|+.+.+  +..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence            34555555566666652 233355566666666666666633 2225566666666666666664332  4455556666


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCcc-ccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFT-LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI  735 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  735 (789)
                      ++++|.|+.+  ..|..++.|+.+++++|+++...+ . ...+.+|+.+++++|.+.  ....+..+..+..+++..|.+
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccc
Confidence            6666666532  334456666666666666663322 1 355566666666666665  223344445555556666666


Q ss_pred             cccCCcccccCCCC--ccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          736 QGNIPLDYGFTLQN--LQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       736 ~~~ip~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      + .+..-.  .+..  |+.+++++|++. ..+..+..+.++..|++.+|+++.
T Consensus       221 ~-~~~~l~--~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~  269 (414)
T KOG0531|consen  221 S-KLEGLN--ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN  269 (414)
T ss_pred             e-eccCcc--cchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence            5 332211  1222  666666666666 333455566666666666666554

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.06  E-value=1.5e-11  Score=124.75  Aligned_cols=244  Identities=20%  Similarity=0.229  Sum_probs=177.9

Q ss_pred             HHHHHHHHhhccccceeeEeccCccccccccc----ccccCccccchhcccCC---cccccCccc-------ccCcccee
Q 041249          541 IECLISMLRIGSKAQKVTILDLESLKLAGSIL----PHIGNLSFLKILNLENN---SFTHEIPSE-------IGRLRRLQ  606 (789)
Q Consensus       541 ~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l----~~l~~l~~L~~L~L~~N---~l~~~~~~~-------~~~l~~L~  606 (789)
                      .+....+.+.......++.++++++..-....    ..+.+.++|+..++++-   ++...+|++       +...++|+
T Consensus        16 ~ed~~~v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~   95 (382)
T KOG1909|consen   16 EEDEKDVEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQ   95 (382)
T ss_pred             HhhhhhHHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCcee
Confidence            34455666777788888899999987655433    34456678888887763   333445554       34456899


Q ss_pred             eecccCCCCccCCCccC----cCCCCCcEEEcccCCCCCCCC-------------cccCCCCCCcEEEccCCCCCccC--
Q 041249          607 VPDLNNNSIGGEIPVNL----SSCSNLIRIGLAKNQLMGKIP-------------SDFGSLSKIEVLSLGFNNLIGSI--  667 (789)
Q Consensus       607 ~L~Ls~N~i~~~~p~~~----~~l~~L~~L~l~~N~l~~~~~-------------~~~~~l~~L~~L~L~~N~l~~~~--  667 (789)
                      +||||+|.|.-..+..|    ..+..|++|.|.+|.+...--             .....-++|+.+..+.|++....  
T Consensus        96 ~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~  175 (382)
T KOG1909|consen   96 KLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGAT  175 (382)
T ss_pred             EeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHH
Confidence            99999999975444443    567899999999999873211             11234568999999999986332  


Q ss_pred             --CcCCCCCCCCCEEEccCCcCCcc----CCccccCCCCCCeeeccCccccc----cCCccccCCCCccEEEccCCcccc
Q 041249          668 --PPPLGNLSSLRKISLAINNLAGS----IPFTLSKLKNLVILYLGVNRLSG----IVPSSIFNISSIAEFDVGENKIQG  737 (789)
Q Consensus       668 --~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~  737 (789)
                        ...|...+.|+.+.++.|.|...    +...|..+++|++|||.+|.++.    .+...+..+++|++|+++++.+..
T Consensus       176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~  255 (382)
T KOG1909|consen  176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN  255 (382)
T ss_pred             HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence              23467789999999999998622    23457899999999999999984    245667788999999999999973


Q ss_pred             c----CCcccccCCCCccEEEccCCccccc----CcccccCCCCCCeeeccCCcC
Q 041249          738 N----IPLDYGFTLQNLQYFSIGTNRITGA----IPPSISNASKLEVFQALNNKL  784 (789)
Q Consensus       738 ~----ip~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l  784 (789)
                      .    +-..+-...++|+.|.|.+|.|+..    +.......+.|..|+|++|++
T Consensus       256 ~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  256 EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            2    2223334578999999999999843    233345688999999999998

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.04  E-value=2.2e-11  Score=126.68  Aligned_cols=209  Identities=22%  Similarity=0.192  Sum_probs=157.1

Q ss_pred             cCccccchhcccCCcccccCc--ccccCccceeeecccCCCCccCCC--ccCcCCCCCcEEEcccCCCCCCCCcc-cCCC
Q 041249          576 GNLSFLKILNLENNSFTHEIP--SEIGRLRRLQVPDLNNNSIGGEIP--VNLSSCSNLIRIGLAKNQLMGKIPSD-FGSL  650 (789)
Q Consensus       576 ~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l  650 (789)
                      .++.+|+.+.|.+..+. ..+  +....+++++.||||+|-+....|  .-...+++|+.|+|+.|++....... -..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            57889999999999988 334  357789999999999999875433  34568999999999999998433222 2357


Q ss_pred             CCCcEEEccCCCCCcc-CCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCC--ccccCCCCccE
Q 041249          651 SKIEVLSLGFNNLIGS-IPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP--SSIFNISSIAE  727 (789)
Q Consensus       651 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~  727 (789)
                      +.|+.|.|+.|.|+-. +-.....+|+|+.|+|..|....+.......+..|+.|||++|.+- ..+  ...+.++.|+.
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence            7999999999999722 1122346799999999999643355555677789999999999998 455  56788999999


Q ss_pred             EEccCCcccccC--Ccc----cccCCCCccEEEccCCccccc-CcccccCCCCCCeeeccCCcCccc
Q 041249          728 FDVGENKIQGNI--PLD----YGFTLQNLQYFSIGTNRITGA-IPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       728 L~Ls~N~l~~~i--p~~----~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      |+++.+.|. .|  |+.    ....+++|++|+++.|+|..- .-..+..+++|+.|....|+|+-+
T Consensus       276 Lnls~tgi~-si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  276 LNLSSTGIA-SIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             hhccccCcc-hhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            999999998 43  222    123678999999999999632 112334567788888888888753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.04  E-value=9e-10  Score=106.64  Aligned_cols=131  Identities=17%  Similarity=0.150  Sum_probs=96.5

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccce-eeeeeccCCCCCCceEEEEeec
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK-VFTACSGVDYQGNDFKALVYEF  353 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~~~~~~lv~e~  353 (789)
                      .+.++.|.++.||++...  ++.|++|+...... ....+..|++.+..+.+.++++ +++...  .     ..++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-----~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--E-----TGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--C-----CCeEEEEe
Confidence            356888999999999875  78899999754432 2235688999999886555544 444321  1     34799999


Q ss_pred             cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--CCCceecCCCCCceecCCCCceeeCcccc
Q 041249          354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--QPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      +++.++...-                  .....++.+++++++.||..+  ...++|+|++|.||+++ ++.++++||+.
T Consensus        73 i~G~~l~~~~------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          73 IEGSELLTED------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             cCCCcccccc------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            9997765420                  012345689999999999886  23369999999999999 66899999998


Q ss_pred             ccc
Q 041249          432 ARF  434 (789)
Q Consensus       432 a~~  434 (789)
                      +..
T Consensus       134 a~~  136 (170)
T cd05151         134 AGM  136 (170)
T ss_pred             ccC
Confidence            764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.96  E-value=1.5e-09  Score=122.00  Aligned_cols=148  Identities=18%  Similarity=0.172  Sum_probs=96.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh----------------------------------hH---
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA----------------------------------SR---  312 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~---  312 (789)
                      ..|+. +.||+|++|.||+|+.+.+|+.||||+.+......                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            46776 79999999999999999779999999997542110                                  11   


Q ss_pred             ---HHHHHHHHHhcCC----CCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhc--cCCCCCccccCCCCCCCHHH
Q 041249          313 ---SFIAECRALRSIR----HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQ  383 (789)
Q Consensus       313 ---~~~~e~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~l~~~~  383 (789)
                         .+..|++.+.+++    +...+.+-.++++.    ....++||||+.++.+.+.-  ...      +...+.+....
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~------g~d~~~la~~~  268 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAA------GTDMKLLAERG  268 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhc------CCCHHHHHHHH
Confidence               2444555555542    33333333333221    12578999999999987642  111      00111222222


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC----ceeeCcccccccCCCC
Q 041249          384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM----VSHVGDFGLARFLPPT  438 (789)
Q Consensus       384 ~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~~~~~~  438 (789)
                      ...++.|       +...|   ++|+|++|.||+++.++    ++++.|||++..++..
T Consensus       269 v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        269 VEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            3333333       34466   99999999999999888    9999999999988655

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.96  E-value=3.6e-09  Score=116.70  Aligned_cols=170  Identities=19%  Similarity=0.198  Sum_probs=126.5

Q ss_pred             EEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCC
Q 041249          288 KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN  367 (789)
Q Consensus       288 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  367 (789)
                      .|.-+.++.+|.|...+...........+-+..++.++||+|++|+.......     ..|+|.|-+.  .|..++... 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-----~~ylvTErV~--Pl~~~lk~l-  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-----TLYLVTERVR--PLETVLKEL-  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-----ceEEEeeccc--cHHHHHHHh-
Confidence            56777789999999987666655566788889999999999999998876655     7899999876  355555432 


Q ss_pred             CCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeee
Q 041249          368 REDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV  447 (789)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  447 (789)
                                  ......--+.||++||.|||+.+  .++|+++.-..|++++.++-||++|.++.....-..  .....
T Consensus       102 ------------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~  165 (690)
T KOG1243|consen  102 ------------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL  165 (690)
T ss_pred             ------------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence                        34556667899999999999765  599999999999999999999999988765432221  00011


Q ss_pred             cccccccCcccCCCCCcCccccchhhHHHHHHHHHh
Q 041249          448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR  483 (789)
Q Consensus       448 ~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG  483 (789)
                      .--..|..|+.+....  -..|-|-||+++||++.|
T Consensus       166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            1112355565443322  236999999999999998

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.95  E-value=5.8e-11  Score=120.45  Aligned_cols=217  Identities=18%  Similarity=0.226  Sum_probs=162.3

Q ss_pred             ccccccccCccccchhcccCCcccccC----cccccCccceeeecccC---CCCccCCCc-------cCcCCCCCcEEEc
Q 041249          569 GSILPHIGNLSFLKILNLENNSFTHEI----PSEIGRLRRLQVPDLNN---NSIGGEIPV-------NLSSCSNLIRIGL  634 (789)
Q Consensus       569 ~~~l~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~---N~i~~~~p~-------~~~~l~~L~~L~l  634 (789)
                      ....+.+..+..++.|+|++|.+...-    .+.+...++|+.-++|+   -+....+|.       ++..+++|++|||
T Consensus        20 ~~v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldL   99 (382)
T KOG1909|consen   20 KDVEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDL   99 (382)
T ss_pred             hhHHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeec
Confidence            334455667889999999999998653    34466778899888887   344445554       3456789999999


Q ss_pred             ccCCCCCCCCcc----cCCCCCCcEEEccCCCCCccCC-------------cCCCCCCCCCEEEccCCcCCccC----Cc
Q 041249          635 AKNQLMGKIPSD----FGSLSKIEVLSLGFNNLIGSIP-------------PPLGNLSSLRKISLAINNLAGSI----PF  693 (789)
Q Consensus       635 ~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~-------------~~~~~l~~L~~L~L~~N~l~~~~----~~  693 (789)
                      |+|.+...-+..    +..++.|++|.|.+|.+.-..-             +....-++|+++..++|++....    ..
T Consensus       100 SDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~  179 (382)
T KOG1909|consen  100 SDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAE  179 (382)
T ss_pred             cccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHH
Confidence            999998444333    4568899999999998852221             12345678999999999997332    33


Q ss_pred             cccCCCCCCeeeccCccccc----cCCccccCCCCccEEEccCCccccc----CCcccccCCCCccEEEccCCcccccCc
Q 041249          694 TLSKLKNLVILYLGVNRLSG----IVPSSIFNISSIAEFDVGENKIQGN----IPLDYGFTLQNLQYFSIGTNRITGAIP  765 (789)
Q Consensus       694 ~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~~  765 (789)
                      .|...+.|+.+.++.|.|..    .+...|..++.|+.|||.+|-++..    +...+ +.+++|++|+++++.+.....
T Consensus       180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL-~s~~~L~El~l~dcll~~~Ga  258 (382)
T KOG1909|consen  180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL-SSWPHLRELNLGDCLLENEGA  258 (382)
T ss_pred             HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh-cccchheeecccccccccccH
Confidence            56778899999999999972    2345688999999999999999722    22223 368899999999999987655


Q ss_pred             ccc-----cCCCCCCeeeccCCcCcc
Q 041249          766 PSI-----SNASKLEVFQALNNKLTG  786 (789)
Q Consensus       766 ~~~-----~~l~~L~~L~l~~N~l~~  786 (789)
                      .+|     ...++|+.|.|.+|.++-
T Consensus       259 ~a~~~al~~~~p~L~vl~l~gNeIt~  284 (382)
T KOG1909|consen  259 IAFVDALKESAPSLEVLELAGNEITR  284 (382)
T ss_pred             HHHHHHHhccCCCCceeccCcchhHH
Confidence            444     236899999999998873

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=8.3e-10  Score=86.72  Aligned_cols=57  Identities=32%  Similarity=0.448  Sum_probs=22.2

Q ss_pred             CCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          677 LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       677 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      |++|+|++|+|+...++.|.++++|++|++++|+|+...|.+|.++++|++|++++|
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            333444444443333333333444444444444443333333334444444444433

...

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.91  E-value=1.8e-09  Score=118.08  Aligned_cols=199  Identities=26%  Similarity=0.290  Sum_probs=149.7

Q ss_pred             CCCCCCcccc--cCCccEEEEEE--cCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC
Q 041249          271 GFSSANLIGT--GSFGSVYKGVL--DEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       271 ~f~~~~~ig~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (789)
                      .|.+...+|.  |.+|.||.+..  .+++..+|+|.-+....  .....=.+|.....+. .|++.++.....     .+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence            4556778899  99999999999  88899999998543322  3333334566666666 589988844443     33


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHH----HHhhhhcCCCCCceecCCCCCceecC
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS----ALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      ....++-.|.+. .++..+....         ...++......+..+...    |+.++|+..   ++|-|+||.||+..
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~---------~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~  256 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTP---------CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTT  256 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcc---------cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecc
Confidence            446777788877 6888877543         233566667777777777    999999887   99999999999999


Q ss_pred             CC-CceeeCcccccccCCCCCCcc---ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          420 EE-MVSHVGDFGLARFLPPTHVQT---SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       420 ~~-~~~kl~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      .+ ...+++|||+...+.+.....   ......|...|++||.. .+-++...|||++|.|..+..+|-.+..
T Consensus       257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence            99 788999999999988776221   11123688899999975 4567899999999999999999866553

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=1.2e-09  Score=85.90  Aligned_cols=59  Identities=36%  Similarity=0.434  Sum_probs=29.8

Q ss_pred             CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcc
Q 041249          652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      +|++|++++|+|+.+.+.+|.++++|++|+|++|+|+...|+.|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555554444445555555555555555554444455555555555555554

...

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.86  E-value=1.7e-08  Score=98.44  Aligned_cols=141  Identities=20%  Similarity=0.142  Sum_probs=99.6

Q ss_pred             CCcccccCCccEEEEEEcC------CceEEEEEEeccccc----------------------hhhHHHH----HHHHHHh
Q 041249          275 ANLIGTGSFGSVYKGVLDE------GRTTVTVKVFNLHHH----------------------RASRSFI----AECRALR  322 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~~~----~e~~~l~  322 (789)
                      ...||.|.=+.||.|....      .+..+|||+++....                      ...+.+.    +|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3478999999999998653      257999999753210                      0012233    7999999


Q ss_pred             cCC--CCccceeeeeeccCCCCCCceEEEEeeccCCCChhh-hccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh-
Q 041249          323 SIR--HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEE-WLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL-  398 (789)
Q Consensus       323 ~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-  398 (789)
                      ++.  .-++...+++.         ..++||||+.++.+.. .+..           ..++..+...+..+++.+|..+ 
T Consensus        82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd-----------~~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKD-----------AKLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhc-----------cccCHHHHHHHHHHHHHHHHHHH
Confidence            884  34555555541         4689999998653321 1211           1234456677889999999999 


Q ss_pred             hcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC
Q 041249          399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH  439 (789)
Q Consensus       399 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  439 (789)
                      |..+   +||||+++.||+++ ++.+.++|||-+-...++.
T Consensus       142 H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~hp~  178 (197)
T cd05146         142 KECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTHPH  178 (197)
T ss_pred             HhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCCCCC
Confidence            7777   99999999999997 4679999999887765543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.76  E-value=8.3e-11  Score=128.86  Aligned_cols=206  Identities=20%  Similarity=0.254  Sum_probs=124.0

Q ss_pred             HHHHHhhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCc-cceeeecccCCCCccCCCcc
Q 041249          544 LISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRL-RRLQVPDLNNNSIGGEIPVN  622 (789)
Q Consensus       544 ~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~i~~~~p~~  622 (789)
                      +..+.++.-+...+..+..|.-.-+.  +-.+.....|+.|.|.++.|..  ...+..+ ..|++|..+ |.+. .+...
T Consensus        76 Lq~i~d~lqkt~~lkl~~~pa~~pt~--pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~-Al~~v  149 (1096)
T KOG1859|consen   76 LQRILDFLQKTKVLKLLPSPARDPTE--PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLD-ALRHV  149 (1096)
T ss_pred             HHHHHHHHhhheeeeecccCCCCCCC--CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHH-HHHHH
Confidence            44455666666666666666555443  4556677788888888888773  2223333 235555433 3322 11111


Q ss_pred             C-------c---CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC
Q 041249          623 L-------S---SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP  692 (789)
Q Consensus       623 ~-------~---~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  692 (789)
                      |       .   ...+|.+.+.++|++. ....++.-++.|+.|+|++|+++..  ..+..|+.|++|||+.|+++.+.-
T Consensus       150 ~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~  226 (1096)
T KOG1859|consen  150 FASCGGDISNSPVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQ  226 (1096)
T ss_pred             HHHhccccccchhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccc
Confidence            1       1   1235677777777776 5555666677777777777777633  256677777777777777773222


Q ss_pred             ccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249          693 FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       693 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  761 (789)
                      -....++ |..|.+++|.++..  ..+.+|.+|+.|||++|-|.+.-.......|..|+.|+|.+|++.
T Consensus       227 l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  227 LSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            2334443 77777777777732  346677777777777777765443333334666777777777776

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.76  E-value=4.2e-09  Score=115.29  Aligned_cols=208  Identities=22%  Similarity=0.204  Sum_probs=151.7

Q ss_pred             cccccHHH-HHHhhcCCCCCCcccccCCccEEEEEEc-CCceEEEEEEeccccch--hhHHHHHHHHHHhcC-CCCccce
Q 041249          257 LLNLSYQN-LHNATDGFSSANLIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHHR--ASRSFIAECRALRSI-RHRNLVK  331 (789)
Q Consensus       257 ~~~~~~~~-~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~  331 (789)
                      ...|.-.+ ....+.+|.....||.|.|+.|++...+ .++..+++|........  ....-..|+.+...+ .|.++++
T Consensus       251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence            33444444 4556679999999999999999998876 77889999987544322  222334566666666 5888887


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      ++.....     .+..++-.||+.+++......          -...++...++.+..|++.++.++|...   ++|+|+
T Consensus       331 ~~~~W~~-----~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~  392 (524)
T KOG0601|consen  331 KNSSWSQ-----LRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDV  392 (524)
T ss_pred             CCCCccc-----cccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhccccccchh---hhcccc
Confidence            6554333     336678889999988766542          2345677788999999999999999777   999999


Q ss_pred             CCCceecCCC-CceeeCcccccccCCCCCCccceeeecccccc-cCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249          412 KPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY-IAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       412 k~~Nill~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      ||+||++..+ +..+++|||.+..+.-..    .....++..| .+++......+..++|+||||..+.|.++|..-
T Consensus       393 ~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  393 KPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cccceeeccchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            9999999886 788999999987532221    1112233344 356666677789999999999999999998654

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.75  E-value=2e-10  Score=101.15  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=96.5

Q ss_pred             CCcEEEcccCCCCCCCCccc---CCCCCCcEEEccCCCCCccCCcCC-CCCCCCCEEEccCCcCCccCCccccCCCCCCe
Q 041249          628 NLIRIGLAKNQLMGKIPSDF---GSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIPFTLSKLKNLVI  703 (789)
Q Consensus       628 ~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  703 (789)
                      .+..+||+.++|. .+++..   .....|+..+|++|.+. ..|+.| ...+.++.|+|++|+|+ .+|..+..|+.|+.
T Consensus        28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~  104 (177)
T KOG4579|consen   28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS  104 (177)
T ss_pred             Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence            4556677777665 444443   33445677788888887 444444 34567888888888888 67777888888888


Q ss_pred             eeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccC
Q 041249          704 LYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISN  770 (789)
Q Consensus       704 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  770 (789)
                      |+++.|.+. ..|..|..+.++..||..+|.+. .||.+++ --.++-..++.++.+.+.-+..+..
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~-~s~~~al~~lgnepl~~~~~~klqa  168 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLF-YSSLPALIKLGNEPLGDETKKKLQA  168 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHh-ccccHHHHHhcCCcccccCcccccc
Confidence            888888888 77888888888888888888888 8888866 2333444566777777655544433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.73  E-value=5e-08  Score=91.76  Aligned_cols=130  Identities=25%  Similarity=0.276  Sum_probs=96.7

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccchh--------hHHHHHHHHHHhcCCC--CccceeeeeeccCCCCCCc
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--------SRSFIAECRALRSIRH--RNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~  345 (789)
                      ..+++|+=+.+|.+.|.  |..+++|.--.+....        ......|++++++++-  -+..-++.+..  +     
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~-----   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--D-----   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--C-----
Confidence            35788999999999885  5557777753332221        3457789999998853  23333343322  2     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ...++|||.++-.+.+.+...                 ...++..+-.-+.-||..+   ||||||.++||.+..+. +.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~  131 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IY  131 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EE
Confidence            457999999998888888432                 3567778888888899999   99999999999998776 89


Q ss_pred             eCcccccccC
Q 041249          426 VGDFGLARFL  435 (789)
Q Consensus       426 l~Dfgla~~~  435 (789)
                      ++|||++...
T Consensus       132 ~IDfGLg~~s  141 (204)
T COG3642         132 FIDFGLGEFS  141 (204)
T ss_pred             EEECCccccc
Confidence            9999998864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.70  E-value=1.4e-10  Score=127.21  Aligned_cols=197  Identities=21%  Similarity=0.254  Sum_probs=135.2

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCC-CCCcEEEcccCCCC----------CCCCc
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSC-SNLIRIGLAKNQLM----------GKIPS  645 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~l~~N~l~----------~~~~~  645 (789)
                      ..+.|+.+..-.-.-++  |-.+..+.+|++|.|.++.|..  ...+..+ ..|++| +.+|.+.          +.+-+
T Consensus        85 kt~~lkl~~~pa~~pt~--pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~n  159 (1096)
T KOG1859|consen   85 KTKVLKLLPSPARDPTE--PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKL-ICHNSLDALRHVFASCGGDISN  159 (1096)
T ss_pred             hheeeeecccCCCCCCC--CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhh-hhhccHHHHHHHHHHhcccccc
Confidence            33444444444433332  5667888899999999998873  2333332 456666 4445443          11222


Q ss_pred             ccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCc
Q 041249          646 DFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI  725 (789)
Q Consensus       646 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  725 (789)
                      .+. ..+|.+.+.++|.++ .+..++.-++.|+.|+|++|+++...  .+..|++|++|||++|.+..+.--....+ +|
T Consensus       160 s~~-Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L  234 (1096)
T KOG1859|consen  160 SPV-WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KL  234 (1096)
T ss_pred             chh-hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hh
Confidence            221 346888999999998 77788888899999999999998443  78889999999999999984333333344 49


Q ss_pred             cEEEccCCcccccCCcccccCCCCccEEEccCCcccccCccc-ccCCCCCCeeeccCCcCcc
Q 041249          726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS-ISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       726 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~  786 (789)
                      +.|.|++|.++ ++-. +- +|.+|+.|||++|-|.+...-. +..+..|..|+|.+|++..
T Consensus       235 ~~L~lrnN~l~-tL~g-ie-~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  235 QLLNLRNNALT-TLRG-IE-NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             eeeeecccHHH-hhhh-HH-hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            99999999998 4432 22 7889999999999888652211 3346678889999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.68  E-value=1.6e-07  Score=95.13  Aligned_cols=146  Identities=21%  Similarity=0.228  Sum_probs=107.8

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCC--ccceeeeeeccCCCCCCceEEEEe
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR--NLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      .+.|+.|..+.||++... +|+.+++|....... .....+..|+++++.+++.  .+.+++++......  ....++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~--~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV--LGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc--cCCceEEE
Confidence            356899999999999886 368899999754432 2356789999999999753  45667776544221  11458999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC-----------------------------
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC-----------------------------  402 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----------------------------  402 (789)
                      ||++++++.+.+..           ..++..++..++.+++++|.+||+..                             
T Consensus        80 e~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (223)
T cd05154          80 ERVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA  148 (223)
T ss_pred             EEeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence            99999877765421           23566777788888888888888531                             


Q ss_pred             ------------------------CCCceecCCCCCceecCC--CCceeeCccccccc
Q 041249          403 ------------------------QPITTHCDLKPSNILLDE--EMVSHVGDFGLARF  434 (789)
Q Consensus       403 ------------------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~  434 (789)
                                              ...++|+|+.+.||++++  +..+.++||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                    244799999999999998  66789999988765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.66  E-value=9.8e-08  Score=89.20  Aligned_cols=144  Identities=20%  Similarity=0.233  Sum_probs=100.7

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ....+.+|+=+.|+++.+.  |+..+||.-..+...        ..++..+|++.+.+++--.|.--.=++.+..     
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----   83 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence            5678999999999999996  788788775333221        2467888999999985333221111121111     


Q ss_pred             eEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---
Q 041249          346 FKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---  421 (789)
Q Consensus       346 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---  421 (789)
                      ..+++|||.++ -++.+++...        .............+..|-..+.-||..+   ++||||..+||++..+   
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~--------~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILST--------MEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHH--------ccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence            45799999986 3677777543        1112223334678889999999999998   9999999999998654   


Q ss_pred             CceeeCcccccccC
Q 041249          422 MVSHVGDFGLARFL  435 (789)
Q Consensus       422 ~~~kl~Dfgla~~~  435 (789)
                      ..+.++|||++...
T Consensus       153 ~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  153 ITPILIDFGLSSVS  166 (229)
T ss_pred             CceEEEeecchhcc
Confidence            45689999998754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.64  E-value=2.4e-07  Score=99.24  Aligned_cols=181  Identities=15%  Similarity=0.166  Sum_probs=140.9

Q ss_pred             CccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCC-CChhh
Q 041249          283 FGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN-GSLEE  361 (789)
Q Consensus       283 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~  361 (789)
                      -.+.|+++...+|..+++|++...+.......-.-+++++++.|.|+|++-.++.... -+..-.++||+|.+. ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence            3689999999999999999996665555555667788999999999999988877333 222358899999886 57777


Q ss_pred             hccCCCCCc-----cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC
Q 041249          362 WLYPVNRED-----EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP  436 (789)
Q Consensus       362 ~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  436 (789)
                      +-.......     .....+...++...+.++.|+..||.++|+.|   +.-+-+.+.+|+++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            765543333     23445667888999999999999999999999   8889999999999999999999988877765


Q ss_pred             CCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249          437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       437 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      .+...              |     -+--++-|.-.||.++..|.||..-
T Consensus       445 ~d~~~--------------~-----le~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPTE--------------P-----LESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCCc--------------c-----hhHHhhhhHHHHHHHHHHHhhcccc
Confidence            44311              0     0113467899999999999999543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.46  E-value=7.7e-08  Score=110.85  Aligned_cols=206  Identities=22%  Similarity=0.288  Sum_probs=142.7

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh---hHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ...++|.+.+-+..|.++.++.+.-...+...++|+......-.   .+....+-...-..++|-++.....+..     
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~-----  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC-----  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC-----
Confidence            45678888888999999999988877677666666653221111   1111122222222233444444333222     


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                      .....+|++|..+++|...++...          ..+..........+..+.+|||...   ++|+|++|.+.++..+++
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh  942 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGH  942 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCC
Confidence            226789999999999999887652          2233334456677888999999776   899999999999999999


Q ss_pred             eeeCcccccccCCCC---------------------C----Cc----cceeeecccccccCcccCCCCCcCccccchhhH
Q 041249          424 SHVGDFGLARFLPPT---------------------H----VQ----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYG  474 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~---------------------~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfG  474 (789)
                      .++.||+........                     .    ..    ...-...||..|.|||...+......+|.|++|
T Consensus       943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen  943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred             cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence            999999833322110                     0    00    111234589999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCcc
Q 041249          475 ILMLELIIRKKPSDIM  490 (789)
Q Consensus       475 vvl~elltG~~P~~~~  490 (789)
                      ++++|.++|..||...
T Consensus      1023 ~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             hhhhhhhcCCCCCCCc
Confidence            9999999999999854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.45  E-value=8.7e-07  Score=86.25  Aligned_cols=128  Identities=22%  Similarity=0.252  Sum_probs=82.5

Q ss_pred             cEEEEEEcCCceEEEEEEeccccc-------------h-------------hhHHHHHHHHHHhcCCCC--ccceeeeee
Q 041249          285 SVYKGVLDEGRTTVTVKVFNLHHH-------------R-------------ASRSFIAECRALRSIRHR--NLVKVFTAC  336 (789)
Q Consensus       285 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~  336 (789)
                      .||.|... ++..||+|..+....             .             ......+|.+.|.++...  ++.+.+.+-
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999886 688999999753310             0             023477899999999755  455555442


Q ss_pred             ccCCCCCCceEEEEeeccC--CCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhh-hhcCCCCCceecCCCC
Q 041249          337 SGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY-LHHDCQPITTHCDLKP  413 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~ivH~dlk~  413 (789)
                               ..++||||++  +..+..+.. .           .++......++.++...+.. +|..|   +||||+.+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~-~-----------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~  135 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKD-V-----------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSE  135 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHH-C-----------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-ST
T ss_pred             ---------CCEEEEEecCCCccchhhHHh-c-----------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCCh
Confidence                     3479999999  434433321 1           11133456677788886666 46887   99999999


Q ss_pred             CceecCCCCceeeCcccccccCCCC
Q 041249          414 SNILLDEEMVSHVGDFGLARFLPPT  438 (789)
Q Consensus       414 ~Nill~~~~~~kl~Dfgla~~~~~~  438 (789)
                      .||+++++ .+.++|||.+....++
T Consensus       136 ~NIlv~~~-~~~iIDf~qav~~~~p  159 (188)
T PF01163_consen  136 YNILVDDG-KVYIIDFGQAVDSSHP  159 (188)
T ss_dssp             TSEEEETT-CEEE--GTTEEETTST
T ss_pred             hhEEeecc-eEEEEecCcceecCCc
Confidence            99999988 9999999988765543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.45  E-value=2.1e-06  Score=88.82  Aligned_cols=146  Identities=14%  Similarity=0.028  Sum_probs=98.8

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccch-----------hhHHHHHHHHHHhcCCCCc--cceeeeeeccCCCC
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----------ASRSFIAECRALRSIRHRN--LVKVFTACSGVDYQ  342 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~  342 (789)
                      +.+-......|++..+  +|+.+.||........           ....+..|.+.+.++...+  ..+.+++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444444455677666  4788999977433211           1124778888888884322  33334443221111


Q ss_pred             CCceEEEEeeccCCC-ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-
Q 041249          343 GNDFKALVYEFMQNG-SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-  420 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-  420 (789)
                      .....++|+|++++- +|.+++...        .....+...+..++.+++..+.-||..|   |+|+|++++|||++. 
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~  174 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLP  174 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecc
Confidence            122468999999976 788887532        0123345677889999999999999999   999999999999975 


Q ss_pred             ------CCceeeCccccccc
Q 041249          421 ------EMVSHVGDFGLARF  434 (789)
Q Consensus       421 ------~~~~kl~Dfgla~~  434 (789)
                            ++.+.++||+.++.
T Consensus       175 ~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        175 FPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             ccCCCCCceEEEEECCcccc
Confidence                  57889999998864

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.45  E-value=3.7e-09  Score=93.21  Aligned_cols=105  Identities=21%  Similarity=0.347  Sum_probs=48.9

Q ss_pred             ccchhcccCCcccccCccc---ccCccceeeecccCCCCccCCCccCc-CCCCCcEEEcccCCCCCCCCcccCCCCCCcE
Q 041249          580 FLKILNLENNSFTHEIPSE---IGRLRRLQVPDLNNNSIGGEIPVNLS-SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEV  655 (789)
Q Consensus       580 ~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  655 (789)
                      .+..+||++++|. -+++.   +.+...|+..+|++|.++ .+|..|. ..+.+++|+|++|+|+ .+|..+..++.|+.
T Consensus        28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~  104 (177)
T KOG4579|consen   28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS  104 (177)
T ss_pred             Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence            4556667777665 23333   233334444555555555 3333332 2234445555555554 34444444444555


Q ss_pred             EEccCCCCCccCCcCCCCCCCCCEEEccCCcCC
Q 041249          656 LSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA  688 (789)
Q Consensus       656 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  688 (789)
                      |+++.|.+. ..|..|..+.+|..|+..+|.+.
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            555444444 33333333444444444444443

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.42  E-value=4.6e-08  Score=97.29  Aligned_cols=63  Identities=14%  Similarity=0.171  Sum_probs=29.8

Q ss_pred             CCCeeeccCccccccC-CccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          700 NLVILYLGVNRLSGIV-PSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       700 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      ++..+-+..|.|.... -..+..++.+.-|+|+.|+|...-.-+...++++|..|.+++|++..
T Consensus       200 nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  200 NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            4444455555444221 12334444555556666655422222222355666666666666543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.41  E-value=1.3e-07  Score=112.67  Aligned_cols=109  Identities=28%  Similarity=0.387  Sum_probs=66.7

Q ss_pred             cccceeeEeccCccc--ccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCC
Q 041249          552 SKAQKVTILDLESLK--LAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNL  629 (789)
Q Consensus       552 ~~c~~l~~l~l~s~~--~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L  629 (789)
                      ..|.+++.+-+..+.  ........|..++.|+.|||++|.=-+.+|+.++.|-+|++|+|++..|+ .+|..+.++++|
T Consensus       542 ~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L  620 (889)
T KOG4658|consen  542 SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKL  620 (889)
T ss_pred             CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhh
Confidence            345555555555554  23222333556677777777766554566777777777777777777776 666677777777


Q ss_pred             cEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249          630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN  661 (789)
Q Consensus       630 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  661 (789)
                      .+|++..+.-...+|.....+++|++|.+..-
T Consensus       621 ~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  621 IYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             heeccccccccccccchhhhcccccEEEeecc
Confidence            77777766544445555555667776666544

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.26  E-value=3.2e-07  Score=109.35  Aligned_cols=129  Identities=28%  Similarity=0.329  Sum_probs=92.2

Q ss_pred             CccccchhcccCCc--ccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          577 NLSFLKILNLENNS--FTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       577 ~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      +.+.|++|-+..|.  +..+..+.|..++.|.+|||++|.=-+.+|..++.+-+|++|+|++..|+ .+|..+.++.+|.
T Consensus       543 ~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~  621 (889)
T KOG4658|consen  543 ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI  621 (889)
T ss_pred             CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence            34568888888886  55455556777888888888887766678888888888888888888887 7888888888888


Q ss_pred             EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC--ccCCccccCCCCCCeeec
Q 041249          655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA--GSIPFTLSKLKNLVILYL  706 (789)
Q Consensus       655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L  706 (789)
                      +|++..+.-...+|.....|++|++|.+..-...  ...-..+.++++|+.+..
T Consensus       622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             eeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            8888887765566666667888888888665422  222223344555554444

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.23  E-value=2.9e-07  Score=90.53  Aligned_cols=185  Identities=21%  Similarity=0.199  Sum_probs=92.4

Q ss_pred             cCccceeeecccCCCCccCCCccC----cCCCCCcEEEcccCCCCCCCCcc-------------cCCCCCCcEEEccCCC
Q 041249          600 GRLRRLQVPDLNNNSIGGEIPVNL----SSCSNLIRIGLAKNQLMGKIPSD-------------FGSLSKIEVLSLGFNN  662 (789)
Q Consensus       600 ~~l~~L~~L~Ls~N~i~~~~p~~~----~~l~~L~~L~l~~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~  662 (789)
                      ..+++|++.+||+|.+....|..+    +.-+.|++|.|++|.+...--.-             ..+-+.|+......|+
T Consensus        89 lkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNR  168 (388)
T COG5238          89 LKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNR  168 (388)
T ss_pred             hcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccch
Confidence            445666666666666655444332    34456666666666654211111             1234556666666666


Q ss_pred             CCccCCcC-----CCCCCCCCEEEccCCcCCccC-----CccccCCCCCCeeeccCcccccc----CCccccCCCCccEE
Q 041249          663 LIGSIPPP-----LGNLSSLRKISLAINNLAGSI-----PFTLSKLKNLVILYLGVNRLSGI----VPSSIFNISSIAEF  728 (789)
Q Consensus       663 l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L  728 (789)
                      +. ..+..     |..-.+|+++.+..|.|.-.-     ...+..+++|++|||.+|.++..    +..++..++.|++|
T Consensus       169 le-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL  247 (388)
T COG5238         169 LE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLREL  247 (388)
T ss_pred             hc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhc
Confidence            64 22211     222245666666666665110     11223456667777777766632    22344455566666


Q ss_pred             EccCCcccccCCcccc-----cCCCCccEEEccCCcccccCccc-----c--cCCCCCCeeeccCCcCc
Q 041249          729 DVGENKIQGNIPLDYG-----FTLQNLQYFSIGTNRITGAIPPS-----I--SNASKLEVFQALNNKLT  785 (789)
Q Consensus       729 ~Ls~N~l~~~ip~~~~-----~~l~~L~~L~L~~N~l~~~~~~~-----~--~~l~~L~~L~l~~N~l~  785 (789)
                      .+.+|-++..-...++     ...++|..|...+|.+.+-+-..     +  ..++-|..|.+.+|+|.
T Consensus       248 ~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~  316 (388)
T COG5238         248 RLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK  316 (388)
T ss_pred             cccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence            6666666522111111     12456666666666654321111     1  23455555556666654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.20  E-value=1.8e-05  Score=83.11  Aligned_cols=202  Identities=15%  Similarity=0.169  Sum_probs=128.4

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccC--CCCCCceEEE
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGV--DYQGNDFKAL  349 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~~~~~~l  349 (789)
                      ...+.+|+|+-+.+|..-.-  + ..+-|++.......+.   +.++.|.+. .||-+..-+.+=+.-  ..++.....+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh--h-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            44678999999999975432  2 2334555433322222   233444444 566543311110000  1122223566


Q ss_pred             EeeccCCC-ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          350 VYEFMQNG-SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       350 v~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      .|..+.+. -...+.....++    ..-....|.-.+..++.+|.+.+.||..|   .+-||+.++|+|++++..+.|.|
T Consensus        88 lmP~v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ecccCCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence            67666654 233333332111    12345789999999999999999999999   88999999999999999999987


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHh-cCCCCcc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIR-KKPSDIM  490 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG-~~P~~~~  490 (789)
                      -..-.....+   .......|...|.+||...     +...++..|-|.+||++++++.| ++||..-
T Consensus       161 sDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         161 SDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            4322221111   1223455888999999765     34568899999999999999986 9999753

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.18  E-value=4.4e-07  Score=90.48  Aligned_cols=202  Identities=22%  Similarity=0.228  Sum_probs=132.2

Q ss_pred             ccccchhcccCCcccccCcc-ccc-CccceeeecccCCCCccC--CCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          578 LSFLKILNLENNSFTHEIPS-EIG-RLRRLQVPDLNNNSIGGE--IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~-~~~-~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      +..++.|-+.++.|..+-.. .|+ ..+.++.|||.+|.|+..  +-.-+.+++.|++|+|+.|++...+...-..+.+|
T Consensus        44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl  123 (418)
T KOG2982|consen   44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL  123 (418)
T ss_pred             ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence            33555666666666533221 233 246788888888888742  23345678888888888888875443322456788


Q ss_pred             cEEEccCCCCCc-cCCcCCCCCCCCCEEEccCCcCCc--cCCcc----------ccCCCCCCeeeccCccccccCCcccc
Q 041249          654 EVLSLGFNNLIG-SIPPPLGNLSSLRKISLAINNLAG--SIPFT----------LSKLKNLVILYLGVNRLSGIVPSSIF  720 (789)
Q Consensus       654 ~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~----------~~~l~~L~~L~Ls~N~l~~~~p~~~~  720 (789)
                      +.|-|.+..+.= .....+..+|.++.|.||.|.+.-  ...+.          +..++.+..+.++-|++...      
T Consensus       124 ~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~------  197 (418)
T KOG2982|consen  124 RVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI------  197 (418)
T ss_pred             EEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh------
Confidence            888888777641 233445667888888888884331  11112          22334455555566666533      


Q ss_pred             CCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc-CcccccCCCCCCeeeccCCcCcc
Q 041249          721 NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA-IPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       721 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                       ++++..+.+..|+|...-...-+..++.+.-|+|+.|+|..- .-+++..+++|..|.+++|++..
T Consensus       198 -Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  198 -FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             -cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence             457888899999987444444444678888999999999742 23456789999999999999875

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.08  E-value=6.1e-06  Score=78.28  Aligned_cols=102  Identities=21%  Similarity=0.208  Sum_probs=43.8

Q ss_pred             CcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccC-CccccCCCCCCeeecc
Q 041249          629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI-PFTLSKLKNLVILYLG  707 (789)
Q Consensus       629 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls  707 (789)
                      ...+||++|.|. .+ +.|..++.|.+|.|++|+|+.+.|.--.-+++|..|.|.+|.|.... -.-+..|++|++|.+-
T Consensus        44 ~d~iDLtdNdl~-~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll  121 (233)
T KOG1644|consen   44 FDAIDLTDNDLR-KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLL  121 (233)
T ss_pred             cceecccccchh-hc-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeec
Confidence            344444444443 11 13444444555555555554333333333344555555555443110 0123444555555555


Q ss_pred             CccccccCC---ccccCCCCccEEEccC
Q 041249          708 VNRLSGIVP---SSIFNISSIAEFDVGE  732 (789)
Q Consensus       708 ~N~l~~~~p---~~~~~l~~L~~L~Ls~  732 (789)
                      +|.++..--   -.+..+++|+.||++.
T Consensus       122 ~Npv~~k~~YR~yvl~klp~l~~LDF~k  149 (233)
T KOG1644|consen  122 GNPVEHKKNYRLYVLYKLPSLRTLDFQK  149 (233)
T ss_pred             CCchhcccCceeEEEEecCcceEeehhh
Confidence            555542111   2234455555555544

>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A

Probab=98.04  E-value=1.3e-05  Score=73.54  Aligned_cols=105  Identities=22%  Similarity=0.251  Sum_probs=34.8

Q ss_pred             cCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCC
Q 041249          622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNL  701 (789)
Q Consensus       622 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  701 (789)
                      +|.++++|+.+.+.. .+..+....|.++++|+.+.+.++ +..+...+|.++++|+.+.+.+ .+.......|..+++|
T Consensus         7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l   83 (129)
T PF13306_consen    7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL   83 (129)
T ss_dssp             TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred             HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence            344444444444442 233333334444444444444432 3334444444444444444433 2222233334444444


Q ss_pred             CeeeccCccccccCCccccCCCCccEEEcc
Q 041249          702 VILYLGVNRLSGIVPSSIFNISSIAEFDVG  731 (789)
Q Consensus       702 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  731 (789)
                      +.+++..| +.......|.+. +|+.+.+.
T Consensus        84 ~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~  111 (129)
T PF13306_consen   84 KNIDIPSN-ITEIGSSSFSNC-NLKEINIP  111 (129)
T ss_dssp             CEEEETTT--BEEHTTTTTT--T--EEE-T
T ss_pred             cccccCcc-ccEEchhhhcCC-CceEEEEC
Confidence            44444333 332333333333 44444443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	789
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-30
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-29
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-23
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-23
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		7e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		2e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-05
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		5e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		6e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-05
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		6e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-05
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		7e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		1e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
4fho_A	231	Crystal Structure Of An Internalin C2 (Inlc2) From		2e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/246 (37%), Positives = 127/246 (51%), Gaps = 29/246 (11%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRH 326
           A+D FS+ N++G G FG VYKG L +G T V VK       +     F  E   +    H
Sbjct: 36  ASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERXQGGELQFQTEVEMISMAVH 94
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
           RNL+++   C          + LVY +M NGS+   L    RE    + P  L+  +R  
Sbjct: 95  RNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCL----RERPESQPP--LDWPKRQR 143
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSS 444
           IA+  A  L YLH  C P   H D+K +NILLDEE  + VGDFGLA+ +     HV  + 
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 202
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
             V+G+IG+IAPEY    + S   DV+ YG+++LELI  ++  D+           AR+A
Sbjct: 203 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL-----------ARLA 249
Query: 505 LPDHVM 510
             D VM
Sbjct: 250 NDDDVM 255

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 87/245 (35%), Positives = 122/245 (49%), Gaps = 27/245 (11%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           A+D F + N++G G FG VYKG L +G      ++           F  E   +    HR
Sbjct: 28  ASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           NL+++   C          + LVY +M NGS+   L    RE    + P  L+  +R  I
Sbjct: 88  NLLRLRGFCMTPTE-----RLLVYPYMANGSVASCL----RERPESQPP--LDWPKRQRI 136
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSI 445
           A+  A  L YLH  C P   H D+K +NILLDEE  + VGDFGLA+ +     HV  +  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-- 194
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
            V+G IG+IAPEY    + S   DV+ YG+++LELI  ++  D+           AR+A 
Sbjct: 195 -VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL-----------ARLAN 242
Query: 506 PDHVM 510
            D VM
Sbjct: 243 DDDVM 247

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 128/261 (49%), Gaps = 27/261 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           AT+ F    LIG G FG VYKGVL +G   V +K       +    F  E   L   RH 
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESSQGIEEFETEIETLSFCRHP 95
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           +LV +   C     + N+   L+Y++M+NG+L+  LY        D    +++  QRL I
Sbjct: 96  HLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGS------DLPTMSMSWEQRLEI 144
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF---LPPTHVQTSS 444
            I  A  L YLH        H D+K  NILLDE  V  + DFG+++    L  TH+    
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV- 200
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
             VKG++GYI PEY +   ++   DVYS+G+++ E++  +  S I+      + N A  A
Sbjct: 201 --VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMVNLAEWA 256
Query: 505 LPDH----VMDIVDSTLLNDV 521
           +  H    +  IVD  L + +
Sbjct: 257 VESHNNGQLEQIVDPNLADKI 277

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 128/261 (49%), Gaps = 27/261 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           AT+ F    LIG G FG VYKGVL +G   V +K       +    F  E   L   RH 
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESSQGIEEFETEIETLSFCRHP 95
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           +LV +   C     + N+   L+Y++M+NG+L+  LY        D    +++  QRL I
Sbjct: 96  HLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGS------DLPTMSMSWEQRLEI 144
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF---LPPTHVQTSS 444
            I  A  L YLH        H D+K  NILLDE  V  + DFG+++    L  TH+    
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV- 200
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
             VKG++GYI PEY +   ++   DVYS+G+++ E++  +  S I+      + N A  A
Sbjct: 201 --VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMVNLAEWA 256
Query: 505 LPDH----VMDIVDSTLLNDV 521
           +  H    +  IVD  L + +
Sbjct: 257 VESHNNGQLEQIVDPNLADKI 277

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 126/288 (43%), Gaps = 26/288 (9%)
Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKI 583
           L  +S  R  ++ +N ++E  I    +  K  +  ILD     L G I   + N + L  
Sbjct: 435 LGSLSKLRDLKLWLN-MLEGEIPQELMYVKTLETLILDFN--DLTGEIPSGLSNCTNLNW 491
Query: 584 LNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKI 643
           ++L NN  T EIP  IGRL  L +  L+NNS  G IP  L  C +LI + L  N   G I
Sbjct: 492 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 551
Query: 644 PSD-FGSLSKIEVLSL------------------GFNNLI---GSIPPPLGNLSSLRKIS 681
           P+  F    KI    +                  G  NL+   G     L  LS+    +
Sbjct: 552 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 611
Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
           +      G    T     +++ L +  N LSG +P  I ++  +   ++G N I G+IP 
Sbjct: 612 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 671
Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           + G  L+ L    + +N++ G IP ++S  + L      NN L+G +P
Sbjct: 672 EVG-DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 718

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 126/288 (43%), Gaps = 26/288 (9%)
Query: 524 LAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKI 583
           L  +S  R  ++ +N ++E  I    +  K  +  ILD     L G I   + N + L  
Sbjct: 438 LGSLSKLRDLKLWLN-MLEGEIPQELMYVKTLETLILDFN--DLTGEIPSGLSNCTNLNW 494
Query: 584 LNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKI 643
           ++L NN  T EIP  IGRL  L +  L+NNS  G IP  L  C +LI + L  N   G I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 644 PSD-FGSLSKIEVLSL------------------GFNNLI---GSIPPPLGNLSSLRKIS 681
           P+  F    KI    +                  G  NL+   G     L  LS+    +
Sbjct: 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
           +      G    T     +++ L +  N LSG +P  I ++  +   ++G N I G+IP 
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           + G  L+ L    + +N++ G IP ++S  + L      NN L+G +P
Sbjct: 675 EVG-DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           N +G G FG VYKG ++   TTV VK    + ++      + F  E + +   +H NLV+
Sbjct: 37  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     G    G+D   LVY +M NGSL      ++R   +D  P  L+   R  IA   
Sbjct: 95  LL----GFSSDGDDL-CLVYVYMPNGSL------LDRLSCLDGTPP-LSWHMRCKIAQGA 142
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A+ +++LH +      H D+K +NILLDE   + + DFGLAR             + G+ 
Sbjct: 143 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTT 199
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            Y+APE  L  E++   D+YS+G+++LE+I
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           N +G G FG VYKG ++   TTV VK    + ++      + F  E + +   +H NLV+
Sbjct: 31  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     G    G+D   LVY +M NGSL      ++R   +D  P  L+   R  IA   
Sbjct: 89  LL----GFSSDGDDL-CLVYVYMPNGSL------LDRLSCLDGTPP-LSWHMRCKIAQGA 136
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A+ +++LH +      H D+K +NILLDE   + + DFGLAR             + G+ 
Sbjct: 137 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTT 193
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            Y+APE  L  E++   D+YS+G+++LE+I
Sbjct: 194 AYMAPE-ALRGEITPKSDIYSFGVVLLEII 222

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           N +G G FG VYKG ++   TTV VK    + ++      + F  E + +   +H NLV+
Sbjct: 37  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     G    G+D   LVY +M NGSL      ++R   +D  P  L+   R  IA   
Sbjct: 95  LL----GFSSDGDDL-CLVYVYMPNGSL------LDRLSCLDGTPP-LSWHMRCKIAQGA 142
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A+ +++LH +      H D+K +NILLDE   + + DFGLAR             + G+ 
Sbjct: 143 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTT 199
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            Y+APE  L  E++   D+YS+G+++LE+I
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GSFG+V++         V + +    H      F+ E   ++ +RH N+V    A +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q  +  ++V E++  GSL   L+     +++D+        +RL++A DVA  ++Y
Sbjct: 105 ----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDER-------RRLSMAYDVAKGMNY 152
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH+   PI  H +LK  N+L+D++    V DFGL+R    T +  SS    G+  ++APE
Sbjct: 153 LHNRNPPIV-HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPE 209
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  +   DVYS+G+++ EL   ++P
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 40/231 (17%)
Query: 7   NRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLM 66
           N L G IPP+I  L +L   Y++   + G+IP  L   ++L T+    N LSGT+PP + 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 67  GLTSLVALDLSRNQFRGSFPTEVGNLINLET-LTVSGNILQGEIPSTLGSCIKLEILEMQ 125
            L +LV +    N+  G+ P   G+   L T +T+S N L G+IP T  + + L  +++ 
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLS 205
Query: 126 GNVFQG----------------------------------LTILDLSRNKLSGEIPEFLV 151
            N+ +G                                  L  LDL  N++ G +P+ L 
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 152 GLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPC 202
            LK + +LN+S+N+L G +P  G  +     +   N  LCG      LP C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS----PLPAC 312

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 567 LAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSC 626
           L G I P I  L+ L  L + + + +  IP  + +++ L   D + N++ G +P ++SS 
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 627 SNLIRIGLAKNQLMGKIPSDFGSLSKI-EVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN 685
            NL+ I    N++ G IP  +GS SK+   +++  N L G IPP   NL +L  + L+ N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 686 NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGF 745
            L G         KN   ++L  N L+               FD+G+  +  N+    G 
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLA---------------FDLGKVGLSKNL---NGL 249
Query: 746 TLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            L+N        NRI G +P  ++    L       N L GE+P
Sbjct: 250 DLRN--------NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           N  G G FG VYKG ++   TTV VK    + ++      + F  E +     +H NLV+
Sbjct: 28  NKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVE 85
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     G    G+D   LVY +  NGSL      ++R   +D  P  L+   R  IA   
Sbjct: 86  LL----GFSSDGDDL-CLVYVYXPNGSL------LDRLSCLDGTPP-LSWHXRCKIAQGA 133
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A+ +++LH +      H D+K +NILLDE   + + DFGLAR             + G+ 
Sbjct: 134 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            Y APE  L  E++   D+YS+G+++LE+I
Sbjct: 191 AYXAPE-ALRGEITPKSDIYSFGVVLLEII 219

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GSFG+V++         V + +    H      F+ E   ++ +RH N+V    A +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q  +  ++V E++  GSL   L+     +++D+        +RL++A DVA  ++Y
Sbjct: 105 ----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDER-------RRLSMAYDVAKGMNY 152
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH+   PI  H DLK  N+L+D++    V DFGL+R      + +      G+  ++APE
Sbjct: 153 LHNRNPPIV-HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEWMAPE 209
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  +   DVYS+G+++ EL   ++P
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ IRH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVTEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 16  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q +++A  +AS + Y
Sbjct: 74  ------EEPIXIVTEYMSKGSLLDFL-----KGETGK---YLRLPQLVDMAAQIASGMAY 119
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +         H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 120 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 175
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 15  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 73  ------EEPIYIVTEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 118
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 119 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 174
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVIEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVIEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVTEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 17  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 75  ------EEPIYIVTEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 120
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 121 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 176
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVCEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 19  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q +++A  +AS + Y
Sbjct: 77  ------EEPIYIVTEYMSKGSLLDFL-----KGETGK---YLRLPQLVDMAAQIASGMAY 122
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 123 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 178
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q +++A  +AS + Y
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFL-----KGETGKY---LRLPQLVDMAAQIASGMAY 295
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 351
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 275 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q +++A  +AS + Y
Sbjct: 333 ------EEPIYIVTEYMSKGSLLDFL-----KGETGKY---LRLPQLVDMAAQIASGMAY 378
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 379 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 434
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q +++A  +AS + Y
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFL-----KGETGKY---LRLPQLVDMAAQIASGMAY 295
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 351
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVTEYMSKGSLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL  +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  G L ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVMEYMSKGCLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q ++++  +AS + Y
Sbjct: 81  ------EEPIYIVTEYMNKGSLLDFL-----KGETGK---YLRLPQLVDMSAQIASGMAY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +         H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 127 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K      + +  +F+ E + ++ +RH  LV+++   S
Sbjct: 193 LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 251 ------EEPIYIVTEYMSKGSLLDFL-----KGEMGKY---LRLPQLVDMAAQIASGMAY 296
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGL R +      T+  G K  I + APE
Sbjct: 297 VE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY-TARQGAKFPIKWTAPE 352
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  G L ++L     + E+ K    L L Q +++A  +AS + Y
Sbjct: 84  ------EEPIYIVTEYMSKGCLLDFL-----KGEMGK---YLRLPQLVDMAAQIASGMAY 129
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 185
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q +++A  +AS + Y
Sbjct: 250 ------EEPIYIVGEYMSKGSLLDFL-----KGETGKY---LRLPQLVDMAAQIASGMAY 295
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    +    H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 351
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++   S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L     + E  K    L L Q ++++  +AS + Y
Sbjct: 81  ------EEPIYIVTEYMNKGSLLDFL-----KGETGK---YLRLPQLVDMSAQIASGMAY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +         H DL+ +NIL+ E +V  V DFGLAR +      T+  G K  I + APE
Sbjct: 127 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL  + +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V +K        +  SF+ E + ++ ++H  LV+++   S
Sbjct: 17  LGNGQFGEVWMGTWN-GNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   +V E+M  GSL ++L         D   R L L   +++A  VA+ + Y
Sbjct: 75  ------EEPIYIVTEYMNKGSLLDFL--------KDGEGRALKLPNLVDMAAQVAAGMAY 120
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +         H DL+ +NIL+   ++  + DFGLAR +      T+  G K  I + APE
Sbjct: 121 IERMN---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEX-TARQGAKFPIKWTAPE 176
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKK 485
             L    +   DV+S+GIL+ EL+ + +
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 81  ----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 127
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 128 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 183
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 81  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 127
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 128 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPE 183
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 85  ----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 131
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 131
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 187
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 131
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 82  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 128
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 129 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 184
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 82  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 128
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 129 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPE 184
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 84  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 130
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 186
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 131
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 93  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 139
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 140 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 195
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 82  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 128
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 129 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 184
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 78  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 124
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 180
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 78  ----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 124
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 180
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 80  ----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 80  ----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 131
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 30  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 88  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 131
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 132 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 187
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 243

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 29  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 87  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 130
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 131 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 186
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 242

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 85  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 128
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 184
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 85  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 128
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTA 184
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 22  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 80  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 123
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 124 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 179
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 235

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 79  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 178
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 23  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 81  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 124
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 125 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 180
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 236

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 26  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 84  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 127
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 128 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTA 183
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 239

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
            ++G G+FG V K           V +  +      ++FI E R L  + H N+VK++ A
Sbjct: 14  EVVGRGAFGVVCKAKW----RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C        +   LV E+ + GSL       N     +  P        ++  +  +  +
Sbjct: 70  CL-------NPVCLVMEYAEGGSL------YNVLHGAEPLP-YYTAAHAMSWCLQCSQGV 115
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            YLH        H DLKP N+LL     V  + DFG A       +QT     KGS  ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWM 170
Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
           APE   GS  S   DV+S+GI++ E+I R+KP D
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 78  ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 124
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF-TAHAGAKFPIKWTAPE 180
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
            ++G G+FG V K           V +  +      ++FI E R L  + H N+VK++ A
Sbjct: 15  EVVGRGAFGVVCKAKW----RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C        +   LV E+ + GSL       N     +  P        ++  +  +  +
Sbjct: 71  CL-------NPVCLVMEYAEGGSL------YNVLHGAEPLP-YYTAAHAMSWCLQCSQGV 116
Query: 396 DYLHHDCQPITTHCDLKPSNILL-DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            YLH        H DLKP N+LL     V  + DFG A       +QT     KGS  ++
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWM 171
Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
           APE   GS  S   DV+S+GI++ E+I R+KP D
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 16  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 74  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 117
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 118 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTA 173
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 229

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 27/235 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 31  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 89  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 132
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 133 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTA 188
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPD 507
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 243

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 79  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 123 AFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTA 178
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 79  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 123 AFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTA 178
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        +N +  L +A  ++SA++Y
Sbjct: 326 ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEY 372
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H +L   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 373 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 428
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 17  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 75  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 118
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H +L+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 119 AFIEERNY---IHRNLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTA 174
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 230

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 278 IGTGSFGSVYKGV-LDEGRTTV-TVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           IG+G FG V+ G  L++ +  + T+K  ++    +   FI E   +  + H  LV+++  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSM----SEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASA 394
           C            LV+EFM++G L ++L          +  R L   + L  + +DV   
Sbjct: 91  C-----LEQAPICLVFEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVCEG 135
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           + YL   C     H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + 
Sbjct: 136 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWA 191
Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
           +PE    S  S+  DV+S+G+LM E+    K
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G FG V+ G     +  V +K        +   FI E   +  + H  LV+++  C 
Sbjct: 15  IGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 71
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                      LV+EFM++G L ++L          +  R L   + L  + +DV   + 
Sbjct: 72  ----LEQAPICLVFEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVCEGMA 117
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL   C     H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +P
Sbjct: 118 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 173
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKK 485
           E    S  S+  DV+S+G+LM E+    K
Sbjct: 174 EVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 276 NLIGTGSFGSVYKGVLDE-GRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V +G L   G+    V +  L   +  R  R F++E   +    H N+++
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 332 VFTACSGVDYQGNDFKALVY-EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           +    +      N    ++  EFM+NG+L+ +L   + +           ++Q + +   
Sbjct: 82  LEGVVT------NSMPVMILTEFMENGALDSFLRLNDGQ---------FTVIQLVGMLRG 126
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----PTHVQTSSI 445
           +AS + YL    +    H DL   NIL++  +V  V DFGL+RFL      PT  +TSS+
Sbjct: 127 IASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT--ETSSL 181
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           G K  I + APE     + ++  D +SYGI+M E++
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 276 NLIGTGSFGSVYKGVLDE-GRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V +G L   G+    V +  L   +  R  R F++E   +    H N+++
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 332 VFTACSGVDYQGNDFKALVY-EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           +    +      N    ++  EFM+NG+L+ +L   + +           ++Q + +   
Sbjct: 80  LEGVVT------NSMPVMILTEFMENGALDSFLRLNDGQ---------FTVIQLVGMLRG 124
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----PTHVQTSSI 445
           +AS + YL    +    H DL   NIL++  +V  V DFGL+RFL      PT+  TSS+
Sbjct: 125 IASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY--TSSL 179
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           G K  I + APE     + ++  D +SYGI+M E++
Sbjct: 180 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G FG V+ G     +  V +K        +   FI E   +  + H  LV+++  C 
Sbjct: 13  IGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                      LV+EFM++G L ++L          +  R L   + L  + +DV   + 
Sbjct: 70  ----LEQAPICLVFEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVCEGMA 115
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL   C     H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +P
Sbjct: 116 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 171
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKK 485
           E    S  S+  DV+S+G+LM E+    K
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                   F  +V E+M  G+L ++L   NRE+        +  +  L +A  ++SA++Y
Sbjct: 99  ----LEPPF-YIVTEYMPYGNLLDYLRECNREE--------VTAVVLLYMATQISSAMEY 145
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H DL   N L+ E  V  V DFGL+R +      T+  G K  I + APE
Sbjct: 146 LE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 201
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               +  S   DV+++G+L+ E+
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G FG V+ G     +  V +K        +   FI E   +  + H  LV+++  C 
Sbjct: 18  IGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                      LV+EFM++G L ++L          +  R L   + L  + +DV   + 
Sbjct: 75  ----LEQAPICLVFEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVCEGMA 120
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL   C     H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +P
Sbjct: 121 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 176
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKK 485
           E    S  S+  DV+S+G+LM E+    K
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 90  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 135
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++     +TSS+G K  + +  PE
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSKFPVRWSPPE 191
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +   F  ++ EFM  G+L ++L   NR++        ++ +  L +A  ++SA++Y
Sbjct: 287 ----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 333
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L    +    H +L   N L+ E  +  V DFGL+R +      T+  G K  I + APE
Sbjct: 334 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 389
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               ++ S   DV+++G+L+ E+
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 27/236 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G  G V+ G  + G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 21  LGAGQAGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL--QRLNIAIDVASAL 395
                  +   ++ E+M+NGSL ++L          K P  + L   + L++A  +A  +
Sbjct: 79  ------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX-TAREGAKFPIKWTA 178
Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKK---PSDIMFEGDMNLHNFARMALPDH 508
           PE       +   DV+S+GIL+ E++   +   P     E   NL    RM  PD+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  + V +  L   +  +  R F++E   +    H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              V T  + V         ++ EFM+NGSL+ +L    R+++         ++Q + + 
Sbjct: 99  LEGVVTKSTPV--------MIITEFMENGSLDSFL----RQND-----GQFTVIQLVGML 141
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----PTHVQTS 443
             +A+ + YL         H DL   NIL++  +V  V DFGL+RFL      PT+  TS
Sbjct: 142 RGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TS 196
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++G K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 197 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 70  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 115
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++      TSS+G K  + +  PE
Sbjct: 116 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE 171
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 74  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 119
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++      TSS+G K  + +  PE
Sbjct: 120 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE 175
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 176 VLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 75  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 120
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++      TSS+G K  + +  PE
Sbjct: 121 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE 176
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 177 VLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 90  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 135
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++      TSS+G K  + +  PE
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE 191
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 81  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++      TSS+G K  + +  PE
Sbjct: 127 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 183 VLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G FG V+ G     +  V +K        +   FI E   +  + H  LV+++  C 
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 72
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                      LV EFM++G L ++L          +  R L   + L  + +DV   + 
Sbjct: 73  ----LEQAPICLVTEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVCEGMA 118
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL   C     H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +P
Sbjct: 119 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 174
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKK 485
           E    S  S+  DV+S+G+LM E+    K
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 273 SSANLIGTGSFGSVYKGVLD--EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHR 327
           +   +IG G FG VYKG+L    G+  V V +  L   +  +    F+ E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 328 NLVKVFTACSGVDYQGNDFKAL--VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           N++++    S        +K +  + E+M+NG+L+++L    RE + +      ++LQ +
Sbjct: 107 NIIRLEGVIS-------KYKPMMIITEYMENGALDKFL----REKDGE-----FSVLQLV 150
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTS 443
            +   +A+ + YL +       H DL   NIL++  +V  V DFGL+R L   P    T+
Sbjct: 151 GMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           S G K  I + APE     + ++  DV+S+GI+M E++
Sbjct: 208 S-GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+    ++  T V VK        +  +F+AE   +++++H  LVK+    +
Sbjct: 23  LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   ++ EFM  GSL ++L    + DE  K P    L + ++ +  +A  + +
Sbjct: 81  ------KEPIYIITEFMAKGSLLDFL----KSDEGSKQP----LPKLIDFSAQIAEGMAF 126
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    Q    H DL+ +NIL+   +V  + DFGLAR +      T+  G K  I + APE
Sbjct: 127 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 182
Query: 458 YGLGSEVSTNGDVYSYGILMLELI 481
                  +   DV+S+GIL++E++
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIV 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 77  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 122
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 123 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 72  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 117
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 73
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 74  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 119
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 120 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG+G FG V+ G     +  V +K        +   FI E   +  + H  LV+++  C 
Sbjct: 15  IGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 71
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                      LV+EFM++G L ++L          +  R L   + L  + +DV   + 
Sbjct: 72  ----LEQAPICLVFEFMEHGCLSDYL----------RTQRGLFAAETLLGMCLDVCEGMA 117
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YL    +    H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +P
Sbjct: 118 YLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 173
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKK 485
           E    S  S+  DV+S+G+LM E+    K
Sbjct: 174 EVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 77  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 122
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 123 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 72  -----YSTAPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 117
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+  +      +  +F  E   LR  RH N++ +F  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMG 99
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y   D  A+V ++ +  SL + L+    +           + Q ++IA   A  +
Sbjct: 100 -----YMTKDNLAIVTQWCEGSSLYKHLHVQETK---------FQMFQLIDIARQTAQGM 145
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA----RFLPPTHVQTSSIGVKGSI 451
           DYLH        H D+K +NI L E +   +GDFGLA    R+     V+  +    GS+
Sbjct: 146 DYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT----GSV 198
Query: 452 GYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
            ++APE     +    S   DVYSYGI++ EL+  + P
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 98
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 99  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 144
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 145 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               Q   F  ++ E+M NG L  +L  +                Q L +  DV  A++Y
Sbjct: 75  K---QRPIF--IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEY 120
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L         H DL   N L++++ V  V DFGL+R++      TSS G K  + +  PE
Sbjct: 121 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSRGSKFPVRWSPPE 176
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
             + S+ S+  D++++G+LM E+
Sbjct: 177 VLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 99
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 100 -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 145
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 146 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+    ++  T V VK        +  +F+AE   +++++H  LVK+    +
Sbjct: 196 LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   ++ EFM  GSL ++L    + DE  K P    L + ++ +  +A  + +
Sbjct: 254 ------KEPIYIITEFMAKGSLLDFL----KSDEGSKQP----LPKLIDFSAQIAEGMAF 299
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    Q    H DL+ +NIL+   +V  + DFGLAR +      T+  G K  I + APE
Sbjct: 300 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 355
Query: 458 YGLGSEVSTNGDVYSYGILMLELI 481
                  +   DV+S+GIL++E++
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIV 379

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 72  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 117
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 34/218 (15%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  + V +  L   +  +  R F++E   +    H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              V T  + V         ++ EFM+NGSL+ +L    R+++         ++Q + + 
Sbjct: 73  LEGVVTKSTPV--------MIITEFMENGSLDSFL----RQND-----GQFTVIQLVGML 115
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----PTHVQTS 443
             +A+ + YL         H  L   NIL++  +V  V DFGL+RFL      PT+  TS
Sbjct: 116 RGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TS 170
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++G K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 171 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 12/214 (5%)
Query: 275 ANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHH--HRASRSFIAECRALRSIRHRNL 329
             ++G G FGSV +G L +   T   V VK   L +   R    F++E   ++   H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           +++   C  +  QG     ++  FM+ G L  +L        ++  P+++ L   L   +
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMV 154
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           D+A  ++YL +       H DL   N +L ++M   V DFGL++ +            K 
Sbjct: 155 DIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
            + +IA E       ++  DV+++G+ M E+  R
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 44/235 (18%)
Query: 272 FSSANLIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           F    LIG+G FG V+K     +G+T V  +V   ++ +A R    E +AL  + H N+V
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-KYNNEKAER----EVKALAKLDHVNIV 68
Query: 331 KVFTACSGVDY---------QGNDFKA---------------LVYEFMQNGSLEEWLYPV 366
                  G DY         + +D+                 +  EF   G+LE+W+   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
            R +++DK    L L ++      +   +DY+H        H DLKPSNI L +     +
Sbjct: 128 RRGEKLDKVL-ALELFEQ------ITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           GDFGL   L     +T S   KG++ Y++PE     +     D+Y+ G+++ EL+
Sbjct: 178 GDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 91
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 92  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 137
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 138 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 99
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+ +  + E         +++ ++IA   A  +
Sbjct: 100 -----YSTKPQLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGM 145
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E++   +GDFGLA              + GSI ++A
Sbjct: 146 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 456 PEYGLGSE---VSTNGDVYSYGILMLELIIRKKP 486
           PE     +    S   DVY++GI++ EL+  + P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ EF+  GSL E+L          K    ++ ++ L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEFLPYGSLREYL---------QKHKERIDHIKLLQYTSQICK 128
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 184
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 112/259 (43%), Gaps = 33/259 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F    LIG+G FG V+K        T  +K    ++ +A R    E +AL  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 332 VFTACSGVDYQ-----GNDFKA------LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
                 G DY       N  ++      +  EF   G+LE+W+    R +++DK    L 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVL-ALE 126
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
           L ++      +   +DY+H        + DLKPSNI L +     +GDFGL   L     
Sbjct: 127 LFEQ------ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           +  S   KG++ Y++PE     +     D+Y+ G+++ EL+      D  FE      + 
Sbjct: 178 RXRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSKFFTDL 231
Query: 501 ARMALPDHVMDIVDSTLLN 519
               + D + D  + TLL 
Sbjct: 232 RDGIISD-IFDKKEKTLLQ 249

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 75
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+    + E+ K          ++IA   A  +
Sbjct: 76  -----YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKL---------IDIARQTARGM 121
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E+    +GDFGLA              + GSI ++A
Sbjct: 122 DYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178
Query: 456 PE---YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE       +  S   DVY++GI++ EL+  + P
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  + V +  L   +  +  R F++E   +    H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              V T C  V         ++ E+M+NGSL+ +L          K      ++Q + + 
Sbjct: 95  LEGVVTKCKPV--------MIITEYMENGSLDAFLR---------KNDGRFTVIQLVGML 137
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIG 446
             + S + YL  D   +  H DL   NIL++  +V  V DFG++R L   P    T+  G
Sbjct: 138 RGIGSGMKYLS-DMSAV--HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR-G 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 194 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 30/204 (14%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+    ++  T V VK        +  +F+AE   +++++H  LVK+    +
Sbjct: 190 LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   ++ EFM  GSL ++L    + DE  K P    L + ++ +  +A  + +
Sbjct: 248 ------KEPIYIITEFMAKGSLLDFL----KSDEGSKQP----LPKLIDFSAQIAEGMAF 293
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           +    Q    H DL+ +NIL+   +V  + DFGLAR           +G K  I + APE
Sbjct: 294 IE---QRNYIHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPE 339
Query: 458 YGLGSEVSTNGDVYSYGILMLELI 481
                  +   DV+S+GIL++E++
Sbjct: 340 AINFGSFTIKSDVWSFGILLMEIV 363

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  V V +  L   +  +  R F+ E   +    H N+V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V EFM+NG+L+ +L          K      ++Q + +   +
Sbjct: 109 L----EGVVTRGKPV-MIVIEFMENGALDAFL---------RKHDGQFTVIQLVGMLRGI 154
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           A+ + YL         H DL   NIL++  +V  V DFGL+R +   P  V T++ G K 
Sbjct: 155 AAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTT-GGKI 210
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE     + ++  DV+SYGI+M E++
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 37/235 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS--IRHR 327
           D      LIG G +G+VYKG LDE    V VKVF+  +    ++FI E    R   + H 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANR---QNFINEKNIYRVPLMEHD 67
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+ +       V   G     LV E+  NGSL ++L           +    + +    +
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----------SLHTSDWVSSCRL 116
Query: 388 AIDVASALDYLHHDC------QPITTHCDLKPSNILLDEEMVSHVGDFGLA------RFL 435
           A  V   L YLH +       +P  +H DL   N+L+  +    + DFGL+      R +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 436 PPTHVQTSSIGVKGSIGYIAPEYGLGS-------EVSTNGDVYSYGILMLELIIR 483
            P     ++I   G+I Y+APE   G+             D+Y+ G++  E+ +R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+    + E+ K          ++IA   A  +
Sbjct: 88  -----YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKL---------IDIARQTARGM 133
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E+    +GDFGLA              + GSI ++A
Sbjct: 134 DYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 456 PE---YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE       +  S   DVY++GI++ EL+  + P
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+       + ++ +  V VK        A + F  E   L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV-----DKAPRNLNLLQRLNI 387
           F  C+    +G     +V+E+M++G L  +L     + ++     D AP  L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 388 AIDVASALDYL---HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           A  VA+ + YL   H        H DL   N L+ + +V  +GDFG++R +  T      
Sbjct: 164 ASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
                 I ++ PE  L  + +T  DV+S+G+++ E+    K
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  + V +  L   +  +  R F++E   +    H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              V T C  V         ++ E+M+NGSL+ +L          K      ++Q + + 
Sbjct: 74  LEGVVTKCKPV--------MIITEYMENGSLDAFLR---------KNDGRFTVIQLVGML 116
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIG 446
             + S + YL         H DL   NIL++  +V  V DFG++R L   P    T+  G
Sbjct: 117 RGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR-G 172
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 173 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V  G  D     V VK   + +   +++F+AE   +  +RH NLV++     
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
            V+ +G  +  +V E+M  GSL ++L    R          L     L  ++DV  A++Y
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 123
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L  +      H DL   N+L+ E+ V+ V DFGL +    T   T  + VK    + APE
Sbjct: 124 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK----WTAPE 175
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
               +  ST  DV+S+GIL+ E+
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEI 198

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  + V +  L   +  +  R F++E   +    H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 332 ---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
              V T C  V         ++ E+M+NGSL+ +L          K      ++Q + + 
Sbjct: 80  LEGVVTKCKPV--------MIITEYMENGSLDAFLR---------KNDGRFTVIQLVGML 122
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIG 446
             + S + YL         H DL   NIL++  +V  V DFG++R L   P    T+  G
Sbjct: 123 RGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR-G 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            K  I + APE     + ++  DV+SYGI+M E++
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V  G  D     V VK   + +   +++F+AE   +  +RH NLV++     
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
            V+ +G  +  +V E+M  GSL ++L    R          L     L  ++DV  A++Y
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 117
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L  +      H DL   N+L+ E+ V+ V DFGL +    T   T  + VK    + APE
Sbjct: 118 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK----WTAPE 169
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
                + ST  DV+S+GIL+ E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+       + ++ +  V VK        A + F  E   L  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV-----DKAPRNLNLLQRLNI 387
           F  C+    +G     +V+E+M++G L  +L     + ++     D AP  L L Q L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 388 AIDVASALDYL---HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           A  VA+ + YL   H        H DL   N L+ + +V  +GDFG++R +  T      
Sbjct: 141 ASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
                 I ++ PE  L  + +T  DV+S+G+++ E+    K
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V  G  D     V VK   + +   +++F+AE   +  +RH NLV++     
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
            V+ +G  +  +V E+M  GSL ++L    R          L     L  ++DV  A++Y
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 132
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L  +      H DL   N+L+ E+ V+ V DFGL +    T   T  + VK    + APE
Sbjct: 133 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK----WTAPE 184
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
                + ST  DV+S+GIL+ E+
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEI 207

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+       + ++ +  V VK        A + F  E   L  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV-----DKAPRNLNLLQRLNI 387
           F  C+    +G     +V+E+M++G L  +L     + ++     D AP  L L Q L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 388 AIDVASALDYL---HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           A  VA+ + YL   H        H DL   N L+ + +V  +GDFG++R +  T      
Sbjct: 135 ASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
                 I ++ PE  L  + +T  DV+S+G+++ E+    K
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 276 NLIGTGSFGSVYKGVL--DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
            +IG G FG VY+     DE          +    +   +   E +    ++H N++   
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII--- 69
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            A  GV  +  +   LV EF + G       P+NR     + P ++     +N A+ +A 
Sbjct: 70  -ALRGVCLKEPNL-CLVMEFARGG-------PLNRVLSGKRIPPDI----LVNWAVQIAR 116
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEM--------VSHVGDFGLARFLPPTHVQTSSI 445
            ++YLH +      H DLK SNIL+ +++        +  + DFGLAR       +T+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKM 172
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              G+  ++APE    S  S   DV+SYG+L+ EL+  + P
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEGRTT---VTVKVFN-LHHHRASRSFIAECRALRSIRH 326
                ++G+G+FG+VYKG+ + EG T    V +K+ N     +A+  F+ E   + S+ H
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 99
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            +LV++   C     Q      LV + M +G L E+++    +D       N+     LN
Sbjct: 100 PHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH--EHKD-------NIGSQLLLN 144
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  + YL    +    H DL   N+L+       + DFGLAR L     + ++ G
Sbjct: 145 WCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 201
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            K  I ++A E     + +   DV+SYG+ + EL+
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 236

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR--SFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG   +    V VK+ N+      +  +F  E   LR  RH N++ +F  
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y      A+V ++ +  SL   L+    + E+ K          ++IA   A  +
Sbjct: 88  -----YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKL---------IDIARQTARGM 133
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH        H DLK +NI L E+    +GDFGLA              + GSI ++A
Sbjct: 134 DYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 456 PE---YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE       +  S   DVY++GI++ EL+  + P
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEGRTT---VTVKVFN-LHHHRASRSFIAECRALRSIRH 326
                ++G+G+FG+VYKG+ + EG T    V +K+ N     +A+  F+ E   + S+ H
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            +LV++   C     Q      LV + M +G L E+         V +   N+     LN
Sbjct: 77  PHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEY---------VHEHKDNIGSQLLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  + YL    +    H DL   N+L+       + DFGLAR L     + ++ G
Sbjct: 122 WCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E     + +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 125
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 181
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 125
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 181
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 76  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 123
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 179
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 180 FWYAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 143
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 199
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 116/257 (45%), Gaps = 34/257 (13%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  +   T V VK        + ++F+ E   +++++H  LV+++   +
Sbjct: 20  LGAGQFGEVWMGYYNNS-TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                  +   ++ EFM  GSL ++L    + DE  K      LL +L + +  +A  + 
Sbjct: 78  K-----EEPIYIITEFMAKGSLLDFL----KSDEGGKV-----LLPKLIDFSAQIAEGMA 123
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           Y+         H DL+ +N+L+ E ++  + DFGLAR +      T+  G K  I + AP
Sbjct: 124 YIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAP 179
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL---------HNFARMA-LP 506
           E       +   +V+S+GIL+ E++   K   I + G  N          +   RM   P
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVTYGK---IPYPGRTNADVMSALSQGYRMPRMENCP 236
Query: 507 DHVMDIVDSTLLNDVED 523
           D + DI+        E+
Sbjct: 237 DELYDIMKMCWKEKAEE 253

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 77  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 124
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 125 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 180
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 181 FWYAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 109 GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 156
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 212
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELF 242

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 82  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 129
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 130 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 185
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 186 FWYAPESLTESKFSVASDVWSFGVVLYELF 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 143
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 199
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 85  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 132
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 133 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 188
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 189 FWYAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 84  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 131
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 132 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 187
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 188 FWYAPESLTESKFSVASDVWSFGVVLYELF 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 83  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 130
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 131 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 186
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 187 FWYAPESLTESKFSVASDVWSFGVVLYELF 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 128
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 184
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 125
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH--VQTSSIGVKGSI 451
            ++YL         H DL   NIL++ E    +GDFGL + LP      +    G +  I
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG-ESPI 181
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V  G  D     V VK   + +   +++F+AE   +  +RH NLV++     
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
            V+ +G  +  +V E+M  GSL ++L    R          L     L  ++DV  A++Y
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 304
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           L  +      H DL   N+L+ E+ V+ V DFGL +    T   T  + VK    + APE
Sbjct: 305 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK----WTAPE 356
Query: 458 YGLGSEVSTNGDVYSYGILMLEL 480
                + ST  DV+S+GIL+ E+
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEI 379

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 116/257 (45%), Gaps = 34/257 (13%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G  +   T V VK        + ++F+ E   +++++H  LV+++   +
Sbjct: 21  LGAGQFGEVWMGYYNNS-TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
                  +   ++ E+M  GSL ++L    + DE  K      LL +L + +  +A  + 
Sbjct: 79  R-----EEPIYIITEYMAKGSLLDFL----KSDEGGKV-----LLPKLIDFSAQIAEGMA 124
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           Y+         H DL+ +N+L+ E ++  + DFGLAR +      T+  G K  I + AP
Sbjct: 125 YIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAP 180
Query: 457 EYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN------LHNFARMA----LP 506
           E       +   DV+S+GIL+ E++   K   I + G  N      L    RM      P
Sbjct: 181 EAINFGCFTIKSDVWSFGILLYEIVTYGK---IPYPGRTNADVMTALSQGYRMPRVENCP 237
Query: 507 DHVMDIVDSTLLNDVED 523
           D + DI+        E+
Sbjct: 238 DELYDIMKMCWKEKAEE 254

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGLAR L   P    T+  G K 
Sbjct: 157 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+          + +  V VK        A + F  E   L +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE--VDKAPRN----LNLLQRLN 386
           +  C        D   +V+E+M++G L ++L     +    VD  PR     L L Q L+
Sbjct: 83  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           IA  +AS + YL         H DL   N L+   ++  +GDFG++R +  T        
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
               I ++ PE  +  + +T  DV+S+G+++ E+    K
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 278 IGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V     Y    ++ +  V VK        A + F  E   L +++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA----PRNLNLLQRLNIA 388
           +  C        D   +V+E+M++G L ++L   +  D V  A    P  L   Q L+IA
Sbjct: 81  YGVCVE-----GDPLIMVFEYMKHGDLNKFL-RAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +A+ + YL         H DL   N L+ E ++  +GDFG++R +  T          
Sbjct: 135 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK 485
             I ++ PE  +  + +T  DV+S G+++ E+    K
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L          K    ++ ++ L     +  
Sbjct: 79  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QKHKERIDHIKLLQYTSQICK 126
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKGSI 451
            ++YL         H +L   NIL++ E    +GDFGL + LP    + +    G +  I
Sbjct: 127 GMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG-ESPI 182
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELF 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 99  L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 144
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 145 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 200
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 82  L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 127
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 128 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 183
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 278 IGTGSFGSVYKGVLD-EGRTT---VTVKVFNLH---HHRASRSFIAECRALRSIRHRNLV 330
           +G G FG V     D EG  T   V VK        +H A      E   LR++ H N+V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENIV 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K    C+  +  GN  K L+ EF+ +GSL+E+L P N+          +NL Q+L  A+ 
Sbjct: 87  KYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL-PKNK--------NKINLKQQLKYAVQ 134
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +   +DYL         H DL   N+L++ E    +GDFGL + +       +    + S
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE  + S+     DV+S+G+ + EL+
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 278 IGTGSFGSVYKGVLD-EGRTT---VTVKVFNLH---HHRASRSFIAECRALRSIRHRNLV 330
           +G G FG V     D EG  T   V VK        +H A      E   LR++ H N+V
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENIV 74
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K    C+  +  GN  K L+ EF+ +GSL+E+L P N+          +NL Q+L  A+ 
Sbjct: 75  KYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL-PKNK--------NKINLKQQLKYAVQ 122
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +   +DYL         H DL   N+L++ E    +GDFGL + +       +    + S
Sbjct: 123 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE  + S+     DV+S+G+ + EL+
Sbjct: 180 PVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 68  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 180 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E   L+S++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L               ++ ++ L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYL---------QAHAERIDHIKLLQYTSQICK 128
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS--I 451
            ++YL         H DL   NIL++ E    +GDFGL + LP    +   +   G   I
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPI 184
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRH 326
           ++  F     +G G++ +VYKG+       V +K   L     + S  I E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V+++     V +  N    LV+EFM N  L++++        V   PR L L     
Sbjct: 63  ENIVRLY----DVIHTENKL-TLVFEFMDN-DLKKYM----DSRTVGNTPRGLELNLVKY 112
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSI 445
               +   L + H +      H DLKP N+L+++     +GDFGLAR F  P +  +S +
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 446 GVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRK 484
               ++ Y AP+  +GS   ST+ D++S G ++ E+I  K
Sbjct: 170 ---VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG V  G L   G+  + V +  L   +  +  R F+ E   +    H N++ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L    + D      + + +L+ ++  +  
Sbjct: 88  L----EGVVTKSKPV-MIVTEYMENGSLDTFL---KKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
            S + Y+H D         L   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 140 LSDMGYVHRD---------LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 189
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + APE     + ++  DV+SYGI+M E++
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL         H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL         H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G+G FG V  G   +G+  V VK+       +   F  E + +  + H  LVK +  CS
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 338 GVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                  ++   +V E++ NG L  +L             + L   Q L +  DV   + 
Sbjct: 74  ------KEYPIYIVTEYISNGCLLNYL---------RSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           +L    Q I  H DL   N L+D ++   V DFG+ R++       SS+G K  + + AP
Sbjct: 119 FLESH-QFI--HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAP 174
Query: 457 EYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDI 489
           E     + S+  DV+++GILM E+  + K P D+
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 77  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 189 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 109 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 154
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 155 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 210
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E+M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL R L   P    T+  G K 
Sbjct: 157 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 276 NLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLHHHRAS-RSFIAECRALRSI-RHRNLVK 331
           ++IG G+FG V K  + +   R    +K    +  +   R F  E   L  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-------PRNLNLLQR 384
           +  AC   +++G  +  L  E+  +G+L ++L   +R  E D A          L+  Q 
Sbjct: 91  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 144
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L+ A DVA  +DYL    Q    H DL   NIL+ E  V+ + DFGL+R           
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 193
Query: 445 IGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G     ++A E    S  +TN DV+SYG+L+ E++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-----RSFIAECRALRSIRH 326
           +   + +G G F +VYK         V +K   L H   +     R+ + E + L+ + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N++ +  A     ++ N   +LV++FM+       L  + +++ +   P ++     + 
Sbjct: 72  PNIIGLLDAFG---HKSN--ISLVFDFMETD-----LEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSI 445
           +       L+YLH   Q    H DLKP+N+LLDE  V  + DFGLA+ F  P       +
Sbjct: 122 L-----QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV 173
Query: 446 GVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
             +    Y APE   G+ +   G D+++ G ++ EL++R         GD +L    R+
Sbjct: 174 VTR---WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP----FLPGDSDLDQLTRI 225

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 276 NLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLHHHRAS-RSFIAECRALRSI-RHRNLVK 331
           ++IG G+FG V K  + +   R    +K    +  +   R F  E   L  +  H N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-------PRNLNLLQR 384
           +  AC   +++G  +  L  E+  +G+L ++L   +R  E D A          L+  Q 
Sbjct: 81  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 134
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L+ A DVA  +DYL    Q    H DL   NIL+ E  V+ + DFGL+R           
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 183
Query: 445 IGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G     ++A E    S  +TN DV+SYG+L+ E++
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEXMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYLS-DMGAV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG+G  G V  G L   G+  V V +  L   +  R  R F++E   +    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E+M+NGSL+ +L   + +           ++Q + +   V
Sbjct: 115 L----EGVVTRGR-LAMIVTEYMENGSLDTFLRTHDGQ---------FTIMQLVGMLRGV 160
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
            + + YL  D   +  H DL   N+L+D  +V  V DFGL+R L   P    T++ G K 
Sbjct: 161 GAGMRYLS-DLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTT-GGKI 216
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + APE       S+  DV+S+G++M E++
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E M+NGSL+ +L          K      ++Q + +   +
Sbjct: 82  L----EGVVTKSKPV-MIVTEXMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 127
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL  D   +  H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 128 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 183
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 70  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 182 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 76  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 131 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 188 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD-EGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVK 331
            +IG+G  G V  G L   G+  V V +  L   +  R  R F++E   +    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E+M+NGSL+ +L   + +           ++Q + +   V
Sbjct: 115 L----EGVVTRGR-LAMIVTEYMENGSLDTFLRTHDGQ---------FTIMQLVGMLRGV 160
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
            + + YL  D   +  H DL   N+L+D  +V  V DFGL+R L   P    T++ G K 
Sbjct: 161 GAGMRYLS-DLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-GGKI 216
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + APE       S+  DV+S+G++M E++
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 74  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 186 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 76  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 131 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 188 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 83  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 138 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 195 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 77  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 189 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 105 KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T   
Sbjct: 160 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 217 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLV 330
           F     +G G FG V++           +K   L +   +R   + E +AL  + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 331 KVFTAC----SGVDYQGNDFKALVYEFMQ---NGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           + F A     +    Q +  K  +Y  MQ     +L++W+   N    +++  R++ L  
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCL-- 121
Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA----------R 433
             +I + +A A+++LH        H DLKPSNI    + V  VGDFGL            
Sbjct: 122 --HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            L P        G  G+  Y++PE   G+  S   D++S G+++ EL+
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNL-HHHRASRSFIAECRALRSIRHRNLVK 331
            ++G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +      +V E M+NGSL+ +L          K      ++Q + +   +
Sbjct: 111 L----EGVVTKSKPV-MIVTEXMENGSLDSFLR---------KHDAQFTVIQLVGMLRGI 156
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTSSIGVKG 449
           AS + YL         H DL   NIL++  +V  V DFGL+R L   P    T+  G K 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKI 212
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            I + +PE     + ++  DV+SYGI++ E++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 276 NLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLHHHRAS-RSFIAECRALRSI-RHRNLVK 331
           ++IG G+FG V K  + +   R    +K    +  +   R F  E   L  +  H N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-------PRNLNLLQR 384
           +  AC   +++G  +  L  E+  +G+L ++L   +R  E D A          L+  Q 
Sbjct: 88  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 141
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L+ A DVA  +DYL    Q    H +L   NIL+ E  V+ + DFGL+R           
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------GQE 190
Query: 445 IGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G     ++A E    S  +TN DV+SYG+L+ E++
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALR 322
           AT  +     IG G++G+VYK         V +K   + +       ++   +A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR-NLNL 381
           +  H N+V++   C+           LV+E + +  L  +L         DKAP   L  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---------DKAPPPGLPA 111
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
               ++       LD+LH +C     H DLKP NIL+       + DFGLAR       Q
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQ 165
Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP
Sbjct: 166 MALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 209

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +     ++V++     GV  QG     ++ E M  G L+ +L  +  E E +      +L
Sbjct: 70  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
            + + +A ++A  + YL+ +      H DL   N  + E+    +GDFG+ R +  T   
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 442 TSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 182 RK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 276 NLIGTGSFGSVYKGV-LDEG---RTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRNLV 330
            ++G+G FG+V+KGV + EG   +  V +KV      R S ++      A+ S+ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++   C G   Q      LV +++  GSL          D V +    L     LN  + 
Sbjct: 97  RLLGLCPGSSLQ------LVTQYLPLGSLL---------DHVRQHRGALGPQLLLNWGVQ 141
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +A  + YL         H +L   N+LL       V DFG+A  LPP   Q      K  
Sbjct: 142 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           I ++A E     + +   DV+SYG+ + EL+
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALR 322
           AT  +     IG G++G+VYK         V +K   + +       ++   +A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR-NLNL 381
           +  H N+V++   C+           LV+E + +  L  +L         DKAP   L  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---------DKAPPPGLPA 111
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
               ++       LD+LH +C     H DLKP NIL+       + DFGLAR       Q
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQ 165
Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP
Sbjct: 166 MALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 276 NLIGTGSFGSVYKGV-LDEG---RTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRNLV 330
            ++G+G FG+V+KGV + EG   +  V +KV      R S ++      A+ S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++   C G   Q      LV +++  GSL          D V +    L     LN  + 
Sbjct: 79  RLLGLCPGSSLQ------LVTQYLPLGSLL---------DHVRQHRGALGPQLLLNWGVQ 123
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +A  + YL         H +L   N+LL       V DFG+A  LPP   Q      K  
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           I ++A E     + +   DV+SYG+ + EL+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 114 LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 160
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 161 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 217
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 29/221 (13%)
Query: 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
             ++G G FG   K    E    + +K          R+F+ E + +R + H N++K   
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI- 73
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
              GV Y+       + E+++ G+L   +  ++ +             QR++ A D+AS 
Sbjct: 74  ---GVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQ---------YPWSQRVSFAKDIASG 120
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI--------- 445
           + YLH        H DL   N L+ E     V DFGLAR +     Q   +         
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 446 ---GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
               V G+  ++APE   G       DV+S+GI++ E+I R
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 25/253 (9%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 88  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 134
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 135 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 191
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP--SDI-MFEGDMNLHNFARMALP 506
            + ++A E     + +T  DV+S+G+L+ EL+ R  P   D+  F+  + L    R+  P
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 251
Query: 507 DHVMDIVDSTLLN 519
           ++  D +   +L 
Sbjct: 252 EYCPDPLYEVMLK 264

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 115 LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 161
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 162 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 218
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 95  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 141
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR +      +  +  G K 
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKL 198
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECR 319
           AT  +     IG G++G+VYK         V +K   + +          ++   +A  R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR-N 378
            L +  H N+V++   C+           LV+E + +  L  +L         DKAP   
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---------DKAPPPG 116
Query: 379 LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438
           L      ++       LD+LH +C     H DLKP NIL+       + DFGLAR     
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--- 170
Query: 439 HVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             Q +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 217

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 96  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 142
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 93  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 140 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 196
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALR 322
           AT  +     IG G++G+VYK         V +K   + +       ++   +A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR-NLNL 381
           +  H N+V++   C+           LV+E + +  L  +L         DKAP   L  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---------DKAPPPGLPA 111
Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
               ++       LD+LH +C     H DLKP NIL+       + DFGLAR       Q
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQ 165
Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP
Sbjct: 166 MALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR---SFIAECRALRSIRHRNLVK 331
            + +G G+FG V  G        V VK+ N    R+         E + L+  RH +++K
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++   S       DF  +V E++  G L +++    R +E++       L Q+      +
Sbjct: 76  LYQVIS----TPTDF-FMVMEYVSGGELFDYICKHGRVEEMEAR----RLFQQ------I 120
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
            SA+DY H   + +  H DLKP N+LLD  M + + DFGL+  +       +S    GS 
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSP 174
Query: 452 GYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
            Y APE   G        D++S G+++  L+    P D
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 94  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 140
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 141 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 197
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 95  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 141
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 198
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 111/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 92  PFFVKLY-----FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET---------CTRFY 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE       S + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 194 FVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 254 PEKFFPK-ARDLVEKLLVLDA 273

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 96  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 142
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + V
Sbjct: 91  LLGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQV 137
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKG 449
           A  + YL         H DL   N +LDE+    V DFGLAR  +    +   +  G K 
Sbjct: 138 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 82  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 137 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK--GGKGLL 191
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK--GGKGLL 194
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR---SFIAECRALRSIRHRNLVK 331
            + +G G+FG V  G        V VK+ N    R+         E + L+  RH +++K
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++   S       DF  +V E++  G L +++    R +E++       L Q+      +
Sbjct: 76  LYQVIS----TPTDF-FMVMEYVSGGELFDYICKHGRVEEMEAR----RLFQQ------I 120
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
            SA+DY H   + +  H DLKP N+LLD  M + + DFGL+  +        S    GS 
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSP 174
Query: 452 GYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
            Y APE   G        D++S G+++  L+    P D
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK--GGKGLL 194
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L           E         +  + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----------EEAEDEIEDIQQEIT 77
Query: 332 VFTACSG---VDYQGNDFK----ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L            P  L+  Q 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQI 126
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E     + DFG+A  L  T ++ ++
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 183
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               G+  ++APE    S   +  D++S GI  +EL   + P
Sbjct: 184 F--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L           E         +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----------EEAEDEIEDIQQEIT 57
Query: 332 VFTACSG---VDYQGNDFK----ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L            P  L+  Q 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQI 106
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E     + DFG+A  L  T ++ ++
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 163
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G+  ++APE    S   +  D++S GI  +EL
Sbjct: 164 FV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 197

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 156 LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 202
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 203 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 111 PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 155
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 156 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 212
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 213 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 98  LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 144
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 201
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEVDKAPRN 378
           +     ++V++     GV  QG     ++ E M  G L+ +L    P    + V   P  
Sbjct: 83  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP-- 135
Query: 379 LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438
            +L + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T
Sbjct: 136 -SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 439 HVQTSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
                  G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 192 DYYRK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRAL 321
           A +  + +  +G GSFG VY+GV      DE  T V +K  N       R  F+ E   +
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEVDKAPRN 378
           +     ++V++     GV  QG     ++ E M  G L+ +L    P    + V   P  
Sbjct: 73  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP-- 125
Query: 379 LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438
            +L + + +A ++A  + YL+ +      H DL   N ++ E+    +GDFG+ R +  T
Sbjct: 126 -SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181
Query: 439 HVQTSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
                  G KG   + +++PE       +T  DV+S+G+++ E+
Sbjct: 182 DYYRK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 102 LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 148
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 149 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 206 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 97  LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 143
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 41/252 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHR 327
           D +     +G G++G VYK +      TV +K   L H       + I E   L+ ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N++++ +         N    L++E+ +N  L++++         DK P ++++    + 
Sbjct: 94  NIIELKSVI-----HHNHRLHLIFEYAEN-DLKKYM---------DKNP-DVSMRVIKSF 137
Query: 388 AIDVASALDYLH-HDCQPITTHCDLKPSNILL-----DEEMVSHVGDFGLAR-FLPPTHV 440
              + + +++ H   C     H DLKP N+LL      E  V  +GDFGLAR F  P   
Sbjct: 138 LYQLINGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 441 QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
            T  I    ++ Y  PE  LGS   ST+ D++S   +  E+++ K P   +F GD  +  
Sbjct: 194 FTHEI---ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTP---LFPGDSEIDQ 246
Query: 500 ----FARMALPD 507
               F  + LPD
Sbjct: 247 LFKIFEVLGLPD 258

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 95  LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 141
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 142 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 198
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 98  LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 144
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLP 201
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +IG G FG VY G L   D  +    VK  N        S F+ E   ++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  +G+    L Y  M++G L  ++    R +  +   ++L     +   + VA
Sbjct: 97  LGIC--LRSEGSPLVVLPY--MKHGDLRNFI----RNETHNPTVKDL-----IGFGLQVA 143
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGS 450
             + +L         H DL   N +LDE+    V DFGLAR +      +  +  G K  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++A E     + +T  DV+S+G+L+ EL+ R  P
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 84  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 139 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 193
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 90  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 135
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANA 191
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 252 PEKFFPK-ARDLVEKLLVLDA 271

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLV 330
           +     +GTG FG V + +  +    V +K         +R  +  E + ++ + H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 331 KVFTACSGVDYQG-NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
                  G+     ND   L  E+ + G L ++L        + + P          +  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-------TLLS 129
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIG 446
           D++SAL YLH +      H DLKP NI+L    + ++  + D G A+ L    + T  +G
Sbjct: 130 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 186
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              ++ Y+APE     + +   D +S+G L  E I   +P
Sbjct: 187 ---TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L           E         +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----------EEAEDEIEDIQQEIT 57
Query: 332 VFTACSG---VDYQGNDFK----ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L            P  L+  Q 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQI 106
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E     + DFG+A  L  T ++ + 
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX 163
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G+  ++APE    S   +  D++S GI  +EL
Sbjct: 164 FV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 197

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 70  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 115
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 116 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 171
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 172 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 231
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 232 PEKFFPK-ARDLVEKLLVLDA 251

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 68  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 113
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 114 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 169
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 229
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 230 PEKFFPK-ARDLVEKLLVLDA 249

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 194
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L           E         +  + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----------EEAEDEIEDIQQEIT 72
Query: 332 VFTACSG---VDYQGNDFK----ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L            P  L+  Q 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQI 121
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E     + DFG+A  L  T ++ + 
Sbjct: 122 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX 178
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G+  ++APE    S   +  D++S GI  +EL
Sbjct: 179 FV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 67  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 112
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 113 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 168
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 169 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 228
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 229 PEKFFPK-ARDLVEKLLVLDA 248

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLV 330
           +     +GTG FG V + +  +    V +K         +R  +  E + ++ + H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 331 KVFTACSGVDYQG-NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
                  G+     ND   L  E+ + G L ++L        + + P          +  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-------TLLS 128
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIG 446
           D++SAL YLH +      H DLKP NI+L    + ++  + D G A+ L    + T  +G
Sbjct: 129 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              ++ Y+APE     + +   D +S+G L  E I   +P
Sbjct: 186 ---TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H DL   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK--GGKGLL 194
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 93  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 138
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 139 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 194
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 195 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 254
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 255 PEKFFPK-ARDLVEKLLVLDA 274

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 69  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 114
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 115 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 170
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 171 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 230
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 231 PEKFFPK-ARDLVEKLLVLDA 250

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G+FG V+ G L    T V VK             F+ E R L+   H N+V++   C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           +    Q      +V E +Q G    +L         + A   L +   L +  D A+ ++
Sbjct: 182 T----QKQPI-YIVMELVQGGDFLTFL-------RTEGA--RLRVKTLLQMVGDAAAGME 227
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-SIGYIA 455
           YL   C     H DL   N L+ E+ V  + DFG++R      V  +S G++   + + A
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTA 283
Query: 456 PEYGLGSEVSTNGDVYSYGILMLE 479
           PE       S+  DV+S+GIL+ E
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWE 307

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 124
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 92  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 254 PEKFFPK-ARDLVEKLLVLDA 273

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 92  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 254 PEKFFPK-ARDLVEKLLVLDA 273

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 89  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 134
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 135 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 190
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 191 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 250
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 251 PEKFFPK-ARDLVEKLLVLDA 270

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 123
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    ++  +    F+ E   +    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 163
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 215
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 81  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 125
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 126 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF---IAECRALRSIRHRN 328
           FS    IG GSFG+VY          V +K  +    +++  +   I E R L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            ++ +  C    Y       LV E+   GS  + L       EV K P     LQ + IA
Sbjct: 116 TIQ-YRGC----YLREHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQEVEIA 157
Query: 389 IDVASALD---YLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
                AL    YLH H+      H D+K  NILL E  +  +GDFG A  + P +     
Sbjct: 158 AVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---- 209
Query: 445 IGVKGSIGYIAPEYGLG-SEVSTNG--DVYSYGILMLELIIRKKP 486
               G+  ++APE  L   E   +G  DV+S GI  +EL  RK P
Sbjct: 210 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 90  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 135
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 252 PEKFFPK-ARDLVEKLLVLDA 271

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 78  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 122
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 123 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G+FG V+ G L    T V VK             F+ E R L+   H N+V++   C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           +    Q      +V E +Q G    +L         + A   +  L  L +  D A+ ++
Sbjct: 182 T----QKQPI-YIVMELVQGGDFLTFL-------RTEGARLRVKTL--LQMVGDAAAGME 227
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-SIGYIA 455
           YL   C     H DL   N L+ E+ V  + DFG++R      V  +S G++   + + A
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTA 283
Query: 456 PEYGLGSEVSTNGDVYSYGILMLE 479
           PE       S+  DV+S+GIL+ E
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWE 307

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V    Y    D     V VK          RS +  E   LR++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDV 391
              C     QG     LV E++  GSL ++L            PR+ + L Q L  A  +
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL------------PRHSIGLAQLLLFAQQI 126
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS- 450
              + YLH        H +L   N+LLD + +  +GDFGLA+ +P  H +   +   G  
Sbjct: 127 CEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDS 182
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE     +     DV+S+G+ + EL+
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 78  PHVCRLLGICLTSTVQ------LIMQLMPFGXLL---------DYVREHKDNIGSQYLLN 122
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 123 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 90  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 135
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 252 PEKFFPK-ARDLVEKLLVLDA 271

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 92  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 254 PEKFFPK-ARDLVEKLLVLDA 273

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+    IG GSFG V+KG+ +  +  V +K+ +L           E         +  + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-----------EEAEDEIEDIQQEIT 73
Query: 332 VFTACSG---VDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K     ++ E++  GS  + L    R    D+        Q 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL----RAGPFDE-------FQI 122
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             +  ++   LDYLH + +    H D+K +N+LL E+    + DFG+A  L  T ++ ++
Sbjct: 123 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 179
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
               G+  ++APE    S   +  D++S GI  +EL   + P+  M
Sbjct: 180 F--VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 128
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 93  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 138
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 139 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 194
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 195 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 254
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 255 PEKFFPK-ARDLVEKLLVLDA 274

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V    Y    D     V VK          RS +  E   LR++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDV 391
              C     QG     LV E++  GSL ++L            PR+ + L Q L  A  +
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL------------PRHSIGLAQLLLFAQQI 126
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS- 450
              + YLH        H +L   N+LLD + +  +GDFGLA+ +P  H +   +   G  
Sbjct: 127 CEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDS 182
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE     +     DV+S+G+ + EL+
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 89  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 134
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 135 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 190
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 191 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 250
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 251 PEKFFPK-ARDLVEKLLVLDA 270

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 124
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 124
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 123
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 124
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 95  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 140
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 141 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 196
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 197 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 256
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 257 PAAFFPK-ARDLVEKLLVLDA 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 74  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 119
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 120 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 175
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 176 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 235
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 236 PEKFFPK-ARDLVEKLLVLDA 255

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 74  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 118
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 119 WCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 87  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 131
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 132 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 188
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGXLL---------DYVREHKDNIGSQYLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V    Y    D     V VK          RS +  E   LR++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDV 391
              C      G     LV E++  GSL ++L            PR+ + L Q L  A  +
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYL------------PRHSIGLAQLLLFAQQI 143
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS- 450
              + YLH        H DL   N+LLD + +  +GDFGLA+ +P  H +   +   G  
Sbjct: 144 CEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EXYRVREDGDS 199
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE     +     DV+S+G+ + EL+
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 102 PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 146
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 147 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 13/218 (5%)
Query: 272 FSSANLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRH 326
           F+   ++G G FGSV +  L   D     V VK+       +S    F+ E   ++   H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 327 RNLVKVFTACSGVDYQGN-DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
            ++ K+         +G      ++  FM++G L  +L        + + P NL L   +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA----SRIGENPFNLPLQTLV 140
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
              +D+A  ++YL         H DL   N +L E+M   V DFGL+R +          
Sbjct: 141 RFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
             K  + ++A E    +  + + DV+++G+ M E++ R
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 83  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 127
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 128 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 97  PFFVKLYFC-----FQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 142
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 143 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 258
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 259 PEKFFPK-ARDLVEKLLVLDA 278

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF---IAECRALRSIRHRN 328
           FS    IG GSFG+VY          V +K  +    +++  +   I E R L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            ++ +  C    Y       LV E+   GS  + L       EV K P     LQ + IA
Sbjct: 77  TIQ-YRGC----YLREHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQEVEIA 118
Query: 389 IDVASALD---YLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
                AL    YLH H+      H D+K  NILL E  +  +GDFG A  + P +     
Sbjct: 119 AVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---- 170
Query: 445 IGVKGSIGYIAPEYGLG-SEVSTNG--DVYSYGILMLELIIRKKP 486
               G+  ++APE  L   E   +G  DV+S GI  +EL  RK P
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +       ++   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 109/261 (41%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 92  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F   + L ++F
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF 253
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 254 PEKFFPK-ARDLVEKLLVLDA 273

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIITLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 71  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 115
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 116 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 109/261 (41%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +V             +K+    H        ++   R + S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 92  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 137
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F   + L ++F
Sbjct: 194 FVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF 253
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 254 PEKFFPK-ARDLVEKLLVLDA 273

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 24/235 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEGRTTV--TVKVFNLHHHRASRSFIAECRALRSIRHRN 328
           F     IG G F  VY+   L +G       V++F+L   +A    I E   L+ + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++K + +      + N+   +V E    G L   +          K  R +         
Sbjct: 94  VIKYYASF----IEDNELN-IVLELADAGDLSRMI------KHFKKQKRLIPERTVWKYF 142
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
           + + SAL+++H        H D+KP+N+ +    V  +GD GL RF   +   T++  + 
Sbjct: 143 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 197
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-MNLHNFAR 502
           G+  Y++PE    +  +   D++S G L+ E+   + P    F GD MNL++  +
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 248

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIIHLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 141 KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 196 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 246
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 163
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 215
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 148
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 200
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 149
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 201
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE--DEVDKAPRNLNLLQRLNIA 388
            +  AC+     G     +V EF + G+L  +L     E     D     L L   +  +
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIG 446
             VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+     
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD-- 205
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNFAR 502
            +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L    R
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTR 265
Query: 503 MALPDHVMDIVDSTLLN 519
           M  PD+    +  T+L+
Sbjct: 266 MRAPDYTTPEMYQTMLD 282

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 84  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 138
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 139 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 189
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 190 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 87  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 141
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 142 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 192
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 193 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 140
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 141 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 192
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 110/258 (42%), Gaps = 23/258 (8%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL-----NLLQRL 385
            +  AC+     G     +V EF + G+L  +L     E    K P +L      L   +
Sbjct: 96  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             +  VA  +++L         H DL   NILL E+ V  + DFGLAR +          
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNFA 501
             +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L    
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 502 RMALPDHVMDIVDSTLLN 519
           RM  PD+    +  T+L+
Sbjct: 269 RMRAPDYTTPEMYQTMLD 286

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 82  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 137 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIAD 187
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 188 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 163
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 215
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 109/261 (41%), Gaps = 28/261 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRS-IRH 326
           + F    ++G GSF +              +K+    H        ++   R + S + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++       +Q ++       + +NG L +++  +   DE            R  
Sbjct: 90  PFFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTRFY 135
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL+YLH        H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-----IRKKPSDIMFEGDMNL-HNF 500
             G+  Y++PE         + D+++ G ++ +L+      R     ++F+  + L ++F
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 501 ARMALPDHVMDIVDSTLLNDV 521
                P    D+V+  L+ D 
Sbjct: 252 PEKFFPK-ARDLVEKLLVLDA 271

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 115 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 165
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 166 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 217
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 148
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 200
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H +L   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 140 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 194
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 278 IGTGSFGSVYKG-----VLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVK 331
           +G GSFG VY+G     +  E  T V VK  N       R  F+ E   ++     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     GV  +G     +V E M +G L+ +L  +  E E +       L + + +A ++
Sbjct: 86  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG-- 449
           A  + YL+        H +L   N ++  +    +GDFG+ R +  T       G KG  
Sbjct: 141 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 195
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
            + ++APE       +T+ D++S+G+++ E+
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 36/225 (16%)
Query: 281 GSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD 340
           G FG V+K  L      V VK+F L   ++ +S   E  +   ++H NL++   A    +
Sbjct: 26  GRFGCVWKAQL--MNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAA----E 78
Query: 341 YQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL-NIAIDVASALD 396
            +G++ +    L+  F   GSL ++L              N+     L ++A  ++  L 
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYL------------KGNIITWNELCHVAETMSRGLS 126
Query: 397 YLHHDC--------QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
           YLH D         +P   H D K  N+LL  ++ + + DFGLA    P      + G  
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV 186
Query: 449 GSIGYIAPEYGLGS-----EVSTNGDVYSYGILMLELIIRKKPSD 488
           G+  Y+APE   G+     +     D+Y+ G+++ EL+ R K +D
Sbjct: 187 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L            ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V E+   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 29/199 (14%)
Query: 286 VYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345
           + K   D+GR +   K     H         E   L+S+ H N++K+F       ++   
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHE----EIYNEISLLKSLDHPNIIKLFDV-----FEDKK 119
Query: 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPI 405
           +  LV EF + G L E +   ++ DE D A          NI   + S + YLH   +  
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHKFDECDAA----------NIMKQILSGICYLH---KHN 166
Query: 406 TTHCDLKPSNILLDEE---MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS 462
             H D+KP NILL+ +   +   + DFGL+ F    +     +   G+  YIAPE  L  
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEV-LKK 222
Query: 463 EVSTNGDVYSYGILMLELI 481
           + +   DV+S G++M  L+
Sbjct: 223 KYNEKCDVWSCGVIMYILL 241

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F+  + IG GSFG VYKG+ +  +  V +K+ +L           E         +  + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDL-----------EEAEDEIEDIQQEIT 69
Query: 332 VFTACSG---VDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           V + C       Y G+  K+    ++ E++  GS  + L P   E+              
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETY-----------I 118
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
             I  ++   LDYLH + +    H D+K +N+LL E+    + DFG+A  L  T ++ + 
Sbjct: 119 ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX 175
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
               G+  ++APE    S      D++S GI  +EL
Sbjct: 176 FV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 149
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 201
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 312 RSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNR 368
           + F  E      + H+N+V +      VD + +D   LV E+++  +L E++    P++ 
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMI----DVD-EEDDCYYLVMEYIEGPTLSEYIESHGPLS- 109
Query: 369 EDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
              VD A   +N   ++         LD + H       H D+KP NIL+D      + D
Sbjct: 110 ---VDTA---INFTNQI---------LDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFD 154
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           FG+A+ L  T + T +  V G++ Y +PE   G       D+YS GI++ E+++ + P
Sbjct: 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRN 328
           +     +G GSFG V           V +K+ N   L           E   LR +RH +
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++K++        +  D   +V E+  N   E + Y V R+   ++  R     Q+    
Sbjct: 76  IIKLYDVI-----KSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEARRF--FQQ---- 121
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             + SA++Y H   +    H DLKP N+LLDE +   + DFGL+  +   +   +S    
Sbjct: 122 --IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--- 173
Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
           GS  Y APE   G        DV+S G+++  ++ R+ P D
Sbjct: 174 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 105 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 155
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 156 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 207
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHR-NLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     +V EF + G+L  +L     E    K AP +L      L   
Sbjct: 132 NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQT 442
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+ 
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLH 498
                +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L 
Sbjct: 245 GD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302
Query: 499 NFARMALPDHVMDIVDSTLLN 519
              RM  PD+    +  T+L+
Sbjct: 303 EGTRMRAPDYTTPEMYQTMLD 323

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRN 328
           +     +G GSFG V           V +K+ N   L           E   LR +RH +
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++K++        +  D   +V E+  N   E + Y V R+   ++  R     Q+    
Sbjct: 75  IIKLYDVI-----KSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEARRF--FQQ---- 120
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             + SA++Y H   +    H DLKP N+LLDE +   + DFGL+  +   +   +S    
Sbjct: 121 --IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--- 172
Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
           GS  Y APE   G        DV+S G+++  ++ R+ P D
Sbjct: 173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRN 328
           +     +G GSFG V           V +K+ N   L           E   LR +RH +
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++K++        +  D   +V E+  N   E + Y V R+   ++  R     Q+    
Sbjct: 70  IIKLYDVI-----KSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEARRF--FQQ---- 115
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             + SA++Y H   +    H DLKP N+LLDE +   + DFGL+  +   +   +S    
Sbjct: 116 --IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--- 167
Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
           GS  Y APE   G        DV+S G+++  ++ R+ P D
Sbjct: 168 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 27/243 (11%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSF-----IAECRAL 321
           A   +     IG G++G V+K   L  G   V +K   +              +A  R L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
            +  H N+V++F  C+           LV+E + +  L  +L         DK P     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---------DKVPEPGVP 118
Query: 382 LQRL-NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
            + + ++   +   LD+LH        H DLKP NIL+       + DFGLAR       
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SF 172
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           Q +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP   +F G  ++   
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKP---LFRGSSDVDQL 228
Query: 501 ARM 503
            ++
Sbjct: 229 GKI 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRN 328
           +     +G GSFG V           V +K+ N   L           E   LR +RH +
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++K++        +  D   +V E+  N   E + Y V R+   ++  R     Q+    
Sbjct: 66  IIKLYDVI-----KSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEARRF--FQQ---- 111
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             + SA++Y H   +    H DLKP N+LLDE +   + DFGL+  +   +   +S    
Sbjct: 112 --IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--- 163
Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
           GS  Y APE   G        DV+S G+++  ++ R+ P D
Sbjct: 164 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHR-NLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED-EVDKAPRNL-----NLLQR 384
            +  AC+     G     +V EF + G+L  +L     E     +AP +L      L   
Sbjct: 97  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQT 442
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+ 
Sbjct: 153 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLH 498
                +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L 
Sbjct: 210 GD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 267
Query: 499 NFARMALPDHVMDIVDSTLLN 519
              RM  PD+    +  T+L+
Sbjct: 268 EGTRMRAPDYTTPEMYQTMLD 288

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 123
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFG A+ L     +  + G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 125 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 175
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 176 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYR 227
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 123
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFG A+ L     +  + G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 27/243 (11%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSF-----IAECRAL 321
           A   +     IG G++G V+K   L  G   V +K   +              +A  R L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
            +  H N+V++F  C+           LV+E + +  L  +L         DK P     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---------DKVPEPGVP 118
Query: 382 LQRL-NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
            + + ++   +   LD+LH        H DLKP NIL+       + DFGLAR       
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SF 172
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           Q +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP   +F G  ++   
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKP---LFRGSSDVDQL 228
Query: 501 ARM 503
            ++
Sbjct: 229 GKI 231

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 81  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 125
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFG A+ L     +  + G
Sbjct: 126 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 27/243 (11%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSF-----IAECRAL 321
           A   +     IG G++G V+K   L  G   V +K   +              +A  R L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
            +  H N+V++F  C+           LV+E + +  L  +L         DK P     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---------DKVPEPGVP 118
Query: 382 LQRL-NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
            + + ++   +   LD+LH        H DLKP NIL+       + DFGLAR       
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SF 172
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           Q +   V  ++ Y APE  L S  +T  D++S G +  E+  R+KP   +F G  ++   
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKP---LFRGSSDVDQL 228
Query: 501 ARM 503
            ++
Sbjct: 229 GKI 231

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 111/258 (43%), Gaps = 24/258 (9%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHR-NLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL-----NLLQRL 385
            +  AC+     G     +V EF + G+L  +L    R + V   P +L      L   +
Sbjct: 97  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLR-SKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             +  VA  +++L         H DL   NILL E+ V  + DFGLAR +          
Sbjct: 152 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNFA 501
             +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L    
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 502 RMALPDHVMDIVDSTLLN 519
           RM  PD+    +  T+L+
Sbjct: 269 RMRAPDYTTPEMYQTMLD 286

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V    Y    D     V VK          RS +  E   LR++ H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDV 391
              C     QG     LV E++  GSL ++L            PR+ + L Q L  A  +
Sbjct: 76  KGCCED---QGEKSVQLVMEYVPLGSLRDYL------------PRHCVGLAQLLLFAQQI 120
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS- 450
              + YLH        H  L   N+LLD + +  +GDFGLA+ +P  H +   +   G  
Sbjct: 121 CEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDS 176
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE     +     DV+S+G+ + EL+
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 38/240 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-------RSFIAECRALRSIRHRNLV 330
           IG G FG V+KG L + ++ V +K   L             + F  E   + ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K++          ++   +V EF+  G L   L        +DKA   +    +L + +D
Sbjct: 87  KLYGLM-------HNPPRMVMEFVPCGDLYHRL--------LDKA-HPIKWSVKLRLMLD 130
Query: 391 VASALDYLHHDCQPITTHCDLKPSNIL---LDEE--MVSHVGDFGLARFLPPTHVQTSSI 445
           +A  ++Y+ +   PI  H DL+  NI    LDE   + + V DFGL++      V + S 
Sbjct: 131 IALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVS- 184
Query: 446 GVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           G+ G+  ++APE  +G+E    +   D YS+ +++  ++  + P D    G +   N  R
Sbjct: 185 GLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++ +G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LIMQLMPFGCLL---------DYVREHKDNIGSQYLLN 128
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 128
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFG A+ L     +  + G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 185
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     +V EF + G+L  +L     E    K AP +L      L   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQT 442
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+ 
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLH 498
                +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L 
Sbjct: 208 GD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 499 NFARMALPDHVMDIVDSTLLN 519
              RM  PD+    +  T+L+
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLD 286

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V    Y    D     V VK          RS +  E   LR++ H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDV 391
              C     QG     LV E++  GSL ++L            PR+ + L Q L  A  +
Sbjct: 77  KGCCED---QGEKSVQLVMEYVPLGSLRDYL------------PRHCVGLAQLLLFAQQI 121
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS- 450
              + YLH        H  L   N+LLD + +  +GDFGLA+ +P  H +   +   G  
Sbjct: 122 CEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDS 177
Query: 451 -IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + + APE     +     DV+S+G+ + EL+
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRN 328
           + +     +G G++G VYK    +GR     ++  +        + I E   L+ + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +                LV+EFM+   L++ L      DE      N   LQ   I 
Sbjct: 81  IVSLIDVI-----HSERCLTLVFEFMEK-DLKKVL------DE------NKTGLQDSQIK 122
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
           I +   L  + H  Q    H DLKP N+L++ +    + DFGLAR F  P    T  +  
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-- 180
Query: 448 KGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
             ++ Y AP+  +GS + ST+ D++S G +  E+I  K
Sbjct: 181 -VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFG A+ L     +  + G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++ +G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 128
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++G+G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 123
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFG A+ L     +  + G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRN 328
           + +     +G G++G VYK    +GR     ++  +        + I E   L+ + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +                LV+EFM+   L++ L      DE      N   LQ   I 
Sbjct: 81  IVSLIDVI-----HSERCLTLVFEFMEK-DLKKVL------DE------NKTGLQDSQIK 122
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
           I +   L  + H  Q    H DLKP N+L++ +    + DFGLAR F  P    T  +  
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-- 180
Query: 448 KGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
             ++ Y AP+  +GS + ST+ D++S G +  E+I  K
Sbjct: 181 -VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 272 FSSANLIGTGSFGSVYKGV-LDEG-RTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           F    ++ +G+FG+VYKG+ + EG +  + V +  L      +A++  + E   + S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++ ++   C     Q      L+ + M  G L          D V +   N+     LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 121
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             + +A  ++YL         H DL   N+L+       + DFGLA+ L     +  + G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
            K  I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR---SFIAECRALRSIRHRNLVKV 332
           + +G G+FG V  G  +     V VK+ N    R+         E + L+  RH +++K+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +   S      + F  +V E++  G L +++    R DE +    +  L Q+      + 
Sbjct: 82  YQVIST---PSDIF--MVMEYVSGGELFDYICKNGRLDEKE----SRRLFQQ------IL 126
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           S +DY H   + +  H DLKP N+LLD  M + + DFGL+  +        S    GS  
Sbjct: 127 SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPN 180
Query: 453 YIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSD 488
           Y APE   G        D++S G+++  L+    P D
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE--DEVDKAPRNLNLLQRLNIA 388
            +  AC+     G     +V EF + G+L  +L     E     D     L L   +  +
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIG 446
             VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+     
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD-- 205
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNFAR 502
            +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L    R
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 265
Query: 503 MALPDHVMDIVDSTLLN 519
           M  PD+    +  T+L+
Sbjct: 266 MRAPDYTTPEMYQTMLD 282

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 139 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 189
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR +            
Sbjct: 190 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
              + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V  +   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-AYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 278 IGTGSFGSVYK----GVLD-EGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           IG G+FG V++    G+L  E  T V VK+         ++ F  E   +    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN--------------REDEVDKAPR 377
           +   C+     G     L++E+M  G L E+L  ++              R       P 
Sbjct: 115 LLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
            L+  ++L IA  VA+ + YL    +    H DL   N L+ E MV  + DFGL+R +  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                +       I ++ PE    +  +T  DV++YG+++ E+ 
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LV   M  G +   +Y V+ ++   + PR +    +      + S L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ------IVSGLEHLH---QRNIIY 312
Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468
            DLKP N+LLD++    + D GLA  L     QT + G  G+ G++APE  LG E   + 
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 469 DVYSYGILMLELIIRKKP 486
           D ++ G+ + E+I  + P
Sbjct: 371 DYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LV   M  G +   +Y V+ ++   + PR +    +      + S L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ------IVSGLEHLH---QRNIIY 312
Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468
            DLKP N+LLD++    + D GLA  L     QT + G  G+ G++APE  LG E   + 
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 469 DVYSYGILMLELIIRKKP 486
           D ++ G+ + E+I  + P
Sbjct: 371 DYFALGVTLYEMIAARGP 388

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 116 ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 166
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+AR +            
Sbjct: 167 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
              + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 224 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LV   M  G +   +Y V+ ++   + PR +    +      + S L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ------IVSGLEHLH---QRNIIY 312
Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468
            DLKP N+LLD++    + D GLA  L     QT + G  G+ G++APE  LG E   + 
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 469 DVYSYGILMLELIIRKKP 486
           D ++ G+ + E+I  + P
Sbjct: 371 DYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408
           LV   M  G +   +Y V+ ++   + PR +    +      + S L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ------IVSGLEHLH---QRNIIY 312
Query: 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468
            DLKP N+LLD++    + D GLA  L     QT + G  G+ G++APE  LG E   + 
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 469 DVYSYGILMLELIIRKKP 486
           D ++ G+ + E+I  + P
Sbjct: 371 DYFALGVTLYEMIAARGP 388

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 28/209 (13%)
Query: 284 GSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343
           G ++KG        V V        R SR F  EC  LR   H N++ V  AC       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PP 80
Query: 344 NDFKALVYEFMQNGSLEEWLYPVNREDE---VDKAPRNLNLLQRLNIAIDVASALDYLHH 400
                L+  +M  GS    LY V  E     VD++       Q +  A+D+A  + +L H
Sbjct: 81  APHPTLITHWMPYGS----LYNVLHEGTNFVVDQS-------QAVKFALDMARGMAFL-H 128
Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL 460
             +P+     L   ++++DE+M + +        +        S G   +  ++APE   
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQ 181
Query: 461 GSEVSTN---GDVYSYGILMLELIIRKKP 486
                TN    D++S+ +L+ EL+ R+ P
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK    +   +    F+ E   +    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA-PRNLNLLQRLNIAID 390
               C GV  Q    + ++ E M  G L+ +L    RE     + P +L +L  L++A D
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARD 149
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           +A    YL  +      H D+   N LL       V+ +GDFG+A+      +  +S   
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ-----DIYRASYYR 201
Query: 448 KG-----SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           KG      + ++ PE  +    ++  D +S+G+L+ E+ 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRH 326
           D F     IG GSFG V     ++ +    +K  N          R+   E + ++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYP-VNREDEVDKAPRNLNLLQRL 385
             LV ++ +     +Q  +   +V + +  G L   L   V+ ++E  K           
Sbjct: 75  PFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL---------- 119
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               ++  ALDYL +  Q I  H D+KP NILLDE    H+ DF +A  LP    +T   
Sbjct: 120 -FICELVMALDYLQN--QRII-HRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQIT 172
Query: 446 GVKGSIGYIAPEY---GLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489
            + G+  Y+APE      G+  S   D +S G+   EL+  ++P  I
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHR-NLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     ++ EF + G+L  +L     E    K AP +L      L   
Sbjct: 86  NLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQT 442
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+ 
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLH 498
                +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L 
Sbjct: 199 GD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 499 NFARMALPDHVMDIVDSTLLN 519
              RM  PD+    +  T+L+
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLD 277

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     ++ EF + G+L  +L     E    K AP +L      L   
Sbjct: 86  NLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQT 442
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P +V+ 
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLH 498
                +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L 
Sbjct: 199 GD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 499 NFARMALPDHVMDIVDSTLLN 519
              RM  PD+    +  T+L+
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLD 277

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 270 DGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSF---IAECRAL 321
           D  +    +G G+FG V          D+ +  VTV V  L      +     ++E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 322 RSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----------YPVNRE 369
           + I +H+N++ +  AC+    Q      +V  +   G+L E+L           Y +NR 
Sbjct: 95  KMIGKHKNIINLLGACT----QDGPLYVIV-GYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
            E     ++L     ++    +A  ++YL    C     H DL   N+L+ E  V  + D
Sbjct: 150 PEEQMTFKDL-----VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 200
Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           FGLAR +        +   +  + ++APE       +   DV+S+G+LM E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 274 SANLIGTGSFGSVYKG-VLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNL 329
           S  +IG G FG VY G  +D+ +  +   + +L      +   +F+ E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAP-RNLNLLQRLNIA 388
           +    A  G+         ++  +M +G L +++          ++P RN  +   ++  
Sbjct: 85  L----ALIGIMLPPEGLPHVLLPYMCHGDLLQFI----------RSPQRNPTVKDLISFG 130
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR------FLPPTHVQT 442
           + VA  ++YL    +    H DL   N +LDE     V DFGLAR      +      + 
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + + VK    + A E       +T  DV+S+G+L+ EL+ R  P
Sbjct: 188 ARLPVK----WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 278 IGTGSFGSVYK-GVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           IGTGS+G   K     +G+  V  ++ +        +  ++E   LR ++H N+V+ +  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              +D + N    +V E+ + G L   +    +E +       L ++ +L +A+      
Sbjct: 74  I--ID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC--- 127
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            +   D      H DLKP+N+ LD +    +GDFGLAR L   H  + +    G+  Y++
Sbjct: 128 -HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMS 184
Query: 456 PEYGLGSEVSTNGDVYSYGILMLEL 480
           PE       +   D++S G L+ EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 28/261 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     +V EF + G+L  +L     E    K AP +L      L   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQT 442
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR  +  P  V+ 
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLH 498
                +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L 
Sbjct: 208 GD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 499 NFARMALPDHVMDIVDSTLLN 519
              RM  PD+    +  T+L+
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLD 286

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 43/239 (17%)
Query: 268 ATDGFSSANLIGTGSFGSVYKG--VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR 325
           A+D F    ++G G+FG V K    LD  R     K+   H      + ++E   L S+ 
Sbjct: 5   ASD-FEEIAVLGQGAFGQVVKARNALD-SRYYAIKKI--RHTEEKLSTILSEVMLLASLN 60
Query: 326 HRNLVKVFTAC----------SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
           H+ +V+ + A           + V  +   F  +  E+ +NG+L + ++  N   + D+ 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM--EYCENGTLYDLIHSENLNQQRDEY 118
Query: 376 PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-- 433
            R         +   +  AL Y+H   Q I  H DLKP NI +DE     +GDFGLA+  
Sbjct: 119 WR---------LFRQILEALSYIH--SQGII-HRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 434 -------FLPPTHVQTSSIGVKGSIG---YIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
                   L   ++  SS  +  +IG   Y+A E   G+   +   D+YS GI+  E+I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSF-IAECRALRSIR 325
           + + + +  L+G GS+G V K    D GR     K       +  +   + E + L+ +R
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H NLV +   C     +      LV+EF+ +  L          D+++  P  L+     
Sbjct: 83  HENLVNLLEVC-----KKKKRWYLVFEFVDHTIL----------DDLELFPNGLDYQVVQ 127
Query: 386 NIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL-PPTHVQTS 443
                + + + + H H+      H D+KP NIL+ +  V  + DFG AR L  P  V   
Sbjct: 128 KYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 444 SIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
            +  +    Y APE  +G  +     DV++ G L+ E+ +     + +F GD ++     
Sbjct: 184 EVATR---WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM----GEPLFPGDSDIDQLYH 236
Query: 503 MAL 505
           + +
Sbjct: 237 IMM 239

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 111/259 (42%), Gaps = 24/259 (9%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     +V EF + G+L  +L     E    K AP +L      L   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR +         
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNF 500
              +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L   
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 501 ARMALPDHVMDIVDSTLLN 519
            RM  PD+    +  T+L+
Sbjct: 268 TRMRAPDYTTPEMYQTMLD 286

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 111/259 (42%), Gaps = 24/259 (9%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     +V EF + G+L  +L     E    K AP +L      L   
Sbjct: 86  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR +         
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNF 500
              +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 501 ARMALPDHVMDIVDSTLLN 519
            RM  PD+    +  T+L+
Sbjct: 259 TRMRAPDYTTPEMYQTMLD 277

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 38/240 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-------RSFIAECRALRSIRHRNLV 330
           IG G FG V+KG L + ++ V +K   L             + F  E   + ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K++          ++   +V EF+  G L   L        +DKA   +    +L + +D
Sbjct: 87  KLYGLM-------HNPPRMVMEFVPCGDLYHRL--------LDKA-HPIKWSVKLRLMLD 130
Query: 391 VASALDYLHHDCQPITTHCDLKPSNIL---LDEE--MVSHVGDFGLARFLPPTHVQTSSI 445
           +A  ++Y+ +   PI  H DL+  NI    LDE   + + V DFG ++      V + S 
Sbjct: 131 IALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVS- 184
Query: 446 GVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           G+ G+  ++APE  +G+E    +   D YS+ +++  ++  + P D    G +   N  R
Sbjct: 185 GLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +        ++    V VK+  +  H     + ++E + +  + +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +  AC+     G     ++ E+   G L  +L      D   +  R L L   L+ +  
Sbjct: 106 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 391 VASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           VA  + +L   +C     H D+   N+LL    V+ +GDFGLAR +    +  S+  VKG
Sbjct: 161 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSNYIVKG 212
Query: 450 S----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 213 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 278 IGTGSFGSVYK-GVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           IGTGS+G   K     +G+  V  ++ +        +  ++E   LR ++H N+V+ +  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              +D + N    +V E+ + G L   +    +E +       L ++ +L +A+      
Sbjct: 74  I--ID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC--- 127
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            +   D      H DLKP+N+ LD +    +GDFGLAR L   H +  +    G+  Y++
Sbjct: 128 -HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGTPYYMS 184
Query: 456 PEYGLGSEVSTNGDVYSYGILMLEL 480
           PE       +   D++S G L+ EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 278 IGTGSFGSVYK-GVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           IGTGS+G   K     +G+  V  ++ +        +  ++E   LR ++H N+V+ +  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              +D + N    +V E+ + G L   +    +E +       L ++ +L +A+      
Sbjct: 74  I--ID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC--- 127
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            +   D      H DLKP+N+ LD +    +GDFGLAR L   H  + +    G+  Y++
Sbjct: 128 -HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMS 184
Query: 456 PEYGLGSEVSTNGDVYSYGILMLEL 480
           PE       +   D++S G L+ EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 41/239 (17%)
Query: 272 FSSANLI-----GTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRAS-RSFIAECRA 320
           F   NL+     G G FG V K          G TTV VK+   +   +  R  ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE----------- 369
           L+ + H +++K++ ACS    Q      L+ E+ + GSL  +L    +            
Sbjct: 80  LKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 370 -----DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424
                D  D+  R L +   ++ A  ++  + YL    +    H DL   NIL+ E    
Sbjct: 135 NSSSLDHPDE--RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKM 189
Query: 425 HVGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + DFGL+R  +   ++V+ S   +   + ++A E       +T  DV+S+G+L+ E++
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 38/240 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-------RSFIAECRALRSIRHRNLV 330
           IG G FG V+KG L + ++ V +K   L             + F  E   + ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K++          ++   +V EF+  G L   L        +DKA   +    +L + +D
Sbjct: 87  KLYGLM-------HNPPRMVMEFVPCGDLYHRL--------LDKA-HPIKWSVKLRLMLD 130
Query: 391 VASALDYLHHDCQPITTHCDLKPSNIL---LDEE--MVSHVGDFGLARFLPPTHVQTSSI 445
           +A  ++Y+ +   PI  H DL+  NI    LDE   + + V DF L++      V + S 
Sbjct: 131 IALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVS- 184
Query: 446 GVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           G+ G+  ++APE  +G+E    +   D YS+ +++  ++  + P D    G +   N  R
Sbjct: 185 GLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 276 NLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLV 330
            ++G+G+FG+VYKG+     +  +  V +KV   +   +A++  + E   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++   C     Q      LV + M  G L          D V +    L     LN  + 
Sbjct: 83  RLLGICLTSTVQ------LVTQLMPYGCLL---------DHVRENRGRLGSQDLLNWCMQ 127
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +A  + YL  D + +  H DL   N+L+       + DFGLAR L     +  + G K  
Sbjct: 128 IAKGMSYLE-DVRLV--HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSD 488
           I ++A E  L    +   DV+SYG+ + EL+    KP D
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G + + L  +++ DE           QR
Sbjct: 71  RHPNILRLY----GYFHDATRV-YLILEYAPRGEVYKELQKLSKFDE-----------QR 114
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 115 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 170
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 171 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 223
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 224 SRVEFTFPDFVTE 236

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 281 GSFGSVYKG-VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGV 339
           G FG V+K  +L+E    V VK+F +   ++ ++   E  +L  ++H N+++      G 
Sbjct: 35  GRFGCVWKAQLLNE---YVAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFI----GA 86
Query: 340 DYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           + +G        L+  F + GSL ++L               ++  +  +IA  +A  L 
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFL-----------KANVVSWNELCHIAETMARGLA 135
Query: 397 YLHHDC-------QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           YLH D        +P  +H D+K  N+LL   + + + DFGLA           + G  G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 450 SIGYIAPEYGLGS-----EVSTNGDVYSYGILMLELIIRKKPSD 488
           +  Y+APE   G+     +     D+Y+ G+++ EL  R   +D
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +        ++    V VK+  +  H     + ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +  AC+     G     ++ E+   G L  +L      D   +  R L L   L+ +  
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 391 VASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           VA  + +L   +C     H D+   N+LL    V+ +GDFGLAR +    +  S+  VKG
Sbjct: 169 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSNYIVKG 220
Query: 450 S----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 221 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 137 IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 192 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 65  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 112
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 113 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 168 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 220
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 221 FRIFRTLGTPDEVV 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 111/259 (42%), Gaps = 24/259 (9%)
Query: 278 IGTGSFGSVYKGV---LDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHR-NLV 330
           +G G+FG V +     +D+  T  TV V  L     H   R+ ++E + L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNL-----NLLQR 384
            +  AC+     G     ++ EF + G+L  +L     E    K AP +L      L   
Sbjct: 86  NLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR +         
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPS---DIMFEGDMNLHNF 500
              +  + ++APE       +   DV+S+G+L+ E+  +   P     I  E    L   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 501 ARMALPDHVMDIVDSTLLN 519
            RM  PD+    +  T+L+
Sbjct: 259 TRMRAPDYTTPEMYQTMLD 277

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 105/244 (43%), Gaps = 26/244 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRH 326
           + F   NL+G GSF  VY+         V +K+ +   ++     +    E +    ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            ++++++       ++ +++  LV E   NG +  +L     ++ V     N    +  +
Sbjct: 71  PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSEN----EARH 116
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
               + + + YLH        H DL  SN+LL   M   + DFGLA  L   H +  ++ 
Sbjct: 117 FMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506
             G+  YI+PE    S      DV+S G +   L+I + P    F+ D   +   ++ L 
Sbjct: 174 --GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTDTVKNTLNKVVLA 227
Query: 507 DHVM 510
           D+ M
Sbjct: 228 DYEM 231

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 57  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 104
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 159
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
             T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 160 TYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 212
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 213 QLFRIFRTLGTPDEVV 228

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 65  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 112
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 113 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 168 THEV---VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 220
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 221 FRIFRTLGTPDEVV 234

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 58  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 105
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 106 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 161 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 213
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 214 FRIFRTLGTPDEVV 227

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 57  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 104
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 105 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 160 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 212
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 213 FRIFRTLGTPDEVV 226

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 109/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYK-----ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 58  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 105
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +  +    +   L + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 106 K--SYLFQLLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 161 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 213
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 214 FRIFRTLGTPDEVV 227

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 57  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 104
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 105 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 160 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 212
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 213 FRIFRTLGTPDEVV 226

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 58  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 105
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 106 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 161 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 213
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 214 FRIFRTLGTPDEVV 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 47/242 (19%)
Query: 272 FSSANLI-----GTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRAS-RSFIAECRA 320
           F   NL+     G G FG V K          G TTV VK+   +   +  R  ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE----------- 369
           L+ + H +++K++ ACS    Q      L+ E+ + GSL  +L    +            
Sbjct: 80  LKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 370 -----DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424
                D  D+  R L +   ++ A  ++  + YL    +    H DL   NIL+ E    
Sbjct: 135 NSSSLDHPDE--RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKM 189
Query: 425 HVGDFGLARFLPPTHVQTSSIGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLE 479
            + DFGL+R      V      VK S G     ++A E       +T  DV+S+G+L+ E
Sbjct: 190 KISDFGLSR-----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 480 LI 481
           ++
Sbjct: 245 IV 246

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 67  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 110
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 111 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTL 167
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
           S    G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 168 S----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 219
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 220 SRVEFTFPDFVTE 232

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 47/242 (19%)
Query: 272 FSSANLI-----GTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRAS-RSFIAECRA 320
           F   NL+     G G FG V K          G TTV VK+   +   +  R  ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE----------- 369
           L+ + H +++K++ ACS    Q      L+ E+ + GSL  +L    +            
Sbjct: 80  LKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 370 -----DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424
                D  D+  R L +   ++ A  ++  + YL    +    H DL   NIL+ E    
Sbjct: 135 NSSSLDHPDE--RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKM 189
Query: 425 HVGDFGLARFLPPTHVQTSSIGVKGSIG-----YIAPEYGLGSEVSTNGDVYSYGILMLE 479
            + DFGL+R      V      VK S G     ++A E       +T  DV+S+G+L+ E
Sbjct: 190 KISDFGLSR-----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 480 LI 481
           ++
Sbjct: 245 IV 246

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 58  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 105
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 106 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 161 THEV---VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 213
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 214 FRIFRTLGTPDEVV 227

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G + + L  +++ DE           QR
Sbjct: 71  RHPNILRLY----GYFHDATRV-YLILEYAPRGEVYKELQKLSKFDE-----------QR 114
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 115 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 168 RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 223
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 224 SRVEFTFPDFVTE 236

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 57
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 58  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 105
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 106 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 161 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 213
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 214 FRIFRTLGTPDEVV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 56
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 57  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 104
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 105 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 160 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 212
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 213 FRIFRTLGTPDEVV 226

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 89  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 144 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 92/236 (38%), Gaps = 33/236 (13%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 120
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV---- 447
           A  + YL         H DL   N+LL    +  +GDFGL R LP    Q     V    
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHXVMQEH 173
Query: 448 -KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
            K    + APE       S   D + +G+ + E+    +   I   G   LH   +
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 92  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 135
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 136 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 191
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 192 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 244
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 245 SRVEFTFPDFVTE 257

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 88  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 143 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 85  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 140 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 151 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 151 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY---PVNREDEVDKA---PRNLNLL 382
           ++ +  AC+    Q      +V E+   G+L E+L    P   E   + +      L+  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
             ++ A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +       
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 90/232 (38%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 124
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           A  + YL         H DL   N+LL    +  +GDFGL R LP            K  
Sbjct: 125 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             + APE       S   D + +G+ + E+    +   I   G   LH   +
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 91/233 (39%), Gaps = 33/233 (14%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 130
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV---- 447
           A  + YL         H DL   N+LL    +  +GDFGL R LP    Q     V    
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHXVMQEH 183
Query: 448 -KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
            K    + APE       S   D + +G+ + E+    +   I   G   LH 
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +        ++    V VK+  +  H     + ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +  AC+     G     ++ E+   G L  +L   +R  E D A           IA  
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPA---------FAIANS 159
Query: 391 VASALDYLHHDCQPI----------TTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
            AS  D LH   Q              H D+   N+LL    V+ +GDFGLAR +    +
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----M 215
Query: 441 QTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             S+  VKG+    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS----FIAECRALRSIRHRNLVKVF 333
           IG GSF +VYKG+  E  TTV V    L   + ++S    F  E   L+ ++H N+V+ +
Sbjct: 34  IGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            +      +G     LV E   +G+L+ +L    +  +V K    + +L+  +    +  
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYL----KRFKVXK----IKVLR--SWCRQILK 140
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            L +LH    PI  H DLK  NI +     S  +GD GLA     +  +     V G+  
Sbjct: 141 GLQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPE 195
Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + APE     +   + DVY++G   LE    + P
Sbjct: 196 FXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 90/232 (38%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 124
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           A  + YL         H DL   N+LL    +  +GDFGL R LP            K  
Sbjct: 125 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             + APE       S   D + +G+ + E+    +   I   G   LH   +
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRN 328
           D +    +IG+G+   V        +  V +K  NL   + S    + E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  +T+     +   D   LV + +  GS+ + +  +     V K      +L    IA
Sbjct: 75  IVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHI-----VAKGEHKSGVLDESTIA 124
Query: 389 I---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               +V   L+YLH + Q    H D+K  NILL E+    + DFG++ FL      T + 
Sbjct: 125 TILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 446 GVKGSIG---YIAPEYGLGSEV---STNGDVYSYGILMLELIIRKKP 486
             K  +G   ++APE  +  +V       D++S+GI  +EL     P
Sbjct: 182 VRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G FG V++G        V VK+F+    R  RS+  E    +++  RH N++  F A
Sbjct: 50  IGKGRFGEVWRGKWRG--EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 103
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               D        LV ++ ++GSL ++L  Y V  E  +              +A+  AS
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-------------KLALSTAS 150
Query: 394 ALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   T  I   
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPN 209
Query: 449 GSIG---YIAPEYGLGS------EVSTNGDVYSYGILMLELIIR 483
             +G   Y+APE    S      E     D+Y+ G++  E+  R
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 71  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 114
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 115 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 170
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 171 ---LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 223
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 224 SRVEFTFPDFVTE 236

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 91/231 (39%), Gaps = 29/231 (12%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 130
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT---HVQTSSIGVK 448
           A  + YL         H DL   N+LL    +  +GDFGL R LP     +V      V 
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 186
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
               + APE       S   D + +G+ + E+    +   I   G   LH 
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 62  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 109
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 110 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 164
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
           T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 165 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 217
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 218 FRIFRTLGTPDEVV 231

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 67  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 110
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 111 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT- 166
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 167 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 219
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 220 SRVEFTFPDFVTE 232

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-RSFIAECRALRSIRHRN 328
           D +    +IG+G+   V        +  V +K  NL   + S    + E +A+    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  +T+     +   D   LV + +  GS+ + +  +     V K      +L    IA
Sbjct: 70  IVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHI-----VAKGEHKSGVLDESTIA 119
Query: 389 I---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               +V   L+YLH + Q    H D+K  NILL E+    + DFG++ FL      T + 
Sbjct: 120 TILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 446 GVKGSIG---YIAPEYGLGSEV---STNGDVYSYGILMLELIIRKKP 486
             K  +G   ++APE  +  +V       D++S+GI  +EL     P
Sbjct: 177 VRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 151 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 89/229 (38%), Gaps = 25/229 (10%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 120
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           A  + YL         H DL   N+LL    +  +GDFGL R LP            K  
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
             + APE       S   D + +G+ + E+    +   I   G   LH 
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 71  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 114
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 115 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 170
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 171 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 223
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 224 SRVEFTFPDFVTE 236

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 90/232 (38%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLD--EGRT-TVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D   G+T +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL          D + K   +  L      A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 120
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           A  + YL         H DL   N+LL    +  +GDFGL R LP            K  
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             + APE       S   D + +G+ + E+    +   I   G   LH   +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G FG V++G        V VK+F+    R  RS+  E    +++  RH N++  F A
Sbjct: 37  IGKGRFGEVWRGKWRG--EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 90
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               D        LV ++ ++GSL ++L  Y V  E  +              +A+  AS
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-------------KLALSTAS 137
Query: 394 ALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   T  I   
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPN 196
Query: 449 GSIG---YIAPEYGLGS------EVSTNGDVYSYGILMLELIIR 483
             +G   Y+APE    S      E     D+Y+ G++  E+  R
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF---NLHHHRASRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV     L           E      +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 106
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 107 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 215
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 216 SRVEFTFPDFVTE 228

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 83  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 126
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 127 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 182
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 183 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 235
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 236 SRVEFTFPDFVTE 248

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 69  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 168
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 169 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 221
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 222 SRVEFTFPDFVTE 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 165
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 166 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 48/259 (18%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-- 378
           L+ + H N+VK+      V +  N    LV+EF+           ++ +D +D +     
Sbjct: 59  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLS----------MDLKDFMDASALTGI 103
Query: 379 -LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLP 436
            L L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158
Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDM 495
           P       +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD 
Sbjct: 159 PVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDS 211
Query: 496 NLHN----FARMALPDHVM 510
            +      F  +  PD V+
Sbjct: 212 EIDQLFRIFRTLGTPDEVV 230

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 278 IGTGSFGSVYKGV---LDEGR----TTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V       LD+ +    T V VK+          S  I+E   ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL---------YPVNREDEVDKAPRNL 379
           ++ +  AC+    Q      +V E+   G+L E+L         Y  N     ++   + 
Sbjct: 81  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +L+   + A  VA  ++YL         H DL   N+L+ E+ V  + DFGLAR +    
Sbjct: 136 DLV---SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +   +  + ++APE       +   DV+S+G+L+ E+ 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 48/259 (18%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-- 378
           L+ + H N+VK+      V +  N    LV+EF+           ++ +D +D +     
Sbjct: 58  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLS----------MDLKDFMDASALTGI 102
Query: 379 -LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLP 436
            L L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157
Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDM 495
           P       +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD 
Sbjct: 158 PVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDS 210
Query: 496 NLHN----FARMALPDHVM 510
            +      F  +  PD V+
Sbjct: 211 EIDQLFRIFRTLGTPDEVV 229

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 108/259 (41%), Gaps = 48/259 (18%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN-- 378
           L+ + H N+VK+      V +  N    LV+EF+            + +D +D +     
Sbjct: 56  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ----------DLKDFMDASALTGI 100
Query: 379 -LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLP 436
            L L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGV 155
Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDM 495
           P       +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD 
Sbjct: 156 PVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDS 208
Query: 496 NLHN----FARMALPDHVM 510
            +      F  +  PD V+
Sbjct: 209 EIDQLFRIFRTLGTPDEVV 227

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G FG V++G        V VK+F+    R  RS+  E    +++  RH N++  F A
Sbjct: 14  IGKGRFGEVWRGKWRG--EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 67
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               D        LV ++ ++GSL ++L  Y V  E  +              +A+  AS
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-------------KLALSTAS 114
Query: 394 ALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   T  I   
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPN 173
Query: 449 GSIG---YIAPEYGLGS------EVSTNGDVYSYGILMLELIIR 483
             +G   Y+APE    S      E     D+Y+ G++  E+  R
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 113
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 114 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 169
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 170 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 222
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 223 SRVEFTFPDFVTE 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G FG V++G        V VK+F+    R  RS+  E    +++  RH N++  F A
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 64
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               D        LV ++ ++GSL ++L  Y V  E  +              +A+  AS
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-------------KLALSTAS 111
Query: 394 ALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   T  I   
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPN 170
Query: 449 GSIG---YIAPEYGLGS------EVSTNGDVYSYGILMLELIIR 483
             +G   Y+APE    S      E     D+Y+ G++  E+  R
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G FG V++G        V VK+F+    R  RS+  E    +++  RH N++  F A
Sbjct: 17  IGKGRFGEVWRGKWRG--EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 70
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               D        LV ++ ++GSL ++L  Y V  E  +              +A+  AS
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-------------KLALSTAS 117
Query: 394 ALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   T  I   
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPN 176
Query: 449 GSIG---YIAPEYGLGS------EVSTNGDVYSYGILMLELIIR 483
             +G   Y+APE    S      E     D+Y+ G++  E+  R
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
            +++  +IG GSFG V++  L E       KV      +  R    E + +R ++H N+V
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIMRIVKHPNVV 95
Query: 331 --KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
             K F   +G D +   F  LV E+     + E +Y  +R     K  + + +L      
Sbjct: 96  DLKAFFYSNG-DKKDEVFLNLVLEY-----VPETVYRASR--HYAKLKQTMPMLLIKLYM 147
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
             +  +L Y+H        H D+KP N+LLD    V  + DFG A+ L       S I  
Sbjct: 148 YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI-- 202
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELI 481
             S  Y APE   G +  +TN D++S G +M EL+
Sbjct: 203 -CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G FG V++G        V VK+F+    R  RS+  E    +++  RH N++  F A
Sbjct: 12  IGKGRFGEVWRGKWRG--EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 65
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               D        LV ++ ++GSL ++L  Y V  E  +              +A+  AS
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-------------KLALSTAS 112
Query: 394 ALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   T  I   
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPN 171
Query: 449 GSIG---YIAPEYGLGS------EVSTNGDVYSYGILMLELIIR 483
             +G   Y+APE    S      E     D+Y+ G++  E+  R
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 69  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 168
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 169 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 221
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 222 SRVEFTFPDFVTE 234

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 108
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T 
Sbjct: 109 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT- 164
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 165 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 217
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 218 SRVEFTFPDFVTE 230

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 165
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 166 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 221
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 222 SRVEFTFPDFVTE 234

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 314 FIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVD 373
           F  E +   ++ H  +V V+ A    +        +V E++   +L + ++      E  
Sbjct: 59  FRREAQNAAALNHPAIVAVY-ATGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGP 112
Query: 374 KAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
             P+     + + +  D   AL++ H +      H D+KP+NI++       V DFG+AR
Sbjct: 113 MTPK-----RAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 434 FLPPT-HVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE 492
            +  + +  T +  V G+  Y++PE   G  V    DVYS G ++ E++  + P    F 
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FT 220
Query: 493 GD 494
           GD
Sbjct: 221 GD 222

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 43/239 (17%)
Query: 268 ATDGFSSANLIGTGSFGSVYKG--VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR 325
           A+D F    ++G G+FG V K    LD  R     K+   H      + ++E   L S+ 
Sbjct: 5   ASD-FEEIAVLGQGAFGQVVKARNALD-SRYYAIKKI--RHTEEKLSTILSEVMLLASLN 60
Query: 326 HRNLVKVFTAC----------SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
           H+ +V+ + A           + V  +   F  +  E+ +N +L + ++  N   + D+ 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM--EYCENRTLYDLIHSENLNQQRDEY 118
Query: 376 PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-- 433
            R         +   +  AL Y+H   Q I  H DLKP NI +DE     +GDFGLA+  
Sbjct: 119 WR---------LFRQILEALSYIH--SQGII-HRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 434 -------FLPPTHVQTSSIGVKGSIG---YIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
                   L   ++  SS  +  +IG   Y+A E   G+   +   D+YS GI+  E+I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 59
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 60  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 107
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 108 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 162
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 163 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 215
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 216 QLFRIFRTLGTPDEVV 231

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKF--SLDLASLILYAYQLST 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG-KLPIKW 178
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 234

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +        ++    V VK+  +  H     + ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA----PRNLNLLQRLN 386
            +  AC+     G     ++ E+   G L  +L   +R  E D A       L+    L+
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 387 IAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
            +  VA  + +L   +C     H D+   N+LL    V+ +GDFGLAR +    +  S+ 
Sbjct: 169 FSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSNY 220
Query: 446 GVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            VKG+    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 67  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 110
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 111 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 163
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 219
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 220 SRVEFTFPDFVTE 232

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 59  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 106
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 162 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 214
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 215 QLFRIFRTLGTPDEVV 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 58  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 105
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 106 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 160
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 161 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 213
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 214 QLFRIFRTLGTPDEVV 229

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 59  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 106
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 162 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 214
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 215 QLFRIFRTLGTPDEVV 230

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 56  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 103
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 159 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 211
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 212 QLFRIFRTLGTPDEVV 227

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 57  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 104
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 159
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 160 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 212
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 213 QLFRIFRTLGTPDEVV 228

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT-HVQTS 443
           + +  D   AL++ H +      H D+KP+NI++       V DFG+AR +  + +  T 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           +  V G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 56  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 103
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 159 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 211
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 212 QLFRIFRTLGTPDEVV 227

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           D +     +GTG+FG V++            K     H     +   E + +  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V +  A     ++ ++   ++YEFM  G L E +      DE +K    ++  + +    
Sbjct: 217 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKV-----ADEHNK----MSEDEAVEYMR 262
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG--DFGLARFLPPTHVQTSSIGV 447
            V   L ++H +      H DLKP NI+   +  + +   DFGL   L P   + S    
Sbjct: 263 QVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVT 316
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGIL 476
            G+  + APE   G  V    D++S G+L
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 58  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 105
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 106 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 160
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 161 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 213
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 214 QLFRIFRTLGTPDEVV 229

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 58  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 105
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 106 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 160
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 161 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 213
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 214 QLFRIFRTLGTPDEVV 229

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 56  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 103
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 159 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 211
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 212 QLFRIFRTLGTPDEVV 227

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 234

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 114
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 115 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 168 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 223
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 224 SRVEFTFPDFVTE 236

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 57  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 104
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 105 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
              +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 160 XHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 212
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 213 FRIFRTLGTPDEVV 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 56  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 103
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 159 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 211
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 212 QLFRIFRTLGTPDEVV 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT-HVQTS 443
           + +  D   AL++ H +      H D+KP+NI++       V DFG+AR +  + +  T 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           +  V G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 57  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 104
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 105 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
              +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 160 XHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 212
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 213 FRIFRTLGTPDEVV 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT-HVQTS 443
           + +  D   AL++ H +      H D+KP+NI++       V DFG+AR +  + +  T 
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           +  V G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 239

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L++++      D        L 
Sbjct: 57  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLP 104
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 159
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 160 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 212
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 213 QLFRIFRTLGTPDEVV 228

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT-HVQTS 443
           + +  D   AL++ H +      H D+KP+NI++       V DFG+AR +  + +  T 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           +  V G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 68  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 111
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 112 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 164
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 165 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 220
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 221 SRVEFTFPDFVTE 233

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 234

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 106 ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 150
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 151 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 206
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 262

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++    IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +     Y   D   +V E++  GSL +    V  E  +D+        Q   +  + 
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCREC 125
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             AL++LH +      H D+K  NILL  +    + DFG    + P   + S++   G+ 
Sbjct: 126 LQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTP 180
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            ++APE           D++S GI+ +E+I  + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 42/254 (16%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+VK+      V +  N    LV+EF+    L++++      D        L L+
Sbjct: 59  ELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKKFM------DASALTGIPLPLI 106
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQ 441
           +     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P    
Sbjct: 107 KSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 161
Query: 442 TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN- 499
              +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  +   
Sbjct: 162 XHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQL 214
Query: 500 ---FARMALPDHVM 510
              F  +  PD V+
Sbjct: 215 FRIFRTLGTPDEVV 228

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 92  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 135
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 136 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 188
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 189 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 244
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 245 SRVEFTFPDFVTE 257

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 83  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 127
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 128 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 183
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 239

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA----------RF 434
           L+I I +A A+++LH        H DLKPSNI    + V  VGDFGL             
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           L P     +  G  G+  Y++PE   G+  S   D++S G+++ EL+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY       +  + +KV F     +A        E      +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +  +    L+ E+   G++   L  +++ DE           QR
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 110 TATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQDTYKRI 218
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKF--SLDLASLILYAYQLST 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 234

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+    L+ ++      D        L 
Sbjct: 59  LKELNHPNIVKLL----DVIHTENKL-YLVFEFLHQ-DLKTFM------DASALTGIPLP 106
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 162 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 214
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 215 QLFRIFRTLGTPDEVV 230

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 75  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 119
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 175
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+ +  L++++      D        L 
Sbjct: 59  LKELNHPNIVKLL----DVIHTENKL-YLVFEFL-SMDLKKFM------DASALTGIPLP 106
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 161
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 162 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 214
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 215 QLFRIFRTLGTPDEVV 230

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 80  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 124
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 125 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 180
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 236

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 22/209 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           D +     +GTG+FG V++            K     H     +   E + +  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V +  A     ++ ++   ++YEFM  G L E +      DE +K   +    + +    
Sbjct: 111 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKV-----ADEHNKMSED----EAVEYMR 156
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG--DFGLARFLPPTHVQTSSIGV 447
            V   L ++H +      H DLKP NI+   +  + +   DFGL   L P   + S    
Sbjct: 157 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVT 210
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGIL 476
            G+  + APE   G  V    D++S G+L
Sbjct: 211 TGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 165
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 166 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 221
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 222 SRVEFTFPDFVTE 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 81  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKY--SLDLASLILYAYQLST 125
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 126 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 181
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 237

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFN---LHHHRASRSFIAECRALR 322
           +D +    ++G GSFG V   +L + + T     VKV +   +       S + E + L+
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N++K++       ++   +  LV E    G L + +    R  EVD A       
Sbjct: 88  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 135
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTH 439
               I   V S + Y+H +      H DLKP N+LL+ +       + DFGL+     TH
Sbjct: 136 ---RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-----TH 184
Query: 440 VQTSSIGVKGSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + S   +K  IG   YIAPE   G+      DV+S G+++  L+
Sbjct: 185 FEASK-KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILL 227

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 68  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 111
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + +FG +   P +   T 
Sbjct: 112 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT- 167
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 168 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 220
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 221 SRVEFTFPDFVTE 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 104/260 (40%), Gaps = 30/260 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V           V VK  +L   +       E   +R   H N+V ++++  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS-- 110
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL Y
Sbjct: 111 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLSVLRALSY 156
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH+       H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 157 LHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC-----AQVSKEVPKRKXLVGTPYWM 208
Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD 514
           APE        T  D++S GI+++E+I  + P     E  +      R +LP  V D+  
Sbjct: 209 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDSLPPRVKDLHK 266
Query: 515 -STLLNDVEDLAIISNQRQR 533
            S++L    DL ++    QR
Sbjct: 267 VSSVLRGFLDLMLVREPSQR 286

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 42/256 (16%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L+ + H N+VK+      V +  N    LV+EF+ +  L++++      D        L 
Sbjct: 57  LKELNHPNIVKLL----DVIHTENKL-YLVFEFL-SMDLKKFM------DASALTGIPLP 104
Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTH 439
           L++     +    A  + H        H DLKP N+L++ E    + DFGLAR F  P  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 159
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F GD  + 
Sbjct: 160 TYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEID 212
Query: 499 N----FARMALPDHVM 510
                F  +  PD V+
Sbjct: 213 QLFRIFRTLGTPDEVV 228

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++       +       L+ E+   G++   L  +++ DE           QR
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + DFG +   P     + 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 165
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 166 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 221
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 222 SRVEFTFPDFVTE 234

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           ++    IG G++G V        +T V +K  +   H    +  + E + L   RH N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         + +  +A+   ++    +E  LY + +  ++        L Q       
Sbjct: 105 GIRDIL-----RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQ------- 152
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-G 449
           +   L Y+H        H DLKPSN+L++      + DFGLAR   P H  T  +     
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508
           +  Y APE  L S+  T   D++S G ++ E++  +     +F G   L         +H
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQL------NH 259
Query: 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIG 551
           ++ I+ S      EDL  I N + R     N ++ L S  ++ 
Sbjct: 260 ILGILGSP---SQEDLNCIINMKAR-----NYLQSLPSKTKVA 294

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E + L+++    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 73
Query: 334 TACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               GV Y  G     LV E++ +G L                    + LQR    +D +
Sbjct: 74  ---RGVSYGPGRPELRLVMEYLPSGCLR-------------------DFLQRHRARLDAS 111
Query: 393 SALDYLHHDCQPI-------TTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSS 444
             L Y    C+ +         H DL   NIL++ E    + DFGLA+ LP         
Sbjct: 112 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVR 171
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
              +  I + APE    +  S   DV+S+G+++ EL 
Sbjct: 172 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++    IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +     Y   D   +V E++  GSL +    V  E  +D+        Q   +  + 
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCREC 125
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             AL++LH +      H D+K  NILL  +    + DFG    + P   + S +   G+ 
Sbjct: 126 LQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM--VGTP 180
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            ++APE           D++S GI+ +E+I  + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSI 324
           A + F     +G G FG+VY     + +  + +KV F     +A        E      +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           RH N+++++    G  +       L+ E+   G++   L  +++ DE           QR
Sbjct: 69  RHPNILRLY----GYFHDATRV-YLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 385 LNIAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               I ++A+AL Y H        H D+KP N+LL       + +FG +   P +   T 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT- 168
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R+
Sbjct: 169 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI 221
Query: 504 A-----LPDHVMD 511
           +      PD V +
Sbjct: 222 SRVEFTFPDFVTE 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++    IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +     Y   D   +V E++  GSL +    V  E  +D+        Q   +  + 
Sbjct: 83  YLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCREC 126
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             AL++LH +      H D+K  NILL  +    + DFG    + P   + S +   G+ 
Sbjct: 127 LQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM--VGTP 181
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            ++APE           D++S GI+ +E+I  + P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++    IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +     Y   D   +V E++  GSL +    V  E  +D+        Q   +  + 
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCREC 125
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             AL++LH +      H D+K  NILL  +    + DFG    + P   + S +   G+ 
Sbjct: 126 LQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM--VGTP 180
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            ++APE           D++S GI+ +E+I  + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G++G VYK   + G T    K+           + I E   L+ ++H N+VK++   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                       LV+E +            + +  +D     L  +   +  + + + + 
Sbjct: 70  -----HTKKRLVLVFEHLDQ----------DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGYIA 455
           Y H        H DLKP N+L++ E    + DFGLAR F  P    T  I    ++ Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI---VTLWYRA 168
Query: 456 PEYGLGS-EVSTNGDVYSYGILMLELI 481
           P+  +GS + ST  D++S G +  E++
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 38/218 (17%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E + L+++    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 76
Query: 334 TACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               GV Y  G     LV E++ +G L                    + LQR    +D +
Sbjct: 77  ---RGVSYGPGRQSLRLVMEYLPSGCLR-------------------DFLQRHRARLDAS 114
Query: 393 SALDYLHHDCQPI-------TTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTS 443
             L Y    C+ +         H DL   NIL++ E    + DFGLA+ LP    +    
Sbjct: 115 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 174
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             G +  I + APE    +  S   DV+S+G+++ EL 
Sbjct: 175 EPG-QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFN---LHHHRASRSFIAECRALR 322
           +D +    ++G GSFG V   +L + + T     VKV +   +       S + E + L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N++K++       ++   +  LV E    G L + +    R  EVD A       
Sbjct: 82  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 129
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTH 439
               I   V S + Y+H +      H DLKP N+LL+ +       + DFGL+     TH
Sbjct: 130 ---RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-----TH 178
Query: 440 VQTSSIGVKGSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + S   +K  IG   YIAPE   G+      DV+S G+++  L+
Sbjct: 179 FEASK-KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILL 221

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 38/218 (17%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E + L+++    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 77
Query: 334 TACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               GV Y  G     LV E++ +G L                    + LQR    +D +
Sbjct: 78  ---RGVSYGPGRQSLRLVMEYLPSGCLR-------------------DFLQRHRARLDAS 115
Query: 393 SALDYLHHDCQPI-------TTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTS 443
             L Y    C+ +         H DL   NIL++ E    + DFGLA+ LP    +    
Sbjct: 116 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 175
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             G +  I + APE    +  S   DV+S+G+++ EL 
Sbjct: 176 EPG-QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 38/218 (17%)
Query: 278 IGTGSFGSV----YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV    Y  + D     V VK          R F  E + L+++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 89
Query: 334 TACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               GV Y  G     LV E++ +G L                    + LQR    +D +
Sbjct: 90  ---RGVSYGPGRQSLRLVMEYLPSGCLR-------------------DFLQRHRARLDAS 127
Query: 393 SALDYLHHDCQPI-------TTHCDLKPSNILLDEEMVSHVGDFGLARFLP--PTHVQTS 443
             L Y    C+ +         H DL   NIL++ E    + DFGLA+ LP    +    
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             G +  I + APE    +  S   DV+S+G+++ EL 
Sbjct: 188 EPG-QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 103/261 (39%), Gaps = 56/261 (21%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALR 322
           + F     IG G++G VYK      R  +T +V  L   R          + I E   L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 323 SIRHRNLVKVFTACSG-------VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
            + H N+VK+              ++   D K     FM   +L     P+ +       
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKT----FMDASALTGIPLPLIKS------ 106
Query: 376 PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-F 434
                LLQ L        A  + H        H DLKP N+L++ E    + DFGLAR F
Sbjct: 107 -YLFQLLQGL--------AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAF 152
Query: 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             P    T  +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F G
Sbjct: 153 GVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPG 205
Query: 494 DMNLHN----FARMALPDHVM 510
           D  +      F  +  PD V+
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVV 226

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 40/232 (17%)
Query: 276 NLIGTGSFGSVYK----GVLDEGRT-TVTVKVFNLHHHRASR-SFIAECRALRSI-RHRN 328
            ++G+G+FG V      G+   G +  V VK+       + R + ++E + +  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 329 LVKVFTAC--SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR---EDEVD-------KAP 376
           +V +  AC  SG  Y       L++E+   G L  +L        EDE++       +  
Sbjct: 111 IVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 377 RNLNLL---QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
            +LN+L     L  A  VA  +++L         H DL   N+L+    V  + DFGLAR
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 434 FLPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            +    +  S+  V+G+    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 221 DI----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF---NLHHHRASRSFIAECRALRSIRH 326
           D F     +G G FG+VY     + +  + +KV     L           E      +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+++++       +       L+ EF   G L + L    R DE   A           
Sbjct: 75  PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----------T 119
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
              ++A AL Y H   +    H D+KP N+L+  +    + DFG +   P    +     
Sbjct: 120 FMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-- 174
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
             G++ Y+ PE   G       D++  G+L  E ++   P D
Sbjct: 175 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 75
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K +VY  +    + E +Y V R     +A + L ++       
Sbjct: 76  VRL----RYFFYSSGEKKDVVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVK 448
            +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I   
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 183
Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +        ++    V VK+  +  H     + ++E + +  + +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY------------PVNREDEVDKAP-R 377
            +  AC+     G     ++ E+   G L  +L             P    + +DK   R
Sbjct: 99  NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 378 NLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
            L L   L+ +  VA  + +L   +C     H D+   N+LL    V+ +GDFGLAR + 
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI- 208
Query: 437 PTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
              +  S+  VKG+    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 209 ---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 458 ----GVITENPVW--IIMELCTLGELRSFL-------QVRKF--SLDLASLILYAYQLST 502
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 558
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 614

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K   N         F+ E   +R   H ++VK+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               GV  +   +  ++ E    G L  +L       +V K   +L+L   +  A  +++
Sbjct: 458 ----GVITENPVW--IIMELCTLGELRSFL-------QVRKF--SLDLASLILYAYQLST 502
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           AL YL         H D+   N+L+       +GDFGL+R++  +    +S G K  I +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 558
Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMN------LHNFARMALP 506
           +APE       ++  DV+ +G+ M E+++   KP    F+G  N      + N  R+ +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPMP 614

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHR 327
           + +     IG GS+G V+K    +    V +K F           IA  E R L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           NLV +        ++      LV+E+  +  L E          +D+  R +      +I
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTVLHE----------LDRYQRGVPEHLVKSI 107
Query: 388 AIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSI 445
                 A+++ H H+C     H D+KP NIL+ +  V  + DFG AR L  P+      +
Sbjct: 108 TWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELI 481
             +    Y +PE  +G ++     DV++ G +  EL+
Sbjct: 164 ATR---WYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 86/222 (38%), Gaps = 25/222 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF---NLHHHRASRSFIAECRALRSIRH 326
           D F     +G G FG+VY     + +  + +KV     L           E      +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+++++       +       L+ EF   G L + L    R DE     R+   ++ L 
Sbjct: 74  PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ----RSATFMEEL- 123
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
                A AL Y H   +    H D+KP N+L+  +    + DFG +   P    +     
Sbjct: 124 -----ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-- 173
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
             G++ Y+ PE   G       D++  G+L  E ++   P D
Sbjct: 174 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G++G VYK   + G T    K+           + I E   L+ ++H N+VK++   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                       LV+E +            + +  +D     L  +   +  + + + + 
Sbjct: 70  -----HTKKRLVLVFEHLDQ----------DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGYIA 455
           Y H        H DLKP N+L++ E    + DFGLAR F  P    T  +    ++ Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRA 168
Query: 456 PEYGLGS-EVSTNGDVYSYGILMLELI 481
           P+  +GS + ST  D++S G +  E++
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 93/235 (39%), Gaps = 27/235 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRH 326
           D F    ++G GSFG V    + E      VKV     +         + E R L   R+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              +     C    +Q  D    V EF+  G L   ++ + +    D+A           
Sbjct: 83  HPFLTQLFCC----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF------- 128
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A ++ SAL +LH        + DLK  N+LLD E    + DFG+ +      V T++  
Sbjct: 129 YAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC 185
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP-----SDIMFEGDMN 496
             G+  YIAPE           D ++ G+L+ E++    P      D +FE  +N
Sbjct: 186 --GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 8/111 (7%)
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT-HVQTS 443
           + +  D   AL++ H +      H D+KP+NIL+       V DFG+AR +  + +    
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           +  V G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G++G VYK   + G T    K+           + I E   L+ ++H N+VK++   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                       LV+E +            + +  +D     L  +   +  + + + + 
Sbjct: 70  -----HTKKRLVLVFEHLDQ----------DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGYIA 455
           Y H        H DLKP N+L++ E    + DFGLAR F  P    T  +    ++ Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRA 168
Query: 456 PEYGLGS-EVSTNGDVYSYGILMLELI 481
           P+  +GS + ST  D++S G +  E++
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A +V  AL+YLH        + DLKP NILLD+     + DFG A+++P       +  +
Sbjct: 112 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXL 163
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+  YIAPE       + + D +S+GIL+ E++    P
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFN---LHHHRASRSFIAECRALR 322
           +D +    ++G GSFG V   +L + + T     VKV +   +       S + E + L+
Sbjct: 48  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N++K++       ++   +  LV E    G L + +    R  EVD A       
Sbjct: 105 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 152
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTH 439
               I   V S + Y+H +      H DLKP N+LL+ +       + DFGL+     TH
Sbjct: 153 ---RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-----TH 201
Query: 440 VQTSSIGVKGSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + S   +K  IG   YIAPE   G+      DV+S G+++  L+
Sbjct: 202 FEASK-KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILL 244

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFN---LHHHRASRSFIAECRALR 322
           +D +    ++G GSFG V   +L + + T     VKV +   +       S + E + L+
Sbjct: 49  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N++K++       ++   +  LV E    G L + +    R  EVD A       
Sbjct: 106 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 153
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTH 439
               I   V S + Y+H +      H DLKP N+LL+ +       + DFGL+     TH
Sbjct: 154 ---RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-----TH 202
Query: 440 VQTSSIGVKGSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + S   +K  IG   YIAPE   G+      DV+S G+++  L+
Sbjct: 203 FEASK-KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILL 245

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++    IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +     Y   D   +V E++  GSL +    V  E  +D+        Q   +  + 
Sbjct: 83  YLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCREC 126
Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             AL++LH +      H ++K  NILL  +    + DFG    + P   + S++   G+ 
Sbjct: 127 LQALEFLHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTP 181
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            ++APE           D++S GI+ +E+I  + P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
            IA+ +  AL++LH     I  H D+KPSN+L++      + DFG++ +L  +  +T   
Sbjct: 157 KIAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 446 GVKGSIGYIAPEYGLGSEVSTNG-----DVYSYGILMLELIIRKKPSD 488
           G K    Y+APE  +  E++  G     D++S GI M+EL I + P D
Sbjct: 215 GCK---PYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 104/263 (39%), Gaps = 56/263 (21%)
Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRA 320
           + + F     IG G++G VYK      R  +T +V  L   R          + I E   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 321 LRSIRHRNLVKVFTACSG-------VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVD 373
           L+ + H N+VK+              ++   D K    +FM   +L     P+ +     
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLK----KFMDASALTGIPLPLIKS---- 110
Query: 374 KAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
                  LLQ L        A  + H        H DLKP N+L++ E    + DFGLAR
Sbjct: 111 ---YLFQLLQGL--------AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLAR 154
Query: 434 -FLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMF 491
            F  P       +    ++ Y APE  LG +  ST  D++S G +  E++ R+     +F
Sbjct: 155 AFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LF 207
Query: 492 EGDMNLHN----FARMALPDHVM 510
            GD  +      F  +  PD V+
Sbjct: 208 PGDSEIDQLFRIFRTLGTPDEVV 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  +    G  Y   +  ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 128 IVGFY----GAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 174
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 175 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 226
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V K         +  K+ +L    A R   I E + L       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 76  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKEAKRIPE--------EILGKVSIA 122
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    Q    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 123 --VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 174
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y+APE   G+  S   D++S G+ ++EL + + P
Sbjct: 175 GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 66  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 112
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 113 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 164
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 66  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 112
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 113 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 164
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 66  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 112
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 113 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 164
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 66  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 112
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 113 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 164
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 36/251 (14%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSIRH 326
           + F     +G G FG+VY     + +  + +KV F     +A        E      +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+++++       +       L+ E+   G++   L  ++R DE           QR  
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDE-----------QRTA 115
Query: 387 IAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T   
Sbjct: 116 TYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT--- 169
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA- 504
            + G++ Y+ PE   G       D++S G+L  E ++   P    FE       + R++ 
Sbjct: 170 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP----FEAHTYQETYRRISR 224
Query: 505 ----LPDHVMD 511
                PD V +
Sbjct: 225 VEFTFPDFVTE 235

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 66  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 112
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 113 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 164
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L + RH N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 134
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 76
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 77  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 130
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVK 448
            +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I   
Sbjct: 131 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 184
Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 227

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 36/251 (14%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-FNLHHHRA--SRSFIAECRALRSIRH 326
           + F     +G G FG+VY     + +  + +KV F     +A        E      +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+++++       +       L+ E+   G++   L  ++R DE           QR  
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDE-----------QRTA 115
Query: 387 IAI-DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             I ++A+AL Y H        H D+KP N+LL       + DFG +   P +   T   
Sbjct: 116 TYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT--- 169
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA- 504
            + G++ Y+ PE   G       D++S G+L  E ++   P    FE       + R++ 
Sbjct: 170 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP----FEAHTYQETYRRISR 224
Query: 505 ----LPDHVMD 511
                PD V +
Sbjct: 225 VEFTFPDFVTE 235

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 93  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 139
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 140 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 191
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 75
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 76  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVK 448
            +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I   
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 183
Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 80
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 81  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 134
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVKG 449
           +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I    
Sbjct: 135 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 188
Query: 450 SIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 230

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECR-ALRSIRH--RN 328
           +   ++IG G    V + V         VK+  +   R S   + E R A R   H  R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 329 LVKVFTACSGVD-YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           +       + +D Y+ + F  LV++ M+ G L ++L         +K    L+  +  +I
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--------TEKVA--LSEKETRSI 205
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              +  A+ +LH +      H DLKP NILLD+ M   + DFG +  L P         +
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---L 259
Query: 448 KGSIGYIAPEY----------GLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G+ GY+APE           G G EV    D+++ G+++  L+    P
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPP 304

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 75
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 76  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVK 448
            +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I   
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 183
Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 94
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 95  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 148
Query: 390 DVASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIG 446
            +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I 
Sbjct: 149 QLFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI- 202
Query: 447 VKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
              S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 203 --CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 245

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 85  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 131
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    + + +    
Sbjct: 132 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV 183
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 87
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 88  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 141
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVK 448
            +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I   
Sbjct: 142 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 195
Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 238

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALR-SIR 325
           + F    ++G GSFG V+     +      +K      +         + E R L  +  
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H  L  +F  C+   +Q  +    V E++  G L   +Y +       ++    +L +  
Sbjct: 78  HPFLTHMF--CT---FQTKENLFFVMEYLNGGDL---MYHI-------QSCHKFDLSRAT 122
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A ++   L +LH        + DLK  NILLD++    + DFG+ +       +T+  
Sbjct: 123 FYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              G+  YIAPE  LG + + + D +S+G+L+ E++I + P
Sbjct: 180 C--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 83
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 84  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 137
Query: 390 DVASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIG 446
            +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I 
Sbjct: 138 QLFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI- 191
Query: 447 VKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
              S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 192 --CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 87
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 88  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 141
Query: 390 DVASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIG 446
            +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I 
Sbjct: 142 QLFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI- 195
Query: 447 VKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
              S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 196 --CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 238

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 130
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508
           +  Y APE  L S+  T   D++S G ++ E++  +     +F G   L         +H
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQL------NH 237
Query: 509 VMDIVDSTLLNDVEDLAIISNQRQR 533
           ++ I+ S    + EDL  I N + R
Sbjct: 238 ILGILGSP---EQEDLNCIINLKAR 259

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 25/223 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           TD +     +G G+F  V + V          K+ N      R  +    E R  R ++H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  + S        F  LV++ +  G L E +       E D +     +L+ +N
Sbjct: 90  PNIVRLHDSISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 144
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MVSHVGDFGLARFLPPTHVQTS 443
                        H  Q    H DLKP N+LL  +       + DFGLA  +     Q +
Sbjct: 145 -------------HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQA 189
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             G  G+ GY++PE           D+++ G+++  L++   P
Sbjct: 190 WFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 75
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 76  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVK 448
            +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I   
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 183
Query: 449 GSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 43/239 (17%)
Query: 268 ATDGFSSANLIGTGSFGSVYKG--VLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR 325
           A+D F    ++G G+FG V K    LD  R     K+   H      + ++E   L S+ 
Sbjct: 5   ASD-FEEIAVLGQGAFGQVVKARNALD-SRYYAIKKI--RHTEEKLSTILSEVXLLASLN 60
Query: 326 HRNLVKVFTAC----------SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
           H+ +V+ + A           + V  +   F  +  E+ +N +L + ++  N   + D+ 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLF--IQXEYCENRTLYDLIHSENLNQQRDEY 118
Query: 376 PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-- 433
            R         +   +  AL Y+H   Q I  H +LKP NI +DE     +GDFGLA+  
Sbjct: 119 WR---------LFRQILEALSYIH--SQGII-HRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 434 -------FLPPTHVQTSSIGVKGSIG---YIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
                   L   ++  SS  +  +IG   Y+A E   G+   +   D YS GI+  E I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 132
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L + RH N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 134
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++A ALD+LH        + DLKP NILLDEE    + DFGL++       +  +    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++ Y+APE       + + D +S+G+LM E++
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 134
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++A ALD+LH        + DLKP NILLDEE    + DFGL++       +  +    G
Sbjct: 135 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 189
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++ Y+APE       + + D +S+G+LM E++
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 221

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++A  LD+LH        + DLKP NILLDEE    + DFGL++       +  +    G
Sbjct: 138 ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCG 192
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++ Y+APE       S + D +SYG+LM E++
Sbjct: 193 TVEYMAPEVVNRQGHSHSADWWSYGVLMFEML 224

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 278 IGTGSFGSVYKGV--LDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFT 334
           +G G+FGSV +GV  + + +  V +KV      +A +   + E + +  + +  +V++  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C        +   LV E    G L ++L  V + +E+        LL ++++ +     
Sbjct: 78  VCQA------EALMLVMEMAGGGPLHKFL--VGKREEIP-VSNVAELLHQVSMGMKYLEE 128
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSIG 452
            +++H D         L   N+LL     + + DFGL++ L    ++    S G K  + 
Sbjct: 129 KNFVHRD---------LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK 178
Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLE-LIIRKKPSDIM 490
           + APE     + S+  DV+SYG+ M E L   +KP   M
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 140
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 141 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 132
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 110
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 111 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 164
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 165 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 217
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 218 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 260

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 132
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
            ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 88
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++        Y   + K  VY  +    + E +Y V R     +A + L ++       
Sbjct: 89  VRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 142
Query: 390 DVASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIG 446
            +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I 
Sbjct: 143 QLFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI- 196
Query: 447 VKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
              S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 197 --CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 239

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 152
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 132
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 132
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 81
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 82  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 135
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 136 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 188
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 189 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 231

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 136
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-G 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 137
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-G 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFI-AECRALRSIRHRN 328
            ++   +IG GSFG VY+  L D G      KV         ++F   E + +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------GKAFKNRELQIMRKLDHCN 74
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V++        Y   + K  VY  +    + E +Y V R     +A + L ++      
Sbjct: 75  IVRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYM 128
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
             +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 183
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 71/158 (44%), Gaps = 34/158 (21%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYP--VNREDEVDKAPRNLNLLQRLNIAIDVASALDYL 398
           Y+ N F  LV++ M+ G L ++L       E E  K  R L         ++V  AL  L
Sbjct: 93  YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL---------LEVICALHKL 143
Query: 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY 458
           +        H DLKP NILLD++M   + DFG +  L P     S   V G+  Y+APE 
Sbjct: 144 N------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCGTPSYLAPEI 194
Query: 459 ----------GLGSEVSTNGDVYSYGILMLELIIRKKP 486
                     G G EV    D++S G++M  L+    P
Sbjct: 195 IECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++A ALD+LH        + DLKP NILLDEE    + DFGL++       +  +    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           ++ Y+APE       + + D +S+G+LM E++
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 136
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFI-AECRALRSIRHRN 328
            ++   +IG GSFG VY+  L D G      KV         ++F   E + +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------GKAFKNRELQIMRKLDHCN 74
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V++        Y   + K  VY  +    + E +Y V R     +A + L ++      
Sbjct: 75  IVRL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYM 128
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
             +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 183
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 130
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           +G G +G V++G+      +V VK+F+    R  +S+  E     ++  RH N++  F A
Sbjct: 16  VGKGRYGEVWRGLWHG--ESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILG-FIA 69
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                   +    L+  + ++GSL ++L     E  +            L +A+  A  L
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA-----------LRLAVSAACGL 118
Query: 396 DYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS---SIGV 447
            +LH +      +P   H D K  N+L+   +   + D GLA      H Q S    IG 
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVM----HSQGSDYLDIGN 174
Query: 448 KGSIG---YIAPEYGLGSEVSTN-------GDVYSYGILMLELIIR 483
              +G   Y+APE  L  ++ T+        D++++G+++ E+  R
Sbjct: 175 NPRVGTKRYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           +G G +G V++G   +G   V VK+F+    R  +S+  E     ++  RH N++  F A
Sbjct: 45  VGKGRYGEVWRGSW-QGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILG-FIA 98
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                   +    L+  + + GSL ++L               L+ +  L I + +AS L
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGL 147
Query: 396 DYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS---IGV 447
            +LH +      +P   H DLK  NIL+ +     + D GLA      H Q+++   +G 
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGN 203
Query: 448 KGSIG---YIAPEYGLGSEVSTNG-------DVYSYGILMLELIIR 483
              +G   Y+APE  L   +  +        D++++G+++ E+  R
Sbjct: 204 NPRVGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 137
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 138
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 139 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 129
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 130 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 136
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R   I E + L       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V  + A     +  +   ++  E M  GSL++ L    R  E         +L +++IA
Sbjct: 69  IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 115
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             V   L YL    +    H D+KPSNIL++      + DFG++  L    +   +    
Sbjct: 116 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEFV 167
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P   M
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 136
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 155
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 156 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 209
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 210 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 262
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 263 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 305

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTV-KVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V + K+    H    +  + E + L   RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQ------- 136
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 104
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 105 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 158
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 159 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 211
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 212 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 254

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA----ECRALRSIRHRN---LV 330
           +G+G++G+V   V  +GRT   V +  L+    S  F      E R L+ +RH N   L+
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            VFT    +D    DF  LV  FM        L  + + +++ +      + Q L     
Sbjct: 91  DVFTPDETLD-DFTDF-YLVMPFMGTD-----LGKLMKHEKLGEDRIQFLVYQMLK---- 139
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
               L Y+H        H DLKP N+ ++E+    + DFGLAR        +   G   +
Sbjct: 140 ---GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVT 188
Query: 451 IGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNL 497
             Y APE  L     T   D++S G +M E+I  K     +F+G  +L
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHL 232

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           F     +G GS+GSVYK +  E    V +K   +      +  I E   ++     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK 88
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR---EDEVDKAPRNLNLLQRLNIA 388
            +    G  ++  D   +V E+   GS+ + +   N+   EDE+        +LQ     
Sbjct: 89  YY----GSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTEDEI------ATILQ----- 132
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
                 L+YLH   +    H D+K  NILL+ E  + + DFG+A  L  T        V 
Sbjct: 133 -STLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVI 186
Query: 449 GSIGYIAPEYGLGSEVSTN--GDVYSYGILMLELIIRKKP 486
           G+  ++APE  +  E+  N   D++S GI  +E+   K P
Sbjct: 187 GTPFWMAPE--VIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 114
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 115 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 168
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 169 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 221
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 222 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 264

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 110
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 111 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 164
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 165 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 217
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 218 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 260

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 18/135 (13%)
Query: 353 FMQNGSLEEWLYPVNREDEVD---KAPRNLNLLQRLNIAIDVASALDYLH-HDCQPITTH 408
           F ++ SL +    V  E++ D   K P  +  L  ++ +  VA  +++L    C     H
Sbjct: 173 FQEDKSLSD----VEEEEDSDGFYKEPITMEDL--ISYSFQVARGMEFLSSRKC----IH 222
Query: 409 CDLKPSNILLDEEMVSHVGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVST 466
            DL   NILL E  V  + DFGLAR  +  P +V+     +   + ++APE       ST
Sbjct: 223 RDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL--PLKWMAPESIFDKIYST 280
Query: 467 NGDVYSYGILMLELI 481
             DV+SYG+L+ E+ 
Sbjct: 281 KSDVWSYGVLLWEIF 295

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           ++   +IG GSFG VY+  L D G      KV      +       E + +R + H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIV 112
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++        Y   + K  VY  +    + E +Y V R     +A + L ++        
Sbjct: 113 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQ 166
Query: 391 VASALDYLHHD--CQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
           +  +L Y+H    C     H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 167 LFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 219
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 220 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 262

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH-------HHRASRSFIAECRALRSIRHRNLV 330
           +G GSFG V      + +  V +K  +         H R  R    E   L+ +RH +++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHII 72
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K++   +       D   +V E+   G L +++    R  E D+  R             
Sbjct: 73  KLYDVIT----TPTDI-VMVIEY-AGGELFDYIVEKKRMTE-DEGRRFFQ---------Q 116
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +  A++Y H   +    H DLKP N+LLD+ +   + DFGL+  +   +   +S    GS
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 451 IGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF 491
             Y APE      Y  G EV    DV+S GI++  +++ + P D  F
Sbjct: 171 PNYAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A ++   L+ LH +      + DLKP NILLD+     + D GLA  +P        +  
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-- 346
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G++GY+APE       + + D ++ G L+ E+I  + P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           +G G +G V++G   +G   V VK+F+    R  +S+  E     ++  RH N++  F A
Sbjct: 16  VGKGRYGEVWRGSW-QGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILG-FIA 69
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                   +    L+  + + GSL ++L               L+ +  L I + +AS L
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGL 118
Query: 396 DYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS---IGV 447
            +LH +      +P   H DLK  NIL+ +     + D GLA      H Q+++   +G 
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGN 174
Query: 448 KGSIG---YIAPEYGLGSEVSTNG-------DVYSYGILMLELIIR 483
              +G   Y+APE  L   +  +        D++++G+++ E+  R
Sbjct: 175 NPRVGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A ++   L+ LH +      + DLKP NILLD+     + D GLA  +P        +  
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-- 346
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            G++GY+APE       + + D ++ G L+ E+I  + P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 40/242 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           IG G +G V+ G     +  V VKVF         S+  E    +++  RH N++    A
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 336 CSGVDYQGNDFKALVY---EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               D +G      +Y   ++ +NGSL ++L               L+    L +A    
Sbjct: 100 ----DIKGTGSWTQLYLITDYHENGSLYDYL-----------KSTTLDAKSMLKLAYSSV 144
Query: 393 SALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPT-HVQTSSI 445
           S L +LH +      +P   H DLK  NIL+ +     + D GLA +F+  T  V     
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 446 GVKGSIGYIAPEYGLGSEVSTN-------GDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
              G+  Y+ PE  L   ++ N        D+YS+G+++ E+  R     I+ E  +  H
Sbjct: 205 TRVGTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 499 NF 500
           + 
Sbjct: 264 DL 265

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALR-SIR 325
           + F    ++G GSFG V+     +      +K      +         + E R L  +  
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H  L  +F  C+   +Q  +    V E++  G L   +Y +       ++    +L +  
Sbjct: 77  HPFLTHMF--CT---FQTKENLFFVMEYLNGGDL---MYHI-------QSCHKFDLSRAT 121
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A ++   L +LH        + DLK  NILLD++    + DFG+ +       +T+  
Sbjct: 122 FYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              G+  YIAPE  LG + + + D +S+G+L+ E++I + P
Sbjct: 179 C--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     IGTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+M  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIKVADFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     IGTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+M  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIKVADFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI--RHRNLVKVFTA 335
           +G G +G V++G   +G   V VK+F+    R  +S+  E     ++  RH N++  F A
Sbjct: 16  VGKGRYGEVWRGSW-QGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILG-FIA 69
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                   +    L+  + + GSL ++L               L+ +  L I + +AS L
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGL 118
Query: 396 DYLHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS---IGV 447
            +LH +      +P   H DLK  NIL+ +     + D GLA      H Q+++   +G 
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGN 174
Query: 448 KGSIG---YIAPEYGLGSEVSTNG-------DVYSYGILMLELIIR 483
              +G   Y+APE  L   +  +        D++++G+++ E+  R
Sbjct: 175 NPRVGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 26/215 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V VK+ +     +S  +    E R ++ + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      LV E+   G + ++L    R  E +   +             + SA+
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ----------IVSAV 126
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPTHVQTSSIGVKGSIGYI 454
            Y H   Q    H DLK  N+LLD +M   + DFG +  F     + T      GS  Y 
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYA 179
Query: 455 APEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           APE   G +      DV+S G+++  L+    P D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 26/215 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V VK+ +     +S  +    E R ++ + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      LV E+   G + ++L    R  E +   +             + SA+
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ----------IVSAV 126
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPTHVQTSSIGVKGSIGYI 454
            Y H   Q    H DLK  N+LLD +M   + DFG +  F     + T      GS  Y 
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYA 179
Query: 455 APEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           APE   G +      DV+S G+++  L+    P D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 89/230 (38%), Gaps = 52/230 (22%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNL- 329
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N+ 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 330 ----------------VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVD 373
                           V + T   G D     +K L  + + N  +  +LY + R     
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADL----YKLLKTQHLSNDHICYFLYQILR----- 155
Query: 374 KAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
                                L Y+H        H DLKPSN+LL+      + DFGLAR
Sbjct: 156 --------------------GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR 192
Query: 434 FLPPTHVQTSSIG-VKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
              P H  T  +     +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 193 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV +         ++ E   L S  H N+VK+  A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y  N+   L+ EF   G+++  +  + R       P   + +Q   +      AL+Y
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELER-------PLTESQIQV--VCKQTLDALNY 150
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGYIAP 456
           LH +      H DLK  NIL   +    + DFG+ A+       + S I   G+  ++AP
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWMAP 204
Query: 457 EYGLGSEVSTN------GDVYSYGILMLEL 480
           E  +  E S +       DV+S GI ++E+
Sbjct: 205 EVVM-CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLV 330
           +++ + IG G++G V     +  +  V +K  +   H    +  + E + L   RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +         +      +V + M+       LY + +   +        L Q       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKCQHLSNDHICYFLYQ------- 136
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG-VKG 449
           +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELI 481
           +  Y APE  L S+  T   D++S G ++ E++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV +         ++ E   L S  H N+VK+  A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y  N+   L+ EF   G+++  +  + R       P   + +Q   +      AL+Y
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELER-------PLTESQIQV--VCKQTLDALNY 150
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGYIAP 456
           LH +      H DLK  NIL   +    + DFG+ A+       + S I   G+  ++AP
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI---GTPYWMAP 204
Query: 457 EYGLGSEVSTN------GDVYSYGILMLEL 480
           E  +  E S +       DV+S GI ++E+
Sbjct: 205 EVVM-CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFN---LHHHRASRSFIAECRALR 322
           +D +    ++G GSFG V   +L + + T     VKV +   +       S + E + L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N+ K++       ++   +  LV E    G L + +    R  EVD A       
Sbjct: 82  QLDHPNIXKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 129
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTH 439
               I   V S + Y H +      H DLKP N+LL+ +       + DFGL+     + 
Sbjct: 130 ---RIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                I   G+  YIAPE   G+      DV+S G+++  L+
Sbjct: 184 KXKDKI---GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILL 221

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 41/227 (18%)
Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVF-NLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +        ++    V VK+  +  H     + ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLE-----------EWLYPVNREDEVDKAPRNL 379
            +  AC+     G     ++ E+   G L            E+ Y  +   E   + R+L
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 380 NLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438
                L+ +  VA  + +L   +C     H D+   N+LL    V+ +GDFGLAR +   
Sbjct: 169 -----LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI--- 216
Query: 439 HVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            +  S+  VKG+    + ++APE       +   DV+SYGIL+ E+ 
Sbjct: 217 -MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G  G V+  V ++    V +K   L   ++ +  + E + +R + H N+VKVF    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLNIAIDVA--- 392
               Q  D           GSL E   +Y V    E D A    N+L++  +  + A   
Sbjct: 79  PSGSQLTD---------DVGSLTELNSVYIVQEYMETDLA----NVLEQGPLLEEHARLF 125
Query: 393 -----SALDYLHHDCQPITTHCDLKPSNILLD-EEMVSHVGDFGLARFLPPTHVQTSSIG 446
                  L Y+H        H DLKP+N+ ++ E++V  +GDFGLAR + P +     + 
Sbjct: 126 MYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 447 VKGSI--GYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRK 484
            +G +   Y +P   L     T   D+++ G +  E++  K
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
           H R   S   E    RS+ H+++V          ++ NDF  +V E  +  SL E    +
Sbjct: 63  HQREKMSM--EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE----L 111
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
           ++  +    P     L+++ +         YLH +      H DLK  N+ L+E++   +
Sbjct: 112 HKRRKALTEPEARYYLRQIVLGCQ------YLHRN---RVIHRDLKLGNLFLNEDLEVKI 162
Query: 427 GDFGLARFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           GDFGLA     T V+      K   G+  YIAPE       S   DV+S G +M  L++ 
Sbjct: 163 GDFGLA-----TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 217
Query: 484 KKPSDIMFEGDMNLHNFARM-----ALPDHVMDIVDS 515
           K P    FE       + R+     ++P H+  +  S
Sbjct: 218 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAAS 250

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
           H R   S   E    RS+ H+++V          ++ NDF  +V E  +  SL E    +
Sbjct: 59  HQREKMSM--EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE----L 107
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
           ++  +    P     L+++ +         YLH +      H DLK  N+ L+E++   +
Sbjct: 108 HKRRKALTEPEARYYLRQIVLGCQ------YLHRN---RVIHRDLKLGNLFLNEDLEVKI 158
Query: 427 GDFGLARFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           GDFGLA     T V+      K   G+  YIAPE       S   DV+S G +M  L++ 
Sbjct: 159 GDFGLA-----TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213
Query: 484 KKPSDIMFEGDMNLHNFARM-----ALPDHVMDIVDS 515
           K P    FE       + R+     ++P H+  +  S
Sbjct: 214 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAAS 246

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 70/158 (44%), Gaps = 34/158 (21%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYP--VNREDEVDKAPRNLNLLQRLNIAIDVASALDYL 398
           Y+ N F  LV++ M+ G L ++L       E E  K  R L         ++V  AL  L
Sbjct: 80  YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL---------LEVICALHKL 130
Query: 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY 458
           +        H DLKP NILLD++M   + DFG +  L P         V G+  Y+APE 
Sbjct: 131 N------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEI 181
Query: 459 ----------GLGSEVSTNGDVYSYGILMLELIIRKKP 486
                     G G EV    D++S G++M  L+    P
Sbjct: 182 IECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 28/209 (13%)
Query: 284 GSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343
           G ++KG        V V        R SR F  EC  LR   H N++ V  AC       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PP 80
Query: 344 NDFKALVYEFMQNGSLEEWLYPVNREDE---VDKAPRNLNLLQRLNIAIDVASALDYLHH 400
                L+  +   GS    LY V  E     VD++       Q +  A+D A    +L H
Sbjct: 81  APHPTLITHWXPYGS----LYNVLHEGTNFVVDQS-------QAVKFALDXARGXAFL-H 128
Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL 460
             +P+     L   ++ +DE+  + +    +            S G   +  ++APE   
Sbjct: 129 TLEPLIPRHALNSRSVXIDEDXTARISXADVK-------FSFQSPGRXYAPAWVAPEALQ 181
Query: 461 GSEVSTN---GDVYSYGILMLELIIRKKP 486
                TN    D +S+ +L+ EL+ R+ P
Sbjct: 182 KKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
           H R   S   E    RS+ H+++V          ++ NDF  +V E  +  SL E    +
Sbjct: 59  HQREKMSM--EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE----L 107
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
           ++  +    P     L+++ +         YLH +      H DLK  N+ L+E++   +
Sbjct: 108 HKRRKALTEPEARYYLRQIVLGCQ------YLHRN---RVIHRDLKLGNLFLNEDLEVKI 158
Query: 427 GDFGLARFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           GDFGLA     T V+      K   G+  YIAPE       S   DV+S G +M  L++ 
Sbjct: 159 GDFGLA-----TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213
Query: 484 KKPSDIMFEGDMNLHNFARM-----ALPDHVMDIVDS 515
           K P    FE       + R+     ++P H+  +  S
Sbjct: 214 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAAS 246

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 88  PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 138
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+DE+    V DFG A+      V+  +  
Sbjct: 139 LTFEYLHSLDLIYRD---------LKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWX 184
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 185 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 218

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++ +VYKG        V +K   L H   A  + I E   L+ ++H N+V +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                       LV+E++ +  L+++L      D+        N++   N+ + +   L 
Sbjct: 70  -----HTEKSLTLVFEYL-DKDLKQYL------DDCG------NIINMHNVKLFLFQLLR 111
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGVKGSIGYIA 455
            L +  +    H DLKP N+L++E     + DFGLAR    PT    + +    ++ Y  
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV---VTLWYRP 168
Query: 456 PEYGLGS-EVSTNGDVYSYGILMLEL 480
           P+  LGS + ST  D++  G +  E+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEM 194

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
           H R   S   E    RS+ H+++V          ++ NDF  +V E  +  SL E    +
Sbjct: 83  HQREKMSM--EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE----L 131
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
           ++  +    P     L+++ +         YLH +      H DLK  N+ L+E++   +
Sbjct: 132 HKRRKALTEPEARYYLRQIVLGCQ------YLHRN---RVIHRDLKLGNLFLNEDLEVKI 182
Query: 427 GDFGLARFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           GDFGLA     T V+      K   G+  YIAPE       S   DV+S G +M  L++ 
Sbjct: 183 GDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
Query: 484 KKPSDIMFEGDMNLHNFARM-----ALPDHVMDIVDS 515
           K P    FE       + R+     ++P H+  +  S
Sbjct: 238 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAAS 270

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 70/158 (44%), Gaps = 34/158 (21%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYP--VNREDEVDKAPRNLNLLQRLNIAIDVASALDYL 398
           Y+ N F  LV++ M+ G L ++L       E E  K  R L         ++V  AL  L
Sbjct: 93  YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL---------LEVICALHKL 143
Query: 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEY 458
           +        H DLKP NILLD++M   + DFG +  L P         V G+  Y+APE 
Sbjct: 144 N------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEI 194
Query: 459 ----------GLGSEVSTNGDVYSYGILMLELIIRKKP 486
                     G G EV    D++S G++M  L+    P
Sbjct: 195 IECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 21/150 (14%)
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSL---EEWLYPVNREDEVDKAPRNLNLLQRLNIAID- 390
            C G+     D   ++YE+M+N S+   +E+ + +      DK       +Q +   I  
Sbjct: 107 TCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVL------DKNYTCFIPIQVIKCIIKS 159
Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           V ++  Y+H+  +    H D+KPSNIL+D+     + DFG + ++    ++    G +G+
Sbjct: 160 VLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----GSRGT 213
Query: 451 IGYIAPEYGLGSEVSTNG---DVYSYGILM 477
             ++ PE+   +E S NG   D++S GI +
Sbjct: 214 YEFMPPEF-FSNESSYNGAKVDIWSLGICL 242

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 21/209 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V           V VK+ +L   +       E   +R  +H N+V+++ +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-- 110
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   +   ++ EF+Q G+L + +  V            LN  Q   +   V  AL Y
Sbjct: 111 ---YLVGEELWVLMEFLQGGALTDIVSQVR-----------LNEEQIATVCEAVLQALAY 156
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH        H D+K  +ILL  +    + DFG    +     +   +   G+  ++APE
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXL--VGTPYWMAPE 211
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               S  +T  D++S GI+++E++  + P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
           H R   S   E    RS+ H+++V          ++ NDF  +V E  +  SL E    +
Sbjct: 81  HQREKMSM--EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE----L 129
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
           ++  +    P     L+++ +         YLH +      H DLK  N+ L+E++   +
Sbjct: 130 HKRRKALTEPEARYYLRQIVLGCQ------YLHRN---RVIHRDLKLGNLFLNEDLEVKI 180
Query: 427 GDFGLARFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           GDFGLA     T V+      K   G+  YIAPE       S   DV+S G +M  L++ 
Sbjct: 181 GDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 235
Query: 484 KKPSDIMFEGDMNLHNFARM-----ALPDHVMDIVDS 515
           K P    FE       + R+     ++P H+  +  S
Sbjct: 236 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAAS 268

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 25/226 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           +  F   +L+G G++G V        G      K+        +   + E + L+  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N++ +F       ++  +   ++ E MQ       L+ V     +        + Q L  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--------PPTH 439
           A+ V    + +H D         LKPSN+L++      V DFGLAR +         PT 
Sbjct: 124 AVKVLHGSNVIHRD---------LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 440 VQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
            Q+  +    +  Y APE  L S + S   DV+S G ++ EL +R+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 103/254 (40%), Gaps = 32/254 (12%)
Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFT 334
           ++G GSFG V K      +    VKV N     ++ + + + E   L+ + H N++K+F 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                    + F  +V E    G L + +    R  E D A           I   V S 
Sbjct: 89  ILED----SSSF-YIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSG 133
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTHVQTSSIGVKGSI 451
           + Y+H   +    H DLKP NILL+ +       + DFGL+            I   G+ 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTA 187
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD 511
            YIAPE   G+      DV+S G+++  L+    P    F G        R+    +  D
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETGKYAFD 242
Query: 512 IVD-STLLNDVEDL 524
           +    T+ +D +DL
Sbjct: 243 LPQWRTISDDAKDL 256

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 26/215 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V V++ +     +S  +    E R ++ + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      LV E+   G + ++L    R  E +   +             + SA+
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ----------IVSAV 126
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPTHVQTSSIGVKGSIGYI 454
            Y H   Q    H DLK  N+LLD +M   + DFG +  F     + T      GS  Y 
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYA 179
Query: 455 APEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           APE   G +      DV+S G+++  L+    P D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           + F    +IG G+FG V    +        +K+ N       R+  A  R  R +     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETACFREERDVLVNGD 148
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRLNI 387
            +  TA     +Q  +   LV ++   G L   L         DK P ++    +  + +
Sbjct: 149 CQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFE-----DKLPEDMARFYIGEMVL 202
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           AID    L Y+H D         +KP N+LLD      + DFG    +       SS+ V
Sbjct: 203 AIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 253
Query: 448 KGSIGYIAPEY------GLGSEVSTNGDVYSYGILMLELIIRKKP--SDIMFEGDMNLHN 499
            G+  YI+PE       G+G +     D +S G+ M E++  + P  ++ + E    + N
Sbjct: 254 -GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311
Query: 500 F-ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQ 532
              R   P HV D+ +     D+    I S +R+
Sbjct: 312 HEERFQFPSHVTDVSEEA--KDLIQRLICSRERR 343

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           + F    +IG G+FG V    +        +K+ N       R+  A  R  R +     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETACFREERDVLVNGD 132
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRLNI 387
            +  TA     +Q  +   LV ++   G L   L         DK P ++    +  + +
Sbjct: 133 CQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFE-----DKLPEDMARFYIGEMVL 186
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           AID    L Y+H D         +KP N+LLD      + DFG    +       SS+ V
Sbjct: 187 AIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 237
Query: 448 KGSIGYIAPEY------GLGSEVSTNGDVYSYGILMLELIIRKKP--SDIMFEGDMNLHN 499
            G+  YI+PE       G+G +     D +S G+ M E++  + P  ++ + E    + N
Sbjct: 238 -GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
Query: 500 F-ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQ 532
              R   P HV D+ +     D+    I S +R+
Sbjct: 296 HEERFQFPSHVTDVSEEA--KDLIQRLICSRERR 327

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV +         ++ E   L S  H N+VK+  A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y  N+   L+ EF   G+++  +  + R       P   + +Q   +      AL+Y
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELER-------PLTESQIQV--VCKQTLDALNY 150
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
           LH +      H DLK  NIL   +    + DFG++     T          G+  ++APE
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPE 205
Query: 458 YGLGSEVSTN------GDVYSYGILMLEL 480
             +  E S +       DV+S GI ++E+
Sbjct: 206 VVM-CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 66  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 115
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 116 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 168 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
           H R   S   E    RS+ H+++V          ++ NDF  +V E  +  SL E    +
Sbjct: 57  HQREKMSM--EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE----L 105
Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426
           ++  +    P     L+++ +         YLH +      H DLK  N+ L+E++   +
Sbjct: 106 HKRRKALTEPEARYYLRQIVLGCQ------YLHRN---RVIHRDLKLGNLFLNEDLEVKI 156
Query: 427 GDFGLARFLPPTHVQTSSIGVK---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483
           GDFGLA     T V+      K   G+  YIAPE       S   DV+S G +M  L++ 
Sbjct: 157 GDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
Query: 484 KKPSDIMFEGDMNLHNFARM-----ALPDHVMDIVDS 515
           K P    FE       + R+     ++P H+  +  S
Sbjct: 212 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAAS 244

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 11/108 (10%)
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
            IA+ +  AL++LH     I  H D+KPSN+L++      + DFG++ +L     +    
Sbjct: 113 KIAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 446 GVKGSIGYIAPEYGLGSEVSTNG-----DVYSYGILMLELIIRKKPSD 488
           G K    Y+APE  +  E++  G     D++S GI M+EL I + P D
Sbjct: 171 GCK---PYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR------ 325
           + S   +G+G++GSV   +       V +K       + SR F +E  A R+ R      
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-------KLSRPFQSEIFAKRAYRELLLLK 96
Query: 326 ---HRN---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
              H N   L+ VFT  S +     DF  LV  FMQ   L++ +     E+++       
Sbjct: 97  HMQHENVIGLLDVFTPASSLR-NFYDF-YLVMPFMQT-DLQKIMGMEFSEEKIQ------ 147
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
                  +   +   L Y+H        H DLKP N+ ++E+    + DFGLAR     H
Sbjct: 148 ------YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----H 193
Query: 440 VQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
                 G   +  Y APE  L     +   D++S G +M E++  K
Sbjct: 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 26/228 (11%)
Query: 271 GFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFI-AECRALRSIRHRN 328
            ++   +IG GSFG VY+  L D G      KV         ++F   E + +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------GKAFKNRELQIMRKLDHCN 74
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V++        Y   + K  VY  +    +   +Y V R     +A + L ++      
Sbjct: 75  IVRL----RYFFYSSGEKKDEVYLNLVLDYVPATVYRVAR--HYSRAKQTLPVIYVKLYM 128
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGV 447
             +  +L Y+H        H D+KP N+LLD +  V  + DFG A+ L       S I  
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 183
Query: 448 KGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             S  Y APE   G ++ +++ DV+S G ++ EL++ +     +F GD
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP----IFPGD 226

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 30/217 (13%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V VK+ +     +S  +    E R ++ + H N+VK+F  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                 +      LV E+   G + ++L  +   +E E     R             + S
Sbjct: 75  I-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ------------IVS 117
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPTHVQTSSIGVKGSIG 452
           A+ Y H   Q    H DLK  N+LLD +M   + DFG +  F     + T      GS  
Sbjct: 118 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPP 170
Query: 453 YIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           Y APE   G +      DV+S G+++  L+    P D
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 278 IGTGSFGSVYKGV--LDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFT 334
           +G G+FGSV +GV  + + +  V +KV      +A +   + E + +  + +  +V++  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C        +   LV E    G L ++L  V + +E+  +     LL ++++ +     
Sbjct: 404 VCQA------EALMLVMEMAGGGPLHKFL--VGKREEIPVS-NVAELLHQVSMGMKYLEE 454
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSIG 452
            +++H +         L   N+LL     + + DFGL++ L    ++    S G K  + 
Sbjct: 455 KNFVHRN---------LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK 504
Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLE-LIIRKKPSDIM 490
           + APE     + S+  DV+SYG+ M E L   +KP   M
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 122 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 172
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+ ++  
Sbjct: 173 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGATWT 218
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASRSFI-AECRALRSIR 325
           D F     +G+G+FG V+   L E R++     +K  N    +     I AE   L+S+ 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N++K+F      DY       +V E  + G L E +       +         L++++
Sbjct: 79  HPNIIKIFEVFE--DYHN---MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH----VGDFGLARFLPPTHVQ 441
                  +AL Y H        H DLKP NIL  ++   H    + DFGLA         
Sbjct: 134 ------MNALAYFHSQH---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKS---D 180
Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             S    G+  Y+APE     +V+   D++S G++M  L+
Sbjct: 181 EHSTNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLL 219

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 103/254 (40%), Gaps = 32/254 (12%)
Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFT 334
           ++G GSFG V K      +    VKV N     ++ + + + E   L+ + H N++K+F 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                    + F  +V E    G L + +    R  E D A           I   V S 
Sbjct: 89  ILE----DSSSF-YIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSG 133
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTHVQTSSIGVKGSI 451
           + Y+H   +    H DLKP NILL+ +       + DFGL+            I   G+ 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTA 187
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD 511
            YIAPE   G+      DV+S G+++  L+    P    F G        R+    +  D
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETGKYAFD 242
Query: 512 IVD-STLLNDVEDL 524
           +    T+ +D +DL
Sbjct: 243 LPQWRTISDDAKDL 256

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR------ 325
           + S   +G+G++GSV   +       V +K       + SR F +E  A R+ R      
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-------KLSRPFQSEIFAKRAYRELLLLK 78
Query: 326 ---HRN---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
              H N   L+ VFT  S +     DF  LV  FMQ   L++ +     E+++       
Sbjct: 79  HMQHENVIGLLDVFTPASSLR-NFYDF-YLVMPFMQT-DLQKIMGLKFSEEKIQ------ 129
Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
                  +   +   L Y+H        H DLKP N+ ++E+    + DFGLAR     H
Sbjct: 130 ------YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----H 175
Query: 440 VQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
                 G   +  Y APE  L     +   D++S G +M E++  K
Sbjct: 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 371 EVDKAPRNL-----NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425
           E ++AP +L      L   +  +  VA  +++L         H DL   NILL E+ V  
Sbjct: 175 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 231
Query: 426 VGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-I 482
           + DFGLAR  +  P +V+      +  + ++APE       +   DV+S+G+L+ E+  +
Sbjct: 232 ICDFGLARDIYKDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 289
Query: 483 RKKPS---DIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
              P     I  E    L    RM  PD+    +  T+L+
Sbjct: 290 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 329

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     IGTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIKVADFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 371 EVDKAPRNL-----NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425
           E ++AP +L      L   +  +  VA  +++L         H DL   NILL E+ V  
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 233
Query: 426 VGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-I 482
           + DFGLAR  +  P +V+      +  + ++APE       +   DV+S+G+L+ E+  +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291
Query: 483 RKKPS---DIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
              P     I  E    L    RM  PD+    +  T+L+
Sbjct: 292 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 103/254 (40%), Gaps = 32/254 (12%)
Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFT 334
           ++G GSFG V K      +    VKV N     ++ + + + E   L+ + H N++K+F 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                    + F  +V E    G L + +    R  E D A           I   V S 
Sbjct: 89  ILE----DSSSF-YIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSG 133
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVS---HVGDFGLARFLPPTHVQTSSIGVKGSI 451
           + Y+H   +    H DLKP NILL+ +       + DFGL+            I   G+ 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTA 187
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD 511
            YIAPE   G+      DV+S G+++  L+    P    F G        R+    +  D
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETGKYAFD 242
Query: 512 IVD-STLLNDVEDL 524
           +    T+ +D +DL
Sbjct: 243 LPQWRTISDDAKDL 256

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 30/217 (13%)
Query: 278 IGTGSFGSVY--KGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
           IG G+F  V   + VL  GR  V VK+ +      +  +    E R ++ + H N+VK+F
Sbjct: 23  IGKGNFAKVKLARHVL-TGRE-VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                   +      LV E+   G + ++L    R  E +   +   ++          S
Sbjct: 81  EVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----------S 125
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPTHVQTSSIGVKGSIG 452
           A+ Y H   Q    H DLK  N+LLD +M   + DFG +  F     + T      GS  
Sbjct: 126 AVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPP 178
Query: 453 YIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           Y APE   G +      DV+S G+++  L+    P D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V V++ +     +S  +    E R ++ + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      LV E+   G + ++L    R  E +   +             + SA+
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ----------IVSAV 126
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-----GS 450
            Y H   Q    H DLK  N+LLD +M   + DFG +           + G K     GS
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--------NEFTFGNKLDEFCGS 175
Query: 451 IGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
             Y APE   G +      DV+S G+++  L+    P D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKXVNHKN 84
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 85  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLXQVI-----QMELDHERMSYLLYQML 136
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 137 -------XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV 186
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 187 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 227

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG+G+ G   + Y  +L+     V +K       + SR F  +  A R+ R   L+KV  
Sbjct: 32  IGSGAQGIVVAAYDAILERN---VAIK-------KLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             + +         L+  F    SLEE+  +Y V     ++    NL+ + ++ +  +  
Sbjct: 82  HKNII--------GLLNVFTPQKSLEEFQDVYIV-----MELMDANLSQVIQMELDHERM 128
Query: 393 SALDY-----LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           S L Y     + H       H DLKPSNI++  +    + DFGLAR    + + T  +  
Sbjct: 129 SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +    Y APE  LG     N D++S G++M E+I
Sbjct: 189 R---YYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V VK+ +     +S  +    E R ++ + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      LV E+   G + ++L    R  E +   +             + SA+
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ----------IVSAV 126
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-----GS 450
            Y H   Q    H DLK  N+LLD +M   + DFG +           + G K     G+
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--------NEFTFGNKLDAFCGA 175
Query: 451 IGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
             Y APE   G +      DV+S G+++  L+    P D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 22/211 (10%)
Query: 273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           S   ++G G FG V+K         +  K+      +       E   +  + H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           + A     ++  +   LV E++  G L          D +     NL  L  +     + 
Sbjct: 152 YDA-----FESKNDIVLVMEYVDGGELF---------DRIIDESYNLTELDTILFMKQIC 197
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG--DFGLARFLPPTHVQTSSIGVKGS 450
             + ++H   Q    H DLKP NIL        +   DFGLAR   P      +    G+
Sbjct: 198 EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GT 251
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             ++APE      VS   D++S G++   L+
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 152
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 153 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 84
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 85  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLXQVI-----QMELDHERMSYLLYQML 136
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 137 -------XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV 186
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 187 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 227

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 371 EVDKAPRNL-----NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425
           E ++AP +L      L   +  +  VA  +++L         H DL   NILL E+ V  
Sbjct: 182 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 238
Query: 426 VGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-I 482
           + DFGLAR  +  P +V+      +  + ++APE       +   DV+S+G+L+ E+  +
Sbjct: 239 ICDFGLARDIYKDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 296
Query: 483 RKKPS---DIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
              P     I  E    L    RM  PD+    +  T+L+
Sbjct: 297 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 336

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 4/176 (2%)
Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGR-LRRLQVPDLNNNSIGGE 618
           LDL+S KL+         L+ L++L L +N     +P+ I + L+ L+   + +N +   
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQA- 99
Query: 619 IPVNL-SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
           +P+ +     NL  + L +NQL    P  F SL+K+  LSLG+N L          L+SL
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSL 159
Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           +++ L  N L         KL  L  L L  N+L  +   +  ++  +    + EN
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG+G+ G   + Y  +L+     V +K       + SR F  +  A R+ R   L+KV  
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIK-------KLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             + +         L+  F    SLEE+  +Y V     ++    NL+ + ++ +  +  
Sbjct: 82  HKNII--------GLLNVFTPQKSLEEFQDVYIV-----MELMDANLSQVIQMELDHERM 128
Query: 393 SALDY-----LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           S L Y     + H       H DLKPSNI++  +    + DFGLAR    + + T  +  
Sbjct: 129 SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +    Y APE  LG     N D++S G++M E+I
Sbjct: 189 R---YYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L +   +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELL 217

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 371 EVDKAPRNL-----NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425
           E ++AP +L      L   +  +  VA  +++L         H DL   NILL E+ V  
Sbjct: 184 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 240
Query: 426 VGDFGLAR--FLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI-I 482
           + DFGLAR  +  P +V+      +  + ++APE       +   DV+S+G+L+ E+  +
Sbjct: 241 ICDFGLARDIYKDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 298
Query: 483 RKKPS---DIMFEGDMNLHNFARMALPDHVMDIVDSTLLN 519
              P     I  E    L    RM  PD+    +  T+L+
Sbjct: 299 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 338

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 77
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 78  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLXQVI-----QMELDHERMSYLLYQML 129
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 130 -------XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV 179
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 180 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 122 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE----PHARFYAAQIV 172
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 173 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 218
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 276 NLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            ++G G FG VY+GV    +     V VK         ++  F++E   ++++ H ++VK
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     G+  +   +  ++ E    G L  +L         ++   +L +L  +  ++ +
Sbjct: 90  LI----GIIEEEPTW--IIMELYPYGELGHYL---------ERNKNSLKVLTLVLYSLQI 134
Query: 392 ASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
             A+ YL   +C     H D+   NIL+       +GDFGL+R++       +S+  +  
Sbjct: 135 CKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLP 189
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           I +++PE       +T  DV+ + + M E++
Sbjct: 190 IKWMSPESINFRRFTTASDVWMFAVCMWEIL 220

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKXVNHKN 84
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 85  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLXQVI-----QMELDHERMSYLLYQML 136
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 137 -------CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV 186
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 187 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           IG+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 91  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 130
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 131 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDD 182
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 183 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           +  F   +L+G G++G V        G      K+        +   + E + L+  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N++ +F       ++  +   ++ E MQ       L+ V     +        + Q L  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--------PPTH 439
           A+ V    + +H D         LKPSN+L++      V DFGLAR +         PT 
Sbjct: 124 AVKVLHGSNVIHRD---------LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 440 VQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
            Q+       +  Y APE  L S + S   DV+S G ++ EL +R+
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 96  PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE----PHARFYAAQIV 146
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 147 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 192
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 193 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 226

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 66  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 115
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 116 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 5/142 (3%)
Query: 645 SDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPF-TLSKLKNLVI 703
           + F  L+K+  L+L +N L         +L+ L  + LA N LA S+P      L  L  
Sbjct: 53  ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDK 111
Query: 704 LYLGVNRLSGIVPSSIFN-ISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG 762
           LYLG N+L  + PS +F+ ++ + E  +  N++Q +IP      L NLQ  S+ TN++  
Sbjct: 112 LYLGGNQLKSL-PSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS 169
Query: 763 AIPPSISNASKLEVFQALNNKL 784
               +     KL+      N+ 
Sbjct: 170 VPHGAFDRLGKLQTITLFGNQF 191

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++G V   V       V VK+ ++        +   E    + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G   +GN  + L  E+   G L + + P     E D A R  + L          + + 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---------AGVV 119
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YLH       TH D+KP N+LLDE     + DFGLA      + +     + G++ Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 457 EYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
           E     E      DV+S GI++  ++  + P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++G V   V       V VK+ ++        +   E    + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G   +GN  + L  E+   G L + + P     E D A R  + L          + + 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---------AGVV 119
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YLH       TH D+KP N+LLDE     + DFGLA      + +     + G++ Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 457 EYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
           E     E      DV+S GI++  ++  + P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++G V   V       V VK+ ++        +   E    + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G   +GN  + L  E+   G L + + P     E D A R  + L          + + 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---------AGVV 119
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YLH       TH D+KP N+LLDE     + DFGLA      + +     + G++ Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 457 EYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
           E     E      DV+S GI++  ++  + P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR 327
           +  F   +L+G G++G V        G      K+        +   + E + L+  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N++ +F       ++  +   ++ E MQ       L+ V     +        + Q L  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--------PPTH 439
           A+ V    + +H D         LKPSN+L++      V DFGLAR +         PT 
Sbjct: 124 AVKVLHGSNVIHRD---------LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 440 VQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK 484
            Q+       +  Y APE  L S + S   DV+S G ++ EL +R+
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 276 NLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            ++G G FG VY+GV    +     V VK         ++  F++E   ++++ H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +     G+  +   +  ++ E    G L  +L         ++   +L +L  +  ++ +
Sbjct: 78  LI----GIIEEEPTW--IIMELYPYGELGHYL---------ERNKNSLKVLTLVLYSLQI 122
Query: 392 ASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
             A+ YL   +C     H D+   NIL+       +GDFGL+R++       +S+  +  
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLP 177
Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           I +++PE       +T  DV+ + + M E++
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEIL 208

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           TD +     IG G+F  V + V          K+ N      R  +    E R  R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  + S        F  LV++ +  G L E +       E D +    + +Q++ 
Sbjct: 63  SNIVRLHDSISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADAS----HCIQQI- 112
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTS 443
                   L+ + H  Q    H DLKP N+LL  +       + DFGLA  +     Q +
Sbjct: 113 --------LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQA 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             G  G+ GY++PE           D+++ G+++  L++   P
Sbjct: 163 WFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 77
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 78  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 128
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 129 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 175
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 176 -RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 217

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 276 NLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            ++G G FG VY+GV    +     V VK         ++  F++E   ++++ H ++VK
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI---A 388
           +     G+  +   +  ++ E    G L  +L             RN N L+ L +   +
Sbjct: 74  LI----GIIEEEPTW--IIMELYPYGELGHYL------------ERNKNSLKVLTLVLYS 115
Query: 389 IDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           + +  A+ YL   +C     H D+   NIL+       +GDFGL+R++       +S+  
Sbjct: 116 LQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-T 170
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +  I +++PE       +T  DV+ + + M E++
Sbjct: 171 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 204

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 94  PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 144
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 145 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 190
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 5/140 (3%)
Query: 647 FGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPF-TLSKLKNLVILY 705
           F  L+K+  L+L +N L         +L+ L  + LA N LA S+P      L  L  LY
Sbjct: 55  FRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLY 113
Query: 706 LGVNRLSGIVPSSIFN-ISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI 764
           LG N+L  + PS +F+ ++ + E  +  N++Q +IP      L NLQ  S+ TN++    
Sbjct: 114 LGGNQLKSL-PSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVP 171
Query: 765 PPSISNASKLEVFQALNNKL 784
             +     KL+      N+ 
Sbjct: 172 HGAFDRLGKLQTITLFGNQF 191

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++G V   V       V VK+ ++        +   E    + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G   +GN  + L  E+   G L + + P     E D A R  + L          + + 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---------AGVV 119
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YLH       TH D+KP N+LLDE     + DFGLA      + +     + G++ Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 457 EYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
           E     E      DV+S GI++  ++  + P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 64  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 113
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 114 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKXQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 66  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 115
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 116 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTAC 336
           +G G++G V   V       V VK+ ++        +   E    + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G   +GN  + L  E+   G L + + P     E D A R  + L          + + 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---------AGVV 118
Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           YLH       TH D+KP N+LLDE     + DFGLA      + +     + G++ Y+AP
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 457 EYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
           E     E      DV+S GI++  ++  + P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G++G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 91  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 130
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 131 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDD 182
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 183 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 152
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 153 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 122 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 172
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 173 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 218
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV           +I E   L +  H  +VK+  A  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 76
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y  +    ++ EF   G+++  +  ++         R L   Q   +   +  AL++
Sbjct: 77  ---YYHDGKLWIMIEFCPGGAVDAIMLELD---------RGLTEPQIQVVCRQMLEALNF 124
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGYIAP 456
           LH        H DLK  N+L+  E    + DFG+ A+ L     + S I   G+  ++AP
Sbjct: 125 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMAP 178
Query: 457 EYGL-----GSEVSTNGDVYSYGILMLEL 480
           E  +      +      D++S GI ++E+
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           L+ VFT    ++ + ND   + +           L   +  + V  A    + +Q L   
Sbjct: 82  LLDVFTPARSLE-EFNDVYLVTH-----------LMGADLNNIVKCAKLTDDHVQFL--I 127
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H      G  
Sbjct: 128 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYV 179
Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
            +  Y APE  L     +   D++S G +M EL+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 96/253 (37%), Gaps = 27/253 (10%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL 329
           + F    +IG G+FG V    L        +K+ N       R+  A  R  R +     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGD 132
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN--LLQRLNI 387
            K  T      +Q ++   LV ++   G L   L         D+ P  +    L  + I
Sbjct: 133 SKWITTLHYA-FQDDNNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVI 186
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           AID    L Y+H D         +KP NIL+D      + DFG    L       SS+ V
Sbjct: 187 AIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 448 KGSIGYIAPEY-----GLGSEVSTNGDVYSYGILMLELIIRKKP--SDIMFEGDMNLHNF 500
            G+  YI+PE      G         D +S G+ M E++  + P  ++ + E    + N 
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
Query: 501 A-RMALPDHVMDI 512
             R   P  V D+
Sbjct: 297 KERFQFPTQVTDV 309

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 152
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 153 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 92
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 93  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 143
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 190
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 -RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 152
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 153 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 94  PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE----PHARFYAAQIV 144
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 145 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 190
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 92
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 93  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 143
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 190
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 96
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 97  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 136
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 137 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDD 188
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 189 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELIIRKKPSDIMFEG 493
            D++S G +M E++  K    I+F G
Sbjct: 206 VDIWSVGCIMGEMVRHK----ILFPG 227

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 82
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 83  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 122
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 123 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 174
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 175 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 85
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 86  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 137
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 138 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 188 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 228

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKXQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 520 DVEDLAIISNQRQRQIRVNNIIEC-----LISMLRIGSKAQKVTILD-------LESLKL 567
           D++ L  ++N  + ++  N I +      L S+ ++   + +VT L        LE L +
Sbjct: 121 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFSSNQVTDLKPLANLTTLERLDI 180
Query: 568 AGSILPHIGNLSFLKILNLE-----NNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN 622
           + + +  I  L+  K+ NLE     NN  +   P  +G L  L    LN N +  +I   
Sbjct: 181 SSNKVSDISVLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIGT- 234
Query: 623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL 682
           L+S +NL  + LA NQ+    P     L+K+  L LG N  I +I  PL  L++L  + L
Sbjct: 235 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ-ISNI-SPLAGLTALTNLEL 290
Query: 683 AINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD 742
             N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+     L 
Sbjct: 291 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSDVSSL- 345
Query: 743 YGFTLQNLQYFSIGTNRITGAIP 765
               L N+ + S G N+I+   P
Sbjct: 346 --ANLTNINWLSAGHNQISDLTP 366

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 122
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 123 IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 174
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 175 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 225 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 265

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 88  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 127
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 128 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 179
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 180 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 93  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 132
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 184
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTA 335
           IG G++G+V+K    E    V +K   L         S + E   L+ ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-- 67
Query: 336 CSGVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
               D   +D K  LV+EF  +  L+++    N   ++D       L Q L   +    +
Sbjct: 68  ----DVLHSDKKLTLVFEFC-DQDLKKYFDSCN--GDLDPEIVKSFLFQLLK-GLGFCHS 119
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGY 453
            + LH D         LKP N+L++      + DFGLAR F  P    ++ +    ++ Y
Sbjct: 120 RNVLHRD---------LKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV---VTLWY 167
Query: 454 IAPEYGLGSEV-STNGDVYSYGILMLELIIRKKP 486
             P+   G+++ ST+ D++S G +  EL    +P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 91  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 130
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 131 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 182
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 183 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 78
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 79  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 130
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 131 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 180
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 181 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 96
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 97  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 136
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 137 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 188
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 189 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 85
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 86  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 137
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 138 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 188 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 98  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 137
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 138 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 189
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 190 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 82  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 121
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 173
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 82
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 83  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 122
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 123 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 174
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 175 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 84
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 85  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 137 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 187 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG VYK    E       KV           +I E   L +  H  +VK+  A  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 84
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y  +    ++ EF   G+++  +  ++         R L   Q   +   +  AL++
Sbjct: 85  ---YYHDGKLWIMIEFCPGGAVDAIMLELD---------RGLTEPQIQVVCRQMLEALNF 132
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGYIAP 456
           LH        H DLK  N+L+  E    + DFG+ A+ L     + S I   G+  ++AP
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMAP 186
Query: 457 EYGL-----GSEVSTNGDVYSYGILMLEL 480
           E  +      +      D++S GI ++E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 91  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 130
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 131 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 182
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 183 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 98  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 137
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 138 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 189
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 190 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 84
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 85  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 124
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 125 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 176
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 177 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 108
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 109 LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 148
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 149 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 200
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 201 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 109/261 (41%), Gaps = 38/261 (14%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASRSFIA-ECRALRSIRHR 327
           F     +GTG+F  V   VL E + T     VK       +   S I  E   LR I+H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+V    A   + Y+  +   LV + +  G L + +       E D +     L+++   
Sbjct: 81  NIV----ALEDI-YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS----TLIRQ--- 128
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSS 444
              V  A+ YLH   +    H DLKP N+L    DEE    + DFGL++      V +++
Sbjct: 129 ---VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA 182
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
            G   + GY+APE       S   D +S G++   L+    P     E D  L  F ++ 
Sbjct: 183 CG---TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDSKL--FEQIL 235
Query: 505 LPDHVMDIVDSTLLNDVEDLA 525
             ++     DS   +D+ D A
Sbjct: 236 KAEYEF---DSPYWDDISDSA 253

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 98  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 137
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 138 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 189
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 190 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 83
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 84  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 123
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 124 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 175
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 176 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 122
Query: 329 LVK---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           ++    VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 123 IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 174
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 175 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 225 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 265

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS-IRHR 327
            + +     +G G++G V   V       V VK+ ++         I +   + + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 66  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 115
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 116 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 83
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 84  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 135
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 136 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 185
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 186 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 77
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 78  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 129
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 130 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 180 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 84
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 85  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 137 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 187 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 227

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ ++
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQM 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 10/108 (9%)
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSIG 452
           L Y+H   Q I  H DLKPSN+L++E     +GDFG+AR L   P   Q        +  
Sbjct: 171 LKYMH-SAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 453 YIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
           Y APE  L   E +   D++S G +  E++ R++    +F G   +H 
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVHQ 271

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 95
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 96  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 135
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 136 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 187
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 188 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN 328
           IG+G+ G   + Y  VLD     V +K  +       H  RA R  +     ++ + H+N
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 78
Query: 329 ---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              L+ VFT    ++   + +  LV E M + +L + +     + E+D    +  L Q L
Sbjct: 79  IISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVI-----QMELDHERMSYLLYQML 130
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +
Sbjct: 131 -------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 180
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
             +    Y APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 181 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 88  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 127
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 128 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 179
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 180 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 93  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 132
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 82  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 121
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 173
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 108
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 109 LLDVFTPARSLE-EFNDVYLVTH--LMGADL-----------------NNIVKCQKLTDD 148
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 149 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 200
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 201 EMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 88  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 127
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 128 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 179
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 180 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR---- 327
           +    +IG GSFG V K    +    V +K+   +  R  R    E R L  +R +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 328 --NLVKVFTACSGVDYQGNDFKAL---VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
             N++ +    +  ++    F+ L   +YE ++    + +  P+ R+             
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK------------- 204
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS--HVGDFGLARFLPPTHV 440
                A  +   LD LH +      HCDLKP NILL ++  S   V DFG + +      
Sbjct: 205 ----FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EH 253
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           Q     ++    Y APE  LG+      D++S G ++ EL+
Sbjct: 254 QRVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELL 293

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR---- 327
           +    +IG GSFG V K    +    V +K+   +  R  R    E R L  +R +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 328 --NLVKVFTACSGVDYQGNDFKAL---VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
             N++ +    +  ++    F+ L   +YE ++    + +  P+ R+             
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK------------- 204
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS--HVGDFGLARFLPPTHV 440
                A  +   LD LH +      HCDLKP NILL ++  S   V DFG + +      
Sbjct: 205 ----FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EH 253
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           Q     ++    Y APE  LG+      D++S G ++ EL+
Sbjct: 254 QRVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELL 293

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 92
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 93  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE----PH 143
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 190
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKEIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFGLA+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIQVTDFGLAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 92  LLDVFTPARSLE-EFNDVYLVTH--LMGADL-----------------NNIVKCQKLTDD 131
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 132 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 183
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 184 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 30/217 (13%)
Query: 278 IGTGSFGSVY--KGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
           IG G+F  V   + +L  GR  V +K+ +      +  +    E R ++ + H N+VK+F
Sbjct: 20  IGKGNFAKVKLARHILT-GRE-VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                   +      L+ E+   G + ++L    R  E +   +             + S
Sbjct: 78  EVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ----------IVS 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA-RFLPPTHVQTSSIGVKGSIG 452
           A+ Y H   Q    H DLK  N+LLD +M   + DFG +  F     + T      GS  
Sbjct: 123 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPP 175
Query: 453 YIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           Y APE   G +      DV+S G+++  L+    P D
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 93  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 132
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 88  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 127
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 128 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDD 179
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 180 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 108/268 (40%), Gaps = 53/268 (19%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV        R  V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENVIG 91
Query: 329 LVKVFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
           L+ VFT  + ++    DF    LV   M    L   +      DE      ++  L    
Sbjct: 92  LLDVFTPATSIE----DFSEVYLVTTLM-GADLNNIVKSQALSDE------HVQFL---- 136
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
               +   L Y+H        H DLKPSN+ ++E+    + DFGLAR            G
Sbjct: 137 -VYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTG 187
Query: 447 VKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
              +  Y APE  L     +   D++S G +M EL+  K     +F G   +    R   
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA----LFPGSDYIDQLKR--- 240
Query: 506 PDHVMDIVDSTLLNDVEDLAIISNQRQR 533
              +M++V +      E LA IS++  R
Sbjct: 241 ---IMEVVGTP---SPEVLAKISSEHAR 262

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 93  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 132
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E++  G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+L+D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 154 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 210
Query: 468 GDVYSYGILMLELIIRKKPSDIMFEG 493
            D++S G +M E++  K    I+F G
Sbjct: 211 VDLWSVGCIMGEMVCHK----ILFPG 232

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 82  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 121
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 173
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 174 EMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 106 LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 145
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 146 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 197
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 198 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 199
Query: 468 GDVYSYGILMLELIIRKKPSDIMFEG 493
            D++S G +M E++  K    I+F G
Sbjct: 200 VDLWSVGCIMGEMVCHK----ILFPG 221

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 106 LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 145
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 146 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 197
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 198 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
             LIG G FG VY G    G   + +      +    ++F  E  A R  RH N+V    
Sbjct: 38  GELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
           AC    +      A++    +  +    LY V R+ ++      L++ +   IA ++   
Sbjct: 97  ACMSPPHL-----AIITSLCKGRT----LYSVVRDAKI-----VLDVNKTRQIAQEIVKG 142
Query: 395 LDYLHHDCQPITTHCDLKPSNILLD--EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           + YLH        H DLK  N+  D  + +++  G F ++  L     +       G + 
Sbjct: 143 MGYLHAKG---ILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 453 YIAPE--YGLGSEV-------STNGDVYSYGILMLELIIRKKP 486
           ++APE    L  +        S + DV++ G +  EL  R+ P
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSIG 452
           L Y+H   Q I  H DLKPSN+L++E     +GDFG+AR L   P   Q        +  
Sbjct: 172 LKYMH-SAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 453 YIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           Y APE  L   E +   D++S G +  E++ R++    +F G   +H  
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVHQL 273

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 33/242 (13%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           FS   +IG G FG VY       R   T K++ +      R  + +   L ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETL-ALNERIMLS 244
Query: 332 V-------FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           +       F  C    +   D  + + + M  G L    Y +++     +A         
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF----- 296
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
              A ++   L+++H+       + DLKP+NILLDE     + D GLA          S 
Sbjct: 297 --YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 445 IGVKGSIGYIAPEY-GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
               G+ GY+APE    G    ++ D +S G ++ +L+    P         + H   RM
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRM 405
Query: 504 AL 505
            L
Sbjct: 406 TL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 33/242 (13%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           FS   +IG G FG VY       R   T K++ +      R  + +   L ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETL-ALNERIMLS 244
Query: 332 V-------FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           +       F  C    +   D  + + + M  G L    Y +++     +A         
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF----- 296
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
              A ++   L+++H+       + DLKP+NILLDE     + D GLA          S 
Sbjct: 297 --YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 445 IGVKGSIGYIAPEY-GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
               G+ GY+APE    G    ++ D +S G ++ +L+    P         + H   RM
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRM 405
Query: 504 AL 505
            L
Sbjct: 406 TL 407

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 273 SSANLIGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSI-R 325
           S    +G G+FG V     Y  +  +   TV VK+     H   R + ++E + L  +  
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V +  AC+     G     ++ E+   G L  +L    + D    +  +  +++  
Sbjct: 109 HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDD 161
Query: 386 ----------NIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
                     + +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR 
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR- 216
Query: 435 LPPTHVQT-SSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               H++  S+  VKG+    + ++APE       +   DV+SYGI + EL 
Sbjct: 217 ----HIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 104
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 105 LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 144
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 145 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 196
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 197 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 92  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 131
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 132 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDD 183
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 184 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 104
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 105 LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 144
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 145 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 196
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 197 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 114/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----ASRSFIAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +           +AE   ++ + +  +V++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 73  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 116
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 117 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 172
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 232
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 233 CPREMYDLMNLCWTYDVEN 251

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF-LPPTHVQTSSIG 446
           + +++ AL+YLH   +    + DLK  N+LLD E    + D+G+ +  L P    ++  G
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                 YIAPE   G +   + D ++ G+LM E++  + P DI+   D
Sbjct: 216 TPN---YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 106 LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 145
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 146 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 197
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 198 EMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 73  KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 114
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 115 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 170
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 230
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 231 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 268

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 33/242 (13%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           FS   +IG G FG VY       R   T K++ +      R  + +   L ++  R ++ 
Sbjct: 190 FSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETL-ALNERIMLS 243
Query: 332 V-------FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           +       F  C    +   D  + + + M  G L    Y +++     +A         
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF----- 295
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
              A ++   L+++H+       + DLKP+NILLDE     + D GLA          S 
Sbjct: 296 --YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 350
Query: 445 IGVKGSIGYIAPEY-GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
               G+ GY+APE    G    ++ D +S G ++ +L+    P         + H   RM
Sbjct: 351 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRM 404
Query: 504 AL 505
            L
Sbjct: 405 TL 406

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 33/242 (13%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           FS   +IG G FG VY       R   T K++ +      R  + +   L ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETL-ALNERIMLS 244
Query: 332 V-------FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR 384
           +       F  C    +   D  + + + M  G L    Y +++     +A         
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF----- 296
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
              A ++   L+++H+       + DLKP+NILLDE     + D GLA          S 
Sbjct: 297 --YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 445 IGVKGSIGYIAPEY-GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
               G+ GY+APE    G    ++ D +S G ++ +L+    P         + H   RM
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRM 405
Query: 504 AL 505
            L
Sbjct: 406 TL 407

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 105/251 (41%), Gaps = 49/251 (19%)
Query: 278 IGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIR-HRNLVKVF 333
           +G G++G V+K +    G      K+F+   +   A R+F  E   L  +  H N+V + 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 334 TACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
                     ND    LV+++M+       L+ V R + ++   +   + Q + +     
Sbjct: 76  NVLRA----DNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKV----- 121
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK---- 448
             + YLH        H D+KPSNILL+ E    V DFGL+R        T++I +     
Sbjct: 122 --IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 449 ---------------GSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFE 492
                           +  Y APE  LGS   T G D++S G ++ E++  K     +F 
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP----IFP 232
Query: 493 GDMNLHNFARM 503
           G   ++   R+
Sbjct: 233 GSSTMNQLERI 243

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKEIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFGLA+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGLAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG+G+ G   + Y  +L+     V +K       + SR F  +  A R+ R   L+KV  
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIK-------KLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             + +         L+  F    SLEE+  +Y V     ++    NL+ + ++ +  +  
Sbjct: 82  HKNII--------GLLNVFTPQKSLEEFQDVYIV-----MELMDANLSQVIQMELDHERM 128
Query: 393 SALDY-----LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           S L Y     + H       H DLKPSNI++  +    + DFGLAR    + + T  +  
Sbjct: 129 SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +    Y APE  LG     N D++S G +M E+I
Sbjct: 189 R---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+L+D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 108/268 (40%), Gaps = 53/268 (19%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV        R  V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENVIG 83
Query: 329 LVKVFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
           L+ VFT  + ++    DF    LV   M    L   +      DE      ++  L    
Sbjct: 84  LLDVFTPATSIE----DFSEVYLVTTLM-GADLNNIVKCQALSDE------HVQFL---- 128
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
               +   L Y+H        H DLKPSN+ ++E+    + DFGLAR            G
Sbjct: 129 -VYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTG 179
Query: 447 VKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
              +  Y APE  L     +   D++S G +M EL+  K     +F G   +    R   
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA----LFPGSDYIDQLKR--- 232
Query: 506 PDHVMDIVDSTLLNDVEDLAIISNQRQR 533
              +M++V +      E LA IS++  R
Sbjct: 233 ---IMEVVGTP---SPEVLAKISSEHAR 254

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 206 VDIWSVGCIMGEMI 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR      + T  +  +    Y APE  LG   + N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR---YYRAPEVILGMGYAAN 205
Query: 468 GDVYSYGILMLELI 481
            D++S G +M EL+
Sbjct: 206 VDIWSVGCIMGELV 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 48/228 (21%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRS 323
           + + + + +G+G++GSV      +    + VK  +      +H  R  R    E R L+ 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR----ELRLLKH 106
Query: 324 IRHRN---LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           ++H N   L+ VFT  + ++ + ND   + +  +    L                  N+ 
Sbjct: 107 MKHENVIGLLDVFTPATSLE-EFNDVYLVTH--LMGADL-----------------NNIV 146
Query: 381 LLQRLN------IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
             Q+L       +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR 
Sbjct: 147 KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR- 202
Query: 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
               H      G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 203 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELL 246

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----ASRSFIAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +           +AE   ++ + +  +V++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++ ++    V+ 
Sbjct: 75  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIELVH---QVSM 118
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 119 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 174
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 235 CPREMYDLMNLCWTYDVEN 253

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +     +     +AE   ++ + +  +V++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 79  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 178
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 238
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 239 CPREMYDLMNLCWTYDVEN 257

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 114/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----ASRSFIAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +           +AE   ++ + +  +V++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 85  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 128
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 184
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 244
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 245 CPREMYDLMNLCWTYDVEN 263

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 69  KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 110
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 111 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 166
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 226
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 227 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 264

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 108/268 (40%), Gaps = 53/268 (19%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV        R  V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENVIG 91
Query: 329 LVKVFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
           L+ VFT  + ++    DF    LV   M    L   +      DE      ++  L    
Sbjct: 92  LLDVFTPATSIE----DFSEVYLVTTLM-GADLNNIVKCQALSDE------HVQFL---- 136
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
               +   L Y+H        H DLKPSN+ ++E+    + DFGLAR            G
Sbjct: 137 -VYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTG 187
Query: 447 VKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
              +  Y APE  L     +   D++S G +M EL+  K     +F G   +    R   
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA----LFPGSDYIDQLKR--- 240
Query: 506 PDHVMDIVDSTLLNDVEDLAIISNQRQR 533
              +M++V +      E LA IS++  R
Sbjct: 241 ---IMEVVGTP---SPEVLAKISSEHAR 262

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+++D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  +    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEM 231

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL  
Sbjct: 86  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 131
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH        H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWM 183
Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE           D++S GI+++E++  + P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 278 IGTGSFG---SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG+G+ G   + Y  +L+     V +K       + SR F  +  A R+ R   L+KV  
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIK-------KLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEW--LYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
             + +         L+  F    SLEE+  +Y V     ++    NL+ + ++ +  +  
Sbjct: 82  HKNII--------GLLNVFTPQKSLEEFQDVYIV-----MELMDANLSQVIQMELDHERM 128
Query: 393 SALDY-----LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           S L Y     + H       H DLKPSNI++  +    + DFGLAR    + + T  +  
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +    Y APE  LG     N D++S G +M E+I
Sbjct: 189 R---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 7/86 (8%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + +    +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELIIRKKPSDIMFEG 493
            D++S G +M E++  K    I+F G
Sbjct: 206 VDIWSVGCIMGEMVCHK----ILFPG 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 92  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 131
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 132 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 183
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 184 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 35/216 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 96
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL  
Sbjct: 97  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 142
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH        H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 143 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWM 194
Query: 455 APE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE       G EV    D++S GI+++E++  + P
Sbjct: 195 APELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 226

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF-LPPTHVQTSSIG 446
           + +++ AL+YLH   +    + DLK  N+LLD E    + D+G+ +  L P    +   G
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 183
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                 YIAPE   G +   + D ++ G+LM E++  + P DI+   D
Sbjct: 184 TPN---YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 112/258 (43%), Gaps = 31/258 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----ASRSFIAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +           +AE   ++ + +  +V++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 79  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 122
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL-PPTHVQTSSIGVKGSIG 452
            + YL    +    H DL   N+LL  +  + + DFGL++ L    +   +    K  + 
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----AL 505
           + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM      
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 239
Query: 506 PDHVMDIVDSTLLNDVED 523
           P  + D+++     DVE+
Sbjct: 240 PREMYDLMNLCWTYDVEN 257

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR      + T  +  +    Y APE  LG     N
Sbjct: 147 HRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTR---YYRAPEVILGMGYKEN 203
Query: 468 GDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
            D++S G +M EL+       ++F+G  ++  + ++
Sbjct: 204 VDIWSVGCIMGELV----KGSVIFQGTDHIDQWNKV 235

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 560 LDLESLKLAG-SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           LD+ S K++  S+L  + NL  L      NN  +   P  +G L  L    LN N +  +
Sbjct: 181 LDISSNKVSDISVLAKLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLK-D 234
Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
           I   L+S +NL  + LA NQ+    P     L+K+  L LG N +  S   PL  L++L 
Sbjct: 235 IGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI--SNISPLAGLTALT 289
Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
            + L  N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+   
Sbjct: 290 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSDV 345
Query: 739 IPLDYGFTLQNLQYFSIGTNRITGAIP 765
             L     L N+ + S G N+I+   P
Sbjct: 346 SSL---ANLTNINWLSAGHNQISDLTP 369

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 20/144 (13%)
Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD-----EEMVS-HVGDFG 430
           R + L+    I+  +   LDY+H  C  I  H D+KP N+L++     E ++   + D G
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
            A +    +  T+SI  +    Y +PE  LG+      D++S   L+ ELI      D +
Sbjct: 184 NACWYDEHY--TNSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELIT----GDFL 234
Query: 491 FEGDMNLHNFARMALPDHVMDIVD 514
           FE D   H++ +    DH+  I++
Sbjct: 235 FEPDEG-HSYTKDD--DHIAQIIE 255

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 35/216 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 94
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL  
Sbjct: 95  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 140
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH        H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 141 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWM 192
Query: 455 APE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE       G EV    D++S GI+++E++  + P
Sbjct: 193 APELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 224

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 92  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 131
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DFGLAR     H   
Sbjct: 132 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 183
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 184 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 70  KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 111
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 112 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 167
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 228 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIQVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 278 IGTGSFGSVY--KGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
           IG G+F  V   + +L  GR  V +K+ +      +  +    E R ++ + H N+VK+F
Sbjct: 23  IGKGNFAKVKLARHILT-GRE-VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                   +      L+ E+   G + ++L    R  E +   +             + S
Sbjct: 81  EVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ----------IVS 125
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK----- 448
           A+ Y H   Q    H DLK  N+LLD +M   + DFG +           ++G K     
Sbjct: 126 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS--------NEFTVGGKLDAFC 174
Query: 449 GSIGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
           G+  Y APE   G +      DV+S G+++  L+    P D
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + D+GLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 520 DVEDLAIISNQRQRQIRVNNIIEC-----LISMLRIGSKAQKVTILD-------LESLKL 567
           D++ L  ++N  + ++  N I +      L S+ ++   + +VT L        LE L +
Sbjct: 121 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFSSNQVTDLKPLANLTTLERLDI 180
Query: 568 AGSILPHIGNLSFLKILNLE-----NNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN 622
           + + +  I  L+  K+ NLE     NN  +   P  +G L  L    LN N +  +I   
Sbjct: 181 SSNKVSDISVLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIGT- 234
Query: 623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL 682
           L+S +NL  + LA NQ+    P     L+K+  L LG N  I +I  PL  L++L  + L
Sbjct: 235 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ-ISNI-SPLAGLTALTNLEL 290
Query: 683 AINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD 742
             N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+     L 
Sbjct: 291 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDVSSL- 345
Query: 743 YGFTLQNLQYFSIGTNRITGAIP 765
               L N+ + S G N+I+   P
Sbjct: 346 --ANLTNINWLSAGHNQISDLTP 366

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 35/216 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 139
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL  
Sbjct: 140 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 185
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH        H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 186 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWM 237
Query: 455 APE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE       G EV    D++S GI+++E++  + P
Sbjct: 238 APELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 269

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +     +     +AE   ++ + +  +V++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 437 GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 480
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 481 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 536
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 596
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 597 CPREMYDLMNLCWTYDVEN 615

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 206 VDIWSVGCIMGEMI 219

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +     +     +AE   ++ + +  +V++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 93  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 136
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 137 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 192
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 252
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 253 CPREMYDLMNLCWTYDVEN 271

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 20/144 (13%)
Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD-----EEMVS-HVGDFG 430
           R + L+    I+  +   LDY+H  C  I  H D+KP N+L++     E ++   + D G
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
            A +    +  T+SI  +    Y +PE  LG+      D++S   L+ ELI      D +
Sbjct: 184 NACWYDEHY--TNSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELIT----GDFL 234
Query: 491 FEGDMNLHNFARMALPDHVMDIVD 514
           FE D   H++ +    DH+  I++
Sbjct: 235 FEPDEG-HSYTKDD--DHIAQIIE 255

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 89
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +      +E           Q   + + V  AL  
Sbjct: 90  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 135
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH        H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 136 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWM 187
Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE           D++S GI+++E++  + P
Sbjct: 188 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 206 VDIWSVGCIMGEMI 219

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 560 LDLESLKLAG-SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           LD+ S K++  S+L  + NL  L      NN  +   P  +G L  L    LN N +  +
Sbjct: 177 LDISSNKVSDISVLAKLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLK-D 230
Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
           I   L+S +NL  + LA NQ+    P     L+K+  L LG N  I +I  PL  L++L 
Sbjct: 231 IGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ-ISNI-SPLAGLTALT 285
Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
            + L  N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+   
Sbjct: 286 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSDV 341
Query: 739 IPLDYGFTLQNLQYFSIGTNRITGAIP 765
             L     L N+ + S G N+I+   P
Sbjct: 342 SSL---ANLTNINWLSAGHNQISDLTP 365

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+AP   L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 138 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 194 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 242
Query: 502 RMA 504
           R+A
Sbjct: 243 RIA 245

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 206 VDIWSVGCIMGEMI 219

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 138 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 194 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 242
Query: 502 RMA 504
           R+A
Sbjct: 243 RIA 245

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 206
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 207 VDIWSVGCIMGEMI 220

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 520 DVEDLAIISNQRQRQIRVNNIIEC-----LISMLRIGSKAQKVTILD-------LESLKL 567
           D++ L  ++N  + ++  N I +      L S+ ++   + +VT L        LE L +
Sbjct: 121 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDI 180
Query: 568 AGSILPHIGNLSFLKILNLE-----NNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN 622
           + + +  I  L+  K+ NLE     NN  +   P  +G L  L    LN N +  +I   
Sbjct: 181 SSNKVSDISVLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIGT- 234
Query: 623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL 682
           L+S +NL  + LA NQ+    P     L+K+  L LG N  I +I  PL  L++L  + L
Sbjct: 235 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ-ISNI-SPLAGLTALTNLEL 290
Query: 683 AINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD 742
             N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+     L 
Sbjct: 291 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDVSSL- 345
Query: 743 YGFTLQNLQYFSIGTNRITGAIP 765
               L N+ + S G N+I+   P
Sbjct: 346 --ANLTNINWLSAGHNQISDLTP 366

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + + T  +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 206 VDIWSVGCIMGEMI 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 35/211 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS G V    +      V VK  +L   +       E   +R  +H N+V+++ +  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 216
Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              Y   D   +V EF++ G+L + +               +N  Q   + + V  AL  
Sbjct: 217 ---YLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSV 262
Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YI 454
           LH        H D+K  +ILL  +    + DFG         V       K  +G   ++
Sbjct: 263 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWM 314
Query: 455 APE----YGLGSEVSTNGDVYSYGILMLELI 481
           APE       G EV    D++S GI+++E++
Sbjct: 315 APELISRLPYGPEV----DIWSLGIMVIEMV 341

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 89  KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 130
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 131 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 186
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 247 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 273 SSANLIGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSI-R 325
           S    +G G+FG V     Y  +  +   TV VK+     H   R + ++E + L  +  
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V +  AC+     G     ++ E+   G L  +L    + D    +  +  +++  
Sbjct: 102 HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDD 154
Query: 386 ----------NIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
                     + +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR 
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 210
Query: 435 LPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +       S+  VKG+    + ++APE       +   DV+SYGI + EL 
Sbjct: 211 IK----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 137 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 192
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 193 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 241
Query: 502 RMA 504
           R+A
Sbjct: 242 RIA 244

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 139 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 195 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 502 RMA 504
           R+A
Sbjct: 244 RIA 246

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 107/263 (40%), Gaps = 38/263 (14%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA----SRSFIAECRALRSIR 325
           D +   +++GTG+F  V   +L E + T  +        +A      S   E   L  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V    A   + Y+      L+ + +  G L + +       E D +          
Sbjct: 75  HPNIV----ALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---------- 119
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNIL---LDEEMVSHVGDFGLARFLPPTHVQT 442
            +   V  A+ YLH        H DLKP N+L   LDE+    + DFGL++   P  V +
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           ++    G+ GY+APE       S   D +S G++   L+    P     E D  L  F +
Sbjct: 177 TAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKL--FEQ 229
Query: 503 MALPDHVMDIVDSTLLNDVEDLA 525
           +   ++     DS   +D+ D A
Sbjct: 230 ILKAEYEF---DSPYWDDISDSA 249

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E+   G +   L  + R  E    P       ++ 
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PHARFYAAQIV 152
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+++D++    V DFG A+      V+  +  
Sbjct: 153 LTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF-LPPTHVQTSSIG 446
           + +++ AL+YLH   +    + DLK  N+LLD E    + D+G+ +  L P    +   G
Sbjct: 112 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 168
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                 YIAPE   G +   + D ++ G+LM E++  + P DI+   D
Sbjct: 169 TPN---YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +     +     +AE   ++ + +  +V++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++   +   V+ 
Sbjct: 438 GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIE---LVHQVSM 481
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 482 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 537
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 597
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 598 CPREMYDLMNLCWTYDVEN 616

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 20/222 (9%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR 327
            + +     +G G+ G V   V       V VK+ ++        +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK +    G   +GN  + L  E+   G L + + P     E D A R  + L     
Sbjct: 65  NVVKFY----GHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLM---- 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
                + + YLH       TH D+KP N+LLDE     + DFGLA      + +     +
Sbjct: 115 -----AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            G++ Y+APE     E      DV+S GI++  ++  + P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRN 328
           F    +IG GSFG V             VKV     +   +  +  ++E    R++  +N
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKN 95
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +   F       +Q  D    V +++  G L    Y + RE       R     +    A
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRE-------RCFLEPRARFYA 145
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            ++ASAL YLH        + DLKP NILLD +    + DFGL +     +  TS+    
Sbjct: 146 AEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-- 200
Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           G+  Y+APE           D +  G ++ E++
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           +D +     +G G+F  V + V          K+ N      R  +    E R  R ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  +      Q   F  LV++ +  G L E +       E D +    + +Q+  
Sbjct: 88  PNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQ-- 136
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTS 443
               +  ++ Y H +      H +LKP N+LL  +       + DFGLA       V  S
Sbjct: 137 ----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDS 184
Query: 444 SI--GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               G  G+ GY++PE       S   D+++ G+++  L++   P
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 23/123 (18%)
Query: 390 DVASALDYLHHDCQPI-TTHCDLKPSNILLDEEMVS-HVGDFGLARFLPP---THVQTSS 444
           ++  ALDY    C  +   H D+KP N+++D E     + D+GLA F  P    +V+ +S
Sbjct: 144 EILKALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 199
Query: 445 IGVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              KG    + Y   +Y L        D++S G ++  +I RK+P    F G  N     
Sbjct: 200 RYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 248
Query: 502 RMA 504
           R+A
Sbjct: 249 RIA 251

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVFTA 335
           IG G+FG V+K    +    V +K   + + +      A  E + L+ ++H N+V +   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 336 CSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           C       N  KA   LV++F ++  L   L  V  +  + +  R + +L          
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML---------L 135
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVK-GS 450
           + L Y+H +      H D+K +N+L+  + V  + DFGLAR F    + Q +    +  +
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 451 IGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
           + Y  PE  LG  +     D++  G +M E+  R   S IM +G+   H  A
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 240

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF-LPPTHVQTSSIG 446
           + +++ AL+YLH   +    + DLK  N+LLD E    + D+G+ +  L P    +   G
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 172
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                 YIAPE   G +   + D ++ G+LM E++  + P DI+   D
Sbjct: 173 TPN---YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 273 SSANLIGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSI-R 325
           S    +G G+FG V     Y  +  +   TV VK+     H   R + ++E + L  +  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V +  AC+     G     ++ E+   G L  +L    + D    +  +  +++  
Sbjct: 86  HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDD 138
Query: 386 ----------NIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
                     + +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR 
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 194
Query: 435 LPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +       S+  VKG+    + ++APE       +   DV+SYGI + EL 
Sbjct: 195 IK----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 89  KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 130
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 131 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKD 186
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 247 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +     +     +AE   ++ + +  +V++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++ ++    V+ 
Sbjct: 95  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIELVH---QVSM 138
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 139 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 194
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 254
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 255 CPREMYDLMNLCWTYDVEN 273

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF----IAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV V  L +     +     +AE   ++ + +  +V++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G       P+N+  + ++  ++ N+++ ++    V+ 
Sbjct: 95  GICEAESWM------LVMEMAELG-------PLNKYLQQNRHVKDKNIIELVH---QVSM 138
Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PPTHVQTSSIGVKGSI 451
            + YL    +    H DL   N+LL  +  + + DFGL++ L     + +  + G K  +
Sbjct: 139 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 194
Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGDMN--LHNFARM----A 504
            + APE     + S+  DV+S+G+LM E     +KP   M   ++   L    RM     
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 254
Query: 505 LPDHVMDIVDSTLLNDVED 523
            P  + D+++     DVE+
Sbjct: 255 CPREMYDLMNLCWTYDVEN 273

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 273 SSANLIGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSI-R 325
           S    +G G+FG V     Y  +  +   TV VK+     H   R + ++E + L  +  
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V +  AC+     G     ++ E+   G L  +L    + D    +  +  +++  
Sbjct: 104 HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDD 156
Query: 386 ----------NIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
                     + +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR 
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 212
Query: 435 LPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +       S+  VKG+    + ++APE       +   DV+SYGI + EL 
Sbjct: 213 IK----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 42/220 (19%)
Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNL-----HHHRASRSFIAECRALRSIRHRN 328
           IG GSFG   K +L    ++GR  V +K  N+          SR  +A    L +++H N
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYV-IKEINISRMSSKEREESRREVA---VLANMKHPN 84
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN----REDEVDKAPRNLNLLQR 384
           +V+   +     ++ N    +V ++ + G L + +        +ED++            
Sbjct: 85  IVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI------------ 127
Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           L+  + +  AL ++H        H D+K  NI L ++    +GDFG+AR L  T V+ + 
Sbjct: 128 LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELAR 183
Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK 484
             + G+  Y++PE       +   D+++ G ++ EL   K
Sbjct: 184 ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 7/86 (8%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + +    +  +    Y APE  LG     N
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR---YYRAPEVILGMGYKEN 205
Query: 468 GDVYSYGILMLELIIRKKPSDIMFEG 493
            D++S G +M E++  K    I+F G
Sbjct: 206 VDLWSVGCIMGEMVCHK----ILFPG 227

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 27/225 (12%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
            + +    +IG G+FG V        +    +K+ +      R+  +F  E R + +  +
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 327 R-NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              +V++F A     +Q + +  +V E+M  G L      VN     D   +        
Sbjct: 134 SPWVVQLFCA-----FQDDKYLYMVMEYMPGGDL------VNLMSNYDVPEKWAKFY--- 179
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               +V  ALD +H        H D+KP N+LLD+     + DFG    +  T +     
Sbjct: 180 --TAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT 234
Query: 446 GVKGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            V G+  YI+PE     G         D +S G+ + E+++   P
Sbjct: 235 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIR 631
           L H  +LS L+I N+  N F ++       L RL    LN NS+  E+P  + + SNL  
Sbjct: 225 LWHALDLSNLQIFNISANIFKYDF------LTRLY---LNGNSLT-ELPAEIKNLSNLRV 274
Query: 632 IGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI 691
           + L+ N+L   +P++ GS  +++     F+N++ ++P   GNL +L+ + +  N L    
Sbjct: 275 LDLSHNRLTS-LPAELGSCFQLKYFYF-FDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQF 332
Query: 692 PFTLS-KLKNLVILYLGVNR 710
              L+ K    +I YL  NR
Sbjct: 333 LKILTEKSVTGLIFYLRDNR 352

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 21/122 (17%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTH---VQTSSI 445
           ++  ALDY H        H D+KP N+++D +     + D+GLA F  P     V+ +S 
Sbjct: 140 ELLKALDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASR 196
Query: 446 GVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             KG    + Y   +Y L        D++S G ++  +I R++P    F G  N     R
Sbjct: 197 YFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRREP---FFHGQDNYDQLVR 245
Query: 503 MA 504
           +A
Sbjct: 246 IA 247

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 91
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    LVK+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 92  KRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE----PH 142
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFG A+    
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGFAK---- 189
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 273 SSANLIGTGSFGSV-----YKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSI-R 325
           S    +G G+FG V     Y  +  +   TV VK+     H   R + ++E + L  +  
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V +  AC+     G     ++ E+   G L  +L    + D    +  +  +++  
Sbjct: 109 HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDD 161
Query: 386 ----------NIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434
                     + +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR 
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 217
Query: 435 LPPTHVQTSSIGVKGS----IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           +       S+  VKG+    + ++APE       +   DV+SYGI + EL 
Sbjct: 218 IK----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 117 KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 158
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 214
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 275 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 117 KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 158
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 214
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 275 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASR-SFIAECRALRSIR 325
           D +   +++GTG+F  V   +L E + T   V +K            S   E   L  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V +        Y+      L+ + +  G L + +       E D +          
Sbjct: 75  HPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---------- 119
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNIL---LDEEMVSHVGDFGLARFLPPTHVQT 442
            +   V  A+ YLH        H DLKP N+L   LDE+    + DFGL++   P  V +
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           ++ G     GY+APE       S   D +S G++   L+    P     E D  L  F +
Sbjct: 177 TACGTP---GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKL--FEQ 229
Query: 503 MALPDHVMDIVDSTLLNDVEDLA 525
           +   ++     DS   +D+ D A
Sbjct: 230 ILKAEYEF---DSPYWDDISDSA 249

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 107/263 (40%), Gaps = 38/263 (14%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASR-SFIAECRALRSIR 325
           D +   +++GTG+F  V   +L E + T   V +K            S   E   L  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V    A   + Y+      L+ + +  G L + +       E D +          
Sbjct: 75  HPNIV----ALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---------- 119
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNIL---LDEEMVSHVGDFGLARFLPPTHVQT 442
            +   V  A+ YLH        H DLKP N+L   LDE+    + DFGL++   P  V +
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           ++    G+ GY+APE       S   D +S G++   L+    P     E D  L  F +
Sbjct: 177 TAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKL--FEQ 229
Query: 503 MALPDHVMDIVDSTLLNDVEDLA 525
           +   ++     DS   +D+ D A
Sbjct: 230 ILKAEYEF---DSPYWDDISDSA 249

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 21/122 (17%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTH---VQTSSI 445
           ++  ALDY H        H D+KP N+++D +     + D+GLA F  P     V+ +S 
Sbjct: 145 ELLKALDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASR 201
Query: 446 GVKGS---IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             KG    + Y   +Y L        D++S G ++  +I R++P    F G  N     R
Sbjct: 202 YFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRREP---FFHGQDNYDQLVR 250
Query: 503 MA 504
           +A
Sbjct: 251 IA 252

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 107/263 (40%), Gaps = 38/263 (14%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASR-SFIAECRALRSIR 325
           D +   +++GTG+F  V   +L E + T   V +K            S   E   L  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V    A   + Y+      L+ + +  G L + +       E D +          
Sbjct: 75  HPNIV----ALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---------- 119
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNIL---LDEEMVSHVGDFGLARFLPPTHVQT 442
            +   V  A+ YLH        H DLKP N+L   LDE+    + DFGL++   P  V +
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           ++    G+ GY+APE       S   D +S G++   L+    P     E D  L  F +
Sbjct: 177 TAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKL--FEQ 229
Query: 503 MALPDHVMDIVDSTLLNDVEDLA 525
           +   ++     DS   +D+ D A
Sbjct: 230 ILKAEYEF---DSPYWDDISDSA 249

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRN- 328
           +S    IG+G    V++ VL+E +    +K  NL    ++   S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 329 -LVKVFTACSGVDYQGNDFKALVYEFMQNGSLE--EWLYPVNREDEVDKAPRNLNLLQRL 385
            +++++      DY+  D    +Y  M+ G+++   WL          K  ++++  +R 
Sbjct: 117 KIIRLY------DYEITD--QYIYMVMECGNIDLNSWL----------KKKKSIDPWERK 158
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           +   ++  A+  +H   Q    H DLKP+N L+ + M+  + DFG+A  + P        
Sbjct: 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKD 214
Query: 446 GVKGSIGYIAPEYGLG-SEVSTNG----------DVYSYGILMLELIIRKKPSDIMFEGD 494
              G++ Y+ PE     S    NG          DV+S G ++  +   K P   +    
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 495 MNLHNFARMALPDHVMDIVD--STLLNDVEDLAIISNQRQR 533
             LH       P+H ++  D     L DV    +  + +QR
Sbjct: 275 SKLHAIID---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G G+F  V + V          K+ N      R  +    E R  R ++H N+V++  +
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            S    +G+ +  L+++ +  G L E +       E D +    + +Q++         L
Sbjct: 90  ISE---EGHHY--LIFDLVTGGELFEDIVAREYYSEADAS----HCIQQI---------L 131
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           + + H  Q    H DLKP N+LL  ++      + DFGLA  +     Q +  G  G+ G
Sbjct: 132 EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPG 189
Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           Y++PE           D+++ G+++  L++   P
Sbjct: 190 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR---- 327
           +    +IG G FG V K    +    V +K+   +  R  R    E R L  +R +    
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 328 --NLVKVFTACSGVDYQGNDFKAL---VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
             N++ +    +  ++    F+ L   +YE ++    + +  P+ R+             
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK------------- 204
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS--HVGDFGLARFLPPTHV 440
                A  +   LD LH +      HCDLKP NILL ++  S   V DFG + +      
Sbjct: 205 ----FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EH 253
Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           Q     ++    Y APE  LG+      D++S G ++ EL+
Sbjct: 254 QRVYXXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELL 293

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
            IA+ +  AL++LH     I  H D+KPSN+L++        DFG++ +L     +    
Sbjct: 140 KIAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 446 GVKGSIGYIAPEYGLGSEVSTNG-----DVYSYGILMLELIIRKKPSD 488
           G K    Y APE  +  E++  G     D++S GI  +EL I + P D
Sbjct: 198 GCKP---YXAPER-INPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 560 LDLESLKLAG-SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           LD+ S K++  S+L  + NL  L      NN  +   P  +G L  L    LN N +  +
Sbjct: 177 LDISSNKVSDISVLAKLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLK-D 230
Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
           I   L+S +NL  + LA NQ+    P     L+K+  L LG N +  S   PL  L++L 
Sbjct: 231 IGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI--SNISPLAGLTALT 285
Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
            + L  N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+   
Sbjct: 286 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV 341
Query: 739 IPLDYGFTLQNLQYFSIGTNRITGAIP 765
             L     L N+ + S G N+I+   P
Sbjct: 342 SSL---ANLTNINWLSAGHNQISDLTP 365

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 14/117 (11%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           +++ AL +LH   Q    + DLKP NI+L+ +    + DFGL +     H  T +    G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCG 183
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELII---------RKKPSDIMFEGDMNL 497
           +I Y+APE  + S  +   D +S G LM +++          RKK  D + +  +NL
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           +D +     +G G+F  V + V          K+ N      R  +    E R  R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  +      Q   F  LV++ +  G L E +       E D +    + +Q+  
Sbjct: 65  PNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQ-- 113
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTS 443
               +  ++ Y H +      H +LKP N+LL  +       + DFGLA       V  S
Sbjct: 114 ----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDS 161
Query: 444 SI--GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               G  G+ GY++PE       S   D+++ G+++  L++   P
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 560 LDLESLKLAG-SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           LD+ S K++  S+L  + NL  L      NN  +   P  +G L  L    LN N +  +
Sbjct: 182 LDISSNKVSDISVLAKLTNLESLIA---TNNQISDITP--LGILTNLDELSLNGNQLK-D 235
Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
           I   L+S +NL  + LA NQ+    P     L+K+  L LG N +  S   PL  L++L 
Sbjct: 236 IGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI--SNISPLAGLTALT 290
Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
            + L  N L    P  +S LKNL  L L  N +S I P S  +++ +       NK+   
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV 346
Query: 739 IPLDYGFTLQNLQYFSIGTNRITGAIP 765
             L     L N+ + S G N+I+   P
Sbjct: 347 SSL---ANLTNINWLSAGHNQISDLTP 370

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA---------ECRALR 322
           +S+ + +G+G+FG V+  V  E    V VK F          +I          E   L 
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVK-FIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            + H N++KV        ++   F  LV E  ++GS  +    ++R   +D+ P    + 
Sbjct: 85  RVEHANIIKVLDI-----FENQGFFQLVME--KHGSGLDLFAFIDRHPRLDE-PLASYIF 136
Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
           ++L  A+      D +H D         +K  NI++ E+    + DFG A +L    +  
Sbjct: 137 RQLVSAVGYLRLKDIIHRD---------IKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187
Query: 443 SSIGVKGSIGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKP 486
           +     G+I Y APE  +G+       +++S G+ +  L+  + P
Sbjct: 188 TFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 14/117 (11%)
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           +++ AL +LH   Q    + DLKP NI+L+ +    + DFGL +     H  T +    G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCG 183
Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELII---------RKKPSDIMFEGDMNL 497
           +I Y+APE  + S  +   D +S G LM +++          RKK  D + +  +NL
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 36/214 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           L+ VFT    ++ + ND   + +           L   +  + V       + +Q L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH-----------LMGADLNNIVKSQKLTDDHVQFL--I 131
Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +   L Y+H        H DLKPSN+ ++E+    + DFGL R     H      G  
Sbjct: 132 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYV 183
Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
            +  Y APE  L     +   D++S G +M EL+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTA 335
           IG G++G+V+K    E    V +K   L         S + E   L+ ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-- 67
Query: 336 CSGVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
               D   +D K  LV+EF  +  L+++    N   ++D       L Q L   +    +
Sbjct: 68  ----DVLHSDKKLTLVFEFC-DQDLKKYFDSCN--GDLDPEIVKSFLFQLLK-GLGFCHS 119
Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSIGY 453
            + LH D         LKP N+L++      + +FGLAR F  P    ++ +    ++ Y
Sbjct: 120 RNVLHRD---------LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV---VTLWY 167
Query: 454 IAPEYGLGSEV-STNGDVYSYGILMLELIIRKKP 486
             P+   G+++ ST+ D++S G +  EL    +P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R  +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E+   G +   L  + R  E    P       ++ 
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSE----PHARFYAAQIV 152
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 153 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIKVADFGFAK-----RVKGRTWX 198
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+        ++ N    +V E++  G +   L  + R  E    P       ++ 
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIV 151
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           +  +   +LD ++ D         LKP N+L+D++    V DFG A+      V+  +  
Sbjct: 152 LTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
           + G+   +APE  L    +   D ++ G+L+ E+
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 275 ANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNL 329
            +L+G GS+G V K VLD     R  V +              +   E + LR +RH+N+
Sbjct: 10  GDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV-NREDEVDKAP-RNLNLLQRLNI 387
           +++      VD   N+ K  +Y  M+        Y V   ++ +D  P +   + Q    
Sbjct: 69  IQL------VDVLYNEEKQKMYMVME--------YCVCGMQEMLDSVPEKRFPVCQAHGY 114
Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              +   L+YLH        H D+KP N+LL       +   G+A  L P     +    
Sbjct: 115 FCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 448 KGSIGYIAPEY--GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           +GS  +  PE   GL +      D++S G+ +  +     P    FEGD
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGD 216

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 25/223 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           TD +     +G G+F  V + +          K+ N      R  +    E R  R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  + S        F  LV++ +  G L E +       E D +     +L+ +N
Sbjct: 63  PNIVRLHDSISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MVSHVGDFGLARFLPPTHVQTS 443
                       H     I  H DLKP N+LL  +       + DFGLA  +     Q +
Sbjct: 118 ------------HCHLNGIV-HRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQA 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             G  G+ GY++PE           D+++ G+++  L++   P
Sbjct: 163 WFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 34/219 (15%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG G+F  V           V VK+ +     +S  +    E R  + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      LV E+   G + ++L    R  E +   +             + SA+
Sbjct: 82  I-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ----------IVSAV 126
Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK-----GS 450
            Y H   Q    H DLK  N+LLD +    + DFG +           + G K     G+
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFS--------NEFTFGNKLDAFCGA 175
Query: 451 IGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSD 488
             Y APE   G +      DV+S G+++  L+    P D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           +D +     +G G+F  V + V          K+ N      R  +    E R  R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  +      Q   F  LV++ +  G L E +       E D +    + +Q+  
Sbjct: 65  PNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQ-- 113
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTS 443
               +  ++ Y H +      H +LKP N+LL  +       + DFGLA       V  S
Sbjct: 114 ----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDS 161
Query: 444 SI--GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               G  G+ GY++PE       S   D+++ G+++  L++   P
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 90/241 (37%), Gaps = 29/241 (12%)
Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF---NLHHHRASRSFIAECRALRSIRH 326
           D F     +G G FG+VY     +    V +KV     +           E      + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+++++       +       L+ E+   G L + L      DE   A           
Sbjct: 83  PNILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA----------T 127
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           I  ++A AL Y H        H D+KP N+LL  +    + DFG +   P    +T    
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC-- 182
Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506
             G++ Y+ PE   G   +   D++  G+L  EL++   P    FE   +   + R+   
Sbjct: 183 --GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP----FESASHNETYRRIVKV 236
Query: 507 D 507
           D
Sbjct: 237 D 237

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 272 FSSANLIGTGSFGS-VYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR-SIRHRNL 329
           F   +++G G+ G+ VY+G+ D  R     ++       A R    E + LR S  H N+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           ++ F  C+  D Q   F+ +  E     +L+E+   V ++D        + LLQ+     
Sbjct: 81  IRYF--CTEKDRQ---FQYIAIELCA-ATLQEY---VEQKDFAHLGLEPITLLQQ----- 126
Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDE-----EMVSHVGDFGLARFLP-PTHVQTS 443
              S L +LH        H DLKP NIL+       ++ + + DFGL + L    H  + 
Sbjct: 127 -TTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNG----DVYSYGILMLELI 481
             GV G+ G+IAPE  L  +   N     D++S G +   +I
Sbjct: 183 RSGVPGTEGWIAPEM-LSEDCKENPTYTVDIFSAGCVFYYVI 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           TD +     +G G+F  V + +          K+ N      R  +    E R  R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  + S        F  LV++ +  G L E +       E D +    + +Q++ 
Sbjct: 63  PNIVRLHDSISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADAS----HCIQQI- 112
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MVSHVGDFGLARFLPPTHVQTS 443
                   L+ ++H       H DLKP N+LL  +       + DFGLA  +     Q +
Sbjct: 113 --------LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQA 162
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             G  G+ GY++PE           D+++ G+++  L++   P
Sbjct: 163 WFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
           +D +     +G G+F  V + V          K+ N      R  +    E R  R ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+V++  +      Q   F  LV++ +  G L E +       E D +    + +Q+  
Sbjct: 64  PNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQ-- 112
Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTS 443
               +  ++ Y H +      H +LKP N+LL  +       + DFGLA       V  S
Sbjct: 113 ----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDS 160
Query: 444 SI--GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
               G  G+ GY++PE       S   D+++ G+++  L++   P
Sbjct: 161 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 47/168 (27%)
Query: 628 NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS------SLRKIS 681
           NLI + L  NQ+    P    +L+KI  L L  N        PL N+S      S++ + 
Sbjct: 70  NLIGLELKDNQITDLTP--LKNLTKITELELSGN--------PLKNVSAIAGLQSIKTLD 119
Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
           L    +    P  L+ L NL +LYL +N+++ I P +                       
Sbjct: 120 LTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA----------------------- 154
Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
             G T  NLQY SIG N++    P  ++N SKL   +A +NK++   P
Sbjct: 155 --GLT--NLQYLSIGNNQVNDLTP--LANLSKLTTLRADDNKISDISP 196

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + DF LAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 92
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    L K+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 93  KRILQAVNFPFLTKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PH 143
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFG A+    
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGFAK---- 190
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVFTA 335
           IG G+FG V+K    +    V +K   + + +      A  E + L+ ++H N+V +   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 336 CSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           C       N  K    LV++F ++  L   L  V  +  + +  R + +L          
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML---------L 135
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVK-GS 450
           + L Y+H +      H D+K +N+L+  + V  + DFGLAR F    + Q +    +  +
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 451 IGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
           + Y  PE  LG  +     D++  G +M E+  R   S IM +G+   H  A
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 92
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    L K+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 93  KRILQAVNFPFLTKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE----PH 143
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFG A+    
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGFAK---- 190
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           ++ +DF  +V E  +  SL E    +++  +    P     +++          + YLH+
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE----LHKRRKAVTEPEARYFMRQ------TIQGVQYLHN 160
Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK---GSIGYIAPE 457
           +      H DLK  N+ L+++M   +GDFGLA     T ++      K   G+  YIAPE
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKTLCGTPNYIAPE 212
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  S   D++S G ++  L++ K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           ++ +DF  +V E  +  SL E    +++  +    P     +++          + YLH+
Sbjct: 95  FEDDDFVYVVLEICRRRSLLE----LHKRRKAVTEPEARYFMRQ------TIQGVQYLHN 144
Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK---GSIGYIAPE 457
           +      H DLK  N+ L+++M   +GDFGLA     T ++      K   G+  YIAPE
Sbjct: 145 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPE 196
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  S   D++S G ++  L++ K P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           ++ +DF  +V E  +  SL E    +++  +    P     +++          + YLH+
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE----LHKRRKAVTEPEARYFMRQ------TIQGVQYLHN 160
Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK---GSIGYIAPE 457
           +      H DLK  N+ L+++M   +GDFGLA     T ++      K   G+  YIAPE
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPE 212
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  S   D++S G ++  L++ K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    +  FGLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400
           ++ +DF  +V E  +  SL E    +++  +    P     +++          + YLH+
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE----LHKRRKAVTEPEARYFMRQ------TIQGVQYLHN 160
Query: 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK---GSIGYIAPE 457
           +      H DLK  N+ L+++M   +GDFGLA     T ++      K   G+  YIAPE
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPE 212
Query: 458 YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
                  S   D++S G ++  L++ K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 270 DGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           D F     +GTGSFG V               +LD+ +    VK+  + H       + E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV---VKLKQIEHT------LNE 92
Query: 318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            R L+++    L K+        ++ N    +V E+   G +   L  + R  E    P 
Sbjct: 93  KRILQAVNFPFLTKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE----PH 143
Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP 437
                 ++ +  +   +LD ++ D         LKP N+++D++    V DFG A+    
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRD---------LKPENLMIDQQGYIKVTDFGFAK---- 190
Query: 438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480
             V+  +  + G+  Y+APE  L    +   D ++ G+L+ E+
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + D GLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 3/74 (4%)
Query: 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN 467
           H DLKPSNI++  +    + DFGLAR    + +    +  +    Y APE  LG     N
Sbjct: 151 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTR---YYRAPEVILGMGYKEN 207
Query: 468 GDVYSYGILMLELI 481
            D++S G +M E+I
Sbjct: 208 VDIWSVGCIMGEMI 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 104/259 (40%), Gaps = 34/259 (13%)
Query: 269 TDGFSSANLIGTGSFGSVY---KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR 325
           +D +     +G+G++G V      +    R    +K  ++     S + + E   L+ + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N++K++       ++      LV E  + G L + +    +  EVD A          
Sbjct: 80  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--------- 125
Query: 386 NIAIDVASALDYLH-HDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQ 441
            I   V S   YLH H+      H DLKP N+LL+    + +  + DFGL+         
Sbjct: 126 -IMKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM 180
Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
              +   G+  YIAPE  L  +     DV+S G+++  L+    P    F G  +     
Sbjct: 181 KERL---GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP----FGGQTDQEILK 232
Query: 502 RMALPDHVMDIVDSTLLND 520
           R+       D  D T ++D
Sbjct: 233 RVEKGKFSFDPPDWTQVSD 251

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVFTA 335
           IG G+FG V+K    +    V +K   + + +      A  E + L+ ++H N+V +   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 336 CSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           C       N  K    LV++F ++  L   L  V  +  + +  R + +L  LN      
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML--LN------ 136
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVK-GS 450
             L Y+H +      H D+K +N+L+  + V  + DFGLAR F    + Q +    +  +
Sbjct: 137 -GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 451 IGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
           + Y  PE  LG  +     D++  G +M E+  R   S IM +G+   H  A
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + D GLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVK 331
           +G   FG VYKG L     G  T  V +  L           F  E      ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY------PVNREDEVDKAPRNLNLLQRL 385
           +     GV  +     ++++ +  +G L E+L        V   D+       L     +
Sbjct: 94  LL----GVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 386 NIAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           ++   +A+ ++YL  HH       H DL   N+L+ +++   + D GL R +        
Sbjct: 149 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 203
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                  I ++APE  +  + S + D++SYG+++ E+ 
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 25/232 (10%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVFTA 335
           IG G+FG V+K    +    V +K   + + +      A  E + L+ ++H N+V +   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 336 CSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           C       N  K    LV++F ++  L   L  V  +  + +  R + +L          
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML---------L 134
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVK-GS 450
           + L Y+H +      H D+K +N+L+  + V  + DFGLAR F    + Q +    +  +
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 451 IGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
           + Y  PE  LG  +     D++  G +M E+  R   S IM +G+   H  A
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 239

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRSFIA----ECRALRSIR 325
           F    L+G G+FG V   +L + + T       +       ++  +A    E R L++ R
Sbjct: 153 FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H      F       +Q +D    V E+   G L    + ++RE       R  +  +  
Sbjct: 210 H-----PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-------RVFSEDRAR 254
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               ++ SALDYLH +   +  + DLK  N++LD++    + DFGL +          + 
Sbjct: 255 FYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 313 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 54/118 (45%), Gaps = 12/118 (10%)
Query: 374 KAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433
           + P    +L ++ +AI    AL YL      I  H D+KPSNILLDE     + DFG++ 
Sbjct: 118 QGPIPERILGKMTVAI--VKALYYLKEKHGVI--HRDVKPSNILLDERGQIKLCDFGISG 173
Query: 434 FLPPTHVQTSSIGVKGSIGYIAPEY-----GLGSEVSTNGDVYSYGILMLELIIRKKP 486
            L     +  S G      Y+APE          +     DV+S GI ++EL   + P
Sbjct: 174 RLVDDKAKDRSAGC---AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRSFIA----ECRALRSIR 325
           F    L+G G+FG V   +L + + T       +       ++  +A    E R L++ R
Sbjct: 150 FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H      F       +Q +D    V E+   G L    + ++RE       R  +  +  
Sbjct: 207 H-----PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-------RVFSEDRAR 251
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               ++ SALDYLH +   +  + DLK  N++LD++    + DFGL +          + 
Sbjct: 252 FYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
              G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 310 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVK 331
           +G   FG VYKG L     G  T  V +  L           F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY------PVNREDEVDKAPRNLNLLQRL 385
           +     GV  +     ++++ +  +G L E+L        V   D+       L     +
Sbjct: 77  LL----GVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 386 NIAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           ++   +A+ ++YL  HH       H DL   N+L+ +++   + D GL R +        
Sbjct: 132 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                  I ++APE  +  + S + D++SYG+++ E+ 
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 27/225 (12%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
            + +    +IG G+FG V        R    +K+ +      R+  +F  E R + +  +
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 327 R-NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              +V++F A     +Q + +  +V E+M  G L      VN     D   +      R 
Sbjct: 133 SPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL------VNLMSNYDVPEK----WARF 177
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A +V  ALD +H        H D+KP N+LLD+     + DFG    +    +     
Sbjct: 178 YTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 446 GVKGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            V G+  YI+PE     G         D +S G+ + E+++   P
Sbjct: 234 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN------LHHHRASRSFIAECRALRSIRHRN--- 328
           +G+G++GSV      +    V VK  +      +H  R  R    E R L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN-- 386
           L+ VFT    ++ + ND   + +  +    L                  N+   Q+L   
Sbjct: 86  LLDVFTPARSLE-EFNDVYLVTH--LMGADLN-----------------NIVKCQKLTDD 125
Query: 387 ----IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               +   +   L Y+H        H DLKPSN+ ++E+    + D GLAR     H   
Sbjct: 126 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDD 177
Query: 443 SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481
              G   +  Y APE  L     +   D++S G +M EL+
Sbjct: 178 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 27/225 (12%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
            + +    +IG G+FG V        R    +K+ +      R+  +F  E R + +  +
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 327 R-NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              +V++F A     +Q + +  +V E+M  G L      VN     D   +      R 
Sbjct: 128 SPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL------VNLMSNYDVPEK----WARF 172
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A +V  ALD +H        H D+KP N+LLD+     + DFG    +    +     
Sbjct: 173 YTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 446 GVKGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            V G+  YI+PE     G         D +S G+ + E+++   P
Sbjct: 229 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 27/225 (12%)
Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH 326
            + +    +IG G+FG V        R    +K+ +      R+  +F  E R + +  +
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 327 R-NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              +V++F A     +Q + +  +V E+M  G L      VN     D   +      R 
Sbjct: 133 SPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL------VNLMSNYDVPEK----WARF 177
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A +V  ALD +H        H D+KP N+LLD+     + DFG    +    +     
Sbjct: 178 YTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 446 GVKGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            V G+  YI+PE     G         D +S G+ + E+++   P
Sbjct: 234 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 103/251 (41%), Gaps = 51/251 (20%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-----SRSFIAECRALRSIRHRNLVKV 332
           IG GS+G V   + ++ R    +K+ N +  R            E R ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWL----------------------YPVNRED 370
           +       Y+   +  LV E    G L + L                       P   E+
Sbjct: 94  YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 371 EVDKA----PRNLNLLQRL----NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422
            ++ +      +L+ +QR     NI   + SAL YLH+  Q I  H D+KP N L     
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGI-CHRDIKPENFLFSTNK 205
Query: 423 VSHVG--DFGLAR-FLPPTHVQTSSIGVK-GSIGYIAPEYGLGSEVSTNG---DVYSYGI 475
              +   DFGL++ F    + +   +  K G+  ++APE  L +   + G   D +S G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-LNTTNESYGPKCDAWSAGV 264
Query: 476 LMLELIIRKKP 486
           L+  L++   P
Sbjct: 265 LLHLLLMGAVP 275

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 46/230 (20%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASRSF---IAECRALRSIR 325
           F    L+G G+FG V   +L + + T     +K+       A       + E R L++ R
Sbjct: 12  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H      F       +Q +D    V E+   G L    + ++RE       R  +  +  
Sbjct: 69  H-----PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-------RVFSEDRAR 113
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               ++ SALDYLH +   +  + DLK  N++LD++    + DFGL +            
Sbjct: 114 FYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK-----------E 160
Query: 446 GVK---------GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+K         G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 161 GIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 46/230 (20%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASRSF---IAECRALRSIR 325
           F    L+G G+FG V   +L + + T     +K+       A       + E R L++ R
Sbjct: 10  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H      F       +Q +D    V E+   G L    + ++RE       R  +  +  
Sbjct: 67  H-----PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-------RVFSEDRAR 111
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               ++ SALDYLH +   +  + DLK  N++LD++    + DFGL +            
Sbjct: 112 FYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK-----------E 158
Query: 446 GVK---------GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+K         G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 159 GIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 46/230 (20%)
Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHRASRSF---IAECRALRSIR 325
           F    L+G G+FG V   +L + + T     +K+       A       + E R L++ R
Sbjct: 11  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H      F       +Q +D    V E+   G L    + ++RE       R  +  +  
Sbjct: 68  H-----PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-------RVFSEDRAR 112
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
               ++ SALDYLH +   +  + DLK  N++LD++    + DFGL +            
Sbjct: 113 FYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK-----------E 159
Query: 446 GVK---------GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+K         G+  Y+APE    ++     D +  G++M E++  + P
Sbjct: 160 GIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           ++G G++G VY G     +  + +K       R S+    E    + ++H+N+V+   + 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
           S      N F  +  E +  GSL   L   ++   +    + +    +      +   L 
Sbjct: 75  S-----ENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTK-----QILEGLK 122
Query: 397 YLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           YL HD Q +  H D+K  N+L++    V  + DFG ++ L   +  T +    G++ Y+A
Sbjct: 123 YL-HDNQIV--HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 177
Query: 456 PE--------YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE        YG  +      D++S G  ++E+   K P
Sbjct: 178 PEIIDKGPRGYGKAA------DIWSLGCTIIEMATGKPP 210

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 32/219 (14%)
Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           ++G G++G VY G     +  + +K       R S+    E    + ++H+N+V+   + 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
               +  N F  +  E +  GSL   L            P   N          +   L 
Sbjct: 88  ----FSENGFIKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 397 YLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           YL HD Q +  H D+K  N+L++    V  + DFG ++ L   +  T +    G++ Y+A
Sbjct: 137 YL-HDNQIV--HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 191
Query: 456 PE--------YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE        YG  +      D++S G  ++E+   K P
Sbjct: 192 PEIIDKGPRGYGKAA------DIWSLGCTIIEMATGKPP 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 39/230 (16%)
Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G GSFG V++    +      VK   L   RA    +  C  L S R   +V ++ A  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPR---IVPLYGA-- 153
Query: 338 GVDYQGNDFKALVYEFMQNGSL-----EEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               +   +  +  E ++ GSL     E+   P +R             L  L  A++  
Sbjct: 154 ---VREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR------------ALYYLGQALE-- 196
Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG--DFGLARFLPPTHVQTSSIG---V 447
             L+YLH        H D+K  N+LL  +  SH    DFG A  L P  +  S +    +
Sbjct: 197 -GLEYLHSR---RILHGDVKADNVLLSSDG-SHAALCDFGHAVCLQPDGLGKSLLTGDYI 251
Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL 497
            G+  ++APE  LG       DV+S   +ML ++    P    F G + L
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 301

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 103/258 (39%), Gaps = 32/258 (12%)
Query: 269 TDGFSSANLIGTGSFGSV---YKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR 325
           +D +     +G+G++G V      +    R    +K  ++     S + + E   L+ + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N++K++       ++      LV E  + G L + +    +  EVD A          
Sbjct: 63  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--------- 108
Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQT 442
            I   V S   YLH   +    H DLKP N+LL+    + +  + DFGL+          
Sbjct: 109 -IMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK 164
Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
             +   G+  YIAPE  L  +     DV+S G+++  L+    P    F G  +     R
Sbjct: 165 ERL---GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP----FGGQTDQEILKR 216
Query: 503 MALPDHVMDIVDSTLLND 520
           +       D  D T ++D
Sbjct: 217 VEKGKFSFDPPDWTQVSD 234

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	789
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-54
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-48
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-47
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-40
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-39
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-26
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-68
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-63
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-55
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-54
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-53
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-50
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-49
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-48
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-43
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-39
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-25
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-43
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-39
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-36
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-30
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-29
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-28
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-28
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-32
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-31
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-07
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-04
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-27
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-27
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-25
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-24
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-28
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-27
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-06
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-22
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-04
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-27
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-27
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-24
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-16
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-25
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-09
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-24
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-22
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-20
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-20
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-20
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-17
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-17
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-04
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-17
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-18
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-18
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-18
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-06
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-17
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-16
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-05
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-04
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-04
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-05
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	3e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-04
4fev_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  249 bits (639), Expect = 1e-76
 Identities = 96/282 (34%), Positives = 144/282 (51%), Gaps = 22/282 (7%)

Query: 246 EQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL 305
            + +P   +  L   S + L  A+D FS+ N++G G FG VYKG L +G T V VK    
Sbjct: 6   AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKE 64

Query: 306 HHHRAS-RSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY 364
              +     F  E   +    HRNL+++   C        + + LVY +M NGS+   L 
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR 119

Query: 365 PVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424
                 E  ++   L+  +R  IA+  A  L YLH  C P   H D+K +NILLDEE  +
Sbjct: 120 ------ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173

Query: 425 HVGDFGLARFLPP--THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII 482
            VGDFGLA+ +    THV T    V+G+IG+IAPEY    + S   DV+ YG+++LELI 
Sbjct: 174 VVGDFGLAKLMDYKDTHVTT---AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230

Query: 483 RKKPSDIMF---EGDMNLHNFARMALPD-HVMDIVDSTLLND 520
            ++  D+     + D+ L ++ +  L +  +  +VD  L  +
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  229 bits (587), Expect = 3e-69
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 16/213 (7%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L +    +SG IP  +  +K LV    S N L G++P S+    +L  I    N +SG 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 61  IPPQLMGLTSLV-ALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           IP      + L  ++ +SRN+  G  P    NL NL  + +S N+L+G+     GS    
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 120 EILEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
           + + +  N              L  LDL  N++ G +P+ L  LK + +LN+S+N+L G 
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 170 VPTEGVFKNASAISVLGNNKLCGGISEFKLPPC 202
           +P  G  +     +   N  LCG      LP C
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCGSP----LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  215 bits (549), Expect = 1e-63
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 7/242 (2%)

Query: 552 SKAQKVTILDLESLKLAGS--ILPHIGNLSFLKILNLEN-NSFTHEIPSEIGRLRRLQVP 608
           ++  +V  LDL  L L     I   + NL +L  L +   N+    IP  I +L +L   
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 609 DLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP 668
            + + ++ G IP  LS    L+ +  + N L G +P    SL  +  ++   N + G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 669 PPLGNLSSL-RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
              G+ S L   ++++ N L G IP T + L NL  + L  N L G       +  +  +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 728 FDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE 787
             + +N +  ++    G   +NL    +  NRI G +P  ++    L       N L GE
Sbjct: 226 IHLAKNSLAFDLG-KVGL-SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 788 VP 789
           +P
Sbjct: 284 IP 285

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  190 bits (484), Expect = 1e-54
 Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 9/233 (3%)

Query: 558 TILDLESL-KLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
             L +  +  L G I P I  L+ L  L + + + +  IP  + +++ L   D + N++ 
Sbjct: 79  NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSK-IEVLSLGFNNLIGSIPPPLGNLS 675
           G +P ++SS  NL+ I    N++ G IP  +GS SK    +++  N L G IPP   NL+
Sbjct: 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
            L  + L+ N L G         KN   ++L  N L+  +   +    ++   D+  N+I
Sbjct: 199 -LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRI 256

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS--ISNASKLEVFQALNNKLTG 786
            G +P      L+ L   ++  N + G IP    +            N  L G
Sbjct: 257 YGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN--NKCLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  170 bits (434), Expect = 9e-48
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 2   LALDSNRLSG--NIPPSIGNLKKLVEPYVSD-NFLKGSIPSSLGLCESLTTIGLFNNNLS 58
           L L    L     IP S+ NL  L   Y+   N L G IP ++     L  + + + N+S
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 59  GTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
           G IP  L  + +LV LD S N   G+ P  + +L NL  +T  GN + G IP + GS  K
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 119 L-EILEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L   + +  N   G          L  +DLSRN L G+        K  + ++L+ N L 
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 168 GMVPTEGVFKNASAISVLGNNKLCGGI 194
             +   G+ KN + +  L NN++ G +
Sbjct: 235 FDLGKVGLSKNLNGLD-LRNNRIYGTL 260

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  170 bits (433), Expect = 2e-47
 Identities = 51/228 (22%), Positives = 99/228 (43%), Gaps = 10/228 (4%)

Query: 570 SILPHIGNLSFL----KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE--IPVNL 623
            I   +GN + L       +  N ++   +     +  R+   DL+  ++     IP +L
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 624 SSCSNLIRIGLAK-NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL 682
           ++   L  + +   N L+G IP     L+++  L +   N+ G+IP  L  + +L  +  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 683 AINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF-DVGENKIQGNIPL 741
           + N L+G++P ++S L NLV +    NR+SG +P S  + S +     +  N++ G IP 
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            +     NL +  +  N + G       +    +      N L  ++ 
Sbjct: 193 TFA--NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  149 bits (378), Expect = 4e-40
 Identities = 57/207 (27%), Positives = 84/207 (40%), Gaps = 18/207 (8%)

Query: 7   NRLSGNIPPSIGNLKKLVEPYVSDNFLKGS--IPSSLGLCESLTTIGLFN-NNLSGTIPP 63
               G +  +     ++    +S   L     IPSSL     L  + +   NNL G IPP
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 64  QLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILE 123
            +  LT L  L ++     G+ P  +  +  L TL  S N L G +P ++ S   L  + 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 124 MQGNVFQG------------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
             GN   G             T + +SRN+L+G+IP     L  +  ++LS N LEG   
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214

Query: 172 TE-GVFKNASAISVLGNNKLCGGISEF 197
              G  KN   I  L  N L   + + 
Sbjct: 215 VLFGSDKNTQKIH-LAKNSLAFDLGKV 240

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  146 bits (370), Expect = 5e-39
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 4/185 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVP-DLNNNSIG 616
             LD     L+G++ P I +L  L  +  + N  +  IP   G   +L     ++ N + 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSS 676
           G+IP   ++  NL  + L++N L G     FGS    + + L  N+L   +   +G   +
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKN 245

Query: 677 LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ 736
           L  + L  N + G++P  L++LK L  L +  N L G +P    N+          NK  
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCL 304

Query: 737 GNIPL 741
              PL
Sbjct: 305 CGSPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  130 bits (329), Expect = 1e-33
 Identities = 44/184 (23%), Positives = 65/184 (35%), Gaps = 18/184 (9%)

Query: 29  SDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT--IPPQLMGLTSLVALDLS-RNQFRGSF 85
            +    G +  +      +  + L   NL     IP  L  L  L  L +   N   G  
Sbjct: 34  CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93

Query: 86  PTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTI 134
           P  +  L  L  L ++   + G IP  L     L  L+   N   G           L  
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153

Query: 135 LDLSRNKLSGEIPEFLVGL-KVIENLNLSYNDLEGMVPTEGVFKNASAISV-LGNNKLCG 192
           +    N++SG IP+      K+  ++ +S N L G +P    F N +   V L  N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSRNMLEG 211

Query: 193 GISE 196
             S 
Sbjct: 212 DASV 215

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  109 bits (276), Expect = 2e-26
 Identities = 44/178 (24%), Positives = 62/178 (34%), Gaps = 19/178 (10%)

Query: 36  SIPSSLGLCESL----TTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSF--PTEV 89
            I   LG   +L     T    N    G +         +  LDLS       +  P+ +
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 90  GNLINLETLTVSG-NILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDL 137
            NL  L  L + G N L G IP  +    +L  L +      G           L  LD 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 138 SRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTE-GVFKNASAISVLGNNKLCGGI 194
           S N LSG +P  +  L  +  +    N + G +P   G F        +  N+L G I
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  105 bits (265), Expect = 4e-25
 Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 3/143 (2%)

Query: 550 IGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPD 609
            GS ++  T + +   +L G I P   NL+ L  ++L  N    +     G  +  Q   
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227

Query: 610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
           L  NS+  ++   +    NL  + L  N++ G +P     L  +  L++ FNNL G I P
Sbjct: 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-P 285

Query: 670 PLGNLSSLRKISLAINNLAGSIP 692
             GNL      + A N      P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 89.5 bits (223), Expect = 1e-19
 Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 2/113 (1%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             +DL    L G      G+    + ++L  NS   ++   +G  + L   DL NN I G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYG 258

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP 670
            +P  L+    L  + ++ N L G+IP   G+L + +V +   N  +   P P
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  228 bits (584), Expect = 1e-68
 Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 23/279 (8%)

Query: 248 SNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH 307
           S+   +      +   +L  AT+ F    LIG G FG VYKGVL +G   V +K      
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPES 75

Query: 308 HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN 367
            +    F  E   L   RH +LV +   C   +        L+Y++M+NG+L+  LY   
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY--- 127

Query: 368 REDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427
                D    +++  QRL I I  A  L YLH        H D+K  NILLDE  V  + 
Sbjct: 128 ---GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181

Query: 428 DFGLARFLP---PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK 484
           DFG+++       TH+ T    VKG++GYI PEY +   ++   DVYS+G+++ E++  +
Sbjct: 182 DFGISKKGTELDQTHLST---VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 485 KPSDIMF-EGDMNLHNFARMALPD-HVMDIVDSTLLNDV 521
                      +NL  +A  +  +  +  IVD  L + +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  213 bits (544), Expect = 4e-63
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 37/287 (12%)

Query: 246 EQSNPNSLINSLLNLSYQNLHNATDGFSS------ANLIGTGSFGSVYKGVLDEGRTTVT 299
           E  +         + S+  L N T+ F         N +G G FG VYKG ++   TTV 
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58

Query: 300 VKVFNLHHHRAS----RSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQ 355
           VK         +    + F  E + +   +H NLV++    S     G+D   LVY +M 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVYMP 113

Query: 356 NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN 415
           NGSL + L            P  L+   R  IA   A+ +++LH +   I  H D+K +N
Sbjct: 114 NGSLLDRLS-----CLDGTPP--LSWHMRCKIAQGAANGINFLHENHH-I--HRDIKSAN 163

Query: 416 ILLDEEMVSHVGDFGLARFLPP---THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYS 472
           ILLDE   + + DFGLAR       T + +    + G+  Y+APE   G E++   D+YS
Sbjct: 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSR---IVGTTAYMAPEALRG-EITPKSDIYS 219

Query: 473 YGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD--HVMDIVDSTL 517
           +G+++LE+I      D   E    L +       +   + D +D  +
Sbjct: 220 FGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKM 265

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  192 bits (489), Expect = 3e-55
 Identities = 61/254 (24%), Positives = 105/254 (41%), Gaps = 29/254 (11%)

Query: 255 NSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF 314
           +S ++L  +NL+  +       +   G FG V+K  L      V VK+F +   + S   
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQD-KQSWQN 65

Query: 315 IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK 374
             E  +L  ++H N+++   A         D   L+  F + GSL ++L           
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA--------- 115

Query: 375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITT-------HCDLKPSNILLDEEMVSHVG 427
               ++  +  +IA  +A  L YLH D   +         H D+K  N+LL   + + + 
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELI 481
           DFGLA           + G  G+  Y+APE  L   ++         D+Y+ G+++ EL 
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELA 232

Query: 482 IRKKPSDIMFEGDM 495
            R   +D   +  M
Sbjct: 233 SRCTAADGPVDEYM 246

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  198 bits (507), Expect = 5e-54
 Identities = 63/245 (25%), Positives = 111/245 (45%), Gaps = 10/245 (4%)

Query: 550 IGSKAQKVTILDLESLKLAGSILPHI---GNLSFLKILNLENNSFTHEIPSEIGRLRRLQ 606
            G K   + +LDL +  ++G+ +           LK L +  N  + ++   + R   L+
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLE 203

Query: 607 VPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGS 666
             D+++N+    IP  L  CS L  + ++ N+L G       + +++++L++  N  +G 
Sbjct: 204 FLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262

Query: 667 IPPPLGNLSSLRKISLAINNLAGSIPFTLS-KLKNLVILYLGVNRLSGIVPSSIFNISSI 725
           IPP    L SL+ +SLA N   G IP  LS     L  L L  N   G VP    + S +
Sbjct: 263 IPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320

Query: 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS-KLEVFQALNNKL 784
               +  N   G +P+D    ++ L+   +  N  +G +P S++N S  L      +N  
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380

Query: 785 TGEVP 789
           +G + 
Sbjct: 381 SGPIL 385

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  197 bits (502), Expect = 2e-53
 Identities = 63/256 (24%), Positives = 116/256 (45%), Gaps = 9/256 (3%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           N+I    +    +     ++  L +   K++G +   +     L+ L++ +N+F+  IP 
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF 218

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS 657
            +G    LQ  D++ N + G+    +S+C+ L  + ++ NQ +G IP     L  ++ LS
Sbjct: 219 -LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLS 275

Query: 658 LGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP 716
           L  N   G IP  L G   +L  + L+ N+  G++P        L  L L  N  SG +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 717 -SSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASK-- 773
             ++  +  +   D+  N+  G +P        +L    + +N  +G I P++    K  
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 774 LEVFQALNNKLTGEVP 789
           L+     NN  TG++P
Sbjct: 396 LQELYLQNNGFTGKIP 411

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  188 bits (479), Expect = 3e-50
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 5/233 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             L L++    G I P + N S L  L+L  N  +  IPS +G L +L+   L  N + G
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
           EIP  L     L  + L  N L G+IPS   + + +  +SL  N L G IP  +G L +L
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG 737
             + L+ N+ +G+IP  L   ++L+ L L  N  +G +P+++F  S      +  N I G
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAG 572

Query: 738 NIPLDYG-FTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
              +      ++   + +       G     ++  S        +    G   
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  185 bits (473), Expect = 1e-49
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 29/263 (11%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
           S   ++  L L    L+G+I   +G+LS L+ L L  N    EIP E+  ++ L+   L+
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474

Query: 612 NNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
            N + GEIP  LS+C+NL  I L+ N+L G+IP   G L  + +L L  N+  G+IP  L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNL----------------------VILYLGVN 709
           G+  SL  + L  N   G+IP  + K                                + 
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594

Query: 710 RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSIS 769
              GI    +  +S+    ++      G+    +     ++ +  +  N ++G IP  I 
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD-NNGSMMFLDMSYNMLSGYIPKEIG 653

Query: 770 NASKLEVFQALN---NKLTGEVP 789
           +   L     LN   N ++G +P
Sbjct: 654 SMPYL---FILNLGHNDISGSIP 673

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  183 bits (466), Expect = 2e-48
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 16/244 (6%)

Query: 555 QKVTILDLESLKLA---GSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
            KVT +DL S  L     ++   + +L+ L+ L L N+     +         L   DL+
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108

Query: 612 NNSIGGEIP--VNLSSCSNLIRIGLAKNQLMGKIP-SDFGSLSKIEVLSLGFNNLIGSIP 668
            NS+ G +    +L SCS L  + ++ N L      S    L+ +EVL L  N++ G+  
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 669 PPL---GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI 725
                      L+ ++++ N ++G +   +S+  NL  L +  N  S  +P  + + S++
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225

Query: 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              D+  NK+ G+       T   L+  +I +N+  G IPP       L+      NK T
Sbjct: 226 QHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFT 282

Query: 786 GEVP 789
           GE+P
Sbjct: 283 GEIP 286

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  171 bits (435), Expect = 1e-44
 Identities = 70/210 (33%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 1   ILALDSNRLSGNIPPSIGN--LKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS 58
            L L SN  SG I P++       L E Y+ +N   G IP +L  C  L ++ L  N LS
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431

Query: 59  GTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
           GTIP  L  L+ L  L L  N   G  P E+  +  LETL +  N L GEIPS L +C  
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491

Query: 119 LEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L  + +  N   G           L IL LS N  SG IP  L   + +  L+L+ N   
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551

Query: 168 GMVPTEGVFKNASAISVLGNNKLCGGISEF 197
           G +P        S    +  N + G    +
Sbjct: 552 GTIPAA--MFKQS--GKIAANFIAGKRYVY 577

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  170 bits (434), Expect = 2e-44
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 7/234 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             L L+   L G I   + N + L  ++L NN  T EIP  IGRL  L +  L+NNS  G
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
            IP  L  C +LI + L  N   G IP+     S      +  N + G     + N    
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMK 584

Query: 678 RKISLAIN--NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
           ++   A N     G     L++L       +      G    +  N  S+   D+  N +
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            G IP + G ++  L   ++G N I+G+IP  + +   L +    +NKL G +P
Sbjct: 645 SGYIPKEIG-SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  166 bits (423), Expect = 5e-43
 Identities = 67/234 (28%), Positives = 103/234 (44%), Gaps = 7/234 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             + L + +L G I   IG L  L IL L NNSF+  IP+E+G  R L   DLN N   G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN--NLIGSIPPPLGNLS 675
            IP  +   S      +A N + GK      +    +      N     G     L  LS
Sbjct: 553 TIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
           +    ++      G    T     +++ L +  N LSG +P  I ++  +   ++G N I
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            G+IP + G  L+ L    + +N++ G IP ++S  + L      NN L+G +P
Sbjct: 669 SGSIPDEVG-DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  165 bits (419), Expect = 1e-42
 Identities = 54/239 (22%), Positives = 92/239 (38%), Gaps = 45/239 (18%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL L +N  SGNIP  +G+ + L+   ++ N   G+IP+++          +  N ++G 
Sbjct: 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGK 573

Query: 61  IPPQLMGLTSLVALDLSRN--QFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
               +           + N  +F+G    ++  L       ++  +  G    T  +   
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633

Query: 119 LEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLS----- 162
           +  L+M  N+  G           L IL+L  N +SG IP+ +  L+ +  L+LS     
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693

Query: 163 -------------------YNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPC 202
                               N+L G +P  G F+       L N  LCG    + LP C
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  165 bits (419), Expect = 2e-42
 Identities = 73/213 (34%), Positives = 99/213 (46%), Gaps = 19/213 (8%)

Query: 1   ILALDSNRLSGNIPP-SIGNLKKLVEPYVSDNFLKGSIPSSLG-LCESLTTIGLFNNNLS 58
            LAL SN  SG +P  ++  ++ L    +S N   G +P SL  L  SL T+ L +NN S
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381

Query: 59  GTIPPQL--MGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC 116
           G I P L      +L  L L  N F G  P  + N   L +L +S N L G IPS+LGS 
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441

Query: 117 IKLEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
            KL  L++  N+ +G           L  L L  N L+GEIP  L     +  ++LS N 
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501

Query: 166 LEGMVPTEGVFKNASAISVL--GNNKLCGGISE 196
           L G +P          +++L   NN   G I  
Sbjct: 502 LTGEIPKW--IGRLENLAILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  164 bits (417), Expect = 3e-42
 Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L +N  +G IPP++ N  +LV  ++S N+L G+IPSSLG    L  + L+ N L G I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P +LM + +L  L L  N   G  P+ + N  NL  +++S N L GEIP  +G    L I
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518

Query: 122 LEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
           L++  N F G           L  LDL+ N  +G IP  +          ++ N + G  
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKR 574

Query: 171 PTEGVFKNASAISVLGNNKL 190
                            N L
Sbjct: 575 YVYIKNDGMKKECHGAGNLL 594

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  163 bits (414), Expect = 6e-42
 Identities = 68/213 (31%), Positives = 92/213 (43%), Gaps = 19/213 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L + SN  S  IP  +G+   L    +S N L G    ++  C  L  + + +N   G 
Sbjct: 204 FLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           IPP    L SL  L L+ N+F G  P  + G    L  L +SGN   G +P   GSC  L
Sbjct: 263 IPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320

Query: 120 EILEMQGNVFQG------------LTILDLSRNKLSGEIPEFLVGLKV-IENLNLSYNDL 166
           E L +  N F G            L +LDLS N+ SGE+PE L  L   +  L+LS N+ 
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380

Query: 167 EGMVPTEGVFKNASAISVL--GNNKLCGGISEF 197
            G +         + +  L   NN   G I   
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  159 bits (405), Expect = 9e-41
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 9/206 (4%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L  N LSG IP S+G+L KL +  +  N L+G IP  L   ++L T+ L  N+L+G 
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           IP  L   T+L  + LS N+  G  P  +G L NL  L +S N   G IP+ LG C  L 
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541

Query: 121 ILEMQGNVFQG-------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE--GMVP 171
            L++  N+F G            ++ N ++G+   ++    + +  + + N LE  G+  
Sbjct: 542 WLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601

Query: 172 TEGVFKNASAISVLGNNKLCGGISEF 197
            +    +      + +    G  S  
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPT 627

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  155 bits (393), Expect = 3e-39
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 23/213 (10%)

Query: 1   ILALDSNRLSGNIPPSI---GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNL 57
           +L L +N +SG             +L    +S N + G +   +  C +L  + + +NN 
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212

Query: 58  SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
           S  I P L   ++L  LD+S N+  G F   +     L+ L +S N   G IP       
Sbjct: 213 STGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLK 269

Query: 118 KLEILEMQGNVFQG------------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
            L+ L +  N F G            LT LDLS N   G +P F     ++E+L LS N+
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329

Query: 166 LEGMVPTEGVFKNASAISVL--GNNKLCGGISE 196
             G +P +        + VL    N+  G + E
Sbjct: 330 FSGELPMD-TLLKMRGLKVLDLSFNEFSGELPE 361

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  150 bits (380), Expect = 1e-37
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 21/212 (9%)

Query: 1   ILALDSNRLSGNIP-PSIGNLKKLVEPYVSDNFLKGSIPSSL---GLCESLTTIGLFNNN 56
            L + SN L           L  L    +S N + G+          C  L  + +  N 
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189

Query: 57  LSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC 116
           +SG +   +    +L  LD+S N F    P  +G+   L+ L +SGN L G+    + +C
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246

Query: 117 IKLEILEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVG-LKVIENLNLSYNDL 166
            +L++L +  N F G         L  L L+ NK +GEIP+FL G    +  L+LS N  
Sbjct: 247 TELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF 306

Query: 167 EGMVPTEGVFKNASAISVL--GNNKLCGGISE 196
            G VP    F + S +  L   +N   G +  
Sbjct: 307 YGAVPPF--FGSCSLLESLALSSNNFSGELPM 336

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  137 bits (348), Expect = 1e-33
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 24/219 (10%)

Query: 2   LALDSNRLS---GNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS 58
           + L S  L+     +  S+ +L  L   ++S++ + GS+        SLT++ L  N+LS
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113

Query: 59  GTIPP--QLMGLTSLVALDLSRNQFRGSFPTEVG-NLINLETLTVSGNILQGEIPSTL-- 113
           G +     L   + L  L++S N          G  L +LE L +S N + G        
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173

Query: 114 -GSCIKLEILEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSY 163
              C +L+ L + GN   G         L  LD+S N  S  IP        +++L++S 
Sbjct: 174 SDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLG-DCSALQHLDISG 232

Query: 164 NDLEGMVPTEGVFKNASAISVL--GNNKLCGGISEFKLP 200
           N L G           + + +L   +N+  G I    L 
Sbjct: 233 NKLSGDFSRA--ISTCTELKLLNISSNQFVGPIPPLPLK 269

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  137 bits (347), Expect = 1e-33
 Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 6/188 (3%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDL--NN 612
           + +  LDL +    G+I   +   S      +  N    +    I      +      N 
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNL 593

Query: 613 NSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG 672
               G     L+  S      +      G     F +   +  L + +N L G IP  +G
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 653

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
           ++  L  ++L  N+++GSIP  +  L+ L IL L  N+L G +P ++  ++ + E D+  
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713

Query: 733 NKIQGNIP 740
           N + G IP
Sbjct: 714 NNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (324), Expect = 8e-31
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 6/173 (3%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENN--SFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             + +  +AG    +I N    K  +   N   F      ++ RL      ++ +   GG
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
                  +  +++ + ++ N L G IP + GS+  + +L+LG N++ GSIP  +G+L  L
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPS----SIFNISSIA 726
             + L+ N L G IP  +S L  L  + L  N LSG +P       F  +   
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  119 bits (300), Expect = 7e-28
 Identities = 39/157 (24%), Positives = 61/157 (38%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
            N I     +       +K        L+  G     +  LS     N+ +  +      
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS 657
                  +   D++ N + G IP  + S   L  + L  N + G IP + G L  + +L 
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 686

Query: 658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFT 694
           L  N L G IP  +  L+ L +I L+ NNL+G IP  
Sbjct: 687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  112 bits (282), Expect = 1e-25
 Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 21/196 (10%)

Query: 18  GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLS 77
             +  +       N    ++ SSL     L ++ L N++++G++        SL +LDLS
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108

Query: 78  RNQFRGSFPT--EVGNLINLETLTVSGNILQGEIP-STLGSCIKLEILEMQGNVFQG--- 131
           RN   G   T   +G+   L+ L VS N L      S       LE+L++  N   G   
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 132 -----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNAS 180
                      L  L +S NK+SG++   +     +E L++S N+    +P  G      
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQ 226

Query: 181 AISVLGNNKLCGGISE 196
            +  +  NKL G  S 
Sbjct: 227 HLD-ISGNKLSGDFSR 241

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  172 bits (437), Expect = 6e-48
 Identities = 62/250 (24%), Positives = 98/250 (39%), Gaps = 37/250 (14%)

Query: 258 LNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAE 317
           +  +        D      LIG G +G+VYKG LDE    V VKVF+  + +   +FI E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQ---NFINE 55

Query: 318 CR--ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA 375
                +  + H N+ +       V   G     LV E+  NGSL ++L            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---------- 105

Query: 376 PRNLNLLQRLNIAIDVASALDYLHHD------CQPITTHCDLKPSNILLDEEMVSHVGDF 429
               + +    +A  V   L YLH +       +P  +H DL   N+L+  +    + DF
Sbjct: 106 -HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164

Query: 430 GLARFLPPT------HVQTSSIGVKGSIGYIAPEY-------GLGSEVSTNGDVYSYGIL 476
           GL+  L             ++I   G+I Y+APE                  D+Y+ G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224

Query: 477 MLELIIRKKP 486
             E+ +R   
Sbjct: 225 YWEIFMRCTD 234

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  170 bits (432), Expect = 2e-47
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 32/242 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG GSFG+V++       + V VK+       A     F+ E   ++ +RH N+V    A
Sbjct: 45  IGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            +    Q  +  ++V E++  GSL   L+          A   L+  +RL++A DVA  +
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGM 150

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YLH+   PI  H +LK  N+L+D++    V DFGL+R    T + +      G+  ++A
Sbjct: 151 NYLHNRNPPIV-HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMA 207

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN--------LHNFARMALPD 507
           PE       +   DVYS+G+++ EL   ++P    +   +N             R+ +P 
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGN-LNPAQVVAAVGFKCKRLEIPR 262

Query: 508 HV 509
           ++
Sbjct: 263 NL 264

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  165 bits (419), Expect = 9e-46
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G+FG V K         V +K   +      ++FI E R L  + H N+VK++ AC 
Sbjct: 16  VGRGAFGVVCKAKWRA--KDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGACL 71

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                 N    LV E+ + GSL   L+         +          ++  +  +  + Y
Sbjct: 72  ------NPV-CLVMEYAEGGSLYNVLHG-------AEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 398 LH-HDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           LH    + +  H DLKP N+LL     V  + DFG A       +QT     KGS  ++A
Sbjct: 118 LHSMQPKALI-HRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMA 171

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE   GS  S   DV+S+GI++ E+I R+KP
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  162 bits (413), Expect = 3e-45
 Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 32/217 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +     G ++KG        + VKV  +     R SR F  EC  LR   H N++ V  A
Sbjct: 18  LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C            L+  +M  GSL   L+        +     ++  Q +  A+D+A  +
Sbjct: 76  CQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMARGM 124

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            +LH   +P+     L   ++++DE+M + +    +              G   +  ++A
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVA 176

Query: 456 PE------YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE             +   D++S+ +L+ EL+ R+ P
Sbjct: 177 PEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (410), Expect = 1e-44
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           IG+GSFG+VYKG        V VK+ N+     +  ++F  E   LR  RH N++     
Sbjct: 32  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            +          A+V ++ +  SL   L+          +     + + ++IA   A  +
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGM 133

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           DYLH   + I  H DLK +NI L E+    +GDFGLA              + GSI ++A
Sbjct: 134 DYLH--AKSII-HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 456 PE---YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE       +  S   DVY++GI++ EL+  + P
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  159 bits (405), Expect = 4e-44
 Identities = 55/251 (21%), Positives = 99/251 (39%), Gaps = 41/251 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-------RSFIAECRALRSIRHRNLV 330
           IG G FG V+KG L + ++ V +K   L             + F  E   + ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K++           +   +V EF+  G L   L               +    +L + +D
Sbjct: 87  KLYGLMH-------NPPRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLMLD 130

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDE-----EMVSHVGDFGLARFLPPTHVQTSSI 445
           +A  ++Y+ +   PI  H DL+  NI L        + + V DFGL++         S  
Sbjct: 131 IALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVS 184

Query: 446 GVKGSIGYIAPE--YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL-----H 498
           G+ G+  ++APE         +   D YS+ +++  ++  + P D    G +        
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244

Query: 499 NFARMALPDHV 509
              R  +P+  
Sbjct: 245 EGLRPTIPEDC 255

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (402), Expect = 7e-44
 Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 47/251 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS----RSFIAECRALRSIRHRNLVKVF 333
           IG G FG VY+         V VK               +   E +    ++H N++ + 
Sbjct: 15  IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C     +  +   LV EF + G L   L           + + +     +N A+ +A 
Sbjct: 73  GVCL----KEPNL-CLVMEFARGGPLNRVL-----------SGKRIPPDILVNWAVQIAR 116

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSH--------VGDFGLARFLPPTHVQTSSI 445
            ++YLH +      H DLK SNIL+ +++ +         + DFGLAR       +T+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKM 172

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN--------L 497
              G+  ++APE    S  S   DV+SYG+L+ EL+  + P    F G ++         
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG-IDGLAVAYGVA 227

Query: 498 HNFARMALPDH 508
            N   + +P  
Sbjct: 228 MNKLALPIPST 238

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  151 bits (383), Expect = 7e-41
 Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 32/232 (13%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAEC--RALRSIRHRNLVKVF 333
             +G G +G V++G        V VK+F+       +S+  E        +RH N++   
Sbjct: 14  ECVGKGRYGEVWRGSWQG--ENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            +     +       L+  + + GSL ++L               L+ +  L I + +AS
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYL-----------QLTTLDTVSCLRIVLSIAS 116

Query: 394 ALDYLHHD-----CQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT--HVQTSSIG 446
            L +LH +      +P   H DLK  NIL+ +     + D GLA     +   +   +  
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 447 VKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE 492
             G+  Y+APE           +     D++++G+++ E+  R   + I+ +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  151 bits (383), Expect = 8e-41
 Identities = 53/225 (23%), Positives = 83/225 (36%), Gaps = 35/225 (15%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
            LIG G FG VY G        V +++ ++        ++F  E  A R  RH N+V   
Sbjct: 39  ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            AC           A++    +  +L   +           A   L++ +   IA ++  
Sbjct: 96  GACM----SPPHL-AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVK 141

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS---IGVKGS 450
            + YLH   + I  H DLK  N+  D   V  + DFGL                    G 
Sbjct: 142 GMGYLH--AKGI-LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 451 IGYIAPE---------YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           + ++APE                S + DV++ G +  EL  R+ P
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  151 bits (383), Expect = 8e-41
 Identities = 59/249 (23%), Positives = 95/249 (38%), Gaps = 37/249 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           +G G FG   K    E  T   + +  L        R+F+ E + +R + H N++K    
Sbjct: 18  LGKGCFGQAIKVTHRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y+       + E+++ G+L   +                   QR++ A D+AS +
Sbjct: 76  L----YKDKRL-NFITEYIKGGTLRGII---------KSMDSQYPWSQRVSFAKDIASGM 121

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP------------PTHVQTS 443
            YLH     I  H DL   N L+ E     V DFGLAR +                 +  
Sbjct: 122 AYLH--SMNI-IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF----EGDMNLHN 499
              V G+  ++APE   G       DV+S+GI++ E+I R            +  +N+  
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238

Query: 500 FARMALPDH 508
           F     P +
Sbjct: 239 FLDRYCPPN 247

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  148 bits (375), Expect = 2e-39
 Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 28/248 (11%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             IG G +G V+ G        V VKVF      AS     E      +RH N++    A
Sbjct: 43  KQIGKGRYGEVWMGKWRG--EKVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                        L+ ++ +NGSL ++L               L+    L +A    S L
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGL 147

Query: 396 DYLH-----HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT--HVQTSSIGVK 448
            +LH        +P   H DLK  NIL+ +     + D GLA         V        
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 449 GSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
           G+  Y+ PE    S    +       D+YS+G+++ E+  R     I+ E  +  H+   
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 503 MALPDHVM 510
                  M
Sbjct: 268 SDPSYEDM 275

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (375), Expect = 2e-39
 Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 32/230 (13%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECR--ALRSIRHRNLVKVF 333
             IG G FG V++G        V VK+F+    R   S+  E        +RH N++   
Sbjct: 48  ESIGKGRFGEVWRGKWRG--EEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFI 102

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
            A +  +        LV ++ ++GSL ++L   NR          + +   + +A+  AS
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYL---NR--------YTVTVEGMIKLALSTAS 150

Query: 394 ALDYLHHD-----CQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT--HVQTSSIG 446
            L +LH +      +P   H DLK  NIL+ +     + D GLA         +  +   
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 447 VKGSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKPSDIM 490
             G+  Y+APE    S    +       D+Y+ G++  E+  R     I 
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  145 bits (367), Expect = 2e-36
 Identities = 44/271 (16%), Positives = 87/271 (32%), Gaps = 34/271 (12%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTH----EIPSEIGRLRRLQV 607
           +   +VT L LE    +G +   IG L+ L++L L ++          P  I      + 
Sbjct: 78  NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137

Query: 608 PDLNNNSIGGEIPVNLS--SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG 665
                                S+LI+  +  +     I        K   +    NN+  
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-T 196

Query: 666 SIPPPLGNLSSLRKISLAINNLAGSIPFT-------------------LSKLKNLVILYL 706
            +   +  L+ LR+  +  +                               LK+L  + +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 707 GVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT-------LQNLQYFSIGTNR 759
                   +P+ +  +  +   +V  N+      L   +         + +Q   IG N 
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316

Query: 760 I-TGAIPPSISNASKLEVFQALNNKLTGEVP 789
           + T  +  S+    KL + + L N+L G++P
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  135 bits (341), Expect = 3e-33
 Identities = 51/280 (18%), Positives = 91/280 (32%), Gaps = 28/280 (10%)

Query: 534 QIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA-GSILPHIGNLSFLKILNLENNSFT 592
           +      ++     L      +K+ I+ +    L    +   +  +  L +L    N   
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343

Query: 593 HEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSDF--GS 649
                  G   +L   +L  N I   IP N       +  +  A N+L   IP+ F   S
Sbjct: 344 -GKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400

Query: 650 LSKIEVLSLGFNNL-------IGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
           +S +  +   +N +          + P      ++  I+L+ N ++       S    L 
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460

Query: 703 ILYLGVNRLSGI-------VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI 755
            + L  N L+ I          +  N   +   D+  NK+          TL  L    +
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDL 520

Query: 756 GTNRITGAIPPSISNASKLEVFQALN------NKLTGEVP 789
             N  +   P    N+S L+ F   N      N+   E P
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  134 bits (340), Expect = 5e-33
 Identities = 24/239 (10%), Positives = 67/239 (28%), Gaps = 19/239 (7%)

Query: 559 ILDLESLKLAGSILPHIGNLSFLKI--LNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
                 +    + + +     F  +    + ++     I        +       +N+I 
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSS 676
             +   +   + L +  +  +  + +   +          +  +     +      NL  
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKD 250

Query: 677 LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI--------VPSSIFNISSIAEF 728
           L  + +        +P  L  L  + ++ +  NR              +       I   
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 729 DVGENKIQ-GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
            +G N ++   +       ++ L       N++ G   P+  +  KL       N++T 
Sbjct: 311 YIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  126 bits (319), Expect = 2e-30
 Identities = 27/218 (12%), Positives = 66/218 (30%), Gaps = 13/218 (5%)

Query: 575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG----EIPVNLSSCSNLI 630
           + +   +  L+LE    +  +P  IG+L  L+V  L ++          P  +S+  +  
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 631 RIGLAKNQLMGKIPSDFG--SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA 688
           +    +                S +    +  +    SI           +I    NN+ 
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI- 195

Query: 689 GSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQ 748
             +   + +L  L   Y+G +          +   +         +      L +   L+
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWD-NLK 249

Query: 749 NLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           +L    +        +P  +    ++++     N+   
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  123 bits (311), Expect = 2e-29
 Identities = 41/259 (15%), Positives = 75/259 (28%), Gaps = 29/259 (11%)

Query: 550 IGSKAQKVTILDLESLKLAG-SILPHIGNLSFLKILNLENNSFTH-------EIPSEIGR 601
                ++V  L     KL     +    ++S +  ++   N            +     +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431

Query: 602 LRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQL-------MGKIPSDFGSLSKIE 654
              +   +L+NN I        S+ S L  I L  N L       +     +F +   + 
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491

Query: 655 VLSLGFNNLIGSIPPPL--GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV---- 708
            + L FN L   +        L  L  I L+ N+     P        L    +      
Sbjct: 492 SIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDA 549

Query: 709 --NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP 766
             NR     P  I    S+ +  +G N I+  +         N+    I  N        
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK---ITPNISVLDIKDNPNISIDLS 605

Query: 767 SISNASKLEVFQALNNKLT 785
            +    +  ++    +K  
Sbjct: 606 YVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  120 bits (302), Expect = 2e-28
 Identities = 39/196 (19%), Positives = 70/196 (35%), Gaps = 30/196 (15%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L    N+L G   P+ G+  KL    ++ N +     +  G  E +  +   +N L   
Sbjct: 334 MLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-Y 391

Query: 61  IPP--QLMGLTSLVALDLSRNQFRG-------SFPTEVGNLINLETLTVSGNILQGEIPS 111
           IP       ++ + A+D S N+                   IN+ ++ +S N +      
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

Query: 112 TLGSCIKLEILEMQGNVFQG------------------LTILDLSRNKLSGEIPEFLVG- 152
              +   L  + + GN+                     LT +DL  NKL+    +F    
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511

Query: 153 LKVIENLNLSYNDLEG 168
           L  +  ++LSYN    
Sbjct: 512 LPYLVGIDLSYNSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  118 bits (298), Expect = 7e-28
 Identities = 30/211 (14%), Positives = 74/211 (35%), Gaps = 27/211 (12%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
              + ++             +              +        + LT + ++N      
Sbjct: 210 QFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 61  IPPQLMGLTSLVALDLSRNQFR--------GSFPTEVGNLINLETLTVSGN-ILQGEIPS 111
           +P  L  L  +  ++++ N+               +      ++ + +  N +    + +
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324

Query: 112 TLGSCIKLEILEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNL 161
           +L    KL +LE   N  +G          L  L+L+ N+++     F    + +ENL+ 
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSF 384

Query: 162 SYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
           ++N L+  +P     K+ S +S +    N++
Sbjct: 385 AHNKLKY-IPNIFDAKSVSVMSAIDFSYNEI 414

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  118 bits (297), Expect = 1e-27
 Identities = 32/212 (15%), Positives = 63/212 (29%), Gaps = 26/212 (12%)

Query: 1   ILALDSNRLSG-------NIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLF 53
            +    N +          + P+      +    +S+N +             L++I L 
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465

Query: 54  NNNLSG-------TIPPQLMGLTSLVALDLSRNQFRGSFPT-EVGNLINLETLTVSGNIL 105
            N L+                   L ++DL  N+            L  L  + +S N  
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF 525

Query: 106 QGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
               P+   +   L+   ++          D   N+   E PE +     +  L +  ND
Sbjct: 526 SK-FPTQPLNSSTLKGFGIRNQ-------RDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 166 LEGMVPTEGVFKNASAISVLGNNKLCGGISEF 197
           +   V  E +  N S +  + +N        +
Sbjct: 578 IRK-VN-EKITPNISVLD-IKDNPNISIDLSY 606

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  107 bits (270), Expect = 2e-24
 Identities = 36/233 (15%), Positives = 77/233 (33%), Gaps = 47/233 (20%)

Query: 1   ILALDSNRLSGNIPPSIGNLK--KLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS 58
                                   L++  ++ +  + SI  S  +    T IG  +NN++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 59  GTIPPQLMGLTSLVALDLSRNQFRG-------------------SFPTEVGNLINLETLT 99
             +   +M LT L    +  + F                     +   +  NL +L  + 
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255

Query: 100 VSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-------------------LTILDLSRN 140
           V       ++P+ L +  +++++ +  N                       + I+ +  N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315

Query: 141 KL-SGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
            L +  +   L  +K +  L   YN LEG +P    F +   ++ L    N++
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA---FGSEIKLASLNLAYNQI 365

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  107 bits (270), Expect = 2e-24
 Identities = 31/236 (13%), Positives = 60/236 (25%), Gaps = 45/236 (19%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKG----SIPSSLGLCESLTTIGLFNNNL 57
           L+L+    SG +P +IG L +L    +  +  K       P  +    S         + 
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 58  SGTIPPQLMGL--------------------------TSLVALDLSRNQFRGSFPTEVGN 91
             T                                       +    N         V  
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMR 204

Query: 92  LINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNV------FQGLTILDLSRNKLSGE 145
           L  L    +  +    E           E  +            + LT +++       +
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 146 IPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV--------LGNNKLCGG 193
           +P FL  L  ++ +N++ N        +  ++  +   V        +G N L   
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 96.6 bits (241), Expect = 8e-21
 Identities = 33/221 (14%), Positives = 64/221 (28%), Gaps = 12/221 (5%)

Query: 568 AGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCS 627
           A  I  ++        LN +N S               +  D+     G    V+L+S  
Sbjct: 26  AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPG----VSLNSNG 81

Query: 628 NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG----SIPPPLGNLSSLRKISLA 683
            +  + L      G++P   G L+++EVL+LG +          P  +    S  +    
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 684 INNLAGSIPFTLSKLK--NLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
             +   +      +    +L+   +  +     +  S        +     N I   +  
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK 200

Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN 782
                L  L+ F +G +                E  Q    
Sbjct: 201 AVM-RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 92.0 bits (229), Expect = 2e-19
 Identities = 26/179 (14%), Positives = 52/179 (29%), Gaps = 33/179 (18%)

Query: 1   ILALDSNRLSG-------NIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCE--SLTTIG 51
            + L  N L+        +   +  N   L    +  N L   +           L  I 
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGID 519

Query: 52  LFNNNLSGTIPPQLMGLTSLVAL------DLSRNQFRGSFPTEVGNLINLETLTVSGNIL 105
           L  N+ S   P Q +  ++L         D   N+    +P  +    +L  L +  N +
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578

Query: 106 QGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
           +  +   +                  +++LD+  N        ++          L Y+
Sbjct: 579 RK-VNEKI---------------TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 92.0 bits (229), Expect = 2e-19
 Identities = 26/180 (14%), Positives = 57/180 (31%), Gaps = 20/180 (11%)

Query: 550 IGSKAQKVTILDLESLKLAG-------SILPHIGNLSFLKILNLENNSFTHEIPSEI--G 600
           + S    ++ ++L    L             +  N   L  ++L  N  T ++  +    
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRAT 510

Query: 601 RLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL------AKNQLMGKIPSDFGSLSKIE 654
            L  L   DL+ NS     P    + S L   G+        N+ + + P        + 
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569

Query: 655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
            L +G N++   +   +    ++  + +  N         +       +  L  ++   I
Sbjct: 570 QLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.2 bits (188), Expect = 2e-14
 Identities = 24/183 (13%), Positives = 46/183 (25%), Gaps = 22/183 (12%)

Query: 8   RLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMG 67
              G       N     E     +        SL     +T + L     SG +P  +  
Sbjct: 48  SQQGFGTQPGANWNFNKEL----DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103

Query: 68  LTSLVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGEIPSTLG--SCIKLEI 121
           LT L  L L  +  +       P  +   ++ E         Q              L  
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163

Query: 122 LEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
             +  +  Q             T +    N ++  + + ++ L  +    +  +      
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222

Query: 171 PTE 173
             E
Sbjct: 223 ICE 225

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.5 bits (186), Expect = 3e-14
 Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 15/127 (11%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVE------PYVSDNFLKGSIPSSLGLCESLTTIGLFN 54
            + L  N  S   P    N   L             N      P  + LC SLT + + +
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575

Query: 55  NNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLG 114
           N++   +  ++    ++  LD+  N       + V   I      +  +  Q      + 
Sbjct: 576 NDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DIR 627

Query: 115 SCIKLEI 121
            C  L+I
Sbjct: 628 GCDALDI 634

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  142 bits (359), Expect = 3e-35
 Identities = 39/236 (16%), Positives = 87/236 (36%), Gaps = 6/236 (2%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           +T+L+L   +L      +    S L  L++  N+ +   P    +L  L+V +L +N + 
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSS 676
                  + C+NL  + L  N +     + F     +  L L  N L  +       L +
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 677 LRKISLAINNLAGSIP--FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK 734
           L+++ L+ N +         +    +L  L L  N++    P     I  +    +   +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206

Query: 735 IQGNIP--LDYGFTLQNLQYFSIGTNRITGAIPPSISN--ASKLEVFQALNNKLTG 786
           +  ++   L       +++  S+  ++++     +      + L +     N L  
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  140 bits (355), Expect = 8e-35
 Identities = 48/241 (19%), Positives = 82/241 (34%), Gaps = 6/241 (2%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
            ++T LD+    ++         L  LK+LNL++N  +            L    L +NS
Sbjct: 49  SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG-- 672
           I            NLI + L+ N L          L  ++ L L  N +       L   
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF---NISSIAEFD 729
             SSL+K+ L+ N +    P     +  L  L+L   +L   +   +      +SI    
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228

Query: 730 VGENKIQGNIPLD-YGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV 788
           +  +++         G    NL    +  N +      S +   +LE F    N +    
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288

Query: 789 P 789
            
Sbjct: 289 S 289

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  132 bits (334), Expect = 4e-32
 Identities = 45/234 (19%), Positives = 90/234 (38%), Gaps = 9/234 (3%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
            + D   LKL   +   +   + + +LNL +N       +   R  +L   D+  N+I  
Sbjct: 7   EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
             P        L  + L  N+L       F   + +  L L  N++      P     +L
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPS--SIFNISSIAEFDVGENKI 735
             + L+ N L+ +   T  +L+NL  L L  N++  +      IF  SS+ + ++  N+I
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQAL---NNKLTG 786
           +   P  +   +  L    +   ++  ++   +         + L   N++L+ 
Sbjct: 184 KEFSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  130 bits (328), Expect = 2e-31
 Identities = 41/210 (19%), Positives = 81/210 (38%), Gaps = 4/210 (1%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLM 640
            ++ +  +   T ++P ++     + V +L +N +      N +  S L  + +  N + 
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKN 700
              P     L  ++VL+L  N L           ++L ++ L  N++         K KN
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 701 LVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD-YGFTLQNLQYFSIGTNR 759
           L+ L L  N LS     +   + ++ E  +  NKIQ     +   F   +L+   + +N+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 760 ITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           I    P       +L      N +L   + 
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLT 212

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  125 bits (317), Expect = 5e-30
 Identities = 55/247 (22%), Positives = 88/247 (35%), Gaps = 16/247 (6%)

Query: 558 TILDLESLKLAGSILPHIG----NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNN 613
             L L +   +   L +        S L ILNL  N  +         L  L+V DL  N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415

Query: 614 SIGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL--IGSIPPP 670
            IG E+         N+  I L+ N+ +    + F  +  ++ L L    L  + S P P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475

Query: 671 LGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS--------GIVPSSIFNI 722
              L +L  + L+ NN+A      L  L+ L IL L  N L+        G     +  +
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535

Query: 723 SSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN 782
           S +   ++  N         +   L  L+   +G N +        +N   L+      N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKD-LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594

Query: 783 KLTGEVP 789
            +T    
Sbjct: 595 LITSVEK 601

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  124 bits (313), Expect = 1e-29
 Identities = 55/247 (22%), Positives = 90/247 (36%), Gaps = 15/247 (6%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
           T L L S  +             L  L+L +N  +        +L  LQ   L+NN I  
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 618 EIPVNLSSCSN--LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG--- 672
                L   +N  L ++ L+ NQ+    P  F ++ ++  L L    L  S+   L    
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLK--NLVILYLGVNRLSGIVPSSIFNISSIAEFDV 730
             +S+R +SL+ + L+ +   T   LK  NL +L L  N L+ +   S   +  +  F +
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 731 GENKIQGNIP--------LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN 782
             N IQ            + Y    ++    SI    +      S      LE     +N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339

Query: 783 KLTGEVP 789
            + G   
Sbjct: 340 DIPGIKS 346

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  120 bits (304), Expect = 2e-28
 Identities = 43/206 (20%), Positives = 68/206 (33%), Gaps = 16/206 (7%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L  N+L      +     +L    V  N +    P        L  + L +N LS  
Sbjct: 29  VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL 88

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
                   T+L  L L  N  +           NL TL +S N L      T      L+
Sbjct: 89  SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148

Query: 121 ILEMQGNVFQG-------------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
            L +  N  Q              L  L+LS N++    P     +  +  L L+   L 
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208

Query: 168 GMVPTE-GVFKNASAISVL--GNNKL 190
             +  +  +    ++I  L   N++L
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQL 234

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  120 bits (302), Expect = 3e-28
 Identities = 45/219 (20%), Positives = 74/219 (33%), Gaps = 11/219 (5%)

Query: 558 TILDLESLKLAGSILPH-IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
            +LDL   ++   +       L  +  + L  N +     +    +  LQ   L   ++ 
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467

Query: 617 G--EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL--------IGS 666
                P       NL  + L+ N +          L K+E+L L  NNL         G 
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527

Query: 667 IPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA 726
               L  LS L  ++L  N            L  L I+ LG+N L+ +  S   N  S+ 
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 727 EFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIP 765
             ++ +N I       +G   +NL    +  N       
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (295), Expect = 2e-27
 Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 29/219 (13%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCE---SLTTIGLFNNNL 57
            L L SN++    P     + +L   ++++  L  S+   L L     S+  + L N+ L
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234

Query: 58  SGTIPPQLMGL--TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGS 115
           S T     +GL  T+L  LDLS N            L  LE   +  N +Q     +L  
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294

Query: 116 CIKLEILEMQGNVFQG--------------------LTILDLSRNKLSGEIPEFLVGLKV 155
              +  L ++ +  +                     L  L++  N + G       GL  
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN 354

Query: 156 IENLNLSYNDLEGMVPTEGVFKNASAISV----LGNNKL 190
           ++ L+LS +       T   F + +   +    L  NK+
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (295), Expect = 2e-27
 Identities = 53/241 (21%), Positives = 84/241 (34%), Gaps = 13/241 (5%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIP-SEIGRLRRLQVPDLNNNSIG 616
            IL+L   K++         L  L++L+L  N    E+   E   L  +    L+ N   
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443

Query: 617 GEIPVNLSSCSNLIRIGLAKNQL--MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
                + +   +L R+ L +  L  +   PS F  L  + +L L  NN+       L  L
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503

Query: 675 SSLRKISLAINNL--------AGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA 726
             L  + L  NNL         G   + L  L +L IL L  N    I      ++  + 
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563

Query: 727 EFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNA-SKLEVFQALNNKLT 785
             D+G N +   +P        +L+  ++  N IT         A   L       N   
Sbjct: 564 IIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622

Query: 786 G 786
            
Sbjct: 623 C 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (294), Expect = 3e-27
 Identities = 46/265 (17%), Positives = 88/265 (33%), Gaps = 17/265 (6%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           N+ +    +   +G K   +T+LDL    L          L  L+   LE N+  H    
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVN---------LSSCSNLIRIGLAKNQLMGKIPSDFG 648
            +  L  ++  +L  +     I +                L  + +  N + G   + F 
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350

Query: 649 SLSKIEVLSLGFNNLIGSIPPPLG----NLSSLRKISLAINNLAGSIPFTLSKLKNLVIL 704
            L  ++ LSL  +                 S L  ++L  N ++       S L +L +L
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410

Query: 705 YLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG- 762
            LG+N +   +    +  + +I E  +  NK        +   + +LQ   +    +   
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL-VPSLQRLMLRRVALKNV 469

Query: 763 -AIPPSISNASKLEVFQALNNKLTG 786
            + P        L +    NN +  
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIAN 494

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  115 bits (290), Expect = 8e-27
 Identities = 53/252 (21%), Positives = 93/252 (36%), Gaps = 21/252 (8%)

Query: 555 QKVTILDLESLKLAGSILPHIG--NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNN 612
           + +  L L + K+       +     S LK L L +N      P     + RL    LNN
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204

Query: 613 NSIGGEIPVNLS---SCSNLIRIGLAKNQLMGKIPSDFGSL--SKIEVLSLGFNNLIGSI 667
             +G  +   L    + +++  + L+ +QL     + F  L  + + +L L +NNL    
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264

Query: 668 PPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLG---------VNRLSGIVPSS 718
                 L  L    L  NN+      +L  L N+  L L          +  L  I   S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324

Query: 719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSIS----NASKL 774
              +  +   ++ +N I G I  +    L NL+Y S+  +  +     + +      S L
Sbjct: 325 FQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 775 EVFQALNNKLTG 786
            +     NK++ 
Sbjct: 384 HILNLTKNKISK 395

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  114 bits (288), Expect = 2e-26
 Identities = 51/224 (22%), Positives = 77/224 (34%), Gaps = 28/224 (12%)

Query: 1   ILALDSNRLSGNIPPS-IGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           +L L  N +   +       L+ + E Y+S N       +S  L  SL  + L    L  
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468

Query: 60  --TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQ--------GEI 109
             + P     L +L  LDLS N         +  L  LE L +  N L         G  
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528

Query: 110 PSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIEN 158
              L     L IL ++ N F             L I+DL  N L+            +++
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588

Query: 159 LNLSYNDLEGMVPT--EGVFKNASAISVLGNNKL---CGGISEF 197
           LNL  N +  +        F+N + +  +  N     C  I+ F
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELD-MRFNPFDCTCESIAWF 631

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  103 bits (259), Expect = 6e-23
 Identities = 39/217 (17%), Positives = 73/217 (33%), Gaps = 27/217 (12%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSI---------PSSLGLCESLTTIG 51
              L+ N +      S+  L  +    +  +F K SI           S    + L  + 
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 52  LFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVG----NLINLETLTVSGNILQG 107
           + +N++ G       GL +L  L LS +       T           L  L ++ N +  
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 108 EIPSTLGSCIKLEILEMQGN---------VFQGLT---ILDLSRNKLSGEIPEFLVGLKV 155
                      LE+L++  N          ++GL     + LS NK           +  
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455

Query: 156 IENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
           ++ L L    L+ +  +   F+    +++L   NN +
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  102 bits (255), Expect = 2e-22
 Identities = 40/201 (19%), Positives = 71/201 (35%), Gaps = 21/201 (10%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNN----- 55
           +L L  N L+     S   L +L   ++  N ++     SL    ++  + L  +     
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 56  ----NLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS 111
               +L          L  L  L++  N   G        LINL+ L++S +        
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT------ 365

Query: 112 TLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
              S   L            L IL+L++NK+S    +    L  +E L+L  N++   + 
Sbjct: 366 ---SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 172 TEGVFKNASAISVL--GNNKL 190
               ++    I  +    NK 
Sbjct: 423 -GQEWRGLENIFEIYLSYNKY 442

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 98.5 bits (246), Expect = 2e-21
 Identities = 42/175 (24%), Positives = 64/175 (36%), Gaps = 16/175 (9%)

Query: 29  SDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTE 88
           S   L   +P  L    ++T + L +N L           + L +LD+  N      P  
Sbjct: 12  SHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 89  VGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDL 137
              L  L+ L +  N L      T   C  L  L +  N  Q            L  LDL
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128

Query: 138 SRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV--LGNNKL 190
           S N LS       V L+ ++ L LS N ++ +   E      S++    L +N++
Sbjct: 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.7 bits (210), Expect = 5e-17
 Identities = 32/178 (17%), Positives = 55/178 (30%), Gaps = 20/178 (11%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFL--------KGSIPSSLGLCESLTTIGL 52
           IL L +N ++      +  L+KL    +  N L         G     L     L  + L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543

Query: 53  FNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPST 112
            +N            L  L  +DL  N       +   N ++L++L +  N++       
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603

Query: 113 LGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
                        G  F+ LT LD+  N            +  I   + +  +L    
Sbjct: 604 F------------GPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.0 bits (203), Expect = 3e-16
 Identities = 36/177 (20%), Positives = 64/177 (36%), Gaps = 17/177 (9%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
              ++ + S        + +TILDL +  +A      +  L  L+IL+L++N+       
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR---- 518

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS 657
                       L  ++  G     L   S+L  + L  N         F  L +++++ 
Sbjct: 519 ------------LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566

Query: 658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSK-LKNLVILYLGVNRLSG 713
           LG NNL         N  SL+ ++L  N +            +NL  L +  N    
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 7e-07
 Identities = 21/137 (15%), Positives = 39/137 (28%), Gaps = 23/137 (16%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
             + IL+LES       +    +L  LKI++L  N+      S       L+  +L  N 
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
           I                                 +   +  L + FN    +       +
Sbjct: 596 ITSVEKKVFG-----------------------PAFRNLTELDMRFNPFDCTCESIAWFV 632

Query: 675 SSLRKISLAINNLAGSI 691
           + + +    I  L+   
Sbjct: 633 NWINETHTNIPELSSHY 649

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (323), Expect = 2e-31
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           + +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C+    +   F  ++ EFM  G+L ++L    RE       + ++ +  L +A  ++SA+
Sbjct: 285 CT----REPPFY-IITEFMTYGNLLDYL----RECN----RQEVSAVVLLYMATQISSAM 331

Query: 396 DYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           +YL   +      H +L   N L+ E  +  V DFGL+R +      T+  G K  I + 
Sbjct: 332 EYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 386

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE    ++ S   DV+++G+L+ E+ 
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIA 413

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  129 bits (327), Expect = 2e-31
 Identities = 41/230 (17%), Positives = 72/230 (31%), Gaps = 6/230 (2%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
              LDL    L         +   L++L+L               L  L    L  N I 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG-SIPPPLGNLS 675
                  S  S+L ++   +  L        G L  ++ L++  N +    +P    NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNL----VILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
           +L  + L+ N +       L  L  +    + L L +N ++ I     F    + +  + 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTLR 208

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN 781
            N    N+       L  L+   +              + S LE    L 
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  129 bits (327), Expect = 2e-31
 Identities = 48/213 (22%), Positives = 81/213 (38%), Gaps = 8/213 (3%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLM 640
            K L+L  N   H           LQV DL+   I         S S+L  + L  N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG-SIPFTLSKLK 699
                 F  LS ++ L     NL      P+G+L +L+++++A N +    +P   S L 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 700 NLVILYLGVNRLSGIVPSSIFNISSI----AEFDVGENKIQGNIPLDYGFTLQNLQYFSI 755
           NL  L L  N++  I  + +  +  +       D+  N +    P    F    L   ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG--AFKEIRLHKLTL 207

Query: 756 GTNRITGAIPP-SISNASKLEVFQALNNKLTGE 787
             N  +  +    I   + LEV + +  +   E
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  129 bits (326), Expect = 2e-31
 Identities = 40/223 (17%), Positives = 83/223 (37%), Gaps = 8/223 (3%)

Query: 562 LESLKLAG----SILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIG 616
           L+ L L+     ++  +   L  L+ L+ ++++        +   LR L   D+++    
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
                  +  S+L  + +A N        D F  L  +  L L    L    P    +LS
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNI-SSIAEFDVGENK 734
           SL+ ++++ NN      F    L +L +L   +N +       + +  SS+A  ++ +N 
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554

Query: 735 IQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSISNASKLEV 776
                        +++ +   +   R+  A P        L +
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  122 bits (308), Expect = 3e-29
 Identities = 38/232 (16%), Positives = 82/232 (35%), Gaps = 6/232 (2%)

Query: 562 LESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG--GEI 619
            + L+L          L    +  L   S           L  L+  DL+ N +   G  
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLR 678
             +    ++L  + L+ N ++  + S+F  L ++E L    +NL          +L +L 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQG 737
            + ++  +   +     + L +L +L +  N         IF  + ++   D+ + +++ 
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
             P  +   L +LQ  ++  N             + L+V     N +     
Sbjct: 485 LSPTAFNS-LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  109 bits (275), Expect = 5e-25
 Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 16/171 (9%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
            L    + L      S+  +L+ L+   +S    + +         SL  + +  N+   
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 60  TIPPQ-LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
              P     L +L  LDLS+ Q     PT   +L +L+ L +S N               
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-- 517

Query: 119 LEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGL-KVIENLNLSYNDLEG 168
                        L +LD S N +     + L      +  LNL+ ND   
Sbjct: 518 -----------NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  108 bits (271), Expect = 1e-24
 Identities = 60/281 (21%), Positives = 91/281 (32%), Gaps = 29/281 (10%)

Query: 7   NRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLM 66
            ++  N+P S  NL       +S N L+     S      L  + L    +         
Sbjct: 20  YKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73

Query: 67  GLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQG 126
            L+ L  L L+ N  +         L +L+ L      L       +G    L+ L +  
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 127 NVFQG------------LTILDLSRNKLSGEIPEFLVGLK----VIENLNLSYNDLEGMV 170
           N+ Q             L  LDLS NK+       L  L     +  +L+LS N +  + 
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193

Query: 171 PTEGVFKNASAIS-VLGNNKLCGGISEF---KLPPCGLKKSTEWRLTFELKLVIAIVSGL 226
           P  G FK        L NN     + +     L    + +        E  L     S L
Sbjct: 194 P--GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 227 MGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHN 267
            GL   L+I             +   L N L N+S  +L +
Sbjct: 252 EGLC-NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  105 bits (263), Expect = 1e-23
 Identities = 36/176 (20%), Positives = 66/176 (37%), Gaps = 6/176 (3%)

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
           +IP NL    +   + L+ N L       F S  +++VL L    +         +LS L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG 737
             + L  N +        S L +L  L      L+ +    I ++ ++ E +V  N IQ 
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQAL----NNKLTGEVP 789
               +Y   L NL++  + +N+I       +    ++ +         N +    P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 99.3 bits (248), Expect = 9e-22
 Identities = 45/249 (18%), Positives = 87/249 (34%), Gaps = 19/249 (7%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTH-EIPSEIGRLRRLQVPDLNNN 613
             +  L      LA      IG+L  LK LN+ +N     ++P     L  L+  DL++N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 614 SIGGEIPVNLSSCSNL----IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
            I      +L     +    + + L+ N +    P  F  +  +  L+L  N    ++  
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMK 218

Query: 670 -PLGNLSSLRKISLAINNLAGSI---PFTLSKLKNLVILYLGVNRLSGI------VPSSI 719
             +  L+ L    L +           F  S L+ L  L +   RL+ +      +    
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 720 FNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQA 779
             +++++ F +    I+      Y F  Q+L+  +    +        + +  +L     
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN---CKFGQFPTLKLKSLKRLTFTSN 335

Query: 780 LNNKLTGEV 788
                  EV
Sbjct: 336 KGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.0 bits (242), Expect = 5e-21
 Identities = 32/173 (18%), Positives = 55/173 (31%), Gaps = 15/173 (8%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSI-PSSLGLCESLTTIGLFNNNLSGTIP 62
           +               L  L    ++ N  + +  P       +LT + L    L    P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 63  PQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEIL 122
                L+SL  L++S N F          L +L+ L  S N +       L         
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL--------- 538

Query: 123 EMQGNVFQGLTILDLSRNKLSGEIP--EFLVGLKVIENLNLSYNDLEGMVPTE 173
               +    L  L+L++N  +       FL  +K    L +    +E   P++
Sbjct: 539 ---QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 96.6 bits (241), Expect = 6e-21
 Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 4/170 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIG 616
             LD+       +       LS L++L +  NSF      +I   LR L   DL+   + 
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL-S 675
              P   +S S+L  + ++ N         +  L+ ++VL    N+++ S    L +  S
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543

Query: 676 SLRKISLAINNLAGSIPFT--LSKLKNLVILYLGVNRLSGIVPSSIFNIS 723
           SL  ++L  N+ A +      L  +K+   L + V R+    PS    + 
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 96.6 bits (241), Expect = 6e-21
 Identities = 34/198 (17%), Positives = 66/198 (33%), Gaps = 24/198 (12%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNL-SG 59
            L L  N +      +   L  L +    +  L       +G  ++L  + + +N + S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLE----TLTVSGNILQGEIPSTLGS 115
            +P     LT+L  LDLS N+ +  + T++  L  +     +L +S N +    P     
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 116 CIKLEILEMQGNVFQGLTILDLSRNKLSGEIPE-FLVGLKVIENLNLSYNDLEGM----V 170
                           L  L L  N  S  + +  + GL  +E   L   +         
Sbjct: 200 I--------------RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 171 PTEGVFKNASAISVLGNN 188
             +   +    +++    
Sbjct: 246 FDKSALEGLCNLTIEEFR 263

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 95.5 bits (238), Expect = 1e-20
 Identities = 51/213 (23%), Positives = 77/213 (36%), Gaps = 25/213 (11%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS--G 59
           L L + +        + +LK+L     +    KG    S     SL  + L  N LS  G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIP-STLGSCIK 118
                  G TSL  LDLS N       +    L  LE L    + L+     S   S   
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 119 LEILEMQGN--------VFQG---LTILDLSRNKLSGEI-PEFLVGLKVIENLNLSYNDL 166
           L  L++           +F G   L +L ++ N       P+    L+ +  L+LS   L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 167 EGMVPTEGVFKNASAISVL--GNNKLCGGISEF 197
           E + P    F + S++ VL   +N      +  
Sbjct: 483 EQLSP--TAFNSLSSLQVLNMSHNNFFSLDTFP 513

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 95.5 bits (238), Expect = 2e-20
 Identities = 41/265 (15%), Positives = 78/265 (29%), Gaps = 34/265 (12%)

Query: 556 KVTILDLESLKLAGSILPH-IGNLSFLKILNLENNSFTHE------IPSEIGRLRRLQVP 608
           ++  L L +   + +++   I  L+ L++  L    F +E        S +  L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 609 DLNNNSI---GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG 665
           +     +     +I    +  +N+    L    +  +   DF      + L L       
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ 318

Query: 666 SIPPPLGNLSSLRKISLAINNLA---------------------GSIPFTLSKLKNLVIL 704
                L +L  L   S    N                       G    +     +L  L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 705 YLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI 764
            L  N +  +  S+   +  +   D   + ++         +L+NL Y  I       A 
Sbjct: 379 DLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 765 PPSISNASKLEVFQALNNKLTGEVP 789
               +  S LEV +   N       
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.8 bits (200), Expect = 6e-16
 Identities = 39/214 (18%), Positives = 62/214 (28%), Gaps = 25/214 (11%)

Query: 2   LALDSNRLSGNIPP-SIGNLKKLVEPYVSDNFLKGSI---PSSLGLCESLTTIGLFNNNL 57
           L L +N  S N+    I  L  L    +     +             E L  + +    L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 58  S------GTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS 111
           +        I      LT++ +  L                   + L +           
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTL 322

Query: 112 TLGSCIKLEILEMQGNVFQG------LTILDLSRNKLS--GEIPEFLVGLKVIENLNLSY 163
            L S  +L     +G           L  LDLSRN LS  G   +   G   ++ L+LS+
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 164 NDLEGMVPTEGVFKNASAISVL--GNNKLCGGIS 195
           N +  M      F     +  L   ++ L     
Sbjct: 383 NGVITMSSN---FLGLEQLEHLDFQHSNLKQMSE 413

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.8 bits (174), Expect = 7e-13
 Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 3/116 (2%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L   +L    P +  +L  L    +S N              SL  +    N++  +
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

Query: 61  IPPQLMGL-TSLVALDLSRNQFRGSFPTE--VGNLINLETLTVSGNILQGEIPSTL 113
              +L    +SL  L+L++N F  +   +  +  + +   L V    ++   PS  
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 29/141 (20%), Positives = 51/141 (36%), Gaps = 5/141 (3%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           N+  E  +    I ++ + +T LDL   +L         +LS L++LN+ +N+F      
Sbjct: 455 NSFQENFLP--DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSC-SNLIRIGLAKNQLMGKIPSD--FGSLSKIE 654
               L  LQV D + N I       L    S+L  + L +N              +    
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572

Query: 655 VLSLGFNNLIGSIPPPLGNLS 675
            L +    +  + P     + 
Sbjct: 573 QLLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 18/84 (21%), Positives = 37/84 (44%), Gaps = 4/84 (4%)

Query: 109 IPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           +P+    C++L   ++  N+      LDLS N L             ++ L+LS  +++ 
Sbjct: 7   VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 169 MVPTEGVFKNASAISVL--GNNKL 190
           +    G +++ S +S L    N +
Sbjct: 67  IED--GAYQSLSHLSTLILTGNPI 88

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (319), Expect = 2e-30
 Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 37/228 (16%)

Query: 277 LIGTGSFGSVYKG---VLDEGRTTVTVKVFNLHHHR---ASRSFIAECRALRSIRHRNLV 330
            I  G  G +Y      ++ GR  V +K   L H     A    +AE + L  + H ++V
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRP-VVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           ++F      D  G+    +V E++   SL+                + L + + +   ++
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------------GQKLPVAEAIAYLLE 190

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           +  AL YLH     +  + DLKP NI+L EE +  + D G                + G+
Sbjct: 191 ILPALSYLHS--IGLV-YNDLKPENIMLTEEQLK-LIDLGAVS----RINSFGY--LYGT 240

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
            G+ APE       +   D+Y+ G  +  L +          G     
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (312), Expect = 3e-30
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             +G G FG V+    +   T V VK        +  +F+AE   +++++H  LVK+   
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            +       +   ++ EFM  GSL ++L    + DE         L + ++ +  +A  +
Sbjct: 252 VTK------EPIYIITEFMAKGSLLDFL----KSDE----GSKQPLPKLIDFSAQIAEGM 297

Query: 396 DYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            ++   +      H DL+ +NIL+   +V  + DFGLAR +   +  T+  G K  I + 
Sbjct: 298 AFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWT 352

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE       +   DV+S+GIL++E++
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIV 379

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  123 bits (311), Expect = 4e-30
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V  G        V VK   + +   +++F+AE   +  +RH NLV++     
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
               +      +V E+M  GSL ++L    R          L     L  ++DV  A++Y
Sbjct: 257 ----EEKGGLYIVTEYMAKGSLVDYL----RSRG----RSVLGGDCLLKFSLDVCEAMEY 304

Query: 398 L-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           L  ++      H DL   N+L+ E+ V+ V DFGL +        ++    K  + + AP
Sbjct: 305 LEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 355

Query: 457 EYGLGSEVSTNGDVYSYGILMLELI 481
           E     + ST  DV+S+GIL+ E+ 
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIY 380

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  119 bits (301), Expect = 6e-30
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 30/218 (13%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKV 332
           +G G FGSV +G L   D     V VK   L +   R    F++E   ++   H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C  +  QG     ++  FM+ G L  +L        ++  P+++ L   L   +D+A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 393 SALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             ++YL + +      H DL   N +L ++M   V DFGL++      + +     +G I
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKK-----IYSGDYYRQGRI 208

Query: 452 GYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
             +     A E     +    ++  DV+++G+ M E+ 
Sbjct: 209 AKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIA 243

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  122 bits (308), Expect = 7e-30
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 22/207 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             +G G FG V+ G    G T V +K        +  +F+ E + ++ +RH  LV+++  
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            S       +   +V E+M  GSL ++L    + +      + L L Q +++A  +AS +
Sbjct: 248 VSE------EPIYIVTEYMSKGSLLDFL----KGET----GKYLRLPQLVDMAAQIASGM 293

Query: 396 DYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            Y+   +      H DL+ +NIL+ E +V  V DFGLAR +   +  T+  G K  I + 
Sbjct: 294 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT 348

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE  L    +   DV+S+GIL+ EL 
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELT 375

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (298), Expect = 1e-29
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 338 GVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y       ++ EFM  G+L ++L    RE       + ++ +  L +A  ++SA+
Sbjct: 80  REPPFY-------IITEFMTYGNLLDYL----RECN----RQEVSAVVLLYMATQISSAM 124

Query: 396 DYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           +YL   +      H DL   N L+ E  +  V DFGL+R +      T+  G K  I + 
Sbjct: 125 EYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 179

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE    ++ S   DV+++G+L+ E+ 
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (312), Expect = 2e-29
 Identities = 39/244 (15%), Positives = 75/244 (30%), Gaps = 25/244 (10%)

Query: 562 LESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPV 621
           L+ +  A S   +       +  N +              L+ L   +L N     ++P 
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509

Query: 622 NLSSCSNLIRIGLAKNQLMG---------KIPSDFGSLSKIEVLSLGFNNLIGSIPPP-- 670
            L     L  + +A N+ +          ++  D  +  KI++  +G+NNL    P    
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASAS 568

Query: 671 LGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFD 729
           L  +  L  +    N +   +         L  L L  N++  I P         +    
Sbjct: 569 LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEI-PEDFCAFTDQVEGLG 625

Query: 730 VGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSIS------NASKLEVFQALNN 782
              NK++  IP  +    +  +       N+I      +IS                  N
Sbjct: 626 FSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYN 683

Query: 783 KLTG 786
           ++  
Sbjct: 684 EIQK 687

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  118 bits (296), Expect = 2e-27
 Identities = 32/237 (13%), Positives = 61/237 (25%), Gaps = 20/237 (8%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           + +   K+       +     L+     N             L+  Q+ +L N      I
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--TFI 440

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRK 679
              +   + L  I  A +       +           +  +     +      NL  L  
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTD 495

Query: 680 ISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI---------VPSSIFNISSIAEFDV 730
           + L        +P  L  L  L  L +  NR             +         I  F +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555

Query: 731 GENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           G N ++   P       +  L       N++      +     KL   +   N++  
Sbjct: 556 GYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE 609

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  117 bits (294), Expect = 4e-27
 Identities = 48/271 (17%), Positives = 88/271 (32%), Gaps = 29/271 (10%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
            N +E   +   +  K  K+ +LD    K+    L   G    L  L L+ N    EIP 
Sbjct: 557 YNNLEEFPASASLQ-KMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPE 612

Query: 598 EIGR-LRRLQVPDLNNNSIGGEIP--VNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS--- 651
           +      +++    ++N +   IP   N  S   +  +  + N++  +  +   S+    
Sbjct: 613 DFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671

Query: 652 --KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNL-------AGSIPFTLSKLKNLV 702
                 ++L +N +           S +  I L+ N +                    L 
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 703 ILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI------ 755
            + L  N+L+ +        +  ++  DV  N      P         L+ F I      
Sbjct: 732 TIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL-NSSQLKAFGIRHQRDA 789

Query: 756 GTNRITGAIPPSISNASKLEVFQALNNKLTG 786
             NRI    P  I+    L   Q  +N +  
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  115 bits (289), Expect = 2e-26
 Identities = 44/255 (17%), Positives = 88/255 (34%), Gaps = 29/255 (11%)

Query: 558 TILDLESLKLAGSILP-HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
            I  +    L        +  +  L +L+  +N   H      G   +L    L+ N I 
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIE 608

Query: 617 GEIPVNL-SSCSNLIRIGLAKNQLMGKIPSDF--GSLSKIEVLSLGFNNLIG-----SIP 668
            EIP +  +    +  +G + N+L   IP+ F   S+  +  +   +N +       S  
Sbjct: 609 -EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666

Query: 669 PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI-------VPSSIFN 721
                  +   ++L+ N +        +    +  + L  N ++ I          +  N
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726

Query: 722 ISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSISNASKLEVFQAL 780
              +   D+  NK+   +  D+  T L  L    +  N  +   P    N+S+L+ F   
Sbjct: 727 TYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784

Query: 781 ------NNKLTGEVP 789
                  N++  + P
Sbjct: 785 HQRDAEGNRILRQWP 799

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  112 bits (281), Expect = 1e-25
 Identities = 41/229 (17%), Positives = 81/229 (35%), Gaps = 42/229 (18%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKG-------------------SIPSSLG 42
           +   +NR++  I  +I  L KL   Y +++                       +   S  
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488

Query: 43  LCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRG---------SFPTEVGNLI 93
             + LT + L+N      +P  L  L  L +L+++ N+                +     
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548

Query: 94  NLETLTVSGNILQG-EIPSTLGSCIKLEILEMQGNVFQG---------LTILDLSRNKLS 143
            ++   +  N L+     ++L   +KL +L+   N  +          LT L L  N++ 
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIE 608

Query: 144 GEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
               +F      +E L  S+N L+  +P     K+   +  +    NK+
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKI 656

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  108 bits (272), Expect = 2e-24
 Identities = 39/259 (15%), Positives = 81/259 (31%), Gaps = 31/259 (11%)

Query: 550 IGSKAQKVTILDLESLKLAGSILP---HIGNLSFLKILNLENNSFTHEIPS-----EIGR 601
             +   +V  L     KL    +P   +  ++  +  ++   N    E  +     +  +
Sbjct: 614 FCAFTDQVEGLGFSHNKL--KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671

Query: 602 LRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQL-------MGKIPSDFGSLSKIE 654
                   L+ N I        ++ S +  I L+ N +       +     ++ +   + 
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 655 VLSLGFNNLIGSIPPPL--GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYL------ 706
            + L FN L  S+        L  L  + ++ N  + S P        L    +      
Sbjct: 732 TIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789

Query: 707 GVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP 766
             NR+    P+ I    S+ +  +G N I+  +          L    I  N        
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEK---LTPQLYILDIADNPNISIDVT 845

Query: 767 SISNASKLEVFQALNNKLT 785
           S+    +  ++  L +K  
Sbjct: 846 SVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  101 bits (252), Expect = 4e-22
 Identities = 27/183 (14%), Positives = 55/183 (30%), Gaps = 25/183 (13%)

Query: 1   ILALDSNRLSGNIPPSIG------NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFN 54
            +    N++      +I                +S N ++            ++TI L N
Sbjct: 648 SVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706

Query: 55  NNLS-------GTIPPQLMGLTSLVALDLSRNQFRGSFPTE--VGNLINLETLTVSGNIL 105
           N ++                   L  +DL  N+   S   +     L  L  + VS N  
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765

Query: 106 QGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
               P+   +  +L+   ++          D   N++  + P  +     +  L +  ND
Sbjct: 766 S-SFPTQPLNSSQLKAFGIRHQ-------RDAEGNRILRQWPTGITTCPSLIQLQIGSND 817

Query: 166 LEG 168
           +  
Sbjct: 818 IRK 820

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  100 bits (251), Expect = 6e-22
 Identities = 42/225 (18%), Positives = 69/225 (30%), Gaps = 40/225 (17%)

Query: 2   LALDSNRLSG---------NIPPSIGNLKKLVEPYVSDNFLKGSIPS-SLGLCESLTTIG 51
           L +  NR             +        K+   Y+  N L+    S SL     L  + 
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579

Query: 52  LFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVG-NLINLETLTVSGNILQGEIP 110
             +N +             L  L L  NQ     P +       +E L  S N L+  IP
Sbjct: 580 CVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635

Query: 111 ST--LGSCIKLEILEMQGNVFQG----------------LTILDLSRNKLSGEIPEFLVG 152
           +     S   +  ++   N                     + + LS N++     E    
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695

Query: 153 LKVIENLNLSYNDL-----EGMVPTEGVFKNASAISVL--GNNKL 190
              I  + LS N +       + P +G +KN   ++ +    NKL
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 8e-21
 Identities = 37/205 (18%), Positives = 67/205 (32%), Gaps = 33/205 (16%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLK-------GSIPSSLGLCESLTTIGLF 53
            + L  N +             +    +S+N +             +      LTTI L 
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736

Query: 54  NNNLSGTIPPQLM--GLTSLVALDLSRNQFRGSFPTEVGNLINLETL------TVSGNIL 105
            N L+ ++        L  L  +D+S N F  SFPT+  N   L+           GN +
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRI 794

Query: 106 QGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
             + P+ + +C               L  L +  N +     +    L +   L+++ N 
Sbjct: 795 LRQWPTGITTC-------------PSLIQLQIGSNDIRKVDEKLTPQLYI---LDIADNP 838

Query: 166 LEGMVPTEGVFKNASAISVLGNNKL 190
              +  T       + + VL  +K 
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 26/212 (12%), Positives = 58/212 (27%), Gaps = 35/212 (16%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L+L      G +P +IG L +L       +    S         +        + +    
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387

Query: 62  PP-QLMGLTSLVALDLSRNQFRG----------------------------SFPTEVGNL 92
               L     L   DL ++                                     +  L
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRL 447

Query: 93  INLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNV------FQGLTILDLSRNKLSGEI 146
             L+ +  + +    +  +        +  +   N        + LT ++L       ++
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

Query: 147 PEFLVGLKVIENLNLSYNDLEGMVPTEGVFKN 178
           P+FL  L  +++LN++ N        +  +  
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 85.7 bits (212), Expect = 2e-17
 Identities = 32/266 (12%), Positives = 76/266 (28%), Gaps = 36/266 (13%)

Query: 553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNN 612
           K  K   + ++  + A  I  +    +  + L+ +N  +     +           +   
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKEL 308

Query: 613 NSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP---- 668
           +  G +  V+L +   +  + LA     G++P   G L++++VLS G ++   S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 669 ---PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI----------- 714
               P  +     +I +    +       L+    L         +  I           
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 715 -----------VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA 763
                      +  +I  ++ +       +    +          +         +    
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY------AKQYEN 482

Query: 764 IPPSISNASKLEVFQALNNKLTGEVP 789
              S SN   L   +  N     ++P
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLP 508

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 79.5 bits (196), Expect = 2e-15
 Identities = 27/192 (14%), Positives = 63/192 (32%), Gaps = 22/192 (11%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKL-------AGSILPHIGNLSFLKILNLENNS 590
            N I+   +   + +    ++ + L +  +             +  N   L  ++L  N 
Sbjct: 682 YNEIQKFPT--ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

Query: 591 FTHEIPSEI--GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL------AKNQLMGK 642
            T  +  +     L  L   D++ N      P    + S L   G+        N+++ +
Sbjct: 740 LT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
            P+   +   +  L +G N++   +   L     L  + +A N        ++       
Sbjct: 798 WPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAG 854

Query: 703 ILYLGVNRLSGI 714
           +  L  ++   I
Sbjct: 855 MYVLLYDKTQDI 866

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 74.1 bits (182), Expect = 1e-13
 Identities = 27/151 (17%), Positives = 50/151 (33%), Gaps = 18/151 (11%)

Query: 1   ILALDSNRLSGNIPPSI--GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGL------ 52
            + L  N+L+  +        L  L    VS N    S P+       L   G+      
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789

Query: 53  FNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN-ILQGEIPS 111
             N +    P  +    SL+ L +  N  R     ++     L  L ++ N  +  ++ S
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTS 846

Query: 112 TLGSCIKLEILEMQGN---VFQGLTILDLSR 139
                I+  +  +  +     +G   L + R
Sbjct: 847 VCPY-IEAGMYVLLYDKTQDIRGCDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.7 bits (160), Expect = 4e-11
 Identities = 15/160 (9%), Positives = 43/160 (26%), Gaps = 16/160 (10%)

Query: 31  NFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVG 90
           +         L     +T + L      G +P  +  LT L  L    +    S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 91  NLINLETLTVSGNILQGEIPS-TLGSCIKLEILEMQGNVF---------QGLTILDLSRN 140
             +  +      + ++       L    +L + ++  +           +  + + L   
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 141 KLSG------EIPEFLVGLKVIENLNLSYNDLEGMVPTEG 174
           ++         I + +  L  ++ +  + +          
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD 468

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  117 bits (296), Expect = 5e-29
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G+G FG+V+KGV     +  +  V +KV      R S         A+ S+ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C G   Q      LV +++  GSL + +    R+         L     LN  + +A
Sbjct: 81  LGLCPGSSLQ------LVTQYLPLGSLLDHV----RQHR-----GALGPQLLLNWGVQIA 125

Query: 393 SALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             + YL  H       H +L   N+LL       V DFG+A  LPP   Q      K  I
Sbjct: 126 KGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            ++A E     + +   DV+SYG+ + EL+
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  121 bits (305), Expect = 5e-29
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             +G G FG V+ G  + G T V +K        +  +F+ E + ++ +RH  LV+++  
Sbjct: 273 VKLGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            S       +   +V E+M  GSL ++L    + +      + L L Q +++A  +AS +
Sbjct: 331 VSE------EPIYIVTEYMSKGSLLDFL----KGET----GKYLRLPQLVDMAAQIASGM 376

Query: 396 DYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            Y+   +      H DL+ +NIL+ E +V  V DFGLAR +   +  T+  G K  I + 
Sbjct: 377 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT 431

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE  L    +   DV+S+GIL+ EL 
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELT 458

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (294), Expect = 7e-29
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 31/219 (14%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKV 332
           +G G FGSV +  L   D     V VK+             F+ E   ++   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 333 FTACSGVDYQGNDFKAL-VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
                    +G     + +  FM++G L  +L        + + P NL L   +   +D+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLVRFMVDI 146

Query: 392 ASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           A  ++YL   +      H DL   N +L E+M   V DFGL+R      + +     +G 
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRK-----IYSGDYYRQGC 197

Query: 451 IGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
              +     A E     L    + + DV+++G+ M E++
Sbjct: 198 ASKLPVKWLALESLADNL---YTVHSDVWAFGVTMWEIM 233

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  115 bits (291), Expect = 7e-29
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             IG G FG V  G        V VK   + +   +++F+AE   +  +RH NLV++   
Sbjct: 27  QTIGKGEFGDVMLGDYRG--NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      +V E+M  GSL ++L    R          L     L  ++DV  A+
Sbjct: 83  IV----EEKGGLYIVTEYMAKGSLVDYL----RSRG----RSVLGGDCLLKFSLDVCEAM 130

Query: 396 DYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           +YL  ++      H DL   N+L+ E+ V+ V DFGL +        ++    K  + + 
Sbjct: 131 EYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT 181

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE     + ST  DV+S+GIL+ E+ 
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIY 208

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  115 bits (291), Expect = 7e-29
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V+ G    G T V VK        +  +F+AE   ++ ++H+ LV+++   +
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                  +   ++ E+M+NGSL ++L    +          L + + L++A  +A  + +
Sbjct: 79  Q------EPIYIITEYMENGSLVDFL----KTPS----GIKLTINKLLDMAAQIAEGMAF 124

Query: 398 L-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP 456
           +   +      H DL+ +NIL+ + +   + DFGLAR +      T+  G K  I + AP
Sbjct: 125 IEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAP 179

Query: 457 EYGLGSEVSTNGDVYSYGILMLELI 481
           E       +   DV+S+GIL+ E++
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIV 204

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  117 bits (295), Expect = 1e-28
 Identities = 58/272 (21%), Positives = 120/272 (44%), Gaps = 23/272 (8%)

Query: 515 STLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574
              +N +   A ++   +  ++  ++ +  +       + + +T L +   K+  + +  
Sbjct: 9   PAPINQIFPDADLAEGIRAVLQKASVTD--VVTQ---EELESITKLVVAGEKV--ASIQG 61

Query: 575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL 634
           I  L+ L+ LNL  N  T   P  +  L +L    +  N I       L + +NL  + L
Sbjct: 62  IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYL 117

Query: 635 AKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFT 694
            ++ +    P    +L+K+  L+LG N+ + S   PL N++ L  +++  + +    P  
Sbjct: 118 NEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPI- 173

Query: 695 LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFS 754
            + L +L  L L  N++  I  S + +++S+  F    N+I    P+     +  L    
Sbjct: 174 -ANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITPVA---NMTRLNSLK 227

Query: 755 IGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           IG N+IT   P  ++N S+L   +   N+++ 
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  109 bits (275), Expect = 4e-26
 Identities = 54/251 (21%), Positives = 118/251 (47%), Gaps = 18/251 (7%)

Query: 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE 598
           N+    I+ +   S   K+T L + + K+  + +  + NL+ L+ L L  ++ +    S 
Sbjct: 72  NLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISP 127

Query: 599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL 658
           +  L ++   +L  N    ++   LS+ + L  + + ++++    P    +L+ +  LSL
Sbjct: 128 LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184

Query: 659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS 718
            +N +      PL +L+SL   +  +N +    P  ++ +  L  L +G N+++ +  S 
Sbjct: 185 NYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SP 238

Query: 719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ 778
           + N+S +   ++G N+I     +     L  L+  ++G+N+I+      ++N S+L    
Sbjct: 239 LANLSQLTWLEIGTNQISDINAVKD---LTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293

Query: 779 ALNNKLTGEVP 789
             NN+L  E  
Sbjct: 294 LNNNQLGNEDM 304

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  109 bits (274), Expect = 5e-26
 Identities = 47/248 (18%), Positives = 97/248 (39%), Gaps = 16/248 (6%)

Query: 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE 598
            I    I+ +        +  L L    +  S +  + NL+ +  LNL  N       S 
Sbjct: 94  YIGTNKITDISALQNLTNLRELYLNEDNI--SDISPLANLTKMYSLNLGANHNL-SDLSP 150

Query: 599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL 658
           +  +  L    +  + +    P  +++ ++L  + L  NQ+    P    SL+ +   + 
Sbjct: 151 LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206

Query: 659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS 718
             N +  +   P+ N++ L  + +  N +    P  L+ L  L  L +G N++S I  ++
Sbjct: 207 YVNQI--TDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260

Query: 719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ 778
           + +++ +   +VG N+I     L+    L  L    +  N++       I   + L    
Sbjct: 261 VKDLTKLKMLNVGSNQISDISVLN---NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317

Query: 779 ALNNKLTG 786
              N +T 
Sbjct: 318 LSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  100 bits (252), Expect = 4e-23
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 19/228 (8%)

Query: 562 LESLKLAG----SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
           + SL L      S L  + N++ L  L +  +       + I  L  L    LN N I  
Sbjct: 134 MYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED 191

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
             P  L+S ++L       NQ+    P    +++++  L +G N +      PL NLS L
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQL 245

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG 737
             + +  N ++  I   +  L  L +L +G N++S I  S + N+S +    +  N++  
Sbjct: 246 TWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGN 301

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
                 G  L NL    +  N IT   P  +++ SK++     N  + 
Sbjct: 302 EDMEVIG-GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 87.2 bits (217), Expect = 1e-18
 Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 19/179 (10%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L +  +++  ++ P I NL  L    ++ N ++   P  L    SL     + N ++   
Sbjct: 160 LTVTESKVK-DVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  +  +T L +L +  N+     P  + NL  L  L +  N +     + +    KL++
Sbjct: 216 P--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKM 269

Query: 122 LEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
           L +  N             L  L L+ N+L  E  E + GL  +  L LS N +  + P
Sbjct: 270 LNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.1 bits (196), Expect = 6e-16
 Identities = 40/200 (20%), Positives = 85/200 (42%), Gaps = 26/200 (13%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L + +N+++     ++ NL  L E Y++++ +    P  L     + ++ L  N+    +
Sbjct: 93  LYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL 148

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
            P L  +T L  L ++ ++ +   P  + NL +L +L+++ N ++   P  L S   L  
Sbjct: 149 SP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHY 203

Query: 122 LEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPT 172
                N             L  L +  NK++   P  L  L  +  L +  N +  +   
Sbjct: 204 FTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA- 260

Query: 173 EGVFKNASAISVL--GNNKL 190
               K+ + + +L  G+N++
Sbjct: 261 ---VKDLTKLKMLNVGSNQI 277

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 34/166 (20%), Positives = 65/166 (39%), Gaps = 23/166 (13%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
                N+++   P  + N+ +L    + +N +    P  L     LT + +  N +S   
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-- 257

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +  LT L  L++  NQ      + + NL  L +L ++ N L  E    +G    L  
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL-- 313

Query: 122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
                      T L LS+N ++   P  L  L  +++ + +   ++
Sbjct: 314 -----------TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 75.7 bits (187), Expect = 7e-15
 Identities = 34/201 (16%), Positives = 76/201 (37%), Gaps = 28/201 (13%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L    ++     +   L+ + +  V+   +       +    +L  + L  N ++   
Sbjct: 27  AVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDIS 82

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  L  L  L  L +  N+   +  + + NL NL  L ++ + +    P  L +  K+  
Sbjct: 83  P--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYS 136

Query: 122 LEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
           L +  N              L  L ++ +K+    P  +  L  + +L+L+YN +E + P
Sbjct: 137 LNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194

Query: 172 TEGVFKNASAISVL--GNNKL 190
                 + +++       N++
Sbjct: 195 ----LASLTSLHYFTAYVNQI 211

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 28/127 (22%), Positives = 53/127 (41%), Gaps = 8/127 (6%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L + +N+++      + NL +L    +  N +     +++     L  + + +N +S  
Sbjct: 225 SLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD- 279

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
               L  L+ L +L L+ NQ        +G L NL TL +S N +    P  L S  K++
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336

Query: 121 ILEMQGN 127
             +    
Sbjct: 337 SADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 32/179 (17%), Positives = 69/179 (38%), Gaps = 20/179 (11%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           LA     ++  I P   +L + +   +    +   +       ES+T + +    ++ +I
Sbjct: 5   LATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +  LT+L  L+L+ NQ     P  + NL+ L  L +  N +     S L +   L  
Sbjct: 60  QG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRE 114

Query: 122 LEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
           L +  +             +  L+L  N    ++   L  +  +  L ++ + ++ + P
Sbjct: 115 LYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 19/121 (15%), Positives = 37/121 (30%), Gaps = 21/121 (17%)

Query: 47  LTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQ 106
             T+      ++   P     L   +   L +             L ++  L V+G  + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 107 GEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
             I   +     L               L+L+ N+++   P  L  L  + NL +  N +
Sbjct: 58  -SIQG-IEYLTNL-------------EYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100

Query: 167 E 167
            
Sbjct: 101 T 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 27/112 (24%), Positives = 47/112 (41%), Gaps = 12/112 (10%)

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
            ++L  +   IN +     F  + L   +   L    ++ +V      + SI +  V   
Sbjct: 2   AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54

Query: 734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           K+     ++Y   L NL+Y ++  N+IT   P  +SN  KL       NK+T
Sbjct: 55  KVASIQGIEY---LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT 101

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  117 bits (296), Expect = 1e-28
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 24/208 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTAC 336
           IG G+FG V+ G L    T V VK             F+ E R L+   H N+V++   C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 337 SGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
           +     Y       +V E +Q G    +L    R +        L +   L +  D A+ 
Sbjct: 182 TQKQPIY-------IVMELVQGGDFLTFL----RTE-----GARLRVKTLLQMVGDAAAG 225

Query: 395 LDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           ++YL    C     H DL   N L+ E+ V  + DFG++R         S    +  + +
Sbjct: 226 MEYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281

Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELI 481
            APE       S+  DV+S+GIL+ E  
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETF 309

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (292), Expect = 1e-28
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 31/213 (14%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G+G+FG+VYKG+     ++ +  V +K         +    + E   + S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C     Q      L+ + M  G L +++    RE +      N+     LN  + +A
Sbjct: 83  LGICLTSTVQ------LITQLMPFGCLLDYV----REHK-----DNIGSQYLLNWCVQIA 127

Query: 393 SALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             ++YL          H DL   N+L+       + DFGLA+ L     +  + G K  I
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 452 GYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
            ++A E   + + +  S   DV+SYG+ + EL+
Sbjct: 184 KWMALESILHRIYTHQS---DVWSYGVTVWELM 213

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  114 bits (288), Expect = 3e-28
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 277 LIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRAS-----RSFIAECRALRSIRHRNL 329
            +G G   +VY    D       V +K   +           + F  E      + H+N+
Sbjct: 18  KLGGGGMSTVYLA-EDTILNIK-VAIKA--IFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 330 VKVFTACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           V +       D  + +D   LV E+++  +L E++            P  L++   +N  
Sbjct: 74  VSMI------DVDEEDDCYYLVMEYIEGPTLSEYI--------ESHGP--LSVDTAINFT 117

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-QTSSIGV 447
             +   + + H     I  H D+KP NIL+D      + DFG+A+ L  T + QT+   V
Sbjct: 118 NQILDGIKHAHD--MRIV-HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH--V 172

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G++ Y +PE   G       D+YS GI++ E+++ + P    F G+
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  118 bits (299), Expect = 5e-28
 Identities = 40/240 (16%), Positives = 79/240 (32%), Gaps = 7/240 (2%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
            +  LDL +  L+  +   +  LS LK L L  N F +           L    +  N+ 
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337

Query: 616 GGEIPVN-LSSCSNLIRIGLAKNQL--MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG 672
             E+    L +  NL  + L+ + +           +LS ++ L+L +N  +        
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397

Query: 673 NLSSLRKISLAINNLAGSIPFT-LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
               L  + LA   L      +    L  L +L L  + L          + ++   ++ 
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457

Query: 732 ENKIQGNIPLDYGF--TLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
            N              TL  L+   +    ++     + ++   +      +N+LT    
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  117 bits (295), Expect = 1e-27
 Identities = 43/256 (16%), Positives = 89/256 (34%), Gaps = 9/256 (3%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           +   E +   +  G     V  ++L+               S L+ L+L     +  +PS
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPS 295

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVL 656
            +  L  L+   L+ N       ++ S+  +L  + +  N    ++ +    +L  +  L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355

Query: 657 SLGFNNL--IGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
            L  +++         L NLS L+ ++L+ N           +   L +L L   RL   
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 715 VPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI---PPSISN 770
              S F N+  +   ++  + +           L  LQ+ ++  N           S+  
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 771 ASKLEVFQALNNKLTG 786
             +LE+       L+ 
Sbjct: 475 LGRLEILVLSFCDLSS 490

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  108 bits (272), Expect = 1e-24
 Identities = 37/231 (16%), Positives = 70/231 (30%), Gaps = 9/231 (3%)

Query: 559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
             + E+L L   I   +   +  + L    N       +   RL  L   DL    I   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 619 IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
                 S   L  + L  N L+    +       ++ L      +      PL N  +L 
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA--EFDVGENKIQ 736
            + L  N+++          + L +L    N +  +    + ++        ++  N I 
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS--KLEVFQALNNKLT 785
           G I     F     Q  + G  +    I   + N++   L +    +    
Sbjct: 193 G-IEPG-AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  105 bits (265), Expect = 8e-24
 Identities = 34/232 (14%), Positives = 68/232 (29%), Gaps = 4/232 (1%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
           T LDL   ++         +   L  L L  N       + +   + L+        I  
Sbjct: 60  TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
              + L +   L  + L  N +            K++VL    N +       + +L   
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 678 RKISLAIN-NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFN--ISSIAEFDVGENK 734
             +SL +N N    I            L  G  +   ++   + N  I S+      +  
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239

Query: 735 IQGNIPLD-YGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            +   P    G    +++  ++  +        +    S L+        L+
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  103 bits (260), Expect = 3e-23
 Identities = 37/234 (15%), Positives = 70/234 (29%), Gaps = 7/234 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             L L +  L       +     LK L       +      +   + L+   L +N I  
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN-NLIGSIPPPLGNLSS 676
                      L  +    N +      D  SL +   LSL  N N I  I P   + + 
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203

Query: 677 LRKISLAINNLAGSIP--FTLSKLKNLVILYLGVNRLSGIVPSSIFNIS--SIAEFDVGE 732
            + ++         I      S +++L +          I P+    +   S+   ++ +
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           +     I  +       LQ   +    ++  +P  +   S L+      NK   
Sbjct: 264 HYFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  103 bits (260), Expect = 3e-23
 Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 19/207 (9%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L +  LS  +P  +  L  L +  +S N  +     S     SLT + +  N     +
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341

Query: 62  PPQ-LMGLTSLVALDLSRNQFRGS--FPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
               L  L +L  LDLS +    S     ++ NL +L++L +S N            C +
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401

Query: 119 LEILEMQGN---------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           LE+L++             FQ    L +L+LS + L     +   GL  +++LNL  N  
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461

Query: 167 EGMVP-TEGVFKNASAISVL--GNNKL 190
                      +    + +L      L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDL 488

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  103 bits (260), Expect = 4e-23
 Identities = 48/238 (20%), Positives = 90/238 (37%), Gaps = 9/238 (3%)

Query: 556 KVTILDLESLKLAGSILPH-IGNLSFLKILNLENNSFT--HEIPSEIGRLRRLQVPDLNN 612
            +T L ++       +    + NL  L+ L+L ++          ++  L  LQ  +L+ 
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385

Query: 613 NSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIP-SDFGSLSKIEVLSLGFNNLIGSIPPPL 671
           N            C  L  + LA  +L  K   S F +L  ++VL+L  + L  S     
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445

Query: 672 GNLSSLRKISLAINNLAGSIPF---TLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF 728
             L +L+ ++L  N+          +L  L  L IL L    LS I   +  ++  +   
Sbjct: 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505

Query: 729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           D+  N++  +       +     Y ++ +N I+  +P  +   S+        N L  
Sbjct: 506 DLSHNRLTSSSIEA--LSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  102 bits (257), Expect = 8e-23
 Identities = 42/242 (17%), Positives = 79/242 (32%), Gaps = 11/242 (4%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
           + +  L      ++      + N   L+ L L +N  +     +     +L+V D  NN+
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164

Query: 615 IGGEIPVNLSSCSNL--IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG 672
           I      ++SS      + + L  N +   I       +  + L+ G    +  I   L 
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223

Query: 673 N--LSSLRKISLAINNLAGSIPFTLSKLK--NLVILYLGVNRLSGIVPSSIFNISSIAEF 728
           N  + SL   +    +     P     L   ++  + L  +    I  ++    S + E 
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283

Query: 729 DVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE 787
           D+    +     L  G   L  L+   +  N+       S SN   L       N    E
Sbjct: 284 DLTATHLSE---LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340

Query: 788 VP 789
           + 
Sbjct: 341 LG 342

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  102 bits (256), Expect = 8e-23
 Identities = 39/233 (16%), Positives = 82/233 (35%), Gaps = 8/233 (3%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIG--RLRRLQVPDLNNNSIGG 617
           L+L    +   I P   + +  + LN         I   +    ++ L +    +     
Sbjct: 184 LNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 618 EIPVNLSSCS--NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
             P         ++  I L K+       + F   S ++ L L   + +  +P  L  LS
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH-LSELPSGLVGLS 301

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENK 734
           +L+K+ L+ N        + S   +L  L +  N     + +    N+ ++ E D+  + 
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 735 IQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           I+ +   +     L +LQ  ++  N        +     +LE+      +L  
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 99.3 bits (248), Expect = 1e-21
 Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 20/207 (9%)

Query: 2   LALDSNRLSGNIPPSIGNLKK--LVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
              +        P     L +  +    +  ++      ++      L  + L   +LS 
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS- 291

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS-TLGSCIK 118
            +P  L+GL++L  L LS N+F         N  +L  L++ GN  + E+ +  L +   
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351

Query: 119 LEILEMQGN----------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
           L  L++  +            + L+    L+LS N+      E       +E L+L++  
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411

Query: 166 LEGMVPTEGVFKNASAISVL--GNNKL 190
           L+     +  F+N   + VL   ++ L
Sbjct: 412 LKVKDA-QSPFQNLHLLKVLNLSHSLL 437

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.2 bits (245), Expect = 2e-21
 Identities = 45/208 (21%), Positives = 76/208 (36%), Gaps = 21/208 (10%)

Query: 2   LALDSNRLSGNIPP-SIGNLKKLVEPYVSDNFLKGSIPSSLGL--CESLTTIGLFNNNLS 58
           L++  N     +    + NL+ L E  +S + ++ S   +L L     L ++ L  N   
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 59  GTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCI 117
                       L  LDL+  + +         NL  L+ L +S ++L            
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

Query: 118 KLEILEMQGN-----------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSY 163
            L+ L +QGN             Q L    IL LS   LS         LK++ +++LS+
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509

Query: 164 NDLEGMVPTEGVFKNASAISV-LGNNKL 190
           N L           +   I + L +N +
Sbjct: 510 NRLTSSSI--EALSHLKGIYLNLASNHI 535

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 97.4 bits (243), Expect = 4e-21
 Identities = 32/198 (16%), Positives = 59/198 (29%), Gaps = 14/198 (7%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L    N L      +   L  L    ++   +      +      L T+ L  N L   
Sbjct: 37  CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
               L G  +L  L   +          + N   LE+L +  N +            KL+
Sbjct: 97  AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLK 156

Query: 121 ILEMQGNVFQGLT-------------ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           +L+ Q N    L+              L+L+ N ++  I        V ++LN       
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNL 215

Query: 168 GMVPTEGVFKNASAISVL 185
            ++          ++ + 
Sbjct: 216 LVIFKGLKNSTIQSLWLG 233

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 95.9 bits (239), Expect = 1e-20
 Identities = 37/188 (19%), Positives = 69/188 (36%), Gaps = 5/188 (2%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTH-EIPSEIGRLRRLQVPDLNNNSIG 616
             L+L   +              L++L+L        +  S    L  L+V +L+++ + 
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKI---PSDFGSLSKIEVLSLGFNNLIGSIPPPLGN 673
                       L  + L  N          +   +L ++E+L L F +L         +
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           L  +  + L+ N L  S    LS LK +  L L  N +S I+PS +  +S     ++ +N
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQN 557

Query: 734 KIQGNIPL 741
            +      
Sbjct: 558 PLDCTCSN 565

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 94.3 bits (235), Expect = 3e-20
 Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 22/212 (10%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPS-SLGLCESLTTIGLFNNNL-- 57
            L L +N+       S  N   L    +  N  +  + +  L   E+L  + L ++++  
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364

Query: 58  SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQG-EIPSTLGSC 116
           S     QL  L+ L +L+LS N+              LE L ++   L+  +  S   + 
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424

Query: 117 IKLEILEMQGN--------VFQG---LTILDLSRNKLSGEI---PEFLVGLKVIENLNLS 162
             L++L +  +        +F G   L  L+L  N            L  L  +E L LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484

Query: 163 YNDLEGMVPTEGVFKNASAISVL--GNNKLCG 192
           + DL  +   +  F +   ++ +   +N+L  
Sbjct: 485 FCDLSSI--DQHAFTSLKMMNHVDLSHNRLTS 514

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.9 bits (234), Expect = 4e-20
 Identities = 37/181 (20%), Positives = 59/181 (32%), Gaps = 14/181 (7%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIP-SSLGLCESLTTIGLFNNNLSGT 60
           L L  N        +     +L    ++   LK     S       L  + L ++ L  +
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVG---NLINLETLTVSGNILQGEIPSTLGSCI 117
                 GL +L  L+L  N F      +      L  LE L +S   L         S  
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 118 KLEILEMQGN--------VFQGLT--ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
            +  +++  N            L    L+L+ N +S  +P  L  L     +NL  N L+
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

Query: 168 G 168
            
Sbjct: 561 C 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.4 bits (230), Expect = 1e-19
 Identities = 43/207 (20%), Positives = 73/207 (35%), Gaps = 20/207 (9%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCE--SLTTIGLFNNNLSG 59
           L L+ N ++G I P   +                 I   L      SL      + +   
Sbjct: 184 LNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 60  TIPPQLMGL--TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
             P    GL   S+ +++L ++ F             L+ L ++   L  E+PS L    
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS 301

Query: 118 KLEILEMQGNVFQG-----------LTILDLSRNKLSGEI-PEFLVGLKVIENLNLSYND 165
            L+ L +  N F+            LT L +  N    E+    L  L+ +  L+LS++D
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 166 LEGMVPTEGVFKNASAISVL--GNNKL 190
           +E         +N S +  L    N+ 
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEP 388

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 83.1 bits (206), Expect = 1e-16
 Identities = 27/144 (18%), Positives = 43/144 (29%), Gaps = 13/144 (9%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL 95
            IP +L    S   +    N L          L +L  LDL+R Q          +   L
Sbjct: 26  EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 96  ETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLSG 144
           +TL ++ N L     + L     L+ L                       L L  N +S 
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 145 EIPEFLVGLKVIENLNLSYNDLEG 168
                    + ++ L+   N +  
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 73.9 bits (182), Expect = 8e-14
 Identities = 31/174 (17%), Positives = 57/174 (32%), Gaps = 17/174 (9%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSI---PSSLGLCESLTTIGLFNNNL 57
           +L L  + L  +       L  L    +  N          +SL     L  + L   +L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

Query: 58  SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
           S         L  +  +DLS N+   S    + +L  +  L ++ N +   +PS L    
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547

Query: 118 KLEILEMQGNVFQG-------LTILDLSRNKLSGEI------PEFLVGLKVIEN 158
           +   + ++ N           L     +  KL          P  L G+++ + 
Sbjct: 548 QQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDV 601

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 19/133 (14%), Positives = 37/133 (27%), Gaps = 28/133 (21%)

Query: 654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG 713
           +  +     L   IP  L   +S   +  + N L      T S+L NL  L L   ++  
Sbjct: 15  KTYNCENLGL-NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASK 773
           I   +  +                            L    +  N +      ++S    
Sbjct: 72  IHEDTFQS-------------------------QHRLDTLVLTANPLIFMAETALSGPKA 106

Query: 774 LEVFQALNNKLTG 786
           L+    +   ++ 
Sbjct: 107 LKHLFFIQTGISS 119

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 4e-06
 Identities = 28/150 (18%), Positives = 52/150 (34%), Gaps = 5/150 (3%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           N+  +  I          ++ IL L    L+        +L  +  ++L +N  T     
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS 657
            +  L+ + + +L +N I   +P  L   S    I L +N L         ++  +E   
Sbjct: 519 ALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYK 573

Query: 658 LGFNNLIGSIPPPLGNLSSLRKISLAINNL 687
                L  +      N   LR + L+   L
Sbjct: 574 ENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  114 bits (287), Expect = 6e-28
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 22/210 (10%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV         D     V VK          R F  E + L+++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
               G    G     LV E++ +G L ++L    +          L+  + L  +  +  
Sbjct: 91  GVSYG---PGRQSLRLVMEYLPSGCLRDFL----QRHR-----ARLDASRLLLYSSQICK 138

Query: 394 ALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH-VQTSSIGVKGSI 451
            ++YL    C     H DL   NIL++ E    + DFGLA+ LP            +  I
Sbjct: 139 GMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    +  S   DV+S+G+++ EL 
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (285), Expect = 6e-28
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 22/214 (10%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
            IG GSF +VYKG+  +     V            S  + F  E   L+ ++H N+V+ F
Sbjct: 33  EIGRGSFKTVYKGLDTETTV-EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR-F 90

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                   +G     LV E M +G+L+ +L          K  + + +    +    +  
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL----------KRFKVMKIKVLRSWCRQILK 140

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            L +L H   P   H DLK  NI +        +GD GLA     +  +     V G+  
Sbjct: 141 GLQFL-HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 195

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           ++APE     +   + DVY++G+ MLE+   + P
Sbjct: 196 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  113 bits (284), Expect = 9e-28
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 23/211 (10%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V         D     V VK           +    E   LR++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C+     G +   L+ EF+ +GSL+E+L     +++       +NL Q+L  A+ + 
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYL----PKNK-----NKINLKQQLKYAVQIC 136

Query: 393 SALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH-VQTSSIGVKGS 450
             +DYL          H DL   N+L++ E    +GDFGL + +       T        
Sbjct: 137 KGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + + APE  + S+     DV+S+G+ + EL+
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  113 bits (284), Expect = 9e-28
 Identities = 58/214 (27%), Positives = 85/214 (39%), Gaps = 31/214 (14%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G          +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++        +      +V E    GSL + L    R+ +      +  L      A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRL----RKHQ-----GHFLLGTLSRYAVQV 130

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           A  + YL    + I  H DL   N+LL    +  +GDFGL R LP            K  
Sbjct: 131 AEGMGYLE-SKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 451 IGYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
             + APE       S  S   D + +G+ + E+ 
Sbjct: 188 FAWCAPESLKTRTFSHAS---DTWMFGVTLWEMF 218

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  111 bits (281), Expect = 1e-27
 Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 28/208 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFTAC 336
           IG+G FG V+ G     +  V +K   +     S   FI E   +  + H  LV+++  C
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 337 SGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                         LV EFM++G L ++L    R                L + +DV   
Sbjct: 73  LEQAPIC-------LVTEFMEHGCLSDYL----RTQR-----GLFAAETLLGMCLDVCEG 116

Query: 395 LDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           + YL          H DL   N L+ E  V  V DFG+ RF+      TSS G K  + +
Sbjct: 117 MAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 171

Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELI 481
            +PE    S  S+  DV+S+G+LM E+ 
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVF 199

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (284), Expect = 1e-27
 Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 38/227 (16%)

Query: 277 LIGTGSFGSVYKG---VLDEGRTTVTVKVFNLHHHRAS-----RSFIAECRALRSIRHRN 328
           L+G G  G VY+    V +  R  V +K+  +    +S          E R    ++  +
Sbjct: 41  LVGRGGMGDVYEAEDTVRE--RI-VALKL--MSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +     G    G  +  +    +    L   L          + P  L   + + I 
Sbjct: 96  VVPIHD--FGEI-DGQLY--VDMRLINGVDLAAML--------RRQGP--LAPPRAVAIV 140

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-QTSSIGV 447
             + SALD  H      T H D+KP NIL+  +  +++ DFG+A       + Q  +   
Sbjct: 141 RQIGSALDAAHA--AGAT-HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--T 195

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G++ Y+APE    S  +   D+Y+   ++ E +    P    ++GD
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  113 bits (284), Expect = 1e-27
 Identities = 45/269 (16%), Positives = 98/269 (36%), Gaps = 20/269 (7%)

Query: 528 SNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLE 587
           SN  Q + R    ++    +L   +       L+L S+ L          LS L+ + ++
Sbjct: 55  SNNPQIETRTGRALKATADLLED-ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112

Query: 588 NNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDF 647
                 E+P  + +   L+   L  N +   +P +++S + L  + +     + ++P   
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170

Query: 648 GS---------LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKL 698
            S         L  ++ L L +  +  S+P  + NL +L+ + +  + L+ ++   +  L
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228

Query: 699 KNLVILYL-GVNRLSGIVPSSIFNISSIAEFDV-GENKIQGNIPLDYGFTLQNLQYFSIG 756
             L  L L G   L    P      + +    +   + +   +PLD    L  L+   + 
Sbjct: 229 PKLEELDLRGCTALRNY-PPIFGGRAPLKRLILKDCSNLL-TLPLDIH-RLTQLEKLDLR 285

Query: 757 TNRITGAIPPSISNASKLEVFQALNNKLT 785
                  +P  I+      +     +   
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 43/227 (18%), Positives = 78/227 (34%), Gaps = 19/227 (8%)

Query: 569 GSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSN 628
           GS   H  + S  + L  + ++        + + +R    D N               SN
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-----NSN 56

Query: 629 LIRIGLAKNQLMGKIPSDFGSLS--KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINN 686
             +I     + +          +      L L    L    P     LS L+ +++    
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 687 LAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP------ 740
           L   +P T+ +   L  L L  N L  + P+SI +++ + E  +        +P      
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 741 --LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
                   L NLQ   +    I  ++P SI+N   L+  +  N+ L+
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 33/187 (17%), Positives = 62/187 (33%), Gaps = 23/187 (12%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCE---------SLTTIG 51
            L L  N L   +P SI +L +L E  +        +P  L   +         +L ++ 
Sbjct: 131 TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR 189

Query: 52  LFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS 111
           L    +  ++P  +  L +L +L +  +    +    + +L  LE L + G       P 
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP 247

Query: 112 TLGSCIKLEILEMQGNVF-----------QGLTILDLSRNKLSGEIPEFLVGLKVIENLN 160
             G    L+ L ++                 L  LDL        +P  +  L     + 
Sbjct: 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307

Query: 161 LSYNDLE 167
           +  +   
Sbjct: 308 VPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 94.2 bits (235), Expect = 4e-21
 Identities = 41/241 (17%), Positives = 87/241 (36%), Gaps = 21/241 (8%)

Query: 562 LESLKLAGS--ILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
            E+L   GS  + P+   LS  +     + +  H            Q+      ++    
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALK-AT 71

Query: 620 PVNLSSCS--NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
              L   +    + + L    L  + P     LS ++ +++    L+  +P  +   + L
Sbjct: 72  ADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYL-GVNRLSGI--------VPSSIFNISSIAEF 728
             ++LA N L  ++P +++ L  L  L +     L+ +               + ++   
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188

Query: 729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV 788
            +    I+ ++P      LQNL+   I  + ++ A+ P+I +  KLE             
Sbjct: 189 RLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245

Query: 789 P 789
           P
Sbjct: 246 P 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 87.7 bits (218), Expect = 6e-19
 Identities = 27/133 (20%), Positives = 52/133 (39%), Gaps = 4/133 (3%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L+   +  ++P SI NL+ L    + ++ L  ++  ++     L  + L        
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244

Query: 61  IPPQLMGLTSLVALDLS-RNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
            PP   G   L  L L   +    + P ++  L  LE L + G +    +PS +      
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 120 EILEMQGNVFQGL 132
            I+ +  ++   L
Sbjct: 304 CIILVPPHLQAQL 316

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 84.2 bits (209), Expect = 9e-18
 Identities = 29/176 (16%), Positives = 56/176 (31%), Gaps = 27/176 (15%)

Query: 14  PPSIGNLKKLVEPYVSDNFLKGSIPSSLGLC--ESLTTIGLFNNNLSGTIPPQLMGLTSL 71
                N         +   LK +    L          + L +  L    P Q   L+ L
Sbjct: 49  AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106

Query: 72  VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---- 127
             + +         P  +     LETLT++ N L+  +P+++ S  +L  L ++      
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164

Query: 128 ----------------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
                               L  L L    +   +P  +  L+ +++L +  + L 
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 34/197 (17%), Positives = 53/197 (26%), Gaps = 42/197 (21%)

Query: 11  GNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLG-----------LCESLTTIGLFNN---- 55
           G+      +       Y   +         L               S       NN    
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 56  ----NLSGTIPPQLMGLTS--LVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEI 109
                        L   T    VAL+L        FP +   L +L+ +T+    L  E+
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 110 PSTLGSCIKLEILEMQGNVF----------QGLTILDLSRNKLSGEIPE---------FL 150
           P T+     LE L +  N              L  L +       E+PE           
Sbjct: 120 PDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

Query: 151 VGLKVIENLNLSYNDLE 167
            GL  +++L L +  + 
Sbjct: 180 QGLVNLQSLRLEWTGIR 196

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 24/168 (14%), Positives = 43/168 (25%), Gaps = 26/168 (15%)

Query: 640 MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP------- 692
           MG         S  E L    +  +      L              + A           
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 693 --------------FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
                            +     V L L    L    P   F +S +    +    +   
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-E 118

Query: 739 IPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ-ALNNKLT 785
           +P         L+  ++  N +  A+P SI++ ++L         +LT
Sbjct: 119 LPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 11/70 (15%), Positives = 23/70 (32%), Gaps = 4/70 (5%)

Query: 5   DSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQ 64
           D + L   +P  I  L +L +  +        +PS +    +   I +   +L   +   
Sbjct: 262 DCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLDQH 319

Query: 65  LMGLTSLVAL 74
                +  A 
Sbjct: 320 R--PVARPAE 327

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  112 bits (282), Expect = 1e-27
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 22/210 (10%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV         D     V VK          R F  E   L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C      G     L+ E++  GSL ++L    ++ +       ++ ++ L     +  
Sbjct: 78  GVCYS---AGRRNLKLIMEYLPYGSLRDYL----QKHK-----ERIDHIKLLQYTSQICK 125

Query: 394 ALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSI 451
            ++YL          H DL   NIL++ E    +GDFGL + LP            +  I
Sbjct: 126 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELF 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  111 bits (279), Expect = 2e-27
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 26/207 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G+G FG V  G    G+  V VK+       +   F  E + +  + H  LVK +  CS
Sbjct: 16  LGSGQFGVVKLGKWK-GQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 338 GVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                Y       +V E++ NG L  +L    R        + L   Q L +  DV   +
Sbjct: 74  KEYPIY-------IVTEYISNGCLLNYL----RSHG-----KGLEPSQLLEMCYDVCEGM 117

Query: 396 DYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            +L  H       H DL   N L+D ++   V DFG+ R++       SS+G K  + + 
Sbjct: 118 AFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSVGTKFPVKWS 172

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
           APE     + S+  DV+++GILM E+ 
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVF 199

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (281), Expect = 3e-27
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 32/227 (14%)

Query: 277 LIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRAS-----RSFIAECRALRSIRHRNL 329
           ++G G    V+    D    R  V VKV  L    A        F  E +   ++ H  +
Sbjct: 19  ILGFGGMSEVHLAR-DLRDHRD-VAVKV--LRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 330 VKVFTACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           V V+   +G           +V E++   +L + +          + P  +   + + + 
Sbjct: 75  VAVYD--TGEAETPAGPLPYIVMEYVDGVTLRDIV--------HTEGP--MTPKRAIEVI 122

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGV 447
            D   AL++ H     I  H D+KP+NI++       V DFG+AR +  +    T +  V
Sbjct: 123 ADACQALNFSHQ--NGII-HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 4e-27
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 30/216 (13%)

Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
            +IG G FG VY G      + R    +K  +          F+ E   +R + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +                ++  +M +G L +++    R  +     RN  +   ++  + V
Sbjct: 87  LIGIML----PPEGLPHVLLPYMCHGDLLQFI----RSPQ-----RNPTVKDLISFGLQV 133

Query: 392 ASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           A  ++YL          H DL   N +LDE     V DFGLAR +      +        
Sbjct: 134 ARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189

Query: 451 --IGYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
             + + A E          +T  DV+S+G+L+ EL+
Sbjct: 190 LPVKWTALESLQTYR---FTTKSDVWSFGVLLWELL 222

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (281), Expect = 4e-27
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 22/210 (10%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G G+FGSV         D     V VK          R F  E   L+S++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C     +      L+ E++  GSL ++L    ++ +       ++ ++ L     +  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYL----QKHK-----ERIDHIKLLQYTSQICK 156

Query: 394 ALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSI 451
            ++YL          H DL   NIL++ E    +GDFGL + LP            +  I
Sbjct: 157 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            + APE    S+ S   DV+S+G+++ EL 
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELF 242

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  110 bits (278), Expect = 4e-27
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG FG V  G    G+  V +K+       +   FI E + + ++ H  LV+++  C+
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 338 GVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                +       ++ E+M NG L  +L    RE             Q L +  DV  A+
Sbjct: 90  KQRPIF-------IITEYMANGCLLNYL----REMR-----HRFQTQQLLEMCKDVCEAM 133

Query: 396 DYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           +YL          H DL   N L++++ V  V DFGL+R++      TSS+G K  + + 
Sbjct: 134 EYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWS 188

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELI 481
            PE  + S+ S+  D++++G+LM E+ 
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIY 215

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  110 bits (278), Expect = 5e-27
 Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 30/212 (14%)

Query: 278 IGTGSFGSVYKGVL--DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFT 334
           +G G+FGSV +GV    + +  V +KV      +A     + E + +  + +  +V++  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C            LV E    G L ++L               + +     +   V+  
Sbjct: 78  VCQAEALM------LVMEMAGGGPLHKFL----VGKR-----EEIPVSNVAELLHQVSMG 122

Query: 395 LDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSIG 452
           + YL   +      H DL   N+LL     + + DFGL++ L       T+    K  + 
Sbjct: 123 MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178

Query: 453 YIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
           + APE   +   S  S   DV+SYG+ M E +
Sbjct: 179 WYAPECINFRKFSSRS---DVWSYGVTMWEAL 207

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  113 bits (286), Expect = 6e-27
 Identities = 61/276 (22%), Positives = 117/276 (42%), Gaps = 25/276 (9%)

Query: 511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570
            I   T +N +     ++ + +  +   N+ +  +S     +   +VT L  + L +   
Sbjct: 7   TITQDTPINQIFTDTALAEKMKTVLGKTNVTD-TVSQ----TDLDQVTTLQADRLGI--K 59

Query: 571 ILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLI 630
            +  +  L+ L  +N  NN  T   P  +  L +L    +NNN I    P  L++ +NL 
Sbjct: 60  SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 115

Query: 631 RIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS 690
            + L  NQ+         +L+ +  L L  N +  S    L  L+SL+++S   N +   
Sbjct: 116 GLTLFNNQI--TDIDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDL 170

Query: 691 IPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNL 750
            P  L+ L  L  L +  N++S I  S +  ++++       N+I    PL     L NL
Sbjct: 171 KP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNL 223

Query: 751 QYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
              S+  N++      ++++ + L      NN+++ 
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  105 bits (265), Expect = 3e-24
 Identities = 59/231 (25%), Positives = 109/231 (47%), Gaps = 20/231 (8%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
            +  L+L S  +  S +  +  L+ L+ L+  N          +  L  L+  D+++N +
Sbjct: 135 NLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV 189

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
                  L+  +NL  +    NQ+    P   G L+ ++ LSL  N L       L +L+
Sbjct: 190 --SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLT 243

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
           +L  + LA N ++   P  LS L  L  L LG N++S I  S +  ++++   ++ EN++
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQL 299

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           +   P+     L+NL Y ++  N I+   P  +S+ +KL+     NNK++ 
Sbjct: 300 EDISPISN---LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 84.2 bits (209), Expect = 3e-17
 Identities = 49/180 (27%), Positives = 71/180 (39%), Gaps = 21/180 (11%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L   +N++S   P  +G L  L E  ++ N LK     +L    +LT + L NN +S  
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 258

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
            P  L GLT L  L L  NQ     P  +  L  L  L ++ N L+   P  + +   L 
Sbjct: 259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLT 312

Query: 121 ILEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
            L +  N             L  L    NK+S      L  L  I  L+  +N +  + P
Sbjct: 313 YLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 83.9 bits (208), Expect = 4e-17
 Identities = 48/251 (19%), Positives = 90/251 (35%), Gaps = 16/251 (6%)

Query: 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE 598
           ++    +  +   +    +T LDL + +++   L  +  L+ L  L L  N  ++  P  
Sbjct: 227 SLNGNQLKDIGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP-- 282

Query: 599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL 658
           +  L  L   +LN N +    P  +S+  NL  + L  N +    P    SL+K++ L  
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338

Query: 659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS 718
             N +  S    L NL+++  +S   N ++   P  L+ L  +  L L     +    + 
Sbjct: 339 YNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394

Query: 719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ 778
             N+S     +  +N     I         +     I  N  +          S+     
Sbjct: 395 KANVSIP---NTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIG 450

Query: 779 ALNNKLTGEVP 789
                 +G V 
Sbjct: 451 KGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 79.6 bits (197), Expect = 9e-16
 Identities = 32/180 (17%), Positives = 71/180 (39%), Gaps = 16/180 (8%)

Query: 610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
             +  I        ++ +  ++  L K  +   +      L ++  L      +      
Sbjct: 9   TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSID 62

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFD 729
            +  L++L +I+ + N L    P  L  L  LV + +  N+++ I  + + N++++    
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLT 118

Query: 730 VGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           +  N+I    PL     L NL    + +N I+     ++S  + L+      N++T   P
Sbjct: 119 LFNNQITDIDPLKN---LTNLNRLELSSNTISD--ISALSGLTSLQQLS-FGNQVTDLKP 172

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 79.2 bits (196), Expect = 1e-15
 Identities = 48/178 (26%), Positives = 67/178 (37%), Gaps = 20/178 (11%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L  D   +       +  L  L +   S+N L    P  L     L  I + NN ++   
Sbjct: 51  LQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  L  LT+L  L L  NQ     P  + NL NL  L +S N +     S L     L+ 
Sbjct: 107 P--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQ 160

Query: 122 LEMQGNV--------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
           L     V           L  LD+S NK+S      L  L  +E+L  + N +  + P
Sbjct: 161 LSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 36/174 (20%), Positives = 60/174 (34%), Gaps = 19/174 (10%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L +N++S   P  +  L KL E  +  N +    P  L    +LT + L  N L    
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  +  L +L  L L  N       + V +L  L+ L    N +     S+L +   +  
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINW 357

Query: 122 LEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           L    N             +T L L+    +     +   + +   +      L
Sbjct: 358 LSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 77.3 bits (191), Expect = 5e-15
 Identities = 34/176 (19%), Positives = 68/176 (38%), Gaps = 19/176 (10%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L +N++S      +  L  L    +++N L+   P  +   ++LT + L+ NN+S  
Sbjct: 269 ELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI 324

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
            P  +  LT L  L    N+      + + NL N+  L+   N +    P  L +  ++ 
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 378

Query: 121 ILEMQGN--------VFQGLTILDLSRNKLSGEI-PEFLVGLKVIENLNLSYNDLE 167
            L +               ++I +  +N     I P  +         ++++N   
Sbjct: 379 QLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 68.8 bits (169), Expect = 3e-12
 Identities = 28/159 (17%), Positives = 56/159 (35%), Gaps = 19/159 (11%)

Query: 15  PSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVAL 74
            +   L + ++  +    +  ++       + +TT+      +       +  L +L  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73

Query: 75  DLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG--- 131
           + S NQ      T + NL  L  + ++ N +    P  L +   L  L +  N       
Sbjct: 74  NFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129

Query: 132 ------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
                 L  L+LS N +S      L GL  ++ L+    
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 18/135 (13%), Positives = 38/135 (28%), Gaps = 16/135 (11%)

Query: 46  SLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNIL 105
            L +  +  +     I      L   +   L +     +      +L  + TL       
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL-- 56

Query: 106 QGEIPSTLGSCIKLEILEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVI 156
             +    +     L  +    N             L  + ++ N+++   P  L  L  +
Sbjct: 57  GIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNL 114

Query: 157 ENLNLSYNDLEGMVP 171
             L L  N +  + P
Sbjct: 115 TGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 8/111 (7%)

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
            L   ++  +     I FT + L   +   LG   ++  V     ++  +         I
Sbjct: 2   PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           +    ++Y   L NL   +   N++T   P  + N +KL      NN++  
Sbjct: 59  KSIDGVEY---LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (277), Expect = 7e-27
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 278 IGTGSFGSVYKGVL--DEGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHRNLVKVF 333
           +G+G+FG+V KG     +   TV VK+     +        +AE   ++ + +  +V++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C    +       LV E  + G L ++L          +  R++     + +   V+ 
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYL----------QQNRHVKDKNIIELVHQVSM 128

Query: 394 ALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH-VQTSSIGVKGSI 451
            + YL   +      H DL   N+LL  +  + + DFGL++ L        +    K  +
Sbjct: 129 GMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184

Query: 452 GYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
            + APE   Y    + S+  DV+S+G+LM E  
Sbjct: 185 KWYAPECINYY---KFSSKSDVWSFGVLMWEAF 214

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  111 bits (279), Expect = 8e-27
 Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 25/210 (11%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G+G+FG+VYKG+     ++ +  V +K         +    + E   + S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C     Q      L+ + M  G L +++    RE +      N+     LN  + +A
Sbjct: 83  LGICLTSTVQ------LITQLMPFGCLLDYV----REHK-----DNIGSQYLLNWCVQIA 127

Query: 393 SALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             ++YL          H DL   N+L+       + DFGLA+ L     +  + G K  I
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            ++A E  L    +   DV+SYG+ + EL+
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELM 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (276), Expect = 8e-27
 Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 31/212 (14%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVF 333
           IG G FG V++G+    +     V +K             F+ E   +R   H ++VK+ 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
              +           ++ E    G L  +L    +  +      +L+L   +  A  +++
Sbjct: 83  GVITENPVW------IIMELCTLGELRSFL----QVRK-----YSLDLASLILYAYQLST 127

Query: 394 ALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           AL YL          H D+   N+L+       +GDFGL+R++  +     +   K  I 
Sbjct: 128 ALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIK 182

Query: 453 YIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
           ++APE   +   +  S   DV+ +G+ M E++
Sbjct: 183 WMAPESINFRRFTSAS---DVWMFGVCMWEIL 211

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (277), Expect = 1e-26
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVF 333
           IG+G  G V  G L    +    V +K     +  R  R F++E   +    H N++++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 334 TACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +             +V E+M+NGSL+ +L    R  +         ++Q + +   V
Sbjct: 117 GVVTRGRLAM-------IVTEYMENGSLDTFL----RTHD-----GQFTIMQLVGMLRGV 160

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP-THVQTSSIGVKGS 450
            + + YL  D   +  H DL   N+L+D  +V  V DFGL+R L        ++ G K  
Sbjct: 161 GAGMRYLS-DLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217

Query: 451 IGYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
           I + APE   +   S  S   DV+S+G++M E++
Sbjct: 218 IRWTAPEAIAFRTFSSAS---DVWSFGVVMWEVL 248

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  110 bits (276), Expect = 2e-26
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           +G GSFG VY+GV      DE  T V +K  N       R  F+ E   ++     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +    S    QG     ++ E M  G L+ +L  +      +      +L + + +A ++
Sbjct: 93  LLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 392 ASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           A  + YL+ +       H DL   N ++ E+    +GDFG+ R      +  +    KG 
Sbjct: 148 ADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRD-----IYETDYYRKGG 198

Query: 451 IGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
            G +     +PE    G+    +T  DV+S+G+++ E+ 
Sbjct: 199 KGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIA 234

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  108 bits (272), Expect = 3e-26
 Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 40/248 (16%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
            LIG+G FG V+K        T  +K    ++ +A R    E +AL  + H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72

Query: 336 CSGVDYQGNDFKA-----------LVYEFMQNGSLEEWLYPVNR----EDEVDKAPRNLN 380
             G DY                  +  EF   G+LE+W+         +           
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-------- 124

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
               L +   +   +DY+H   + I  + DLKPSNI L +     +GDFGL   L     
Sbjct: 125 ----LELFEQITKGVDYIH-SKKLI--NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
           +T S    G++ Y++PE     +     D+Y+ G+++ EL+         FE      + 
Sbjct: 178 RTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDL 231

Query: 501 ARMALPDH 508
               + D 
Sbjct: 232 RDGIISDI 239

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  108 bits (273), Expect = 3e-26
 Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 29/213 (13%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKV 332
           +G G FG V         D     V VK          RS +  E   LR++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
              C            LV E++  GSL ++L              ++ L Q L  A  + 
Sbjct: 99  KGCCEDAGAASL---QLVMEYVPLGSLRDYL----PR-------HSIGLAQLLLFAQQIC 144

Query: 393 SALDYLHHDCQPITTHC---DLKPSNILLDEEMVSHVGDFGLARFLPPTH-VQTSSIGVK 448
             + YLH        H    DL   N+LLD + +  +GDFGLA+ +P  H          
Sbjct: 145 EGMAYLH------AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             + + APE     +     DV+S+G+ + EL+
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  113 bits (283), Expect = 4e-26
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 24/209 (11%)

Query: 278 IGTGSFGSVYKGVL--DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVFT 334
           +G G+FGSV +GV    + +  V +KV      +A     + E + +  + +  +V++  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
            C            LV E    G L ++L               + +     +   V+  
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFL----VGKR-----EEIPVSNVAELLHQVSMG 448

Query: 395 LDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSIG 452
           + YL   +      H +L   N+LL     + + DFGL++ L       T+    K  + 
Sbjct: 449 MKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           + APE     + S+  DV+SYG+ M E +
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEAL 533

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (268), Expect = 8e-26
 Identities = 45/212 (21%), Positives = 91/212 (42%), Gaps = 31/212 (14%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVKVF 333
           +G G FG VY+GV       +  V VK         ++  F++E   ++++ H ++VK+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                      +   ++ E    G L  +L      ++      +L +L  +  ++ +  
Sbjct: 80  GIIEE------EPTWIIMELYPYGELGHYL----ERNK-----NSLKVLTLVLYSLQICK 124

Query: 394 ALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           A+ YL   +C     H D+   NIL+       +GDFGL+R++        +   +  I 
Sbjct: 125 AMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIK 179

Query: 453 YIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
           +++PE   +      +T  DV+ + + M E++
Sbjct: 180 WMSPESINFR---RFTTASDVWMFAVCMWEIL 208

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (272), Expect = 1e-25
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 278 IGTGSFGSVYKGVL---DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVF 333
           +G G FG V  G L    +   +V +K   + +  +  R F+ E   +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 334 TACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              +             +V E+M+NGSL+ +L    R+ +         ++Q + +   +
Sbjct: 113 GVVTKSKPVM-------IVTEYMENGSLDSFL----RKHD-----AQFTVIQLVGMLRGI 156

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP-THVQTSSIGVKGS 450
           AS + YL  D   +  H DL   NIL++  +V  V DFGL R L        ++ G K  
Sbjct: 157 ASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           I + +PE     + ++  DV+SYGI++ E++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 2e-25
 Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 36/219 (16%)

Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N          F+ E   ++   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C     +G+    +V  +M++G L  ++    R +       N  +   +   + V
Sbjct: 155 LLGICL--RSEGSPL--VVLPYMKHGDLRNFI----RNET-----HNPTVKDLIGFGLQV 201

Query: 392 ASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
           A  + +L          H DL   N +LDE+    V DFGLAR +   + +        +
Sbjct: 202 AKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKT 254

Query: 451 IGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
              +     A E          +T  DV+S+G+L+ EL+
Sbjct: 255 GAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELM 290

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  106 bits (267), Expect = 3e-25
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 33/215 (15%)

Query: 278 IGTGSFGSVYKGVL----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKV 332
           IG G FG VYKG+L     +    V +K     +  +    F+ E   +    H N++++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 333 FTACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
               S             ++ E+M+NG+L+++L    RE +        ++LQ + +   
Sbjct: 112 EGVISKYKPMM-------IITEYMENGALDKFL----REKD-----GEFSVLQLVGMLRG 155

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-PTHVQTSSIGVKG 449
           +A+ + YL  +   +  H DL   NIL++  +V  V DFGL+R L        ++ G K 
Sbjct: 156 IAAGMKYLA-NMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 450 SIGYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
            I + APE   Y    + ++  DV+S+GI+M E++
Sbjct: 213 PIRWTAPEAISYR---KFTSASDVWSFGIVMWEVM 244

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  105 bits (265), Expect = 3e-25
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 30/216 (13%)

Query: 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG VY G L   D  +    VK  N +        F+ E   ++   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C     +G+    +V  +M++G L  ++    R +       N  +   +   + V
Sbjct: 91  LLGICL--RSEGSPL--VVLPYMKHGDLRNFI----RNET-----HNPTVKDLIGFGLQV 137

Query: 392 ASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT--HVQTSSIGVK 448
           A  + YL          H DL   N +LDE+    V DFGLAR +     +   +  G K
Sbjct: 138 AKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 449 GSIGYIAPE---YGLGSEVSTNGDVYSYGILMLELI 481
             + ++A E       +  S   DV+S+G+L+ EL+
Sbjct: 194 LPVKWMALESLQTQKFTTKS---DVWSFGVLLWELM 226

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  109 bits (274), Expect = 6e-25
 Identities = 37/209 (17%), Positives = 76/209 (36%), Gaps = 11/209 (5%)

Query: 562 LESLKLAGSILPHIGNLSF-------LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
           L  L L+ + L   G  S+       L+ L+L  N     + +    L  LQ  D  +++
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHST 410

Query: 615 IGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP-LG 672
           +      +   S   L+ + ++           F  L+ +  L +  N+   +       
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
           N ++L  + L+   L          L  L +L +  N L  +  S    + S++  D   
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
           N+I+           ++L +F++  N + 
Sbjct: 531 NRIET-SKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  109 bits (274), Expect = 7e-25
 Identities = 42/230 (18%), Positives = 72/230 (31%), Gaps = 6/230 (2%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
              +DL    L         N S L+ L+L               L  L    L  N I 
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG-SIPPPLGNLS 675
              P + S  ++L  +   + +L        G L  ++ L++  N +    +P    NL+
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNL----VILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
           +L  + L+ N +       L  L+      + L + +N +  I     F    + E  + 
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFI-QDQAFQGIKLHELTLR 212

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN 781
            N    NI       L  L    +            I   S +E    + 
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  108 bits (271), Expect = 2e-24
 Identities = 47/272 (17%), Positives = 95/272 (34%), Gaps = 11/272 (4%)

Query: 519 NDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNL 578
            +     I+       +   ++    I  L    K  K   L +   +L         +L
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF---PTLDL 327

Query: 579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG--GEIPVNLSSCSNLIRIGLAK 636
            FLK L L  N  +  I  +   L  L   DL+ N++   G    +    ++L  + L+ 
Sbjct: 328 PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385

Query: 637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTL 695
           N  +  + ++F  L +++ L    + L          +L  L  + ++  N         
Sbjct: 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444

Query: 696 SKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFS 754
             L +L  L +  N       S++F N +++   D+ + +++  I      TL  LQ  +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLN 503

Query: 755 IGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           +  N +        +    L       N++  
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  106 bits (266), Expect = 6e-24
 Identities = 49/235 (20%), Positives = 81/235 (34%), Gaps = 11/235 (4%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
                   KL+  +   I   S  K ++L  N               LQ  DL+   I  
Sbjct: 14  ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
                     +L  + L  N +    P  F  L+ +E L      L      P+G L +L
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 678 RKISLAINNLAG-SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNIS----SIAEFDVGE 732
           +K+++A N +    +P   S L NLV + L  N +  I  + +  +          D+  
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP-SISNASKLEVFQALNNKLTG 786
           N I   I  D  F    L   ++  N  +  I    + N + L V + +  +   
Sbjct: 191 NPID-FIQ-DQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  100 bits (250), Expect = 6e-22
 Identities = 33/200 (16%), Positives = 69/200 (34%), Gaps = 3/200 (1%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIP- 596
            N +               +  LDL        +  +   L  L+ L+ ++++       
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEF 417

Query: 597 SEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEV 655
           S    L +L   D++  +   +        ++L  + +A N       S+ F + + +  
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477

Query: 656 LSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIV 715
           L L    L          L  L+ ++++ NNL        ++L +L  L    NR+    
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537

Query: 716 PSSIFNISSIAEFDVGENKI 735
                   S+A F++  N +
Sbjct: 538 GILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 97.0 bits (242), Expect = 5e-21
 Identities = 39/203 (19%), Positives = 70/203 (34%), Gaps = 18/203 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            + L  N L      S  N  +L    +S   ++     +      L+ + L  N +   
Sbjct: 36  NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQG-EIPSTLGSCIKL 119
            P    GLTSL  L     +        +G LI L+ L V+ N +   ++P+   +   L
Sbjct: 96  SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL 155

Query: 120 EILEMQGNVFQG---------------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
             +++  N  Q                   LD+S N +     +   G+K +  L L  N
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGN 214

Query: 165 DLEGMVPTEGVFKNASAISVLGN 187
                +  +   +N + + V   
Sbjct: 215 FNSSNIM-KTCLQNLAGLHVHRL 236

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 96.6 bits (241), Expect = 6e-21
 Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 14/179 (7%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIP-SSLGLCESLTTIGLFNNNLSG 59
            L L  N     +  +   L++L       + LK     S+    E L  + +   N   
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIK 118
                 +GLTSL  L ++ N F+ +  + V  N  NL  L +S   L+        +  +
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498

Query: 119 LEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           L++L M  N         +     L+ LD S N++           K +   NL+ N +
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 88.6 bits (220), Expect = 2e-18
 Identities = 31/181 (17%), Positives = 63/181 (34%), Gaps = 4/181 (2%)

Query: 594 EIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI 653
            +   I  +  +      +  +  ++P ++ S  +   I L+ N L       F + S++
Sbjct: 3   SLNPCIEVVPNITY-QCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSEL 58

Query: 654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG 713
           + L L    +          L  L  + L  N +    P + S L +L  L     +L+ 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASK 773
           +    I  + ++ + +V  N I       Y   L NL +  +  N I       +    +
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

Query: 774 L 774
            
Sbjct: 179 N 179

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 88.2 bits (219), Expect = 3e-18
 Identities = 32/157 (20%), Positives = 58/157 (36%), Gaps = 2/157 (1%)

Query: 558 TILDLESLKLAGSILPH-IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
             LD +   L          +L  L  L++   +   +       L  L    +  NS  
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461

Query: 617 GEIPVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
                N  ++ +NL  + L+K QL       F +L ++++L++  NNL+         L 
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS 712
           SL  +  + N +  S        K+L    L  N ++
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.8 bits (218), Expect = 4e-18
 Identities = 47/226 (20%), Positives = 74/226 (32%), Gaps = 39/226 (17%)

Query: 1   ILALDSNR----------------LSGN---IPPSIGNLKKLVEPYVSDNFLKGSIPSSL 41
            L++   +                L+ N   I      L  L    +S N L  S   S 
Sbjct: 311 SLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSY 370

Query: 42  GL--CESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETL 98
                 SL  + L  N     +    MGL  L  LD   +  +         +L  L  L
Sbjct: 371 SDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429

Query: 99  TVSGNILQGEIPSTLGSCIKLEILEMQGN---------VFQGLT---ILDLSRNKLSGEI 146
            +S    + +          L  L+M GN         VF   T    LDLS+ +L    
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 147 PEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
                 L  ++ LN+S+N+L  +      +    ++S L    N++
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDS--SHYNQLYSLSTLDCSFNRI 533

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.5 bits (207), Expect = 9e-17
 Identities = 34/214 (15%), Positives = 64/214 (29%), Gaps = 28/214 (13%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKG-SIPSSLGLCESLTTIGLFNNNLSGT 60
           L     +L+      IG L  L +  V+ NF+    +P+      +L  + L  N +   
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168

Query: 61  IPPQLMGLT----SLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPST-LGS 115
               L  L       ++LD+S N        +    I L  LT+ GN     I  T L +
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227

Query: 116 CIKLEILEMQGNVFQGL-------------------TILDLSRNKLSGEIPEFLVGLKVI 156
              L +  +    F+                         L+      +       L  +
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287

Query: 157 ENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKL 190
             ++L+   ++ +               +   +L
Sbjct: 288 SAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQL 319

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.8 bits (205), Expect = 2e-16
 Identities = 36/172 (20%), Positives = 62/172 (36%), Gaps = 20/172 (11%)

Query: 11  GNIPPSIGNLKKLVEPYV--SDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGL 68
           G++ P I  +  +        D  L   +P  +    S   I L  N L           
Sbjct: 2   GSLNPCIEVVPNIT---YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNF 55

Query: 69  TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN- 127
           + L  LDLSR +           L +L  L ++GN +Q   P +      LE L      
Sbjct: 56  SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 128 -------VFQGLT---ILDLSRNKLSG-EIPEFLVGLKVIENLNLSYNDLEG 168
                      L     L+++ N +   ++P +   L  + +++LSYN ++ 
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  104 bits (262), Expect = 7e-25
 Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 35/239 (14%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTA 335
            +G G FG V++           +K   L +   A    + E +AL  + H  +V+ F A
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 336 C----SGVDYQGNDFKALVY---EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
                +    Q +  K  +Y   +  +  +L++W+      +E +++         L+I 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS-------VCLHIF 124

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
           + +A A+++LH     +  H DLKPSNI    + V  VGDFGL   +     + + +   
Sbjct: 125 LQIAEAVEFLH-SKGLM--HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 449 GSIG----------YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL 497
            +            Y++PE   G+  S   D++S G+++ EL+         F   M  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------FSTQMER 233

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  105 bits (263), Expect = 1e-24
 Identities = 54/253 (21%), Positives = 105/253 (41%), Gaps = 33/253 (13%)

Query: 249 NPNSLINSLLNLSYQNLHNAT-DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH 307
           + +   +S ++L  +NL+  + + +     IG GSFG        E      +K  N+  
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61

Query: 308 H--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYP 365
              +       E   L +++H N+V+   +     ++ N    +V ++ + G L + +  
Sbjct: 62  MSSKEREESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINA 116

Query: 366 VNR----EDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421
                  ED++            L+  + +  AL ++H D + +  H D+K  NI L ++
Sbjct: 117 QKGVLFQEDQI------------LDWFVQICLALKHVH-DRKIL--HRDIKSQNIFLTKD 161

Query: 422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
               +GDFG+AR L  T     +    G+  Y++PE       +   D+++ G ++ EL 
Sbjct: 162 GTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219

Query: 482 IRKKPSDIMFEGD 494
             K      FE  
Sbjct: 220 TLKHA----FEAG 228

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (260), Expect = 1e-24
 Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 45/223 (20%)

Query: 278 IGTGSFGSVYKGVL-------DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           +G G+F  ++KGV            T V +KV +  H   S SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 331 KVFTACSGVD--YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
             +  C   D          LV EF++ GSL+ +L    ++++       +N+L +L +A
Sbjct: 76  LNYGVCVCGDENI-------LVQEFVKFGSLDTYL----KKNK-----NCINILWKLEVA 119

Query: 389 IDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSH--------VGDFGLARFLPPTH 439
             +A+A+ +L  +       H ++   NILL  E            + D G++  +    
Sbjct: 120 KQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---- 171

Query: 440 VQTSSIGVKGSIGYIAPE-YGLGSEVSTNGDVYSYGILMLELI 481
                  ++  I ++ PE       ++   D +S+G  + E+ 
Sbjct: 172 --LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  104 bits (262), Expect = 1e-24
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 38/224 (16%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+         ++ +  V VK        A + F  E   L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWL-----YPVNREDEVDKAPRNLNLLQRLNI 387
           F  C+    +G     +V+E+M++G L  +L              D AP  L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 388 AIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
           A  VA+ + YL   H       H DL   N L+ + +V  +GDFG++R      + ++  
Sbjct: 164 ASQVAAGMVYLAGLHFV-----HRDLATRNCLVGQGLVVKIGDFGMSRD-----IYSTDY 213

Query: 446 GVKGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
              G    +      PE   Y      +T  DV+S+G+++ E+ 
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVLWEIF 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  103 bits (260), Expect = 2e-24
 Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 46/233 (19%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           +G G FG V K          G TTV VK+   +   +     ++E   L+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--------------YPVNREDEVDKAPR 377
           ++ ACS    Q      L+ E+ + GSL  +L                 N         R
Sbjct: 91  LYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 378 NLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
            L +   ++ A  ++  + YL          H DL   NIL+ E     + DFGL+R   
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR--- 198

Query: 437 PTHVQTSSIGVKGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
              V      VK S G I     A E     +    +T  DV+S+G+L+ E++
Sbjct: 199 --DVYEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIV 246

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  103 bits (259), Expect = 2e-24
 Identities = 39/232 (16%), Positives = 85/232 (36%), Gaps = 15/232 (6%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
            +  I  +    L  ++     +   +K L+L  N  +    +++    +L++ +L++N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
           +  E   +L S S L  + L  N +      +      IE L    NN I  +       
Sbjct: 70  L-YETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN-ISRVSC--SRG 119

Query: 675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGEN 733
              + I LA N +             +  L L +N +  +  + +  +  ++   ++  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            I     +        L+   + +N++   + P   +A+ +      NNKL 
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 38/188 (20%), Positives = 69/188 (36%), Gaps = 18/188 (9%)

Query: 13  IPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLV 72
           I     N  +     V+D+ LK ++ S      ++  + L  N LS      L   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 73  ALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN----- 127
            L+LS N        ++ +L  L TL ++ N +       L     +E L    N     
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114

Query: 128 ---VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV 184
                QG   + L+ NK++            ++ L+L  N+++  V    +  ++  +  
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEH 173

Query: 185 L--GNNKL 190
           L    N +
Sbjct: 174 LNLQYNFI 181

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 41/249 (16%), Positives = 93/249 (37%), Gaps = 18/249 (7%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           ++ ++  ++   +   A  V  LDL    L+      +   + L++LNL +N        
Sbjct: 19  DSSLKQALA--SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS 657
           ++  L  L+  DLNNN +       L    ++  +  A N +  ++          + + 
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCS--RGQGKKNIY 126

Query: 658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAG-SIPFTLSKLKNLVILYLGVNRLSGIVP 716
           L  N +        G  S ++ + L +N +   +     +    L  L L  N +  +  
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185

Query: 717 SSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEV 776
             +   + +   D+  NK+   +  ++  +   + + S+  N++   I  ++  +  LE 
Sbjct: 186 GQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEH 241

Query: 777 FQALNNKLT 785
           F    N   
Sbjct: 242 FDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 36/200 (18%), Positives = 72/200 (36%), Gaps = 23/200 (11%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L++N +       +     +   + ++N +   +  S G  +    I L NN ++   
Sbjct: 85  LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLR 136

Query: 62  PPQLMGLTSLVALDLSRNQFRG-SFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
                  + +  LDL  N+    +F     +   LE L +  N +  ++   +    KL+
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLK 194

Query: 121 ILEMQGN-------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
            L++  N        FQ    +T + L  NKL   I + L   + +E+ +L  N      
Sbjct: 195 TLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-G 252

Query: 171 PTEGVFKNASAISVLGNNKL 190
                F     +  +    +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 29/159 (18%), Positives = 57/159 (35%), Gaps = 11/159 (6%)

Query: 562 LESLKLAG---SILP--HIGNLSFLKILNLENNSFTH-EIPSEIGRLRRLQVPDLNNNSI 615
            +++ LA    ++L     G  S ++ L+L+ N                L+  +L  N I
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
             ++       + L  + L+ N+L   +  +F S + +  +SL  NN +  I   L    
Sbjct: 182 Y-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR-NNKLVLIEKALRFSQ 237

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
           +L    L  N             KN  +  +    +  +
Sbjct: 238 NLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKL 275

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 29/167 (17%), Positives = 52/167 (31%), Gaps = 16/167 (9%)

Query: 1   ILALDSNRLSG-NIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
            L L  N +   N      +   L    +  NF+   +   +     L T+ L +N L+ 
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA- 204

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
            + P+      +  + L  N+        +    NLE   + GN            C  L
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH---------CGTL 254

Query: 120 EILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
                +    +  T+   +  KL+G+  E      +         DL
Sbjct: 255 RDFFSKNQ--RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 21/161 (13%), Positives = 57/161 (35%), Gaps = 23/161 (14%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
           I     + ++ ++  +  ++L  ++     +  +++++ L+ N L+      L+    L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 703 ILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ------------------GNIPLDYG 744
           +L L  N L       + ++S++   D+  N +Q                    +     
Sbjct: 62  LLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS-- 117

Query: 745 FTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              Q  +   +  N+IT          S+++      N++ 
Sbjct: 118 -RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 19/120 (15%), Positives = 45/120 (37%), Gaps = 8/120 (6%)

Query: 666 SIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI 725
           +I     N +  +   +  ++L  ++        N+  L L  N LS I  + +   + +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              ++  N +   + L+   +L  L+   +  N +       +     +E   A NN ++
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  102 bits (257), Expect = 2e-24
 Identities = 56/234 (23%), Positives = 87/234 (37%), Gaps = 43/234 (18%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFT 334
            IGTGS+G   K         +  K  +         +  ++E   LR ++H N+V+ + 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR------EDEVDKAPRNLNLLQRLNIA 388
               +D        +V E+ + G L   +    +      E+ V            L + 
Sbjct: 73  --RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFV------------LRVM 117

Query: 389 IDVASALDYLHHDCQPITT--HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
             +  AL   H       T  H DLKP+N+ LD +    +GDFGLAR L        +  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-- 175

Query: 447 VKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             G+  Y++PE      Y   S      D++S G L+ EL     P    F   
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  103 bits (258), Expect = 3e-24
 Identities = 55/257 (21%), Positives = 91/257 (35%), Gaps = 43/257 (16%)

Query: 242 RKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGV-LDEGRTTVTV 300
           R+   +   +  + S      +        F   + +G GS+G V+K    ++GR    V
Sbjct: 29  RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL-YAV 87

Query: 301 KVFNLHHH--RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNG 357
           K         +     +AE  +   + +H   V++  A     ++      L  E     
Sbjct: 88  KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELCG-P 141

Query: 358 SLEEWLYPVNR---EDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS 414
           SL++          E +V                 D   AL +LH     +  H D+KP+
Sbjct: 142 SLQQHCEAWGASLPEAQV------------WGYLRDTLLALAHLH-SQGLV--HLDVKPA 186

Query: 415 NILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE-----YGLGSEVSTNGD 469
           NI L       +GDFGL   L            +G   Y+APE     YG  +      D
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSYGTAA------D 237

Query: 470 VYSYGILMLELIIRKKP 486
           V+S G+ +LE+    + 
Sbjct: 238 VFSLGLTILEVACNMEL 254

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  103 bits (258), Expect = 3e-24
 Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 36/238 (15%)

Query: 270 DGFSSANLIGTGSFGSVYKGV-LDEGRTTV--TVKVFNLHHHRASRSFIAECRALRSIRH 326
             F     IG G F  VY+   L +G       V++F+L   +A    I E   L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR------EDEVDKAPRNLN 380
            N++K + +     +  ++   +V E    G L   +    +      E  V        
Sbjct: 92  PNVIKYYAS-----FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------- 138

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
                   + + SAL+++H        H D+KP+N+ +    V  +GD GL RF      
Sbjct: 139 ----WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-MNL 497
              S  + G+  Y++PE    +  +   D++S G L+ E+   + P    F GD MNL
Sbjct: 192 AAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 243

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  102 bits (257), Expect = 3e-24
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 39/225 (17%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           +G G+FG V+          + +  V VK        A + F  E   L +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLLQRLN 386
           +  C      G+    +V+E+M++G L ++L        +  + +  +A   L L Q L+
Sbjct: 83  YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 387 IAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           IA  +AS + YL   H       H DL   N L+   ++  +GDFG++R      V ++ 
Sbjct: 138 IASQIASGMVYLASQHFV-----HRDLATRNCLVGANLLVKIGDFGMSRD-----VYSTD 187

Query: 445 IGVKGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
               G    +      PE   Y      +T  DV+S+G+++ E+ 
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIF 229

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  107 bits (268), Expect = 3e-24
 Identities = 61/310 (19%), Positives = 109/310 (35%), Gaps = 66/310 (21%)

Query: 218 LVIAIVSGLMGLALTLSISFLC----------WVRKRKEQSNPNSLINSLLNLSYQNLHN 267
           L +   S  +   +   I   C           +R +KE       I  L N   Q + +
Sbjct: 297 LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRS 356

Query: 268 ATDGFSSAN-------------------------------LIGTGSFGSVYKGVL---DE 293
            T   S  +                                IG G FG V++G+    + 
Sbjct: 357 HTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN 416

Query: 294 GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352
               V +K             F+ E   +R   H ++VK+    +           ++ E
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW------IIME 470

Query: 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH-HDCQPITTHCDL 411
               G L  +L    +  +      +L+L   +  A  +++AL YL          H D+
Sbjct: 471 LCTLGELRSFL----QVRK-----FSLDLASLILYAYQLSTALAYLESKRF----VHRDI 517

Query: 412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVY 471
              N+L+       +GDFGL+R++  +    +S G K  I ++APE       ++  DV+
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINFRRFTSASDVW 576

Query: 472 SYGILMLELI 481
            +G+ M E++
Sbjct: 577 MFGVCMWEIL 586

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (255), Expect = 5e-24
 Identities = 49/226 (21%), Positives = 87/226 (38%), Gaps = 40/226 (17%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVK 331
           +G   FG VYKG L      E    V +K             F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLLQRL 385
           +    +    +     ++++ +  +G L E+L        V   D+       L     +
Sbjct: 77  LLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 386 NIAIDVASALDYL--HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           ++   +A+ ++YL  HH       H DL   N+L+ +++   + D GL R      V  +
Sbjct: 132 HLVAQIAAGMEYLSSHHVV-----HKDLATRNVLVYDKLNVKISDLGLFRE-----VYAA 181

Query: 444 SIGVKGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
                     +     APE   YG     S + D++SYG+++ E+ 
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVF 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  102 bits (257), Expect = 5e-24
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 25/220 (11%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRNLV 330
           +G G+FG V +         +   TV VK+     H   R   ++E + L  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--------YPVNREDEVDKAPRNLNLL 382
            +  AC+     G     ++ E+   G L  +L                ++     L+L 
Sbjct: 91  NLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 383 QRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             L+ +  VA  + +L   +C     H DL   NILL    ++ + DFGLAR +      
Sbjct: 146 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                 +  + ++APE       +   DV+SYGI + EL 
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  102 bits (256), Expect = 6e-24
 Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 32/223 (14%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRNLV 330
           +G G+FG V +             TV VK+       +     ++E + L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLLQR 384
            +  AC+    +      ++ EF + G+L  +L      +   +    D     L L   
Sbjct: 95  NLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 385 LNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           +  +  VA  +++L    C     H DL   NILL E+ V  + DFGLAR      +   
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARD-----IYKD 201

Query: 444 SIGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
              V+     +     APE       +   DV+S+G+L+ E+ 
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  102 bits (257), Expect = 6e-24
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 33/222 (14%)

Query: 276 NLIGTGSFGSVYKGVL--DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRNLVK 331
           ++IG G+FG V K  +  D  R    +K    +  +     F  E   L  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLLQRL 385
           +  AC    Y       L  E+  +G+L ++L               +     L+  Q L
Sbjct: 91  LLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 386 NIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444
           + A DVA  +DYL          H DL   NIL+ E  V+ + DFGL+R           
Sbjct: 146 HFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR--------GQE 193

Query: 445 IGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
           + VK ++G +     A E    S  +TN DV+SYG+L+ E++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  101 bits (254), Expect = 1e-23
 Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 46/231 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA- 335
           ++G G+FG V K           +K           + ++E   L S+ H+ +V+ + A 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 336 ----CSGVDYQGNDFKALVY---EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
                          K+ ++   E+ +NG+L + ++  N   + D+            + 
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---------WRLF 122

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +  AL Y+H   Q I  H DLKP NI +DE     +GDFGLA+ +  +          
Sbjct: 123 RQILEALSYIHS--QGII-HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 449 ------------GSIGYIAPE-------YGLGSEVSTNGDVYSYGILMLEL 480
                       G+  Y+A E       Y    ++    D+YS GI+  E+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEM 224

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (255), Expect = 1e-23
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 31/223 (13%)

Query: 276 NLIGTGSFGSVYKGVL-----DEGRTTVTVKVFN-LHHHRASRSFIAECRALRSI-RHRN 328
             +G G+FG V +        ++    V VK+     H     + ++E + +  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL----YPVNREDEVDKAPRNLNLLQR 384
           +V +  AC+     G     ++ E+   G L  +L      +  +     A    +    
Sbjct: 112 IVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 385 LNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
           L+ +  VA  + +L   +C     H D+   N+LL    V+ +GDFGLAR      +   
Sbjct: 167 LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMND 217

Query: 444 SIGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
           S  +      +     APE       +   DV+SYGIL+ E+ 
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (255), Expect = 1e-23
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 38/222 (17%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK             F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
               C GV  Q      ++ E M  G L+ +L    R       P +L +L  L++A D+
Sbjct: 98  ----CIGVSLQSLPR-FILMELMAGGDLKSFLRE-TRPRPSQ--PSSLAMLDLLHVARDI 149

Query: 392 ASALDYL-HHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A    YL  +       H D+   N LL       V+ +GDFG+AR      +  +S   
Sbjct: 150 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRASYYR 200

Query: 448 KGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
           KG    +      PE    G+    ++  D +S+G+L+ E+ 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIF 239

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  102 bits (255), Expect = 2e-23
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 35/225 (15%)

Query: 278 IGTGSFGSVYKGVL-------DEGRTTVTVKVFN-LHHHRASRSFIAECRALRSI-RHRN 328
           +G G+FG V                T V VK+       +     I+E   ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLL 382
           ++ +  AC+    Q      ++ E+   G+L E+L            +        L+  
Sbjct: 137 IINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 383 QRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             ++ A  VA  ++YL    C     H DL   N+L+ E+ V  + DFGLAR      + 
Sbjct: 192 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARD-----IH 242

Query: 442 TSSIGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
                 K + G +     APE       +   DV+S+G+L+ E+ 
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  100 bits (252), Expect = 4e-23
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 38/222 (17%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           +G G+FG VY+G +     D     V VK             F+ E   +    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
                     Q      ++ E M  G L+ +L    R       P +L +L  L++A D+
Sbjct: 139 CIGVSL----QSLPR-FILLELMAGGDLKSFLRE-TRPRPSQ--PSSLAMLDLLHVARDI 190

Query: 392 ASALDYL-HHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           A    YL  +       H D+   N LL       V+ +GDFG+AR      +  +    
Sbjct: 191 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRAGYYR 241

Query: 448 KGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
           KG    +      PE    G+    ++  D +S+G+L+ E+ 
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIF 280

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  100 bits (250), Expect = 6e-23
 Identities = 58/233 (24%), Positives = 91/233 (39%), Gaps = 46/233 (19%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRHRNLVK 331
           IG G+FG V++         E  T V VK+         ++ F  E   +    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--------------YPVNREDEVDKAPR 377
           +   C+     G     L++E+M  G L E+L                  R       P 
Sbjct: 115 LLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 378 NLNLLQRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
            L+  ++L IA  VA+ + YL          H DL   N L+ E MV  + DFGL+R   
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRN-- 223

Query: 437 PTHVQTSSIGVKGSIGYI-----APE---YGLGSEVSTNGDVYSYGILMLELI 481
              + ++          I      PE   Y      +T  DV++YG+++ E+ 
Sbjct: 224 ---IYSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIF 270

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 35/225 (15%)

Query: 278 IGTGSFGSVYKGVL-------DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G+FG V             +   TV VK+          S  ++E   ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLL 382
           ++ +  AC+    Q      ++ E+   G+L E+L            D        +   
Sbjct: 103 IINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 383 QRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             ++    +A  ++YL    C     H DL   N+L+ E  V  + DFGLAR      + 
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD-----IN 208

Query: 442 TSSIGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
                 K + G +     APE       +   DV+S+G+LM E+ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  100 bits (251), Expect = 2e-22
 Identities = 39/232 (16%), Positives = 85/232 (36%), Gaps = 15/232 (6%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
            +  I  +    L  ++     +   +K L+L  N  +    +++    +L++ +L++N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
           +  E   +L S S L  + L  N +      +      IE L    NN I  +       
Sbjct: 70  L-YETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN-ISRVSC--SRG 119

Query: 675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGEN 733
              + I LA N +             +  L L +N +  +  + +  +  ++   ++  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            I     +        L+   + +N++   + P   +A+ +      NNKL 
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 89.1 bits (221), Expect = 1e-18
 Identities = 37/184 (20%), Positives = 68/184 (36%), Gaps = 18/184 (9%)

Query: 17  IGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDL 76
             N  +     V+D+ LK ++ S      ++  + L  N LS      L   T L  L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 77  SRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------V 128
           S N        ++ +L  L TL ++ N +       L     +E L    N         
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSR 118

Query: 129 FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--G 186
            QG   + L+ NK++            ++ L+L  N+++  V    +  ++  +  L   
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQ 177

Query: 187 NNKL 190
            N +
Sbjct: 178 YNFI 181

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 80.3 bits (198), Expect = 7e-16
 Identities = 35/193 (18%), Positives = 69/193 (35%), Gaps = 18/193 (9%)

Query: 9   LSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGL 68
           L+ N    +     +   + ++N +   +  S G  +    I L NN ++          
Sbjct: 87  LNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCR 143

Query: 69  TSLVALDLSRNQFRG-SFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN 127
           + +  LDL  N+    +F     +   LE L +  N +  ++   +    KL+ L++  N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSN 201

Query: 128 -------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFK 177
                   FQ    +T + L  NKL   I + L   + +E+ +L  N           F 
Sbjct: 202 KLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFS 259

Query: 178 NASAISVLGNNKL 190
               +  +    +
Sbjct: 260 KNQRVQTVAKQTV 272

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 79.9 bits (197), Expect = 8e-16
 Identities = 39/177 (22%), Positives = 66/177 (37%), Gaps = 21/177 (11%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L SN L       + +L  L    +++N++       L +  S+ T+   NNN+S  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQG-EIPSTLGSCIKL 119
           +            + L+ N+       + G    ++ L +  N +          S   L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 120 EILEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           E L +Q N         VF  L  LDLS NKL+  +         +  ++L  N L 
Sbjct: 172 EHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.1 bits (156), Expect = 8e-11
 Identities = 23/185 (12%), Positives = 49/185 (26%), Gaps = 18/185 (9%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L SN+L+  + P   +   +    + +N L   I  +L   ++L    L  N      
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL-- 119
                   +     +++   +                       +          I L  
Sbjct: 254 LRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312

Query: 120 ---EILEMQGNVFQG----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
               +L  QG+  +              +D  + +    I +  +  +    L      L
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372

Query: 167 EGMVP 171
           +  V 
Sbjct: 373 DEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 28/201 (13%), Positives = 64/201 (31%), Gaps = 7/201 (3%)

Query: 545 ISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRR 604
           I  ++      K+  LDL S KLA  + P   + + +  ++L NN     I   +   + 
Sbjct: 181 IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 605 LQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLI 664
           L+  DL  N        +  S +  ++  +AK  +      +    +   +   G     
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQT-VAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

Query: 665 GSIPPPLGNLSSLRKISLAINNLAGS----IPFTLSKLKNLVILYLGVNRLSGIVPSSIF 720
               P    L +L++   A+ +  GS    +            +     +   ++     
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357

Query: 721 NISSIAEFDVGENKIQGNIPL 741
              +    +  +  +   +  
Sbjct: 358 RKQAKITLEQKKKALDEQVSN 378

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 21/161 (13%), Positives = 57/161 (35%), Gaps = 23/161 (14%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
           I     + ++ ++  +  ++L  ++     +  +++++ L+ N L+      L+    L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 703 ILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ------------------GNIPLDYG 744
           +L L  N L       + ++S++   D+  N +Q                    +     
Sbjct: 62  LLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS-- 117

Query: 745 FTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              Q  +   +  N+IT          S+++      N++ 
Sbjct: 118 -RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 19/120 (15%), Positives = 45/120 (37%), Gaps = 8/120 (6%)

Query: 666 SIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI 725
           +I     N +  +   +  ++L  ++        N+  L L  N LS I  + +   + +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              ++  N +   + L+   +L  L+   +  N +       +     +E   A NN ++
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 15/170 (8%), Positives = 43/170 (25%), Gaps = 15/170 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG- 59
           +  +    +      +          +      +           +L        +  G 
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323

Query: 60  ---TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC 116
               +  +         +D  + Q+R              TL      L  ++ +   + 
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA- 382

Query: 117 IKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
                 E+ G + Q +  ++L          E    L+++  +   Y ++
Sbjct: 383 ----HAELDGTLQQAVGQIELQH------ATEEQSPLQLLRAIVKRYEEM 422

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 40/230 (17%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRNLV 330
           +G+G+FG V                V VK+       + R   ++E + +  +  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-------------YPVNREDEVDKAPR 377
            +  AC+           L++E+   G L  +L             Y   +  E ++   
Sbjct: 113 NLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 378 NLNLLQRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
            L     L  A  VA  +++L    C     H DL   N+L+    V  + DFGLAR   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR--- 220

Query: 437 PTHVQTSSIGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
              + + S  V      +     APE       +   DV+SYGIL+ E+ 
Sbjct: 221 --DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 35/225 (15%)

Query: 278 IGTGSFGSVYKGVL-------DEGRTTVTVKVFNLHHHRASRS-FIAECRALRSI-RHRN 328
           +G G FG V             +   TV VK+          S  ++E   ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLL 382
           ++ +  AC+    Q      ++ E+   G+L E+L            D        +   
Sbjct: 149 IINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 383 QRLNIAIDVASALDYL-HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             ++    +A  ++YL    C     H DL   N+L+ E  V  + DFGLAR      + 
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD-----IN 254

Query: 442 TSSIGVKGSIGYI-----APEYGLGSEVSTNGDVYSYGILMLELI 481
                 K + G +     APE       +   DV+S+G+LM E+ 
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 98.6 bits (245), Expect = 3e-22
 Identities = 29/259 (11%), Positives = 64/259 (24%), Gaps = 38/259 (14%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            +  G    V+     E      +KVF     +             A   +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 334 TACS-----------------GVDYQGNDFKA----LVYEFMQNGSLEEWLYPVNREDEV 372
                                 +    +D+      L+        LE      +  D V
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLF---STLDFV 184

Query: 373 DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432
                +  +L    +   +      L    + +  H    P N+ +  +    +GD    
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQS--KGLV-HGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 433 RFLPPTHVQTSSIGVKGSIGYIAPEY--GLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
                T    SS      + Y   E+     +  +   + +  G+ +  +     P  ++
Sbjct: 242 W-KVGTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 491 FEGDMNLHNFARMALPDHV 509
             G         + +P   
Sbjct: 297 TPGIKGSWKRPSLRVPGTD 315

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 43/237 (18%), Positives = 82/237 (34%), Gaps = 42/237 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +G G F  V             +K    H  +       E    R   H N++++   C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR------EDEVDKAPRNLNLLQRLNIAID 390
                  ++   L+  F + G+L   +  +        ED++            L + + 
Sbjct: 96  LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNFLTEDQI------------LWLLLG 142

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS------ 444
           +   L+ +H   +    H DLKP+NILL +E    + D G           +        
Sbjct: 143 ICRGLEAIHA--KGY-AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 445 -IGVKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
               + +I Y APE      + +  E +   DV+S G ++  ++  + P    ++  
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMV 249

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 39/233 (16%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIR 325
            +   +  ++++G G+  +V++G   +      +KVFN +   R     + E   L+ + 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR-----EDEVDKAPRNLN 380
           H+N+VK+F      +      K L+ EF   GSL   L   +      E E         
Sbjct: 66  HKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-------- 114

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGDFGLARFLP 436
               L +  DV   +++L      I  H ++KP NI+     D + V  + DFG AR L 
Sbjct: 115 ----LIVLRDVVGGMNHLRE--NGI-VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG--------DVYSYGILMLELI 481
                 S     G+  Y+ P+    + +  +         D++S G+      
Sbjct: 168 DDEQFVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  100 bits (250), Expect = 5e-22
 Identities = 61/279 (21%), Positives = 104/279 (37%), Gaps = 31/279 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVF-TA 335
           +GTG FG V + +  +    V +K         +R     E + ++ + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL---QRLNIAIDVA 392
                   ND   L  E+ + G L ++L              N   L       +  D++
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL----------NQFENCCGLKEGPIRTLLSDIS 131

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           SAL YLH     I  H DLKP NI+L    + ++  + D G A+ L    + T  +   G
Sbjct: 132 SALRYLHE--NRI-IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---G 185

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509
           ++ Y+APE     + +   D +S+G L  E I   +P    F  +     +         
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVREKSN 241

Query: 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISML 548
             IV     +D+      S+       ++ I+   +   
Sbjct: 242 EHIVVY---DDLTGAVKFSSVLPTPNHLSGILAGKLERW 277

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 22/214 (10%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           ++G G++G VY G  L      + +K       R S+    E    + ++H+N+V+    
Sbjct: 29  VLGKGTYGIVYAGRDLSNQV-RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL-- 85

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             G   +    K +  E +  GSL   L       +      N   +        +   L
Sbjct: 86  --GSFSENGFIK-IFMEQVPGGSLSALL-----RSKWGPLKDNEQTIG--FYTKQILEGL 135

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            YLH +      H D+K  N+L++    V  + DFG ++ L   +  T +    G++ Y+
Sbjct: 136 KYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYM 190

Query: 455 APE--YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           APE             D++S G  ++E+   K P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 51/250 (20%), Positives = 87/250 (34%), Gaps = 29/250 (11%)

Query: 242 RKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGV-LDEGRTTVTV 300
              + + N   L+   L              +    +G GSFG V++      G     V
Sbjct: 30  LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF-QCAV 88

Query: 301 KVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLE 360
           K   L   R       E  A   +    +V ++    G   +G     +  E ++ GSL 
Sbjct: 89  KKVRLEVFRVE-----ELVACAGLSSPRIVPLY----GAVREGPWVN-IFMELLEGGSLG 138

Query: 361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420
           + +  +    E        +              L+YLH        H D+K  N+LL  
Sbjct: 139 QLIKQMGCLPE--------DRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185

Query: 421 EMVS-HVGDFGLARFLPPTHVQTSSIG---VKGSIGYIAPEYGLGSEVSTNGDVYSYGIL 476
           +     + DFG A  L P  +  S +    + G+  ++APE  +G       D++S   +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 477 MLELIIRKKP 486
           ML ++    P
Sbjct: 246 MLHMLNGCHP 255

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 96.0 bits (239), Expect = 4e-21
 Identities = 54/239 (22%), Positives = 92/239 (38%), Gaps = 41/239 (17%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL-HHHRASRSFIAECRALR-SIRHRNL 329
             S  ++G GS G+V      +GR  V VK   +     A      E + L  S  H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALM----EIKLLTESDDHPNV 71

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           ++ +  CS      + F  +  E   N +L++    V  ++  D+  +       +++  
Sbjct: 72  IRYY--CS---ETTDRFLYIALELC-NLNLQDL---VESKNVSDENLKLQKEYNPISLLR 122

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG-------------DFGLARFLP 436
            +AS + +LH     I  H DLKP NIL+                      DFGL + L 
Sbjct: 123 QIASGVAHLHS--LKII-HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 437 P--THVQTSSIGVKGSIGYIAPEYGLGSEVSTNG-------DVYSYGILMLELIIRKKP 486
              +  +T+     G+ G+ APE    S             D++S G +   ++ + K 
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.9 bits (236), Expect = 5e-21
 Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 39/223 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN-LHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           ++G G+  +V++G   +      +KVFN +   R     + E   L+ + H+N+VK+F  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR-----EDEVDKAPRNLNLLQRLNIAID 390
               +      K L+ EF   GSL   L   +      E E             L +  D
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF------------LIVLRD 120

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           V   +++L      I  H ++KP NI+     D + V  + DFG AR L       S   
Sbjct: 121 VVGGMNHLRE--NGI-VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY- 176

Query: 447 VKGSIGYIAPEYGLGSEVSTNG--------DVYSYGILMLELI 481
             G+  Y+ P+    + +  +         D++S G+      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 57/286 (19%), Positives = 117/286 (40%), Gaps = 45/286 (15%)

Query: 245 KEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN 304
               + + +     NL +Q++      +S    IG+G    V++ + ++ +    +K  N
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVN 61

Query: 305 LH--HHRASRSFIAECRALRSIRHRNL--VKVFTACSGVDYQGNDFKALVYEFM--QNGS 358
           L    ++   S+  E   L  ++  +   ++++      DY+  D    +Y  M   N  
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY------DYEITDQY--IYMVMECGNID 113

Query: 359 LEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418
           L  WL          K  ++++  +R +   ++  A+  +H     I  H DLKP+N L+
Sbjct: 114 LNSWL----------KKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIV-HSDLKPANFLI 160

Query: 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE-----------YGLGSEVSTN 467
            + M+  + DFG+A  + P           G++ Y+ PE               S++S  
Sbjct: 161 VDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219

Query: 468 GDVYSYGILMLELIIRKKPSDIMFEGDMN-LHNFARMALPDHVMDI 512
            DV+S G ++  +   K P    F+  +N +     +  P+H ++ 
Sbjct: 220 SDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 95.2 bits (237), Expect = 7e-21
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 32/225 (14%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR-SIRHRNLV 330
           F   +++G G+ G++    + + R  V VK         +     E + LR S  H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADR---EVQLLRESDEHPNVI 81

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           + F  C+    +   F+ +  E     +L+         + V++       L+ + +   
Sbjct: 82  RYF--CT---EKDRQFQYIAIELCA-ATLQ---------EYVEQKDFAHLGLEPITLLQQ 126

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDE-----EMVSHVGDFGLARFL-PPTHVQTSS 444
             S L +LH     I  H DLKP NIL+       ++ + + DFGL + L    H  +  
Sbjct: 127 TTSGLAHLHS--LNIV-HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 445 IGVKGSIGYIAPEY---GLGSEVSTNGDVYSYGILMLELIIRKKP 486
            GV G+ G+IAPE          +   D++S G +   +I     
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 93.8 bits (233), Expect = 1e-20
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 22/218 (10%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRN 328
           D F   + +G G+ G V+K         +  K+ +L    A R+ I  E + L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V       G  Y   +   +  E M  GSL++ L    R  E               ++
Sbjct: 93  IVG----FYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGK----------VS 137

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
           I V   L YL    + +  H D+KPSNIL++      + DFG++  L  +   +      
Sbjct: 138 IAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FV 191

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 51/243 (20%), Positives = 86/243 (35%), Gaps = 40/243 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTA 335
           ++  G F  VY+           +K    +    +R+ I E   ++ +  H N+V+  +A
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 336 CSGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNR-----EDEVDKAPRNLNLLQRLNIA 388
            S    + +  +A      +   G L E+L  +        D V            L I 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV------------LKIF 142

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS---- 444
                A+ ++H    PI  H DLK  N+LL  +    + DFG A  +      + S    
Sbjct: 143 YQTCRAVQHMHRQKPPII-HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 445 ------IGVKGSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                 I    +  Y  PE    Y     +    D+++ G ++  L  R+ P    FE  
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDG 256

Query: 495 MNL 497
             L
Sbjct: 257 AKL 259

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 40/228 (17%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNL--VK 331
             IG+G    V++ + ++ +    +K  NL         S+  E   L  ++  +   ++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 332 VFTACSGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           ++      DY+  D    +Y  M+  N  L  WL          K  ++++  +R +   
Sbjct: 121 LY------DYEITDQY--IYMVMECGNIDLNSWL----------KKKKSIDPWERKSYWK 162

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++  A+  +H     I  H DLKP+N L+ + M+  + DFG+A  + P           G
Sbjct: 163 NMLEAVHTIHQ--HGIV-HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 450 SIGYIAPE-----------YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           ++ Y+ PE               S++S   DV+S G ++  +   K P
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 47/240 (19%), Positives = 97/240 (40%), Gaps = 36/240 (15%)

Query: 278 IGTGSFGSVY---------------KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR 322
           +  G F  +                K +L++ R         +        F  E + + 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            I++   +       G+     D   ++YE+M+N S+ ++       D+       + ++
Sbjct: 99  DIKNEYCLTCE----GI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
           +   I   V ++  Y+H++      H D+KPSNIL+D+     + DFG + ++    ++ 
Sbjct: 154 KC--IIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209

Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNG---DVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
           S    +G+  ++ PE+   +E S NG   D++S GI +  +     P    F   ++L  
Sbjct: 210 S----RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 52/274 (18%), Positives = 94/274 (34%), Gaps = 73/274 (26%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
            +G G FG V++     +       ++   +   A    + E +AL  + H  +V+ F A
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 336 CSGVDYQGNDF------------------------------------------------- 346
                 +                                                     
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 347 KALVY---EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ 403
           K  +Y   +  +  +L++W+      ++ +           L+I I +A A+++LH    
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHG-------VCLHIFIQIAEAVEFLH-SKG 184

Query: 404 PITTHCDLKPSNILLDEEMVSHVGDFGLARFL----------PPTHVQTSSIGVKGSIGY 453
            +  H DLKPSNI    + V  VGDFGL   +           P     +  G  G+  Y
Sbjct: 185 LM--HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS 487
           ++PE   G+  S   D++S G+++ EL+      
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 53/255 (20%), Positives = 107/255 (41%), Gaps = 45/255 (17%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNL--VK 331
             IG+G    V++ + ++ +    +K  NL    ++   S+  E   L  ++  +   ++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 332 VFTACSGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           ++      DY+  D    +Y  M+  N  L  WL          K  ++++  +R +   
Sbjct: 74  LY------DYEITDQY--IYMVMECGNIDLNSWL----------KKKKSIDPWERKSYWK 115

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++  A+  +H     I  H DLKP+N L+ + M+  + DFG+A  + P           G
Sbjct: 116 NMLEAVHTIHQ--HGIV-HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 450 SIGYIAPE-----------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN-L 497
           ++ Y+ PE               S++S   DV+S G ++  +   K P    F+  +N +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQI 227

Query: 498 HNFARMALPDHVMDI 512
                +  P+H ++ 
Sbjct: 228 SKLHAIIDPNHEIEF 242

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.8 bits (230), Expect = 4e-20
 Identities = 40/282 (14%), Positives = 78/282 (27%), Gaps = 47/282 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN----------------------LHHHRASRSF 314
           ++G     +  +    E   +  V V                        L   +  +  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 315 IAECRALRS---IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE 371
               R +     ++     K+              +  +Y  MQ  +L+ +   +     
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 203

Query: 372 VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431
             K+   L    RL + + V   L  LHH    +  H  L+P +I+LD+     +  F  
Sbjct: 204 THKS---LVHHARLQLTLQVIRLLASLHH--YGLV-HTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG-----DVYSYGILMLELIIRKKP 486
                 + V     G        A       +          D ++ G+ +  +     P
Sbjct: 258 LVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 487 SDIMFEGDMNLHNFARM-----ALPDHVMDIVDSTLLNDVED 523
                  D  L     +      +P  V  +++  L    ED
Sbjct: 317 ----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKED 354

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 91.6 bits (227), Expect = 5e-20
 Identities = 41/284 (14%), Positives = 90/284 (31%), Gaps = 32/284 (11%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVT-----VKVFNLHHHRASRSFIAECRALRSIRHRNLV 330
           +L+G G+F  VY+    +           +KV    +             L+       +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K ++A     +   +   LV E    G+L   +       E     + +     ++ A+ 
Sbjct: 131 KFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPE-----KVMPQGLVISFAMR 180

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG-----------DFGLARFLPPTH 439
           +   ++ + HDC+ I  H D+KP N +L    +               D G +  +    
Sbjct: 181 MLYMIEQV-HDCEII--HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH- 498
             T       + G+   E       +   D +     +  ++           G+     
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

Query: 499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIE 542
            F R+   D   +     +LN + D   + +    + ++  + +
Sbjct: 298 LFRRLPHLDMWNEFFH-VMLN-IPDCHHLPSLDLLRQKLKKVFQ 339

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 89.6 bits (223), Expect = 7e-20
 Identities = 52/243 (21%), Positives = 91/243 (37%), Gaps = 36/243 (14%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKV 332
             +G G FG+VY     + +  + +KV     L           E      +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +       +       L+ E+   G++   L  +++ DE  +               ++A
Sbjct: 75  YGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-QRTAT---------YITELA 119

Query: 393 SALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           +AL Y H         H D+KP N+LL       + DFG +   P +          G++
Sbjct: 120 NALSYCHSKRVI----HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 171

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD--MNLHN---FARMALP 506
            Y+ PE   G       D++S G+L  E ++ K P    FE +     +          P
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFP 227

Query: 507 DHV 509
           D V
Sbjct: 228 DFV 230

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 93.0 bits (231), Expect = 9e-20
 Identities = 59/307 (19%), Positives = 99/307 (32%), Gaps = 68/307 (22%)

Query: 522 EDLAIISNQRQRQIRVNNIIECLISMLRI------------GSKAQKVTILDLESLKLAG 569
              A     R R   V  +  CL +   +                  +T L +    L  
Sbjct: 16  RRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLT- 74

Query: 570 SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL------ 623
           S+      L   + L +  N  T  +P     L  L +       +   +P  L      
Sbjct: 75  SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL-PALPSGLCKLWIF 129

Query: 624 --------SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
                        L  + ++ NQL   +P+    L K+       NN + S+P     L 
Sbjct: 130 GNQLTSLPVLPPGLQELSVSDNQL-ASLPALPSELCKLWAY----NNQLTSLPMLPSGLQ 184

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVI-----------------LYLGVNRLSGIVPSS 718
            L   S++ N LA S+P   S+L  L                   L +  NRL+ +    
Sbjct: 185 EL---SVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL- 239

Query: 719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ 778
               S + E  V  N++  ++P+        L   S+  N++T  +P S+ + S      
Sbjct: 240 ---PSELKELMVSGNRLT-SLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290

Query: 779 ALNNKLT 785
              N L+
Sbjct: 291 LEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 85.3 bits (211), Expect = 3e-17
 Identities = 54/190 (28%), Positives = 79/190 (41%), Gaps = 42/190 (22%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L +  N+L+ ++P     L++L    VSDN L  S+P+       L     +NN L+ ++
Sbjct: 126 LWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SL 176

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLI-----------------NLETLTVSGNI 104
           P    GL  L    +S NQ   S PT    L                   L+ L VSGN 
Sbjct: 177 PMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNR 232

Query: 105 LQGEIPSTLGSCIKLEILEMQGN-------VFQGLTILDLSRNKLSGEIPEFLVGLKVIE 157
           L   +P        L+ L + GN       +  GL  L + RN+L+  +PE L+ L    
Sbjct: 233 LT-SLPVLPSE---LKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSET 287

Query: 158 NLNLSYNDLE 167
            +NL  N L 
Sbjct: 288 TVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 81.5 bits (201), Expect = 4e-16
 Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 32/175 (18%)

Query: 1   ILALDSNRLSGNIPPSIG-NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           +L +  + L+  +P  +  ++  L    + DN L  S+P+       L T+ +  N L+ 
Sbjct: 44  VLNVGESGLT-TLPDCLPAHITTL---VIPDNNLT-SLPALPP---ELRTLEVSGNQLT- 94

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           ++P    GL  L            + P+       L  L + GN L   +P        L
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLP-ALPS------GLCKLWIFGNQLT-SLPVLPPG---L 143

Query: 120 EILEMQGN-------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           + L +  N       +   L  L    N+L+  +P    GL+    L++S N L 
Sbjct: 144 QELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDNQLA 194

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 71.1 bits (174), Expect = 7e-13
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 34/175 (19%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L   +N+L+ ++P     L++L    VSDN L  S+P+       L  +  +NN L+ ++
Sbjct: 166 LWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPS---ELYKLWAYNNRLT-SL 216

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL-- 119
           P      + L  L +S N+   S P     L   + L VSGN L   +P      + L  
Sbjct: 217 PALP---SGLKELIVSGNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPSGLLSLSV 268

Query: 120 ----------EILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
                      ++ +        T ++L  N LS    + L  +      +    
Sbjct: 269 YRNQLTRLPESLIHLSS-----ETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 63.4 bits (154), Expect = 2e-10
 Identities = 31/176 (17%), Positives = 61/176 (34%), Gaps = 25/176 (14%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
           ++  L   + +L  S+      L   + L++ +N     +P+    L +L   +    S+
Sbjct: 162 ELCKLWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL 216

Query: 616 GGEIPVNL--------------SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN 661
                  L                 S L  + ++ N+L   +P     L     LS+   
Sbjct: 217 PALPS-GLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLPSGL---LSLSVY-R 270

Query: 662 NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPS 717
           N +  +P  L +LSS   ++L  N L+      L ++ +       + R      S
Sbjct: 271 NQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 28/122 (22%)

Query: 68  LTSLVALDLSRNQFRGSFPTEVGNLI------------------NLETLTVSGNILQGEI 109
                 L++  +    + P  +   I                   L TL VSGN L   +
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SL 96

Query: 110 PSTLGSCIKLEILEMQGN----VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
           P      ++L I          +  GL  L +  N+L+  +P    GL   + L++S N 
Sbjct: 97  PVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGL---QELSVSDNQ 152

Query: 166 LE 167
           L 
Sbjct: 153 LA 154

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 27/126 (21%), Positives = 42/126 (33%), Gaps = 7/126 (5%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L +  NRL+ ++P     L  L    V  N L   +P SL    S TT+ L  N LS   
Sbjct: 246 LMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT 300

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              L  +TS         +F  +  +       L     + + L            +  +
Sbjct: 301 LQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA--AADWLVPAREGEPAPADRWHM 358

Query: 122 LEMQGN 127
              + N
Sbjct: 359 FGQEDN 364

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 54/251 (21%), Positives = 99/251 (39%), Gaps = 50/251 (19%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHRASRSFIAECRALRSIR 325
              D F    + G G+FG+V  G       +V +K V        +R  +   + L  + 
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNRE-LQIMQDLAVLH 77

Query: 326 HRNLVK---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
           H N+V+    F    G   + + +  +V E++      + L+   R     +      L+
Sbjct: 78  HPNIVQLQSYFYT-LGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILI 131

Query: 383 Q-------RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARF 434
           +       R         ++  LH     +  H D+KP N+L++E   +  + DFG A+ 
Sbjct: 132 KVFLFQLIR---------SIGCLHLPSVNVC-HRDIKPHNVLVNEADGTLKLCDFGSAKK 181

Query: 435 LPPTHVQTSSIGVKGSIGYI------APEYGLGS-EVSTNGDVYSYGILMLELIIRKKPS 487
           L P+    +         YI      APE   G+   +T  D++S G +  E+++  +P 
Sbjct: 182 LSPSEPNVA---------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EP- 230

Query: 488 DIMFEGDMNLH 498
             +F GD +  
Sbjct: 231 --IFRGDNSAG 239

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 46/290 (15%), Positives = 82/290 (28%), Gaps = 62/290 (21%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS------RSFIAECRALRSIRH---- 326
           ++G     +  +    E   +  V V        S      +  +   R LR I++    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 327 ---------------RNLVKVFTACSGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNRE 369
                              K+              +  +Y  MQ    +  E L   +  
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 370 DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429
            +      +L    RL + + V   L  LHH    +  H  L+P +I+LD+     +  F
Sbjct: 200 HK------SLVHHARLQLTLQVIRLLASLHH--YGL-VHTYLRPVDIVLDQRGGVFLTGF 250

Query: 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG-----------DVYSYGILML 478
                        SS     S G+  PE        +             D ++ G+++ 
Sbjct: 251 EHLV--RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 479 ELIIRKKPSDIMFEGDMNLHNFAR-----MALPDHVMDIVDSTLLNDVED 523
            +     P       D  L            +P  V  +++  L    ED
Sbjct: 305 WIWCADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKED 350

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 50/234 (21%), Positives = 92/234 (39%), Gaps = 16/234 (6%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
           LE L+L  +I+  +      NL  L+ L L +N     IP  +   L  L   D++ N I
Sbjct: 58  LEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI 116

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP-LGN 673
              +        NL  + +  N L+  I    F  L+ +E L+L   N + SIP   L +
Sbjct: 117 VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN-LTSIPTEALSH 174

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           L  L  + L   N+     ++  +L  L +L +        +  +     ++    +   
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234

Query: 734 KIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNNKLT 785
            +   +P       L  L++ ++  N I+  I  S+     +L+  Q +  +L 
Sbjct: 235 NLT-AVP-YLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 46/212 (21%), Positives = 80/212 (37%), Gaps = 11/212 (5%)

Query: 579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKN 637
           +  ++L+L  N        E      L+  +LN N +   +     ++  NL  +GL  N
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90

Query: 638 QLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIPF-T 694
           +L   IP   F  LS +  L +   N I  +   +  +L +L+ + +  N+L   I    
Sbjct: 91  RL-KLIPLGVFTGLSNLTKLDIS-ENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRA 147

Query: 695 LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYF 753
            S L +L  L L    L+ I   ++ ++  +    +    I   I  DY F  L  L+  
Sbjct: 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIR-DYSFKRLYRLKVL 205

Query: 754 SIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            I        + P+      L      +  LT
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 49/235 (20%), Positives = 94/235 (40%), Gaps = 16/235 (6%)

Query: 561 DLESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
           +   L L  + +  +      +   L+ L L  N  +   P     L  L+   L +N +
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 616 GGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP-LG 672
              IP+   +  SNL ++ +++N++   +    F  L  ++ L +G +N +  I      
Sbjct: 93  -KLIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVG-DNDLVYISHRAFS 149

Query: 673 NLSSLRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
            L+SL +++L   NL  SIP   LS L  L++L L    ++ I   S   +  +   ++ 
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP-SISNASKLEVFQALNNKLT 785
                  +         NL   SI    +T A+P  ++ +   L       N ++
Sbjct: 209 HWPYLDTMT-PNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 89.4 bits (222), Expect = 7e-19
 Identities = 44/234 (18%), Positives = 86/234 (36%), Gaps = 16/234 (6%)

Query: 562 LESLKLAGSILPHIGNLSF-----LKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
           L +L L  + L  I    F     L  L++  N     +   +   L  L+  ++ +N +
Sbjct: 82  LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140

Query: 616 GGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLG 672
              I     S  ++L ++ L K  L   IP++    L  + VL L  +  I +I      
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR-HLNINAIRDYSFK 197

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
            L  L+ + ++      ++        NL  L +    L+ +   ++ ++  +   ++  
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSY 257

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNNKLT 785
           N I   I       L  LQ   +   ++   + P      + L V     N+LT
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 79.0 bits (195), Expect = 2e-15
 Identities = 35/179 (19%), Positives = 72/179 (40%), Gaps = 15/179 (8%)

Query: 1   ILALDSNRLSGNIPP-SIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
            L L+   L+ +IP  ++ +L  L+   +    +      S      L  + + +     
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIK 118
           T+ P  +   +L +L ++      + P     +L+ L  L +S N +     S L   ++
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273

Query: 119 LEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           L+ +++ G          F+GL    +L++S N+L+         +  +E L L  N L
Sbjct: 274 LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 42/183 (22%), Positives = 72/183 (39%), Gaps = 11/183 (6%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
           LE L L    L  I      +L  L +L L + +    I      RL RL+V ++++   
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPY 212

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGN 673
              +  N     NL  + +    L   +P      L  +  L+L   N I +I    L  
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS-YNPISTIEGSMLHE 270

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           L  L++I L    LA   P+    L  L +L +  N+L+ +  S   ++ ++    +  N
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330

Query: 734 KIQ 736
            + 
Sbjct: 331 PLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 41/201 (20%), Positives = 74/201 (36%), Gaps = 23/201 (11%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPS-SLGLCESLTTIGLFNNNLS 58
            L +  N L   I       L  L +  +    L  SIP+ +L     L  + L + N++
Sbjct: 132 SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189

Query: 59  GTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS-TLGSC 116
             I       L  L  L++S   +  +        +NL +L+++   L   +P   +   
Sbjct: 190 -AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHL 247

Query: 117 IKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEF-LVGLKVIENLNLSYN 164
           + L  L +  N        +      L  + L   +L+  +  +   GL  +  LN+S N
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306

Query: 165 DLEGMVPTEGVFKNASAISVL 185
            L   +  E VF +   +  L
Sbjct: 307 QLT-TLE-ESVFHSVGNLETL 325

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 19/205 (9%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           +L L  NR+   +      +   L E  +++N +    P +     +L T+GL +N L  
Sbjct: 36  LLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK- 93

Query: 60  TIPPQ-LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS-TLGSCI 117
            IP     GL++L  LD+S N+          +L NL++L V  N L   I         
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152

Query: 118 KLEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
            LE L ++              L    +L L    ++         L  ++ L +S+   
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212

Query: 167 EGMVPTEGVFKNASAISV-LGNNKL 190
              +         +  S+ + +  L
Sbjct: 213 LDTMT-PNCLYGLNLTSLSITHCNL 236

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.8 bits (166), Expect = 5e-12
 Identities = 39/170 (22%), Positives = 61/170 (35%), Gaps = 21/170 (12%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL 95
           ++P   G+      + L  N +      +      L  L+L+ N      P    NL NL
Sbjct: 25  AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 96  ETLTVSGNILQGEIPS-TLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLS 143
            TL +  N L+  IP         L  L++  N        +FQ L     L++  N L 
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141

Query: 144 GEIPE-FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
             I      GL  +E L L   +L   +PT     +   + VL   +  +
Sbjct: 142 -YISHRAFSGLNSLEQLTLEKCNLT-SIPT-EALSHLHGLIVLRLRHLNI 188

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 27/134 (20%), Positives = 55/134 (41%), Gaps = 8/134 (5%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE-IGRLRRLQVPDLNNNSIG 616
            +L++       ++ P+      L  L++ + + T  +P   +  L  L+  +L+ N I 
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPI- 260

Query: 617 GEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGN 673
             I  + L     L  I L   QL   +    F  L+ + VL++   N + ++      +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVS-GNQLTTLEESVFHS 318

Query: 674 LSSLRKISLAINNL 687
           + +L  + L  N L
Sbjct: 319 VGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 7/145 (4%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPPP-LGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701
           +P      ++  +L LG N  I ++      +   L ++ L  N ++   P   + L NL
Sbjct: 26  VPEGI--PTETRLLDLGKNR-IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 702 VILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRI 760
             L L  NRL  I       +S++ + D+ ENKI   +  DY F  L NL+   +G N +
Sbjct: 83  RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILL-DYMFQDLYNLKSLEVGDNDL 140

Query: 761 TGAIPPSISNASKLEVFQALNNKLT 785
                 + S  + LE        LT
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLT 165

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.5 bits (225), Expect = 5e-19
 Identities = 45/209 (21%), Positives = 75/209 (35%), Gaps = 9/209 (4%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLM 640
            K L+L  N   H           LQV DL+   I         S S+L  + L  N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA-GSIPFTLSKLK 699
                 F  LS ++ L     NL      P+G+L +L+++++A N +    +P   S L 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 700 NLVILYLGVNRLSGIVPSSIFNISS----IAEFDVGENKIQGNIPLDYGFTLQNLQYFSI 755
           NL  L L  N++  I  + +  +          D+  N +   I     F    L   ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPG-AFKEIRLHKLTL 207

Query: 756 GTNRITGAIPPSISNASKLEVFQALNNKL 784
             N  +  +  +      L   +     L
Sbjct: 208 RNNFDSLNVMKTCI--QGLAGLEVHRLVL 234

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 87.8 bits (218), Expect = 4e-18
 Identities = 46/258 (17%), Positives = 105/258 (40%), Gaps = 15/258 (5%)

Query: 533 RQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFT 592
             +   +++   I  ++  S       L+L + K      P +  L  LK L   +N   
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ--FPTL-KLKSLKRLTFTSNKGG 338

Query: 593 HEIPSEIGRLRRLQVPDLNNNSIG--GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSL 650
           +   SE+  L  L+  DL+ N +   G    +    ++L  + L+ N ++  + S+F  L
Sbjct: 339 N-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395

Query: 651 SKIEVLSLGFNNLIGSIPPP--LGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV 708
            ++E L    +NL   +       +L +L  + ++  +   +     + L +L +L +  
Sbjct: 396 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454

Query: 709 NRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS 767
           N         IF  + ++   D+ + +++  +      +L +LQ  ++ +N++  ++P  
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLK-SVPDG 512

Query: 768 I-SNASKLEVFQALNNKL 784
           I    + L+      N  
Sbjct: 513 IFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.7 bits (215), Expect = 9e-18
 Identities = 55/216 (25%), Positives = 82/216 (37%), Gaps = 25/216 (11%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFL--KGSIPSSLGLCESLTTIGLFNNNLSG 59
           L   SN+       S  +L  L    +S N L  KG    S     SL  + L  N +  
Sbjct: 330 LTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIK 118
           T+    +GL  L  LD   +  +      V  +L NL  L +S    +            
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 119 LEILEMQGN---------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           LE+L+M GN         +F  L     LDLS+ +L    P     L  ++ LN++ N L
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

Query: 167 EGMVPTEGVFKNASAISV--LGNNKL---CGGISEF 197
           +  VP +G+F   +++    L  N     C  I   
Sbjct: 507 K-SVP-DGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 85.2 bits (211), Expect = 3e-17
 Identities = 39/219 (17%), Positives = 76/219 (34%), Gaps = 5/219 (2%)

Query: 527 ISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLE--SLKLAGSILPHIGNLSFLKIL 584
               + + ++                    +  LDL    L   G         + LK L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 585 NLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQLMGKI 643
           +L  N     + S    L +L+  D  ++++      +   S  NLI + ++        
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 644 PSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
              F  LS +EVL +  N+   +  P     L +L  + L+   L    P   + L +L 
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 703 ILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
           +L +  N+L  +       ++S+ +  +  N    + P 
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 80.5 bits (199), Expect = 7e-16
 Identities = 40/201 (19%), Positives = 71/201 (35%), Gaps = 18/201 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L  N L      S  +  +L    +S   ++     +      L+T+ L  N +   
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQ-GEIPSTLGSCIKL 119
                 GL+SL  L              +G+L  L+ L V+ N++Q  ++P    +   L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 120 EILEMQGNVFQGLT---------------ILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
           E L++  N  Q +                 LDLS N ++   P     ++ +  L L  N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNN 210

Query: 165 DLEGMVPTEGVFKNASAISVL 185
                V  +   +  + + V 
Sbjct: 211 FDSLNVM-KTCIQGLAGLEVH 230

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.4 bits (183), Expect = 7e-14
 Identities = 34/144 (23%), Positives = 55/144 (38%), Gaps = 14/144 (9%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL 95
            IP    L  S   + L  N L             L  LDLSR + +        +L +L
Sbjct: 21  KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 96  ETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKL-S 143
            TL ++GN +Q            L+ L                 L     L+++ N + S
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 144 GEIPEFLVGLKVIENLNLSYNDLE 167
            ++PE+   L  +E+L+LS N ++
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ 162

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.0 bits (182), Expect = 8e-14
 Identities = 40/203 (19%), Positives = 64/203 (31%), Gaps = 25/203 (12%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
           L S  +   +     N        + +          L    SL  +   +N        
Sbjct: 289 LVSVTIE-RVKDFSYNFG-WQHLELVNCKFGQFPTLKLK---SLKRLTFTSNKGGN--AF 341

Query: 64  QLMGLTSLVALDLSRNQFR--GSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
             + L SL  LDLSRN     G          +L+ L +S N +   + S      +LE 
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 400

Query: 122 LEMQGN---------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
           L+ Q +         VF     L  LD+S             GL  +E L ++ N  +  
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 170 VPTEGVFKNASAISVL--GNNKL 190
                +F     ++ L     +L
Sbjct: 461 FL-PDIFTELRNLTFLDLSQCQL 482

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.1 bits (177), Expect = 3e-13
 Identities = 38/222 (17%), Positives = 73/222 (32%), Gaps = 10/222 (4%)

Query: 570 SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNL 629
           S L  + NL+  +      + +  +I      L  +    L + +I   +  + S     
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGW 306

Query: 630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA- 688
             + L   +          SL ++       +N  G+      +L SL  + L+ N L+ 
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFT----SNKGGNAFS-EVDLPSLEFLDLSRNGLSF 361

Query: 689 -GSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTL 747
            G    +     +L  L L  N +  +  S+   +  +   D   + ++         +L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420

Query: 748 QNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           +NL Y  I       A     +  S LEV +   N       
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 4e-12
 Identities = 43/228 (18%), Positives = 79/228 (34%), Gaps = 16/228 (7%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTH-EIPSEIGRLRRLQVPDLNNN 613
             +  L      LA      IG+L  LK LN+ +N     ++P     L  L+  DL++N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 614 SIGGEIPVNLSSCSNL----IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
            I      +L     +    + + L+ N +   I        ++  L+L  N    ++  
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 670 -PLGNLSSLRKISLAI------NNLAGSIPFTLSKLKNLVILYLGVNRLSGI---VPSSI 719
             +  L+ L    L +       NL       L  L NL I    +  L      +    
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 720 FNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS 767
             +++++ F +    I+      Y F  Q+L+  +    +       S
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.9 bits (161), Expect = 3e-11
 Identities = 26/129 (20%), Positives = 48/129 (37%), Gaps = 2/129 (1%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
            L    + L      S+  +L+ L+   +S    + +         SL  + +  N+   
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 60  TIPPQ-LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIK 118
              P     L +L  LDLS+ Q     PT   +L +L+ L ++ N L+            
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519

Query: 119 LEILEMQGN 127
           L+ + +  N
Sbjct: 520 LQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 1/87 (1%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           +L +  N    N  P I   L+ L    +S   L+   P++     SL  + + +N L  
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFP 86
                   LTSL  + L  N +  S P
Sbjct: 509 VPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 48/266 (18%), Positives = 91/266 (34%), Gaps = 61/266 (22%)

Query: 272 FSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI-RHR 327
           F     IG+G FGSV+K V   +G     +K            ++ + E  A   + +H 
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           ++V+ F+A     +  +D   +  E+   GSL + +       E  +        +  ++
Sbjct: 72  HVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAI------SENYRIMSYFKEAELKDL 120

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV-------------------GD 428
            + V   L Y+H        H D+KPSNI +    + +                    GD
Sbjct: 121 LLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPE-------YGLGSEVSTNGDVYSYGILMLELI 481
            G    +    V+       G   ++A E       +   +      D+++  + ++   
Sbjct: 178 LGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKA------DIFALALTVVCAA 225

Query: 482 IRKKPSDIMFEGDMNLHNFARMALPD 507
             +        GD   H   +  LP 
Sbjct: 226 GAEPLP---RNGDQ-WHEIRQGRLPR 247

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 34/211 (16%), Positives = 82/211 (38%), Gaps = 10/211 (4%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI--GGEIPVNLSSCSNLIRIGLAKNQ 638
              L LE+N           +L +L    L++N +   G    +    ++L  + L+ N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 639 LMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP--LGNLSSLRKISLAINNLAGSIPFTLS 696
           +   + S+F  L ++E L    +N +  +       +L +L  + ++  +   +     +
Sbjct: 90  V-ITMSSNFLGLEQLEHLDFQHSN-LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147

Query: 697 KLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI 755
            L +L +L +  N         IF  + ++   D+ + +++  +      +L +LQ  ++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206

Query: 756 GTNRITGAIPPSI-SNASKLEVFQALNNKLT 785
             N    ++        + L+V     N + 
Sbjct: 207 SHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 41/194 (21%), Positives = 74/194 (38%), Gaps = 20/194 (10%)

Query: 1   ILALDSNRLS--GNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS 58
            L+L SN LS  G    S      L    +S N +  ++ S+    E L  +   ++NL 
Sbjct: 56  KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114

Query: 59  GTIPPQ--LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN-ILQGEIPSTLGS 115
             +      + L +L+ LD+S    R +F      L +LE L ++GN   +  +P     
Sbjct: 115 -QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

Query: 116 CIKLEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
              L  L++            F  L+   +L++S N            L  ++ L+ S N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233

Query: 165 DLEGMVPTEGVFKN 178
            +      +   ++
Sbjct: 234 HIM-TSK-KQELQH 245

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 37/201 (18%), Positives = 78/201 (38%), Gaps = 12/201 (5%)

Query: 545 ISMLRIGSKA----QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI- 599
           +S     S++      +  LDL    +  ++  +   L  L+ L+ ++++        + 
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122

Query: 600 GRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLS 657
             LR L   D+++            +  S+L  + +A N        D F  L  +  L 
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 658 LGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP 716
           L     +  + P    +LSSL+ ++++ NN      F    L +L +L   +N +     
Sbjct: 182 LSQCQ-LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240

Query: 717 SSIFNI-SSIAEFDVGENKIQ 736
             + +  SS+A  ++ +N   
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 40/171 (23%), Positives = 63/171 (36%), Gaps = 20/171 (11%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ--FRGSFPTEVGNLI 93
           S+P+  G+  S T + L +N L          LT L  L LS N   F+G          
Sbjct: 21  SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 94  NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------VFQG---LTILDLSRNK 141
           +L+ L +S N +   + S      +LE L+ Q +         VF     L  LD+S   
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 142 LSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
                     GL  +E L ++ N  +       +F     ++ L     +L
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELRNLTFLDLSQCQL 187

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 40/209 (19%), Positives = 76/209 (36%), Gaps = 11/209 (5%)

Query: 582 KILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLM 640
             +   +   T  +P+ I     RL   +L +N +           + L ++ L+ N L 
Sbjct: 10  TEIRCNSKGLT-SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 641 GK--IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPF-TLSK 697
            K          + ++ L L FN +I ++      L  L  +    +NL     F     
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124

Query: 698 LKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGT 757
           L+NL+ L +               +SS+    +  N  Q N   D    L+NL +  +  
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 758 NRITGAIPPSI-SNASKLEVFQALNNKLT 785
            ++   + P+  ++ S L+V    +N   
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFF 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 27/206 (13%)

Query: 4   LDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS--GT 60
            +S  L+ ++P  I  +  +L    +  N L+            LT + L +N LS  G 
Sbjct: 14  CNSKGLT-SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIP--STLGSCIK 118
                 G TSL  LDLS N    +  +    L  LE L    + L+ ++   S   S   
Sbjct: 70  CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN 127

Query: 119 LEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPE-FLVGLKVIENLNLSYNDL 166
           L  L++           +F GL+   +L ++ N             L+ +  L+LS   L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187

Query: 167 EGMVPTEGVFKNASAISVL--GNNKL 190
           E  +     F + S++ VL   +N  
Sbjct: 188 E-QLS-PTAFNSLSSLQVLNMSHNNF 211

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 58/227 (25%), Positives = 85/227 (37%), Gaps = 47/227 (20%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK-- 331
            +G G F   ++    + +     K+     L           E    RS+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 332 -VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR--EDEVDKAPRNLNLLQRLNIA 388
             F     V +       +V E  +  SL E         E E     R   L Q     
Sbjct: 82  GFFEDNDFV-F-------VVLELCRRRSLLELHKRRKALTEPEA----RYY-LRQ----- 123

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +     YLH +      H DLK  N+ L+E++   +GDFGLA     T V+      K
Sbjct: 124 --IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKK 173

Query: 449 ---GSIGYIAPE----YGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488
              G+  YIAPE     G   EV    DV+S G +M  L++ K P +
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFE 216

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 89.4 bits (222), Expect = 1e-18
 Identities = 42/232 (18%), Positives = 85/232 (36%), Gaps = 10/232 (4%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
            + D  S     SI   +   + +K L+L  N  T+    ++     LQV  L ++ I  
Sbjct: 8   GVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-N 63

Query: 618 EIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIG-SIPPPLGNL 674
            I  +   S  +L  + L+ N L   + S  FG LS ++ L+L  N      +     NL
Sbjct: 64  TIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122

Query: 675 SSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           ++L+ + +        I     + L +L  L +    L      S+ +I  I    +  +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           +    +   +   L +++Y  +    +       +         + L  + +
Sbjct: 183 ESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.8 bits (210), Expect = 3e-17
 Identities = 38/239 (15%), Positives = 90/239 (37%), Gaps = 10/239 (4%)

Query: 557 VTILDLESLKLAGSILPH-IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
           +  LDL   K+   I    +   + L++L L+++            L  L+  DL++N +
Sbjct: 28  MKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMG-KIPSDFGSLSKIEVLSLGFNNLIGSIPPP-LGN 673
                      S+L  + L  N      + S F +L+ ++ L +G       I       
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           L+SL ++ +   +L      +L  ++++  L L ++  + ++      +SS+   ++ + 
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206

Query: 734 KIQGN--IPLDYGFTLQNLQYFSIGTNRIT----GAIPPSISNASKLEVFQALNNKLTG 786
            +      PL        ++  +   + +T      +   +    +L   +  +  L G
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 81.7 bits (202), Expect = 3e-16
 Identities = 41/234 (17%), Positives = 82/234 (35%), Gaps = 18/234 (7%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           +  L +    L   +      L  +K + +EN+       S    L+ L+  DL+ N + 
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 617 GEIPVN---LSSCSNLIRIGLAKNQL--MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
            E   N     +  +L  + L++N L  M K      +L  +  L +  N     +P   
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT-FHPMPDSC 406

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
                +R ++L+   +   +   +   + L +L +  N L          +  + E  + 
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFSL----FLPRLQELYIS 459

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNNKL 784
            NK++    L        L    I  N++  ++P  I    + L+      N  
Sbjct: 460 RNKLKT---LPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.0 bits (182), Expect = 7e-14
 Identities = 46/249 (18%), Positives = 80/249 (32%), Gaps = 24/249 (9%)

Query: 561 DLESLKLAGSILPHI-----GNLSFLKILNLENNSFTH-EIPSEIGRLRRLQVPDLNNNS 614
            LE L L+ + L  +     G LS LK LNL  N +    + S    L  LQ   + N  
Sbjct: 75  SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134

Query: 615 IGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGN 673
              EI     +  ++L  + +    L         S+  I  L+L  +     +      
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA------- 726
           LSS+R + L   NLA      L   +    +     R S +   S   +  +        
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

Query: 727 EFDVGENKIQGNIPLDYG----------FTLQNLQYFSIGTNRITGAIPPSISNASKLEV 776
           E +  +  + G    +                 ++   I    +   +    S   K++ 
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314

Query: 777 FQALNNKLT 785
               N+K+ 
Sbjct: 315 ITVENSKVF 323

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.8 bits (179), Expect = 2e-13
 Identities = 34/182 (18%), Positives = 64/182 (35%), Gaps = 15/182 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L  N+++      +     L    +  + +      +     SL  + L +N+LS +
Sbjct: 30  SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-S 88

Query: 61  IPPQ-LMGLTSLVALDLSRNQFRG-SFPTEVGNLINLETLTVSGNILQGEIP-STLGSCI 117
           +       L+SL  L+L  N ++     +   NL NL+TL +       EI         
Sbjct: 89  LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148

Query: 118 KLEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
            L  LE++    +            +  L L  ++ +  +  F   L  +  L L   +L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208

Query: 167 EG 168
             
Sbjct: 209 AR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.7 bits (176), Expect = 5e-13
 Identities = 41/181 (22%), Positives = 65/181 (35%), Gaps = 20/181 (11%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L +    L  ++      L+K+    V ++ +     S     +SL  + L  N +   
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349

Query: 61  IPPQ---LMGLTSLVALDLSRNQFRGSFPTEVG---NLINLETLTVSGNILQGEIPSTLG 114
                       SL  L LS+N  R S          L NL +L +S N     +P +  
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407

Query: 115 SCIKLEILEMQGN--------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
              K+  L +           + Q L +LD+S N L      FL  L+    L +S N L
Sbjct: 408 WPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQE---LYISRNKL 463

Query: 167 E 167
           +
Sbjct: 464 K 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 39/246 (15%), Positives = 89/246 (36%), Gaps = 33/246 (13%)

Query: 518 LNDVEDLAIISNQRQRQIRVNNIIECLISML--RIGSKAQKVTILDLESLKLAGSILPHI 575
            ++ + ++ +       IR  +I +  +      + S  +KV  + +E+ K+   +    
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FLVPCSF 329

Query: 576 G-NLSFLKILNLENNSFTHEI---PSEIGRLRRLQVPDLNNNSIG--GEIPVNLSSCSNL 629
             +L  L+ L+L  N    E     +  G    LQ   L+ N +    +    L +  NL
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389

Query: 630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG 689
             + +++N     +P       K+  L+L    +   +        +L  + ++ NNL  
Sbjct: 390 TSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGI-RVVKT--CIPQTLEVLDVSNNNLD- 444

Query: 690 SIPFTLSKLK-------------------NLVILYLGVNRLSGIVPSSIFNISSIAEFDV 730
           S    L +L+                    L+++ +  N+L  +       ++S+ +  +
Sbjct: 445 SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504

Query: 731 GENKIQ 736
             N   
Sbjct: 505 HTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 38/181 (20%), Positives = 63/181 (34%), Gaps = 24/181 (13%)

Query: 1   ILALDSNRLSGNIPPS---IGNLKKLVEPYVSDNFLKGSIPSSLGLC---ESLTTIGLFN 54
            L L  N +      +    G    L    +S N L+ S+  +  +    ++LT++ +  
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISR 396

Query: 55  NNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLG 114
           N     +P        +  L+LS    R    T       LE L VS N L       L 
Sbjct: 397 NTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLP 451

Query: 115 SCIKLEILEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND 165
               L+ L +  N         +F  L ++ +SRN+L          L  ++ + L  N 
Sbjct: 452 R---LQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508

Query: 166 L 166
            
Sbjct: 509 W 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 65.9 bits (161), Expect = 3e-11
 Identities = 38/170 (22%), Positives = 60/170 (35%), Gaps = 19/170 (11%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL 95
           SIPS  GL  ++ ++ L  N ++      L    +L  L L  ++          +L +L
Sbjct: 19  SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 96  ETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------VFQGLT---ILDLSRNKLS 143
           E L +S N L     S  G    L+ L + GN         +F  LT    L +   +  
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136

Query: 144 GEIPE-FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV--LGNNKL 190
            EI      GL  +  L +    L          K+   I    L  ++ 
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQS--QSLKSIRDIHHLTLHLSES 184

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 30/250 (12%), Positives = 77/250 (30%), Gaps = 22/250 (8%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             L++++L L       + ++  +  L L  +     +      L  ++  +L + ++  
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

Query: 618 EIPVNLSSCSNLIRIGLAKNQL----------MGKIPSDFGSLSKIEVLSLGFNNLIGSI 667
                L        +     +           + K+      LS++E      N L    
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270

Query: 668 PPPLGNLS--------SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSI 719
           P     +S        ++R++ +    L   +    S L+ +  + +  +++  +  S  
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330

Query: 720 FNISSIAEFDVGENKIQGNIPLDYGF--TLQNLQYFSIGTNRIT--GAIPPSISNASKLE 775
            ++ S+   D+ EN +      +        +LQ   +  N +         +     L 
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 776 VFQALNNKLT 785
                 N   
Sbjct: 391 SLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 33/259 (12%), Positives = 74/259 (28%), Gaps = 58/259 (22%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG- 59
            L + +  L      S+ +++ +    +  +     +     +  S+  + L + NL+  
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211

Query: 60  ---------------------------------TIPPQLMGLTSLVALDLSRNQFRGSFP 86
                                             +   ++ L+ +   D + N      P
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP 271

Query: 87  TEVG--------NLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQ 130
           +E            + +  L +    L  ++ +      K++ + ++ +          Q
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331

Query: 131 G---LTILDLSRNKLSGEI---PEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV 184
               L  LDLS N +  E             ++ L LS N L  M  T  +      ++ 
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391

Query: 185 L--GNNKLCGGISEFKLPP 201
           L    N         + P 
Sbjct: 392 LDISRNTFHPMPDSCQWPE 410

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.8 bits (153), Expect = 3e-10
 Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 18/161 (11%)

Query: 44  CESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN 103
           C++       + + + +IP  L    ++ +LDLS N+       ++    NL+ L +  +
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 104 ILQGEIPSTLGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLSG-EIPEFLV 151
            +         S   LE L++  N         F     L  L+L  N      +     
Sbjct: 61  RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120

Query: 152 GLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
            L  ++ L +   +    +     F   ++++ L      L
Sbjct: 121 NLTNLQTLRIGNVETFSEIR-RIDFAGLTSLNELEIKALSL 160

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 33/252 (13%), Positives = 72/252 (28%), Gaps = 30/252 (11%)

Query: 562 LESLKLAGSILPHIGNLSF-----LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           +  L L  S    +  +       ++ L L + +      S +                 
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233

Query: 617 G----------EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSK--------IEVLSL 658
                      ++   +   S +       N L    PS+   +S+        I  L +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIV--- 715
               L   +      L  +++I++  + +          LK+L  L L  N +       
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353

Query: 716 PSSIFNISSIAEFDVGENKIQGNIPLDYGFT--LQNLQYFSIGTNRITGAIPPSISNASK 773
            +      S+    + +N ++ ++         L+NL    I  N     +P S     K
Sbjct: 354 SACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411

Query: 774 LEVFQALNNKLT 785
           +      +  + 
Sbjct: 412 MRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 6e-09
 Identities = 36/164 (21%), Positives = 56/164 (34%), Gaps = 8/164 (4%)

Query: 625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLA 683
           SC                IPS     + ++ L L FN  I  I    L   ++L+ + L 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNK-ITYIGHGDLRACANLQVLILK 58

Query: 684 INNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDY 743
            + +          L +L  L L  N LS +  S    +SS+   ++  N  Q  + +  
Sbjct: 59  SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTS 117

Query: 744 GFT-LQNLQYFSIGTNRITGAIPP-SISNASKLEVFQALNNKLT 785
            F  L NLQ   IG       I     +  + L   +     L 
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 24/130 (18%), Positives = 52/130 (40%), Gaps = 10/130 (7%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L +  N     +P S    +K+    +S   ++  + +   + ++L  + + NNNL  +
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-S 445

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
                + L  L  L +SRN+ + + P +      L  + +S N L+            L+
Sbjct: 446 FS---LFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500

Query: 121 ILEMQGNVFQ 130
            + +  N + 
Sbjct: 501 KIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 29/220 (13%), Positives = 57/220 (25%), Gaps = 31/220 (14%)

Query: 2   LALDSNRLSG-NIPPSIGNLKKLVEPYVSDNFLKGSIP-SSLGLCESLTTIGLFNNNLSG 59
           L L  N      +     NL  L    + +      I         SL  + +   +L  
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTL------ 113
                L  +  +  L L  ++           L ++  L +    L     S L      
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222

Query: 114 ---------------GSCIKLEILEMQGNVFQGLTILDLSRNKL---SGEIPEFLVGLKV 155
                           S  +L  L         +   D + N L   +    + +  L  
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282

Query: 156 IENLNLSYNDLEGMVPT---EGVFKNASAISVL--GNNKL 190
           +E + +    +           V+     +  +   N+K+
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 88.5 bits (220), Expect = 1e-18
 Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 47/288 (16%)

Query: 517 LLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG 576
             ++ E  A   N  QR++ V+ + +CL          ++   L+L +L L  S LP   
Sbjct: 42  AWSEWERNAPPGNGEQREMAVSRLRDCLD---------RQAHELELNNLGL--SSLPE-- 88

Query: 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPV--------------- 621
               L+ L    NS T E+P     L+ L V + N  ++    P+               
Sbjct: 89  LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP 147

Query: 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKIS 681
            L + S L  I +  N L  K+P    SL   E ++ G N L     P L NL  L  I 
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQL--EELPELQNLPFLTAIY 201

Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
              N+L   +P     L+++     G N L       + N+  +       N ++  +P 
Sbjct: 202 ADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254

Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
                  +L+  ++  N +T  +P    + + L+V + + + L+   P
Sbjct: 255 ----LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 87.4 bits (217), Expect = 3e-18
 Identities = 47/228 (20%), Positives = 77/228 (33%), Gaps = 33/228 (14%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             +   + +L    LP + NL FL  +  +NNS   ++P     L  +      NN +  
Sbjct: 176 EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNIL-- 227

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
           E    L +   L  I    N L   +P    SL  + V     +N +  +P    +L+ L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR----DNYLTDLPELPQSLTFL 282

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG 737
                  + L+   P       NL  L    N +  +         S+ E +V  NK+  
Sbjct: 283 DVSENIFSGLSELPP-------NLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI- 330

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            +P         L+      N +   +P    N   L+      N L 
Sbjct: 331 ELP----ALPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 84.3 bits (209), Expect = 3e-17
 Identities = 43/228 (18%), Positives = 76/228 (33%), Gaps = 35/228 (15%)

Query: 571 ILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSS----- 625
           I P   + +FL+     +++ T E+P E   ++         +      P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 626 --------CSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
                         + L    L   +P     L   E L    N+L   +P    +L SL
Sbjct: 62  VSRLRDCLDRQAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSL 116

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG 737
              +  +  L+   P        L  L +  N+L  +    + N S +   DV  N ++ 
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK- 166

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            +P        +L++ + G N++     P + N   L    A NN L 
Sbjct: 167 KLP----DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 208

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 82.7 bits (205), Expect = 9e-17
 Identities = 47/244 (19%), Positives = 78/244 (31%), Gaps = 40/244 (16%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKI-------------LNLENNSFTHEIPSEIGR 601
           +  T       +   +  P  G    + +             L L N   +  +P     
Sbjct: 34  KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 92

Query: 602 LRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN 661
           L  L     + NS+  E+P    S  +L+        L    P        +E L +  N
Sbjct: 93  LESL---VASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNN 141

Query: 662 NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFN 721
            L     P L N S L+ I +  N+L   +P       +L  +  G N+L  +    + N
Sbjct: 142 QL--EKLPELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLEEL--PELQN 193

Query: 722 ISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN 781
           +  +       N ++    L       +L+    G N +     P + N   L    A N
Sbjct: 194 LPFLTAIYADNNSLKKLPDL-----PLSLESIVAGNNILE--ELPELQNLPFLTTIYADN 246

Query: 782 NKLT 785
           N L 
Sbjct: 247 NLLK 250

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 82.7 bits (205), Expect = 1e-16
 Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 21/170 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           +A  +N+L     P + NL  L   Y  +N LK  +P       SL +I   NN L    
Sbjct: 178 IAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNIL--EE 229

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
            P+L  L  L  +    N  + + P       +LE L V  N L  ++P    S   L++
Sbjct: 230 LPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDV 284

Query: 122 LEMQGNVFQ----GLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
            E   +        L  L+ S N++   + +    L+    LN+S N L 
Sbjct: 285 SENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEE---LNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 33/170 (19%), Positives = 59/170 (34%), Gaps = 23/170 (13%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
               S+ L+  +P    N+K   E Y + +  + + P   G    +    L +       
Sbjct: 16  PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL----- 69

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
                       L+L+      S P       +LE+L  S N L  E+P    S   L +
Sbjct: 70  ------DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLV 118

Query: 122 LEMQGNVF----QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
                         L  L +S N+L  ++PE       ++ +++  N L+
Sbjct: 119 DNNNLKALSDLPPLLEYLGVSNNQLE-KLPELQ-NSSFLKIIDVDNNSLK 166

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 41/190 (21%), Positives = 62/190 (32%), Gaps = 39/190 (20%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPS---------------SLGLCES 46
           L    N L+  +P    +LK L+    +   L    P                 L     
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSF 154

Query: 47  LTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQ 106
           L  I + NN+L   +P       SL  +    NQ       E+ NL  L  +    N L+
Sbjct: 155 LKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK 208

Query: 107 GEIPSTLGSCIKLEILEMQGNVF---------QGLTILDLSRNKLSGEIPEFLVGLKVIE 157
            ++P    S   LE +    N+            LT +    N L   +P+    L+   
Sbjct: 209 -KLPDLPLS---LESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--- 260

Query: 158 NLNLSYNDLE 167
            LN+  N L 
Sbjct: 261 ALNVRDNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 47/277 (16%), Positives = 92/277 (33%), Gaps = 56/277 (20%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           NN ++ L  +         +  +   +  L    LP + NL FL  +  +NN     +P 
Sbjct: 204 NNSLKKLPDLP------LSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD 254

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMG-------------KIP 644
               L  L   ++ +N +  ++P    S + L       + L               +I 
Sbjct: 255 LPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 310

Query: 645 SDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVIL 704
           S       +E L++  N LI  +P     L  L     + N+LA  +P      +NL  L
Sbjct: 311 SLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP---ELPQNLKQL 362

Query: 705 YLGVNRLSGIVPSSIFN----------------ISSIAEFDVGENKIQGNIPLDYGFTLQ 748
           ++  N L    P    +                  ++ +  V  N ++   P       +
Sbjct: 363 HVEYNPLREF-PDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP----DIPE 416

Query: 749 NLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           +++   + + R+      +     KLE     ++   
Sbjct: 417 SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 46/185 (24%), Positives = 69/185 (37%), Gaps = 36/185 (19%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           +  D+N L   +P    +L+ L    V DN+L   +P        L       + LS  +
Sbjct: 242 IYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-EL 295

Query: 62  PPQLMGL--------------TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQG 107
           PP L  L               SL  L++S N+     P     L   E L  S N L  
Sbjct: 296 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA- 350

Query: 108 EIPSTLGSCIKLEILEMQGNVFQGL-----TILDLSRNKLSGEIPEFLVGLKVIENLNLS 162
           E+P    +   L+ L ++ N  +       ++ DL  N    E+PE    LK    L++ 
Sbjct: 351 EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQ---LHVE 404

Query: 163 YNDLE 167
            N L 
Sbjct: 405 TNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.9 bits (156), Expect = 1e-10
 Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 5/107 (4%)

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           I P+ +  T L       +      P E  N+ +      + +  +   P   G   ++ 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 121 ILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           +  ++  + +    L+L+   LS  +PE    L   E+L  S N L 
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT 104

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 29/170 (17%), Positives = 62/170 (36%), Gaps = 28/170 (16%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L   SN +  ++     +L++L    VS+N L   +P+       L  +    N+L+  +
Sbjct: 302 LNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPALPP---RLERLIASFNHLA-EV 352

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P       +L  L +  N  R  FP    ++ +L       N    E+P    +   L+ 
Sbjct: 353 PELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQN---LKQ 400

Query: 122 LEMQGNVFQ-------GLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
           L ++ N  +        +  L ++  ++             +E+    ++
Sbjct: 401 LHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 20/121 (16%), Positives = 35/121 (28%), Gaps = 25/121 (20%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLG----------------LC 44
            L    N L+  +P    NLK+L   +V  N L+   P                    L 
Sbjct: 341 RLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELP 395

Query: 45  ESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNI 104
           ++L  + +  N L    P     +  L    ++  +    +         LE      + 
Sbjct: 396 QNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHH 451

Query: 105 L 105
            
Sbjct: 452 H 452

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 50/239 (20%), Positives = 93/239 (38%), Gaps = 25/239 (10%)

Query: 562 LESLKLAGSILPHIG-----NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           L +L L  + +  I       L  L+ L L  N    E+P ++   + LQ   ++ N I 
Sbjct: 78  LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT 134

Query: 617 GEIPVN-LSSCSNLIRIGLAKNQL-MGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLGN 673
            ++  +  +  + +I + L  N L    I +  F  + K+  + +   N I +IP   G 
Sbjct: 135 -KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQ--GL 190

Query: 674 LSSLRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
             SL ++ L  N +   +   +L  L NL  L L  N +S +   S+ N   + E  +  
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITG------AIPPSISNASKLEVFQALNNKLT 785
           NK+   +P       + +Q   +  N I+         P   +  +        +N + 
Sbjct: 250 NKLV-KVPGGL-ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 81.6 bits (202), Expect = 8e-17
 Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 15/210 (7%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQL 639
             +L+L+NN  T     +   L+ L    L NN I  +I     +    L R+ L+KNQL
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQL 112

Query: 640 MGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSI--PFTLS 696
             ++P        ++ L +   N I  +       L+ +  + L  N L  S        
Sbjct: 113 -KELPE--KMPKTLQELRVH-ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
            +K L  + +    ++ I P  +    S+ E  +  NKI   +       L NL    + 
Sbjct: 169 GMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224

Query: 757 TNRITGAIPP-SISNASKLEVFQALNNKLT 785
            N I+ A+   S++N   L      NNKL 
Sbjct: 225 FNSIS-AVDNGSLANTPHLRELHLNNNKLV 253

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 32/212 (15%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNL- 57
            L L  N+L   +P  +   K L E  V +N +   +  S+  GL   +  + L  N L 
Sbjct: 104 RLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGL-NQMIVVELGTNPLK 158

Query: 58  SGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS-TLGS 115
           S  I      G+  L  + ++      + P   G   +L  L + GN +  ++ + +L  
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKG 214

Query: 116 CIKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
              L  L +  N               L  L L+ NKL  ++P  L   K I+ + L  N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273

Query: 165 DLE----GMVPTEGVFKNASAISV--LGNNKL 190
           ++           G     ++ S   L +N +
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 43/194 (22%), Positives = 75/194 (38%), Gaps = 17/194 (8%)

Query: 1   ILALDSNRL-SGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLS 58
           ++ L +N L S  I       +KKL    ++D  +  +IP   GL  SLT + L  N ++
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 205

Query: 59  GTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
             +    L GL +L  L LS N         + N  +L  L ++ N L  ++P  L    
Sbjct: 206 -KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263

Query: 118 KLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFK 177
            ++++ +  N    +   D          P +         ++L  N ++        F+
Sbjct: 264 YIQVVYLHNNNISAIGSNDFCP-------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316

Query: 178 NASAISV--LGNNK 189
                +   LGN K
Sbjct: 317 CVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 25/168 (14%)

Query: 27  YVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP-QLMGLTSLVALDLSRNQFRGSF 85
             SD  L+  +P  L        + L NN ++  I       L +L  L L  N+     
Sbjct: 37  QCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKIS 92

Query: 86  PTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGE 145
           P     L+ LE L +S N L+ E+P                 + + L  L +  N+++ +
Sbjct: 93  PGAFAPLVKLERLYLSKNQLK-ELPE---------------KMPKTLQELRVHENEIT-K 135

Query: 146 IPEF-LVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
           + +    GL  +  + L  N L+      G F+    +S +   +  +
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 35/147 (23%), Positives = 55/147 (37%), Gaps = 12/147 (8%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701
           +P D        +L L  N  I  I      NL +L  + L  N ++   P   + L  L
Sbjct: 46  VPKDLPP--DTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 702 VILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRI 760
             LYL  N+L  + P  +    ++ E  V EN+I   +     F  L  +    +GTN +
Sbjct: 103 ERLYLSKNQLKEL-PEKMP--KTLQELRVHENEIT-KVR-KSVFNGLNQMIVVELGTNPL 157

Query: 761 T-GAIPPSI-SNASKLEVFQALNNKLT 785
               I         KL   +  +  +T
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNIT 184

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 49/238 (20%), Positives = 88/238 (36%), Gaps = 20/238 (8%)

Query: 550 IGSKAQKVTILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEIGR-LRRLQV 607
           +      +T+L LE   L+ S+   I  N   L  L++ NN+    I  +  +    LQ 
Sbjct: 112 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQN 169

Query: 608 PDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSI 667
             L++N +     V+LS   +L    ++ N L     S       +E L    +N I  +
Sbjct: 170 LQLSSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDAS-HNSINVV 220

Query: 668 PPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
             P+     L  + L  NNL       L     LV + L  N L  I+      +  +  
Sbjct: 221 RGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276

Query: 728 FDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
             +  N++   + L  G  +  L+   +  N +   +  +     +LE     +N + 
Sbjct: 277 LYISNNRLV-ALNLY-GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 30/177 (16%), Positives = 74/177 (41%), Gaps = 10/177 (5%)

Query: 562 LESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPV 621
           L    ++ ++L  +     ++ L+  +NS    +   +     L +  L +N++  +   
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLT-DTA- 242

Query: 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKIS 681
            L +   L+ + L+ N+L   +   F  + ++E L +  NN + ++      + +L+ + 
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS-NNRLVALNLYGQPIPTLKVLD 301

Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
           L+ N+L   +     +   L  LYL  N +  +  S+   + ++    +  N    N
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 47/247 (19%), Positives = 92/247 (37%), Gaps = 32/247 (12%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGE 618
           + ++              L+  KI+  +N++    +P+ +    R++++ +LN+  I  E
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQI-EE 83

Query: 619 IPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPL-GNLS 675
           I     +    + ++ +  N +   +P   F ++  + VL L   N + S+P  +  N  
Sbjct: 84  IDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLE-RNDLSSLPRGIFHNTP 141

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-----------NISS 724
            L  +S++ NNL      T     +L  L L  NRL+ +   S+             +S+
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLST 200

Query: 725 IA------EFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ 778
           +A      E D   N I   +          L    +  N +T      + N   L    
Sbjct: 201 LAIPIAVEELDASHNSIN-VVRGP---VNVELTILKLQHNNLTD--TAWLLNYPGLVEVD 254

Query: 779 ALNNKLT 785
              N+L 
Sbjct: 255 LSYNELE 261

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 39/212 (18%), Positives = 80/212 (37%), Gaps = 22/212 (10%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           L +L ++ + L  I        + L+ L L +N  TH +   +  +  L   +++ N + 
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS 199

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSS 676
                 L+    +  +  + N +   +        ++ +L L  NNL       L N   
Sbjct: 200 -----TLAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQHNNLTD--TAWLLNYPG 249

Query: 677 LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ 736
           L ++ L+ N L   +     K++ L  LY+  NRL  +       I ++   D+  N + 
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL 308

Query: 737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI 768
            ++  +       L+   +  N I   +  S 
Sbjct: 309 -HVERNQ-PQFDRLENLYLDHNSIV-TLKLST 337

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 36/218 (16%), Positives = 82/218 (37%), Gaps = 13/218 (5%)

Query: 570 SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSN 628
            I  ++        ++++  +       E   L   ++    N+++  ++P   L S   
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 70

Query: 629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNL 687
           +  + L   Q+       F     I+ L +GFN  I  +PP    N+  L  + L  N+L
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 688 AGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTL 747
           +            L  L +  N L  I   +    +S+    +  N++  ++ L     +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LI 185

Query: 748 QNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            +L + ++  N ++     +++    +E   A +N + 
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 218

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 40/257 (15%), Positives = 87/257 (33%), Gaps = 37/257 (14%)

Query: 555 QKVTILDLESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVP 608
           + +T+ + + +    S +  +      +   +++LNL +     EI +        +Q  
Sbjct: 40  EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKL 98

Query: 609 DLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGS 666
            +  N+I   +P +   +   L  + L +N L   +P   F +  K+  LS+  NN +  
Sbjct: 99  YMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS-NNNLER 155

Query: 667 IPPP-LGNLSSLRKISLAINNLAGSIPF-----------------TLSKLKNLVILYLGV 708
           I        +SL+ + L+ N L   +                   TL+    +  L    
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASH 214

Query: 709 NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI 768
           N ++ +    +     +    +  N +       +      L    +  N +   +    
Sbjct: 215 NSINVV-RGPVN--VELTILKLQHNNL---TDTAWLLNYPGLVEVDLSYNELEKIMYHPF 268

Query: 769 SNASKLEVFQALNNKLT 785
               +LE     NN+L 
Sbjct: 269 VKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 40/198 (20%), Positives = 73/198 (36%), Gaps = 26/198 (13%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L SNRL+ ++      +  L    VS N L     S+L +  ++  +   +N+++  
Sbjct: 169 NLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-V 219

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           +   +     L  L L  N         + N   L  + +S N L+  +        +LE
Sbjct: 220 VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275

Query: 121 ILEMQGN-------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
            L +  N         Q +    +LDLS N L   +         +ENL L +N +  + 
Sbjct: 276 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL- 333

Query: 171 PTEGVFKNASAISVLGNN 188
                      +++  N+
Sbjct: 334 -KLSTHHTLKNLTLSHND 350

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 45/206 (21%), Positives = 79/206 (38%), Gaps = 22/206 (10%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
           L    +S N+  ++     + E   S N +   +     +   LT + L +NNL  T   
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTA 242

Query: 64  QLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKLEIL 122
            L+    LV +DLS N+            +  LE L +S N L   +         L++L
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 123 EMQGNV----------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPT 172
           ++  N           F  L  L L  N +   +   L     ++NL LS+ND +     
Sbjct: 301 DLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSL 356

Query: 173 EGVFKNASAISVLGNNKLCGGISEFK 198
             +F+N +  +V   ++ C    + +
Sbjct: 357 RALFRNVARPAVDDADQHCKIDYQLE 382

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 27/201 (13%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           L L+ N LS ++P  I  N  KL    +S+N L+     +     SL  + L +N L+  
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 179

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           +   L  + SL   ++S N       + +   I +E L  S N +   +       ++L 
Sbjct: 180 VDLSL--IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELT 229

Query: 121 ILEMQGN------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
           IL++Q N             L  +DLS N+L   +    V ++ +E L +S N L  +  
Sbjct: 230 ILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-- 287

Query: 172 TEGVFKNASAISVL--GNNKL 190
                +    + VL   +N L
Sbjct: 288 -NLYGQPIPTLKVLDLSHNHL 307

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 30/162 (18%), Positives = 63/162 (38%), Gaps = 11/162 (6%)

Query: 562 LESLKLAGSILPHIGNLSF--LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           +E L  + + +  +       L IL L++N+ T    + +     L   DL+ N +  +I
Sbjct: 207 VEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KI 263

Query: 620 PVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678
             +       L R+ ++ N+L+  +      +  ++VL L  +N +  +         L 
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS-HNHLLHVERNQPQFDRLE 321

Query: 679 KISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF 720
            + L  N++  ++    S    L  L L  N        ++F
Sbjct: 322 NLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALF 360

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 39/178 (21%), Positives = 63/178 (35%), Gaps = 27/178 (15%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           L++ +N L   I          L    +S N L   +   L L  SL    +  N LS  
Sbjct: 146 LSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-- 199

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
               L    ++  LD S N         V   + L  L +  N L     + L +   L 
Sbjct: 200 ---TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLV 251

Query: 121 ILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
            +++  N         F     L  L +S N+L   +  +   +  ++ L+LS+N L 
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 34/179 (18%), Positives = 58/179 (32%), Gaps = 18/179 (10%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           + +D              L         ++ ++    + L     +  + L +  +   I
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84

Query: 62  PPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKL 119
                    ++  L +  N  R   P  V  N+  L  L +  N L         +  KL
Sbjct: 85  DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 143

Query: 120 EILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             L M  N         FQ  T    L LS N+L+  +   L  +  + + N+SYN L 
Sbjct: 144 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 31/143 (21%), Positives = 47/143 (32%), Gaps = 20/143 (13%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL L  N L+      + N   LVE  +S N L+  +       + L  + + NN L   
Sbjct: 230 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           +      + +L  LDLS N               LE L +  N +               
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-------------- 331

Query: 121 ILEMQGNVFQGLTILDLSRNKLS 143
              ++ +    L  L LS N   
Sbjct: 332 --TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 26/156 (16%), Positives = 52/156 (33%), Gaps = 17/156 (10%)

Query: 46  SLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGN 103
           +   +   N+ +   +P   L     +  L+L+  Q      T        ++ L +  N
Sbjct: 46  NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 103

Query: 104 ILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVG 152
            ++   P    +   L +L ++ N        +F        L +S N L     +    
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163

Query: 153 LKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNN 188
              ++NL LS N L  +     +  +    +V  N 
Sbjct: 164 TTSLQNLQLSSNRLTHV--DLSLIPSLFHANVSYNL 197

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 31/169 (18%), Positives = 61/169 (36%), Gaps = 17/169 (10%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLIN 94
            I S+L        + +           + + L +   +    +  R   P  +  +   
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLS 143
           +E L ++   ++            ++ L M  N        VFQ    LT+L L RN LS
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 144 GEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
                       +  L++S N+LE +   +  F+  +++  L   +N+L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERI--EDDTFQATTSLQNLQLSSNRL 177

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 89.5 bits (222), Expect = 2e-18
 Identities = 41/206 (19%), Positives = 80/206 (38%), Gaps = 11/206 (5%)

Query: 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLA 635
            L+  + L L  N       S    L +LQ+ +L +      I      +  NL  + L 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP--LGNLSSLRKISLAINNLAG-SIP 692
            +++    P  F  L  +  L L F  L  ++       NL +L ++ L+ N +    + 
Sbjct: 82  SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141

Query: 693 FTLSKLKNLVILYLGVNRLSGIVPSSIFNIS--SIAEFDVGENKIQGNIPLDYG-----F 745
            +  KL +L  +    N++  +    +  +   +++ F +  N +   + +D+G     F
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201

Query: 746 TLQNLQYFSIGTNRITGAIPPSISNA 771
               L+   +  N  T  I  + SNA
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNA 227

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 84.5 bits (209), Expect = 7e-17
 Identities = 65/309 (21%), Positives = 100/309 (32%), Gaps = 37/309 (11%)

Query: 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRV----NNIIECLISMLRIGSKAQKVTILDLE 563
                +     N +      S      I       + I+        G     V  LDL 
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS 274

Query: 564 SLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN 622
              +  S+   +   L  LK+LNL  N            L  LQV +L+ N +G     N
Sbjct: 275 HGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333

Query: 623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL 682
                 +  I L KN +       F  L K++ L L  N L       +  + S+  I L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFL 388

Query: 683 AINNLAGSIPFTLS---------------------KLKNLVILYLGVNRLSGIVPSSIF- 720
           + N L       L+                     ++ +L IL L  NR S         
Sbjct: 389 SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448

Query: 721 NISSIAEFDVGENKIQG----NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEV 776
              S+ +  +GEN +Q      +  D    L +LQ   +  N +    P   S+ + L  
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508

Query: 777 FQALNNKLT 785
               +N+LT
Sbjct: 509 LSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 81.0 bits (200), Expect = 6e-16
 Identities = 47/251 (18%), Positives = 87/251 (34%), Gaps = 33/251 (13%)

Query: 562 LESLKLAGSILPHIGNLSF-------LKILNLENNSFTHEIPSEIG------RLRRLQVP 608
           L+S+  + + +  +            L   +L  NS    +  + G      R   L++ 
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209

Query: 609 DLNNNSIGGEIPVNLSSC------------SNLIRIGLAKNQLMGKIPSDFGSL--SKIE 654
           D++ N    +I  N S+              +++  G   + +     + F  L  S + 
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR 269

Query: 655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
            L L    +          L  L+ ++LA N +          L NL +L L  N L  +
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329

Query: 715 VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKL 774
             S+ + +  +A  D+ +N I   I       L+ LQ   +  N +T     +I     +
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSI 383

Query: 775 EVFQALNNKLT 785
                  NKL 
Sbjct: 384 PDIFLSGNKLV 394

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 74.1 bits (182), Expect = 9e-14
 Identities = 47/238 (19%), Positives = 90/238 (37%), Gaps = 24/238 (10%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
            KV  +DL+   +A         L  L+ L+L +N+ T      I  +  +    L+ N 
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNK 392

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMG-KIPSDFGSLSKIEVLSLGFNNLIGSIPPP--L 671
           +   +P    + + +    L++N+L    I      +  +++L L  N    S       
Sbjct: 393 LV-TLPKINLTANLIH---LSENRLENLDILYFLLRVPHLQILILNQNR-FSSCSGDQTP 447

Query: 672 GNLSSLRKISLAINNLAGSI-----PFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA 726
               SL ++ L  N L  +            L +L +LYL  N L+ + P    +++++ 
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 727 EFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL 784
              +  N++     L +     NL+   I  N++    P    +   L V    +NK 
Sbjct: 508 GLSLNSNRLTV---LSHNDLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 36/183 (19%), Positives = 64/183 (34%), Gaps = 21/183 (11%)

Query: 6   SNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQ- 64
              L+  +P  +   ++L    +S N+++    SS    E L  + L +     TI  + 
Sbjct: 13  FCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68

Query: 65  LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEI--PSTLGSCIKLEIL 122
              L +L  LDL  ++     P     L +L  L +    L   +       +   L  L
Sbjct: 69  FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128

Query: 123 EMQGN---------VFQGLT---ILDLSRNKLSGEIPEFLVGLKV--IENLNLSYNDLEG 168
           ++  N          F  L     +D S N++       L  L+   +   +L+ N L  
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188

Query: 169 MVP 171
            V 
Sbjct: 189 RVS 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 72.5 bits (178), Expect = 3e-13
 Identities = 31/185 (16%), Positives = 60/185 (32%), Gaps = 20/185 (10%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSI-PSSLGLCESLTTIGLFNNNLSG 59
            L L  N +      S   L++L    +   +   +I   +     +L  + L ++ +  
Sbjct: 28  RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY- 86

Query: 60  TIPPQ-LMGLTSLVALDLSRNQFRGSF--PTEVGNLINLETLTVSGNILQG-EIPSTLGS 115
            + P    GL  L  L L       +        NL  L  L +S N ++   +  + G 
Sbjct: 87  FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146

Query: 116 CIKLEILEMQGNVFQG-------------LTILDLSRNKLSGEIPE-FLVGLKVIENLNL 161
              L+ ++   N                 L+   L+ N L   +   +   +    N+ L
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206

Query: 162 SYNDL 166
              D+
Sbjct: 207 EILDV 211

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.8 bits (176), Expect = 6e-13
 Identities = 34/220 (15%), Positives = 69/220 (31%), Gaps = 32/220 (14%)

Query: 2   LALDSNRLSGNIPPSIGNLKK--LVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
                + +      +   L +  +    +S  F+           + L  + L  N ++ 
Sbjct: 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK 304

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
                  GL +L  L+LS N     + +    L  +  + +  N +      T     KL
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364

Query: 120 EILEMQGNVFQ--------------------------GLTILDLSRNKLSG-EIPEFLVG 152
           + L+++ N                                ++ LS N+L   +I  FL+ 
Sbjct: 365 QTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLR 424

Query: 153 LKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
           +  ++ L L+ N        +       ++  L  G N L
Sbjct: 425 VPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENML 463

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.3 bits (167), Expect = 6e-12
 Identities = 45/208 (21%), Positives = 77/208 (37%), Gaps = 27/208 (12%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L  N+++     +   L  L    +S N L     S+      +  I L  N+++  
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
                  L  L  LDL  N       T +  + ++  + +SGN L   +P      +   
Sbjct: 354 QDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKI---NLTAN 404

Query: 121 ILEMQGNVFQG------------LTILDLSRNKLSG-EIPEFLVGLKVIENLNLSYNDLE 167
           ++ +  N  +             L IL L++N+ S     +       +E L L  N L+
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464

Query: 168 GMVPTE---GVFKNASAISVL--GNNKL 190
               TE    VF+  S + VL   +N L
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYL 492

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 33/142 (23%), Positives = 51/142 (35%), Gaps = 24/142 (16%)

Query: 54  NNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTL 113
             NL+  +P     L +   L LS N  R    +    L  L+ L +        I    
Sbjct: 13  FCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK-- 66

Query: 114 GSCIKLEILEMQGNVFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
                          F+    L ILDL  +K+    P+   GL  +  L L +  L   V
Sbjct: 67  -------------EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 171 PTEGVFKNASAISVL--GNNKL 190
             +G F+N  A++ L    N++
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQI 135

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 39/174 (22%), Positives = 65/174 (37%), Gaps = 27/174 (15%)

Query: 1   ILALDSNRLSG-NIPPSIGNLKKLVEPYVSDNFLKG-SIPSSLGLCESLTTIGLFNNNLS 58
           ++ L  NRL   +I   +  +  L    ++ N     S   +     SL  + L  N L 
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464

Query: 59  GTIPPQL-----MGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTL 113
                +L      GL+ L  L L+ N      P    +L  L  L+++ N          
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN---------- 514

Query: 114 GSCIKLEILEMQGNVFQG-LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
                  +  +  N     L ILD+SRN+L    P+  V L V+   ++++N  
Sbjct: 515 ------RLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVL---DITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 39/200 (19%), Positives = 71/200 (35%), Gaps = 19/200 (9%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI-----GNLSFLKILNLENNSFT 592
           N    C        +    +  L L    L  +    +       LS L++L L +N   
Sbjct: 436 NRFSSCSGDQTPSENP--SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493

Query: 593 HEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSK 652
              P     L  L+   LN+N +   +  N    +NL  + +++NQL+   P  F SLS 
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRL-TVLSHNDLP-ANLEILDISRNQLLAPNPDVFVSLSV 551

Query: 653 IEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI----PFTLS--KLKNLVILYL 706
           ++   +  N  I         ++ L   ++ I      I    P + S   L +L     
Sbjct: 552 LD---ITHNKFICEC-ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGC 607

Query: 707 GVNRLSGIVPSSIFNISSIA 726
               +   +  S+F + ++ 
Sbjct: 608 DEEEVLKSLKFSLFIVCTVT 627

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 60/250 (24%), Positives = 98/250 (39%), Gaps = 49/250 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK-- 331
           L+G GSF  VY+         V +K+ +   ++     +    E +    ++H ++++  
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 332 -VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR---EDEVDKAPRNLNLLQRLNI 387
             F   + V Y       LV E   NG +  +L    +   E+E     R+  + Q    
Sbjct: 78  NYFEDSNYV-Y-------LVLEMCHNGEMNRYLKNRVKPFSENEA----RHF-MHQ---- 120

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              + + + YLH        H DL  SN+LL   M   + DFGLA     T ++      
Sbjct: 121 ---IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKH 169

Query: 448 K---GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD--MNLHN--- 499
               G+  YI+PE    S      DV+S G +   L+I + P    F+ D   N  N   
Sbjct: 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTDTVKNTLNKVV 225

Query: 500 FARMALPDHV 509
            A   +P  +
Sbjct: 226 LADYEMPSFL 235

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 88.5 bits (219), Expect = 2e-18
 Identities = 54/274 (19%), Positives = 101/274 (36%), Gaps = 41/274 (14%)

Query: 516 TLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI 575
           +  +  E  A+    R   + +  + ECLI+           + L L  L L+ S+  ++
Sbjct: 31  SAWDKWEKQALPGENRNEAVSL--LKECLINQF---------SELQLNRLNLS-SLPDNL 78

Query: 576 GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA 635
                + +L +  N+    +P     L  L   D  +N +   +P   +S  +L    + 
Sbjct: 79  PPQ--ITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPASLKHLD---VD 128

Query: 636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTL 695
            NQL   +P     L   E ++   NN +  +P    +L  L   S+  N L   +P   
Sbjct: 129 NNQLT-MLPELPALL---EYINAD-NNQLTMLPELPTSLEVL---SVRNNQL-TFLP--- 176

Query: 696 SKLKNLVILYLGVNRLSGIVPSSIFNISSIAE----FDVGENKIQGNIPLDYGFTLQNLQ 751
              ++L  L +  N L  + P+         E    F   EN+I  +IP +   +L    
Sbjct: 177 ELPESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRIT-HIPENIL-SLDPTC 233

Query: 752 YFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              +  N ++  I  S+S  +    +       +
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 85.0 bits (210), Expect = 2e-17
 Identities = 43/165 (26%), Positives = 61/165 (36%), Gaps = 27/165 (16%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L    NRLS  +P    +LK L    V +N L   +P        L  I   NN L+  +
Sbjct: 105 LDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-ML 155

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P      TSL  L +  NQ     P       +LE L VS N+L+  +P+        E 
Sbjct: 156 PELP---TSLEVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEE 207

Query: 122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
                             N+++  IPE ++ L     + L  N L
Sbjct: 208 T---------EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 24/132 (18%), Positives = 45/132 (34%), Gaps = 14/132 (10%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           +  D+N+L+  +P    +L+ L    V +N L   +P       SL  + +  N L  ++
Sbjct: 145 INADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPELPE---SLEALDVSTNLLE-SL 195

Query: 62  PPQLMGLTSL----VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCI 117
           P   +         +      N+     P  + +L    T+ +  N L   I  +L    
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254

Query: 118 KLEILEMQGNVF 129
                      F
Sbjct: 255 AQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 22/119 (18%), Positives = 42/119 (35%), Gaps = 11/119 (9%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLF----NNNL 57
           L++ +N+L+  +P    +L+ L    VS N L+ S+P+            +F     N +
Sbjct: 165 LSVRNNQLTF-LPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219

Query: 58  SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC 116
           +  IP  ++ L     + L  N    S   E  +    +       I          + 
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 22/119 (18%), Positives = 37/119 (31%), Gaps = 25/119 (21%)

Query: 52  LFNNNLSGT---IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGE 108
            F N +SGT                   +RN+           +     L ++   L   
Sbjct: 17  SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-S 73

Query: 109 IPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           +P  L                  +T+L++++N L   +PE    L   E L+   N L 
Sbjct: 74  LPDNLP---------------PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS 113

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 44/234 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK---VFT 334
           IG GSFG VY+  L +    V +K         +R    E + +R + H N+V+    F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
             S  + +   +  LV +++      E +Y V R     K    +  ++       +  +
Sbjct: 118 --SSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVK--LYMYQLFRS 168

Query: 395 LDYLHHD--CQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTHVQTSSIGVKGSI 451
           L Y+H    C     H D+KP N+LLD +     + DFG A+ L       S        
Sbjct: 169 LAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-------- 215

Query: 452 GYI------APEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
            YI      APE   G+   +++ DV+S G ++ EL++  +P   +F GD  + 
Sbjct: 216 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFPGDSGVD 264

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 59/235 (25%), Positives = 87/235 (37%), Gaps = 55/235 (23%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK-- 331
            +G G F   ++    + +     K+     L           E    RS+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 332 -VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR----EDEVDKAPRNLNLLQRLN 386
             F     V +       +V E  +  SL E      R    E E          L+++ 
Sbjct: 108 GFFEDNDFV-F-------VVLELCRRRSLLELH--KRRKALTEPEARY------YLRQI- 150

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
                     YLH +      H DLK  N+ L+E++   +GDFGLA     T V+     
Sbjct: 151 -----VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGER 197

Query: 447 VK---GSIGYIAPEY----GLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            K   G+  YIAPE     G   EV    DV+S G +M  L++ K P    FE  
Sbjct: 198 KKVLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 244

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 23/209 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFI-AECR-ALRSIRHRNLVKVFTA 335
           +G G++G V K         + VK      +   +  +  +   ++R++     V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             G  ++  D   +  E M + SL+++        +V    + +       IA+ +  AL
Sbjct: 71  FYGALFREGDVW-ICMELM-DTSLDKFY------KQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           ++LH     I  H D+KPSN+L++      + DFG++ +L     +    G K    Y+A
Sbjct: 123 EHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCK---PYMA 177

Query: 456 PE----YGLGSEVSTNGDVYSYGILMLEL 480
           PE           S   D++S GI M+EL
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIEL 206

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 29/227 (12%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIR 325
              D +    +IG+G+   V        +  V +K  NL   + S   +  E +A+    
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V  +T+     +   D   LV + +  GS+ + +  +  + E          L   
Sbjct: 72  HPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDES 121

Query: 386 NIAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
            IA    +V   L+YLH + Q I  H D+K  NILL E+    + DFG++ FL      T
Sbjct: 122 TIATILREVLEGLEYLHKNGQ-I--HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178

Query: 443 SSIGVKGSIG---YIAPE-----YGLGSEVSTNGDVYSYGILMLELI 481
            +   K  +G   ++APE      G   +     D++S+GI  +EL 
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELA 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 31/222 (13%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            +G G FG+VY     + +  + +KV     L           E      +RH N+++++
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                  +       L+ EF   G L + L    R DE  ++              ++A 
Sbjct: 81  NY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSAT---------FMEELAD 125

Query: 394 ALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           AL Y H         H D+KP N+L+  +    + DFG +   P    +T      G++ 
Sbjct: 126 ALHYCHERKV----IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLD 177

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           Y+ PE   G       D++  G+L  E ++   P    F+  
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 50/216 (23%), Positives = 80/216 (37%), Gaps = 27/216 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRAL-RSIRHRNLVKVFTA 335
           +G+G+ G V+K    +    + VK      ++     I  +   + +S     +V+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C G      D   +  E M   + +          E               + + +  AL
Sbjct: 89  CFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGK----------MTVAIVKAL 137

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            YL      I  H D+KPSNILLDE     + DFG++  L     +  S G      Y+A
Sbjct: 138 YYLKEKHGVI--HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA---AYMA 192

Query: 456 PE-----YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           PE          +     DV+S GI ++EL   + P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 88.0 bits (217), Expect = 6e-18
 Identities = 105/596 (17%), Positives = 188/596 (31%), Gaps = 157/596 (26%)

Query: 120 EILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNA 179
            I+  +  V   L +     +K    + +F     V E L ++Y  L   + TE   +  
Sbjct: 53  HIIMSKDAVSGTLRLFWTLLSKQEEMVQKF-----VEEVLRINYKFLMSPIKTE--QRQP 105

Query: 180 SAISVLGN---NKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIA----------IVSGL 226
           S ++ +     ++L      F        K    RL   LKL  A          ++ G+
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFA-------KYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158

Query: 227 MG-----LALT--LSISFLC-------WVRKRKEQSNPNSLINSLLNLSYQ---NLHNAT 269
           +G     +AL   LS    C       W+  +   S P +++  L  L YQ   N  + +
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS-PETVLEMLQKLLYQIDPNWTSRS 217

Query: 270 DGFSSA------------NLIGTGSFGSVYKG---VLDEGRTTVTVKVFNLHHHRASRSF 314
           D  S+              L+        Y+    VL   +       FNL         
Sbjct: 218 DHSSNIKLRIHSIQAELRRLL----KSKPYENCLLVLLNVQNAKAWNAFNLS-------- 265

Query: 315 IAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK 374
              C+ L + R + +    +A +      +     +        L ++L     +     
Sbjct: 266 ---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL-----DCRPQD 317

Query: 375 APRNLNLLQRLNIAIDVASALD-------YLHHDCQPITTHCDLKPS-NILLDEEMVSHV 426
            PR +       ++I   S  D       + H +C  +TT   ++ S N+L   E     
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT--IIESSLNVLEPAEYRKMF 375

Query: 427 GDFGLARFLPPTHVQTSSIGV--KGSIGY----IAPEYGLGSEVSTNGDVYSYGILMLEL 480
               +  F P  H+ T  + +     I      +  +    S V       +  I  + L
Sbjct: 376 DRLSV--FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433

Query: 481 IIRKKPSDIMFEGDMNLH-------NFARMALPDHVMDIVDSTLLNDVED---------- 523
            ++ K  +     +  LH       N  +    D         L+    D          
Sbjct: 434 ELKVKLEN-----EYALHRSIVDHYNIPKTFDSDD--------LIPPYLDQYFYSHIGHH 480

Query: 524 LAIISNQRQ----RQIRVN-NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNL 578
           L  I +  +    R + ++   +E            QK+   D  +   +GSIL  +  L
Sbjct: 481 LKNIEHPERMTLFRMVFLDFRFLE------------QKI-RHDSTAWNASGSILNTLQQL 527

Query: 579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL 634
            F K          + I     +  RL V  + +     E  +  S  ++L+RI L
Sbjct: 528 KFYK---------PY-ICDNDPKYERL-VNAILDFLPKIEENLICSKYTDLLRIAL 572

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.6 bits (138), Expect = 1e-08
 Identities = 72/418 (17%), Positives = 147/418 (35%), Gaps = 92/418 (22%)

Query: 396 DYLHHDCQPITTHCDLK-----PSNILLDEEMVSHVGDFGLARFLPPTHVQTS-----SI 445
           D L         + D K     P +IL  EE + H+        +    V  +     ++
Sbjct: 20  DILSVFEDAFVDNFDCKDVQDMPKSILSKEE-IDHI-------IMSKDAVSGTLRLFWTL 71

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKPSDI--MFEGDMN-LHNFA 501
             K        +  +   +  N     Y  LM  +    ++PS +  M+    + L+N  
Sbjct: 72  LSKQEEMV---QKFVEEVLRIN-----YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQ--RQIRVNNIIECLISMLRIGSKAQKVTI 559
           ++    +V      + L     L      RQ   ++R    +  +  +L  G    K T 
Sbjct: 124 QVFAKYNV------SRLQPYLKL------RQALLELRPAKNV-LIDGVLGSG----K-TW 165

Query: 560 LDLESLKLAGSILPHIGNLSFLKI--LNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
           + L+    +  +   +      KI  LNL+N +    +   + +L     P+  + S   
Sbjct: 166 VALDVCL-SYKVQCKMDF----KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220

Query: 618 E-IPVNLSSCSNLIRIGLA----KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG 672
             I + + S    +R  L     +N L+  +  +  +       +L    L+ +    + 
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 673 N-LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN------RLSGIVPSSIFNISSI 725
           + LS+     +++++   S+  T  ++K+L++ YL          +    P     +S I
Sbjct: 279 DFLSAATTTHISLDHH--SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP---RRLSII 333

Query: 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEV---FQAL 780
           AE       I+     D   T  N ++  +  +++T  I  S++     E    F  L
Sbjct: 334 AES------IR-----DGLATWDNWKH--VNCDKLTTIIESSLNVLEPAEYRKMFDRL 378

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 1e-07
 Identities = 59/448 (13%), Positives = 116/448 (25%), Gaps = 138/448 (30%)

Query: 66  M---GLTSLVALDLSRNQFRGSFPTEV-----GN-------LINLETL--TVSGNILQGE 108
           +   G T +        + +     ++      N       L  L+ L   +  N     
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217

Query: 109 -----IPSTLGSCIKLEILE-MQGNVFQ-GLTILDLSRNKLSGEIPEFLVGLK------- 154
                I   + S I+ E+   ++   ++  L +L   +N        F +  K       
Sbjct: 218 DHSSNIKLRIHS-IQAELRRLLKSKPYENCLLVLLNVQNA--KAWNAFNLSCKILLTTRF 274

Query: 155 --VIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPP--C-------- 202
             V + L+ +      +             S+L             LP            
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK---YLDCRPQDLPREVLTTNPRRLS 331

Query: 203 --------GLKKSTEWRLTFELKLVIAIVSGLMGLA--------LTLSISFLCWVRKRKE 246
                   GL     W+     KL   I S L  L           LS+ F         
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV-F-------PP 383

Query: 247 QSN-PNSLINSL-LNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN 304
            ++ P  L++ +  ++   ++    +     +L+      S                   
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS---------------- 427

Query: 305 LHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG-----ND---FKALVYEFMQ 355
           +   +   +  +    AL    HR++V  +      D         D   +  + +    
Sbjct: 428 IPSIYLELKVKLENEYAL----HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483

Query: 356 NGSLEEW-LYP------------VNREDEVDKAPRN-LNLLQRLNIAIDVASALDYLHHD 401
               E   L+             +  +     A  + LN LQ+L           Y  + 
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---------YKPY- 533

Query: 402 CQPITTHCDLKPSNILLDEEMVSHVGDF 429
              I  +           E +V+ + DF
Sbjct: 534 ---ICDNDP-------KYERLVNAILDF 551

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 52/274 (18%), Positives = 108/274 (39%), Gaps = 22/274 (8%)

Query: 512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571
           I   T +N +     ++N  +     +N+ +         +    +T L      +  + 
Sbjct: 3   ITQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQ---ADLDGITTLSAFGTGV--TT 55

Query: 572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIR 631
           +  +  L+ L  L L++N  T    + +  L ++   +L+ N +  +    ++   ++  
Sbjct: 56  IEGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKT 111

Query: 632 IGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI 691
           + L   Q+    P     LS ++VL L   N I +I P L  L++L+ +S+    ++   
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLD-LNQITNISP-LAGLTNLQYLSIGNAQVSDLT 167

Query: 692 PFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQ 751
           P  L+ L  L  L    N++S I  S + ++ ++ E  +  N+I    PL       NL 
Sbjct: 168 P--LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLAN---TSNLF 220

Query: 752 YFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
             ++    IT       +N     V +  +    
Sbjct: 221 IVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 21/175 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L+     ++  I   +  L  L+   + DN +   + + L     +T + L  N L   +
Sbjct: 46  LSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPLK-NV 100

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              + GL S+  LDL+  Q     P  +  L NL+ L +  N +   I   L     L+ 
Sbjct: 101 SA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQY 155

Query: 122 LEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L +                LT L    NK+S +I   L  L  +  ++L  N + 
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 31/162 (19%), Positives = 64/162 (39%), Gaps = 19/162 (11%)

Query: 19  NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSR 78
            L   ++     + +      +    + +TT+  F   ++ TI   +  L +L+ L+L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 79  NQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------VF 129
           NQ        + NL  +  L +SGN L  +  S +     ++ L++              
Sbjct: 73  NQITD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 130 QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
             L +L L  N+++  I   L GL  ++ L++    +  + P
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP 168

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 38/174 (21%), Positives = 63/174 (36%), Gaps = 19/174 (10%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L  N L  N+   I  L+ +    ++   +    P  L    +L  + L  N ++  I
Sbjct: 90  LELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NI 144

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
            P L GLT+L  L +   Q      T + NL  L TL    N +  +I   L S   L  
Sbjct: 145 SP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIE 199

Query: 122 LEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           + ++ N             L I+ L+   ++ +   +   L V   +       
Sbjct: 200 VHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 26/135 (19%), Positives = 50/135 (37%), Gaps = 17/135 (12%)

Query: 65  LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEM 124
              L + + +   ++           +L  + TL+  G  +   I   +     L  LE+
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 125 QGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGV 175
           + N             +T L+LS N L       + GL+ I+ L+L+   +  + P  G 
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTPLAG- 127

Query: 176 FKNASAISVLGNNKL 190
             N   +  L  N++
Sbjct: 128 LSNLQVLY-LDLNQI 141

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 83.4 bits (207), Expect = 9e-18
 Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 35/208 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GS+G V   V    R     K    +       F  E   ++S+ H N+++++    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              ++ N    LV E    G L E +       E D A           I  DV SA+ Y
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVAY 121

Query: 398 LHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            H     +  H DLKP N L      +    + DFGLA    P  +  + +   G+  Y+
Sbjct: 122 CHK--LNV-AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYV 175

Query: 455 APE-----YGLGSEVSTNGDVYSYGILM 477
           +P+     YG   E     D +S G++M
Sbjct: 176 SPQVLEGLYGP--EC----DEWSAGVMM 197

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++    IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI-- 389
              +     Y   D   +V E++  GSL          D V +       +    IA   
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSL---------TDVVTETC-----MDEGQIAAVC 122

Query: 390 -DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            +   AL++LH +      H D+K  NILL  +    + DFG    + P   + S++   
Sbjct: 123 RECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--- 176

Query: 449 GSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             +G   ++APE           D++S GI+ +E+I
Sbjct: 177 --VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 14/231 (6%)

Query: 558 TILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
             L+L    +   I      +L  L++L L  NS    I       L  L   +L +N +
Sbjct: 78  RYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWL 135

Query: 616 GGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP-LG 672
              IP       S L  + L  N +   IPS  F  +  +  L LG    +  I      
Sbjct: 136 -TVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
            L +L+ ++L + N+   +P  L+ L  L  L +  N    I P S   +SS+ +  V  
Sbjct: 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNN 782
           +++   I  +    L +L   ++  N ++ ++P  + +    L      +N
Sbjct: 252 SQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 12/210 (5%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQL 639
            + LNL  N+           L  L+V  L  NSI  +I V   +  ++L  + L  N L
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWL 135

Query: 640 MGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIP-FTLS 696
              IPS  F  LSK+  L L  NN I SIP      + SL ++ L        I      
Sbjct: 136 -TVIPSGAFEYLSKLRELWLR-NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
            L NL  L LG+  +  +   ++  +  + E ++  N     I       L +L+   + 
Sbjct: 194 GLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVM 250

Query: 757 TNRITGAIPP-SISNASKLEVFQALNNKLT 785
            ++++  I   +    + L      +N L+
Sbjct: 251 NSQVS-LIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 32/204 (15%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNLS 58
           L L  N +   I       L  L    + DN+L   IPS     L   L  + L NN + 
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYL-SKLRELWLRNNPIE 160

Query: 59  GTIPPQ-LMGLTSLVALDLSR-NQFR----GSFPTEVGNLINLETLTVSGNILQGEIPST 112
            +IP      + SL+ LDL    +      G+F      L NL+ L +    ++ ++P  
Sbjct: 161 -SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF----EGLFNLKYLNLGMCNIK-DMP-N 213

Query: 113 LGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNL 161
           L   + LE LEM GN         F G   L  L +  +++S        GL  +  LNL
Sbjct: 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273

Query: 162 SYNDLEGMVPTEGVFKNASAISVL 185
           ++N+L   +P   +F     +  L
Sbjct: 274 AHNNLS-SLP-HDLFTPLRYLVEL 295

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 42/210 (20%), Positives = 70/210 (33%), Gaps = 30/210 (14%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNL 57
            L L  N +   I      +L  L    +  N ++  I      GL  SL T+ LF+N L
Sbjct: 79  YLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGL-ASLNTLELFDNWL 135

Query: 58  SGTIPPQ-LMGLTSLVALDLSRNQFR----GSFPTEVGNLINLETLTVSG-NILQGEIPS 111
           +  IP      L+ L  L L  N        +F      + +L  L +     L+     
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAF----NRVPSLMRLDLGELKKLEYISEG 190

Query: 112 TLGSCIKLEILEMQGN------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLS 162
                  L+ L +                L  L++S N      P    GL  ++ L + 
Sbjct: 191 AFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 163 YNDLEGMVPTEGVFKNASAISVL--GNNKL 190
            + +  +      F   +++  L   +N L
Sbjct: 251 NSQVSLI--ERNAFDGLASLVELNLAHNNL 278

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 40/195 (20%), Positives = 63/195 (32%), Gaps = 48/195 (24%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPP-QLMGLTSLVALDLSRNQ--------FRG--- 83
            +P   G+  +   + L  NN+   I       L  L  L L RN         F G   
Sbjct: 68  EVPQ--GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS 124

Query: 84  ------------SFPTEV-GNLINLETLTVSGNILQGEIPS-TLGSCIKLEILEMQGN-- 127
                         P+     L  L  L +  N ++  IPS        L  L++     
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183

Query: 128 -------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFK 177
                   F+GL     L+L    +  ++P     L  +E L +S N         G F 
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGNHFP--EIRPGSFH 239

Query: 178 NASAISVLG--NNKL 190
             S++  L   N+++
Sbjct: 240 GLSSLKKLWVMNSQV 254

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 36/166 (21%), Positives = 62/166 (37%), Gaps = 12/166 (7%)

Query: 625 SCSN-LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISL 682
           SCSN   ++   +  L  ++P      S    L+L  NN I  I      +L  L  + L
Sbjct: 51  SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENN-IQMIQADTFRHLHHLEVLQL 106

Query: 683 AINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD 742
             N++        + L +L  L L  N L+ I   +   +S + E  +  N I+ +IP  
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP-S 164

Query: 743 YGFT-LQNLQYFSIG-TNRITGAIPPSI-SNASKLEVFQALNNKLT 785
           Y F  + +L    +G   ++   I          L+        + 
Sbjct: 165 YAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK 209

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 7/107 (6%)

Query: 562 LESLKLAG---SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           L+ L L       +P++  L  L+ L +  N F    P     L  L+   + N+ +   
Sbjct: 198 LKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-L 256

Query: 619 IPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNL 663
           I  N     ++L+ + LA N L   +P D F  L  +  L L  N  
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 51/276 (18%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHH--RASRSFIAECRALRSIR 325
           + +   IG+G+ G V           V +K     F    H  RA R    E   ++ + 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVN 82

Query: 326 HRNLVK---VFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           H+N++    VFT    ++    +F+   +V E M     +  L  V + +   +    L 
Sbjct: 83  HKNIIGLLNVFTPQKSLE----EFQDVYIVMELM-----DANLCQVIQMELDHERMSYL- 132

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
           L Q L         + +LH     I  H DLKPSNI++  +    + DFGLAR    + +
Sbjct: 133 LYQMLC-------GIKHLH-SAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
            T  +  +    Y APE  LG     N D++S G +M E+I       ++F G  ++  +
Sbjct: 183 MTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQW 235

Query: 501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR 536
                 + V++ + +      E +  +    +  + 
Sbjct: 236 ------NKVIEQLGTP---CPEFMKKLQPTVRTYVE 262

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 53/258 (20%), Positives = 88/258 (34%), Gaps = 60/258 (23%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK---VFT 334
           +GTGSFG V +    E      +K         +R    E   ++ + H N++K    F 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 335 ACS---GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
                     Q  D    +       +       VN           LN++    +   +
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-----LNVIMEY-VPDTL 124

Query: 392 ASALDYLHHDCQPITT-----------------------HCDLKPSNILLDEEMVS-HVG 427
              L       + I                         H D+KP N+L++ +  +  + 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 428 DFGLARFLPPTHVQTSSIGVKGSIGYI------APEYGLGSEVSTNG-DVYSYGILMLEL 480
           DFG A+ L P+    +         YI      APE  LG+   T   D++S G +  EL
Sbjct: 185 DFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 481 IIRKKPSDIMFEGDMNLH 498
           I+  KP   +F G+ ++ 
Sbjct: 236 ILG-KP---LFSGETSID 249

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 12/210 (5%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQL 639
            ++LNL  N       +    LR L++  L+ N I   I +   +  +NL  + L  N+L
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRL 124

Query: 640 MGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIP-FTLS 696
              IP+  F  LSK++ L L  NN I SIP      + SLR++ L        I      
Sbjct: 125 -TTIPNGAFVYLSKLKELWLR-NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
            L NL  L L +  L  I   ++  +  + E D+  N +   I       L +LQ   + 
Sbjct: 183 GLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMI 239

Query: 757 TNRITGAIPP-SISNASKLEVFQALNNKLT 785
            ++I   I   +  N   L      +N LT
Sbjct: 240 QSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 12/211 (5%)

Query: 577 NLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGL 634
           +L  L+IL L  N     I       L  L   +L +N +   IP       S L  + L
Sbjct: 86  HLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWL 143

Query: 635 AKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIP 692
             N +   IPS  F  +  +  L LG    +  I       LS+LR ++LA+ NL   IP
Sbjct: 144 RNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201

Query: 693 FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQY 752
             L+ L  L  L L  N LS I P S   +  + +  + +++IQ  I  +    LQ+L  
Sbjct: 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259

Query: 753 FSIGTNRITGAIPPSI-SNASKLEVFQALNN 782
            ++  N +T  +P  + +    LE     +N
Sbjct: 260 INLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 13/205 (6%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
           LE L+L+ + +  I       L+ L  L L +N  T  IP+     L +L+   L NN I
Sbjct: 90  LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148

Query: 616 GGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLGN 673
              IP    +   +L R+ L + + +  I    F  LS +  L+L   NL     P L  
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPNLTP 205

Query: 674 LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
           L  L ++ L+ N+L+   P +   L +L  L++  +++  I  ++  N+ S+ E ++  N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265

Query: 734 KIQGNIPLDYGFTLQNLQYFSIGTN 758
            +   +P D    L +L+   +  N
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 32/204 (15%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNLS 58
           L L  N +   I       L  L    + DN L  +IP+     L   L  + L NN + 
Sbjct: 93  LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYL-SKLKELWLRNNPIE 149

Query: 59  GTIPPQL-MGLTSLVALDLSR-NQFR----GSFPTEVGNLINLETLTVSGNILQGEIPST 112
            +IP      + SL  LDL    +      G+F      L NL  L ++   L+ EIP  
Sbjct: 150 -SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF----EGLSNLRYLNLAMCNLR-EIP-N 202

Query: 113 LGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNL 161
           L   IKL+ L++ GN         FQG   L  L + ++++          L+ +  +NL
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262

Query: 162 SYNDLEGMVPTEGVFKNASAISVL 185
           ++N+L  ++P   +F     +  +
Sbjct: 263 AHNNLT-LLP-HDLFTPLHHLERI 284

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 20/205 (9%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           +L L  N++   I  +   +L+ L    +S N ++     +     +L T+ LF+N L+ 
Sbjct: 68  LLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT- 125

Query: 60  TIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPS-TLGSC 116
           TIP    + L+ L  L L  N    S P+     + +L  L +        I        
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184

Query: 117 IKLEILEMQGN------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             L  L +                L  LDLS N LS   P    GL  ++ L +  + ++
Sbjct: 185 SNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244

Query: 168 GMVPTEGVFKNASAISVL--GNNKL 190
            +      F N  ++  +   +N L
Sbjct: 245 VI--ERNAFDNLQSLVEINLAHNNL 267

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 43/195 (22%), Positives = 67/195 (34%), Gaps = 48/195 (24%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPP-QLMGLTSLVALDLSRNQ--------FRG--- 83
            +P   G+  +   + L  N +   I       L  L  L LSRN         F G   
Sbjct: 57  EVPD--GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113

Query: 84  ------------SFPTEV-GNLINLETLTVSGNILQGEIPS-TLGSCIKLEILEMQGN-- 127
                       + P      L  L+ L +  N ++  IPS        L  L++     
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172

Query: 128 -------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFK 177
                   F+G   L  L+L+   L  EIP     L  ++ L+LS N L  + P  G F+
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLT-PLIKLDELDLSGNHLSAIRP--GSFQ 228

Query: 178 NASAISVLG--NNKL 190
               +  L    +++
Sbjct: 229 GLMHLQKLWMIQSQI 243

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 34/147 (23%), Positives = 57/147 (38%), Gaps = 10/147 (6%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701
           +P      +   +L+L  N  I  I      +L  L  + L+ N++        + L NL
Sbjct: 58  VPDGI--STNTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 702 VILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIG-TNR 759
             L L  NRL+ I   +   +S + E  +  N I+ +IP  Y F  + +L+   +G   R
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIP-SYAFNRIPSLRRLDLGELKR 172

Query: 760 ITGAIPPSI-SNASKLEVFQALNNKLT 785
           ++  I        S L         L 
Sbjct: 173 LS-YISEGAFEGLSNLRYLNLAMCNLR 198

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 30/107 (28%), Positives = 43/107 (40%), Gaps = 7/107 (6%)

Query: 562 LESLKLAG---SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           L  L LA      +P++  L  L  L+L  N  +   P     L  LQ   +  + I   
Sbjct: 187 LRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-V 245

Query: 619 IPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNL 663
           I  N   +  +L+ I LA N L   +P D F  L  +E + L  N  
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 85.5 bits (212), Expect = 2e-17
 Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 30/249 (12%)

Query: 243 KRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV 302
               Q +  +     +     +L    + +     +G+G++G V             +K+
Sbjct: 13  NLYFQGDLQATPGMFITSKKGHLS---EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69

Query: 303 FNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLE 360
                    ++   + E   L+ + H N++K++       ++      LV E  + G L 
Sbjct: 70  IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELF 124

Query: 361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL-- 418
           + +    + +EVD A           I   V S + YLH     I  H DLKP N+LL  
Sbjct: 125 DEIIHRMKFNEVDAA----------VIIKQVLSGVTYLHK--HNIV-HRDLKPENLLLES 171

Query: 419 -DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
            +++ +  + DFGL+            +   G+  YIAPE  L  +     DV+S G+++
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEV-LRKKYDEKCDVWSIGVIL 227

Query: 478 LELIIRKKP 486
             L+    P
Sbjct: 228 FILLAGYPP 236

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 45/220 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS---------FIAECRALRSI-RHR 327
           +G G    V + +         VK+ ++    +  +          + E   LR +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N++++        Y+ N F  LV++ M+ G L ++L       E +             I
Sbjct: 85  NIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR----------KI 129

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              +   +  LH     I  H DLKP NILLD++M   + DFG +  L P          
Sbjct: 130 MRALLEVICALHK--LNIV-HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-- 184

Query: 448 KGSIGYIAPE----------YGLGSEVSTNGDVYSYGILM 477
            G+  Y+APE           G G EV    D++S G++M
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 27/213 (12%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
             S   IG GS G V           V VK+ +L   +       E   +R  +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++ +     Y   +   ++ EF+Q G+L + +    R +E   A           +   V
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIA----------TVCEAV 150

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             AL YLH     I  H D+K  +ILL  +    + DFG    +     +  S+     +
Sbjct: 151 LQALAYLHAQ-GVI--HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-----V 202

Query: 452 G---YIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           G   ++APE    S  +T  D++S GI+++E++
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 19/214 (8%)

Query: 562 LESLKLAGSILPHIG-----NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           L +L L  + +  I       L  L+ L +  N    EIP  +     L    +++N I 
Sbjct: 80  LYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR 136

Query: 617 GEIPVN-LSSCSNLIRIGLAKNQL-MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
            ++P    S   N+  I +  N L             K+  L +    L   IP      
Sbjct: 137 -KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLP 192

Query: 675 SSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
            +L ++ L  N +  +I    L +   L  L LG N++  I   S+  + ++ E  +  N
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251

Query: 734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS 767
           K+   +P      L+ LQ   + TN IT  +  +
Sbjct: 252 KLS-RVPAGL-PDLKLLQVVYLHTNNIT-KVGVN 282

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 17/214 (7%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQL 639
             +L+L+NN  +     +   L+ L    L NN I  +I     S    L ++ ++KN L
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNHL 114

Query: 640 MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP-LGNLSSLRKISLAINNLAGSI--PFTLS 696
             +IP      S +  L +  +N I  +P      L ++  I +  N L  S   P    
Sbjct: 115 -VEIPP--NLPSSLVELRIH-DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
            L  L  L +   +L+GI P  +    ++ E  +  NKIQ  I L+       L    +G
Sbjct: 171 GL-KLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225

Query: 757 TNRITGAIPPSI-SNASKLEVFQALNNKLTGEVP 789
            N+I   I     S    L      NNKL+  VP
Sbjct: 226 HNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVP 257

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 48/202 (23%), Positives = 77/202 (38%), Gaps = 43/202 (21%)

Query: 2   LALDSNRLSGNIPP-SIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           L L +N++S  I   +   L+KL + Y+S N L   IP    L  SL  + + +N +   
Sbjct: 83  LVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-K 137

Query: 61  IPPQ-LMGLTSLVALDLSRNQFR------GSFP--------------TEV--GNLINLET 97
           +P     GL ++  +++  N         G+F               T +       L  
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE 197

Query: 98  LTVSGNILQGEIPS-TLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLSGE 145
           L +  N +Q  I    L    KL  L +  N            L     L L  NKLS  
Sbjct: 198 LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255

Query: 146 IPEFLVGLKVIENLNLSYNDLE 167
           +P  L  LK+++ + L  N++ 
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 17/164 (10%)

Query: 560 LDLESLKLAGSILPHI--GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIG 616
           L L  L+++ + L  I       L  L+L++N     I  E   R  +L    L +N I 
Sbjct: 172 LKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR 230

Query: 617 GEIPVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP------ 669
             I    LS    L  + L  N+L  ++P+    L  ++V+ L  NN I  +        
Sbjct: 231 -MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN-ITKVGVNDFCPV 287

Query: 670 -PLGNLSSLRKISLAINNLAGSI--PFTLSKLKNLVILYLGVNR 710
                 +    ISL  N +      P T   + + + +  G  +
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 35/210 (16%), Positives = 66/210 (31%), Gaps = 28/210 (13%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLK-GSIPSSLGLCESLTTIGLFNNNLSG 59
           L +  NR+   +P  +   L+ +    +  N L+             L  + +    L+ 
Sbjct: 128 LRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT- 185

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIK 118
            IP  L    +L  L L  N+ + +   E       L  L +  N ++     +L     
Sbjct: 186 GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242

Query: 119 LEILEMQGN-------VFQGLT---ILDLSRNKLSGEIPE-------FLVGLKVIENLNL 161
           L  L +  N           L    ++ L  N ++ ++         F V       ++L
Sbjct: 243 LRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISL 301

Query: 162 SYNDLEGMVPTEGVFKNASAISV--LGNNK 189
             N +         F+  +       GN K
Sbjct: 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 39/164 (23%), Positives = 59/164 (35%), Gaps = 22/164 (13%)

Query: 29  SDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP-QLMGLTSLVALDLSRNQFRGSFPT 87
           SD  LK ++P  +      T + L NN++S  +      GL  L AL L  N+       
Sbjct: 41  SDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEK 96

Query: 88  EVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIP 147
               L  L+ L +S N L  EIP                N+   L  L +  N++     
Sbjct: 97  AFSPLRKLQKLYISKNHLV-EIPP---------------NLPSSLVELRIHDNRIRKVPK 140

Query: 148 EFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV-LGNNKL 190
               GL+ +  + +  N LE      G F       + +   KL
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 11/146 (7%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701
           +P +        +L L  N+ I  +       L  L  + L  N ++       S L+ L
Sbjct: 48  VPKEISP--DTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 702 VILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRI 760
             LY+  N L  I P ++   SS+ E  + +N+I+  +P    F+ L+N+    +G N +
Sbjct: 105 QKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIR-KVP-KGVFSGLRNMNCIEMGGNPL 159

Query: 761 T-GAIPPSISNASKLEVFQALNNKLT 785
                 P   +  KL   +    KLT
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT 185

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 83.3 bits (206), Expect = 4e-17
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 18/223 (8%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G++G VYK    +G+      +  +     S S   E   LR ++H N++ +     
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
                 +    L++++ ++  L   +   +R  + +K P  L      ++   +   + Y
Sbjct: 89  S---HADRKVWLLFDYAEH-DLWHIIK-FHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 398 LHHDCQPITTHCDLKPSNILLDEEMVSH----VGDFGLAR-FLPPTHVQTSSIGVKGSIG 452
           LH +      H DLKP+NIL+  E        + D G AR F  P         V  +  
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200

Query: 453 YIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           Y APE  LG+   +   D+++ G +  EL +  +P   +F   
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAEL-LTSEP---IFHCR 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 39/239 (16%)

Query: 262 YQNLHNATD---GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAEC 318
           Y+++    D    +     +G G+FG VYK    E       KV           +I E 
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67

Query: 319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN 378
             L +  H  +VK+  A     Y  +    ++ EF   G++         +  + +  R 
Sbjct: 68  EILATCDHPYIVKLLGA-----YYHDGKLWIMIEFCPGGAV---------DAIMLELDRG 113

Query: 379 LNLLQRLNIAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL 435
           L   Q   I +    +  AL++LH   + I  H DLK  N+L+  E    + DFG++   
Sbjct: 114 LTEPQ---IQVVCRQMLEALNFLHSK-RII--HRDLKAGNVLMTLEGDIRLADFGVSAKN 167

Query: 436 PPTHVQTSSIGVKGSIG---YIAPEYGLGSEVSTNG-----DVYSYGILMLELIIRKKP 486
             T  +  S      IG   ++APE  +   +         D++S GI ++E+   + P
Sbjct: 168 LKTLQKRDSF-----IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 22/209 (10%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFI-AECR-ALRSIRHRNLVKVFTA 335
           IG G++GSV K V       + VK          +  +  +    +RS     +V+ + A
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                ++  D   +  E M + S +++   V     V        +L +  I +    AL
Sbjct: 90  L----FREGDCW-ICMELM-STSFDKFYKYVYS---VLDDVIPEEILGK--ITLATVKAL 138

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           ++L  + + I  H D+KPSNILLD      + DFG++  L  +  +T   G +    Y+A
Sbjct: 139 NHLKENLKII--HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCR---PYMA 193

Query: 456 PE----YGLGSEVSTNGDVYSYGILMLEL 480
           PE               DV+S GI + EL
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 11/206 (5%)

Query: 561 DLESLKLAGSILPHIG-----NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
             + + L G+ + H+          L IL L +N       +    L  L+  DL++N+ 
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 616 GGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLG 672
              +          L  + L +  L  ++    F  L+ ++ L L  +N + ++P     
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ-DNALQALPDDTFR 150

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
           +L +L  + L  N ++         L +L  L L  NR++ + P +  ++  +    +  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTN 758
           N +   +P +    L+ LQY  +  N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 48/201 (23%), Positives = 77/201 (38%), Gaps = 24/201 (11%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNLS 58
           + L  NR+S ++P +     + L   ++  N L   I ++   GL   L  + L +N   
Sbjct: 37  IFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGL-ALLEQLDLSDNAQL 93

Query: 59  GTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPS-TLGS 115
            ++ P    GL  L  L L R   +      +   L  L+ L +  N LQ  +P  T   
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151

Query: 116 CIKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
              L  L + GN         F+G   L  L L +N+++   P     L  +  L L  N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 165 DLEGMVPTEGVFKNASAISVL 185
           +L   +P         A+  L
Sbjct: 212 NLS-ALP-TEALAPLRALQYL 230

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 36/174 (20%), Positives = 60/174 (34%), Gaps = 28/174 (16%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFR----GSFPTEVGN 91
           ++P   G+  +   I L  N +S           +L  L L  N        +F      
Sbjct: 25  AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF----TG 78

Query: 92  LINLETLTVSGNILQGEIPS-TLGSCIKLEILEMQGN--------VFQGLT---ILDLSR 139
           L  LE L +S N     +   T     +L  L +           +F+GL     L L  
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 140 NKLSGEIPE-FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
           N L   +P+     L  + +L L  N +  +   E  F+   ++  L    N++
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSV--PERAFRGLHSLDRLLLHQNRV 189

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 10/172 (5%)

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP-LGNLSS 676
            +PV + +     RI L  N++     + F +   + +L L  N  +  I       L+ 
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLAL 81

Query: 677 LRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
           L ++ L+ N    S+   T   L  L  L+L    L  + P     ++++    + +N +
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 736 QGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNNKLT 785
           Q  +P D  F  L NL +  +  NRI+ ++P         L+      N++ 
Sbjct: 142 Q-ALPDD-TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA 190

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 39/171 (22%), Positives = 64/171 (37%), Gaps = 28/171 (16%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNLS 58
           L L  N    ++ P+    L +L   ++    L+  +   L  GL  +L  + L +N L 
Sbjct: 85  LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL-AALQYLYLQDNALQ 142

Query: 59  GTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSC 116
             +P      L +L  L L  N+   S P      L +L+ L +  N +   +       
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHP----- 194

Query: 117 IKLEILEMQGNVFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
                     + F+ L     L L  N LS    E L  L+ ++ L L+ N
Sbjct: 195 ----------HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 8/85 (9%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNLS 58
           L L  NR+S ++P      L  L    +  N +   +       L   L T+ LF NNLS
Sbjct: 158 LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDL-GRLMTLYLFANNLS 214

Query: 59  GTIPPQLM-GLTSLVALDLSRNQFR 82
             +P + +  L +L  L L+ N + 
Sbjct: 215 -ALPTEALAPLRALQYLRLNDNPWV 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.0 bits (207), Expect = 6e-17
 Identities = 47/229 (20%), Positives = 86/229 (37%), Gaps = 17/229 (7%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
           +    +L+   +  +       L+ +  +   N+     +   I  L  +    LN N +
Sbjct: 22  ETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKL 77

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
             +I   L++  NL  + L +N++   + S    L K++ LSL  N  I  I   L +L 
Sbjct: 78  T-DIK-PLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNG-ISDING-LVHLP 131

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
            L  + L  N +   I   LS+L  L  L L  N++S I    +  ++ +    + +N I
Sbjct: 132 QLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 187

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL 784
                L     L+NL    + +           SN       +  +  L
Sbjct: 188 SDLRALAG---LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.8 bits (183), Expect = 5e-14
 Identities = 49/258 (18%), Positives = 96/258 (37%), Gaps = 29/258 (11%)

Query: 512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIE-----------------CLISMLRIGSKA 554
           I  ST +  +      +   +  ++  ++ +                   I  ++     
Sbjct: 5   ITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYL 64

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
             VT L L   KL  + +  + NL  L  L L+ N    ++ S +  L++L+   L +N 
Sbjct: 65  PNVTKLFLNGNKL--TDIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNG 120

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
           I  +I   L     L  + L  N++     +    L+K++ LSL  +N I  I P L  L
Sbjct: 121 IS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLE-DNQISDIVP-LAGL 174

Query: 675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK 734
           + L+ + L+ N+++  +   L+ LKNL +L L          +   N+         +  
Sbjct: 175 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232

Query: 735 IQGNIPLDYGFTLQNLQY 752
           +     +      +    
Sbjct: 233 LVTPEIISDDGDYEKPNV 250

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 38/176 (21%), Positives = 74/176 (42%), Gaps = 15/176 (8%)

Query: 610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
             +  I  +I     + +  I+  L K  +          L+ I+ +    ++ I S+  
Sbjct: 6   TVSTPIK-QIF-PDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSD-IKSVQG 60

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFD 729
            +  L ++ K+ L  N L   I   L+ LKNL  L+L  N++  +  SS+ ++  +    
Sbjct: 61  -IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLS 115

Query: 730 VGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           +  N I     L     L  L+   +G N+IT      +S  +KL+     +N+++
Sbjct: 116 LEHNGISDINGLV---HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 25/166 (15%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
               S  +   I P      + ++  +    +  ++        S+  I   N+++  ++
Sbjct: 4   TITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV 58

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +  L ++  L L+ N+     P  + NL NL  L +  N ++ ++ S+L    KL+ 
Sbjct: 59  QG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKS 113

Query: 122 LEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L              L  N +S +I   LV L  +E+L L  N + 
Sbjct: 114 L-------------SLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 34/172 (19%), Positives = 63/172 (36%), Gaps = 8/172 (4%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L+L+ N +S +I   + +L +L   Y+ +N +  +  + L     L T+ L +N +S  
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-D 167

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           I P L GLT L  L LS+N    S    +  L NL+ L +       +  +   + +   
Sbjct: 168 IVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224

Query: 121 ILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPT 172
            ++          I+    +     +   L       +         G    
Sbjct: 225 TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 31/149 (20%), Positives = 57/149 (38%), Gaps = 7/149 (4%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L L +N+++ +I   +  L KL    + DN +   I   L     L  + L  N++S  +
Sbjct: 136 LYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL 190

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVS-GNILQGEIPSTLGSCIKLE 120
              L GL +L  L+L   +          NL+   T+  + G+++  EI S  G   K  
Sbjct: 191 RA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 249

Query: 121 ILEMQGNVFQGLTILDLSRNKLSGEIPEF 149
           +          ++ +      +      F
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTIGKAKARF 278

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 82.8 bits (205), Expect = 9e-17
 Identities = 63/247 (25%), Positives = 100/247 (40%), Gaps = 32/247 (12%)

Query: 250 PNSLINSLLNLSYQNLHNATDGFSSA----NLIGTGSFGSVYKGVLDEGRTTVTVKVFN- 304
           P S+++ L       + ++T  FS       ++G GSFG V             VKV + 
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 305 --LHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEW 362
             +       S + E + L+ + H N++K++       ++   +  LV E    G L + 
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDE 116

Query: 363 LYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---D 419
           +    R  EVD A           I   V S + Y+H     I  H DLKP N+LL    
Sbjct: 117 IISRKRFSEVDAA----------RIIRQVLSGITYMHK--NKIV-HRDLKPENLLLESKS 163

Query: 420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE 479
           ++    + DFGL+     +      I   G+  YIAPE  L        DV+S G+++  
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEV-LHGTYDEKCDVWSTGVILYI 219

Query: 480 LIIRKKP 486
           L+    P
Sbjct: 220 LLSGCPP 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 64/249 (25%), Positives = 103/249 (41%), Gaps = 45/249 (18%)

Query: 263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR 322
           +        +++  +IG GSFG V++  L E    V +K         +R    E + +R
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMR 87

Query: 323 SIRHRNLVK---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            ++H N+V     F   S  D +   F  LV E++      E +Y  +R     K    +
Sbjct: 88  IVKHPNVVDLKAFFY--SNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPM 140

Query: 380 NLLQRLNIAIDVASALDYLHHD--CQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLP 436
            L++       +  +L Y+H    C     H D+KP N+LLD       + DFG A+ L 
Sbjct: 141 LLIK--LYMYQLLRSLAYIHSIGIC-----HRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

Query: 437 PTHVQTSSIGVKGSIGYI------APEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDI 489
                 S         YI      APE   G+   +TN D++S G +M EL+   +P   
Sbjct: 194 AGEPNVS---------YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP--- 240

Query: 490 MFEGDMNLH 498
           +F G+  + 
Sbjct: 241 LFPGESGID 249

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 49/249 (19%), Positives = 85/249 (34%), Gaps = 44/249 (17%)

Query: 259 NLSYQNLHNATDG---FSSANLIGTG--SFGSVYKGVLDEGRTTVTVKVFNLHHHRASR- 312
           NL +Q + +       +    +IG G     +V           VTV+  NL        
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70

Query: 313 -SFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE 371
                E    +   H N+V          +  ++   +V  FM  GS ++ +        
Sbjct: 71  TFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLI-------- 117

Query: 372 VDKAPRNLNLLQRLNIAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428
                  ++ +  L IA     V  ALDY+HH    +  H  +K S+IL+  +   ++  
Sbjct: 118 ---CTHFMDGMNELAIAYILQGVLKALDYIHHMGY-V--HRSVKASHILISVDGKVYLSG 171

Query: 429 FGLARFLPPTHV--QTSSIGVKGSIG---YIAPE------YGLGSEVSTNGDVYSYGILM 477
                 +       +      K S+    +++PE       G  ++     D+YS GI  
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITA 227

Query: 478 LELIIRKKP 486
            EL     P
Sbjct: 228 CELANGHVP 236

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 82.7 bits (204), Expect = 2e-16
 Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 20/233 (8%)

Query: 555 QKVTILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEIGR-LRRLQVPDLNN 612
             +T+L LE   L+ S+   I  N   L  L++ NN+    I  +  +    LQ   L++
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180

Query: 613 NSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG 672
           N +     V+LS   +L    ++ N L     S       +E L    +N I  +  P+ 
Sbjct: 181 NRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDAS-HNSINVVRGPV- 230

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
               L  + L  NNL       L     LV + L  N L  I+      +  +    +  
Sbjct: 231 -NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287

Query: 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           N++   + L  G  +  L+   +  N +   +  +     +LE     +N + 
Sbjct: 288 NRLV-ALNLY-GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 81.5 bits (201), Expect = 4e-16
 Identities = 30/177 (16%), Positives = 74/177 (41%), Gaps = 10/177 (5%)

Query: 562 LESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPV 621
           L    ++ ++L  +     ++ L+  +NS    +   +     L +  L +N++  +   
Sbjct: 194 LFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLT-DTA- 248

Query: 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKIS 681
            L +   L+ + L+ N+L   +   F  + ++E L +  NN + ++      + +L+ + 
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS-NNRLVALNLYGQPIPTLKVLD 307

Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN 738
           L+ N+L   +     +   L  LYL  N +  +  S+   + ++    +  N    N
Sbjct: 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWDCN 360

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.0 bits (192), Expect = 5e-15
 Identities = 43/230 (18%), Positives = 93/230 (40%), Gaps = 20/230 (8%)

Query: 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGE 618
           + ++              L+  KI+  +N++    +P+ +    R++++ +LN+  I  E
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQI-EE 89

Query: 619 IPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPL-GNLS 675
           I     +    + ++ +  N +   +P   F ++  + VL L   N + S+P  +  N  
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLE-RNDLSSLPRGIFHNTP 147

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
            L  +S++ NNL      T     +L  L L  NRL+ +   S+    S+   +V  N +
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLI--PSLFHANVSYNLL 204

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
              +          ++      N I   +   ++   +L + +  +N LT
Sbjct: 205 S-TLA-----IPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT 245

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.9 bits (189), Expect = 9e-15
 Identities = 45/251 (17%), Positives = 88/251 (35%), Gaps = 39/251 (15%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
            + +    S +  +      +   +++LNL +     EI +        +Q   +  N+I
Sbjct: 53  QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI 111

Query: 616 GGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP-LG 672
              +P ++  +   L  + L +N L   +P   F +  K+  LS+  NN +  I      
Sbjct: 112 R-YLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMS-NNNLERIEDDTFQ 168

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
             +SL+ + L+ N L   +  +L  + +L    +  N LS     ++    ++ E D   
Sbjct: 169 ATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 220

Query: 733 NKI----------------QGN--IPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKL 774
           N I                Q N      +      L    +  N +   +        +L
Sbjct: 221 NSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 280

Query: 775 EVFQALNNKLT 785
           E     NN+L 
Sbjct: 281 ERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.9 bits (189), Expect = 1e-14
 Identities = 36/218 (16%), Positives = 82/218 (37%), Gaps = 13/218 (5%)

Query: 570 SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSN 628
            I  ++        ++++  +       E   L   ++    N+++  ++P   L S   
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 76

Query: 629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNL 687
           +  + L   Q+       F     I+ L +GFN  I  +PP    N+  L  + L  N+L
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDL 135

Query: 688 AGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTL 747
           +            L  L +  N L  I   +    +S+    +  N++  ++ L     +
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LI 191

Query: 748 QNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            +L + ++  N ++     +++    +E   A +N + 
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.5 bits (188), Expect = 2e-14
 Identities = 39/212 (18%), Positives = 80/212 (37%), Gaps = 22/212 (10%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
           L +L ++ + L  I        + L+ L L +N  TH +   +  +  L   +++ N + 
Sbjct: 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS 205

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSS 676
                 L+    +  +  + N +   +        ++ +L L  NNL       L N   
Sbjct: 206 -----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPG 255

Query: 677 LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ 736
           L ++ L+ N L   +     K++ L  LY+  NRL  +       I ++   D+  N + 
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL 314

Query: 737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI 768
            ++  +       L+   +  N I   +  S 
Sbjct: 315 -HVERNQ-PQFDRLENLYLDHNSIV-TLKLST 343

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.3 bits (185), Expect = 4e-14
 Identities = 38/201 (18%), Positives = 80/201 (39%), Gaps = 22/201 (10%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           I+   ++ +   +P ++  + +++    ++D  ++     +     ++  + +  N +  
Sbjct: 55  IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 112

Query: 60  TIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCI 117
            +PP     +  L  L L RN    S P  +  N   L TL++S N L+     T  +  
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 171

Query: 118 KLEILEMQGN--------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
            L+ L++  N        +   L   ++S N LS      L     +E L+ S+N +  +
Sbjct: 172 SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVV 226

Query: 170 VPTEGVFKNASAISVLGNNKL 190
                V    + +  L +N L
Sbjct: 227 --RGPVNVELTILK-LQHNNL 244

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 40/198 (20%), Positives = 73/198 (36%), Gaps = 26/198 (13%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L SNRL+ ++      +  L    VS N L     S+L +  ++  +   +N+++  
Sbjct: 175 NLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-V 225

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           +   +     L  L L  N         + N   L  + +S N L+  +        +LE
Sbjct: 226 VRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281

Query: 121 ILEMQGN-------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
            L +  N         Q +    +LDLS N L   +         +ENL L +N +  + 
Sbjct: 282 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL- 339

Query: 171 PTEGVFKNASAISVLGNN 188
                      +++  N+
Sbjct: 340 -KLSTHHTLKNLTLSHND 356

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 27/202 (13%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           +L L+ N LS ++P  I  N  KL    +S+N L+     +     SL  + L +N L+ 
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT- 184

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
            +   L  + SL   ++S N       + +   I +E L  S N +   +       ++L
Sbjct: 185 HVDLSL--IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVEL 234

Query: 120 EILEMQGN------VFQG---LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
            IL++Q N             L  +DLS N+L   +    V ++ +E L +S N L  + 
Sbjct: 235 TILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL- 293

Query: 171 PTEGVFKNASAISVL--GNNKL 190
                 +    + VL   +N L
Sbjct: 294 --NLYGQPIPTLKVLDLSHNHL 313

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 72.3 bits (177), Expect = 3e-13
 Identities = 44/194 (22%), Positives = 76/194 (39%), Gaps = 22/194 (11%)

Query: 9   LSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGL 68
           +S N+  ++     + E   S N +   +     +   LT + L +NNL  T    L+  
Sbjct: 199 VSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNY 253

Query: 69  TSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN 127
             LV +DLS N+            +  LE L +S N L   +         L++L++  N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311

Query: 128 V----------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFK 177
                      F  L  L L  N +   +   L     ++NL LS+ND +       +F+
Sbjct: 312 HLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFR 367

Query: 178 NASAISVLGNNKLC 191
           N +  +V   ++ C
Sbjct: 368 NVARPAVDDADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 25/133 (18%), Positives = 58/133 (43%), Gaps = 7/133 (5%)

Query: 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS 614
            ++TIL L+   L  +    + N   L  ++L  N     +     +++RL+   ++NN 
Sbjct: 232 VELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNL 674
           +   + +       L  + L+ N L+  +  +     ++E L L  +N I ++       
Sbjct: 290 L-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD-HNSIVTLKL--STH 344

Query: 675 SSLRKISLAINNL 687
            +L+ ++L+ N+ 
Sbjct: 345 HTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.6 bits (157), Expect = 7e-11
 Identities = 31/143 (21%), Positives = 47/143 (32%), Gaps = 20/143 (13%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL L  N L+      + N   LVE  +S N L+  +       + L  + + NN L   
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           +      + +L  LDLS N               LE L +  N +               
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-------------- 337

Query: 121 ILEMQGNVFQGLTILDLSRNKLS 143
              ++ +    L  L LS N   
Sbjct: 338 --TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 34/179 (18%), Positives = 58/179 (32%), Gaps = 18/179 (10%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           + +D              L         ++ ++    + L     +  + L +  +   I
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90

Query: 62  PPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKL 119
                    ++  L +  N  R   P  V  N+  L  L +  N L         +  KL
Sbjct: 91  DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149

Query: 120 EILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             L M  N         FQ  T    L LS N+L+  +   L  +  + + N+SYN L 
Sbjct: 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.5 bits (149), Expect = 7e-10
 Identities = 28/156 (17%), Positives = 54/156 (34%), Gaps = 17/156 (10%)

Query: 46  SLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGN 103
           +   +   N+ +   +P   L     +  L+L+  Q      T        ++ L +  N
Sbjct: 52  NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 109

Query: 104 ILQGEIPSTLGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVG 152
            ++   P    +   L +L ++ N        +F     LT L +S N L     +    
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169

Query: 153 LKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNN 188
              ++NL LS N L  +     +  +    +V  N 
Sbjct: 170 TTSLQNLQLSSNRLTHV--DLSLIPSLFHANVSYNL 203

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 31/169 (18%), Positives = 61/169 (36%), Gaps = 17/169 (10%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLIN 94
            I S+L        + +           + + L +   +    +  R   P  +  +   
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLS 143
           +E L ++   ++            ++ L M  N        VFQ    LT+L L RN LS
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136

Query: 144 GEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
                       +  L++S N+LE +   +  F+  +++  L   +N+L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERI--EDDTFQATTSLQNLQLSSNRL 183

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 19/123 (15%), Positives = 40/123 (32%), Gaps = 3/123 (2%)

Query: 664 IGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNIS 723
              I   L        + + +        F    L N  I+    + +  +  + + +  
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75

Query: 724 SIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNN 782
            +   ++ + +I+  I          +Q   +G N I   +PP +  N   L V     N
Sbjct: 76  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133

Query: 783 KLT 785
            L+
Sbjct: 134 DLS 136

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 59/283 (20%)

Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSI 324
              + +   IG+G+ G V           V +K     F  +   A R++  E   ++ +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAY-RELVLMKCV 118

Query: 325 RHRNLVK---VFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            H+N++    VFT    ++    +F+   LV E M     +  L  V + +   +    L
Sbjct: 119 NHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 169

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
            L Q L         + +LH     I  H DLKPSNI++  +    + DFGLAR    + 
Sbjct: 170 -LYQMLC-------GIKHLH-SAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

Query: 440 VQTSSIGVKGSIGYI------APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493
           + T          Y+      APE  LG     N D++S G +M E++  K    I+F G
Sbjct: 219 MMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 265

Query: 494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR 536
              +  +      + V++ + +      E +  +    +  + 
Sbjct: 266 RDYIDQW------NKVIEQLGTP---CPEFMKKLQPTVRNYVE 299

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 37/210 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN--LHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G GSFG V K      +    VKV N     ++ + + + E   L+ + H N++K+F  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 + +    +V E    G L + +    R  E D A           I   V S +
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGI 134

Query: 396 DYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            Y+H     I  H DLKP NILL   +++    + DFGL+            I   G+  
Sbjct: 135 TYMHK--HNIV-HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAY 188

Query: 453 YIAPE-----YGLGSEVSTNGDVYSYGILM 477
           YIAPE     Y    +     DV+S G+++
Sbjct: 189 YIAPEVLRGTYDE--KC----DVWSAGVIL 212

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 47/242 (19%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFNLHHHR------ASRSFIAECRA 320
             +     IG G++G V+K    + +     V +K   +            R  +A  R 
Sbjct: 11  QQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRH 67

Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN---GSLEEWLYPVNREDEVDKAPR 377
           L +  H N+V++F  C+           LV+E +       L++   P    + +    +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI----K 123

Query: 378 NLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF--- 434
           ++ + Q L         LD+LH        H DLKP NIL+       + DFGLAR    
Sbjct: 124 DM-MFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

Query: 435 -LPPTH-VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE 492
            +  T  V T        + Y APE  L S  +T  D++S G +  E+  R+KP   +F 
Sbjct: 173 QMALTSVVVT--------LWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKP---LFR 220

Query: 493 GD 494
           G 
Sbjct: 221 GS 222

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 37/210 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G GSFG V K      +    VKV N     ++ + + + E   L+ + H N++K+F  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 + +    +V E    G L + +    R  E D A           I   V S +
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGI 134

Query: 396 DYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            Y+H     I  H DLKP NILL   +++    + DFGL+            I   G+  
Sbjct: 135 TYMHK--HNIV-HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAY 188

Query: 453 YIAPE-----YGLGSEVSTNGDVYSYGILM 477
           YIAPE     Y    +     DV+S G+++
Sbjct: 189 YIAPEVLRGTY--DEKC----DVWSAGVIL 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 59/245 (24%), Positives = 94/245 (38%), Gaps = 33/245 (13%)

Query: 255 NSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSF 314
            SL  +    L +    F    L+G G++G VYKG   +      +KV ++         
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EI 67

Query: 315 IAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEV 372
             E   L+    HRN+   + A    +  G D +  LV EF   GS+ + +         
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---- 123

Query: 373 DKAPRNLNLLQRLNIAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429
                  N L+   IA    ++   L +LH        H D+K  N+LL E     + DF
Sbjct: 124 -------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173

Query: 430 GLARFLPPTHVQTSSIGVKGSIG---YIAPEYGLGSEVSTNG-----DVYSYGILMLELI 481
           G++  L  T  + ++      IG   ++APE     E          D++S GI  +E+ 
Sbjct: 174 GVSAQLDRTVGRRNTF-----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

Query: 482 IRKKP 486
               P
Sbjct: 229 EGAPP 233

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 28/229 (12%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHR 327
             +     IG G++G+V+K    E    V +K   L         S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+V++      V +       LV+EF     L+++          D    +L+     + 
Sbjct: 62  NIVRLH----DVLHSDKKL-TLVFEFCDQ-DLKKYF---------DSCNGDLDPEIVKSF 106

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIG 446
              +   L + H        H DLKP N+L++      + +FGLAR F  P    ++ + 
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV- 162

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           V  ++ Y  P+   G+++ ST+ D++S G +  EL    +P   +F G+
Sbjct: 163 V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFI-AECRALRSIR 325
           +  + F+    IG GSFG V+KG+ +  +  V +K+ +L         I  E   L    
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
              + K + +     Y  +    ++ E++  GS  + L P                L   
Sbjct: 79  SPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLEP--------------GPLDET 119

Query: 386 NIAI---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
            IA    ++   LDYLH + +    H D+K +N+LL E     + DFG+A  L  T ++ 
Sbjct: 120 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

Query: 443 SSIGVKGSIG---YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           ++      +G   ++APE    S   +  D++S GI  +EL   + P
Sbjct: 177 NTF-----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 45/208 (21%), Positives = 77/208 (37%), Gaps = 34/208 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G+G+FG V++ V          K  N  +     +   E   +  + H  L+ +  A  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116

Query: 338 GVDYQGNDFKALVYEFMQNGSL------EEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
              ++      L+ EF+  G L      E++        E +            N     
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMS-----EAEVI----------NYMRQA 158

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKG 449
              L ++H     I  H D+KP NI+ + +  S V   DFGLA  L P  +   +     
Sbjct: 159 CEGLKHMHE--HSIV-HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---A 212

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILM 477
           +  + APE      V    D+++ G+L 
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 59/256 (23%), Positives = 97/256 (37%), Gaps = 48/256 (18%)

Query: 243 KRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV 302
             +E      +  +      +      + +     +G+G++G V       G +   +KV
Sbjct: 9   SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 303 FNLHHHRASRSFIA-------------ECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349
                    R                 E   L+S+ H N++K+F       ++   +  L
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYL 123

Query: 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC 409
           V EF + G L E +   ++ DE D A          NI   + S + YLH     I  H 
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAA----------NIMKQILSGICYLHK--HNI-VHR 170

Query: 410 DLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE-----YGLG 461
           D+KP NILL   +  +   + DFGL+ F    +     +   G+  YIAPE     Y   
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEVLKKKY--N 225

Query: 462 SEVSTNGDVYSYGILM 477
            +     DV+S G++M
Sbjct: 226 EKC----DVWSCGVIM 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 44/218 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN--------LHHHRASRSFIAECRALRSIRHRNL 329
           +G+G+ G V      +    V +K+ +              + +   E   L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           +K+        +   D+  +V E M+ G L + +    R  E                  
Sbjct: 78  IKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK----------LYFY 121

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            +  A+ YLH     I  H DLKP N+LL   +E+ +  + DFG ++ L  T +  +   
Sbjct: 122 QMLLAVQYLHE--NGI-IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC- 177

Query: 447 VKGSIGYIAPE-------YGLGSEVSTNGDVYSYGILM 477
             G+  Y+APE        G    V    D +S G+++
Sbjct: 178 --GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 80.1 bits (198), Expect = 7e-16
 Identities = 35/234 (14%), Positives = 85/234 (36%), Gaps = 26/234 (11%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
            +   +T LD  +  +  + +  I  L+ L  L   +N+ T  +   + +   L     +
Sbjct: 39  EQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACD 93

Query: 612 NNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
           +N +     ++++  + L  +    N+L      D      +  L+    N +  I   +
Sbjct: 94  SNKLTN---LDVTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCA-RNTLTEI--DV 144

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
            + + L ++   +N     +    +    L  L    N+++ +    +     +   +  
Sbjct: 145 SHNTQLTELDCHLNKKITKLDV--TPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCD 199

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
            N I   + L+       L +    +N++T  I   ++  ++L  F    N LT
Sbjct: 200 TNNIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 46/211 (21%), Positives = 78/211 (36%), Gaps = 23/211 (10%)

Query: 575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL 634
              L+ L  L+  N+S T    + I +L  L      +N+I     ++LS  +NL  +  
Sbjct: 38  EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLAC 92

Query: 635 AKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFT 694
             N+L      D   L+K+  L+   N L       +     L  ++ A N L       
Sbjct: 93  DSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT---EID 143

Query: 695 LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFS 754
           +S    L  L   +N+   I    +   + +   D   NKI   + +      + L   +
Sbjct: 144 VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELDVSQ---NKLLNRLN 197

Query: 755 IGTNRITGAIPPSISNASKLEVFQALNNKLT 785
             TN IT      ++   +L      +NKLT
Sbjct: 198 CDTNNITK---LDLNQNIQLTFLDCSSNKLT 225

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 41/245 (16%), Positives = 78/245 (31%), Gaps = 42/245 (17%)

Query: 562 LESLKLAGSILPHI--GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI 619
           L  L  A + L  I   + + L  L+   N    ++   +    +L   D + N I    
Sbjct: 129 LTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI---T 183

Query: 620 PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRK 679
            +++S    L R+    N +      D     ++  L    N L   I   +  L+ L  
Sbjct: 184 ELDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTY 237

Query: 680 ISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS-------------------IF 720
              ++N L   +    S L  L  L+     L  I  +                    + 
Sbjct: 238 FDCSVNPLT-ELDV--STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVT 294

Query: 721 NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQAL 780
           + + +   D     I   + L        L Y  +    +T  +   +S+ +KL+    +
Sbjct: 295 HNTQLYLLDCQAAGIT-ELDLSQ---NPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347

Query: 781 NNKLT 785
           N  + 
Sbjct: 348 NAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 64.3 bits (157), Expect = 7e-11
 Identities = 35/234 (14%), Positives = 77/234 (32%), Gaps = 22/234 (9%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
           ++  ++T LD  S KL  + +  +  L+ L   +   N  T    S + +L  L      
Sbjct: 209 NQNIQLTFLDCSSNKL--TEID-VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL---HCI 262

Query: 612 NNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
              +   + ++L+  + LI       + + ++  D    +++ +L      +   +   L
Sbjct: 263 QTDL---LEIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-EL--DL 314

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
                L  + L    L   +   +S    L  L      +     SS+  I ++      
Sbjct: 315 SQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEA 369

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           E +    I +       N    ++  + +     P         V+    N +T
Sbjct: 370 EGQT---ITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 35/209 (16%), Positives = 71/209 (33%), Gaps = 23/209 (11%)

Query: 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAK 636
           N +       E  +       ++  L  L   D +N+SI  ++   +   + L ++    
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSL---DCHNSSI-TDMT-GIEKLTGLTKLICTS 73

Query: 637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLS 696
           N +      D    + +  L+   +N + ++   +  L+ L  ++   N L       +S
Sbjct: 74  NNITTL---DLSQNTNLTYLAC-DSNKLTNL--DVTPLTKLTYLNCDTNKLT---KLDVS 124

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
           +   L  L    N L+ I    + + + + E D   NK    + +        L      
Sbjct: 125 QNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVTP---QTQLTTLDCS 178

Query: 757 TNRITGAIPPSISNASKLEVFQALNNKLT 785
            N+IT      +S    L       N +T
Sbjct: 179 FNKITEL---DVSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 38/174 (21%), Positives = 58/174 (33%), Gaps = 25/174 (14%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L  D+N+L+  +  S      L     + N L   I   +     LT +    N      
Sbjct: 111 LNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--IT 162

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +   T L  LD S N+       +V     L  L    N +  ++   L   I+L  
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216

Query: 122 LEMQGNV--------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L+   N            LT  D S N L+ E+   +  L  +  L+    DL 
Sbjct: 217 LDCSSNKLTEIDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 37/175 (21%), Positives = 69/175 (39%), Gaps = 26/175 (14%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L   ++ ++ ++   I  L  L +   + N +  ++   L    +LT +   +N L+  +
Sbjct: 47  LDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NL 100

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +  LT L  L+   N+       +V     L  L  + N L  EI   +    +L  
Sbjct: 101 D--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTE 152

Query: 122 LEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L+   N             LT LD S NK++ E+   +   K++  LN   N++ 
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 25/163 (15%), Positives = 59/163 (36%), Gaps = 15/163 (9%)

Query: 627 SNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINN 686
            N      A  ++          L+ +  L    +++  +    +  L+ L K+    NN
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNN 75

Query: 687 LAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFT 746
           +  ++    S+  NL  L    N+L+ +    +  ++ +   +   NK+   + +     
Sbjct: 76  IT-TLDL--SQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLDVS---Q 125

Query: 747 LQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
              L Y +   N +T      +S+ ++L       NK   ++ 
Sbjct: 126 NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 35/208 (16%), Positives = 64/208 (30%), Gaps = 12/208 (5%)

Query: 562 LESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPV 621
           L +L    + L  I      +++  +          ++    +L + D     I     +
Sbjct: 256 LTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI---TEL 312

Query: 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKIS 681
           +LS    L+ + L   +L  ++  D    +K++ LS   N  I      +G + +L    
Sbjct: 313 DLSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCV-NAHIQDF-SSVGKIPALNNNF 367

Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSG----IVPSSIFNISSIAEFDVGENKIQG 737
            A          TL+     + +   +    G    I P               EN    
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTD 427

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITGAIP 765
           N  + Y FT +N       T       P
Sbjct: 428 NPAVTYTFTSENGAIVGTVTTPFEAPQP 455

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 26/176 (14%), Positives = 43/176 (24%), Gaps = 23/176 (13%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
                N L+  +  S   L KL   +     L   I   L     L             +
Sbjct: 238 FDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL 291

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              +   T L  LD            ++     L  L ++   L  E+   +    KL+ 
Sbjct: 292 D--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS 343

Query: 122 LEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
           L                  L     +  +      E L    +   ++    D  G
Sbjct: 344 LSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 30/156 (19%), Positives = 54/156 (34%), Gaps = 22/156 (14%)

Query: 19  NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSR 78
           N    V    +   ++ +   S     +LT++   N++++  +   +  LT L  L  + 
Sbjct: 19  NFASEVA---AAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTS 73

Query: 79  NQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQ 130
           N        ++    NL  L    N L   +   +    KL  L    N           
Sbjct: 74  NNITT---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNP 127

Query: 131 GLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
            LT L+ +RN L+ EI   +     +  L+   N  
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK 160

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 24/131 (18%), Positives = 43/131 (32%), Gaps = 16/131 (12%)

Query: 45  ESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNI 104
           ++  +       +  T       L +L +LD   +       T +  L  L  L  + N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75

Query: 105 LQGEIPSTLGSCIKLEILEMQGN--------VFQGLTILDLSRNKLSGEIPEFLVGLKVI 156
           +   +   L     L  L    N            LT L+   NKL+ ++   +    ++
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLL 129

Query: 157 ENLNLSYNDLE 167
             LN + N L 
Sbjct: 130 TYLNCARNTLT 140

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 50/210 (23%), Positives = 80/210 (38%), Gaps = 37/210 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
           ++G+G+F  V+            +K           S   E   L+ I+H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRE--DEVDKAPRNLNLLQRLNIAIDVASA 394
               Y+      LV + +  G L + +  + R    E D +           +   V SA
Sbjct: 75  ----YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDAS----------LVIQQVLSA 118

Query: 395 LDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           + YLH     I  H DLKP N+L    +E     + DFGL++      + T      G+ 
Sbjct: 119 VKYLHE--NGIV-HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTP 171

Query: 452 GYIAPE----YGLGSEVSTNGDVYSYGILM 477
           GY+APE          V    D +S G++ 
Sbjct: 172 GYVAPEVLAQKPYSKAV----DCWSIGVIT 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 44/219 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRA--------LRSIR-HRN 328
           IG G    V + V         VK+  +   R S   + E R         LR +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++ +  +     Y+ + F  LV++ M+ G L ++L       E +            +I 
Sbjct: 162 IITLIDS-----YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIM 206

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             +  A+ +LH     I  H DLKP NILLD+ M   + DFG +  L P           
Sbjct: 207 RSLLEAVSFLH--ANNIV-HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--- 260

Query: 449 GSIGYIAPE----------YGLGSEVSTNGDVYSYGILM 477
           G+ GY+APE           G G EV    D+++ G+++
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVIL 295

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 34/209 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G G+F  V + V          K+ N      R  +    E R  R ++H N+V++  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 Q   F  LV++ +  G L E +       E D +          +    +  ++
Sbjct: 74  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESI 118

Query: 396 DYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            Y H     I  H +LKP N+LL    +     + DFGLA  +  +          G+ G
Sbjct: 119 AYCHS--NGIV-HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPG 172

Query: 453 YIAPE----YGLGSEVSTNGDVYSYGILM 477
           Y++PE          V    D+++ G+++
Sbjct: 173 YLSPEVLKKDPYSKPV----DIWACGVIL 197

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 60/251 (23%), Positives = 100/251 (39%), Gaps = 34/251 (13%)

Query: 242 RKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVK 301
            +  +  NP       L+          + F     +G GS+GSVYK +  E    V +K
Sbjct: 2   LETVQLRNPPRRQLKKLD-EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 302 VFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEE 361
              +      +  I E   ++     ++VK + +     Y  N    +V E+   GS+  
Sbjct: 61  QVPVES--DLQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSV-- 111

Query: 362 WLYPVNREDEVDKAPRNLNLLQRLNIAI---DVASALDYLHHDCQPITTHCDLKPSNILL 418
                   D +    + L   +   IA         L+YLH   + I  H D+K  NILL
Sbjct: 112 -------SDIIRLRNKTLTEDE---IATILQSTLKGLEYLHFM-RKI--HRDIKAGNILL 158

Query: 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG---YIAPEYGLGSEVSTNGDVYSYGI 475
           + E  + + DFG+A  L  T  + +++     IG   ++APE       +   D++S GI
Sbjct: 159 NTEGHAKLADFGVAGQLTDTMAKRNTV-----IGTPFWMAPEVIQEIGYNCVADIWSLGI 213

Query: 476 LMLELIIRKKP 486
             +E+   K P
Sbjct: 214 TAIEMAEGKPP 224

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 55/250 (22%), Positives = 99/250 (39%), Gaps = 37/250 (14%)

Query: 261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL-HHHRASRSFIAECR 319
           S+       D +     +G G +  V++ +       V VK+       +  R    E +
Sbjct: 27  SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIK 82

Query: 320 ALRSIR-HRNLVKVFTACSGVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPR 377
            L ++R   N++ +      +         ALV+E + N   ++ LY    + ++    R
Sbjct: 83  ILENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDI----R 133

Query: 378 NLNLLQRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFL 435
              + + L        ALDY H         H D+KP N+++D E     + D+GLA F 
Sbjct: 134 FY-MYEILK-------ALDYCHSMGI----MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181

Query: 436 PPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            P       +    S  +  PE  +  ++   + D++S G ++  +I RK+P    F G 
Sbjct: 182 HPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 235

Query: 495 MNLHNFARMA 504
            N     R+A
Sbjct: 236 DNYDQLVRIA 245

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 46/211 (21%), Positives = 81/211 (38%), Gaps = 28/211 (13%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
            S   ++G G FG V+K         +  K+      +       E   +  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED---EVDKAPRNLNLLQRLNIA 388
           ++ A     ++  +   LV E++  G L + +  ++      E+D               
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTI----------LFM 193

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIG 446
             +   + ++H     I  H DLKP NIL        +   DFGLAR   P      +  
Sbjct: 194 KQICEGIRHMHQ--MYIL-HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF- 249

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
             G+  ++APE      VS   D++S G++ 
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 44/218 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN--------LHHHRASRSFIAECRALRSIRHRNL 329
           +G+G+ G V      +    V +++ +              + +   E   L+ + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           +K+       DY       +V E M+ G L + +    R  E                  
Sbjct: 203 IKIKNFFDAEDYY------IVLELMEGGELFDKVVGNKRLKEATCK----------LYFY 246

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            +  A+ YLH     I  H DLKP N+LL   +E+ +  + DFG ++ L  T +  +   
Sbjct: 247 QMLLAVQYLHE--NGI-IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC- 302

Query: 447 VKGSIGYIAPE-------YGLGSEVSTNGDVYSYGILM 477
             G+  Y+APE        G    V    D +S G+++
Sbjct: 303 --GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 40/242 (16%), Positives = 88/242 (36%), Gaps = 16/242 (6%)

Query: 557 VTILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNS 614
           V  LDL + ++   I          L+ L L +N     I  +    L  L+  DL+ N 
Sbjct: 54  VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 615 IGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PL 671
           +   +  +     S+L  + L  N       +  F  L+K+++L +G  +    I     
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
             L+ L ++ +  ++L    P +L  ++N+  L L + +   ++   +   SS+   ++ 
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 732 ENKIQGN-------IPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL 784
           +  +             +        +   I    +   +   ++  S L   +   N+L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 785 TG 786
             
Sbjct: 290 KS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 36/206 (17%), Positives = 70/206 (33%), Gaps = 23/206 (11%)

Query: 1   ILALDSNRLSGNIPPSI--GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNN 56
            L L  N     +  +    +L KL    V +      I      GL   L  + +  ++
Sbjct: 128 FLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL-TFLEELEIDASD 185

Query: 57  LSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLG 114
           L  +  P+ L  + ++  L L   Q              ++E L +    L     S L 
Sbjct: 186 LQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243

Query: 115 SCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEG 174
           +     +++           + ++   L  ++ + L  +  +  L  S N L+  VP +G
Sbjct: 244 TGETNSLIKK-----FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVP-DG 295

Query: 175 VFKNASAISV--LGNNKL---CGGIS 195
           +F   +++    L  N     C  I 
Sbjct: 296 IFDRLTSLQKIWLHTNPWDCSCPRID 321

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 36/189 (19%), Positives = 71/189 (37%), Gaps = 20/189 (10%)

Query: 562 LESLKLAG---SILPHIG---NLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNS 614
           L  L L G     L       +L+ L+IL + N     +I  +    L  L+  +++ + 
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185

Query: 615 IGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL----IGSIPP 669
           +        L S  N+  + L   Q +  +       S +E L L   +L       +  
Sbjct: 186 LQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244

Query: 670 ----PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISS 724
                L    + R + +   +L   +   L+++  L+ L    N+L  + P  IF  ++S
Sbjct: 245 GETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSV-PDGIFDRLTS 302

Query: 725 IAEFDVGEN 733
           + +  +  N
Sbjct: 303 LQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 23/172 (13%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPP-QLMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
           SIPS  GL E++ ++ L NN ++  I    L    +L AL L+ N    +   +   +L 
Sbjct: 45  SIPS--GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100

Query: 94  NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------VFQGLT---ILDLSRNK 141
           +LE L +S N L     S       L  L + GN         +F  LT   IL +    
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 142 LSGEIPE-FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL--GNNKL 190
              +I      GL  +E L +  +DL+   P     K+   +S L     + 
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEP--KSLKSIQNVSHLILHMKQH 210

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 25/141 (17%), Positives = 45/141 (31%), Gaps = 18/141 (12%)

Query: 562 LESLKLAGSILPHIGNLSF-----LKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
           LE L++  S L      S      +  L L        +          ++  +L +  +
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDL 234

Query: 616 GG----EIPV----NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSI 667
                 E+      +L        + +    L  ++      +S +  L    N L  S+
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SV 292

Query: 668 PPP-LGNLSSLRKISLAINNL 687
           P      L+SL+KI L  N  
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 24/123 (19%), Positives = 53/123 (43%), Gaps = 6/123 (4%)

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFD 729
           P G   +++ + L+ N +       L +  NL  L L  N ++ I   S  ++ S+   D
Sbjct: 47  PSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106

Query: 730 VGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSI--SNASKLEVFQALNNKLTG 786
           +  N +  N+   + F  L +L + ++  N     +  +   S+ +KL++ +  N     
Sbjct: 107 LSYNYLS-NLSSSW-FKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT 163

Query: 787 EVP 789
           ++ 
Sbjct: 164 KIQ 166

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 49/211 (23%), Positives = 79/211 (37%), Gaps = 36/211 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIRHRNLVKVFTAC 336
           +G+G+FG V+            +K  N    +       AE   L+S+ H N++K+F   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 337 SGVDYQGNDFKALVYEFMQNGSL----EEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               ++      +V E  + G L               E   A           +   + 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA----------ELMKQMM 134

Query: 393 SALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           +AL Y H   Q +  H DLKP NIL           + DFGLA         T++    G
Sbjct: 135 NALAYFHS--QHVV-HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---G 188

Query: 450 SIGYIAPE---YGLGSEVSTNGDVYSYGILM 477
           +  Y+APE     +  +     D++S G++M
Sbjct: 189 TALYMAPEVFKRDVTFKC----DIWSAGVVM 215

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 43/243 (17%)

Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSF-------IAECR 319
           AT  +     IG G++G+VYK         V +K   + +               +A  R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN---GSLEEWLYPVNREDEVDKAP 376
            L +  H N+V++   C+           LV+E +       L++   P    + +    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---- 122

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FL 435
           ++L + Q L         LD+LH +C     H DLKP NIL+       + DFGLAR + 
Sbjct: 123 KDL-MRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 436 PP---TH-VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF 491
                T  V T        + Y APE  L S  +T  D++S G +  E+  R+KP   +F
Sbjct: 172 YQMALTPVVVT--------LWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP---LF 219

Query: 492 EGD 494
            G+
Sbjct: 220 CGN 222

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 54/272 (19%), Positives = 90/272 (33%), Gaps = 57/272 (20%)

Query: 251 NSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA 310
           +S     L     +L      +     IG GS+G V   + ++ R    +K+ N +  R 
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 311 S-----RSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYP 365
                      E R ++ + H N+ +++       Y+   +  LV E    G L + L  
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNV 121

Query: 366 VNREDEVDKAPRNLNLLQRL------------------------------NIAIDVASAL 395
              +     A   +                                    NI   + SAL
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSI--GVKGSI 451
            YLH+  Q I  H D+KP N L        +   DFGL++     +           G+ 
Sbjct: 182 HYLHN--QGIC-HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238

Query: 452 GYIAPE------YGLGSEVSTNGDVYSYGILM 477
            ++APE         G +     D +S G+L+
Sbjct: 239 YFVAPEVLNTTNESYGPKC----DAWSAGVLL 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 34/209 (16%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN--LHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G G+F  V + V          K+ N      R  +    E R  R ++H N+V++  +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 Q   F  LV++ +  G L E +       E D +          +    +  ++
Sbjct: 97  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESI 141

Query: 396 DYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            Y H     I  H +LKP N+LL    +     + DFGLA  +  +          G+ G
Sbjct: 142 AYCHS--NGIV-HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPG 195

Query: 453 YIAPE----YGLGSEVSTNGDVYSYGILM 477
           Y++PE          V    D+++ G+++
Sbjct: 196 YLSPEVLKKDPYSKPV----DIWACGVIL 220

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 30/229 (13%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHR 327
           + +     +G G++G VYK    +GR  V +K   L         + I E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+V +                LV+EFM+   L++ L         D+    L   Q    
Sbjct: 80  NIVSLIDVI-----HSERCLTLVFEFMEK-DLKKVL---------DENKTGLQDSQIKIY 124

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIG 446
              +   + + H        H DLKP N+L++ +    + DFGLAR F  P    T  + 
Sbjct: 125 LYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV- 180

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           V  ++ Y AP+  +GS+  ST+ D++S G +  E+ I  KP   +F G 
Sbjct: 181 V--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEM-ITGKP---LFPGV 223

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.1 bits (195), Expect = 2e-15
 Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 28/205 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +GTG+FG V++            K     H     +   E + +  +RH  LV +  A  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED---EVDKAPRNLNLLQRLNIAIDVASA 394
              ++ ++   ++YEFM  G L E +   +  +   E +                 V   
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAV----------EYMRQVCKG 267

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIG 452
           L ++H        H DLKP NI+   +  + +   DFGL   L P      +    G+  
Sbjct: 268 LCHMHE--NNYV-HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAE 321

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILM 477
           + APE   G  V    D++S G+L 
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLS 346

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 24/187 (12%), Positives = 64/187 (34%), Gaps = 13/187 (6%)

Query: 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAK 636
                    L  +S  +   +++  L  +    L N ++  ++   +    N+  + +  
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVT-DLT-GIEYAHNIKDLTINN 75

Query: 637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLS 696
                   +    LS +E L +   ++     P L  L+SL  + ++ +    SI   ++
Sbjct: 76  IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 697 KLKNLVILYLGVN-RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI 755
            L  +  + L  N  ++ I    +  +  +   ++  + +     ++       L     
Sbjct: 134 TLPKVNSIDLSYNGAITDI--MPLKTLPELKSLNIQFDGVHDYRGIE---DFPKLNQLYA 188

Query: 756 GTNRITG 762
            +  I G
Sbjct: 189 FSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 25/176 (14%), Positives = 57/176 (32%), Gaps = 29/176 (16%)

Query: 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE 598
            +    ++ L     A  +  L + ++    +    I  LS L+ L +     T +    
Sbjct: 50  TLANINVTDLTGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPN 107

Query: 599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL 658
           +  L  L + D+++++    I   +++   +                          + L
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKV------------------------NSIDL 143

Query: 659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
            +N  I  I  PL  L  L+ +++  + +       +     L  LY     + G 
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 27/153 (17%), Positives = 62/153 (40%), Gaps = 14/153 (9%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           + L +  ++ ++   I     + +  +++        + +    +L  + +   +++   
Sbjct: 49  ITLANINVT-DLTG-IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDK 104

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
            P L GLTSL  LD+S +    S  T++  L  + ++ +S N    +I   L +  +L+ 
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKS 163

Query: 122 LEMQGN---------VFQGLTILDLSRNKLSGE 145
           L +Q +          F  L  L      + G+
Sbjct: 164 LNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.9 bits (151), Expect = 4e-11
 Identities = 23/159 (14%), Positives = 58/159 (36%), Gaps = 18/159 (11%)

Query: 6   SNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQL 65
               S     +   +  L    +++  +   + + +    ++  + + N + +   P  +
Sbjct: 29  LLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--I 84

Query: 66  MGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQ 125
            GL++L  L +            +  L +L  L +S +     I + + +  K+      
Sbjct: 85  SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV------ 138

Query: 126 GNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
                    +DLS N    +I   L  L  +++LN+ ++
Sbjct: 139 -------NSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 28/146 (19%), Positives = 52/146 (35%), Gaps = 20/146 (13%)

Query: 19  NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSR 78
             K  +   +  +       + +    SLT I L N N++      +    ++  L ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 79  NQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLS 138
                  P  +  L NLE L + G  +  +    L     L             T+LD+S
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL-------------TLLDIS 120

Query: 139 RNKLSGEIPEFLVGLKVIENLNLSYN 164
            +     I   +  L  + +++LSYN
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 17/120 (14%), Positives = 42/120 (35%), Gaps = 8/120 (6%)

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFD 729
           P     +     L  ++ A     T +++ +L  + L    ++ +  + I    +I +  
Sbjct: 18  PDSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLT 72

Query: 730 VGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
           +         P+     L NL+   I    +T    P++S  + L +    ++     + 
Sbjct: 73  INNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 16/106 (15%), Positives = 37/106 (34%), Gaps = 17/106 (16%)

Query: 68  LTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN 127
           + SL  + L+         T +    N++ LT++                    +    N
Sbjct: 43  MNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHAT-----------NYNPISGLSN 89

Query: 128 VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTE 173
               L  L +    ++ +    L GL  +  L++S++  +  + T+
Sbjct: 90  ----LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 41/229 (17%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVF 333
            L+G GS+G V K    +    V +K F           IA  E + L+ +RH NLV + 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             C     +      LV+EF+ +             D+++  P  L+          + +
Sbjct: 91  EVC-----KKKKRWYLVFEFVDH----------TILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 394 ALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL--PP---TH-VQTSSIG 446
            + + H H+      H D+KP NIL+ +  V  + DFG AR L  P       V T    
Sbjct: 136 GIGFCHSHNI----IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT---- 187

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
                 Y APE  +G        DV++ G L+ E+    +P   +F GD
Sbjct: 188 ----RWYRAPELLVGDVKYGKAVDVWAIGCLVTEM-FMGEP---LFPGD 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 24/223 (10%), Positives = 57/223 (25%), Gaps = 60/223 (26%)

Query: 277 LIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRASRS---FIAECRALRSIRHRNLVK 331
             G       ++ + D    R  V +   +             ++    L  I    + +
Sbjct: 38  FHGGVPPLQFWQAL-DTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           V      V  +      +V E+++ GSL+E                + + +  +     +
Sbjct: 96  VLDV---VHTRAGGL--VVAEWIRGGSLQEVA------------DTSPSPVGAIRAMQSL 138

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
           A+A D  H     +       PS + +  +    +                         
Sbjct: 139 AAAADAAHR--AGVA-LSIDHPSRVRVSIDGDVVLAYP---------------------- 173

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             +          +   D+   G  +  L++ + P        
Sbjct: 174 ATMPD-------ANPQDDIRGIGASLYALLVNRWP----LPEA 205

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 25/240 (10%)

Query: 247 QSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH 306
           +  P +          Q      + F    ++G GSF +V             +K+    
Sbjct: 7   EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66

Query: 307 H---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL 363
           H            E   +  + H   VK++       +Q ++       + +NG L +++
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI 121

Query: 364 YPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423
             +   DE            R   A ++ SAL+YLH   + I  H DLKP NILL+E+M 
Sbjct: 122 RKIGSFDE-TCT--------RFYTA-EIVSALEYLHG--KGII-HRDLKPENILLNEDM- 167

Query: 424 SHV--GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
            H+   DFG A+ L P   Q  +    G+  Y++PE         + D+++ G ++ +L+
Sbjct: 168 -HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 75.2 bits (186), Expect = 5e-15
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHR 327
           + +     IG G++G VYK   + G T   +K   L         + I E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK++     V +       LV+E +    L++ L         D     L  +   + 
Sbjct: 61  NIVKLY----DVIHTKKRL-VLVFEHLDQ-DLKKLL---------DVCEGGLESVTAKSF 105

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIG 446
            + + + + Y H        H DLKP N+L++ E    + DFGLAR F  P    T  I 
Sbjct: 106 LLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI- 161

Query: 447 VKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           V  ++ Y AP+  +GS+  ST  D++S G +  E+ +   P   +F G 
Sbjct: 162 V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM-VNGTP---LFPGV 204

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 46/210 (21%), Positives = 80/210 (38%), Gaps = 31/210 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA------ECRALRSIRHRNLVK 331
           +G+G F  V K            K       RASR  ++      E   LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +        Y+      L+ E +  G L ++L       E +            +    +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEAT----------SFIKQI 124

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH----VGDFGLARFLPPTHVQTSSIGV 447
              ++YLH   + I  H DLKP NI+L ++ +      + DFGLA  +       +    
Sbjct: 125 LDGVNYLHT--KKIA-HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
            G+  ++APE      +    D++S G++ 
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 46/210 (21%), Positives = 79/210 (37%), Gaps = 31/210 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA------ECRALRSIRHRNLVK 331
           +G+G F  V K            K       RASR  +       E   LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +        Y+      L+ E +  G L ++L       E +            +    +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEAT----------SFIKQI 124

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH----VGDFGLARFLPPTHVQTSSIGV 447
              ++YLH   + I  H DLKP NI+L ++ +      + DFGLA  +       +    
Sbjct: 125 LDGVNYLHT--KKIA-HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
            G+  ++APE      +    D++S G++ 
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 77.2 bits (190), Expect = 7e-15
 Identities = 43/236 (18%), Positives = 93/236 (39%), Gaps = 16/236 (6%)

Query: 557 VTILDLESLKLAGSILPHIGNLSF-----LKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
           V    + ++KL G +     + S      L I  + ++ F             + + +  
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 612 NNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
            +       +  S  S  + +  + N L   +  + G L+++E L L  N L   +    
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSKIA 367

Query: 672 G---NLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
                + SL+++ ++ N+++        S  K+L+ L +  N L+  +   +     I  
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKV 425

Query: 728 FDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNN 782
            D+  NKI+ +IP      L+ LQ  ++ +N++  ++P  I    + L+      N
Sbjct: 426 LDLHSNKIK-SIPKQV-VKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 42/203 (20%), Positives = 74/203 (36%), Gaps = 19/203 (9%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           I  + S+               +     + +  +               +   NN L+ T
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVG---NLINLETLTVSGNILQ-GEIPSTLGSC 116
           +      LT L  L L  NQ +            + +L+ L +S N +   E        
Sbjct: 340 VFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398

Query: 117 IKLEILEMQGN-----VF----QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             L  L M  N     +F      + +LDL  NK+   IP+ +V L+ ++ LN++ N L+
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457

Query: 168 GMVPTEGVFKNASAISV--LGNN 188
             VP +G+F   +++    L  N
Sbjct: 458 -SVP-DGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 32/181 (17%), Positives = 67/181 (37%), Gaps = 6/181 (3%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
            + I +          +     +S    L+  NN  T  +    G L  L+   L  N +
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 616 G--GEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLG 672
               +I    +   +L ++ +++N +              +  L++  N L  +I   L 
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419

Query: 673 NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732
               ++ + L  N +  SIP  + KL+ L  L +  N+L  +       ++S+ +  +  
Sbjct: 420 -PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477

Query: 733 N 733
           N
Sbjct: 478 N 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 34/196 (17%), Positives = 79/196 (40%), Gaps = 6/196 (3%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
            TIL++    ++      I +LS L+IL + +N   +   S     + L+  DL++N + 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 617 GEIPVNLSSCSNLIRIGLAKNQL-MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
               ++     NL  + L+ N      I  +FG++S+++ L L   +L  S   P+ +L+
Sbjct: 83  K---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
             + + +               L++     L +   +      I ++S     ++  + I
Sbjct: 140 ISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 736 QGNIPLDYGFTLQNLQ 751
           +  +  +      ++ 
Sbjct: 198 KCVLEDNKCSYFLSIL 213

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 36/258 (13%), Positives = 88/258 (34%), Gaps = 12/258 (4%)

Query: 538 NNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS 597
           + I++  +  +     +    +L+        SIL  +     L  L L N   T     
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238

Query: 598 EIGRL---RRLQVPDLNNNSIGGEIPVNLSSCSN-----LIRIGLAKNQLMGKIPSDFGS 649
            I +L     +    ++N  + G++       S      L    +  +         +  
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298

Query: 650 LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN 709
            S + + +   +            +S    +  + N L  ++      L  L  L L +N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 710 RLSGI-VPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS 767
           +L  +   + +   + S+ + D+ +N +  +         ++L   ++ +N +T  I   
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 768 ISNASKLEVFQALNNKLT 785
           +    +++V    +NK+ 
Sbjct: 419 LP--PRIKVLDLHSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 48/277 (17%), Positives = 92/277 (33%), Gaps = 26/277 (9%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           IL +  N +S      I +L KL    +S N ++    S     + L  + L +N L   
Sbjct: 25  ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKL 119
           I        +L  LDLS N F      +  GN+  L+ L +S   L+      +      
Sbjct: 84  ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 120 EILEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMV 170
           ++L + G            Q      L     + +   F++ + V    NL  ++++ ++
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201

Query: 171 PTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLA 230
                    S ++ L  N               L   T   +       I I+  +    
Sbjct: 202 EDNKCSYFLSILAKLQTN-------------PKLSNLTLNNIETTWNSFIRILQLVWHTT 248

Query: 231 LTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHN 267
           +         ++ + +  + +    SL  LS   + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 32/179 (17%), Positives = 58/179 (32%), Gaps = 23/179 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           + L       +   S  +LK L    V  +           +  ++       +      
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
                 ++  + LD S N    +     G+L  LETL +  N              +L+ 
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN--------------QLKE 362

Query: 122 LEMQGNVFQGLT---ILDLSRNKL-SGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVF 176
           L     +   +     LD+S+N +   E        K + +LN+S N L     T+ +F
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL-----TDTIF 416

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 46/230 (20%), Positives = 77/230 (33%), Gaps = 13/230 (5%)

Query: 48  TTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQG 107
             +    N L   +P  L        L++S+N     + +++ +L  L  L +S N +Q 
Sbjct: 3   FLVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59

Query: 108 EIPSTLGSCIKLEILEMQGNVFQ--------GLTILDLSRNKL-SGEIPEFLVGLKVIEN 158
              S      +LE L++  N            L  LDLS N   +  I +    +  ++ 
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119

Query: 159 LNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKL 218
           L LS   LE          N S + ++             L     +       T +   
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179

Query: 219 VIAIVSGLMGLALTLS-ISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHN 267
            I  VS      L LS I  +    K     +  + + +   LS   L+N
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 38/248 (15%), Positives = 78/248 (31%), Gaps = 26/248 (10%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLIN 94
            +P    L +  T + +  N +S      ++ L+ L  L +S N+ +      V      
Sbjct: 14  HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------VFQGLT---ILDLSRNKL 142
           LE L +S N L  +I       + L+ L++  N          F  ++    L LS   L
Sbjct: 71  LEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127

Query: 143 SGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPC 202
                  +  L + + L +           +   +     +    + +     EF     
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETY----GEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183

Query: 203 GLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRK---RKEQSNPNSLINSLLN 259
              K+        +K V+        L++   +     +        ++  NS I  L  
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243

Query: 260 LSYQNLHN 267
           + +  +  
Sbjct: 244 VWHTTVWY 251

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 31/182 (17%), Positives = 59/182 (32%), Gaps = 32/182 (17%)

Query: 609 DLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP 668
           D + N +   +P +LS       + +++N +     SD  SLSK+ +L +  +N I  + 
Sbjct: 6   DRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIIS-HNRIQYLD 61

Query: 669 PP-LGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
                    L  + L+ N L   I        NL  L L  N    +     F       
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFG------ 112

Query: 728 FDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE 787
                              +  L++  + T  +  +    I++ +  +V   L      +
Sbjct: 113 ------------------NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154

Query: 788 VP 789
             
Sbjct: 155 ED 156

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 25/113 (22%), Positives = 49/113 (43%), Gaps = 6/113 (5%)

Query: 577 NLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA 635
            +  L+ L++  NS +++         + L   ++++N +   I   L     +  + L 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLH 429

Query: 636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNL 687
            N++   IP     L  ++ L++  N L  S+P      L+SL+KI L  N  
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 4/107 (3%)

Query: 558 TILDLESLKLAGSILP-HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
             LD+    ++             L  LN+ +N  T  I   +    R++V DL++N I 
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL 663
             IP  +     L  + +A NQL       F  L+ ++ + L  N  
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 34/208 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +G G+   VY+      +    +KV         +    E   L  + H N++K+    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI- 116

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
               ++     +LV E +  G L + +       E D A          +    +  A+ 
Sbjct: 117 ----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVA 162

Query: 397 YLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           YLH     I  H DLKP N+L      +    + DFGL++ +    +  +     G+ GY
Sbjct: 163 YLHE--NGIV-HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGY 216

Query: 454 IAPE----YGLGSEVSTNGDVYSYGILM 477
            APE       G EV    D++S GI+ 
Sbjct: 217 CAPEILRGCAYGPEV----DMWSVGIIT 240

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 41/227 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA--ECRALRSIRHRNLVKVFTA 335
           IG GS+G V+K    +    V +K F           IA  E R L+ ++H NLV +   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              V  +      LV+E+  +              E+D+  R +      +I      A+
Sbjct: 69  --EVFRRKRRL-HLVFEYCDH----------TVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 396 DYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP-----TH-VQTSSIGVK 448
           ++ H H+C     H D+KP NIL+ +  V  + DFG AR L          V T      
Sbjct: 116 NFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT------ 165

Query: 449 GSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
               Y +PE  +G        DV++ G +  EL +   P   ++ G 
Sbjct: 166 --RWYRSPELLVGDTQYGPPVDVWAIGCVFAEL-LSGVP---LWPGK 206

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 44/211 (20%), Positives = 80/211 (37%), Gaps = 37/211 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTA 335
           +G G+F  V + V           + N      R  +    E R  R ++H N+V++  +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                        L+++ +  G L E +       E D +          +    +  A+
Sbjct: 79  -----ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCIQQILEAV 123

Query: 396 DYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            + H     +  H +LKP N+LL    +     + DFGLA  +          G  G+ G
Sbjct: 124 LHCHQ--MGVV-HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPG 178

Query: 453 YIAPE------YGLGSEVSTNGDVYSYGILM 477
           Y++PE      YG    V    D+++ G+++
Sbjct: 179 YLSPEVLRKDPYGK--PV----DLWACGVIL 203

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 28/228 (12%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRN 328
           + +   + +G G++ +VYKG        V +K   L H   A  + I E   L+ ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +V +      + +       LV+E++    L+++L         D     +N+       
Sbjct: 62  IVTLH----DIIHTEKSL-TLVFEYLDK-DLKQYL---------DDCGNIINMHNVKLFL 106

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGV 447
             +   L Y H        H DLKP N+L++E     + DFGLAR    PT    + + V
Sbjct: 107 FQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV-V 162

Query: 448 KGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             ++ Y  P+  LGS   ST  D++  G +  E+    +P   +F G 
Sbjct: 163 --TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM-ATGRP---LFPGS 204

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 39/222 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVF 333
            IG GSFG V     ++ +    +K  N          R+   E + ++ + H  LV ++
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR--EDEVDKAPRNLNLLQRLNIAIDV 391
            +     +Q  +   +V + +  G L   L       E+ V           +L I  ++
Sbjct: 82  YS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-----------KLFIC-EL 124

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             ALDYL +  Q I  H D+KP NILLDE    H+ DF +A  LP     T+   + G+ 
Sbjct: 125 VMALDYLQN--QRII-HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTK 178

Query: 452 GYIAPE-------YGLGSEVSTNGDVYSYGILMLELIIRKKP 486
            Y+APE        G    V    D +S G+   EL+  ++P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 50/255 (19%), Positives = 97/255 (38%), Gaps = 55/255 (21%)

Query: 277 LIGTGSFGSVYKGVLD-EGRTTVTVKVF--NLHHHRASRSFIAECRALRSIR-------- 325
            +G G F +V+    D    T V +K+   +  +  A+     E + L+ +         
Sbjct: 26  KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKED 81

Query: 326 HRNLVKVFTACSGVDYQGNDFK--ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
                 +       +++G +     +V+E +   +L   +       + +     L  ++
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK------KYEHRGIPLIYVK 134

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH------VGDFGLARFLPP 437
           +  I+  +   LDY+H  C  I  H D+KP N+L++            + D G A +   
Sbjct: 135 Q--ISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190

Query: 438 TH---VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            +   +QT          Y +PE  LG+      D++S   L+ ELI      D +FE D
Sbjct: 191 HYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPD 238

Query: 495 ------MNLHNFARM 503
                  +  + A++
Sbjct: 239 EGHSYTKDDDHIAQI 253

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 61/279 (21%), Positives = 107/279 (38%), Gaps = 56/279 (20%)

Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSI 324
              + S   +G+G++GSV   +       V +K     F      A R++  E   L+ +
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAY-RELLLLKHM 80

Query: 325 RHRNLVK---VFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
           +H N++    VFT  S +     +F    LV  FM     +  L  +      ++  + L
Sbjct: 81  QHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYL 131

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT- 438
            + Q L         L Y+H     +  H DLKP N+ ++E+    + DFGLAR      
Sbjct: 132 -VYQMLK-------GLKYIH-SAGVV--HRDLKPGNLAVNEDCELKILDFGLARHADAEM 180

Query: 439 --HVQTSSIGVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDM 495
             +V T          Y APE  L         D++S G +M E++  K     +F+G  
Sbjct: 181 TGYVVTRW--------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKD 228

Query: 496 NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
            L           ++ +         E +  ++++  + 
Sbjct: 229 YLDQL------TQILKVTGVP---GTEFVQKLNDKAAKS 258

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 29/205 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G G FG V++ V    + T   K   +           E   L   RHRN++ +  +  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES-- 69

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED---EVDKAPRNLNLLQRLNIAIDVASA 394
              ++  +   +++EF+    + E +          E +            +    V  A
Sbjct: 70  ---FESMEELVMIFEFISGLDIFERI--NTSAFELNEREIV----------SYVHQVCEA 114

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIG 452
           L +LH     I  H D++P NI+      S +   +FG AR L P            +  
Sbjct: 115 LQFLHS--HNIG-HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPE 168

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILM 477
           Y APE      VST  D++S G L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 48/230 (20%), Positives = 85/230 (36%), Gaps = 17/230 (7%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
           +    +L+   +  +       L+ +  +   N+         I  L  +    LN N +
Sbjct: 25  ETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKL 80

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
             +I   L++  NL  + L +N++  K  S    L K++ LSL  N  I  I   L +L 
Sbjct: 81  T-DIK-PLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNG-ISDING-LVHLP 134

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
            L  + L  N +   I   LS+L  L  L L  N++S I    +  ++ +    + +N I
Sbjct: 135 QLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 190

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
                L     L+NL    + +           SN       +  +  L 
Sbjct: 191 SDLRALAG---LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 17/209 (8%)

Query: 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAK 636
             +     NL+  S T  +      L  +     NN+ I   +   +    N+ ++ L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQ-GIQYLPNVTKLFLNG 77

Query: 637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLS 696
           N+L   I     +L  +  L L   N +  +   L +L  L+ +SL  N ++  I   L 
Sbjct: 78  NKL-TDI-KPLANLKNLGWLFLD-ENKVKDL-SSLKDLKKLKSLSLEHNGIS-DING-LV 131

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
            L  L  LYLG N+++ I  + +  ++ +    + +N+I   +PL     L  LQ   + 
Sbjct: 132 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLS 186

Query: 757 TNRITGAIPPSISNASKLEVFQALNNKLT 785
            N I+  +   ++    L+V +  + +  
Sbjct: 187 KNHISD-LRA-LAGLKNLDVLELFSQECL 213

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 36/164 (21%), Positives = 71/164 (43%), Gaps = 13/164 (7%)

Query: 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKIS 681
           +  + +  I+  L K  +          L+ I+ +    ++ I S+   +  L ++ K+ 
Sbjct: 19  SDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSD-IKSVQG-IQYLPNVTKLF 74

Query: 682 LAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741
           L  N L   I   L+ LKNL  L+L  N++  +  SS+ ++  +    +  N I     L
Sbjct: 75  LNGNKLT-DIKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDINGL 130

Query: 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
                L  L+   +G N+IT      +S  +KL+     +N+++
Sbjct: 131 V---HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 30/158 (18%), Positives = 63/158 (39%), Gaps = 19/158 (12%)

Query: 19  NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSR 78
              + ++  +    +      +     S+  I   N+++  ++   +  L ++  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77

Query: 79  NQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------VF 129
           N+     P  + NL NL  L +  N ++ ++ S+L    KL+ L ++ N           
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDINGLVHL 133

Query: 130 QGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             L  L L  NK++      L  L  ++ L+L  N + 
Sbjct: 134 PQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 40/175 (22%), Positives = 74/175 (42%), Gaps = 21/175 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
             L    ++  +      L  + +   +++ +K S+   +    ++T + L  N L+  I
Sbjct: 29  DNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DI 83

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
            P L  L +L  L L  N+ +      + +L  L++L++  N +  +I   L    +LE 
Sbjct: 84  KP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLES 138

Query: 122 LEMQGNV---------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L +  N             L  L L  N++S +I   L GL  ++NL LS N + 
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 19/175 (10%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L+ N+L+ +I P + NLK L   ++ +N +K  + SSL   + L ++ L +N +S  
Sbjct: 72  KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-D 126

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
           I   L+ L  L +L L  N+   +  T +  L  L+TL++  N +  +I   L    KL+
Sbjct: 127 ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQ 181

Query: 121 ILEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
            L +  N           + L +L+L   +   +       L V   +  +   L
Sbjct: 182 NLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 47/272 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK---VFNLHHHRASRSFIAECRALRSIRHRNLVK--- 331
           +G G++G V           V +K    F+     A R+   E + L+  +H N++    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTL-REIKILKHFKHENIITIFN 76

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +    S  ++  N+   ++ E M     +  L+ V     +        + Q L      
Sbjct: 77  IQRPDSFENF--NEV-YIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLR----- 123

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
             A+  LH     I  H DLKPSN+L++      V DFGLAR +  +    S    + S 
Sbjct: 124 --AVKVLH-GSNVI--HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 452 --GYI------APEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
              ++      APE  L S   +   DV+S G ++ EL +R+     +F G    H    
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIFPGRDYRHQL-- 232

Query: 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
                 +  I+ +   +   DL  I + R R+
Sbjct: 233 ----LLIFGIIGTP--HSDNDLRCIESPRARE 258

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 39/175 (22%), Positives = 56/175 (32%), Gaps = 26/175 (14%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCE----SLTTIGLFNNN- 56
           L++            +     L    +SDN   G       LC     +L  + L N   
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 57  --LSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTL 113
              SG           L  LDLS N  R +           L +L +S   L+ ++P  L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272

Query: 114 GSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG 168
                             L++LDLS N+L    P     L  + NL+L  N    
Sbjct: 273 ---------------PAKLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 38/210 (18%), Positives = 65/210 (30%), Gaps = 24/210 (11%)

Query: 2   LALDSNRLSGNIPPSIGNL--KKLVEPYVSDNFLKGSIPSSLGL----CESLTTIGLFNN 55
           L L++  ++G  PP +       L    + +            L       L  + +   
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 56  NLSGTIPPQLMGLTSLVALDLSRNQFRGSFP----TEVGNLINLETLTVSGNILQGEIPS 111
           +       Q+    +L  LDLS N   G               L+ L +    ++     
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSG 218

Query: 112 TLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPE-FLVGLKVIENLNLSYNDLEGMV 170
              +                L  LDLS N L              + +LNLS+  L+ + 
Sbjct: 219 VCSALAAA---------RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV- 268

Query: 171 PTEGVFKNASAISVLGNNKLCGGISEFKLP 200
             +G+    S +  L  N+L    S  +LP
Sbjct: 269 -PKGLPAKLSVLD-LSYNRLDRNPSPDELP 296

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 38/244 (15%), Positives = 73/244 (29%), Gaps = 29/244 (11%)

Query: 552 SKAQKVTILDLESLKLAGSILPH---IGNLSFLKILNLENNSFTHEIPSEIGRL--RRLQ 606
            K+  +  L + + ++   IL     +  +S L+ L LEN   T   P  +       L 
Sbjct: 65  IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124

Query: 607 VPDLNNNSIGGE--IPVNLSSCS--NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNN 662
           + +L N S          L       L  + +A+   +            +  L L  N 
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184

Query: 663 LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNI 722
            +G                      +   P     L+ L +   G+   SG+  +     
Sbjct: 185 ELGERGLI-----------------SALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227

Query: 723 SSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN 782
             +   D+  N ++             L   ++    +   +P  +   +KL V     N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYN 284

Query: 783 KLTG 786
           +L  
Sbjct: 285 RLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 37/194 (19%), Positives = 69/194 (35%), Gaps = 17/194 (8%)

Query: 556 KVTILDLESLKLAG--SILPHIGNLSF--LKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
            + IL+L ++  A   + L  +       LK+L++      +    ++     L   DL+
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 612 NNSIGGEIPVNLSSC----SNLIRIGLAKNQ---LMGKIPSDFGSLSKIEVLSLGFNNLI 664
           +N   GE  +  + C      L  + L         G   +   +  +++ L L  N+L 
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241

Query: 665 GSIPPPL-GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNIS 723
            +   P     S L  ++L+   L   +P  L     L +L L  NRL      S   + 
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELP 296

Query: 724 SIAEFDVGENKIQG 737
            +    +  N    
Sbjct: 297 QVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 38/214 (17%), Positives = 72/214 (33%), Gaps = 15/214 (7%)

Query: 487 SDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLIS 546
            ++   G              +++++ + +       LA +    +  ++V +I +    
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162

Query: 547 ML--RIGSKAQKVTILDLESLKLAGSI-LPHI---GNLSFLKILNLENNSFTH---EIPS 597
                       ++ LDL      G   L           L++L L N           +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPV-NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL 656
                 +LQ  DL++NS+       +    S L  + L+   L  ++P   G  +K+ VL
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPK--GLPAKLSVL 279

Query: 657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS 690
            L +N L     P    L  +  +SL  N    S
Sbjct: 280 DLSYNRL--DRNPSPDELPQVGNLSLKGNPFLDS 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 54/278 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK--VFNLHHHRASRSFIAECRALRSIRHRNLVK---V 332
           +G G  G V+  V ++    V +K  V          +   E + +R + H N+VK   +
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHAL-REIKIIRRLDHDNIVKVFEI 76

Query: 333 FTACSGVDYQG----NDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
                           +  +  +V E+M     E  L  V  +  + +    L + Q L 
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPTHVQTSSI 445
                   L Y+H     +  H DLKP+N+ ++ E +   +GDFGLAR + P +     +
Sbjct: 132 -------GLKYIH-SANVL--HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 446 GVKGSIGYI------APEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLH 498
                   +      +P   L     T   D+++ G +  E++  K     +F G   L 
Sbjct: 182 -----SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELE 232

Query: 499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR 536
                     +++ +        ED   + +     IR
Sbjct: 233 QM------QLILESIPVV---HEEDRQELLSVIPVYIR 261

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 55/270 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK-- 331
           +G+G++GSV      +    V VK     F      A R++  E R L+ ++H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTY-RELRLLKHMKHENVIGLL 94

Query: 332 -VFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            VFT    ++    +F    LV   M        L  + +  ++        + Q L   
Sbjct: 95  DVFTPARSLE----EFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILR-- 143

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT---HVQTSSI 445
                 L Y+H     I  H DLKPSN+ ++E+    + DFGLAR        +V T   
Sbjct: 144 -----GLKYIH-SADII--HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW- 194

Query: 446 GVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
                  Y APE  L         D++S G +M EL+  +     +F G  ++       
Sbjct: 195 -------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQL---- 239

Query: 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
               ++ +V +      E L  IS++  R 
Sbjct: 240 --KLILRLVGTP---GAELLKKISSESARN 264

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 45/216 (20%), Positives = 77/216 (35%), Gaps = 40/216 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKV-----FNLHHHRASRSFIAECRALRSIRHRNLVKV 332
           IG G F  V + +  E      VK+     F      ++     E      ++H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSL----EEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
                   Y  +    +V+EFM    L     +         E   +          +  
Sbjct: 92  LET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS----------HYM 136

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSI 445
             +  AL Y H     I  H D+KP  +LL   +      +G FG+A  L  + +     
Sbjct: 137 RQILEALRYCHD--NNII-HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-- 191

Query: 446 GVKGSIGYIAPE----YGLGSEVSTNGDVYSYGILM 477
           G  G+  ++APE       G  V    DV+  G+++
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.0 bits (179), Expect = 7e-14
 Identities = 42/215 (19%), Positives = 83/215 (38%), Gaps = 25/215 (11%)

Query: 581 LKILNLENNSFTHEIPSEI--GRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKN 637
             +L+L +N+ +  + +E    RL  L    L++N +   I         NL  + L+ N
Sbjct: 41  TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 638 QLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPF-- 693
            L   +    F  L  +EVL L +NN I  +      +++ L+K+ L+ N ++   P   
Sbjct: 99  HLH-TLDEFLFSDLQALEVLLL-YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 694 --TLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN--------IPLDY 743
               +KL  L++L L  N+L  +  + +  + +  +  +    +  N          L  
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY---LHNNPLECDCKLYQLFS 212

Query: 744 GFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQ 778
            +  + L         +       + N   L+ F 
Sbjct: 213 HWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFN 247

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 39/192 (20%), Positives = 70/192 (36%), Gaps = 43/192 (22%)

Query: 12  NIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLC--ESLTTIGLFNNNLSGTIPPQ-LMGL 68
           ++P     L       +S N L   + +        +L ++ L +N+L+  I  +  + +
Sbjct: 36  SLPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 69  TSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN 127
            +L  LDLS N    +    +  +L  LE L +  N +   +                 N
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDR---------------N 130

Query: 128 VFQGLT---ILDLSRNKLSGEIPE----FLVGLKVIENLNLSYNDLEGMVPTEGVFKNAS 180
            F+ +     L LS+N++S   P         L  +  L+LS N L+ +       +   
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPL--TDLQKLP 187

Query: 181 AISV----LGNN 188
           A       L NN
Sbjct: 188 AWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 33/151 (21%), Positives = 58/151 (38%), Gaps = 19/151 (12%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPPP--LGNLSSLRKISLAINNLAGSIP-FTLSKLK 699
           +PS         +L L  NN +  +        L++L  + L+ N+L   I       + 
Sbjct: 37  LPSY------TALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 700 NLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIGT 757
           NL  L L  N L  +    +F ++ ++    +  N I   +     F  +  LQ   +  
Sbjct: 89  NLRYLDLSSNHLHTL-DEFLFSDLQALEVLLLYNNHIV-VVD-RNAFEDMAQLQKLYLSQ 145

Query: 758 NRITGAIPPSISNASKLEVFQAL---NNKLT 785
           N+I+      I + +KL     L   +NKL 
Sbjct: 146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 35/137 (25%), Positives = 61/137 (44%), Gaps = 16/137 (11%)

Query: 562 LESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
           L SL L+ + L  I       +  L+ L+L +N     +   +   L+ L+V  L NN I
Sbjct: 66  LHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI 124

Query: 616 GGEIPVN-LSSCSNLIRIGLAKNQLMGKIP----SDFGSLSKIEVLSLGFNNLIGSIPP- 669
              +  N     + L ++ L++NQ+  + P     D   L K+ +L L  +N +  +P  
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL-SSNKLKKLPLT 181

Query: 670 PLGNLSSLRKISLAINN 686
            L  L +  K  L ++N
Sbjct: 182 DLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 26/124 (20%), Positives = 55/124 (44%), Gaps = 10/124 (8%)

Query: 666 SIPPPLGNLSSLRKISLAINNLAGSIP--FTLSKLKNLVILYLGVNRLSGIVPSSIFNIS 723
           ++P  L   S    + L+ NNL+  +   +T ++L NL  L L  N L+ I   +   + 
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 724 SIAEFDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALN 781
           ++   D+  N +   +     F+ LQ L+   +  N I   +  +   + ++L+      
Sbjct: 89  NLRYLDLSSNHLH-TLDEFL-FSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145

Query: 782 NKLT 785
           N+++
Sbjct: 146 NQIS 149

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 55/270 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK-- 331
           +G+G++G+V   V       V +K     F      A R++  E R L+ +RH N++   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAY-RELRLLKHMRHENVIGLL 90

Query: 332 -VFTACSGVDYQGNDFKA--LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            VFT    +D    DF    LV  FM        L  + + +++ +      + Q L   
Sbjct: 91  DVFTPDETLD----DFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLK-- 139

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT---HVQTSSI 445
                 L Y+H     I  H DLKP N+ ++E+    + DFGLAR        +V T   
Sbjct: 140 -----GLRYIH-AAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 190

Query: 446 GVKGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
                  Y APE  L     T   D++S G +M E+I  K     +F+G  +L       
Sbjct: 191 -------YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHLDQL---- 235

Query: 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
               +M +  +      E +  + +   + 
Sbjct: 236 --KEIMKVTGTP---PAEFVQRLQSDEAKN 260

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 45/234 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIA-ECRALRSIRHRNLVKV 332
           L+G GS+G V + +  E      VK+     L       + +  E + LR +RH+N++++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 333 FTACSGVDYQGNDFKA-LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
                 V Y     K  +V E+   G  E       +   V +A        +L      
Sbjct: 72  VD----VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG---YFCQL------ 118

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT----HVQTSSIGV 447
              L+YLH        H D+KP N+LL       +   G+A  L P       +TS    
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--- 172

Query: 448 KGSIGYIAPE-------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            GS  +  PE       +  G +V    D++S G+ +  +     P    FEGD
Sbjct: 173 -GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 35/234 (14%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHR 327
           D +     +G G++G VYK +      TV +K   L H       + I E   L+ ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N++++ +    V +  +    L++E+ +N  L++++         DK P ++++    + 
Sbjct: 94  NIIELKS----VIHHNHRL-HLIFEYAEN-DLKKYM---------DKNP-DVSMRVIKSF 137

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG-----DFGLAR-FLPPTHVQ 441
              + + +++ H        H DLKP N+LL     S        DFGLAR F  P    
Sbjct: 138 LYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194

Query: 442 TSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           T  I +  ++ Y  PE  LGS   ST+ D++S   +  E+ + K P   +F GD
Sbjct: 195 THEI-I--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEM-LMKTP---LFPGD 241

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 31/210 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA------ECRALRSIRHRNLVK 331
           +G+G F  V K            K        +SR  ++      E   LR IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +        ++      L+ E +  G L ++L       E +                 +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEAT----------QFLKQI 117

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH----VGDFGLARFLPPTHVQTSSIGV 447
              + YLH   + I  H DLKP NI+L ++ V +    + DFG+A  +   +   +    
Sbjct: 118 LDGVHYLHS--KRIA-HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-- 172

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
            G+  ++APE      +    D++S G++ 
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 53/223 (23%), Positives = 84/223 (37%), Gaps = 49/223 (21%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIA-----ECRALRSIRHRNL 329
           +G+G+FG V+  V  E    V VK      +                E   L  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR----EDEVDKAPRNLNLLQRL 385
           +KV        ++   F  LV E   +G L+ + +        E       R     Q  
Sbjct: 92  IKVLDI-----FENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFR-----Q-- 138

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-QTSS 444
                + SA+ YL         H D+K  NI++ E+    + DFG A +L    +  T  
Sbjct: 139 -----LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190

Query: 445 IGVKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELI 481
               G+I Y APE      Y  G E+    +++S G+ +  L+
Sbjct: 191 ----GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLV 224

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 27/190 (14%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTA 335
           ++G G+   V   +         VK+              E   L   + HRN++++   
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                ++  D   LV+E M+ GS+   ++     +E++ +           +  DVASAL
Sbjct: 80  -----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVASAL 124

Query: 396 DYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVK---- 448
           D+LH+  + I  H DLKP NIL    ++     + DF L   +      +     +    
Sbjct: 125 DFLHN--KGIA-HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 449 -GSIGYIAPE 457
            GS  Y+APE
Sbjct: 182 CGSAEYMAPE 191

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 46/177 (25%), Positives = 66/177 (37%), Gaps = 19/177 (10%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG 59
           IL L  N L      +      +L +  +    L   +     L   L T+ L +N L  
Sbjct: 35  ILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQVDGTL-PVLGTLDLSHNQLQ- 90

Query: 60  TIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIK 118
           ++P     L +L  LD+S N+   S P      L  L+ L + GN L+   P  L    K
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149

Query: 119 LEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
           LE L +  N        +  GL     L L  N L   IP+   G  ++    L  N
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 11/181 (6%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLM 640
             IL+L  N       + +    RL   +L+   +  ++ V   +   L  + L+ NQL 
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQL- 89

Query: 641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIP-FTLSKL 698
             +P    +L  + VL + FN  + S+P      L  L+++ L  N L  ++P   L+  
Sbjct: 90  QSLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147

Query: 699 KNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGT 757
             L  L L  N L+ + P+ +   + ++    + EN +   IP    F    L +  +  
Sbjct: 148 PKLEKLSLANNNLTEL-PAGLLNGLENLDTLLLQENSLY-TIP-KGFFGSHLLPFAFLHG 204

Query: 758 N 758
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 44/169 (26%), Positives = 67/169 (39%), Gaps = 22/169 (13%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL 95
           ++P    L +  T + L  N L       LM  T L  L+L R +       + G L  L
Sbjct: 24  ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVL 79

Query: 96  ETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLSG 144
            TL +S N LQ  +P    +   L +L++  N          +GL     L L  N+L  
Sbjct: 80  GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137

Query: 145 EIPE-FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLG--NNKL 190
            +P   L     +E L+L+ N+L   +P  G+      +  L    N L
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELP-AGLLNGLENLDTLLLQENSL 184

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 39/214 (18%), Positives = 74/214 (34%), Gaps = 21/214 (9%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQL 639
           +  ++L  NS      +   RL+ LQ   +   + G  I  N     S+LI + L  NQ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 640 MGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP--LGNLSSLRKISLAINNLAGSIPFTL- 695
             ++ +  F  L+ +EVL+L   NL G++        L+SL  + L  NN+    P +  
Sbjct: 92  -LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 696 SKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI 755
             ++   +L L  N++  I             F +                L ++    +
Sbjct: 151 LNMRRFHVLDLTFNKVKSI-CEEDLLNFQGKHFTL--------------LRLSSITLQDM 195

Query: 756 GTNRITGAIPPSISNASKLEVFQALNNKLTGEVP 789
               +      +    + +       N     + 
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 37/179 (20%), Positives = 70/179 (39%), Gaps = 10/179 (5%)

Query: 514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573
           D+     ++ L + ++        +   +   +    G +A  V   DL   K+  ++L 
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLK 292

Query: 574 HI-GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLI 630
            +  + + L+ L L  N     I       L  L   +L+ N + G I   +  +   L 
Sbjct: 293 SVFSHFTDLEQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLE 350

Query: 631 RIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNL 687
            + L+ N +   +    F  L  ++ L+L   N + S+P      L+SL+KI L  N  
Sbjct: 351 VLDLSYNHIRA-LGDQSFLGLPNLKELALD-TNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 29/164 (17%), Positives = 54/164 (32%), Gaps = 33/164 (20%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
            +P+ +        + L  N+++  +       L  L  L + +              L 
Sbjct: 27  ELPAHV------NYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79

Query: 94  NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG---LTILDLSRNKL-SGEIPE- 148
           +L  L +  N    ++ +                 F G   L +L L++  L    +   
Sbjct: 80  SLIILKLDYNQFL-QLET---------------GAFNGLANLEVLTLTQCNLDGAVLSGN 123

Query: 149 FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV--LGNNKL 190
           F   L  +E L L  N+++ + P    F N     V  L  NK+
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQP-ASFFLNMRRFHVLDLTFNKV 166

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 37/237 (15%), Positives = 69/237 (29%), Gaps = 30/237 (12%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNLS 58
            + L  N ++     S   L+ L    V        I ++   GL  SL  + L  N   
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL-SSLIILKLDYNQFL 92

Query: 59  GTIPPQ-LMGLTSLVALDLSRNQFRGSF-PTEV-GNLINLETLTVSGNILQGEIPSTL-G 114
             +      GL +L  L L++    G+         L +LE L +  N ++   P++   
Sbjct: 93  -QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 115 SCIKLEILEMQGN--------VFQGLT-------------ILDLSRNKLSGEIPEFLVGL 153
           +  +  +L++  N                           + D++   L  E        
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211

Query: 154 KVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEW 210
             I  L+LS N  +     +  F   +   +                    K    +
Sbjct: 212 TSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 43/218 (19%), Positives = 79/218 (36%), Gaps = 20/218 (9%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDL----NN 612
           T+ D+    L      +    + +  L+L  N F   +       +   ++  L    + 
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250

Query: 613 NSIGGEIPVNLSSCSNLIRIGLAKNQL---------MGKIPSD-FGSLSKIEVLSLGFNN 662
           N        N     N    GL  + +         +  +    F   + +E L+L  N 
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE 310

Query: 663 LIGSIPP-PLGNLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSSIF 720
            I  I       L+ L K++L+ N L GSI       L  L +L L  N +  +   S  
Sbjct: 311 -INKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368

Query: 721 NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTN 758
            + ++ E  +  N+++ ++P      L +LQ   + TN
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 36/209 (17%), Positives = 72/209 (34%), Gaps = 21/209 (10%)

Query: 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI---- 632
            LS + + ++       E      +   +   DL+ N     +           +I    
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245

Query: 633 ---------GLAKNQLMGKIPSDFGSL--SKIEVLSLGFNNLIGSIPPPL-GNLSSLRKI 680
                                  F  L  S ++   L   + I ++   +  + + L ++
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS-KSKIFALLKSVFSHFTDLEQL 304

Query: 681 SLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNI 739
           +LA N +          L +L+ L L  N L  I  S +F N+  +   D+  N I+  +
Sbjct: 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI-DSRMFENLDKLEVLDLSYNHIR-AL 362

Query: 740 PLDYGFTLQNLQYFSIGTNRITGAIPPSI 768
                  L NL+  ++ TN++  ++P  I
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-SVPDGI 390

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 44/228 (19%), Positives = 81/228 (35%), Gaps = 39/228 (17%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTI---------- 50
           +  ++   L      +      +    +S N  K S+        + T I          
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 51  ---GLFNNNLSGTIPPQLMGL--TSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNI 104
                 + N          GL  + +   DLS+++   +    V  +  +LE LT++ N 
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNE 310

Query: 105 LQGEIPS-TLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPE-FLV 151
           +  +I          L  L +  N        +F+ L    +LDLS N +   + +   +
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368

Query: 152 GLKVIENLNLSYNDLEGMVPTEGVFKNASAISV--LGNNKL---CGGI 194
           GL  ++ L L  N L+  VP +G+F   +++    L  N     C  I
Sbjct: 369 GLPNLKELALDTNQLK-SVP-DGIFDRLTSLQKIWLHTNPWDCSCPRI 414

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 39/206 (18%), Positives = 71/206 (34%), Gaps = 21/206 (10%)

Query: 2   LALDSNRLSGNIPPSI--GNLKKLVEPYVSDN-----------FLKGSIPSSLGLCESLT 48
           L L  N +   I P+    N+++     ++ N             +G   + L L  S+T
Sbjct: 134 LVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS-SIT 191

Query: 49  TIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGE 108
              +    L           TS+  LDLS N F+ S      + I    +          
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 109 IPSTLGSCI--KLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           + S+ G       +    +G    G+   DLS++K+   +         +E L L+ N++
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI 311

Query: 167 EGMVPTEGVFKNASAISVL--GNNKL 190
             +   +  F   + +  L    N L
Sbjct: 312 NKI--DDNAFWGLTHLLKLNLSQNFL 335

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.0 bits (179), Expect = 2e-13
 Identities = 44/237 (18%), Positives = 96/237 (40%), Gaps = 16/237 (6%)

Query: 556 KVTILDLESLKLAGSILPHIGN-----LSFLKILNLENNSFTHEIPSEIGRLRRLQVPDL 610
            V  L++ +L +   I           L  L I +++N  F     +       + +  L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336

Query: 611 NNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL--IGSIP 668
           + +       V   S S+   +   +N     +     +L +++ L L  N L     + 
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA 396

Query: 669 PPLGNLSSLRKISLAINNL-AGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
               N+SSL  + +++N+L + +   T +  +++++L L  N L+G V   +     +  
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454

Query: 728 FDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQALNN 782
            D+  N+I     +    T LQ LQ  ++ +N++  ++P  +    + L+     +N
Sbjct: 455 LDLHNNRIMS---IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 39/203 (19%), Positives = 74/203 (36%), Gaps = 19/203 (9%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           I  + +     +         ++    +S +              S T +    N  + +
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQ----GEIPSTLGSC 116
           +      L  L  L L RN  + +F        N+ +L      L          T    
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427

Query: 117 IKLEILEMQGN-----VFQGLT----ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
             + +L +  N     VF+ L     +LDL  N++   IP+ +  L+ ++ LN++ N L+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486

Query: 168 GMVPTEGVFKNASAISV--LGNN 188
             VP +GVF   +++    L +N
Sbjct: 487 -SVP-DGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.0 bits (140), Expect = 8e-09
 Identities = 36/181 (19%), Positives = 70/181 (38%), Gaps = 12/181 (6%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQL 639
            K L+L  NS +     +I  L  L+V  L++N I   +  ++     +L  + ++ N+L
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112

Query: 640 MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP--LGNLSSLRKISLAINNLAGSIPFTLSK 697
              I      ++ +  L L FN+    +P     GNL+ L  + L+       +      
Sbjct: 113 -QNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVA 167

Query: 698 LKNL--VILYLGVNRLSGIVPSSIFNI-SSIAEFDVGENKIQGNIPLDYGFTLQNLQYFS 754
             +L  ++L L    + G    S+    +++       N +           L +LQ  +
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 755 I 755
           I
Sbjct: 228 I 228

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 31/186 (16%), Positives = 60/186 (32%), Gaps = 23/186 (12%)

Query: 2   LALDSNRLSGNIPPSIGN-----LKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNN 56
           L + +  ++  I           LK L+  +V +     S  +   +   +    L  ++
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340

Query: 57  LSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC 116
                       +S   L+ ++N F  S       L  L+TL +  N L+          
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399

Query: 117 IKLEILEMQGNVFQG---------------LTILDLSRNKLSGEIPEFLVGLKVIENLNL 161
             +  LE                       + +L+LS N L+G +   L     ++ L+L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDL 457

Query: 162 SYNDLE 167
             N + 
Sbjct: 458 HNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 48/278 (17%), Positives = 91/278 (32%), Gaps = 30/278 (10%)

Query: 1   ILALDSNRLSGNIPPS-IGNLKKLVEPYVSDNFLKGSIPSSL-GLCESLTTIGLFNNNLS 58
            L+L  N +S  +    I  L +L    +S N ++ S+   +    + L  + + +N L 
Sbjct: 56  ALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ 113

Query: 59  GTIPPQLMGLTSLVALDLSRNQFRGSFPT--EVGNLINLETLTVSGNILQGEIPSTLGSC 116
             I      + SL  LDLS N F    P   E GNL  L  L +S    + ++     + 
Sbjct: 114 -NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAH 168

Query: 117 IKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVF 176
           + L  +            LDL    + G   E L          + + +    V      
Sbjct: 169 LHLSCIL-----------LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217

Query: 177 KNASAISVLGNNKLCGGISEF-KLPPCGLKKSTEWRLTFE-----LKLVIAIVSGLMGLA 230
                + +                     +  T   +T +      K  + +        
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277

Query: 231 LT-LSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHN 267
           +  L+I  L  + +R ++        +L +L  +++ N
Sbjct: 278 VEYLNIYNLT-ITERIDREEFTYSETALKSLMIEHVKN 314

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 49/267 (18%), Positives = 85/267 (31%), Gaps = 57/267 (21%)

Query: 44  CESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN 103
            E  + +   N NL+  +P  L       AL LS+N               L        
Sbjct: 30  NELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-----------ELR------- 68

Query: 104 ILQGEIPSTLGSCIKLEILEMQGN--------VFQG---LTILDLSRNKLSGEIPEFLVG 152
                    +    +L +L +  N        VF     L  LD+S N+L       +  
Sbjct: 69  ------MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMAS 122

Query: 153 LKVIENLNLSYNDLEGMVPTEGVFKNASAISVLG--NNKLCGGISEFKLPPCGLKKSTEW 210
           L+   +L+LS+ND + + P    F N + ++ LG    K        +L    +      
Sbjct: 123 LR---HLDLSFNDFDVL-PVCKEFGNLTKLTFLGLSAAKFR------QLDLLPVAHLHL- 171

Query: 211 RLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATD 270
                L LV   + G    +L +  + +  +       +PNSL +  +N+S   L +   
Sbjct: 172 -SCILLDLVSYHIKGGETESLQIPNTTVLHLV-----FHPNSLFSVQVNMSVNALGHLQL 225

Query: 271 GFSSANLIGTGSFGSVYKGVLDEGRTT 297
                N        +    +       
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLL 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 56/264 (21%), Positives = 94/264 (35%), Gaps = 64/264 (24%)

Query: 278 IGTGSFGSVYKGVL-----DEGRTTVTVK-VFNLHHHRASRSFIAECRALRSI-RHRNLV 330
           +G G+FG V +             TV VK +     H   R+ ++E + L  I  H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 331 KVFTACSGVD------------------------------------YQGNDFKALVYEFM 354
            +  AC+                                        QG D+   +   +
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 355 QNGS---------------LEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDVASALDYL 398
           +                   E+ L  V  E+  +   ++ L L   +  +  VA  +++L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 399 -HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPE 457
               C     H DL   NILL E+ V  + DFGLAR +            +  + ++APE
Sbjct: 210 ASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 458 YGLGSEVSTNGDVYSYGILMLELI 481
                  +   DV+S+G+L+ E+ 
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIF 289

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 45/210 (21%), Positives = 79/210 (37%), Gaps = 31/210 (14%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA------ECRALRSIRHRNLVK 331
           +G+G F  V K            K       ++SR  ++      E   L+ I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +        Y+      L+ E +  G L ++L       E +                 +
Sbjct: 79  LHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEAT----------EFLKQI 123

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILL-DEEMVSH---VGDFGLARFLPPTHVQTSSIGV 447
            + + YLH     I  H DLKP NI+L D  +      + DFGLA  +   +   +    
Sbjct: 124 LNGVYYLHS--LQIA-HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
            G+  ++APE      +    D++S G++ 
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 23/231 (9%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIR 325
           +++  F     +G G++ +VYKG+       V +K   L        + I E   ++ ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N+V+++        +      LV+EFM N  L++++        V   PR L L    
Sbjct: 62  HENIVRLYDVIHT---ENKLT--LVFEFMDN-DLKKYM----DSRTVGNTPRGLELNLVK 111

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSS 444
                +   L + H +      H DLKP N+L+++     +GDFGLAR F  P +  +S 
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168

Query: 445 IGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           + V  ++ Y AP+  +GS   ST+ D++S G ++ E+ I  KP   +F G 
Sbjct: 169 V-V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM-ITGKP---LFPGT 212

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 45/227 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR------ASRSFIAECRALRSIRHRNLVK 331
           IG G+FG V+K    +    V +K   + + +      A R    E + L+ ++H N+V 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80

Query: 332 VFTACSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +   C       N  K    LV++F ++  L   L                 L +   + 
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL---------SNVLVKFTLSEIKRVM 130

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             + + L Y+H +      H D+K +N+L+  + V  + DFGLAR          S+   
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF--------SLAKN 179

Query: 449 GSIG----------YIAPEYGLGSEV-STNGDVYSYGILMLELIIRK 484
                         Y  PE  LG        D++  G +M E+  R 
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 33/233 (14%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTV---KVFN---LHHHRASRSFIAECRALRS 323
           D F    ++G G FG V+     + + T  +   K  N   L   +  +  + E + L  
Sbjct: 185 DWFLDFRVLGRGGFGEVF---ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           +  R +V +  A     ++      LV   M  G +   +Y V+ ++   + PR      
Sbjct: 242 VHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-----A 291

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQ 441
               A  + S L++LH   + I  + DLKP N+LLD++   +V   D GLA  L     +
Sbjct: 292 IFYTA-QIVSGLEHLHQ--RNII-YRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTK 345

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           T      G+ G++APE  LG E   + D ++ G+ + E+I  + P    F   
Sbjct: 346 TKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 46/209 (22%), Positives = 79/209 (37%), Gaps = 37/209 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           +G GSF    K V  +      VK+ +      ++  I   +      H N+VK+     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEV-- 74

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
              +       LV E +  G L E +       E + +           I   + SA+ +
Sbjct: 75  ---FHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVSH 121

Query: 398 LHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           +H     +  H DLKP N+L    ++ +   + DFG AR  PP +    +     ++ Y 
Sbjct: 122 MHD--VGVV-HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYA 176

Query: 455 APE------YGLGSEVSTNGDVYSYGILM 477
           APE      Y          D++S G+++
Sbjct: 177 APELLNQNGYDE--SC----DLWSLGVIL 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 44/211 (20%), Positives = 77/211 (36%), Gaps = 41/211 (19%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL-RSIRHRNLVKVFTAC 336
           IG GS+    + +         VK+ +      +     E   L R  +H N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV- 84

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
               Y    +  +V E M+ G L + +       E + +           +   +   ++
Sbjct: 85  ----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS----------AVLFTITKTVE 130

Query: 397 YLHHDCQPITTHCDLKPSNILL--DEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIG 452
           YLH   Q +  H DLKPSNIL   +      +   DFG A+ L   +          +  
Sbjct: 131 YLH--AQGVV-HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPCYTAN 185

Query: 453 YIAPE------YGLGSEVSTNGDVYSYGILM 477
           ++APE      Y          D++S G+L+
Sbjct: 186 FVAPEVLERQGYDA--AC----DIWSLGVLL 210

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 62/297 (20%), Positives = 104/297 (35%), Gaps = 66/297 (22%)

Query: 262 YQNLHNATDGFSSANLIGTGSFGSVY------------KGVLDEGRTTVTVKVFNLHHHR 309
              LH     ++    I +GS+G+V             K V +      TV + +     
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS-DSFL 72

Query: 310 ASRSFIAECRALRSIRHRNLVK---VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPV 366
             R    E R L    H N++    +F          +    LV E M        L  V
Sbjct: 73  CKRVL-REIRLLNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELM-----RTDLAQV 123

Query: 367 NREDEVDKAPRNLNLL--QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424
             +  +  +P+++       L         L  LH +   +  H DL P NILL +    
Sbjct: 124 IHDQRIVISPQHIQYFMYHILL-------GLHVLH-EAGVV--HRDLHPGNILLADNNDI 173

Query: 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYI------APEYGLGSEVSTNG-DVYSYGILM 477
            + DF LAR       +T          Y+      APE  +  +  T   D++S G +M
Sbjct: 174 TICDFNLAREDTADANKT---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224

Query: 478 LELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
            E+  RK     +F G    +        + ++++V +     +ED+ + S+   R 
Sbjct: 225 AEMFNRK----ALFRGSTFYNQL------NKIVEVVGTP---KIEDVVMFSSPSARD 268

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 19/213 (8%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQL 639
            K L+L  N   H           LQV DL+   I   I      S S+L  + L  N +
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPI 88

Query: 640 MGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPF--TL 695
              +    F  LS ++ L     N + S+   P+G+L +L+++++A N +  S       
Sbjct: 89  Q-SLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145

Query: 696 SKLKNLVILYLGVNRLSGIVPSSIFNI-----SSIAEFDVGENKIQGNIPLDYGFTLQNL 750
           S L NL  L L  N++  I   +   +           D+  N +   I     F    L
Sbjct: 146 SNLTNLEHLDLSSNKIQSI-YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG-AFKEIRL 202

Query: 751 QYFSIGTNRITGAIPPSI-SNASKLEVFQALNN 782
           +  ++ TN++  ++P  I    + L+      N
Sbjct: 203 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 19/212 (8%)

Query: 558 TILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSI 615
             LDL    L   +  +   +   L++L+L        I       L  L    L  N I
Sbjct: 31  KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88

Query: 616 GGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP--L 671
              + +   S  S+L ++   +  L   + +   G L  ++ L++  +NLI S   P   
Sbjct: 89  -QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA-HNLIQSFKLPEYF 145

Query: 672 GNLSSLRKISLAINNLAGSIP---FT-LSKLKNLVI-LYLGVNRLSGIVPSSIFNISSIA 726
            NL++L  + L+ N +  SI       L ++  L + L L +N ++ I     F    + 
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLK 203

Query: 727 EFDVGENKIQGNIPLDYGFTLQNLQYFSIGTN 758
           E  +  N+++ ++P      L +LQ   + TN
Sbjct: 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 16/177 (9%)

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSS 676
           +IP NL    +   + L+ N L       F S  +++VL L     I +I      +LS 
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLS-RCEIQTIEDGAYQSLSH 77

Query: 677 LRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSSIFNI-SSIAEFDVGENK 734
           L  + L  N +  S+     S L +L  L      L+ +  +       ++ E +V  N 
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKELNVAHNL 135

Query: 735 IQGNIPLDYGFT-LQNLQYFSIGTNRITGAIPPSI-SNASKLEVFQAL----NNKLT 785
           IQ +  L   F+ L NL++  + +N+I  +I  +      ++ +         N + 
Sbjct: 136 IQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 29/186 (15%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL-GLCESLTTIGLFNNNLS 58
           +L L    +   I      +L  L    ++ N ++ S+         SL  +     NL+
Sbjct: 56  VLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113

Query: 59  GTIPPQL-MGLTSLVALDLSRNQFR-----GSFPTEVGNLINLETLTVSGNILQGEIPST 112
            ++       L +L  L+++ N  +       F     NL NLE L +S N +Q    + 
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS----NLTNLEHLDLSSNKIQSIYCTD 168

Query: 113 LGSCIKLEILEM------------QGNVFQG--LTILDLSRNKLSGEIPEFLVGLKVIEN 158
           L    ++ +L +            Q   F+   L  L L  N+L          L  ++ 
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQK 228

Query: 159 LNLSYN 164
           + L  N
Sbjct: 229 IWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 28/176 (15%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPP-QLMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
            IP    L  S   + L  N L   +          L  LDLSR + + +       +L 
Sbjct: 21  KIPD--NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76

Query: 94  NLETLTVSGNILQGEIPS-TLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNK 141
           +L TL ++GN +Q  +          L+ L                 L     L+++ N 
Sbjct: 77  HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 142 L-SGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV------LGNNKL 190
           + S ++PE+   L  +E+L+LS N ++  +      +    + +      L  N +
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY-CTDLRVLHQMPLLNLSLDLSLNPM 189

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 69/270 (25%), Positives = 106/270 (39%), Gaps = 51/270 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK---VFNLHHHRASRSFIAECRALRSIRHRNLVK--- 331
           IG G++G V     +  +  V +K    F  H     R+   E + L   RH N++    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTL-REIKILLRFRHENIIGIND 92

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +  A +       D   +V + M     E  LY + +   +        L Q L      
Sbjct: 93  IIRAPTIEQM--KDV-YIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILR----- 139

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSI 451
              L Y+H     +  H DLKPSN+LL+      + DFGLAR   P H  T  +      
Sbjct: 140 --GLKYIH-SANVL--HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-----T 189

Query: 452 GYI------APEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
            Y+      APE  L S+  T   D++S G ++ E++  +     +F G   L       
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYLDQL---- 241

Query: 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
             +H++ I+ S      EDL  I N + R 
Sbjct: 242 --NHILGILGSP---SQEDLNCIINLKARN 266

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 42/227 (18%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVFT 334
           IG G+F  V           V +K+ +   L+     + F  E R ++ + H N+VK+F 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
               ++ +   +  L+ E+   G + ++L    R  E  +A               + SA
Sbjct: 82  V---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKE-KEARS---------KFRQIVSA 126

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL-ARFLPPTHVQTSSIGVKGSIGY 453
           + Y H        H DLK  N+LLD +M   + DFG    F     +        G+  Y
Sbjct: 127 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPY 179

Query: 454 IAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            APE      Y  G EV    DV+S G+++  L+    P    F+G 
Sbjct: 180 AAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ 217

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 38/216 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVFTA 335
            +G G++G V   V       V VK+ ++         I  E    + + H N+VK +  
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY-- 71

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             G   +GN    L  E+   G L + + P     E   A R      +L       + +
Sbjct: 72  --GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPE-PDAQR---FFHQL------MAGV 118

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL----PPTHVQTSSIGVKGSI 451
            YLH     I TH D+KP N+LLDE     + DFGLA           +        G++
Sbjct: 119 VYLHG--IGI-THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTL 171

Query: 452 GYIAPE------YGLGSEVSTNGDVYSYGILMLELI 481
            Y+APE      +     V    DV+S GI++  ++
Sbjct: 172 PYVAPELLKRREF-HAEPV----DVWSCGIVLTAML 202

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 37/206 (17%), Positives = 70/206 (33%), Gaps = 25/206 (12%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHR-NLVKVFT 334
           +G G F  V + +          K               + E   L   +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                 Y+      L+ E+   G +            + +    ++    + +   +   
Sbjct: 97  V-----YENTSEIILILEYAAGGEIFSLC--------LPELAEMVSENDVIRLIKQILEG 143

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEEMVSH---VGDFGLARFLPPTHVQTSSIGVKGSI 451
           + YLH     I  H DLKP NILL          + DFG++R +         +   G+ 
Sbjct: 144 VYYLHQ--NNIV-HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTP 197

Query: 452 GYIAPEYGLGSEVSTNGDVYSYGILM 477
            Y+APE      ++T  D+++ GI+ 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIA 223

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 60/224 (26%), Positives = 89/224 (39%), Gaps = 36/224 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS---RSFIAECRALRSIRHRN 328
           FS    IG GSFG+VY          V +K  +    +++   +  I E R L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
            ++         Y       LV E+    +           D ++   + L  ++   IA
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCLGSAS----------DLLEVHKKPLQEVE---IA 157

Query: 389 I---DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                    L YLH     I  H D+K  NILL E  +  +GDFG A  +        + 
Sbjct: 158 AVTHGALQGLAYLHSH-NMI--HRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 208

Query: 446 GVKGSIGYIAPEYGLGSEVSTNG---DVYSYGILMLELIIRKKP 486
              G+  ++APE  L  +        DV+S GI  +EL  RK P
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 28/214 (13%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-----SFIAECRALRSIRHRNLVKV 332
           +G G F +VYK         V +K   L H   ++     + + E + L+ + H N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
                      ++  +LV++FM+   LE  +               L         +   
Sbjct: 78  L----DAFGHKSNI-SLVFDFMET-DLEVII---------KDNSLVLTPSHIKAYMLMTL 122

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR-FLPPTHVQTSSIGVKGSI 451
             L+YLH        H DLKP+N+LLDE  V  + DFGLA+ F  P    T  + V  + 
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-V--TR 176

Query: 452 GYIAPEYGLGSEV-STNGDVYSYGILMLELIIRK 484
            Y APE   G+ +     D+++ G ++ EL++R 
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 55/240 (22%), Positives = 85/240 (35%), Gaps = 42/240 (17%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTV---KVFNLHH---HRASRSFIAECRALRS 323
           D F    +IG G+F  V    + + + T  V   K+ N            F  E   L +
Sbjct: 61  DDFEILKVIGRGAFSEVA---VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
              R + ++  A     +Q  ++  LV E+   G L   L         + A        
Sbjct: 118 GDRRWITQLHFA-----FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-------- 164

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQ 441
           R  +A ++  A+D +H        H D+KP NILLD     H+   DFG    L      
Sbjct: 165 RFYLA-EIVMAIDSVHR--LGYV-HRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTV 218

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVY-------SYGILMLELIIRKKPSDIMFEGD 494
            S + V G+  Y++PE             Y       + G+   E+   + P    F  D
Sbjct: 219 RSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP----FYAD 273

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 59/247 (23%)

Query: 277 LIGTGSFGSVYKGVLDEGR-TTVTVKVF--NLHHHRASRSFIAECRALRSIRHR------ 327
           +IG GSFG V K   D      V +K+       HR +     E R L  +R +      
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTM 159

Query: 328 NLVKVFTACSGVDYQGN---DFKAL---VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           N++ +        ++ +    F+ L   +YE ++    +                 +L L
Sbjct: 160 NVIHMLEN---FTFRNHICMTFELLSMNLYELIKKNKFQ---------------GFSLPL 201

Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH--VGDFGLARFLPPTH 439
           +++   A  +   LD LH   + I  HCDLKP NILL ++  S   V DFG + +     
Sbjct: 202 VRK--FAHSILQCLDALH-KNRII--HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

Query: 440 ---VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN 496
              +Q+          Y APE  LG+      D++S G ++ EL+        +  G+  
Sbjct: 257 YTYIQSRF--------YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDE 304

Query: 497 LHNFARM 503
               A M
Sbjct: 305 GDQLACM 311

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 41/187 (21%), Positives = 77/187 (41%), Gaps = 16/187 (8%)

Query: 575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL 634
              L+     NL   S T  +      L  +Q  + +N++I   +   +   +NL  + L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLA-GMQFFTNLKELHL 70

Query: 635 AKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFT 694
           + NQ+   + S    L+K+E LS+   N + ++       + L ++ L  N L      +
Sbjct: 71  SHNQIS-DL-SPLKDLTKLEELSVN-RNRLKNLNG--IPSACLSRLFLDNNELR-DTD-S 123

Query: 695 LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFS 754
           L  LKNL IL +  N+L  I    +  +S +   D+  N+I     L     L+ + +  
Sbjct: 124 LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGGLT---RLKKVNWID 178

Query: 755 IGTNRIT 761
           +   +  
Sbjct: 179 LTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 44/230 (19%), Positives = 80/230 (34%), Gaps = 18/230 (7%)

Query: 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
                +L    +  + L     LS ++  N +N++      + +     L+   L++N I
Sbjct: 20  NAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHNQI 75

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS 675
             ++   L   + L  + + +N+L   +  +    + +  L L  N L       L +L 
Sbjct: 76  S-DLS-PLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNEL--RDTDSLIHLK 128

Query: 676 SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735
           +L  +S+  N L  SI   L  L  L +L L  N ++      +  +  +   D+   K 
Sbjct: 129 NLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184

Query: 736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
             N P+ Y   L           R     P  ISN         L     
Sbjct: 185 V-NEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 36/176 (20%), Positives = 73/176 (41%), Gaps = 16/176 (9%)

Query: 610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
                I  ++       +N ++  L K  +          LS ++  +   +N I S+  
Sbjct: 4   QRPTPIN-QVF-PDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSN-IQSLAG 58

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFD 729
            +   ++L+++ L+ N ++  +   L  L  L  L +  NRL  +       +S +    
Sbjct: 59  -MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---F 112

Query: 730 VGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           +  N+++    L     L+NL+  SI  N++  +I   +   SKLEV     N++T
Sbjct: 113 LDNNELRDTDSLI---HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 37/173 (21%), Positives = 64/173 (36%), Gaps = 22/173 (12%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
                ++  + P    L   V+  +    +  +   S      +      N+N+  ++  
Sbjct: 4   QRPTPIN-QVFP-DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG 58

Query: 64  QLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILE 123
            +   T+L  L LS NQ     P  + +L  LE L+V+ N L+  +         L  L 
Sbjct: 59  -MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLF 112

Query: 124 MQGNV---------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           +  N           + L IL +  NKL   I   L  L  +E L+L  N++ 
Sbjct: 113 LDNNELRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 35/174 (20%), Positives = 66/174 (37%), Gaps = 20/174 (11%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
              D++ +  ++   +     L E ++S N +   + S L     L  + +  N L   +
Sbjct: 46  FNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NL 100

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
               +    L  L L  N+        + +L NLE L++  N L+  I   LG   KLE+
Sbjct: 101 NG--IPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEV 154

Query: 122 LEMQGN---------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL 166
           L++ GN           + +  +DL+  K   E  ++   L +   +       
Sbjct: 155 LDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 33/218 (15%), Positives = 67/218 (30%), Gaps = 17/218 (7%)

Query: 557 VTILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIP----SEIGRLRRLQVPDLN 611
              L     KL   I          L+ + +  N     I     S + +L  +++    
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI--EK 88

Query: 612 NNSIGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP 669
            N++   I      +  NL  + ++   +   +P        +  +L +  N  I +I  
Sbjct: 89  ANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 670 -PLGNLSS-LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
                LS     + L  N +        +  +   +     N L  +        S    
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206

Query: 728 FDVGENKIQGNIPLDYGFT-LQNLQYFSIGTNRITGAI 764
            D+   +I  ++P  YG   L+ L+  S    +    +
Sbjct: 207 LDISRTRIH-SLP-SYGLENLKKLRARSTYNLKKLPTL 242

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 39/201 (19%), Positives = 67/201 (33%), Gaps = 31/201 (15%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNL 57
            L     +L   I          L +  +S N +   I + +   L   L  I +   N 
Sbjct: 34  ELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL-PKLHEIRIEKANN 91

Query: 58  SGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGS 115
              I P+    L +L  L +S    +   P     + +    L +  N            
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN------------ 138

Query: 116 CIKLEILEMQGNVFQGLT----ILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVP 171
              + I  ++ N F GL+    IL L++N +         G ++ E      N+LE +  
Sbjct: 139 ---INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN 195

Query: 172 TEGVFKNASAISVL--GNNKL 190
              VF  AS   +L     ++
Sbjct: 196 --DVFHGASGPVILDISRTRI 214

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 33/173 (19%), Positives = 52/173 (30%), Gaps = 23/173 (13%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
            IPS   L  +   +      L   I      G   L  +++S+N        +V  NL 
Sbjct: 23  EIPS--DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79

Query: 94  NLETLTVS-GNILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNK 141
            L  + +   N L    P    +   L+ L +                    +LD+  N 
Sbjct: 80  KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139

Query: 142 LSGEIPEF-LVGLKV-IENLNLSYNDLEGMVPTEGVFKNASAISV--LGNNKL 190
               I     VGL      L L+ N ++  +     F       +    NN L
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIH-NSAFNGTQLDELNLSDNNNL 190

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 31/150 (20%), Positives = 59/150 (39%), Gaps = 31/150 (20%)

Query: 562 LESLKLAGSILPHIGNLSF-----LKILNLENNSFTHEIPSEI--GRLRRLQVPDLNNNS 614
           L+ L ++ + + H+ ++         +L++++N   H I      G      +  LN N 
Sbjct: 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165

Query: 615 IGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIP----- 668
           I  EI  +  + + L  + L+ N  + ++P+D F   S   +L +     I S+P     
Sbjct: 166 IQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR-IHSLPSYGLE 223

Query: 669 ----------------PPLGNLSSLRKISL 682
                           P L  L +L + SL
Sbjct: 224 NLKKLRARSTYNLKKLPTLEKLVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 23/129 (17%), Positives = 47/129 (36%), Gaps = 8/129 (6%)

Query: 661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF 720
            + +  IP  L    +  ++   +  L        S   +L  + +  N +  ++ + +F
Sbjct: 18  ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75

Query: 721 -NISSIAEFDV-GENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS--ISNASKLEV 776
            N+  + E  +   N +   I  +    L NLQY  I    I   +P    I +  K+ +
Sbjct: 76  SNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133

Query: 777 FQALNNKLT 785
               N  + 
Sbjct: 134 DIQDNINIH 142

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 38/232 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVT---VKVFN---LHHHRASRSFIAECRALRSIR 325
           F    ++G G FG V      + R T      K      +   +     + E + L  + 
Sbjct: 186 FRQYRVLGKGGFGEVC---ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED-EVDKAPRNLNLLQR 384
            R +V +  A     Y+  D   LV   M  G L+  +Y + +      +A         
Sbjct: 243 SRFVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA--------V 289

Query: 385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQT 442
              A ++   L+ LH   + I  + DLKP NILLD+    H+   D GLA  +P      
Sbjct: 290 FYAA-EICCGLEDLHR--ERIV-YRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIK 343

Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             +   G++GY+APE       + + D ++ G L+ E+I  + P    F+  
Sbjct: 344 GRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 53/223 (23%), Positives = 85/223 (38%), Gaps = 36/223 (16%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTV---KVFNLHH---HRASRSFIAECRALRSIR 325
           F    +IG G+FG V    + + +    V   K+ N         +  F  E   L +  
Sbjct: 76  FEILKVIGRGAFGEVA---VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
            + +  +  A     +Q ++   LV ++   G L   L         + A        R 
Sbjct: 133 SKWITTLHYA-----FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA--------RF 179

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTS 443
            +A ++  A+D +H        H D+KP NIL+D     H+   DFG    L       S
Sbjct: 180 YLA-EMVIAIDSVHQ--LHYV-HRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQS 233

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNG-----DVYSYGILMLELI 481
           S+ V G+  YI+PE     E          D +S G+ M E++
Sbjct: 234 SVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 53/234 (22%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            +G G+FG V  G        V VK+ N   +           E + L+  RH +++K++
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 334 T--ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR----EDEVDKAPRNLNLLQRLNI 387
              +     +       +V E++  G L +  Y        E E  +      L Q++  
Sbjct: 78  QVISTPTDFF-------MVMEYVSGGELFD--YICKHGRVEEMEARR------LFQQI-- 120

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-QTSSIG 446
                SA+DY H        H DLKP N+LLD  M + + DFGL+  +      +TS   
Sbjct: 121 ----LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 171

Query: 447 VKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             GS  Y APE      Y  G EV    D++S G+++  L+    P    F+ +
Sbjct: 172 --GSPNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLP----FDDE 214

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 56/210 (26%), Positives = 82/210 (39%), Gaps = 38/210 (18%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIA-ECRALRSIRHRNLVKVFTA 335
            +G G++G V   V       V VK+ ++         I  E    + + H N+VK +  
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY-- 71

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
             G   +GN    L  E+   G L + + P     E   A R      +L       + +
Sbjct: 72  --GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPE-PDAQR---FFHQL------MAGV 118

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL----PPTHVQTSSIGVKGSI 451
            YLH     I TH D+KP N+LLDE     + DFGLA           +        G++
Sbjct: 119 VYLHG--IGI-THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTL 171

Query: 452 GYIAPE------YGLGSEVSTNGDVYSYGI 475
            Y+APE      +     V    DV+S GI
Sbjct: 172 PYVAPELLKRREF-HAEPV----DVWSCGI 196

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 59/261 (22%), Positives = 97/261 (37%), Gaps = 54/261 (20%)

Query: 241 VRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTV 300
           +RK K   N  S     +N        A D +    +IG G+FG V    L   ++T  V
Sbjct: 41  LRKNKNIDNFLSRYKDTINKIRDLRMKAED-YEVVKVIGRGAFGEVQ---LVRHKSTRKV 96

Query: 301 ---KVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354
              K+ +         S  F  E   +       +V++F A     +Q + +  +V E+M
Sbjct: 97  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYM 151

Query: 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA--------SALDYLHHDCQPIT 406
             G L                   +NL+   ++    A         ALD +H       
Sbjct: 152 PGGDL-------------------VNLMSNYDVPEKWARFYTAEVVLALDAIHS--MGFI 190

Query: 407 THCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIGYIAPE--YGLGS 462
            H D+KP N+LLD+    H+   DFG    +    +      V G+  YI+PE     G 
Sbjct: 191 -HRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246

Query: 463 EVSTNGDV--YSYGILMLELI 481
           +     +   +S G+ + E++
Sbjct: 247 DGYYGRECDWWSVGVFLYEML 267

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 41/213 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL-RSIRHRNLVKVFTA 335
           ++G G  G V +           +K+      +A +    E     ++    ++V +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED----EVDKAPRNLNLLQRLNIAIDV 391
              + +       ++ E M+ G L   +    R D    E + A           I  D+
Sbjct: 91  YENMHHGKRCL-LIIMECMEGGELFSRI--QERGDQAFTEREAA----------EIMRDI 137

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
            +A+ +LH     I  H D+KP N+L    +++ V  + DFG A+      +QT      
Sbjct: 138 GTAIQFLHS--HNIA-HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PC 190

Query: 449 GSIGYIAPE----YGLGSEVSTNGDVYSYGILM 477
            +  Y+APE               D++S G++M
Sbjct: 191 YTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 55/259 (21%), Positives = 96/259 (37%), Gaps = 64/259 (24%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIA----------------- 316
            IG GS+G V     +   T   +KV +   L                            
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 317 ------ECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN--- 367
                 E   L+ + H N+VK+      +D    D   +V+E +  G + E   P     
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVME--VPTLKPL 134

Query: 368 REDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427
            ED+     +            D+   ++YLH+  Q I  H D+KPSN+L+ E+    + 
Sbjct: 135 SEDQARFYFQ------------DLIKGIEYLHY--QKII-HRDIKPSNLLVGEDGHIKIA 179

Query: 428 DFGLARFLPPTHV--QTSSIGVKGSIGYIAPEYGLGSEVSTNG---DVYSYGILMLELII 482
           DFG++     +      +     G+  ++APE    +    +G   DV++ G+ +   + 
Sbjct: 180 DFGVSNEFKGSDALLSNTV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

Query: 483 RKKPSDIMFEGD--MNLHN 499
            + P    F  +  M LH+
Sbjct: 236 GQCP----FMDERIMCLHS 250

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 44/224 (19%), Positives = 69/224 (30%), Gaps = 57/224 (25%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIA---ECRALRSIR----H 326
           L+G G FG+V+ G     R  V +KV     +         +    E   L  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGS-----LEEWLYPVNREDEVDKAPRNLNL 381
             ++++                   ++ +        LE    P+  +D  D       L
Sbjct: 98  PGVIRL------------------LDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPL 136

Query: 382 LQRL--NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS-HVGDFGLARFLPPT 438
            +         V +A+ + H        H D+K  NIL+D       + DFG    L   
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

Query: 439 HVQTSSIGVKGSIGYIAPE------YGLGSEVSTNGDVYSYGIL 476
                     G+  Y  PE      Y           V+S GIL
Sbjct: 194 PYTDFD----GTRVYSPPEWISRHQY-HALPA----TVWSLGIL 228

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 51/244 (20%), Positives = 80/244 (32%), Gaps = 67/244 (27%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN----------LHHHRASRSFIAECRALRSIRH 326
           L+G+G FGSVY G+       V +K              +  R       E   L+ +  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105

Query: 327 R--NLVKVFTACSGVDYQGNDFKALVYEFMQNGS-----LEEWLYPVNREDEVDKAPRNL 379
               ++++                   ++ +        LE    P   +D  D      
Sbjct: 106 GFSGVIRL------------------LDWFERPDSFVLILE---RPEPVQDLFDFITERG 144

Query: 380 NLLQRL--NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLP 436
            L + L  +    V  A+ + H+       H D+K  NIL+D       + DFG    L 
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK 201

Query: 437 PTHVQTSSIGVKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490
            T          G+  Y  PE      Y  G        V+S GIL+ +++    P    
Sbjct: 202 DTVYTDFD----GTRVYSPPEWIRYHRY-HGRSA----AVWSLGILLYDMVCGDIP---- 248

Query: 491 FEGD 494
           FE D
Sbjct: 249 FEHD 252

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 15/185 (8%)

Query: 581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQL 639
            K L+L++N  +        RL +L++  LN+N +   +P  +     NL  + +  N+L
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97

Query: 640 MGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIP---FT 694
              +P   F  L  +  L L   N + S+PP +  +L+ L  +SL  N L  S+P   F 
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLD-RNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 695 LSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYF 753
             KL +L  L L  N+L  + P   F  ++ +    +  N+++  +P     +L+ L+  
Sbjct: 155 --KLTSLKELRLYNNQLKRV-PEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210

Query: 754 SIGTN 758
            +  N
Sbjct: 211 QLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 23/181 (12%)

Query: 1   ILALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNL 57
            L L SN+LS ++P      L KL   Y++DN L+ ++P+ +   L ++L T+ + +N L
Sbjct: 41  KLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKEL-KNLETLWVTDNKL 97

Query: 58  SGTIPPQLM-GLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTL-G 114
              +P  +   L +L  L L RNQ + S P  V  +L  L  L++  N LQ  +P  +  
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 115 SCIKLEILEMQGN--------VFQGLT---ILDLSRNKLSGEIPEFLVGLKVIENLNLSY 163
               L+ L +  N         F  LT    L L  N+L          L+ ++ L L  
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

Query: 164 N 164
           N
Sbjct: 215 N 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 15/152 (9%)

Query: 577 NLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGL 634
            L+ L++L L +N     +P+ I   L+ L+   + +N +   +P+ +     NL  + L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRL 116

Query: 635 AKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLG---NLSSLRKISLAINNLAGS 690
            +NQL   +P   F SL+K+  LSLG+N L  S+P   G    L+SL+++ L  N L   
Sbjct: 117 DRNQL-KSLPPRVFDSLTKLTYLSLGYNEL-QSLPK--GVFDKLTSLKELRLYNNQLK-R 171

Query: 691 IPF-TLSKLKNLVILYLGVNRLSGIVPSSIFN 721
           +P     KL  L  L L  N+L  + P   F+
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRV-PEGAFD 202

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 8/134 (5%)

Query: 556 KVTILDLESLKLAGSILPHI-GNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNN 613
            +  L +   KL  ++   +   L  L  L L+ N     +P  +   L +L    L  N
Sbjct: 86  NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYN 143

Query: 614 SIGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PL 671
            +   +P  +    ++L  + L  NQL       F  L++++ L L  NN +  +P    
Sbjct: 144 EL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL-DNNQLKRVPEGAF 201

Query: 672 GNLSSLRKISLAIN 685
            +L  L+ + L  N
Sbjct: 202 DSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 21/138 (15%)

Query: 69  TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTL-GSCIKLEILEMQGN 127
                LDL  N+           L  L  L ++ N LQ  +P+ +      LE L +  N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 128 --------VFQGLT---ILDLSRNKLSGEIPE--FLVGLKVIENLNLSYNDLEGMVPTEG 174
                   VF  L     L L RN+L   +P   F   L  +  L+L YN+L+  +P +G
Sbjct: 96  KLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF-DSLTKLTYLSLGYNELQ-SLP-KG 151

Query: 175 VFKNASAISV--LGNNKL 190
           VF   +++    L NN+L
Sbjct: 152 VFDKLTSLKELRLYNNQL 169

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 57/235 (24%), Positives = 85/235 (36%), Gaps = 45/235 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            IG+G+FG          +  V VK             R    E    RS+RH N+V+  
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                  +      A++ E+   G L E +    R  E D+A       Q+L       S
Sbjct: 83  EVILTPTHL-----AIIMEYASGGELYERICNAGRFSE-DEARF---FFQQL------LS 127

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSH--VGDFGLARFLPPTHVQTSSIGVKGSI 451
            + Y H        H DLK  N LLD        + DFG ++         S++   G+ 
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTP 181

Query: 452 GYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
            YIAPE      Y  G       DV+S G+ +  +++   P    FE      ++
Sbjct: 182 AYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP----FEDPEEPRDY 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 37/229 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVT---VKVF---NLHHHRASRSFIAECRALRSIRHRNLV 330
           L+G G+FG V    L + + T     +K+     +         + E R L++ RH  L 
Sbjct: 155 LLGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +  +     +Q +D    V E+   G L   L       E D+A        R   A +
Sbjct: 212 ALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSE-DRA--------RFYGA-E 256

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           + SALDYLH +   +  + DLK  N++LD++   H+   DFGL +          +    
Sbjct: 257 IVSALDYLHSEKNVV--YRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFC-- 310

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP-----SDIMFE 492
           G+  Y+APE    ++     D +  G++M E++  + P      + +FE
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.1 bits (161), Expect = 3e-11
 Identities = 52/229 (22%), Positives = 82/229 (35%), Gaps = 53/229 (23%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTV---KVFN---------LHHHRASRSFIAECR 319
           FS   +IG G FG VY         T  +   K  +                R  ++   
Sbjct: 191 FSVHRIIGRGGFGEVY---GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS--- 244

Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            + +     +V +  A     +   D  + + + M  G L   L       E        
Sbjct: 245 LVSTGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADM---- 294

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPP 437
               R   A ++   L+++H+  + +  + DLKP+NILLDE    HV   D GLA     
Sbjct: 295 ----RFYAA-EIILGLEHMHN--RFV-VYRDLKPANILLDEH--GHVRISDLGLACDFSK 344

Query: 438 THVQTSSIGVKGSIGYIAPE-----YGLGSEVSTNGDVYSYGILMLELI 481
                S     G+ GY+APE         S      D +S G ++ +L+
Sbjct: 345 KKPHASV----GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLL 385

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 49/232 (21%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            +G G+FG V  G  +     V VK+ N   +           E + L+  RH +++K++
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR----EDEVDKAPRNLNLLQRLNIAI 389
                          +V E++  G L +  Y        E E  +      L Q++    
Sbjct: 83  QV-----ISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKESRR------LFQQI---- 125

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-QTSSIGVK 448
              S +DY H        H DLKP N+LLD  M + + DFGL+  +      +TS     
Sbjct: 126 --LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---- 176

Query: 449 GSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           GS  Y APE      Y  G EV    D++S G+++  L+    P    F+ D
Sbjct: 177 GSPNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDD 219

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 50/251 (19%), Positives = 84/251 (33%), Gaps = 61/251 (24%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIRHRNLVK-- 331
           IG GS+G VY          V +K    +F        R    E   L  ++   +++  
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRIL-REITILNRLKSDYIIRLY 91

Query: 332 -VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN-------LLQ 383
            +      + +  ++   +V E       +  L       ++ K P  L        L  
Sbjct: 92  DLIIPDDLLKF--DEL-YIVLEIA-----DSDLK------KLFKTPIFLTEEHIKTILYN 137

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
            L          +++H +   I  H DLKP+N LL+++    V DFGLAR +        
Sbjct: 138 LLL-------GENFIH-ESGII--HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 444 SIGVKGSIG--------------------YIAPEYGLGSEVSTNG-DVYSYGILMLELII 482
              ++ +                      Y APE  L  E  T   D++S G +  EL+ 
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 483 RKKPSDIMFEG 493
             +        
Sbjct: 248 MLQSHINDPTN 258

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 31/130 (23%), Positives = 55/130 (42%), Gaps = 4/130 (3%)

Query: 582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLM 640
             + LE N+     P      ++L+  DL+NN I  E+  +      +L  + L  N++ 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTLSKLK 699
               S F  L  +++L L  N +   +      +L +L  +SL  N L      T S L+
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 700 NLVILYLGVN 709
            +  ++L  N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 35/131 (26%), Positives = 53/131 (40%), Gaps = 15/131 (11%)

Query: 595 IPSEIGRLRRLQVPDLNNNSIGGEIPVN-LSSCSNLIRIGLAKNQLMGKIPSD-FGSLSK 652
           +P  I  +       L  N+I   IP    S    L RI L+ NQ+  ++  D F  L  
Sbjct: 30  LPETITEI------RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 653 IEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNR 710
           +  L L  N +   +P  L   L SL+ + L  N +   +       L NL +L L  N+
Sbjct: 82  LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139

Query: 711 LSGIVPSSIFN 721
           L   +    F+
Sbjct: 140 LQT-IAKGTFS 149

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 38/142 (26%), Positives = 57/142 (40%), Gaps = 17/142 (11%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
            IP+   L E++T I L  N +   IPP        L  +DLS NQ       +    L 
Sbjct: 25  EIPT--NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 94  NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKL 142
           +L +L + GN +     S       L++L +  N         FQ L    +L L  NKL
Sbjct: 81  SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 143 SGEIPEFLVGLKVIENLNLSYN 164
                     L+ I+ ++L+ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 9/144 (6%)

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL-GNLSS 676
           EIP NL     +  I L +N +    P  F    K+  + L  NN I  + P     L S
Sbjct: 25  EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLS-NNQISELAPDAFQGLRS 81

Query: 677 LRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENK 734
           L  + L  N +   +P      L +L +L L  N+++ +     F ++ ++    + +NK
Sbjct: 82  LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCL-RVDAFQDLHNLNLLSLYDNK 139

Query: 735 IQGNIPLDYGFTLQNLQYFSIGTN 758
           +Q  I       L+ +Q   +  N
Sbjct: 140 LQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 19/135 (14%)

Query: 69  TSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS-TLGSCIKLEILEMQGN 127
            ++  + L +N  +   P        L  + +S N +  E+          L  L + GN
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 128 --------VFQGLT---ILDLSRNKLSGEIPEFL-VGLKVIENLNLSYNDLEGMVPTEGV 175
                   +F+GL    +L L+ NK++  +       L  +  L+L  N L+  +  +G 
Sbjct: 91  KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIA-KGT 147

Query: 176 FKNASAISV--LGNN 188
           F    AI    L  N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 54/234 (23%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            +G GSFG V      + +  V +K  +   L           E   L+ +RH +++K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74

Query: 334 TACSGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNR----EDEVDKAPRNLNLLQRLNI 387
                  Y        +   ++   G L +  Y V +    EDE  +        Q++  
Sbjct: 75  -------YDVITTPTDIVMVIEYAGGELFD--YIVEKKRMTEDEGRR------FFQQI-- 117

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV-QTSSIG 446
                 A++Y H        H DLKP N+LLD+ +   + DFGL+  +   +  +TS   
Sbjct: 118 ----ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-- 168

Query: 447 VKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
             GS  Y APE      Y  G EV    DV+S GI++  +++ + P    F+ +
Sbjct: 169 --GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLP----FDDE 211

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 45/214 (21%), Positives = 78/214 (36%), Gaps = 44/214 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL-RSIRHRNLVKVFTAC 336
           +G G  G V +      +    +K+      +A R    E     R+ +  ++V++    
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED----EVDKAPRNLNLLQRLNIAIDVA 392
               Y G     +V E +  G L   +   +R D    E + +           I   + 
Sbjct: 125 EN-LYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREAS----------EIMKSIG 171

Query: 393 SALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
            A+ YLH     I  H D+KP N+L        +  + DFG A+     +  T+      
Sbjct: 172 EAIQYLHS--INIA-HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---Y 225

Query: 450 SIGYIAPE------YGLGSEVSTNGDVYSYGILM 477
           +  Y+APE      Y          D++S G++M
Sbjct: 226 TPYYVAPEVLGPEKYDK--SC----DMWSLGVIM 253

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 1e-10
 Identities = 33/227 (14%), Positives = 83/227 (36%), Gaps = 9/227 (3%)

Query: 538 NNIIECLISMLRIGSKAQKVTIL-DLESLKLAGSILPHIGNL--SFLKILNLENNSFTHE 594
           ++  EC++   R     +       L   +L+      + +   S  ++  LE  +    
Sbjct: 326 DSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCL 385

Query: 595 IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE 654
           + + I  +R L        ++     +          +   +++ + +        + + 
Sbjct: 386 L-TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVR 444

Query: 655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
           VL L   +L  ++   L  L  +  + L+ N L  ++P  L+ L+ L +L    N L  +
Sbjct: 445 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV 501

Query: 715 VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
               + N+  + E  +  N++Q +  +    +   L   ++  N + 
Sbjct: 502 --DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 56.3 bits (135), Expect = 3e-08
 Identities = 29/102 (28%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 27  YVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFP 86
           +++   L  ++   L     +T + L +N L   +PP L  L  L  L  S N    +  
Sbjct: 447 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD 502

Query: 87  TEVGNLINLETLTVSGN-ILQGEIPSTLGSCIKLEILEMQGN 127
             V NL  L+ L +  N + Q      L SC +L +L +QGN
Sbjct: 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 30/175 (17%), Positives = 54/175 (30%), Gaps = 18/175 (10%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPP 63
           +                ++L    +S       + S L  C+ L  +   N     TI  
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390

Query: 64  QLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSG--NILQGEIPSTLGSCIKLEI 121
            +  L  L+    +   F     + +  +  +    +    +    E          + +
Sbjct: 391 LMRALDPLLYEKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445

Query: 122 LEMQGNV---------FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
           L +                +T LDLS N+L   +P  L  L+ +E L  S N LE
Sbjct: 446 LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.4 bits (117), Expect = 4e-06
 Identities = 32/216 (14%), Positives = 67/216 (31%), Gaps = 17/216 (7%)

Query: 573 PHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI 632
                    K   L  +        +     +L   +L+       +   L SC  L  +
Sbjct: 320 VIWTGSDSQKECVLLKDR-PECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQEL 377

Query: 633 GLAKNQLMGKIPSDFGSLSKIEVLSLG---FNNLIGSIPPPLGNLSSLRKISLAINNLAG 689
                  +  I     +L  +         F+ L    P     L  LR   L  N    
Sbjct: 378 EPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN---- 433

Query: 690 SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQN 749
                  +  ++ +L+L    L+ +    +  +  +   D+  N+++  +P      L+ 
Sbjct: 434 --SVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALA-ALRC 487

Query: 750 LQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           L+      N +   +   ++N  +L+     NN+L 
Sbjct: 488 LEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 48.6 bits (115), Expect = 7e-06
 Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 4/81 (4%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG-T 60
           L L  NRL   +PP++  L+ L     SDN L+ ++   +     L  + L NN L    
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSA 524

Query: 61  IPPQLMGLTSLVALDLSRNQF 81
               L+    LV L+L  N  
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.5 bits (107), Expect = 6e-05
 Identities = 27/172 (15%), Positives = 52/172 (30%), Gaps = 27/172 (15%)

Query: 4   LDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTI--------GLFNN 55
                L    P +   L  ++    + + L      +L    +L  +            +
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLL-YEKETLQYFSTLKAVDPMRAAYLDDLRS 427

Query: 56  NLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGS 115
                     M    +  L L+      +    +  L+ +  L +S N L+  +P  L +
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAA 484

Query: 116 CIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE 167
              LE+L               S N L   +   +  L  ++ L L  N L+
Sbjct: 485 LRCLEVL-------------QASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 55/246 (22%), Positives = 81/246 (32%), Gaps = 70/246 (28%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK-VFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFT 334
           IGTGS+G V +      +  V +K +  +        R    E   L  + H ++VKV  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLD 119

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVD-----KAPRNLN-------LL 382
                D +  D   +V E                  + D     + P  L        L 
Sbjct: 120 IVIPKDVEKFDELYVVLEIA----------------DSDFKKLFRTPVYLTELHIKTLLY 163

Query: 383 QRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
             L         + Y+H         H DLKP+N L++++    V DFGLAR +      
Sbjct: 164 NLLV-------GVKYVHSAGI----LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 442 TSSIGVKGSIG-------------------------YIAPEYGLGSEVSTNG-DVYSYGI 475
            S + +                              Y APE  L  E  T   DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 476 LMLELI 481
           +  EL+
Sbjct: 273 IFAELL 278

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 45/242 (18%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHR------ 327
           +LIG GSFG V K      +  V +K+          ++    E R L  +         
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKY 116

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
            +V +        ++ +    LV+E      L   LY + R    +    +LNL ++   
Sbjct: 117 YIVHLKRH---FMFRNHLC--LVFE-----MLSYNLYDLLRNT--NFRGVSLNLTRK--F 162

Query: 388 AIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEMVSH--VGDFGLARFLPPTH---VQ 441
           A  + +AL +L   +   I  HCDLKP NILL     S   + DFG +  L       +Q
Sbjct: 163 AQQMCTALLFLATPELSII--HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
           +          Y +PE  LG       D++S G +++E+       + +F G   +    
Sbjct: 221 SRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT----GEPLFSGANEVDQMN 268

Query: 502 RM 503
           ++
Sbjct: 269 KI 270

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--------HRASRSFIAECRAL 321
           D F     +GTGSFG V      E      +K+ +           H      + E R L
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TLNEKRIL 95

Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
           +++    LVK+  +     ++ N    +V E++  G +   L  + R  E   A      
Sbjct: 96  QAVNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHA------ 143

Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTH 439
             R   A  +    +YLH     +  + DLKP N+L+D++   ++   DFG A+ +    
Sbjct: 144 --RFYAA-QIVLTFEYLHS--LDLI-YRDLKPENLLIDQQ--GYIQVTDFGFAKRVKGR- 194

Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
             T ++   G+   +APE  L    +   D ++ G+L+ E+ 
Sbjct: 195 --TWTLC--GTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 66/286 (23%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVK----VFNLHHHRASRSFIAECRALRSIR-HRNLVK- 331
           +G G++G V+K +       V VK     F  +   A R+F  E   L  +  H N+V  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTF-REIMILTELSGHENIVNL 74

Query: 332 --VFTACSGVD-YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
             V  A +  D Y       LV+++M     E  L+ V R + ++   +   + Q +   
Sbjct: 75  LNVLRADNDRDVY-------LVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIK-- 120

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
                 + YLH     +  H D+KPSNILL+ E    V DFGL+R        T++I + 
Sbjct: 121 -----VIKYLH-SGGLL--HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 449 GSIG-------------------YIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSD 488
            +                     Y APE  LGS   T G D++S G ++ E++  K    
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK---- 228

Query: 489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ 534
            +F G   ++        + ++ ++D       ED+  I +   + 
Sbjct: 229 PIFPGSSTMNQL------ERIIGVIDFP---SNEDVESIQSPFAKT 265

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 47/244 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTV---KVFN----LHHHRASRSFIAECRALRSIRHRN- 328
           ++GTG++G V+      G  T  +   KV      +   + +     E + L  IR    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           LV +  A     +Q      L+ +++  G L   L    R  E  +         ++ + 
Sbjct: 121 LVTLHYA-----FQTETKLHLILDYINGGELFTHLSQRERFTE-HEV--------QIYVG 166

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLA-RFLPPTHVQTSSI 445
            ++  AL++LH     I  + D+K  NILLD     HV   DFGL+  F+     +    
Sbjct: 167 -EIVLALEHLHK--LGII-YRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDF 220

Query: 446 GVKGSIGYIAPE------YGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
              G+I Y+AP+       G    V    D +S G+LM EL+    P    F  D   ++
Sbjct: 221 C--GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVDGEKNS 270

Query: 500 FARM 503
            A +
Sbjct: 271 QAEI 274

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.7 bits (146), Expect = 5e-10
 Identities = 33/204 (16%), Positives = 63/204 (30%), Gaps = 36/204 (17%)

Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV--------FNLHHHRASRSFIAECR 319
            T+       IG G FG V++ + D   T V +K+         N  H +     + E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 320 ALRSIRH-----RNLVKVFTACSGVD-YQGNDFKALVYEFMQ----NGSLEE-------- 361
             + +        N  + F   + V   QG+    L+  +       GS  +        
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 362 -----WLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI 416
                  +     D      +  +L    +I   + ++L       +    H DL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 417 LLDEEMVSHVGDFGLAR-FLPPTH 439
           LL +  +  +      +    P+ 
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSC 217

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.1 bits (144), Expect = 2e-09
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 35/227 (15%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTV---KVFN----LHHHRASRSFIAECRALRSIRHRNL 329
           ++G G +G V++     G  T  +   KV      + + + +    AE   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V +  A     +Q      L+ E++  G L   L       E D A           +A 
Sbjct: 84  VDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFME-DTA--------CFYLA- 128

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGV 447
           +++ AL +LH   + I  + DLKP NI+L+ +   HV   DFGL +        T +   
Sbjct: 129 EISMALGHLHQ--KGII-YRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFC- 182

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G+I Y+APE  + S  +   D +S G LM +++    P    F G+
Sbjct: 183 -GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 29/151 (19%), Positives = 50/151 (33%), Gaps = 10/151 (6%)

Query: 577 NLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIP--VNLSSCSNLIRIG 633
           NLS +  + + N      I  +    L  L+   + N  +    P    + S      + 
Sbjct: 78  NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILE 136

Query: 634 LAKNQLMGKIPSD-FGSLSK-IEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI 691
           +  N  M  IP + F  L      L L  NN   S+     N + L  + L  N     I
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLY-NNGFTSVQGYAFNGTKLDAVYLNKNKYLTVI 195

Query: 692 P-FTLSKLKN-LVILYLGVNRLSGIVPSSIF 720
                  + +   +L +    ++ + PS   
Sbjct: 196 DKDAFGGVYSGPSLLDVSQTSVTAL-PSKGL 225

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 7/162 (4%)

Query: 627 SNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAI 684
            +   + L +  L   IPS  F +L  I  + +  +  +  +      NLS +  I +  
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 685 NNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVP-SSIFNISSIAEFDVGENKIQGNIPLD 742
                 I    L +L  L  L +    L      + +++       ++ +N    +IP++
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 743 YGFTLQN-LQYFSIGTNRITGAIPPSISNASKLEVFQALNNK 783
               L N      +  N  T ++     N +KL+      NK
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 34/220 (15%), Positives = 66/220 (30%), Gaps = 39/220 (17%)

Query: 561 DLESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
             ++LKL  + L  I      NL  +  + +  +    ++ S                  
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS---------------- 75

Query: 616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPP--LG 672
                    + S +  I +   + +  I  D    L  ++ L +  N  +   P    + 
Sbjct: 76  -------FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF-NTGLKMFPDLTKVY 127

Query: 673 NLSSLRKISLAINNLAGSIP-FTLSKLKN-LVILYLGVNRLSGIVPSSIFNISSIAEFDV 730
           +      + +  N    SIP      L N  + L L  N  + +     FN + +    +
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSV-QGYAFNGTKLDAVYL 186

Query: 731 GENKIQGNIPLDYGFT--LQNLQYFSIGTNRITGAIPPSI 768
            +NK    I     F           +    +T A+P   
Sbjct: 187 NKNKYLTVID-KDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 31/170 (18%), Positives = 61/170 (35%), Gaps = 28/170 (16%)

Query: 2   LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKGSIP--SSLGLCESLTTIGLFNNNLS 58
           + + + R    I P     L  L    + +  LK   P  + +   +    + + +N   
Sbjct: 85  IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143

Query: 59  GTIPPQ-LMGLTS-LVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC 116
            +IP     GL +  + L L  N F  S      N   L+ + ++ N             
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY----------- 191

Query: 117 IKLEILEMQGNVFQG----LTILDLSRNKLSGEIP-EFLVGLKVIENLNL 161
               +  +  + F G     ++LD+S+  ++  +P + L  LK +   N 
Sbjct: 192 ----LTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 25/135 (18%), Positives = 49/135 (36%), Gaps = 10/135 (7%)

Query: 577 NLSFLKILNLENNSFTHEIPSE--IGRLRRLQVPDLNNNSIGGEIPVNLSS--CSNLIRI 632
            L  LK L + N       P    +       + ++ +N     IPVN     C+  + +
Sbjct: 103 ELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161

Query: 633 GLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL--GNLSSLRKISLAINNLAGS 690
            L  N     +     + +K++ + L  N  +  I      G  S    + ++  ++  +
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-A 219

Query: 691 IPF-TLSKLKNLVIL 704
           +P   L  LK L+  
Sbjct: 220 LPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 27/165 (16%), Positives = 50/165 (30%), Gaps = 31/165 (18%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
            IPS   L  S  T+ L   +L  TIP      L ++  + +S +       +    NL 
Sbjct: 25  RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 94  NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLT---ILDLSRNKLSGEIPE-- 148
            +  + +        I                 +  + L     L +    L    P+  
Sbjct: 81  KVTHIEIRNTRNLTYIDP---------------DALKELPLLKFLGIFNTGLK-MFPDLT 124

Query: 149 FLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISV---LGNNKL 190
            +    +   L ++ N     +P    F+     ++   L NN  
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIP-VNAFQGLCNETLTLKLYNNGF 168

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 54/254 (21%), Positives = 94/254 (37%), Gaps = 51/254 (20%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHR-----NL 329
            +G G+FG V      + +    VKV      + R+++    E   L+ I++      N+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           VK         Y  +    L++E +   SL E +         +    ++  ++     I
Sbjct: 99  VKYHGK---FMYYDHMC--LIFEPL-GPSLYEII------TRNNYNGFHIEDIKL--YCI 144

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILL--DEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
           ++  AL+YL         H DLKP NILL       S +    +         +T S G+
Sbjct: 145 EILKALNYLR-KMSLT--HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 448 K----GS--------IGYI------APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489
           K    G            I      APE  L      + D++S+G ++ EL        +
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT----GSL 257

Query: 490 MFEGDMNLHNFARM 503
           +F    ++ + A M
Sbjct: 258 LFRTHEHMEHLAMM 271

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 57/265 (21%), Positives = 92/265 (34%), Gaps = 77/265 (29%)

Query: 277 LIGTGSFGSVYKGVLD--EGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHR----- 327
            +G G+FG V +  LD   G++ V +K+      +  A+R    E   L+ I+ +     
Sbjct: 26  NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENK 81

Query: 328 -NLVKVFTACSGVDYQGN---DFKAL---VYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
              V +       ++ G+    F+ L    +EF++  +                 P  L 
Sbjct: 82  FLCVLMSDW---FNFHGHMCIAFELLGKNTFEFLKENN---------------FQPYPLP 123

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG------------- 427
            ++   +A  +  AL +LH + Q    H DLKP NIL        +              
Sbjct: 124 HVRH--MAYQLCHALRFLH-ENQLT--HTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178

Query: 428 ------DFGLARFLPPTH---VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILML 478
                 DFG A F    H   V T          Y  PE  L    +   DV+S G ++ 
Sbjct: 179 TSIRVADFGSATFDHEHHTTIVATRH--------YRPPEVILELGWAQPCDVWSIGCILF 230

Query: 479 ELIIRKKPSDIMFEGDMNLHNFARM 503
           E          +F+   N  +   M
Sbjct: 231 EYYR----GFTLFQTHENREHLVMM 251

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 9e-09
 Identities = 40/232 (17%), Positives = 81/232 (34%), Gaps = 45/232 (19%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKVF 333
            IG G FG +Y   ++    +V         +        F  E +  +       ++ +
Sbjct: 42  PIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFT-ELKFYQRAAKPEQIQKW 99

Query: 334 TACSGVDYQG--------------NDFKALVYEFMQNG-SLEEWLYPVNREDEVDKAPRN 378
                + Y G                ++ ++ +    G  L++           +   + 
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---------EANAKR 148

Query: 379 LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLA-RFL 435
            +    L +++ +   L+Y+H        H D+K SN+LL+ +    V   D+GLA R+ 
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205

Query: 436 PP-THVQTSSIGVKGSIGYIAPEYG-----LGSEVSTNGDVYSYGILMLELI 481
           P   H   ++   +   G    E+       G   S  GD+   G  M++ +
Sbjct: 206 PEGVHKAYAADPKRCHDG--TIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 38/227 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVT---VKVF---NLHHHRASRSFIAECRAL-RSIRHRNL 329
           ++G GSFG V    L E + T     VK+     +         + E R L    +   L
Sbjct: 348 VLGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
            ++ +      +Q  D    V E++  G L   +  V R  E   A            A 
Sbjct: 405 TQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-PHA--------VFYAA- 449

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGV 447
           ++A  L +L    + I  + DLK  N++LD E   H+   DFG+ +      V T +   
Sbjct: 450 EIAIGLFFLQS--KGII-YRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC- 503

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G+  YIAPE         + D +++G+L+ E++  + P    FEG+
Sbjct: 504 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.0 bits (136), Expect = 2e-08
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 40/220 (18%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--------HRASRSFIAECRALRS 323
           F     +GTGSFG V+            +KV             H        E   L  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLMLSI 62

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           + H  +++++       +Q      ++ ++++ G L   L    R      A        
Sbjct: 63  VTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVA-------- 108

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQ 441
           +   A +V  AL+YLH   + I  + DLKP NILLD+    H+   DFG A+++P     
Sbjct: 109 KFYAA-EVCLALEYLHS--KDII-YRDLKPENILLDKN--GHIKITDFGFAKYVPDV--- 159

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
           T ++   G+  YIAPE       + + D +S+GIL+ E++
Sbjct: 160 TYTLC--GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 25/132 (18%), Positives = 50/132 (37%), Gaps = 16/132 (12%)

Query: 595 IPSEIGRLRRLQVPDLNNNSIGGEIPVN--LSSCSNLIRIGLAKNQLMGKIPSD-FGSLS 651
           IP     L       LNNN     +           L +I  + N++   I    F   S
Sbjct: 30  IPQYTAEL------RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGAS 81

Query: 652 KIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVN 709
            +  + L  +N + ++   +   L SL+ + L  N +   +   +   L ++ +L L  N
Sbjct: 82  GVNEILLT-SNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 710 RLSGIVPSSIFN 721
           +++ +     F+
Sbjct: 140 QITTV-APGAFD 150

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 29/160 (18%), Positives = 57/160 (35%), Gaps = 36/160 (22%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLM--GLTSLVALDLSRNQFR----GSFPTEV 89
            IP    + +    + L NN  +  +    +   L  L  ++ S N+      G+F    
Sbjct: 25  KIPE--HIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAF---- 77

Query: 90  GNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLT---ILDLSRNKLSGEI 146
                +  + ++ N L+  +                  +F+GL     L L  N+++  +
Sbjct: 78  EGASGVNEILLTSNRLE-NVQH---------------KMFKGLESLKTLMLRSNRIT-CV 120

Query: 147 PEFL-VGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVL 185
                +GL  +  L+L  N +   V   G F    ++S L
Sbjct: 121 GNDSFIGLSSVRLLSLYDNQITT-VA-PGAFDTLHSLSTL 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 31/136 (22%), Positives = 57/136 (41%), Gaps = 13/136 (9%)

Query: 557 VTILDLESLKLAGSILPHIG---NLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNN 612
              L L + +   ++L   G    L  L+ +N  NN  T +I          +    L +
Sbjct: 34  TAELRLNNNEF--TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 613 NSIGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPP- 669
           N +   +   +     +L  + L  N++   + +D F  LS + +LSL ++N I ++ P 
Sbjct: 91  NRL-ENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSL-YDNQITTVAPG 147

Query: 670 PLGNLSSLRKISLAIN 685
               L SL  ++L  N
Sbjct: 148 AFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 27/132 (20%), Positives = 50/132 (37%), Gaps = 11/132 (8%)

Query: 2   LALDSNRLSGNIPPSIG--NLKKLVEPYVSDNFLKGSIPSSL--GLCESLTTIGLFNNNL 57
           L L++N  +  +  +     L +L +   S+N +   I      G    +  I L +N L
Sbjct: 37  LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA-SGVNEILLTSNRL 93

Query: 58  SGTIPPQLM-GLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGS 115
              +  ++  GL SL  L L  N+       +    L ++  L++  N +    P    +
Sbjct: 94  E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151

Query: 116 CIKLEILEMQGN 127
              L  L +  N
Sbjct: 152 LHSLSTLNLLAN 163

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 55.6 bits (135), Expect = 2e-08
 Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVT---VKVF---NLHHHRASRSFIAECRALRSIRHRNLV 330
           ++G GSFG V+      G        +KV     L      R+   E   L  + H  +V
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           K+  A     +Q      L+ +F++ G L   L       E +          +  +A +
Sbjct: 90  KLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDV--------KFYLA-E 134

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           +A ALD+LH     I  + DLKP NILLDEE   H+   DFGL++       +  S    
Sbjct: 135 LALALDHLHS--LGII-YRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFC-- 187

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           G++ Y+APE       + + D +S+G+LM E++    P    F+G 
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP----FQGK 229

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 46/228 (20%), Positives = 78/228 (34%), Gaps = 40/228 (17%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            IG+G FG +Y              V  + +      F  E +  + +  ++ +K +   
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102

Query: 337 SGVDYQG--------------NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
             +DY G                ++ +V E      L++                     
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQKIS----------GQNGTFKKS 151

Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLA-RFLPP-T 438
             L + I +   L+Y+H +      H D+K +N+LL  +    V   D+GL+ R+ P   
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

Query: 439 HVQTSSIGVKGSIGYIAPEYG-----LGSEVSTNGDVYSYGILMLELI 481
           H Q      KG  G    E+       G  +S   DV   G  ML  +
Sbjct: 209 HKQYQENPRKGHNG--TIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 59/287 (20%), Positives = 94/287 (32%), Gaps = 89/287 (31%)

Query: 254 INSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS 313
           I  L N  Y  +            +G G F +V+     +G+  V +KV     H    +
Sbjct: 31  IGDLFNGRYHVIRK----------LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA 80

Query: 314 FIAECRALRSIR-----HRNLVKVFTACSGVDYQGNDFK--ALVYEFMQNGSLEEWLYPV 366
              E R L+S+R       N   V          G +     +V+E + +  L +W+   
Sbjct: 81  LD-EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKS 138

Query: 367 NREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL-------- 418
           N +         L  +++  I   V   LDYLH  C+ I  H D+KP NILL        
Sbjct: 139 NYQ------GLPLPCVKK--IIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIR 188

Query: 419 -----------------------------------------DEEMVSHVGDFGLARFLPP 437
                                                     E++   + D G A ++  
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248

Query: 438 TH---VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELI 481
                +QT          Y + E  +GS  +T  D++S   +  EL 
Sbjct: 249 HFTEDIQTRQ--------YRSLEVLIGSGYNTPADIWSTACMAFELA 287

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 37/226 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVT---VKVF---NLHHHRASRSFIAECRALRSIRHRNLV 330
           L+G G+FG V    L   + T     +K+     +         + E R L++ RH  L 
Sbjct: 12  LLGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +  A     +Q +D    V E+   G L   L       E ++A        R   A +
Sbjct: 69  ALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTE-ERA--------RFYGA-E 113

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           + SAL+YLH   + +  + D+K  N++LD++   H+   DFGL +          +    
Sbjct: 114 IVSALEYLHS--RDVV-YRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFC-- 166

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           G+  Y+APE    ++     D +  G++M E++  + P    F   
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQ 208

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 56/265 (21%), Positives = 96/265 (36%), Gaps = 77/265 (29%)

Query: 277 LIGTGSFGSVYKGV-LDEGRTTVTVKVF--NLHHHRASRSFIAECRALRSIRHR------ 327
            +G G+FG V + +    G   V VK+      +  A+RS   E + L  +         
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77

Query: 328 NLVKVFTACSGVDYQGN---DFKAL---VYEFM-QNGSLEEWLYPVNREDEVDKAPRNLN 380
             V++       ++ G+    F+ L    Y+F+ +NG                  P  L+
Sbjct: 78  RCVQMLEW---FEHHGHICIVFELLGLSTYDFIKENG----------------FLPFRLD 118

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG------------- 427
            +++  +A  +  ++++LH   +    H DLKP NIL  +   +                
Sbjct: 119 HIRK--MAYQICKSVNFLH-SNKLT--HTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173

Query: 428 ------DFGLARFLPPTH---VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILML 478
                 DFG A +    H   V T          Y APE  L    S   DV+S G +++
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRH--------YRAPEVILALGWSQPCDVWSIGCILI 225

Query: 479 ELIIRKKPSDIMFEGDMNLHNFARM 503
           E  +       +F    +  + A M
Sbjct: 226 EYYL----GFTVFPTHDSKEHLAMM 246

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 15/98 (15%), Positives = 26/98 (26%), Gaps = 2/98 (2%)

Query: 637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNLAGSIPFTL 695
                           +  L +     +  +    L  L  LR +++  + L    P   
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 696 SKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733
                L  L L  N L  +         S+ E  +  N
Sbjct: 77  HFTPRLSRLNLSFNALESL-SWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 4/100 (4%)

Query: 6   SNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPS-SLGLCESLTTIGLFNNNLSGTIPPQ 64
           +   + +    +   + L E Y+ +      +    L     L  + +  + L   + P 
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 65  -LMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN 103
                  L  L+LS N    S   +    ++L+ L +SGN
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 4/94 (4%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQ-LMGLTSLVALDLSRNQFRGSFPTEV-GNLI 93
                L   E+LT + + N      +  + L GL  L  L + ++  R     +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 94  NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN 127
            L  L +S N L+  +       + L+ L + GN
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 3e-06
 Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 22/127 (17%)

Query: 44  CESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLINLETLTVSG 102
               + +     + +      L G  +L  L +   Q            L  L  LT+  
Sbjct: 7   PHGSSGL-RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 103 NILQGEIPSTLGSCIKLEILEMQGNVFQG---LTILDLSRNKLSGEIPEFLVGLKVIENL 159
           +                 +  +  + F     L+ L+LS N L     + + GL  ++ L
Sbjct: 66  S----------------GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQEL 108

Query: 160 NLSYNDL 166
            LS N L
Sbjct: 109 VLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 21/119 (17%), Positives = 38/119 (31%), Gaps = 26/119 (21%)

Query: 570 SILPHIGNLSFLKILNLENNSFTHEIPSE-IGRLRRLQVPDLNNNSIGGEIPVNLSSCSN 628
             L H+     L  L +EN      +    +  L  L+   +  + +   +         
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-------- 72

Query: 629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNL 687
                          P  F    ++  L+L FN L  S+        SL+++ L+ N L
Sbjct: 73  ---------------PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 12/97 (12%), Positives = 32/97 (32%), Gaps = 3/97 (3%)

Query: 666 SIPPPLGNLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSSIFNISS 724
                L    +L ++ +        +    L  L  L  L +  + L  + P +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 725 IAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
           ++  ++  N ++ ++         +LQ   +  N + 
Sbjct: 82  LSRLNLSFNALE-SLSWK-TVQGLSLQELVLSGNPLH 116

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 17/148 (11%)

Query: 582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLM 640
           + L+L++        +    L +L   +L+ N +   +   +    + L  +GLA NQL 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 641 GKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLG---NLSSLRKISLAINNLAGSIP---F 693
             +P   F  L++++ L LG  N + S+P   G    L+ L+++ L  N L  SIP   F
Sbjct: 97  -SLPLGVFDHLTQLDKLYLG-GNQLKSLPS--GVFDRLTKLKELRLNTNQLQ-SIPAGAF 151

Query: 694 TLSKLKNLVILYLGVNRLSGIVPSSIFN 721
              KL NL  L L  N+L  + P   F+
Sbjct: 152 D--KLTNLQTLSLSTNQLQSV-PHGAFD 176

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 14/159 (8%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIG 616
             LDL+S  LA         L+ L  LNL+ N     + + +   L  L    L NN + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL- 95

Query: 617 GEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLG-- 672
             +P+ +    + L ++ L  NQL   +PS  F  L+K++ L L   N + SIP   G  
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLN-TNQLQSIPA--GAF 151

Query: 673 -NLSSLRKISLAINNLAGSIPF-TLSKLKNLVILYLGVN 709
             L++L+ +SL+ N L  S+P     +L  L  + L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 49/171 (28%), Positives = 69/171 (40%), Gaps = 27/171 (15%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLIN 94
           S+PS  G+      + L +  L+        GLT L  L+L  NQ + +    V  +L  
Sbjct: 28  SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGN--------VFQGLT---ILDLSRNKLS 143
           L TL ++ N L            +L+ L + GN        VF  LT    L L+ N+L 
Sbjct: 85  LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 144 GEIPE--F--LVGLKVIENLNLSYNDLEGMVPTEGVFKNASAIS--VLGNN 188
             IP   F  L  L+    L+LS N L+  VP  G F     +    L  N
Sbjct: 145 -SIPAGAFDKLTNLQT---LSLSTNQLQS-VP-HGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 35/134 (26%), Positives = 46/134 (34%), Gaps = 23/134 (17%)

Query: 74  LDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN------ 127
           LDL               L  L  L +  N LQ           +L  L +  N      
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99

Query: 128 --VFQGLT---ILDLSRNKLSGEIPE--F--LVGLKVIENLNLSYNDLEGMVPTEGVFKN 178
             VF  LT    L L  N+L   +P   F  L  LK    L L+ N L+  +P  G F  
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK---ELRLNTNQLQS-IP-AGAFDK 153

Query: 179 ASAISVLG--NNKL 190
            + +  L    N+L
Sbjct: 154 LTNLQTLSLSTNQL 167

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 31/183 (16%), Positives = 58/183 (31%), Gaps = 36/183 (19%)

Query: 278 IGTGSFGSVYKGV--------LDEGRTTVTVKV----------FNLHHHRASRSFIAECR 319
               + G +Y+              +   ++K+           N     A    + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            L S     +        GV    + ++ LV       SL+  L    +          L
Sbjct: 110 KLYSTPLLAIPTCM--GFGV--HQDKYRFLVLP-SLGRSLQSALDVSPK--------HVL 156

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPP 437
           +    L +A  +  AL++LH +      H ++   NI +D E  S V    +G A    P
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213

Query: 438 THV 440
           +  
Sbjct: 214 SGK 216

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 38/227 (16%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVT---VKVF---NLHHHRASRSFIAECRAL-RSIRHRNL 329
           ++G GSFG V+   L E + T     +K      +         + E R L  +  H  L
Sbjct: 24  MLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
             +F       +Q  +    V E++  G L   +   ++ D      R          A 
Sbjct: 81  THMFCT-----FQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SR-----ATFYAA- 125

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGV 447
           ++   L +LH   + I  + DLK  NILLD++   H+   DFG+ +       +T++   
Sbjct: 126 EIILGLQFLHS--KGIV-YRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFC- 179

Query: 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
            G+  YIAPE  LG + + + D +S+G+L+ E++I + P    F G 
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 51.5 bits (124), Expect = 5e-07
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 13/106 (12%)

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           +A  L +L    + I  + DLK  N++LD E   H+   DFG+ +      V T +    
Sbjct: 130 IAIGLFFLQS--KGII-YRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC-- 182

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           G+  YIAPE         + D +++G+L+ E++  + P    FEG+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 31/138 (22%), Positives = 58/138 (42%), Gaps = 16/138 (11%)

Query: 625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN-NLIGSIPPPLGNLSSLRKISLA 683
           +  + IRI   +  +           ++ E + L      I  +   L  L + + ++L+
Sbjct: 6   TIKDAIRIFEERKSV---------VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALS 56

Query: 684 INNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDY 743
            NN+   I  +LS ++NL IL LG N +  I         ++ E  +  N+I     ++ 
Sbjct: 57  TNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLD-AVADTLEELWISYNQIASLSGIE- 112

Query: 744 GFTLQNLQYFSIGTNRIT 761
              L NL+   +  N+IT
Sbjct: 113 --KLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 35/166 (21%), Positives = 65/166 (39%), Gaps = 24/166 (14%)

Query: 548 LRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQV 607
           +RI  + + V   + E ++L         +     I  ++           +  L+  + 
Sbjct: 11  IRIFEERKSVVATEAEKVEL---------HGMIPPIEKMDAT---------LSTLKACKH 52

Query: 608 PDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSI 667
             L+ N+I  +I  +LS   NL  + L +N +  KI +       +E L +   N I S+
Sbjct: 53  LALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI-SYNQIASL 108

Query: 668 PPPLGNLSSLRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLS 712
              +  L +LR + ++ N +        L+ L  L  L L  N L 
Sbjct: 109 SG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 30/142 (21%), Positives = 60/142 (42%), Gaps = 6/142 (4%)

Query: 642 KIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701
           K+ +   +L   + L+L   N I  I   L  + +LR +SL  N +   I    +    L
Sbjct: 39  KMDATLSTLKACKHLALS-TNNIEKISS-LSGMENLRILSLGRNLIK-KIENLDAVADTL 95

Query: 702 VILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
             L++  N+++ +  S I  + ++    +  NKI     +D    L  L+   +  N + 
Sbjct: 96  EELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153

Query: 762 GAIPPSISNAS-KLEVFQALNN 782
                + + +  ++EV + L N
Sbjct: 154 NDYKENNATSEYRIEVVKRLPN 175

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 30/158 (18%), Positives = 59/158 (37%), Gaps = 24/158 (15%)

Query: 23  LVEPYVSDNFLKGSIPSSLGLCESLTTIGLFN--NNLSGTIPPQLMGLTSLVALDLSRNQ 80
           + +     + ++        +      + L      +   +   L  L +   L LS N 
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59

Query: 81  FRGSFPTEV---GNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGN---------V 128
                  ++     + NL  L++  N+++ +I +       LE L +  N          
Sbjct: 60  I-----EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGIEK 113

Query: 129 FQGLTILDLSRNKLS--GEIPEFLVGLKVIENLNLSYN 164
              L +L +S NK++  GEI + L  L  +E+L L+ N
Sbjct: 114 LVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 24/113 (21%), Positives = 49/113 (43%), Gaps = 10/113 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            LAL +N +   I   +  ++ L    +  N +K  I +   + ++L  + +  N ++ +
Sbjct: 52  HLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-S 107

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEV---GNLINLETLTVSGNILQGEIP 110
           +   +  L +L  L +S N+       E+     L  LE L ++GN L  +  
Sbjct: 108 LSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGNPLYNDYK 157

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           ++ AL+YLH   + I  + DLK  N+LLD E   H+   D+G+ +        TS+    
Sbjct: 119 ISLALNYLHE--RGII-YRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-- 171

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  YIAPE   G +   + D ++ G+LM E++  + P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           ++ AL+YLH   + I  + DLK  N+LLD E   H+   D+G+ +        TS+    
Sbjct: 162 ISLALNYLHE--RGII-YRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-- 214

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
           G+  YIAPE   G +   + D ++ G+LM E++  + P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 13/106 (12%)

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           +ASAL YLH     I  + DLKP NILLD +   H+   DFGL +     +  TS+    
Sbjct: 148 IASALGYLHS--LNIV-YRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC-- 200

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           G+  Y+APE           D +  G ++ E++    P    F   
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP----FYSR 242

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 24/114 (21%), Positives = 45/114 (39%), Gaps = 3/114 (2%)

Query: 649 SLSKIEVLSL-GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLG 707
           + + +  L L    +  G I        +L  +SL    L  S+   L KL  L  L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 708 VNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
            NR+ G +      + ++   ++  NK++    L+    L+ L+   +    +T
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 34/164 (20%), Positives = 55/164 (33%), Gaps = 29/164 (17%)

Query: 545 ISMLRIGSKAQKVTILDLESLKLA-GSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLR 603
           I +         V  L L++ K   G I         L+ L+L N      + + + +L 
Sbjct: 14  IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLP 71

Query: 604 RLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL 663
           +L+  +L+ N I G + +      NL  + L+ N+L      D  +L             
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLE------------ 114

Query: 664 IGSIPPPLGNLSSLRKISLAIN---NLAGSIPFTLSKLKNLVIL 704
                 PL  L  L+ + L      NL          L  L  L
Sbjct: 115 ------PLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 25/96 (26%), Positives = 37/96 (38%), Gaps = 5/96 (5%)

Query: 34  KGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLI 93
            G I        +L  + L N  L  ++   L  L  L  L+LS N+  G        L 
Sbjct: 38  DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLP 95

Query: 94  NLETLTVSGNILQ--GEIPSTLGSCIKLEILEMQGN 127
           NL  L +SGN L+    +   L     L+ L++   
Sbjct: 96  NLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 38/196 (19%), Positives = 55/196 (28%), Gaps = 45/196 (22%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGT----IPPQLMGLTSLVALDLSRNQF---------- 81
            +  +L  C  L T+ L +N    T    +   L   T L  L L  N            
Sbjct: 85  LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144

Query: 82  ---RGSFPTEVGNLINLETLTVSGNILQGE----IPSTLGSCIKLEILEMQGN------- 127
                +   +  N   L ++    N L+         T  S   L  ++M  N       
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 128 ---------VFQGLTILDLSRNKLSGE----IPEFLVGLKVIENLNLSYNDLEGMVPTEG 174
                      Q L +LDL  N  +      +   L     +  L L+   L       G
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS----ARG 260

Query: 175 VFKNASAISVLGNNKL 190
                 A S L N  L
Sbjct: 261 AAAVVDAFSKLENIGL 276

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 32/204 (15%), Positives = 62/204 (30%), Gaps = 37/204 (18%)

Query: 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE 598
           ++     S +  G        +  E  +    +L  +     L  + L +N+F       
Sbjct: 61  DLEIAEFSDIFTGR-------VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP 113

Query: 599 IGRL----RRLQVPDLNNNSIGGE-------------IPVNLSSCSNLIRIGLAKNQL-- 639
           +         L+   L+NN +G +             +     +   L  I   +N+L  
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173

Query: 640 --MGKIPSDFGSLSKIEVLSLGFNNL-----IGSIPPPLGNLSSLRKISLAINNL----A 688
             M +    F S   +  + +  N +        +   L     L+ + L  N      +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233

Query: 689 GSIPFTLSKLKNLVILYLGVNRLS 712
            ++   L    NL  L L    LS
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLS 257

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 17/148 (11%), Positives = 44/148 (29%), Gaps = 18/148 (12%)

Query: 37  IPSSLGLCESLTTIGLFNNNLSGTIPPQLMGL----------TSLVALDLSRNQFRGSFP 86
           +  ++   + L      +             L            L  + LS N F  +  
Sbjct: 52  LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111

Query: 87  TEVGNLI----NLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKL 142
             + + +     LE L +  N L  +  + +   ++   +  +      L  +   RN+L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

Query: 143 SGE----IPEFLVGLKVIENLNLSYNDL 166
                    +     +++  + +  N +
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGI 199

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 41.2 bits (97), Expect = 9e-04
 Identities = 26/147 (17%), Positives = 47/147 (31%), Gaps = 31/147 (21%)

Query: 39  SSLGLCESLTTIGLFNNNL-----SGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVG--- 90
            +      L T+ +  N +        +   L     L  LDL  N F     T +G   
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-----THLGSSA 235

Query: 91  ------NLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSG 144
                 +  NL  L ++  +L        G+   ++      N   GL  L L  N++  
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSAR-----GAAAVVDAFSKLEN--IGLQTLRLQYNEIEL 288

Query: 145 E----IPEFLVG-LKVIENLNLSYNDL 166
           +    +   +   +  +  L L+ N  
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 42/167 (25%), Positives = 64/167 (38%), Gaps = 36/167 (21%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G+FG +  G        V +K+        +     E R           K   +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFY---------KQLGSGD 65

Query: 338 G---VDYQG--NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           G   V Y G    + A+V E +   SLE+           D   R  +L   L IAI + 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLE-LLGPSLEDLF---------DLCDRTFSLKTVLMIAIQLI 115

Query: 393 SALDYLH-HDCQPITTHCDLKPSNILL-----DEEMVSHVGDFGLAR 433
           S ++Y+H  +      + D+KP N L+       + V H+ DF LA+
Sbjct: 116 SRMEYVHSKNL----IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 13/106 (12%)

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVK 448
           + SAL +LH   + I  + DLK  N+LLD E   H    DFG+ +      V T++    
Sbjct: 133 IISALMFLHD--KGII-YRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFC-- 185

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494
           G+  YIAPE           D ++ G+L+ E++    P    FE +
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP----FEAE 227

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 26/114 (22%), Positives = 45/114 (39%), Gaps = 3/114 (2%)

Query: 649 SLSKIEVLSL-GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLG 707
           + S ++ L L    +  G +         L  +S     L  SI   L KL  L  L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 708 VNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
            NR+SG +        ++   ++  NKI+    ++    L+NL+   +    +T
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 9e-06
 Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 5/106 (4%)

Query: 602 LRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN 661
           ++ L + +  +N    ++         L  +      L   I ++   L+K++ L L  N
Sbjct: 19  VKELVLDNSRSNEG--KLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELSDN 74

Query: 662 NLIGSIPPPLGNLSSLRKISLAINNLAG-SIPFTLSKLKNLVILYL 706
            + G +        +L  ++L+ N +   S    L KL+NL  L L
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL 120

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 25/104 (24%), Positives = 46/104 (44%), Gaps = 4/104 (3%)

Query: 2   LALDSNRLS-GNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           L LD++R + G +       ++L      +  L  SI ++L     L  + L +N +SG 
Sbjct: 22  LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79

Query: 61  IPPQLMGLTSLVALDLSRNQFRG-SFPTEVGNLINLETLTVSGN 103
           +        +L  L+LS N+ +  S    +  L NL++L +   
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 6e-04
 Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 10/87 (11%)

Query: 91  NLINLETLTVSGN-ILQGEIPSTLGSCIKLEILEMQGN---------VFQGLTILDLSRN 140
              +++ L +  +   +G++        +LE L                  L  L+LS N
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDN 74

Query: 141 KLSGEIPEFLVGLKVIENLNLSYNDLE 167
           ++SG +         + +LNLS N ++
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 7/131 (5%)

Query: 582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLM 640
           +IL L +N  T   P     L  L+   L +N + G +PV +  S + L  + L  NQL 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 641 GKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPF-TLSKL 698
             +PS  F  L  ++ L +  N L   +P  +  L+ L  ++L  N L  SIP     +L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRL 158

Query: 699 KNLVILYLGVN 709
            +L   YL  N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 16/131 (12%)

Query: 595 IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKI 653
           IP+    L       L++N I    P    S  NL  + L  NQL   +P   F SL+++
Sbjct: 38  IPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 654 EVLSLGFNNLIGSIPPPLG---NLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR 710
            VL LG N L   +P        L  L+++ +  N L   +P  + +L +L  L L  N+
Sbjct: 91  TVLDLGTNQL-TVLPS--AVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146

Query: 711 LSGIVPSSIFN 721
           L   +P   F+
Sbjct: 147 LKS-IPHGAFD 156

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 26/147 (17%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLIN 94
           S+P+  G+  +   + L +N ++   P     L +L  L L  NQ   + P  V  +L  
Sbjct: 33  SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLT---ILDLSRNKLSGEIPEFLV 151
           L  L +  N L   +PS                VF  L     L +  NKL+ E+P  + 
Sbjct: 90  LTVLDLGTNQLT-VLPS---------------AVFDRLVHLKELFMCCNKLT-ELPRGIE 132

Query: 152 GLKVIENLNLSYNDLEGMVPTEGVFKN 178
            L  + +L L  N L+  +P  G F  
Sbjct: 133 RLTHLTHLALDQNQLKS-IP-HGAFDR 157

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 3/113 (2%)

Query: 649 SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV 708
           +  +   L L     I  I      L     I  + N +   +      L+ L  L +  
Sbjct: 17  NAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNN 73

Query: 709 NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761
           NR+  I       +  + E  +  N +     LD   +L++L Y  I  N +T
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 34/172 (19%), Positives = 59/172 (34%), Gaps = 41/172 (23%)

Query: 547 MLRIGSKA-QKVTILD----LESLKLAGSILPHIGNL----SFLKILNLENNSFTHEIPS 597
           M+++ ++  ++            L L G  +P I NL         ++  +N    EI  
Sbjct: 1   MVKLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDN----EIRK 56

Query: 598 --EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEV 655
                 LRRL+   +NNN I         +  +L  + L  N L      + G L     
Sbjct: 57  LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLD---- 107

Query: 656 LSLGFNNLIGSIPPPLGNLSSLRKISLAIN---NLAGSIPFTLSKLKNLVIL 704
                         PL +L SL  + +  N   N      + + K+  + +L
Sbjct: 108 --------------PLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 33/163 (20%), Positives = 57/163 (34%), Gaps = 29/163 (17%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL-RSIRHRNLVKVFTAC 336
           +G G  G V +      +    +K+      +       E     R+ +  ++V++    
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED----EVDKAPRNLNLLQRLNIAIDVA 392
               Y G     +V E +  G L   +   +R D    E + +           I   + 
Sbjct: 81  EN-LYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREAS----------EIMKSIG 127

Query: 393 SALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLA 432
            A+ YLH     I  H D+KP N+L        +  + DFG A
Sbjct: 128 EAIQYLH--SINIA-HRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 27/182 (14%)

Query: 551 GSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIG---RLRRLQV 607
            ++   +  +   +  +    +  I  L  ++ L L  N        +I     L  L  
Sbjct: 37  QNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTY 89

Query: 608 PDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIG 665
             L  N +   +P  +    +NL  + L +NQL   +P   F  L+ +  L+L  +N + 
Sbjct: 90  LILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA-HNQLQ 146

Query: 666 SIPPPLG---NLSSLRKISLAINNLAGSIP---FTLSKLKNLVILYLGVNRLSGIVPSSI 719
           S+P   G    L++L ++ L+ N L  S+P   F   KL  L  L L  N+L   VP  +
Sbjct: 147 SLPK--GVFDKLTNLTELDLSYNQLQ-SLPEGVF--DKLTQLKDLRLYQNQLKS-VPDGV 200

Query: 720 FN 721
           F+
Sbjct: 201 FD 202

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 17/169 (10%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
              +L+   +          L+ +  +   N+         I  L  ++   L  N +  
Sbjct: 22  IKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH- 76

Query: 618 EIPVNLSSCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPLGN-LS 675
           +I   L   +NL  + L  NQL   +P+  F  L+ ++ L L  N L  S+P  + + L+
Sbjct: 77  DISA-LKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLT 133

Query: 676 SLRKISLAINNLAGSIP---FTLSKLKNLVILYLGVNRLSGIVPSSIFN 721
           +L  ++LA N L  S+P   F   KL NL  L L  N+L  + P  +F+
Sbjct: 134 NLTYLNLAHNQLQ-SLPKGVF--DKLTNLTELDLSYNQLQSL-PEGVFD 178

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 53/189 (28%), Positives = 77/189 (40%), Gaps = 43/189 (22%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLT---TIGLFNNNLS 58
           +  +++ +       I  L  +    +  N L       +   + LT    + L  N L 
Sbjct: 46  IIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ 98

Query: 59  GTIPPQLM-GLTSLVALDLSRNQFRGSFPTEVGN-LINLETLTVSGNILQGEIPSTLGSC 116
            ++P  +   LT+L  L L  NQ + S P  V + L NL  L ++ N LQ  +P      
Sbjct: 99  -SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPK----- 150

Query: 117 IKLEILEMQGNVFQGLT---ILDLSRNKLSGEIPE--F--LVGLKVIENLNLSYNDLEGM 169
                      VF  LT    LDLS N+L   +PE  F  L  LK   +L L  N L+  
Sbjct: 151 ----------GVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLK---DLRLYQNQLKS- 195

Query: 170 VPTEGVFKN 178
           VP +GVF  
Sbjct: 196 VP-DGVFDR 203

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 9/108 (8%)

Query: 582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLM 640
             L L+ N FT  +P E+   + L + DL+NN I   +     S+ + L+ + L+ N+L 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR 91

Query: 641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG---NLSSLRKISLAIN 685
              P  F  L  + +LSL  N++   +P   G   +LS+L  +++  N
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDI-SVVPE--GAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 30/117 (25%), Positives = 47/117 (40%), Gaps = 25/117 (21%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLIN 94
            +P   G+   +T + L  N  +  +P +L     L  +DLS N+   +   +   N+  
Sbjct: 24  VLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLT---ILDLSRNKLSGEIPE 148
           L TL +S N L+  IP                  F GL    +L L  N +S  +PE
Sbjct: 80  LLTLILSYNRLR-CIPP---------------RTFDGLKSLRLLSLHGNDIS-VVPE 119

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 33/118 (27%), Positives = 49/118 (41%), Gaps = 12/118 (10%)

Query: 643 IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV 702
           IP D      +  L L  N     +P  L N   L  I L+ N ++     + S +  L+
Sbjct: 29  IPRD------VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 703 ILYLGVNRLSGIVPSSIFN-ISSIAEFDVGENKIQGNIPLDYGF-TLQNLQYFSIGTN 758
            L L  NRL  I P   F+ + S+    +  N I   +P +  F  L  L + +IG N
Sbjct: 82  TLILSYNRLRCI-PPRTFDGLKSLRLLSLHGNDIS-VVP-EGAFNDLSALSHLAIGAN 136

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 24/160 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH-RNLVKVFTAC 336
           IG+GSFG +Y G        V +K+              E +  + ++    +  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIR--W 72

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            G +    D+  +V E +   SLE+           +   R  +L   L +A  + S ++
Sbjct: 73  CGAE---GDYNVMVME-LLGPSLEDLF---------NFCSRKFSLKTVLLLADQMISRIE 119

Query: 397 YLHHDCQPITTHCDLKPSNILL---DEEMVSHVGDFGLAR 433
           Y+H        H D+KP N L+    +  + ++ DFGLA+
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 30/199 (15%), Positives = 56/199 (28%), Gaps = 49/199 (24%)

Query: 281 GSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV-KVFTACSGV 339
            S   VYK  L      + +K+ +  +   +     E   +  +  +  V KV       
Sbjct: 25  MSPAKVYK--LVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH- 81

Query: 340 DYQGNDFKALVYEFMQNGSL-EEWLYPVNREDEVDKAPRNLNLLQRLNIA---------- 388
              G     L+          EE+    + E  ++     + L   ++I+          
Sbjct: 82  --DGWSN--LLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137

Query: 389 ---------------------------IDVASALDYLHH---DCQPITTHCDLKPSNILL 418
                                       D     D+L     + + + +H DL  SNI +
Sbjct: 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV 197

Query: 419 DEEMVSHVGDFGLARFLPP 437
            +  VS   D G +     
Sbjct: 198 KDGKVSGFIDLGRSGRADK 216

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 36/166 (21%), Positives = 59/166 (35%), Gaps = 34/166 (20%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG GSFG +++G        V +K         +     E R           K+   C+
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTY---------KLLAGCT 66

Query: 338 G---VDYQG--NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           G   V Y G       LV + +   SLE+ L         D   R  ++      A  + 
Sbjct: 67  GIPNVYYFGQEGLHNVLVID-LLGPSLEDLL---------DLCGRKFSVKTVAMAAKQML 116

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEM-----VSHVGDFGLAR 433
           + +  +H        + D+KP N L+         + +V DFG+ +
Sbjct: 117 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 17/121 (14%)

Query: 595 IPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSD-FGSLSK 652
           IP     L       LN+N +G      L     +L+++ L +NQL   I  + F   S 
Sbjct: 27  IPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 653 IEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIP---FTLSKLKNLVILYLGV 708
           I+ L LG N +   I   +   L  L+ ++L  N ++  +    F    L +L  L L  
Sbjct: 80  IQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSF--EHLNSLTSLNLAS 135

Query: 709 N 709
           N
Sbjct: 136 N 136

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 24/160 (15%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLV-KVFTAC 336
           IG+GSFG +Y G   +    V +K+   +        + E +  R ++    +  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVR--W 70

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
            GV+    D+  LV + +   SLE+           +   R L+L   L +A  + + ++
Sbjct: 71  FGVE---GDYNVLVMD-LLGPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSH---VGDFGLAR 433
           ++H        H D+KP N L+     ++   + DFGLA+
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 11/79 (13%), Positives = 21/79 (26%), Gaps = 9/79 (11%)

Query: 359 LEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418
           +   L   +  D+         + + +            L      + TH D    N++ 
Sbjct: 157 MNNGLVDASDFDDERNGWPVEQVWKEM---------HKLLPFSPDSVVTHGDFSLDNLIF 207

Query: 419 DEEMVSHVGDFGLARFLPP 437
           DE  +    D G       
Sbjct: 208 DEGKLIGCIDVGRVGIADR 226

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	789
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.98
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.98
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.98
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.98
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.98
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.98
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.98
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.98
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.98
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.98
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.98
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.98
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.98
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.98
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.98
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.98
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.98
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.98
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.98
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.98
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.98
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.98
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.98
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.98
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.98
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.98
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.98
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.98
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.98
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.98
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.98
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.98
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.98
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.93
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.93
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.91
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.9
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.85
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.84
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.75
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.7
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.67
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.64
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.63
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.62
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.62
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.59
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.54
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.53
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.48
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.38
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.37
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.37
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.33
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.13
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.12
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.99
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.99
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.92
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.91
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.82
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.77
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.6
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.59
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.55
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.54
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.51
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.5
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.05
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.81
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.65
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.59
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.44
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.4
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.37
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.26
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.07
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.06
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.71
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.65
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.62
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.45
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.33
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.05
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.73
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	94.48
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.28
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.94
3mes_A	424	Choline kinase; malaria, structural genomics, stru	89.97
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.39
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	86.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	86.0
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.89

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.6e-52  Score=502.40  Aligned_cols=183  Identities=33%  Similarity=0.489  Sum_probs=159.5

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|+|++|++++.+|.  +.+++|++|+|++|++++.+|. ++.+++|++|+|++|++++.+|..++.+++|++|+|++|+
T Consensus       182 ~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~  258 (768)
T 3rgz_A          182 HLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ  258 (768)
T ss_dssp             EEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSC
T ss_pred             EEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCc
Confidence            489999999987764  8899999999999999988887 9999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCC-cccccccccCCCCC-----------ccceeecCCcccCCCchh
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSC-IKLEILEMQGNVFQ-----------GLTILDLSRNKLSGEIPE  148 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~l~l~~N~~~-----------~l~~l~ls~N~l~~~~p~  148 (789)
                      +++.+|..  .+++|++|++++|+++|.+|..+... ++|++|++++|++.           .|+.|+|++|.++|.+|.
T Consensus       259 l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~  336 (768)
T 3rgz_A          259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM  336 (768)
T ss_dssp             CEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH
T ss_pred             ccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH
Confidence            99888765  88999999999999999999988775 99999999999764           389999999999988886


Q ss_pred             h-hcCcccccEEecccCCCCCCCCCc-cccc-CCccccccCCC
Q 041249          149 F-LVGLKVIENLNLSYNDLEGMVPTE-GVFK-NASAISVLGNN  188 (789)
Q Consensus       149 ~-~~~~~~l~~l~ls~N~~~~~~~~~-~~~~-~~~~~~~~~n~  188 (789)
                      . +..+++|+.|++++|++++.+|.. .... .+..+.+.+|.
T Consensus       337 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~  379 (768)
T 3rgz_A          337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN  379 (768)
T ss_dssp             HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSE
T ss_pred             HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCC
Confidence            6 899999999999999999777764 2233 66666666664

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.2e-50  Score=486.15  Aligned_cols=480  Identities=30%  Similarity=0.457  Sum_probs=395.9

Q ss_pred             CEEcCCCCCCccCCcC---ccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEcc
Q 041249            1 ILALDSNRLSGNIPPS---IGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLS   77 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~---~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~   77 (789)
                      +|||++|++++..|..   ++++++|++|++++|.+++..|.  +.+++|++|+|++|++++.+|. ++.+++|++|+|+
T Consensus       155 ~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls  231 (768)
T 3rgz_A          155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS  231 (768)
T ss_dssp             EEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECC
T ss_pred             EEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECc
Confidence            4899999999999987   89999999999999999987764  8899999999999999988887 9999999999999


Q ss_pred             CCcCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCC------------ccceeecCCcccCCC
Q 041249           78 RNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ------------GLTILDLSRNKLSGE  145 (789)
Q Consensus        78 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~------------~l~~l~ls~N~l~~~  145 (789)
                      +|++++.+|..++.+++|++|++++|++++.+|..  .+++|++|++++|++.            .|+.|+|++|.+++.
T Consensus       232 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             SSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             CCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            99999999999999999999999999999888876  8999999999999763            489999999999999


Q ss_pred             chhhhcCcccccEEecccCCCCCCCCCc--ccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhh
Q 041249          146 IPEFLVGLKVIENLNLSYNDLEGMVPTE--GVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIV  223 (789)
Q Consensus       146 ~p~~~~~~~~l~~l~ls~N~~~~~~~~~--~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~  223 (789)
                      +|..+..+++|+.|++++|.+++.+|..  ..++.++.+.+.+|.... ..+..                          
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~-~~p~~--------------------------  362 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG-ELPES--------------------------  362 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEE-CCCTT--------------------------
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCc-cccHH--------------------------
Confidence            9999999999999999999999777753  456677777777774310 00000                          


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEe
Q 041249          224 SGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF  303 (789)
Q Consensus       224 ~~~~~v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~  303 (789)
                                                            +..                                       
T Consensus       363 --------------------------------------l~~---------------------------------------  365 (768)
T 3rgz_A          363 --------------------------------------LTN---------------------------------------  365 (768)
T ss_dssp             --------------------------------------HHH---------------------------------------
T ss_pred             --------------------------------------HHh---------------------------------------
Confidence                                                  000                                       


Q ss_pred             ccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHH
Q 041249          304 NLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ  383 (789)
Q Consensus       304 ~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~  383 (789)
                                       +.    +++.. +..      .+. .  +.-+....      +...           .+    
T Consensus       366 -----------------l~----~~L~~-L~L------s~N-~--l~~~~~~~------~~~~-----------~~----  393 (768)
T 3rgz_A          366 -----------------LS----ASLLT-LDL------SSN-N--FSGPILPN------LCQN-----------PK----  393 (768)
T ss_dssp             -----------------HT----TTCSE-EEC------CSS-E--EEEECCTT------TTCS-----------TT----
T ss_pred             -----------------hh----cCCcE-EEc------cCC-C--cCCCcChh------hhhc-----------cc----
Confidence                             00    00000 000      000 0  00000000      0000           00    


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC
Q 041249          384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE  463 (789)
Q Consensus       384 ~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  463 (789)
                               ..|++|+                          +.+-.                .                
T Consensus       394 ---------~~L~~L~--------------------------L~~n~----------------l----------------  406 (768)
T 3rgz_A          394 ---------NTLQELY--------------------------LQNNG----------------F----------------  406 (768)
T ss_dssp             ---------CCCCEEE--------------------------CCSSE----------------E----------------
T ss_pred             ---------CCccEEE--------------------------CCCCc----------------c----------------
Confidence                     0000000                          00000                0                


Q ss_pred             cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHH
Q 041249          464 VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIEC  543 (789)
Q Consensus       464 ~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  543 (789)
                                        +|..|                                                         
T Consensus       407 ------------------~~~~p---------------------------------------------------------  411 (768)
T 3rgz_A          407 ------------------TGKIP---------------------------------------------------------  411 (768)
T ss_dssp             ------------------EEECC---------------------------------------------------------
T ss_pred             ------------------ccccC---------------------------------------------------------
Confidence                              00000                                                         


Q ss_pred             HHHHHhhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccC
Q 041249          544 LISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNL  623 (789)
Q Consensus       544 ~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~  623 (789)
                           .....|.+++.+++..+.+....+..+.++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..|
T Consensus       412 -----~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l  486 (768)
T 3rgz_A          412 -----PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL  486 (768)
T ss_dssp             -----GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred             -----HHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHH
Confidence                 112356778899999999998999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccc--------
Q 041249          624 SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTL--------  695 (789)
Q Consensus       624 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--------  695 (789)
                      .++++|++|+|++|++++.+|.+|..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+        
T Consensus       487 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~  566 (768)
T 3rgz_A          487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA  566 (768)
T ss_dssp             GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBC
T ss_pred             hcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhh
Confidence            999999999999999999999999999999999999999999999999999999999999999987777543        


Q ss_pred             --------------------------------------------------------------cCCCCCCeeeccCccccc
Q 041249          696 --------------------------------------------------------------SKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       696 --------------------------------------------------------------~~l~~L~~L~Ls~N~l~~  713 (789)
                                                                                    ..+++|+.|||++|++++
T Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g  646 (768)
T 3rgz_A          567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG  646 (768)
T ss_dssp             CSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBS
T ss_pred             hhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccc
Confidence                                                                          345789999999999999


Q ss_pred             cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      .+|..|+.+++|+.|+|++|+++|.+|..+. ++++|+.|||++|++++.+|..+..+++|+.|++++|+++|.||
T Consensus       647 ~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~-~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVG-DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCSCCCGGGG-GCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             cCCHHHhccccCCEEeCcCCccCCCCChHHh-CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            9999999999999999999999999999998 89999999999999999999999999999999999999999998

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.8e-46  Score=437.51  Aligned_cols=454  Identities=19%  Similarity=0.172  Sum_probs=369.7

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|||++|++++..|.+|+++++|++|+|++|++++..|++|+.+++|++|+|++|++++..|..|+.+++|++|+|++|+
T Consensus        37 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  116 (606)
T 3t6q_A           37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG  116 (606)
T ss_dssp             EEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSC
T ss_pred             EEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccC
Confidence            48999999999889999999999999999999999899999999999999999999998889999999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCc-----------cc--eeecCCcccCCCch
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LT--ILDLSRNKLSGEIP  147 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~-----------l~--~l~ls~N~l~~~~p  147 (789)
                      +++..|..++.+++|++|++++|++++..+..+..+++|++|++++|++.+           |+  .|++++|.+++..|
T Consensus       117 i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~  196 (606)
T 3t6q_A          117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP  196 (606)
T ss_dssp             CSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECT
T ss_pred             cccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccCh
Confidence            997667889999999999999999997544455569999999999998754           56  79999999998777


Q ss_pred             hhhcCc---------------------------------------------------ccccEEecccCCCCCCCCCc-cc
Q 041249          148 EFLVGL---------------------------------------------------KVIENLNLSYNDLEGMVPTE-GV  175 (789)
Q Consensus       148 ~~~~~~---------------------------------------------------~~l~~l~ls~N~~~~~~~~~-~~  175 (789)
                      ..+...                                                   .+|+.|++++|.+++.++.. ..
T Consensus       197 ~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~  276 (606)
T 3t6q_A          197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC  276 (606)
T ss_dssp             TTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTT
T ss_pred             hHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhcc
Confidence            654321                                                   16889999999999887763 44


Q ss_pred             ccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHHHHHHHhcccCCCCCcccc
Q 041249          176 FKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLIN  255 (789)
Q Consensus       176 ~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~~~~~~~~k~~~~~~~~~~  255 (789)
                      ++.+..+.+.+|....  .+.. ...                                                      
T Consensus       277 l~~L~~L~l~~n~l~~--lp~~-l~~------------------------------------------------------  299 (606)
T 3t6q_A          277 FSGLQELDLTATHLSE--LPSG-LVG------------------------------------------------------  299 (606)
T ss_dssp             CTTCSEEECTTSCCSC--CCSS-CCS------------------------------------------------------
T ss_pred             ccCCCEEeccCCccCC--CChh-hcc------------------------------------------------------
Confidence            5566666666663210  0000 000                                                      


Q ss_pred             ccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeee
Q 041249          256 SLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA  335 (789)
Q Consensus       256 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  335 (789)
                                                                                            .+++      
T Consensus       300 ----------------------------------------------------------------------l~~L------  303 (606)
T 3t6q_A          300 ----------------------------------------------------------------------LSTL------  303 (606)
T ss_dssp             ----------------------------------------------------------------------CTTC------
T ss_pred             ----------------------------------------------------------------------cccC------
Confidence                                                                                  0000      


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                                                                                  .+|+-.+             
T Consensus       304 ------------------------------------------------------------~~L~l~~-------------  310 (606)
T 3t6q_A          304 ------------------------------------------------------------KKLVLSA-------------  310 (606)
T ss_dssp             ------------------------------------------------------------CEEECTT-------------
T ss_pred             ------------------------------------------------------------CEEECcc-------------
Confidence                                                                        0000000             


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCc
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM  495 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~  495 (789)
                           +   ++.+                         ..|                                       
T Consensus       311 -----n---~l~~-------------------------~~~---------------------------------------  318 (606)
T 3t6q_A          311 -----N---KFEN-------------------------LCQ---------------------------------------  318 (606)
T ss_dssp             -----C---CCSB-------------------------GGG---------------------------------------
T ss_pred             -----C---CcCc-------------------------Cch---------------------------------------
Confidence                 0   0000                         000                                       


Q ss_pred             cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc-cc
Q 041249          496 NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL-PH  574 (789)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l-~~  574 (789)
                                                                           .....+.+++.+++..+......+ ..
T Consensus       319 -----------------------------------------------------~~~~~l~~L~~L~l~~n~~~~~~~~~~  345 (606)
T 3t6q_A          319 -----------------------------------------------------ISASNFPSLTHLSIKGNTKRLELGTGC  345 (606)
T ss_dssp             -----------------------------------------------------GCGGGCTTCSEEECCSCSSCCBCCSST
T ss_pred             -----------------------------------------------------hhhhccCcCCEEECCCCCcccccchhh
Confidence                                                                 001123445566666666654443 34


Q ss_pred             ccCccccchhcccCCcccccC--cccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCc-ccCCCC
Q 041249          575 IGNLSFLKILNLENNSFTHEI--PSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPS-DFGSLS  651 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~  651 (789)
                      +..+++|++|++++|++++..  +..|..+++|++|++++|++++..|..|..+++|++|++++|++.+..+. .|..++
T Consensus       346 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  425 (606)
T 3t6q_A          346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH  425 (606)
T ss_dssp             TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCT
T ss_pred             hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcc
Confidence            888999999999999999776  77899999999999999999989999999999999999999999877655 489999


Q ss_pred             CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCcc---CCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249          652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS---IPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF  728 (789)
Q Consensus       652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  728 (789)
                      +|++|++++|++++..|..|..+++|++|+|++|++++.   .+..+..+++|++|+|++|++++..|.+|..+++|++|
T Consensus       426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  505 (606)
T 3t6q_A          426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV  505 (606)
T ss_dssp             TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence            999999999999999999999999999999999999862   34679999999999999999999889999999999999


Q ss_pred             EccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      +|++|++++..|..+. .+++| +|+|++|++++.+|..+..+++|+.|++++|++++.
T Consensus       506 ~Ls~N~l~~~~~~~l~-~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          506 DLSHNRLTSSSIEALS-HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             ECCSSCCCGGGGGGGT-TCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             ECCCCccCcCChhHhC-ccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            9999999966666665 89999 999999999998999999999999999999999874

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1e-45  Score=432.65  Aligned_cols=503  Identities=17%  Similarity=0.147  Sum_probs=376.7

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQF   81 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l   81 (789)
                      +|+++..++ .+|..+..  .+++|+|++|.|++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++|++
T Consensus        17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            688999999 88988854  799999999999988899999999999999999999988899999999999999999999


Q ss_pred             CCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCc-----------cceeecCCcccCCCchhhh
Q 041249           82 RGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFL  150 (789)
Q Consensus        82 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~-----------l~~l~ls~N~l~~~~p~~~  150 (789)
                      ++..|..|+.+++|++|++++|++++..|..++++++|++|++++|++.+           |+.|++++|.+++..|..+
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  173 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM  173 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence            98889999999999999999999997778889999999999999998753           7899999999998889999


Q ss_pred             cCccccc--EEecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHH
Q 041249          151 VGLKVIE--NLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG  228 (789)
Q Consensus       151 ~~~~~l~--~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~  228 (789)
                      ..+++|+  .|++++|++++.+|.......+..+.+.+|...                                      
T Consensus       174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~--------------------------------------  215 (606)
T 3t6q_A          174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL--------------------------------------  215 (606)
T ss_dssp             HTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCH--------------------------------------
T ss_pred             hhhcccceeEEecCCCccCccChhHhhhccccccccCCchhH--------------------------------------
Confidence            9999998  899999999988776532223333333333100                                      


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc
Q 041249          229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH  308 (789)
Q Consensus       229 v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~  308 (789)
                                                                                                      
T Consensus       216 --------------------------------------------------------------------------------  215 (606)
T 3t6q_A          216 --------------------------------------------------------------------------------  215 (606)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHHHHHHhcCCCCccceee-eeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHH
Q 041249          309 RASRSFIAECRALRSIRHRNLVKVF-TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI  387 (789)
Q Consensus       309 ~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i  387 (789)
                            .   ..+..+.+..+..+. +.+....               ...+...                         
T Consensus       216 ------~---~~~~~l~~~~l~~l~~~~~~~~~---------------~~~i~~~-------------------------  246 (606)
T 3t6q_A          216 ------L---VIFKGLKNSTIQSLWLGTFEDMD---------------DEDISPA-------------------------  246 (606)
T ss_dssp             ------H---HHHHHTTTCEEEEEECCCCTTSC---------------CCCCCGG-------------------------
T ss_pred             ------H---HHhhhccccchhheechhhcccc---------------ccccChh-------------------------
Confidence                  0   000000000000000 0000000               0000000                         


Q ss_pred             HHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCcc
Q 041249          388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN  467 (789)
Q Consensus       388 ~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k  467 (789)
                         ...++..+.      +.+-++.-.+          +.+                         ..|+.+.....=..
T Consensus       247 ---~~~~l~~~~------L~~L~l~~n~----------l~~-------------------------~~~~~~~~l~~L~~  282 (606)
T 3t6q_A          247 ---VFEGLCEMS------VESINLQKHY----------FFN-------------------------ISSNTFHCFSGLQE  282 (606)
T ss_dssp             ---GGGGGGGSE------EEEEECTTCC----------CSS-------------------------CCTTTTTTCTTCSE
T ss_pred             ---HhchhhcCc------eeEEEeecCc----------cCc-------------------------cCHHHhccccCCCE
Confidence               000000000      0000000000          000                         00000000000000


Q ss_pred             ccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHH
Q 041249          468 GDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISM  547 (789)
Q Consensus       468 ~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  547 (789)
                      -                                          ++-+-.+.                           .+
T Consensus       283 L------------------------------------------~l~~n~l~---------------------------~l  293 (606)
T 3t6q_A          283 L------------------------------------------DLTATHLS---------------------------EL  293 (606)
T ss_dssp             E------------------------------------------ECTTSCCS---------------------------CC
T ss_pred             E------------------------------------------eccCCccC---------------------------CC
Confidence            0                                          00000000                           00


Q ss_pred             HhhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcc-cccCccceeeecccCCCCccCC--CccCc
Q 041249          548 LRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPS-EIGRLRRLQVPDLNNNSIGGEI--PVNLS  624 (789)
Q Consensus       548 ~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~--p~~~~  624 (789)
                      .+-...+.+++.+++..+.+....+..+..+++|++|++++|.+.+.+|. .|..+++|++|++++|.+++..  +..+.
T Consensus       294 p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  373 (606)
T 3t6q_A          294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR  373 (606)
T ss_dssp             CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTT
T ss_pred             ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcc
Confidence            01123467788999999998887788899999999999999999866655 4899999999999999999766  78899


Q ss_pred             CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcC-CCCCCCCCEEEccCCcCCccCCccccCCCCCCe
Q 041249          625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP-LGNLSSLRKISLAINNLAGSIPFTLSKLKNLVI  703 (789)
Q Consensus       625 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  703 (789)
                      .+++|++|++++|++.+..|..|..+++|++|++++|++++..+.. |..+++|++|++++|++++..|..|..+++|++
T Consensus       374 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  453 (606)
T 3t6q_A          374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH  453 (606)
T ss_dssp             TCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCE
T ss_pred             cCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCE
Confidence            9999999999999999888999999999999999999998776654 899999999999999999888999999999999


Q ss_pred             eeccCcccccc---CCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeecc
Q 041249          704 LYLGVNRLSGI---VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQAL  780 (789)
Q Consensus       704 L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  780 (789)
                      |++++|++++.   .+..+..+++|++|+|++|++++..|..+. .+++|++|+|++|++++..|..+..+++| .|+++
T Consensus       454 L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~  531 (606)
T 3t6q_A          454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT-SLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA  531 (606)
T ss_dssp             EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECC
T ss_pred             EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhc-cccCCCEEECCCCccCcCChhHhCccccc-EEECc
Confidence            99999999862   346799999999999999999955555554 89999999999999999999999999999 99999


Q ss_pred             CCcCcccCC
Q 041249          781 NNKLTGEVP  789 (789)
Q Consensus       781 ~N~l~~~~P  789 (789)
                      +|++++.+|
T Consensus       532 ~N~l~~~~~  540 (606)
T 3t6q_A          532 SNHISIILP  540 (606)
T ss_dssp             SSCCCCCCG
T ss_pred             CCcccccCH
Confidence            999998765

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=3.1e-45  Score=434.52  Aligned_cols=231  Identities=23%  Similarity=0.232  Sum_probs=186.6

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCc-ccccCccceeeecccCCCCccCCCccCcCCCCCcEEEc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIP-SEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      .++.+++..+.+....+..+..+++|++|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|++|++
T Consensus       382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l  461 (680)
T 1ziw_A          382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML  461 (680)
T ss_dssp             CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEEC
T ss_pred             cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchh
Confidence            56677777777777777778888888888888888876555 56888888888888888888777888888888888888


Q ss_pred             ccCCCC--CCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC--------ccccCCCCCCee
Q 041249          635 AKNQLM--GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP--------FTLSKLKNLVIL  704 (789)
Q Consensus       635 ~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L  704 (789)
                      ++|.+.  +..|..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++|++++..+        ..|.++++|++|
T Consensus       462 ~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L  541 (680)
T 1ziw_A          462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL  541 (680)
T ss_dssp             TTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEE
T ss_pred             ccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEE
Confidence            888876  4577788888888888888888887777788888888888888888875422        237788888888


Q ss_pred             eccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCccccc-CCCCCCeeeccCCc
Q 041249          705 YLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSIS-NASKLEVFQALNNK  783 (789)
Q Consensus       705 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~  783 (789)
                      +|++|+|+...+..|..+++|+.|+|++|+|+ .+|...|.++++|+.|+|++|+|++..+..+. .+++|+.|++++|+
T Consensus       542 ~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~  620 (680)
T 1ziw_A          542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLN-TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP  620 (680)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCC
T ss_pred             ECCCCCCCCCCHHHcccccCcceeECCCCCCC-cCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCC
Confidence            88888888555567888888888888888888 78877776788888888888888887777777 67888888888888


Q ss_pred             Cccc
Q 041249          784 LTGE  787 (789)
Q Consensus       784 l~~~  787 (789)
                      +.+.
T Consensus       621 ~~c~  624 (680)
T 1ziw_A          621 FDCT  624 (680)
T ss_dssp             CCBC
T ss_pred             cccC
Confidence            8763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.1e-45  Score=427.60  Aligned_cols=229  Identities=20%  Similarity=0.169  Sum_probs=194.6

Q ss_pred             cceeeEeccCcccccccccccccCccccchhcccCCccccc--CcccccCccceeeecccCCCCccCCCccCcCCCCCcE
Q 041249          554 AQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHE--IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIR  631 (789)
Q Consensus       554 c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~  631 (789)
                      +.+++.+++..+......  .+..+++|++|++++|++++.  .|..+..+++|++|++++|.++ .+|..|..+++|++
T Consensus       327 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~  403 (606)
T 3vq2_A          327 LPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH  403 (606)
T ss_dssp             CSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCE
T ss_pred             CCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCe
Confidence            344555555555433222  567889999999999999876  3788899999999999999998 46688999999999


Q ss_pred             EEcccCCCCCCCC-cccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCc-cCCccccCCCCCCeeeccCc
Q 041249          632 IGLAKNQLMGKIP-SDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG-SIPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       632 L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N  709 (789)
                      |++++|++.+..| ..|..+++|++|++++|++++..|..|.++++|++|+|++|++++ .+|..|..+++|++|+|++|
T Consensus       404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n  483 (606)
T 3vq2_A          404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC  483 (606)
T ss_dssp             EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             eECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC
Confidence            9999999997777 678899999999999999998899999999999999999999987 47888999999999999999


Q ss_pred             cccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCC-CCCeeeccCCcCccc
Q 041249          710 RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS-KLEVFQALNNKLTGE  787 (789)
Q Consensus       710 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~  787 (789)
                      ++++..|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|+|+ .+|..+..++ +|+.|++++|++.+.
T Consensus       484 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN-QLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACI  560 (606)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT-TCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred             cCCccChhhhcccccCCEEECCCCcCCCcCHHHcc-CCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccC
Confidence            99988889999999999999999999965566665 8999999999999999 5677788887 599999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-47  Score=404.16  Aligned_cols=268  Identities=19%  Similarity=0.252  Sum_probs=210.6

Q ss_pred             CCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++...+.||+|+||+||+|.+.     .+++.||||+++.... ...++|.+|++++++++|||||+++|+|....    
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~----  102 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ----  102 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC----
Confidence            3455678999999999999974     3568999999975533 34578999999999999999999999998765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                       ..++|||||++|+|.+++........      .......++|.+++.|+.|||.||+|||+.+   ||||||||+|||+
T Consensus       103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl  178 (308)
T 4gt4_A          103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV  178 (308)
T ss_dssp             -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence             78999999999999999965422111      0112346999999999999999999999988   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      ++++++||+|||+|+...............||+.|||||++.++.|+.|+|||||||++|||+| |+.||.....  ..+
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~  256 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDV  256 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence            9999999999999997755443333445679999999999999999999999999999999998 8999974311  122


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccccC
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGN  577 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~  577 (789)
                      ...+......       +                       ....|...+.+++..|++.+|.+||++.++...+.++++
T Consensus       257 ~~~i~~~~~~-------~-----------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          257 VEMIRNRQVL-------P-----------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             HHHHHTTCCC-------C-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             HHHHHcCCCC-------C-----------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            2222211000       0                       011455567789999999999999999998777777665


Q ss_pred             c
Q 041249          578 L  578 (789)
Q Consensus       578 l  578 (789)
                      +
T Consensus       307 l  307 (308)
T 4gt4_A          307 L  307 (308)
T ss_dssp             -
T ss_pred             C
Confidence            5

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.3e-44  Score=427.04  Aligned_cols=211  Identities=20%  Similarity=0.204  Sum_probs=155.5

Q ss_pred             ccceeeEeccCccccccccc-ccccCccccchhcccCCcccccCcccccCccceeeecccCCCCc--cCCCccCcCCCCC
Q 041249          553 KAQKVTILDLESLKLAGSIL-PHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG--GEIPVNLSSCSNL  629 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~p~~~~~l~~L  629 (789)
                      .+.+++.+++..+.+....+ ..+.++++|++|++++|++++..+..|..+++|++|++++|.++  +..|..|.++++|
T Consensus       403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L  482 (680)
T 1ziw_A          403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL  482 (680)
T ss_dssp             TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred             CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence            45567777777777765443 56777888888888888887777777888888888888888776  4567777888888


Q ss_pred             cEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCC--------cCCCCCCCCCEEEccCCcCCccCCccccCCCCC
Q 041249          630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP--------PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNL  701 (789)
Q Consensus       630 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  701 (789)
                      ++|++++|+|++..+..|.++++|++|+|++|++++..+        ..|.++++|++|+|++|+|+.+.+..|.++++|
T Consensus       483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L  562 (680)
T 1ziw_A          483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL  562 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence            888888888887667777788888888888888775422        236777888888888888875555567888888


Q ss_pred             CeeeccCccccccCCccccCCCCccEEEccCCcccccCCccccc-CCCCccEEEccCCcccccC
Q 041249          702 VILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGF-TLQNLQYFSIGTNRITGAI  764 (789)
Q Consensus       702 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~-~l~~L~~L~L~~N~l~~~~  764 (789)
                      ++|+|++|+|++..+..|..+++|+.|+|++|+|+ .++...+. .+++|+.|+|++|++...-
T Consensus       563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~~~L~~l~l~~N~~~c~c  625 (680)
T 1ziw_A          563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT-SVEKKVFGPAFRNLTELDMRFNPFDCTC  625 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCC-BCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred             ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCC-ccChhHhcccccccCEEEccCCCcccCC
Confidence            88888888888666666777788888888888887 55555443 4677888888888776543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.3e-47  Score=400.68  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=207.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||+||+|++.     .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.+    
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence            56778889999999999999985     357889999998776667788999999999999999999999998766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCC---ccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNRE---DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                       ..++|||||++|+|.++++.....   .........++|.+++.|+.|||.||+|||+.+   ||||||||+|||++++
T Consensus        89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence             789999999999999999754110   001123567999999999999999999999988   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      +++||+|||+|+...............||+.|||||++.+..|+.|+|||||||++|||+| |+.||.....  ..+...
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~  242 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC  242 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence            9999999999997655443333334569999999999999999999999999999999999 9999974211  111121


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      +......                              .....|..++.+++..|++.+|..||++..+...+.
T Consensus       243 i~~~~~~------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          243 ITQGRVL------------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             HHHTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHcCCCC------------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1111000                              001134556778999999999999999988754443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=401.56  Aligned_cols=267  Identities=24%  Similarity=0.335  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||+||+|+++.     +++.||||+++.......+.|.+|++++++++|||||+++|+|.+..    
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR----  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence            466777899999999999999753     57899999998776666788999999999999999999999998765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCcc-----ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDE-----VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                       ..++|||||++|+|.++++.......     .......++|.+++.|+.|||.||+|||+.+   ||||||||+|||++
T Consensus       117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~  192 (329)
T 4aoj_A          117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG  192 (329)
T ss_dssp             -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred             -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence             78999999999999999976522110     1123457999999999999999999999887   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHH
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLH  498 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~  498 (789)
                      +++++||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....  ..+.
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~  270 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAI  270 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence            999999999999998765554444445679999999999999999999999999999999999 8999974211  1111


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG  576 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~  576 (789)
                      ..+.....        +                      .....|..++.+++..|++.+|.+||++.++...+..+.
T Consensus       271 ~~i~~g~~--------~----------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          271 DCITQGRE--------L----------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHHTCC--------C----------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCC--------C----------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            22211110        0                      011134556778999999999999999998866555443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.2e-44  Score=421.36  Aligned_cols=227  Identities=17%  Similarity=0.171  Sum_probs=203.7

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccC--CCccCcCCCCCc
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE--IPVNLSSCSNLI  630 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~  630 (789)
                      .+.+++.+++..+.+ ...+ .+ .+++|++|++++|+..+..  .+..+++|++|++++|++++.  .|..+..+++|+
T Consensus       305 ~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~  379 (606)
T 3vq2_A          305 KHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR  379 (606)
T ss_dssp             TTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCC
T ss_pred             ccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCccc
Confidence            456788888888888 4444 56 9999999999999665433  678999999999999999966  388899999999


Q ss_pred             EEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCC-cCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCc
Q 041249          631 RIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP-PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  709 (789)
                      +|++++|.+++ +|..|..+++|+.|++++|++++..| ..|.++++|++|++++|++++..|..|.++++|++|++++|
T Consensus       380 ~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  458 (606)
T 3vq2_A          380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN  458 (606)
T ss_dssp             EEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTC
T ss_pred             EeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCC
Confidence            99999999984 66889999999999999999998887 78999999999999999999999999999999999999999


Q ss_pred             cccc-cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          710 RLSG-IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       710 ~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ++++ .+|..|..+++|+.|+|++|++++..|..+. ++++|++|+|++|++++..|..|..+++|+.|++++|+++.
T Consensus       459 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  535 (606)
T 3vq2_A          459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD-TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET  535 (606)
T ss_dssp             EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC
T ss_pred             cCCCcchHHhhccCCCCCEEECCCCcCCccChhhhc-ccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc
Confidence            9997 4799999999999999999999955555554 89999999999999999889999999999999999999985

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=394.93  Aligned_cols=258  Identities=26%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +..++|...+.||+|+||+||+|++.   ..||||+++...  ....+.|.+|++++++++|||||+++|+|...     
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----  104 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-----  104 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-----
Confidence            44567888899999999999999986   359999987543  34457899999999999999999999998542     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++|||||++|+|.+++...         ...+++.+++.|+.|||.||+|||+.+   ||||||||+|||+++++++
T Consensus       105 -~~~iVmEy~~gGsL~~~l~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~  171 (307)
T 3omv_A          105 -NLAIVTQWCEGSSLYKHLHVQ---------ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTV  171 (307)
T ss_dssp             -SCEEEEECCSSCBHHHHHHTS---------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEE
T ss_pred             -eEEEEEEcCCCCCHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcE
Confidence             579999999999999999643         346899999999999999999999987   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      ||+|||+|+...............||+.|||||++.   .+.|+.|+|||||||++|||+||+.||...... ..+...+
T Consensus       172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~  250 (307)
T 3omv_A          172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMV  250 (307)
T ss_dssp             EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHH
T ss_pred             EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHH
Confidence            999999999876544333445567999999999985   356999999999999999999999999732111 1111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....       .+|.+..                   ...+|...+.+++..|++.++.+||++.++...+
T Consensus       251 ~~~~-------~~p~~~~-------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          251 GRGY-------ASPDLSK-------------------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             HTTC-------CCCCSTT-------------------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             hcCC-------CCCCccc-------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            1111       1111110                   1124556677899999999999999998875443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=435.08  Aligned_cols=167  Identities=22%  Similarity=0.196  Sum_probs=133.1

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCC-cccccCCCCCCEEEccCCc
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI-PPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~   80 (789)
                      .|+++++++ .+|.   -.++|++|+|++|.|++..|..|+.+++|++|+|++|.+.+.+ |..|..+++|++|+|++|.
T Consensus         9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A            9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred             EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence            577888888 6676   3567888888888888777888888888888888888666555 6678888888888888888


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCcc--ccCCcccccccccCCCCCc------------cceeecCCcccCCCc
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPST--LGSCIKLEILEMQGNVFQG------------LTILDLSRNKLSGEI  146 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~~~~------------l~~l~ls~N~l~~~~  146 (789)
                      +++..|..|+.+++|++|+|++|++++.+|..  +.++++|++|+|++|.+.+            |+.|+|++|.+++..
T Consensus        85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~  164 (844)
T 3j0a_A           85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC  164 (844)
T ss_dssp             CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred             CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence            88777888888888888888888888766654  7888888888888886632            778888888888888


Q ss_pred             hhhhcCc--ccccEEecccCCCCCCCCC
Q 041249          147 PEFLVGL--KVIENLNLSYNDLEGMVPT  172 (789)
Q Consensus       147 p~~~~~~--~~l~~l~ls~N~~~~~~~~  172 (789)
                      |..+..+  ++|+.|++++|.+++..+.
T Consensus       165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~  192 (844)
T 3j0a_A          165 EHELEPLQGKTLSFFSLAANSLYSRVSV  192 (844)
T ss_dssp             SGGGHHHHHCSSCCCEECCSBSCCCCCC
T ss_pred             HHHcccccCCccceEECCCCcccccccc
Confidence            8888777  7888899999988876554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.6e-44  Score=423.30  Aligned_cols=205  Identities=22%  Similarity=0.255  Sum_probs=125.5

Q ss_pred             cccCccc-cchhcccCCcccccCcccccCcc--ceeeecccCCCCccCCCccCc-------CCCCCcEEEcccCCCCCCC
Q 041249          574 HIGNLSF-LKILNLENNSFTHEIPSEIGRLR--RLQVPDLNNNSIGGEIPVNLS-------SCSNLIRIGLAKNQLMGKI  643 (789)
Q Consensus       574 ~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~i~~~~p~~~~-------~l~~L~~L~l~~N~l~~~~  643 (789)
                      .+..+++ |++|+|++|+++ .+|..+..++  +|++|++++|+|++..|..|.       .+++|++|+|++|+|+...
T Consensus       371 ~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp  449 (636)
T 4eco_A          371 NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP  449 (636)
T ss_dssp             TSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCC
T ss_pred             hhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCC
Confidence            3445556 666666666666 5565555543  666666666666666666666       5566666666666666333


Q ss_pred             CcccCCCCCCcEEEccCCCCCccCCcCCCCCC-------CCCEEEccCCcCCccCCcccc--CCCCCCeeeccCcccccc
Q 041249          644 PSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS-------SLRKISLAINNLAGSIPFTLS--KLKNLVILYLGVNRLSGI  714 (789)
Q Consensus       644 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~  714 (789)
                      +..|..+++|++|+|++|+++.+.+..+..+.       +|++|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ 
T Consensus       450 ~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-  527 (636)
T 4eco_A          450 KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-  527 (636)
T ss_dssp             THHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-
T ss_pred             HHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-
Confidence            33445566666666666666633333333222       6666666666666 5555554  66666666666666664 


Q ss_pred             CCccccCCCCccEEEc------cCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          715 VPSSIFNISSIAEFDV------GENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       715 ~p~~~~~l~~L~~L~L------s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      +|..+..+++|+.|+|      ++|++.+.+|..+. .+++|++|+|++|+|+ .+|..+.  ++|+.|++++|+++
T Consensus       528 ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT-LCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG-GCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTC
T ss_pred             cChhhhcCCCCCEEECCCCcccccCcccccChHHHh-cCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCc
Confidence            6666666666666666      34555656666665 5666666666666663 4555544  56666666666554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=407.12  Aligned_cols=209  Identities=17%  Similarity=0.216  Sum_probs=164.2

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCC--CccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI--PVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      .+++|++|++++|.+.+..+.  ..+++|++|++++|.+++..  |..+.++++|++|++++|++.+..+ .|..+++|+
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~  399 (570)
T 2z63_A          323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLE  399 (570)
T ss_dssp             BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCC
T ss_pred             cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCC
Confidence            567788888888887765554  67788888888888887553  6677788888888888888875444 477888888


Q ss_pred             EEEccCCCCCccCC-cCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc-ccCCccccCCCCccEEEccC
Q 041249          655 VLSLGFNNLIGSIP-PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS-GIVPSSIFNISSIAEFDVGE  732 (789)
Q Consensus       655 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~  732 (789)
                      +|++++|++++..| ..|.++++|++|+|++|++++..|..|.++++|++|++++|+++ +.+|..|..+++|++|+|++
T Consensus       400 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~  479 (570)
T 2z63_A          400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  479 (570)
T ss_dssp             EEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             EEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCC
Confidence            88888888876655 46778888888888888888778888888888888888888887 46788888888888888888


Q ss_pred             CcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       733 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      |++++..|..+. .+++|++|+|++|++++..+..|..+++|+.|++++|+++|..|
T Consensus       480 n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          480 CQLEQLSPTAFN-SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             SCCCEECTTTTT-TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CccccCChhhhh-cccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            888855455554 78888888888888887777778888888888888888887654

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.4e-43  Score=406.38  Aligned_cols=478  Identities=17%  Similarity=0.188  Sum_probs=337.6

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQF   81 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l   81 (789)
                      .|+++|+++ .+|+.+.  ++|++|+|++|++++..|..|+.+++|++|+|++|+|++..|..|+.+++|++|+|++|++
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            477888888 7777764  6888999999998887788888889999999999999877778888889999999999998


Q ss_pred             CCCCcccccCCCCCCEEeccCCCCCC-cCCccccCCcccccccccCCCC------------CccceeecCCcccCCCchh
Q 041249           82 RGSFPTEVGNLINLETLTVSGNILQG-EIPSTLGSCIKLEILEMQGNVF------------QGLTILDLSRNKLSGEIPE  148 (789)
Q Consensus        82 ~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~~------------~~l~~l~ls~N~l~~~~p~  148 (789)
                      ++..|..|+.+++|++|++++|++++ .+|..++++++|++|++++|++            +.|+.|++++|.+++.+|.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  166 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ  166 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence            86666678888899999999998886 3567888888899999888862            2378889999999888888


Q ss_pred             hhcCcccccEEecccCCCCCCCCCc-ccccCCccccccCCCccccCCCcCCC-CCCCCCCCcccccceeeeEeehhhHHH
Q 041249          149 FLVGLKVIENLNLSYNDLEGMVPTE-GVFKNASAISVLGNNKLCGGISEFKL-PPCGLKKSTEWRLTFELKLVIAIVSGL  226 (789)
Q Consensus       149 ~~~~~~~l~~l~ls~N~~~~~~~~~-~~~~~~~~~~~~~n~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~v~~~~~~  226 (789)
                      .+..+++|+.|++++|.+...++.. +.++.+..+.+.+|........+... ..+.                       
T Consensus       167 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~-----------------------  223 (549)
T 2z81_A          167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS-----------------------  223 (549)
T ss_dssp             TTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCC-----------------------
T ss_pred             hhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhh-----------------------
Confidence            8888888999999988876544322 23556666777776532110000000 0000                       


Q ss_pred             HHHHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc
Q 041249          227 MGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH  306 (789)
Q Consensus       227 ~~v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~  306 (789)
                                                                                              .+|.+...
T Consensus       224 ------------------------------------------------------------------------~L~~L~l~  231 (549)
T 2z81_A          224 ------------------------------------------------------------------------PMKKLAFR  231 (549)
T ss_dssp             ------------------------------------------------------------------------CCCEEEEE
T ss_pred             ------------------------------------------------------------------------cccceecc
Confidence                                                                                    00000000


Q ss_pred             cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHH
Q 041249          307 HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN  386 (789)
Q Consensus       307 ~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~  386 (789)
                      ...                                                                     +...    
T Consensus       232 ~n~---------------------------------------------------------------------l~~~----  238 (549)
T 2z81_A          232 GSV---------------------------------------------------------------------LTDE----  238 (549)
T ss_dssp             SCE---------------------------------------------------------------------EEHH----
T ss_pred             ccc---------------------------------------------------------------------cchh----
Confidence            000                                                                     0000    


Q ss_pred             HHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCc
Q 041249          387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVST  466 (789)
Q Consensus       387 i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  466 (789)
                      ....+.+.+.++....                    ...+.+-...                +... .++          
T Consensus       239 ~~~~l~~~~~~~~~L~--------------------~l~l~~~~~~----------------~~~~-~~~----------  271 (549)
T 2z81_A          239 SFNELLKLLRYILELS--------------------EVEFDDCTLN----------------GLGD-FNP----------  271 (549)
T ss_dssp             HHHHHHGGGGGCTTCC--------------------EEEEESCEEE----------------CCSC-CCC----------
T ss_pred             HHHHHHHHhhhhcccc--------------------cccccccccc----------------cccc-ccc----------
Confidence            0001111111111000                    0000000000                0000 000          


Q ss_pred             cccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHH
Q 041249          467 NGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLIS  546 (789)
Q Consensus       467 k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (789)
                                          .                             .                             
T Consensus       272 --------------------~-----------------------------~-----------------------------  273 (549)
T 2z81_A          272 --------------------S-----------------------------E-----------------------------  273 (549)
T ss_dssp             --------------------C-----------------------------T-----------------------------
T ss_pred             --------------------c-----------------------------c-----------------------------
Confidence                                0                             0                             


Q ss_pred             HHhhccccceeeEeccCccccccc-----ccccccCccccchhcccCCcccccCcccc-cCccceeeecccCCCCccCCC
Q 041249          547 MLRIGSKAQKVTILDLESLKLAGS-----ILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIP  620 (789)
Q Consensus       547 l~~i~~~c~~l~~l~l~s~~~~~~-----~l~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~i~~~~p  620 (789)
                       .+....+.+++.+++..+.+...     ....+...++|++|++++|+++ .+|..+ ..+++|++|+|++|++++..|
T Consensus       274 -~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~  351 (549)
T 2z81_A          274 -SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL  351 (549)
T ss_dssp             -TTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHH
T ss_pred             -hhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccc
Confidence             01123344555555544443221     1112234578999999999998 566655 689999999999999998764


Q ss_pred             ---ccCcCCCCCcEEEcccCCCCCCCC--cccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccc
Q 041249          621 ---VNLSSCSNLIRIGLAKNQLMGKIP--SDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTL  695 (789)
Q Consensus       621 ---~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  695 (789)
                         ..++.+++|++|++++|+|++..+  ..+..+++|++|++++|+++ .+|..+..+++|++|+|++|+|+ .+|..+
T Consensus       352 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~  429 (549)
T 2z81_A          352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI  429 (549)
T ss_dssp             HHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS
T ss_pred             cchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh
Confidence               347889999999999999985432  45889999999999999999 67888999999999999999998 455544


Q ss_pred             cCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCC
Q 041249          696 SKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLE  775 (789)
Q Consensus       696 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  775 (789)
                      .  ++|++|+|++|+|++.+    ..+++|++|+|++|+|+ .+|...  .+++|++|+|++|+|++.+|..+..+++|+
T Consensus       430 ~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  500 (549)
T 2z81_A          430 P--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDAS--LFPVLLVMKISRNQLKSVPDGIFDRLTSLQ  500 (549)
T ss_dssp             C--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGG--GCTTCCEEECCSSCCCCCCTTGGGGCTTCC
T ss_pred             c--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCCcc--cCccCCEEecCCCccCCcCHHHHhcCcccC
Confidence            3  58999999999999643    57899999999999999 999843  699999999999999998899999999999


Q ss_pred             eeeccCCcCcccC
Q 041249          776 VFQALNNKLTGEV  788 (789)
Q Consensus       776 ~L~l~~N~l~~~~  788 (789)
                      .|++++|+++|..
T Consensus       501 ~L~l~~N~~~~~~  513 (549)
T 2z81_A          501 KIWLHTNPWDCSC  513 (549)
T ss_dssp             EEECCSSCBCCCH
T ss_pred             EEEecCCCccCCC
Confidence            9999999998864

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=406.77  Aligned_cols=452  Identities=19%  Similarity=0.204  Sum_probs=351.5

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|||++|+++ .+|..+.  ++|++|+|++|.+++..|+.|..+++|++|+|++|+|++..|..|+.+++|++|+|++|+
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            4899999999 7898886  899999999999998888899999999999999999998889999999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCC-cCCccccCCcccccccccCCCCCc--------c--ceeecCCccc--CCCch
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQG-EIPSTLGSCIKLEILEMQGNVFQG--------L--TILDLSRNKL--SGEIP  147 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~~~~--------l--~~l~ls~N~l--~~~~p  147 (789)
                      ++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++.+        |  +.|++++|.+  ++..|
T Consensus        81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~  157 (520)
T 2z7x_B           81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP  157 (520)
T ss_dssp             CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCT
T ss_pred             ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeeccccccccccc
Confidence            99 78876  89999999999999997 478999999999999999998863        6  9999999999  88889


Q ss_pred             hhhcCcc-cccEEecccCCCCCCCCCc--ccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhH
Q 041249          148 EFLVGLK-VIENLNLSYNDLEGMVPTE--GVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVS  224 (789)
Q Consensus       148 ~~~~~~~-~l~~l~ls~N~~~~~~~~~--~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~  224 (789)
                      ..+..+. ....+++++|.+.+.++..  ..+..+..+.+.+|....         .|                      
T Consensus       158 ~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~---------~~----------------------  206 (520)
T 2z7x_B          158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN---------KC----------------------  206 (520)
T ss_dssp             TTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTT---------TT----------------------
T ss_pred             ccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccc---------cc----------------------
Confidence            8888776 4556889999998876653  223444444454442100         00                      


Q ss_pred             HHHHHHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEec
Q 041249          225 GLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN  304 (789)
Q Consensus       225 ~~~~v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~  304 (789)
                                                                                                      
T Consensus       207 --------------------------------------------------------------------------------  206 (520)
T 2z7x_B          207 --------------------------------------------------------------------------------  206 (520)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             cccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHH
Q 041249          305 LHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR  384 (789)
Q Consensus       305 ~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~  384 (789)
                             ..+...+..+..+  +++..+               .+  ....                       ++..  
T Consensus       207 -------~~~~~~~~~l~~l--~~L~~L---------------~l--~~~~-----------------------l~~~--  235 (520)
T 2z7x_B          207 -------SYFLSILAKLQTN--PKLSNL---------------TL--NNIE-----------------------TTWN--  235 (520)
T ss_dssp             -------HHHHHHHHGGGGC--TTCCEE---------------EE--EEEE-----------------------EEHH--
T ss_pred             -------ceeecchhhhccc--cchhhc---------------cc--cccc-----------------------cCHH--
Confidence                   0000000000000  000000               00  0000                       0000  


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc
Q 041249          385 LNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV  464 (789)
Q Consensus       385 ~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  464 (789)
                                                                                                      
T Consensus       236 --------------------------------------------------------------------------------  235 (520)
T 2z7x_B          236 --------------------------------------------------------------------------------  235 (520)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHH
Q 041249          465 STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECL  544 (789)
Q Consensus       465 ~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  544 (789)
                                                                                                    ..
T Consensus       236 ------------------------------------------------------------------------------~~  237 (520)
T 2z7x_B          236 ------------------------------------------------------------------------------SF  237 (520)
T ss_dssp             ------------------------------------------------------------------------------HH
T ss_pred             ------------------------------------------------------------------------------HH
Confidence                                                                                          00


Q ss_pred             HHHHhhccccceeeEeccCcccccccccccc-----cCccccchhcccCCcccccCc-ccccCc---cceeeecccCCCC
Q 041249          545 ISMLRIGSKAQKVTILDLESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIP-SEIGRL---RRLQVPDLNNNSI  615 (789)
Q Consensus       545 ~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~i  615 (789)
                      ..+.. ...+.+++.+++..+.+.+..+..+     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+
T Consensus       238 ~~~~~-~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l  314 (520)
T 2z7x_B          238 IRILQ-LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRM  314 (520)
T ss_dssp             HHHHH-HHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCC
T ss_pred             HHHHH-HhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcc
Confidence            00000 0012355666666676666666666     8899999999999999  355 555555   6799999999998


Q ss_pred             ccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCc--cCCcCCCCCCCCCEEEccCCcCCccCCc
Q 041249          616 GGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG--SIPPPLGNLSSLRKISLAINNLAGSIPF  693 (789)
Q Consensus       616 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~  693 (789)
                      ....  .+..+++|++|++++|++++..|..|..+++|++|+|++|++++  ..|..|..+++|++|+|++|++++.+|.
T Consensus       315 ~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~  392 (520)
T 2z7x_B          315 VHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK  392 (520)
T ss_dssp             CCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG
T ss_pred             cccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc
Confidence            7432  23688999999999999998889999999999999999999996  4567799999999999999999974555


Q ss_pred             -cccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCC
Q 041249          694 -TLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS  772 (789)
Q Consensus       694 -~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  772 (789)
                       .|..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..++ .+++|++|+|++|+|++..+..+..++
T Consensus       393 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~  468 (520)
T 2z7x_B          393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQLKSVPDGIFDRLT  468 (520)
T ss_dssp             CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh-cCCCCCEEECCCCcCCccCHHHhccCC
Confidence             589999999999999999988877664  79999999999999 9999998 899999999999999954444589999


Q ss_pred             CCCeeeccCCcCccc
Q 041249          773 KLEVFQALNNKLTGE  787 (789)
Q Consensus       773 ~L~~L~l~~N~l~~~  787 (789)
                      +|+.|++++|++++.
T Consensus       469 ~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          469 SLQKIWLHTNPWDCS  483 (520)
T ss_dssp             TCCEEECCSSCBCCC
T ss_pred             cccEEECcCCCCccc
Confidence            999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.2e-45  Score=381.23  Aligned_cols=249  Identities=19%  Similarity=0.281  Sum_probs=206.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||+||+|+...+++.||||+++..   .....+.+.+|++++++++|||||++++++.+.+     
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence            36799999999999999999999999999999999643   2334577999999999999999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++.++..|+.||+.||+|||+++   ||||||||+|||++.++++|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~----------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vK  172 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ  172 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEE
Confidence            899999999999999999643          56899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||+|+...............||+.|||||++.+..|+.++||||+||++|||++|+.||...     +..+..+...
T Consensus       173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~  247 (311)
T 4aw0_A          173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAKII  247 (311)
T ss_dssp             ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHH
Confidence            99999999887655444455678999999999999989999999999999999999999999732     1222222111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      ...      ..+..                      ....++.+++.+|.+.++..|++..+.
T Consensus       248 ~~~------~~~p~----------------------~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          248 KLE------YDFPE----------------------KFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             HTC------CCCCT----------------------TCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             cCC------CCCCc----------------------ccCHHHHHHHHHHccCCHhHCcChHHH
Confidence            100      00000                      112234577889999999999998875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-44  Score=377.36  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=196.8

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      ...+.||+|+||+||+|.+..+++.||+|++....  ....+.|.+|++++++++|||||++++++.... .+....++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence            44567999999999999999999999999996542  334567999999999999999999999986432 122357999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCcc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDF  429 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df  429 (789)
                      ||||.+|+|.+++...          ..+++..+..|+.||+.||+|||+++ ++||||||||+|||++. ++.+||+||
T Consensus       108 mEy~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             EeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeC
Confidence            9999999999999643          56899999999999999999999874 46999999999999984 789999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |+|+......    .....||+.|||||++. ++|+.++|||||||++|||+||+.||...    .......+.......
T Consensus       177 Gla~~~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~~~i~~~~~  247 (290)
T 3fpq_A          177 GLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRRVTSGVK  247 (290)
T ss_dssp             TGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCC
T ss_pred             cCCEeCCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CcHHHHHHHHHcCCC
Confidence            9998754332    33567999999999875 46999999999999999999999999632    122222222111100


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ....+                          ..+..++.+++..|++.+|.+|++..+...+
T Consensus       248 ~~~~~--------------------------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 PASFD--------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CGGGG--------------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCC--------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000                          0122345678889999999999998876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.4e-45  Score=387.98  Aligned_cols=252  Identities=20%  Similarity=0.256  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++|||||++++++.+..     ..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----SL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----EE
Confidence            57889999999999999999999999999999996542  334567999999999999999999999998766     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      |+||||+.+|+|.+++...        ....+++.++..|+.||+.||+|||+.+   ||||||||+|||++.++++||+
T Consensus        99 yiVmEy~~gg~L~~~i~~~--------~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQ--------KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHHc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEc
Confidence            9999999999999999643        3356788999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+|+......  .......||+.|||||++.+..|+.++|||||||++|||+||+.||...     +..+.+......
T Consensus       168 DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~  240 (350)
T 4b9d_A          168 DFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMKNLVLKIISG  240 (350)
T ss_dssp             STTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHT
T ss_pred             ccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcC
Confidence            999999764322  1223456999999999999999999999999999999999999999732     222222211111


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...     .+.                      ..+..++.+++..|++.++.+|++..+...+
T Consensus       241 ~~~-----~~~----------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 SFP-----PVS----------------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCC-----CCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-----CCC----------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000     000                      0123345678889999999999998876443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-44  Score=383.70  Aligned_cols=251  Identities=21%  Similarity=0.250  Sum_probs=206.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|+..+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++...+     ..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            46888899999999999999999999999999998766666778899999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+|+|.+++..           ..+++.++..|+.||+.||+|||+.+   ||||||||+|||++.++++||+||
T Consensus       149 vmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DF  214 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF  214 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecC
Confidence            9999999999999853           35899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |+|+.......  ......||+.|||||++....|+.++|||||||++|||++|+.||....  .......+....+   
T Consensus       215 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~---  287 (346)
T 4fih_A          215 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP---  287 (346)
T ss_dssp             TTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSC---
T ss_pred             cCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCC---
Confidence            99998765432  2334679999999999999999999999999999999999999997321  1111111221111   


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                           +.+.                    .......++.+++..|++.++..|++..++..+
T Consensus       288 -----~~~~--------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          288 -----PRLK--------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             -----CCCS--------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CCCC--------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 1110                    011223445678889999999999998877554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-42  Score=414.33  Aligned_cols=220  Identities=19%  Similarity=0.229  Sum_probs=158.7

Q ss_pred             eeEeccCcccccccccccccCccc--cchhcccCCcccccCcccc---c--CccceeeecccCCCCccCCCcc-CcCCCC
Q 041249          557 VTILDLESLKLAGSILPHIGNLSF--LKILNLENNSFTHEIPSEI---G--RLRRLQVPDLNNNSIGGEIPVN-LSSCSN  628 (789)
Q Consensus       557 l~~l~l~s~~~~~~~l~~l~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~i~~~~p~~-~~~l~~  628 (789)
                      ++.+++..+.+. ..+..+..++.  |+.|+|++|++++.+|...   .  .+.+|+.|+|++|+|+ .+|.. +..+++
T Consensus       621 L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~  698 (876)
T 4ecn_A          621 VEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSP  698 (876)
T ss_dssp             CCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCC
T ss_pred             CCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCC
Confidence            555666666665 44556655544  8888888888877655422   2  3347888888888888 44544 457788


Q ss_pred             CcEEEcccCCCCCCCCcc-cCCC-------CCCcEEEccCCCCCccCCcCCC--CCCCCCEEEccCCcCCccCCccccCC
Q 041249          629 LIRIGLAKNQLMGKIPSD-FGSL-------SKIEVLSLGFNNLIGSIPPPLG--NLSSLRKISLAINNLAGSIPFTLSKL  698 (789)
Q Consensus       629 L~~L~l~~N~l~~~~~~~-~~~l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l  698 (789)
                      |+.|+|++|+|+ .+|.. +...       ++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++
T Consensus       699 L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L  775 (876)
T 4ecn_A          699 ISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS  775 (876)
T ss_dssp             CSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred             CCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcC
Confidence            888888888888 44443 3322       27888888888887 6677776  78888888888888885 67778888


Q ss_pred             CCCCeeeccC------ccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCC
Q 041249          699 KNLVILYLGV------NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS  772 (789)
Q Consensus       699 ~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  772 (789)
                      ++|+.|+|++      |++.+.+|.+|..+++|+.|+|++|+| +.+|..++   ++|+.|+|++|++....+..+....
T Consensus       776 ~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~---~~L~~LdLs~N~l~~i~~~~~~~~~  851 (876)
T 4ecn_A          776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT---PQLYILDIADNPNISIDVTSVCPYI  851 (876)
T ss_dssp             TTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC---SSSCEEECCSCTTCEEECGGGHHHH
T ss_pred             CCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc---CCCCEEECCCCCCCccChHHccccc
Confidence            8888888866      777778888888888888888888888 48888754   5788888888888766666666655


Q ss_pred             CCCeeeccCCcCc
Q 041249          773 KLEVFQALNNKLT  785 (789)
Q Consensus       773 ~L~~L~l~~N~l~  785 (789)
                      .+..+.|..|++.
T Consensus       852 ~~~~~~L~~n~~~  864 (876)
T 4ecn_A          852 EAGMYVLLYDKTQ  864 (876)
T ss_dssp             HTTCCEEECCTTS
T ss_pred             cchheeecCCCcc
Confidence            6666666666543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-44  Score=388.05  Aligned_cols=276  Identities=21%  Similarity=0.220  Sum_probs=215.6

Q ss_pred             ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEeccccc-hhhHHHHHHHHHHhcCCC-Ccccee
Q 041249          260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHHH-RASRSFIAECRALRSIRH-RNLVKV  332 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l  332 (789)
                      +...+++...++|...+.||+|+||+||+|.+...     ++.||||+++.... ...+.|.+|++++.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            44456777788999999999999999999998643     46899999976543 345779999999999965 999999


Q ss_pred             eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCc
Q 041249          333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPIT  406 (789)
Q Consensus       333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i  406 (789)
                      +|+|....    ...++|||||++|+|.++++......      ........+++.+++.|+.|||.||+|||+.+   |
T Consensus       134 ~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i  206 (353)
T 4ase_A          134 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C  206 (353)
T ss_dssp             EEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             EEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence            99986542    25799999999999999997542110      00112456899999999999999999999988   9


Q ss_pred             eecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcC
Q 041249          407 THCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKK  485 (789)
Q Consensus       407 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~  485 (789)
                      |||||||+|||+++++++||+|||+|+...............||+.|||||++.+..|+.|+|||||||++|||+| |+.
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            9999999999999999999999999998766554444556779999999999999999999999999999999998 999


Q ss_pred             CCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          486 PSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       486 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      ||...... ..+...+.......        .                      ...|..++.+++..|++.+|.+||++
T Consensus       287 Pf~~~~~~-~~~~~~i~~g~~~~--------~----------------------p~~~~~~~~~li~~c~~~dP~~RPt~  335 (353)
T 4ase_A          287 PYPGVKID-EEFCRRLKEGTRMR--------A----------------------PDYTTPEMYQTMLDCWHGEPSQRPTF  335 (353)
T ss_dssp             SSTTCCCS-HHHHHHHHHTCCCC--------C----------------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCHH-HHHHHHHHcCCCCC--------C----------------------CccCCHHHHHHHHHHcCcChhHCcCH
Confidence            99743211 12222222211110        0                      11234556788899999999999999


Q ss_pred             cccccccc
Q 041249          566 KLAGSILP  573 (789)
Q Consensus       566 ~~~~~~l~  573 (789)
                      .++..++.
T Consensus       336 ~eil~~L~  343 (353)
T 4ase_A          336 SELVEHLG  343 (353)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88755443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=417.71  Aligned_cols=233  Identities=24%  Similarity=0.218  Sum_probs=187.8

Q ss_pred             cceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEE
Q 041249          554 AQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIG  633 (789)
Q Consensus       554 c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  633 (789)
                      +.+++.+++..+.+....+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus       265 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  344 (844)
T 3j0a_A          265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID  344 (844)
T ss_dssp             TSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEE
T ss_pred             cCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEE
Confidence            46788899999988888888899999999999999999988899999999999999999999988899999999999999


Q ss_pred             cccCCCCCCCCcccCCCCCCcEEEccCCCCCccCC------------------c----------------------CCCC
Q 041249          634 LAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP------------------P----------------------PLGN  673 (789)
Q Consensus       634 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------------~----------------------~~~~  673 (789)
                      +++|+|+...+..|.++++|++|+|++|.+++...                  .                      .+.+
T Consensus       345 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~  424 (844)
T 3j0a_A          345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLR  424 (844)
T ss_dssp             CCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTT
T ss_pred             CCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhc
Confidence            99999998888889999999999999999874321                  0                      0225


Q ss_pred             CCCCCEEEccCCcCCccCCc-cccCCCCCCeeeccCcccc-----ccCCccccCCCCccEEEccCCcccccCCcccccCC
Q 041249          674 LSSLRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLS-----GIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTL  747 (789)
Q Consensus       674 l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  747 (789)
                      +++|++|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|+|+ .+|...+.++
T Consensus       425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l  503 (844)
T 3j0a_A          425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHL  503 (844)
T ss_dssp             CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHT-TCCTTSSSSC
T ss_pred             CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCccc-ccChhHccch
Confidence            56677777777777644332 3455677777777777776     344466778888888888888888 5555555588


Q ss_pred             CCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          748 QNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       748 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      ++|++|+|++|+|++..+..+.  ++|+.|+|++|++++.+|
T Consensus       504 ~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~  543 (844)
T 3j0a_A          504 TALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNP  543 (844)
T ss_dssp             CSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCS
T ss_pred             hhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCCh
Confidence            8888888888888877666665  788888888888888765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-43  Score=375.88  Aligned_cols=267  Identities=23%  Similarity=0.263  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      +|...+.||+|+||+||+|++.  |+.||||+++.... ....++.|+..+.+++|||||+++|+|..... .....++|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence            4566789999999999999985  89999999964432 22334567777788999999999999976431 12257999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC-----CCCceecCCCCCceecCCCCcee
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ||||++|+|.++++..           .++|.++.+++.|+|.||+|||+.+     .++||||||||+|||++.++++|
T Consensus        80 ~Ey~~~gsL~~~l~~~-----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             ecCCCCCcHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            9999999999999643           5899999999999999999999872     44699999999999999999999


Q ss_pred             eCcccccccCCCCCCc--cceeeecccccccCcccCCCC------CcCccccchhhHHHHHHHHHhcCCCCccccC----
Q 041249          426 VGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIRKKPSDIMFEG----  493 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~sfGvvl~elltG~~P~~~~~~~----  493 (789)
                      |+|||+|+........  .......||+.|||||++.+.      ++++|+|||||||++|||+||+.|+......    
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            9999999887654422  223345799999999998654      4789999999999999999999887533211    


Q ss_pred             ------CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccc
Q 041249          494 ------DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKL  567 (789)
Q Consensus       494 ------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~  567 (789)
                            ......+.+.....    ..+|.+..                 .....++...+.+++..|++.+|..||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~----~~rp~~p~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  287 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQ----KLRPNIPN-----------------RWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTS----CCCCCCCG-----------------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             hhcccccchHHHHHHHHhcc----cCCCCCCc-----------------cccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence                  11222222211111    11222211                 1122356677889999999999999999988


Q ss_pred             cccccc
Q 041249          568 AGSILP  573 (789)
Q Consensus       568 ~~~~l~  573 (789)
                      +...+.
T Consensus       288 i~~~L~  293 (303)
T 3hmm_A          288 IKKTLS  293 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            755443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.4e-44  Score=379.63  Aligned_cols=248  Identities=21%  Similarity=0.240  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|...+.||+|+||+||+|++..+++.||||+++....     ..+|++++++++|||||++++++.+..     ..++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~i  127 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-----WVNI  127 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            457777889999999999999999999999999975432     246999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~D  428 (789)
                      ||||+++|+|.+++...          ..+++.++..|+.||+.||+|||+++   ||||||||+|||++.++ ++||+|
T Consensus       128 vmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~D  194 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQM----------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD  194 (336)
T ss_dssp             EECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECC
T ss_pred             EEeccCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEee
Confidence            99999999999999643          46899999999999999999999988   99999999999999987 699999


Q ss_pred             ccccccCCCCCCc---cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          429 FGLARFLPPTHVQ---TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       429 fgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      ||+|+........   .......||+.|||||++.+..|+.++|||||||++|||+||+.||....... -+....... 
T Consensus       195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~-  272 (336)
T 4g3f_A          195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEP-  272 (336)
T ss_dssp             CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSC-
T ss_pred             CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCC-
Confidence            9999987654421   12234579999999999999999999999999999999999999997533221 111111110 


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                       ....++                           ...+...+.+++..|++.+|.+|++..+...
T Consensus       273 -~~~~~~---------------------------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~  309 (336)
T 4g3f_A          273 -PPIREI---------------------------PPSCAPLTAQAIQEGLRKEPVHRASAMELRR  309 (336)
T ss_dssp             -CGGGGS---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCchhc---------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence             000000                           1123445667888999999999998877543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=384.78  Aligned_cols=251  Identities=21%  Similarity=0.250  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|...+.||+|+||.||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++...+     ..|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence            46888999999999999999999999999999998776666778999999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      |||||.+|+|.+++..           ..+++.++..|+.||+.||+|||+++   ||||||||+|||++.++++||+||
T Consensus       226 VmEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecC
Confidence            9999999999999853           35899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |+|+.......  ......||+.|||||++.+..|+.++|||||||++|||++|+.||....  .......+....+   
T Consensus       292 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~---  364 (423)
T 4fie_A          292 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP---  364 (423)
T ss_dssp             TTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCC---
T ss_pred             ccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCC---
Confidence            99998755432  2334679999999999999999999999999999999999999996321  1111122221111   


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                           +.+..                    ...+...+.+++..|+..++..|++..+...+
T Consensus       365 -----~~~~~--------------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 -----PRLKN--------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -----CCCSC--------------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CCCcc--------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 11100                    01123345678889999999999998877554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-43  Score=364.67  Aligned_cols=247  Identities=23%  Similarity=0.290  Sum_probs=187.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|....+++.||||+++...   ......+.+|++++++++||||+++++++...+     .
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-----E   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----E
Confidence            58999999999999999999999999999999996442   233567999999999999999999999998766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+ +|+|.+++...          ..+++.++..++.|++.||+|||+++   |+||||||+|||++.++++||
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl  153 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQR----------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI  153 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHS----------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEE
T ss_pred             EEEEEeCC-CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEE
Confidence            99999999 68999998644          46899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+|+......   ......||+.|||||++.+..+ +.++||||+||++|||+||+.||...     +.....+...
T Consensus       154 ~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~i~  225 (275)
T 3hyh_A          154 ADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKNIS  225 (275)
T ss_dssp             CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             eecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
Confidence            9999998765443   2234679999999999988776 68999999999999999999999732     2222222111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...      +.+.                      ......+.++..+|.+.+|.+|++..++..+
T Consensus       226 ~~~------~~~p----------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          226 NGV------YTLP----------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HTC------CCCC----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             cCC------CCCC----------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            000      0000                      0112344578889999999999988876543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=390.82  Aligned_cols=228  Identities=20%  Similarity=0.245  Sum_probs=201.0

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEE
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI  632 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L  632 (789)
                      .|.+++.+++..+.+. ..+..+..+ +|++|++++|+++ .+|.  ..+++|++|++++|.+.+..+.  ..+++|++|
T Consensus       280 ~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L  352 (570)
T 2z63_A          280 CLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFL  352 (570)
T ss_dssp             GGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEE
T ss_pred             CcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEE
Confidence            3556777888777766 456677778 9999999999999 5555  4788999999999999876655  788999999


Q ss_pred             EcccCCCCCCC--CcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC-ccccCCCCCCeeeccCc
Q 041249          633 GLAKNQLMGKI--PSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVN  709 (789)
Q Consensus       633 ~l~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N  709 (789)
                      ++++|++++..  +..+.++++|++|++++|++++..+. |..+++|++|++++|++++..| ..|.++++|++|++++|
T Consensus       353 ~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n  431 (570)
T 2z63_A          353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT  431 (570)
T ss_dssp             ECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTS
T ss_pred             eCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCC
Confidence            99999998654  67788999999999999999966555 9999999999999999997766 57899999999999999


Q ss_pred             cccccCCccccCCCCccEEEccCCccc-ccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccC
Q 041249          710 RLSGIVPSSIFNISSIAEFDVGENKIQ-GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV  788 (789)
Q Consensus       710 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  788 (789)
                      ++++..|..|..+++|++|+|++|.++ +.+|..+. .+++|++|+|++|++++..|..|..+++|+.|++++|++++.+
T Consensus       432 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  510 (570)
T 2z63_A          432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT-ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP  510 (570)
T ss_dssp             CCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             cccccchhhhhcCCcCcEEECcCCcCccccchhhhh-cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCC
Confidence            999999999999999999999999998 57887765 8999999999999999988999999999999999999999876


Q ss_pred             C
Q 041249          789 P  789 (789)
Q Consensus       789 P  789 (789)
                      |
T Consensus       511 ~  511 (570)
T 2z63_A          511 D  511 (570)
T ss_dssp             T
T ss_pred             H
Confidence            4

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=7.6e-42  Score=400.66  Aligned_cols=223  Identities=21%  Similarity=0.218  Sum_probs=193.1

Q ss_pred             eccCcccccccccccccCccccchhcccCCcccccCcccccCccc-eeeecccCCCCccCCCccCcCCC--CCcEEEccc
Q 041249          560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRR-LQVPDLNNNSIGGEIPVNLSSCS--NLIRIGLAK  636 (789)
Q Consensus       560 l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~i~~~~p~~~~~l~--~L~~L~l~~  636 (789)
                      +++..+.+.+..+ .+..+++|++|+|++|+++ .+|..|..+++ |++|++++|+|+ .+|..+..++  +|++|++++
T Consensus       335 L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~  411 (636)
T 4eco_A          335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY  411 (636)
T ss_dssp             EECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred             EeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence            3344444443344 6778899999999999999 78888999999 999999999999 7888888765  999999999


Q ss_pred             CCCCCCCCcccC-------CCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCC-------CCC
Q 041249          637 NQLMGKIPSDFG-------SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLK-------NLV  702 (789)
Q Consensus       637 N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~  702 (789)
                      |++++..|..|.       .+++|++|+|++|++++..+..+..+++|++|+|++|+|+...+..+..+.       +|+
T Consensus       412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~  491 (636)
T 4eco_A          412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT  491 (636)
T ss_dssp             SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCC
T ss_pred             CcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCcc
Confidence            999999999888       888999999999999966555677799999999999999944444444433       999


Q ss_pred             eeeccCccccccCCcccc--CCCCccEEEccCCcccccCCcccccCCCCccEEEc------cCCcccccCcccccCCCCC
Q 041249          703 ILYLGVNRLSGIVPSSIF--NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI------GTNRITGAIPPSISNASKL  774 (789)
Q Consensus       703 ~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L------~~N~l~~~~~~~~~~l~~L  774 (789)
                      +|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..++ .+++|++|+|      ++|++.+.+|..+..+++|
T Consensus       492 ~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~-~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L  568 (636)
T 4eco_A          492 SIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL-NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL  568 (636)
T ss_dssp             EEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG-GCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred             EEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhh-cCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence            9999999999 7888887  99999999999999995 999988 8999999999      5688888999999999999


Q ss_pred             CeeeccCCcCcccCC
Q 041249          775 EVFQALNNKLTGEVP  789 (789)
Q Consensus       775 ~~L~l~~N~l~~~~P  789 (789)
                      +.|+|++|++ +.+|
T Consensus       569 ~~L~Ls~N~l-~~ip  582 (636)
T 4eco_A          569 TQLQIGSNDI-RKVN  582 (636)
T ss_dssp             CEEECCSSCC-CBCC
T ss_pred             CEEECCCCcC-CccC
Confidence            9999999999 6665

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1e-40  Score=386.52  Aligned_cols=224  Identities=19%  Similarity=0.244  Sum_probs=188.5

Q ss_pred             eeeEeccCcccccccccccc-----cCccccchhcccCCcccccCc-ccccCc---cceeeecccCCCCccCCCccCcCC
Q 041249          556 KVTILDLESLKLAGSILPHI-----GNLSFLKILNLENNSFTHEIP-SEIGRL---RRLQVPDLNNNSIGGEIPVNLSSC  626 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~i~~~~p~~~~~l  626 (789)
                      +++.+++..+.+.+..+..+     .+++.|+.+++..|.+  .+| ..+..+   .+|++|++++|.+....  ....+
T Consensus       277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l  352 (562)
T 3a79_B          277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSP  352 (562)
T ss_dssp             SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSC
T ss_pred             cccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCC
Confidence            67777888887776666666     7888888888888888  244 333333   56999999999987332  23688


Q ss_pred             CCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccC--CcCCCCCCCCCEEEccCCcCCccCC-ccccCCCCCCe
Q 041249          627 SNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSI--PPPLGNLSSLRKISLAINNLAGSIP-FTLSKLKNLVI  703 (789)
Q Consensus       627 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~  703 (789)
                      ++|++|++++|++++..|..|.++++|++|+|++|++++..  |..|.++++|++|+|++|++++.+| ..|..+++|++
T Consensus       353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~  432 (562)
T 3a79_B          353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV  432 (562)
T ss_dssp             CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred             CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence            99999999999999889999999999999999999999643  4678999999999999999997455 46899999999


Q ss_pred             eeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCc
Q 041249          704 LYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK  783 (789)
Q Consensus       704 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  783 (789)
                      |+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..++ .+++|++|+|++|+|++..+..+..+++|+.|++++|+
T Consensus       433 L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~  508 (562)
T 3a79_B          433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT-HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP  508 (562)
T ss_dssp             EECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTT-SSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCC
T ss_pred             EECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhc-CCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCC
Confidence            99999999977776654  68999999999999 9999998 89999999999999995444448999999999999999


Q ss_pred             Cccc
Q 041249          784 LTGE  787 (789)
Q Consensus       784 l~~~  787 (789)
                      +++.
T Consensus       509 ~~c~  512 (562)
T 3a79_B          509 WDCT  512 (562)
T ss_dssp             BCCC
T ss_pred             cCCC
Confidence            9875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8.1e-41  Score=393.02  Aligned_cols=212  Identities=20%  Similarity=0.209  Sum_probs=189.2

Q ss_pred             ccccCccccchhcccCCcccc--cCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCC-cccCC
Q 041249          573 PHIGNLSFLKILNLENNSFTH--EIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIP-SDFGS  649 (789)
Q Consensus       573 ~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~  649 (789)
                      .....+++|+.|++++|.+..  ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++++|......+ ..|..
T Consensus       365 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~  443 (635)
T 4g8a_A          365 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS  443 (635)
T ss_dssp             CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTT
T ss_pred             cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccc
Confidence            345578999999999999864  35566778899999999999998 556788899999999999988775544 46889


Q ss_pred             CCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcC-CccCCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249          650 LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNL-AGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF  728 (789)
Q Consensus       650 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  728 (789)
                      +++++.++++.|++.+..+..+..++.|+.|+|++|++ .+..|..|..+++|++|+|++|+|++..|.+|.++++|++|
T Consensus       444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L  523 (635)
T 4g8a_A          444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  523 (635)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence            99999999999999999999999999999999999984 44678899999999999999999999999999999999999


Q ss_pred             EccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCC-CCCCeeeccCCcCcc
Q 041249          729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNA-SKLEVFQALNNKLTG  786 (789)
Q Consensus       729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~  786 (789)
                      +|++|+|+ .++...+.++++|++|+|++|+|++..|..+..+ ++|+.|+|++|++++
T Consensus       524 ~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          524 NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             ECTTSCCC-BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             ECCCCcCC-CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            99999999 6766666689999999999999999999999998 689999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-43  Score=369.55  Aligned_cols=201  Identities=27%  Similarity=0.323  Sum_probs=169.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||+|+||+||+|+..   .+++.||||+++...  ......+..|++++++++|||||++++++....   
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG---   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT---
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC---
Confidence            367999999999999999999873   457899999996542  233457889999999999999999999998766   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ||||||||+|||++.+++
T Consensus       100 --~~~ivmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~  164 (304)
T 3ubd_A          100 --KLYLILDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGH  164 (304)
T ss_dssp             --EEEEEECCCTTCEEHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSC
T ss_pred             --EEEEEEEcCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCC
Confidence              899999999999999999643          46899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +||+|||+|+.......  ......||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus       165 vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          165 IKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             EEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            99999999987644332  22346799999999999999999999999999999999999999973

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-42  Score=364.20  Aligned_cols=206  Identities=25%  Similarity=0.443  Sum_probs=163.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-------
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDY-------  341 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------  341 (789)
                      ++|...+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++|||||++++++...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            468889999999999999999999999999999975543 345678999999999999999999999865431       


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                      ......++||||+.+|+|.+++....       .....++..+..|+.|++.||+|||+++   ||||||||+|||++.+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-------TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-------SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-------CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence            11224799999999999999997551       2233566778899999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCc----------cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          422 MVSHVGDFGLARFLPPTHVQ----------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +++||+|||+|+........          .......||+.|||||++.+..|+.++|||||||++|||++   ||.
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            99999999999987654321          12234569999999999999999999999999999999996   775

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.7e-40  Score=371.69  Aligned_cols=190  Identities=20%  Similarity=0.244  Sum_probs=145.1

Q ss_pred             ccCccccchhcccCCcccccCcccccCc---cceeeecccCCCCccCC----------CccCcC--CCCCcEEEcccCCC
Q 041249          575 IGNLSFLKILNLENNSFTHEIPSEIGRL---RRLQVPDLNNNSIGGEI----------PVNLSS--CSNLIRIGLAKNQL  639 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~i~~~~----------p~~~~~--l~~L~~L~l~~N~l  639 (789)
                      +..+++|++|++++|++++..|..|..+   ++|+.|++++|.+.+..          +..+..  .++|++|++++|++
T Consensus       208 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l  287 (455)
T 3v47_A          208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI  287 (455)
T ss_dssp             TTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCC
T ss_pred             ccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccc
Confidence            3456789999999999998888887665   89999999999766432          122222  25778888888888


Q ss_pred             CCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccc
Q 041249          640 MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSI  719 (789)
Q Consensus       640 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  719 (789)
                      .+..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..|.+|
T Consensus       288 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  367 (455)
T 3v47_A          288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF  367 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             cccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhc
Confidence            77777777777888888888888877777777777888888888888877777777777888888888888877777777


Q ss_pred             cCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCc
Q 041249          720 FNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIP  765 (789)
Q Consensus       720 ~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~  765 (789)
                      ..+++|++|+|++|+|+ .+|...+..+++|++|+|++|++++..|
T Consensus       368 ~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          368 LGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cccccccEEECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence            77788888888888887 6666665577778888888888776655

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=8e-41  Score=398.75  Aligned_cols=177  Identities=18%  Similarity=0.197  Sum_probs=146.9

Q ss_pred             ccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcC-C-------CCCcEEEcccCCCCCCCCcccC-
Q 041249          578 LSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSS-C-------SNLIRIGLAKNQLMGKIPSDFG-  648 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~-l-------~~L~~L~l~~N~l~~~~~~~~~-  648 (789)
                      +++|+.|+|++|+++...+..+..+++|+.|+|++|+|+ .+|..+.. .       ++|++|+|++|+|+ .+|..+. 
T Consensus       672 ~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~  749 (876)
T 4ecn_A          672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA  749 (876)
T ss_dssp             CCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGST
T ss_pred             CCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhh
Confidence            457899999999999544444568999999999999999 55554433 2       38999999999999 7788876 


Q ss_pred             -CCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC------CcCCccCCccccCCCCCCeeeccCccccccCCccccC
Q 041249          649 -SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI------NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFN  721 (789)
Q Consensus       649 -~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  721 (789)
                       .+++|+.|+|++|+|++ +|..+.++++|+.|+|++      |++.+.+|..|.++++|+.|+|++|+| +.+|..+. 
T Consensus       750 ~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~-  826 (876)
T 4ecn_A          750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT-  826 (876)
T ss_dssp             TTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-
T ss_pred             ccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc-
Confidence             89999999999999996 688899999999999976      888889999999999999999999999 48888766 


Q ss_pred             CCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249          722 ISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       722 l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  761 (789)
                       ++|+.|||++|+|. .+....+.....+..+.|.+|++.
T Consensus       827 -~~L~~LdLs~N~l~-~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          827 -PQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             -SSSCEEECCSCTTC-EEECGGGHHHHHTTCCEEECCTTS
T ss_pred             -CCCCEEECCCCCCC-ccChHHccccccchheeecCCCcc
Confidence             69999999999998 655454434556777888888766

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.2e-40  Score=384.99  Aligned_cols=455  Identities=17%  Similarity=0.196  Sum_probs=327.3

Q ss_pred             ccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEec
Q 041249           21 KKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTV  100 (789)
Q Consensus        21 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  100 (789)
                      +.....+.++|.++ .+|+.+.  ++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|+.+++|++|+|
T Consensus         5 ~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             CTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            34445789999999 7888765  89999999999999888899999999999999999999888889999999999999


Q ss_pred             cCCCCCCcCCccccCCcccccccccCCCCC------------ccceeecCCcccCCCch-hhhcCcccccEEecccCCCC
Q 041249          101 SGNILQGEIPSTLGSCIKLEILEMQGNVFQ------------GLTILDLSRNKLSGEIP-EFLVGLKVIENLNLSYNDLE  167 (789)
Q Consensus       101 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~------------~l~~l~ls~N~l~~~~p-~~~~~~~~l~~l~ls~N~~~  167 (789)
                      ++|++++..|..|+++++|++|++++|++.            .|+.|++++|.+.+.+| ..+..+++|++|++++|.++
T Consensus        82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A           82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence            999999887888999999999999999875            27899999999555554 68999999999999999999


Q ss_pred             CCCCCc-ccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHHHHHHHhccc
Q 041249          168 GMVPTE-GVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWVRKRKE  246 (789)
Q Consensus       168 ~~~~~~-~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~~~~~~~~k~  246 (789)
                      +..|.. +....+..+.+.+|....  .                                                    
T Consensus       162 ~~~~~~l~~l~~L~~L~l~~n~~~~--~----------------------------------------------------  187 (549)
T 2z81_A          162 NYQSQSLKSIRDIHHLTLHLSESAF--L----------------------------------------------------  187 (549)
T ss_dssp             EECTTTTTTCSEEEEEEEECSBSTT--H----------------------------------------------------
T ss_pred             ccChhhhhccccCceEecccCcccc--c----------------------------------------------------
Confidence            877654 334455555555553100  0                                                    


Q ss_pred             CCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC
Q 041249          247 QSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH  326 (789)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h  326 (789)
                                      .+                                                .+      ...  .
T Consensus       188 ----------------~~------------------------------------------------~~------~~~--l  195 (549)
T 2z81_A          188 ----------------LE------------------------------------------------IF------ADI--L  195 (549)
T ss_dssp             ----------------HH------------------------------------------------HH------HHS--T
T ss_pred             ----------------ch------------------------------------------------hh------Hhh--c
Confidence                            00                                                00      000  0


Q ss_pred             CccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCc
Q 041249          327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPIT  406 (789)
Q Consensus       327 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i  406 (789)
                      +++..+                 -....   .+.......          .                           ++
T Consensus       196 ~~L~~L-----------------~L~~n---~l~~~~~~~----------~---------------------------~~  218 (549)
T 2z81_A          196 SSVRYL-----------------ELRDT---NLARFQFSP----------L---------------------------PV  218 (549)
T ss_dssp             TTBSEE-----------------EEESC---BCTTCCCCC----------C---------------------------SS
T ss_pred             ccccEE-----------------EccCC---ccccccccc----------c---------------------------ch
Confidence            000000                 00000   000000000          0                           00


Q ss_pred             eecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249          407 THCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       407 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      ..           .-...+.-++.                  +                                     
T Consensus       219 ~~-----------~~~~L~~L~l~------------------~-------------------------------------  232 (549)
T 2z81_A          219 DE-----------VSSPMKKLAFR------------------G-------------------------------------  232 (549)
T ss_dssp             CC-----------CCCCCCEEEEE------------------S-------------------------------------
T ss_pred             hh-----------hhhcccceecc------------------c-------------------------------------
Confidence            00           00000000000                  0                                     


Q ss_pred             CCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          487 SDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                                                  -.+.                      ......+......+.++..+++..+.
T Consensus       233 ----------------------------n~l~----------------------~~~~~~l~~~~~~~~~L~~l~l~~~~  262 (549)
T 2z81_A          233 ----------------------------SVLT----------------------DESFNELLKLLRYILELSEVEFDDCT  262 (549)
T ss_dssp             ----------------------------CEEE----------------------HHHHHHHHGGGGGCTTCCEEEEESCE
T ss_pred             ----------------------------cccc----------------------hhHHHHHHHHhhhhcccccccccccc
Confidence                                        0000                      00011122223345566666666665


Q ss_pred             cccc------ccccccCccccchhcccCCccccc-----CcccccCccceeeecccCCCCccCCCccC-cCCCCCcEEEc
Q 041249          567 LAGS------ILPHIGNLSFLKILNLENNSFTHE-----IPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGL  634 (789)
Q Consensus       567 ~~~~------~l~~l~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~l  634 (789)
                      ....      ....+..+++|+.|++.++.+...     .+..+....+|++|++++|+++ .+|..+ .++++|++|++
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~L  341 (549)
T 2z81_A          263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL  341 (549)
T ss_dssp             EECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEEC
T ss_pred             ccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEc
Confidence            5432      223456788899999999987642     1222344578999999999998 677666 67999999999


Q ss_pred             ccCCCCCCCC---cccCCCCCCcEEEccCCCCCccCC--cCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCc
Q 041249          635 AKNQLMGKIP---SDFGSLSKIEVLSLGFNNLIGSIP--PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       635 ~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  709 (789)
                      ++|++.+..|   ..+..+++|++|+|++|++++..+  ..+..+++|++|+|++|+|+ .+|..+..+++|++|++++|
T Consensus       342 s~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N  420 (549)
T 2z81_A          342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST  420 (549)
T ss_dssp             CSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTS
T ss_pred             cCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCC
Confidence            9999997653   347889999999999999986543  45889999999999999999 78889999999999999999


Q ss_pred             cccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          710 RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       710 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      +|+ .+|..+.  ++|+.|+|++|+|++ ++    ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|
T Consensus       421 ~l~-~l~~~~~--~~L~~L~Ls~N~l~~-~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~  490 (549)
T 2z81_A          421 GIR-VVKTCIP--QTLEVLDVSNNNLDS-FS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPD  490 (549)
T ss_dssp             CCS-CCCTTSC--TTCSEEECCSSCCSC-CC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCT
T ss_pred             Ccc-cccchhc--CCceEEECCCCChhh-hc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCH
Confidence            998 4555443  689999999999994 43    26899999999999999 5665 4679999999999999998765

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.8e-39  Score=363.40  Aligned_cols=379  Identities=20%  Similarity=0.209  Sum_probs=278.9

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCC-cccccCCCCCCEEEccCCc
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI-PPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~   80 (789)
                      +++++++++ .+|+ +  .++|++|+|++|.|++..|..|+.+++|++|+|++|.+.+.+ |..|..+++|++|+|++|+
T Consensus        15 ~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~   90 (455)
T 3v47_A           15 AICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ   90 (455)
T ss_dssp             EECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT
T ss_pred             cCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCc
Confidence            688999998 7887 4  378999999999999888999999999999999999998665 5679999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCcc--ccCCcccccccccCCCCCccceeecCCcccCCCchhh-hcCccccc
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPST--LGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEF-LVGLKVIE  157 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~-~~~~~~l~  157 (789)
                      +++..|..|+.+++|++|+|++|++++.+|..  +..+++|++|+|+             +|++++..|.. +..+++|+
T Consensus        91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~-------------~n~l~~~~~~~~~~~l~~L~  157 (455)
T 3v47_A           91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR-------------DNNIKKIQPASFFLNMRRFH  157 (455)
T ss_dssp             TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECC-------------SSBCCSCCCCGGGGGCTTCC
T ss_pred             cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECC-------------CCccCccCcccccCCCCccc
Confidence            99888999999999999999999999866654  7777776655554             55566666765 78899999


Q ss_pred             EEecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHH
Q 041249          158 NLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISF  237 (789)
Q Consensus       158 ~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~  237 (789)
                      +|++++|++++.++..  +....                                                         
T Consensus       158 ~L~L~~n~l~~~~~~~--l~~l~---------------------------------------------------------  178 (455)
T 3v47_A          158 VLDLTFNKVKSICEED--LLNFQ---------------------------------------------------------  178 (455)
T ss_dssp             EEECTTCCBSCCCTTT--SGGGT---------------------------------------------------------
T ss_pred             EEeCCCCcccccChhh--hhccc---------------------------------------------------------
Confidence            9999999998765542  00000                                                         


Q ss_pred             HHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHH
Q 041249          238 LCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAE  317 (789)
Q Consensus       238 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e  317 (789)
                                                                               +.  .++.+....          
T Consensus       179 ---------------------------------------------------------~~--~L~~L~l~~----------  189 (455)
T 3v47_A          179 ---------------------------------------------------------GK--HFTLLRLSS----------  189 (455)
T ss_dssp             ---------------------------------------------------------TC--EEEEEECTT----------
T ss_pred             ---------------------------------------------------------cc--ccccccccc----------
Confidence                                                                     00  000000000          


Q ss_pred             HHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 041249          318 CRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY  397 (789)
Q Consensus       318 ~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~  397 (789)
                                                          .   .+                                      
T Consensus       190 ------------------------------------n---~l--------------------------------------  192 (455)
T 3v47_A          190 ------------------------------------I---TL--------------------------------------  192 (455)
T ss_dssp             ------------------------------------C---BC--------------------------------------
T ss_pred             ------------------------------------C---cc--------------------------------------
Confidence                                                0   00                                      


Q ss_pred             hhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHH
Q 041249          398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILM  477 (789)
Q Consensus       398 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl  477 (789)
                                                   .+                         +++...              +   
T Consensus       193 -----------------------------~~-------------------------~~~~~~--------------~---  201 (455)
T 3v47_A          193 -----------------------------QD-------------------------MNEYWL--------------G---  201 (455)
T ss_dssp             -----------------------------TT-------------------------CSTTCT--------------T---
T ss_pred             -----------------------------cc-------------------------cchhhc--------------c---
Confidence                                         00                         000000              0   


Q ss_pred             HHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhcccccee
Q 041249          478 LELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKV  557 (789)
Q Consensus       478 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l  557 (789)
                                                                                         .....-...+.++
T Consensus       202 -------------------------------------------------------------------~~~~~~~~~~~~L  214 (455)
T 3v47_A          202 -------------------------------------------------------------------WEKCGNPFKNTSI  214 (455)
T ss_dssp             -------------------------------------------------------------------HHHHCCTTTTCEE
T ss_pred             -------------------------------------------------------------------cccccccccccee
Confidence                                                                               0000001123455


Q ss_pred             eEeccCcccccccccccccCc---cccchhcccCCccccc----------CcccccCc--cceeeecccCCCCccCCCcc
Q 041249          558 TILDLESLKLAGSILPHIGNL---SFLKILNLENNSFTHE----------IPSEIGRL--RRLQVPDLNNNSIGGEIPVN  622 (789)
Q Consensus       558 ~~l~l~s~~~~~~~l~~l~~l---~~L~~L~L~~N~l~~~----------~~~~~~~l--~~L~~L~Ls~N~i~~~~p~~  622 (789)
                      +.+++..+.+....+..+..+   ++|+.|++++|.+.+.          .+..|..+  ++|++|++++|.+++..|..
T Consensus       215 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~  294 (455)
T 3v47_A          215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV  294 (455)
T ss_dssp             EEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTT
T ss_pred             eeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhh
Confidence            556666665555544444433   7788888888765432          12223322  57888888888888888888


Q ss_pred             CcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC
Q 041249          623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV  702 (789)
Q Consensus       623 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  702 (789)
                      |..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|+
T Consensus       295 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  374 (455)
T 3v47_A          295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK  374 (455)
T ss_dssp             TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             cccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccccccc
Confidence            88888888888888888877788888888888888888888888788888888888888888888877788888888888


Q ss_pred             eeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          703 ILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       703 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      +|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus       375 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             EEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            88888888887666777888888888888888887776

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=360.47  Aligned_cols=207  Identities=24%  Similarity=0.315  Sum_probs=175.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~  345 (789)
                      .++|...+.||+|+||+||+|.+..+++.||||+++...  ....+.+.+|+++|+.++|||||++++++.... +....
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357899999999999999999999999999999996542  233567889999999999999999999886543 22334


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..|+|||||. |+|.+++...          +.+++.++..|+.||+.||+|||+.+   ||||||||+|||++.++.+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~----------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS----------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEeCCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEE
Confidence            7899999996 7899998644          57999999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCC--CccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+|+......  .........||+.|||||++.+. .++.++||||+||++|||++|+.||..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            99999999775433  22233456799999999998775 469999999999999999999999973

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=368.76  Aligned_cols=426  Identities=19%  Similarity=0.184  Sum_probs=321.6

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|||++|++++..|++|+++++|++|+|++|+|++..|+.|+.+++|++|+|++|+|+ .+|..  .+++|++|+|++|+
T Consensus        25 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~  101 (520)
T 2z7x_B           25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNA  101 (520)
T ss_dssp             EEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSC
T ss_pred             EEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCc
Confidence            4899999999888899999999999999999999888999999999999999999999 67776  89999999999999


Q ss_pred             CCC-CCcccccCCCCCCEEeccCCCCCCcCCccccCCccc--ccccccCCCC--Cc------------cceeecCCcccC
Q 041249           81 FRG-SFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL--EILEMQGNVF--QG------------LTILDLSRNKLS  143 (789)
Q Consensus        81 l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L--~~l~l~~N~~--~~------------l~~l~ls~N~l~  143 (789)
                      +++ .+|..|+.+++|++|++++|++++   ..+..+++|  ++|++++|++  .+            ...+++++|.+.
T Consensus       102 l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~  178 (520)
T 2z7x_B          102 FDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF  178 (520)
T ss_dssp             CSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCC
T ss_pred             cccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcch
Confidence            997 578999999999999999999986   457777888  9999999988  21            225789999998


Q ss_pred             CCchh-hhcCcccccEEecccCC-------CCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCccccccee
Q 041249          144 GEIPE-FLVGLKVIENLNLSYND-------LEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFE  215 (789)
Q Consensus       144 ~~~p~-~~~~~~~l~~l~ls~N~-------~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (789)
                      +.+++ .+..+++|+.|++++|.       +.+.++..+....+..+.+.+|.....                       
T Consensus       179 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~-----------------------  235 (520)
T 2z7x_B          179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN-----------------------  235 (520)
T ss_dssp             CCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHH-----------------------
T ss_pred             hhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHH-----------------------
Confidence            87664 57789999999999998       666665545556666666655432000                       


Q ss_pred             eeEeehhhHHHHHHHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCc
Q 041249          216 LKLVIAIVSGLMGLALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGR  295 (789)
Q Consensus       216 ~~~~v~~~~~~~~v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~  295 (789)
                               ..                                    ..                               
T Consensus       236 ---------~~------------------------------------~~-------------------------------  239 (520)
T 2z7x_B          236 ---------SF------------------------------------IR-------------------------------  239 (520)
T ss_dssp             ---------HH------------------------------------HH-------------------------------
T ss_pred             ---------HH------------------------------------HH-------------------------------
Confidence                     00                                    00                               


Q ss_pred             eEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceee-eeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccC
Q 041249          296 TTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVF-TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK  374 (789)
Q Consensus       296 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  374 (789)
                                        +.   ...   ..+++..+. ..+.            +.     |.+...+.          
T Consensus       240 ------------------~~---~~~---~~~~L~~L~l~~n~------------l~-----~~~p~~~~----------  268 (520)
T 2z7x_B          240 ------------------IL---QLV---WHTTVWYFSISNVK------------LQ-----GQLDFRDF----------  268 (520)
T ss_dssp             ------------------HH---HHH---HTSSCSEEEEEEEE------------EE-----SCCCCCCC----------
T ss_pred             ------------------HH---HHh---hhCcccEEEeeccc------------cc-----Cccccchh----------
Confidence                              00   000   000000000 0000            00     00000000          


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeeccccccc
Q 041249          375 APRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI  454 (789)
Q Consensus       375 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  454 (789)
                                                                           ++.                        
T Consensus       269 -----------------------------------------------------~~~------------------------  271 (520)
T 2z7x_B          269 -----------------------------------------------------DYS------------------------  271 (520)
T ss_dssp             -----------------------------------------------------CCC------------------------
T ss_pred             -----------------------------------------------------hcc------------------------
Confidence                                                                 000                        


Q ss_pred             CcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhh
Q 041249          455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQ  534 (789)
Q Consensus       455 aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  534 (789)
                                                                                                      
T Consensus       272 --------------------------------------------------------------------------------  271 (520)
T 2z7x_B          272 --------------------------------------------------------------------------------  271 (520)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhchhHHHHHHHHhhccccceeeEeccCccccccccc-ccccCc---cccchhcccCCcccccCcccccCccceeeecc
Q 041249          535 IRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL-PHIGNL---SFLKILNLENNSFTHEIPSEIGRLRRLQVPDL  610 (789)
Q Consensus       535 ~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l-~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  610 (789)
                                      ...+.+++.+++..+..  ..+ ..+..+   ++|+.|++++|.+....  .+..+++|++|++
T Consensus       272 ----------------~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~L  331 (520)
T 2z7x_B          272 ----------------GTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDF  331 (520)
T ss_dssp             ----------------SCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEEC
T ss_pred             ----------------cccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEe
Confidence                            00112222233333322  111 222222   56899999999987432  1368899999999


Q ss_pred             cCCCCccCCCccCcCCCCCcEEEcccCCCCC--CCCcccCCCCCCcEEEccCCCCCccCCc-CCCCCCCCCEEEccCCcC
Q 041249          611 NNNSIGGEIPVNLSSCSNLIRIGLAKNQLMG--KIPSDFGSLSKIEVLSLGFNNLIGSIPP-PLGNLSSLRKISLAINNL  687 (789)
Q Consensus       611 s~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l  687 (789)
                      ++|++++..|..+..+++|++|++++|+|++  .+|..|..+++|++|+|++|++++.+|. .|..+++|++|+|++|++
T Consensus       332 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l  411 (520)
T 2z7x_B          332 SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL  411 (520)
T ss_dssp             CSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCC
T ss_pred             ECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCC
Confidence            9999998899999999999999999999996  4567799999999999999999984554 588999999999999999


Q ss_pred             CccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc
Q 041249          688 AGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       688 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      ++..|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|...+..+++|++|+|++|++++.
T Consensus       412 ~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          412 TDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             CGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             Ccchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence            888887765  79999999999999 78888889999999999999999 89988666899999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.2e-39  Score=365.98  Aligned_cols=199  Identities=23%  Similarity=0.302  Sum_probs=173.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhH---HHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASR---SFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ++|...++||+|+||+||+|+...+++.||||+++...   .....   ..+.++++++.++|||||++++++...+   
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~---  265 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD---  265 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS---
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC---
Confidence            68999999999999999999999999999999996431   12222   2334567778889999999999998876   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..|+||||+.+|+|.+++...          ..+++..+..|+.||+.||+|||+.+   ||||||||+|||++.+++
T Consensus       266 --~lylVmEy~~GGdL~~~l~~~----------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~  330 (689)
T 3v5w_A          266 --KLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGH  330 (689)
T ss_dssp             --EEEEEECCCCSCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSC
T ss_pred             --EEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCC
Confidence              899999999999999999643          46899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +||+|||+|+......    .....||+.|||||++..+ .|+.++||||+||++|||++|+.||...
T Consensus       331 vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          331 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             EEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             EEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999876543    2235799999999999754 6999999999999999999999999743

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.7e-37  Score=360.93  Aligned_cols=183  Identities=20%  Similarity=0.121  Sum_probs=148.3

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQF   81 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l   81 (789)
                      .|+++.+++ .+|+.+-  +.+++|||++|+|++..|.+|.++++|++|+|++|+|++..|.+|..|++|++|+|++|+|
T Consensus        36 ~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l  112 (635)
T 4g8a_A           36 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI  112 (635)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence            467888888 7887663  4789999999999977778899999999999999999977777899999999999999999


Q ss_pred             CCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCc------------cceeecCCcccCCCchhh
Q 041249           82 RGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG------------LTILDLSRNKLSGEIPEF  149 (789)
Q Consensus        82 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~------------l~~l~ls~N~l~~~~p~~  149 (789)
                      ++..|..|.++++|++|+|++|++++..+..|+++++|++|++++|++.+            |+.|+|++|+|++..|..
T Consensus       113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence            86666778999999999999999997667789999999999999997742            788999999999888887


Q ss_pred             hcCcccc----cEEecccCCCCCCCCCcccccCCccccccCC
Q 041249          150 LVGLKVI----ENLNLSYNDLEGMVPTEGVFKNASAISVLGN  187 (789)
Q Consensus       150 ~~~~~~l----~~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n  187 (789)
                      +..+..+    ..++++.|+++..++..........+...+|
T Consensus       193 l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n  234 (635)
T 4g8a_A          193 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN  234 (635)
T ss_dssp             GHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred             ccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence            7766544    4688999999887776533333344444444

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-38  Score=339.61  Aligned_cols=283  Identities=31%  Similarity=0.461  Sum_probs=230.3

Q ss_pred             ccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeec
Q 041249          258 LNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS  337 (789)
Q Consensus       258 ~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  337 (789)
                      .++++.++..++++|...+.||+|+||.||+|.+. +++.||||.+........+.+.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            45666777889999999999999999999999976 78999999987776666788999999999999999999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ...     ..++||||+.+|+|.+++...      ......+++.++..++.|++.||+|||+.+   ++||||||+||+
T Consensus       106 ~~~-----~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil  171 (321)
T 2qkw_B          106 ERN-----EMILIYKYMENGNLKRHLYGS------DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINIL  171 (321)
T ss_dssp             CTT-----CCEEEEECCTTCBTGGGSSSS------CCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEE
T ss_pred             CCC-----eEEEEEEcCCCCcHHHHHhcc------CCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEE
Confidence            655     789999999999999999654      122346899999999999999999999988   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcccc-CCcc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE-GDMN  496 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~-~~~~  496 (789)
                      ++.++.+||+|||+++...............||..|+|||.+.+..++.++||||||+++|||++|+.||..... +...
T Consensus       172 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~  251 (321)
T 2qkw_B          172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN  251 (321)
T ss_dssp             ECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred             ECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence            999999999999999876544333333445689999999999888999999999999999999999999976533 3445


Q ss_pred             HHHHHHHhCCCc-hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          497 LHNFARMALPDH-VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       497 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...|........ ....+++.+....                  ..++...+.+++..|++.++.+||+...+...+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          252 LAEWAVESHNNGQLEQIVDPNLADKI------------------RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             HHHHTHHHHTTTCCCSSSSSSCTTCS------------------CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhhccccccHHHhcChhhcccc------------------CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            666654433332 4455555443221                  2356677889999999999999999988755443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-38  Score=343.12  Aligned_cols=200  Identities=23%  Similarity=0.312  Sum_probs=170.5

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  342 (789)
                      .-.+.|...+.||+|+||+||+|+.+   .+++.||||.+....  ....+.+|+++++.+ .||||+++++++...+  
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~--   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND--   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT--
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC--
Confidence            34678999999999999999999874   357899999985443  345678899999998 6999999999988766  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-  421 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-  421 (789)
                         ..++||||+++|+|.+++.             .+++.++..++.|++.||+|||+.+   ||||||||+|||++.+ 
T Consensus        94 ---~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~  154 (361)
T 4f9c_A           94 ---HVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRL  154 (361)
T ss_dssp             ---EEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTT
T ss_pred             ---EEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCC
Confidence               8999999999999999983             3789999999999999999999998   9999999999999877 


Q ss_pred             CceeeCcccccccCCCCCCc--------------------------cceeeecccccccCcccCCCC-CcCccccchhhH
Q 041249          422 MVSHVGDFGLARFLPPTHVQ--------------------------TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYG  474 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfG  474 (789)
                      +.+||+|||+|+...+....                          .......||+.|+|||++.+. .|+.++||||+|
T Consensus       155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG  234 (361)
T 4f9c_A          155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG  234 (361)
T ss_dssp             TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence            79999999999876543211                          112234699999999998876 489999999999


Q ss_pred             HHHHHHHHhcCCCCc
Q 041249          475 ILMLELIIRKKPSDI  489 (789)
Q Consensus       475 vvl~elltG~~P~~~  489 (789)
                      |++|||++|+.||..
T Consensus       235 ~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          235 VIFLSLLSGRYPFYK  249 (361)
T ss_dssp             HHHHHHHHTCSSSSC
T ss_pred             HHHHHHHHCCCCCCC
Confidence            999999999999963

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.7e-38  Score=359.78  Aligned_cols=253  Identities=22%  Similarity=0.237  Sum_probs=205.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||+||+|..+.+++.||+|++........+.+.+|+++|+.++|||||++++++....     ..++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-----EEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEE
Confidence            67999999999999999999999999999999997766666778999999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC--CceeeC
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--MVSHVG  427 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~  427 (789)
                      |||||.+|+|.+++...         ...+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+
T Consensus       232 v~E~~~gg~L~~~i~~~---------~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~  299 (573)
T 3uto_A          232 IYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI  299 (573)
T ss_dssp             EEECCCCCBHHHHHTCT---------TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEeecCCCcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEe
Confidence            99999999999998543         246899999999999999999999998   9999999999999854  799999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+|+.+....   ......||+.|||||++.+..|+.++||||+||++|||++|+.||...     +..+..+.....
T Consensus       300 DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~~~~~~~i~~~  371 (573)
T 3uto_A          300 DFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSC  371 (573)
T ss_dssp             CCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTT
T ss_pred             eccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHhC
Confidence            999999876543   233457999999999999999999999999999999999999999732     111221111110


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .      ..+..                  ...........+++..|.+.++..|++..+...+
T Consensus       372 ~------~~~~~------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          372 D------WNMDD------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             C------CCCCS------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C------CCCCc------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      00000                  0000122344577889999999999988876544

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.5e-38  Score=336.25  Aligned_cols=286  Identities=32%  Similarity=0.517  Sum_probs=235.0

Q ss_pred             ccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeee
Q 041249          256 SLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       256 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      ....|++.++..++++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4568999999999999999999999999999999865 689999999875533 23447899999999999999999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      ++....     ..++||||+.+|+|.+++...      ......+++..+..++.|++.||+|||+...++|+||||||+
T Consensus        95 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           95 FCMTPT-----ERLLVYPYMANGSVASCLRER------PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             EECCSS-----CCEEEEECCTTCBHHHHHHCC------STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             EEecCC-----ceEEEEEeccCCCHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            997665     789999999999999999754      123456999999999999999999999993334999999999


Q ss_pred             ceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc---c
Q 041249          415 NILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM---F  491 (789)
Q Consensus       415 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~---~  491 (789)
                      ||+++.++.+||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||+..   .
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             hEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            999999999999999999987644322 233455999999999998889999999999999999999999999743   3


Q ss_pred             cCCccHHHHHHHhCCCc-hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          492 EGDMNLHNFARMALPDH-VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ........|++...... .....+..+....                  ..++...+.+++..|++.++.+||+...+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  304 (326)
T 3uim_A          243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNY------------------KDEEVEQLIQVALLCTQSSPMERPKMSEVVR  304 (326)
T ss_dssp             TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC------------------CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred             ccchhHHHHHHHHhhchhhhhhcChhhcccc------------------CHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence            34556777777666554 5555565554332                  2355677889999999999999999988755


Q ss_pred             cc
Q 041249          571 IL  572 (789)
Q Consensus       571 ~l  572 (789)
                      .+
T Consensus       305 ~L  306 (326)
T 3uim_A          305 ML  306 (326)
T ss_dssp             HH
T ss_pred             Hh
Confidence            44

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=9.7e-37  Score=353.07  Aligned_cols=147  Identities=18%  Similarity=0.197  Sum_probs=129.3

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      ++|+++|+++ .+|..+.  ++|++|+|++|.|++..|+.|+.+++|++|+|++|+|++..|..|+.+++|++|+|++|+
T Consensus        35 ~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  111 (562)
T 3a79_B           35 MVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR  111 (562)
T ss_dssp             EEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCc
Confidence            4799999999 5888775  799999999999998888899999999999999999998889999999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCC-cCCccccCCcccccccccCCCCCc--------c--ceeecCCccc--CCCch
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQG-EIPSTLGSCIKLEILEMQGNVFQG--------L--TILDLSRNKL--SGEIP  147 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~~~~--------l--~~l~ls~N~l--~~~~p  147 (789)
                      ++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++..        |  +.|++++|.+  ++..|
T Consensus       112 l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~  188 (562)
T 3a79_B          112 LQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET  188 (562)
T ss_dssp             CC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSC
T ss_pred             CC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCc
Confidence            98 78776  89999999999999996 356899999999999999998753        5  8999999999  77766


Q ss_pred             hhhcCc
Q 041249          148 EFLVGL  153 (789)
Q Consensus       148 ~~~~~~  153 (789)
                      ..+..+
T Consensus       189 ~~l~~l  194 (562)
T 3a79_B          189 ESLQIP  194 (562)
T ss_dssp             CEEEEC
T ss_pred             cccccc
Confidence            665543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=4.9e-36  Score=336.34  Aligned_cols=183  Identities=21%  Similarity=0.280  Sum_probs=139.1

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEc
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL  658 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  658 (789)
                      ++|++|++++|+++ .+|. |..+++|++|++++|++++ +|..   +++|++|++++|++++ +|..   +++|++|++
T Consensus       215 ~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l  284 (454)
T 1jl5_A          215 LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDV  284 (454)
T ss_dssp             TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred             CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEEC
Confidence            58999999999999 6674 9999999999999999995 5543   4899999999999995 5653   478999999


Q ss_pred             cCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCC-CCCCeeeccCccccccCCccccCCCCccEEEccCCcccc
Q 041249          659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKL-KNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG  737 (789)
Q Consensus       659 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  737 (789)
                      ++|++++. |..   .++|++|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++|+.|++++|+++ 
T Consensus       285 s~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-  350 (454)
T 1jl5_A          285 SENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-  350 (454)
T ss_dssp             CSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-
T ss_pred             cCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-
Confidence            99999963 221   2689999999999985 33    23 589999999999995 6654   588999999999999 


Q ss_pred             cCCcccccCCCCccEEEccCCcccc--cCcccccCC-------------CCCCeeeccCCcCcc--cCC
Q 041249          738 NIPLDYGFTLQNLQYFSIGTNRITG--AIPPSISNA-------------SKLEVFQALNNKLTG--EVP  789 (789)
Q Consensus       738 ~ip~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l-------------~~L~~L~l~~N~l~~--~~P  789 (789)
                      .+|.    .+++|++|+|++|++++  .+|.++..+             ++|+.|++++|+++|  .+|
T Consensus       351 ~lp~----~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP  415 (454)
T 1jl5_A          351 EVPE----LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIP  415 (454)
T ss_dssp             CCCC----CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------
T ss_pred             cccc----hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccch
Confidence            7887    36899999999999998  678888887             889999999999998  665

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4e-36  Score=320.22  Aligned_cols=280  Identities=29%  Similarity=0.427  Sum_probs=224.5

Q ss_pred             ccccccHHHHHHhhcCCCCC------CcccccCCccEEEEEEcCCceEEEEEEeccc----cchhhHHHHHHHHHHhcCC
Q 041249          256 SLLNLSYQNLHNATDGFSSA------NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH----HHRASRSFIAECRALRSIR  325 (789)
Q Consensus       256 ~~~~~~~~~~~~~~~~f~~~------~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~  325 (789)
                      +...|++.++..++++|+..      +.||+|+||.||+|.+  +++.||||++...    .....+.+.+|++++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            56789999999999999988      8999999999999987  4889999998643    2334577999999999999


Q ss_pred             CCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCC
Q 041249          326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPI  405 (789)
Q Consensus       326 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~  405 (789)
                      ||||+++++++....     ..++||||+.+|+|.+++...       .....+++..+..++.|++.||+|||+.+   
T Consensus        89 h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---  153 (307)
T 2nru_A           89 HENLVELLGFSSDGD-----DLCLVYVYMPNGSLLDRLSCL-------DGTPPLSWHMRCKIAQGAANGINFLHENH---  153 (307)
T ss_dssp             CTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTG-------GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             CCCeEEEEEEEecCC-----ceEEEEEecCCCcHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---
Confidence            999999999987655     789999999999999998643       12356899999999999999999999998   


Q ss_pred             ceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcC
Q 041249          406 TTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK  485 (789)
Q Consensus       406 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~  485 (789)
                      ++||||||+||+++.++.+||+|||.++...............||..|+|||.+. +.++.++||||||+++|||++|+.
T Consensus       154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~  232 (307)
T 2nru_A          154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLP  232 (307)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCC
T ss_pred             eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999998776544333334456999999999875 468999999999999999999999


Q ss_pred             CCCccccCCccHHHHHHHhC--CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccC
Q 041249          486 PSDIMFEGDMNLHNFARMAL--PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLE  563 (789)
Q Consensus       486 P~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~  563 (789)
                      ||...... ..+..+.+...  ...+.+.+++.+...                   ...+...+.+++..|++.++..||
T Consensus       233 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~Rp  292 (307)
T 2nru_A          233 AVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDA-------------------DSTSVEAMYSVASQCLHEKKNKRP  292 (307)
T ss_dssp             SBCTTBSS-SBTTHHHHHHHTTSCCHHHHSCSSCSCC-------------------CHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             CcccCcch-HHHHHHHHHhhhhhhhhhhhcccccccc-------------------chHHHHHHHHHHHHHcCCCcccCc
Confidence            99854332 22223322221  122445555544321                   224566778899999999999999


Q ss_pred             cccccccccc
Q 041249          564 SLKLAGSILP  573 (789)
Q Consensus       564 s~~~~~~~l~  573 (789)
                      +...+...+.
T Consensus       293 s~~~l~~~L~  302 (307)
T 2nru_A          293 DIKKVQQLLQ  302 (307)
T ss_dssp             CHHHHHHHHH
T ss_pred             CHHHHHHHHH
Confidence            9987754443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=337.11  Aligned_cols=150  Identities=21%  Similarity=0.185  Sum_probs=117.7

Q ss_pred             EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 041249            2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQF   81 (789)
Q Consensus         2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l   81 (789)
                      +++++++++ .+|..+.  +++++|+|++|+|++..|+.|..+++|++|+|++|+|++..|..|..+++|++|+|++|++
T Consensus        16 v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l   92 (477)
T 2id5_A           16 VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL   92 (477)
T ss_dssp             EECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             EEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence            577888888 7777664  5788888888888877788888888888888888888877788888888888888888888


Q ss_pred             CCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEec
Q 041249           82 RGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNL  161 (789)
Q Consensus        82 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~l  161 (789)
                      ++..+..|..+++|++|+|++|++++..|..|..+++|++|++++|+             +++..|..+..+++|+.|++
T Consensus        93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~-------------l~~~~~~~~~~l~~L~~L~l  159 (477)
T 2id5_A           93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND-------------LVYISHRAFSGLNSLEQLTL  159 (477)
T ss_dssp             CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTT-------------CCEECTTSSTTCTTCCEEEE
T ss_pred             CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCc-------------cceeChhhccCCCCCCEEEC
Confidence            85444567888888888888888887777778777777665555544             44555667777888888888


Q ss_pred             ccCCCC
Q 041249          162 SYNDLE  167 (789)
Q Consensus       162 s~N~~~  167 (789)
                      ++|+++
T Consensus       160 ~~n~l~  165 (477)
T 2id5_A          160 EKCNLT  165 (477)
T ss_dssp             ESCCCS
T ss_pred             CCCcCc
Confidence            888665

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.4e-35  Score=331.02  Aligned_cols=173  Identities=29%  Similarity=0.423  Sum_probs=125.8

Q ss_pred             ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      +..+++|++|++++|++++.  ..+..+++|++|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|+
T Consensus       217 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  290 (466)
T 1o6v_A          217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT  290 (466)
T ss_dssp             GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence            44566777788888877743  346777778888888888775543  7777788888888888775433  67777888


Q ss_pred             EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCc
Q 041249          655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK  734 (789)
Q Consensus       655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  734 (789)
                      .|++++|++++..+  +..+++|++|+|++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|+
T Consensus       291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence            88888888775443  6777788888888888776554  67777888888888887754  467777788888888888


Q ss_pred             ccccCCcccccCCCCccEEEccCCcccc
Q 041249          735 IQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       735 l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      +++..|  + ..+++|++|++++|++++
T Consensus       365 l~~~~~--~-~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          365 ISDLTP--L-ANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CCBCGG--G-TTCTTCCEEECCCEEEEC
T ss_pred             cCccch--h-hcCCCCCEEeccCCcccC
Confidence            875555  3 367778888888887775

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=8.4e-36  Score=334.47  Aligned_cols=185  Identities=21%  Similarity=0.304  Sum_probs=107.4

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+..+++|++|++++|++++ +|..   +++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|
T Consensus       232 ~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L  299 (454)
T 1jl5_A          232 ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNL  299 (454)
T ss_dssp             CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTC
T ss_pred             ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcC
Confidence            36678888888888888885 4443   3678888888888885 4543   3778888888888885 2321   2578


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      +.|++++|++++. +..   .++|++|++++|++++ +|..   +++|++|++++|+++ .+|.   .+++|++|+|++|
T Consensus       300 ~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N  367 (454)
T 1jl5_A          300 YYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYN  367 (454)
T ss_dssp             CEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSS
T ss_pred             CEEECcCCcCCcc-cCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCC
Confidence            8888888888753 211   2478888888888884 5543   478888888888888 4565   4678888888888


Q ss_pred             cccc--cCCcccccCC-------------CCccEEEccCCcccc--cCcccccCCCCCCeeeccCCcCcccCC
Q 041249          734 KIQG--NIPLDYGFTL-------------QNLQYFSIGTNRITG--AIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       734 ~l~~--~ip~~~~~~l-------------~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      ++++  .+|..+. .+             ++|++|++++|++++  .+|.      .++.|.+.+|.+.+.+|
T Consensus       368 ~l~~l~~ip~~l~-~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~  433 (454)
T 1jl5_A          368 PLREFPDIPESVE-DLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYE  433 (454)
T ss_dssp             CCSSCCCCCTTCC-EEECCC-----------------------------------------------------
T ss_pred             CCCcCCCChHHHH-hhhhcccccccccccCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCccc
Confidence            8886  5776654 45             789999999999986  4443      35667788888877654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-36  Score=322.55  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|....+++.||||++........+.+.+|+.++++++||||+++++++...+     ..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence            468999999999999999999998899999999998776666788999999999999999999999998766     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...           .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        94 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D  159 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD  159 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEECCCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEee
Confidence            999999999999998532           4889999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||++.........  .....||..|+|||.+.+..++.++|||||||++|||++|+.||...... ...........+  
T Consensus       160 fg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~--  234 (297)
T 3fxz_A          160 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTP--  234 (297)
T ss_dssp             CTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSC--
T ss_pred             CCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--
Confidence            9999877654422  23456999999999999999999999999999999999999999632110 001111111100  


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                             ...                    ....+...+.+++..|++.++..|++..+...+
T Consensus       235 -------~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 -------ELQ--------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -------CCS--------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -------CCC--------------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                   000                    011223445678889999999999999877553

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-37  Score=326.55  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++....     ..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeE
Confidence            467888999999999999999999899999999987666667788999999999999999999999998765     799


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        84 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---------DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---------CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECC
T ss_pred             EEEEecCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEee
Confidence            999999999999999643         356899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCcc------------ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCC--
Q 041249          429 FGLARFLPPTHVQT------------SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD--  494 (789)
Q Consensus       429 fgla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~--  494 (789)
                      ||+++.........            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.......  
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            99998775443211            1113569999999999999999999999999999999999999987542211  


Q ss_pred             --ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          495 --MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       495 --~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                        ...........+                                  ..+...+.+++..|++.++.+||+.......+
T Consensus       232 ~~~~~~~~~~~~~~----------------------------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L  277 (310)
T 3s95_A          232 FGLNVRGFLDRYCP----------------------------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL  277 (310)
T ss_dssp             SSBCHHHHHHHTCC----------------------------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HhhhhhccccccCC----------------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence              111111111111                                  12233455788899999999999988775544


Q ss_pred             c
Q 041249          573 P  573 (789)
Q Consensus       573 ~  573 (789)
                      .
T Consensus       278 ~  278 (310)
T 3s95_A          278 E  278 (310)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.9e-36  Score=321.60  Aligned_cols=264  Identities=21%  Similarity=0.210  Sum_probs=213.0

Q ss_pred             ccccHHHHHHhhcC----------CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCC
Q 041249          258 LNLSYQNLHNATDG----------FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR  327 (789)
Q Consensus       258 ~~~~~~~~~~~~~~----------f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  327 (789)
                      ..++++++..+++.          |+..+.||+|+||.||+|....+++.||||++........+.+.+|++++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46888898888875          66677999999999999999988999999999877666677899999999999999


Q ss_pred             ccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCce
Q 041249          328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT  407 (789)
Q Consensus       328 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv  407 (789)
                      ||+++++++....     ..++||||+.+|+|.+++..           ..+++.++..++.|++.||+|||+.+   |+
T Consensus       103 niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~---iv  163 (321)
T 2c30_A          103 NVVEMYKSYLVGE-----ELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHAQG---VI  163 (321)
T ss_dssp             TBCCEEEEEEETT-----EEEEEECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             CcceEEEEEEECC-----EEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence            9999999998765     89999999999999999853           35899999999999999999999988   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      ||||||+||+++.++.+||+|||++.........  .....||..|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999877544321  23456999999999999999999999999999999999999999


Q ss_pred             CccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccc
Q 041249          488 DIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKL  567 (789)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~  567 (789)
                      .....  ......+....        .+.+..                    .......+.+++..|++.++..||+...
T Consensus       242 ~~~~~--~~~~~~~~~~~--------~~~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e  291 (321)
T 2c30_A          242 FSDSP--VQAMKRLRDSP--------PPKLKN--------------------SHKVSPVLRDFLERMLVRDPQERATAQE  291 (321)
T ss_dssp             TTSCH--HHHHHHHHHSS--------CCCCTT--------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCH--HHHHHHHhcCC--------CCCcCc--------------------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            63211  11111111111        111100                    0122334567788999999999999987


Q ss_pred             ccccc
Q 041249          568 AGSIL  572 (789)
Q Consensus       568 ~~~~l  572 (789)
                      +..++
T Consensus       292 ll~hp  296 (321)
T 2c30_A          292 LLDHP  296 (321)
T ss_dssp             HHTSG
T ss_pred             HhcCh
Confidence            75543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.8e-35  Score=330.48  Aligned_cols=133  Identities=18%  Similarity=0.157  Sum_probs=105.6

Q ss_pred             CCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCc
Q 041249            7 NRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFP   86 (789)
Q Consensus         7 n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p   86 (789)
                      ....+..+.+++++++|++|++++|.|++. | .++.+++|++|+|++|+|++ +|  ++.+++|++|+|++|++++ +|
T Consensus        28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~  101 (457)
T 3bz5_A           28 FEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD  101 (457)
T ss_dssp             TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC
T ss_pred             cCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee
Confidence            344556666788999999999999999964 6 68999999999999999996 44  8899999999999999985 44


Q ss_pred             ccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCC
Q 041249           87 TEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL  166 (789)
Q Consensus        87 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~  166 (789)
                        ++.+++|++|++++|++++ +|  ++.+++|++|++++|++.             + ++  +..+++|+.|++++|+.
T Consensus       102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~-------------~-l~--l~~l~~L~~L~l~~n~~  160 (457)
T 3bz5_A          102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLT-------------E-ID--VSHNTQLTELDCHLNKK  160 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCS-------------C-CC--CTTCTTCCEEECTTCSC
T ss_pred             --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccc-------------e-ec--cccCCcCCEEECCCCCc
Confidence              8899999999999999986 44  777777777766666544             3 22  55666777777777754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-36  Score=325.77  Aligned_cols=254  Identities=20%  Similarity=0.244  Sum_probs=203.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+++++.++||||+++++++....     ..+
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~   81 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQY   81 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eEE
Confidence            688899999999999999999998999999999865433 23466889999999999999999999998765     889


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~D  148 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD  148 (323)
T ss_dssp             EEEECCTTEEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEcCCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEE
Confidence            999999999999998643          56899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||+++...............||..|+|||.+.+..+ +.++|||||||++|||++|+.||.........+..|.......
T Consensus       149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (323)
T 3tki_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL  228 (323)
T ss_dssp             CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS
T ss_pred             eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC
Confidence            999987654443333345679999999999987775 8899999999999999999999975443333333332211110


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .                              ........+.+++..|.+.++.+|++..++...
T Consensus       229 ~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 N------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             T------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0                              001223345578889999999999998877543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-36  Score=326.49  Aligned_cols=268  Identities=22%  Similarity=0.291  Sum_probs=206.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|++.  ++.||||++.... ........|+..+++++||||+++++++..... .....+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence            468889999999999999999986  7999999996543 334456679999999999999999999876441 123579


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC----------CCCCceecCCCCCceec
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD----------CQPITTHCDLKPSNILL  418 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~----------~~~~ivH~dlk~~Nill  418 (789)
                      +||||+.+|+|.+++...           .+++.++..++.|++.||+|||+.          +   |+||||||+||++
T Consensus        99 lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill  164 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-----------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL  164 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred             EEEecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence            999999999999999543           489999999999999999999988          6   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      +.++.+||+|||+++...............||..|+|||.+.+     ..++.++|||||||++|||++|+.||......
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            9999999999999987765544333344679999999999876     35778999999999999999999999754332


Q ss_pred             Cc-----------cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEecc
Q 041249          494 DM-----------NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDL  562 (789)
Q Consensus       494 ~~-----------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l  562 (789)
                      ..           ....+........    ..+.+.                 ..+....+...+.+++..|++.++.+|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~R  303 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKK----KRPVLR-----------------DYWQKHAGMAMLCETIEECWDHDAEAR  303 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCC-----------------GGGGSSHHHHHHHHHHHHHTCSSGGGS
T ss_pred             hccchhhhhccCCchhhhhhhhhccc----CCCCcc-----------------ccccccchHHHHHHHHHHHccCChhhC
Confidence            11           1111111111110    011111                 011223456678899999999999999


Q ss_pred             Ccccccccccccc
Q 041249          563 ESLKLAGSILPHI  575 (789)
Q Consensus       563 ~s~~~~~~~l~~l  575 (789)
                      |+..++...+..+
T Consensus       304 ps~~ell~~L~~l  316 (322)
T 3soc_A          304 LSAGCVGERITQM  316 (322)
T ss_dssp             CCHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHH
Confidence            9998876555444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-35  Score=330.51  Aligned_cols=193  Identities=19%  Similarity=0.204  Sum_probs=143.4

Q ss_pred             ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      +..+++|+.|+|++|++++..+..|..+++|++|++++|.+.+.+|..+....+|++|++++|+|+...+..|..+++|+
T Consensus       172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  251 (477)
T 2id5_A          172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR  251 (477)
T ss_dssp             HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred             hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence            44567788888888888877777788888888888888877777777666667888888888888855445778888888


Q ss_pred             EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCc
Q 041249          655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK  734 (789)
Q Consensus       655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  734 (789)
                      .|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  331 (477)
T 2id5_A          252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP  331 (477)
T ss_dssp             EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred             eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence            88888888887777788888888888888888887778888888888888888888887666777888888888888888


Q ss_pred             ccccCCcccccCCCCccEEEccCCcccccCccccc
Q 041249          735 IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSIS  769 (789)
Q Consensus       735 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  769 (789)
                      +....+..++  ...+..+.+.++......|..+.
T Consensus       332 l~c~c~~~~~--~~~~~~~~~~~~~~~C~~p~~~~  364 (477)
T 2id5_A          332 LACDCRLLWV--FRRRWRLNFNRQQPTCATPEFVQ  364 (477)
T ss_dssp             EECSGGGHHH--HTTTTSSCCTTCCCBEEESGGGT
T ss_pred             ccCccchHhH--HhhhhccccCccCceeCCchHHc
Confidence            8744333332  12233344555554434444443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.3e-34  Score=323.85  Aligned_cols=186  Identities=26%  Similarity=0.415  Sum_probs=152.7

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+..+++|++|++++|++++..+  +..+++|++|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|
T Consensus       238 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L  311 (466)
T 1o6v_A          238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNL  311 (466)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTC
T ss_pred             hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCC
Confidence            46678899999999999997655  8999999999999999996544  8899999999999999996544  8899999


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      +.|+|++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|
T Consensus       312 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n  385 (466)
T 1o6v_A          312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  385 (466)
T ss_dssp             SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCE
T ss_pred             CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCC
Confidence            999999999997765  78999999999999999964  479999999999999999998777  899999999999999


Q ss_pred             cccccCCcccc------cCCCCccEEEccCCcccc----cCcccccCCC
Q 041249          734 KIQGNIPLDYG------FTLQNLQYFSIGTNRITG----AIPPSISNAS  772 (789)
Q Consensus       734 ~l~~~ip~~~~------~~l~~L~~L~L~~N~l~~----~~~~~~~~l~  772 (789)
                      +++ .+|..+.      ..+.++..+.++.+.+++    ..|.++-+++
T Consensus       386 ~~~-~~p~~~~~~~~ip~~~~~~~~~~~~~~~is~~g~~~~~~~~w~~~  433 (466)
T 1o6v_A          386 AWT-NAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP  433 (466)
T ss_dssp             EEE-CCCBCCCSEEEEECCCBCTTSCBCCCSEESTTCEEETTEEEEECC
T ss_pred             ccc-CCchhhcccceecccccccCCCeecCceecCCcEEeCCceEECCC
Confidence            999 5565432      113344444555555543    3555555544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.8e-36  Score=332.33  Aligned_cols=213  Identities=22%  Similarity=0.266  Sum_probs=185.6

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeee
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTA  335 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~  335 (789)
                      .+.+.++..++++|...++||+|+||+||+|++..+++.||+|+++..   .......+.+|+.++..++||||++++++
T Consensus        63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345677778899999999999999999999999989999999999643   22233458899999999999999999999


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      |....     ..++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   ||||||||+|
T Consensus       143 ~~~~~-----~~~lV~Ey~~gg~L~~~l~~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~N  205 (437)
T 4aw2_A          143 FQDDN-----NLYLVMDYYVGGDLLTLLSKF---------EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDN  205 (437)
T ss_dssp             EECSS-----EEEEEECCCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred             EeeCC-----EEEEEEecCCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHH
Confidence            98766     899999999999999999642         356899999999999999999999998   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||++.++++||+|||+++........ ......||+.|+|||++.     .+.++.++|||||||++|||++|+.||..
T Consensus       206 ILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          206 ILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999876544321 223357999999999986     56799999999999999999999999973

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.7e-36  Score=322.28  Aligned_cols=250  Identities=20%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-----   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence            346899999999999999999999889999999998654  2334567889999999999999999999987665     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             EEEEEEECCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEE
Confidence            899999999999999998543          45899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcC-ccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|||+++.......   .....||+.|+|||.+.+..++ +++|||||||++|||++|+.||+..     +........
T Consensus       155 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i  226 (328)
T 3fe3_A          155 IADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKELRERV  226 (328)
T ss_dssp             ECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred             EeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence            999999987654432   2345699999999999887764 8999999999999999999999732     222222211


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ....      ..+.                      ......+.++...|.+.++..|++..++..+
T Consensus       227 ~~~~------~~~p----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          227 LRGK------YRIP----------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHCC------CCCC----------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HhCC------CCCC----------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1100      0000                      0112334577888999999999999887554

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-35  Score=319.61  Aligned_cols=201  Identities=23%  Similarity=0.296  Sum_probs=178.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      -++|...+.||+|+||.||+|....+++.||+|+++..   .......+.+|+++++.++||||+++++++....     
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-----
Confidence            36788899999999999999999989999999999654   2334567889999999999999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++.++..++.||+.||+|||+.+   |+||||||+||+++.++++|
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk  145 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEE
Confidence            899999999999999998643          46899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       146 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          146 ITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             ECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence            999999986443321  22345699999999999999999999999999999999999999973

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=321.06  Aligned_cols=201  Identities=27%  Similarity=0.386  Sum_probs=177.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      -++|...+.||+|+||.||+|....+++.||+|++...   .....+.+.+|+++++.++||||+++++++....     
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-----   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            36788999999999999999999999999999998643   2334567889999999999999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++++|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN----------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEE
Confidence            899999999999999999643          56899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |+|||+++......   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||...
T Consensus       156 L~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          156 ITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             EeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            99999999875443   2234669999999999874   35899999999999999999999999743

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-35  Score=318.98  Aligned_cols=254  Identities=19%  Similarity=0.180  Sum_probs=203.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .+.|...+.||+|+||.||+|....+++.||+|+++.....      ....+.+|++++++++||||+++++++....  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--   88 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT--   88 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence            46788999999999999999999999999999999755322      2467999999999999999999999997765  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        89 ---~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~  152 (361)
T 2yab_A           89 ---DVVLILELVSGGELFDFLAQK----------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKN  152 (361)
T ss_dssp             ---EEEEEEECCCSCBHHHHHTTC----------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTT
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCC
Confidence               899999999999999999643          46899999999999999999999998   99999999999998877


Q ss_pred             ----ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          423 ----VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       423 ----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                          .+||+|||+++.......   .....||+.|+|||.+....++.++|||||||++|+|++|+.||....     ..
T Consensus       153 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-----~~  224 (361)
T 2yab_A          153 IPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQ  224 (361)
T ss_dssp             SSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HH
T ss_pred             CCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HH
Confidence                799999999988765432   234569999999999998899999999999999999999999997321     11


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ........        .......                .........+.+++..|...++..|++..+...++
T Consensus       225 ~~~~~i~~--------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          225 ETLANITA--------VSYDFDE----------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             HHHHHHHT--------TCCCCCH----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HHHHHHHh--------cCCCCCc----------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            11111100        0000000                00012233456788899999999999998775543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-35  Score=314.32  Aligned_cols=254  Identities=21%  Similarity=0.243  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+++++.++||||+++++++....     ..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEE
Confidence            367888999999999999999999999999999987443 34567889999999999999999999997766     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC--CCceee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE--EMVSHV  426 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl  426 (789)
                      +||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.  ++.+||
T Consensus        78 lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl  145 (321)
T 1tki_A           78 MIFEFISGLDIFERINTS---------AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHTSS---------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEEeCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEE
Confidence            999999999999999643         346899999999999999999999998   999999999999987  789999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .......  
T Consensus       146 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i--  215 (321)
T 1tki_A          146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENI--  215 (321)
T ss_dssp             CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH--
T ss_pred             EECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHH--
Confidence            9999999876543   23345689999999999988899999999999999999999999973211     1111111  


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                            ........                ..........+.+++..|.+.++..|++..+...++
T Consensus       216 ------~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          216 ------MNAEYTFD----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ------HHTCCCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ------HcCCCCCC----------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence                  00000000                000112234566888899999999999998875543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-35  Score=325.30  Aligned_cols=265  Identities=20%  Similarity=0.309  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-------CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-------EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      .++|...+.||+|+||.||+|.+.       .++..||||+++.... ...+.+.+|+++++++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999874       3467899999975533 3456799999999999 899999999999765


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP  413 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~  413 (789)
                      .     ..++||||+.+|+|.+++.......      ........+++.++..++.|++.||+|||+.+   |+||||||
T Consensus       160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp  231 (370)
T 2psq_A          160 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA  231 (370)
T ss_dssp             S-----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred             C-----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccch
Confidence            5     7899999999999999997542110      00112346899999999999999999999998   99999999


Q ss_pred             CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcccc
Q 041249          414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFE  492 (789)
Q Consensus       414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~  492 (789)
                      +|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999997765443333334557889999999999999999999999999999999 9999974211


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                        ..+...+......                              .....+...+.+++..|++.++..||+..+....+
T Consensus       312 --~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L  359 (370)
T 2psq_A          312 --EELFKLLKEGHRM------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  359 (370)
T ss_dssp             --GGHHHHHHTTCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --HHHHHHHhcCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence              1122221111100                              00113344567888899999999999998875544


Q ss_pred             c
Q 041249          573 P  573 (789)
Q Consensus       573 ~  573 (789)
                      .
T Consensus       360 ~  360 (370)
T 2psq_A          360 D  360 (370)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.3e-36  Score=326.16  Aligned_cols=278  Identities=21%  Similarity=0.234  Sum_probs=213.8

Q ss_pred             ccccHHHHHHhhcCCCCCCcccccCCccEEEEEE-----cCCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccc
Q 041249          258 LNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLV  330 (789)
Q Consensus       258 ~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv  330 (789)
                      ..+...+++...++|...+.||+|+||.||+|.+     ..+++.||||+++.... ...+.+.+|++++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3456677778889999999999999999999994     44568999999976533 3456799999999999 799999


Q ss_pred             eeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCcc---------------------------------------
Q 041249          331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE---------------------------------------  371 (789)
Q Consensus       331 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------  371 (789)
                      ++++++....    ...++||||+.+|+|.+++........                                       
T Consensus        90 ~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (359)
T 3vhe_A           90 NLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS  165 (359)
T ss_dssp             CEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred             eeeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence            9999987643    247999999999999999976522100                                       


Q ss_pred             -----------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          372 -----------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       372 -----------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                                       .......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  242 (359)
T 3vhe_A          166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD  242 (359)
T ss_dssp             ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceee
Confidence                             0001223899999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249          435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV  513 (789)
Q Consensus       435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (789)
                      ..............||..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..+...+.........   
T Consensus       243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~---  318 (359)
T 3vhe_A          243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAP---  318 (359)
T ss_dssp             TTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCCCCCC---
T ss_pred             ecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCCCCCC---
Confidence            765544444445668899999999998899999999999999999998 99999743221 1122222211111000   


Q ss_pred             cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                                                 ..+...+.+++..|++.++.+||+..++...+.
T Consensus       319 ---------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          319 ---------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             ---------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence                                       112334567888999999999999987755443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.5e-35  Score=317.31  Aligned_cols=204  Identities=24%  Similarity=0.373  Sum_probs=177.7

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY  341 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  341 (789)
                      ....++|...+.||+|+||.||+|++..+++.||||+++...   ......+..|.+++..+ +||||+++++++.... 
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence            345678999999999999999999999899999999996542   33456678899999877 9999999999998766 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        92 ----~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  154 (345)
T 1xjd_A           92 ----NLFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKD  154 (345)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT
T ss_pred             ----EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCC
Confidence                899999999999999998643          46899999999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +++||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          155 GHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             SCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            9999999999986543321  23346799999999999999999999999999999999999999973

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-36  Score=331.27  Aligned_cols=259  Identities=24%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +...++|...+.||+|+||+||+|.+..+++.||||+++.... .....+.+|++++++++||||++++++|....    
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----  185 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ----  185 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC----
Confidence            3445788889999999999999999998899999999875432 33457889999999999999999999997655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+++|+|.+++...         +..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus       186 -~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~  252 (377)
T 3cbl_A          186 -PIYIVMELVQGGDFLTFLRTE---------GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVL  252 (377)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             -CcEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcE
Confidence             689999999999999998643         245899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |+.||.....  ......+..
T Consensus       253 kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~  330 (377)
T 3cbl_A          253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEK  330 (377)
T ss_dssp             EECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHT
T ss_pred             EECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999987554322111122335678999999998899999999999999999998 9999973211  111111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ....                              .....|...+.+++..|++.++.+||+...+...+.
T Consensus       331 ~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          331 GGRL------------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             TCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            1000                              001123445678889999999999999987754443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=321.65  Aligned_cols=201  Identities=27%  Similarity=0.350  Sum_probs=173.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||+||+|+...+++.||||+++..   .......+..|.+++..+ +||||+++++++....    
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----   97 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD----   97 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC----
Confidence            46899999999999999999999989999999999654   233456688899999988 7999999999998766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++++
T Consensus        98 -~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~i  163 (353)
T 3txo_A           98 -RLFFVMEFVNGGDLMFHIQKS----------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHC  163 (353)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred             -EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCE
Confidence             899999999999999998643          56899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       164 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  226 (353)
T 3txo_A          164 KLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA  226 (353)
T ss_dssp             EECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence            9999999986443321  23345799999999999888899999999999999999999999973

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.3e-35  Score=311.21  Aligned_cols=261  Identities=21%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhc--CCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS--IRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|.+  +++.||||++...   ....+..|.+++..  ++||||+++++++.... .....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence            56899999999999999999998  4899999998643   23445556666555  79999999999876532 12235


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh--------cCCCCCceecCCCCCceec
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH--------HDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivH~dlk~~Nill  418 (789)
                      .++||||+.+|+|.+++..           ..+++..+..++.|++.||+|||        ..+   |+||||||+||++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill  146 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILV  146 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEE
T ss_pred             eEEehhhccCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEE
Confidence            8999999999999999943           35899999999999999999999        666   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCcc--ceeeecccccccCcccCCCC------CcCccccchhhHHHHHHHHHh-------
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGSIGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIR-------  483 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~sfGvvl~elltG-------  483 (789)
                      +.++.+||+|||+++.........  ......||..|+|||.+...      .+++++|||||||++|||++|       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999998765544221  12234699999999998876      567899999999999999999       


Q ss_pred             ---cCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEe
Q 041249          484 ---KKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTIL  560 (789)
Q Consensus       484 ---~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l  560 (789)
                         +.||..............+......    ..+.+..                 .+....+...+.+++..|++.++.
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~  285 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQ----QRPNIPN-----------------RWFSDPTLTSLAKLMKECWYQNPS  285 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCG-----------------GGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred             ccccccccccCCCCcchhhhhHHHhccC----CCCCCCh-----------------hhccCccHHHHHHHHHHHhhcChh
Confidence               7787655444444444433222211    0111110                 111224566788999999999999


Q ss_pred             ccCccccccc
Q 041249          561 DLESLKLAGS  570 (789)
Q Consensus       561 ~l~s~~~~~~  570 (789)
                      +||+...+..
T Consensus       286 ~Rps~~~i~~  295 (301)
T 3q4u_A          286 ARLTALRIKK  295 (301)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCCCHHHHHH
Confidence            9999887744

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.6e-36  Score=317.49  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=195.6

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .++....++|...+.||+|+||+||+|.+.  ++.||||++....  ....+.+.+|++++++++||||+++++++....
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            344455678899999999999999999874  8899999986553  233467899999999999999999999987655


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+.+|+|.+++...       .....+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.
T Consensus       108 -----~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~  174 (309)
T 3p86_A          108 -----NLSIVTEYLSRGSLYRLLHKS-------GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDK  174 (309)
T ss_dssp             -----CCEEEEECCTTCBHHHHHHST-------THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECT
T ss_pred             -----ceEEEEecCCCCcHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeC
Confidence                 789999999999999999754       11234899999999999999999999874 45999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~  500 (789)
                      ++.+||+|||+++.......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||......  .....
T Consensus       175 ~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~  250 (309)
T 3p86_A          175 KYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAA  250 (309)
T ss_dssp             TCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHH
T ss_pred             CCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence            99999999999986544321  123456999999999999999999999999999999999999999732111  11111


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      +......       ..+                      ...+...+.+++..|++.++.+||+...+...+.
T Consensus       251 ~~~~~~~-------~~~----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          251 VGFKCKR-------LEI----------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             HHHSCCC-------CCC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcCCC-------CCC----------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1101000       000                      0122345668888999999999999987755443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.2e-35  Score=318.14  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=202.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||.||+|....+++.||+|++....  ....+.+.+|++++++++||||+++++++....     .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            467999999999999999999999899999999996543  234567899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC---c
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---V  423 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~---~  423 (789)
                      .++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.+.   .
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~  169 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA  169 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTC----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCC
Confidence            89999999999999998643          46899999999999999999999998   99999999999998654   5


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +||+|||++........   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..+...+..
T Consensus       170 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~  244 (362)
T 2bdw_A          170 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKA  244 (362)
T ss_dssp             EEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh
Confidence            99999999987764432   2345699999999999988999999999999999999999999963211  111111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....    ..                       ......+...+.+++..|.+.++..|++......++
T Consensus       245 ~~~~----~~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          245 GAYD----YP-----------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             TCCC----CC-----------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             CCCC----CC-----------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            1000    00                       000012234556788899999999999998776543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-35  Score=323.51  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=191.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||+||+|++.   .++..||||+++... ....+.+.+|++++++++||||+++++++....    
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK----  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence            468999999999999999999986   457789999997553 334567999999999999999999999997655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+++|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus       120 -~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  186 (373)
T 2qol_A          120 -PVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVC  186 (373)
T ss_dssp             -SCEEEEECCTTCBHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             -ceEEEEeCCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCE
Confidence             789999999999999999643         346899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      ||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |+.||....     ..+..+
T Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-----~~~~~~  261 (373)
T 2qol_A          187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIK  261 (373)
T ss_dssp             EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-----HHHHHH
T ss_pred             EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH
Confidence            99999999987654321 12223346778999999998899999999999999999998 999996321     111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      ..         +...+.                  .....+...+.+++..|++.++.+||++..+...+..
T Consensus       262 ~i---------~~~~~~------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~  306 (373)
T 2qol_A          262 AV---------DEGYRL------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK  306 (373)
T ss_dssp             HH---------HTTEEC------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH---------HcCCCC------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence            11         100000                  0011334567788999999999999999887654443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=318.64  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||+||+|.+..+   +..||||+++.. .....+.+.+|++++++++||||+++++++....     
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  123 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-----  123 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-----
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            5677789999999999999999744   445999999755 3344567999999999999999999999987655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH---------DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEE
Confidence            789999999999999999543         346899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          426 VGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |+|||+++........ .......+|..|+|||.+....++.++|||||||++|||++ |+.||.....  ......+..
T Consensus       192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~  269 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEE  269 (325)
T ss_dssp             ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHT
T ss_pred             ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHc
Confidence            9999999987654422 22233456788999999988899999999999999999999 9999963211  111111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      ....                              .....+...+.+++..|++.++.+||+...+...+..
T Consensus       270 ~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          270 GYRL------------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             TCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC------------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1000                              0011234456688899999999999999887655443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.8e-35  Score=309.89  Aligned_cols=201  Identities=23%  Similarity=0.400  Sum_probs=172.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|++.+++++||||+++++++....     .
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~   85 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-----C   85 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-----E
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-----e
Confidence            57888999999999999999999899999999985432   233567899999999999999999999987665     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl  152 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESH----------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKI  152 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence            99999999999999998643          46899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          153 FDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             CCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             EeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999999876543321 22345699999999999998999999999999999999999999973

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-35  Score=326.91  Aligned_cols=209  Identities=22%  Similarity=0.309  Sum_probs=181.8

Q ss_pred             cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeec
Q 041249          261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACS  337 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  337 (789)
                      .+.++....++|...+.||+|+||+||+|+...+++.||+|+++..   .......+.+|+++++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3456677789999999999999999999999989999999998643   2233456889999999999999999999998


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ...     ..++||||+.+|+|.+++...           .+++..+..++.|++.||+|||+.+   ||||||||+|||
T Consensus       140 ~~~-----~~~lV~E~~~gg~L~~~l~~~-----------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NIL  200 (410)
T 3v8s_A          140 DDR-----YLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNML  200 (410)
T ss_dssp             CSS-----EEEEEECCCTTEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred             ECC-----EEEEEEeCCCCCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHee
Confidence            766     899999999999999998532           4789999999999999999999998   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC----cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE----VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.++++||+|||+++....... .......||+.|+|||++....    ++.++|||||||++|||++|+.||..
T Consensus       201 l~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          201 LDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             ECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence            99999999999999987755431 1223457999999999987654    88999999999999999999999973

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-35  Score=313.27  Aligned_cols=253  Identities=17%  Similarity=0.170  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      +.|...+.||+|+||.||+|....+++.||+|+++.....      ....+.+|++++++++||||+++++++....   
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---   87 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT---   87 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence            5688899999999999999999989999999998654322      3567999999999999999999999987765   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-  422 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-  422 (789)
                        ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++ 
T Consensus        88 --~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~  152 (326)
T 2y0a_A           88 --DVILILELVAGGELFDFLAEK----------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNV  152 (326)
T ss_dssp             --EEEEEEECCCSCBHHHHHTTS----------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSS
T ss_pred             --EEEEEEEcCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCC
Confidence              899999999999999999643          56899999999999999999999998   99999999999999887 


Q ss_pred             ---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          423 ---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       423 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                         .+||+|||+++.......   .....||+.|+|||.+....++.++|||||||++|||++|+.||.....  .....
T Consensus       153 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~  227 (326)
T 2y0a_A          153 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA  227 (326)
T ss_dssp             SSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH
T ss_pred             CCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHH
Confidence               899999999988754432   2235699999999999988999999999999999999999999963211  01111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .+....         ....                  ......+...+.+++..|++.++..|++...+..++
T Consensus       228 ~~~~~~---------~~~~------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          228 NVSAVN---------YEFE------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             HHHHTC---------CCCC------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             HHHhcC---------CCcC------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            111000         0000                  000012234456788899999999999998775543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.1e-35  Score=305.41  Aligned_cols=254  Identities=20%  Similarity=0.244  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-----EEE
Confidence            57888999999999999999999899999999997543 334578999999999999999999999987765     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +|+||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  148 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD  148 (276)
T ss_dssp             EEEECCTTEEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEee
Confidence            999999999999998543          46899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.+................|+..|+|||.+....+ +.++||||||+++|||++|+.||.........+..|.......
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (276)
T 2yex_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL  228 (276)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS
T ss_pred             CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc
Confidence            999987654432222334568999999999987765 7899999999999999999999975443333333332211000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                            .                        ........+.+++..|.+.++..|++...+..+
T Consensus       229 ------~------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 ------N------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ------T------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------C------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                  0                        001223345678889999999999998877543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-34  Score=317.69  Aligned_cols=254  Identities=18%  Similarity=0.191  Sum_probs=205.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||.||+|....+++.||+|++..........+.+|++++++++||||+++++++....     ..+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-----EEE
Confidence            367899999999999999999999899999999997665556678999999999999999999999997765     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC--CCceee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE--EMVSHV  426 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl  426 (789)
                      +||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.  .+.+||
T Consensus       125 lv~E~~~gg~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL  192 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKI  192 (387)
T ss_dssp             EEEECCCCCBHHHHTTCT---------TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEE
T ss_pred             EEEEcCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEE
Confidence            999999999999998643         346899999999999999999999998   999999999999974  478999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH-hC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM-AL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~-~~  505 (789)
                      +|||+++.......   .....||..|+|||++....++.++|||||||++|||++|+.||.....  ......+.. .+
T Consensus       193 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~  267 (387)
T 1kob_A          193 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDW  267 (387)
T ss_dssp             CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCC
T ss_pred             EecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC
Confidence            99999998765432   2345699999999999999999999999999999999999999973211  111111111 00


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .      .++..                      .......+.+++..|++.++..|++...+..++
T Consensus       268 ~------~~~~~----------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          268 E------FDEDA----------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             C------CCSST----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             C------CCccc----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence            0      00000                      012234566888999999999999998775543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.9e-35  Score=320.53  Aligned_cols=201  Identities=24%  Similarity=0.308  Sum_probs=176.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||+||+|+...+++.||+|+++...   ......+..|..++.++ +||||+++++++....    
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----  126 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----  126 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence            467889999999999999999999999999999997542   23345688899999887 8999999999998766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|..++...          ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++++
T Consensus       127 -~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~i  192 (396)
T 4dc2_A          127 -RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHI  192 (396)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred             -EEEEEEEcCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCE
Confidence             899999999999999998643          46899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       193 kL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          193 KLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             EECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             EEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            9999999986433221  23346799999999999999999999999999999999999999964

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-35  Score=312.00  Aligned_cols=197  Identities=25%  Similarity=0.353  Sum_probs=176.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|+...+++.||+|+++...   ......+.+|+.+++.++||||+++++++....     .
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----Q   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----E
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-----E
Confidence            57888999999999999999999899999999996542   234567889999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++++||
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL  147 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKS----------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI  147 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHT----------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEE
Confidence            99999999999999999643          46899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       148 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          148 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            999999876542     2235699999999999999999999999999999999999999973

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.4e-35  Score=314.59  Aligned_cols=248  Identities=19%  Similarity=0.270  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|.+..+++.||||++...   .......+.+|+++++.++||||+++++++....     .
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~   83 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-----D   83 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            5788899999999999999999889999999998643   2233467899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+ +|++.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl  149 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEK----------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI  149 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEE
T ss_pred             EEEEEECC-CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEE
Confidence            99999999 68999888543          46899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||++........   .....||+.|+|||.+.+..+ ++++|||||||++|||++|+.||+......           
T Consensus       150 ~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------  215 (336)
T 3h4j_B          150 ADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------  215 (336)
T ss_dssp             CCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------
T ss_pred             EEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------
Confidence            99999987655432   223569999999999988776 789999999999999999999997432110           


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                        -...+......                    ........+.+++..|.+.++..|++..+...++
T Consensus       216 --~~~~i~~~~~~--------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          216 --LFKKVNSCVYV--------------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             --CBCCCCSSCCC--------------------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             --HHHHHHcCCCC--------------------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence              00000000000                    0001223455788899999999999998876544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=307.43  Aligned_cols=253  Identities=18%  Similarity=0.229  Sum_probs=194.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--------------------------hhhHHHHHHHHHHh
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--------------------------RASRSFIAECRALR  322 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  322 (789)
                      .++|...+.||+|+||.||+|....+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3678889999999999999999998999999999865421                          12356889999999


Q ss_pred             cCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 041249          323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC  402 (789)
Q Consensus       323 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~  402 (789)
                      +++||||+++++++....   ....++||||+.+|+|.+++.           ...+++.++..++.|++.||+|||+.+
T Consensus        92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~  157 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLHYQK  157 (298)
T ss_dssp             TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999987532   237899999999999988653           246899999999999999999999998


Q ss_pred             CCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC---cCccccchhhHHHHHH
Q 041249          403 QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLE  479 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~sfGvvl~e  479 (789)
                         |+||||||+||+++.++.+||+|||+++.......  ......||..|+|||.+....   ++.++|||||||++||
T Consensus       158 ---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          158 ---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             ---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred             ---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence               99999999999999999999999999987654432  123456999999999987765   4789999999999999


Q ss_pred             HHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeE
Q 041249          480 LIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTI  559 (789)
Q Consensus       480 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~  559 (789)
                      |++|+.||...     ....+......... ..  +.                       ...+...+.+++..|++.++
T Consensus       233 l~~g~~pf~~~-----~~~~~~~~~~~~~~-~~--~~-----------------------~~~~~~~l~~li~~~l~~dp  281 (298)
T 2zv2_A          233 FVFGQCPFMDE-----RIMCLHSKIKSQAL-EF--PD-----------------------QPDIAEDLKDLITRMLDKNP  281 (298)
T ss_dssp             HHHSSCSSCCS-----SHHHHHHHHHHCCC-CC--CS-----------------------SSCCCHHHHHHHHHHTCSCT
T ss_pred             HHHCCCCCCCc-----cHHHHHHHHhcccC-CC--CC-----------------------ccccCHHHHHHHHHHhhcCh
Confidence            99999999732     11111111100000 00  00                       00123345678889999999


Q ss_pred             eccCcccccccc
Q 041249          560 LDLESLKLAGSI  571 (789)
Q Consensus       560 l~l~s~~~~~~~  571 (789)
                      .+|++..++..+
T Consensus       282 ~~R~s~~e~l~h  293 (298)
T 2zv2_A          282 ESRIVVPEIKLH  293 (298)
T ss_dssp             TTSCCHHHHTTC
T ss_pred             hhCCCHHHHhcC
Confidence            999998876443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=324.96  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++|...+.||+|+||+||+|.+.     .+++.||||+++.. .......+..|+.++++++||||+++++++....  
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence            467888999999999999999954     45778999999654 3344567899999999999999999999987655  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++....   ........+++.++..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus       148 ---~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          148 ---PRFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHHS---CCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSS
T ss_pred             ---CCEEEEEeCCCCCHHHHHHhhc---cccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCC
Confidence               6799999999999999997541   11223456899999999999999999999998   99999999999999544


Q ss_pred             ---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHH
Q 041249          423 ---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLH  498 (789)
Q Consensus       423 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~  498 (789)
                         .+||+|||+++...............||..|+|||.+.+..++.++|||||||++|||++ |+.||.....  ..+.
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~  296 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVL  296 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred             CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence               599999999986543332222334557899999999988899999999999999999998 9999973211  1111


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      ..+......                              .....+...+.+++..|++.++.+||+...+...+..+
T Consensus       297 ~~i~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          297 EFVTSGGRM------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCC------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111111000                              00112334566888999999999999998886555443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-35  Score=314.05  Aligned_cols=274  Identities=24%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||+||+|.+    ..+++.||||++........+.+.+|++++++++||||+++++++...+   .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence            35788889999999999999994    5578999999998766666788999999999999999999999985432   1


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV  153 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC---------GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEE
T ss_pred             CceEEEEEeCCCCCHHHHHHhc---------ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeE
Confidence            2479999999999999999643         245899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+....      ..+.+.
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~------~~~~~~  227 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRM  227 (295)
T ss_dssp             EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH------HHHHHH
T ss_pred             EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh------HHHHhh
Confidence            99999999987654422 22223457778999999998899999999999999999999999986321      111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...........         ..... ......+......+...+.+++..|++.++.+||+..++...+.
T Consensus       228 ~~~~~~~~~~~---------~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          228 IGNDKQGQMIV---------FHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HCTTCCTHHHH---------HHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hcCccccchhH---------HHHHH-HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            11000000000         00000 00000001112245566778999999999999999988755443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.3e-36  Score=325.45  Aligned_cols=270  Identities=16%  Similarity=0.240  Sum_probs=204.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEeccccchh-----------hHHHHHHHHHHhcCCCCccce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHHHRA-----------SRSFIAECRALRSIRHRNLVK  331 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~  331 (789)
                      ..++|...+.||+|+||+||+|.+..+     ++.||||++.......           ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999999754     5789999986543211           123445666778889999999


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      +++++.... .+....++||||+ +|+|.+++...         ...+++.++..|+.|++.||+|||+.+   |+||||
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDl  178 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEAN---------AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDI  178 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecC
Confidence            999987642 2223689999999 89999998643         356899999999999999999999998   999999


Q ss_pred             CCCceecC--CCCceeeCcccccccCCCCCCc-----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhc
Q 041249          412 KPSNILLD--EEMVSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK  484 (789)
Q Consensus       412 k~~Nill~--~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~  484 (789)
                      ||+|||++  .++.+||+|||+++........     .......||..|+|||++.+..++.++|||||||++|||++|+
T Consensus       179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  258 (364)
T 3op5_A          179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH  258 (364)
T ss_dssp             CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999  8899999999999877543311     1123345999999999999999999999999999999999999


Q ss_pred             CCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCc
Q 041249          485 KPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLES  564 (789)
Q Consensus       485 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s  564 (789)
                      .||...... .....+.+......+.+..++.+..                     ..+...+.+++..|++.++.+||+
T Consensus       259 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~  316 (364)
T 3op5_A          259 LPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPL  316 (364)
T ss_dssp             CTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             CCccccccC-HHHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCC
Confidence            999843222 2233333333222233333322210                     123456778888999999999999


Q ss_pred             ccccccccc
Q 041249          565 LKLAGSILP  573 (789)
Q Consensus       565 ~~~~~~~l~  573 (789)
                      .......+.
T Consensus       317 ~~~l~~~l~  325 (364)
T 3op5_A          317 YENLRDILL  325 (364)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            887754443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.7e-35  Score=324.58  Aligned_cols=255  Identities=18%  Similarity=0.211  Sum_probs=202.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|....+++.||+|++....  ....+.+.+|++++++++||||+++++++....     .
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-----H   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-----E
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-----E
Confidence            467889999999999999999999999999999997553  234567899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---CCCc
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---EEMV  423 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~---~~~~  423 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++   +++.
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~----------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~  151 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAR----------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAA  151 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCC
T ss_pred             EEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCc
Confidence            99999999999999988643          56899999999999999999999998   99999999999998   4678


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +||+|||++........  ......||+.|+|||.+....++.++|||||||++|+|++|+.||....  ...+...+..
T Consensus       152 vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~  227 (444)
T 3soa_A          152 VKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKA  227 (444)
T ss_dssp             EEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred             EEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHh
Confidence            99999999987765432  1234569999999999999899999999999999999999999996321  1111111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ...    +...+                       ....+...+.+++..|.+.++.+|++..++..++
T Consensus       228 ~~~----~~~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          228 GAY----DFPSP-----------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             TCC----CCCTT-----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             CCC----CCCcc-----------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            100    00000                       0012234456788899999999999998876544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.9e-35  Score=317.87  Aligned_cols=256  Identities=18%  Similarity=0.206  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +.|...+.||+|+||+||+|....+++.||||++....     ....+.+.+|+++++.++||||+++++++....    
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----   99 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG----   99 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----
Confidence            56888999999999999999999899999999986432     123577999999999999999999999988765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc-
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV-  423 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~-  423 (789)
                       ..++||||+.+|+|.+++...      ......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++. 
T Consensus       100 -~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~  169 (351)
T 3c0i_A          100 -MLYMVFEFMDGADLCFEIVKR------ADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENS  169 (351)
T ss_dssp             -EEEEEEECCSSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTT
T ss_pred             -EEEEEEeCCCCCCHHHHHHHh------cccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCC
Confidence             899999999999998887532      112345899999999999999999999998   999999999999986654 


Q ss_pred             --eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          424 --SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       424 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                        +||+|||+++.......  ......||+.|+|||.+....++.++|||||||++|||++|+.||....+  ..+....
T Consensus       170 ~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~  245 (351)
T 3c0i_A          170 APVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGII  245 (351)
T ss_dssp             CCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHH
T ss_pred             CcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHH
Confidence              99999999988765432  12345699999999999998999999999999999999999999974211  0011111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      +.....            ..                .........+.+++..|++.++..|++...+..+
T Consensus       246 ~~~~~~------------~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 KGKYKM------------NP----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HTCCCC------------CH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCCC------------Cc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            100000            00                0001223456678889999999999998877543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6e-35  Score=316.82  Aligned_cols=253  Identities=20%  Similarity=0.217  Sum_probs=186.9

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..+.|...+.||+|+||.||+|.+..+++.||||+++...  ..+.+.+|++++++++||||+++++++....     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----EI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-----eE
Confidence            4578999999999999999999999889999999987443  3467889999999999999999999997765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~  424 (789)
                      ++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.   ++.+
T Consensus       124 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~  190 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEK----------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL  190 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTC----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCE
Confidence            9999999999999998643          45899999999999999999999998   999999999999975   8899


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.......
T Consensus       191 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~  267 (349)
T 2w4o_A          191 KIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE  267 (349)
T ss_dssp             EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred             EEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence            999999998765432   12345689999999999998999999999999999999999999964322111111111100


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .     ....+.                       ..+....+.+++..|.+.++..|++......+
T Consensus       268 ~-----~~~~~~-----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          268 Y-----YFISPW-----------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             C-----CCCTTT-----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C-----ccCCch-----------------------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     000000                       01223345688889999999999999877543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-35  Score=318.08  Aligned_cols=257  Identities=22%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceE----EEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT----VTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||+|+||+||+|.+..+++.    ||+|.++... ....+.+.+|++++++++||||++++++|...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            35788899999999999999998766654    5888775432 34457899999999999999999999999753    


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++|+||+.+|+|.+++...         ...+++..+..|+.|++.||+|||+.+   |+||||||+||+++.++.
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~  155 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHS---------TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred             --CeEEEEEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCC
Confidence              478999999999999998643         356899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.||+....  ..+...+.
T Consensus       156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~  233 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE  233 (327)
T ss_dssp             EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH
T ss_pred             EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHH
Confidence            99999999998766554444445567889999999999999999999999999999999 9999974321  12222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      .....                              .....+...+.+++..|++.++.+||++..+...+..+
T Consensus       234 ~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          234 KGERL------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             TTCCC------------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             cCCCC------------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11100                              00112334566888899999999999998875544433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-35  Score=322.61  Aligned_cols=213  Identities=21%  Similarity=0.276  Sum_probs=184.9

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeee
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTA  335 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~  335 (789)
                      .+.+.+.....++|...+.||+|+||+||+|+...+++.||+|+++..   .......+.+|++++..++||||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            345667777889999999999999999999999989999999999643   22234568899999999999999999999


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      +....     ..++||||+.+|+|.+++...         +..+++..+..++.|++.||+|||+.+   ||||||||+|
T Consensus       130 ~~~~~-----~~~lVmE~~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~N  192 (412)
T 2vd5_A          130 FQDEN-----YLYLVMEYYVGGDLLTLLSKF---------GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDN  192 (412)
T ss_dssp             EECSS-----EEEEEECCCCSCBHHHHHHHH---------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred             EeeCC-----EEEEEEcCCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHH
Confidence            98766     899999999999999999642         246899999999999999999999998   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCC-------CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-------GSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ||++.++++||+|||+++........ ......||+.|+|||++.       ...++.++|||||||++|||++|+.||.
T Consensus       193 ILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  271 (412)
T 2vd5_A          193 ILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY  271 (412)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             eeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence            99999999999999999887654321 122357999999999987       4578999999999999999999999997


Q ss_pred             c
Q 041249          489 I  489 (789)
Q Consensus       489 ~  489 (789)
                      .
T Consensus       272 ~  272 (412)
T 2vd5_A          272 A  272 (412)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-34  Score=309.65  Aligned_cols=206  Identities=27%  Similarity=0.428  Sum_probs=162.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||+||+|....+++.||+|+++.... .....+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-----KL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-----EE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-----eE
Confidence            4689999999999999999999998999999999975533 33567889999999999999999999987655     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+. |+|.+++....    .......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRT----VGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHH----SSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEecC-CCHHHHHHhcc----ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence            99999999 69998885431    1123356899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.++.......  ......||..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999987654321  12234689999999998764 589999999999999999999999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.8e-35  Score=314.68  Aligned_cols=258  Identities=19%  Similarity=0.257  Sum_probs=202.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||+||+|....+++.||||++.....  ...+..|+++++++ +||||+++++++....     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-----YN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-----EE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-----cc
Confidence            4688999999999999999999988999999999865432  34688999999999 9999999999988765     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc----
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV----  423 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~----  423 (789)
                      ++||||+ +|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.    
T Consensus        81 ~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~  147 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLC---------DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQ  147 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTT
T ss_pred             EEEEEeC-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCc
Confidence            9999999 89999998643         356899999999999999999999998   999999999999998887    


Q ss_pred             -eeeCcccccccCCCCCCcc-----ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249          424 -SHVGDFGLARFLPPTHVQT-----SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL  497 (789)
Q Consensus       424 -~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~  497 (789)
                       +||+|||+++.........     ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....+  ..
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~  225 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL  225 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence             9999999999765443211     123467999999999999999999999999999999999999999743211  11


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhch-hHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNN-IIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ....+.....                       ... .+... ...+. .+.+++..|++.++.+||+...+...+.
T Consensus       226 ~~~~~~i~~~-----------------------~~~-~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          226 KERYQKIGDT-----------------------KRA-TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHHHHH-----------------------HHH-SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHhh-----------------------hcc-CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            1111110000                       000 00000 01123 6778889999999999999887755443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-34  Score=314.40  Aligned_cols=201  Identities=22%  Similarity=0.295  Sum_probs=177.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|....+++.||+|+++..   .......+..|.+++..+ +||+|+++++++....    
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----   94 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----   94 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS----
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC----
Confidence            46899999999999999999999988999999999654   223456788999999988 8999999999998766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++++
T Consensus        95 -~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~v  160 (353)
T 2i0e_A           95 -RLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHI  160 (353)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred             -EEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcE
Confidence             899999999999999998643          45899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       161 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          161 KIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             EECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence            9999999986443221  23345799999999999999999999999999999999999999973

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=317.08  Aligned_cols=249  Identities=22%  Similarity=0.219  Sum_probs=195.3

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeec
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEF  353 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  353 (789)
                      ..+.||+|+||.||+|....+++.||+|+++.......+.+.+|++++++++||||+++++++....     ..++||||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~E~  167 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVMEY  167 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEEC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEeC
Confidence            3568999999999999999899999999998766566778999999999999999999999998765     89999999


Q ss_pred             cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec--CCCCceeeCcccc
Q 041249          354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL--DEEMVSHVGDFGL  431 (789)
Q Consensus       354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl  431 (789)
                      +.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+|||+  ++++.+||+|||+
T Consensus       168 ~~~~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~  235 (373)
T 2x4f_A          168 VDGGELFDRIIDE---------SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGL  235 (373)
T ss_dssp             CTTCEEHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred             CCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCC
Confidence            9999999988533         246899999999999999999999998   9999999999999  6778999999999


Q ss_pred             cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249          432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD  511 (789)
Q Consensus       432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  511 (789)
                      ++.......   .....||+.|+|||++....++.++|||||||++|||++|+.||..... ...+..+....+...   
T Consensus       236 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~---  308 (373)
T 2x4f_A          236 ARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLE---  308 (373)
T ss_dssp             CEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCSC---
T ss_pred             ceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC---
Confidence            998765442   2234599999999999988999999999999999999999999973211 011111111111100   


Q ss_pred             hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                        +                       .........+.+++..|.+.++..|++..+...+
T Consensus       309 --~-----------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          309 --D-----------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             --S-----------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --h-----------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0                       0011223456688899999999999998877543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-34  Score=312.04  Aligned_cols=257  Identities=20%  Similarity=0.287  Sum_probs=197.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-------
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-------  341 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------  341 (789)
                      ++|...+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            57888999999999999999999899999999997543 3346789999999999999999999999865431       


Q ss_pred             ---------------------------------------------CCCceEEEEeeccCCCChhhhccCCCCCccccCCC
Q 041249          342 ---------------------------------------------QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAP  376 (789)
Q Consensus       342 ---------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  376 (789)
                                                                   ......++||||+.+|+|.+++...       ...
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~  158 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-------CSL  158 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-------CSG
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-------cCc
Confidence                                                         1122479999999999999999765       223


Q ss_pred             CCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCc----------cceee
Q 041249          377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ----------TSSIG  446 (789)
Q Consensus       377 ~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~  446 (789)
                      ...++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........          .....
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence            44577789999999999999999998   999999999999999999999999999987655321          12233


Q ss_pred             ecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHH
Q 041249          447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAI  526 (789)
Q Consensus       447 ~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  526 (789)
                      ..||..|+|||.+.+..++.++|||||||++|||++|..|+...       .......        ......        
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~--------~~~~~~--------  292 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDV--------RNLKFP--------  292 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHH--------HTTCCC--------
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHh--------hccCCC--------
Confidence            56999999999999989999999999999999999988775411       1111100        000000        


Q ss_pred             hhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          527 ISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                                 .........+.+++..|++.++.+||+..++..
T Consensus       293 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          293 -----------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             -----------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             -----------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                       011122334567888999999999999887644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.4e-35  Score=314.93  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceE----EEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTT----VTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||+||+|.+..+++.    ||+|.+.... ......+.+|+.++++++||||+++++++...     
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-----   87 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-----
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            5788889999999999999999767665    7888775432 33346688899999999999999999998532     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++|+||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        88 -~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~  154 (325)
T 3kex_A           88 -SLQLVTQYLPLGSLLDHVRQH---------RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQV  154 (325)
T ss_dssp             -SEEEEEECCTTCBSHHHHHSS---------GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCE
T ss_pred             -ccEEEEEeCCCCCHHHHHHHc---------cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeE
Confidence             589999999999999998643         246889999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+++...............|+..|+|||.+....++.++|||||||++|||++ |+.||.....  ......+..
T Consensus       155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~  232 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEK  232 (325)
T ss_dssp             EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHT
T ss_pred             EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHc
Confidence            9999999998876654444455678889999999998899999999999999999999 9999974321  122222221


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      ........                              .+...+.+++..|++.++.+||+...+...+..+
T Consensus       233 ~~~~~~~~------------------------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          233 GERLAQPQ------------------------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             TCBCCCCT------------------------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCC------------------------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11110111                              1222344678899999999999998876554433

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-34  Score=312.51  Aligned_cols=200  Identities=25%  Similarity=0.313  Sum_probs=176.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||.||+|+...+++.||+|+++...   ......+..|++++.++ +||||+++++++....     
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-----   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-----
Confidence            57888999999999999999999899999999997542   23356688899999988 8999999999998765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++++|
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~k  150 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIK  150 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEE
Confidence            899999999999999998643          46899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       151 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          151 LTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             ECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            999999986433221  23345799999999999998999999999999999999999999964

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-35  Score=318.28  Aligned_cols=272  Identities=23%  Similarity=0.332  Sum_probs=207.5

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeee
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTAC  336 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  336 (789)
                      .++....++|...+.||+|+||.||+|.+.     .+++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344556789999999999999999999997     3458999999975533 3457799999999999999999999999


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCc--------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED--------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDC  402 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~  402 (789)
                      ....     ..++||||+.+|+|.+++.......              ........+++.++..++.|++.||+|||+.+
T Consensus       120 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  194 (343)
T 1luf_A          120 AVGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  194 (343)
T ss_dssp             CSSS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCC-----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            7655     7899999999999999997531100              00111367899999999999999999999998


Q ss_pred             CCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249          403 QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII  482 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt  482 (789)
                         |+||||||+||+++.++.+||+|||+++...............+|..|+|||.+....++.++||||||+++|||++
T Consensus       195 ---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          195 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence               99999999999999999999999999987654433223334568899999999988889999999999999999999


Q ss_pred             -hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEec
Q 041249          483 -RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILD  561 (789)
Q Consensus       483 -G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~  561 (789)
                       |+.||....     ..+...........     ..                      ...+...+.+++..|++.++.+
T Consensus       272 ~g~~p~~~~~-----~~~~~~~~~~~~~~-----~~----------------------~~~~~~~l~~li~~~l~~~p~~  319 (343)
T 1luf_A          272 YGLQPYYGMA-----HEEVIYYVRDGNIL-----AC----------------------PENCPLELYNLMRLCWSKLPAD  319 (343)
T ss_dssp             TTCCTTTTSC-----HHHHHHHHHTTCCC-----CC----------------------CTTCCHHHHHHHHHHTCSSGGG
T ss_pred             cCCCcCCCCC-----hHHHHHHHhCCCcC-----CC----------------------CCCCCHHHHHHHHHHcccCccc
Confidence             999997321     11111111110000     00                      0123345668888999999999


Q ss_pred             cCccccccccccc
Q 041249          562 LESLKLAGSILPH  574 (789)
Q Consensus       562 l~s~~~~~~~l~~  574 (789)
                      ||+...+...+..
T Consensus       320 Rps~~~~~~~L~~  332 (343)
T 1luf_A          320 RPSFCSIHRILQR  332 (343)
T ss_dssp             SCCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHH
Confidence            9999877554443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-35  Score=336.46  Aligned_cols=261  Identities=23%  Similarity=0.345  Sum_probs=209.2

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      +.+...++|...+.||+|+||+||+|.+..++..||||+++.... ..+.+.+|++++++++||||++++++|....   
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---  289 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP---  289 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCC---
Confidence            344556778889999999999999999998899999999975432 3578999999999999999999999997665   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus       290 --~~~lv~E~~~~g~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~  356 (495)
T 1opk_A          290 --PFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHL  356 (495)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             --cEEEEEEccCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCc
Confidence              789999999999999999653        2356899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||.....  ..+.+.+.
T Consensus       357 ~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~  433 (495)
T 1opk_A          357 VKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE  433 (495)
T ss_dssp             EEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHH
T ss_pred             EEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH
Confidence            99999999998754331 11223446788999999988899999999999999999999 9999874321  11222221


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      .....                              .....|...+.+++..|++.++.+||++..+...+..
T Consensus       434 ~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~  475 (495)
T 1opk_A          434 KDYRM------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  475 (495)
T ss_dssp             TTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cCCCC------------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            11100                              0111344567788899999999999999887554443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-34  Score=314.43  Aligned_cols=197  Identities=24%  Similarity=0.314  Sum_probs=176.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|+...+++.||+|+++...   ......+.+|+++++.++||||+++++++....     .
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----N  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----E
Confidence            57888999999999999999999899999999986442   234567889999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++++||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL  182 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEE
Confidence            99999999999999999643          45899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++......     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       183 ~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          183 TDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             CCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence            9999998765432     235699999999999998999999999999999999999999973

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=315.31  Aligned_cols=246  Identities=22%  Similarity=0.198  Sum_probs=189.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||++.....  ........|+..+.++ +||||++++++|....     .
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-----~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-----E
Confidence            578889999999999999999998999999999864422  2334455566666555 8999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+ +|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl  198 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAW---------GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKL  198 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHH---------CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEE
T ss_pred             EEEEEecc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEE
Confidence            99999999 57898888543         346899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||++........   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+...       ..|...   
T Consensus       199 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~---  264 (311)
T 3p1a_A          199 GDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQQL---  264 (311)
T ss_dssp             CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHHHH---
T ss_pred             ccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHH---
Confidence            99999987654432   233559999999998765 7999999999999999999997766421       111110   


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                            ......                  ......+...+.+++..|.+.++.+|++..++...
T Consensus       265 ------~~~~~~------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          265 ------RQGYLP------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ------TTTCCC------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------hccCCC------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                  000000                  00011233456688889999999999998876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-35  Score=314.47  Aligned_cols=207  Identities=23%  Similarity=0.377  Sum_probs=169.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||+++....   .....+.+|++++++++||||+++++++...... ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA-GP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT-EE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC-Cc
Confidence            3678889999999999999999988999999999975532   2345789999999999999999999998654311 12


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEE
T ss_pred             ccEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEE
Confidence            459999999999999998643          46899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++........ .......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999877654322 223345689999999999988999999999999999999999999963

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.2e-34  Score=302.39  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh-------hHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-------SRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||+||+|.+..+++.||+|++.......       .+.+.+|++++++++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            468888999999999999999999899999999986543221       167899999999999999999999986533 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                            ++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+ ++++||||||+||+++.+
T Consensus        97 ------~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~  160 (287)
T 4f0f_A           97 ------RMVMEFVPCGDLYHRLLDK---------AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSL  160 (287)
T ss_dssp             ------EEEEECCTTCBHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCC
T ss_pred             ------eEEEEecCCCCHHHHHhcc---------cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEecc
Confidence                  7999999999999888643         356899999999999999999999874 459999999999999877


Q ss_pred             Cc-----eeeCcccccccCCCCCCccceeeecccccccCcccCC--CCCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249          422 MV-----SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL--GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD  494 (789)
Q Consensus       422 ~~-----~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~  494 (789)
                      +.     +||+|||+++.....     .....||..|+|||.+.  ...+++++|||||||++|||++|+.||.......
T Consensus       161 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          161 DENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            76     999999999854432     23456899999999984  4568999999999999999999999997543322


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ............       .+.+                      ...+...+.+++..|++.++.+||+...+..
T Consensus       236 ~~~~~~~~~~~~-------~~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          236 IKFINMIREEGL-------RPTI----------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHHHHSCC-------CCCC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCC-------CCCC----------------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            222222211110       0111                      1123345668888999999999999887643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.1e-34  Score=307.14  Aligned_cols=250  Identities=20%  Similarity=0.206  Sum_probs=179.9

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEEEeec
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKALVYEF  353 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~  353 (789)
                      .+.||+|+||+||+|.+..+++.||||++...   ....+.+|++++..+. ||||+++++++....     ..++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-----~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-----HTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----EEEEEEEc
Confidence            57899999999999999989999999998533   3467788999999996 999999999998765     88999999


Q ss_pred             cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC---ceeeCccc
Q 041249          354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFG  430 (789)
Q Consensus       354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg  430 (789)
                      +.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++   .+||+|||
T Consensus        88 ~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           88 LNGGELFERIKKK----------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             CCSCBHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             cCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccc
Confidence            9999999999643          56899999999999999999999998   99999999999997665   89999999


Q ss_pred             ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC--CccHHHHHHHhCCCc
Q 041249          431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG--DMNLHNFARMALPDH  508 (789)
Q Consensus       431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~  508 (789)
                      +++........  .....||..|+|||.+....++.++|||||||++|||++|+.||......  .....+........ 
T Consensus       155 ~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-  231 (325)
T 3kn6_A          155 FARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-  231 (325)
T ss_dssp             TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-
T ss_pred             cceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-
Confidence            99876554321  23356899999999999999999999999999999999999999753221  11222222211111 


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                             .....                ..........+.+++..|.+.++.+|++...+..+
T Consensus       232 -------~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          232 -------DFSFE----------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -------CCCCC----------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -------CCCCC----------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                   11000                00011234456688889999999999999887544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-34  Score=327.93  Aligned_cols=204  Identities=25%  Similarity=0.386  Sum_probs=180.6

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ..++|...+.||+|+||.||+|....+++.||+|++...   .......+.+|++++++++||||+++++++....    
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----  257 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----  257 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC----
Confidence            356789999999999999999999989999999999643   2333566889999999999999999999998765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...        ....+++..+..++.||+.||+|||+.+   ||||||||+|||++.++++
T Consensus       258 -~l~lVmEy~~gg~L~~~l~~~--------~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~v  325 (576)
T 2acx_A          258 -ALCLVLTLMNGGDLKFHIYHM--------GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI  325 (576)
T ss_dssp             -EEEEEECCCCSCBHHHHHHSS--------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             -EEEEEEEcCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCe
Confidence             899999999999999998654        2345899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       326 KL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          326 RISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             EECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             EEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            9999999988765432   23457999999999999989999999999999999999999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-34  Score=314.60  Aligned_cols=213  Identities=26%  Similarity=0.330  Sum_probs=186.2

Q ss_pred             ccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-----CCc
Q 041249          254 INSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-----HRN  328 (789)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~n  328 (789)
                      .+....+++.+.....++|...+.||+|+||+||+|.+..+++.||||+++.. ....+.+..|+++++.+.     |||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            34567788888888889999999999999999999999889999999998643 234556788999999986     999


Q ss_pred             cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCcee
Q 041249          329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH  408 (789)
Q Consensus       329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH  408 (789)
                      |+++++++...+     ..++||||+ +++|.+++...        ....+++.++..++.|++.||+|||+.+   |||
T Consensus        98 iv~~~~~~~~~~-----~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH  160 (360)
T 3llt_A           98 IVKYHGKFMYYD-----HMCLIFEPL-GPSLYEIITRN--------NYNGFHIEDIKLYCIEILKALNYLRKMS---LTH  160 (360)
T ss_dssp             BCCEEEEEEETT-----EEEEEECCC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             eecccceeeECC-----eeEEEEcCC-CCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence            999999998766     899999999 89999999654        2345899999999999999999999998   999


Q ss_pred             cCCCCCceecCC-------------------------CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC
Q 041249          409 CDLKPSNILLDE-------------------------EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE  463 (789)
Q Consensus       409 ~dlk~~Nill~~-------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  463 (789)
                      |||||+|||++.                         ++.+||+|||+++......     ....||..|+|||++.+..
T Consensus       161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~  235 (360)
T 3llt_A          161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLG  235 (360)
T ss_dssp             SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCC
T ss_pred             CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCC
Confidence            999999999976                         7899999999998755432     2356899999999999999


Q ss_pred             cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          464 VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       464 ~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.++|||||||++|||++|+.||..
T Consensus       236 ~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          236 WDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCccchHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=310.52  Aligned_cols=278  Identities=18%  Similarity=0.221  Sum_probs=209.0

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.|...+.||+|+||+||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++....   ....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence            56888899999999999999999889999999997543 334567889999999999999999999986543   23679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCce
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVS  424 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~  424 (789)
                      +||||+.+|+|.+++...       .....+++.++..++.|++.||+|||+.+   |+||||||+||++    +.++.+
T Consensus        86 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             EEEECCTTCBHHHHHHSG-------GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred             EEEeCCCCCCHHHHHHHh-------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence            999999999999999754       12234899999999999999999999998   9999999999999    888899


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCC--------CCCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL--------GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                      ||+|||+++.......   .....||..|+|||.+.        ...++.++|||||||++|||++|+.||.........
T Consensus       156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9999999998765442   22356899999999875        567899999999999999999999999754322221


Q ss_pred             --HHHHHHHhCCCchhh-h---ccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          497 --LHNFARMALPDHVMD-I---VDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       497 --~~~~~~~~~~~~~~~-~---~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                        ...-+....+..... +   ....+....          ...............+.++...|.+.+|..|++..+...
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~  302 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSG----------DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEES----------SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCc----------cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence              111122222221111 1   110110000          000001122345566778899999999999999988755


Q ss_pred             ccc
Q 041249          571 ILP  573 (789)
Q Consensus       571 ~l~  573 (789)
                      .+.
T Consensus       303 h~~  305 (319)
T 4euu_A          303 ETS  305 (319)
T ss_dssp             HHH
T ss_pred             ccH
Confidence            543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6.9e-33  Score=311.05  Aligned_cols=150  Identities=23%  Similarity=0.253  Sum_probs=117.3

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|||++|++++ +| +++.+++|++|++++|+|++. |  ++.+++|++|+|++|+|++. |  ++.+++|++|+|++|+
T Consensus        46 ~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~  117 (457)
T 3bz5_A           46 SLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNK  117 (457)
T ss_dssp             EEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSC
T ss_pred             EEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCc
Confidence            48999999996 46 799999999999999999964 5  89999999999999999964 4  8999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCC---------CccceeecCCcccCCCchhhhc
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVF---------QGLTILDLSRNKLSGEIPEFLV  151 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~---------~~l~~l~ls~N~l~~~~p~~~~  151 (789)
                      +++ +|  ++.+++|++|++++|++++ +|  ++.+++|++|++++|+.         +.|+.|++++|++++ +|  +.
T Consensus       118 l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~  188 (457)
T 3bz5_A          118 LTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VS  188 (457)
T ss_dssp             CSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CT
T ss_pred             CCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cc
Confidence            995 65  8999999999999999996 43  78888888888877732         224445555555543 22  44


Q ss_pred             CcccccEEecccCCCC
Q 041249          152 GLKVIENLNLSYNDLE  167 (789)
Q Consensus       152 ~~~~l~~l~ls~N~~~  167 (789)
                      .+++|+.|++++|+++
T Consensus       189 ~l~~L~~L~l~~N~l~  204 (457)
T 3bz5_A          189 QNKLLNRLNCDTNNIT  204 (457)
T ss_dssp             TCTTCCEEECCSSCCS
T ss_pred             cCCCCCEEECcCCcCC
Confidence            4444455555544444

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.5e-35  Score=314.50  Aligned_cols=273  Identities=21%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCce---EEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeee
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTAC  336 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  336 (789)
                      ++++....++|...+.||+|+||+||+|.+..++.   .||||+++..  .....+.+.+|++++++++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34455567889999999999999999999876654   8999999755  344567899999999999999999999998


Q ss_pred             ccCCCCC-CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          337 SGVDYQG-NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       337 ~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      ......+ ....++||||+.+|+|.+++....    .......+++.++..++.|++.||+|||+.+   |+||||||+|
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~N  167 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASR----IGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARN  167 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHH----C---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhh----ccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcce
Confidence            7654211 112489999999999999986431    1112336899999999999999999999998   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCC
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGD  494 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~  494 (789)
                      |+++.++.+||+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....  
T Consensus       168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--  245 (323)
T 3qup_A          168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--  245 (323)
T ss_dssp             EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--
T ss_pred             EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--
Confidence            9999999999999999988765553333444557889999999988899999999999999999999 8999974321  


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ......+......        .                      ....+...+.+++..|++.++.+||+.......+.
T Consensus       246 ~~~~~~~~~~~~~--------~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          246 AEIYNYLIGGNRL--------K----------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             GGHHHHHHTTCCC--------C----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC--------C----------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111111111000        0                      01123345668889999999999999877654444

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-35  Score=316.43  Aligned_cols=270  Identities=20%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACS  337 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  337 (789)
                      .+...++|...+.||+|+||.||+|.+.     .+++.||||+++.. .......+.+|++++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4455688999999999999999999972     35678999999754 234457899999999999 8999999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCc-------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCC
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED-------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQP  404 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~  404 (789)
                      ...     ..++||||+++|+|.+++......-             ........+++..+..++.|++.||+|||+.+  
T Consensus       120 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  192 (344)
T 1rjb_A          120 LSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--  192 (344)
T ss_dssp             SSS-----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eCC-----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            755     7899999999999999997642110             00011245899999999999999999999998  


Q ss_pred             CceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-h
Q 041249          405 ITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-R  483 (789)
Q Consensus       405 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G  483 (789)
                       |+||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |
T Consensus       193 -ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          193 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             -cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence             99999999999999999999999999987765544333444567889999999988899999999999999999998 9


Q ss_pred             cCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccC
Q 041249          484 KKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLE  563 (789)
Q Consensus       484 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~  563 (789)
                      +.||...... ..+...++......        .                      ...+...+.+++..|++.++..||
T Consensus       272 ~~p~~~~~~~-~~~~~~~~~~~~~~--------~----------------------~~~~~~~l~~li~~~l~~dp~~Rp  320 (344)
T 1rjb_A          272 VNPYPGIPVD-ANFYKLIQNGFKMD--------Q----------------------PFYATEEIYIIMQSCWAFDSRKRP  320 (344)
T ss_dssp             CCSSTTCCCS-HHHHHHHHTTCCCC--------C----------------------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCcccCCcH-HHHHHHHhcCCCCC--------C----------------------CCCCCHHHHHHHHHHcCCCchhCc
Confidence            9999743211 12222222111100        0                      012234566788899999999999


Q ss_pred             cccccccccc
Q 041249          564 SLKLAGSILP  573 (789)
Q Consensus       564 s~~~~~~~l~  573 (789)
                      +...+...+.
T Consensus       321 s~~~l~~~l~  330 (344)
T 1rjb_A          321 SFPNLTSFLG  330 (344)
T ss_dssp             CHHHHHHHHH
T ss_pred             CHHHHHHHHH
Confidence            9987755443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-34  Score=303.53  Aligned_cols=273  Identities=21%  Similarity=0.236  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||+++....  .....+.+|++++++++||||+++++++....     ..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EE
Confidence            467888999999999999999998999999999975432  33477889999999999999999999998765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+ ++.+.+...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~  143 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSC---------NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCC-CHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence            999999986 555555322         356899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.++.......  ......||..|+|||.+.+.. ++.++|||||||++|||++|..|+.........+....+....
T Consensus       144 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~  221 (292)
T 3o0g_A          144 NFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             CCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            9999987654332  123356899999999988766 8999999999999999999998875332222222222222111


Q ss_pred             Cc--hhhhc----cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DH--VMDIV----DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~--~~~~~----d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..  .+...    +........         ...............+.+++..|.+.++..|++..++..+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          222 PTEEQWPSMTKLPDYKPYPMYP---------ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCC---------TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChhhhhhhccccccccccccc---------CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            10  10000    000000000         0000000111234456688889999999999998877543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.3e-34  Score=307.20  Aligned_cols=276  Identities=21%  Similarity=0.216  Sum_probs=199.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|.+. +++.||+|+++....  .....+.+|++++++++||||+++++++....     .
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-----C   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-----C
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-----E
Confidence            367888999999999999999996 689999999865432  23467889999999999999999999987655     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+. |++.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        94 ~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl  160 (311)
T 3niz_A           94 LTLVFEFME-KDLKKVLDEN---------KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL  160 (311)
T ss_dssp             EEEEEECCS-EEHHHHHHTC---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEcCCC-CCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEE
Confidence            899999999 4788877543         345899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+++.......  ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+.......-
T Consensus       161 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~  237 (311)
T 3niz_A          161 ADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILG  237 (311)
T ss_dssp             CCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHC
T ss_pred             ccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHC
Confidence            99999987654332  1233468999999999876 56899999999999999999999999754322 22222222111


Q ss_pred             CCc---hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDH---VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~---~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...   .....+....... .+.    ......+......+..++.+++..|.+.++..|++..++..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          238 TPNPREWPQVQELPLWKQR-TFQ----VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCCTTTSGGGTTSHHHHSC-CCC----CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCChHHhhhhhccchhhhc-ccc----cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            110   1111000000000 000    000000000111233456788899999999999999877543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.7e-35  Score=303.14  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=202.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++.+++||||+++++++....     ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   78 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-----PI   78 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----ce
Confidence            4567888999999999999999887 677899999975433 3467899999999999999999999987655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+++|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~  146 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH---------GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVS  146 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEEC
T ss_pred             EEEEEccCCCcHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEc
Confidence            9999999999999998643         345899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.+......... ......++..|+|||.+....++.++||||||+++|||++ |+.||+....     .........
T Consensus       147 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~  220 (268)
T 3sxs_A          147 DFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----SEVVLKVSQ  220 (268)
T ss_dssp             CTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHT
T ss_pred             cCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----HHHHHHHHc
Confidence            99999877655422 1223446778999999988889999999999999999999 9999973211     111111100


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      ..  ....+                         ..+...+.+++..|++.++..||+.......+..+
T Consensus       221 ~~--~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          221 GH--RLYRP-------------------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             TC--CCCCC-------------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CC--CCCCC-------------------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            00  00000                         01223456788899999999999998875555443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-34  Score=315.91  Aligned_cols=209  Identities=14%  Similarity=0.145  Sum_probs=175.9

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEE-----EcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC---CCccceeeeee
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGV-----LDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR---HRNLVKVFTAC  336 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~  336 (789)
                      +....++|...+.||+|+||+||+|.     ...+++.||||+++..   ....+..|++++.+++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            33456789999999999999999994     4567899999998644   3456777888888776   99999999999


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCce
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI  416 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Ni  416 (789)
                      ...+     ..++||||+.+|+|.+++...     .......+++.++..|+.|++.||+|||+.+   ||||||||+||
T Consensus       137 ~~~~-----~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NI  203 (365)
T 3e7e_A          137 LFQN-----GSVLVGELYSYGTLLNAINLY-----KNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNF  203 (365)
T ss_dssp             ECSS-----CEEEEECCCCSCBHHHHHHHH-----HTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGE
T ss_pred             ecCC-----CcEEEEeccCCCcHHHHHHHh-----hcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHE
Confidence            8766     789999999999999999642     0112456999999999999999999999988   99999999999


Q ss_pred             ecCC-----------CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcC
Q 041249          417 LLDE-----------EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK  485 (789)
Q Consensus       417 ll~~-----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~  485 (789)
                      |++.           ++.+||+|||+|+...............||..|+|||++.+..++.++|||||||++|||+||+.
T Consensus       204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  283 (365)
T 3e7e_A          204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY  283 (365)
T ss_dssp             EECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             EecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence            9998           89999999999976543333333445679999999999999999999999999999999999999


Q ss_pred             CCCc
Q 041249          486 PSDI  489 (789)
Q Consensus       486 P~~~  489 (789)
                      ||..
T Consensus       284 pf~~  287 (365)
T 3e7e_A          284 MKVK  287 (365)
T ss_dssp             CCEE
T ss_pred             cccc
Confidence            9964

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-34  Score=300.28  Aligned_cols=251  Identities=22%  Similarity=0.225  Sum_probs=201.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .+.|...+.||+|+||+||+|.+..++..||+|.+........+.+.+|++++++++||||+++++++....     ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----DIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----eEE
Confidence            356888999999999999999999899999999997766666788999999999999999999999998765     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---CCCCcee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSH  425 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~k  425 (789)
                      +||||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||++   +.++.+|
T Consensus        83 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~  149 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK----------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLK  149 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEeccCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEE
Confidence            999999999999988543          45899999999999999999999998   9999999999999   7889999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||.+........   .....||..|+|||.+.+ .++.++||||||+++|||++|+.||......  .....+....
T Consensus       150 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~  223 (277)
T 3f3z_A          150 LIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGT  223 (277)
T ss_dssp             ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred             EEecccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC
Confidence            999999987664432   233568999999998764 5999999999999999999999999742111  1111111000


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                                 ....                ......+...+.+++..|.+.++..|++......
T Consensus       224 -----------~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 -----------FTFP----------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----------CCCC----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----------CCCC----------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       0000                0000123345668888999999999999887644

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.4e-34  Score=323.26  Aligned_cols=206  Identities=25%  Similarity=0.395  Sum_probs=180.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|+...+++.||+|++....   ......+..|++++++++||||+++++++....     
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-----  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----
Confidence            468888999999999999999999899999999996442   233467889999999999999999999988765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++....      .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++++|
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEE
Confidence            8999999999999999986541      12356899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |+|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       330 L~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          330 ISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             ECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             EeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            9999999987654321  23357999999999999989999999999999999999999999753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-34  Score=309.37  Aligned_cols=265  Identities=23%  Similarity=0.299  Sum_probs=205.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ..++|...+.||+|+||.||+|.+.     .+++.||||+++... ....+.+.+|++++++++||||+++++++.... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-
Confidence            4567888999999999999999983     456899999997543 334577899999999999999999999987655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCc--------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCce
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNRED--------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT  407 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv  407 (789)
                          ..++||||+.+|+|.+++.......              ........+++.++..++.|++.||+|||+.+   |+
T Consensus       100 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv  172 (314)
T 2ivs_A          100 ----PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV  172 (314)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ----ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence                7899999999999999997542100              00012245899999999999999999999998   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKP  486 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P  486 (789)
                      ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987765543333334557889999999988889999999999999999999 9999


Q ss_pred             CCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          487 SDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                      |.....  ..+...+......        ..                      ...+...+.+++..|++.++.+||+..
T Consensus       253 ~~~~~~--~~~~~~~~~~~~~--------~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          253 YPGIPP--ERLFNLLKTGHRM--------ER----------------------PDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             STTCCG--GGHHHHHHTTCCC--------CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCH--HHHHHHhhcCCcC--------CC----------------------CccCCHHHHHHHHHHccCChhhCcCHH
Confidence            974321  1122222211110        00                      012334566888999999999999988


Q ss_pred             cccccc
Q 041249          567 LAGSIL  572 (789)
Q Consensus       567 ~~~~~l  572 (789)
                      .+...+
T Consensus       301 ~l~~~l  306 (314)
T 2ivs_A          301 DISKDL  306 (314)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            775443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=310.65  Aligned_cols=243  Identities=23%  Similarity=0.294  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--------hhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--------RASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .++|...+.||+|+||+||+|.+..+++.||||+++....        .....+.+|++++++++||||+++++++....
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4678999999999999999999998999999999975431        13346788999999999999999999997765


Q ss_pred             CCCCceEEEEeeccCCC-ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          341 YQGNDFKALVYEFMQNG-SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                           ..++||||+..| +|.+++...          ..+++..+..++.|++.||+|||..+   |+||||||+||+++
T Consensus       103 -----~~~lv~e~~~~g~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  164 (335)
T 3dls_A          103 -----FFQLVMEKHGSGLDLFAFIDRH----------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIA  164 (335)
T ss_dssp             -----EEEEEEECCTTSCBHHHHHHTC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred             -----EEEEEEEeCCCCccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEc
Confidence                 889999999877 999998644          46899999999999999999999998   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                      .++.+||+|||+++.......   .....||..|+|||.+.+..+ +.++|||||||++|||++|+.||....+      
T Consensus       165 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------  235 (335)
T 3dls_A          165 EDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------  235 (335)
T ss_dssp             TTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------
T ss_pred             CCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------
Confidence            999999999999998765442   234569999999999988776 8899999999999999999999973211      


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                                   ........                    ...+...+.+++..|++.++..|++...+...
T Consensus       236 -------------~~~~~~~~--------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -------------TVEAAIHP--------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -------------GTTTCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -------------HHhhccCC--------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         11110000                    00122345678889999999999998877554

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-34  Score=303.22  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=200.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++....     ..+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceE
Confidence            467888999999999999999997 578899999975432 3467899999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D  149 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD  149 (269)
T ss_dssp             EEEECCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC
T ss_pred             EEEEeCCCCcHHHHHHhc---------CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecc
Confidence            999999999999999643         346899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||....     ...........
T Consensus       150 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----~~~~~~~~~~~  223 (269)
T 4hcu_A          150 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTG  223 (269)
T ss_dssp             TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTT
T ss_pred             cccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhcC
Confidence            999987654321 11223446778999999988899999999999999999999 999997321     11111111000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                           ..+..                      ...+...+.+++..|++.++.+||+.......+.
T Consensus       224 -----~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          224 -----FRLYK----------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             -----CCCCC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----ccCCC----------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence                 00000                      0012234567888999999999999887754433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-34  Score=304.73  Aligned_cols=258  Identities=16%  Similarity=0.210  Sum_probs=203.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||.||+|....+++.||||++....  ....+.+|++.++++ +|+|++++++++....     ..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-----ee
Confidence            467889999999999999999998899999999985432  345688999999999 7999999999987665     88


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc----
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV----  423 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~----  423 (789)
                      ++||||+ +++|.+++...         +..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.    
T Consensus        82 ~lv~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEEec-CCCHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCC
Confidence            9999999 89999999643         345899999999999999999999988   999999999999987765    


Q ss_pred             -eeeCcccccccCCCCCCc-----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCc--
Q 041249          424 -SHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM--  495 (789)
Q Consensus       424 -~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~--  495 (789)
                       +||+|||.++........     .......||..|+|||.+.+..++.++||||||+++|||++|+.||........  
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence             999999999987654321     123345699999999999999999999999999999999999999975322110  


Q ss_pred             cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          496 NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .+........+....                           .....+...+.+++..|++.++.+||+...+...+.
T Consensus       229 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          229 KYERIGEKKQSTPLR---------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHHHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHhhccCccHH---------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            011111100000000                           001123456778889999999999999987755444

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=306.23  Aligned_cols=283  Identities=24%  Similarity=0.235  Sum_probs=202.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-----hhhHHHHHHHHHHhcCC---CCccceeeeeeccC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-----RASRSFIAECRALRSIR---HRNLVKVFTACSGV  339 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  339 (789)
                      .+++|...+.||+|+||+||+|.+..+++.||||+++....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            46789999999999999999999988999999999864422     12346777887777764   99999999999775


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      ........++||||+. |+|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+||+++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA--------PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVT  154 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC--------CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEc
Confidence            5334445799999998 6999998754        2345899999999999999999999998   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                      .++.+||+|||.++.......   .....||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~  230 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGK  230 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHH
T ss_pred             CCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            999999999999987654432   23456899999999999999999999999999999999999999743211 11112


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ......... .+.+..........+  ..  ...........+....+.+++..|.+.++..|++..++..+
T Consensus       231 i~~~~~~~~-~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          231 IFDLIGLPP-EDDWPRDVSLPRGAF--PP--RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHCCCC-TTTSCSSCSSCGGGS--CC--CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCCCC-hhhccchhhcccccc--CC--CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            211111000 000000000000000  00  00000000111234556688889999999999999877543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-34  Score=305.34  Aligned_cols=258  Identities=26%  Similarity=0.359  Sum_probs=188.9

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ...+.|...+.||+|+||+||+|.+.   ..||+|+++...  ....+.+.+|++++++++||||+++++++...     
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   92 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-----   92 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC-----
Confidence            34568899999999999999999875   359999987553  33457799999999999999999999976432     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+++|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        93 -~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~  159 (289)
T 3og7_A           93 -QLAIVTQWCEGSSLYHHLHAS---------ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTV  159 (289)
T ss_dssp             -SCEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             -ccEEEEEecCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCE
Confidence             579999999999999998643         356899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      ||+|||+++...............||..|+|||.+.   ...++.++||||||+++|||++|+.||...... ......+
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~  238 (289)
T 3og7_A          160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMV  238 (289)
T ss_dssp             EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHH
T ss_pred             EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHh
Confidence            999999998765443333334456999999999886   567899999999999999999999999743221 1122222


Q ss_pred             HHhC-CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          502 RMAL-PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       502 ~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .... .......                           ...+...+.+++..|++.++.+||+.......+.
T Consensus       239 ~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          239 GRGSLSPDLSKV---------------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             HHTSCCCCTTSS---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccccCcchhhc---------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1111 1100000                           1133456678889999999999999887754433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=316.75  Aligned_cols=268  Identities=21%  Similarity=0.327  Sum_probs=208.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC-------CceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeecc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSG  338 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  338 (789)
                      ..++|...+.||+|+||+||+|.+..       .++.||||+++.... .....+.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            45688889999999999999999742       346899999975533 3457799999999999 99999999999977


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      ..     ..++||||+.+|+|.+++.......      ........+++.++..|+.|++.||+|||+.+   |+|||||
T Consensus       147 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk  218 (382)
T 3tt0_A          147 DG-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA  218 (382)
T ss_dssp             SS-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             CC-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence            65     7899999999999999997542110      01122356999999999999999999999998   9999999


Q ss_pred             CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccc
Q 041249          413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMF  491 (789)
Q Consensus       413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~  491 (789)
                      |+||+++.++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.||... 
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-  297 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-  297 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Confidence            9999999999999999999998765543333444567889999999999999999999999999999999 99998632 


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          ...+..+......     .+.                      ....+...+.+++..|++.++.+||+..++...
T Consensus       298 ----~~~~~~~~~~~~~-----~~~----------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 ----PVEELFKLLKEGH-----RMD----------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ----CHHHHHHHHHTTC-----CCC----------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CHHHHHHHHHcCC-----CCC----------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                1122211111100     000                      011233456688889999999999999888655


Q ss_pred             cccc
Q 041249          572 LPHI  575 (789)
Q Consensus       572 l~~l  575 (789)
                      +..+
T Consensus       347 L~~~  350 (382)
T 3tt0_A          347 LDRI  350 (382)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-34  Score=308.65  Aligned_cols=273  Identities=22%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcC---CceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeee
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTAC  336 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~  336 (789)
                      +.++....++|...+.||+|+||.||+|.+..   +++.||+|+++...  ....+.+.+|++++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34455567788899999999999999998864   45689999987553  33456799999999999999999999998


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCce
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI  416 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Ni  416 (789)
                      ......+....++||||+.+|+|.+++.....    ......+++.++..++.|++.||.|||+.+   |+||||||+||
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI  178 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL----ETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC  178 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTB----TTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGE
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhh----hcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence            87653333456999999999999999853311    123467999999999999999999999988   99999999999


Q ss_pred             ecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCc
Q 041249          417 LLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDM  495 (789)
Q Consensus       417 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~  495 (789)
                      +++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....  .
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~  256 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--H  256 (313)
T ss_dssp             EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--G
T ss_pred             EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--H
Confidence            999999999999999987765443333344567889999999998899999999999999999999 8899864321  1


Q ss_pred             cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          496 NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .....+......        .                      ....+...+.+++..|++.++..||+.......+.
T Consensus       257 ~~~~~~~~~~~~--------~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          257 EMYDYLLHGHRL--------K----------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             GHHHHHHTTCCC--------C----------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHcCCCC--------C----------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            122211111100        0                      01123345668888999999999999887755443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.6e-34  Score=315.82  Aligned_cols=207  Identities=21%  Similarity=0.204  Sum_probs=178.4

Q ss_pred             hhcCCCCCCccccc--CCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTG--SFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ..++|...+.||+|  +||+||+|.+..+++.||||+++...  ....+.+.+|++++++++||||+++++++....   
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN---   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC---
Confidence            35678899999999  99999999999899999999997553  334567888999999999999999999998766   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus       100 --~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~  166 (389)
T 3gni_B          100 --ELWVVTSFMAYGSAKDLICTH--------FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGK  166 (389)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHT--------CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred             --EEEEEEEccCCCCHHHHHhhh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence              899999999999999998643        2345899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCC-----ccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          424 SHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +||+|||.+........     ........||..|+|||.+.+  ..++.++|||||||++|||++|+.||...
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999998876533221     111223468899999999987  57999999999999999999999999743

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-34  Score=324.52  Aligned_cols=252  Identities=24%  Similarity=0.317  Sum_probs=200.7

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      +...++|...+.||+|+||+||+|.+.  ++.||||+++...  ..+.+.+|++++++++||||+++++++....    .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  260 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G  260 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----S
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----C
Confidence            345678888999999999999999986  7899999997543  4578999999999999999999999986543    2


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+|
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~k  329 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAK  329 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH--------CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEE
Confidence            589999999999999999643        2334789999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|||+++......     ....++..|+|||.+....++.++|||||||++|||++ |+.||......  .....+...
T Consensus       330 l~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~  402 (450)
T 1k9a_A          330 VSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG  402 (450)
T ss_dssp             ECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTT
T ss_pred             EeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC
Confidence            99999998654322     12356789999999999999999999999999999998 99999743211  122221111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...                              .....|...+.+++..|++.++.+||+.......+.
T Consensus       403 ~~~------------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          403 YKM------------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             CCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC------------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            100                              011134556778899999999999999987754443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-34  Score=313.84  Aligned_cols=201  Identities=26%  Similarity=0.327  Sum_probs=167.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHH-HhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRA-LRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|+...+++.||+|+++...   ......+..|..+ ++.++||||+++++++....    
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~----  112 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----  112 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence            467889999999999999999999899999999996543   2233456667776 57789999999999998766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...          ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++++
T Consensus       113 -~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~i  178 (373)
T 2r5t_A          113 -KLYFVLDYINGGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHI  178 (373)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             -EEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCE
Confidence             899999999999999998643          46888999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       179 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          179 VLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             EECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            9999999986433221  22345799999999999999999999999999999999999999973

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-34  Score=305.77  Aligned_cols=252  Identities=26%  Similarity=0.356  Sum_probs=190.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|.+.  ++.||||.+...  ...+.+.+|++++++++||||+++++++.+       ..+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~   75 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC   75 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence            356788899999999999999986  789999998633  345789999999999999999999998863       368


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc-eeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV-SHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~  427 (789)
                      +||||+.+|+|.+++...       .....+++..++.++.|+++||+|||+.+...|+||||||+||+++.++. +||+
T Consensus        76 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~  148 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGA-------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC  148 (307)
T ss_dssp             EEEECCTTCBHHHHHHCS-------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEEcCCCCCHHHHHhcc-------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence            999999999999999754       12235788999999999999999999943334999999999999988876 7999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||.+.......     ....||..|+|||.+.+..++.++||||||+++|||++|+.||+.................  
T Consensus       149 Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--  221 (307)
T 2eva_A          149 DFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--  221 (307)
T ss_dssp             CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--
T ss_pred             cccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--
Confidence            999997654322     2345899999999999999999999999999999999999999743221111111111000  


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                            .+..                      ...+...+.+++..|++.++.+||+...+...+.
T Consensus       222 ------~~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          222 ------RPPL----------------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             ------CCCC----------------------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCc----------------------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence                  0000                      0122344667888999999999999887754443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-34  Score=325.91  Aligned_cols=201  Identities=24%  Similarity=0.293  Sum_probs=167.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|....+++.||||+++..   .......+.+|+++++.++||||+++++++....     
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence            46789999999999999999999999999999999644   2333466788999999999999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCce
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~  288 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHI  288 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCE
T ss_pred             EEEEEEeeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCE
Confidence            899999999999999998543          468999999999999999999997 77   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       289 kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          289 KITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            9999999986543321  22346799999999999999999999999999999999999999963

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.2e-34  Score=320.39  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|.+..+++.||||+++...   ......+.+|+++++.++||||+++++++....     .
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~   90 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-----D   90 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----E
Confidence            57888999999999999999999899999999996442   223467899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL  157 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKN----------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKI  157 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSS----------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEE
Confidence            99999999999999999643          46899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+++.......   .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+...     .....+...
T Consensus       158 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~  229 (476)
T 2y94_A          158 ADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKKIC  229 (476)
T ss_dssp             CCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHHHH
T ss_pred             Eeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHh
Confidence            99999998765432   223569999999999988765 789999999999999999999997321     111111111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .        .....                    .......+.+++..|.+.++..|++...+..++
T Consensus       230 ~--------~~~~~--------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          230 D--------GIFYT--------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             T--------TCCCC--------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             c--------CCcCC--------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence            1        00000                    001123455778889999999999998776543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4e-34  Score=300.37  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=197.8

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +.++|...+.||+|+||+||+|.+..+++.||+|++....   ......+.+|++++++++||||+++++++....    
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   82 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC----
Confidence            4568889999999999999999999899999999985432   223567899999999999999999999997765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        83 -~~~lv~e~~~~~~l~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           83 -RVYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             -EEEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCE
T ss_pred             -EEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCE
Confidence             789999999999999998643          45899999999999999999999888   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||++.......    .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...     ......+..
T Consensus       149 ~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~  219 (279)
T 3fdn_A          149 KIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRI  219 (279)
T ss_dssp             EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred             EEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----cHHHHHHHH
Confidence            999999987654433    22356899999999999989999999999999999999999999732     111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..      ......                      ......+.+++..|.+.++.+||+..++..+
T Consensus       220 ~~------~~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          220 SR------VEFTFP----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HH------TCCCCC----------------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             Hh------CCCCCC----------------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00      000000                      0122345577889999999999998877554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-35  Score=328.64  Aligned_cols=263  Identities=22%  Similarity=0.361  Sum_probs=207.7

Q ss_pred             cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      ...+.+...++|...+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++.. .
T Consensus       179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~  255 (454)
T 1qcf_A          179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E  255 (454)
T ss_dssp             CTTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C
Confidence            34455667788999999999999999999997 57889999997543 346789999999999999999999999852 2


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+.+|+|.+++...        ....+++.++..++.|+|.||+|||+.+   |+||||||+|||++.
T Consensus       256 -----~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~  319 (454)
T 1qcf_A          256 -----PIYIITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSA  319 (454)
T ss_dssp             -----SCEEEECCCTTCBHHHHHHSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECT
T ss_pred             -----ccEEEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECC
Confidence                 579999999999999999643        2235788999999999999999999998   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~  499 (789)
                      ++.+||+|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||.....  .....
T Consensus       320 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~  396 (454)
T 1qcf_A          320 SLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIR  396 (454)
T ss_dssp             TCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH
T ss_pred             CCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence            99999999999987654321 11123346788999999988899999999999999999999 9999973211  11111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      .+......                              .....|...+.+++..|++.++.+||++..+...+..+
T Consensus       397 ~i~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          397 ALERGYRM------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             HHHHTCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHcCCCC------------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11111100                              00113455677889999999999999998876555443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.5e-34  Score=316.43  Aligned_cols=254  Identities=19%  Similarity=0.225  Sum_probs=192.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--------hhhHHHHHHHHHHhcCCCCccceeeeeeccC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--------RASRSFIAECRALRSIRHRNLVKVFTACSGV  339 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  339 (789)
                      ..++|...+.||+|+||+||+|....+++.||||++.....        .....+.+|++++++++||||+++++++...
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            35789999999999999999999999999999999865421        1123588999999999999999999997532


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                            ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++
T Consensus       213 ------~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~  273 (419)
T 3i6u_A          213 ------DYYIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS  273 (419)
T ss_dssp             ------EEEEEEECCTTCBGGGGTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEES
T ss_pred             ------ceEEEEEcCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEe
Confidence                  579999999999999988643          56899999999999999999999998   99999999999997


Q ss_pred             CC---CceeeCcccccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          420 EE---MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       420 ~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      .+   +.+||+|||+++......   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||......
T Consensus       274 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          274 SQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             cCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            54   459999999999875433   2234569999999999863   56899999999999999999999999743221


Q ss_pred             CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       ..+...+.........+                           ........+.+++..|.+.++.+|++......+
T Consensus       351 -~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          351 -VSLKDQITSGKYNFIPE---------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -CCHHHHHHTTCCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHHHHHhcCCCCCCch---------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             22222222111100000                           001223456688889999999999999877544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.5e-34  Score=299.50  Aligned_cols=253  Identities=20%  Similarity=0.264  Sum_probs=201.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....  ......+.+|++++++++||||+++++++....     .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-----E
Confidence            468899999999999999999999899999999996543  234567889999999999999999999997665     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc---
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV---  423 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~---  423 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.   
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~  146 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA  146 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCc
Confidence            89999999999999888543          46899999999999999999999998   999999999999986655   


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +||+|||.+........   .....||..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ......+..
T Consensus       147 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~  221 (284)
T 3kk8_A          147 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKA  221 (284)
T ss_dssp             EEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHh
Confidence            99999999987765432   2235689999999999999999999999999999999999999963211  111111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ....    ...+                       ....+...+.+++..|.+.++.+||+..+...+
T Consensus       222 ~~~~----~~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          222 GAYD----YPSP-----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TCCC----CCTT-----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cccc----CCch-----------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1000    0000                       001223445678889999999999999887554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6e-34  Score=305.50  Aligned_cols=253  Identities=19%  Similarity=0.181  Sum_probs=202.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .+.|...+.||+|+||.||+|....+++.||+|+++.....      ....+.+|++++++++||||+++++++....  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence            35788899999999999999999989999999998654322      3567999999999999999999999987765  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++
T Consensus        89 ---~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~  152 (321)
T 2a2a_A           89 ---DVVLILELVSGGELFDFLAQK----------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKN  152 (321)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHTC----------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTT
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCC
Confidence               899999999999999999643          46889999999999999999999998   99999999999999887


Q ss_pred             ----ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          423 ----VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       423 ----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                          .+||+|||++........   .....||..|+|||.+....++.++||||||+++|||++|+.||....     ..
T Consensus       153 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~  224 (321)
T 2a2a_A          153 IPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQ  224 (321)
T ss_dssp             SSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HH
T ss_pred             CCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-----HH
Confidence                799999999987765432   233568999999999998899999999999999999999999996321     11


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .........        .....                ..........+.+++..|.+.++..|++......+
T Consensus       225 ~~~~~i~~~--------~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          225 ETLANITSV--------SYDFD----------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHHHHHHTT--------CCCCC----------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhc--------ccccC----------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111111000        00000                00001223456688889999999999999877554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-34  Score=298.82  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=180.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|....+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-----   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-----
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-----
Confidence            357888999999999999999998899999999986442   223467899999999999999999999987765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+++|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~k  152 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK  152 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence            889999999999999998643         356899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||.+.........  .....||..|+|||...+..++.++||||||+++|||++|+.||.......     ......
T Consensus       153 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~  225 (278)
T 3cok_A          153 IADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNKVV  225 (278)
T ss_dssp             ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC
T ss_pred             EEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHHHh
Confidence            9999999876543321  223568999999999998889999999999999999999999997432110     000000


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .      .+....                      ......+.+++..|++.++.+||+...+..+
T Consensus       226 ~------~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          226 L------ADYEMP----------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             S------SCCCCC----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             h------cccCCc----------------------cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            0      000000                      0122345678889999999999998877543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-35  Score=315.03  Aligned_cols=254  Identities=19%  Similarity=0.271  Sum_probs=191.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCC--CccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRH--RNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~  343 (789)
                      ..+.|...+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++.+++|  +||+++++++....   
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~---   82 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---   82 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC---
Confidence            3467888999999999999999986 68999999986543  3335778999999999976  99999999988765   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||| +.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++ ++.
T Consensus        83 --~~~lv~e-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~  145 (343)
T 3dbq_A           83 --YIYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGM  145 (343)
T ss_dssp             --EEEEEEC-CCSEEHHHHHHHS----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTE
T ss_pred             --EEEEEEe-CCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCc
Confidence              8999999 5678999999643          56899999999999999999999998   99999999999997 578


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCC-----------CCcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----------SEVSTNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      +||+|||+++...............||+.|+|||++..           ..++.++|||||||++|||++|+.||.....
T Consensus       146 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  225 (343)
T 3dbq_A          146 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  225 (343)
T ss_dssp             EEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence            99999999998765554333445679999999999754           6789999999999999999999999974322


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .   .....         .+.++.......                  ..+...+.+++..|++.++..|++...+..++
T Consensus       226 ~---~~~~~---------~~~~~~~~~~~~------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          226 Q---ISKLH---------AIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             H---HHHHH---------HHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             H---HHHHH---------HHhcCCcccCCc------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            1   11111         111111111000                  01123455788899999999999998875543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-34  Score=305.95  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=208.6

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      +.+...++|...+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++....   
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   82 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP---   82 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC---
Confidence            44456788999999999999999999999889999999996543 34567899999999999999999999987655   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        83 --~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~  149 (288)
T 3kfa_A           83 --PFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHL  149 (288)
T ss_dssp             --SEEEEEECCTTEEHHHHHHHC--------CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGC
T ss_pred             --CEEEEEEcCCCCcHHHHHHhc--------ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCC
Confidence              789999999999999999653        3356899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||.+........ .......++..|+|||.+....++.++||||||+++|+|++ |+.||.....  ......+.
T Consensus       150 ~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~  226 (288)
T 3kfa_A          150 VKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE  226 (288)
T ss_dssp             EEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHH
T ss_pred             EEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh
Confidence            99999999998765432 22234457789999999988899999999999999999999 9999874321  11222221


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ......                              ....+...+.+++..|.+.++..||+...+...+
T Consensus       227 ~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l  266 (288)
T 3kfa_A          227 KDYRME------------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF  266 (288)
T ss_dssp             TTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCCCC------------------------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence            111100                              0112334566888899999999999998775443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.1e-34  Score=301.36  Aligned_cols=254  Identities=20%  Similarity=0.246  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|.....||+|+||.||+|.+..+++.||||.+........+.+.+|+++++.++||||+++++++....     ..++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEEE
Confidence            45666779999999999999999899999999998766666788999999999999999999999997765     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~D  428 (789)
                      ||||+.+++|.+++...       .....+++..+..++.|++.||+|||+.+   ++||||||+||+++. ++.+||+|
T Consensus        97 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~D  166 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSK-------WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISD  166 (295)
T ss_dssp             EEECCSEEEHHHHHHHT-------TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECC
T ss_pred             EEEeCCCCCHHHHHHhh-------ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEee
Confidence            99999999999998643       12345678899999999999999999998   999999999999987 89999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      ||.+........  ......|+..|+|||.+....  ++.++||||||+++|||++|+.||.................  
T Consensus       167 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  242 (295)
T 2clq_A          167 FGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--  242 (295)
T ss_dssp             TTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--
T ss_pred             cccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--
Confidence            999987654321  122356899999999987654  88999999999999999999999963211110110000000  


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                            ..+.+.                      ..+...+.+++..|++.++-.||+......
T Consensus       243 ------~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 ------VHPEIP----------------------ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ------CCCCCC----------------------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ------cccccc----------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  011111                      122345567888999999999999887643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-34  Score=300.62  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=188.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc----hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH----RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|.+.  ++.||||+++....    ...+.+.+|+++++.++||||+++++++....    
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   79 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP----   79 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----
Confidence            467888999999999999999985  88999999865432    22467899999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC----
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE----  420 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~----  420 (789)
                       ..++||||+.+|+|.+++..           +.+++..+..++.|++.||+|||+.+..+++||||||+||+++.    
T Consensus        80 -~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~  147 (271)
T 3dtc_A           80 -NLCLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN  147 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS-----------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred             -ceEEEEEcCCCCCHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence             78999999999999999842           36899999999999999999999988667999999999999986    


Q ss_pred             ----CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          421 ----EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       421 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                          ++.+||+|||.++.......    ....|+..|+|||.+.+..+++++||||||+++|||++|+.||.....    
T Consensus       148 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----  219 (271)
T 3dtc_A          148 GDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----  219 (271)
T ss_dssp             SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----
T ss_pred             ccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence                67899999999987654332    234689999999999888899999999999999999999999973211    


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       ...........    .....                      ...+...+.+++..|++.++.+||+..+....
T Consensus       220 -~~~~~~~~~~~----~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          220 -LAVAYGVAMNK----LALPI----------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             -HHHHHHHHTSC----CCCCC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHhhhcCC----CCCCC----------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence             11111000000    00000                      01233456688889999999999998876443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.8e-34  Score=309.34  Aligned_cols=248  Identities=25%  Similarity=0.272  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +.|...+.||+|+||+||+|....+++.||||++.....   ...+.+.+|++++++++||||+++++++....     .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----e
Confidence            457888999999999999999988999999999965432   23467899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+. |++.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL  195 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL  195 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEE
T ss_pred             EEEEEecCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEE
Confidence            899999998 6888877432         256899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||+++......      ...||+.|+|||.+.   .+.++.++|||||||++|||++|+.||....     .......
T Consensus       196 ~DfG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~  264 (348)
T 1u5q_A          196 GDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYH  264 (348)
T ss_dssp             CCCTTCBSSSSBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHH
T ss_pred             eeccCceecCCCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHH
Confidence            9999998765432      346899999999874   5679999999999999999999999986321     1111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....     ..+....                     ..+...+.+++..|++.++..||+.......+
T Consensus       265 ~~~~-----~~~~~~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          265 IAQN-----ESPALQS---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             HHHS-----CCCCCCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             HHhc-----CCCCCCC---------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            1000     0010000                     01223455778899999999999998876544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.1e-34  Score=309.77  Aligned_cols=255  Identities=21%  Similarity=0.201  Sum_probs=192.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||++....+++.||||++.... .....+.+|+..+++++||||+++++++....     ..+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-----EEE
Confidence            468899999999999999999999999999999996443 23467889999999999999999999998765     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc--eee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV--SHV  426 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl  426 (789)
                      +||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.  +||
T Consensus        93 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl  159 (361)
T 3uc3_A           93 IIMEYASGGELYERICNA----------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKI  159 (361)
T ss_dssp             EEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEE
T ss_pred             EEEEeCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEE
Confidence            999999999999998543          46899999999999999999999998   999999999999987765  999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCcc-ccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTN-GDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+++......   ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||...... ..+....+...
T Consensus       160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~  235 (361)
T 3uc3_A          160 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRIL  235 (361)
T ss_dssp             CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHH
T ss_pred             eecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHh
Confidence            9999998543322   1233569999999999988887655 99999999999999999999743221 22233222221


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....      .+.                    ........+.+++..|++.++..|++...+..++
T Consensus       236 ~~~~------~~~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          236 SVKY------SIP--------------------DDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             TTCC------CCC--------------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             cCCC------CCC--------------------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            1100      000                    0001223456788899999999999998876554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-34  Score=304.00  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=195.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc-------eEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR-------TTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||+||+|.+..++       +.||+|++........+.+.+|++++++++||||+++++++.... 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence            457888899999999999999988655       579999997776667788999999999999999999999997655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        86 ----~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           86 ----ENILVQEFVKFGSLDTYLKKN---------KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIRE  149 (289)
T ss_dssp             ----CCEEEEECCTTCBHHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEEC
T ss_pred             ----CCEEEEECCCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecC
Confidence                679999999999999999643         234899999999999999999999998   9999999999999988


Q ss_pred             Cc--------eeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          422 MV--------SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       422 ~~--------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      +.        +||+|||.+......      ....|+..|+|||.+.+ ..++.++||||||+++|||++|..|+.....
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            87        999999998765332      23457889999999887 6799999999999999999996555432211


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      . .........  .......                              +...+.+++..|++.++.+||+...+...+
T Consensus       224 ~-~~~~~~~~~--~~~~~~~------------------------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          224 S-QRKLQFYED--RHQLPAP------------------------------KAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             H-HHHHHHHHT--TCCCCCC------------------------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             h-HHHHHHhhc--cCCCCCC------------------------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            1 011111110  0000000                              011244677889999999999988775444


Q ss_pred             c
Q 041249          573 P  573 (789)
Q Consensus       573 ~  573 (789)
                      .
T Consensus       271 ~  271 (289)
T 4fvq_A          271 N  271 (289)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-33  Score=304.73  Aligned_cols=270  Identities=23%  Similarity=0.309  Sum_probs=197.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhc--CCCCccceeeeeeccCCCCCCc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS--IRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..++|...+.||+|+||.||+|++.  ++.||||++....   ...+..|.+++..  ++||||+++++++..... ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCC
Confidence            3478999999999999999999986  8999999985332   2334445555554  489999999999876521 113


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC-----CCCceecCCCCCceecCC
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC-----QPITTHCDLKPSNILLDE  420 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~dlk~~Nill~~  420 (789)
                      ..++||||+.+|+|.+++..           ..+++.++..++.|++.||+|||+.+     .+.|+||||||+||+++.
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             ceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            78999999999999999953           25899999999999999999999881     113999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCcc--ceeeecccccccCcccCCCCCcCcc------ccchhhHHHHHHHHHh---------
Q 041249          421 EMVSHVGDFGLARFLPPTHVQT--SSIGVKGSIGYIAPEYGLGSEVSTN------GDVYSYGILMLELIIR---------  483 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------~DV~sfGvvl~elltG---------  483 (789)
                      ++.+||+|||+++.........  ......||..|+|||.+....++.+      +|||||||++|||++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            9999999999998765443211  1223469999999999987766555      9999999999999999         


Q ss_pred             -cCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEecc
Q 041249          484 -KKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDL  562 (789)
Q Consensus       484 -~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l  562 (789)
                       +.||............+........    ..+.+..                 .....++...+.+++..|++.++.+|
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~R  316 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREIVCIKK----LRPSFPN-----------------RWSSDECLRQMGKLMTECWAHNPASR  316 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCG-----------------GGGGSHHHHHHHHHHHHHSCSSGGGS
T ss_pred             ccccHhhhcCCCCchhhhHHHHhhhc----cCccccc-----------------cchhhHHHHHHHHHHHHhhhhChhhC
Confidence             5555543333333333322221111    1111110                 11223677788899999999999999


Q ss_pred             Ccccccccccccc
Q 041249          563 ESLKLAGSILPHI  575 (789)
Q Consensus       563 ~s~~~~~~~l~~l  575 (789)
                      |+...+...+..+
T Consensus       317 ps~~ell~~L~~l  329 (337)
T 3mdy_A          317 LTALRVKKTLAKM  329 (337)
T ss_dssp             CCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHH
Confidence            9998876555443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-34  Score=308.45  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=206.7

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEE-----cCCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      ...++|...+.||+|+||.||+|.+     ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3456888899999999999999986     34678999999975543 3457799999999999 999999999999765


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCc--------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED--------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      .     ..++||||+.+|+|.+++.......        ........+++.++..++.|++.||+|||+.+   ++||||
T Consensus       100 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl  171 (313)
T 1t46_A          100 G-----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL  171 (313)
T ss_dssp             S-----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             C-----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence            5     7899999999999999997542110        00112345899999999999999999999998   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM  490 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~  490 (789)
                      ||+||+++.++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            99999999999999999999998776554333344557889999999988899999999999999999999 99999743


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ... .............        ..                      ...+...+.+++..|++.++..||+...+..
T Consensus       252 ~~~-~~~~~~~~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          252 PVD-SKFYKMIKEGFRM--------LS----------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             CSS-HHHHHHHHHTCCC--------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cch-hHHHHHhccCCCC--------CC----------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            221 1122222211110        00                      0122345667888999999999999887754


Q ss_pred             cc
Q 041249          571 IL  572 (789)
Q Consensus       571 ~l  572 (789)
                      .+
T Consensus       301 ~L  302 (313)
T 1t46_A          301 LI  302 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-34  Score=308.33  Aligned_cols=201  Identities=23%  Similarity=0.277  Sum_probs=165.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||.||++...   .+++.||+|+++...    ......+.+|++++++++||||+++++++.... 
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG-   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence            467889999999999999999984   578999999997542    233456888999999999999999999997765 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        95 ----~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           95 ----KLYLILEYLSGGELFMQLERE----------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTT
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCC
Confidence                789999999999999998643          45789999999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.+||+|||+++.......  ......||..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            9999999999986543321  12235689999999999998999999999999999999999999973

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.1e-34  Score=299.42  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      |...+.||+|+||+||+|.+..++..||+|.+....  ....+.+.+|++++++++||||+++++++.... .+....++
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  106 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEEE
Confidence            566778999999999999999899999999986542  344577899999999999999999999876532 22346899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC-CCCceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD-EEMVSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D  428 (789)
                      ||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+ ++++||||||+||+++ +++.+||+|
T Consensus       107 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEecCCCCHHHHHHHc----------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEee
Confidence            99999999999999643          46889999999999999999999874 3599999999999998 789999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||++.......    .....||..|+|||.+. +.++.++||||||+++|+|++|+.||....    ......+......
T Consensus       176 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~  246 (290)
T 1t4h_A          176 LGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGV  246 (290)
T ss_dssp             TTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTC
T ss_pred             CCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC----cHHHHHHHHhccC
Confidence            99998655443    23456899999999876 569999999999999999999999996321    2222222221111


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....+                          ..+...+.+++..|++.++..|++...+..+
T Consensus       247 ~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 KPASFD--------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CCGGGG--------------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccccC--------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            000000                          0112346688889999999999998876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.1e-35  Score=312.34  Aligned_cols=274  Identities=20%  Similarity=0.306  Sum_probs=209.1

Q ss_pred             ccHHHHHHhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceee
Q 041249          260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVF  333 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~  333 (789)
                      +..++++.+.++|...+.||+|+||.||+|.+.     .+++.||||.+..... .....+.+|++++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344566677889999999999999999999886     3578899999975433 3456789999999999999999999


Q ss_pred             eeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249          334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP  413 (789)
Q Consensus       334 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~  413 (789)
                      +++....     ..++||||+.+|+|.+++...............+++..+..++.|++.||+|||+.+   |+||||||
T Consensus        95 ~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp  166 (322)
T 1p4o_A           95 GVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAA  166 (322)
T ss_dssp             EEECSSS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSG
T ss_pred             EEEccCC-----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCcc
Confidence            9987655     789999999999999998643110000111245789999999999999999999998   99999999


Q ss_pred             CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcccc
Q 041249          414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFE  492 (789)
Q Consensus       414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~  492 (789)
                      +||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...  
T Consensus       167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--  244 (322)
T 1p4o_A          167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--  244 (322)
T ss_dssp             GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--
T ss_pred             ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--
Confidence            999999999999999999987654332222233456889999999988889999999999999999999 89998632  


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                         ...+..+.........                           ....+...+.+++..|++.++..||+...+...+
T Consensus       245 ---~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L  294 (322)
T 1p4o_A          245 ---SNEQVLRFVMEGGLLD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  294 (322)
T ss_dssp             ---CHHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---CHHHHHHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence               1112211111110000                           0012334566788899999999999998875544


Q ss_pred             c
Q 041249          573 P  573 (789)
Q Consensus       573 ~  573 (789)
                      .
T Consensus       295 ~  295 (322)
T 1p4o_A          295 K  295 (322)
T ss_dssp             G
T ss_pred             H
Confidence            4

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.8e-34  Score=317.74  Aligned_cols=252  Identities=19%  Similarity=0.262  Sum_probs=191.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCC--CCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIR--HRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~  344 (789)
                      .+.|...+.||+|+||.||+|... +++.||||++....  ......+.+|++++.+++  ||||+++++++....    
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~----  129 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----  129 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC----
Confidence            356889999999999999999987 48999999986543  334577999999999996  599999999988766    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||| +.+|+|.+++...          ..+++.++..++.||+.||+|||+.+   |+||||||+|||++ ++.+
T Consensus       130 -~~~lv~E-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~  193 (390)
T 2zmd_A          130 -YIYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML  193 (390)
T ss_dssp             -EEEEEEE-CCSEEHHHHHHHC----------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCE
T ss_pred             -EEEEEEe-cCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeE
Confidence             7999999 5678999998644          46788999999999999999999988   99999999999995 5899


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCC-----------CCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----------SEVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      ||+|||+++...............||+.|+|||++..           ..++.++|||||||++|||++|+.||......
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  273 (390)
T 2zmd_A          194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  273 (390)
T ss_dssp             EECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             EEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence            9999999998765543333344569999999998764           46899999999999999999999999732211


Q ss_pred             CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                          .....        .++++.......                  ..+...+.+++..|++.++..||+..++..+
T Consensus       274 ----~~~~~--------~~~~~~~~~~~~------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 ----ISKLH--------AIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----HHHHH--------HHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHH--------HHhCccccCCCC------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                11111        111111111000                  0112345578889999999999999877544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.4e-34  Score=320.77  Aligned_cols=203  Identities=26%  Similarity=0.321  Sum_probs=160.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|++++++++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36899999999999999999999989999999998643  3334577899999999999999999999997655444557


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+. |+|.+++...          ..+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP----------VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEeccc-cchhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence            899999985 6899988543          56899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCc-------------------------cceeeecccccccCcccC-CCCCcCccccchhhHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQ-------------------------TSSIGVKGSIGYIAPEYG-LGSEVSTNGDVYSYGILMLEL  480 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~sfGvvl~el  480 (789)
                      +|||+++........                         .......||..|+|||++ ....++.++|||||||++|||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999987533211                         123345689999999976 456699999999999999999


Q ss_pred             HHhcC
Q 041249          481 IIRKK  485 (789)
Q Consensus       481 ltG~~  485 (789)
                      ++|..
T Consensus       278 ltg~~  282 (458)
T 3rp9_A          278 LNMIK  282 (458)
T ss_dssp             HTTST
T ss_pred             HHhcc
Confidence            99533

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-34  Score=313.57  Aligned_cols=203  Identities=24%  Similarity=0.348  Sum_probs=164.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++.++. ||||+++++++...+   ..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CC
Confidence            46888999999999999999999999999999998543  3344567889999999997 999999999986533   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+. |+|.+++..           ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~k  149 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVK  149 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEE
Confidence            6899999998 689888853           35889999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCC-------------------CccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcC
Q 041249          426 VGDFGLARFLPPTH-------------------VQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKK  485 (789)
Q Consensus       426 l~Dfgla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~  485 (789)
                      |+|||+++......                   .........||..|+|||.+.+ ..++.++|||||||++|||++|+.
T Consensus       150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  229 (388)
T 3oz6_A          150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP  229 (388)
T ss_dssp             ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence            99999998764321                   1112234569999999999876 578999999999999999999999


Q ss_pred             CCCc
Q 041249          486 PSDI  489 (789)
Q Consensus       486 P~~~  489 (789)
                      ||..
T Consensus       230 pf~~  233 (388)
T 3oz6_A          230 IFPG  233 (388)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            9974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.9e-34  Score=317.18  Aligned_cols=206  Identities=23%  Similarity=0.295  Sum_probs=172.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||+++..  .....+.+.+|++++++++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999643  3334578899999999999999999999987765444457


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+. |+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----------IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCC-cCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence            899999987 5999998643          56899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCc--------------------cceeeecccccccCcccC-CCCCcCccccchhhHHHHHHHHHhcC
Q 041249          427 GDFGLARFLPPTHVQ--------------------TSSIGVKGSIGYIAPEYG-LGSEVSTNGDVYSYGILMLELIIRKK  485 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~sfGvvl~elltG~~  485 (789)
                      +|||+++........                    .......||..|+|||.+ ....++.++|||||||++|||++|..
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            999999987644321                    123456789999999985 55669999999999999999998766


Q ss_pred             CCC
Q 041249          486 PSD  488 (789)
Q Consensus       486 P~~  488 (789)
                      ||.
T Consensus       251 p~~  253 (432)
T 3n9x_A          251 SHI  253 (432)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            664

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-34  Score=309.75  Aligned_cols=270  Identities=19%  Similarity=0.224  Sum_probs=199.9

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      ++....++|...+.||+|+||+||+|....+++.||+|++...     .....+.+.+|++++++++||||+++++++..
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            4555678899999999999999999999989999999998644     23445789999999999999999999999977


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCc------------------------------cccCCCCCCCHHHHHHHH
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------------------------------EVDKAPRNLNLLQRLNIA  388 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------~~~~~~~~l~~~~~~~i~  388 (789)
                      ..     ..++||||+.+|+|.+++.......                              ........+++..+..++
T Consensus       100 ~~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A          100 EQ-----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             SS-----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             CC-----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence            65     8999999999999999985210000                              000112234667788999


Q ss_pred             HHHHHHHhhhhcCCCCCceecCCCCCceecCCCC--ceeeCcccccccCCCCC--CccceeeecccccccCcccCCC--C
Q 041249          389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEM--VSHVGDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLG--S  462 (789)
Q Consensus       389 ~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~  462 (789)
                      .|++.||+|||+.+   |+||||||+||+++.++  .+||+|||+++......  .........||+.|+|||.+..  .
T Consensus       175 ~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          175 RQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            99999999999998   99999999999998776  89999999998764322  1112334569999999999865  6


Q ss_pred             CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHH
Q 041249          463 EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIE  542 (789)
Q Consensus       463 ~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (789)
                      .++.++|||||||++|||++|+.||.....     .+.....        .........                .....
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~--------~~~~~~~~~----------------~~~~~  302 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVND-----ADTISQV--------LNKKLCFEN----------------PNYNV  302 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--------HHCCCCTTS----------------GGGGG
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHH--------HhcccccCC----------------ccccc
Confidence            789999999999999999999999963211     1111111        111100000                00012


Q ss_pred             HHHHHHhhccccceeeEeccCccccccc
Q 041249          543 CLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       543 ~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....+.+++..|++.++.+|++...+..
T Consensus       303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          303 LSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            2345667888999999999999887644

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=313.04  Aligned_cols=265  Identities=18%  Similarity=0.235  Sum_probs=196.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC---CceEEEEEEeccccch-----------hhHHHHHHHHHHhcCCCCccceeee
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHHHR-----------ASRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      .++|...+.||+|+||+||+|.+..   ++..||||+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3578889999999999999999986   7889999998654322           1234678889999999999999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      ++.... .+....++||||+ +++|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  180 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERL-GIDLQKISGQN----------GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAA  180 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECE-EEEHHHHCBGG----------GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             cccccc-CCCcEEEEEEecc-CCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHH
Confidence            987632 2234789999999 89999999644          37899999999999999999999998   999999999


Q ss_pred             ceecCCCC--ceeeCcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          415 NILLDEEM--VSHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       415 Nill~~~~--~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      ||+++.++  .+||+|||+++.......     ........||..|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999887  999999999987754321     11123456999999999999889999999999999999999999999


Q ss_pred             CccccCCccHHHHHHHh---CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCc
Q 041249          488 DIMFEGDMNLHNFARMA---LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLES  564 (789)
Q Consensus       488 ~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s  564 (789)
                      .................   .+....+..                         ....+...+.+++..|++.++.+||+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps  315 (345)
T 2v62_A          261 EQNLKDPVAVQTAKTNLLDELPQSVLKWA-------------------------PSGSSCCEIAQFLVCAHSLAYDEKPN  315 (345)
T ss_dssp             GGGTTCHHHHHHHHHHHHHTTTHHHHHHS-------------------------CTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             cccccccHHHHHHHHhhcccccHHHHhhc-------------------------cccccHHHHHHHHHHHhhcCcccCCC
Confidence            64322211111111111   110000000                         00123446778888999999999999


Q ss_pred             ccccccccc
Q 041249          565 LKLAGSILP  573 (789)
Q Consensus       565 ~~~~~~~l~  573 (789)
                      ...+...+.
T Consensus       316 ~~~l~~~L~  324 (345)
T 2v62_A          316 YQALKKILN  324 (345)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHHHHh
Confidence            988755444

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.2e-34  Score=313.91  Aligned_cols=255  Identities=17%  Similarity=0.186  Sum_probs=190.1

Q ss_pred             cCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhc-CCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS-IRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|... +.||+|+||+||+|.+..+++.||||+++.     ...+.+|++++.+ .+||||+++++++.... .+....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEE
Confidence            456665 689999999999999998999999999853     2456788888754 48999999999876421 122368


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~  424 (789)
                      ++||||+.+|+|.+++...        ....+++.++..|+.|++.||+|||+.+   |+||||||+|||++.   ++.+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCcHHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccE
Confidence            9999999999999999754        2346899999999999999999999998   999999999999998   7899


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCC--ccHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD--MNLHNFAR  502 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~--~~~~~~~~  502 (789)
                      ||+|||+++......   ......||..|+|||++....++.++|||||||++|||++|+.||.......  ......+.
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999998765432   1234568999999999999999999999999999999999999997542211  11222211


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....    ...+                       ....+...+.+++..|++.++..|++...+..+
T Consensus       281 ~~~~~----~~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          281 MGQYE----FPNP-----------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HTCCC----CCTT-----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCccc----CCCc-----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11000    0000                       001233456688899999999999998877544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-34  Score=304.45  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=198.9

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .....++|...+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|++++.+++||||+++++++....    
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   92 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR----   92 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC----
Confidence            3345678888999999999999999987 778899999975433 3467899999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        93 -~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~  159 (283)
T 3gen_A           93 -PIFIITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV  159 (283)
T ss_dssp             -SEEEEECCCTTCBHHHHHHCG---------GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCE
T ss_pred             -CeEEEEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCE
Confidence             789999999999999999642         245899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||.++........ ......+|..|+|||.+....++.++||||||+++|||++ |+.||......  .....+..
T Consensus       160 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~  236 (283)
T 3gen_A          160 KVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQ  236 (283)
T ss_dssp             EECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHT
T ss_pred             EEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhc
Confidence            99999999876543211 1123346788999999998899999999999999999998 99999732111  11111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ...        ...                      ...+...+.+++..|++.++.+||+.......+
T Consensus       237 ~~~--------~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          237 GLR--------LYR----------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             TCC--------CCC----------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ccC--------CCC----------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            100        000                      001223466788899999999999998775433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=309.27  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=195.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceE----EEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTT----VTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      .++|...+.||+|+||+||+|.+..+++.    ||+|.+... .....+.+.+|++++++++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            36788999999999999999999767665    477776533 334567899999999999999999999998753    


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++|+||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred             --CceEEEEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCC
Confidence              478999999999999998643         346899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.||......  .+...+.
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~  233 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE  233 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH
Confidence            99999999998765554333444557889999999999999999999999999999999 99999743221  2222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      ......                              ....+...+.+++..|++.++..||+.......+..+
T Consensus       234 ~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          234 KGERLP------------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             TTCCCC------------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCC------------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111100                              0112334566788899999999999998876555444

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-33  Score=297.90  Aligned_cols=250  Identities=20%  Similarity=0.221  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|....+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence            357888999999999999999999899999999986542   234567899999999999999999999997765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k  155 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK  155 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEE
Confidence            789999999999999988543          46899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||.+.........  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....     ..+......
T Consensus       156 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~  228 (294)
T 2rku_A          156 IGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIK  228 (294)
T ss_dssp             ECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHH
T ss_pred             EEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHh
Confidence            9999999876543321  223568999999999998889999999999999999999999997321     111111110


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...      ..+.                      ......+.+++..|++.++..|++.......
T Consensus       229 ~~~------~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 KNE------YSIP----------------------KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             TTC------CCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hcc------CCCc----------------------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000      0000                      0112345577889999999999999887543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-34  Score=325.26  Aligned_cols=259  Identities=26%  Similarity=0.418  Sum_probs=198.6

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .+.+...++|...+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++.. .  
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~--  251 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--  251 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C--
Confidence            344556678888999999999999999997 45779999997543 235679999999999999999999999864 2  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+|||+++++
T Consensus       252 ---~~~iv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~  317 (452)
T 1fmk_A          252 ---PIYIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENL  317 (452)
T ss_dssp             ---SCEEEECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             ---ceEEEehhhcCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCC
Confidence               579999999999999999632        2245899999999999999999999998   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~  501 (789)
                      .+||+|||+++........ ......++..|+|||.+..+.++.++|||||||++|||++ |+.||.....  ......+
T Consensus       318 ~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i  394 (452)
T 1fmk_A          318 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV  394 (452)
T ss_dssp             CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH
T ss_pred             CEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence            9999999999877543311 1223457789999999988899999999999999999999 9999963211  0111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ......                              .....|...+.+++..|++.++.+||+.......+.
T Consensus       395 ~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~  436 (452)
T 1fmk_A          395 ERGYRM------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  436 (452)
T ss_dssp             HTTCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCCC------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            111000                              001134456778899999999999999987754443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-34  Score=310.59  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=207.0

Q ss_pred             cCCCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||.||+|.+    ..+++.||||++........+.+.+|++++++++||||+++++++...+   ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG---RQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---SC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---Cc
Confidence            5788899999999999999994    5678999999998776666778999999999999999999999886432   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~k  167 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRH---------RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVK  167 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEeecCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEE
Confidence            689999999999999998642         235899999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|||.++......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....      .+....
T Consensus       168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~------~~~~~~  241 (327)
T 3lxl_A          168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA------EFLRMM  241 (327)
T ss_dssp             ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHC
T ss_pred             EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc------hhhhhc
Confidence            99999999876554321 22334588889999999888899999999999999999999999863211      111100


Q ss_pred             CC----Cc---hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          505 LP----DH---VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       505 ~~----~~---~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ..    ..   ..+.+....                  +......+...+.+++..|++.++.+||+...+...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          242 GCERDVPALSRLLELLEEGQ------------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             C----CCHHHHHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccccccccHHHHHHHhhccc------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            00    00   000000000                  01111234556778899999999999999988755443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-34  Score=307.79  Aligned_cols=277  Identities=21%  Similarity=0.229  Sum_probs=211.7

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccce
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVK  331 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~  331 (789)
                      .+...++....++|...+.||+|+||+||+|.+.     .+++.||||+++.... ...+.+.+|++++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            4556666777889999999999999999999863     4678999999975533 3456789999999999 7999999


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPI  405 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~  405 (789)
                      +++++....    ...++||||+.+|+|.+++........      .......+++..+..++.|++.||+|||+.+   
T Consensus        96 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---  168 (316)
T 2xir_A           96 LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---  168 (316)
T ss_dssp             EEEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             EEEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            999986543    257999999999999999976521100      0001233889999999999999999999998   


Q ss_pred             ceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hc
Q 041249          406 TTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RK  484 (789)
Q Consensus       406 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~  484 (789)
                      |+||||||+||+++.++.+||+|||.++...............||..|+|||.+.+..++.++||||||+++|||++ |+
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999997765544333445568889999999988899999999999999999998 99


Q ss_pred             CCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCc
Q 041249          485 KPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLES  564 (789)
Q Consensus       485 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s  564 (789)
                      .||....... .+...+.......        ..                      ..+...+.+++..|++.++..||+
T Consensus       249 ~p~~~~~~~~-~~~~~~~~~~~~~--------~~----------------------~~~~~~l~~li~~~l~~dp~~Rps  297 (316)
T 2xir_A          249 SPYPGVKIDE-EFCRRLKEGTRMR--------AP----------------------DYTTPEMYQTMLDCWHGEPSQRPT  297 (316)
T ss_dssp             CSSTTCCCSH-HHHHHHHHTCCCC--------CC----------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCcccchhH-HHHHHhccCccCC--------CC----------------------CCCCHHHHHHHHHHcCCChhhCcC
Confidence            9997432211 1111111111100        00                      012234567888999999999999


Q ss_pred             ccccccccc
Q 041249          565 LKLAGSILP  573 (789)
Q Consensus       565 ~~~~~~~l~  573 (789)
                      ...+...+.
T Consensus       298 ~~ell~~L~  306 (316)
T 2xir_A          298 FSELVEHLG  306 (316)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            887755443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.1e-34  Score=303.28  Aligned_cols=265  Identities=22%  Similarity=0.213  Sum_probs=195.6

Q ss_pred             cCCCC-CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSS-ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|.. .+.||+|+||+||+|....+++.||||++..........+.+|++++.++ +||||+++++++....     ..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-----~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-----RF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----EE
Confidence            45666 47899999999999999889999999999766656677899999999985 7999999999998765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc---e
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV---S  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~  424 (789)
                      ++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.   +
T Consensus        87 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~  153 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKR----------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPV  153 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSE
T ss_pred             EEEEEcCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCce
Confidence            9999999999999998643          46899999999999999999999998   999999999999998775   9


Q ss_pred             eeCcccccccCCCCCC-----ccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249          425 HVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD  494 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~  494 (789)
                      ||+|||++........     ........||..|+|||.+..     ..++.++|||||||++|||++|+.||.......
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  233 (316)
T 2ac3_A          154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD  233 (316)
T ss_dssp             EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred             EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence            9999999987653321     111223459999999999865     568999999999999999999999997543221


Q ss_pred             ccHHHHHHHhCC----Cc-hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          495 MNLHNFARMALP----DH-VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       495 ~~~~~~~~~~~~----~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ....   .....    .. ...+.......                +..........+.+++..|.+.++..|++..++.
T Consensus       234 ~~~~---~~~~~~~~~~~~~~~i~~~~~~~----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          234 CGWD---RGEACPACQNMLFESIQEGKYEF----------------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             SCC-------CCHHHHHHHHHHHHHCCCCC----------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             cccc---ccccchhHHHHHHHHHhccCccc----------------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence            1000   00000    00 00000000000                0000112334567888999999999999998775


Q ss_pred             cc
Q 041249          570 SI  571 (789)
Q Consensus       570 ~~  571 (789)
                      .+
T Consensus       295 ~h  296 (316)
T 2ac3_A          295 QH  296 (316)
T ss_dssp             HS
T ss_pred             cC
Confidence            43

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=305.44  Aligned_cols=274  Identities=22%  Similarity=0.279  Sum_probs=193.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      -++|...+.||+|+||.||+|.+  +++.||||+++..... ....+.|+..+..++||||+++++.+......+....+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            46888899999999999999987  5899999998643321 12223444445568999999999876554444555679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC---------CCCCceecCCCCCceecC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD---------CQPITTHCDLKPSNILLD  419 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~---------~~~~ivH~dlk~~Nill~  419 (789)
                      +||||+++|+|.+++...           ..++..+..++.|++.||+|||+.         +   |+||||||+|||++
T Consensus        89 lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~  154 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH-----------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK  154 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred             EEEecCCCCcHHHHHhhc-----------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence            999999999999999543           348889999999999999999988         6   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCC------ccceeeecccccccCcccCCC-------CCcCccccchhhHHHHHHHHHhcCC
Q 041249          420 EEMVSHVGDFGLARFLPPTHV------QTSSIGVKGSIGYIAPEYGLG-------SEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      .++.+||+|||+++.......      ........||..|+|||.+.+       ..++.++|||||||++|||++|+.|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            999999999999987754321      112223469999999999876       4578899999999999999999887


Q ss_pred             CCccccCCccHHHHHHHhCCCc-h---hh-hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEec
Q 041249          487 SDIMFEGDMNLHNFARMALPDH-V---MD-IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILD  561 (789)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~-~---~~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~  561 (789)
                      +............+........ .   .. ......+....+            .......+...+.+++..|++.++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~  302 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE------------AWKENSLAVRSLKETIEDCWDQDAEA  302 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT------------TCCCCSHHHHHHHHHHHHHSCSSGGG
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc------------ccccccchHHHHHHHHHHHhcCChhh
Confidence            7532211100000000000000 0   00 000000000000            00011235567889999999999999


Q ss_pred             cCcccccccc
Q 041249          562 LESLKLAGSI  571 (789)
Q Consensus       562 l~s~~~~~~~  571 (789)
                      ||+..++...
T Consensus       303 Rps~~e~l~~  312 (336)
T 3g2f_A          303 RLTAQXAEER  312 (336)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcchHHHHHH
Confidence            9999887443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-34  Score=305.01  Aligned_cols=200  Identities=25%  Similarity=0.325  Sum_probs=169.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|.+..+++.||+|++.....  ...+.+.+|++++++++||||+++++++....     ..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----RL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----eE
Confidence            568888999999999999999998999999999865433  23567889999999999999999999998765     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.++++.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQ----------RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTS----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCchHHHHHhhh----------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEe
Confidence            9999999999999887543          56899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.+........  ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       145 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  205 (311)
T 4agu_A          145 DFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG  205 (311)
T ss_dssp             CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            9999987654332  1234568999999999876 5689999999999999999999999974

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.2e-34  Score=307.78  Aligned_cols=268  Identities=20%  Similarity=0.307  Sum_probs=204.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEc-------CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeecc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLD-------EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSG  338 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  338 (789)
                      ..++|...+.||+|+||.||+|.+.       .+++.||||+++.... .....+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3468888999999999999999975       3567899999975533 3456789999999999 89999999999876


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      ..     ..++||||+.+|+|.+++........      .......+++.++..++.|++.||+|||+.+   |+|||||
T Consensus       113 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk  184 (334)
T 2pvf_A          113 DG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA  184 (334)
T ss_dssp             SS-----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred             CC-----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCc
Confidence            55     78999999999999999976521100      0011345899999999999999999999998   9999999


Q ss_pred             CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccc
Q 041249          413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMF  491 (789)
Q Consensus       413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~  491 (789)
                      |+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999999998765543333334557889999999988889999999999999999999 999996321


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .  ..+...+......        ..                      ...+...+.+++..|++.++..||+...+...
T Consensus       265 ~--~~~~~~~~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 V--EELFKLLKEGHRM--------DK----------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             H--HHHHHHHHHTCCC--------CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H--HHHHHHHhcCCCC--------CC----------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1  1111111111100        00                      01233456678889999999999999887655


Q ss_pred             cccc
Q 041249          572 LPHI  575 (789)
Q Consensus       572 l~~l  575 (789)
                      +..+
T Consensus       313 L~~l  316 (334)
T 2pvf_A          313 LDRI  316 (334)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            4433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-33  Score=303.12  Aligned_cols=265  Identities=17%  Similarity=0.195  Sum_probs=202.9

Q ss_pred             cccHHHHHHhhcCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC-CCCccceeee
Q 041249          259 NLSYQNLHNATDGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI-RHRNLVKVFT  334 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~  334 (789)
                      .+.|+..+.-.+.|... +.||+|+||.||+|....+++.||+|+++....  .....+.+|++++.++ .||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34444445555667766 889999999999999998999999999875432  3357889999999999 5699999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      ++....     ..++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+
T Consensus        97 ~~~~~~-----~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~  160 (327)
T 3lm5_A           97 VYENTS-----EIILILEYAAGGEIFSLCLPE--------LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQ  160 (327)
T ss_dssp             EEECSS-----EEEEEEECCTTEEGGGGGSSC--------C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred             EEEeCC-----eEEEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChH
Confidence            997665     799999999999999998643        3456899999999999999999999998   999999999


Q ss_pred             ceecCC---CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccc
Q 041249          415 NILLDE---EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF  491 (789)
Q Consensus       415 Nill~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~  491 (789)
                      ||+++.   ++.+||+|||+++.......   .....||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus       161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          161 NILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             GEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998   78999999999998754432   223569999999999999999999999999999999999999996321


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .. ..+... ...... ..                          ......+...+.+++..|.+.++..||+...+..+
T Consensus       238 ~~-~~~~~i-~~~~~~-~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          238 NQ-ETYLNI-SQVNVD-YS--------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HH-HHHHHH-HHTCCC-CC--------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ch-HHHHHH-Hhcccc-cC--------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11 001111 110000 00                          00011233446678889999999999998877543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-34  Score=312.18  Aligned_cols=270  Identities=20%  Similarity=0.274  Sum_probs=207.0

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCc-----eEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeee
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGR-----TTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTAC  336 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~  336 (789)
                      +.+...++|...+.||+|+||.||+|.+..++     +.||+|.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            44556788999999999999999999987554     4799999975533 3456799999999999 899999999999


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCc----cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED----EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK  412 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk  412 (789)
                      ....     ..++||||+.+|+|.+++.......    ........+++..+..++.|++.||+|||+.+   |+|||||
T Consensus       120 ~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  191 (333)
T 2i1m_A          120 THGG-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA  191 (333)
T ss_dssp             CSSS-----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred             ecCC-----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcc
Confidence            7665     7899999999999999986431000    00011346899999999999999999999998   9999999


Q ss_pred             CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccc
Q 041249          413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMF  491 (789)
Q Consensus       413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~  491 (789)
                      |+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            9999999999999999999987655443333334557889999999988899999999999999999999 999997432


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .. ..+............                              ...+...+.+++..|++.++..||+...+...
T Consensus       272 ~~-~~~~~~~~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          272 VN-SKFYKLVKDGYQMAQ------------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             SS-HHHHHHHHHTCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hh-HHHHHHHhcCCCCCC------------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            21 112222222211100                              01123345678889999999999999877543


Q ss_pred             c
Q 041249          572 L  572 (789)
Q Consensus       572 l  572 (789)
                      +
T Consensus       321 L  321 (333)
T 2i1m_A          321 L  321 (333)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.9e-34  Score=303.02  Aligned_cols=256  Identities=21%  Similarity=0.216  Sum_probs=185.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..++|...+.||+|+||+||+|.+..+++.||+|+++....  ...+.+.++...++.++||||+++++++....     
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----
Confidence            45788999999999999999999988999999999975532  22344555666688889999999999998655     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCce
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ..++||||+. |++.+++...      ......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQV------IDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCE
T ss_pred             CEEEEEehhc-cchHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCE
Confidence            7899999998 5887776431      12345789999999999999999999997 7   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccC----CCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYG----LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~  500 (789)
                      ||+|||.++.......   .....||..|+|||.+    ....++.++||||||+++|||++|+.||+........+...
T Consensus       150 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  226 (290)
T 3fme_A          150 KMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV  226 (290)
T ss_dssp             EBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred             EEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence            9999999987655432   2234689999999995    55678999999999999999999999997432211112221


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....+.         ..                     ...+...+.+++..|++.++.+||+...+..+
T Consensus       227 ~~~~~~~---------~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          227 VEEPSPQ---------LP---------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHSCCCC---------CC---------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             hccCCCC---------cc---------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            1111110         00                     00123345678889999999999999877553

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.4e-33  Score=313.26  Aligned_cols=202  Identities=22%  Similarity=0.259  Sum_probs=168.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .++|...+.||+|+||+||+|....+++.||||++...  .....+.+.+|+++++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46888999999999999999999989999999999654  33445778899999999999999999999875532 2334


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.++ +.+.+.            ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeCCCCC-HHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence            689999999864 555553            23789999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999998765432   22345689999999999999999999999999999999999999963

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-33  Score=308.80  Aligned_cols=286  Identities=19%  Similarity=0.206  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|++++.+++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468899999999999999999999899999999997543 3334778999999999999999999999876654444578


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+. |+|.+++..           ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus       106 ~iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence            99999998 589988853           35899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCcc-ceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          428 DFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       428 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |||.++......... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.....  ......+....
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~  248 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGIL  248 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG--GGHHHHHHHHH
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHHHh
Confidence            999998776443211 12345799999999986554 489999999999999999999999974321  11222211111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhh-hhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQR-QRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .....+.+..........+ ..+... ....+..........+.+++..|.+.++..|++...+..++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNY-LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHH-HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             CCCCHHHHHHhhhhhHHHH-HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            1111111000000000000 000000 00000001112345567889999999999999998875543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-34  Score=306.79  Aligned_cols=266  Identities=18%  Similarity=0.188  Sum_probs=203.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|+||.||++....+++.||||++........+.+.+|++++++++||||+++++++.... ......
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCcee
Confidence            3467889999999999999999998899999999997666666788999999999999999999999986322 122367


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+||+.+|+|.+++...      ......+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus       106 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERL------KDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHH------HTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999998642      123457899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCc-------cceeeecccccccCcccCCCCC---cCccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249          428 DFGLARFLPPTHVQ-------TSSIGVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL  497 (789)
Q Consensus       428 Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~  497 (789)
                      |||.+.........       .......||..|+|||.+....   +++++||||||+++|||++|+.||+.........
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  256 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV  256 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence            99998765432110       0111234789999999987543   7899999999999999999999997432222222


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ..........       +                       ....+...+.+++..|++.++..||+...+...+.
T Consensus       257 ~~~~~~~~~~-------~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          257 ALAVQNQLSI-------P-----------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHHHHCC--C-------C-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hHHhhccCCC-------C-----------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            2222111000       0                       00122345668888999999999999987755443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-33  Score=296.16  Aligned_cols=251  Identities=18%  Similarity=0.188  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ++|...+.||+|+||.||+|....+++.||+|+++....      ...+.+.+|++++++++||||+++++++....   
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT---   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC---
Confidence            468888999999999999999998999999999865422      13577999999999999999999999997755   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-  422 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-  422 (789)
                        ..++||||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++ 
T Consensus        82 --~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  146 (283)
T 3bhy_A           82 --DVVLILELVSGGELFDFLAEK----------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNV  146 (283)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSS
T ss_pred             --eEEEEEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCC
Confidence              789999999999999998533          46899999999999999999999998   99999999999998877 


Q ss_pred             ---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          423 ---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       423 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                         .+||+|||.+........   .....|+..|+|||.+....++.++||||||+++|||++|+.||....     ...
T Consensus       147 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~  218 (283)
T 3bhy_A          147 PNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----KQE  218 (283)
T ss_dssp             SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHH
T ss_pred             CCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----hHH
Confidence               899999999987654332   223468999999999998899999999999999999999999997321     111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ........      .....                  ..........+.+++..|++.++..||+......
T Consensus       219 ~~~~~~~~------~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          219 TLTNISAV------NYDFD------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHHHTT------CCCCC------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhHhc------ccCCc------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            11111000      00000                  0001122345668889999999999999887644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.7e-33  Score=296.34  Aligned_cols=246  Identities=21%  Similarity=0.272  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ......+.+|++++++++||||+++++++....     .
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   88 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-----R   88 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----E
Confidence            67888999999999999999999899999999986442   233467899999999999999999999987655     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl  155 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKH----------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI  155 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEE
Confidence            89999999999999998643          45899999999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.+.......    .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....     .....+....
T Consensus       156 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~  226 (284)
T 2vgo_A          156 ADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----HTETHRRIVN  226 (284)
T ss_dssp             CCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHT
T ss_pred             ecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----HhHHHHHHhc
Confidence            9999987665432    223568999999999999999999999999999999999999997321     1111111110


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .      +..+..                      .....+.+++..|.+.++..|++......
T Consensus       227 ~------~~~~~~----------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          227 V------DLKFPP----------------------FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             T------CCCCCT----------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c------ccCCCC----------------------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            0      000100                      11234557888999999999999887644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.9e-33  Score=303.45  Aligned_cols=249  Identities=20%  Similarity=0.233  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|++++++++||||+++++++....     
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----
Confidence            35788899999999999999999989999999998644   2234567899999999999999999999998765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~k  181 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK  181 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEE
Confidence            899999999999999988543          46899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||.++........  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....     ..+......
T Consensus       182 l~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~  254 (335)
T 2owb_A          182 IGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIK  254 (335)
T ss_dssp             ECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHH
T ss_pred             EeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHh
Confidence            9999999877543321  233568999999999988889999999999999999999999997321     111111000


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..      ...+.                      ..+...+.+++..|++.++.+|++......
T Consensus       255 ~~------~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          255 KN------EYSIP----------------------KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HT------CCCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cC------CCCCC----------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      00000                      011234557788999999999999987754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5e-34  Score=300.65  Aligned_cols=253  Identities=22%  Similarity=0.244  Sum_probs=194.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++++....     ..+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-----eEE
Confidence            57888999999999999999999899999999987554 334578999999999999999999999997665     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---CCCCcee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSH  425 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~k  425 (789)
                      +||||+.+|+|.+++...      ......+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+|
T Consensus        97 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~k  167 (285)
T 3is5_A           97 IVMETCEGGELLERIVSA------QARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIK  167 (285)
T ss_dssp             EEECCCSCCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEEeCCCCcHHHHHHhh------hhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEE
Confidence            999999999999988532      112356899999999999999999999998   9999999999999   4567899


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||.++.......   .....||..|+|||.+. +.++.++||||||+++|||++|+.||.....  ...........
T Consensus       168 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~  241 (285)
T 3is5_A          168 IIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKATYKE  241 (285)
T ss_dssp             ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC
T ss_pred             EEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HHHHhhhccCC
Confidence            999999987654332   23456899999999875 5789999999999999999999999973211  11111111110


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      +         .....                   .......+.+++..|.+.++.+||+..++..
T Consensus       242 ~---------~~~~~-------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 P---------NYAVE-------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C---------CCCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             c---------ccccc-------------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         00000                   0011234557888999999999999887644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-33  Score=300.51  Aligned_cols=251  Identities=21%  Similarity=0.222  Sum_probs=197.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||+||+|....+++.||+|+++.........+.+|++++++++||||+++++++....     ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   83 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----HYYL   83 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----EEEE
Confidence            57888999999999999999999899999999998665555677899999999999999999999987665     8899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---CCCCceee
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVSHV  426 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl  426 (789)
                      ||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||++   +.++.+||
T Consensus        84 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl  150 (304)
T 2jam_A           84 VMQLVSGGELFDRILER----------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMI  150 (304)
T ss_dssp             EECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEB
T ss_pred             EEEcCCCccHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEE
Confidence            99999999999988543          45889999999999999999999998   9999999999999   78899999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||.++......    .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.....  ..+...+.....
T Consensus       151 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~  224 (304)
T 2jam_A          151 TDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYY  224 (304)
T ss_dssp             CSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCC
T ss_pred             ccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCC
Confidence            9999998654332    2234589999999999999999999999999999999999999963211  111111111100


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .    . +...                      .......+.+++..|.+.++..|++......+
T Consensus       225 ~----~-~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 E----F-ESPF----------------------WDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             C----C-CTTT----------------------TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             C----C-Cccc----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0    0 0000                      01123345678889999999999999876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.8e-34  Score=296.45  Aligned_cols=252  Identities=20%  Similarity=0.296  Sum_probs=195.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|.+.  ++.||||+++...  ....+.+.+|++++++++||||+++++++....   ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence            357888999999999999999985  8899999997553  334567999999999999999999999987652   236


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+ ++++||||||+||+++.++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l  154 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEG--------TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARI  154 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSC--------SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEE
T ss_pred             eEeeecccCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeE
Confidence            79999999999999999754        2336899999999999999999999764 45999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCc---cccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVST---NGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||.+......       ...||..|+|||.+.+..++.   ++||||||+++|||++|+.||.....     ......
T Consensus       155 ~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~  222 (271)
T 3kmu_A          155 SMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMK  222 (271)
T ss_dssp             EGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHH
T ss_pred             Eeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHH
Confidence            988887654332       245889999999988765444   89999999999999999999973211     111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ....    ...+.+.                      ..+...+.+++..|++.++..||+...+...+
T Consensus       223 ~~~~----~~~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L  265 (271)
T 3kmu_A          223 VALE----GLRPTIP----------------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL  265 (271)
T ss_dssp             HHHS----CCCCCCC----------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhc----CCCCCCC----------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            1000    0001110                      12234566788899999999999988765433

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-33  Score=299.72  Aligned_cols=202  Identities=21%  Similarity=0.259  Sum_probs=166.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      -++|...+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|++++++++||||+++++++....     
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG-----  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-----
Confidence            3688999999999999999999998999999999975432   23477899999999999999999999987765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQ----------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             eEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEE
Confidence            889999999999999998643          45899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||++......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          175 LVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             ECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             EecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999876544321 12245689999999999999999999999999999999999999973

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.7e-35  Score=318.91  Aligned_cols=254  Identities=15%  Similarity=0.109  Sum_probs=188.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHH---HHHhcCCCCccceeeeeec----
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAEC---RALRSIRHRNLVKVFTACS----  337 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~----  337 (789)
                      ..++|...+.||+|+||+||+|++..+++.||||++...   .....+.+.+|+   +.+++++||||+++++.+.    
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            356788899999999999999999888999999999743   334567889999   5566668999999985443    


Q ss_pred             ---cCCC-------CCCc-----eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 041249          338 ---GVDY-------QGND-----FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC  402 (789)
Q Consensus       338 ---~~~~-------~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~  402 (789)
                         ....       ....     ..++||||+ +|+|.+++....   ........+++..+..|+.|++.||+|||+.+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~---~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL---SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH---HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc---ccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence               2210       0000     278999999 589999997531   11112334556889999999999999999998


Q ss_pred             CCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-----------CcCccccch
Q 041249          403 QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----------EVSTNGDVY  471 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~  471 (789)
                         |+||||||+|||++.++.+||+|||+++....     ......| ..|+|||++...           .++.++|||
T Consensus       227 ---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw  297 (377)
T 3byv_A          227 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW  297 (377)
T ss_dssp             ---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred             ---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence               99999999999999999999999999986432     2234557 999999999877           899999999


Q ss_pred             hhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhc
Q 041249          472 SYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIG  551 (789)
Q Consensus       472 sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  551 (789)
                      ||||++|||++|+.||.......             ....+.. ..                       ..+...+.+++
T Consensus       298 SlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~-~~-----------------------~~~~~~~~~li  340 (377)
T 3byv_A          298 ALGLVIYWIWCADLPITKDAALG-------------GSEWIFR-SC-----------------------KNIPQPVRALL  340 (377)
T ss_dssp             HHHHHHHHHHHSSCCC------C-------------CSGGGGS-SC-----------------------CCCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCccccccc-------------chhhhhh-hc-----------------------cCCCHHHHHHH
Confidence            99999999999999996321110             0001110 00                       12234566788


Q ss_pred             cccceeeEeccCcccccccc
Q 041249          552 SKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       552 ~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..|++.++..|++...+..+
T Consensus       341 ~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          341 EGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHcCCCchhCCCHHHHhhC
Confidence            89999999999998877543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-34  Score=310.99  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=187.2

Q ss_pred             CCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .|...+.||+|+||+||+|.+..+   ...||||.++.. .....+.+.+|++++++++||||++++++|...+    ..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----SC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----CC
Confidence            355668899999999999998533   346899998654 3345678999999999999999999999875432    25


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL  233 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKV  233 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred             eEEEEECCCCCCHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEE
Confidence            78999999999999999643         345789999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCc--cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          427 GDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....  ......+..
T Consensus       234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~~  311 (373)
T 3c1x_A          234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQ  311 (373)
T ss_dssp             CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHHT
T ss_pred             eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHHc
Confidence            999999876544321  12234457789999999998999999999999999999999 6777753211  122222211


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ....     .                         ....+...+.+++..|++.++.+||+.......+.
T Consensus       312 ~~~~-----~-------------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          312 GRRL-----L-------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             TCCC-----C-------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC-----C-------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1000     0                         00123345668888999999999999988754443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3e-33  Score=297.43  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=203.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .+.|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++....     ..
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eE
Confidence            356888999999999999999998899999999997553 344578999999999999999999999988765     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+++|.+++..           ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        96 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  161 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLA  161 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEe
Confidence            999999999999999853           35899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||.+........  ......|+..|+|||.+....++.++||||||+++|||++|+.||.....  ......+....  
T Consensus       162 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~--  235 (303)
T 3a7i_A          162 DFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLIPKNN--  235 (303)
T ss_dssp             CCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC--
T ss_pred             ecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHhhcCC--
Confidence            9999987654331  12345689999999999999999999999999999999999999973211  11111111111  


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                            .+.+..                      .+...+.+++..|++.++..||+...+...+
T Consensus       236 ------~~~~~~----------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 ------PPTLEG----------------------NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ------CCCCCS----------------------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ------CCCCcc----------------------ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                  111111                      1233466788899999999999998876544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-33  Score=298.47  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCce---EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .|...+.||+|+||+||+|.+..+++   .||+|.+..... ...+.+.+|++++++++||||+++++++...+    ..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CC
Confidence            34556899999999999999754443   799999875433 34578899999999999999999999987544    23


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++|+||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl  165 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSP---------QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV  165 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEecccCCCHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence            48999999999999999643         356789999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCC--CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          427 GDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       427 ~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      +|||.++......  .........++..|+|||.+.+..++.++||||||+++|||++|..|+.... +...+...+...
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~  244 (298)
T 3pls_A          166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQG  244 (298)
T ss_dssp             CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTT
T ss_pred             CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcC
Confidence            9999998765443  1122234567889999999999999999999999999999999766654221 112222222221


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .....                              ...+...+.+++..|++.++.+||+.......+
T Consensus       245 ~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  282 (298)
T 3pls_A          245 RRLPQ------------------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV  282 (298)
T ss_dssp             CCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCC------------------------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            11100                              012233566788899999999999988775443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.3e-34  Score=301.37  Aligned_cols=255  Identities=20%  Similarity=0.289  Sum_probs=189.3

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      ...++|...+.||+|+||.||+|.+..+   +..||+|.++... ....+.+.+|+..+++++||||+++++++.+ .  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~--   88 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N--   88 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S--
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-C--
Confidence            4456788899999999999999998643   5679999987543 3345679999999999999999999999743 2  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++
T Consensus        89 ---~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  153 (281)
T 1mp8_A           89 ---PVWIIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSND  153 (281)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHT---------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred             ---ccEEEEecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCC
Confidence               578999999999999998643         246899999999999999999999998   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~  501 (789)
                      .+||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |+.||......  .....+
T Consensus       154 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i  230 (281)
T 1mp8_A          154 CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI  230 (281)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH
T ss_pred             CEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH
Confidence            9999999999877544321 1223446788999999988889999999999999999997 99999743221  222222


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ......        ..                      ...+...+.+++..|++.++..||+.......+
T Consensus       231 ~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  271 (281)
T 1mp8_A          231 ENGERL--------PM----------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL  271 (281)
T ss_dssp             HTTCCC--------CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HcCCCC--------CC----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            111000        00                      012334566888899999999999988765443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-33  Score=328.40  Aligned_cols=202  Identities=22%  Similarity=0.293  Sum_probs=178.2

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (789)
                      ..++|...+.||+|+||.||+|....+++.||||+++..   .......+..|.+++..+ +||+|+++++++...+   
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~---  415 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---  415 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS---
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC---
Confidence            456899999999999999999999999999999999743   334456788899999988 7999999999987765   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...          ..+++.++..|+.||+.||+|||+.+   ||||||||+|||++.+++
T Consensus       416 --~~~lV~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~  480 (674)
T 3pfq_A          416 --RLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH  480 (674)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSC
T ss_pred             --EEEEEEeCcCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCc
Confidence              899999999999999999643          46899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +||+|||+++.......  ......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus       481 ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          481 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             EEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence            99999999986543332  23346799999999999999999999999999999999999999973

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-33  Score=296.26  Aligned_cols=199  Identities=25%  Similarity=0.372  Sum_probs=168.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|.. .+++.||+|.++....  .....+.+|++++++++||||+++++++....     ..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence            4678889999999999999998 4789999999865432  23467889999999999999999999997765     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+ +|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~  142 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVC---------EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIA  142 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTS---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEecCC-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEe
Confidence            999999985 898888643         246889999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.++.......  ......||..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       143 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          143 DFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999987643321  12234689999999998764 589999999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-33  Score=307.40  Aligned_cols=214  Identities=22%  Similarity=0.229  Sum_probs=174.8

Q ss_pred             cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-----------hhHHHHHHHHHHhcCCCC
Q 041249          259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----------ASRSFIAECRALRSIRHR  327 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~  327 (789)
                      +..+.++....++|...+.||+|+||.||+|... .++.||||++......           ..+.+.+|++++++++||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            4456788889999999999999999999999987 5899999998543221           136799999999999999


Q ss_pred             ccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCce
Q 041249          328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT  407 (789)
Q Consensus       328 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv  407 (789)
                      ||+++++++...........++||||+. |++.+++...         ...+++..+..++.|++.||+|||+.+   |+
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv  156 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---------RIVISPQHIQYFMYHILLGLHVLHEAG---VV  156 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCc---CE
Confidence            9999999986654344447899999999 6888887543         346899999999999999999999998   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      ||||||+||+++.++.+||+|||.++.......   .....||..|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus       157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          157 HRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            999999999999999999999999986544332   234568899999999877 6789999999999999999999999


Q ss_pred             CCc
Q 041249          487 SDI  489 (789)
Q Consensus       487 ~~~  489 (789)
                      |..
T Consensus       234 f~~  236 (362)
T 3pg1_A          234 FRG  236 (362)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-33  Score=304.55  Aligned_cols=268  Identities=19%  Similarity=0.218  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||.||+|....+++.||||++.....  ...+.+.+|++++++++||||+++++++....     ..
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   99 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-----RW   99 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----EE
Confidence            578888999999999999999998999999999864432  23566889999999999999999999998765     88


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.++++.++....          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus       100 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFP----------NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EEEEECCSEEHHHHHHHST----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEecCCcchHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEE
Confidence            9999999999998886533          45899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.++.......  ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.........
T Consensus       167 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  243 (331)
T 4aaa_A          167 DFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGN  243 (331)
T ss_dssp             CCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCS
T ss_pred             eCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Confidence            9999987654332  12235689999999998775 6899999999999999999999999743211 111111111000


Q ss_pred             --Cch----------hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 --DHV----------MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 --~~~----------~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                        ...          .....+.+.....             .......+...+.+++..|++.++..||+..++..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          244 LIPRHQELFNKNPVFAGVRLPEIKEREP-------------LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCHHHHHHHHHCGGGTTCCCCCCSSCCC-------------HHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CChhhhhHhhhccccccccCccccccch-------------hhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000          0000111100000             000111345567788999999999999999887554

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-34  Score=306.27  Aligned_cols=279  Identities=20%  Similarity=0.244  Sum_probs=195.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||+|....+++.||+|+++..... ....+.+|++++++++||||+++++++....     ..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence            4688889999999999999999989999999998654322 2234567999999999999999999987665     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+. |+|.+++...         +..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D  143 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDC---------GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLAD  143 (324)
T ss_dssp             EEEECCS-EEHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECS
T ss_pred             EEecccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEcc
Confidence            9999998 5898888643         346899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.++.......  ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.....  ......+......
T Consensus       144 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~  219 (324)
T 3mtl_A          144 FGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGT  219 (324)
T ss_dssp             SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCC
T ss_pred             CcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCC
Confidence            999987654321  1223468999999999876 5689999999999999999999999974321  1222222222111


Q ss_pred             chhhhccCCcccChhhHHHhhhhh-hhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQR-QRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ...+.++......  .+....... ...............+.+++..|.+.++..|++..++..++
T Consensus       220 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          220 PTEETWPGILSNE--EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             CCTTTSTTGGGCH--HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             CChHhchhhhcch--hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence            1111111000000  000000000 00000001112344567889999999999999998876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=328.43  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=192.3

Q ss_pred             cccccCCccEEEEEEc--CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeec
Q 041249          277 LIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEF  353 (789)
Q Consensus       277 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  353 (789)
                      .||+|+||.||+|.+.  .++..||||+++... ....+.+.+|++++++++||||++++++|.. +     ..++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----ALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----SEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----CeEEEEEe
Confidence            7999999999999886  356789999997653 3456789999999999999999999999864 2     58999999


Q ss_pred             cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccc
Q 041249          354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR  433 (789)
Q Consensus       354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  433 (789)
                      +.+|+|.+++...         ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       417 ~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          417 AGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             CTTCBHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            9999999999643         356899999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249          434 FLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMD  511 (789)
Q Consensus       434 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  511 (789)
                      ........ .......++..|+|||++....++.++|||||||++|||++ |+.||.....  ..+...+......    
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~----  558 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRM----  558 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTCCC----
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCC----
Confidence            87544321 11223345689999999988899999999999999999998 9999974321  1122222111100    


Q ss_pred             hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                                                .....|...+.+++..|++.++.+||+...+...+
T Consensus       559 --------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L  593 (613)
T 2ozo_A          559 --------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  593 (613)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred             --------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence                                      01113455677899999999999999998775443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-34  Score=314.94  Aligned_cols=279  Identities=19%  Similarity=0.233  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.|...+.||+|+||+||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++....   ....+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence            56888899999999999999999899999999997543 233567889999999999999999999987543   23679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCce
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVS  424 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~  424 (789)
                      +||||+.+|+|.+++...       .....+++.++..++.|++.||+|||+.+   |+||||||+||++    +.++.+
T Consensus        86 lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             EEECCCTTEEHHHHTTSG-------GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred             EEEecCCCCCHHHHHHhh-------hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence            999999999999999754       12234899999999999999999999998   9999999999999    788889


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCC--------CCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--------SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                      ||+|||+++.......   .....||..|+|||.+..        ..++.++|||||||++|||++|+.||.........
T Consensus       156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            9999999987755432   223569999999998764        56889999999999999999999999754332222


Q ss_pred             HHHHHH--HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          497 LHNFAR--MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       497 ~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .....+  ...+......+.....+...   |...   ..............+.++...|.+.+|..|++......
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~---~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPID---WSGD---MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEE---EESS---CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcc---cCcc---CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            222221  11221111111100000000   0000   00001112345567778889999999999999887633

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-33  Score=304.25  Aligned_cols=254  Identities=19%  Similarity=0.230  Sum_probs=196.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||.||+|....+++.||||+++....    ...+|++++.++ +||||+++++++....     ..
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK-----YV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-----EE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-----EE
Confidence            4678899999999999999999998999999999965432    245688888888 7999999999997765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC----Cc
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE----MV  423 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~----~~  423 (789)
                      ++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||++.++    +.
T Consensus        92 ~lv~E~~~gg~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~  158 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQ----------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPES  158 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTC----------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGG
T ss_pred             EEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCe
Confidence            9999999999999998644          46899999999999999999999998   9999999999998543    35


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +||+|||+++.......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....  .........
T Consensus       159 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~  234 (342)
T 2qr7_A          159 IRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILAR  234 (342)
T ss_dssp             EEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHH
T ss_pred             EEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHH
Confidence            99999999987654432  12235689999999999888899999999999999999999999974321  122222211


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ...... .. ....                      .......+.+++..|.+.++..|++...+..++
T Consensus       235 i~~~~~-~~-~~~~----------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          235 IGSGKF-SL-SGGY----------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             HHHCCC-CC-CSTT----------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             HccCCc-cc-Cccc----------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            100000 00 0000                      001233455788899999999999988775543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.8e-34  Score=306.45  Aligned_cols=263  Identities=21%  Similarity=0.314  Sum_probs=197.9

Q ss_pred             hhcCCCCCCcccccCCccEEEEEE-----cCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ..++|...+.||+|+||.||+|.+     ..+++.||||++... .......+.+|++++++++||||+++++++.... 
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence            346899999999999999999994     456789999999644 3344567899999999999999999999987655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC--
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--  419 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--  419 (789)
                          ..++||||+.+|+|.+++.....   .......+++.++..++.|++.||.|||+.+   |+||||||+||+++  
T Consensus       107 ----~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          107 ----PRFILMELMAGGDLKSFLRETRP---RPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP  176 (327)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTSC---CSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred             ----CcEEEEecCCCCcHHHHHHhhcc---cccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecC
Confidence                67999999999999999975411   1123356899999999999999999999998   99999999999998  


Q ss_pred             -CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          420 -EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       420 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                       ++..+||+|||.+................|+..|+|||.+....++.++||||||+++|||++ |+.||....  ....
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~  254 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEV  254 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHH
Confidence             455799999999986544432222334557889999999988899999999999999999998 999986321  1111


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...+......        ..                      ...+...+.+++..|++.++.+||+...+...+.
T Consensus       255 ~~~~~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          255 LEFVTSGGRM--------DP----------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHHHHTTCCC--------CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhcCCCC--------CC----------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            1111111000        00                      0123345668888999999999999988755444

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.6e-33  Score=301.66  Aligned_cols=268  Identities=20%  Similarity=0.239  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||+||+|....+++.||||+++..   ..+.+.+|++++++++ ||||+++++++....   ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCce
Confidence            36788999999999999999999889999999998633   3467899999999997 999999999987632   2368


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl  426 (789)
                      ++||||+.+++|.+++.             .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++ .+||
T Consensus       109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl  172 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL  172 (330)
T ss_dssp             EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEE
Confidence            99999999999999873             3688999999999999999999998   99999999999999776 8999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||+++.......   .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+....+..-
T Consensus       173 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~  249 (330)
T 3nsz_A          173 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  249 (330)
T ss_dssp             CCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred             EeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence            99999987765442   223468899999999877 66899999999999999999999999643222112222111111


Q ss_pred             CCc---------------hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          506 PDH---------------VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       506 ~~~---------------~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...               ..+.........+.+          .............+.+++..|.+.++..|++..++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWER----------FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGG----------GCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhHHHHhccccccchhhhhhhccccchhh----------hccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111               111111111111100          0001111123456778899999999999999987755


Q ss_pred             c
Q 041249          571 I  571 (789)
Q Consensus       571 ~  571 (789)
                      +
T Consensus       320 h  320 (330)
T 3nsz_A          320 H  320 (330)
T ss_dssp             S
T ss_pred             C
Confidence            4

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-33  Score=297.14  Aligned_cols=260  Identities=18%  Similarity=0.269  Sum_probs=198.9

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|+||+||+|.+..+++.||||++....  ....+.+|+++++.++|++++..++.+....    ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCC----Cce
Confidence            3578999999999999999999998899999999875443  2345888999999999999888887774432    378


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---CCCCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~  424 (789)
                      ++||||+ +|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||++   ++++.+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~  147 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCE
T ss_pred             EEEEEcc-CCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeE
Confidence            9999999 89999998632         346899999999999999999999998   9999999999999   788999


Q ss_pred             eeCcccccccCCCCCCc-----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC--CccH
Q 041249          425 HVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG--DMNL  497 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~--~~~~  497 (789)
                      ||+|||.++........     .......||..|+|||.+.+..++.++|||||||++|||++|+.||......  ...+
T Consensus       148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  227 (296)
T 4hgt_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  227 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred             EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence            99999999987654321     1223456999999999999999999999999999999999999999753221  1112


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ........+.....                           ....+...+.+++..|++.++.+||+...+...+.
T Consensus       228 ~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          228 ERISEKKMSTPIEV---------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHHHSCHHH---------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             hhhhcccccchhhh---------------------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            22211111100000                           00122345678889999999999999887755443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-33  Score=300.97  Aligned_cols=259  Identities=20%  Similarity=0.275  Sum_probs=192.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|....+++.||+|+++..   .......+.+|++++++++||||+++++++....     .
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~  106 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E  106 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----c
Confidence            5788899999999999999999889999999998753   2334567899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...      ......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHF------KKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCCHHHHHHHh------cccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEE
Confidence            99999999999999998532      112456899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||++........  ......|+..|+|||.+....++.++||||||+++|||++|+.||....   .....+.+....
T Consensus       178 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~  252 (310)
T 2wqm_A          178 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEQ  252 (310)
T ss_dssp             CCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC------CCHHHHHHHHHT
T ss_pred             EeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---hhHHHHHHHhhc
Confidence            99999987654332  1223468999999999999999999999999999999999999996322   122222221111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .....     ..                     ...+...+.+++..|++.++..||+...+...+.
T Consensus       253 ~~~~~-----~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~  293 (310)
T 2wqm_A          253 CDYPP-----LP---------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK  293 (310)
T ss_dssp             TCSCC-----CC---------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccCCC-----Cc---------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            00000     00                     0122345667888999999999999987754443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-33  Score=304.64  Aligned_cols=201  Identities=25%  Similarity=0.398  Sum_probs=165.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..++|...+.||+|+||+||+|....+++.||||+++....  .....+.+|++++++++||||+++++++....     
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  106 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-----  106 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-----
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-----
Confidence            45689999999999999999999998999999999965532  23456789999999999999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec-----CC
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL-----DE  420 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill-----~~  420 (789)
                      ..++||||+. |+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||++     +.
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~  172 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDKN----------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASE  172 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----
T ss_pred             EEEEEEecCC-CCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCc
Confidence            8999999998 5999998644          45899999999999999999999998   9999999999999     45


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.+||+|||.++.......  ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          173 TPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            56799999999987653321  123345799999999988754 89999999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.5e-34  Score=298.20  Aligned_cols=262  Identities=21%  Similarity=0.254  Sum_probs=201.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|++++++++||||+++++++....   ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence            467888999999999999999999899999999997543  334567999999999999999999999875422   237


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--CCCceecCCCCCceecCCCCce
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--QPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      .++||||+++|+|.+++...      ......+++..+..++.|++.||+|||+.+  ..+++||||||+||+++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~  155 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV  155 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred             EEEEEeCCCCCCHHHHHHhh------cccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence            89999999999999998643      112345899999999999999999999876  3449999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||.++.......  ......|+..|+|||.+....++.++||||||+++|||++|+.||.....  ..+...+...
T Consensus       156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~  231 (279)
T 2w5a_A          156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREG  231 (279)
T ss_dssp             EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred             EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhc
Confidence            9999999987654431  12234589999999999888999999999999999999999999974311  1111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...        .+.                      ..+...+.+++..|++.++.+||+...+...+.
T Consensus       232 ~~~--------~~~----------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 KFR--------RIP----------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCC--------CCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ccc--------cCC----------------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            100        000                      122345668888999999999999988765443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-33  Score=304.72  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=192.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCC----ceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEG----RTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|...+.||+|+||+||+|.+..+    +..||||+++.... .....+.+|++++++++||||+++++++....    
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK----  119 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence            4666778999999999999998644    34699999975533 34567899999999999999999999987655    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus       120 -~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~  186 (333)
T 1mqb_A          120 -PMMIITEYMENGALDKFLREK---------DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVC  186 (333)
T ss_dssp             -SEEEEEECCTTEEHHHHHHHT---------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             -CcEEEEeCCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcE
Confidence             789999999999999998643         346899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      ||+|||.++........ .......++..|+|||.+....++.++||||||+++|||++ |+.||.....  ..+...+.
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~  264 (333)
T 1mqb_A          187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN  264 (333)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH
T ss_pred             EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH
Confidence            99999999887654321 12223446788999999988899999999999999999999 9999963211  11111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .....        .                      ....+...+.+++..|++.++..||+...+...+.
T Consensus       265 ~~~~~--------~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          265 DGFRL--------P----------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             TTCCC--------C----------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCcC--------C----------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11000        0                      00123345668889999999999999887755544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.5e-33  Score=300.70  Aligned_cols=269  Identities=23%  Similarity=0.304  Sum_probs=206.8

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhc--CCCCccceeeeeeccCCCCC
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS--IRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~~~~  343 (789)
                      ....++|...+.||+|+||.||+|.+.  ++.||||+++..   ....+..|++++..  ++||||+++++++..... .
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-T  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-S
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-c
Confidence            344578999999999999999999984  899999998533   34567788888877  789999999999876531 1


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh--------cCCCCCceecCCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH--------HDCQPITTHCDLKPSN  415 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivH~dlk~~N  415 (789)
                      ....++||||+.+|+|.+++..           ..+++.++..++.|++.||+|||        ..+   |+||||||+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N  177 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKN  177 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGG
T ss_pred             cceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHH
Confidence            1268999999999999999953           25899999999999999999999        666   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCcc--ceeeecccccccCcccCCCC------CcCccccchhhHHHHHHHHHh----
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQT--SSIGVKGSIGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIR----  483 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~sfGvvl~elltG----  483 (789)
                      |+++.++++||+|||++..........  ......||..|+|||.+...      .++.++|||||||++|||++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999998765543211  12345699999999998765      345799999999999999999    


Q ss_pred             ------cCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhcccccee
Q 041249          484 ------KKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKV  557 (789)
Q Consensus       484 ------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l  557 (789)
                            +.||............+.+......    ..+.+..                 .+...++...+.+++..|++.
T Consensus       258 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~  316 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPN-----------------RWQSCEALRVMAKIMRECWYA  316 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCG-----------------GGGTSHHHHHHHHHHHHHCCS
T ss_pred             CcccccccCccccCcCcccHHHHHHHHHHHH----hCCCCcc-----------------cccchhHHHHHHHHHHHHhcc
Confidence                  6777654444444444444332211    1111111                 111235667788999999999


Q ss_pred             eEeccCcccccccccccc
Q 041249          558 TILDLESLKLAGSILPHI  575 (789)
Q Consensus       558 ~~l~l~s~~~~~~~l~~l  575 (789)
                      ++.+||+...+...+..+
T Consensus       317 dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          317 NGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             SGGGSCCHHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHH
Confidence            999999998886655544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.7e-32  Score=299.05  Aligned_cols=137  Identities=18%  Similarity=0.114  Sum_probs=104.1

Q ss_pred             CCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEE
Q 041249           19 NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETL   98 (789)
Q Consensus        19 ~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   98 (789)
                      .++++++|++++|.++..-+..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..|..|+.+++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            46788888888888884444446788888888888888887667788888888888888888886667778888888888


Q ss_pred             eccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCCCC
Q 041249           99 TVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEG  168 (789)
Q Consensus        99 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~~~  168 (789)
                      +|++|++++..+..|.++++|++|++++             |.+++..|..+..+++|+.|++++|++++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~-------------n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSN-------------NNLERIEDDTFQATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCS-------------SCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCC-------------CccCccChhhccCCCCCCEEECCCCcCCc
Confidence            8888888843344457777666555544             44555567778888888888888887764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.5e-34  Score=301.04  Aligned_cols=271  Identities=24%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCCccEEEEEE----cCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      +.|...+.||+|+||.||+|.+    ..+++.||+|+++... ......+.+|++++++++||||+++++++....   .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence            3477788999999999999994    5678999999997543 334578999999999999999999999987642   2


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~  165 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKN---------KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQV  165 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCE
Confidence            2679999999999999998533         245899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||.+......... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....      ..+.+.
T Consensus       166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~  239 (302)
T 4e5w_A          166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKM  239 (302)
T ss_dssp             EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHH
T ss_pred             EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhc
Confidence            99999999987655422 22334568888999999998899999999999999999999999975321      111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..+......        ...   .........+......+...+.+++..|++.++.+||+...+...+
T Consensus       240 ~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  297 (302)
T 4e5w_A          240 IGPTHGQMT--------VTR---LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF  297 (302)
T ss_dssp             HCSCCGGGH--------HHH---HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             cCCcccccC--------HHH---HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            111000000        000   0000000000001123345677889999999999999998775433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.4e-33  Score=296.92  Aligned_cols=259  Identities=18%  Similarity=0.269  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||.||+|....+++.||||++....  ..+.+.+|+++++.++|+++++.++.+....    ...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCC----CceE
Confidence            568999999999999999999998899999999986543  2356899999999999999888877764432    3679


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---CCCcee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSH  425 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~k  425 (789)
                      +||||+ +++|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++   +++.+|
T Consensus        82 lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k  148 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEE
T ss_pred             EEEEec-CCCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEE
Confidence            999999 89999998632         246899999999999999999999998   99999999999994   888999


Q ss_pred             eCcccccccCCCCCCc-----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC--CccHH
Q 041249          426 VGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG--DMNLH  498 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~--~~~~~  498 (789)
                      |+|||.++........     .......||..|+|||.+.+..++.++|||||||++|||++|+.||......  ...+.
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 3uzp_A          149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence            9999999987654421     1123456999999999999999999999999999999999999999753221  11222


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .............                           ....+...+.+++..|++.++.+||+...+...+.
T Consensus       229 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          229 RISEKKMSTPIEV---------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHHSCHHH---------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             hhcccccCCchHH---------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            2221111100000                           00123445678889999999999999887755443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.9e-34  Score=301.67  Aligned_cols=256  Identities=21%  Similarity=0.294  Sum_probs=197.8

Q ss_pred             HhhcCCCCCC-cccccCCccEEEEEE--cCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          267 NATDGFSSAN-LIGTGSFGSVYKGVL--DEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       267 ~~~~~f~~~~-~ig~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ...++|...+ .||+|+||+||+|.+  ..+++.||||+++...  ....+.+.+|++++++++||||+++++++.. . 
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-   90 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-   90 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-C-
Confidence            3445677777 999999999999965  4567899999997543  2335789999999999999999999999832 2 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.+
T Consensus        91 ----~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~  153 (291)
T 1xbb_A           91 ----SWMLVMEMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ  153 (291)
T ss_dssp             ----SEEEEEECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             ----CcEEEEEeCCCCCHHHHHHhC----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCC
Confidence                579999999999999999643          45899999999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~  499 (789)
                      +.+||+|||++.......... ......++..|+|||.+....++.++||||||+++|||++ |+.||.....  .....
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~  231 (291)
T 1xbb_A          154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTA  231 (291)
T ss_dssp             TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH
T ss_pred             CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Confidence            999999999998876554321 1223346788999999988889999999999999999999 9999974211  11111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .+.....        +..                      ...+...+.+++..|++.++.+||+...+...+.
T Consensus       232 ~~~~~~~--------~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          232 MLEKGER--------MGC----------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             HHHTTCC--------CCC----------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHHcCCC--------CCC----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111100        000                      0123345668889999999999999887754433

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.4e-34  Score=309.10  Aligned_cols=199  Identities=24%  Similarity=0.349  Sum_probs=175.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++....     ..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----EE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----EE
Confidence            467888999999999999999999899999999997653 334577999999999999999999999998765     79


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      ++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl  173 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL  173 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEECCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEE
Confidence            9999999999999999643          4588999999999999999999985 7   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||++.......    .....||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       174 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          174 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             CCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             EECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999987553221    2235689999999999999999999999999999999999999974

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-33  Score=300.74  Aligned_cols=272  Identities=21%  Similarity=0.253  Sum_probs=184.8

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ....++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++....    
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   86 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----   86 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS----
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC----
Confidence            345678999999999999999999998889999999986543 334567889999999999999999999998765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+.+|+|.+++......  .......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        87 -~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~  160 (303)
T 2vwi_A           87 -ELWLVMKLLSGGSVLDIIKHIVAK--GEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSV  160 (303)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHHT--TTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             -CcEEEehhccCCchHHHHHHHhhc--cccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCE
Confidence             789999999999999998631000  0112356899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCC---ccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249          425 HVGDFGLARFLPPTHV---QTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~  500 (789)
                      ||+|||.+........   ........||..|+|||.+.. ..++.++||||||+++|||++|+.||......  .....
T Consensus       161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~  238 (303)
T 2vwi_A          161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLML  238 (303)
T ss_dssp             EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHH
T ss_pred             EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHH
Confidence            9999999987754431   112233568999999999876 46899999999999999999999999743221  11111


Q ss_pred             HHHhCCCchh-hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          501 ARMALPDHVM-DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       501 ~~~~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....+.... ...++...                      ..+...+.+++..|++.++..||+...+..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          239 TLQNDPPSLETGVQDKEML----------------------KKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHTSSCCCTTC-----CCC----------------------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhccCCCccccccccchhh----------------------hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            1111111110 01111111                      1223456678889999999999999887554

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.98  E-value=1.2e-33  Score=297.07  Aligned_cols=255  Identities=20%  Similarity=0.285  Sum_probs=197.6

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcC---CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ..++|...+.||+|+||+||+|.+..   ++..||+|.+.... ....+.+.+|++++++++||||+++++++...    
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE----   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence            45788899999999999999999753   24569999987553 34467899999999999999999999997643    


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        86 --~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  151 (281)
T 3cc6_A           86 --PTWIIMELYPYGELGHYLERN---------KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPEC  151 (281)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTE
T ss_pred             --CCEEEEecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCc
Confidence              468999999999999998643         345899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||.+......... ......++..|+|||......++.++||||||+++|||++ |+.||.....  ......+.
T Consensus       152 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~  228 (281)
T 3cc6_A          152 VKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLE  228 (281)
T ss_dssp             EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHH
T ss_pred             EEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHh
Confidence            999999999877554321 1223457889999999988889999999999999999998 9999963322  12222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .......                              ...+...+.+++..|++.++..||+.......+.
T Consensus       229 ~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          229 KGDRLPK------------------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             HTCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCC------------------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence            1111000                              0112344667888999999999999987754443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=2.5e-33  Score=302.43  Aligned_cols=264  Identities=19%  Similarity=0.180  Sum_probs=187.2

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCC---
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDY---  341 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~---  341 (789)
                      +....+|...+.||+|+||.||+|.+..+++.||||++........+.+.+|+..+.++. ||||+++++++.....   
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            344568889999999999999999999899999999987666666778999999999996 9999999999853321   


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                      ......++|+||+. |+|.+++...       .....+++.++..++.|++.||+|||+.+ ++|+||||||+||+++.+
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence            23446899999997 7999888542       12346899999999999999999999774 359999999999999999


Q ss_pred             CceeeCcccccccCCCCCCcc----------ceeeecccccccCcccC---CCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          422 MVSHVGDFGLARFLPPTHVQT----------SSIGVKGSIGYIAPEYG---LGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +.+||+|||+++.........          ......||..|+|||.+   .+..++.++|||||||++|||++|+.||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999999876543211          11134589999999998   56678999999999999999999999996


Q ss_pred             ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      ....     ............        .                      ..+...+.+++..|++.++.+|++..++
T Consensus       255 ~~~~-----~~~~~~~~~~~~--------~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~  299 (337)
T 3ll6_A          255 DGAK-----LRIVNGKYSIPP--------H----------------------DTQYTVFHSLIRAMLQVNPEERLSIAEV  299 (337)
T ss_dssp             ----------------CCCCT--------T----------------------CCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred             chhH-----HHhhcCcccCCc--------c----------------------cccchHHHHHHHHHccCChhhCcCHHHH
Confidence            3211     111111110000        0                      0111224467888999999999998877


Q ss_pred             ccccc
Q 041249          569 GSILP  573 (789)
Q Consensus       569 ~~~l~  573 (789)
                      ...+.
T Consensus       300 l~~l~  304 (337)
T 3ll6_A          300 VHQLQ  304 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            55443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.98  E-value=3.3e-34  Score=328.53  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=204.6

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ..+++...++|...+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|++++++++|+||+++++++.. . 
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~-  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c-
Confidence            3445556678888999999999999999997 45779999997544 235679999999999999999999999864 2 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+|+|.+++...        ....+++.++..|+.||+.||+|||+.+   ||||||||+|||++++
T Consensus       335 ----~~~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~  399 (535)
T 2h8h_A          335 ----PIYIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN  399 (535)
T ss_dssp             ----SCEEEECCCTTEEHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             ----cceEeeehhcCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCC
Confidence                579999999999999999642        2245899999999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      +.+||+|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||.....  ..+...
T Consensus       400 ~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~  476 (535)
T 2h8h_A          400 LVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ  476 (535)
T ss_dssp             GCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHH
T ss_pred             CcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence            9999999999987653221 11123446788999999988899999999999999999999 9999963211  011111


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      +......                              .....|...+.+++..|++.++.+||+...+...+..
T Consensus       477 i~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          477 VERGYRM------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  520 (535)
T ss_dssp             HHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHcCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111000                              0011344566788999999999999999877554443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.98  E-value=4.7e-33  Score=302.50  Aligned_cols=207  Identities=23%  Similarity=0.346  Sum_probs=172.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---CCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY---QGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~~  344 (789)
                      ++|...+.||+|+||+||+|....+++.||||++....  ......+.+|++++++++||||+++++++.....   ...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57888999999999999999998899999999986543  2335678899999999999999999999876431   112


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+.+ ++.+.+...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence            368999999985 777766533         345899999999999999999999998   9999999999999999999


Q ss_pred             eeCcccccccCCCCCC--ccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHV--QTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+++.......  ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  231 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  231 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999987764331  222334568999999998876 4589999999999999999999999974

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=1.2e-33  Score=294.65  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ..++|...+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++....     ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   78 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PI   78 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SC
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----Ce
Confidence            3467888899999999999999997 678899999975543 3467899999999999999999999987655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+++|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~  146 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS  146 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEEC
T ss_pred             EEEEeCCCCCcHHHHHhhC---------cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEc
Confidence            9999999999999998643         246889999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||.+........ .......++..|+|||.+....++.++||||||+++|||++ |+.||.....  ......+.....
T Consensus       147 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~~  223 (267)
T 3t9t_A          147 DFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFR  223 (267)
T ss_dssp             CTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCC
T ss_pred             ccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCc
Confidence            9999987654321 11123446788999999988889999999999999999999 8999873211  111111111100


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .        ..                      ...+...+.+++..|++.++.+||+.......+
T Consensus       224 ~--------~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (267)
T 3t9t_A          224 L--------YK----------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL  259 (267)
T ss_dssp             C--------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C--------CC----------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            0        00                      001233456788899999999999988765433

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.98  E-value=2.6e-33  Score=295.18  Aligned_cols=249  Identities=18%  Similarity=0.204  Sum_probs=197.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||+||+|.+..+++.||+|+++..  .......+.+|+..+.++ +||||+++++++....     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-----   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-----   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-----
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----
Confidence            46788899999999999999999989999999998754  334457788999999999 9999999999997766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-----
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-----  420 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-----  420 (789)
                      ..++||||+++|+|.+++...      ......+++.++..++.|++.||+|||+.+   |+||||||+||+++.     
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~  155 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISEN------YRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPN  155 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------
T ss_pred             eEEEEEEecCCCcHHHHHHhh------cccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCc
Confidence            899999999999999999643      111246899999999999999999999998   999999999999984     


Q ss_pred             --------------CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcC
Q 041249          421 --------------EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKK  485 (789)
Q Consensus       421 --------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~  485 (789)
                                    ...+||+|||.+.......      ...||..|+|||.+.+. .+++++|||||||++|||++|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~  229 (289)
T 1x8b_A          156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP  229 (289)
T ss_dssp             --------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence                          4588999999998876543      23489999999998776 57789999999999999999988


Q ss_pred             CCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          486 PSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       486 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      |+...    .......+...         +.+.                      ..+...+.+++..|++.++.+||+.
T Consensus       230 ~~~~~----~~~~~~~~~~~---------~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~  274 (289)
T 1x8b_A          230 LPRNG----DQWHEIRQGRL---------PRIP----------------------QVLSQEFTELLKVMIHPDPERRPSA  274 (289)
T ss_dssp             CCSSS----HHHHHHHTTCC---------CCCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCcch----hHHHHHHcCCC---------CCCC----------------------cccCHHHHHHHHHHhCCCcccCCCH
Confidence            76421    11111111000         0111                      0123345678889999999999999


Q ss_pred             ccccccc
Q 041249          566 KLAGSIL  572 (789)
Q Consensus       566 ~~~~~~l  572 (789)
                      .....++
T Consensus       275 ~~ll~h~  281 (289)
T 1x8b_A          275 MALVKHS  281 (289)
T ss_dssp             HHHHTCT
T ss_pred             HHHhhCh
Confidence            8775543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=3.5e-33  Score=304.97  Aligned_cols=201  Identities=24%  Similarity=0.308  Sum_probs=167.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .+.|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36788899999999999999999989999999998543  23335678899999999999999999999876531 2223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+ +++|.+++..           ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEE
Confidence            569999999 7899998853           35889999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++......     ....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       169 l~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          169 ILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             ECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999765432     23468999999999877 6799999999999999999999999973

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.98  E-value=8.6e-34  Score=297.81  Aligned_cols=258  Identities=23%  Similarity=0.388  Sum_probs=201.4

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      +.+...++|...+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|++++++++||||+++++++...    
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   80 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE----   80 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC----
Confidence            33445578888999999999999999987 67889999986543 2356799999999999999999999997532    


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.
T Consensus        81 --~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~  147 (279)
T 1qpc_A           81 --PIYIITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLS  147 (279)
T ss_dssp             --SCEEEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred             --CcEEEEecCCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCC
Confidence              478999999999999999643        1236899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||.+......... ......++..|+|||.+..+.++.++||||||+++|||++ |+.||.....  ......+.
T Consensus       148 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~  224 (279)
T 1qpc_A          148 CKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE  224 (279)
T ss_dssp             EEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH
T ss_pred             EEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHHHh
Confidence            999999999887654311 1223446788999999988889999999999999999999 9999863211  11111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ....        +..                      ...+...+.+++..|++.++..||+.......+.
T Consensus       225 ~~~~--------~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          225 RGYR--------MVR----------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             TTCC--------CCC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccC--------CCC----------------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            1100        000                      0123345668888999999999999887654443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2e-33  Score=296.34  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             cCCCCCC-cccccCCccEEEEEEc--CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSAN-LIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~-~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+ .||+|+||.||+|.+.  .+++.||||+++... ....+.+.+|++++++++||||+++++++.. .     
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C-----
Confidence            4555555 8999999999999864  457889999997653 3446779999999999999999999999843 2     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhC---------CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEE
Confidence            589999999999999998643         356899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          426 VGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |+|||.+......... .......+|..|+|||.+....++.++||||||+++|||++ |+.||.....  ..+...+..
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~  228 (287)
T 1u59_A          151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ  228 (287)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred             ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhc
Confidence            9999999987654422 11223446889999999988889999999999999999998 9999974321  112222211


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...        +..                      ...+...+.+++..|++.++..||+...+...+.
T Consensus       229 ~~~--------~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          229 GKR--------MEC----------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCC--------CCC----------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCc--------CCC----------------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            100        000                      0123445668889999999999999987754443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.98  E-value=2.8e-33  Score=296.83  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=194.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ..|...+.||+|+||+||+|.+..+   ...||+|.+..... ...+.+.+|++++++++||||++++++|...+    .
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----C
Confidence            4677789999999999999997533   34689999875433 34577999999999999999999999975433    2


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~k  168 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVK  168 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT---------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEE
T ss_pred             ceEEEEeCCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEE
Confidence            678999999999999999643         356789999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCC--ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHh-cCCCCccccCCccHHHHHH
Q 041249          426 VGDFGLARFLPPTHV--QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       426 l~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG-~~P~~~~~~~~~~~~~~~~  502 (789)
                      |+|||.++.......  ........+|..|+|||.+.+..++.++||||||+++|||++| ..||... .. ........
T Consensus       169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~~-~~~~~~~~  246 (298)
T 3f66_A          169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NT-FDITVYLL  246 (298)
T ss_dssp             ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-CT-TTHHHHHH
T ss_pred             ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-CH-HHHHHHHh
Confidence            999999987754432  1223345578899999999888999999999999999999995 5555422 11 11222111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .......                              ...+...+.+++..|++.++.+||+.......+.
T Consensus       247 ~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          247 QGRRLLQ------------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             TTCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCC------------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1110000                              0112334667888999999999999887754443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.98  E-value=7.8e-33  Score=294.40  Aligned_cols=253  Identities=19%  Similarity=0.282  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||.||+|....+++.||+|+++...    ......+.+|++++++++||||+++++++....   ..
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---KQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CC
Confidence            68999999999999999999999899999999996542    234578999999999999999999999985322   23


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+| +.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSV--------PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHS--------TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             eEEEEehhccCC-HHHHHHhC--------cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEE
Confidence            689999999977 66666433        2356899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |+|||.+................|+..|+|||...+..  ++.++||||||+++|||++|+.||...     ........
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~  224 (305)
T 2wtk_C          150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYKLFEN  224 (305)
T ss_dssp             ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHH
T ss_pred             eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHH
Confidence            99999999876544333444566999999999987643  488999999999999999999999732     11111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....      ...+.                      ..+...+.+++..|++.++..|++......
T Consensus       225 i~~~------~~~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          225 IGKG------SYAIP----------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHC------CCCCC----------------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HhcC------CCCCC----------------------CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1000      00000                      122344567888999999999999887644

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.98  E-value=3.3e-33  Score=317.28  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=201.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .+.|...+.||+|+||.||+|....+++.||||++....   ......+.+|++++++++||||+++++++....     
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-----   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            357888999999999999999999999999999986442   344678999999999999999999999998765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---CCCC
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEM  422 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---~~~~  422 (789)
                      ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||++   +.++
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  166 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISR----------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDA  166 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC----------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTC
T ss_pred             EEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCC
Confidence            899999999999999988644          56899999999999999999999998   9999999999999   5678


Q ss_pred             ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~  502 (789)
                      .+||+|||+++.......   .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.....  ......+.
T Consensus       167 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~  240 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVE  240 (484)
T ss_dssp             CEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             cEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH
Confidence            999999999987765432   223569999999998865 799999999999999999999999973211  11111111


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..           .+....                .........+.+++..|.+.+|..|++......+
T Consensus       241 ~~-----------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          241 KG-----------KYTFEL----------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HC-----------CCCCCS----------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cC-----------CCCCCC----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            11           000000                0001223455678889999999999999877554

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.98  E-value=4.7e-33  Score=303.85  Aligned_cols=256  Identities=20%  Similarity=0.287  Sum_probs=200.7

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--------hhhHHHHHHHHHHhcC-CCCccceeeee
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--------RASRSFIAECRALRSI-RHRNLVKVFTA  335 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~  335 (789)
                      .....++|...+.||+|+||.||+|.+..+++.||||+++....        ...+.+.+|++++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            34445789999999999999999999988899999999865431        1245688999999999 79999999999


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      +....     ..++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+.+   ++|+||||+|
T Consensus       169 ~~~~~-----~~~lv~e~~~g~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~N  230 (365)
T 2y7j_A          169 YESSS-----FMFLVFDLMRKGELFDYLTEK----------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPEN  230 (365)
T ss_dssp             EEBSS-----EEEEEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             EeeCC-----EEEEEEEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence            87655     899999999999999998532          46899999999999999999999998   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC------CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG------SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+++.++.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||..
T Consensus       231 Il~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          231 ILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             EEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999987765432   234569999999998753      3589999999999999999999999963


Q ss_pred             cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ...  ......+....           ......                ....+...+.+++..|.+.++..|++...+.
T Consensus       308 ~~~--~~~~~~i~~~~-----------~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell  358 (365)
T 2y7j_A          308 RRQ--ILMLRMIMEGQ-----------YQFSSP----------------EWDDRSSTVKDLISRLLQVDPEARLTAEQAL  358 (365)
T ss_dssp             SSH--HHHHHHHHHTC-----------CCCCHH----------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCH--HHHHHHHHhCC-----------CCCCCc----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            211  11111111100           000000                0012234466788899999999999987764


Q ss_pred             c
Q 041249          570 S  570 (789)
Q Consensus       570 ~  570 (789)
                      .
T Consensus       359 ~  359 (365)
T 2y7j_A          359 Q  359 (365)
T ss_dssp             H
T ss_pred             c
Confidence            4

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.98  E-value=3.1e-33  Score=305.18  Aligned_cols=201  Identities=23%  Similarity=0.322  Sum_probs=156.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~  345 (789)
                      .++|...+.||+|+||.||+|....+++.||||++...  .....+.+.+|+++++.++||||+++++++.... .....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36888999999999999999999989999999998643  2334567889999999999999999999986542 11223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++|+|++ +++|.+++..           ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             CCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             eEEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence            579999999 5788888742           35899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||+++.....     .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  232 (367)
T 2fst_X          173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  232 (367)
T ss_dssp             ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999875433     233568999999999877 6799999999999999999999999963

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=1e-33  Score=297.85  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-------
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-------  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------  341 (789)
                      .++|...+.||+|+||.||+|.+..+++.||+|.++...    ..+.+|++++++++||||+++++++....+       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            357888999999999999999999899999999986543    356789999999999999999998754221       


Q ss_pred             ----CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          342 ----QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       342 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                          ......++||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   |+||||||+||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil  154 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR--------RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIF  154 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHG--------GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEE
Confidence                1123579999999999999999643        2356899999999999999999999998   999999999999


Q ss_pred             cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249          418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL  497 (789)
Q Consensus       418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~  497 (789)
                      ++.++.+||+|||.+........   .....|+..|+|||.+.+..++.++||||||+++|||++|..|+...       
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------  224 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------  224 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------
T ss_pred             EcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------
Confidence            99999999999999988765432   22345899999999998888999999999999999999999987521       


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI  575 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l  575 (789)
                      ..+....        .+..+..                      .+...+.+++..|++.++..||+..+....+..+
T Consensus       225 ~~~~~~~--------~~~~~~~----------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          225 SKFFTDL--------RDGIISD----------------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHHHHHH--------HTTCCCT----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHh--------hcccccc----------------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111111        0101100                      1122345778899999999999998875554433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.98  E-value=1.9e-33  Score=327.73  Aligned_cols=247  Identities=22%  Similarity=0.310  Sum_probs=191.8

Q ss_pred             CcccccCCccEEEEEEc--CCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|.+.  .+++.||||+++....  ...+.+.+|++++++++||||++++++|...      ..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence            47999999999999664  4578999999975432  3357899999999999999999999998532      478999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+.+|+|.+++...          ..+++.++..|+.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus       449 E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             ECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             EccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCC
Confidence            999999999999643          56899999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCch
Q 041249          432 ARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       432 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      ++....... ........+|..|+|||++....++.++|||||||++|||++ |+.||......  .+...+......  
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~--  591 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERM--  591 (635)
T ss_dssp             HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC--
T ss_pred             ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC--
Confidence            998765442 222233457789999999998899999999999999999998 99999732111  111111111000  


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                            .                      ....+...+.+++..|++.++.+||+...+...+.
T Consensus       592 ------~----------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          592 ------G----------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             ------C----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ------C----------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                  0                      01134456778899999999999999987754443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.98  E-value=4.6e-33  Score=316.60  Aligned_cols=251  Identities=19%  Similarity=0.243  Sum_probs=194.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+.|...+.||+|+||+||+|....+++.||+|++....  ......+.+|+++++.++||||+++++++....     .
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----N  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            346888999999999999999999899999999986543  334678899999999999999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---Cc
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MV  423 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~~  423 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+++..   +.
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  177 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR----------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL  177 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCC
T ss_pred             EEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCc
Confidence            99999999999999988543          46899999999999999999999998   9999999999999764   55


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +||+|||+++.......   .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.....  ..+...+..
T Consensus       178 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~  251 (494)
T 3lij_A          178 IKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEK  251 (494)
T ss_dssp             EEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence            99999999987654431   23456999999999876 5799999999999999999999999973211  111111111


Q ss_pred             h-CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 A-LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~-~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      . ....     .+                       ........+.+++..|.+.++..|++...+..+
T Consensus       252 ~~~~~~-----~~-----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          252 GKYTFD-----SP-----------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             TCCCCC-----SG-----------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCCCC-----ch-----------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1 0000     00                       001223345578889999999999998877554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.98  E-value=5.7e-33  Score=315.27  Aligned_cols=250  Identities=22%  Similarity=0.252  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|...+.||+|+||+||+|....+++.||||++...  .......+.+|++++++++||||+++++++....     ..
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~   96 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----SF   96 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-----EE
Confidence            5788899999999999999999989999999998643  2334578899999999999999999999998765     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---CCCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~  424 (789)
                      ++||||+.+|+|.+++...          ..+++.++..++.|++.||.|||+.+   |+||||||+||+++   .++.+
T Consensus        97 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  163 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDI  163 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCE
T ss_pred             EEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCE
Confidence            9999999999999988543          46899999999999999999999998   99999999999995   55689


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH-
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM-  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~-  503 (789)
                      ||+|||+++.......   .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.....  ......+.. 
T Consensus       164 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~  237 (486)
T 3mwu_A          164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETG  237 (486)
T ss_dssp             EECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred             EEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC
Confidence            9999999987654432   234569999999999864 699999999999999999999999963211  111111111 


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .+...            .                .........+.+++..|.+.+|..|++...+..+
T Consensus       238 ~~~~~------------~----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 KYAFD------------L----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCCSC------------S----------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCC------------C----------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000            0                0001223445678889999999999998876544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.98  E-value=5.3e-32  Score=298.64  Aligned_cols=150  Identities=19%  Similarity=0.200  Sum_probs=128.3

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|++++|.++...+..+..+++|++|++++|.+++..+..|+.+++|++|+|++|++++..|..++.+++|++|+|++|+
T Consensus        49 ~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  128 (390)
T 3o6n_A           49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND  128 (390)
T ss_dssp             EEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCc
Confidence            47899999995444557899999999999999998888899999999999999999998888889999999999999999


Q ss_pred             CCCCCccc-ccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEE
Q 041249           81 FRGSFPTE-VGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENL  159 (789)
Q Consensus        81 l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l  159 (789)
                      ++ .+|.. |+.+++|++|++++|++++..|..+..+++|++|++++|++.+             .   .+..+++|+.|
T Consensus       129 l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------~---~~~~l~~L~~L  191 (390)
T 3o6n_A          129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-------------V---DLSLIPSLFHA  191 (390)
T ss_dssp             CC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-------------C---CGGGCTTCSEE
T ss_pred             cC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc-------------c---cccccccccee
Confidence            99 55554 6999999999999999998888889998888887777766542             2   14556788999


Q ss_pred             ecccCCCC
Q 041249          160 NLSYNDLE  167 (789)
Q Consensus       160 ~ls~N~~~  167 (789)
                      ++++|.++
T Consensus       192 ~l~~n~l~  199 (390)
T 3o6n_A          192 NVSYNLLS  199 (390)
T ss_dssp             ECCSSCCS
T ss_pred             eccccccc
Confidence            98888664

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.98  E-value=7e-33  Score=300.66  Aligned_cols=271  Identities=16%  Similarity=0.185  Sum_probs=201.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh-----------------hHHHHHHHHHHhcCCCCccce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-----------------SRSFIAECRALRSIRHRNLVK  331 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~  331 (789)
                      .++|...+.||+|+||.||+|.+  +++.||||++.......                 ...+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  79999999986442221                 178999999999999999999


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCD  410 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~d  410 (789)
                      +++++...+     ..++||||+.+|+|.+++.......  ......+++..+..++.|++.||+|||+ .+   ++|||
T Consensus       108 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d  177 (348)
T 2pml_X          108 CEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLD--KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRD  177 (348)
T ss_dssp             CSEEEESSS-----EEEEEEECCTTCBSSEESSSEESSC--SSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCC
T ss_pred             EEEEEeeCC-----eEEEEEeccCCCcHHHHHHHhhhhh--hccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecC
Confidence            999998765     8999999999999999832110000  0124678999999999999999999998 87   99999


Q ss_pred             CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCc-cccchhhHHHHHHHHHhcCCCC
Q 041249          411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVST-NGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |||+||+++.++.+||+|||.+......    ......|+..|+|||...+. .++. ++||||||+++|||++|+.||.
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999876543    23345689999999999887 6766 9999999999999999999997


Q ss_pred             ccccCCccHHHHHHHh-C--CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          489 IMFEGDMNLHNFARMA-L--PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       489 ~~~~~~~~~~~~~~~~-~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      ..... ......+... .  +........+.....               .......+...+.+++..|++.++..|++.
T Consensus       254 ~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  317 (348)
T 2pml_X          254 LKISL-VELFNNIRTKNIEYPLDRNHFLYPLTNKK---------------STCSNNFLSNEDIDFLKLFLRKNPAERITS  317 (348)
T ss_dssp             CSSCS-HHHHHHHTSCCCCCCCSSSSSTTTTCC-----------------------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCcH-HHHHHHHhccCcCCccchhhhhccccccc---------------cccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence            43221 1111111111 0  000000000000000               000011234566788899999999999999


Q ss_pred             cccccc
Q 041249          566 KLAGSI  571 (789)
Q Consensus       566 ~~~~~~  571 (789)
                      ..+..+
T Consensus       318 ~e~l~h  323 (348)
T 2pml_X          318 EDALKH  323 (348)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            877553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.98  E-value=5e-33  Score=291.42  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=192.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||++....   ......+.+|++.+++++||||+++++++....     
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-----   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence            367888999999999999999999889999999986442   233567899999999999999999999987765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~  151 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKH----------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAK  151 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEE
Confidence            899999999999999998643          45889999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|||.+........   .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||+..     ......+..
T Consensus       152 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~  223 (276)
T 2h6d_A          152 IADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPTLFKKI  223 (276)
T ss_dssp             ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred             EeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHh
Confidence            999999987754431   223468899999999987765 78999999999999999999999732     111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ....      ..+.                      ..+...+.+++..|.+.++..||+...+..+
T Consensus       224 ~~~~------~~~~----------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          224 RGGV------FYIP----------------------EYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHCC------CCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hcCc------ccCc----------------------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0000      0000                      0122345678889999999999999876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.98  E-value=9.8e-33  Score=292.62  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=199.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---------chhhHHHHHHHHHHhcCC-CCccceeeeeecc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---------HRASRSFIAECRALRSIR-HRNLVKVFTACSG  338 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  338 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||+++...         ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468889999999999999999999899999999996543         122456889999999995 9999999999876


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      ..     ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||++
T Consensus        96 ~~-----~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~  157 (298)
T 1phk_A           96 NT-----FFFLVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILL  157 (298)
T ss_dssp             SS-----EEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CC-----eEEEEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEE
Confidence            55     899999999999999998643          46899999999999999999999998   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCC------CCCcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL------GSEVSTNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      +.++.+||+|||.+........   .....|+..|+|||.+.      ...++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             CTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            9999999999999987765432   22356899999999874      45689999999999999999999999963211


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                        ......+......    ...+                       ....+...+.+++..|++.++..|++......
T Consensus       235 --~~~~~~~~~~~~~----~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 --MLMLRMIMSGNYQ----FGSP-----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHHHHHTCCC----CCTT-----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHhcCCcc----cCcc-----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              1111111110000    0000                       01123345668889999999999999887754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.98  E-value=2.9e-33  Score=300.82  Aligned_cols=269  Identities=21%  Similarity=0.229  Sum_probs=199.3

Q ss_pred             ccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeee
Q 041249          258 LNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTAC  336 (789)
Q Consensus       258 ~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  336 (789)
                      ..+++.++....+.|...+.||+|+||.||+|.+..+++.||||++.... .....+.+|+++++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            44556666677889999999999999999999998889999999986543 3456789999999999 899999999998


Q ss_pred             ccCCCCC-CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          337 SGVDYQG-NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       337 ~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      ......+ ....++||||+.+|+|.+++...        ....+++..+..++.|++.||+|||+.+   ++||||||+|
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~N  159 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQN  159 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHH
Confidence            7643211 33789999999999999998643        2356889999999999999999999998   9999999999


Q ss_pred             eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |+++.++.+||+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||...
T Consensus       160 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          160 VLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             EEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999987653321  122346899999999987     566899999999999999999999999632


Q ss_pred             ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ...  .....+.. .+       .+...                     ...+...+.+++..|+..++..||+...+..
T Consensus       238 ~~~--~~~~~~~~-~~-------~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          238 HPM--RALFLIPR-NP-------APRLK---------------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CHH--HHHHHHHH-SC-------CCCCS---------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cHH--HHHHHhhc-Cc-------cccCC---------------------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            110  00000000 00       00000                     0012234567888999999999999887754


Q ss_pred             c
Q 041249          571 I  571 (789)
Q Consensus       571 ~  571 (789)
                      +
T Consensus       287 h  287 (326)
T 2x7f_A          287 H  287 (326)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.98  E-value=8.5e-33  Score=295.46  Aligned_cols=252  Identities=21%  Similarity=0.213  Sum_probs=197.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .+.|...+.||+|+||.||+|.+..+++.||+|.+....  ....+.+|++++.+++||||+++++++....     ..+
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  100 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DLW  100 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence            467889999999999999999999889999999986543  3467899999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...         ...+++.++..++.|++.||.|||..+   ++|+||||+||+++.++.+||+|
T Consensus       101 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  168 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLR---------NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLAD  168 (314)
T ss_dssp             EEEECCTTEEHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred             EEeecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEee
Confidence            999999999999998522         346899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||.+........  ......|+..|+|||.+....++.++||||||+++|||++|+.||......  ..........   
T Consensus       169 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~---  241 (314)
T 3com_A          169 FGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNP---  241 (314)
T ss_dssp             CTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC---
T ss_pred             cccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCC---
Confidence            999987654321  123456899999999999989999999999999999999999999732110  0000000000   


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                           .+...                    ....+...+.+++..|++.++..||+......+
T Consensus       242 -----~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          242 -----PPTFR--------------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -----CCCCS--------------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -----CcccC--------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 00000                    001123456688889999999999999877553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.98  E-value=4.9e-32  Score=315.52  Aligned_cols=138  Identities=17%  Similarity=0.117  Sum_probs=118.7

Q ss_pred             CCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEE
Q 041249           19 NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETL   98 (789)
Q Consensus        19 ~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   98 (789)
                      .+++++.|++++|.+.+..+..|+.+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            46889999999999996555668899999999999999998888899999999999999999998778889999999999


Q ss_pred             eccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCCCCC
Q 041249           99 TVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM  169 (789)
Q Consensus        99 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~~~~  169 (789)
                      +|++|+|++..+..|+++++|++|+|+             +|.+++..|..+..+++|+.|++++|.+++.
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls-------------~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMS-------------NNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECC-------------SSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEee-------------CCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            999999996555667888777665554             5556677788899999999999999988754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.98  E-value=3.8e-34  Score=306.57  Aligned_cols=262  Identities=22%  Similarity=0.311  Sum_probs=199.7

Q ss_pred             CCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          272 FSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      |...+.||+|+||+||++.+    ..+++.||||+++.... .....+.+|++++++++||||+++++++....   ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence            47789999999999988765    34688999999976533 34567999999999999999999999987642   237


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...           .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-----------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecccCCcHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEE
Confidence            89999999999999999643           3899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          427 GDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      +|||.+......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......   ..  ....
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~--~~~~  250 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LE--LIGI  250 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HH--HHCS
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hh--hhcc
Confidence            999999988765432 12234457888999999998899999999999999999999999987421110   00  0000


Q ss_pred             CCc------hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          506 PDH------VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       506 ~~~------~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ...      ..+.++....                  ......+...+.+++..|++.++.+||+...+...+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGER------------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccchhHHHHHHHHhcccC------------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            000      0011111000                  0111234456778899999999999999987754443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.98  E-value=2.2e-33  Score=298.26  Aligned_cols=254  Identities=22%  Similarity=0.253  Sum_probs=195.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .+.|...+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++....     ..+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----KLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----eEE
Confidence            467888999999999999999999889999999997766666788999999999999999999999987655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...         ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        93 lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             EEEECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEE
Confidence            999999999999988532         245899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccC-----CCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYG-----LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||++.......  .......|+..|+|||.+     ....++.++||||||+++|||++|+.||...... .......+.
T Consensus       161 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~  237 (302)
T 2j7t_A          161 FGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS  237 (302)
T ss_dssp             CHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS
T ss_pred             CCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHhcc
Confidence            99875422111  011234589999999987     4667899999999999999999999999732110 011111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..+         ...                    ....+...+.+++..|++.++..||+......+
T Consensus       238 ~~~---------~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          238 DPP---------TLL--------------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CCC---------CCS--------------------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CCc---------ccC--------------------CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000         000                    011223456678889999999999999877554

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.98  E-value=7.9e-33  Score=315.48  Aligned_cols=253  Identities=22%  Similarity=0.280  Sum_probs=198.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-------------hhhHHHHHHHHHHhcCCCCccceeeee
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-------------RASRSFIAECRALRSIRHRNLVKVFTA  335 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~~  335 (789)
                      .++|...+.||+|+||+||+|....+++.||+|++.....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            5789999999999999999999998999999999865421             235678999999999999999999999


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN  415 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N  415 (789)
                      +....     ..++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+|
T Consensus       115 ~~~~~-----~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~N  176 (504)
T 3q5i_A          115 FEDKK-----YFYLVTEFYEGGELFEQIINR----------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPEN  176 (504)
T ss_dssp             EECSS-----EEEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             EEcCC-----EEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHH
Confidence            98765     899999999999999988543          46899999999999999999999998   9999999999


Q ss_pred             eecCCCC---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249          416 ILLDEEM---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE  492 (789)
Q Consensus       416 ill~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~  492 (789)
                      |+++.++   .+||+|||+++.......   .....||+.|+|||.+. +.++.++|||||||++|+|++|+.||.... 
T Consensus       177 il~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  251 (504)
T 3q5i_A          177 ILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-  251 (504)
T ss_dssp             EEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             EEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence            9998775   699999999988765432   23356999999999876 569999999999999999999999997321 


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                          .........        ...+.....                ........+.+++..|.+.++..|++..++..++
T Consensus       252 ----~~~~~~~i~--------~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          252 ----DQDIIKKVE--------KGKYYFDFN----------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             ----HHHHHHHHH--------HCCCCCCHH----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----HHHHHHHHH--------cCCCCCCcc----------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence                111111110        000000000                0012234566788899999999999998775543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.98  E-value=6.3e-33  Score=297.68  Aligned_cols=253  Identities=19%  Similarity=0.220  Sum_probs=195.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--------hhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--------RASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....        .....+.+|++++++++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            3578889999999999999999998999999999864321        1234588999999999999999999998543 


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.
T Consensus        88 -----~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~  149 (322)
T 2ycf_A           88 -----DYYIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSS  149 (322)
T ss_dssp             -----SEEEEEECCTTEETHHHHSTT----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESS
T ss_pred             -----ceEEEEecCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEec
Confidence                 379999999999999998643          56899999999999999999999998   999999999999987


Q ss_pred             CCc---eeeCcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249          421 EMV---SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD  494 (789)
Q Consensus       421 ~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~  494 (789)
                      ++.   +||+|||.++......   ......||..|+|||.+.   ...++.++|||||||++|||++|+.||...... 
T Consensus       150 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  225 (322)
T 2ycf_A          150 QEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-  225 (322)
T ss_dssp             SSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-
T ss_pred             CCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-
Confidence            654   9999999998765432   122346899999999863   567899999999999999999999999743222 


Q ss_pred             ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..+...+.........+                           ....+...+.+++..|++.++..|++......+
T Consensus       226 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          226 VSLKDQITSGKYNFIPE---------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             SCHHHHHHHTCCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHhCccccCch---------------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            12222222111100000                           001223456688889999999999999877543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.98  E-value=6.4e-33  Score=301.58  Aligned_cols=206  Identities=24%  Similarity=0.339  Sum_probs=174.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||+++... ......+.+|++++++++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468889999999999999999999899999999996543 3345678899999999999999999999876544445578


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+. |+|.+++..           ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence            99999998 689988853           35899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCcc--------ceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQT--------SSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.++.........        ......||..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999876433111        1223468999999998754 6789999999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=3.2e-33  Score=307.46  Aligned_cols=284  Identities=19%  Similarity=0.172  Sum_probs=196.9

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY---  341 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  341 (789)
                      ++...++|...+.||+|+||+||+|....+++.||||++.....    ...+|+++++.++||||+++++++.....   
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567789999999999999999999998999999999864432    23479999999999999999999854321   


Q ss_pred             ------------------------------CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHH
Q 041249          342 ------------------------------QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV  391 (789)
Q Consensus       342 ------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  391 (789)
                                                    ......++||||+. |+|.+.+...      ......+++..+..++.|+
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~l~~~~~~~i~~qi  150 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF------IRSGRSIPMNLISIYIYQL  150 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH------HhcCCCCCHHHHHHHHHHH
Confidence                                          22335889999999 5777766431      1134578999999999999


Q ss_pred             HHHHhhhhcCCCCCceecCCCCCceecC-CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCcccc
Q 041249          392 ASALDYLHHDCQPITTHCDLKPSNILLD-EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGD  469 (789)
Q Consensus       392 a~gL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~D  469 (789)
                      +.||+|||+.+   |+||||||+||+++ +++.+||+|||.++.......   .....||..|+|||.+.+. .++.++|
T Consensus       151 ~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (383)
T 3eb0_A          151 FRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSID  224 (383)
T ss_dssp             HHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchh
Confidence            99999999988   99999999999997 688999999999997754432   2234588999999998765 4899999


Q ss_pred             chhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc--hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHH
Q 041249          470 VYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH--VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISM  547 (789)
Q Consensus       470 V~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  547 (789)
                      ||||||++|||++|+.||..... ...+...++..-...  .....++......     ........++......+...+
T Consensus       225 iwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  298 (383)
T 3eb0_A          225 LWSIGCVFGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVR-----FPTLKAKDWRKILPEGTPSLA  298 (383)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CC-----CCCCCCCCHHHHSCTTCCHHH
T ss_pred             hhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCccccccc-----CCccCcccHHhhCCCCCCHHH
Confidence            99999999999999999974211 111222222111110  0000111000000     000000000000111234456


Q ss_pred             HhhccccceeeEeccCcccccccc
Q 041249          548 LRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       548 ~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .+++..|.+.++..|++..++..+
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          299 IDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcC
Confidence            788999999999999999877543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.98  E-value=5.6e-33  Score=297.44  Aligned_cols=206  Identities=23%  Similarity=0.344  Sum_probs=167.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCC--------
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD--------  340 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  340 (789)
                      .++|...+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357888999999999999999999889999999998766666788999999999999999999999875432        


Q ss_pred             -CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          341 -YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       341 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                       .......++||||+. |+|.+++..           ..+++..+..++.|++.||+|||+.+   |+||||||+||+++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN  154 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence             122347899999998 699998843           35889999999999999999999998   99999999999997


Q ss_pred             -CCCceeeCcccccccCCCCCC-ccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          420 -EEMVSHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       420 -~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                       +++.+||+|||.++....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence             567999999999997754321 112223457889999998765 6789999999999999999999999974

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.6e-33  Score=301.88  Aligned_cols=273  Identities=22%  Similarity=0.273  Sum_probs=196.0

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-----hhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      ...++|...+.||+|+||.||+|.+..+++.||||++......     ..+.+.+|++++++++||||+++++++.... 
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-
Confidence            3457899999999999999999999988999999998654221     2357889999999999999999999987655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+.+ ++.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        86 ----~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~  148 (346)
T 1ua2_A           86 ----NISLVFDFMET-DLEVIIKDN---------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN  148 (346)
T ss_dssp             ----CCEEEEECCSE-EHHHHHTTC---------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             ----ceEEEEEcCCC-CHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCC
Confidence                78999999996 888888543         346888999999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~  500 (789)
                      +.+||+|||+++.......  ......||..|+|||.+.+. .++.++|||||||++|||++|..||..... ...+...
T Consensus       149 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i  225 (346)
T 1ua2_A          149 GVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRI  225 (346)
T ss_dssp             CCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred             CCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHH
Confidence            9999999999987754332  12335689999999998764 489999999999999999999999864311 1112222


Q ss_pred             HHHhC-CC-c-hhhhc---cCCcccChhhHHHhhhhhhhhhh-hchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          501 ARMAL-PD-H-VMDIV---DSTLLNDVEDLAIISNQRQRQIR-VNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       501 ~~~~~-~~-~-~~~~~---d~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..... +. . ..+..   +........           ..+ ......+...+.+++..|.+.++..|++..++..+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          226 FETLGTPTEEQWPDMCSLPDYVTFKSFP-----------GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHHCCCCTTTSSSTTSSTTCCCCCCCC-----------CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHcCCCChhhhhhhccCcccccccccC-----------CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            22111 10 0 11100   000000000           000 00011234567788899999999999999877543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.3e-33  Score=305.13  Aligned_cols=203  Identities=24%  Similarity=0.312  Sum_probs=172.5

Q ss_pred             hcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcC-CCCccceeeeeeccCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSI-RHRNLVKVFTACSGVD  340 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  340 (789)
                      .++|...+.||+|+||.||+|...   .+++.||||+++...    ......+..|+++++++ .||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            367889999999999999999984   478999999986432    23345678899999999 6999999999987765


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.
T Consensus       133 -----~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          133 -----KLHLILDYINGGELFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDS  194 (355)
T ss_dssp             -----EEEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             -----eEEEEeecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence                 789999999999999998643          46899999999999999999999998   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      ++.+||+|||+++........ ......||..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       195 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            999999999999876543321 2233569999999999885  34789999999999999999999999743

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.98  E-value=1.2e-31  Score=312.25  Aligned_cols=117  Identities=15%  Similarity=0.121  Sum_probs=94.5

Q ss_pred             CCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccc
Q 041249           43 LCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEIL  122 (789)
Q Consensus        43 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l  122 (789)
                      .+++++.|++++|.++...+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            36788999999999986556667889999999999999987777789999999999999999998778888888777666


Q ss_pred             cccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCCCCCCCC
Q 041249          123 EMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPT  172 (789)
Q Consensus       123 ~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~~~~~~~  172 (789)
                      +|++|.             +++..+..|..+++|++|++++|.|++.+|.
T Consensus       129 ~L~~n~-------------l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~  165 (597)
T 3oja_B          129 VLERND-------------LSSLPRGIFHNTPKLTTLSMSNNNLERIEDD  165 (597)
T ss_dssp             ECCSSC-------------CCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred             EeeCCC-------------CCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence            555544             5544555578889999999999988876553

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.98  E-value=4.4e-31  Score=286.42  Aligned_cols=170  Identities=21%  Similarity=0.303  Sum_probs=80.3

Q ss_pred             ccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEE
Q 041249          578 LSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS  657 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  657 (789)
                      +++|++|++++|++++..+  +..+++|++|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|++|+
T Consensus       176 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  249 (347)
T 4fmz_A          176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE  249 (347)
T ss_dssp             CTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             CCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEE
Confidence            3444555555555553222  4455555555555555553322  4455555555555555553222  44555555555


Q ss_pred             ccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccc
Q 041249          658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG  737 (789)
Q Consensus       658 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  737 (789)
                      +++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++
T Consensus       250 l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~  325 (347)
T 4fmz_A          250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD  325 (347)
T ss_dssp             CCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred             CCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence            555555432  2344455555555555555432  234445555555555555544444444445555555555555442


Q ss_pred             cCCcccccCCCCccEEEccCCcc
Q 041249          738 NIPLDYGFTLQNLQYFSIGTNRI  760 (789)
Q Consensus       738 ~ip~~~~~~l~~L~~L~L~~N~l  760 (789)
                      ..|  + ..+++|++|++++|+|
T Consensus       326 ~~~--~-~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          326 IRP--L-ASLSKMDSADFANQVI  345 (347)
T ss_dssp             CGG--G-GGCTTCSEESSSCC--
T ss_pred             ccC--h-hhhhccceeehhhhcc
Confidence            222  1 1344444444444444

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.98  E-value=8.8e-34  Score=303.07  Aligned_cols=265  Identities=19%  Similarity=0.275  Sum_probs=195.8

Q ss_pred             ccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCC--CCccce
Q 041249          256 SLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIR--HRNLVK  331 (789)
Q Consensus       256 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~  331 (789)
                      +...+.++.+....++|...+.||+|+||.||++... +++.||||++....  ......+.+|++++.+++  |+||++
T Consensus        14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             ------CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            4455666677777889999999999999999999986 58999999996543  334577899999999997  599999


Q ss_pred             eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      +++++....     ..++||| +.+++|.+++...          ..+++.++..++.|++.||+|||+.+   |+||||
T Consensus        93 ~~~~~~~~~-----~~~lv~e-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dl  153 (313)
T 3cek_A           93 LYDYEITDQ-----YIYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDL  153 (313)
T ss_dssp             EEEEEECSS-----EEEEEEC-CCSEEHHHHHHHC----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred             EEEEeecCC-----EEEEEEe-cCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence            999988765     7899999 6678999998643          46889999999999999999999998   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-----------CCcCccccchhhHHHHHHH
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----------SEVSTNGDVYSYGILMLEL  480 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~sfGvvl~el  480 (789)
                      ||+||++++ +.+||+|||.++...............|+..|+|||.+..           ..++.++||||||+++|||
T Consensus       154 kp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el  232 (313)
T 3cek_A          154 KPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM  232 (313)
T ss_dssp             CGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred             CcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence            999999964 8999999999998765543333334568999999999865           4689999999999999999


Q ss_pred             HHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEe
Q 041249          481 IIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTIL  560 (789)
Q Consensus       481 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l  560 (789)
                      ++|+.||......   ...+ .        .+.++......                  ...+...+.+++..|++.++.
T Consensus       233 ~~g~~pf~~~~~~---~~~~-~--------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~  282 (313)
T 3cek_A          233 TYGKTPFQQIINQ---ISKL-H--------AIIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPK  282 (313)
T ss_dssp             HHSSCTTTTCCSH---HHHH-H--------HHHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTT
T ss_pred             HhCCCchhhHHHH---HHHH-H--------HHHhcccccCC------------------cccchHHHHHHHHHHccCCcc
Confidence            9999999743221   1111 1        11111111000                  001123456778899999999


Q ss_pred             ccCcccccccc
Q 041249          561 DLESLKLAGSI  571 (789)
Q Consensus       561 ~l~s~~~~~~~  571 (789)
                      .||+...+...
T Consensus       283 ~Rps~~ell~h  293 (313)
T 3cek_A          283 QRISIPELLAH  293 (313)
T ss_dssp             TSCCHHHHHTS
T ss_pred             cCcCHHHHhcC
Confidence            99998876543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.98  E-value=1.3e-32  Score=300.06  Aligned_cols=293  Identities=17%  Similarity=0.178  Sum_probs=194.9

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-  341 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  341 (789)
                      .+.....++|...+.||+|+||+||+|.+..+++.||||++.... .......++++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566789999999999999999999999899999999985432 234467788888999999999999999865432 


Q ss_pred             -CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh--cCCCCCceecCCCCCceec
Q 041249          342 -QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH--HDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       342 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivH~dlk~~Nill  418 (789)
                       ......++||||+.++ +...+...      ......+++..+..++.|++.||.|||  +.+   |+||||||+||++
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll  164 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNY------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLV  164 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHH------HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEE
Confidence             1222478999999964 44333211      113456889999999999999999999  777   9999999999999


Q ss_pred             CC-CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249          419 DE-EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN  496 (789)
Q Consensus       419 ~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~  496 (789)
                      +. ++.+||+|||+++.......   .....||..|+|||.+.+.. ++.++|||||||++|||++|+.||..... ...
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~  240 (360)
T 3e3p_A          165 NEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQ  240 (360)
T ss_dssp             ETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred             eCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHH
Confidence            97 89999999999997765442   22346899999999986654 89999999999999999999999974321 112


Q ss_pred             HHHHHHHhCCCc--hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          497 LHNFARMALPDH--VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       497 ~~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      +....+......  ....+++......  +..................+...+.+++..|.+.++..|++..++..++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          241 LHEIVRVLGCPSREVLRKLNPSHTDVD--LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             HHHHHHHHCCCCHHHHHHHCTTCCCGG--GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHHcCCCCHHHHHhcccchhhcc--ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            222222111111  1111111111000  0000000000000111122456778999999999999999998875543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.98  E-value=4.1e-33  Score=299.66  Aligned_cols=265  Identities=24%  Similarity=0.346  Sum_probs=203.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|.+    ..+++.||||++........+.+.+|++++++++||||+++++++....   .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence            35678889999999999999995    4578999999998776666788999999999999999999999886533   2


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~  184 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV  184 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHS---------TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEE
T ss_pred             CceEEEEECCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcE
Confidence            2579999999999999999643         245899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....      ..+.+.
T Consensus       185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~  258 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRM  258 (326)
T ss_dssp             EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHH
T ss_pred             EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHh
Confidence            999999999876554221 1223457778999999988889999999999999999999999986321      111111


Q ss_pred             hCCCc--------hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDH--------VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~--------~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .-...        +.+.+....                  +......+...+.+++..|++.++..||+...+...+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L  317 (326)
T 2w1i_A          259 IGNDKQGQMIVFHLIELLKNNG------------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV  317 (326)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hccccchhhhHHHHHHHhhcCC------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            10000        000000000                  0001123455677889999999999999988775443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.98  E-value=4.4e-31  Score=286.39  Aligned_cols=194  Identities=26%  Similarity=0.376  Sum_probs=166.6

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      .+++|++|++++|.+++..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|++.+..+  +..+++|++|
T Consensus       153 ~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L  226 (347)
T 4fmz_A          153 NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL  226 (347)
T ss_dssp             TCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             hCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEE
Confidence            45667888899999885544  8899999999999999995533  8899999999999999995544  8899999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++++|++++..+  +..+++|++|++++|+++. + ..+..+++|++|++++|++++.  ..+..+++|+.|++++|+++
T Consensus       227 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~  300 (347)
T 4fmz_A          227 KIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLG  300 (347)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             EccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCC
Confidence            999999985544  8899999999999999995 3 4699999999999999999964  46899999999999999999


Q ss_pred             ccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      +..|..+. .+++|++|+|++|++++..|  +..+++|+.|++++|+|+
T Consensus       301 ~~~~~~l~-~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          301 NEDMEVIG-GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGGHHHHH-TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CcChhHhh-ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            55555454 89999999999999997666  889999999999999986

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.98  E-value=1.6e-32  Score=293.07  Aligned_cols=232  Identities=27%  Similarity=0.452  Sum_probs=220.2

Q ss_pred             ceeeEeccCcccccc--cccccccCccccchhcccC-CcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcE
Q 041249          555 QKVTILDLESLKLAG--SILPHIGNLSFLKILNLEN-NSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIR  631 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~--~~l~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~  631 (789)
                      .+++.+++..+.+.+  ..+..+.++++|++|+|++ |++.+.+|..|..+++|++|+|++|+|++.+|..|.++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            578999999999988  7889999999999999995 9999999999999999999999999999999999999999999


Q ss_pred             EEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCC-CCCEEEccCCcCCccCCccccCCCCCCeeeccCcc
Q 041249          632 IGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLS-SLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       632 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      |+|++|++++.+|..|..+++|++|+|++|++++.+|..|..++ +|++|+|++|++++.+|..|..++ |++|+|++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            99999999999999999999999999999999999999999998 999999999999999999999997 9999999999


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      +++..|..|..+++|+.|+|++|++++.+|. +. .+++|++|+|++|+|++.+|..+..+++|+.|++++|+++|.+|
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-cc-ccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            9999999999999999999999999966665 43 78999999999999999999999999999999999999999887

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.98  E-value=1.4e-32  Score=309.46  Aligned_cols=259  Identities=19%  Similarity=0.269  Sum_probs=198.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcccee-eeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV-FTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....  ...+..|++++..++|++.+.. ..++....     ..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-----~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGD-----YN   78 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT-----EE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC-----EE
Confidence            4689999999999999999999988999999999765433  2458899999999987554444 44444333     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---CCCCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---DEEMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~  424 (789)
                      ++||||+ +++|.+++...         ...+++.+++.|+.||+.||+|||..+   ||||||||+|||+   +.++.+
T Consensus        79 ~lvme~~-g~sL~~ll~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~v  145 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQV  145 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCE
T ss_pred             EEEEECC-CCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeE
Confidence            9999999 89999999643         346899999999999999999999998   9999999999999   588999


Q ss_pred             eeCcccccccCCCCCCc-----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCc--cH
Q 041249          425 HVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM--NL  497 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~--~~  497 (789)
                      ||+|||+++........     .......||..|+|||++.+..++.++|||||||++|||++|+.||........  .+
T Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (483)
T 3sv0_A          146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY  225 (483)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred             EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence            99999999987654421     122256799999999999999999999999999999999999999975322110  11


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH  574 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~  574 (789)
                      ..+...........                           ....+..++.+++..|++.++.+||+...+...+..
T Consensus       226 ~~i~~~~~~~~~~~---------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          226 EKISEKKVATSIEA---------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHHHHHHHSCHHH---------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHhhccccccHHH---------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11111111000000                           001234567788999999999999999877554443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=6e-33  Score=298.53  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEE--EEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTV--TVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  344 (789)
                      .++|...+.||+|+||.||+|.+..++..+  |+|.++.. .....+.+.+|++++.++ +||||+++++++....    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT----
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC----
Confidence            367888999999999999999998788755  99988643 334456789999999999 8999999999997765    


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                       ..++||||+++|+|.+++........      .......+++.++..++.|++.||+|||+.+   |+||||||+||++
T Consensus       100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~  175 (327)
T 1fvr_A          100 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV  175 (327)
T ss_dssp             -EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             -ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEE
Confidence             89999999999999999975410000      0012357899999999999999999999998   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~  497 (789)
                      +.++.+||+|||+++......   ......++..|+|||.+....++.++||||||+++|||++ |+.||...     ..
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~  247 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TC  247 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CH
T ss_pred             cCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-----cH
Confidence            999999999999998543221   1123346789999999988889999999999999999998 99999632     11


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ..........     ..+.                      ....+...+.+++..|++.++..||+.......+
T Consensus       248 ~~~~~~~~~~-----~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          248 AELYEKLPQG-----YRLE----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             HHHHHHGGGT-----CCCC----------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhhcC-----CCCC----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            1221111000     0000                      0112334566888899999999999988775443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=1.4e-32  Score=301.02  Aligned_cols=200  Identities=23%  Similarity=0.312  Sum_probs=168.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC-CCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ-GND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~~~  345 (789)
                      .++|...+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|++++++++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            368888999999999999999999899999999996542  23357788999999999999999999998765421 112


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+. |+|.+++.            ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence            3499999998 68888773            34899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.++......     ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       185 L~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          185 ILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999998654332     23568999999999877 6799999999999999999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=1e-33  Score=307.86  Aligned_cols=262  Identities=15%  Similarity=0.149  Sum_probs=196.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC--------CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcccee--------
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE--------GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV--------  332 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l--------  332 (789)
                      .++|...+.||+|+||.||+|.+..        .++.||+|++...     ..+.+|++++++++||||+++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3678889999999999999999986        3789999998643     468899999999999999984        


Q ss_pred             -------eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCC
Q 041249          333 -------FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPI  405 (789)
Q Consensus       333 -------~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~  405 (789)
                             ++++...    ....++||||+ +|+|.+++...        ....+++.++..++.|++.||+|||+.+   
T Consensus       116 ~~~i~~~~~~~~~~----~~~~~lv~e~~-~~~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---  179 (352)
T 2jii_A          116 LLAIPTCMGFGVHQ----DKYRFLVLPSL-GRSLQSALDVS--------PKHVLSERSVLQVACRLLDALEFLHENE---  179 (352)
T ss_dssp             TCSCCCCCEEEEET----TTEEEEEEECC-CEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ccCccchhhccccC----CcEEEEEecCC-CcCHHHHHHhC--------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                   4444321    23789999999 89999999643        2356899999999999999999999998   


Q ss_pred             ceecCCCCCceecCCCC--ceeeCcccccccCCCCCCc-----cceeeecccccccCcccCCCCCcCccccchhhHHHHH
Q 041249          406 TTHCDLKPSNILLDEEM--VSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILML  478 (789)
Q Consensus       406 ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~  478 (789)
                      |+||||||+||+++.++  .+||+|||+++........     .......||..|+|||.+.+..++.++|||||||++|
T Consensus       180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  259 (352)
T 2jii_A          180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML  259 (352)
T ss_dssp             CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence            99999999999999998  9999999999877543211     1122346999999999999989999999999999999


Q ss_pred             HHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceee
Q 041249          479 ELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVT  558 (789)
Q Consensus       479 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~  558 (789)
                      ||++|+.||.........+......... ...+..+....                     .......+.+++..|++.+
T Consensus       260 el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~d  317 (352)
T 2jii_A          260 KWLYGFLPWTNCLPNTEDIMKQKQKFVD-KPGPFVGPCGH---------------------WIRPSETLQKYLKVVMALT  317 (352)
T ss_dssp             HHHHSCCTTGGGTTCHHHHHHHHHHHHH-SCCCEECTTSC---------------------EECCCHHHHHHHHHHHTCC
T ss_pred             HHHhCCCCcccCCcCHHHHHHHHHhccC-Chhhhhhhccc---------------------cCCCcHHHHHHHHHHHhCC
Confidence            9999999998543222222222221110 00111111100                     0012345668888999999


Q ss_pred             EeccCcccccccccc
Q 041249          559 ILDLESLKLAGSILP  573 (789)
Q Consensus       559 ~l~l~s~~~~~~~l~  573 (789)
                      +..||+...+...+.
T Consensus       318 p~~Rps~~~l~~~L~  332 (352)
T 2jii_A          318 YEEKPPYAMLRNNLE  332 (352)
T ss_dssp             TTCCCCHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHH
Confidence            999999887754443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=4.3e-32  Score=297.07  Aligned_cols=201  Identities=22%  Similarity=0.252  Sum_probs=164.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  346 (789)
                      ++|...+.||+|+||.||+|....+++.||||++...  .....+.+.+|+++++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            6888999999999999999999989999999998653  23345678899999999999999999999875431 22346


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+ ++.+++.            ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       105 ~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEEcCCC-CHHHHHh------------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence            8999999984 7877774            23788999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  228 (371)
T 2xrw_A          169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  228 (371)
T ss_dssp             CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9999998765432   12335689999999999998999999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=2.8e-32  Score=301.32  Aligned_cols=202  Identities=23%  Similarity=0.320  Sum_probs=170.2

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC--------CCccceeeeeeccCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR--------HRNLVKVFTACSGVDY  341 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~~~~~  341 (789)
                      ++|...+.||+|+||+||+|+...+++.||||+++.. ....+.+.+|++++++++        |+||+++++++.....
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            6788999999999999999999989999999999643 234567889999999985        7889999999863221


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~  420 (789)
                       .....++||||+ +|++.+++...        ....+++.++..++.|++.||+|||+. +   ||||||||+|||++.
T Consensus       116 -~~~~~~lv~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~  182 (397)
T 1wak_A          116 -NGTHICMVFEVL-GHHLLKWIIKS--------NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSV  182 (397)
T ss_dssp             -TEEEEEEEECCC-CCBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECC
T ss_pred             -CCceEEEEEecc-CccHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEec
Confidence             123789999999 45666665432        235689999999999999999999998 7   999999999999997


Q ss_pred             CC-------------------------------------------------ceeeCcccccccCCCCCCccceeeecccc
Q 041249          421 EM-------------------------------------------------VSHVGDFGLARFLPPTHVQTSSIGVKGSI  451 (789)
Q Consensus       421 ~~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~  451 (789)
                      ++                                                 .+||+|||.+.......     ....||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~  257 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTR  257 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCC
Confidence            75                                                 89999999998765432     2346899


Q ss_pred             cccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          452 GYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       452 ~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            999999999989999999999999999999999999754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=2.7e-33  Score=293.91  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=189.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||.||+|.+.  ++.||||+++...  ..+.+.+|++++++++||||+++++++....    ...+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceE
Confidence            467888999999999999999885  8899999986443  4567899999999999999999999875432    2579


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~D  160 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD  160 (278)
T ss_dssp             EEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEee
Confidence            999999999999998643        1223788999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||.+.......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....  ......+....  
T Consensus       161 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~--  231 (278)
T 1byg_A          161 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY--  231 (278)
T ss_dssp             CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTC--
T ss_pred             ccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC--
Confidence            99988654332     12357889999999988889999999999999999998 9999974311  11111111100  


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                            .+..                      ...+...+.+++..|++.++..||+.......+
T Consensus       232 ------~~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  268 (278)
T 1byg_A          232 ------KMDA----------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL  268 (278)
T ss_dssp             ------CCCC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ------CCCC----------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence                  0000                      112334566888899999999999988775433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=2.7e-32  Score=304.13  Aligned_cols=198  Identities=26%  Similarity=0.320  Sum_probs=171.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC------CCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI------RHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  342 (789)
                      ...|...+.||+|+||+||+|....+++.||||+++... .....+..|+++++.+      .|+||+++++++....  
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~--  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN--  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--
Confidence            356888999999999999999999899999999996542 3345677788877776      5779999999988765  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+. |+|.+++...        ....+++..+..++.|++.||+|||+.+   ||||||||+|||++.++
T Consensus       173 ---~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~  237 (429)
T 3kvw_A          173 ---HICMTFELLS-MNLYELIKKN--------KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQG  237 (429)
T ss_dssp             ---EEEEEECCCC-CBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTT
T ss_pred             ---eEEEEEeccC-CCHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCC
Confidence               8999999997 6899988654        2345899999999999999999999998   99999999999999988


Q ss_pred             c--eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          423 V--SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       423 ~--~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      .  +||+|||++.......     ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       238 ~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            7  9999999998755432     234689999999999999999999999999999999999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=1.8e-33  Score=308.08  Aligned_cols=259  Identities=9%  Similarity=-0.024  Sum_probs=180.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHH---HHHhcCCCCccceeeeeec-----
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAEC---RALRSIRHRNLVKVFTACS-----  337 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~-----  337 (789)
                      ..+|...+.||+|+||+||+|.+..+++.||||++.....   ...+.+.+|+   +.++. +||||++++..+.     
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            4568889999999999999999998999999999976532   3345677784   45555 7999888653332     


Q ss_pred             --cCCC------------CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHH------HHHHHHHHHHHhh
Q 041249          338 --GVDY------------QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQR------LNIAIDVASALDY  397 (789)
Q Consensus       338 --~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~~  397 (789)
                        ....            ......++||||+. |+|.+++...         +..+++..+      ..++.|++.||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHH
Confidence              1110            00135799999999 8999999643         123455556      7888999999999


Q ss_pred             hhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--CCcCccccchhhHH
Q 041249          398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGI  475 (789)
Q Consensus       398 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGv  475 (789)
                      ||+.+   |+||||||+|||++.++.+||+|||+++......     ....+|..|+|||.+.+  ..++.++|||||||
T Consensus       210 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          210 LQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            99998   9999999999999999999999999999764321     13457799999999987  67999999999999


Q ss_pred             HHHHHHHhcCCCCccccCCccHHHHHHHhCCCc-hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhcccc
Q 041249          476 LMLELIIRKKPSDIMFEGDMNLHNFARMALPDH-VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKA  554 (789)
Q Consensus       476 vl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c  554 (789)
                      ++|||++|+.||.........       .+... ..........                  ......+...+.+++..|
T Consensus       282 il~elltg~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~  336 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKG-------SWKRPSLRVPGTDSLA------------------FGSCTPLPDFVKTLIGRF  336 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTT-------CCCBCCTTSCCCCSCC------------------CTTSSCCCHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCcCccccc-------chhhhhhhhccccccc------------------hhhccCCCHHHHHHHHHH
Confidence            999999999999754221100       00000 0000000000                  000012344566888899


Q ss_pred             ceeeEeccCcccccccc
Q 041249          555 QKVTILDLESLKLAGSI  571 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~  571 (789)
                      ++.++..|++...+..+
T Consensus       337 L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          337 LNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TCSSTTTCCCHHHHTTS
T ss_pred             cCCChhhCCCHHHHhcC
Confidence            99999999999877543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=2e-32  Score=294.17  Aligned_cols=208  Identities=28%  Similarity=0.385  Sum_probs=173.8

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEc-CCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVD  340 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~  340 (789)
                      .+.++|...+.||+|+||.||+|.+. .+++.||+|+++....  .....+.+|+++++.+   +||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45678999999999999999999994 6789999999865432  2234566777777666   8999999999987332


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                      .......++||||+. |+|.+++...        ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~  155 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS  155 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS--------CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcC
Confidence            223347899999998 6999998654        2345899999999999999999999998   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++.+||+|||.++......   ......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus       156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999998765332   22345689999999999999999999999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=295.41  Aligned_cols=200  Identities=23%  Similarity=0.311  Sum_probs=167.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC-CCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ-GND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~~~  345 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999999899999999986542  23356788999999999999999999998765311 112


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+. |+|.+++.            ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~k  166 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK  166 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEE
T ss_pred             eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEE
Confidence            3599999998 68887763            24899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |+|||.++.....     .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999875432     223568999999999877 6789999999999999999999999974

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=1.1e-32  Score=290.97  Aligned_cols=255  Identities=23%  Similarity=0.292  Sum_probs=189.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++|...+.||+|+||+||+|.+...   +..||||+++..   .....+.+.+|++++++++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            46788899999999999999997532   236999998754   234467899999999999999999999998653   


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++|+||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++
T Consensus        94 ---~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~  158 (291)
T 1u46_A           94 ---PMKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD  158 (291)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred             ---CceeeEecccCCCHHHHHHhc---------cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCC
Confidence               378999999999999998642         245889999999999999999999998   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      .+||+|||.+.......... ......++..|+|||......++.++||||||+++|||++ |+.||....     ..+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~  233 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQI  233 (291)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHH
T ss_pred             CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HHHH
Confidence            99999999999876554321 2234557889999999988889999999999999999999 999997321     1122


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .........    ...                      ....+...+.+++..|++.++.+||+.......+
T Consensus       234 ~~~~~~~~~----~~~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  279 (291)
T 1u46_A          234 LHKIDKEGE----RLP----------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL  279 (291)
T ss_dssp             HHHHHTSCC----CCC----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHccCC----CCC----------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            211111000    000                      0012334566888899999999999998775433

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=3.2e-32  Score=292.87  Aligned_cols=259  Identities=21%  Similarity=0.192  Sum_probs=177.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||.||+|....+++.||||+++.... .....+..|+. +++.++||||+++++++....     .
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-----~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----D   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----E
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----c
Confidence            4688899999999999999999998999999999975532 33445556665 777789999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCcee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      .++||||+.+ +|.+++...     .......+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+|
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYV-----YSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHH-----HHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEEeecCC-ChHHHHHHH-----HhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEE
Confidence            8999999995 777776421     011235689999999999999999999997 7   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccC----CCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYG----LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      |+|||+++.......   .....||..|+|||.+    ....++.++||||||+++|||++|+.||......    .+..
T Consensus       167 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~  239 (327)
T 3aln_A          167 LCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----FDQL  239 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----HHHH
Confidence            999999987654332   2234689999999998    4566899999999999999999999999742111    0000


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....     ...+.+..                  .....+...+.+++..|++.++..||+...+...
T Consensus       240 ~~~~~-----~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          240 TQVVK-----GDPPQLSN------------------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCC-----SCCCCCCC------------------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHhc-----CCCCCCCC------------------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00000     00001100                  0011234456788899999999999999877554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.7e-32  Score=293.69  Aligned_cols=262  Identities=21%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      ..++.....++|...+.||+|+||.||+|.+..   .||+|+++...  ....+.+.+|++++++++||||+++++++..
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            345556667899999999999999999999863   49999986542  2334568889999999999999999999987


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      ..     ..++|+||+.+++|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||++
T Consensus       101 ~~-----~~~iv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~  163 (319)
T 2y4i_B          101 PP-----HLAIITSLCKGRTLYSVVRDA---------KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFY  163 (319)
T ss_dssp             SS-----CEEEECBCCCSEEHHHHTTSS---------CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEE
T ss_pred             CC-----ceEEEeecccCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEE
Confidence            65     789999999999999999643         346899999999999999999999998   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCC---CccceeeecccccccCcccCCC---------CCcCccccchhhHHHHHHHHHhcCC
Q 041249          419 DEEMVSHVGDFGLARFLPPTH---VQTSSIGVKGSIGYIAPEYGLG---------SEVSTNGDVYSYGILMLELIIRKKP  486 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DV~sfGvvl~elltG~~P  486 (789)
                      + ++.+||+|||+++......   .........|+..|+|||.+..         ..++.++||||||+++|||++|+.|
T Consensus       164 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  242 (319)
T 2y4i_B          164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP  242 (319)
T ss_dssp             C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            8 6799999999987654322   1122233458999999998864         4579999999999999999999999


Q ss_pred             CCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          487 SDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                      |....     ...........     ..+....                     ..+...+.+++..|+..++.+||+..
T Consensus       243 ~~~~~-----~~~~~~~~~~~-----~~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~  291 (319)
T 2y4i_B          243 FKTQP-----AEAIIWQMGTG-----MKPNLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFT  291 (319)
T ss_dssp             SSSCC-----HHHHHHHHHTT-----CCCCCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCCCC-----HHHHHHHhccC-----CCCCCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            97321     11111111000     0010000                     01122355788899999999999988


Q ss_pred             cccccccc
Q 041249          567 LAGSILPH  574 (789)
Q Consensus       567 ~~~~~l~~  574 (789)
                      .+...+..
T Consensus       292 ~l~~~l~~  299 (319)
T 2y4i_B          292 KLMDMLEK  299 (319)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHH
Confidence            77554443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=3.4e-32  Score=293.68  Aligned_cols=258  Identities=16%  Similarity=0.174  Sum_probs=172.6

Q ss_pred             hcCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|... +.||+|+||+||+|.+..+++.||||++....    ....+....+..+.||||+++++++.... .+....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence            4678874 47999999999999999899999999985432    22223334456679999999999986532 122358


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~  424 (789)
                      ++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+||+++.   ++.+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER--------GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCE
T ss_pred             EEEEeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceE
Confidence            9999999999999999754        3356899999999999999999999998   999999999999986   4569


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||.++......    .....||..|+|||.+....++.++||||||+++|||++|+.||.........  ......
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~  244 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRR  244 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHh
Confidence            999999998765432    22356899999999998889999999999999999999999999743221100  000000


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..........                       .....+...+.+++..|.+.++.+|++...+..+
T Consensus       245 ~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          245 IRLGQYGFPN-----------------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ------CCCT-----------------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhccccccCc-----------------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000000000                       0001233456678889999999999999877543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=1.2e-31  Score=289.44  Aligned_cols=198  Identities=23%  Similarity=0.322  Sum_probs=170.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEE-cCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCc------cceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRN------LVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||+||+|.+ ..+++.||||+++... .....+.+|+++++.++|++      ++++++++.... 
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~-   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG-   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-
Confidence            36888999999999999999998 5578999999986432 34567888999999887654      999999987765 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-  420 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-  420 (789)
                          ..++||||+ +++|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+||+++. 
T Consensus        91 ----~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           91 ----HICIVFELL-GLSTYDFIKEN--------GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQS  154 (339)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCC
T ss_pred             ----cEEEEEcCC-CCCHHHHHHhc--------CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecc
Confidence                899999999 78999998644        2346889999999999999999999998   999999999999987 


Q ss_pred             ------------------CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249          421 ------------------EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII  482 (789)
Q Consensus       421 ------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt  482 (789)
                                        ++.+||+|||.++......     ....||..|+|||.+.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence                              6689999999998755432     23468999999999999899999999999999999999


Q ss_pred             hcCCCCc
Q 041249          483 RKKPSDI  489 (789)
Q Consensus       483 G~~P~~~  489 (789)
                      |+.||..
T Consensus       230 g~~pf~~  236 (339)
T 1z57_A          230 GFTVFPT  236 (339)
T ss_dssp             SSCSCCC
T ss_pred             CCCCCCC
Confidence            9999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=6.5e-32  Score=284.79  Aligned_cols=251  Identities=22%  Similarity=0.245  Sum_probs=197.1

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|....+++.||+|++....  ......+.+|++++++++||||+++++++....     .
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----S   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-----e
Confidence            467889999999999999999998889999999986543  334578999999999999999999999987755     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---Cc
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MV  423 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~~  423 (789)
                      .++|+||+.+++|.+++...          ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.+   +.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             EEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCccc
Confidence            89999999999999988543          46899999999999999999999998   9999999999999754   47


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~  503 (789)
                      +||+|||++........   .....|+..|+|||.+.+ .++.++||||||+++|+|++|+.||....     ..+..+.
T Consensus       163 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~  233 (287)
T 2wei_A          163 IKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDILKR  233 (287)
T ss_dssp             EEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred             EEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence            99999999987654432   123458899999998765 58999999999999999999999997421     1111111


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....        .....                ......+...+.+++..|++.++..|++......
T Consensus       234 ~~~~--------~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          234 VETG--------KYAFD----------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHC--------CCCCC----------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHcC--------CCCCC----------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            1000        00000                0000122345668888999999999999877643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=2.8e-32  Score=303.32  Aligned_cols=278  Identities=19%  Similarity=0.205  Sum_probs=193.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  348 (789)
                      ..|...+.||+|+||.||+|.+..+++.||||++....    ....+|++++++++||||+++++++..... ......+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35778899999999999999999889999999986432    223469999999999999999998854321 1222467


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~  427 (789)
                      +||||+.+ ++.+.+...      ......+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+
T Consensus       130 lv~e~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHY------SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             EEEECCCE-EHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred             eehhcccc-cHHHHHHHH------hhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEec
Confidence            99999996 555554321      112457899999999999999999999988   9999999999999965 578999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||+++.......   .....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...++..-.
T Consensus       200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~  275 (420)
T 1j1b_A          200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGT  275 (420)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCS
T ss_pred             cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            9999997654432   2234689999999998765 699999999999999999999999974211 1122222221111


Q ss_pred             Cc--hhhhccCCcccC-hhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DH--VMDIVDSTLLND-VEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~--~~~~~d~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..  .....++..... ...      .....+...........+.+++.+|...++..|++..++..+
T Consensus       276 p~~~~~~~~~~~~~~~~~p~------~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQ------IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCC------CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHhhChhhhhhccCc------cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            10  000111111000 000      000000000001223456788899999999999999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=4e-32  Score=288.24  Aligned_cols=259  Identities=20%  Similarity=0.244  Sum_probs=191.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCC--------
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD--------  340 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  340 (789)
                      .++|...+.||+|+||.||+|....+++.||||.++.. ....+.+.+|++++++++||||+++++++....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45788899999999999999999889999999998643 334567899999999999999999999876532        


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                      .......++||||+.+|+|.+++...         ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE---------NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDE  151 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS---------CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc---------ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcC
Confidence            11234689999999999999999643         345788899999999999999999998   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCC------------ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCC
Q 041249          421 EMVSHVGDFGLARFLPPTHV------------QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      ++.+||+|||.+........            ........|+..|+|||.+.+. .++.++|||||||++|||++   ||
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence            99999999999987653321            1122345689999999998764 68999999999999999998   55


Q ss_pred             CccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccc
Q 041249          488 DIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKL  567 (789)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~  567 (789)
                      ....    ......+......  ....+.+                      ...+...+.+++..|++.++..||+...
T Consensus       229 ~~~~----~~~~~~~~~~~~~--~~~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~  280 (303)
T 1zy4_A          229 STGM----ERVNILKKLRSVS--IEFPPDF----------------------DDNKMKVEKKIIRLLIDHDPNKRPGART  280 (303)
T ss_dssp             SSHH----HHHHHHHHHHSTT--CCCCTTC----------------------CTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCch----hHHHHHHhccccc--cccCccc----------------------cccchHHHHHHHHHHHhcCcccCcCHHH
Confidence            4211    1111111110000  0000111                      0122334567888999999999999987


Q ss_pred             cccc
Q 041249          568 AGSI  571 (789)
Q Consensus       568 ~~~~  571 (789)
                      ...+
T Consensus       281 ll~h  284 (303)
T 1zy4_A          281 LLNS  284 (303)
T ss_dssp             HHHS
T ss_pred             HhCC
Confidence            7543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=8.3e-32  Score=309.38  Aligned_cols=278  Identities=20%  Similarity=0.223  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||+++.. .......+.+|++++++++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999999889999999998754 33445779999999999999999999999765321 223467


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc---e
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV---S  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~  424 (789)
                      ++||||+.+|+|.+++...       .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +
T Consensus        94 ~LVmEy~~ggsL~~~L~~~-------~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQF-------ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSS-------SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEE
T ss_pred             EEEEEeCCCCCHHHHHHhc-------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeE
Confidence            9999999999999999754       22346889999999999999999999998   999999999999997664   8


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||.+........   .....||..|+|||.+.+..++.++|||||||++|||++|+.||...    .....|....
T Consensus       164 KL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~----~~~~~~~~~i  236 (676)
T 3qa8_A          164 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN----WQPVQWHGKV  236 (676)
T ss_dssp             EECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS----CHHHHSSTTC
T ss_pred             EEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc----cchhhhhhhh
Confidence            9999999998765442   23456899999999999999999999999999999999999999632    1222222111


Q ss_pred             CCCchhh-hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          505 LPDHVMD-IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       505 ~~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....... .......+...      .......+..........+.+++..|...+|..||+..+...
T Consensus       237 ~~~~~~~~~~~~~l~g~~~------~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~  297 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVK------FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN  297 (676)
T ss_dssp             C------CCSCCCCSSSCC------CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred             hcccchhhhhhhhhccccc------cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence            1111000 00100000000      000000001112234566778999999999999999987643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.5e-31  Score=296.40  Aligned_cols=210  Identities=22%  Similarity=0.302  Sum_probs=155.0

Q ss_pred             CCCC-CCcccccCCccEEEEEEc--CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSS-ANLIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~-~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|.. .++||+|+||+||+|.+.  .+++.||||++....  ....+.+|++++++++||||+++++++....   ....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeE
Confidence            4554 568999999999999976  457899999986432  3357889999999999999999999985422   2378


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCc
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMV  423 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~  423 (789)
                      ++||||+. |+|.+++....... .......+++..+..|+.|++.||+|||+.+   |+||||||+|||+    +.++.
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence            99999998 47777764320000 0112235899999999999999999999998   9999999999999    77889


Q ss_pred             eeeCcccccccCCCCCC-ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          424 SHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +||+|||+++....... ........||..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999999998764332 1223346789999999998874 5899999999999999999999999743

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=3.2e-32  Score=300.39  Aligned_cols=278  Identities=21%  Similarity=0.198  Sum_probs=191.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  348 (789)
                      ..|...+.||+|+||.||+|.+..+++ ||+|.+.....    ...+|+++++.++||||+++++++..... ......+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468889999999999999999985555 88887743322    22369999999999999999999865442 2233478


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC-CCCceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD-EEMVSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~  427 (789)
                      +||||+.++.+.......       .....+++..+..++.|++.||+|||+.+   |+||||||+||+++ .++.+||+
T Consensus       115 lv~e~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYA-------KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             EEEECCSEEHHHHHHHHH-------HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEeeccCccHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEe
Confidence            999999975444332111       12356899999999999999999999998   99999999999999 78999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      |||+++........   ....||..|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+...++..-.
T Consensus       185 DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~  260 (394)
T 4e7w_A          185 DFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGT  260 (394)
T ss_dssp             CCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCC
T ss_pred             eCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            99999887544322   234689999999998765 589999999999999999999999974211 1112222221111


Q ss_pred             Cc--hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DH--VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..  .....++.......     .......+...........+.+++.+|.+.++..|++..++..+
T Consensus       261 p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKF-----PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCC-----CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHhhChhhhhhcc-----ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            10  00001110000000     00000000000011234467788999999999999998877543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=6e-30  Score=275.67  Aligned_cols=142  Identities=27%  Similarity=0.351  Sum_probs=103.7

Q ss_pred             CCCCCccCCcCccCC------ccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCC
Q 041249            6 SNRLSGNIPPSIGNL------KKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRN   79 (789)
Q Consensus         6 ~n~~~~~~p~~~~~l------~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N   79 (789)
                      .+.+. .+|..+...      .+++.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus        13 ~~~l~-~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n   88 (332)
T 2ft3_A           13 IPDLD-SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN   88 (332)
T ss_dssp             -------------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCccc-cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCC
Confidence            34444 566555433      37899999999988 7787664  68999999999998777778999999999999999


Q ss_pred             cCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEE
Q 041249           80 QFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENL  159 (789)
Q Consensus        80 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l  159 (789)
                      ++++..|..|+.+++|++|+|++|+++ .+|..+.  ++             |++|++++|++++..+..+..+++|+.|
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~-------------L~~L~l~~n~i~~~~~~~~~~l~~L~~L  152 (332)
T 2ft3_A           89 KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SS-------------LVELRIHDNRIRKVPKGVFSGLRNMNCI  152 (332)
T ss_dssp             CCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TT-------------CCEEECCSSCCCCCCSGGGSSCSSCCEE
T ss_pred             ccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--cc-------------CCEEECCCCccCccCHhHhCCCccCCEE
Confidence            998777888999999999999999988 5665443  33             4555666666776666678888899999


Q ss_pred             ecccCCCC
Q 041249          160 NLSYNDLE  167 (789)
Q Consensus       160 ~ls~N~~~  167 (789)
                      ++++|+++
T Consensus       153 ~l~~n~l~  160 (332)
T 2ft3_A          153 EMGGNPLE  160 (332)
T ss_dssp             ECCSCCCB
T ss_pred             ECCCCccc
Confidence            99888774

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=7.1e-30  Score=275.10  Aligned_cols=149  Identities=20%  Similarity=0.250  Sum_probs=126.5

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      ++++++|+++ .+|..+.  ++|++|++++|.|++..|+.|..+++|++|+|++|+|++..|..|+.+++|++|+|++|+
T Consensus        37 ~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  113 (332)
T 2ft3_A           37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH  113 (332)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred             EEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence            3789999998 8888874  689999999999998888899999999999999999998889999999999999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEe
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLN  160 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~  160 (789)
                      ++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|++..           .+..|..+..+ +|+.|+
T Consensus       114 l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-----------~~~~~~~~~~l-~L~~L~  178 (332)
T 2ft3_A          114 LV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN-----------SGFEPGAFDGL-KLNYLR  178 (332)
T ss_dssp             CC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG-----------GGSCTTSSCSC-CCSCCB
T ss_pred             CC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc-----------CCCCcccccCC-ccCEEE
Confidence            98 7887766  799999999999997666778998888887777766542           12456666666 778888


Q ss_pred             cccCCCC
Q 041249          161 LSYNDLE  167 (789)
Q Consensus       161 ls~N~~~  167 (789)
                      +++|+++
T Consensus       179 l~~n~l~  185 (332)
T 2ft3_A          179 ISEAKLT  185 (332)
T ss_dssp             CCSSBCS
T ss_pred             CcCCCCC
Confidence            8777664

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=2.6e-32  Score=292.60  Aligned_cols=244  Identities=18%  Similarity=0.211  Sum_probs=196.7

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch------hhHHHHHHHHHHhcCC--CCccceeeeeecc
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR------ASRSFIAECRALRSIR--HRNLVKVFTACSG  338 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~  338 (789)
                      ...++|...+.||+|+||.||+|.+..+++.||||+++.....      ....+..|++++++++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999999989999999999655322      2355778999999996  5999999999987


Q ss_pred             CCCCCCceEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249          339 VDYQGNDFKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL  417 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil  417 (789)
                      ..     ..++|+|++.. ++|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||+||+
T Consensus       120 ~~-----~~~lv~e~~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl  181 (320)
T 3a99_A          120 PD-----SFVLILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENIL  181 (320)
T ss_dssp             SS-----EEEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred             CC-----cEEEEEEcCCCCccHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEE
Confidence            65     78999999986 8999998643          46889999999999999999999998   999999999999


Q ss_pred             cC-CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCc
Q 041249          418 LD-EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDM  495 (789)
Q Consensus       418 l~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~  495 (789)
                      ++ +++.+||+|||+++......    .....||..|+|||.+....+ +.++||||||+++|||++|+.||...     
T Consensus       182 l~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----  252 (320)
T 3a99_A          182 IDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----  252 (320)
T ss_dssp             EETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----
T ss_pred             EeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----
Confidence            99 78999999999998876443    223568999999999877665 78899999999999999999999631     


Q ss_pred             cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          496 NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                        ........          ...                      ..+...+.+++..|++.++.+||+...+...
T Consensus       253 --~~~~~~~~----------~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          253 --EEIIRGQV----------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --HHHHHCCC----------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --hhhhcccc----------ccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11111000          000                      0122345678889999999999999877543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=5.4e-32  Score=289.65  Aligned_cols=253  Identities=20%  Similarity=0.195  Sum_probs=176.9

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||.||+|.+..+++.||||++......  ..+.+.++..+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-----D   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----E
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----c
Confidence            46788899999999999999999989999999999755322  2344555666788889999999999998765     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCcee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      .++||||+ ++.+..+...         ....+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~k  165 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKR---------MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIK  165 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEecc-CCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEE
Confidence            99999999 3445444422         134689999999999999999999985 7   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~  500 (789)
                      |+|||.+........   .....|+..|+|||.+.     ...++.++||||||+++|||++|+.||.........+...
T Consensus       166 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (318)
T 2dyl_A          166 LCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV  242 (318)
T ss_dssp             ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             EEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence            999999987654332   22346899999999984     4568999999999999999999999997422111111111


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .+.. +        +.+..                    ...+...+.+++..|++.++..||+...+..+
T Consensus       243 ~~~~-~--------~~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          243 LQEE-P--------PLLPG--------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHSC-C--------CCCCS--------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             hccC-C--------CCCCc--------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1110 0        00000                    00123345678889999999999999877554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=1.1e-29  Score=273.30  Aligned_cols=129  Identities=25%  Similarity=0.286  Sum_probs=110.8

Q ss_pred             CccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEe
Q 041249           20 LKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLT   99 (789)
Q Consensus        20 l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   99 (789)
                      ..+++.++++++.++ .+|..+.  +.|++|+|++|+|++..+..|+.+++|++|+|++|++++..|..|+.+++|++|+
T Consensus        30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            348999999999998 7887665  7899999999999987777899999999999999999977799999999999999


Q ss_pred             ccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCCC
Q 041249          100 VSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE  167 (789)
Q Consensus       100 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~~  167 (789)
                      +++|+++ .+|..+.  +             .|+.|++++|.+++..+..+..+++|+.|++++|+++
T Consensus       107 Ls~n~l~-~l~~~~~--~-------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  158 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP--K-------------TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK  158 (330)
T ss_dssp             CCSSCCS-BCCSSCC--T-------------TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC
T ss_pred             CCCCcCC-ccChhhc--c-------------cccEEECCCCcccccCHhHhcCCccccEEECCCCcCC
Confidence            9999998 6676543  2             4556667777788777888999999999999999774

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=5e-32  Score=316.85  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=197.6

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD  340 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  340 (789)
                      .....++|...+.||+|+||.||+|.+..+   +..||||.++... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence            334456777888999999999999998633   5679999986543 3345779999999999999999999999843 2


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                           ..++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.
T Consensus       464 -----~~~lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~  526 (656)
T 2j0j_A          464 -----PVWIIMELCTLGELRSFLQVR---------KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSS  526 (656)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHHT---------TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEE
T ss_pred             -----ceEEEEEcCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeC
Confidence                 579999999999999999643         245899999999999999999999998   999999999999999


Q ss_pred             CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249          421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~  499 (789)
                      ++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||.....  .....
T Consensus       527 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~  603 (656)
T 2j0j_A          527 NDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIG  603 (656)
T ss_dssp             TTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH
T ss_pred             CCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHH
Confidence            999999999999987554322 1223456789999999988899999999999999999997 9999973211  11111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .+......        ..                      ...+...+.+++..|++.++..||+.......+.
T Consensus       604 ~i~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          604 RIENGERL--------PM----------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             HHHHTCCC--------CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHcCCCC--------CC----------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            11111100        00                      1123445668889999999999999887754433

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=2.4e-31  Score=292.40  Aligned_cols=208  Identities=25%  Similarity=0.276  Sum_probs=173.6

Q ss_pred             cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CC-----ccceeee
Q 041249          261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HR-----NLVKVFT  334 (789)
Q Consensus       261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~  334 (789)
                      .+.+.....++|...+.||+|+||+||+|....+++.||||+++... .....+..|+++++.++ |+     +|+++++
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            33444455689999999999999999999999899999999996432 33466778888888874 55     4999999


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      ++....     ..++||||+. |+|.+++...        ....+++..+..++.|++.||+|||++ ..+||||||||+
T Consensus       124 ~~~~~~-----~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~  188 (382)
T 2vx3_A          124 HFMFRN-----HLCLVFEMLS-YNLYDLLRNT--------NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPE  188 (382)
T ss_dssp             EEEETT-----EEEEEEECCC-CBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGG
T ss_pred             eeccCC-----ceEEEEecCC-CCHHHHHhhc--------CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcc
Confidence            987765     8999999996 5999998654        234589999999999999999999953 123999999999


Q ss_pred             ceecC--CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          415 NILLD--EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       415 Nill~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||++  .++.+||+|||+++......     ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       189 NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          189 NILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             GEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99995  47889999999998875432     235689999999999999999999999999999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-32  Score=291.73  Aligned_cols=245  Identities=19%  Similarity=0.204  Sum_probs=188.4

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcC----CCCccceeee
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSI----RHRNLVKVFT  334 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~  334 (789)
                      .....++|...+.||+|+||.||+|....+++.||||++.....      .....+..|++++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34446789999999999999999999988999999999965432      1233466788888888    8999999999


Q ss_pred             eeccCCCCCCceEEEEeec-cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEF-MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP  413 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~  413 (789)
                      ++....     ..++|+|+ +.+++|.+++...          ..+++..+..++.|++.||+|||+.+   |+||||||
T Consensus       106 ~~~~~~-----~~~~v~e~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp  167 (312)
T 2iwi_A          106 WFETQE-----GFMLVLERPLPAQDLFDYITEK----------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKD  167 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSG
T ss_pred             EEecCC-----eEEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence            987655     78999999 7889999998643          45899999999999999999999998   99999999


Q ss_pred             CceecC-CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccc
Q 041249          414 SNILLD-EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMF  491 (789)
Q Consensus       414 ~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~  491 (789)
                      +||+++ .++.+||+|||.++......    .....|+..|+|||.+....+ +.++||||||+++|||++|+.||... 
T Consensus       168 ~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-  242 (312)
T 2iwi_A          168 ENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-  242 (312)
T ss_dssp             GGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-
T ss_pred             hhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-
Confidence            999999 88999999999998876543    223558999999999877666 45899999999999999999999631 


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                            .......          ..+.                      ..+...+.+++..|++.++..|++...+..
T Consensus       243 ------~~~~~~~----------~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          243 ------QEILEAE----------LHFP----------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------HHHHHTC----------CCCC----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------HHHhhhc----------cCCc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  1111100          0000                      012234567888999999999999987754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=4.1e-31  Score=287.28  Aligned_cols=198  Identities=23%  Similarity=0.298  Sum_probs=168.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc-eEEEEEEeccccchhhHHHHHHHHHHhcCCCCc------cceeeeeeccCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR-TTVTVKVFNLHHHRASRSFIAECRALRSIRHRN------LVKVFTACSGVDY  341 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  341 (789)
                      .++|...+.||+|+||+||+|....++ +.||+|+++.. ......+..|++++++++|++      ++.+++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-
Confidence            368889999999999999999997666 79999999643 234567888999999987766      888888887655 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec---
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL---  418 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill---  418 (789)
                          ..++||||+ ++++.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+||++   
T Consensus        96 ----~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           96 ----HMCIAFELL-GKNTFEFLKEN--------NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNS  159 (355)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCC
T ss_pred             ----eEEEEEecc-CCChHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecc
Confidence                889999999 56777776543        2346899999999999999999999988   9999999999999   


Q ss_pred             ----------------CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249          419 ----------------DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII  482 (789)
Q Consensus       419 ----------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt  482 (789)
                                      +.++.+||+|||.++......     ....||..|+|||.+.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence                            567899999999998755432     23468999999999999999999999999999999999


Q ss_pred             hcCCCCc
Q 041249          483 RKKPSDI  489 (789)
Q Consensus       483 G~~P~~~  489 (789)
                      |+.||..
T Consensus       235 g~~pf~~  241 (355)
T 2eu9_A          235 GFTLFQT  241 (355)
T ss_dssp             SSCSCCC
T ss_pred             CCCCCCC
Confidence            9999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=1.8e-31  Score=292.43  Aligned_cols=203  Identities=20%  Similarity=0.284  Sum_probs=170.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-----------CCccceeeeeec
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-----------HRNLVKVFTACS  337 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  337 (789)
                      .++|...+.||+|+||+||+|....+++.||||++.... .....+.+|++++++++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357888999999999999999998899999999986432 34567888999999886           899999999987


Q ss_pred             cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCce
Q 041249          338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNI  416 (789)
Q Consensus       338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Ni  416 (789)
                      .... .....++||||+ +++|.+++...        ....+++..+..++.|++.||+|||+. +   |+||||||+||
T Consensus        97 ~~~~-~~~~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI  163 (373)
T 1q8y_A           97 HKGP-NGVHVVMVFEVL-GENLLALIKKY--------EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV  163 (373)
T ss_dssp             EEET-TEEEEEEEECCC-CEEHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred             ccCC-CCceEEEEEecC-CCCHHHHHHHh--------hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence            5431 223679999999 88999998653        234589999999999999999999997 8   99999999999


Q ss_pred             ecC------CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          417 LLD------EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       417 ll~------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +++      ..+.+||+|||++.......     ....||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            994      45589999999998765432     2346899999999999989999999999999999999999999743

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=2.1e-31  Score=297.54  Aligned_cols=257  Identities=19%  Similarity=0.201  Sum_probs=182.4

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      ...+.||+|+||+||.+.. .+++.||||++...   ..+.+.+|++++.++ +||||+++++++....     ..++||
T Consensus        18 ~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~~~lv~   88 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYIAL   88 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEEEE
T ss_pred             eccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----eEEEEE
Confidence            4467899999999986544 47899999998643   235678899999886 8999999999987655     899999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC----------
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE----------  421 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~----------  421 (789)
                      ||+. |+|.+++.......   ......++..+..++.||+.||+|||+.+   |+||||||+|||++.+          
T Consensus        89 E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             CCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             ecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccC
Confidence            9996 69999997542111   00111233456789999999999999998   9999999999999653          


Q ss_pred             ---CceeeCcccccccCCCCCCc--cceeeecccccccCcccCCC-------CCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249          422 ---MVSHVGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLG-------SEVSTNGDVYSYGILMLELII-RKKPSD  488 (789)
Q Consensus       422 ---~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~sfGvvl~ellt-G~~P~~  488 (789)
                         +.+||+|||+++........  .......||..|+|||++.+       ..++.++|||||||++|||++ |+.||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               58999999999987654422  12234579999999999865       568999999999999999999 999997


Q ss_pred             ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      .....   ...+.+......       ...                  ..........+.+++..|++.++..||+...+
T Consensus       242 ~~~~~---~~~i~~~~~~~~-------~~~------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  293 (434)
T 2rio_A          242 DKYSR---ESNIIRGIFSLD-------EMK------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKV  293 (434)
T ss_dssp             STTTH---HHHHHHTCCCCC-------CCT------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             Cchhh---HHHHhcCCCCcc-------ccc------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence            43221   122222111110       000                  00112344567788999999999999999887


Q ss_pred             ccccc
Q 041249          569 GSILP  573 (789)
Q Consensus       569 ~~~l~  573 (789)
                      ..++-
T Consensus       294 l~hp~  298 (434)
T 2rio_A          294 LRHPL  298 (434)
T ss_dssp             HTSGG
T ss_pred             HhCCc
Confidence            66554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=2.9e-29  Score=270.11  Aligned_cols=176  Identities=20%  Similarity=0.265  Sum_probs=109.7

Q ss_pred             ccchhcccCCcccc--cCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEE
Q 041249          580 FLKILNLENNSFTH--EIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS  657 (789)
Q Consensus       580 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  657 (789)
                      +|++|++++|+++.  ..+..|..+++|++|++++|.++ .+|..+.  ++|++|++++|++++..|..|..+++|++|+
T Consensus       146 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  222 (330)
T 1xku_A          146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLG  222 (330)
T ss_dssp             TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred             cccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence            34455555555532  44555666666666666666666 3444333  5666666666666665566666666777777


Q ss_pred             ccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccC------CCCccEEEcc
Q 041249          658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFN------ISSIAEFDVG  731 (789)
Q Consensus       658 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls  731 (789)
                      |++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|++..+..|..      .+.|+.|+++
T Consensus       223 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~  301 (330)
T 1xku_A          223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF  301 (330)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred             CCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEee
Confidence            7777766666666666667777777777776 56666666777777777777776555555533      3567778888


Q ss_pred             CCcccc-cCCcccccCCCCccEEEccCCc
Q 041249          732 ENKIQG-NIPLDYGFTLQNLQYFSIGTNR  759 (789)
Q Consensus       732 ~N~l~~-~ip~~~~~~l~~L~~L~L~~N~  759 (789)
                      +|++.. .++...|..+.+++.++|++|+
T Consensus       302 ~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          302 SNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cCcccccccCccccccccceeEEEecccC
Confidence            887752 2555556577788888888774

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.1e-31  Score=295.40  Aligned_cols=253  Identities=21%  Similarity=0.241  Sum_probs=182.5

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ...+|...+.||+|+||+||.... .+++.||||++.....   ..+.+|+++++.+ +||||+++++++....     .
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-----~   92 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ-----F   92 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT-----E
T ss_pred             ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC-----E
Confidence            455788889999999999654333 3689999999864332   2356899999999 8999999999987765     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-----C
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-----E  421 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-----~  421 (789)
                      .++||||+. |+|.+++...         ...+.+.++..++.|++.||+|||+.+   |+||||||+||+++.     .
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~  159 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQK---------DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGK  159 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---------SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTB
T ss_pred             EEEEEECCC-CCHHHHHHhc---------CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCc
Confidence            899999997 6999998654         123444556789999999999999998   999999999999953     3


Q ss_pred             CceeeCcccccccCCCCCC-ccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249          422 MVSHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN  496 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~  496 (789)
                      ..+||+|||+++....... ........||..|+|||++.   ...++.++|||||||++|||++ |+.||......   
T Consensus       160 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---  236 (432)
T 3p23_A          160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---  236 (432)
T ss_dssp             CCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---
T ss_pred             eeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---
Confidence            4678999999998765432 12234467999999999987   4567889999999999999999 99998632111   


Q ss_pred             HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ...   ........+...+                        .......+.+++..|++.++..|++...+..++
T Consensus       237 ~~~---~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          237 QAN---ILLGACSLDCLHP------------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             HHH---HHTTCCCCTTSCT------------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             HHH---HHhccCCccccCc------------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            111   1111100000000                        012233456788899999999999998876554

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.97  E-value=4.3e-31  Score=281.93  Aligned_cols=232  Identities=28%  Similarity=0.453  Sum_probs=217.9

Q ss_pred             cccceeeEeccCc-ccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCc
Q 041249          552 SKAQKVTILDLES-LKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLI  630 (789)
Q Consensus       552 ~~c~~l~~l~l~s-~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~  630 (789)
                      ..+.+++.+++.+ +.+....+..+.++++|++|+|++|++++.+|..|..+++|++|+|++|+|++.+|..|..+++|+
T Consensus        73 ~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  152 (313)
T 1ogq_A           73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV  152 (313)
T ss_dssp             GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred             hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCC
Confidence            3567889999995 888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEcccCCCCCCCCcccCCCC-CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCc
Q 041249          631 RIGLAKNQLMGKIPSDFGSLS-KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  709 (789)
                      +|++++|++++.+|..|..++ +|++|+|++|++++..|..|..++ |++|+|++|++++..|..|..+++|+.|+|++|
T Consensus       153 ~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  231 (313)
T 1ogq_A          153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN  231 (313)
T ss_dssp             EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred             eEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCC
Confidence            999999999989999999998 999999999999999999999997 999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCc-Cccc
Q 041249          710 RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK-LTGE  787 (789)
Q Consensus       710 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~  787 (789)
                      ++++.+|. +..+++|++|+|++|+|++.+|..+. .+++|++|+|++|++++.+|.. ..+++|+.+++++|+ ++|.
T Consensus       232 ~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          232 SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             EECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred             ceeeecCc-ccccCCCCEEECcCCcccCcCChHHh-cCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence            99976665 88999999999999999989998876 8999999999999999998887 889999999999998 7774

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=1e-30  Score=308.75  Aligned_cols=198  Identities=23%  Similarity=0.313  Sum_probs=168.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcC-CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .++|...+.||+|+||+||+|.+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999975 68999999986443 344567899999999999999999999998765333334


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++.            ..+++.++..|+.||+.||.|||+.+   ||||||||+||+++.+ .+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred             eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence            799999999999988663            25899999999999999999999998   9999999999999986 8999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+++.....      ....||+.|+|||++.++ ++.++|||||||++|||++|..|+..
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            999999876543      235699999999988655 48999999999999999999998863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=7.7e-31  Score=291.07  Aligned_cols=254  Identities=15%  Similarity=0.081  Sum_probs=182.4

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCC-Cccceeeee-------
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH-RNLVKVFTA-------  335 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l~~~-------  335 (789)
                      ..+.+|...+.||+|+||+||+|.+..+++.||||+++....   ...+.+.+|+.+++.++| +|...+..+       
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            445567788899999999999999998999999999874432   235789999999999987 332222111       


Q ss_pred             --------------eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC
Q 041249          336 --------------CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD  401 (789)
Q Consensus       336 --------------~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~  401 (789)
                                    +...........+++|+++ .++|.+++....   ........+++..++.++.|++.||+|||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~---~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL---SHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHH---HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhh---cccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                          0000000011346666655 478988884210   0011245688899999999999999999999


Q ss_pred             CCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccC----------CCCCcCccccch
Q 041249          402 CQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYG----------LGSEVSTNGDVY  471 (789)
Q Consensus       402 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DV~  471 (789)
                      +   ||||||||+|||++.++.+||+|||+++.....     .....| ..|+|||++          ....++.++|||
T Consensus       231 ~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          231 G---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             T---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             C---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            8   999999999999999999999999998875433     233457 999999998          566789999999


Q ss_pred             hhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhc
Q 041249          472 SYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIG  551 (789)
Q Consensus       472 sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  551 (789)
                      ||||++|||++|+.||......                 +..+..+..                    ...+...+.+++
T Consensus       302 SlGvil~elltg~~Pf~~~~~~-----------------~~~~~~~~~--------------------~~~~~~~~~~li  344 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAAL-----------------GGSEWIFRS--------------------CKNIPQPVRALL  344 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGG-----------------SCSGGGGSS--------------------CCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchh-----------------hhHHHHHhh--------------------cccCCHHHHHHH
Confidence            9999999999999999743211                 000000000                    001224466788


Q ss_pred             cccceeeEeccCccccccc
Q 041249          552 SKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       552 ~~c~~l~~l~l~s~~~~~~  570 (789)
                      ..|++.++.+|++......
T Consensus       345 ~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          345 EGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHTCSSGGGSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            8999999999999877654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.96  E-value=2.3e-32  Score=308.39  Aligned_cols=109  Identities=20%  Similarity=0.201  Sum_probs=70.0

Q ss_pred             ccCCeEecCCCcCCCCCCcc-ccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEEccCCcCCCCCcccc-cCCC-
Q 041249           21 KKLVEPYVSDNFLKGSIPSS-LGLCESLTTIGLFNNNLSG----TIPPQLMGLTSLVALDLSRNQFRGSFPTEV-GNLI-   93 (789)
Q Consensus        21 ~~l~~L~ls~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~-   93 (789)
                      ++|++|+|++|+++...... +..+++|++|+|++|++++    .+|..+..+++|++|+|++|.+++..+..+ ..+. 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            45677777777776433332 5667777777777777763    345666777777777777777764333333 2343 


Q ss_pred             ---CCCEEeccCCCCCC----cCCccccCCcccccccccCCCC
Q 041249           94 ---NLETLTVSGNILQG----EIPSTLGSCIKLEILEMQGNVF  129 (789)
Q Consensus        94 ---~L~~L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~~  129 (789)
                         +|++|+|++|+++.    .+|..+..+++|++|++++|++
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i  125 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL  125 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcC
Confidence               57777777777763    4566677777766666666554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=2e-30  Score=279.94  Aligned_cols=196  Identities=17%  Similarity=0.179  Sum_probs=158.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--------hhhHHHHHHHHHHhcCC---------CCccce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--------RASRSFIAECRALRSIR---------HRNLVK  331 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv~  331 (789)
                      .++|...+.||+|+||+||+|++  +++.||||+++....        ...+.+.+|+++++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46788899999999999999998  579999999975532        22377889999988886         555555


Q ss_pred             ee-----------------eeeccCC--------CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHH
Q 041249          332 VF-----------------TACSGVD--------YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN  386 (789)
Q Consensus       332 l~-----------------~~~~~~~--------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~  386 (789)
                      +.                 +++....        .......++||||+.+|++.+.+..           ..+++.++..
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~  165 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKS  165 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHH
Confidence            54                 4443310        0113479999999999977766632           3578999999


Q ss_pred             HHHHHHHHHhhhh-cCCCCCceecCCCCCceecCCCC--------------------ceeeCcccccccCCCCCCcccee
Q 041249          387 IAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEM--------------------VSHVGDFGLARFLPPTHVQTSSI  445 (789)
Q Consensus       387 i~~~ia~gL~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~  445 (789)
                      |+.|++.||+||| +.+   ||||||||+|||++.++                    .+||+|||+|+.....       
T Consensus       166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------  235 (336)
T 2vuw_A          166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred             HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence            9999999999999 888   99999999999999886                    8999999999876532       


Q ss_pred             eecccccccCcccCCCCCcCccccchhhHHH-HHHHHHhcCCCC
Q 041249          446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGIL-MLELIIRKKPSD  488 (789)
Q Consensus       446 ~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvv-l~elltG~~P~~  488 (789)
                      ...||..|+|||.+.+.. +.++||||+|++ .+++++|..||.
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            246999999999988655 899999998877 777889999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=1.2e-29  Score=269.09  Aligned_cols=236  Identities=17%  Similarity=0.199  Sum_probs=177.7

Q ss_pred             cCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHH-hcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL-RSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|... +.||+|+||.||+|....+++.||+|+++.     ...+.+|++++ +..+||||+++++++.... .+....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceE
Confidence            466666 789999999999999998999999999853     24577888888 5559999999999986521 122368


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~  424 (789)
                      ++||||+.+|+|.+++...        ....+++.++..++.|++.||+|||+.+   |+||||||+||+++.   ++.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC--------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence            9999999999999999754        3356899999999999999999999998   999999999999998   7899


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||++....                        +..++.++|||||||++|||++|+.||.......         .
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---------~  206 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------I  206 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh---------h
Confidence            999999986532                        2457889999999999999999999996321110         0


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ...-...+.......                +......+...+.+++..|++.++..|++...+..+
T Consensus       207 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          207 SPGMKTRIRMGQYEF----------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -CCSCCSSCTTCCSS----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hHHHHHHHhhccccC----------------CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000000000000000                000112334567788899999999999998877543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=3.9e-28  Score=255.53  Aligned_cols=225  Identities=18%  Similarity=0.192  Sum_probs=200.7

Q ss_pred             EeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCC
Q 041249          559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQ  638 (789)
Q Consensus       559 ~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~  638 (789)
                      .++.....+... +..  -.++|++|+|++|++++..+..|..+++|++|+|++|.|++..|..|.++++|++|++++|+
T Consensus        15 ~~~c~~~~l~~i-p~~--~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~   91 (285)
T 1ozn_A           15 TTSCPQQGLQAV-PVG--IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (285)
T ss_dssp             EEECCSSCCSSC-CTT--CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEcCcCCcccC-CcC--CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence            455555444432 222  24689999999999998888889999999999999999998889999999999999999997


Q ss_pred             -CCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCc
Q 041249          639 -LMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPS  717 (789)
Q Consensus       639 -l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  717 (789)
                       ++...|..|..+++|++|++++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  171 (285)
T 1ozn_A           92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER  171 (285)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence             8877788999999999999999999988899999999999999999999977777899999999999999999977777


Q ss_pred             cccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          718 SIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       718 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      .|..+++|+.|+|++|.|++..|..+. .+++|++|+|++|+|++..+..+..+++|+.|++++|++++.
T Consensus       172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  240 (285)
T 1ozn_A          172 AFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             HhcCccccCEEECCCCcccccCHhHcc-CcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence            899999999999999999955566655 899999999999999988778899999999999999999863

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.6e-28  Score=263.69  Aligned_cols=227  Identities=17%  Similarity=0.253  Sum_probs=211.0

Q ss_pred             cceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEE
Q 041249          554 AQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIG  633 (789)
Q Consensus       554 c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  633 (789)
                      ..+++.+++..+.+. ..+..+.++++|++|+|++|+++ .+|..|..+++|++|+|++|+|+ .+|..|.++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            467888999999887 66777889999999999999999 88999999999999999999999 7899999999999999


Q ss_pred             cccCCCCCCCCcccCC---------CCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCee
Q 041249          634 LAKNQLMGKIPSDFGS---------LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVIL  704 (789)
Q Consensus       634 l~~N~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  704 (789)
                      +++|.+.+.+|..+..         +++|++|+|++|+|+ .+|..|.++++|++|+|++|+++ .+|..|..+++|++|
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L  234 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL  234 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence            9999888888887754         999999999999999 88889999999999999999999 567789999999999


Q ss_pred             eccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcC
Q 041249          705 YLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL  784 (789)
Q Consensus       705 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  784 (789)
                      +|++|.+.+.+|..|..+++|+.|+|++|.+.+.+|..+. .+++|++|+|++|++.+.+|..+.++++|+.+++..|.+
T Consensus       235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            9999999999999999999999999999999989999876 899999999999999999999999999999999998876


Q ss_pred             cc
Q 041249          785 TG  786 (789)
Q Consensus       785 ~~  786 (789)
                      ..
T Consensus       314 ~~  315 (328)
T 4fcg_A          314 AQ  315 (328)
T ss_dssp             CC
T ss_pred             HH
Confidence            54

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=7.2e-29  Score=261.07  Aligned_cols=171  Identities=12%  Similarity=0.109  Sum_probs=150.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      +.|...+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|++.+++++||||+++++++...+     .
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-----G  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-----c
Confidence            568889999999999999999998899999999975532   23477999999999999999999999987765     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+++|.+++...            ....+...|+.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl  170 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVL  170 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEE
T ss_pred             EEEEEEecCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEE
Confidence            89999999999999998422            255678899999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++++                      |++       .++.++|||||||++|||++|+.||..
T Consensus       171 ~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~  204 (286)
T 3uqc_A          171 AYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPE  204 (286)
T ss_dssp             CSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred             Eecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            8543                      333       368999999999999999999999974

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=6.2e-28  Score=270.39  Aligned_cols=229  Identities=23%  Similarity=0.217  Sum_probs=209.5

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEc
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      .+++.+++..+.+....+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            35677899999998888889999999999999999999888899999999999999999999777778999999999999


Q ss_pred             ccCCCCCCCCcccCCCCCCcEEEccC-CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc
Q 041249          635 AKNQLMGKIPSDFGSLSKIEVLSLGF-NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       635 ~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                      ++|+|+...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~  221 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA  221 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCE
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCc
Confidence            99999987788899999999999999 5666666668999999999999999999 566 58999999999999999999


Q ss_pred             cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ..|..|..+++|+.|+|++|+|+ .++...+.++++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus       222 ~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          222 IRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             ECTTTTTTCTTCCEEECTTCCCC-EECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             cChhhhccCccCCEEECCCCcee-EEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            88999999999999999999999 6665656689999999999999998888889999999999999999864

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=2.2e-28  Score=260.29  Aligned_cols=231  Identities=21%  Similarity=0.221  Sum_probs=208.9

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCccccc--CcccccCccceeeecccCCCCccCCCccCcCCCCCcEE
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHE--IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI  632 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L  632 (789)
                      .+++.+++..+.+.......|.++++|++|+|++|+++..  .+..+..+++|++|+|++|.++ .+|..+..+++|++|
T Consensus        28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L  106 (306)
T 2z66_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL  106 (306)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence            3678889999988866556689999999999999999844  3677888999999999999999 577789999999999


Q ss_pred             EcccCCCCCCCC-cccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCc-cCCccccCCCCCCeeeccCcc
Q 041249          633 GLAKNQLMGKIP-SDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG-SIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       633 ~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      ++++|++++..+ ..|..+++|++|++++|++++..+..|.++++|++|+|++|++++ ..|..|..+++|++|+|++|+
T Consensus       107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  186 (306)
T 2z66_A          107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  186 (306)
T ss_dssp             ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence            999999996655 579999999999999999999999999999999999999999986 588999999999999999999


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCC-CCCeeeccCCcCccc
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS-KLEVFQALNNKLTGE  787 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~  787 (789)
                      +++..|..|..+++|+.|+|++|+|+ .++...+..+++|++|+|++|++++..|..+..++ +|+.|++++|++++.
T Consensus       187 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          187 LEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCS-BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             cCCcCHHHhcCCCCCCEEECCCCccC-ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            99888999999999999999999999 66665556899999999999999999999999985 999999999999874

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.95  E-value=2.1e-32  Score=308.72  Aligned_cols=159  Identities=23%  Similarity=0.221  Sum_probs=120.2

Q ss_pred             CEEcCCCCCCccCCcC-ccCCccCCeEecCCCcCCC----CCCccccCCCCCCEEEccCCcCCCCCcccc-cCCC----C
Q 041249            1 ILALDSNRLSGNIPPS-IGNLKKLVEPYVSDNFLKG----SIPSSLGLCESLTTIGLFNNNLSGTIPPQL-MGLT----S   70 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~-~~~l~~l~~L~ls~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~----~   70 (789)
                      .|||++|+++...... +..+++|++|+|++|.+++    .+++.+..+++|++|+|++|.+++..+..+ ..++    +
T Consensus         7 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~   86 (461)
T 1z7x_W            7 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK   86 (461)
T ss_dssp             EEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCC
T ss_pred             ehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCc
Confidence            4899999998654444 7789999999999999984    457788899999999999999986444333 3455    7


Q ss_pred             CCEEEccCCcCCC----CCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCC-
Q 041249           71 LVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGE-  145 (789)
Q Consensus        71 L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~-  145 (789)
                      |++|+|++|+++.    .+|..+..+++|++|+|++|.+++..+..+...  +      ......|+.|+|++|.+++. 
T Consensus        87 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~--l------~~~~~~L~~L~L~~n~l~~~~  158 (461)
T 1z7x_W           87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG--L------LDPQCRLEKLQLEYCSLSAAS  158 (461)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH--H------TSTTCCCCEEECTTSCCBGGG
T ss_pred             eeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH--H------hcCCCcceEEECCCCCCCHHH
Confidence            9999999999984    568899999999999999999985544433320  0      00112345556666666653 


Q ss_pred             ---chhhhcCcccccEEecccCCCC
Q 041249          146 ---IPEFLVGLKVIENLNLSYNDLE  167 (789)
Q Consensus       146 ---~p~~~~~~~~l~~l~ls~N~~~  167 (789)
                         ++..+..+++|++|++++|+++
T Consensus       159 ~~~l~~~l~~~~~L~~L~L~~n~i~  183 (461)
T 1z7x_W          159 CEPLASVLRAKPDFKELTVSNNDIN  183 (461)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHHHHHhhCCCCCEEECcCCCcc
Confidence               4666777899999999999774

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=3.2e-28  Score=261.32  Aligned_cols=206  Identities=22%  Similarity=0.330  Sum_probs=194.5

Q ss_pred             ccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEE
Q 041249          578 LSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS  657 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  657 (789)
                      .+.++.|+|++|+++ .+|..+..+++|++|+|++|.|+ .+|..|.++++|++|+|++|+++ .+|..|..+++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            578999999999999 67888899999999999999999 88999999999999999999999 7898999999999999


Q ss_pred             ccCCCCCccCCcCCCC---------CCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249          658 LGFNNLIGSIPPPLGN---------LSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF  728 (789)
Q Consensus       658 L~~N~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  728 (789)
                      |++|++.+.+|..+..         +++|++|+|++|+|+ .+|..|.++++|++|+|++|+++ .+|..+..+++|++|
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L  234 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL  234 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence            9999998899988765         999999999999999 88999999999999999999999 577789999999999


Q ss_pred             EccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      +|++|.+.+.+|..+. ++++|++|+|++|.+.+.+|..+..+++|+.|++++|++.|.+|
T Consensus       235 ~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP  294 (328)
T 4fcg_A          235 DLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP  294 (328)
T ss_dssp             ECTTCTTCCBCCCCTT-CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCC
T ss_pred             ECcCCcchhhhHHHhc-CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhcc
Confidence            9999999989998876 89999999999999999999999999999999999999999987

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=7.6e-28  Score=270.65  Aligned_cols=229  Identities=19%  Similarity=0.174  Sum_probs=209.1

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEc
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      .+++.+++..+.+....+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            35778999999998888899999999999999999999988899999999999999999999887888999999999999


Q ss_pred             ccCCCCCCCCcccCCCCCCcEEEccC-CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc
Q 041249          635 AKNQLMGKIPSDFGSLSKIEVLSLGF-NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       635 ~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                      ++|+|+...+..|..+++|+.|+|++ |.++...+..|.++++|++|+|++|+|++ +| .+..+++|+.|+|++|+|++
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~  232 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPE  232 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSE
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcc
Confidence            99999977777899999999999999 66776666789999999999999999994 45 58999999999999999999


Q ss_pred             cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ..|..|..+++|+.|+|++|+|+ .++...+.++++|++|+|++|+|++..+..|..+++|+.|+|++|++.+
T Consensus       233 ~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          233 IRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             ECGGGGTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             cCcccccCccCCCEEEeCCCcCc-eECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            99999999999999999999999 5555555589999999999999998888889999999999999999865

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.7e-27  Score=249.38  Aligned_cols=209  Identities=22%  Similarity=0.203  Sum_probs=192.1

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEc
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL  658 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  658 (789)
                      ++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            47999999999999888889999999999999999999888889999999999999999999888889999999999999


Q ss_pred             cCCCCCccCCcCCCCCCCCCEEEccCCcCCcc-CCccccCCCCCCeeeccCccccccCCccccCCCCcc----EEEccCC
Q 041249          659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGS-IPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA----EFDVGEN  733 (789)
Q Consensus       659 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N  733 (789)
                      ++|++++..+..|..+++|++|+|++|++++. +|..|.++++|++|+|++|++++..+..|..+++|+    .|++++|
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            99999988887899999999999999999864 589999999999999999999988888888887777    9999999


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      +|+ .+|...+ ...+|++|+|++|+|++..+..|..+++|+.|++++|++++..|
T Consensus       188 ~l~-~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          188 PMN-FIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCC-EECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             ccc-ccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            999 7777777 56699999999999998777788999999999999999998643

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=3.9e-28  Score=263.85  Aligned_cols=233  Identities=16%  Similarity=0.142  Sum_probs=201.4

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEc
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      .+++.+++..+.+.......+.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|++
T Consensus        52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred             ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence            36788999999888776778999999999999999999888889999999999999999999665566999999999999


Q ss_pred             ccCCCCCCCC-cccCCCCCCcEEEccCC-CCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc
Q 041249          635 AKNQLMGKIP-SDFGSLSKIEVLSLGFN-NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       635 ~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      ++|+++...+ ..|..+++|++|++++| .+++..+..|.++++|++|++++|++++..|..|..+++|++|++++|+++
T Consensus       132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~  211 (353)
T 2z80_A          132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI  211 (353)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred             CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence            9999995444 47999999999999999 588777889999999999999999999888999999999999999999998


Q ss_pred             ccCCccccCCCCccEEEccCCcccccC-------------------------------CcccccCCCCccEEEccCCccc
Q 041249          713 GIVPSSIFNISSIAEFDVGENKIQGNI-------------------------------PLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       713 ~~~p~~~~~l~~L~~L~Ls~N~l~~~i-------------------------------p~~~~~~l~~L~~L~L~~N~l~  761 (789)
                      ...+..+..+++|+.|+|++|++++..                               |..+ ..+++|++|+|++|+|+
T Consensus       212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l-~~l~~L~~L~Ls~N~l~  290 (353)
T 2z80_A          212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL-NQISGLLELEFSRNQLK  290 (353)
T ss_dssp             THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHH-HTCTTCCEEECCSSCCC
T ss_pred             cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHH-hcccCCCEEECCCCCCC
Confidence            544444556899999999999998432                               2223 37899999999999999


Q ss_pred             ccCcccccCCCCCCeeeccCCcCcccC
Q 041249          762 GAIPPSISNASKLEVFQALNNKLTGEV  788 (789)
Q Consensus       762 ~~~~~~~~~l~~L~~L~l~~N~l~~~~  788 (789)
                      ...+..|..+++|+.|++++|++++..
T Consensus       291 ~i~~~~~~~l~~L~~L~L~~N~~~~~~  317 (353)
T 2z80_A          291 SVPDGIFDRLTSLQKIWLHTNPWDCSC  317 (353)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence            554444689999999999999999854

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=2.1e-27  Score=249.92  Aligned_cols=208  Identities=19%  Similarity=0.210  Sum_probs=193.1

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCC-CccCCCccCcCCCCCcEEE
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS-IGGEIPVNLSSCSNLIRIG  633 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l~~L~~L~  633 (789)
                      .+++.+++..+.+....+..|..+++|++|+|++|++++..|..|..+++|++|+|++|. ++...|..|..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            367788999999888777889999999999999999998889999999999999999997 8877789999999999999


Q ss_pred             cccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc
Q 041249          634 LAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       634 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                      +++|++++..|..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            99999998888899999999999999999998888889999999999999999997777789999999999999999999


Q ss_pred             cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      ..|..|..+++|+.|+|++|+|+ .+|...+..+++|++|+|++|++...
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~  240 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCD  240 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCS-CCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             cCHhHccCcccccEeeCCCCcCC-cCCHHHcccCcccCEEeccCCCccCC
Confidence            88999999999999999999999 67777666899999999999999853

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.5e-26  Score=239.69  Aligned_cols=202  Identities=21%  Similarity=0.245  Sum_probs=118.8

Q ss_pred             cchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       581 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      .+++++++|+++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|++++|+|+...+..|.++++|++|+|++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            345566666666 3444332  3566666666666655455566666666666666666644444555666666666666


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~  173 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVP  173 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCC
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc-EeC
Confidence            6666555555566666666666666666555555666666666666666666544455566666666666666665 455


Q ss_pred             cccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          741 LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       741 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ...+..+++|++|+|++|+|++..+..|..+++|+.|++++|++.+
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            4444456666666666666665555555566666666666666543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=1.3e-26  Score=260.54  Aligned_cols=226  Identities=19%  Similarity=0.172  Sum_probs=197.9

Q ss_pred             eEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccC
Q 041249          558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKN  637 (789)
Q Consensus       558 ~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N  637 (789)
                      ..++.....+. ..|..+.  ++|++|+|++|+|+++.|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            34444444433 2333332  68999999999999989999999999999999999999888899999999999999999


Q ss_pred             CCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC-CcCCccCCccccCCCCCCeeeccCccccccCC
Q 041249          638 QLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI-NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP  716 (789)
Q Consensus       638 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  716 (789)
                      +|+...+..|..+++|++|+|++|+|+...+..|.++++|++|+|++ |.++...+..|.++++|++|+|++|+|++ +|
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~  212 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP  212 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence            99987788899999999999999999988888999999999999999 56775666689999999999999999995 44


Q ss_pred             ccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          717 SSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       717 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                       .+..+++|+.|+|++|+|+ .++...+.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|
T Consensus       213 -~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  283 (452)
T 3zyi_A          213 -NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH  283 (452)
T ss_dssp             -CCTTCTTCCEEECTTSCCS-EECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             -cccccccccEEECcCCcCc-ccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh
Confidence             5889999999999999999 5544545599999999999999999999999999999999999999997543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=4.3e-28  Score=258.65  Aligned_cols=204  Identities=17%  Similarity=0.178  Sum_probs=181.6

Q ss_pred             CccccchhcccCCcccccCcccc--cCccceeeecccCCCCccCCCccCcCC-----CCCcEEEcccCCCCCCCCcccCC
Q 041249          577 NLSFLKILNLENNSFTHEIPSEI--GRLRRLQVPDLNNNSIGGEIPVNLSSC-----SNLIRIGLAKNQLMGKIPSDFGS  649 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~i~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~  649 (789)
                      ++++|++|+|++|++++..|..+  ..+++|++|+|++|+|++. |..+..+     ++|++|+|++|+|++..|..|..
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            68999999999999999899886  8999999999999999977 8888877     99999999999999888899999


Q ss_pred             CCCCcEEEccCCCCCcc--CCcCC--CCCCCCCEEEccCCcCCc---cCCccccCCCCCCeeeccCccccccCC-ccccC
Q 041249          650 LSKIEVLSLGFNNLIGS--IPPPL--GNLSSLRKISLAINNLAG---SIPFTLSKLKNLVILYLGVNRLSGIVP-SSIFN  721 (789)
Q Consensus       650 l~~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~  721 (789)
                      +++|++|+|++|++.+.  .+..+  ..+++|++|+|++|+|++   .....+.++++|++|+|++|+|++..| ..+..
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            99999999999998765  23334  889999999999999983   222445788999999999999998775 56777


Q ss_pred             CCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          722 ISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       722 l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      +++|++|+|++|+|+ .+|..++   ++|++|+|++|+|++. |. +..+++|+.|++++|+|++.
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~---~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP---AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC---SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc---CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence            899999999999999 9999875   8999999999999976 55 89999999999999999974

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=1.4e-26  Score=259.39  Aligned_cols=225  Identities=22%  Similarity=0.183  Sum_probs=197.1

Q ss_pred             EeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCC
Q 041249          559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQ  638 (789)
Q Consensus       559 ~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~  638 (789)
                      .++.....+. ..|..+.  ++++.|+|++|+|+++.+..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|+
T Consensus        47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~  123 (440)
T 3zyj_A           47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR  123 (440)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence            3444444433 3343333  679999999999998888999999999999999999998888999999999999999999


Q ss_pred             CCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC-CcCCccCCccccCCCCCCeeeccCccccccCCc
Q 041249          639 LMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI-NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPS  717 (789)
Q Consensus       639 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  717 (789)
                      |+...+..|..+++|++|+|++|+|+...+..|.++++|++|+|++ |.++...+..|.++++|++|+|++|+|+ .+| 
T Consensus       124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-  201 (440)
T 3zyj_A          124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-  201 (440)
T ss_dssp             CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-
T ss_pred             CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-
Confidence            9977777899999999999999999988888999999999999999 5666556668999999999999999999 555 


Q ss_pred             cccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          718 SIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       718 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      .+..+++|+.|+|++|+|+ .++...+.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|
T Consensus       202 ~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  272 (440)
T 3zyj_A          202 NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH  272 (440)
T ss_dssp             CCTTCSSCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT
T ss_pred             ccCCCcccCEEECCCCccC-ccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh
Confidence            4889999999999999999 5544445599999999999999999999999999999999999999997543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.94  E-value=6.1e-27  Score=249.07  Aligned_cols=226  Identities=17%  Similarity=0.191  Sum_probs=195.6

Q ss_pred             EeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccC--CCccCcCCCCCcEEEccc
Q 041249          559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE--IPVNLSSCSNLIRIGLAK  636 (789)
Q Consensus       559 ~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~l~~  636 (789)
                      .++..+..+.. .+..+  .++|++|+|++|+++.+.+..|..+++|++|+|++|+|+..  .|..+..+++|++|++++
T Consensus        11 ~l~c~~~~l~~-ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~   87 (306)
T 2z66_A           11 EIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF   87 (306)
T ss_dssp             EEECCSSCCSS-CCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred             EEEcCCCCccc-CCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence            44554444432 23322  26899999999999976666789999999999999999843  367778899999999999


Q ss_pred             CCCCCCCCcccCCCCCCcEEEccCCCCCccCC-cCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc-c
Q 041249          637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP-PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG-I  714 (789)
Q Consensus       637 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~  714 (789)
                      |.+. .+|..|..+++|++|++++|++++..+ ..|..+++|++|++++|++++..+..|.++++|++|++++|++++ .
T Consensus        88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  166 (306)
T 2z66_A           88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF  166 (306)
T ss_dssp             CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred             Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence            9998 577779999999999999999997665 689999999999999999998899999999999999999999986 6


Q ss_pred             CCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          715 VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       715 ~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      .|..|..+++|++|+|++|+|++..|..+ ..+++|++|+|++|++++..+..+..+++|+.|++++|++++.+|
T Consensus       167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  240 (306)
T 2z66_A          167 LPDIFTELRNLTFLDLSQCQLEQLSPTAF-NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK  240 (306)
T ss_dssp             ECSCCTTCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred             chhHHhhCcCCCEEECCCCCcCCcCHHHh-cCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence            89999999999999999999994445555 489999999999999998888889999999999999999998754

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=2.7e-26  Score=241.69  Aligned_cols=205  Identities=20%  Similarity=0.253  Sum_probs=176.8

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+.++++++++++++|+++. +|..+.  ++++.|+|++|.|++..+..|.++++|++|+|++|+|++..+  ...+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred             cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence            36678889999999999984 555443  588999999999998888889999999999999999985433  3788899


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      ++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            99999999998 67788889999999999999999777788999999999999999999877788889999999999999


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      +|+ .+|..++..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+
T Consensus       159 ~l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          159 NLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CCS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             cCC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            998 888888778999999999999999 577778888899999999998864

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.93  E-value=7.1e-27  Score=253.89  Aligned_cols=231  Identities=19%  Similarity=0.119  Sum_probs=199.4

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEE
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI  632 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L  632 (789)
                      .|......+..++.+.. .|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            44444445555555543 343333  589999999999998777789999999999999999998888999999999999


Q ss_pred             EcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCC-cCCCCCCCCCEEEccCC-cCCccCCccccCCCCCCeeeccCcc
Q 041249          633 GLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIP-PPLGNLSSLRKISLAIN-NLAGSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       633 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      ++++|+|++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .++...+..|.++++|++|++++|+
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~  185 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD  185 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence            999999997666669999999999999999996555 58999999999999999 5887778899999999999999999


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccC--------------------------
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI--------------------------  764 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~--------------------------  764 (789)
                      +++..|..|..+++|++|++++|.++ .+|..++..+++|++|+|++|++++..                          
T Consensus       186 l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~  264 (353)
T 2z80_A          186 LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE  264 (353)
T ss_dssp             CCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred             cCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence            99988999999999999999999997 888887767999999999999998743                          


Q ss_pred             -----cccccCCCCCCeeeccCCcCccc
Q 041249          765 -----PPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       765 -----~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                           |..+..+++|+.|++++|+++..
T Consensus       265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i  292 (353)
T 2z80_A          265 SLFQVMKLLNQISGLLELEFSRNQLKSV  292 (353)
T ss_dssp             HHHHHHHHHHTCTTCCEEECCSSCCCCC
T ss_pred             chhhhHHHHhcccCCCEEECCCCCCCcc
Confidence                 44567889999999999999853

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.93  E-value=2.8e-27  Score=252.38  Aligned_cols=228  Identities=18%  Similarity=0.204  Sum_probs=191.9

Q ss_pred             cccceeeEeccCcccccccccccccCccccchhcccCCccc-ccCccccc-------CccceeeecccCCCCccCCCccC
Q 041249          552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFT-HEIPSEIG-------RLRRLQVPDLNNNSIGGEIPVNL  623 (789)
Q Consensus       552 ~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~i~~~~p~~~  623 (789)
                      ..+.+++.+++..+.+  ..+..+...  |+.|+|++|+++ ..+|..+.       ++++|++|+|++|+|++.+|..+
T Consensus        40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  115 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL  115 (312)
T ss_dssp             EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred             ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence            3445566777777776  445555544  999999999995 44666555       79999999999999999999886


Q ss_pred             --cCCCCCcEEEcccCCCCCCCCcccCCC-----CCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCcc--CCcc
Q 041249          624 --SSCSNLIRIGLAKNQLMGKIPSDFGSL-----SKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS--IPFT  694 (789)
Q Consensus       624 --~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~  694 (789)
                        ..+++|++|+|++|++++. |..|..+     ++|++|+|++|++++..|..|.++++|++|+|++|++.+.  .|..
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA  194 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence              8999999999999999976 8888777     8999999999999988889999999999999999998765  3334


Q ss_pred             c--cCCCCCCeeeccCccccc---cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCccccc
Q 041249          695 L--SKLKNLVILYLGVNRLSG---IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSIS  769 (789)
Q Consensus       695 ~--~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  769 (789)
                      +  ..+++|++|+|++|+|++   .....+..+++|+.|+|++|+|++.+|...+..+++|++|+|++|+|+ .+|..+.
T Consensus       195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~  273 (312)
T 1wwl_A          195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP  273 (312)
T ss_dssp             SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred             HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence            4  899999999999999983   223455688999999999999997676665557899999999999999 6777766


Q ss_pred             CCCCCCeeeccCCcCccc
Q 041249          770 NASKLEVFQALNNKLTGE  787 (789)
Q Consensus       770 ~l~~L~~L~l~~N~l~~~  787 (789)
                        ++|+.|+|++|+|++.
T Consensus       274 --~~L~~L~Ls~N~l~~~  289 (312)
T 1wwl_A          274 --AKLSVLDLSYNRLDRN  289 (312)
T ss_dssp             --SEEEEEECCSSCCCSC
T ss_pred             --CCceEEECCCCCCCCC
Confidence              8999999999999986

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=6.2e-26  Score=236.94  Aligned_cols=204  Identities=22%  Similarity=0.233  Sum_probs=156.3

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+..+++|+.|++++|.++. + ..+..+++|++|+|++|.+++.  ..+..+++|++|++++|++++..+..|..+++|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            34567778888888888773 3 3477788888888888888753  467788888888888888887777777888888


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      ++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|+|++..+..|..+++|+.|+|++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            88888888888777777788888888888888888766667788888888888888888776777778888888888888


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      +++ .+|...+..+++|++|+|++|++.+.       +++|+.|+++.|.++|.+|
T Consensus       192 ~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip  239 (272)
T 3rfs_A          192 QLK-SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVR  239 (272)
T ss_dssp             CCS-CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBB
T ss_pred             cCC-ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCccc
Confidence            887 45555545788888888888877643       4467778888888888765

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.93  E-value=2.1e-26  Score=246.11  Aligned_cols=222  Identities=19%  Similarity=0.219  Sum_probs=195.3

Q ss_pred             hhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCC
Q 041249          549 RIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSN  628 (789)
Q Consensus       549 ~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~  628 (789)
                      .+...+.+++.+++..+.+....+..|..+++|++|+|++|++++..+  |..+++|++|+|++|+|++..     ..++
T Consensus        28 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~  100 (317)
T 3o53_A           28 SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPS  100 (317)
T ss_dssp             HHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTT
T ss_pred             HHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCC
Confidence            344567899999999999998878899999999999999999997655  999999999999999998543     2389


Q ss_pred             CcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccc-cCCCCCCeeecc
Q 041249          629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTL-SKLKNLVILYLG  707 (789)
Q Consensus       629 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls  707 (789)
                      |++|++++|+|++..+..   +++|++|++++|++++..+..|..+++|++|+|++|++++..+..+ ..+++|++|+|+
T Consensus       101 L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~  177 (317)
T 3o53_A          101 IETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ  177 (317)
T ss_dssp             CCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred             cCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECC
Confidence            999999999999665543   6789999999999998888899999999999999999998777777 479999999999


Q ss_pred             CccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          708 VNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       708 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      +|+|++. |. ...+++|++|+|++|+|+ .+|..+. .+++|++|+|++|+|+ .+|..+..+++|+.|++++|+++
T Consensus       178 ~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~-~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~  250 (317)
T 3o53_A          178 YNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH  250 (317)
T ss_dssp             TSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGG-GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCB
T ss_pred             CCcCccc-cc-ccccccCCEEECCCCcCC-cchhhhc-ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCcc
Confidence            9999965 33 345899999999999999 7777765 8999999999999999 46788999999999999999998

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.93  E-value=1.1e-24  Score=251.66  Aligned_cols=142  Identities=25%  Similarity=0.294  Sum_probs=99.0

Q ss_pred             cchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       581 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      |+.|++++|+|++ +|   ..+++|+.|+|++|.|++ +|..   +++|+.|++++|.|+ .+|..   +++|+.|+|++
T Consensus       163 L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~  230 (622)
T 3g06_A          163 LCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSG  230 (622)
T ss_dssp             CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCS
T ss_pred             CCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccC
Confidence            4456666777764 44   345678888888888874 4432   367888888888887 44432   46788888888


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |+|++ +|   ..+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|++++.+|
T Consensus       231 N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~  301 (622)
T 3g06_A          231 NRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL  301 (622)
T ss_dssp             SCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHH
T ss_pred             CccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCH
Confidence            88874 44   34577888888888887 4554   5567888888888887 667777788888888888888876655


Q ss_pred             ccc
Q 041249          741 LDY  743 (789)
Q Consensus       741 ~~~  743 (789)
                      ..+
T Consensus       302 ~~l  304 (622)
T 3g06_A          302 QAL  304 (622)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=5.9e-25  Score=229.25  Aligned_cols=208  Identities=22%  Similarity=0.238  Sum_probs=184.4

Q ss_pred             cccce-eeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCc
Q 041249          552 SKAQK-VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLI  630 (789)
Q Consensus       552 ~~c~~-l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~  630 (789)
                      +.|.. ...++...+.+.. .+..+.  ++|++|+|++|++++..+..|..+++|++|+|++|+|+...+..|.++++|+
T Consensus        12 C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~   88 (270)
T 2o6q_A           12 CSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE   88 (270)
T ss_dssp             BEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCC
T ss_pred             CEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCC
Confidence            44542 4567777777664 344333  6799999999999988888999999999999999999977777789999999


Q ss_pred             EEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcc
Q 041249          631 RIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      +|++++|+++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        89 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A           89 TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             EEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence            99999999998777889999999999999999998888899999999999999999997777779999999999999999


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      |++..+..|..+++|+.|+|++|+|+ .+|...+..+++|+.|+|++|++...
T Consensus       169 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          169 LKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             CcEeChhHhccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEEecCCCeeCC
Confidence            99887888999999999999999999 78887776899999999999998743

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=3.3e-26  Score=259.03  Aligned_cols=225  Identities=19%  Similarity=0.209  Sum_probs=199.9

Q ss_pred             HHHhhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcC
Q 041249          546 SMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSS  625 (789)
Q Consensus       546 ~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~  625 (789)
                      .+..+...+.+++.+++..+.+....+..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.|++..+     
T Consensus        25 ~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----   97 (487)
T 3oja_A           25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----   97 (487)
T ss_dssp             HHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----
T ss_pred             HHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----
Confidence            344555677899999999999998888899999999999999999997666  9999999999999999995543     


Q ss_pred             CCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCcccc-CCCCCCee
Q 041249          626 CSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLS-KLKNLVIL  704 (789)
Q Consensus       626 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L  704 (789)
                      .++|++|++++|.|++..+.   .+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|. .+++|+.|
T Consensus        98 ~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L  174 (487)
T 3oja_A           98 GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (487)
T ss_dssp             CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence            28999999999999976654   457899999999999999999999999999999999999998888886 79999999


Q ss_pred             eccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcC
Q 041249          705 YLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL  784 (789)
Q Consensus       705 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  784 (789)
                      +|++|.|++..+  +..+++|+.|+|++|.|+ .+|..+. .+++|+.|+|++|.|++ +|..+..+++|+.|++++|++
T Consensus       175 ~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~-~~~~~~~-~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l  249 (487)
T 3oja_A          175 NLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF  249 (487)
T ss_dssp             ECTTSCCCEEEC--CCCCTTCCEEECCSSCCC-EECGGGG-GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred             ecCCCccccccc--cccCCCCCEEECCCCCCC-CCCHhHc-CCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence            999999996633  446899999999999999 6777765 89999999999999995 677899999999999999999


Q ss_pred             c
Q 041249          785 T  785 (789)
Q Consensus       785 ~  785 (789)
                      +
T Consensus       250 ~  250 (487)
T 3oja_A          250 H  250 (487)
T ss_dssp             C
T ss_pred             c
Confidence            8

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.93  E-value=3e-24  Score=248.04  Aligned_cols=129  Identities=26%  Similarity=0.254  Sum_probs=108.2

Q ss_pred             ccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEE
Q 041249          578 LSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS  657 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  657 (789)
                      +++|+.|+|++|+|++ +|..   +++|+.|++++|.|+ .+|..   +++|++|+|++|+|++ +|   ..+++|+.|+
T Consensus       180 ~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~  247 (622)
T 3g06_A          180 PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELM  247 (622)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEE
Confidence            4578899999999995 4543   478999999999999 55543   4789999999999995 55   4568999999


Q ss_pred             ccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCC
Q 041249          658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNIS  723 (789)
Q Consensus       658 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  723 (789)
                      |++|+|+ .+|.   .+++|++|+|++|+|+ .+|..|.++++|+.|+|++|.+++..|..+..++
T Consensus       248 Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          248 VSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            9999998 4555   5789999999999999 7788999999999999999999988888776543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=9.4e-25  Score=227.96  Aligned_cols=206  Identities=21%  Similarity=0.237  Sum_probs=185.4

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      .+..+..+++..+.+...  ..+..+++|+.|++++|.++. + ..+..+++|++|++++|++++ + ..+..+++|++|
T Consensus        17 ~~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L   90 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYL   90 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEE
T ss_pred             hHHHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEE
Confidence            456777889999988854  346788999999999999983 3 468899999999999999985 3 478999999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      +|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+|+
T Consensus        91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  170 (272)
T 3rfs_A           91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ  170 (272)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence            99999999888888999999999999999999888888999999999999999999888888899999999999999999


Q ss_pred             ccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                       .+|...+..+++|++|+|++|++++..+..+..+++|+.|++++|+++|..|
T Consensus       171 -~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          171 -SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             -CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             -ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence             7777766689999999999999999888889999999999999999998765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=1.2e-26  Score=266.31  Aligned_cols=186  Identities=17%  Similarity=0.037  Sum_probs=131.7

Q ss_pred             ccccCCccEEEEEEcCCceEEEEEEecccc----------chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249          278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH----------HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+.|++|.++.++-...|+.+++|++....          ....+++.+|+++|+++ .|+||+++++++.+..     .
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-----~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-----S  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-----E
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-----E
Confidence            456777777776666678999999996441          22346799999999999 7999999999998766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .||||||+++|+|.+++...          ..++..   +|+.||+.||+|+|++|   ||||||||+|||+++++++||
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~----------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL  380 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAG----------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARL  380 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTT----------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHhC----------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEE
Confidence            99999999999999999654          345543   58899999999999999   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                      +|||+|+........  .....||+.|||||++.+ ++..++|+||+|++++++.+|..|+
T Consensus       381 ~DFGlAr~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          381 IDFGSIVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CCCTTEESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             eecccCeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            999999977654322  234679999999999864 6778899999999999887766554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=2.1e-25  Score=237.57  Aligned_cols=204  Identities=16%  Similarity=0.135  Sum_probs=178.7

Q ss_pred             CccccchhcccCCcccccCcccc--cCccceeeecccCCCCccCCC----ccCcCCCCCcEEEcccCCCCCCCCcccCCC
Q 041249          577 NLSFLKILNLENNSFTHEIPSEI--GRLRRLQVPDLNNNSIGGEIP----VNLSSCSNLIRIGLAKNQLMGKIPSDFGSL  650 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~i~~~~p----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  650 (789)
                      .+++|++|+|++|++++..|..+  ..+++|++|+|++|.|++..+    ..+..+++|++|+|++|+|.+..+..|..+
T Consensus        89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l  168 (310)
T 4glp_A           89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF  168 (310)
T ss_dssp             HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred             ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence            45779999999999999999988  899999999999999997655    445679999999999999998888999999


Q ss_pred             CCCcEEEccCCCCCcc---C-CcCCCCCCCCCEEEccCCcCCccCCc----cccCCCCCCeeeccCccccccCCccccCC
Q 041249          651 SKIEVLSLGFNNLIGS---I-PPPLGNLSSLRKISLAINNLAGSIPF----TLSKLKNLVILYLGVNRLSGIVPSSIFNI  722 (789)
Q Consensus       651 ~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  722 (789)
                      ++|++|+|++|++.+.   . +..+..+++|++|+|++|+|+ .++.    .+..+++|++|+|++|+|++..|..+..+
T Consensus       169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  247 (310)
T 4glp_A          169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC  247 (310)
T ss_dssp             TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred             CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence            9999999999998752   2 334578999999999999998 3443    35788999999999999998878888877


Q ss_pred             ---CCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          723 ---SSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       723 ---~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                         ++|++|+|++|+|+ .+|..++   ++|++|+|++|+|++. |. +..+++|+.|++++|+|+..
T Consensus       248 ~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~~  309 (310)
T 4glp_A          248 MWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLVP  309 (310)
T ss_dssp             CCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSCC
T ss_pred             cCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCCC
Confidence               69999999999999 9998875   7999999999999964 33 68899999999999999864

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=6e-25  Score=229.99  Aligned_cols=207  Identities=20%  Similarity=0.177  Sum_probs=187.1

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      .++.+++..+.+.......|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            57889999999887777789999999999999999998888899999999999999999998888999999999999999


Q ss_pred             cCCCCCCCCcccCCCCCCcEEEccCCCCCcc-CCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC----eeeccCcc
Q 041249          636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGS-IPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV----ILYLGVNR  710 (789)
Q Consensus       636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  710 (789)
                      +|++.+..+..|..+++|++|++++|++++. +|..|.++++|++|+|++|++++..+..|..+++|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            9999987777899999999999999999874 589999999999999999999988888888777777    89999999


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccC
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI  764 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~  764 (789)
                      +++..+..+. ..+|+.|+|++|+|+ .+|..++..+++|++|+|++|++++..
T Consensus       189 l~~~~~~~~~-~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          189 MNFIQPGAFK-EIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             CCEECTTSSC-SCCEEEEECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             ccccCccccC-CCcccEEECCCCcee-ecCHhHhcccccccEEEccCCcccccC
Confidence            9966555554 458999999999999 888887778999999999999998654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=5.4e-25  Score=225.16  Aligned_cols=198  Identities=14%  Similarity=0.105  Sum_probs=174.8

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCC-CccCCCccCcCCCCCcEEEccc-CCCCCCCCcccCCCCCCcEE
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS-IGGEIPVNLSSCSNLIRIGLAK-NQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L  656 (789)
                      ++|++|+|++|+|+++.+..|..+++|++|++++|+ ++++.+..|.++++|++|++++ |+|+...+..|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            389999999999998888899999999999999997 9877777999999999999999 99997777899999999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCC---EEEccCC-cCCccCCccccCCCCCC-eeeccCccccccCCccccCCCCccEEEcc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLR---KISLAIN-NLAGSIPFTLSKLKNLV-ILYLGVNRLSGIVPSSIFNISSIAEFDVG  731 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  731 (789)
                      ++++|++++ +|. |..+++|+   +|++++| +++...+..|.++++|+ .|++++|+++...+..|.. ++|+.|+|+
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~  187 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN  187 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence            999999996 665 88999998   9999999 99987788899999999 9999999999444444544 899999999


Q ss_pred             CCc-ccccCCcccccCC-CCccEEEccCCcccccCcccccCCCCCCeeeccCCc
Q 041249          732 ENK-IQGNIPLDYGFTL-QNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK  783 (789)
Q Consensus       732 ~N~-l~~~ip~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  783 (789)
                      +|+ ++ .+|...+.++ ++|++|+|++|+|++. |..  .+++|+.|+++++.
T Consensus       188 ~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          188 KNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNTW  237 (239)
T ss_dssp             TCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC-
T ss_pred             CCCCcc-cCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCcc
Confidence            995 98 8888777788 9999999999999954 433  67789999998873

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.92  E-value=2e-25  Score=238.64  Aligned_cols=218  Identities=17%  Similarity=0.179  Sum_probs=187.4

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      .+...++..+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+  |..+++|++|+++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            34555566665554444556678899999999999998888999999999999999999997654  9999999999999


Q ss_pred             cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccC
Q 041249          636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIV  715 (789)
Q Consensus       636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  715 (789)
                      +|+|++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..|..+++|++|+|++|++++..
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            99998433     3489999999999999776554   578999999999999888889999999999999999999887


Q ss_pred             Ccccc-CCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          716 PSSIF-NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       716 p~~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      +..+. .+++|++|+|++|.|+ .+|...  .+++|++|+|++|+|++. |..+..+++|+.|++++|++++.
T Consensus       161 ~~~~~~~l~~L~~L~L~~N~l~-~~~~~~--~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~l  229 (317)
T 3o53_A          161 FAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLI  229 (317)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCC-EEECCC--CCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEE
T ss_pred             HHHHhhccCcCCEEECCCCcCc-cccccc--ccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccch
Confidence            87774 7899999999999999 666554  489999999999999965 55589999999999999999863

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=3.5e-24  Score=225.52  Aligned_cols=201  Identities=20%  Similarity=0.188  Sum_probs=179.5

Q ss_pred             cceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEE
Q 041249          554 AQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIG  633 (789)
Q Consensus       554 c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  633 (789)
                      +.+++.++...+.+.. .+..+.  +.++.|+|++|+|++..+..|..+++|++|+|++|.|++..+  ...+++|++|+
T Consensus         9 l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~   83 (290)
T 1p9a_G            9 VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLD   83 (290)
T ss_dssp             STTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEE
T ss_pred             cCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEE
Confidence            4456777777777663 333333  689999999999998889999999999999999999996543  37899999999


Q ss_pred             cccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc
Q 041249          634 LAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       634 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                      |++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++
T Consensus        84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  162 (290)
T 1p9a_G           84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (290)
T ss_dssp             CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence            9999999 788889999999999999999998888999999999999999999998888889999999999999999997


Q ss_pred             cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      ..+..|..+++|+.|+|++|+|+ .+|..++ .+++|+.|+|++|++..
T Consensus       163 l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~-~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCBCC
T ss_pred             cCHHHhcCcCCCCEEECCCCcCC-ccChhhc-ccccCCeEEeCCCCccC
Confidence            77778889999999999999999 9999998 78899999999999864

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=7.2e-24  Score=218.47  Aligned_cols=181  Identities=21%  Similarity=0.242  Sum_probs=161.9

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEc
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL  658 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  658 (789)
                      ...++++++++.++ .+|..+.  ++++.|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            45678999999999 5666554  58999999999999888889999999999999999999888888999999999999


Q ss_pred             cCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccccc
Q 041249          659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGN  738 (789)
Q Consensus       659 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  738 (789)
                      ++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~  169 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-S  169 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-C
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC-c
Confidence            999999888888999999999999999999777777899999999999999999777778999999999999999999 6


Q ss_pred             CCcccccCCCCccEEEccCCccccc
Q 041249          739 IPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       739 ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      +|...+..+++|++|+|++|+++..
T Consensus       170 ~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          170 VPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCHHHHhCCCCCCEEEeeCCceeCC
Confidence            7766666899999999999999865

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.91  E-value=2.3e-27  Score=276.25  Aligned_cols=229  Identities=12%  Similarity=0.059  Sum_probs=148.0

Q ss_pred             cccceeeEeccCccccccccc-ccccCccccchhcccCCcccc-cCcccccCccceeeeccc-----------CCCCccC
Q 041249          552 SKAQKVTILDLESLKLAGSIL-PHIGNLSFLKILNLENNSFTH-EIPSEIGRLRRLQVPDLN-----------NNSIGGE  618 (789)
Q Consensus       552 ~~c~~l~~l~l~s~~~~~~~l-~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls-----------~N~i~~~  618 (789)
                      ..|.+++.+++..+.+....+ ..+..+++|++|+++ |.+.. .++..+..+++|++|+++           .|.+++.
T Consensus       290 ~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~  368 (592)
T 3ogk_B          290 PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR  368 (592)
T ss_dssp             GGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHH
T ss_pred             hhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHH
Confidence            345667777777777443333 335678888888888 44443 334444667788888888           3566643


Q ss_pred             CC-ccCcCCCCCcEEEcccCCCCCCCCcccCC-CCCCcEEEcc----CCCCCcc-----CCcCCCCCCCCCEEEccCC--
Q 041249          619 IP-VNLSSCSNLIRIGLAKNQLMGKIPSDFGS-LSKIEVLSLG----FNNLIGS-----IPPPLGNLSSLRKISLAIN--  685 (789)
Q Consensus       619 ~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--  685 (789)
                      .. ..+..+++|++|+++.|++++..+..+.. +++|+.|+++    .|++++.     ++..+.++++|++|+|+.|  
T Consensus       369 ~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~  448 (592)
T 3ogk_B          369 GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQG  448 (592)
T ss_dssp             HHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGG
T ss_pred             HHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCC
Confidence            22 22345788888888888887655555544 7788888885    6677643     2223556788888888743  


Q ss_pred             cCCccCCcccc-CCCCCCeeeccCccccc-cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc
Q 041249          686 NLAGSIPFTLS-KLKNLVILYLGVNRLSG-IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       686 ~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      .+++..+..+. .+++|++|+|++|++++ .++..+..+++|+.|+|++|.|++.....+...+++|++|+|++|++++.
T Consensus       449 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          449 GLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             GCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             CccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            36654444443 47788888888888875 34455577788888888888876543444444678888888888888765


Q ss_pred             Cccccc-CCCCCCeeeccC
Q 041249          764 IPPSIS-NASKLEVFQALN  781 (789)
Q Consensus       764 ~~~~~~-~l~~L~~L~l~~  781 (789)
                      ....+. .++.+....+..
T Consensus       529 ~~~~l~~~~p~l~~~~~~~  547 (592)
T 3ogk_B          529 GQDLMQMARPYWNIELIPS  547 (592)
T ss_dssp             CTTGGGGCCTTEEEEEECC
T ss_pred             HHHHHHHhCCCcEEEEecC
Confidence            433333 456655555444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.91  E-value=4.8e-25  Score=249.44  Aligned_cols=198  Identities=18%  Similarity=0.182  Sum_probs=177.3

Q ss_pred             cCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcE
Q 041249          576 GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEV  655 (789)
Q Consensus       576 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  655 (789)
                      ..+++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|  |..+++|++|+|++|.|++..+     .++|++
T Consensus        31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~  103 (487)
T 3oja_A           31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET  103 (487)
T ss_dssp             TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred             ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence            345699999999999999889999999999999999999997765  9999999999999999985433     389999


Q ss_pred             EEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCcccc-CCCCccEEEccCCc
Q 041249          656 LSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF-NISSIAEFDVGENK  734 (789)
Q Consensus       656 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~  734 (789)
                      |++++|+|++..+..   +++|++|+|++|+|++..|..|+++++|+.|+|++|.|++..|..+. .+++|+.|+|++|.
T Consensus       104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            999999999776654   57899999999999998899999999999999999999998888887 79999999999999


Q ss_pred             ccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          735 IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       735 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      |+ .+|...  .+++|++|+|++|.|++.+| .+..+++|+.|+|++|+|++.
T Consensus       181 l~-~~~~~~--~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~l  229 (487)
T 3oja_A          181 IY-DVKGQV--VFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLI  229 (487)
T ss_dssp             CC-EEECCC--CCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEE
T ss_pred             cc-cccccc--cCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCccc
Confidence            99 555544  58999999999999997554 589999999999999999974

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2.1e-24  Score=220.74  Aligned_cols=198  Identities=17%  Similarity=0.141  Sum_probs=175.3

Q ss_pred             hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCC-CCCCCCcccCCCCCCcEEEccC-
Q 041249          583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQ-LMGKIPSDFGSLSKIEVLSLGF-  660 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~-  660 (789)
                      .+++..+.++ .+|. +..  +|++|++++|+|+++.+..|.++++|++|++++|+ ++.+.+..|.++++|++|++++ 
T Consensus        15 ~~~v~c~~l~-~ip~-~~~--~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~   90 (239)
T 2xwt_C           15 DFRVTCKDIQ-RIPS-LPP--STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT   90 (239)
T ss_dssp             TTEEEECSCS-SCCC-CCT--TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEE
T ss_pred             cceeEccCcc-ccCC-CCC--cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCC
Confidence            3343344466 4565 433  89999999999998888899999999999999997 9877777899999999999999 


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC---eeeccCc-cccccCCccccCCCCcc-EEEccCCcc
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV---ILYLGVN-RLSGIVPSSIFNISSIA-EFDVGENKI  735 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l  735 (789)
                      |++++..+..|.++++|++|+|++|++++ +|. |..+++|+   +|++++| ++++..+..|..+++|+ .|++++|+|
T Consensus        91 n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l  168 (239)
T 2xwt_C           91 RNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF  168 (239)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred             CCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence            99998888899999999999999999995 676 99999998   9999999 99988788899999999 999999999


Q ss_pred             cccCCcccccCCCCccEEEccCCc-ccccCcccccCC-CCCCeeeccCCcCcccC
Q 041249          736 QGNIPLDYGFTLQNLQYFSIGTNR-ITGAIPPSISNA-SKLEVFQALNNKLTGEV  788 (789)
Q Consensus       736 ~~~ip~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~  788 (789)
                      + .+|...+.. ++|++|+|++|+ +++..+..|..+ ++|+.|++++|++++..
T Consensus       169 ~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~  221 (239)
T 2xwt_C          169 T-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP  221 (239)
T ss_dssp             C-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCC
T ss_pred             c-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCC
Confidence            9 999988844 899999999995 998888899999 99999999999998653

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.1e-23  Score=217.08  Aligned_cols=184  Identities=20%  Similarity=0.231  Sum_probs=160.7

Q ss_pred             ccc-ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCc
Q 041249          552 SKA-QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLI  630 (789)
Q Consensus       552 ~~c-~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~  630 (789)
                      +.| .....++...+.+.. .+..+.  +.|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+
T Consensus        10 C~C~~~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~   86 (251)
T 3m19_A           10 CTCNEGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG   86 (251)
T ss_dssp             SEEEGGGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             eEcCCCCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCC
Confidence            556 345667777776653 333333  6899999999999988888899999999999999999988888899999999


Q ss_pred             EEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcc
Q 041249          631 RIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      +|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        87 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A           87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            99999999998888889999999999999999998888888999999999999999997777789999999999999999


Q ss_pred             ccccCCccccCCCCccEEEccCCccccc
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGN  738 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  738 (789)
                      |++..+..|..+++|+.|+|++|++++.
T Consensus       167 l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          167 LQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            9988888899999999999999999844

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.91  E-value=6e-24  Score=225.93  Aligned_cols=195  Identities=26%  Similarity=0.385  Sum_probs=154.2

Q ss_pred             ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249          575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE  654 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  654 (789)
                      +.++++|++|++++|.++. +| .+..+++|++|+|++|.|++..+  +..+++|++|+|++|++++ ++ .+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence            4567888888888888884 44 57888888888888888885443  8888888888888888884 33 588888888


Q ss_pred             EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCc
Q 041249          655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK  734 (789)
Q Consensus       655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  734 (789)
                      +|+|++|++++. + .+..+++|++|+|++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|+
T Consensus       111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK  184 (308)
T ss_dssp             EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence            888888888754 3 37888888888888888885443  8888888888888888885433  8888888888888888


Q ss_pred             ccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          735 IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       735 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      |+ .++.  +..+++|++|+|++|++++..  .+..+++|+.|++++|++++
T Consensus       185 l~-~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          185 IS-DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CC-CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             cC-cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            88 5554  337888888888888888654  37888888888888888876

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.90  E-value=6.7e-27  Score=272.39  Aligned_cols=185  Identities=13%  Similarity=0.035  Sum_probs=140.6

Q ss_pred             cCccccchhccc-----------CCcccccCc-ccccCccceeeecccCCCCccCCCccCcC-CCCCcEEEcc----cCC
Q 041249          576 GNLSFLKILNLE-----------NNSFTHEIP-SEIGRLRRLQVPDLNNNSIGGEIPVNLSS-CSNLIRIGLA----KNQ  638 (789)
Q Consensus       576 ~~l~~L~~L~L~-----------~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~-l~~L~~L~l~----~N~  638 (789)
                      ..+++|++|+|+           .|.+++... ..+..+++|++|+++.|.+++..+..+.. +++|++|+++    .|.
T Consensus       339 ~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~  418 (592)
T 3ogk_B          339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREER  418 (592)
T ss_dssp             HHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSC
T ss_pred             HhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcc
Confidence            357789999999           467775433 33556899999999999999877777765 8999999997    778


Q ss_pred             CCCC-----CCcccCCCCCCcEEEccCCC--CCccCCcCCC-CCCCCCEEEccCCcCCcc-CCccccCCCCCCeeeccCc
Q 041249          639 LMGK-----IPSDFGSLSKIEVLSLGFNN--LIGSIPPPLG-NLSSLRKISLAINNLAGS-IPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       639 l~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~-~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N  709 (789)
                      +++.     ++..+.++++|+.|+|++|.  +++..+..+. .+++|++|+|++|++++. ++..+.++++|++|+|++|
T Consensus       419 l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n  498 (592)
T 3ogk_B          419 ITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC  498 (592)
T ss_dssp             CSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred             ccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence            8853     23336679999999998543  6655544443 478999999999999863 4555688999999999999


Q ss_pred             ccccc-CCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcc
Q 041249          710 RLSGI-VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRI  760 (789)
Q Consensus       710 ~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l  760 (789)
                      .|++. ++..+..+++|+.|+|++|++++.--..+...++.+....+..++-
T Consensus       499 ~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~~  550 (592)
T 3ogk_B          499 CFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRV  550 (592)
T ss_dssp             CCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC--
T ss_pred             CCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCccc
Confidence            98755 3445567999999999999998543444555788888877776643

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=1.4e-22  Score=202.44  Aligned_cols=181  Identities=20%  Similarity=0.217  Sum_probs=151.2

Q ss_pred             chhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249          582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN  661 (789)
Q Consensus       582 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  661 (789)
                      +.++++++.++ .+|..+  .++|++|++++|+|++..+..|..+++|++|++++|+|++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            45677778877 445443  357899999999998777777888999999999999998777777888999999999999


Q ss_pred             CCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCc
Q 041249          662 NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL  741 (789)
Q Consensus       662 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~  741 (789)
                      ++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+    
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----  162 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----  162 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence            9987777778889999999999999997777778899999999999999997777778889999999999998762    


Q ss_pred             ccccCCCCccEEEccCCcccccCcccccCCCC
Q 041249          742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASK  773 (789)
Q Consensus       742 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  773 (789)
                          .+++|++|+++.|++++.+|..++.++.
T Consensus       163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence                4567889999999999999988887764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=3.1e-23  Score=220.77  Aligned_cols=202  Identities=17%  Similarity=0.168  Sum_probs=174.5

Q ss_pred             cceeeEeccCcccccccccccc--cCccccchhcccCCcccccCc----ccccCccceeeecccCCCCccCCCccCcCCC
Q 041249          554 AQKVTILDLESLKLAGSILPHI--GNLSFLKILNLENNSFTHEIP----SEIGRLRRLQVPDLNNNSIGGEIPVNLSSCS  627 (789)
Q Consensus       554 c~~l~~l~l~s~~~~~~~l~~l--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~  627 (789)
                      +.+++.+++..+.+....+..+  ..+++|++|+|++|++++..+    ..+..+++|++|+|++|+|++..|..|..++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            4569999999999988888888  899999999999999997655    4466899999999999999988889999999


Q ss_pred             CCcEEEcccCCCCCC----CCcccCCCCCCcEEEccCCCCCccCCc----CCCCCCCCCEEEccCCcCCccCCccccCC-
Q 041249          628 NLIRIGLAKNQLMGK----IPSDFGSLSKIEVLSLGFNNLIGSIPP----PLGNLSSLRKISLAINNLAGSIPFTLSKL-  698 (789)
Q Consensus       628 ~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-  698 (789)
                      +|++|+|++|++.+.    .+..+..+++|++|+|++|+++. ++.    .+..+++|++|+|++|+|++..|..+..+ 
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  248 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM  248 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence            999999999998642    23345789999999999999973 333    35788999999999999998878888777 


Q ss_pred             --CCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          699 --KNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       699 --~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                        ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|.  +..+++|++|+|++|+|+.
T Consensus       249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~-~~~~--~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLN-RAPQ--PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCC-SCCC--TTSCCCCSCEECSSTTTSC
T ss_pred             CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCC-CCch--hhhCCCccEEECcCCCCCC
Confidence              69999999999999 6777775  79999999999999 6665  3478999999999999984

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=7.3e-25  Score=241.05  Aligned_cols=242  Identities=17%  Similarity=0.205  Sum_probs=198.3

Q ss_pred             HHhhccccceeeEeccCcccccccccc----cccCccccchhcccCC---cccccCcccc-------cCccceeeecccC
Q 041249          547 MLRIGSKAQKVTILDLESLKLAGSILP----HIGNLSFLKILNLENN---SFTHEIPSEI-------GRLRRLQVPDLNN  612 (789)
Q Consensus       547 l~~i~~~c~~l~~l~l~s~~~~~~~l~----~l~~l~~L~~L~L~~N---~l~~~~~~~~-------~~l~~L~~L~Ls~  612 (789)
                      +.+....|.+++.+++..+.+....+.    .+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            334455688899999999988766443    3678999999999996   4555566555       7889999999999


Q ss_pred             CCCcc----CCCccCcCCCCCcEEEcccCCCCCCCCccc----CCC---------CCCcEEEccCCCCC-ccCC---cCC
Q 041249          613 NSIGG----EIPVNLSSCSNLIRIGLAKNQLMGKIPSDF----GSL---------SKIEVLSLGFNNLI-GSIP---PPL  671 (789)
Q Consensus       613 N~i~~----~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l---------~~L~~L~L~~N~l~-~~~~---~~~  671 (789)
                      |.|++    .+|..+..+++|++|+|++|.|+...+..+    ..+         ++|++|+|++|+++ +.++   ..|
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            99997    467788999999999999999974433333    333         89999999999997 3444   467


Q ss_pred             CCCCCCCEEEccCCcCCc-----cCCccccCCCCCCeeeccCcccc----ccCCccccCCCCccEEEccCCccccc----
Q 041249          672 GNLSSLRKISLAINNLAG-----SIPFTLSKLKNLVILYLGVNRLS----GIVPSSIFNISSIAEFDVGENKIQGN----  738 (789)
Q Consensus       672 ~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----  738 (789)
                      ..+++|++|+|++|+|+.     ..|..+..+++|+.|+|++|.|+    ..+|..+..+++|+.|+|++|.|++.    
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  263 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  263 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence            788999999999999983     34558899999999999999996    57888999999999999999999854    


Q ss_pred             CCcccc-cCCCCccEEEccCCcccc----cCcccc-cCCCCCCeeeccCCcCcccC
Q 041249          739 IPLDYG-FTLQNLQYFSIGTNRITG----AIPPSI-SNASKLEVFQALNNKLTGEV  788 (789)
Q Consensus       739 ip~~~~-~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~  788 (789)
                      +|..+. ..+++|++|+|++|+|++    .+|..+ .++++|+.|++++|++++..
T Consensus       264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            455542 138999999999999997    477777 66899999999999999864

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=1.9e-23  Score=238.47  Aligned_cols=188  Identities=16%  Similarity=0.147  Sum_probs=144.5

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .+...+.||+|+||+||+|.+  .++.+++|........        ..+.+.+|++++++++||||+++..++....  
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--  412 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--  412 (540)
T ss_dssp             -----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--
T ss_pred             cCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--
Confidence            334567999999999999965  4788899886433211        1345899999999999999995555554433  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+++|+|.+++..                  +..++.|++.||+|||+.+   |+||||||+|||++.  
T Consensus       413 ---~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--  466 (540)
T 3en9_A          413 ---NKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--  466 (540)
T ss_dssp             ---TTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--
T ss_pred             ---ccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--
Confidence               56999999999999999852                  4589999999999999998   999999999999999  


Q ss_pred             ceeeCcccccccCCCCCCcc-----ceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          423 VSHVGDFGLARFLPPTHVQT-----SSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      ++||+|||+++.........     ......||+.|||||++..  ..|+.++|+|+-.+-..+-+.++.+|.
T Consensus       467 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          467 DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99999999999886543211     1234679999999999876  568899999999999999888887764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.87  E-value=4.4e-25  Score=257.10  Aligned_cols=229  Identities=13%  Similarity=0.095  Sum_probs=146.1

Q ss_pred             ccceeeEeccCccccccccccc-ccCccccchhcccCCccccc-CcccccCccceeeecc---------cCCCCccCCCc
Q 041249          553 KAQKVTILDLESLKLAGSILPH-IGNLSFLKILNLENNSFTHE-IPSEIGRLRRLQVPDL---------NNNSIGGEIPV  621 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~-l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L---------s~N~i~~~~p~  621 (789)
                      .|.+++.+++..+.+....+.. +..+++|++|++++| ++.. ++.....+++|++|++         +.|.+++....
T Consensus       287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~  365 (594)
T 2p1m_B          287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV  365 (594)
T ss_dssp             HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred             hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence            5677888888877744333332 457788888888877 4422 2222334777888877         33555543333


Q ss_pred             cCc-CCCCCcEEEcccCCCCCCCCcccC-CCCCCcEEEcc--C----CCCCccCC-----cCCCCCCCCCEEEccCCcCC
Q 041249          622 NLS-SCSNLIRIGLAKNQLMGKIPSDFG-SLSKIEVLSLG--F----NNLIGSIP-----PPLGNLSSLRKISLAINNLA  688 (789)
Q Consensus       622 ~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~~-----~~~~~l~~L~~L~L~~N~l~  688 (789)
                      .+. ++++|++|+++.|.+++.....+. .+++|+.|+|+  +    |+++....     ..+..+++|++|+|++ .++
T Consensus       366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~  444 (594)
T 2p1m_B          366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT  444 (594)
T ss_dssp             HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred             HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence            332 477888888888888754444443 47788888888  3    55552211     1245677888888876 666


Q ss_pred             ccCCccccC-CCCCCeeeccCccccccCCccc-cCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcc
Q 041249          689 GSIPFTLSK-LKNLVILYLGVNRLSGIVPSSI-FNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP  766 (789)
Q Consensus       689 ~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~  766 (789)
                      +..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.....+...+++|++|++++|+++.....
T Consensus       445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~  524 (594)
T 2p1m_B          445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACK  524 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHH
T ss_pred             HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHH
Confidence            555555554 7788888888888876555554 56788888888888886444444444577888888888887644334


Q ss_pred             cc-cCCCCCCeeeccCCc
Q 041249          767 SI-SNASKLEVFQALNNK  783 (789)
Q Consensus       767 ~~-~~l~~L~~L~l~~N~  783 (789)
                      .+ ..+++|+...+..+.
T Consensus       525 ~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          525 LLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             HHHHHCTTEEEEEECSSS
T ss_pred             HHHHhCCCCEEEEecCCC
Confidence            44 456777666665553

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=3.7e-22  Score=212.12  Aligned_cols=192  Identities=21%  Similarity=0.356  Sum_probs=167.1

Q ss_pred             cceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEE
Q 041249          554 AQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIG  633 (789)
Q Consensus       554 c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  633 (789)
                      +.+++.+++..+.+..  .+.+..+++|++|+|++|++++..+  +..+++|++|+|++|+|++.  ..+..+++|++|+
T Consensus        40 l~~L~~L~l~~~~i~~--l~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~  113 (308)
T 1h6u_A           40 LDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD  113 (308)
T ss_dssp             HHTCCEEECTTSCCCC--CTTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred             cCCcCEEEeeCCCccC--chhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence            4567788888887654  3468899999999999999996555  99999999999999999954  4799999999999


Q ss_pred             cccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc
Q 041249          634 LAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       634 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                      +++|++++ ++ .+..+++|++|++++|++++..+  +..+++|++|+|++|++++..+  +..+++|+.|++++|++++
T Consensus       114 l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          114 LTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             CTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence            99999995 44 38999999999999999986544  8899999999999999995443  9999999999999999996


Q ss_pred             cCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      ..+  +..+++|+.|+|++|+|+ .++. + ..+++|++|+|++|++++
T Consensus       188 ~~~--l~~l~~L~~L~L~~N~l~-~~~~-l-~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNNQIS-DVSP-L-ANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTSCCC-BCGG-G-TTCTTCCEEEEEEEEEEC
T ss_pred             Chh--hcCCCCCCEEEccCCccC-cccc-c-cCCCCCCEEEccCCeeec
Confidence            544  899999999999999999 5553 3 489999999999999986

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=6.1e-22  Score=226.00  Aligned_cols=190  Identities=23%  Similarity=0.322  Sum_probs=115.7

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEE
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI  632 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L  632 (789)
                      .|.+++.+++..+.+.. .+..+  .++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|++|
T Consensus        57 ~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L  125 (571)
T 3cvr_A           57 LINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHL  125 (571)
T ss_dssp             HHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEE
T ss_pred             ccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEE
Confidence            34466666666666554 33333  256667777777766 344   335666677777777764 444 444  66777


Q ss_pred             EcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc
Q 041249          633 GLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       633 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      +|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+
T Consensus       126 ~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          126 DVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             ECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred             ECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC
Confidence            777777664 444   45667777777777664 343   45666777777777664 454 54  66777777777766


Q ss_pred             ccCCccccCCCCc-------cEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCC
Q 041249          713 GIVPSSIFNISSI-------AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNA  771 (789)
Q Consensus       713 ~~~p~~~~~l~~L-------~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  771 (789)
                       .+|. |..  +|       +.|+|++|+|+ .+|..++ .+++|+.|+|++|+|++.+|..+..+
T Consensus       194 -~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          194 -SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENIL-SLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             -SCCC-CC----------CCEEEECCSSCCC-CCCGGGG-GSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             -chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHh-cCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence             4454 443  55       66777777776 6666666 46667777777777766666665553

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=9.4e-22  Score=196.42  Aligned_cols=173  Identities=20%  Similarity=0.238  Sum_probs=155.3

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN  685 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  685 (789)
                      +.++++++.++ .+|..+  .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            56788999998 566555  368999999999999877778999999999999999999888888999999999999999


Q ss_pred             cCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCc
Q 041249          686 NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIP  765 (789)
Q Consensus       686 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~  765 (789)
                      +|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|...+..+++|++|+|++|++.+   
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~---  162 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDC---  162 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCHHHhccCCCccEEEecCCCeec---
Confidence            999777778999999999999999999877778999999999999999999 7777766689999999999998874   


Q ss_pred             ccccCCCCCCeeeccCCcCcccCC
Q 041249          766 PSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       766 ~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                          .+++|+.|+++.|+++|.+|
T Consensus       163 ----~~~~l~~L~~~~n~~~g~ip  182 (208)
T 2o6s_A          163 ----TCPGIRYLSEWINKHSGVVR  182 (208)
T ss_dssp             ----CTTTTHHHHHHHHHCTTTBB
T ss_pred             ----CCCCHHHHHHHHHhCCceee
Confidence                45689999999999999887

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=3.9e-22  Score=216.08  Aligned_cols=192  Identities=16%  Similarity=0.127  Sum_probs=135.9

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCccCCC-ccCcCCCCCcE-EEcccCCCCCCCCcccCCCCCCcEE
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIP-VNLSSCSNLIR-IGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      +++++|+|++|+|+.+.+.+|.++++|++|+|++|+|.+.+| .+|.++++|++ +.++.|+|+.+.|+.|.++++|++|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            567888888888886666678888888888888888765444 56777777664 5666788887777778888888888


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccC-CcCCccCCccccCCC-CCCeeeccCccccccCCccccCCCCccEEEccC-C
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAI-NNLAGSIPFTLSKLK-NLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE-N  733 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N  733 (789)
                      ++++|+|++..+..+....++..|++.+ |+++...+..|..+. .++.|+|++|+|+. +|.......+|++|++++ |
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n  188 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNN  188 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCT
T ss_pred             cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCC
Confidence            8888888766666666667777777754 567655566666664 57778888888874 444444556777777764 5


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCC
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS  772 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  772 (789)
                      .++ .||.++|.++++|++|+|++|+|+...+..|.+++
T Consensus       189 ~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~  226 (350)
T 4ay9_X          189 NLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK  226 (350)
T ss_dssp             TCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCC
T ss_pred             ccc-CCCHHHhccCcccchhhcCCCCcCccChhhhccch
Confidence            565 77777776777888888888888755444444333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=1.4e-21  Score=212.59  Aligned_cols=176  Identities=19%  Similarity=0.218  Sum_probs=134.9

Q ss_pred             chhcccCCcccccCcccccCccceeeecccCCCCccCCCccCc-CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLS-SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       582 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      +.+++++|+++ .+|..+.  ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            46788888888 4565543  3578888888888877777776 888888888888888877777788888888888888


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccc---cCCCCccEEEccCCcccc
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSI---FNISSIAEFDVGENKIQG  737 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~  737 (789)
                      |+|++..+..|.++++|++|+|++|+|+...|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|+ 
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~-  176 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-  176 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC-
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC-
Confidence            88887777778888888888888888887777888888888888888888885444444   46778888888888887 


Q ss_pred             cCCcccccCCCC--ccEEEccCCccc
Q 041249          738 NIPLDYGFTLQN--LQYFSIGTNRIT  761 (789)
Q Consensus       738 ~ip~~~~~~l~~--L~~L~L~~N~l~  761 (789)
                      .+|...+..++.  |+.|+|++|++.
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             ccCHHHhhhccHhhcceEEecCCCcc
Confidence            777655556666  377888888776

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.86  E-value=1.7e-23  Score=227.86  Aligned_cols=236  Identities=19%  Similarity=0.188  Sum_probs=188.0

Q ss_pred             ccccceeeEeccCccccccccc----ccccCcc-ccchhcccCCcccccCcccccCc-----cceeeecccCCCCccCCC
Q 041249          551 GSKAQKVTILDLESLKLAGSIL----PHIGNLS-FLKILNLENNSFTHEIPSEIGRL-----RRLQVPDLNNNSIGGEIP  620 (789)
Q Consensus       551 ~~~c~~l~~l~l~s~~~~~~~l----~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~i~~~~p  620 (789)
                      .....+++.+++..+.+.....    ..+..++ +|++|+|++|+|++..+..|..+     ++|++|+|++|+|++..+
T Consensus        18 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~   97 (362)
T 3goz_A           18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSS   97 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCH
T ss_pred             HhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHH
Confidence            3445568999999999887776    7778888 89999999999998888888776     899999999999997766


Q ss_pred             cc----CcCC-CCCcEEEcccCCCCCCCCccc----CC-CCCCcEEEccCCCCCccCCcC----CCCCC-CCCEEEccCC
Q 041249          621 VN----LSSC-SNLIRIGLAKNQLMGKIPSDF----GS-LSKIEVLSLGFNNLIGSIPPP----LGNLS-SLRKISLAIN  685 (789)
Q Consensus       621 ~~----~~~l-~~L~~L~l~~N~l~~~~~~~~----~~-l~~L~~L~L~~N~l~~~~~~~----~~~l~-~L~~L~L~~N  685 (789)
                      ..    +..+ ++|++|+|++|+|++..+..+    .. .++|++|+|++|+++...+..    +..++ +|++|+|++|
T Consensus        98 ~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n  177 (362)
T 3goz_A           98 DELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN  177 (362)
T ss_dssp             HHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTS
T ss_pred             HHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCC
Confidence            64    4444 899999999999987665443    34 369999999999998544433    34555 9999999999


Q ss_pred             cCCccCCccc----cCC-CCCCeeeccCcccccc----CCccccCC-CCccEEEccCCcccccCCc----ccccCCCCcc
Q 041249          686 NLAGSIPFTL----SKL-KNLVILYLGVNRLSGI----VPSSIFNI-SSIAEFDVGENKIQGNIPL----DYGFTLQNLQ  751 (789)
Q Consensus       686 ~l~~~~~~~~----~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~~~ip~----~~~~~l~~L~  751 (789)
                      +|++..+..+    ..+ ++|++|+|++|+|++.    ++..+..+ ++|++|+|++|.|+ ..+.    .++..+++|+
T Consensus       178 ~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~~~~l~~L~  256 (362)
T 3goz_A          178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH-GPSLENLKLLKDSLKHLQ  256 (362)
T ss_dssp             CGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC-CCCHHHHHHTTTTTTTCS
T ss_pred             CCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC-cHHHHHHHHHHhcCCCcc
Confidence            9997776544    445 6999999999999963    55666664 59999999999998 4433    3344789999


Q ss_pred             EEEccCCcccccC-------cccccCCCCCCeeeccCCcCccc
Q 041249          752 YFSIGTNRITGAI-------PPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       752 ~L~L~~N~l~~~~-------~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      +|+|++|++.+..       +..+..+++|+.||+++|++.+.
T Consensus       257 ~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             EEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             EEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            9999999965443       33567888899999999999875

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.85  E-value=2.3e-21  Score=210.07  Aligned_cols=202  Identities=17%  Similarity=0.152  Sum_probs=174.0

Q ss_pred             chhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCC-CcccCCCCCCcE-EEcc
Q 041249          582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKI-PSDFGSLSKIEV-LSLG  659 (789)
Q Consensus       582 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~-L~L~  659 (789)
                      ++++.++|+++ .+|..+  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+ +.+|.++++|.+ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            45788899999 567665  358999999999999766678999999999999999986555 457899998775 6778


Q ss_pred             CCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccC-ccccccCCccccCCC-CccEEEccCCcccc
Q 041249          660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV-NRLSGIVPSSIFNIS-SIAEFDVGENKIQG  737 (789)
Q Consensus       660 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~  737 (789)
                      +|+|+++.|.+|..+++|++|++++|+|+...+..+....++..|++++ |++....+..|..+. .++.|+|++|+|+ 
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-  167 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-  167 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence            8999999999999999999999999999977777888888899999966 688877777888875 6999999999999 


Q ss_pred             cCCcccccCCCCccEEEccC-CcccccCcccccCCCCCCeeeccCCcCcccC
Q 041249          738 NIPLDYGFTLQNLQYFSIGT-NRITGAIPPSISNASKLEVFQALNNKLTGEV  788 (789)
Q Consensus       738 ~ip~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  788 (789)
                      .||..+| ...+|++|++++ |.++.+.+.+|..+++|+.|||++|+|+...
T Consensus       168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp  218 (350)
T 4ay9_X          168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP  218 (350)
T ss_dssp             EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred             CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence            9999988 678999999975 7788666678999999999999999998653

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.85  E-value=2.7e-23  Score=226.41  Aligned_cols=226  Identities=17%  Similarity=0.170  Sum_probs=180.0

Q ss_pred             ccCcccccccccccccCccccchhcccCCcccccCc----ccccCcc-ceeeecccCCCCccCCCccCcCC-----CCCc
Q 041249          561 DLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIP----SEIGRLR-RLQVPDLNNNSIGGEIPVNLSSC-----SNLI  630 (789)
Q Consensus       561 ~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l-----~~L~  630 (789)
                      ++..+.+.+..+..+...++|++|+|++|+|++..+    ..|..++ +|++|+|++|+|++..+..|..+     ++|+
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            345555555555666666779999999999998777    7788888 89999999999998877777765     9999


Q ss_pred             EEEcccCCCCCCCCcc----cCCC-CCCcEEEccCCCCCccCCcCC----CC-CCCCCEEEccCCcCCccCC----cccc
Q 041249          631 RIGLAKNQLMGKIPSD----FGSL-SKIEVLSLGFNNLIGSIPPPL----GN-LSSLRKISLAINNLAGSIP----FTLS  696 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~----~~~l-~~L~~L~L~~N~l~~~~~~~~----~~-l~~L~~L~L~~N~l~~~~~----~~~~  696 (789)
                      +|+|++|+|++..+..    +..+ ++|++|+|++|+|++..+..+    .. .++|++|+|++|+|+...+    ..+.
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~  163 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA  163 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence            9999999999766664    4444 899999999999987766554    34 3699999999999995443    3445


Q ss_pred             CCC-CCCeeeccCccccccCCcccc----CC-CCccEEEccCCccccc----CCcccccCCCCccEEEccCCcccccCc-
Q 041249          697 KLK-NLVILYLGVNRLSGIVPSSIF----NI-SSIAEFDVGENKIQGN----IPLDYGFTLQNLQYFSIGTNRITGAIP-  765 (789)
Q Consensus       697 ~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~~-  765 (789)
                      .++ +|++|+|++|+|++..+..+.    .+ ++|+.|||++|.|++.    ++..+....++|++|+|++|+|++..+ 
T Consensus       164 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  243 (362)
T 3goz_A          164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE  243 (362)
T ss_dssp             TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred             cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence            665 999999999999977765444    44 5999999999999841    566665335699999999999997655 


Q ss_pred             ---ccccCCCCCCeeeccCCcCcc
Q 041249          766 ---PSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       766 ---~~~~~l~~L~~L~l~~N~l~~  786 (789)
                         ..+..+++|+.|+|++|++++
T Consensus       244 ~l~~~~~~l~~L~~L~L~~n~l~~  267 (362)
T 3goz_A          244 NLKLLKDSLKHLQTVYLDYDIVKN  267 (362)
T ss_dssp             HHHHTTTTTTTCSEEEEEHHHHTT
T ss_pred             HHHHHHhcCCCccEEEeccCCccc
Confidence               345677999999999998554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.85  E-value=3.9e-21  Score=202.37  Aligned_cols=175  Identities=23%  Similarity=0.293  Sum_probs=141.8

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+..+++|++|++++|.+++. + .+..+++|++|+|++|+|++..+  +..+++|++|++++|++++ ++ .+..+++|
T Consensus        41 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L  114 (291)
T 1h6t_A           41 TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKL  114 (291)
T ss_dssp             CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTC
T ss_pred             chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCC
Confidence            345688888999999988854 3 37888889999999999986544  8888999999999999884 33 48888899


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      ++|+|++|++++.  ..+..+++|++|+|++|++++.  ..+..+++|++|+|++|+|++..|  +..+++|+.|+|++|
T Consensus       115 ~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N  188 (291)
T 1h6t_A          115 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN  188 (291)
T ss_dssp             CEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCC
Confidence            9999999998854  4678888999999999998854  578888899999999999986544  888889999999999


Q ss_pred             cccccCCcccccCCCCccEEEccCCccccc
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      .|+ .+|. + ..+++|+.|++++|+++..
T Consensus       189 ~i~-~l~~-l-~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          189 HIS-DLRA-L-AGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             CCC-BCGG-G-TTCTTCSEEEEEEEEEECC
T ss_pred             cCC-CChh-h-ccCCCCCEEECcCCcccCC
Confidence            988 6664 3 4788899999999988854

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=2.6e-21  Score=220.79  Aligned_cols=181  Identities=22%  Similarity=0.325  Sum_probs=157.2

Q ss_pred             ccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEcc
Q 041249          580 FLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLG  659 (789)
Q Consensus       580 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  659 (789)
                      +|+.|+|++|+|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999997 666553  78999999999999 667   457999999999999996 776 665  99999999


Q ss_pred             CCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccC
Q 041249          660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNI  739 (789)
Q Consensus       660 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i  739 (789)
                      +|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            999996 555   68999999999999995 665   67899999999999996 676 65  89999999999999 99


Q ss_pred             CcccccCCCCc-------cEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          740 PLDYGFTLQNL-------QYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       740 p~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      |. +. .  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus       196 p~-~~-~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          196 PA-VP-V--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             CC-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             hh-HH-H--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence            98 54 2  77       99999999999 578888889999999999999998654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.85  E-value=5.5e-24  Score=247.85  Aligned_cols=210  Identities=12%  Similarity=0.048  Sum_probs=146.4

Q ss_pred             hccccceeeEeccCcccccccccccc-cCccccchhcc---------cCCcccccCccccc-CccceeeecccCCCCccC
Q 041249          550 IGSKAQKVTILDLESLKLAGSILPHI-GNLSFLKILNL---------ENNSFTHEIPSEIG-RLRRLQVPDLNNNSIGGE  618 (789)
Q Consensus       550 i~~~c~~l~~l~l~s~~~~~~~l~~l-~~l~~L~~L~L---------~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~i~~~  618 (789)
                      +...|.+++.+++..+ ........+ ..+++|++|++         ..+.+++.....+. .+++|++|+++.|.+++.
T Consensus       309 ~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~  387 (594)
T 2p1m_B          309 LLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNA  387 (594)
T ss_dssp             HHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHH
T ss_pred             HHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHH
Confidence            3446677778887776 322223333 34788999988         34566654444443 478899999999999866


Q ss_pred             CCccCc-CCCCCcEEEcc--c----CCCCCCCC-----cccCCCCCCcEEEccCCCCCccCCcCCCC-CCCCCEEEccCC
Q 041249          619 IPVNLS-SCSNLIRIGLA--K----NQLMGKIP-----SDFGSLSKIEVLSLGFNNLIGSIPPPLGN-LSSLRKISLAIN  685 (789)
Q Consensus       619 ~p~~~~-~l~~L~~L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N  685 (789)
                      .+..+. .+++|++|+++  +    |.++....     ..+..+++|+.|+|++ +++...+..+.. +++|++|+|++|
T Consensus       388 ~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~  466 (594)
T 2p1m_B          388 ALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFA  466 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred             HHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCC
Confidence            555554 58899999999  4    56663211     1256778999999977 676655555554 788999999999


Q ss_pred             cCCccCCccc-cCCCCCCeeeccCccccccCCc-cccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249          686 NLAGSIPFTL-SKLKNLVILYLGVNRLSGIVPS-SIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       686 ~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  761 (789)
                      .+++..+..+ ..+++|++|+|++|.+++.... .+..+++|+.|++++|+++..-...+...+++|+...+..+.-.
T Consensus       467 ~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~  544 (594)
T 2p1m_B          467 GDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP  544 (594)
T ss_dssp             CSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred             CCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence            9976555555 6789999999999999754443 34558899999999999864333334346788888777776543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=3.5e-21  Score=209.45  Aligned_cols=175  Identities=21%  Similarity=0.245  Sum_probs=126.5

Q ss_pred             EeccCcccccccccccccCccccchhcccCCcccccCccccc-CccceeeecccCCCCccCCCccCcCCCCCcEEEcccC
Q 041249          559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIG-RLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKN  637 (789)
Q Consensus       559 ~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N  637 (789)
                      .++...+.+.. .|..+.  +.++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            44555554442 233322  3467788888888877777676 7888888888888888776777888888888888888


Q ss_pred             CCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccc---cCCCCCCeeeccCcccccc
Q 041249          638 QLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTL---SKLKNLVILYLGVNRLSGI  714 (789)
Q Consensus       638 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~  714 (789)
                      +|+...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|   ..+++|+.|+|++|+|++.
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence            8876666677888888888888888887777788888888888888888875444445   5677888888888888865


Q ss_pred             CCccccCCCC--ccEEEccCCccc
Q 041249          715 VPSSIFNISS--IAEFDVGENKIQ  736 (789)
Q Consensus       715 ~p~~~~~l~~--L~~L~Ls~N~l~  736 (789)
                      .+..|..++.  ++.|+|++|++.
T Consensus       179 ~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          179 PLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CHHHhhhccHhhcceEEecCCCcc
Confidence            5567777776  477888888876

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.84  E-value=9e-23  Score=219.80  Aligned_cols=228  Identities=15%  Similarity=0.165  Sum_probs=182.7

Q ss_pred             ceeeEeccCcccccccccccccCccccchhcccCCccccc-CcccccCccceeeecccCCCCccCCCccCcCCCCCcEEE
Q 041249          555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHE-IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIG  633 (789)
Q Consensus       555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  633 (789)
                      .++..+++..+.+....+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+..+..+++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4567777888777655444 66789999999999999866 788889999999999999999888888899999999999


Q ss_pred             cccC-CCCCC-CCcccCCCCCCcEEEccCC-CCCcc-CCcCCCCCC-CCCEEEccCC--cCC-ccCCccccCCCCCCeee
Q 041249          634 LAKN-QLMGK-IPSDFGSLSKIEVLSLGFN-NLIGS-IPPPLGNLS-SLRKISLAIN--NLA-GSIPFTLSKLKNLVILY  705 (789)
Q Consensus       634 l~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~  705 (789)
                      +++| .+++. ++..+..+++|++|++++| ++++. ++..+..++ +|++|+|++|  .++ +.+|..+.++++|+.|+
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~  228 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD  228 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence            9999 67752 5666788999999999999 88854 566678888 9999999999  455 45677788899999999


Q ss_pred             ccCcc-ccccCCccccCCCCccEEEccCCcccccCCcc--cccCCCCccEEEccCCcccccCcccccCC-CCCCeeeccC
Q 041249          706 LGVNR-LSGIVPSSIFNISSIAEFDVGENKIQGNIPLD--YGFTLQNLQYFSIGTNRITGAIPPSISNA-SKLEVFQALN  781 (789)
Q Consensus       706 Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~  781 (789)
                      +++|. +++..+..+..+++|+.|+|++|. . ..+..  .+..+++|++|+|++| ++.   ..+..+ .++..|++++
T Consensus       229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~-~-~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~  302 (336)
T 2ast_B          229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY-D-IIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINC  302 (336)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTCT-T-CCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESC
T ss_pred             CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC-C-CCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEec
Confidence            99999 777778889999999999999995 1 22331  2347899999999999 543   334444 2477788999


Q ss_pred             CcCcccCC
Q 041249          782 NKLTGEVP  789 (789)
Q Consensus       782 N~l~~~~P  789 (789)
                      |++++..|
T Consensus       303 n~l~~~~~  310 (336)
T 2ast_B          303 SHFTTIAR  310 (336)
T ss_dssp             CCSCCTTC
T ss_pred             ccCccccC
Confidence            99999766

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.84  E-value=4.6e-23  Score=226.65  Aligned_cols=216  Identities=18%  Similarity=0.246  Sum_probs=179.8

Q ss_pred             cccccccCccccchhcccCCcccccCc----ccccCccceeeecccCC---CCccCCCccC-------cCCCCCcEEEcc
Q 041249          570 SILPHIGNLSFLKILNLENNSFTHEIP----SEIGRLRRLQVPDLNNN---SIGGEIPVNL-------SSCSNLIRIGLA  635 (789)
Q Consensus       570 ~~l~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N---~i~~~~p~~~-------~~l~~L~~L~l~  635 (789)
                      .....+..+++|++|+|++|+|+...+    ..|..+++|++|+|++|   ++++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            445677788999999999999997644    44778999999999996   4555566555       789999999999


Q ss_pred             cCCCCC----CCCcccCCCCCCcEEEccCCCCCccCCcCCCC----C---------CCCCEEEccCCcCC-ccCC---cc
Q 041249          636 KNQLMG----KIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGN----L---------SSLRKISLAINNLA-GSIP---FT  694 (789)
Q Consensus       636 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~N~l~-~~~~---~~  694 (789)
                      +|+|+.    .+|..+..+++|++|+|++|.++...+..+..    +         ++|++|+|++|+|+ ..++   ..
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  182 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  182 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence            999996    36778889999999999999997554444433    3         89999999999997 3444   46


Q ss_pred             ccCCCCCCeeeccCccccc-----cCCccccCCCCccEEEccCCccc----ccCCcccccCCCCccEEEccCCccccc--
Q 041249          695 LSKLKNLVILYLGVNRLSG-----IVPSSIFNISSIAEFDVGENKIQ----GNIPLDYGFTLQNLQYFSIGTNRITGA--  763 (789)
Q Consensus       695 ~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~ip~~~~~~l~~L~~L~L~~N~l~~~--  763 (789)
                      |..+++|++|+|++|+|+.     ..|..+..+++|+.|+|++|.|+    +.+|..+. .+++|++|+|++|+|++.  
T Consensus       183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~  261 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-SWPNLRELGLNDCLLSARGA  261 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG-GCTTCCEEECTTCCCCHHHH
T ss_pred             HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc-cCCCcCEEECCCCCCchhhH
Confidence            7789999999999999983     34558899999999999999996    57887666 899999999999999976  


Q ss_pred             --CcccccC--CCCCCeeeccCCcCcc
Q 041249          764 --IPPSISN--ASKLEVFQALNNKLTG  786 (789)
Q Consensus       764 --~~~~~~~--l~~L~~L~l~~N~l~~  786 (789)
                        ++..+..  +++|+.|+|++|++++
T Consensus       262 ~~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          262 AAVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             HHHHHHHhhccCCCeEEEECcCCcCCH
Confidence              5666644  8999999999999987

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=3.5e-21  Score=202.78  Aligned_cols=189  Identities=22%  Similarity=0.314  Sum_probs=97.5

Q ss_pred             cchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       581 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      +..+.+..+.+++..+  +..+++|+.|++++|.|+.. + .+..+++|++|++++|++++..+  +..+++|++|+|++
T Consensus        26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~   99 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE   99 (291)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence            3344444554443221  23455555555555555522 2 35555555555555555553322  55555555555555


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |++++.  ..+..+++|++|+|++|+|++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|+|++|+|+ .++
T Consensus       100 n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~-~~~  172 (291)
T 1h6t_A          100 NKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV  172 (291)
T ss_dssp             SCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC-CCG
T ss_pred             CcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc-cch
Confidence            555532  2255555555555555555532  2455555555555555555533  34555555555555555555 333


Q ss_pred             cccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          741 LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       741 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      .  +..+++|++|+|++|+|++. + .+..+++|+.|++++|+++.
T Consensus       173 ~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          173 P--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             G--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             h--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            2  22555555555555555532 2 25555555555555555543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=1.3e-20  Score=189.70  Aligned_cols=152  Identities=24%  Similarity=0.293  Sum_probs=131.8

Q ss_pred             chhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249          582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN  661 (789)
Q Consensus       582 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  661 (789)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|++..|+.|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            46788888888 4565543  67899999999999777778999999999999999999888888999999999999999


Q ss_pred             CCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          662 NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       662 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      +|+++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            999777777888999999999999999888888999999999999999999777778888999999999999987

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.84  E-value=3.1e-22  Score=215.56  Aligned_cols=224  Identities=17%  Similarity=0.190  Sum_probs=188.2

Q ss_pred             eeEeccCcccccccccccccCc--cccchhcccCCcccccCcccccCccceeeecccCCCCccC-CCccCcCCCCCcEEE
Q 041249          557 VTILDLESLKLAGSILPHIGNL--SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE-IPVNLSSCSNLIRIG  633 (789)
Q Consensus       557 l~~l~l~s~~~~~~~l~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~  633 (789)
                      ++.+++..+.+.   +..+..+  +.++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            556666666554   3455666  8999999999999977666 56799999999999999866 788899999999999


Q ss_pred             cccCCCCCCCCcccCCCCCCcEEEccCC-CCCcc-CCcCCCCCCCCCEEEccCC-cCCcc-CCccccCCC-CCCeeeccC
Q 041249          634 LAKNQLMGKIPSDFGSLSKIEVLSLGFN-NLIGS-IPPPLGNLSSLRKISLAIN-NLAGS-IPFTLSKLK-NLVILYLGV  708 (789)
Q Consensus       634 l~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~  708 (789)
                      +++|++++..+..+..+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            9999999878888999999999999999 78753 5666888999999999999 99864 577789999 999999999


Q ss_pred             c--ccc-ccCCccccCCCCccEEEccCCc-ccccCCcccccCCCCccEEEccCCc-ccccCcccccCCCCCCeeeccCCc
Q 041249          709 N--RLS-GIVPSSIFNISSIAEFDVGENK-IQGNIPLDYGFTLQNLQYFSIGTNR-ITGAIPPSISNASKLEVFQALNNK  783 (789)
Q Consensus       709 N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~ip~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~  783 (789)
                      |  .++ +.+|..+..+++|+.|+|++|. +++..+..+. .+++|++|+|++|. ++......+..+++|+.|++++| 
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~-~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF-QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG-GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh-CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence            9  555 4677888899999999999999 7766777665 89999999999995 44332336888999999999999 


Q ss_pred             Ccc
Q 041249          784 LTG  786 (789)
Q Consensus       784 l~~  786 (789)
                      ++.
T Consensus       283 i~~  285 (336)
T 2ast_B          283 VPD  285 (336)
T ss_dssp             SCT
T ss_pred             cCH
Confidence            654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=2.9e-20  Score=187.17  Aligned_cols=153  Identities=21%  Similarity=0.298  Sum_probs=135.6

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN  685 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  685 (789)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            57899999998 6676654  68999999999999877778999999999999999999888999999999999999999


Q ss_pred             cCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          686 NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       686 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      +|+...+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+ .++...+..+++|++|+|++|++..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-EECHHHHhCCCCCCEEEeCCCCcCC
Confidence            999777777899999999999999999888899999999999999999998 7777666689999999999999864

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=1.2e-20  Score=189.92  Aligned_cols=158  Identities=19%  Similarity=0.208  Sum_probs=136.4

Q ss_pred             chhcccCCcccccCcccccCccceeeecccCCCCccCCC-ccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIP-VNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       582 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      +++++++|.++. +|..+.  ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            478899999984 566553  356899999999997755 4588999999999999999987888899999999999999


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            99998888889999999999999999998888999999999999999999998889999999999999999999986555


Q ss_pred             cc
Q 041249          741 LD  742 (789)
Q Consensus       741 ~~  742 (789)
                      ..
T Consensus       171 l~  172 (220)
T 2v70_A          171 LA  172 (220)
T ss_dssp             GH
T ss_pred             hH
Confidence            43

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=1.6e-20  Score=216.62  Aligned_cols=179  Identities=22%  Similarity=0.288  Sum_probs=148.6

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+..+++|+.|+|++|.|+. ++ .|..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|++ +| .+..+++|
T Consensus        38 ~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L  111 (605)
T 1m9s_A           38 TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKL  111 (605)
T ss_dssp             CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTC
T ss_pred             chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCC
Confidence            35678889999999999984 34 48889999999999999986554  8899999999999999984 44 68889999


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      +.|+|++|+|++.  ..+..+++|+.|+|++|+|++.  ..|..+++|+.|+|++|+|++..|  +..+++|+.|+|++|
T Consensus       112 ~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N  185 (605)
T 1m9s_A          112 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN  185 (605)
T ss_dssp             CEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCC
Confidence            9999999999853  4588899999999999999854  578899999999999999997655  889999999999999


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCccc
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS  767 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~  767 (789)
                      +|+ .+| .+ ..+++|+.|+|++|++++.....
T Consensus       186 ~i~-~l~-~l-~~l~~L~~L~L~~N~l~~~p~~~  216 (605)
T 1m9s_A          186 HIS-DLR-AL-AGLKNLDVLELFSQECLNKPINH  216 (605)
T ss_dssp             CCC-BCG-GG-TTCTTCSEEECCSEEEECCCCCC
T ss_pred             CCC-CCh-HH-ccCCCCCEEEccCCcCcCCcccc
Confidence            998 554 34 37899999999999988654333

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=5e-20  Score=186.72  Aligned_cols=155  Identities=21%  Similarity=0.247  Sum_probs=137.5

Q ss_pred             eeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC
Q 041249          605 LQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI  684 (789)
Q Consensus       605 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  684 (789)
                      -+.++.++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            567899999998 6676554  8999999999999988888999999999999999999877778889999999999999


Q ss_pred             CcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccC
Q 041249          685 NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI  764 (789)
Q Consensus       685 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~  764 (789)
                      |+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|...+..+++|+.|+|++|++....
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            9999777778899999999999999999 78888999999999999999998 777776668999999999999988543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=3.1e-20  Score=187.01  Aligned_cols=154  Identities=19%  Similarity=0.253  Sum_probs=131.6

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCC-cccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIP-SDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI  684 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  684 (789)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            58899999998 5676654  456899999999997654 4588899999999999999988888999999999999999


Q ss_pred             CcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc
Q 041249          685 NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       685 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                      |+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+ ..+++|++|+|++|++...
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF-DTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTT-TTCTTCCEEECCSCCEECS
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHh-cCCCCCCEEEecCcCCcCC
Confidence            99998888889999999999999999998888999999999999999999984445444 4899999999999998754

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=9.6e-20  Score=184.64  Aligned_cols=156  Identities=24%  Similarity=0.268  Sum_probs=142.2

Q ss_pred             cchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       581 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      -+.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            467999999999 5665543  7899999999999998899999999999999999999977777899999999999999


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.+..+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            9999888888999999999999999999 788899999999999999999997777889999999999999999985443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.82  E-value=7.1e-21  Score=199.06  Aligned_cols=154  Identities=19%  Similarity=0.123  Sum_probs=121.6

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------------------hhhHHHHHHHHHHhc
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------------------RASRSFIAECRALRS  323 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~  323 (789)
                      ...+.....-|...+.||+|+||.||+|.+ .+++.||+|+++....                  .....+.+|++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            344555566777789999999999999999 6899999999964321                  134568999999999


Q ss_pred             CCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 041249          324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ  403 (789)
Q Consensus       324 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~  403 (789)
                      ++  | +++.+.+.. .     ..++||||+++|+|.+ +...                ....++.|++.||+|||..+ 
T Consensus       161 l~--~-~~v~~~~~~-~-----~~~lvmE~~~g~~L~~-l~~~----------------~~~~i~~qi~~~l~~lH~~g-  213 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-E-----GNAVLMELIDAKELYR-VRVE----------------NPDEVLDMILEEVAKFYHRG-  213 (282)
T ss_dssp             TT--T-SSSCCEEEE-E-----TTEEEEECCCCEEGGG-CCCS----------------CHHHHHHHHHHHHHHHHHTT-
T ss_pred             cc--C-CCcCeEEec-c-----ceEEEEEecCCCcHHH-cchh----------------hHHHHHHHHHHHHHHHHHCC-
Confidence            99  4 566554432 2     4699999999999998 4211                24469999999999999998 


Q ss_pred             CCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC
Q 041249          404 PITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG  461 (789)
Q Consensus       404 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  461 (789)
                        |+||||||+|||++ ++.+||+|||+|+..               ..|+|||++..
T Consensus       214 --iiHrDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r  253 (282)
T 1zar_A          214 --IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER  253 (282)
T ss_dssp             --EECSCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred             --CEeCCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence              99999999999999 999999999998743               34678887643

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=4.7e-20  Score=212.76  Aligned_cols=189  Identities=23%  Similarity=0.359  Sum_probs=89.5

Q ss_pred             cchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249          581 LKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF  660 (789)
Q Consensus       581 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  660 (789)
                      +..+++..+.+....+  +..+++|+.|++++|.|+. +| .|..+++|+.|+|++|+|++..+  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            3444444444443222  3344455555555555542 22 34455555555555555553222  44555555555555


Q ss_pred             CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249          661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP  740 (789)
Q Consensus       661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip  740 (789)
                      |+|++ +| .|..+++|+.|+|++|+|++ + ..+..|++|+.|+|++|+|++.  ..|..+++|+.|+|++|.|++..|
T Consensus        97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            55542 22 34455555555555555542 2 2345555555555555555532  344555555555555555542222


Q ss_pred             cccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          741 LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       741 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                        + ..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++
T Consensus       171 --l-~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          171 --L-AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             --G-TTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             --h-ccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence              2 2455555555555555532  234455555555555555444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=4.6e-20  Score=191.09  Aligned_cols=171  Identities=25%  Similarity=0.286  Sum_probs=111.4

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      ++.++..+++++|.+++. + .+..+++|++|++++|.|+ .+| .+..+++|++|+|++|+|++..+  |..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            456666777777777643 3 4666777777777777776 334 56677777777777777774333  6677777777


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      +|++|++++. |. +.. ++|++|+|++|+|++ ++ .+..+++|+.|+|++|+|++. + .+..+++|+.|+|++|+|+
T Consensus        91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            7777777643 32 222 677777777777764 33 467777777777777777743 3 5667777777777777776


Q ss_pred             ccCCcccccCCCCccEEEccCCccccc
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGA  763 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~  763 (789)
                       .+ ..+ ..+++|+.|+|++|++++.
T Consensus       164 -~~-~~l-~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          164 -NT-GGL-TRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -BC-TTS-TTCCCCCEEEEEEEEEECC
T ss_pred             -ch-HHh-ccCCCCCEEeCCCCcccCC
Confidence             33 223 3677777777777777644

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.80  E-value=6.7e-20  Score=189.88  Aligned_cols=171  Identities=18%  Similarity=0.274  Sum_probs=150.0

Q ss_pred             CccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEE
Q 041249          601 RLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKI  680 (789)
Q Consensus       601 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  680 (789)
                      .+.++..+++++|.+++..  .+..+++|++|++++|.|+ .++ .+..+++|++|+|++|+|++..+  |..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            5778999999999999543  6889999999999999998 455 68899999999999999996654  9999999999


Q ss_pred             EccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcc
Q 041249          681 SLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRI  760 (789)
Q Consensus       681 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l  760 (789)
                      +|++|+|++ +|. +.. ++|++|+|++|+|++.  ..+..+++|+.|+|++|+|+ .+| .+ ..+++|++|+|++|+|
T Consensus        91 ~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~-~~~-~l-~~l~~L~~L~L~~N~i  162 (263)
T 1xeu_A           91 SVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIV-ML-GFLSKLEVLDLHGNEI  162 (263)
T ss_dssp             ECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCC-BCG-GG-GGCTTCCEEECTTSCC
T ss_pred             ECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCC-CCh-HH-ccCCCCCEEECCCCcC
Confidence            999999995 443 333 8999999999999953  36999999999999999999 665 34 4899999999999999


Q ss_pred             cccCcccccCCCCCCeeeccCCcCccc
Q 041249          761 TGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       761 ~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      ++.  ..+..+++|+.|++++|++++.
T Consensus       163 ~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          163 TNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             cch--HHhccCCCCCEEeCCCCcccCC
Confidence            976  7789999999999999999875

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.80  E-value=1.1e-19  Score=179.78  Aligned_cols=153  Identities=13%  Similarity=0.204  Sum_probs=89.5

Q ss_pred             cCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCE
Q 041249          600 GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRK  679 (789)
Q Consensus       600 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  679 (789)
                      ..+++|+.|++++|.|+ .+| .+..+++|++|++++|.++ . +..+..+++|++|++++|++++..+..|..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            45566666666666666 444 4666666666666666554 2 235666666666666666666555566666666666


Q ss_pred             EEccCCcCCccCCccccCCCCCCeeeccCcc-ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCC
Q 041249          680 ISLAINNLAGSIPFTLSKLKNLVILYLGVNR-LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTN  758 (789)
Q Consensus       680 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N  758 (789)
                      |+|++|++++..|..|..+++|++|++++|+ ++ .+| .+..+++|+.|++++|+|+ .++ .+. .+++|++|++++|
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~-~~~-~l~-~l~~L~~L~l~~N  191 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH-DYR-GIE-DFPKLNQLYAFSQ  191 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC-CCT-TGG-GCSSCCEEEECBC
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc-ChH-Hhc-cCCCCCEEEeeCc
Confidence            6666666665555566666666666666665 44 333 4555666666666666665 344 222 4555555655555


Q ss_pred             ccc
Q 041249          759 RIT  761 (789)
Q Consensus       759 ~l~  761 (789)
                      +|.
T Consensus       192 ~i~  194 (197)
T 4ezg_A          192 TIG  194 (197)
T ss_dssp             ---
T ss_pred             ccC
Confidence            554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.80  E-value=1.3e-19  Score=179.23  Aligned_cols=156  Identities=19%  Similarity=0.246  Sum_probs=136.6

Q ss_pred             CcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC
Q 041249          623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV  702 (789)
Q Consensus       623 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  702 (789)
                      ...+++|++|++++|.|+ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..+..|+.+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            367889999999999999 566 6889999999999999886  335789999999999999999987899999999999


Q ss_pred             eeeccCccccccCCccccCCCCccEEEccCCc-ccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccC
Q 041249          703 ILYLGVNRLSGIVPSSIFNISSIAEFDVGENK-IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN  781 (789)
Q Consensus       703 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  781 (789)
                      +|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+ ..+++|++|++++|+|++. + .+..+++|+.|++++
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l-~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~  190 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PL-KTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFS  190 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GG-GGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECB
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hh-cCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeC
Confidence            99999999998889999999999999999998 76 777 34 4899999999999999964 3 788999999999999


Q ss_pred             CcCccc
Q 041249          782 NKLTGE  787 (789)
Q Consensus       782 N~l~~~  787 (789)
                      |++.+.
T Consensus       191 N~i~~~  196 (197)
T 4ezg_A          191 QTIGGK  196 (197)
T ss_dssp             C-----
T ss_pred             cccCCc
Confidence            999763

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=5.8e-22  Score=227.33  Aligned_cols=196  Identities=18%  Similarity=0.154  Sum_probs=157.5

Q ss_pred             cCccccchhcccCCcccccCcccccCccceeeecccCCC-------------CccCCCccCcCCCCCcEEE-cccCCCCC
Q 041249          576 GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS-------------IGGEIPVNLSSCSNLIRIG-LAKNQLMG  641 (789)
Q Consensus       576 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-------------i~~~~p~~~~~l~~L~~L~-l~~N~l~~  641 (789)
                      ..+++|+.|+|++|+|+ .+|..++.+++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|.+..
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~  424 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD  424 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence            56888999999999998 789999999999999998775             5667788888888888888 56554331


Q ss_pred             CCCc------ccCC--CCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccc
Q 041249          642 KIPS------DFGS--LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       642 ~~~~------~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                       ++.      .+..  ...|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++
T Consensus       425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~  500 (567)
T 1dce_A          425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN  500 (567)
T ss_dssp             -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred             -hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence             110      0000  1258999999999985 565 899999999999999999 788899999999999999999995


Q ss_pred             cCCccccCCCCccEEEccCCcccccC-CcccccCCCCccEEEccCCcccccCccc---ccCCCCCCeeec
Q 041249          714 IVPSSIFNISSIAEFDVGENKIQGNI-PLDYGFTLQNLQYFSIGTNRITGAIPPS---ISNASKLEVFQA  779 (789)
Q Consensus       714 ~~p~~~~~l~~L~~L~Ls~N~l~~~i-p~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~l  779 (789)
                       +| .|..+++|+.|+|++|+|++.. |..+. .+++|+.|+|++|+|++.+|..   +..+++|+.|++
T Consensus       501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          501 -VD-GVANLPRLQELLLCNNRLQQSAAIQPLV-SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             -CG-GGTTCSSCCEEECCSSCCCSSSTTGGGG-GCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             -Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHh-cCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence             66 8999999999999999999554 77776 8999999999999999765432   334788998875

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=5.2e-19  Score=174.03  Aligned_cols=133  Identities=23%  Similarity=0.308  Sum_probs=74.4

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCc-ccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPS-DFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI  684 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  684 (789)
                      +++++++|+|+ .+|..+..  +|++|++++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            34455555554 34443322  555555555555544432 355555555666665655555555555556666666666


Q ss_pred             CcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCc
Q 041249          685 NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL  741 (789)
Q Consensus       685 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~  741 (789)
                      |+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            666555555556666666666666666655566666666666666666666544443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=1.9e-18  Score=170.01  Aligned_cols=127  Identities=23%  Similarity=0.289  Sum_probs=115.1

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCc-cccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCC
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPS-SLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRN   79 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N   79 (789)
                      .||+++|+++ .+|..+..  +|++|++++|+|++..+. .|+.+++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus        12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            3799999997 88887755  999999999999977665 4899999999999999999988999999999999999999


Q ss_pred             cCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCC
Q 041249           80 QFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ  130 (789)
Q Consensus        80 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~  130 (789)
                      +|++..|..|..+++|++|+|++|+|++.+|..|..+++|++|+|++|.+.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence            999888888999999999999999999988999999988888877777765

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.1e-19  Score=214.94  Aligned_cols=192  Identities=22%  Similarity=0.233  Sum_probs=115.7

Q ss_pred             hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCC
Q 041249          583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNN  662 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  662 (789)
                      .++++.|++. ..|..|..+++|+.|+|++|.|. .+|..+..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+
T Consensus       205 ~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~  281 (727)
T 4b8c_D          205 EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR  281 (727)
T ss_dssp             ------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred             Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence            3344445554 55777888888888888888888 67777778888888888888888 778888888888888888888


Q ss_pred             CCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCC-CccEEEccCCcccccCCc
Q 041249          663 LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNIS-SIAEFDVGENKIQGNIPL  741 (789)
Q Consensus       663 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~ip~  741 (789)
                      |+ .+|..|.+|++|++|+|++|.|+ .+|..|++|++|+.|+|++|.|++.+|..+..+. .+..|+|++|.+++.+|.
T Consensus       282 l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~  359 (727)
T 4b8c_D          282 LT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH  359 (727)
T ss_dssp             CS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred             CC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence            88 66888888888888888888887 6777788888888888888888888888776543 233478888888877775


Q ss_pred             ccccCCCCccEEEccCC--------cccccCcccccCCCCCCeeeccCCcCcc
Q 041249          742 DYGFTLQNLQYFSIGTN--------RITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       742 ~~~~~l~~L~~L~L~~N--------~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      .       |+.|++++|        .|.+..+..+..+.++....++.|-+++
T Consensus       360 ~-------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          360 E-------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             C------------------------------------------------CCCG
T ss_pred             c-------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence            4       455667666        4444445555666667777778887753

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.75  E-value=1.3e-19  Score=207.84  Aligned_cols=196  Identities=16%  Similarity=0.177  Sum_probs=161.5

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCc-------------ccccCcccccCccceeeec-ccCCCCccC
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNS-------------FTHEIPSEIGRLRRLQVPD-LNNNSIGGE  618 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~i~~~  618 (789)
                      .|.++..+++..+.+. ..|..++++++|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+...
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L  425 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL  425 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchh
Confidence            4667778888888876 568899999999999998775             5667888889999999998 666644311


Q ss_pred             CCc------cCcC--CCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCcc
Q 041249          619 IPV------NLSS--CSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS  690 (789)
Q Consensus       619 ~p~------~~~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  690 (789)
                       +.      .+..  ...|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..|+++++|++|+|++|+|++ 
T Consensus       426 -~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-  500 (567)
T 1dce_A          426 -RSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-  500 (567)
T ss_dssp             -HHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-
T ss_pred             -hhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-
Confidence             10      0110  1358999999999995 676 999999999999999999 789999999999999999999995 


Q ss_pred             CCccccCCCCCCeeeccCccccccC-CccccCCCCccEEEccCCcccccCCcc--cccCCCCccEEEc
Q 041249          691 IPFTLSKLKNLVILYLGVNRLSGIV-PSSIFNISSIAEFDVGENKIQGNIPLD--YGFTLQNLQYFSI  755 (789)
Q Consensus       691 ~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip~~--~~~~l~~L~~L~L  755 (789)
                      +| .|+++++|+.|+|++|+|++.. |..|..+++|+.|+|++|+|++..|..  +...+++|+.|++
T Consensus       501 lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            67 8999999999999999999776 999999999999999999999444422  2334899999975

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=8e-18  Score=180.48  Aligned_cols=182  Identities=16%  Similarity=0.152  Sum_probs=149.4

Q ss_pred             cCcccccC--------ccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCC--
Q 041249          594 EIPSEIGR--------LRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL--  663 (789)
Q Consensus       594 ~~~~~~~~--------l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l--  663 (789)
                      +.+.+|.+        +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+..  
T Consensus        84 I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~  162 (329)
T 3sb4_A           84 VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR  162 (329)
T ss_dssp             ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH
T ss_pred             cCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh
Confidence            34556777        88999999988 88877778899999999999999988877788888888787777665221  


Q ss_pred             --CccCCcCC--------------------------------------------------CCCCCCCEEEccCCcCCccC
Q 041249          664 --IGSIPPPL--------------------------------------------------GNLSSLRKISLAINNLAGSI  691 (789)
Q Consensus       664 --~~~~~~~~--------------------------------------------------~~l~~L~~L~L~~N~l~~~~  691 (789)
                        ......+|                                                  ..+++|+.|+|++|+++.+.
T Consensus       163 ~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~  242 (329)
T 3sb4_A          163 FKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIP  242 (329)
T ss_dssp             TSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEEC
T ss_pred             ccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceec
Confidence              11111111                                                  02789999999999999778


Q ss_pred             CccccCCCCCCeeeccCccccccCCccccCCCCcc-EEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccC
Q 041249          692 PFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIA-EFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISN  770 (789)
Q Consensus       692 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  770 (789)
                      +.+|.+|++|+.|+|.+| ++.+.+.+|.++++|+ .|++++ .++ .|+...|.++++|+.|++++|.++.+.+.+|.+
T Consensus       243 ~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~  319 (329)
T 3sb4_A          243 DFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTLGDELFGN  319 (329)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEECTTTTCT
T ss_pred             HhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCccchhhhcC
Confidence            889999999999999998 8878888999999999 999999 787 899888889999999999999999888889999


Q ss_pred             CCCCCeeec
Q 041249          771 ASKLEVFQA  779 (789)
Q Consensus       771 l~~L~~L~l  779 (789)
                      +++|+.++.
T Consensus       320 ~~~L~~ly~  328 (329)
T 3sb4_A          320 GVPSKLIYK  328 (329)
T ss_dssp             TCCCCEEEC
T ss_pred             Ccchhhhcc
Confidence            999999874

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=5.4e-19  Score=209.01  Aligned_cols=192  Identities=18%  Similarity=0.164  Sum_probs=122.3

Q ss_pred             cccchhcccCCcccccCcccccCccc-----eeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRR-----LQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~-----L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      +.++.|+|.+|.+.. .+..+....+     +..++++.|++. ..|..|..+++|+.|+|++|+|. .+|..+..+++|
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L  249 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL  249 (727)
T ss_dssp             ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred             CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence            557788888888885 3443322222     233344556665 66888999999999999999998 677667789999


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      ++|+|++|+|+ .+|..|.++++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|..+++|+.|+|++|
T Consensus       250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N  326 (727)
T 4b8c_D          250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN  326 (727)
T ss_dssp             SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred             CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence            99999999999 88899999999999999999999 78999999999999999999998 77888999999999999999


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                      +|++.+|..+......+..|+|++|.+++.+|..+      +.|++++|
T Consensus       327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l------~~l~l~~n  369 (727)
T 4b8c_D          327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER------RFIEINTD  369 (727)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred             ccCCCChHHHhhcchhhhHHhhccCcccCcCcccc------ceeEeecc
Confidence            99988887765221223457899999998887654      45555555

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.72  E-value=8.3e-18  Score=161.55  Aligned_cols=131  Identities=22%  Similarity=0.189  Sum_probs=53.2

Q ss_pred             ceeeecccCCCCc-cCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEc
Q 041249          604 RLQVPDLNNNSIG-GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL  682 (789)
Q Consensus       604 ~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  682 (789)
                      +|++|++++|.|+ +.+|..+..+++|++|++++|+|++.  ..|..+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            3444444444443 33333344444444444444444422  33444444444444444444333333333444444444


Q ss_pred             cCCcCCccC-CccccCCCCCCeeeccCccccccCC---ccccCCCCccEEEccCCccc
Q 041249          683 AINNLAGSI-PFTLSKLKNLVILYLGVNRLSGIVP---SSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       683 ~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++|+|++.. +..+..+++|+.|++++|++++..+   ..|..+++|+.|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            444444211 1334444444444444444442222   23344444444444444443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=2.5e-17  Score=158.14  Aligned_cols=137  Identities=23%  Similarity=0.251  Sum_probs=112.2

Q ss_pred             CCCCcEEEcccCCCC-CCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCee
Q 041249          626 CSNLIRIGLAKNQLM-GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVIL  704 (789)
Q Consensus       626 l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  704 (789)
                      .++|++|++++|+++ +.+|..|..+++|++|+|++|++++.  ..|..+++|++|+|++|++++.+|..+.++++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            378899999999987 67787888889999999999998865  778888999999999999987688778888899999


Q ss_pred             eccCccccccC-CccccCCCCccEEEccCCcccccCCc---ccccCCCCccEEEccCCcccccCcc
Q 041249          705 YLGVNRLSGIV-PSSIFNISSIAEFDVGENKIQGNIPL---DYGFTLQNLQYFSIGTNRITGAIPP  766 (789)
Q Consensus       705 ~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip~---~~~~~l~~L~~L~L~~N~l~~~~~~  766 (789)
                      +|++|+|++.. +..+..+++|+.|++++|+++ .+|.   ..+..+++|++|++++|.+. ..|.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            99999988542 277888888999999999988 6665   44557888888888888887 3444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.70  E-value=7.5e-17  Score=158.54  Aligned_cols=126  Identities=25%  Similarity=0.350  Sum_probs=62.5

Q ss_pred             hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCC
Q 041249          583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNN  662 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  662 (789)
                      .+++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4555555555 3333322  34555555555555 444555555555555555555554444445555555555555555


Q ss_pred             CCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc
Q 041249          663 LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       663 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      |+++.|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            55444444555555555555555555333334444444444444444443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.69  E-value=1.3e-16  Score=156.94  Aligned_cols=128  Identities=23%  Similarity=0.301  Sum_probs=113.9

Q ss_pred             cEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCc
Q 041249          630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       630 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  709 (789)
                      +++++++|.|+ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            68999999998 5666543  58999999999998 67789999999999999999999888888999999999999999


Q ss_pred             cccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          710 RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       710 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      +|++..|..|..+++|+.|+|++|+|+ .+|...+..+++|+.|+|++|++..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeec
Confidence            999888889999999999999999998 8888777689999999999999864

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=2e-16  Score=153.35  Aligned_cols=134  Identities=24%  Similarity=0.280  Sum_probs=115.9

Q ss_pred             CCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeecc
Q 041249          628 NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLG  707 (789)
Q Consensus       628 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  707 (789)
                      ..+.+++++|+++ .+|..+  .++|+.|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus         8 ~~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             ETTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            3578999999998 455443  3689999999999998877888999999999999999997777778999999999999


Q ss_pred             CccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCc
Q 041249          708 VNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIP  765 (789)
Q Consensus       708 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~  765 (789)
                      +|+|++..+..|..+++|+.|+|++|+|+ .+|..++..+++|++|+|++|++++..|
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            99999777778899999999999999998 7888877679999999999999986544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=2.2e-16  Score=153.00  Aligned_cols=129  Identities=21%  Similarity=0.226  Sum_probs=65.5

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN  685 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  685 (789)
                      +.+++++|+++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            34444444444 2332221  34555555555555444444455555555555555555444444555555555555555


Q ss_pred             cCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccc
Q 041249          686 NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG  737 (789)
Q Consensus       686 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  737 (789)
                      +|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            5554444445555555555555555554444444555555555555555553

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=3.5e-17  Score=153.78  Aligned_cols=107  Identities=20%  Similarity=0.178  Sum_probs=44.3

Q ss_pred             ceeeecccCCCCc-cCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEc
Q 041249          604 RLQVPDLNNNSIG-GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISL  682 (789)
Q Consensus       604 ~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  682 (789)
                      +|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..|..+++|++|+|++|++++.+|..+..+++|++|++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            4444444444444 33444444444444444444444432  33444444444444444444333333333444444444


Q ss_pred             cCCcCCcc-CCccccCCCCCCeeeccCcccc
Q 041249          683 AINNLAGS-IPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       683 ~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      ++|++++. .+..+..+++|++|++++|+++
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            44444321 1133334444444444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=7.7e-17  Score=151.42  Aligned_cols=108  Identities=20%  Similarity=0.282  Sum_probs=54.2

Q ss_pred             CCCcEEEcccCCCC-CCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeee
Q 041249          627 SNLIRIGLAKNQLM-GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILY  705 (789)
Q Consensus       627 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  705 (789)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            44555555555554 34444555555555555555555533  4445555555555555555543444444455555555


Q ss_pred             ccCcccccc-CCccccCCCCccEEEccCCccc
Q 041249          706 LGVNRLSGI-VPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       706 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      +++|++++. .+..+..+++|++|++++|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            555555432 1244444444555555555444

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.67  E-value=4.5e-17  Score=168.02  Aligned_cols=141  Identities=21%  Similarity=0.164  Sum_probs=107.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceE--EEEEEeccccch------------------------hhHHHHHHHHHHhcC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTT--VTVKVFNLHHHR------------------------ASRSFIAECRALRSI  324 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  324 (789)
                      -|...+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|++.+.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999999657888  999997543111                        113688999999999


Q ss_pred             CCCcc--ceeeeeeccCCCCCCceEEEEeeccCC-C----ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 041249          325 RHRNL--VKVFTACSGVDYQGNDFKALVYEFMQN-G----SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY  397 (789)
Q Consensus       325 ~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~  397 (789)
                      .|+++  ..+++.    .     ..++||||+.. |    +|.++...             .++.....++.|++.||.|
T Consensus       128 ~~~~i~~p~~~~~----~-----~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~  185 (258)
T 1zth_A          128 KEAGVSVPQPYTY----M-----KNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKR  185 (258)
T ss_dssp             HHTTCCCCCEEEE----E-----TTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCeEEEc----C-----CCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHH
Confidence            88764  333332    1     45899999952 4    56655421             1244577899999999999


Q ss_pred             hh-cCCCCCceecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249          398 LH-HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT  438 (789)
Q Consensus       398 LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  438 (789)
                      || ..+   ||||||||+|||+++  .++|+|||+|....++
T Consensus       186 lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          186 LYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             HHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             HHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            99 888   999999999999998  9999999999876443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.64  E-value=3.1e-16  Score=151.83  Aligned_cols=132  Identities=12%  Similarity=0.116  Sum_probs=68.0

Q ss_pred             cCCCCCcEEEcccCCCCCCCCcccCCCC-CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC
Q 041249          624 SSCSNLIRIGLAKNQLMGKIPSDFGSLS-KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV  702 (789)
Q Consensus       624 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  702 (789)
                      .++++|++|++++|+++. +|. +..+. +|++|+|++|+|++.  ..|..+++|++|+|++|+|++..+..|..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            344455555555555542 232 22222 555555555555533  3455555555555555555543333345555555


Q ss_pred             eeeccCccccccCCc--cccCCCCccEEEccCCcccccCCcc---cccCCCCccEEEccCCccc
Q 041249          703 ILYLGVNRLSGIVPS--SIFNISSIAEFDVGENKIQGNIPLD---YGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       703 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~ip~~---~~~~l~~L~~L~L~~N~l~  761 (789)
                      +|+|++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..   ++..+++|+.|++++|.+.
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            5555555554 3333  5555566666666666665 55543   2225566666666666554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.63  E-value=7.8e-16  Score=164.92  Aligned_cols=198  Identities=14%  Similarity=0.061  Sum_probs=167.7

Q ss_pred             cceeeEeccCccccc--------------------ccccccccC--------ccccchhcccCCcccccCcccccCccce
Q 041249          554 AQKVTILDLESLKLA--------------------GSILPHIGN--------LSFLKILNLENNSFTHEIPSEIGRLRRL  605 (789)
Q Consensus       554 c~~l~~l~l~s~~~~--------------------~~~l~~l~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L  605 (789)
                      +.+++.+++..+.+.                    ......|.+        +++|++|+|.+ +++.+.+.+|.++++|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L  126 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL  126 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence            567778888877776                    223356777        99999999999 8998888899999999


Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCC----CCCCCccc----------------------------------
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQL----MGKIPSDF----------------------------------  647 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l----~~~~~~~~----------------------------------  647 (789)
                      +.|++++|.++.+.+.+|.++.++..+.+..+..    ......+|                                  
T Consensus       127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~  206 (329)
T 3sb4_A          127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF  206 (329)
T ss_dssp             CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred             ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence            9999999999888889999988888888776321    11111112                                  


Q ss_pred             ----------------CCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC-eeeccCcc
Q 041249          648 ----------------GSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV-ILYLGVNR  710 (789)
Q Consensus       648 ----------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~  710 (789)
                                      ..+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.+|++|+ .+++.+ .
T Consensus       207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~  284 (329)
T 3sb4_A          207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S  284 (329)
T ss_dssp             EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred             EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence                            02789999999999999999999999999999999998 8878888999999999 999999 8


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEc
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSI  755 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L  755 (789)
                      ++.+.+.+|.++++|+.|++++|.++ .|+...|.++++|+.++.
T Consensus       285 l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          285 VTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CCEECTTTTTTCTTEEEEEECSSCCC-EECTTTTCTTCCCCEEEC
T ss_pred             ceEEchhhhhCCccCCEEEeCCCccC-ccchhhhcCCcchhhhcc
Confidence            88788899999999999999999999 999999989999999874

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.63  E-value=1.7e-16  Score=153.61  Aligned_cols=132  Identities=20%  Similarity=0.210  Sum_probs=100.9

Q ss_pred             ccCccceeeecccCCCCccCCCccCcCC-CCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCC
Q 041249          599 IGRLRRLQVPDLNNNSIGGEIPVNLSSC-SNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL  677 (789)
Q Consensus       599 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  677 (789)
                      +..+.+|+.|++++|+|+. +|. +..+ ++|++|++++|+|++.  ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            5667778888888888873 444 4444 4888888888888754  567788888888888888886655556788888


Q ss_pred             CEEEccCCcCCccCCc--cccCCCCCCeeeccCccccccCCc----cccCCCCccEEEccCCccc
Q 041249          678 RKISLAINNLAGSIPF--TLSKLKNLVILYLGVNRLSGIVPS----SIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       678 ~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++|+|++|+|+ .+|.  .+..+++|+.|++++|.++ ..|.    .+..+++|+.||+++|.+.
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            88888888886 5555  7888888888888888888 4555    3888888888888888876

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.62  E-value=4.2e-15  Score=163.02  Aligned_cols=217  Identities=12%  Similarity=0.037  Sum_probs=110.6

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      .++.+.+|. .+.......|.++++|+.++|.+|+++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.+++.
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            344444443 23333334455555555555555555544444444 345555555432 443444555555555555555


Q ss_pred             cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC-----ccCCccccCCCCCCeeeccCcc
Q 041249          636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA-----GSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      +| ++.+...+|.+ .+|+.+.+ .|.++.+.+.+|.++++|+.+++.+|.+.     .+.+.+|.+|++|+.++|. |.
T Consensus       235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~  310 (401)
T 4fdw_A          235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ES  310 (401)
T ss_dssp             TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TT
T ss_pred             CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-Cc
Confidence            43 33344444554 45555555 34455455555555555555555555543     2444555555555555555 33


Q ss_pred             ccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCC-CCCeeeccCC
Q 041249          711 LSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNAS-KLEVFQALNN  782 (789)
Q Consensus       711 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N  782 (789)
                      ++.+...+|.++++|+.++|..| ++ .|+...|.++ +|+.|++++|.+....+..|.+++ ++..|++..+
T Consensus       311 i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~  380 (401)
T 4fdw_A          311 IRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAE  380 (401)
T ss_dssp             CCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred             eEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHH
Confidence            55444555555555666655433 44 5555555455 566666655555544455555553 4555555544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.62  E-value=3.3e-15  Score=163.84  Aligned_cols=219  Identities=11%  Similarity=0.048  Sum_probs=187.9

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      +++.+.++.+ +.......|.++ +|+.++|.. .++.+.+.+|.++++|+.++|++|+++.+...+|. +.+|+.+.+.
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp  211 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP  211 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred             CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence            5677777766 444555677774 699999986 78878888999999999999999999977667777 6999999999


Q ss_pred             cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc---
Q 041249          636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS---  712 (789)
Q Consensus       636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---  712 (789)
                      .| ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.| .|.++.+.+.+|.+|++|+.+++.+|.+.   
T Consensus       212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~  287 (401)
T 4fdw_A          212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP  287 (401)
T ss_dssp             TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred             Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence            55 77677889999999999999875 78788899988 78999999 56677678889999999999999998875   


Q ss_pred             --ccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          713 --GIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       713 --~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                        .+.+.+|.++++|+.++|. |.++ .|+...|.++.+|+.++|..| ++.+.+.+|.++ +|+.+++++|.+..
T Consensus       288 ~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~  359 (401)
T 4fdw_A          288 EAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ  359 (401)
T ss_dssp             TCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred             ccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence              5778899999999999999 5588 999999989999999999665 777888999999 99999999987654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.59  E-value=8.4e-18  Score=166.24  Aligned_cols=133  Identities=19%  Similarity=0.301  Sum_probs=73.6

Q ss_pred             cCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCC
Q 041249          622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNL  701 (789)
Q Consensus       622 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  701 (789)
                      .|..+++|++|++++|+|++ +| .+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++ +| .+..+++|
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L  117 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence            45555555555555555553 34 4555555555555555555 344444445556666666666653 33 45556666


Q ss_pred             CeeeccCccccccCC-ccccCCCCccEEEccCCcccccCCcc---------cccCCCCccEEEccCCccc
Q 041249          702 VILYLGVNRLSGIVP-SSIFNISSIAEFDVGENKIQGNIPLD---------YGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       702 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~~---------~~~~l~~L~~L~L~~N~l~  761 (789)
                      ++|++++|+|++..+ ..+..+++|++|++++|++++.+|..         ++..+++|+.||  +|.++
T Consensus       118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            666666666663222 35666666666666666666444432         223566666665  55555

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=5.5e-18  Score=167.60  Aligned_cols=156  Identities=20%  Similarity=0.226  Sum_probs=136.1

Q ss_pred             cccCccccchhcccCCcccccCcc------cccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCccc
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPS------EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDF  647 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~  647 (789)
                      .+.....++.++++.+.+++..|.      .|..+++|++|+|++|+|++ +| .+.++++|++|++++|+|+ .+|..+
T Consensus        13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~   89 (198)
T 1ds9_A           13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD   89 (198)
T ss_dssp             HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred             HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence            356677889999999999988877      89999999999999999996 66 8999999999999999999 678778


Q ss_pred             CCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC-ccccCCCCCCeeeccCccccccCCcc--------
Q 041249          648 GSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIVPSS--------  718 (789)
Q Consensus       648 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~--------  718 (789)
                      ..+++|++|+|++|++++. | .+..+++|++|+|++|+|+...+ ..+..+++|++|++++|++++..|..        
T Consensus        90 ~~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~  167 (198)
T 1ds9_A           90 AVADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI  167 (198)
T ss_dssp             HHHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHH
T ss_pred             hcCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHH
Confidence            8889999999999999964 4 68889999999999999985333 47899999999999999998776653        


Q ss_pred             --ccCCCCccEEEccCCccc
Q 041249          719 --IFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       719 --~~~l~~L~~L~Ls~N~l~  736 (789)
                        +..+++|+.||  +|.++
T Consensus       168 ~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          168 EVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHCSSCSEEC--CGGGT
T ss_pred             HHHHhCCCcEEEC--CcccC
Confidence              88999999997  78876

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.54  E-value=3.1e-14  Score=136.73  Aligned_cols=104  Identities=21%  Similarity=0.239  Sum_probs=58.4

Q ss_pred             CCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEeccC
Q 041249           23 LVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSG  102 (789)
Q Consensus        23 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  102 (789)
                      .+.|++++|.|+ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            345566666665 3554442  5566666666666655555566666666666666666544444455666666666666


Q ss_pred             CCCCCcCCccccCCcccccccccCCCC
Q 041249          103 NILQGEIPSTLGSCIKLEILEMQGNVF  129 (789)
Q Consensus       103 N~l~~~~p~~~~~l~~L~~l~l~~N~~  129 (789)
                      |+|++..|..|..+++|++|+|++|++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~  114 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPW  114 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence            666644444555555555555555443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=4e-14  Score=136.49  Aligned_cols=103  Identities=17%  Similarity=0.176  Sum_probs=59.1

Q ss_pred             CeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEeccCC
Q 041249           24 VEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN  103 (789)
Q Consensus        24 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  103 (789)
                      +.+++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45666666664 5555443  56666666666666555556666666666666666666333333556666666666666


Q ss_pred             CCCCcCCccccCCcccccccccCCCC
Q 041249          104 ILQGEIPSTLGSCIKLEILEMQGNVF  129 (789)
Q Consensus       104 ~l~~~~p~~~~~l~~L~~l~l~~N~~  129 (789)
                      +|++..+..|..+++|++|+|++|.+
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~  117 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPW  117 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCB
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCc
Confidence            66644444455555555555555544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.53  E-value=4.4e-14  Score=135.69  Aligned_cols=104  Identities=23%  Similarity=0.270  Sum_probs=58.5

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN  685 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  685 (789)
                      +.+++++|.|+ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            45566666665 3444332  55566666666665555555555556666666666665555555555555555555555


Q ss_pred             cCCccCCccccCCCCCCeeeccCcccc
Q 041249          686 NLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       686 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      +|++..+..|..+++|++|+|++|.++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            555444444555555555555555554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=6.5e-14  Score=134.95  Aligned_cols=104  Identities=22%  Similarity=0.298  Sum_probs=58.5

Q ss_pred             eeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCC
Q 041249          606 QVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN  685 (789)
Q Consensus       606 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  685 (789)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45566666665 4444443  55666666666666555555555666666666666665544444555555555555555


Q ss_pred             cCCccCCccccCCCCCCeeeccCcccc
Q 041249          686 NLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       686 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      +|++..+..|..+++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            555444444555555555555555555

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.48  E-value=2.2e-14  Score=153.74  Aligned_cols=145  Identities=14%  Similarity=0.163  Sum_probs=100.7

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------------hhHHH--------HHHHHHHhc
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------------ASRSF--------IAECRALRS  323 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~e~~~l~~  323 (789)
                      .....-|.+...||.|++|.||+|... +|+.||||+++.....              .....        .+|.+.+.+
T Consensus        91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           91 AARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            333345888999999999999999986 7999999997643110              01112        234445555


Q ss_pred             CCCCccc--eeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC
Q 041249          324 IRHRNLV--KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD  401 (789)
Q Consensus       324 l~h~niv--~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~  401 (789)
                      +.+.++.  ..++.         ...++||||+.++++..+....                ....++.|++.+|.|||..
T Consensus       170 L~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~~----------------~~~~l~~qll~~l~~lH~~  224 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSVP----------------DPASLYADLIALILRLAKH  224 (397)
T ss_dssp             HHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCCS----------------CHHHHHHHHHHHHHHHHHT
T ss_pred             HHhcCCCCCeeeec---------cCceEEEEecCCccHhhhcccH----------------HHHHHHHHHHHHHHHHHHC
Confidence            5333221  11111         1237999999988887654211                2356789999999999999


Q ss_pred             CCCCceecCCCCCceecCCCC----------ceeeCcccccccCCCCC
Q 041249          402 CQPITTHCDLKPSNILLDEEM----------VSHVGDFGLARFLPPTH  439 (789)
Q Consensus       402 ~~~~ivH~dlk~~Nill~~~~----------~~kl~Dfgla~~~~~~~  439 (789)
                      |   ||||||||.|||+++++          .+.|+||+-+-...++.
T Consensus       225 g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp~  269 (397)
T 4gyi_A          225 G---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHPN  269 (397)
T ss_dssp             T---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTSTT
T ss_pred             C---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCCCCC
Confidence            8   99999999999998776          37899999776655443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.38  E-value=3.4e-15  Score=162.14  Aligned_cols=159  Identities=19%  Similarity=0.169  Sum_probs=93.8

Q ss_pred             ccccchhcccCCcccccCcccccCc-----cceeeecccCCCCccCCCccC-cCCCCCcEEEcccCCCCCCCCccc----
Q 041249          578 LSFLKILNLENNSFTHEIPSEIGRL-----RRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLMGKIPSDF----  647 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~~----  647 (789)
                      ++.|+.|+|++|.|+......|..+     ++|++|+|++|.|+......+ ..+++|++|+|++|.|+......+    
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            4567888888888876544444333     578888888888764333333 234567777777777764322222    


Q ss_pred             -CCCCCCcEEEccCCCCCcc----CCcCCCCCCCCCEEEccCCcCCccC----CccccCCCCCCeeeccCcccccc----
Q 041249          648 -GSLSKIEVLSLGFNNLIGS----IPPPLGNLSSLRKISLAINNLAGSI----PFTLSKLKNLVILYLGVNRLSGI----  714 (789)
Q Consensus       648 -~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----  714 (789)
                       ...++|++|+|++|.|+..    ++..+..+++|++|+|++|+|+...    +..+..+++|+.|+|++|.|++.    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             2345677777777776532    2223345566667777766665321    34445555666666666666532    


Q ss_pred             CCccccCCCCccEEEccCCccc
Q 041249          715 VPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       715 ~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++..+...++|++|||++|.|+
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCC
T ss_pred             HHHHHHhCCCCCEEeccCCCCC
Confidence            2233344556666666666665

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.37  E-value=4.6e-15  Score=161.10  Aligned_cols=183  Identities=14%  Similarity=0.092  Sum_probs=107.2

Q ss_pred             ccceeeecccCCCCccCCCccCc-----CCCCCcEEEcccCCCCCCCCcc-cCCCCCCcEEEccCCCCCccCCcCC----
Q 041249          602 LRRLQVPDLNNNSIGGEIPVNLS-----SCSNLIRIGLAKNQLMGKIPSD-FGSLSKIEVLSLGFNNLIGSIPPPL----  671 (789)
Q Consensus       602 l~~L~~L~Ls~N~i~~~~p~~~~-----~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~----  671 (789)
                      ++.|+.|+|++|.|+......+.     ..++|++|+|++|.|+...... ...+++|+.|+|++|+|+......+    
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            34677777777777643333332     2257777888877776322222 2234567777888777764433333    


Q ss_pred             -CCCCCCCEEEccCCcCCcc----CCccccCCCCCCeeeccCcccccc----CCccccCCCCccEEEccCCccccc----
Q 041249          672 -GNLSSLRKISLAINNLAGS----IPFTLSKLKNLVILYLGVNRLSGI----VPSSIFNISSIAEFDVGENKIQGN----  738 (789)
Q Consensus       672 -~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  738 (789)
                       ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|++.    ++..+...++|+.|+|++|.|++.    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             2456777788887777642    333446677777888888777642    245566667777888888777632    


Q ss_pred             CCcccccCCCCccEEEccCCcccccCcccccCCCC-----CCeee--ccCCcCc
Q 041249          739 IPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASK-----LEVFQ--ALNNKLT  785 (789)
Q Consensus       739 ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----L~~L~--l~~N~l~  785 (789)
                      ++..+. ..++|++|+|++|.|++.....+..+..     |+.+.  +..|.++
T Consensus       231 l~~~L~-~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          231 LARAAR-EHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             HHHHHH-HCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             HHHHHH-hCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            222222 3567777888887777654444443321     44555  5555443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.37  E-value=1.2e-12  Score=141.18  Aligned_cols=102  Identities=23%  Similarity=0.243  Sum_probs=50.7

Q ss_pred             EEcCCC-CCCccCCcCccCCccCCeEecCC-CcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCC
Q 041249            2 LALDSN-RLSGNIPPSIGNLKKLVEPYVSD-NFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRN   79 (789)
Q Consensus         2 l~l~~n-~~~~~~p~~~~~l~~l~~L~ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N   79 (789)
                      +|++++ +|+ .+|. |..+++|++|+|++ |+|++..|+.|+.+++|++|+|++|+|++..|..|..|++|++|||++|
T Consensus        13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            345554 555 3444 55555555555553 5555444445555555555555555555544445555555555555555


Q ss_pred             cCCCCCcccccCCCCCCEEeccCCCCC
Q 041249           80 QFRGSFPTEVGNLINLETLTVSGNILQ  106 (789)
Q Consensus        80 ~l~~~~p~~~~~l~~L~~L~l~~N~l~  106 (789)
                      +|++..|..|..+. |+.|+|++|.|.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            55532222233332 555555555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=7.1e-13  Score=142.95  Aligned_cols=104  Identities=19%  Similarity=0.172  Sum_probs=79.9

Q ss_pred             eecccCC-CCccCCCccCcCCCCCcEEEccc-CCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccC
Q 041249          607 VPDLNNN-SIGGEIPVNLSSCSNLIRIGLAK-NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAI  684 (789)
Q Consensus       607 ~L~Ls~N-~i~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  684 (789)
                      .++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|+++.|..|.++++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4577777 777 4666 88888888888885 888876667788888888888888888877777788888888888888


Q ss_pred             CcCCccCCccccCCCCCCeeeccCccccc
Q 041249          685 NNLAGSIPFTLSKLKNLVILYLGVNRLSG  713 (789)
Q Consensus       685 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  713 (789)
                      |+|++..+..|..++ |+.|+|++|.+..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            888866666666665 8888888887763

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.33  E-value=3.5e-11  Score=131.99  Aligned_cols=115  Identities=11%  Similarity=0.042  Sum_probs=75.3

Q ss_pred             cCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEeccCCCCCCcCCc
Q 041249           32 FLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS  111 (789)
Q Consensus        32 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  111 (789)
                      .++.+-..+|.+|++|+.+.|.++ ++..-..+|.+|++|+.+++.++ ++..-..+|..+.+|+.+.+..+ +...-..
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            355444567889999999999754 76444567889999999999766 55233557888889988887755 4324455


Q ss_pred             cccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccC
Q 041249          112 TLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN  164 (789)
Q Consensus       112 ~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N  164 (789)
                      +|.++..+.......               ....-..+|.++++|+.+.+.++
T Consensus       135 aF~~~~~~~~~~~~~---------------~~~i~~~aF~~c~~L~~i~l~~~  172 (394)
T 4fs7_A          135 AFKGCDFKEITIPEG---------------VTVIGDEAFATCESLEYVSLPDS  172 (394)
T ss_dssp             TTTTCCCSEEECCTT---------------CCEECTTTTTTCTTCCEEECCTT
T ss_pred             eeecccccccccCcc---------------ccccchhhhcccCCCcEEecCCc
Confidence            666654333222111               11122356888888998887654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.13  E-value=7.3e-10  Score=121.44  Aligned_cols=111  Identities=14%  Similarity=0.134  Sum_probs=82.5

Q ss_pred             CcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCC
Q 041249          668 PPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTL  747 (789)
Q Consensus       668 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  747 (789)
                      ..+|.++..|+.+.+.++..+ +...+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++ .|+...|.++
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C  333 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGC  333 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTC
T ss_pred             cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCC
Confidence            345666777777777655544 556677777788888775 4566566778888888888888765 66 7888888788


Q ss_pred             CCccEEEccCCcccccCcccccCCCCCCeeeccCCc
Q 041249          748 QNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK  783 (789)
Q Consensus       748 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  783 (789)
                      .+|+.+.|..+ ++.+...+|.++++|+.+++.+|.
T Consensus       334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          334 EQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             TTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred             CCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence            88888888654 666667888888888888888764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.12  E-value=6.5e-10  Score=121.84  Aligned_cols=217  Identities=13%  Similarity=-0.011  Sum_probs=160.7

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEE
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI  632 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L  632 (789)
                      .|.+++.+.+|.... ......|.++++|+.+++..| ++.+...+|.++..|+.+.+..+...  +...+....+|+.+
T Consensus       160 ~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i  235 (394)
T 4fs7_A          160 TCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNI  235 (394)
T ss_dssp             TCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEE
T ss_pred             ccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceE
Confidence            577888888886543 344567889999999999877 66567778999999999998877655  23344455788888


Q ss_pred             EcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc
Q 041249          633 GLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS  712 (789)
Q Consensus       633 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  712 (789)
                      .+..+. ..+...+|.++.+|+.+.+..+... +...+|..+..++.+.+..+.+   ....|..+.+|+.+.+..+ ++
T Consensus       236 ~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~  309 (394)
T 4fs7_A          236 IIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VK  309 (394)
T ss_dssp             EECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CC
T ss_pred             EECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cc
Confidence            886543 3355667888888888888776544 7777788888888887776543   3456778888888888655 66


Q ss_pred             ccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249          713 GIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       713 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                      .+...+|.++++|+.++|..+ ++ .|+...|.++.+|+.+++..| ++.+...+|.++++|+.+++.++
T Consensus       310 ~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          310 FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            566677888888888888654 66 787777777888888888766 66667778888888888887654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.99  E-value=4.1e-09  Score=115.49  Aligned_cols=134  Identities=11%  Similarity=0.114  Sum_probs=104.6

Q ss_pred             CcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCC
Q 041249          644 PSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNIS  723 (789)
Q Consensus       644 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  723 (789)
                      ..+|.++.+|+.+.+.++.. .+...+|.++++|+.+.+. +.++.+...+|.++++|+.+++..+ ++.+...+|.++.
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~  334 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE  334 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             cceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence            34678889999999976654 4888999999999999996 5676677889999999999999865 7767788999999


Q ss_pred             CccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          724 SIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       724 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      +|+.+.|..+ ++ .|+...|.++.+|+.+++.+|....   ..+....+|+.+.+..|.+.
T Consensus       335 ~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          335 QLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             TCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred             CCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence            9999999765 77 8999999899999999999987652   56777889999999877653

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.99  E-value=9e-11  Score=126.22  Aligned_cols=84  Identities=8%  Similarity=0.190  Sum_probs=43.9

Q ss_pred             CCCCCCeeeccCccccccCCcccc---CCCCccEEEccCCccccc----CCcccccCCCCccEEEccCCcccccCccccc
Q 041249          697 KLKNLVILYLGVNRLSGIVPSSIF---NISSIAEFDVGENKIQGN----IPLDYGFTLQNLQYFSIGTNRITGAIPPSIS  769 (789)
Q Consensus       697 ~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  769 (789)
                      .+++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.|.+.    ++..+. .+++|+.|+|++|.|+...-..+.
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~-~l~~L~~L~L~~n~i~d~~~~~l~  328 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD-KIKHLKFINMKYNYLSDEMKKELQ  328 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHH-HHTTCSEEECCSBBCCHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcc-cCCcceEEECCCCcCCHHHHHHHH
Confidence            355666666666666543333332   355666666666666532    222221 356666666666666643333333


Q ss_pred             C-CCCCCeeeccCCc
Q 041249          770 N-ASKLEVFQALNNK  783 (789)
Q Consensus       770 ~-l~~L~~L~l~~N~  783 (789)
                      . +  ...+++++|+
T Consensus       329 ~al--g~~~~~~~~~  341 (362)
T 2ra8_A          329 KSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHC--CSEEECCSBC
T ss_pred             HHc--CCEEEecCCc
Confidence            3 2  2446666554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.92  E-value=2e-09  Score=110.73  Aligned_cols=145  Identities=17%  Similarity=0.068  Sum_probs=110.7

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .-++|......+.|+.+.||++...  ++.+++|+...........+..|+++++.+. |..+.++++++....     .
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~-----~   84 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-----W   84 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-----E
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC-----c
Confidence            3457877788888889999999754  6899999986532233446889999999884 677788888876544     7


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-------------------------
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-------------------------  401 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-------------------------  401 (789)
                      .++||||+++.++.+....               ......++.+++++++.||..                         
T Consensus        85 ~~lv~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             EEEEEECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             eEEEEEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence            8999999999888876421               112347889999999999981                         


Q ss_pred             -------------------------------CCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          402 -------------------------------CQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       402 -------------------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                                                     ..+.++|||+++.||+++++..+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                           114489999999999998766668999987653

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.91  E-value=3.7e-10  Score=121.42  Aligned_cols=137  Identities=15%  Similarity=0.111  Sum_probs=87.8

Q ss_pred             ccCCCCCCcEEEccCCC-CCccCCcCCCCCCCCCEEEccCCcCCccCCcccc--CCCCCCeeeccC--cccccc-----C
Q 041249          646 DFGSLSKIEVLSLGFNN-LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLS--KLKNLVILYLGV--NRLSGI-----V  715 (789)
Q Consensus       646 ~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~  715 (789)
                      .+..+++|+.|+|++|. +.  .+. +. +++|++|+|..|.++......+.  .+++|+.|+|+.  |...+.     +
T Consensus       167 ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l  242 (362)
T 2ra8_A          167 VLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF  242 (362)
T ss_dssp             HHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred             HHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence            34455666677666652 21  222 32 66777777777766543333333  567777777753  221111     1


Q ss_pred             Cccc--cCCCCccEEEccCCcccccCCccccc--CCCCccEEEccCCcccccC----cccccCCCCCCeeeccCCcCcc
Q 041249          716 PSSI--FNISSIAEFDVGENKIQGNIPLDYGF--TLQNLQYFSIGTNRITGAI----PPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       716 p~~~--~~l~~L~~L~Ls~N~l~~~ip~~~~~--~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ...+  ..+++|+.|+|++|.+.+..+..++.  .+++|++|+|+.|.|++..    +..+..+++|+.|++++|.++.
T Consensus       243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            1122  25789999999999998544444431  4789999999999998753    3334567999999999999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.82  E-value=3.6e-09  Score=108.54  Aligned_cols=139  Identities=19%  Similarity=0.090  Sum_probs=97.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCc--cceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRN--LVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~  346 (789)
                      ..++....+.+.|..+.||++... ++..+++|+....   ....+..|+++++.+.+.+  +.+++++.....     .
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~-----~   89 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG-----R   89 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----C
T ss_pred             cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC-----C
Confidence            344544333345666999999764 5678999997543   2345788999999885445  445777765433     5


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC------------------------
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC------------------------  402 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------  402 (789)
                      .++||||+++.++.  ....                ....++.+++..++.||...                        
T Consensus        90 ~~~v~e~i~G~~l~--~~~~----------------~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SSHL----------------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG  151 (264)
T ss_dssp             EEEEEECCSSEETT--TSCC----------------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred             CEEEEEecCCcccC--cCcC----------------CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence            79999999987773  2110                12357778888888888643                        


Q ss_pred             -------------------------------CCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          403 -------------------------------QPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       403 -------------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                                                     ...++|||++|.||+++++..+.++||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                           12399999999999998876678999998754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.77  E-value=1e-07  Score=103.73  Aligned_cols=221  Identities=10%  Similarity=0.017  Sum_probs=138.9

Q ss_pred             ccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCC------------------
Q 041249          553 KAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNS------------------  614 (789)
Q Consensus       553 ~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~------------------  614 (789)
                      .|.+++.+.+|+. +.......|.++ +|+.+.+..+ ++.+...+|... +|+.+++..+-                  
T Consensus        67 ~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~lp~~~~~i~~~~F~~~~l~~~~~  142 (379)
T 4h09_A           67 SCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEFPGATTEIGNYIFYNSSVKRIVI  142 (379)
T ss_dssp             TCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEECCTTCCEECTTTTTTCCCCEEEE
T ss_pred             CCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccCCCccccccccccccceeeeeec
Confidence            4677777777754 333344556655 4666655433 443444445443 56666665432                  


Q ss_pred             ---CccCCCccCcCCCCCcEEEcccCCCC-----------------------------------CCCCcccCCCCCCcEE
Q 041249          615 ---IGGEIPVNLSSCSNLIRIGLAKNQLM-----------------------------------GKIPSDFGSLSKIEVL  656 (789)
Q Consensus       615 ---i~~~~p~~~~~l~~L~~L~l~~N~l~-----------------------------------~~~~~~~~~l~~L~~L  656 (789)
                         ++.+....|..+.+++.+.+..+...                                   ......|....+|+.+
T Consensus       143 ~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i  222 (379)
T 4h09_A          143 PKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKI  222 (379)
T ss_dssp             CTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEE
T ss_pred             cceeeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeeccccccccccee
Confidence               12122334555555555554432211                                   0112234455566666


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      .+..+ ++.+...+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.....+|.++++|+.+.+.++.++
T Consensus       223 ~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~  299 (379)
T 4h09_A          223 TITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE  299 (379)
T ss_dssp             ECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC
T ss_pred             eeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc
Confidence            66544 45566677777888888888765 55566677888888888888654 55466677888888888888888887


Q ss_pred             ccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                       .|+...|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+
T Consensus       300 -~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          300 -TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             -EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             -eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence             788888878888888888654 66566778888888888877544

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.60  E-value=1.3e-07  Score=102.00  Aligned_cols=146  Identities=14%  Similarity=0.161  Sum_probs=106.3

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEec--ccc-chhhHHHHHHHHHHhcCC--CCccceeeeeeccCCCCCCceEE
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFN--LHH-HRASRSFIAECRALRSIR--HRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ..+.++.|.++.||+....  +..+++|...  ... ......+..|.++++.+.  +..+.++++++.+....  ...+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~--g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI--GRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT--SSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc--CCeE
Confidence            3567889999999998875  4678888875  332 122356788999999986  45578888887654321  2468


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--------------------------
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--------------------------  402 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------  402 (789)
                      +||||+++..+.+..            ...++..++..++.+++..|+.||...                          
T Consensus       118 ~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             EEEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            999999987764421            134678888999999999999999731                          


Q ss_pred             -----------------------------CCCceecCCCCCceecCCCCc--eeeCcccccccC
Q 041249          403 -----------------------------QPITTHCDLKPSNILLDEEMV--SHVGDFGLARFL  435 (789)
Q Consensus       403 -----------------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~~  435 (789)
                                                   .+.++|||+++.||++++++.  +.+.||+.+..-
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                         256999999999999997753  589999988753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.59  E-value=6.1e-07  Score=97.46  Aligned_cols=210  Identities=11%  Similarity=0.042  Sum_probs=149.5

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccc------------cCcccccCccceeeecccCCCCccCCCccC
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTH------------EIPSEIGRLRRLQVPDLNNNSIGGEIPVNL  623 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~------------~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~  623 (789)
                      .+.....+.. ........+..+..++.+.+..+....            .....+.....+..+.+..+.-. .....+
T Consensus       136 ~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f  213 (379)
T 4h09_A          136 SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGF  213 (379)
T ss_dssp             CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTT
T ss_pred             eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeeccc
Confidence            3444444433 222334456666777766665544321            12223444445555555444333 556777


Q ss_pred             cCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCe
Q 041249          624 SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVI  703 (789)
Q Consensus       624 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  703 (789)
                      ..+.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.
T Consensus       214 ~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~  290 (379)
T 4h09_A          214 SYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTK  290 (379)
T ss_dssp             TTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCE
T ss_pred             ccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccc
Confidence            88889999988766 44366778889999999999766 77788888999999999999755 55566778999999999


Q ss_pred             eeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCC
Q 041249          704 LYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASK  773 (789)
Q Consensus       704 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  773 (789)
                      +.+.++.++.+...+|.++.+|+.++|..+ ++ .|+...|.++.+|+.+.+..+ ++.+...+|.++..
T Consensus       291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~  357 (379)
T 4h09_A          291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSI  357 (379)
T ss_dssp             EEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSC
T ss_pred             ccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCC
Confidence            999999888777889999999999999765 76 888888888999999999765 66666778877643

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.55  E-value=6.2e-09  Score=100.95  Aligned_cols=121  Identities=16%  Similarity=0.142  Sum_probs=75.1

Q ss_pred             CccccCCCCCCEEEccCC-cCCC----CCcccccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEeccCCCCCCc
Q 041249           38 PSSLGLCESLTTIGLFNN-NLSG----TIPPQLMGLTSLVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGE  108 (789)
Q Consensus        38 ~~~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~  108 (789)
                      ...+...+.|++|+|++| .|+.    .+...+...++|++|+|++|.+..    .+...+...++|++|+|++|+|+..
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            344566777777777777 7763    244556667778888888887763    2344455566788888888887732


Q ss_pred             ----CCccccCCcccccccc--cCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCCC
Q 041249          109 ----IPSTLGSCIKLEILEM--QGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLE  167 (789)
Q Consensus       109 ----~p~~~~~l~~L~~l~l--~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~~  167 (789)
                          +...+...++|++|+|  ++|.+..-.         ...+.+.+...++|++|++++|.+.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g---------~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGNNV---------EMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHH---------HHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCHHH---------HHHHHHHHHhCCCcCEEeccCCCCC
Confidence                3445555555555555  444443100         0014456667777888888888876

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.54  E-value=2.5e-08  Score=104.98  Aligned_cols=191  Identities=18%  Similarity=0.156  Sum_probs=121.3

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCc--cceeeeeeccCCCCCCceEEEEe
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRN--LVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      .+.++.|....||+..     ..+++|.....  .....+..|.+.++.+. +..  +.++++......  .....++||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEE
Confidence            4568999999999863     45888886432  34567889999998873 332  334444332211  111348899


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC------------------------------
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD------------------------------  401 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------  401 (789)
                      |++++.++.+...            ..++..++..++.+++..++.||..                              
T Consensus        96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            9999877764321            2356677778888888888888862                              


Q ss_pred             -------------------------CCCCceecCCCCCceecCC--CCceeeCcccccccCCCCCCccceee--------
Q 041249          402 -------------------------CQPITTHCDLKPSNILLDE--EMVSHVGDFGLARFLPPTHVQTSSIG--------  446 (789)
Q Consensus       402 -------------------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~--------  446 (789)
                                               ..+.++|+|+++.||++++  ...+.++||+.+....+...-.....        
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~  243 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME  243 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence                                     1245899999999999998  45679999998876433211000000        


Q ss_pred             ----ecccccccC-cccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          447 ----VKGSIGYIA-PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       447 ----~~gt~~y~a-PE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                          .....++.. |+...  +.....+.|++|.++|++.+|+.+|.
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                000011111 22111  11223689999999999999998864

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.51  E-value=1.3e-08  Score=103.82  Aligned_cols=93  Identities=18%  Similarity=0.198  Sum_probs=52.5

Q ss_pred             cccCccccch--hcccCCccc---ccCcccccCccceeeecccCCCCcc--CCCccCcCCCCCcEEEcccCCCCCCCCcc
Q 041249          574 HIGNLSFLKI--LNLENNSFT---HEIPSEIGRLRRLQVPDLNNNSIGG--EIPVNLSSCSNLIRIGLAKNQLMGKIPSD  646 (789)
Q Consensus       574 ~l~~l~~L~~--L~L~~N~l~---~~~~~~~~~l~~L~~L~Ls~N~i~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~~  646 (789)
                      .+...+.|+.  ++++.|+..   +..+.....+++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       136 ~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          136 GLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             TGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             HcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            3555666666  667777543   1112222456677777777777775  2344555667777777777777643  12


Q ss_pred             cCCCC--CCcEEEccCCCCCccCC
Q 041249          647 FGSLS--KIEVLSLGFNNLIGSIP  668 (789)
Q Consensus       647 ~~~l~--~L~~L~L~~N~l~~~~~  668 (789)
                      +..+.  +|++|+|++|.+.+..|
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhhcccCCcceEEccCCcCccccC
Confidence            22222  56666666666654433

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.51  E-value=8.1e-09  Score=105.28  Aligned_cols=106  Identities=16%  Similarity=0.184  Sum_probs=65.4

Q ss_pred             hcccCCcccccCcc-cccCccceee--ecccCCCCccCCCc----cCcCCCCCcEEEcccCCCCCC--CCcccCCCCCCc
Q 041249          584 LNLENNSFTHEIPS-EIGRLRRLQV--PDLNNNSIGGEIPV----NLSSCSNLIRIGLAKNQLMGK--IPSDFGSLSKIE  654 (789)
Q Consensus       584 L~L~~N~l~~~~~~-~~~~l~~L~~--L~Ls~N~i~~~~p~----~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~  654 (789)
                      |...+|.-++.++- .|...+.|..  ++++.|+.. .++.    ...++++|++|+|++|+|++.  +|+.+..+++|+
T Consensus       121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~  199 (267)
T 3rw6_A          121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK  199 (267)
T ss_dssp             HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCC
T ss_pred             HHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCC
Confidence            44444544443332 2666677777  788888654 3332    224678888888888888863  345566778888


Q ss_pred             EEEccCCCCCccCCcCCCCCC--CCCEEEccCCcCCccCC
Q 041249          655 VLSLGFNNLIGSIPPPLGNLS--SLRKISLAINNLAGSIP  692 (789)
Q Consensus       655 ~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~  692 (789)
                      .|+|++|+|++.  ..+..+.  +|++|+|++|.+++.+|
T Consensus       200 ~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          200 ILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             EEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             EEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence            888888888754  2233333  66666666666654443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.50  E-value=1.1e-08  Score=99.26  Aligned_cols=43  Identities=14%  Similarity=0.061  Sum_probs=20.1

Q ss_pred             cccCccceeeecccCC-CCccC----CCccCcCCCCCcEEEcccCCCC
Q 041249          598 EIGRLRRLQVPDLNNN-SIGGE----IPVNLSSCSNLIRIGLAKNQLM  640 (789)
Q Consensus       598 ~~~~l~~L~~L~Ls~N-~i~~~----~p~~~~~l~~L~~L~l~~N~l~  640 (789)
                      .+...+.|++|+|++| .|...    +...+...++|++|+|++|.|.
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   78 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            3444555566666655 55421    1223333444555555555443

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.81  E-value=5.6e-05  Score=79.22  Aligned_cols=138  Identities=17%  Similarity=0.106  Sum_probs=92.2

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCC---ccceeeeeeccCCCCCCceEEEEe
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR---NLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      .+.++.|....||+.     +..+++|+..  .......+..|.+++..+.+.   .+.+++.++...    ....++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEEEE
Confidence            456788888899987     4668888853  223456789999999999642   245555555321    12568999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC------------------------------
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD------------------------------  401 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------  401 (789)
                      ||+++.++.+...            ..++..++..++.+++..|+.||..                              
T Consensus        93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            9999877765321            1134444555555555555555543                              


Q ss_pred             ---------------------------CCCCceecCCCCCceecCC---CCc-eeeCcccccccC
Q 041249          402 ---------------------------CQPITTHCDLKPSNILLDE---EMV-SHVGDFGLARFL  435 (789)
Q Consensus       402 ---------------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgla~~~  435 (789)
                                                 ..+.++|+|+++.||++++   ++. ..|+||+.+..-
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                       2334699999999999997   455 489999987653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.81  E-value=5.8e-06  Score=78.08  Aligned_cols=34  Identities=15%  Similarity=0.094  Sum_probs=15.0

Q ss_pred             CCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249          628 NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN  661 (789)
Q Consensus       628 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  661 (789)
                      +|+.||++++.|+..--..+.++++|+.|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            4555555555544322223334444444444444

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.65  E-value=0.00012  Score=74.97  Aligned_cols=136  Identities=18%  Similarity=0.081  Sum_probs=92.5

Q ss_pred             cccccCCc-cEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEEEeecc
Q 041249          277 LIGTGSFG-SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       277 ~ig~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      .+..|..+ .||+.....++..+++|+-...   ....+..|.+.++.+. +--+.++++++...+     ..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~-----~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD-----DAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-----EEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-----eEEEEEEee
Confidence            34445544 6999888767888999986432   3456788999988874 333667777776554     789999999


Q ss_pred             CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC---------------------------------
Q 041249          355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD---------------------------------  401 (789)
Q Consensus       355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~---------------------------------  401 (789)
                      ++.++.+.....              ......++.+++..|+-||..                                 
T Consensus       103 ~G~~~~~~~~~~--------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (272)
T 4gkh_A          103 PGKTAFQVLEEY--------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFD  168 (272)
T ss_dssp             CSEEHHHHHHHC--------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCC
T ss_pred             CCccccccccCC--------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcc
Confidence            987766543211              112234455555555555542                                 


Q ss_pred             ----------------------CCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          402 ----------------------CQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       402 ----------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                                            ..+.++|+|+.+.||+++++..+-|+||+.+..
T Consensus       169 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          169 DERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                  122369999999999999877778999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.59  E-value=2.2e-05  Score=74.13  Aligned_cols=87  Identities=9%  Similarity=0.076  Sum_probs=62.5

Q ss_pred             CCCCEEEccCCcCCccCCccccCCCCCCeeeccCcc-ccccCCccccCC----CCccEEEccCCc-ccccCCcccccCCC
Q 041249          675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR-LSGIVPSSIFNI----SSIAEFDVGENK-IQGNIPLDYGFTLQ  748 (789)
Q Consensus       675 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~ip~~~~~~l~  748 (789)
                      .+|+.|||+++.|+..--..+.++++|+.|+|+++. |++.--..+..+    ++|++|+|++|. |++.-=..+. .++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~-~~~  139 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALH-HFR  139 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGG-GCT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHh-cCC
Confidence            468999999998887666677888899999999884 775544555554    368888888875 7632112233 678


Q ss_pred             CccEEEccCCc-ccc
Q 041249          749 NLQYFSIGTNR-ITG  762 (789)
Q Consensus       749 ~L~~L~L~~N~-l~~  762 (789)
                      +|++|+|+++. +++
T Consensus       140 ~L~~L~L~~c~~Itd  154 (176)
T 3e4g_A          140 NLKYLFLSDLPGVKE  154 (176)
T ss_dssp             TCCEEEEESCTTCCC
T ss_pred             CCCEEECCCCCCCCc
Confidence            88888888875 653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.40  E-value=2.8e-05  Score=74.86  Aligned_cols=117  Identities=11%  Similarity=0.112  Sum_probs=72.9

Q ss_pred             ccCCCCCCEEEccCC-cCCC----CCcccccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEeccCCCCCCc---
Q 041249           41 LGLCESLTTIGLFNN-NLSG----TIPPQLMGLTSLVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGE---  108 (789)
Q Consensus        41 ~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~---  108 (789)
                      +..-+.|++|+|++| +|..    .+...+..-+.|+.|+|++|++..    .+...+..-+.|++|+|++|+|+..   
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344567777888774 7752    245566777788888888888762    2344455567788888888888732   


Q ss_pred             -CCccccCCcccccccccCCCCCccceeecCCcccCC----CchhhhcCcccccEEecccCCCC
Q 041249          109 -IPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSG----EIPEFLVGLKVIENLNLSYNDLE  167 (789)
Q Consensus       109 -~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~----~~p~~~~~~~~l~~l~ls~N~~~  167 (789)
                       +-.++..-+.|++|+|++|..          +.+..    .+-+.+..-++|+.|+++.|.+.
T Consensus       117 ala~aL~~N~tL~~L~L~n~~~----------~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQRQ----------SVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSS----------CCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHhhCCceeEEECCCCcC----------cCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence             223444444455555543321          02221    35567777778888999888763

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.37  E-value=6.3e-05  Score=72.37  Aligned_cols=111  Identities=11%  Similarity=0.068  Sum_probs=80.0

Q ss_pred             cCCccCCeEecCCC-cCCC----CCCccccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEEccCCcCCC----C
Q 041249           18 GNLKKLVEPYVSDN-FLKG----SIPSSLGLCESLTTIGLFNNNLSG----TIPPQLMGLTSLVALDLSRNQFRG----S   84 (789)
Q Consensus        18 ~~l~~l~~L~ls~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~   84 (789)
                      .+-+.|++|+|++| +|..    .+.+++..-+.|+.|+|++|+|+.    .+...+..-+.|++|+|++|+|+.    .
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            45678999999996 7763    355667777899999999999983    356667788999999999999984    2


Q ss_pred             CcccccCCCCCCEEeccCC---CCCC----cCCccccCCcccccccccCCC
Q 041249           85 FPTEVGNLINLETLTVSGN---ILQG----EIPSTLGSCIKLEILEMQGNV  128 (789)
Q Consensus        85 ~p~~~~~l~~L~~L~l~~N---~l~~----~~p~~~~~l~~L~~l~l~~N~  128 (789)
                      +-..+..-+.|++|+|++|   .+..    .+-..+..-+.|+.|+++.|.
T Consensus       118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence            4455777778999999976   3442    233444555555555554443

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.32  E-value=0.00053  Score=74.58  Aligned_cols=76  Identities=20%  Similarity=0.155  Sum_probs=48.6

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccc-------hhhHHHHHHHHHHhcCCC--Cccc-eeeeeeccCCCCCC
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-------RASRSFIAECRALRSIRH--RNLV-KVFTACSGVDYQGN  344 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~~  344 (789)
                      .+.+|.|..+.||++....+++.|+||.......       .....+..|.++++.+..  +..+ +++.+..  +    
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~--~----  108 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--E----  108 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--T----
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC--C----
Confidence            4578999999999998765678899998653211       123456778888887732  4444 4554422  1    


Q ss_pred             ceEEEEeeccCCC
Q 041249          345 DFKALVYEFMQNG  357 (789)
Q Consensus       345 ~~~~lv~e~~~~g  357 (789)
                       ..++|||++.+.
T Consensus       109 -~~~lvmE~l~g~  120 (397)
T 2olc_A          109 -MAVTVMEDLSHL  120 (397)
T ss_dssp             -TTEEEECCCTTS
T ss_pred             -ccEEEEEeCCCc
Confidence             357999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.26  E-value=0.00061  Score=72.88  Aligned_cols=84  Identities=7%  Similarity=-0.016  Sum_probs=54.7

Q ss_pred             Ccc-cccCCccEEEEEEc--C----CceEEEEEEecccc---chhhHHHHHHHHHHhcCC-C--CccceeeeeeccCCCC
Q 041249          276 NLI-GTGSFGSVYKGVLD--E----GRTTVTVKVFNLHH---HRASRSFIAECRALRSIR-H--RNLVKVFTACSGVDYQ  342 (789)
Q Consensus       276 ~~i-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~  342 (789)
                      +.| +.|....+|+....  .    +++.+++|......   ......+..|.++++.+. +  -.+.++++++......
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888999988753  1    15678899865432   111245778888888874 3  3466777776543211


Q ss_pred             CCceEEEEeeccCCCChhh
Q 041249          343 GNDFKALVYEFMQNGSLEE  361 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~  361 (789)
                        ...++||||+++..+.+
T Consensus       106 --g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 --GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             --SSCEEEEECCCCBCCCB
T ss_pred             --CCceEEEEecCCCChhh
Confidence              24589999999876654

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.07  E-value=0.00067  Score=60.91  Aligned_cols=56  Identities=18%  Similarity=0.282  Sum_probs=35.9

Q ss_pred             EEEccCCcCC-ccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          679 KISLAINNLA-GSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       679 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            6667777765 24454433  25677777777777555666667777777777777664

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.06  E-value=0.00076  Score=60.53  Aligned_cols=57  Identities=18%  Similarity=0.248  Sum_probs=46.8

Q ss_pred             CeeeccCcccc-ccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249          702 VILYLGVNRLS-GIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       702 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  761 (789)
                      ..++.+++.++ ..+|..+.  ++|+.|+|++|+|+ .+|..+|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            47899999987 34565432  36999999999998 899998888999999999999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.71  E-value=0.009  Score=63.02  Aligned_cols=44  Identities=27%  Similarity=0.216  Sum_probs=34.1

Q ss_pred             HHHHHhhhhc----------CCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          391 VASALDYLHH----------DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       391 ia~gL~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                      +..++.+|+.          .....++|||+.+.||+++.+..+.++||+.+..
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4445666663          1245699999999999998888999999987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.65  E-value=0.0076  Score=62.79  Aligned_cols=76  Identities=17%  Similarity=0.126  Sum_probs=57.2

Q ss_pred             CCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC---CCccceeeeeeccCCCCCCceEEEE
Q 041249          274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR---HRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      ..+.|+.|....+|+...  ++..+++|+....   ....+..|.+.++.+.   ...+.++++.+....     ..++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g-----~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG-----HSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS-----EEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC-----ceEEE
Confidence            345789999999999876  3678889987532   3567888999888883   356777777765433     68999


Q ss_pred             eeccCCCCh
Q 041249          351 YEFMQNGSL  359 (789)
Q Consensus       351 ~e~~~~g~L  359 (789)
                      |||+++..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.62  E-value=0.0044  Score=63.89  Aligned_cols=78  Identities=17%  Similarity=0.103  Sum_probs=56.8

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCC---ccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHR---NLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~  347 (789)
                      .....+.+|.|..+.||+.+.. +|+.|++|+...........+..|.+.|+.+.-.   -+.+++++.         ..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence            3445667899999999999987 7889999987655545556789999999888422   244445442         23


Q ss_pred             EEEeeccCCCC
Q 041249          348 ALVYEFMQNGS  358 (789)
Q Consensus       348 ~lv~e~~~~g~  358 (789)
                      ++||||+..+.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            78999988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.43  E-value=0.0054  Score=63.72  Aligned_cols=71  Identities=10%  Similarity=0.090  Sum_probs=43.3

Q ss_pred             CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcc-ceeeeeeccCCCCCCceEEEE
Q 041249          272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL-VKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv  350 (789)
                      +...+.|+.|....+|+.      ..+++|+....... ......|.+.++.+...++ .++++.+.+       ..+++
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v   85 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMV   85 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEE
Confidence            444678888999999998      45888887543211 1123567777776632222 455555432       24689


Q ss_pred             eecc-CC
Q 041249          351 YEFM-QN  356 (789)
Q Consensus       351 ~e~~-~~  356 (789)
                      +||+ ++
T Consensus        86 ~e~i~~g   92 (301)
T 3dxq_A           86 TRYIAGA   92 (301)
T ss_dssp             EECCTTC
T ss_pred             EeecCCC
Confidence            9999 44

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.08  E-value=0.018  Score=62.91  Aligned_cols=80  Identities=10%  Similarity=0.060  Sum_probs=45.6

Q ss_pred             CCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC---CcCccccchhhHHHHHH
Q 041249          403 QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS---EVSTNGDVYSYGILMLE  479 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~sfGvvl~e  479 (789)
                      .+.++|||+++.||+++++. ++++||+.+..-++...-.... ..-...|++|+.....   ......++++....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            45599999999999998776 9999999887643221100000 0001234555544311   11223445566666776


Q ss_pred             HHHhc
Q 041249          480 LIIRK  484 (789)
Q Consensus       480 lltG~  484 (789)
                      ..+++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            65543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.45  E-value=0.037  Score=59.21  Aligned_cols=150  Identities=11%  Similarity=0.144  Sum_probs=82.5

Q ss_pred             CCcccccCCccEEEEEEcC-------CceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249          275 ANLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  346 (789)
                      .+.+..|-...+|+.....       .++.+++|+.-.. ......+.+|.++++.+. +.-..++++.+..        
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence            3456678888999998752       3578999986322 223455668989888874 3223566666532        


Q ss_pred             EEEEeeccCCCChhhh-ccCC----------CCCccc-cCCCCCCC--HHHHHHHHHHHHH-------------------
Q 041249          347 KALVYEFMQNGSLEEW-LYPV----------NREDEV-DKAPRNLN--LLQRLNIAIDVAS-------------------  393 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~-l~~~----------~~~~~~-~~~~~~l~--~~~~~~i~~~ia~-------------------  393 (789)
                       .+|+||+++.++..- +...          .+.... ...++...  |.++.++..++..                   
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             389999997554321 0000          000000 00112222  3445555544322                   


Q ss_pred             HHhh----hhcC-CCCCceecCCCCCceecCCC----CceeeCccccccc
Q 041249          394 ALDY----LHHD-CQPITTHCDLKPSNILLDEE----MVSHVGDFGLARF  434 (789)
Q Consensus       394 gL~~----LH~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~  434 (789)
                      .+.+    |... ....++|+|+.+.||+++++    ..+.++||..+..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            1222    2222 23458999999999999876    6889999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.39  E-value=0.055  Score=59.48  Aligned_cols=75  Identities=13%  Similarity=0.155  Sum_probs=47.4

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcc-ceeeeeeccCCCCCCceEEEEeec
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL-VKVFTACSGVDYQGNDFKALVYEF  353 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~  353 (789)
                      .+.|+.|-...+|+......+..+++|+........ -....|.++++.+...++ .++++.+.  .       .+|+||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N-------GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEEEe
Confidence            346777888999999886435889999874332111 123678888888864444 45666652  1       259999


Q ss_pred             cCCCCh
Q 041249          354 MQNGSL  359 (789)
Q Consensus       354 ~~~g~L  359 (789)
                      +++.++
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            986443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.33  E-value=0.029  Score=61.34  Aligned_cols=72  Identities=19%  Similarity=0.291  Sum_probs=47.6

Q ss_pred             CcccccCCccEEEEEEcC-------CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcc-ceeeeeeccCCCCCCceE
Q 041249          276 NLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL-VKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~  347 (789)
                      +.|+.|....+|+.....       .++.+++|+.....  ....+..|.++++.+...++ .++++.+..         
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---------  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG---------  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---------
Confidence            457778889999998753       25789999984321  11455678888888843333 556665431         


Q ss_pred             EEEeeccCCCC
Q 041249          348 ALVYEFMQNGS  358 (789)
Q Consensus       348 ~lv~e~~~~g~  358 (789)
                      .+|+||+++.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            38999997533

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.05  E-value=0.11  Score=54.61  Aligned_cols=33  Identities=27%  Similarity=0.236  Sum_probs=27.9

Q ss_pred             CCCceecCCCCCceecCCC----CceeeCcccccccC
Q 041249          403 QPITTHCDLKPSNILLDEE----MVSHVGDFGLARFL  435 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~~  435 (789)
                      ...++|||+.+.||+++++    ..+.++||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4569999999999999875    67899999987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.73  E-value=0.051  Score=56.68  Aligned_cols=171  Identities=13%  Similarity=0.081  Sum_probs=83.6

Q ss_pred             ccHHHHHHhhcCCCC-----CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCc--ccee
Q 041249          260 LSYQNLHNATDGFSS-----ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRN--LVKV  332 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~-----~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l  332 (789)
                      ++.+++...-..|..     .+.|+.|....+|+.... + ..+++|.....  .....+..|++++..+....  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-C-ccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            444555554444554     234666777899998875 3 36888987642  12234566777777663222  2333


Q ss_pred             eeeeccCCC-CCCceEEEEeeccCCCChhh--------------hccCCCCC--ccccCCCCCCCHHHHHH---------
Q 041249          333 FTACSGVDY-QGNDFKALVYEFMQNGSLEE--------------WLYPVNRE--DEVDKAPRNLNLLQRLN---------  386 (789)
Q Consensus       333 ~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~--~~~~~~~~~l~~~~~~~---------  386 (789)
                      +........ .-....+++++|+++..+..              .++.....  ...........|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            322110000 00124689999998754321              01100000  00000000011221100         


Q ss_pred             ---HHHHHHHHHhhhhc----CCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          387 ---IAIDVASALDYLHH----DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       387 ---i~~~ia~gL~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                         +...+...+++++.    .....++|+|+.+.||+++++..+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               00113334444442    1234589999999999999876668999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=94.48  E-value=0.056  Score=57.73  Aligned_cols=73  Identities=15%  Similarity=0.252  Sum_probs=42.8

Q ss_pred             CcccccCCccEEEEEEcCC--------ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCc-cceeeeeeccCCCCCCce
Q 041249          276 NLIGTGSFGSVYKGVLDEG--------RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRN-LVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~  346 (789)
                      +.++.|....+|+.....+        ++.+++|+....... ......|.++++.+...+ ..++++...         
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~---------  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN---------  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC---------
Confidence            4567788889999987531        268899987543221 112467788887774333 345565431         


Q ss_pred             EEEEeeccCCCC
Q 041249          347 KALVYEFMQNGS  358 (789)
Q Consensus       347 ~~lv~e~~~~g~  358 (789)
                      .++|+||+++..
T Consensus       109 ~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 GGRIEEWLYGDP  120 (369)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CcEEEEEecCCc
Confidence            268999998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.91  E-value=0.62  Score=48.38  Aligned_cols=79  Identities=11%  Similarity=0.137  Sum_probs=46.7

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCc--cceeeeeeccCCC-CCCceEEEEee
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRN--LVKVFTACSGVDY-QGNDFKALVYE  352 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~-~~~~~~~lv~e  352 (789)
                      ..++ |....||+.... +|+.+++|...... .....+..|.+++..+....  +.+++.. ..... ......++++|
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEE
Confidence            3466 778899988765 46679999986332 12345667888777773222  3444443 11100 00125678999


Q ss_pred             ccCCCC
Q 041249          353 FMQNGS  358 (789)
Q Consensus       353 ~~~~g~  358 (789)
                      |+++..
T Consensus       108 ~i~G~~  113 (328)
T 1zyl_A          108 SVGGRQ  113 (328)
T ss_dssp             CCCCEE
T ss_pred             ecCCCC
Confidence            998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.28  E-value=0.43  Score=50.09  Aligned_cols=33  Identities=18%  Similarity=0.289  Sum_probs=28.3

Q ss_pred             CCCceecCCCCCceecCCCCceeeCcccccccC
Q 041249          403 QPITTHCDLKPSNILLDEEMVSHVGDFGLARFL  435 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  435 (789)
                      ...++|+|+.+.||++++++.+.++||+.+..-
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            445999999999999998888999999876653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=89.97  E-value=0.32  Score=52.70  Aligned_cols=74  Identities=11%  Similarity=0.150  Sum_probs=46.6

Q ss_pred             CcccccCCccEEEEEEcCC-------ceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249          276 NLIGTGSFGSVYKGVLDEG-------RTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.+..|-...+|+......       ++.+++|+..... ...-...+|.++++.+. +.-..++++.+.         .
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---------~  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP---------E  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET---------T
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC---------C
Confidence            4566677889999987621       5789999864332 11223467888887774 222345555432         2


Q ss_pred             EEEeeccCCCCh
Q 041249          348 ALVYEFMQNGSL  359 (789)
Q Consensus       348 ~lv~e~~~~g~L  359 (789)
                      +.|+||+++.++
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.39  E-value=0.4  Score=33.03  Aligned_cols=30  Identities=17%  Similarity=0.186  Sum_probs=17.8

Q ss_pred             EeehhhHHHHHHHHHHHHHHHHHHHhcccC
Q 041249          218 LVIAIVSGLMGLALTLSISFLCWVRKRKEQ  247 (789)
Q Consensus       218 ~~v~~~~~~~~v~~~~~~~~~~~~~~~k~~  247 (789)
                      ++.++++++..+++++.+++++|+|+++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            345555556666666666666777665543

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=86.96  E-value=0.47  Score=32.77  Aligned_cols=29  Identities=17%  Similarity=0.071  Sum_probs=17.6

Q ss_pred             EeehhhHHHHHHHHHHHHHHHHHHHhccc
Q 041249          218 LVIAIVSGLMGLALTLSISFLCWVRKRKE  246 (789)
Q Consensus       218 ~~v~~~~~~~~v~~~~~~~~~~~~~~~k~  246 (789)
                      +++++++++..+++++++++++|+|++.+
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            45555666666666666666666666543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=86.00  E-value=0.96  Score=43.63  Aligned_cols=103  Identities=18%  Similarity=0.147  Sum_probs=65.5

Q ss_pred             ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCC
Q 041249          358 SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP  437 (789)
Q Consensus       358 ~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  437 (789)
                      +|.+.|..         .+.++++.++..++.|.+.+|.-.-....+  ..+=+.|..|++..+|.+...+ ..+.    
T Consensus        34 SL~eIL~~---------~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           34 SLEEILRL---------YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             cHHHHHHH---------cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----
Confidence            68888754         367899999999999999998876211101  1223356888888888887654 1110    


Q ss_pred             CCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249          438 THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS  487 (789)
Q Consensus       438 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~  487 (789)
                                .....+.|||... ...+.+.=|||+|+++|.-+--..|-
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                      1223466888763 34578899999999999988744443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.89  E-value=3.8  Score=39.40  Aligned_cols=88  Identities=16%  Similarity=0.247  Sum_probs=65.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCc
Q 041249          377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAP  456 (789)
Q Consensus       377 ~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP  456 (789)
                      +.++...+++++..|+....++++     -+|--+.|+|++++.++.+++.-.|+-..++|..                 
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~~-----------------  133 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQNVVDPLP-----------------  133 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEETTTBSCCC-----------------
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCccCCCCCC-----------------
Confidence            356788999999999998877764     3688899999999999999999888755544332                 


Q ss_pred             ccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          457 EYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       457 E~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                             .++..=.-.+=+++..+++++..|+....+
T Consensus       134 -------~~ee~fL~qyKAliiall~~K~~Fe~l~~G  163 (215)
T 4ann_A          134 -------VSEAEFLTRYKALVICAFNEKQSFDALVEG  163 (215)
T ss_dssp             -------CCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred             -------CCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence                   111112335667888899999999765443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	789
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-40
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-37
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-34
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-33
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-31
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	7e-08
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-50
 Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 30/255 (11%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
             IG+GSFG+VYKG        V VK+ N+        ++F  E   LR  RH N++   
Sbjct: 14  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
              +          A+V ++ +  SL   L+                +++ ++IA   A 
Sbjct: 71  GYSTA------PQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQ 115

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
            +DYLH   + I  H DLK +NI L E++   +GDFGLA              + GSI +
Sbjct: 116 GMDYLH--AKSII-HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 454 IAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM 510
           +APE     +    S   DVY++GI++ EL+  + P    +    N      M    ++ 
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYLS 228

Query: 511 DIVDSTLLNDVEDLA 525
             +     N  + + 
Sbjct: 229 PDLSKVRSNCPKAMK 243

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 5e-48
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 22/220 (10%)

Query: 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS-FIAECRALRSIRH 326
             D F   + +G G+ G V+K         +  K+ +L    A R+  I E + L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             +V  + A        +   ++  E M  GSL++ L    R          +       
Sbjct: 64  PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGR----------IPEQILGK 108

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
           ++I V   L YL    + +  H D+KPSNIL++      + DFG++  L  +   +    
Sbjct: 109 VSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 162

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486
             G+  Y++PE   G+  S   D++S G+ ++E+ + + P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 6e-47
 Identities = 57/239 (23%), Positives = 105/239 (43%), Gaps = 23/239 (9%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             +G G FG V+ G  +     V VK        +  +F+AE   ++ ++H+ LV+++  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTK-VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            +       +   ++ E+M+NGSL ++L           +   L + + L++A  +A  +
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            ++         H DL+ +NIL+ + +   + DFGLAR +          G K  I + A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD---MNLHNFARMALPDHVMD 511
           PE       +   DV+S+GIL+ E++   +             NL    RM  PD+  +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 3e-46
 Identities = 64/286 (22%), Positives = 117/286 (40%), Gaps = 40/286 (13%)

Query: 261 SYQNLHNATDGFSSA---------NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHH 308
           ++++ + A   F+            +IG G FG V  G L    +    V +K     + 
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 309 -RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN 367
            +  R F++E   +    H N++ +           +    ++ EFM+NGSL+ +L    
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLR--- 119

Query: 368 REDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427
                 +      ++Q + +   +A+ + YL         H DL   NIL++  +V  V 
Sbjct: 120 ------QNDGQFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVS 170

Query: 428 DFGLARFLPP---THVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK 484
           DFGL+RFL         TS++G K  I + APE     + ++  DV+SYGI+M E++   
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 485 KP-------SDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
           +         D++   + +      M  P  +  ++      D   
Sbjct: 231 ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 7e-46
 Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 24/251 (9%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTA 335
           IG GSF +VYKG+  E    V            S  + F  E   L+ ++H N+V+ + +
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +G     LV E M +G+L+ +L          K  + + +    +    +   L
Sbjct: 77  WESTV-KGKKCIVLVTELMTSGTLKTYL----------KRFKVMKIKVLRSWCRQILKGL 125

Query: 396 DYLHHDCQPITTHCDLKPSNILL-DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
            +LH    PI  H DLK  NI +        +GD GLA     +  +     V G+  ++
Sbjct: 126 QFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 180

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD 514
           APE     +   + DVY++G+ MLE+   + P    +    N     R           D
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFD 235

Query: 515 STLLNDVEDLA 525
              + +V+++ 
Sbjct: 236 KVAIPEVKEII 246

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 8e-45
 Identities = 56/264 (21%), Positives = 99/264 (37%), Gaps = 21/264 (7%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHR 327
           + +     IGTGS+G   K         +  K  +      +  +  ++E   LR ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+V+ +        + N    +V E+ + G L   +    +E +       L+    L +
Sbjct: 64  NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQY------LDEEFVLRV 114

Query: 388 AIDVASALDYLH--HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
              +  AL   H   D      H DLKP+N+ LD +    +GDFGLAR L        + 
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA- 173

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM--NLHNFARM 503
              G+  Y++PE       +   D++S G L+ EL     P     + ++   +      
Sbjct: 174 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232

Query: 504 ALPDHV----MDIVDSTLLNDVED 523
            +P        +I+   L      
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYH 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-43
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 29/250 (11%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             IG G FG V  G        V VK   + +   +++F+AE   +  +RH NLV++   
Sbjct: 13  QTIGKGEFGDVMLGDYRG--NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                 +      +V E+M  GSL ++L          +    L     L  ++DV  A+
Sbjct: 69  I----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 116

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YL  +      H DL   N+L+ E+ V+ V DFGL +    T         K  + + A
Sbjct: 117 EYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTA 168

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDS 515
           PE     + ST  DV+S+GIL+ E+    +         + L +        + MD  D 
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPDG 224

Query: 516 TLLNDVEDLA 525
                V ++ 
Sbjct: 225 -CPPAVYEVM 233

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 4e-43
 Identities = 53/253 (20%), Positives = 95/253 (37%), Gaps = 32/253 (12%)

Query: 268 ATDGFSSANL-IGTGSFGSVYKGVL--DEGRTTVTVKVFNLHHHRASR-SFIAECRALRS 323
             D    A++ +G G+FGSV +GV    + +  V +KV      +A     + E + +  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
           + +  +V++   C            LV E    G L ++L               + +  
Sbjct: 66  LDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV---------GKREEIPVSN 110

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-T 442
              +   V+  + YL    +    H DL   N+LL     + + DFGL++ L       T
Sbjct: 111 VAELLHQVSMGMKYLE--EKNFV-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167

Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD------MN 496
           +    K  + + APE     + S+  DV+SYG+ M E +   +     ++          
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAF 224

Query: 497 LHNFARMALPDHV 509
           +    RM  P   
Sbjct: 225 IEQGKRMECPPEC 237

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-42
 Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 27/255 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             +G G FG V+ G  +     V +K        +  +F+ E + ++ +RH  LV+++  
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTR-VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
            S       +   +V E+M  GSL ++L          +  + L L Q +++A  +AS +
Sbjct: 81  VS------EEPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIASGM 126

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            Y+         H DL+ +NIL+ E +V  V DFGLAR +          G K  I + A
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTA 182

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKP-------SDIMFEGDMNLHNFARMALPDH 508
           PE  L    +   DV+S+GIL+ EL  + +         +++ + +           P+ 
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242

Query: 509 VMDIVDSTLLNDVED 523
           + D++      + E+
Sbjct: 243 LHDLMCQCWRKEPEE 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (391), Expect = 1e-42
 Identities = 62/280 (22%), Positives = 104/280 (37%), Gaps = 37/280 (13%)

Query: 258 LNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR 312
           LN    +L    +       IG G+FG V++         E  T V VK+         +
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 313 S-FIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLY------- 364
           + F  E   +    + N+VK+   C            L++E+M  G L E+L        
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115

Query: 365 -------PVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417
                     R       P  L+  ++L IA  VA+ + YL         H DL   N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCL 172

Query: 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILM 477
           + E MV  + DFGL+R +       +       I ++ PE    +  +T  DV++YG+++
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232

Query: 478 LELIIRKKPSDIMFEGD------MNLHNFARMALPDHVMD 511
            E+          + G         + +   +A P++   
Sbjct: 233 WEIFSYGLQ---PYYGMAHEEVIYYVRDGNILACPENCPL 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-42
 Identities = 53/242 (21%), Positives = 94/242 (38%), Gaps = 27/242 (11%)

Query: 276 NLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVK 331
             +G+G+FG+V KG     +   TV VK+     +  +     +AE   ++ + +  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C        +   LV E  + G L ++L             R++     + +   V
Sbjct: 73  MIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQV 116

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           +  + YL         H DL   N+LL  +  + + DFGL++ L        +    K  
Sbjct: 117 SMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP---SDIMFEGDMNLHNFARMALPD 507
           + + APE     + S+  DV+S+G+LM E     +         E    L    RM  P 
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233

Query: 508 HV 509
             
Sbjct: 234 GC 235

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 8e-42
 Identities = 62/295 (21%), Positives = 109/295 (36%), Gaps = 36/295 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTT-----VTVKVFNLHHHRASR-SFIAECRALRSI-RHRNL 329
           ++G+G+FG V          T     V VK+       + R + ++E + +  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL-------------YPVNREDEVDKAP 376
           V +  AC       +    L++E+   G L  +L             Y   +  E ++  
Sbjct: 104 VNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 377 RNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436
             L     L  A  VA  +++L    +    H DL   N+L+    V  + DFGLAR + 
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF--KSCV-HRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN 496
                      +  + ++APE       +   DV+SYGIL+ E+          + G   
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPV 272

Query: 497 LHNFARMALPDHVMDIVDSTLLNDVEDLA---IISNQRQRQIRVNNIIECLISML 548
             NF ++      MD        ++  +       + R+R     N+   L   L
Sbjct: 273 DANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKR-PSFPNLTSFLGCQL 325

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 9e-42
 Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 27/233 (11%)

Query: 262 YQNLH---NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAEC 318
           Y+++    N  D +     +G G+FG VYK    E       KV +         ++ E 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRN 378
             L S  H N+VK+  A         +   ++ EF   G+++  +          +  R 
Sbjct: 61  DILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVML---------ELERP 106

Query: 379 LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438
           L   Q   +      AL+YLH     I  H DLK  NIL   +    + DFG++     T
Sbjct: 107 LTESQIQVVCKQTLDALNYLHD--NKI-IHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

Query: 439 HVQTSSIGVKGSIGYIAPEY-----GLGSEVSTNGDVYSYGILMLELIIRKKP 486
             +  S    G+  ++APE                DV+S GI ++E+   + P
Sbjct: 164 IQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 54/266 (20%), Positives = 104/266 (39%), Gaps = 38/266 (14%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRH 326
           + F     +G G FG+VY     + +  + +KV     L           E      +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N+++++               L+ E+   G++   L  +++ DE           +   
Sbjct: 66  PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQ----------RTAT 110

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
              ++A+AL Y H   + +  H D+KP N+LL       + DFG +   P +   T    
Sbjct: 111 YITELANALSYCHS--KRVI-HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---- 163

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA-- 504
           + G++ Y+ PE   G       D++S G+L  E ++ K P    FE +     + R++  
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRV 219

Query: 505 -------LPDHVMDIVDSTLLNDVED 523
                  + +   D++   L ++   
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQ 245

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 6e-41
 Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 28/246 (11%)

Query: 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACS 337
           IG G FG V++G        V VK+F+    R S    AE      +RH N++    A +
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397
             +        LV ++ ++GSL ++L               + +   + +A+  AS L +
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAH 115

Query: 398 LHHDC-----QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQTSSIGVKGS 450
           LH +      +P   H DLK  NIL+ +     + D GLA         +  +     G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 451 IGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
             Y+APE    S      E     D+Y+ G++  E+  R     I  +  +  ++     
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 505 LPDHVM 510
                M
Sbjct: 236 PSVEEM 241

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 8e-41
 Identities = 66/255 (25%), Positives = 102/255 (40%), Gaps = 27/255 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             IG+G FG V+ G        V +K        +   FI E   +  + H  LV+++  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDK-VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C            LV+EFM++G L ++L         +           L + +DV   +
Sbjct: 69  C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGM 114

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
            YL   C     H DL   N L+ E  V  V DFG+ RF+      TSS G K  + + +
Sbjct: 115 AYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWAS 170

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKP-------SDIMFEGDMNLHNFARMALPDH 508
           PE    S  S+  DV+S+G+LM E+    K        S+++ +       +       H
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230

Query: 509 VMDIVDSTLLNDVED 523
           V  I++       ED
Sbjct: 231 VYQIMNHCWKERPED 245

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 51/252 (20%), Positives = 95/252 (37%), Gaps = 20/252 (7%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRN 328
           + +     +G G++G V   V       V VK+ ++        +   E    + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           +VK +        +  + + L  E+   G L + +          +    +         
Sbjct: 65  VVKFYGHR-----REGNIQYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFF 109

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVK 448
             + + + YLH       TH D+KP N+LLDE     + DFGLA      + +     + 
Sbjct: 110 HQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166

Query: 449 GSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507
           G++ Y+APE     E      DV+S GI++  ++  + P D   +      ++       
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226

Query: 508 HVMDIVDSTLLN 519
           +    +DS  L 
Sbjct: 227 NPWKKIDSAPLA 238

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 62/258 (24%), Positives = 106/258 (41%), Gaps = 33/258 (12%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             +GTG FG V  G        V +K+       +   FI E + + ++ H  LV+++  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C            ++ E+M NG L  +L  +                Q L +  DV  A+
Sbjct: 68  C-----TKQRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAM 113

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YL         H DL   N L++++ V  V DFGL+R++      TSS+G K  + +  
Sbjct: 114 EYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSP 169

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA----------L 505
           PE  + S+ S+  D++++G+LM E+    K     +E   N      +A           
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFTNSETAEHIAQGLRLYRPHLA 226

Query: 506 PDHVMDIVDSTLLNDVED 523
            + V  I+ S      ++
Sbjct: 227 SEKVYTIMYSCWHEKADE 244

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (373), Expect = 3e-40
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 23/250 (9%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
           + +G G +G VY+GV  +   TV VK            F+ E   ++ I+H NLV++   
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
           C            ++ EFM  G+L ++L   NR        + ++ +  L +A  ++SA+
Sbjct: 82  C-----TREPPFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAM 128

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           +YL    +    H DL   N L+ E  +  V DFGL+R +        + G K  I + A
Sbjct: 129 EYLEK--KNFI-HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTA 184

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDS 515
           PE    ++ S   DV+++G+L+ E+              ++L     +   D+ M+  + 
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYRMERPEG 240

Query: 516 TLLNDVEDLA 525
                V +L 
Sbjct: 241 -CPEKVYELM 249

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (374), Expect = 3e-40
 Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 30/224 (13%)

Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIR 325
              FS    IG GSFG+VY          V +K  +      +   +  I E R L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N ++                 LV E+    + +                + L  ++  
Sbjct: 74  HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLE----------VHKKPLQEVEIA 118

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
            +       L YLH     +  H D+K  NILL E  +  +GDFG A  + P +      
Sbjct: 119 AVTHGALQGLAYLHS--HNMI-HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----- 170

Query: 446 GVKGSIGYIAPEYGLGSEVSTNG---DVYSYGILMLELIIRKKP 486
              G+  ++APE  L  +        DV+S GI  +EL  RK P
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 4e-40
 Identities = 57/249 (22%), Positives = 96/249 (38%), Gaps = 33/249 (13%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTT---VTVKVFN-LHHHRASRSFIAECRALRSIRHRNLVK 331
            +IG G FG VY G L +         VK  N +        F+ E   ++   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           +   C     +      +V  +M++G L  ++              N  +   +   + V
Sbjct: 93  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQV 139

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ--TSSIGVKG 449
           A  +            H DL   N +LDE+    V DFGLAR +         +  G K 
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA-------R 502
            + ++A E     + +T  DV+S+G+L+ EL+ R  P       D+N  +         R
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRR 252

Query: 503 MALPDHVMD 511
           +  P++  D
Sbjct: 253 LLQPEYCPD 261

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 63/286 (22%), Positives = 122/286 (42%), Gaps = 30/286 (10%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEG----RTTVTVKVFNLHHHRASR-SFIAECRALRSIRH 326
            +   +IG G FG VYKG+L          V +K     +    R  F+ E   +    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
            N++++                ++ E+M+NG+L+++         + +     ++LQ + 
Sbjct: 69  HNIIRLEGVI-----SKYKPMMIITEYMENGALDKF---------LREKDGEFSVLQLVG 114

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT-SSI 445
           +   +A+ + YL +       H DL   NIL++  +V  V DFGL+R L      T ++ 
Sbjct: 115 MLRGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505
           G K  I + APE     + ++  DV+S+GI+M E++   +        +++ H   +   
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMKAIN 227

Query: 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIR--VNNIIECLISMLR 549
               +        + +  L +   Q++R  R    +I+  L  ++R
Sbjct: 228 DGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-39
 Identities = 56/260 (21%), Positives = 99/260 (38%), Gaps = 37/260 (14%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335
             IG G+ G+VY  +       V ++  NL         I E   +R  ++ N+V    +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
                    D   +V E++  GSL + +     ++            Q   +  +   AL
Sbjct: 86  Y-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG-----------QIAAVCRECLQAL 129

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455
           ++LH     +  H D+K  NILL  +    + DFG    + P   + S++   G+  ++A
Sbjct: 130 EFLHS--NQV-IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMA 184

Query: 456 PEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA----------- 504
           PE           D++S GI+ +E+I  + P    +  +  L     +A           
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPE 240

Query: 505 -LPDHVMDIVDSTLLNDVED 523
            L     D ++  L  DVE 
Sbjct: 241 KLSAIFRDFLNRCLDMDVEK 260

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 52/266 (19%), Positives = 93/266 (34%), Gaps = 34/266 (12%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           + F    ++G GSF +V             +K+    H            E   +  + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
              VK++        Q ++       + +NG L +++  +   DE               
Sbjct: 68  PFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------------- 109

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
                A  +  L +       H DLKP NILL+E+M   + DFG A+ L P   Q  +  
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA-- 504
             G+  Y++PE         + D+++ G ++ +L+    P    F        F ++   
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKL 225

Query: 505 -------LPDHVMDIVDSTLLNDVED 523
                        D+V+  L+ D   
Sbjct: 226 EYDFPEKFFPKARDLVEKLLVLDATK 251

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-39
 Identities = 57/255 (22%), Positives = 93/255 (36%), Gaps = 27/255 (10%)

Query: 276 NLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHHHRASR-SFIAECRALRSI-RHRN 328
             +G G+FG V +         +   TV VK+     H   R + ++E + L  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--------YPVNREDEVDKAPRNLN 380
           +V +  AC            ++ E+   G L  +L                ++     L+
Sbjct: 89  IVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
           L   L+ +  VA  + +L         H DL   NILL    ++ + DFGLAR +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
                  +  + ++APE       +   DV+SYGI + EL             D   +  
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 501 A----RMALPDHVMD 511
                RM  P+H   
Sbjct: 261 IKEGFRMLSPEHAPA 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  145 bits (367), Expect = 7e-39
 Identities = 57/258 (22%), Positives = 97/258 (37%), Gaps = 31/258 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +GTG+FG V++            K     H     +   E + +  +RH  LV +  A 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                + ++   ++YEFM  G L E +               ++  + +     V   L 
Sbjct: 93  -----EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLC 138

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           ++H +      H DLKP NI+   +  + +   DFGL   L P   + S     G+  + 
Sbjct: 139 HMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFA 192

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKP------SDIMF---EGDMNLHNFARMAL 505
           APE   G  V    D++S G+L   L+    P       + +      D N+ + A   +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 506 PDHVMDIVDSTLLNDVED 523
            +   D +   LL D   
Sbjct: 253 SEDGKDFIRKLLLADPNT 270

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 56/291 (19%), Positives = 108/291 (37%), Gaps = 33/291 (11%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKV-----FNLHHHRASRSFIAECRAL 321
             T+ F    ++G+G+FG+VYKG+       V + V           +A++  + E   +
Sbjct: 7   KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 322 RSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNL 381
            S+ + ++ ++   C            L+ + M  G L +++          +   N+  
Sbjct: 66  ASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVR---------EHKDNIGS 110

Query: 382 LQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441
              LN  + +A  ++YL         H DL   N+L+       + DFGLA+ L     +
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

Query: 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501
             + G K  I ++A E  L    +   DV+SYG+ + EL+             +     +
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEIS 223

Query: 502 RMALPDHVMDIVDSTLLNDVEDLA---IISNQRQRQIRVNNIIECLISMLR 549
            +      +         DV  +     + +   R  +   +I     M R
Sbjct: 224 SILEKGERLPQ-PPICTIDVYMIMVKCWMIDADSR-PKFRELIIEFSKMAR 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 26/266 (9%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS---RSFIAECRALRSI-R 325
           +     ++IG G+FG V K  + +    +   +  +  + +    R F  E   L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNL 379
           H N++ +  AC     +   +  L  E+  +G+L ++L      +        +     L
Sbjct: 70  HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +  Q L+ A DVA  +DYL    +    H DL   NIL+ E  V+ + DFGL+R      
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499
            +T     +  + ++A E    S  +TN DV+SYG+L+ E++             M    
Sbjct: 182 KKTM---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAE 234

Query: 500 FARMALPDHVMDIVDSTLLNDVEDLA 525
                   + ++   +   ++V DL 
Sbjct: 235 LYEKLPQGYRLEKPLN-CDDEVYDLM 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 52/256 (20%), Positives = 103/256 (40%), Gaps = 19/256 (7%)

Query: 276 NLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNL 329
             +G GSFG VY+GV      DE  T V +K  N     R    F+ E   ++     ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++                ++ E M  G L+ +L  +      +      +L + + +A 
Sbjct: 86  VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           ++A  + YL+        H DL   N ++ E+    +GDFG+ R +  T           
Sbjct: 141 EIADGMAYLNA--NKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509
            + +++PE       +T  DV+S+G+++ E+    +         ++     R  +   +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLRFVMEGGL 253

Query: 510 MDIVDSTLLNDVEDLA 525
           +D  D+   + + +L 
Sbjct: 254 LDKPDN-CPDMLFELM 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 6e-37
 Identities = 49/240 (20%), Positives = 97/240 (40%), Gaps = 26/240 (10%)

Query: 277 LIGTGSFGSVYKGVL-DEGRTTVTVKVFNLHHHRAS---RSFIAECRALRSIRHRNLVKV 332
            IG G FG V++G+        + V +    +  +      F+ E   +R   H ++VK+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
               +       +   ++ E    G L  +L              +L+L   +  A  ++
Sbjct: 74  IGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLS 118

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
           +AL YL         H D+   N+L+       +GDFGL+R++  +    +S G    I 
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LPIK 174

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD---MNLHNFARMALPDHV 509
           ++APE       ++  DV+ +G+ M E+++         + +     + N  R+ +P + 
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 6e-37
 Identities = 59/255 (23%), Positives = 91/255 (35%), Gaps = 29/255 (11%)

Query: 278 IGTGSFGSVYKGVLDEG---RTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVK 331
           +G GSFG V +G  D       +V VK      L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391
           ++               +V E    GSL + L          K   +  L      A+ V
Sbjct: 76  LYGVVL------TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQV 120

Query: 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ-TSSIGVKGS 450
           A  + YL         H DL   N+LL    +  +GDFGL R LP            K  
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 451 IGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM 510
             + APE       S   D + +G+ + E+    +     + G        ++      +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGERL 234

Query: 511 DIVDSTLLNDVEDLA 525
              +     D+ ++ 
Sbjct: 235 PRPED-CPQDIYNVM 248

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  137 bits (346), Expect = 5e-36
 Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 26/229 (11%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +G+G+FG V++ V          K  N  +     +   E   +  + H  L+ +  A 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                +      L+ EF+  G L + +               ++  + +N        L 
Sbjct: 96  -----EDKYEMVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLK 141

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           ++H     I  H D+KP NI+ + +  S V   DFGLA  L P  +   +     +  + 
Sbjct: 142 HMHE--HSI-VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFA 195

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
           APE      V    D+++ G+L   L+    P    F G+ +L     +
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNV 240

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 4e-35
 Identities = 59/252 (23%), Positives = 94/252 (37%), Gaps = 22/252 (8%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVT-----VKVFNLHH-HRASRSFIAECRALRSIRHRNL 329
             +G G+FG V +        T T     VK+      H   R+ ++E + L  I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL------YPVNREDEVDKAPRNLNLLQ 383
           V       G   +      ++ EF + G+L  +L      +   +    D     L L  
Sbjct: 79  VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
            +  +  VA  +++L         H DL   NILL E+ V  + DFGLAR +        
Sbjct: 136 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 444 SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP----SDIMFEGDMNLHN 499
               +  + ++APE       +   DV+S+G+L+ E+            I  E    L  
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252

Query: 500 FARMALPDHVMD 511
             RM  PD+   
Sbjct: 253 GTRMRAPDYTTP 264

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  132 bits (332), Expect = 5e-35
 Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 35/272 (12%)

Query: 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---ASRSFIAECRALRSIR 325
           +D +    ++G G    V+          V VKV      R       F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H  +V V+         G     +V E++   +L + ++              +   + +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEGP----------MTPKRAI 114

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH-VQTSS 444
            +  D   AL++ H +      H D+KP+NI++       V DFG+AR +  +    T +
Sbjct: 115 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171

Query: 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
             V G+  Y++PE   G  V    DVYS G ++ E++  + P    F GD  +    +  
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 227

Query: 505 -------------LPDHVMDIVDSTLLNDVED 523
                        L   +  +V   L  + E+
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPEN 259

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (329), Expect = 4e-34
 Identities = 46/243 (18%), Positives = 84/243 (34%), Gaps = 23/243 (9%)

Query: 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRA 320
           ++   +  D +   +++GTG+F  V        +  V +K            S   E   
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLN 380
           L  I+H N+V +         +      L+ + +  G L + +                 
Sbjct: 61  LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRI----------VEKGFYT 105

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
                 +   V  A+ YLH                  LDE+    + DFGL++   P  V
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
            +++    G+ GY+APE       S   D +S G++   L+    P    F  + +   F
Sbjct: 166 LSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLF 218

Query: 501 ARM 503
            ++
Sbjct: 219 EQI 221

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-34
 Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 28/265 (10%)

Query: 276 NLIGTGSFGSVYKGVL-------DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RH 326
             +G G+FG V                T V VK+       +     I+E   ++ I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNR------EDEVDKAPRNLN 380
           +N++ +  AC       +    ++ E+   G+L E+L            +        L+
Sbjct: 79  KNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 381 LLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440
               ++ A  VA  ++YL    +    H DL   N+L+ E+ V  + DFGLAR +     
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
              +   +  + ++APE       +   DV+S+G+L+ E+              + +   
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEEL 246

Query: 501 ARMALPDHVMDIVDSTLLNDVEDLA 525
            ++    H MD   S   N++  + 
Sbjct: 247 FKLLKEGHRMDK-PSNCTNELYMMM 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  129 bits (324), Expect = 8e-34
 Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 46/279 (16%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---------HRASRSFIAECRA 320
           + +    ++G G    V + +         VK+ ++                + + E   
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 321 LRSIR-HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
           LR +  H N++++         + N F  LV++ M+ G L ++L               L
Sbjct: 63  LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYL----------TEKVTL 107

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439
           +  +   I   +   +  LH        H DLKP NILLD++M   + DFG +  L P  
Sbjct: 108 SEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164

Query: 440 VQTSSIGVKGSIGYIAPEYGLGSEVSTNG------DVYSYGILMLELIIRKKPSD----- 488
                  V G+  Y+APE    S    +       D++S G++M  L+    P       
Sbjct: 165 KLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221

Query: 489 ----IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523
               ++  G+    +       D V D+V   L+   + 
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 37/267 (13%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRAL-RSIR 325
           + F    ++G GSFG V+     +      +K      +         + E R L  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H  L  +F        Q  +    V E++  G L   +          ++    +L +  
Sbjct: 62  HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHI----------QSCHKFDLSRAT 106

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
             A ++   L +LH        + DLK  NILLD++    + DFG+ +       +T++ 
Sbjct: 107 FYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 163

Query: 446 GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-----MNLHNF 500
              G+  YIAPE  LG + + + D +S+G+L+ E++I + P    F G       +    
Sbjct: 164 --CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRM 217

Query: 501 ARMALPDHV----MDIVDSTLLNDVED 523
                P  +     D++    + + E 
Sbjct: 218 DNPFYPRWLEKEAKDLLVKLFVREPEK 244

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 5e-33
 Identities = 57/262 (21%), Positives = 97/262 (37%), Gaps = 40/262 (15%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +G G FG V++ V    + T   K   +           E   L   RHRN++ +  + 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                +  +   +++EF+    + E +         + +   LN  + ++    V  AL 
Sbjct: 71  -----ESMEELVMIFEFISGLDIFERI---------NTSAFELNEREIVSYVHQVCEALQ 116

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHV--GDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           +LH     I  H D++P NI+      S +   +FG AR L P         +  +  Y 
Sbjct: 117 FLHS--HNI-GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA---------- 504
           APE      VST  D++S G L+  L+    P    F  + N      +           
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQIIENIMNAEYTFDEEA 226

Query: 505 ---LPDHVMDIVDSTLLNDVED 523
              +    MD VD  L+ + + 
Sbjct: 227 FKEISIEAMDFVDRLLVKERKS 248

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  125 bits (314), Expect = 4e-32
 Identities = 56/260 (21%), Positives = 100/260 (38%), Gaps = 39/260 (15%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRHRNLVKV 332
             +GTGSFG V+            +KV     +   +       E   L  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVA 392
           +        Q      ++ ++++ G L   L    R                   A +V 
Sbjct: 70  WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----------VAKFYAAEVC 114

Query: 393 SALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            AL+YLH   + I  + DLKP NILLD+     + DFG A+++P          + G+  
Sbjct: 115 LALEYLHS--KDII-YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPD 166

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA-------- 504
           YIAPE       + + D +S+GIL+ E++    P    F     +  + ++         
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAELRFPP 222

Query: 505 -LPDHVMDIVDSTLLNDVED 523
              + V D++   +  D+  
Sbjct: 223 FFNEDVKDLLSRLITRDLSQ 242

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  126 bits (317), Expect = 4e-32
 Identities = 52/262 (19%), Positives = 91/262 (34%), Gaps = 29/262 (11%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH------HRASRSFIAECRALRS 323
           + FS   +IG G FG VY     +      +K  +            + +       + +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 324 IRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQ 383
                +V +  A         D  + + + M  G L   L       E            
Sbjct: 64  GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSE----------AD 108

Query: 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTS 443
               A ++   L+++H+       + DLKP+NILLDE     + D GLA           
Sbjct: 109 MRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA- 164

Query: 444 SIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502
                G+ GY+APE    G    ++ D +S G ++ +L+    P       D +  +   
Sbjct: 165 ---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221

Query: 503 MALPDHVMDIVDSTLLNDVEDL 524
           + +   + D     L + +E L
Sbjct: 222 LTMAVELPDSFSPELRSLLEGL 243

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 8e-32
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 24/235 (10%)

Query: 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK 331
           ++   +IG GSFG VY+  L +    V +K         +R    E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77

Query: 332 VFTAC-SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
           +     S  + +   +  LV +++         +         +A + L ++        
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQ 130

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVKG 449
           +  +L Y+H     I  H D+KP N+LLD +  V  + DFG A+ L       S I  + 
Sbjct: 131 LFRSLAYIHS--FGI-CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 186

Query: 450 SIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
              Y APE   G+   T+  DV+S G ++ EL++ +      F GD  +     +
Sbjct: 187 --YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 9e-32
 Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 25/234 (10%)

Query: 276 NLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNL 329
             IG G++G V+K   L  G   V +K   +         ++   +A  R L +  H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 330 VKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAI 389
           V++F  C+           LV+E +                        +      ++  
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF 123

Query: 390 DVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449
            +   LD+LH        H DLKP NIL+       + DFGLAR        TS +    
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---V 177

Query: 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
           ++ Y APE  L S  +T  D++S G +  E+  RK      F G  ++    ++
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKI 227

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-31
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 30/234 (12%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS-----RSFIAECRALRSIRHRNLV 330
           + +G G F +VYK         V +K   L H   +     R+ + E + L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
            +  A            +LV++FM+                       L         + 
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDLEVII----------KDNSLVLTPSHIKAYMLM 108

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGS 450
               L+YLH        H DLKP+N+LLDE  V  + DFGLA+     +   +      +
Sbjct: 109 TLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VT 163

Query: 451 IGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
             Y APE   G+ +     D+++ G ++ EL++R         GD +L    R+
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRI 213

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 4e-31
 Identities = 54/245 (22%), Positives = 92/245 (37%), Gaps = 18/245 (7%)

Query: 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASR-SFIAECRALRSIR 325
           +    +++ + IG G++G V     +  +  V +K  +   H+      + E + L   R
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
           H N++ +         +      LV   M    L + L             ++L+     
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL-----------KTQHLSNDHIC 112

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSI 445
                +   L Y+H        H DLKPSN+LL+      + DFGLAR   P H  T  +
Sbjct: 113 YFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169

Query: 446 G-VKGSIGYIAPEYGLGSEVSTN-GDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
                +  Y APE  L S+  T   D++S G ++ E++  +         D   H    +
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229

Query: 504 ALPDH 508
             P  
Sbjct: 230 GSPSQ 234

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 4e-30
 Identities = 44/231 (19%), Positives = 82/231 (35%), Gaps = 28/231 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRAL-RSIRHRNLVKVFTA 335
           ++G G  G V +      +    +K+      +       E     R+ +  ++V++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL 395
              + Y G     +V E +  G L   +         D+  +     +   I   +  A+
Sbjct: 74  YENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAI 124

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEEM---VSHVGDFGLARFLPPTHVQTSSIGVKGSIG 452
            YLH        H D+KP N+L   +    +  + DFG A+         S      +  
Sbjct: 125 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPY 178

Query: 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
           Y+APE     +   + D++S G++M  L+    P    F  +  L     M
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGM 225

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-29
 Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 35/248 (14%)

Query: 266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS------FIAECR 319
            N  D + +   +G+G F  V K            K       ++SR          E  
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379
            L+ I+H N++ +         +      L+ E +  G L ++L              +L
Sbjct: 66  ILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLA----------EKESL 110

Query: 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS----HVGDFGLARFL 435
              +       + +    +++       H DLKP NI+L +  V      + DFGLA  +
Sbjct: 111 TEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167

Query: 436 PPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM 495
              +   +   + G+  ++APE      +    D++S G++   L+    P    F GD 
Sbjct: 168 DFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDT 220

Query: 496 NLHNFARM 503
                A +
Sbjct: 221 KQETLANV 228

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (290), Expect = 4e-29
 Identities = 43/227 (18%), Positives = 81/227 (35%), Gaps = 27/227 (11%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            IG+GSFG +Y G        V +K+              E +  + ++    +     C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                   D+  +V E +     + + +            R  +L   L +A  + S ++
Sbjct: 72  ----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISRIE 117

Query: 397 YLHHDCQPITTHCDLKPSNIL---LDEEMVSHVGDFGLARFLPPTHVQT-----SSIGVK 448
           Y+H   +    H D+KP N L     +  + ++ DFGLA+               +  + 
Sbjct: 118 YIHS--KNFI-HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 449 GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM 495
           G+  Y +    LG E S   D+ S G +++   +   P   +     
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 25/236 (10%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
             IG G+FG V+K    +    V +K   + + +     + + E + L+ ++H N+V + 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 334 TACSGVDYQGNDFKA---LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390
             C       N  K    LV++F ++                        L +   +   
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----------NVLVKFTLSEIKRVMQM 125

Query: 391 VASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPP--THVQTSSIGVK 448
           + + L Y+H +      H D+K +N+L+  + V  + DFGLAR                 
Sbjct: 126 LLNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 449 GSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
            ++ Y  PE  LG  +     D++  G +M E+  R        +G+   H  A +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALI 234

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-28
 Identities = 49/260 (18%), Positives = 81/260 (31%), Gaps = 38/260 (14%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH------HRASRSFIAECRALRSIR--HRN 328
           L+G+G FGSVY G+       V +K                     E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388
           ++++         +  D   L+ E  +                       L      +  
Sbjct: 71  VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFF 116

Query: 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGV 447
             V  A+ + H+    +  H D+K  NIL+D       + DFG    L  T         
Sbjct: 117 WQVLEAVRHCHN--CGV-LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 169

Query: 448 KGSIGYIAPEYGLGSEVSTNG-DVYSYGILMLELIIRKKPSDIMFEGD---MNLHNFARM 503
            G+  Y  PE+            V+S GIL+ +++    P    FE D   +    F R 
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQ 225

Query: 504 ALPDHVMDIVDSTLLNDVED 523
            +      ++   L     D
Sbjct: 226 RVSSECQHLIRWCLALRPSD 245

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 7e-28
 Identities = 53/276 (19%), Positives = 91/276 (32%), Gaps = 21/276 (7%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVF 333
             IG G++G+V+K    E    V +K   L         S + E   L+ ++H+N+V++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                     +    LV+EF      + +       D               +    +  
Sbjct: 68  DVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDP----------EIVKSFLFQLLK 112

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
            L + H        H DLKP N+L++      + +FGLAR       +  S  V      
Sbjct: 113 GLGFCHSRNVL---HRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYR 168

Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIV 513
                      ST+ D++S G +  EL    +P     + D  L    R+          
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLR 549
             T L D +   +          V  +      +L+
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  111 bits (279), Expect = 8e-28
 Identities = 38/229 (16%), Positives = 73/229 (31%), Gaps = 29/229 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            IG GSFG +++G        V +K         +     E R  + +     +      
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALD 396
                Q      LV + +            + ED +D   R  ++      A  + + + 
Sbjct: 70  ----GQEGLHNVLVIDLLGP----------SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115

Query: 397 YLHHDCQPITTHCDLKPSNILLDEEMVSHVG-----DFGLARFLPPTHVQTSSI-----G 446
            +H        + D+KP N L+      +       DFG+ +F      +          
Sbjct: 116 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM 495
           + G+  Y++    LG E S   D+ + G + +  +    P   +     
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 57/237 (24%), Positives = 90/237 (37%), Gaps = 26/237 (10%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHR 327
           + F     IG G++G VYK         V +K   L         + I E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 328 NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNI 387
           N+VK+            +   LV+EF+     +              A   + L    + 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA---------SALTGIPLPLIKSY 107

Query: 388 AIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447
              +   L + H        H DLKP N+L++ E    + DFGLAR         +    
Sbjct: 108 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV- 163

Query: 448 KGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
             ++ Y APE  LG +  ST  D++S G +  E++ R+      F GD  +    R+
Sbjct: 164 -VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRI 215

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 28/231 (12%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVF 333
             IG G++G VYK   + G T   +K   L         + I E   L+ ++H N+VK++
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
                          LV+E +     +            D     L  +   +  + + +
Sbjct: 67  DVI-----HTKKRLVLVFEHLDQDLKKLL----------DVCEGGLESVTAKSFLLQLLN 111

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
            + Y H   + +  H DLKP N+L++ E    + DFGLAR                ++ Y
Sbjct: 112 GIAYCHD--RRVL-HRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWY 166

Query: 454 IAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
            AP+  +GS+  ST  D++S G +  E++         F G        R+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRI 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 8e-27
 Identities = 50/266 (18%), Positives = 90/266 (33%), Gaps = 36/266 (13%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN---LHHHRASRSFIAECRALRSIRH 326
           + F    L+G G+FG V             +K+     +         + E R L++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             L  +  A      Q +D    V E+   G L   L       E           +   
Sbjct: 65  PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEE----------RARF 109

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
              ++ SAL    +       + D+K  N++LD++    + DFGL +         +   
Sbjct: 110 YGAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 164

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-----MNLHNFA 501
             G+  Y+APE    ++     D +  G++M E++  + P    F          L    
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILME 220

Query: 502 RMALPDHV----MDIVDSTLLNDVED 523
            +  P  +      ++   L  D + 
Sbjct: 221 EIRFPRTLSPEAKSLLAGLLKKDPKQ 246

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (274), Expect = 1e-26
 Identities = 52/285 (18%), Positives = 105/285 (36%), Gaps = 31/285 (10%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFN--LHHHRASRSFIAECRALRSIRHRNLVKVFT 334
            IG+G+ G V           V +K  +    +   ++    E   ++ + H+N++ +  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 335 ACSGVD-YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             +     +      LV E M     +     ++ E             +   +   +  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------------RMSYLLYQMLC 130

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
            + +LH        H DLKPSNI++  +    + DFGLAR    + + T  +    +  Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 184

Query: 454 IAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM-----ALPDH 508
            APE  LG     N D++S G +M E++  K      F G   +  + ++          
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKVIEQLGTPCPE 240

Query: 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSK 553
            M  +  T+ N VE+    +     ++  +++        ++ + 
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (273), Expect = 2e-26
 Identities = 52/248 (20%), Positives = 89/248 (35%), Gaps = 35/248 (14%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRH 326
           D F     +GTGSFG V      E      +K+ +       +     + E R L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 327 RNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLN 386
             LVK+  +              V E++  G +   L  + R           +      
Sbjct: 101 PFLVKLEFSFKDNSNLYM-----VMEYVAGGEMFSHLRRIGR----------FSEPHARF 145

Query: 387 IAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIG 446
            A  +    +YLH     +  + DLKP N+L+D++    V DFG A+ +           
Sbjct: 146 YAAQIVLTFEYLHS--LDLI-YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 197

Query: 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD-----MNLHNFA 501
           + G+   +APE  L    +   D ++ G+L+ E+     P    F  D            
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSG 253

Query: 502 RMALPDHV 509
           ++  P H 
Sbjct: 254 KVRFPSHF 261

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 6e-26
 Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 28/231 (12%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFT 334
            +G+G++G+V   V       V +K           ++    E R L+ +RH N++ +  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 335 ACSGVDYQGNDFK-ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
             +  +   +     LV  FM     +   +              L   +   +   +  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQFLVYQMLK 132

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
            L Y+H        H DLKP N+ ++E+    + DFGLAR            G   +  Y
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWY 184

Query: 454 IAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
            APE  L     +   D++S G +M E+I  K      F+G  +L     +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEI 231

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  106 bits (264), Expect = 1e-25
 Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 31/232 (13%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFT 334
             +G G +  V++ +       V VK+         +    E + L ++R   N++ +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASA 394
                    +   ALV+E + N   ++               + L          ++  A
Sbjct: 98  IV---KDPVSRTPALVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKA 141

Query: 395 LDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
           LDY H        H D+KP N+++D E     + D+GLA F  P       +    S  +
Sbjct: 142 LDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYF 195

Query: 454 IAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504
             PE  +  +    + D++S G ++  +I RK+P    F G  N     R+A
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIA 244

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 4e-25
 Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 26/231 (11%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVF 333
           + +G+G++GSV      +    V VK  +        ++    E R L+ ++H N++ + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS 393
              +            +   +    L                 + L       +   +  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNI-----------VKCQKLTDDHVQFLIYQILR 132

Query: 394 ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY 453
            L Y+H        H DLKPSN+ ++E+    + DFGLAR            G   +  Y
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWY 184

Query: 454 IAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503
            APE  L     +   D++S G +M EL+  +      F G  ++     +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLI 231

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (262), Expect = 4e-25
 Identities = 66/354 (18%), Positives = 117/354 (33%), Gaps = 28/354 (7%)

Query: 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTAC 336
            +G G F +V+        T V +K+              E + L+ +   +  K  +  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78

Query: 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDK-APRNLNLLQRLNIAIDVASAL 395
           +    +  D          +  +   +   N    + K   R + L+    I+  +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 396 DYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYI 454
           DY+H  C  I  H D+KP N+L++      ++    +A                 +  Y 
Sbjct: 139 DYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 455 APEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD 514
           +PE  LG+      D++S   L+ ELI         FE D             H     D
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPD-----------EGHSYTKDD 241

Query: 515 STLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574
             +   +E L  + +   R  +          +LR  SK +   + D+ + K   S    
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

Query: 575 IGNLSFL-KILNLENNS-------FTHEIPSEIGRLRRLQVPDLNNNSIGGEIP 620
                FL  +L L+            H    +   +  ++VPD      G +IP
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIP 355

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-24
 Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 31/244 (12%)

Query: 270 DGFSSANLIGTGSFGSVYKGVLDEGRTT---VTVKVFN----LHHHRASRSFIAECRALR 322
           + F    ++GTG++G V+      G  T     +KV      +   + +     E + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 323 SIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382
            IR    +          +Q      L+ +++  G L   L    R  E +         
Sbjct: 84  HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE--------- 130

Query: 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQT 442
               + I V   +  L H  +    + D+K  NILLD      + DFGL++         
Sbjct: 131 ----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TE 185

Query: 443 SSIGVKGSIGYIAPEYGLGSEVSTNG--DVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500
            +    G+I Y+AP+   G +   +   D +S G+LM EL+    P    F  D   ++ 
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQ 241

Query: 501 ARMA 504
           A ++
Sbjct: 242 AEIS 245

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.1 bits (194), Expect = 2e-17
 Identities = 25/170 (14%), Positives = 45/170 (26%), Gaps = 33/170 (19%)

Query: 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNL----------HHHRASRSFIAECRALRSIR 325
            L+G G   +V+    ++      VK   +                  F           
Sbjct: 6   KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRL 385
            R L K+        Y      A++ E +    L         E                
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE---------------- 107

Query: 386 NIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFL 435
            +   +   +   +H       H DL   N+L+ EE +  + DF  +  +
Sbjct: 108 -VLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (181), Expect = 4e-15
 Identities = 41/245 (16%), Positives = 74/245 (30%), Gaps = 27/245 (11%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEI--------------------- 595
              + L   +++            L IL L +N                           
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 596 ----PSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS 651
               P+    L RL    L+   +    P      + L  + L  N L       F  L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRL 711
            +  L L  N +          L SL ++ L  N +A   P     L  L+ LYL  N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 712 SGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNA 771
           S +   ++  + ++    + +N    +           LQ F   ++ +  ++P  ++  
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLAGR 271

Query: 772 SKLEV 776
               +
Sbjct: 272 DLKRL 276

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (132), Expect = 7e-09
 Identities = 32/144 (22%), Positives = 47/144 (32%), Gaps = 17/144 (11%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L L  NR+S     +   L  L    +  N +    P +      L T+ LF NNLS  
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
               L  L +L  L L+ N +             L+    S + +   +P  L       
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL------- 268

Query: 121 ILEMQGNVFQGLTILDLSRNKLSG 144
                     G  +  L+ N L G
Sbjct: 269 ---------AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.3 bits (126), Expect = 4e-08
 Identities = 39/192 (20%), Positives = 60/192 (31%), Gaps = 17/192 (8%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
            L LD   L    P     L  L   Y+ DN L+     +     +LT + L  N +S  
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
                 GL SL  L L +N+     P    +L  L TL +  N                 
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN-------------LSA 215

Query: 121 ILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNAS 180
           +        + L  L L+ N    +          ++    S +++   +P         
Sbjct: 216 LPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR--LAGRD 272

Query: 181 AISVLGNNKLCG 192
            +  L  N L G
Sbjct: 273 -LKRLAANDLQG 283

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.4 bits (181), Expect = 5e-15
 Identities = 63/262 (24%), Positives = 97/262 (37%), Gaps = 65/262 (24%)

Query: 2   LALDSNRLSGN--IPPSIGNLKKLVEPYVSDN-FLKGSIPSSLGLCESLTTIGLFNN--- 55
           L L    L     IP S+ NL  L   Y+     L G IP ++     L  + + +    
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 56  ---------------------NLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLIN 94
                                 LSGT+PP +  L +LV +    N+  G+ P   G+   
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 95  LET-LTVSGNILQGEIPSTLGSCIKLEILE------------------------------ 123
           L T +T+S N L G+IP T  +     +                                
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 124 ---MQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNAS 180
               +  + + L  LDL  N++ G +P+ L  LK + +LN+S+N+L G +P  G  +   
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294

Query: 181 AISVLGNNKLCGGISEFKLPPC 202
             +   N  LCG      LP C
Sbjct: 295 VSAYANNKCLCGSP----LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 9e-14
 Identities = 55/242 (22%), Positives = 91/242 (37%), Gaps = 5/242 (2%)

Query: 551 GSKAQKVTILDLESLKLAG--SILPHIGNLSFLKILNLENN-SFTHEIPSEIGRLRRLQV 607
            ++  +V  LDL  L L     I   + NL +L  L +    +    IP  I +L +L  
Sbjct: 46  DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105

Query: 608 PDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSI 667
             + + ++ G IP  LS    L+ +  + N L G +P    SL  +  ++   N + G+I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 668 PPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAE 727
           P   G+ S L        N             NL  + L  N L G       +  +  +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 728 FDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE 787
             + +N +  ++         N        NRI G +P  ++    L       N L GE
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 788 VP 789
           +P
Sbjct: 284 IP 285

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.0 bits (141), Expect = 6e-10
 Identities = 21/67 (31%), Positives = 29/67 (43%), Gaps = 1/67 (1%)

Query: 626 CSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN 685
             NL  + L  N++ G +P     L  +  L++ FNNL G I P  GNL      + A N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301

Query: 686 NLAGSIP 692
                 P
Sbjct: 302 KCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.7 bits (135), Expect = 3e-09
 Identities = 31/154 (20%), Positives = 57/154 (37%), Gaps = 3/154 (1%)

Query: 474 GILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQR 533
           G +        K    M      L         +  +  VD +      D +++    + 
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 534 QIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTH 593
             +++     L   L     ++ +  LDL + ++ G++   +  L FL  LN+  N+   
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282

Query: 594 EIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCS 627
           EIP + G L+R  V    NN      P  L +C+
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 50.9 bits (120), Expect = 3e-07
 Identities = 17/86 (19%), Positives = 32/86 (37%), Gaps = 25/86 (29%)

Query: 585 NLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIP 644
           +L NN     +P  + +L+ L   +++ N++ GEIP                        
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP------------------------ 285

Query: 645 SDFGSLSKIEVLSLGFNNLIGSIPPP 670
              G+L + +V +   N  +   P P
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLP 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 74.7 bits (182), Expect = 9e-15
 Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 15/189 (7%)

Query: 570 SILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNL 629
           S +  +G L+ L  L+L  N         +  L  L   DL NN I    P  LS  + L
Sbjct: 210 SDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 265

Query: 630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG 689
             + L  NQ+    P     L+ +  L L  N L    P    NL +L  ++L  NN++ 
Sbjct: 266 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISD 321

Query: 690 SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQN 749
             P   S L  L  L+   N++S    SS+ N+++I     G N+I    PL     L  
Sbjct: 322 ISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN---LTR 374

Query: 750 LQYFSIGTN 758
           +    +   
Sbjct: 375 ITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 74.3 bits (181), Expect = 1e-14
 Identities = 42/195 (21%), Positives = 83/195 (42%), Gaps = 14/195 (7%)

Query: 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSE 598
                 IS +        +  L L   +L    +  + +L+ L  L+L NN  ++  P  
Sbjct: 203 IATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-- 258

Query: 599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSL 658
           +  L +L    L  N I    P+   +    + +    N+   +  S   +L  +  L+L
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLEL----NENQLEDISPISNLKNLTYLTL 314

Query: 659 GFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS 718
            FNN+    P  + +L+ L+++  A N +  S   +L+ L N+  L  G N++S + P  
Sbjct: 315 YFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP-- 368

Query: 719 IFNISSIAEFDVGEN 733
           + N++ I +  + + 
Sbjct: 369 LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 71.2 bits (173), Expect = 1e-13
 Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 21/172 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L+L+ N+L      ++ +L  L +  +++N +    P  L     LT + L  N +S   
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
           P  L GLT+L  L+L+ NQ      + + NL NL  LT+  N +    P  + S  KL+ 
Sbjct: 280 P--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 333

Query: 122 LEMQGNVFQG---------LTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
           L    N             +  L    N++S   P  L  L  I  L L+  
Sbjct: 334 LFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.0 bits (157), Expect = 1e-11
 Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 15/190 (7%)

Query: 600 GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLG 659
            +L  L+     NN I    P+ +   +NL  + L  NQL         SL+ +  L L 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSI 719
            N +      PL  L+ L ++ L  N ++   P     L  L  L L  N+      S I
Sbjct: 250 NNQISN--LAPLSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQ--LEDISPI 303

Query: 720 FNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQA 779
            N+ ++    +  N I    P+    +L  LQ      N+++     S++N + +    A
Sbjct: 304 SNLKNLTYLTLYFNNISDISPVS---SLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 780 LNNKLTGEVP 789
            +N+++   P
Sbjct: 359 GHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 64.3 bits (155), Expect = 2e-11
 Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 28/147 (19%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIP--------------------SS 40
            L L +N++S   P  +  L KL E  +  N +    P                    S 
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302

Query: 41  LGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTV 100
           +   ++LT + L+ NN+S   P  +  LT L  L  + N+      + + NL N+  L+ 
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 101 SGNILQGEIPSTLGSCIKLEILEMQGN 127
             N +    P  L +  ++  L +   
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 2e-05
 Identities = 34/153 (22%), Positives = 62/153 (40%), Gaps = 20/153 (13%)

Query: 54  NNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTL 113
           NN +S   P  ++  T+L  L L+ NQ +      + +L NL  L ++ N +    P  L
Sbjct: 206 NNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259

Query: 114 GSCIKLEILEMQGNVFQGLTILDLSRNKLSGEI-------PEFLVGLKVIENLNLSYNDL 166
               KL  L++  N    ++ L       + E+          +  LK +  L L +N++
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319

Query: 167 EGMVPTEGVFKNASAISVL--GNNKLCGGISEF 197
             + P      + + +  L   NNK+   +S  
Sbjct: 320 SDISP----VSSLTKLQRLFFANNKV-SDVSSL 347

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.002
 Identities = 19/96 (19%), Positives = 38/96 (39%), Gaps = 10/96 (10%)

Query: 614 SIGGEIPVN----LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
           +I  + P+N     ++ +  ++  L K  +   +      L ++  L       I SI  
Sbjct: 5   TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG-IKSIDG 61

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILY 705
            +  L++L +I+ + N L    P     L  LV + 
Sbjct: 62  -VEYLNNLTQINFSNNQLTDITPL--KNLTKLVDIL 94

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 7/86 (8%)

Query: 693 FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQY 752
           FT + L   +   LG   ++  V  +  ++  +         I+    ++Y   L NL  
Sbjct: 16  FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEY---LNNLTQ 70

Query: 753 FSIGTNRITGAIPPSISNASKLEVFQ 778
            +   N++T   P  + N +KL    
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDIL 94

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 69.7 bits (169), Expect = 2e-13
 Identities = 48/232 (20%), Positives = 96/232 (41%), Gaps = 10/232 (4%)

Query: 557 VTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG 616
             +LDL++ K+         NL  L  L L NN  +   P     L +L+   L+ N + 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNL--IGSIPPPLGNL 674
                   +   L      +N++     S F  L+++ V+ LG N L   G        +
Sbjct: 93  ELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 675 SSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENK 734
             L  I +A  N+  +IP  L    +L  L+L  N+++ +  +S+  ++++A+  +  N 
Sbjct: 150 KKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 735 IQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786
           I             +L+   +  N++   +P  +++   ++V    NN ++ 
Sbjct: 207 ISAVDN-GSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 67.4 bits (163), Expect = 1e-12
 Identities = 41/240 (17%), Positives = 79/240 (32%), Gaps = 12/240 (5%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
              + +  L L + K++         L  L+ L L  N            L+ L+V +  
Sbjct: 52  KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE 111

Query: 612 NNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL 671
              +   +   L+    +        +  G     F  + K+  + +   N+  +IP   
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ-- 167

Query: 672 GNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731
           G   SL ++ L  N +      +L  L NL  L L  N +S +   S+ N   + E  + 
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227

Query: 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITG------AIPPSISNASKLEVFQALNNKLT 785
            NK+            + +Q   +  N I+         P   +  +        +N + 
Sbjct: 228 NNKLVKVPG--GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.4 bits (158), Expect = 4e-12
 Identities = 41/199 (20%), Positives = 66/199 (33%), Gaps = 9/199 (4%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L +N+++        NLK L    + +N +    P +      L  + L  N L   
Sbjct: 35  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 94

Query: 61  IPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE 120
                  L  L   +    + R S    +  +I +E L  +     G          KL 
Sbjct: 95  PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLS 153

Query: 121 ILEMQGN--------VFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPT 172
            + +           +   LT L L  NK++      L GL  +  L LS+N +  +   
Sbjct: 154 YIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213

Query: 173 EGVFKNASAISVLGNNKLC 191
                       L NNKL 
Sbjct: 214 SLANTPHLRELHLNNNKLV 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.9 bits (141), Expect = 6e-10
 Identities = 27/162 (16%), Positives = 55/162 (33%), Gaps = 4/162 (2%)

Query: 624 SSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLA 683
             C   +R+    +  + K+P D        +L L  N +         NL +L  + L 
Sbjct: 6   FRCQCHLRVVQCSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILI 63

Query: 684 INNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDY 743
            N ++   P   + L  L  LYL  N+L  +       +  +   +    K++ ++    
Sbjct: 64  NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--N 121

Query: 744 GFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785
           G     +        + +G    +     KL   +  +  +T
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 4e-09
 Identities = 37/190 (19%), Positives = 67/190 (35%), Gaps = 23/190 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L  +  + SG    +   +KKL    ++D  +  +IP   GL  SLT + L  N ++   
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVD 187

Query: 62  PPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
              L GL +L  L LS N         + N  +L  L ++ N              KL  
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN--------------KLVK 233

Query: 122 LEMQGNVFQGLTILDLSRNKLSG------EIPEFLVGLKVIENLNLSYNDLEGMVPTEGV 175
           +       + + ++ L  N +S         P +         ++L  N ++        
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293

Query: 176 FKNASAISVL 185
           F+     + +
Sbjct: 294 FRCVYVRAAV 303

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 4e-09
 Identities = 32/181 (17%), Positives = 62/181 (34%), Gaps = 15/181 (8%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINL 95
            +P  L        + L NN ++         L +L  L L  N+     P     L+ L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 96  ETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLS----------RNKLSGE 145
           E L +S N L+        +  +L + E +    +      L+            K SG 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 146 IPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLK 205
                 G+K +  + ++  ++  +   +G+  + + +  L  NK+    +        L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTI--PQGLPPSLTELH-LDGNKITKVDAASLKGLNNLA 198

Query: 206 K 206
           K
Sbjct: 199 K 199

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.8 bits (133), Expect = 6e-09
 Identities = 42/266 (15%), Positives = 84/266 (31%), Gaps = 20/266 (7%)

Query: 13  IPPSIG-NLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSL 71
           +P  +  +   L    + +N +           ++L T+ L NN +S   P     L  L
Sbjct: 25  VPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 72  VALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLE-------ILEM 124
             L LS+NQ +         L  L         ++  + + L   I +E          +
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 125 QGNVFQGLTIL---DLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEGVFKNASA 181
           +   FQG+  L    ++   ++  IP+ L     +  L+L  N +  +        N  A
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 182 ISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLCWV 241
              L  N +    +        L++        +L  V   ++    +   + +      
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNN--NKLVKVPGGLADHKYIQ-VVYLHNNNIS 255

Query: 242 RKRKEQSNPNSLINSLLNLSYQNLHN 267
                   P        + S  +L +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFS 281

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.4 bits (93), Expect = 6e-04
 Identities = 28/155 (18%), Positives = 47/155 (30%), Gaps = 13/155 (8%)

Query: 115 SCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGMVPTEG 174
            C  L + ++  ++     +LDL  NK++         LK +  L L  N +  + P  G
Sbjct: 16  QCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP--G 73

Query: 175 VFKNASAISVL--GNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALT 232
            F     +  L    N+L     +       L+              I  V   +   L 
Sbjct: 74  AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE---------ITKVRKSVFNGLN 124

Query: 233 LSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHN 267
             I         K     N     +  LSY  + +
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.6 bits (119), Expect = 7e-08
 Identities = 15/147 (10%), Positives = 40/147 (27%), Gaps = 3/147 (2%)

Query: 625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLA 683
                  +   ++  +            +  L +     +  +       L  LR +++ 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 684 INNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDY 743
            + L    P        L  L L  N L  +         S+ E  +  N +  +  L +
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPLHCSCALRW 123

Query: 744 GFTLQNLQYFSIGTNRITGAIPPSISN 770
               +      +   ++       +++
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAH 150

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 23/145 (15%), Positives = 38/145 (26%), Gaps = 2/145 (1%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIG 616
           + L           L H+     L  L +EN      +       L  L+   +  + + 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 617 GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSS 676
              P        L R+ L+ N L          LS  E++  G           L     
Sbjct: 70  FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEE 129

Query: 677 LRKISLAINNLAGSIPFTLSKLKNL 701
                +    L       L+ + N 
Sbjct: 130 EGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (83), Expect = 0.004
 Identities = 19/96 (19%), Positives = 33/96 (34%), Gaps = 2/96 (2%)

Query: 36  SIPSSLGLCESLTTIGLFNNNLSGTIPPQLM-GLTSLVALDLSRNQFRGSFPTEVGNLIN 94
                L   E+LT + + N      +  + + GL  L  L + ++  R   P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 95  LETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ 130
           L  L +S N     +       + L+ L + GN   
Sbjct: 82  LSRLNLSFN-ALESLSWKTVQGLSLQELVLSGNPLH 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.2 bits (114), Expect = 2e-07
 Identities = 25/127 (19%), Positives = 52/127 (40%), Gaps = 9/127 (7%)

Query: 582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMG 641
           ++L+L +   T  +   + +L  +   DL++N +    P  L++   L  +  + N L  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE- 56

Query: 642 KIPSDFGSLSKIEVLSLGFNNLIG-SIPPPLGNLSSLRKISLAINNLA---GSIPFTLSK 697
                  +L +++ L L  N L   +   PL +   L  ++L  N+L    G        
Sbjct: 57  -NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 698 LKNLVIL 704
           L ++  +
Sbjct: 116 LPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 26/120 (21%), Positives = 50/120 (41%), Gaps = 7/120 (5%)

Query: 559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE 618
           +L L    L  ++L H+  L  +  L+L +N      P+ +  LR L+V   ++N++   
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 619 IPVNLSSCSNLIRIGLAKNQL-MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL 677
             V   +   L  + L  N+L          S  ++ +L+L  N+L          L+ +
Sbjct: 59  DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 4e-06
 Identities = 22/108 (20%), Positives = 44/108 (40%), Gaps = 5/108 (4%)

Query: 655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI 714
           VL L   +L  ++   L  L  +  + L+ N L    P  L+ L+ L +L    N L  +
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 715 VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG 762
               + N+  + E  +  N++Q +  +    +   L   ++  N +  
Sbjct: 59  --DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 1e-05
 Identities = 30/118 (25%), Positives = 42/118 (35%), Gaps = 19/118 (16%)

Query: 52  LFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS 111
           L + +L  T+   L  L  +  LDLS N+ R   P  +  L  LE L  S N L+     
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61

Query: 112 TLGSCIKLEILEMQGNVFQGLTILDLSRNKL-SGEIPEFLVGLKVIENLNLSYNDLEG 168
                ++                L L  N+L      + LV    +  LNL  N L  
Sbjct: 62  ANLPRLQ---------------ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 6/109 (5%)

Query: 1   ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGT 60
           +L L    L+  +   +  L  +    +S N L+   P +L     L  +   +N     
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56

Query: 61  IPPQLMGLTSLVALDLSRNQFRG-SFPTEVGNLINLETLTVSGNILQGE 108
               +  L  L  L L  N+ +  +    + +   L  L + GN L  E
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 0.001
 Identities = 24/111 (21%), Positives = 45/111 (40%), Gaps = 7/111 (6%)

Query: 678 RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG 737
           R + LA  +L  ++   L +L  +  L L  NRL  + P+    ++++   +V +     
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54

Query: 738 NIPLDYGFTLQNLQYFSIGTNRITG-AIPPSISNASKLEVFQALNNKLTGE 787
              +D    L  LQ   +  NR+   A    + +  +L +     N L  E
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 4e-07
 Identities = 37/229 (16%), Positives = 73/229 (31%), Gaps = 12/229 (5%)

Query: 558 TILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGG 617
             LDL    L   +   + +   +        SF  +  +E     R+Q  DL+N+ I  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG-VIAFRC-PRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60

Query: 618 E-IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPP------ 670
             +   LS CS L  + L   +L   I +     S +  L+L   +              
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 671 --LGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF 728
             L  L+          ++  ++      +  L +     N     + + +    ++   
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 729 DVGENKIQGNIPLDYGFTLQNLQYFSI-GTNRITGAIPPSISNASKLEV 776
           D+ ++ +  N      F L  LQ+ S+     I       +     L+ 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 7e-05
 Identities = 17/95 (17%), Positives = 40/95 (42%), Gaps = 3/95 (3%)

Query: 48  TTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQG 107
            T+ L   NL   +  +L+    ++A    R+        E  +   ++ + +S ++++ 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 108 E-IPSTLGSCIKLEILEMQGNVFQGLTILDLSRNK 141
             +   L  C KL+ L ++G       +  L++N 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 5e-07
 Identities = 25/111 (22%), Positives = 37/111 (33%), Gaps = 25/111 (22%)

Query: 52  LFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPS 111
            + N  S  I        SL  L++S N+     P        LE L  S N L  E+P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 112 TLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLS 162
              +                L  L +  N L  E P+    +   E+L ++
Sbjct: 322 LPQN----------------LKQLHVEYNPLR-EFPDIPESV---EDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 20/83 (24%), Positives = 34/83 (40%), Gaps = 9/83 (10%)

Query: 573 PHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI 632
                   L+ LN+ NN    E+P+   RL RL     + N +  E+P       NL ++
Sbjct: 278 SLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHL-AEVP---ELPQNLKQL 329

Query: 633 GLAKNQLMGKIPSDFGSLSKIEV 655
            +  N L  + P    S+  + +
Sbjct: 330 HVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 9e-06
 Identities = 25/95 (26%), Positives = 31/95 (32%), Gaps = 9/95 (9%)

Query: 27  YVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFP 86
               N     I S   L  SL  + + NN L   +P        L  L  S N      P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHL-AEVP 320

Query: 87  TEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEI 121
                  NL+ L V  N L+ E P    S   L +
Sbjct: 321 ELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 21/92 (22%), Positives = 37/92 (40%), Gaps = 9/92 (9%)

Query: 610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPP 669
              N+   EI        +L  + ++ N+L+ ++P+    L   E L   FN+L   +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHL-AEVPE 321

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701
              NL  L    +  N L    P     +++L
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 15/70 (21%), Positives = 26/70 (37%), Gaps = 9/70 (12%)

Query: 2   LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTI 61
           L + +N+L   +P     L++L     S N L   +P       +L  + +  N L    
Sbjct: 289 LNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EF 339

Query: 62  PPQLMGLTSL 71
           P     +  L
Sbjct: 340 PDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 7e-05
 Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 9/89 (10%)

Query: 637 NQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLS 696
           N    +I S       +E L++  N LI  +P     L  L     + N+L   +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHL-AEVP---E 321

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSI 725
             +NL  L++  N L    P    ++  +
Sbjct: 322 LPQNLKQLHVEYNPLREF-PDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 26/97 (26%), Positives = 42/97 (43%), Gaps = 14/97 (14%)

Query: 519 NDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNL 578
           ++ E  A   N  QR++ V+ + +CL               L+L +L L  S LP +   
Sbjct: 11  SEWERNAPPGNGEQREMAVSRLRDCLDRQA---------HELELNNLGL--SSLPEL--P 57

Query: 579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSI 615
             L+ L    NS T E+P     L+ L V + N  ++
Sbjct: 58  PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 16/98 (16%), Positives = 32/98 (32%), Gaps = 14/98 (14%)

Query: 685 NNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYG 744
           N  +  I        +L  L +  N+L  + P+    +  +       N +   +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIEL-PALPPRLERL---IASFNHLA-EVP---- 320

Query: 745 FTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN 782
              QNL+   +  N +    P    +   L     +N+
Sbjct: 321 ELPQNLKQLHVEYNPLRE-FPDIPESVEDLR----MNS 353

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 17/97 (17%), Positives = 35/97 (36%), Gaps = 13/97 (13%)

Query: 574 HIGNLSFLKILNLENNSFTHE----IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSS---- 625
                S L++L L +   +      + + +     L+  DL+NN +G    + L      
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 626 -CSNLIRIGLAKNQLMGKIPSDFGSLSK----IEVLS 657
               L ++ L       ++     +L K    + V+S
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 5e-06
 Identities = 17/95 (17%), Positives = 27/95 (28%), Gaps = 12/95 (12%)

Query: 64  QLMGLTSLVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL 119
                + L  L L+          S    +    +L  L +S N L       L   ++ 
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR- 422

Query: 120 EILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLK 154
                       L  L L     S E+ + L  L+
Sbjct: 423 -------QPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 6e-06
 Identities = 13/101 (12%), Positives = 32/101 (31%), Gaps = 10/101 (9%)

Query: 70  SLVALDLSRNQFRGSFPTEV-GNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNV 128
            + +LD+   +   +   E+   L   + + +    L       + S ++         V
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR---------V 53

Query: 129 FQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDLEGM 169
              L  L+L  N+L       ++      +  +    L+  
Sbjct: 54  NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 12/80 (15%), Positives = 26/80 (32%), Gaps = 16/80 (20%)

Query: 93  INLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGE----IPE 148
           +++++L +    L     + L   ++               ++ L    L+      I  
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQ------------QCQVVRLDDCGLTEARCKDISS 49

Query: 149 FLVGLKVIENLNLSYNDLEG 168
            L     +  LNL  N+L  
Sbjct: 50  ALRVNPALAELNLRSNELGD 69

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 13/110 (11%), Positives = 33/110 (30%), Gaps = 21/110 (19%)

Query: 581 LKILNLENNSFTHEIPSEI-GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQL 639
           ++ L+++    +    +E+   L++ QV  L++  +      ++SS              
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50

Query: 640 MGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG 689
                        +  L+L  N L       +          +   +L  
Sbjct: 51  -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 6e-04
 Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 13/95 (13%)

Query: 19  NLKKLVEPYVSDNFLKGS-IPSSLGLCESLTTIGLFNNNLSG----TIPPQLMGLTSLVA 73
           +++ L    +    L  +     L L +    + L +  L+      I   L    +L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 74  LDLSRNQFRGSFPTEVG-----NLINLETLTVSGN 103
           L+L  N+        V          ++ L++   
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 18/102 (17%), Positives = 35/102 (34%), Gaps = 16/102 (15%)

Query: 91  NLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFL 150
               L  L ++   +     S+L + +              L  LDLS N L       L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLL---------ANHSLRELDLSNNCLGDAGILQL 417

Query: 151 V-GLK----VIENLNLSYNDLEGMVPT--EGVFKNASAISVL 185
           V  ++    ++E L L        +    + + K+  ++ V+
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 12/80 (15%), Positives = 25/80 (31%), Gaps = 9/80 (11%)

Query: 555 QKVTILDLESLKL----AGSILPHIGNLSFLKILNLENNSFTHEIPSEIGR-----LRRL 605
             + +L L    +      S+   +     L+ L+L NN        ++          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 606 QVPDLNNNSIGGEIPVNLSS 625
           +   L +     E+   L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 14/74 (18%), Positives = 21/74 (28%), Gaps = 5/74 (6%)

Query: 653 IEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNL----AGSIPFTLSKLKNLVILYLG 707
           I+ L +    L  +    L   L   + + L    L       I   L     L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 708 VNRLSGIVPSSIFN 721
            N L  +    +  
Sbjct: 64  SNELGDVGVHCVLQ 77

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 9/85 (10%)

Query: 644 PSDFGSLSKIEVLSLGFNNL----IGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSK-- 697
                  S + VL L   ++      S+   L    SLR++ L+ N L  +    L +  
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 698 ---LKNLVILYLGVNRLSGIVPSSI 719
                 L  L L     S  +   +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 10/90 (11%)

Query: 2  LALDSNRLSGNIPPSI-GNLKKLVEPYVSDNFLKG----SIPSSLGLCESLTTIGLFNNN 56
          L +    LS      +   L++     + D  L       I S+L +  +L  + L +N 
Sbjct: 7  LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 57 LSGTIPPQLMGL-----TSLVALDLSRNQF 81
          L       ++         +  L L     
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 4e-05
 Identities = 23/137 (16%), Positives = 46/137 (33%), Gaps = 7/137 (5%)

Query: 572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIR 631
                N    + L+L        I +    L +    D ++N I             L  
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67

Query: 632 IGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIG-SIPPPLGNLSSLRKISL---AINNL 687
           + +  N++         +L  +  L L  N+L+      PL +L SL  + +    + N 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 688 AGSIPFTLSKLKNLVIL 704
                + + K+  + +L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 7e-05
 Identities = 40/203 (19%), Positives = 65/203 (32%), Gaps = 25/203 (12%)

Query: 552 SKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLN 611
           SK      ++ +   L  ++ P +       IL+L  N       + +    RL   +L+
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 612 NNSIGGEIPVNLSS---------------------CSNLIRIGLAKNQLMGKIPSDFGSL 650
              +                                  L  + ++ N+L          L
Sbjct: 64  RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 651 SKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR 710
            +++ L L  N L    P  L     L K+SLA NNL       L+ L+NL  L L  N 
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 711 LSGIVPSSIFNISSIAEFDVGEN 733
           L   +P   F    +    +  N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 15/66 (22%), Positives = 24/66 (36%), Gaps = 3/66 (4%)

Query: 16 SIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALD 75
           +  +   +E       L  ++P  L   +  T + L  N L       LM  T L  L+
Sbjct: 5  EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 76 LSRNQF 81
          L R + 
Sbjct: 62 LDRAEL 67

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 8e-04
 Identities = 21/76 (27%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 7   NRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLM 66
           N L    P  +    KL +  +++N L       L   E+L T+ L  N+L  TIP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 67  GLTSLVALDLSRNQFR 82
           G   L    L  N + 
Sbjct: 193 GSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 8e-04
 Identities = 31/208 (14%), Positives = 62/208 (29%), Gaps = 26/208 (12%)

Query: 598 EIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS 657
           E+ ++      + +  ++   +P +L    +   + L++N L     +     +++  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 658 L-GFNNLIGSIPPPLGNLSSLRKISLAI--------------------NNLAGSIPFTLS 696
           L         +   L  L +L      +                    N L       L 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756
            L  L  LYL  N L  + P  +     + +  +  N +           L+NL    + 
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG-LENLDTLLLQ 180

Query: 757 TNRITGAIPPSISNASKLEVFQALNNKL 784
            N +   IP     +  L       N  
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 12/60 (20%), Positives = 17/60 (28%), Gaps = 3/60 (5%)

Query: 44  CESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSGN 103
             S   +     NL+  +PP L        L LS N         +     L  L +   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.4 bits (85), Expect = 0.004
 Identities = 13/50 (26%), Positives = 21/50 (42%)

Query: 115 SCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYN 164
           +C K  +  +  ++ +  TIL LS N L       L+    +  LNL   
Sbjct: 16  NCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 21/75 (28%), Positives = 34/75 (45%), Gaps = 4/75 (5%)

Query: 27  YVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFP 86
           Y+S    + S  + L     LTT+   +N +S   P  L  L +L+ + L  NQ     P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

Query: 87  TEVGNLINLETLTVS 101
             + N  NL  +T++
Sbjct: 213 --LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 15/61 (24%), Positives = 26/61 (42%), Gaps = 4/61 (6%)

Query: 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKIS 681
            L++ S L  +    N++    P    SL  +  + L  N +      PL N S+L  ++
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVT 223

Query: 682 L 682
           L
Sbjct: 224 L 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 3/46 (6%)

Query: 661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYL 706
           +N I  I P L +L +L ++ L  N ++   P  L+   NL I+ L
Sbjct: 182 DNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 3e-04
 Identities = 23/149 (15%), Positives = 52/149 (34%), Gaps = 6/149 (4%)

Query: 607 VPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGS 666
           + +L    +  ++ + +S   +  +  L    L  +   D  + +   VL+   +++  +
Sbjct: 1   LNELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAAT 56

Query: 667 IPPPLGNLSSLRKISLAINNLAG--SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISS 724
           +     N+  L  ++L+ N L     +   + K  NL IL L  N L             
Sbjct: 57  LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116

Query: 725 IAEFDVGENKIQGNIPLDYGFTLQNLQYF 753
           + E  +  N +         +     + F
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERF 145

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 15/93 (16%), Positives = 33/93 (35%), Gaps = 12/93 (12%)

Query: 670 PLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFD 729
           PLG+      +   I  +     F+       +   L    ++  V  +   ++SI +  
Sbjct: 2   PLGS--ETITVPTPIKQI-----FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQII 52

Query: 730 VGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG 762
              + I+    + Y   L N+    +  N++T 
Sbjct: 53  ANNSDIKSVQGIQY---LPNVTKLFLNGNKLTD 82

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 12/86 (13%), Positives = 28/86 (32%), Gaps = 3/86 (3%)

Query: 584 LNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKI 643
           L L  N             +  ++   +NN++           S  + + +++ ++    
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 644 PSDFGSLSKIEVLSLGFNNLIGSIPP 669
                +L K+   S    NL   +P 
Sbjct: 218 SYGLENLKKLRARST--YNL-KKLPT 240

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	789
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.95
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.94
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.89
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.81
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.76
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.65
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.64
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.61
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.58
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.45
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.42
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.42
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.41
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.4
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.4
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.38
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.72
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.6
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.74
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.73
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.73
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.2
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.05
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.93
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.66
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	89.62

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-45  Score=375.66  Aligned_cols=254  Identities=20%  Similarity=0.243  Sum_probs=203.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|+..+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++.+..     ..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----eeE
Confidence            578899999999999999999998999999999975532 33467899999999999999999999998766     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ||||||||+|||+++++.+||+|
T Consensus        80 ivmEy~~gg~L~~~l~~~----------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~D  146 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD  146 (271)
T ss_dssp             EEEECCTTEEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred             EEEeccCCCcHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEcc
Confidence            999999999999999644          56899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||+|+...............||+.|||||++.+..+ +.++|||||||++|||+||+.||.........+..+.......
T Consensus       147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~  226 (271)
T d1nvra_         147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL  226 (271)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS
T ss_pred             chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            999998765543333445679999999999988775 6789999999999999999999975433322222221110000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..                              .......+.++..+|.+.++..|++..++..+
T Consensus       227 ~~------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         227 NP------------------------------WKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TT------------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             Cc------------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00                              01122344577889999999999998877544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-45  Score=377.04  Aligned_cols=259  Identities=26%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ...++|...+.||+|+||+||+|+++   ..||||+++..  .....+.|.+|++++++++||||++++|++...     
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-----   76 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-----   76 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc-----
Confidence            44578999999999999999999875   35999998654  344567899999999999999999999997542     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++||||+++|+|.+++...         ...+++.++..|+.|||+||+|||+.+   ||||||||+|||++.++++
T Consensus        77 -~~~lv~Ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~  143 (276)
T d1uwha_          77 -QLAIVTQWCEGSSLYHHLHII---------ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTV  143 (276)
T ss_dssp             -SCEEEEECCCEEEHHHHHHTS---------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSE
T ss_pred             -EEEEEEecCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCE
Confidence             479999999999999999643         246899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      ||+|||+|+...............||+.|||||++..   +.|+.++|||||||++|||+||+.||...... ..+...+
T Consensus       144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~~~  222 (276)
T d1uwha_         144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMV  222 (276)
T ss_dssp             EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHH
T ss_pred             EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-HHHHHHH
Confidence            9999999998766554444456779999999999864   45899999999999999999999999743211 1111112


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      ......       |.+.                   ....+|...+.+++..|++.++..||++..+...++
T Consensus       223 ~~~~~~-------p~~~-------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         223 GRGYLS-------PDLS-------------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             HHTSCC-------CCGG-------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hcCCCC-------Ccch-------------------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            211111       1110                   001134556778899999999999999987754443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-44  Score=375.95  Aligned_cols=266  Identities=24%  Similarity=0.382  Sum_probs=197.3

Q ss_pred             cccHHHHHHhhcCCC---------CCCcccccCCccEEEEEEcCCce---EEEEEEeccc-cchhhHHHHHHHHHHhcCC
Q 041249          259 NLSYQNLHNATDGFS---------SANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLH-HHRASRSFIAECRALRSIR  325 (789)
Q Consensus       259 ~~~~~~~~~~~~~f~---------~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~  325 (789)
                      .+||+|+..|+.+|+         ..+.||+|+||+||+|.+..+++   .||||.+... .....+.|.+|++++++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            456777777765554         45789999999999999975553   6899988654 3344567999999999999


Q ss_pred             CCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCC
Q 041249          326 HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPI  405 (789)
Q Consensus       326 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~  405 (789)
                      |||||+++|+|....     ..++||||+++|+|.+++...         ...+++.++..|+.|||+||+|||+.+   
T Consensus        86 HpnIv~l~g~~~~~~-----~~~iv~Ey~~~g~L~~~~~~~---------~~~l~~~~~~~i~~qia~gl~yLH~~~---  148 (299)
T d1jpaa_          86 HPNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLADMN---  148 (299)
T ss_dssp             CTTBCCEEEEECSSS-----SCEEEEECCTTEEHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             CCCCccEEEEEeeCC-----EEEEEEEecCCCcceeeeccc---------cCCCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence            999999999997765     789999999999999988643         346899999999999999999999988   


Q ss_pred             ceecCCCCCceecCCCCceeeCcccccccCCCCCCc---cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249          406 TTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ---TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII  482 (789)
Q Consensus       406 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt  482 (789)
                      ||||||||+|||++.++++||+|||+|+........   .......||+.|||||.+.++.++.++|||||||++|||+|
T Consensus       149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t  228 (299)
T d1jpaa_         149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS  228 (299)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence            999999999999999999999999999987654422   12223458899999999999999999999999999999998


Q ss_pred             -hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEec
Q 041249          483 -RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILD  561 (789)
Q Consensus       483 -G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~  561 (789)
                       |+.||.....  ..+...+......                              ....++...+.+++..|++.++.+
T Consensus       229 ~g~~Pf~~~~~--~~~~~~i~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~~P~~  276 (299)
T d1jpaa_         229 YGERPYWDMTN--QDVINAIEQDYRL------------------------------PPPMDCPSALHQLMLDCWQKDRNH  276 (299)
T ss_dssp             TSCCTTTTCCH--HHHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred             CCCCCCCCCCH--HHHHHHHHcCCCC------------------------------CCCccchHHHHHHHHHHcCCCHhH
Confidence             8999973211  1122222211100                              011134456678899999999999


Q ss_pred             cCcccccccccc
Q 041249          562 LESLKLAGSILP  573 (789)
Q Consensus       562 l~s~~~~~~~l~  573 (789)
                      ||++.++...++
T Consensus       277 RPs~~ei~~~L~  288 (299)
T d1jpaa_         277 RPKFGQIVNTLD  288 (299)
T ss_dssp             SCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHH
Confidence            999988755443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=363.70  Aligned_cols=247  Identities=20%  Similarity=0.283  Sum_probs=203.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|+++.+++.||+|++...   .......+.+|++++++++||||+++++++.+..     .
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----R   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-----E
Confidence            5788899999999999999999989999999998643   2334567899999999999999999999998766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.+   ||||||||+|||++.++.+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~----------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl  147 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI  147 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeecCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEee
Confidence            99999999999999998643          46899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP  506 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~  506 (789)
                      +|||+|+......    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...     +..+..+....
T Consensus       148 ~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~  218 (263)
T d2j4za1         148 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISR  218 (263)
T ss_dssp             CCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHT
T ss_pred             cccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHHHHHHHc
Confidence            9999998765443    23457999999999999999999999999999999999999999632     22222221111


Q ss_pred             CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..      +.+.                      ..+...+.++...|.+.++.+|++..++..+
T Consensus       219 ~~------~~~p----------------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         219 VE------FTFP----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             TC------CCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CC------CCCC----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            10      0000                      0122345577889999999999998876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-43  Score=367.53  Aligned_cols=251  Identities=22%  Similarity=0.262  Sum_probs=205.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|...+.||+|+||+||+|....+++.||||+++.......+.+.+|++++++++||||+++++++...+     ..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence            46999999999999999999999899999999998766666778999999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.+|+|.+++..           ..+++.++..|+.|++.||+|||+.+   ||||||||+|||++.++++||+||
T Consensus        95 vmEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccc
Confidence            9999999999998753           35899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |+|+.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+....+...+.  
T Consensus       161 G~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~~--  235 (293)
T d1yhwa1         161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTPE--  235 (293)
T ss_dssp             TTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSCC--
T ss_pred             hhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCC--
Confidence            99998765432  223456999999999999999999999999999999999999999632110 0111111111110  


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                             +.                    ....+...+.+++..|++.++..|++..+...+
T Consensus       236 -------~~--------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 -------LQ--------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             -------CS--------------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             -------CC--------------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00                    001223445678889999999999998877544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-44  Score=373.50  Aligned_cols=260  Identities=23%  Similarity=0.347  Sum_probs=209.4

Q ss_pred             HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249          262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY  341 (789)
Q Consensus       262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  341 (789)
                      |+++++..++|...+.||+|+||+||+|.+..+++.||||+++... ...+++.+|++++++++|||||+++|+|...+ 
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-   86 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-   86 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC-
Confidence            3445566778888999999999999999999889999999986543 34567999999999999999999999998765 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++||||+++|++.+++...        ....+++..+..|+.|||.||+|||+.+   ||||||||+|||++++
T Consensus        87 ----~~~iv~E~~~~g~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~  151 (287)
T d1opja_          87 ----PFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN  151 (287)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             ----eeEEEeecccCcchHHHhhhc--------cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCC
Confidence                789999999999999998643        3467899999999999999999999988   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      +++||+|||+|+........ ......|++.|+|||.+.++.|+.|+|||||||++|||++|+.|+..... ...+.+.+
T Consensus       152 ~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i  229 (287)
T d1opja_         152 HLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELL  229 (287)
T ss_dssp             GCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHH
T ss_pred             CcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHH
Confidence            99999999999987654422 23345688999999999999999999999999999999998777642211 11111122


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ......        .                      ....+...+.+++..|++.++.+||++..+..
T Consensus       230 ~~~~~~--------~----------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         230 EKDYRM--------E----------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HTTCCC--------C----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCC--------C----------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            111110        0                      01123445678899999999999999987744

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=366.58  Aligned_cols=259  Identities=22%  Similarity=0.264  Sum_probs=192.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|....+++.||||+++...  ....+.+.+|++++++++||||+++++++.+..   ....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence            68999999999999999999999899999999986553  334567899999999999999999999986432   2257


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--CCCceecCCCCCceecCCCCcee
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--QPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ++||||+++|+|.+++...      ......+++.++..++.|++.||+|||+.+  ..+||||||||+|||++.++.+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          81 YIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            9999999999999998543      112357899999999999999999999864  23599999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||+|+.......  ......||+.|||||.+.+..+++++|||||||++|||+||+.||.....  ..+...+....
T Consensus       155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~  230 (269)
T d2java1         155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGK  230 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTC
T ss_pred             EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCC
Confidence            999999998765432  22346799999999999999999999999999999999999999973211  11111111110


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ..        .+.                      ..+..++.+++.+|++.++-.||+..+...+
T Consensus       231 ~~--------~~~----------------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 FR--------RIP----------------------YRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CC--------CCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CC--------CCC----------------------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            00        000                      1223356678889999999999998876443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=362.90  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=191.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|.+. +++.||||+++... ...+++.+|++++++++||||++++|+|...+     ..+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~   76 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC   76 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceE
Confidence            457888899999999999999997 67889999997543 34567999999999999999999999998765     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+++|+|.+++...         ...+++.++..|+.|+|.||+|||+.+   |+||||||+|||+++++.+||+|
T Consensus        77 lv~E~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~D  144 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSD  144 (263)
T ss_dssp             EEEECCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECS
T ss_pred             EEEEecCCCcHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecc
Confidence            999999999999998643         356899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      ||+++........ ......||..|+|||.+.+..++.|+|||||||++|||+||..|+... .....+.+.+.......
T Consensus       145 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~~~  222 (263)
T d1sm2a_         145 FGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLY  222 (263)
T ss_dssp             CC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHHHTCCCC
T ss_pred             cchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHHhcCCCC
Confidence            9999877654322 223456899999999999999999999999999999999965444321 11111222222211110


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                           .                         ...|..++.+++..|++.++.+||++.++...
T Consensus       223 -----~-------------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         223 -----K-------------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----C-------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----C-------------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                 0                         11234456788999999999999999887543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-43  Score=364.60  Aligned_cols=250  Identities=19%  Similarity=0.276  Sum_probs=201.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||+||+|.+..+++.||||+++..   .....+.+.+|++++++++||||+++++++.+..     
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-----
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-----
Confidence            36899999999999999999999989999999998643   2334567999999999999999999999998765     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.+   ||||||||+|||+++++.+|
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~----------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vk  148 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ  148 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEEEccCCCCHHHhhhcc----------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEE
Confidence            899999999999999988643          56899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||...     +.....+...
T Consensus       149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~  223 (288)
T d1uu3a_         149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQKII  223 (288)
T ss_dssp             ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHHHHHHHHH
Confidence            99999999887655444445567999999999999999999999999999999999999999732     1122222111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ...      ..+.                      ......+.+++.+|.+.++..|++..+..
T Consensus       224 ~~~------~~~p----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         224 KLE------YDFP----------------------EKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             TTC------CCCC----------------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             cCC------CCCC----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            110      0000                      01223455788899999999999988753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=367.75  Aligned_cols=257  Identities=23%  Similarity=0.379  Sum_probs=202.7

Q ss_pred             HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++..++|...+.||+|+||+||+|.++ +++.||||+++... ...+.|.+|++++++++|||||+++|++.+.      
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------   80 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------   80 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------
Confidence            344567888899999999999999987 67899999996543 3456799999999999999999999988542      


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+++|+|.+++...        ....+++.+++.|+.|||+||+|||+.+   |+||||||+|||+++++.+|
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~--------~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~K  149 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCK  149 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred             CeEEEEEeCCCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeeccccee
Confidence            468999999999999987643        2346899999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||+|+........ ......||+.|+|||.+.++.++.|+|||||||++|||+||..|+..... ...+.+.+....
T Consensus       150 l~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~  227 (272)
T d1qpca_         150 IADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGY  227 (272)
T ss_dssp             ECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTC
T ss_pred             eccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcC
Confidence            9999999987654321 22345689999999999999999999999999999999997666542211 111112211111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .        +..                      ...+...+.+++..|++.++.+||++..+...++
T Consensus       228 ~--------~~~----------------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         228 R--------MVR----------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             C--------CCC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C--------CCC----------------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            0        000                      0123445678889999999999999988755443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=358.10  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=196.1

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      ...+.||+|+||+||+|.+..+++.||+|.+....  ....+.+.+|++++++++||||+++++++.... .+....++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence            44568999999999999999899999999986543  334567899999999999999999999986532 223468999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC-CCCceeeCcc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD-EEMVSHVGDF  429 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df  429 (789)
                      |||+++|+|.+++...          ..+++.++..++.||+.||+|||+++ ++||||||||+|||++ +++.+||+||
T Consensus        91 mE~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EeCCCCCcHHHHHhcc----------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence            9999999999999643          56899999999999999999999874 4599999999999996 5789999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      |+|+......    .....||+.|||||++.+ +++.++|||||||++|||++|+.||...    .+.....+.......
T Consensus       160 Gla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~----~~~~~~~~~i~~~~~  230 (270)
T d1t4ha_         160 GLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRRVTSGVK  230 (270)
T ss_dssp             TGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCC
T ss_pred             CcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc----ccHHHHHHHHHcCCC
Confidence            9998754432    335679999999998764 6999999999999999999999999632    122222222111100


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      ....+                          ..+..++.+++..|++.++.+|++..+...
T Consensus       231 ~~~~~--------------------------~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PASFD--------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CGGGG--------------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccC--------------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            00000                          112234567889999999999998877644

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-43  Score=365.30  Aligned_cols=258  Identities=23%  Similarity=0.367  Sum_probs=195.1

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCc----eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGR----TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++.|+..++||+|+||+||+|.++.++    ..||||+++.... .....|.+|++++++++|||||+++|+|....  
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--   82 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--   82 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--
Confidence            4567888999999999999999987544    4799999965533 34567899999999999999999999998765  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|++.+++...         ...+++.++..++.|+|.||+|||+.+   |+||||||+|||++.++
T Consensus        83 ---~~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~  147 (283)
T d1mqba_          83 ---PMMIITEYMENGALDKFLREK---------DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNL  147 (283)
T ss_dssp             ---SEEEEEECCTTEEHHHHHHHT---------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred             ---ceEEEEEecccCcchhhhhcc---------cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCC
Confidence               789999999999999887543         356899999999999999999999988   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA  501 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~  501 (789)
                      .+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ..+...+
T Consensus       148 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i  226 (283)
T d1mqba_         148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAI  226 (283)
T ss_dssp             CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHH
T ss_pred             eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHH
Confidence            9999999999987654422 2233456899999999999999999999999999999999976665422111 1111111


Q ss_pred             HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      .....        +.                      ...++...+.+++..|++.++..||++.++...++
T Consensus       227 ~~~~~--------~~----------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         227 NDGFR--------LP----------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             HTTCC--------CC----------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             hccCC--------CC----------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence            11110        00                      11134456778999999999999999987754443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-43  Score=363.74  Aligned_cols=253  Identities=23%  Similarity=0.263  Sum_probs=204.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|+..+.||+|+||+||+|.+..+++.||||+++.......+.+.+|++++++++||||+++++++....     ..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence            46788899999999999999999999999999998776667788999999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+++|+|.+++...         ...+++.++..++.|++.||+|||+.+   ||||||||+|||++.++++||+||
T Consensus        87 vmEy~~~g~L~~~~~~~---------~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DF  154 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---------ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADF  154 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEec
Confidence            99999999999987532         346899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |+|+......  .......||+.|+|||++.     ...|+.++|||||||++|||+||+.||...... ..+....+..
T Consensus       155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~  231 (288)
T d2jfla1         155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSE  231 (288)
T ss_dssp             TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSC
T ss_pred             hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCC
Confidence            9997654321  1122456999999999874     456899999999999999999999999743211 1111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .+         .+                    .....+...+.+++.+|++.++..|++..+...+
T Consensus       232 ~~---------~~--------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 PP---------TL--------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CC---------CC--------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CC---------CC--------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            10         00                    0011233456678889999999999999887554

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=361.67  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             cCCCCCCc-ccccCCccEEEEEEcC--CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANL-IGTGSFGSVYKGVLDE--GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~-ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+. ||+|+||+||+|.++.  ++..||||+++... ....+.|.+|++++++++|||||+++|+|...      
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence            45666664 9999999999998863  35579999997553 34467899999999999999999999998642      


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+++|+|.+++...         ...+++.++..++.|+|.||+|||+.+   ||||||||+||+++.++.+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCcee
Confidence            479999999999999997543         356899999999999999999999988   99999999999999999999


Q ss_pred             eCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          426 VGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      |+|||+|+........ .......||+.|+|||++..+.++.++|||||||++|||+| |+.||....  ...+...+..
T Consensus       150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~  227 (285)
T d1u59a_         150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQ  227 (285)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHT
T ss_pred             eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHc
Confidence            9999999988655432 22234568899999999999999999999999999999998 999997432  1122222221


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ....        ..                      ...+..++.+++..|++.++.+||++..+...
T Consensus       228 ~~~~--------~~----------------------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~  265 (285)
T d1u59a_         228 GKRM--------EC----------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQR  265 (285)
T ss_dssp             TCCC--------CC----------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCC--------CC----------------------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            1110        00                      11344566788999999999999998776443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-43  Score=371.54  Aligned_cols=201  Identities=24%  Similarity=0.340  Sum_probs=179.0

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ...|+|...+.||+|+||+||+|.+..+++.||+|+++... ......+.+|++++++++|||||+++++|....     
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----   77 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----   77 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----
Confidence            45688999999999999999999999899999999997553 344567899999999999999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCce
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ..++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++++
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~----------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~v  144 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEI  144 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCE
T ss_pred             EEEEEEEcCCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCE
Confidence            899999999999999999643          4689999999999999999999974 7   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+|||+|+......    .....||+.|+|||++.+..|++++||||+||++|||++|+.||..
T Consensus       145 kl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         145 KLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             EECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             EEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999999998764322    2345799999999999999999999999999999999999999974

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-42  Score=350.96  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=203.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      .++|...+.||+|+||+||+|+++ +++.||||+++.... ..+++.+|++++++++||||++++|+|....     ..+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceE
Confidence            478999999999999999999996 788999999975433 3568999999999999999999999997655     789


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+.+|++.+++...         ...+++..+..++.|+|+||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        76 iv~Ey~~~g~l~~~~~~~---------~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~D  143 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSD  143 (258)
T ss_dssp             EEEECCTTEEHHHHHHSG---------GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEccCCCcHHHhhhcc---------ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECc
Confidence            999999999999997543         356889999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||+++........ ......||+.|+|||.+.+..++.|+|||||||++|||+| |+.||......  .+...+......
T Consensus       144 fG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~  220 (258)
T d1k2pa_         144 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRL  220 (258)
T ss_dssp             CSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCC
T ss_pred             chhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCCC
Confidence            9999877654322 2334568999999999999999999999999999999998 89998743211  111111111100


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                           ..|                         ..+..++.+++..|++.+|-+||+..++..
T Consensus       221 -----~~p-------------------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~  253 (258)
T d1k2pa_         221 -----YRP-------------------------HLASEKVYTIMYSCWHEKADERPTFKILLS  253 (258)
T ss_dssp             -----CCC-------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -----CCc-------------------------ccccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                 001                         123345678899999999999999887643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=366.92  Aligned_cols=265  Identities=20%  Similarity=0.291  Sum_probs=204.9

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCc-----eEEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGR-----TTVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVD  340 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  340 (789)
                      ..++|...+.||+|+||+||+|++...+     ..||||.+... .......+.+|++++.++ +|||||+++++|....
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            3467888999999999999999986443     47999998654 334457899999999998 8999999999998766


Q ss_pred             CCCCceEEEEeeccCCCChhhhccCCCCCc-------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCce
Q 041249          341 YQGNDFKALVYEFMQNGSLEEWLYPVNRED-------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT  407 (789)
Q Consensus       341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv  407 (789)
                           ..++||||+++|+|.+++......-             ........+++.+++.|+.|||+||+|||+.+   ||
T Consensus       115 -----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---Ii  186 (325)
T d1rjba_         115 -----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV  186 (325)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             -----eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence                 7899999999999999997642110             00112346899999999999999999999988   99


Q ss_pred             ecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCC
Q 041249          408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKP  486 (789)
Q Consensus       408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P  486 (789)
                      ||||||+||+++.++++||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||+| |+.|
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence            999999999999999999999999998766554444445668999999999999999999999999999999998 8999


Q ss_pred             CCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          487 SDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                      |...... ..+...++......                              ....+..++.+++..|++.+|.+||++.
T Consensus       267 f~~~~~~-~~~~~~~~~~~~~~------------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         267 YPGIPVD-ANFYKLIQNGFKMD------------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             STTCCCS-HHHHHHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCHH-HHHHHHHhcCCCCC------------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9743211 12222222211110                              0113345667889999999999999998


Q ss_pred             ccccc
Q 041249          567 LAGSI  571 (789)
Q Consensus       567 ~~~~~  571 (789)
                      ++..+
T Consensus       316 ei~~~  320 (325)
T d1rjba_         316 NLTSF  320 (325)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-42  Score=356.68  Aligned_cols=244  Identities=22%  Similarity=0.302  Sum_probs=193.2

Q ss_pred             CcccccCCccEEEEEEcC--CceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249          276 NLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY  351 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  351 (789)
                      +.||+|+||+||+|.++.  .++.||||+++..  .....+.+.+|++++++++|||||+++|+|...      ..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            479999999999998753  4578999999644  333457899999999999999999999998542      468999


Q ss_pred             eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249          352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL  431 (789)
Q Consensus       352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  431 (789)
                      ||+++|+|.+++...          ..+++.++..|+.|||.||+|||+.+   ||||||||+|||++.++.+|++|||+
T Consensus        87 E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          87 EMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             ECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EcCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhh
Confidence            999999999998644          56899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCch
Q 041249          432 ARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHV  509 (789)
Q Consensus       432 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  509 (789)
                      ++......... ......||+.|+|||.+....++.++|||||||++|||+| |+.||.....  ..+...+......  
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~~~--  229 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERM--  229 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCC--
T ss_pred             hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCCCC--
Confidence            99876554322 2334568999999999999999999999999999999998 8999973211  1112222111000  


Q ss_pred             hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                            .                      ....|..++.+++..|++.++..||++..+..
T Consensus       230 ------~----------------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~  262 (277)
T d1xbba_         230 ------G----------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  262 (277)
T ss_dssp             ------C----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------C----------------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                  0                      01134456678899999999999999987644

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-41  Score=358.25  Aligned_cols=252  Identities=21%  Similarity=0.218  Sum_probs=186.4

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      +.|...+.||+|+||+||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++....     ..+
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-----HLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            56888999999999999999999899999999996543 233456889999999999999999999998766     899


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---CCCcee
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSH  425 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~k  425 (789)
                      +||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.+   ||||||||+||++.   +++.+|
T Consensus        84 lvmE~~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vk  150 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEK----------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIM  150 (307)
T ss_dssp             EEECCCCSCBHHHHHHTC----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EEEeccCCCcHHHhhhcc----------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEE
Confidence            999999999999999644          56899999999999999999999998   99999999999994   578999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||+|+.......   .....||+.|||||.+.+..|++++|||||||++|||++|+.||....     ..+......
T Consensus       151 l~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~  222 (307)
T d1a06a_         151 ISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQIL  222 (307)
T ss_dssp             ECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHH
T ss_pred             EeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHh
Confidence            999999987654432   233569999999999999999999999999999999999999997321     111111111


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ... ... +..                      ........+.+++..|.+.+|..|++..++..+
T Consensus       223 ~~~-~~~-~~~----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         223 KAE-YEF-DSP----------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTC-CCC-CTT----------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccC-CCC-CCc----------------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            100 000 000                      001223345678889999999999999877543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-41  Score=357.10  Aligned_cols=246  Identities=24%  Similarity=0.286  Sum_probs=198.0

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .|+..+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|++++++++|||||++++++....     ..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----EE
Confidence            48888999999999999999998999999999875532   23457899999999999999999999998766     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+|++..++...          ..+++.++..++.||+.||.|||+.+   ||||||||+|||++.++++||+
T Consensus        91 ~iv~E~~~~g~l~~~~~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEEEEecCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEe
Confidence            9999999999987766432          56899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      |||+|+......      ...||+.|||||++.+   +.|+.++|||||||++|||++|+.||....    ....+.+..
T Consensus       158 DFG~a~~~~~~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~~~i~  227 (309)
T d1u5ra_         158 DFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIA  227 (309)
T ss_dssp             CCTTCBSSSSBC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHH
T ss_pred             ecccccccCCCC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----HHHHHHHHH
Confidence            999998765432      3569999999999753   568999999999999999999999996321    111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       ...     .+.+..                     ..+...+.+++..|++.+|..|++..+...+
T Consensus       228 -~~~-----~~~~~~---------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         228 -QNE-----SPALQS---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -HSC-----CCCCSC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -hCC-----CCCCCC---------------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             000     011100                     1123356678889999999999999887554

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.3e-41  Score=360.17  Aligned_cols=253  Identities=22%  Similarity=0.229  Sum_probs=205.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||+||+|.+..+|+.||||++........+.+.+|++++++++||||+++++++.+..     ..++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            57999999999999999999999899999999997766666778999999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC--CCceeeC
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE--EMVSHVG  427 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~  427 (789)
                      ||||+.+|+|.+++...         ...+++.++..|+.||+.||+|||+.+   ||||||||+|||++.  ++.+||+
T Consensus       101 vmE~~~gg~L~~~l~~~---------~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2         101 IYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EECCCCSCBHHHHHTCT---------TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EEEcCCCCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEe
Confidence            99999999999998543         346899999999999999999999998   999999999999964  5789999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+|+......   ......||+.|||||++.+..++.++|||||||++|||++|+.||...     +..+..+.....
T Consensus       169 DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~  240 (350)
T d1koaa2         169 DFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSC  240 (350)
T ss_dssp             CCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHT
T ss_pred             ecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhC
Confidence            999999876544   234467999999999999999999999999999999999999999632     112222111000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .      ....                  ..........+.+++.+|.+.++-.|++..++..+
T Consensus       241 ~------~~~~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         241 D------WNMD------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             C------CCSC------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             C------CCCC------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      0000                  00001223345678889999999999998876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.5e-41  Score=358.62  Aligned_cols=253  Identities=18%  Similarity=0.187  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||+||+|....+++.||||+++.........+.+|++++++++||||+++++++.+..     ..++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            57999999999999999999999899999999997666556678899999999999999999999998765     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC--CCCceeeC
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--EEMVSHVG  427 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~  427 (789)
                      ||||+.+|+|.+++...         ...+++.++..|+.||+.||+|||+.+   ||||||||+|||++  .++.+||+
T Consensus       104 vmE~~~gg~L~~~~~~~---------~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_         104 ILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             EEECCCCCBHHHHTTCT---------TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEcCCCChHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEe
Confidence            99999999999887543         356899999999999999999999998   99999999999998  57899999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+|+......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||.....  ......+......
T Consensus       172 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~~  246 (352)
T d1koba_         172 DFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE  246 (352)
T ss_dssp             CCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC
T ss_pred             ecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC
Confidence            999999886654   23346799999999999999999999999999999999999999963211  1111111111000


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       .    ++..                      ......++.+++..|.+.++..|++..++..+
T Consensus       247 -~----~~~~----------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 -F----DEDA----------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -C----CSST----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -C----Cccc----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0    0000                      01223345688899999999999999877543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-42  Score=356.53  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=195.8

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .-++|...+.||+|+||+||+|.++ +++.||||+++... ...+.|.+|++++++++|||||+++|+|.+.      ..
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~   86 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PI   86 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC------Ce
Confidence            3467889999999999999999998 45679999996443 3457899999999999999999999998542      47


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.+|++..++...        ....++|.+++.|+.|||.||+|||+.+   |+||||||+|||++.++++||+
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~  155 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA  155 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEecCCCchhhhhhhc--------ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEc
Confidence            8999999999999988643        2346899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+|+........ ......||..|+|||++..+.++.++|||||||++|||++|+.|+...... ......+......
T Consensus       156 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~  233 (285)
T d1fmka3         156 DFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRM  233 (285)
T ss_dssp             CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCC
T ss_pred             ccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCC
Confidence            99999887554422 233456899999999999999999999999999999999977666532111 1122222211110


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                              ..                      ...+..++.+++.+|++.++..||++..+...+
T Consensus       234 --------~~----------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  268 (285)
T d1fmka3         234 --------PC----------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL  268 (285)
T ss_dssp             --------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --------CC----------------------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                    00                      113345677889999999999999998875433

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=358.63  Aligned_cols=253  Identities=22%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  344 (789)
                      ++|+..+.||+|+||+||+|.+..+++    +||+|.++.. .....+.+.+|++++++++|||||+++|+|.+.     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            579999999999999999999976665    5888888644 334567899999999999999999999999764     


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                       ..++++||+.+|+|.+++...         ...+++..+..|+.|||.||+|||+.+   ||||||||+|||++.++++
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHT---------SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEE
T ss_pred             -CeeEEEEeccCCccccccccc---------ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCe
Confidence             468899999999999887643         457899999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM  503 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~  503 (789)
                      ||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||+| |+.||+....  ..+...++.
T Consensus       151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~  228 (317)
T d1xkka_         151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK  228 (317)
T ss_dssp             EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHH
T ss_pred             EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999998876654444455678999999999999999999999999999999999 7888864321  122232222


Q ss_pred             hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .....                              ....|...+.+++..|++.++.+||++..+...+
T Consensus       229 ~~~~~------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         229 GERLP------------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             TCCCC------------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCC------------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            11100                              0113445567889999999999999998875543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-41  Score=357.53  Aligned_cols=271  Identities=24%  Similarity=0.328  Sum_probs=208.7

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeee
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTAC  336 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~  336 (789)
                      .+++...++|+..+.||+|+||+||+|+++     .+++.||||+++..... ..+++.+|++++++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            445566789999999999999999999986     34688999999755433 356799999999999999999999999


Q ss_pred             ccCCCCCCceEEEEeeccCCCChhhhccCCCCCc--------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 041249          337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED--------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDC  402 (789)
Q Consensus       337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~  402 (789)
                      ....     ..++||||+.+|+|.+++.......              ........+++.+++.|+.|+|.||+|||+.+
T Consensus        86 ~~~~-----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~  160 (301)
T d1lufa_          86 AVGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  160 (301)
T ss_dssp             CSSS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCC-----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence            8765     7899999999999999986432110              01122446899999999999999999999988


Q ss_pred             CCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249          403 QPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII  482 (789)
Q Consensus       403 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt  482 (789)
                         +|||||||+|||++.++++||+|||+|+...............|++.|+|||.+....++.|+|||||||++|||++
T Consensus       161 ---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         161 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence               99999999999999999999999999987765554444455678999999999999999999999999999999999


Q ss_pred             hc-CCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEec
Q 041249          483 RK-KPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILD  561 (789)
Q Consensus       483 G~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~  561 (789)
                      |. .||.....  ......++....        +..                      ...+..++.+++..|++.++.+
T Consensus       238 ~~~~p~~~~~~--~e~~~~v~~~~~--------~~~----------------------p~~~~~~~~~li~~cl~~~P~~  285 (301)
T d1lufa_         238 YGLQPYYGMAH--EEVIYYVRDGNI--------LAC----------------------PENCPLELYNLMRLCWSKLPAD  285 (301)
T ss_dssp             TTCCTTTTSCH--HHHHHHHHTTCC--------CCC----------------------CTTCCHHHHHHHHHHTCSSGGG
T ss_pred             cCCCCCCCCCH--HHHHHHHHcCCC--------CCC----------------------CccchHHHHHHHHHHcCCChhH
Confidence            85 56653211  111222221110        000                      0123445678999999999999


Q ss_pred             cCcccccccccc
Q 041249          562 LESLKLAGSILP  573 (789)
Q Consensus       562 l~s~~~~~~~l~  573 (789)
                      ||++.++...+.
T Consensus       286 RPt~~ev~~~L~  297 (301)
T d1lufa_         286 RPSFCSIHRILQ  297 (301)
T ss_dssp             SCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHH
Confidence            999988755443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=348.53  Aligned_cols=251  Identities=17%  Similarity=0.174  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      +.|...+.||+|+||+||+|.+..+++.||||+++....      ...+.+.+|++++++++||||+++++++.+..   
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---   86 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT---   86 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence            578999999999999999999998999999999864321      23567999999999999999999999998766   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-  422 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-  422 (789)
                        ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ||||||||+||+++.++ 
T Consensus        87 --~~~iv~E~~~gg~L~~~i~~~----------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~  151 (293)
T d1jksa_          87 --DVILILELVAGGELFDFLAEK----------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNV  151 (293)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSS
T ss_pred             --EEEEEEEcCCCccccchhccc----------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCC
Confidence              899999999999999998643          46899999999999999999999998   99999999999998776 


Q ss_pred             ---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          423 ---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       423 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                         .+|++|||+|+.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...     +..+
T Consensus       152 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~  223 (293)
T d1jksa_         152 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQE  223 (293)
T ss_dssp             SSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH
T ss_pred             cccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-----CHHH
Confidence               589999999998765442   23456899999999999999999999999999999999999999732     1111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS  570 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~  570 (789)
                      .........      ....                  ......+...+.+++.+|++.++..|++..++..
T Consensus       224 ~~~~i~~~~------~~~~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         224 TLANVSAVN------YEFE------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHTTC------CCCC------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcC------CCCC------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111100      0000                  0001122344567888999999999999887644

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=353.13  Aligned_cols=200  Identities=24%  Similarity=0.298  Sum_probs=179.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||.||+|....+++.||||+++..   .....+.+.+|+.++++++||||+++++++.+..     .
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----R   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----E
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-----c
Confidence            6799999999999999999999999999999999644   2334577889999999999999999999998876     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|+|.+++...          ..+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~----------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl  146 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred             cccceeccCCCchhhhhhcc----------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEE
Confidence            99999999999999998644          56889999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+|+.......  ......||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus       147 ~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~  207 (337)
T d1o6la_         147 TDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             CCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence            99999997654332  23346799999999999999999999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-40  Score=351.55  Aligned_cols=197  Identities=25%  Similarity=0.354  Sum_probs=177.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|++++++++||||+++++++....     .
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----Q   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----E
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-----e
Confidence            5788899999999999999999989999999999643   2334577999999999999999999999998766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|++..++...          ..+++..+..++.|++.||+|||+.+   ||||||||+|||++.++.+||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL  145 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKS----------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI  145 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHT----------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEE
T ss_pred             eeeEeeecCCcccccccccc----------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEE
Confidence            99999999999999988644          56788889999999999999999988   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+|+......     ....||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus       146 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         146 TDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             CCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence            9999999875432     246799999999999999999999999999999999999999973

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=351.41  Aligned_cols=273  Identities=22%  Similarity=0.246  Sum_probs=199.0

Q ss_pred             HHHHHhhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeee
Q 041249          263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTA  335 (789)
Q Consensus       263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~  335 (789)
                      .+++..-++|...+.||+|+||+||+|.+..     +++.||||+++... ....+.+..|++.+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            4444556789999999999999999999853     35789999987543 33456788888888887 68999999998


Q ss_pred             eccCCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceec
Q 041249          336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC  409 (789)
Q Consensus       336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~  409 (789)
                      +....    ...++||||+++|+|.+++.......      ........+++.++..++.|||.||+|||+.+   ||||
T Consensus        86 ~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr  158 (299)
T d1ywna1          86 CTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  158 (299)
T ss_dssp             ECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             eccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence            86543    25799999999999999996541110      00112346899999999999999999999988   9999


Q ss_pred             CCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhc-CCCC
Q 041249          410 DLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSD  488 (789)
Q Consensus       410 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~-~P~~  488 (789)
                      ||||+|||++.++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999876655444445567999999999999999999999999999999999975 5665


Q ss_pred             ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      .. .....+...++........                              ..+..++.+++..|++.++..||++.++
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~l~~li~~cl~~dP~~Rpt~~ei  287 (299)
T d1ywna1         239 GV-KIDEEFCRRLKEGTRMRAP------------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSEL  287 (299)
T ss_dssp             TC-CCSHHHHHHHHHTCCCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CC-CHHHHHHHHHhcCCCCCCC------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            32 1122222222222111111                              1233456688899999999999999887


Q ss_pred             ccccc
Q 041249          569 GSILP  573 (789)
Q Consensus       569 ~~~l~  573 (789)
                      ..++.
T Consensus       288 l~~L~  292 (299)
T d1ywna1         288 VEHLG  292 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            55443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-41  Score=345.56  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=191.3

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      -++|...+.||+|+||.||+|.++  ++.||||+++..  ...+.+.+|++++++++||||++++|+|.+.+    ...+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEE
Confidence            356778899999999999999985  788999999643  34567999999999999999999999986532    2579


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD  428 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  428 (789)
                      +||||+++|+|.+++...        ....+++.+++.|+.|||.||+|||+.+   ||||||||+||+++.++.+|++|
T Consensus        78 lv~ey~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~d  146 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD  146 (262)
T ss_dssp             EEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEEeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecc
Confidence            999999999999999643        2235899999999999999999999887   99999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      ||+++......     ....++..|+|||++.++++++++|||||||++|||+| |+.||...  ....+..++......
T Consensus       147 fg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~~  219 (262)
T d1byga_         147 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM  219 (262)
T ss_dssp             CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCC
T ss_pred             cccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCC
Confidence            99998764432     23457899999999999999999999999999999998 67777632  222333333221111


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                              .+                      ...+..++.+++..|++.++.+||++......+
T Consensus       220 --------~~----------------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L  254 (262)
T d1byga_         220 --------DA----------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL  254 (262)
T ss_dssp             --------CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --------CC----------------------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                    01                      112334566888999999999999998875433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-40  Score=355.42  Aligned_cols=244  Identities=20%  Similarity=0.235  Sum_probs=194.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHH---HHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSF---IAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ++|...+.||+|+||.||+|++..+++.||||++....   ......+   ..|+++++.++||||+++++++....   
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~---   80 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD---   80 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS---
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC---
Confidence            68999999999999999999999999999999985332   1222233   34577888889999999999998766   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|+|.+++...          ..+++.++..++.||+.||+|||+.+   ||||||||+|||++.++.
T Consensus        81 --~~~ivmE~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~  145 (364)
T d1omwa3          81 --KLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGH  145 (364)
T ss_dssp             --EEEEEECCCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSC
T ss_pred             --EEEEEEEecCCCcHHHHHHhc----------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCc
Confidence              899999999999999999643          56788999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+|+......    .....||+.|+|||++..+ .|++++|||||||++|||+||+.||......  ......+
T Consensus       146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~  219 (364)
T d1omwa3         146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDR  219 (364)
T ss_dssp             EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHH
T ss_pred             EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence            9999999999776543    2345699999999998765 5899999999999999999999999743222  2222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      ......      +.+.                      ..+..++.+++..|.+.+|..|++.
T Consensus       220 ~~~~~~------~~~~----------------------~~~s~~~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         220 MTLTMA------VELP----------------------DSFSPELRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             HSSSCC------CCCC----------------------SSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred             hcccCC------CCCC----------------------CCCCHHHHHHHHHHcccCHHHhCCC
Confidence            222111      0000                      0122345578889999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-40  Score=346.29  Aligned_cols=244  Identities=21%  Similarity=0.277  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHh-cCCCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALR-SIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||+||+|+...+++.||||+++..   .......+..|+.++. .++||||+++++++.+..     
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-----   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-----   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence            5788999999999999999999999999999999643   2333455666777665 689999999999998776     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+++|+|.+++...          ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++++|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~----------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~k  143 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIK  143 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             ceeEEEeecCCCcHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCcee
Confidence            899999999999999999644          46889999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL  505 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~  505 (789)
                      |+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...     +..+..+...
T Consensus       144 l~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~  216 (320)
T d1xjda_         144 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSIR  216 (320)
T ss_dssp             ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             ccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHH
Confidence            999999987654432  233457999999999999999999999999999999999999999732     1222221110


Q ss_pred             CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249          506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK  566 (789)
Q Consensus       506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~  566 (789)
                      ..      ++.+.                      ..+...+.+++.+|...++-.|++..
T Consensus       217 ~~------~~~~p----------------------~~~s~~~~dli~~~L~~dP~~R~s~~  249 (320)
T d1xjda_         217 MD------NPFYP----------------------RWLEKEAKDLLVKLFVREPEKRLGVR  249 (320)
T ss_dssp             HC------CCCCC----------------------TTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred             cC------CCCCC----------------------ccCCHHHHHHHHHhcccCCCCCcCHH
Confidence            00      01110                      01223455788899999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=348.76  Aligned_cols=267  Identities=23%  Similarity=0.273  Sum_probs=196.6

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      +|...+.||+|+||+||+|++.  |+.||||+++.... .....+.|+..+..++||||++++|+|.... ......++|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            4556778999999999999974  89999999864422 2223445666667889999999999997654 222367999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC-----CCCceecCCCCCceecCCCCcee
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC-----QPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      |||+.+|+|.++++..           .++|.++..++.|+|.||+|+|+.+     .++||||||||+|||+++++++|
T Consensus        80 ~Ey~~~g~L~~~l~~~-----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EecccCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            9999999999999643           5899999999999999999999752     34599999999999999999999


Q ss_pred             eCcccccccCCCCCCc--cceeeecccccccCcccCCCC------CcCccccchhhHHHHHHHHHhcCCCCccccCC---
Q 041249          426 VGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIRKKPSDIMFEGD---  494 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~---  494 (789)
                      |+|||+++........  .......||+.|+|||++.+.      .++.|+|||||||++|||+||..|+.......   
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            9999999987654422  223356799999999998754      37889999999999999999998885432111   


Q ss_pred             -------ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccc
Q 041249          495 -------MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKL  567 (789)
Q Consensus       495 -------~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~  567 (789)
                             .......+.        ..+...+....             ..+...++...+.+++.+|++.++..||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~--------~~~~~~~p~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  287 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKV--------VCEQKLRPNIP-------------NRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             TTTSCSSCCHHHHHHH--------HTTSCCCCCCC-------------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             hhcccccchHHHHHHH--------HhccccCCCCC-------------cccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence                   111111111        11111111100             01122356677889999999999999999988


Q ss_pred             cccccc
Q 041249          568 AGSILP  573 (789)
Q Consensus       568 ~~~~l~  573 (789)
                      +...+.
T Consensus       288 i~~~L~  293 (303)
T d1vjya_         288 IKKTLS  293 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            754443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-40  Score=346.31  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             CCcccccCCccEEEEEEcCCc---eEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249          275 ANLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV  350 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  350 (789)
                      .++||+|+||+||+|.+..++   ..||||.++.. .....++|.+|++++++++||||++++|+|...+    ...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence            468999999999999986443   36899998643 4445678999999999999999999999986533    268999


Q ss_pred             eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249          351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG  430 (789)
Q Consensus       351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  430 (789)
                      |||+.+|++.+++...         ...+++.+++.++.|+|.||.|+|+.+   |+||||||+|||+++++.+||+|||
T Consensus       108 ~E~~~~g~l~~~~~~~---------~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EECCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEeecCchhhhhccc---------cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEeccc
Confidence            9999999999998643         456788899999999999999999888   9999999999999999999999999


Q ss_pred             ccccCCCCCC--ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249          431 LARFLPPTHV--QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH  508 (789)
Q Consensus       431 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  508 (789)
                      +++.......  ........||+.|+|||.+.++.++.|+||||||+++|||+||+.||...... ..+..++...... 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~~-  253 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRL-  253 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC-
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC-
Confidence            9998765542  22233456899999999999999999999999999999999988887632211 1122222111100 


Q ss_pred             hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                          .+                         ...+...+.+++..|++.+|-.||++.++...+
T Consensus       254 ----~~-------------------------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  288 (311)
T d1r0pa_         254 ----LQ-------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  288 (311)
T ss_dssp             ----CC-------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ----CC-------------------------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence                00                         012334567889999999999999999885443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.8e-40  Score=342.99  Aligned_cols=207  Identities=23%  Similarity=0.375  Sum_probs=171.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  345 (789)
                      .++|...+.||+|+||+||+|.+..+++.||||+++...   ......+.+|++++++++||||+++++++...+ ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            367899999999999999999999899999999996543   233467899999999999999999999987644 1223


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+.+|+|.+++...          ..+++.++..++.|++.||+|||+.+   ||||||||+|||++.++..+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEE
T ss_pred             eEEEEEECCCCCEehhhhccc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccce
Confidence            579999999999999988643          56899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCC-CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTH-VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++|||.+....... .........||+.|+|||.+.+..+++++|||||||++|||+||+.||..
T Consensus       152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence            99999988765443 22233456799999999999999999999999999999999999999973

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-39  Score=336.75  Aligned_cols=252  Identities=21%  Similarity=0.253  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---------hhHHHHHHHHHHhcCC-CCccceeeeeeccC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---------ASRSFIAECRALRSIR-HRNLVKVFTACSGV  339 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  339 (789)
                      ++|...+.||+|+||+||+|+...+++.||||+++.....         ..+.+.+|++++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6788899999999999999999989999999998654221         2346889999999996 99999999999876


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      +     ..++||||+++|+|.+++...          ..+++.++..++.||+.||+|||..+   ||||||||+||+++
T Consensus        83 ~-----~~~ivmE~~~~g~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~  144 (277)
T d1phka_          83 T-----FFFLVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD  144 (277)
T ss_dssp             S-----EEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred             c-----ceEEEEEcCCCchHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEc
Confidence            6     899999999999999999643          46899999999999999999999998   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC------CCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG------SEVSTNGDVYSYGILMLELIIRKKPSDIMFEG  493 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~  493 (789)
                      .++.+||+|||+++.......   .....||..|+|||.+.+      ..++.++||||+||++|||++|+.||..... 
T Consensus       145 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-  220 (277)
T d1phka_         145 DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-  220 (277)
T ss_dssp             TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred             CCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-
Confidence            999999999999998765442   234569999999998753      3478999999999999999999999974311 


Q ss_pred             CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                       ......+...-.         .+                  +......+..++.+++.+|.+.++.+|++..++..+
T Consensus       221 -~~~~~~i~~~~~---------~~------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         221 -MLMLRMIMSGNY---------QF------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -HHHHHHHHHTCC---------CC------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -HHHHHHHHhCCC---------CC------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             111111110000         00                  000112334566788999999999999998876443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=343.97  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=191.0

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG  343 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  343 (789)
                      ..++|...+.||+|+||+||+|.+..+   +..||||.++.... ...+.+.+|++++++++||||++++|++.+ .   
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~---   80 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N---   80 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S---
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C---
Confidence            346788889999999999999998643   45789999865433 335679999999999999999999999853 2   


Q ss_pred             CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249          344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV  423 (789)
Q Consensus       344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~  423 (789)
                        ..++||||+.+|++.+++...         ...+++.++..++.||+.||+|||+.+   ||||||||+||+++.++.
T Consensus        81 --~~~iv~E~~~~g~l~~~~~~~---------~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~  146 (273)
T d1mp8a_          81 --PVWIIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC  146 (273)
T ss_dssp             --SCEEEEECCTTEEHHHHHHHT---------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred             --eEEEEEEeccCCcHHhhhhcc---------CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCc
Confidence              579999999999999987533         356899999999999999999999998   999999999999999999


Q ss_pred             eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249          424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR  502 (789)
Q Consensus       424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~  502 (789)
                      +||+|||+|+........ ......||+.|+|||.+....++.++|||||||++|||+| |..||.....  ..+...+.
T Consensus       147 ~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~  223 (273)
T d1mp8a_         147 VKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIE  223 (273)
T ss_dssp             EEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH
T ss_pred             EEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHH
Confidence            999999999876544322 2334568999999999999999999999999999999998 8999874322  22222222


Q ss_pred             HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      ......        +                      ..++...+.+++..|++.++.+||++.++...+
T Consensus       224 ~~~~~~--------~----------------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L  263 (273)
T d1mp8a_         224 NGERLP--------M----------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL  263 (273)
T ss_dssp             TTCCCC--------C----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCC--------C----------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            111100        0                      113345667889999999999999998775443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-39  Score=349.34  Aligned_cols=197  Identities=24%  Similarity=0.314  Sum_probs=177.5

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++|...+.||+|+||+||+|.++.+++.||||+++..   .....+.+.+|+++++.++||||+++++++....     .
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----N  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-----c
Confidence            5789999999999999999999989999999998643   2333567899999999999999999999998766     8


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++||||+.+|++.+++...          ..+++.++..|+.||+.||.|||+.+   ||||||||+|||++.++++||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL  182 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             cccccccccccchhhhHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEe
Confidence            89999999999999998643          46899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||+|+......     ....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       183 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         183 TDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             CCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence            9999999875432     235699999999999999999999999999999999999999973

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-39  Score=341.89  Aligned_cols=252  Identities=21%  Similarity=0.246  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      ++|...+.||+|+||+||+|.+..+++.||||+++... .....+.+|++++++++||||+++++++.+..     ..++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~l   78 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELVM   78 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEE
Confidence            57888999999999999999999999999999997553 33456889999999999999999999998766     8999


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC--CceeeC
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--MVSHVG  427 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~  427 (789)
                      ||||+.+|+|.+++...         +..+++.++..|+.||+.||+|||+.+   |+||||||+|||++.+  ..+|++
T Consensus        79 vmE~~~gg~L~~~i~~~---------~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          79 IFEFISGLDIFERINTS---------AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEc
Confidence            99999999999999643         346899999999999999999999998   9999999999999854  588999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD  507 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~  507 (789)
                      |||+++......   ......||+.|+|||...+..++.++||||+||++|||++|+.||....     ..+..+..   
T Consensus       147 DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~~~~~~i---  215 (321)
T d1tkia_         147 EFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENI---  215 (321)
T ss_dssp             CCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH---
T ss_pred             ccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----HHHHHHHH---
Confidence            999998875443   2334568999999999999999999999999999999999999997321     11111111   


Q ss_pred             chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                           ........                ......+...+.+++..|...++.+|++..+...+
T Consensus       216 -----~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         216 -----MNAEYTFD----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----HHTCCCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----HhCCCCCC----------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00000000                00001223345678889999999999998876543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=350.17  Aligned_cols=268  Identities=20%  Similarity=0.306  Sum_probs=208.8

Q ss_pred             HHHhhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249          265 LHNATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSG  338 (789)
Q Consensus       265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  338 (789)
                      ++...++|...+.||+|+||+||+|.++.     +++.||||+++... ......+.+|++++++++||||++++|+|..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            44556788888999999999999999852     35789999997543 3334578999999999999999999999976


Q ss_pred             CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249          339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL  418 (789)
Q Consensus       339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill  418 (789)
                      ..     ..++||||+.+|+|.+++...............+++..+..++.|+|.||.|||+.+   ||||||||+|||+
T Consensus        95 ~~-----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl  166 (308)
T d1p4oa_          95 GQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  166 (308)
T ss_dssp             SS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             CC-----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence            65     789999999999999998643111111123345789999999999999999999987   9999999999999


Q ss_pred             CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhc-CCCCccccCCccH
Q 041249          419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMNL  497 (789)
Q Consensus       419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~-~P~~~~~~~~~~~  497 (789)
                      ++++++||+|||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||. .||..     .+.
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~  241 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSN  241 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----CCH
Confidence            999999999999999876555444444556899999999999999999999999999999999985 66642     222


Q ss_pred             HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                      .++..........+                           ....+...+.+++..|++.++.+||++..+...+
T Consensus       242 ~~~~~~i~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  289 (308)
T d1p4oa_         242 EQVLRFVMEGGLLD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  289 (308)
T ss_dssp             HHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhCCCCC---------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            22222111110000                           0113445677899999999999999998775433

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=344.37  Aligned_cols=268  Identities=21%  Similarity=0.288  Sum_probs=210.3

Q ss_pred             HhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          267 NATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      ...++|...+.||+|+||.||+|++.     .+++.||||+++.... .....+.+|+.+++++ +|||||+++|+|...
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34567888899999999999999874     4568999999975543 3456799999999999 699999999999876


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCc--------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED--------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL  411 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl  411 (789)
                      .     ..++||||+.+|+|.+++.......        ........+++..+..++.|||.||+|||+++   +|||||
T Consensus       100 ~-----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDL  171 (311)
T d1t46a_         100 G-----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL  171 (311)
T ss_dssp             S-----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             C-----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence            5     7899999999999999987542210        11123446899999999999999999999998   999999


Q ss_pred             CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccc
Q 041249          412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF  491 (789)
Q Consensus       412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~  491 (789)
                      ||+||+++.++.+|++|||.++...............||+.|+|||.+.++.++.++|||||||++|||+|+..|+....
T Consensus       172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998876665555566789999999999999999999999999999999999655554333


Q ss_pred             cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      .....+.+.++...+....                              ..+...+.+++..|++.++.+||++..+...
T Consensus       252 ~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~  301 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLSP------------------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCc------------------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2222333343332221100                              1223456788999999999999999887544


Q ss_pred             c
Q 041249          572 L  572 (789)
Q Consensus       572 l  572 (789)
                      +
T Consensus       302 L  302 (311)
T d1t46a_         302 I  302 (311)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=337.67  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=190.0

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  342 (789)
                      .++|+..+.||+|+||+||+|.+...   ...||||+++..   .....+.|.+|++++++++||||++++|+|...   
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---   83 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   83 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence            35788889999999999999997533   347899998654   333456899999999999999999999999642   


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM  422 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~  422 (789)
                         ..++||||+.+|++.+++...         ...+++..++.++.|+|.||.|||+.+   |+||||||+||+++.++
T Consensus        84 ---~~~lv~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~  148 (273)
T d1u46a_          84 ---PMKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD  148 (273)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred             ---chheeeeeecCcchhhhhhcc---------cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccccc
Confidence               468999999999999887543         346899999999999999999999988   99999999999999999


Q ss_pred             ceeeCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249          423 VSHVGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF  500 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~  500 (789)
                      .+||+|||+++......... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...     +..+.
T Consensus       149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~  223 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQI  223 (273)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHH
T ss_pred             ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHH
Confidence            99999999999886665332 2334567889999999999999999999999999999998 89999632     12222


Q ss_pred             HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249          501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG  569 (789)
Q Consensus       501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~  569 (789)
                      ........        .+                  ......+...+.+++..|++.+|-.||++..+.
T Consensus       224 ~~~i~~~~--------~~------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         224 LHKIDKEG--------ER------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             HHHHHTSC--------CC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHhCC--------CC------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            21111111        00                  000112334566889999999999999988764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-40  Score=343.32  Aligned_cols=266  Identities=21%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCc-------eEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGR-------TTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGV  339 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  339 (789)
                      .++|...+.||+|+||.||+|+....+       ..||||+++.... .....+..|+..+.++ +||||++++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467788899999999999999976443       5799999976543 4457888999999888 899999999999876


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP  413 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~  413 (789)
                      .     ..++||||+.+|+|.+++.......      ........+++.+++.++.|+|.||+|||+.+   ||||||||
T Consensus        92 ~-----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp  163 (299)
T d1fgka_          92 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA  163 (299)
T ss_dssp             S-----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             C-----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecc
Confidence            5     7899999999999999997652110      11223467999999999999999999999998   99999999


Q ss_pred             CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcccc
Q 041249          414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFE  492 (789)
Q Consensus       414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~  492 (789)
                      +|||++.++.+||+|||.++...............|++.|+|||.+.++.|++|+||||||||+|||++ |+.||.....
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999999999999999998876665555556779999999999999999999999999999999998 6888763211


Q ss_pred             CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249          493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL  572 (789)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l  572 (789)
                        ..+.+.+......        ..                      ...+..++.+++.+|++.++..||++.++...+
T Consensus       244 --~~~~~~i~~~~~~--------~~----------------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         244 --EELFKLLKEGHRM--------DK----------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             --HHHHHHHHTTCCC--------CC----------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --HHHHHHHHcCCCC--------CC----------------------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence              1122222211110        00                      012334567899999999999999999885544


Q ss_pred             cc
Q 041249          573 PH  574 (789)
Q Consensus       573 ~~  574 (789)
                      +.
T Consensus       292 ~~  293 (299)
T d1fgka_         292 DR  293 (299)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-39  Score=344.19  Aligned_cols=257  Identities=16%  Similarity=0.158  Sum_probs=196.9

Q ss_pred             cCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|.+. ++||+|+||.||+|.+..+++.||||+++.     ...+.+|++++.++ +||||+++++++.... ......
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEE
Confidence            578775 469999999999999998999999999853     34677899887665 8999999999886422 122368


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCce
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVS  424 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~  424 (789)
                      ++||||+++|+|.+++...        ....+++.++..|+.|++.||+|||+.+   |+||||||+|||++.   .+.+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--------~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--------SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCE
T ss_pred             EEEEECCCCCcHHHHHHhc--------CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccc
Confidence            9999999999999999653        3457999999999999999999999998   999999999999985   4579


Q ss_pred             eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249          425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA  504 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~  504 (789)
                      ||+|||+|+.......   .....||+.|+|||++.+..|+.++|||||||++|||+||+.||......  .........
T Consensus       154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~~  228 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTR  228 (335)
T ss_dssp             EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C
T ss_pred             cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHHH
Confidence            9999999998765442   23456999999999999999999999999999999999999999643211  111111111


Q ss_pred             CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      ....       ...                ++......+..++.+++..|.+.++-.|++..++..+
T Consensus       229 i~~~-------~~~----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 IRMG-------QYE----------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CCSC-------SSS----------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcC-------CCC----------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1000       000                0001112334556788889999999999998876443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=342.69  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCce--EEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  345 (789)
                      ++|...+.||+|+||+||+|+++.++.  .||||.++.. .....+.+.+|+++++++ +||||++++|+|....     
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence            678888999999999999999987766  4777877543 334556799999999999 7999999999998766     


Q ss_pred             eEEEEeeccCCCChhhhccCCCCC------ccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNRE------DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD  419 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~  419 (789)
                      ..++||||+++|+|.++++.....      .........+++..+..++.|||.||.|+|+.+   ||||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEc
Confidence            899999999999999999754110      001123467999999999999999999999988   99999999999999


Q ss_pred             CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcC-CCCccccCCccHH
Q 041249          420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKK-PSDIMFEGDMNLH  498 (789)
Q Consensus       420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~-P~~~~~~~~~~~~  498 (789)
                      .++.+||+|||+++.......   .....||..|+|||.+..+.++.++|||||||++|||++|.. ||..     .+..
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-----~~~~  233 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----MTCA  233 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHH
T ss_pred             CCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-----CCHH
Confidence            999999999999987654332   223458999999999999999999999999999999999765 5642     1222


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP  573 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~  573 (789)
                      +..+.....     ..+.                      ....+..++.+++.+|++.++-+||++.++...+.
T Consensus       234 ~~~~~i~~~-----~~~~----------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         234 ELYEKLPQG-----YRLE----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             HHHHHGGGT-----CCCC----------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhc-----CCCC----------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            222211100     0000                      11133456778889999999999999998865443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-39  Score=336.66  Aligned_cols=195  Identities=26%  Similarity=0.368  Sum_probs=166.2

Q ss_pred             CCcccccCCccEEEEEEcCCceEEEEEEeccccch-----hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      .++||+|+||+||+|.+..+++.||||+++.....     ..+.+.+|++++++++||||+++++++...+     ..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----ceee
Confidence            46899999999999999989999999998654322     2356889999999999999999999998766     7899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF  429 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  429 (789)
                      ||||+.++++..+...          ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        78 vmE~~~~~~~~~~~~~----------~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDN----------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             EEECCSEEHHHHHTTC----------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             hhhhhcchHHhhhhhc----------ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccC
Confidence            9999999887776643          356888999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |.|+........  .....||+.|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus       145 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         145 GLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             GGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence            999876654322  2235689999999988755 579999999999999999999999963

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=335.55  Aligned_cols=201  Identities=26%  Similarity=0.379  Sum_probs=170.9

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      |+|...+.||+|+||+||+|.+..+++.||||+++....  .....+.+|++++++++||||+++++++.+..     ..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence            689999999999999999999998999999999965432  33578899999999999999999999998766     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++||||+.++.+ +++...        ....+++.++..++.|++.||+|||+.+   ||||||||+|||++.++.+|++
T Consensus        77 ~iv~e~~~~~~~-~~~~~~--------~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~  144 (298)
T d1gz8a_          77 YLVFEFLHQDLK-KFMDAS--------ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLA  144 (298)
T ss_dssp             EEEEECCSEEHH-HHHHHT--------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEeecCCchh-hhhhhh--------cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceec
Confidence            999999986544 443222        2456899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.|+.......  ......||+.|+|||...... ++.++|||||||++|||++|+.||..
T Consensus       145 DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         145 DFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             STTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence            9999987755432  223456999999999877655 58999999999999999999999973

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=330.57  Aligned_cols=241  Identities=19%  Similarity=0.212  Sum_probs=192.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCC--CCccceeeeeeccCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIR--HRNLVKVFTACSGVDY  341 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  341 (789)
                      ++|...+.||+|+||+||+|++..+++.||||+++....      .....+.+|++++++++  ||||+++++++...+ 
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~-   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD-   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence            468889999999999999999998999999999864421      12244678999999986  899999999998766 


Q ss_pred             CCCceEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249          342 QGNDFKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE  420 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~  420 (789)
                          ..++||||+.+ +++.+++...          ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.
T Consensus        83 ----~~~lv~e~~~~~~~l~~~~~~~----------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~  145 (273)
T d1xwsa_          83 ----SFVLILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL  145 (273)
T ss_dssp             ----EEEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEET
T ss_pred             ----eEEEEEEeccCcchHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEec
Confidence                89999999976 5777777533          56899999999999999999999998   999999999999985


Q ss_pred             -CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249          421 -EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH  498 (789)
Q Consensus       421 -~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~  498 (789)
                       ++.+||+|||+|+......    .....||+.|+|||++.+.++ +.++|||||||++|||++|+.||...       .
T Consensus       146 ~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~  214 (273)
T d1xwsa_         146 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------E  214 (273)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------H
T ss_pred             CCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------h
Confidence             4799999999998765443    234569999999999987765 67799999999999999999999731       1


Q ss_pred             HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249          499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI  571 (789)
Q Consensus       499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~  571 (789)
                      +..+....      ..+                          ....++.+++.+|.+.++..|++..+...+
T Consensus       215 ~i~~~~~~------~~~--------------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         215 EIIRGQVF------FRQ--------------------------RVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HHHHCCCC------CSS--------------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhhcccC------CCC--------------------------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11111000      000                          112345578889999999999998877543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=329.71  Aligned_cols=207  Identities=26%  Similarity=0.337  Sum_probs=171.8

Q ss_pred             hhcCCCCCCcccccCCccEEEEEEcCC-ceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCC
Q 041249          268 ATDGFSSANLIGTGSFGSVYKGVLDEG-RTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDY  341 (789)
Q Consensus       268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~  341 (789)
                      +.++|...+.||+|+||+||+|.+..+ ++.||||+++....  .....+.+|+++++.+   +||||++++++|.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357899999999999999999998644 67899999865422  2234566777766655   79999999999865544


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                      ......++++||+.+|.+......         ....+++..+..++.|++.||+|||+.+   ||||||||+|||++.+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~  152 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV---------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS  152 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS---------CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             ccCceEEEEEEeccCCchhhhhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCC
Confidence            444578999999998876554432         2456899999999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +.+|++|||.++......   ......||+.|+|||++.+..|++++||||+||++|||++|+.||..
T Consensus       153 ~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~  217 (305)
T d1blxa_         153 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  217 (305)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence            999999999988654332   23346799999999999999999999999999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-37  Score=325.00  Aligned_cols=199  Identities=24%  Similarity=0.339  Sum_probs=170.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++|...+.||+|+||+||+|.++ +++.||||+++...  ....+.+.+|+.++++++||||+++++++....     ..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            57888899999999999999997 78999999996553  233578999999999999999999999998766     89


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++++|++.++.+..+....          ..+++.++..++.||+.||+|||+.+   ||||||||+|||++.++.+|++
T Consensus        76 ~i~~e~~~~~~~~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~  142 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCE----------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIA  142 (286)
T ss_dssp             EEEEECCSEEHHHHHHTST----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeehhhhHHHHHhhc----------CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEec
Confidence            9999999987777776433          67999999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||.+........  ......|++.|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus       143 DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         143 DFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence            9999988754432  22334588999999998764 579999999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-37  Score=329.67  Aligned_cols=206  Identities=22%  Similarity=0.303  Sum_probs=170.7

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      ++.|...+.||+|+||+||+|+...+++.||||+++... ....+.+.+|++++++++||||+++++++.......... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~-   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD-   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC-
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce-
Confidence            346888899999999999999999899999999996543 334567899999999999999999999987654333323 


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      +++++|+.+|+|.+++..           ..+++..+..++.|++.||+|||+.+   ||||||||+|||++.++.+||+
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~  151 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC  151 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEeecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEc
Confidence            444566778999999853           35899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          428 DFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       428 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |||+|+........ .......||+.|+|||.+... .++.++||||+||++|||++|+.||..
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~  215 (345)
T d1pmea_         152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG  215 (345)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence            99999877654322 223456699999999998554 579999999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-37  Score=324.05  Aligned_cols=207  Identities=21%  Similarity=0.314  Sum_probs=170.1

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---CCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY---QGN  344 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~~  344 (789)
                      ++|+..+.||+|+||+||+|++..+++.||||++...  ......++.+|++++++++||||+++++++.....   ...
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788899999999999999999989999999998644  33345778999999999999999999999866431   122


Q ss_pred             ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249          345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS  424 (789)
Q Consensus       345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~  424 (789)
                      ...++||||+..+.+......          ...++...+..++.|++.||.|||+.+   ||||||||+|||++.++.+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~----------~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV----------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT----------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             ceEEEEEeccCCCccchhhhc----------ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence            357999999998877665532          356888999999999999999999988   9999999999999999999


Q ss_pred             eeCcccccccCCCCCCc--cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          425 HVGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       425 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      |++|||+++........  .......||+.|+|||.+.+. .+++|+|||||||++|||++|+.||..
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            99999999877654421  122235699999999998765 589999999999999999999999963

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-36  Score=316.56  Aligned_cols=202  Identities=20%  Similarity=0.287  Sum_probs=172.6

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC-CccceeeeeeccCCCCCCceE
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH-RNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~  347 (789)
                      .++|...+.||+|+||+||+|++..+++.||||+++...  ....+.+|++.++.+.| +|++.+++++....     ..
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-----cc
Confidence            357888999999999999999999899999999985432  33457889999999965 89999999887655     78


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-----CC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-----EM  422 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-----~~  422 (789)
                      ++||||+ +|+|.+++...         ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.     .+
T Consensus        77 ~~vme~~-~~~l~~~~~~~---------~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~  143 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN  143 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEEec-CCCHHHHHHhh---------ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCC
Confidence            9999998 57999888643         356899999999999999999999988   999999999999974     56


Q ss_pred             ceeeCcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          423 VSHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       423 ~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      .+|++|||+|+.......     ........||+.|||||.+.+..++.++|||||||++|||+||+.||...
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~  216 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  216 (293)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence            899999999998765432     11233457999999999999999999999999999999999999999743

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-36  Score=317.68  Aligned_cols=253  Identities=19%  Similarity=0.269  Sum_probs=190.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL  349 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  349 (789)
                      +.|...+.||+|+||+||+|++..+++.||||++.....  ..++..|+++++.++|++++..++.+....    ...++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~----~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET----TEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC----CEEEE
Confidence            568899999999999999999998999999999865432  345788999999998888777666654332    37899


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---CCCceee
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD---EEMVSHV  426 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl  426 (789)
                      ||||+. |++...+..         ..+.+++.++..++.|++.||+|||+.+   ||||||||+|||++   .+..+|+
T Consensus        81 vme~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          81 VMELLG-PSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             EEECCC-CBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEEcC-Cchhhhhhh---------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeee
Confidence            999996 456555532         2357899999999999999999999998   99999999999875   4567999


Q ss_pred             CcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCc--cHHH
Q 041249          427 GDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDM--NLHN  499 (789)
Q Consensus       427 ~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~--~~~~  499 (789)
                      +|||+|+.......     ........||+.|+|||.+.+..+++++|||||||++|||+||+.||........  .+..
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            99999998765432     1223345799999999999999999999999999999999999999975422211  1111


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA  568 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~  568 (789)
                      +..........+                           ....+..++.+++..|++.++.+||+....
T Consensus       228 ~~~~~~~~~~~~---------------------------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i  269 (299)
T d1ckia_         228 ISEKKMSTPIEV---------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYL  269 (299)
T ss_dssp             HHHHHHHSCHHH---------------------------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred             hhcccCCCChhH---------------------------hccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            111110000000                           011344566788889999999999987654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-36  Score=322.67  Aligned_cols=201  Identities=24%  Similarity=0.305  Sum_probs=166.4

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND  345 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  345 (789)
                      .+.|...+.||+|+||+||+|.+..+++.||||+++..  .....+.+.+|++++++++|||||+++++|...+. ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35788899999999999999999989999999999744  22335678899999999999999999999876542 2333


Q ss_pred             eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249          346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH  425 (789)
Q Consensus       346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  425 (789)
                      ..++||||+ ++++..+.+.           ..+++..+..++.|++.||+|||+.+   ||||||||+|||++.++.+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecc-cccHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence            579999999 4567776642           35899999999999999999999998   99999999999999999999


Q ss_pred             eCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ++|||.|+......     ....||..|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       162 l~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         162 ILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             ECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence            99999998765433     345699999999998764 579999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-36  Score=323.38  Aligned_cols=202  Identities=24%  Similarity=0.328  Sum_probs=165.9

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCceEEE
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDFKAL  349 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~l  349 (789)
                      +|+..++||+|+||+||+|++..+++.||||+++....    ...+|++++++++||||+++++++..... ....+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            46678899999999999999999999999999965432    23469999999999999999999865432 23346799


Q ss_pred             EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceeeCc
Q 041249          350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVGD  428 (789)
Q Consensus       350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~D  428 (789)
                      ||||+++|.+..+....       .....+++.++..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|
T Consensus        97 v~Ey~~~~~~~~l~~~~-------~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             EEECCSEEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECC
T ss_pred             EEeccCCccHHHHHhhh-------hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEec
Confidence            99999976444333211       13357899999999999999999999988   99999999999999775 899999


Q ss_pred             ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      ||+++........   ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       167 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         167 FGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence            9999887654422   23568999999998765 5689999999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=311.76  Aligned_cols=199  Identities=23%  Similarity=0.326  Sum_probs=174.6

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|+..+.||+|+||+||+|++..+++.||||+++...  ......+.+|+++++.++||||+++++++....     ..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence            46888899999999999999999999999999996543  334678999999999999999999999998776     88


Q ss_pred             EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249          348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG  427 (789)
Q Consensus       348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  427 (789)
                      ++|+|++.++++..++...          +.+++..+..++.|++.||+|||..+   ||||||||+|||++.++.+|++
T Consensus        77 ~iv~~~~~~~~l~~~~~~~----------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~  143 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN----------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred             eEEeeeccccccccccccc----------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeee
Confidence            9999999999988877543          57789999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      |||.++........  .....++..|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus       144 DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         144 NFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             CCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             ecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            99999987654422  22345778899999887665 6999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=319.41  Aligned_cols=248  Identities=21%  Similarity=0.247  Sum_probs=194.7

Q ss_pred             cCCCCCCcccccCCccEEEEEE---cCCceEEEEEEecccc----chhhHHHHHHHHHHhcCCC-CccceeeeeeccCCC
Q 041249          270 DGFSSANLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHH----HRASRSFIAECRALRSIRH-RNLVKVFTACSGVDY  341 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  341 (789)
                      ++|+..+.||+|+||+||+|..   +.+++.||||+++...    ....+.+.+|++++++++| |||+++++++.... 
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~-  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence            6799999999999999999987   4468999999986432    2335678899999999976 89999999988766 


Q ss_pred             CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249          342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE  421 (789)
Q Consensus       342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~  421 (789)
                          ..++|+||+.+|+|.+++...          ..++......++.|++.||+|+|+.+   ||||||||+||+++.+
T Consensus       103 ----~~~~v~e~~~~~~L~~~i~~~----------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_         103 ----KLHLILDYINGGELFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSN  165 (322)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             ----ceeeeeecccccHHHHHHHhc----------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCC
Confidence                899999999999999998654          45678889999999999999999998   9999999999999999


Q ss_pred             CceeeCcccccccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249          422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN  499 (789)
Q Consensus       422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~  499 (789)
                      +.+||+|||+++........ ......|++.|+|||.+...  .++.++|||||||++|||++|+.||....... ....
T Consensus       166 ~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~  243 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAE  243 (322)
T ss_dssp             SCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHH
T ss_pred             CCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            99999999999877544322 23345699999999998764  47889999999999999999999997543221 1122


Q ss_pred             HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249          500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL  565 (789)
Q Consensus       500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~  565 (789)
                      ..+.....      .+.+                      ..++...+.++..+|.+.++.+|++.
T Consensus       244 i~~~~~~~------~~~~----------------------~~~~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         244 ISRRILKS------EPPY----------------------PQEMSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             HHHHHHHC------CCCC----------------------CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             HHHhcccC------CCCC----------------------cccCCHHHHHHHHHHcccCHHHcCCC
Confidence            21111000      0000                      01234456678889999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-35  Score=317.13  Aligned_cols=196  Identities=23%  Similarity=0.342  Sum_probs=169.7

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEE
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKA  348 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  348 (789)
                      ++|...+.||+|+||+||+|++..+++.||||+++..   ..+.+.+|++++++++ ||||+++++++....   ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCcee
Confidence            6799999999999999999999989999999998643   3467889999999995 999999999986432   23689


Q ss_pred             EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceeeC
Q 041249          349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVG  427 (789)
Q Consensus       349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~  427 (789)
                      +||||+.+|+|..+.             +.+++.++..++.||+.||+|||+++   ||||||||+|||++.++ .+|++
T Consensus       109 ~v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             EEEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeec
Confidence            999999999987754             35899999999999999999999998   99999999999998655 68999


Q ss_pred             cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      |||+|+.......   .....+|..|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus       173 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         173 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             CGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            9999998765442   23456899999999987654 799999999999999999999999743

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-35  Score=319.09  Aligned_cols=202  Identities=22%  Similarity=0.296  Sum_probs=169.8

Q ss_pred             hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249          269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF  346 (789)
Q Consensus       269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  346 (789)
                      ++.|...+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999999899999999997543  234567889999999999999999999987554333334


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .++++||+.+|+|.+++..           +.+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+|+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl  162 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  162 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             eEEEEEeecCCchhhhccc-----------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence            5677888899999999853           35899999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI  489 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~  489 (789)
                      +|||.+......     .....|+..|+|||...+. .++.++|||||||++|+|++|+.||..
T Consensus       163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            999999765432     2345689999999987665 468999999999999999999999963

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-35  Score=314.01  Aligned_cols=200  Identities=22%  Similarity=0.262  Sum_probs=162.8

Q ss_pred             cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCce
Q 041249          270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDF  346 (789)
Q Consensus       270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  346 (789)
                      +.|...+.||+|+||+||+|.+..+++.||||+++...  ......+.+|+.++++++||||+++++++..... .....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57888999999999999999999899999999996542  3345678999999999999999999999876543 24458


Q ss_pred             EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249          347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV  426 (789)
Q Consensus       347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  426 (789)
                      .|+||||+.++.+.. +.            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++..|+
T Consensus        97 ~~iv~Ey~~~~l~~~-~~------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred             eEEEEeccchHHHHh-hh------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence            899999998655544 32            34789999999999999999999998   999999999999999999999


Q ss_pred             CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249          427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD  488 (789)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~  488 (789)
                      +|||+++......   ......+|..|+|||.+.+..+++++||||+||++|||++|+.||.
T Consensus       161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~  219 (355)
T d2b1pa1         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_dssp             CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence            9999988765443   2334568999999999999999999999999999999999999996

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=2.9e-30  Score=279.11  Aligned_cols=201  Identities=20%  Similarity=0.236  Sum_probs=158.7

Q ss_pred             CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-----------CCccceeeeeeccC
Q 041249          271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-----------HRNLVKVFTACSGV  339 (789)
Q Consensus       271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~  339 (789)
                      .|...+.||+|+||+||+|+...+++.||||+++... ...+.+.+|+++++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            3888999999999999999999899999999997543 23456778888888775           57899999887543


Q ss_pred             CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceec
Q 041249          340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILL  418 (789)
Q Consensus       340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill  418 (789)
                      .   ....+++++++..+.........       .....+++..+..++.|++.||+|||+ .+   |+||||||+|||+
T Consensus        93 ~---~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll  159 (362)
T d1q8ya_          93 G---PNGVHVVMVFEVLGENLLALIKK-------YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM  159 (362)
T ss_dssp             E---TTEEEEEEEECCCCEEHHHHHHH-------TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred             c---ccceeeeeeeccccccccccccc-------ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence            2   22456666666554322222111       234678889999999999999999997 77   9999999999999


Q ss_pred             CCCC------ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249          419 DEEM------VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM  490 (789)
Q Consensus       419 ~~~~------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~  490 (789)
                      +.++      .+|++|||.+.......     ....||..|+|||......++.++||||+||+++||++|+.||...
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            8654      48999999998654332     2356999999999999999999999999999999999999999743

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.95  E-value=1.2e-28  Score=260.70  Aligned_cols=231  Identities=27%  Similarity=0.454  Sum_probs=179.7

Q ss_pred             eeeEeccCcccccc--cccccccCccccchhcccC-CcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEE
Q 041249          556 KVTILDLESLKLAG--SILPHIGNLSFLKILNLEN-NSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRI  632 (789)
Q Consensus       556 ~l~~l~l~s~~~~~--~~l~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L  632 (789)
                      +++.+++.++.+.+  ..+..+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|+|++..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            68899999988876  3578999999999999997 89999999999999999999999999999999999999999999


Q ss_pred             EcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCC-CEEEccCCcCCccCCccccCCCCCCeeeccCccc
Q 041249          633 GLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSL-RKISLAINNLAGSIPFTLSKLKNLVILYLGVNRL  711 (789)
Q Consensus       633 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  711 (789)
                      ++++|++.+.+|..|.++++|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999999999999999999999999999999999999998888776 888888888887777666655433 466666666


Q ss_pred             cccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          712 SGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       712 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                      .+.+|..+..+++|+.|++++|.+++.+| .+. .+++|+.|+|++|+|++.+|..|+++++|+.|+|++|+|+|.+|
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~-~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP  285 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             ccccccccccccccccccccccccccccc-ccc-cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence            65555555555566666666666554333 232 45556666666666655555556666666666666666665555

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=3e-26  Score=249.01  Aligned_cols=190  Identities=28%  Similarity=0.439  Sum_probs=157.8

Q ss_pred             cCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcE
Q 041249          576 GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEV  655 (789)
Q Consensus       576 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  655 (789)
                      ..+++++.+++++|.+++..|  +...++|++|++++|+++. + +.+..+++|+.|++++|++++..  .+..+++|++
T Consensus       194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~  267 (384)
T d2omza2         194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE  267 (384)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred             ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCE
Confidence            345677888899999986654  4567889999999999984 3 46888999999999999998544  3788899999


Q ss_pred             EEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcc
Q 041249          656 LSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI  735 (789)
Q Consensus       656 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  735 (789)
                      |++++|++++..  .+..++.++.+++++|++++  ...+..+++++.|++++|+|++..  .+..+++|++|++++|+|
T Consensus       268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l  341 (384)
T d2omza2         268 LKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV  341 (384)
T ss_dssp             EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred             eeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence            999999998543  37788999999999999984  335888899999999999999653  388899999999999999


Q ss_pred             cccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249          736 QGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       736 ~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                      + .++ .+. ++++|++|+|++|+|++..|  +.++++|+.|++++|
T Consensus       342 ~-~l~-~l~-~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         342 S-DVS-SLA-NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             C-CCG-GGG-GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             C-CCh-hHc-CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            8 666 344 79999999999999997654  889999999999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.94  E-value=3.1e-27  Score=249.65  Aligned_cols=232  Identities=28%  Similarity=0.450  Sum_probs=214.1

Q ss_pred             cccceeeEeccCc-ccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCc
Q 041249          552 SKAQKVTILDLES-LKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLI  630 (789)
Q Consensus       552 ~~c~~l~~l~l~s-~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~  630 (789)
                      ..+.+++.+++.+ +.+.+..|..|+++++|++|+|++|++.+..+..+..+.+|+.+++++|++.+.+|..|.++++|+
T Consensus        73 ~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~  152 (313)
T d1ogqa_          73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV  152 (313)
T ss_dssp             GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred             hcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccc
Confidence            4677889999986 678888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEcccCCCCCCCCcccCCCCCC-cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCc
Q 041249          631 RIGLAKNQLMGKIPSDFGSLSKI-EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVN  709 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  709 (789)
                      ++++++|.+.+.+|+.+..+.++ +.+++++|++++..|..+.++.. ..+++++|.+.+.+|..+..+++|+.+++++|
T Consensus       153 ~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~  231 (313)
T d1ogqa_         153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN  231 (313)
T ss_dssp             EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred             eeecccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence            99999999999999999888876 89999999999999999988764 47999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCc-Cccc
Q 041249          710 RLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK-LTGE  787 (789)
Q Consensus       710 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~  787 (789)
                      .+++.+ ..+..+++|+.|+|++|+|+|.+|..+. ++++|++|+|++|+|+|.+|+ +.++++|+.+++++|+ ++|.
T Consensus       232 ~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~-~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         232 SLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             EECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             cccccc-cccccccccccccCccCeecccCChHHh-CCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence            999655 4688999999999999999999999987 899999999999999998885 5789999999999997 6775

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.93  E-value=8.2e-25  Score=237.50  Aligned_cols=167  Identities=27%  Similarity=0.392  Sum_probs=138.6

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      ..++|++|++++|+++. + ..+..+++|+.|++++|.+++..  .+..+++|++|++++|++++..  .+..++.++.+
T Consensus       217 ~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l  290 (384)
T d2omza2         217 ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNL  290 (384)
T ss_dssp             GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEE
T ss_pred             ccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccc
Confidence            35678889999999984 3 35788899999999999998653  4788899999999999998543  37788999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      +++.|++++.  ..+..+++++.|++++|+|++..  .+..+++|++|++++|+|++ ++ .|..+++|++|++++|+|+
T Consensus       291 ~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~  364 (384)
T d2omza2         291 ELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQIS  364 (384)
T ss_dssp             ECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCC
T ss_pred             cccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCC
Confidence            9999999853  45788899999999999998653  38889999999999999984 44 6899999999999999999


Q ss_pred             ccCCcccccCCCCccEEEccCC
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTN  758 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N  758 (789)
                       .+++ + .++++|++|+|++|
T Consensus       365 -~l~~-l-~~l~~L~~L~L~~N  383 (384)
T d2omza2         365 -DLTP-L-ANLTRITQLGLNDQ  383 (384)
T ss_dssp             -BCGG-G-TTCTTCSEEECCCE
T ss_pred             -CChh-h-ccCCCCCEeeCCCC
Confidence             4443 3 47999999999988

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.7e-25  Score=231.10  Aligned_cols=207  Identities=19%  Similarity=0.203  Sum_probs=191.0

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc-cCCCCCCCCcccCCCCCCcEEE
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA-KNQLMGKIPSDFGSLSKIEVLS  657 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~-~N~l~~~~~~~~~~l~~L~~L~  657 (789)
                      +.+++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+..+..++.++.. .|.++...+..|.++++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            568999999999998777889999999999999999998889999999999999875 6778877788999999999999


Q ss_pred             ccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccc
Q 041249          658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG  737 (789)
Q Consensus       658 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  737 (789)
                      +++|.+....+..+..+++|+.+++++|+|+++.+..|..+++|+.|++++|+|++..+.+|.++++|+.|++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            99999998888889999999999999999998778899999999999999999998889999999999999999999995


Q ss_pred             cCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249          738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       738 ~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ..|.. +.++++|++|++++|++++..+..|..+++|+.|++++|++.+
T Consensus       192 i~~~~-f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         192 VHPHA-FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             ECTTT-TTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cChhH-hhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            44554 5589999999999999999889999999999999999999875

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.5e-25  Score=227.85  Aligned_cols=198  Identities=21%  Similarity=0.270  Sum_probs=102.4

Q ss_pred             ccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEcc
Q 041249          580 FLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLG  659 (789)
Q Consensus       580 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  659 (789)
                      .+.++|.++++|+ .+|..+.  +++++|||++|+|+++.+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|+
T Consensus        11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls   85 (266)
T d1p9ag_          11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS   85 (266)
T ss_dssp             TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred             CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence            3344455555555 2343332  24555555555555444445555555555555555555 222 23445555555555


Q ss_pred             CCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccC
Q 041249          660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNI  739 (789)
Q Consensus       660 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i  739 (789)
                      +|+++ ..+..+.++++|++|++++|++....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|+ .+
T Consensus        86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~-~~  163 (266)
T d1p9ag_          86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-EL  163 (266)
T ss_dssp             SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CC
T ss_pred             ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc-cc
Confidence            55555 33444555555555555555555444555555555555555555555444445555555555555555555 44


Q ss_pred             CcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249          740 PLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT  785 (789)
Q Consensus       740 p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  785 (789)
                      |.+.+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus       164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            4444434555555555555555 34444455555555555555543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.92  E-value=1.6e-23  Score=219.94  Aligned_cols=124  Identities=25%  Similarity=0.296  Sum_probs=71.1

Q ss_pred             CCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEeccC
Q 041249           23 LVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVSG  102 (789)
Q Consensus        23 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  102 (789)
                      .+.++=++++|+ .+|..+.  +++++|+|++|+|+...+.+|..+++|++|++++|.+....|..|..+++|++|++++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            445555555665 5555443  4566666666666643334566666666666666666644555666666677777776


Q ss_pred             CCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCC
Q 041249          103 NILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYND  165 (789)
Q Consensus       103 N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~  165 (789)
                      |+++ .+|..+.  ..             +..|++++|.+.+..+..+.....+..++...|.
T Consensus        89 n~l~-~l~~~~~--~~-------------l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~  135 (305)
T d1xkua_          89 NQLK-ELPEKMP--KT-------------LQELRVHENEITKVRKSVFNGLNQMIVVELGTNP  135 (305)
T ss_dssp             SCCS-BCCSSCC--TT-------------CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSC
T ss_pred             CccC-cCccchh--hh-------------hhhhhccccchhhhhhhhhhcccccccccccccc
Confidence            6666 3443321  12             2334444455554445555556666677666664

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.9e-24  Score=219.19  Aligned_cols=193  Identities=21%  Similarity=0.219  Sum_probs=172.5

Q ss_pred             ccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCC
Q 041249          561 DLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLM  640 (789)
Q Consensus       561 ~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~  640 (789)
                      +..++.+.. .|+.+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++
T Consensus        16 ~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~   90 (266)
T d1p9ag_          16 NCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ   90 (266)
T ss_dssp             ECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS
T ss_pred             EccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc
Confidence            444445442 344443  579999999999998777889999999999999999994 43 4678999999999999998


Q ss_pred             CCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCcccc
Q 041249          641 GKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIF  720 (789)
Q Consensus       641 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  720 (789)
                       ..+..+.++++|+.|++++|++.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|++..+..|.
T Consensus        91 -~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~  169 (266)
T d1p9ag_          91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN  169 (266)
T ss_dssp             -SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTT
T ss_pred             -ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccc
Confidence             5677899999999999999999988899999999999999999999988888899999999999999999988888999


Q ss_pred             CCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249          721 NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       721 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  761 (789)
                      .+++|++|+|++|+|+ .+|.+++ .+++|+.|+|++|++.
T Consensus       170 ~l~~L~~L~Ls~N~L~-~lp~~~~-~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         170 GLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCBC
T ss_pred             cccccceeecccCCCc-ccChhHC-CCCCCCEEEecCCCCC
Confidence            9999999999999999 9999998 8999999999999876

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=6.4e-24  Score=220.62  Aligned_cols=206  Identities=19%  Similarity=0.209  Sum_probs=189.7

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecc-cCCCCccCCCccCcCCCCCcEEEc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDL-NNNSIGGEIPVNLSSCSNLIRIGL  634 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L-s~N~i~~~~p~~~~~l~~L~~L~l  634 (789)
                      .++.+++..+.+.......|.++++|++|++++|++..+.+..+..+..+..++. ..|.++...+..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            3577899999988777778999999999999999999888888999999999876 467888777899999999999999


Q ss_pred             ccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccccc
Q 041249          635 AKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGI  714 (789)
Q Consensus       635 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  714 (789)
                      ++|.+....+..+....+|+.+++++|+|+++.+.+|..+++|+.|+|++|+|++..+..|.++++|+++++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            99999977788899999999999999999988889999999999999999999988899999999999999999999999


Q ss_pred             CCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249          715 VPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG  762 (789)
Q Consensus       715 ~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~  762 (789)
                      .|.+|..+++|++||+++|+++ .++...+..+++|++|+|++|++..
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCS-CCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             ChhHhhhhhhcccccccccccc-cccccccccccccCEEEecCCCCCC
Confidence            9999999999999999999999 7777777689999999999999874

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.89  E-value=1.7e-22  Score=212.02  Aligned_cols=222  Identities=22%  Similarity=0.297  Sum_probs=171.6

Q ss_pred             eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249          556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~  635 (789)
                      .++.+++..+.+.......|.++++|++|++++|.+..+.|..|.++++|++|++++|+|+ .+|..+  ...+..|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~  108 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH  108 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhcc
Confidence            4566777777766555566777777888888887777666777777777788888777777 344332  2355666666


Q ss_pred             cCCCCCC--------------------------CCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCc
Q 041249          636 KNQLMGK--------------------------IPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAG  689 (789)
Q Consensus       636 ~N~l~~~--------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  689 (789)
                      +|.+.+.                          .+..|..+++|+.+++++|+++ .+|..+  +++|++|++++|.++.
T Consensus       109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~  185 (305)
T d1xkua_         109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK  185 (305)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCE
T ss_pred             ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCC
Confidence            6655422                          2334556778889999999887 445443  5789999999999998


Q ss_pred             cCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccc-
Q 041249          690 SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI-  768 (789)
Q Consensus       690 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~-  768 (789)
                      ..+..|.+++.+++|++++|++++..+.+|..+++|++|+|++|+|+ .+|.++. .+++|++|+|++|+|+......| 
T Consensus       186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~-~l~~L~~L~Ls~N~i~~i~~~~f~  263 (305)
T d1xkua_         186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA-DHKYIQVVYLHNNNISAIGSNDFC  263 (305)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT-TCSSCCEEECCSSCCCCCCTTSSS
T ss_pred             CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccc-cccCCCEEECCCCccCccChhhcc
Confidence            88899999999999999999999888899999999999999999998 8888776 79999999999999996544444 


Q ss_pred             -----cCCCCCCeeeccCCcCc
Q 041249          769 -----SNASKLEVFQALNNKLT  785 (789)
Q Consensus       769 -----~~l~~L~~L~l~~N~l~  785 (789)
                           ..+.+|+.|+|++|+++
T Consensus       264 ~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         264 PPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CSSCCTTSCCCSEEECCSSSSC
T ss_pred             CcchhcccCCCCEEECCCCcCc
Confidence                 45678999999999986

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=1.5e-20  Score=182.76  Aligned_cols=172  Identities=20%  Similarity=0.258  Sum_probs=93.3

Q ss_pred             eecccCCCCccCCCccCcCCCCCcEEEcccCCCCC-CCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCC
Q 041249          607 VPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMG-KIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN  685 (789)
Q Consensus       607 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  685 (789)
                      +++.++|+++ .+|..+.  +++++|+|++|+|+. ..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            3455555555 3443332  355555555555543 22344555556666666666665555555555666666666666


Q ss_pred             cCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCc
Q 041249          686 NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIP  765 (789)
Q Consensus       686 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~  765 (789)
                      +|+.+.|.+|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+....+..++  ...++.+.+..|.++...|
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBCSS
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEeCCC
Confidence            66655555566666666666666666655555566666666666666666533222222  1234555556666654444


Q ss_pred             ccccCCCCCCeeeccCCcCcc
Q 041249          766 PSISNASKLEVFQALNNKLTG  786 (789)
Q Consensus       766 ~~~~~l~~L~~L~l~~N~l~~  786 (789)
                      ..   +..++.++|+.|.|+.
T Consensus       167 ~~---l~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         167 SK---VRDVQIKDLPHSEFKC  184 (192)
T ss_dssp             TT---TTTSBGGGSCTTTCCC
T ss_pred             hh---hcCCEeeecCHhhCcC
Confidence            33   3345556666666654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.81  E-value=1.1e-20  Score=183.36  Aligned_cols=169  Identities=20%  Similarity=0.174  Sum_probs=120.4

Q ss_pred             CCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------------------hhhHHHHHHHHHHhcCCCCccceeee
Q 041249          273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------------------RASRSFIAECRALRSIRHRNLVKVFT  334 (789)
Q Consensus       273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~  334 (789)
                      ...+.||+|+||+||+|... +|+.||||+++....                  ........|.+.+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34678999999999999986 789999998753211                  01234566888999999999998876


Q ss_pred             eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249          335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS  414 (789)
Q Consensus       335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~  414 (789)
                      +.         ..+++|||++++.+.++                 +......++.|++.|++|||..+   |+||||||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~  132 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQY  132 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred             ec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChh
Confidence            53         23799999997554432                 23345679999999999999998   999999999


Q ss_pred             ceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHH
Q 041249          415 NILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILM  477 (789)
Q Consensus       415 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl  477 (789)
                      |||++++ .++++|||.|....+........   .....+ .+. ...+|+.++||||..--+
T Consensus       133 NILv~~~-~~~liDFG~a~~~~~~~~~~~l~---rd~~~~-~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         133 NVLVSEE-GIWIIDFPQSVEVGEEGWREILE---RDVRNI-ITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             SEEEETT-EEEECCCTTCEETTSTTHHHHHH---HHHHHH-HHH-HHHHHCCCCCHHHHHHHH
T ss_pred             heeeeCC-CEEEEECCCcccCCCCCcHHHHH---HHHHHH-HHH-HcCCCCCcccHHHHHHHH
Confidence            9999865 48999999998765443211100   000000 011 135678899999976544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=4.5e-20  Score=186.41  Aligned_cols=202  Identities=18%  Similarity=0.154  Sum_probs=167.2

Q ss_pred             cccchhcccCCcccccCcccccCccceeeecccCCCCccCC-CccCcCCCCCcEEEccc-CCCCCCCCcccCCCCCCcEE
Q 041249          579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEI-PVNLSSCSNLIRIGLAK-NQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L  656 (789)
                      +++++|+|++|+|+.+.+.+|.++++|++|++++|.+...+ +..|.+++++++|++.. |.+....+..|.++++|++|
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            47899999999999777778999999999999999998654 56789999999999874 78887888889999999999


Q ss_pred             EccCCCCCccCCcC-CCCCCCCCEEEccCCcCCccCCccccCCC-CCCeeeccCccccccCCccccCCCCccEE-EccCC
Q 041249          657 SLGFNNLIGSIPPP-LGNLSSLRKISLAINNLAGSIPFTLSKLK-NLVILYLGVNRLSGIVPSSIFNISSIAEF-DVGEN  733 (789)
Q Consensus       657 ~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~Ls~N  733 (789)
                      ++++|+++...+.. +..+..+..+..+++++....+..|.+++ .++.|++++|+++...+.. ....+++.+ ++++|
T Consensus       109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~-~~~~~l~~~~~l~~n  187 (242)
T d1xwdc1         109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA-FNGTQLDELNLSDNN  187 (242)
T ss_dssp             EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTT-TTTCCEEEEECTTCT
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccc-ccchhhhcccccccc
Confidence            99999998554332 34567777778888899877778888775 7999999999999555544 455565555 67889


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                      +|+ .+|...|.++++|++|+|++|+|+...+..|.++++|+.+++.+.
T Consensus       188 ~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l  235 (242)
T d1xwdc1         188 NLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL  235 (242)
T ss_dssp             TCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred             ccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence            998 999998888999999999999999777777888888888877653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=1.5e-19  Score=180.53  Aligned_cols=191  Identities=25%  Similarity=0.363  Sum_probs=163.1

Q ss_pred             cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249          574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI  653 (789)
Q Consensus       574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  653 (789)
                      .+.++.+|++|++.+|+|+. ++ .+..+++|++|++++|+|++..  .+..+++|++|++++|.++ .++ .+.++++|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L  109 (227)
T d1h6ua2          36 TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSI  109 (227)
T ss_dssp             CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTC
T ss_pred             CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc-ccc-cccccccc
Confidence            45678899999999999995 43 5899999999999999999654  3899999999999999998 344 58899999


Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      +.+++++|+..+.  ..+...+.+..+.++++.+...  ..+..+++|+.|++++|.+++.  ..+.++++|++|+|++|
T Consensus       110 ~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n  183 (227)
T d1h6ua2         110 KTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDN  183 (227)
T ss_dssp             CEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSS
T ss_pred             ccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCC
Confidence            9999999998744  3467789999999999999843  3478899999999999999844  34889999999999999


Q ss_pred             cccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccC
Q 041249          734 KIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN  781 (789)
Q Consensus       734 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  781 (789)
                      +++ .++. + .++++|++|+|++|+|++..|  +.++++|+.|++++
T Consensus       184 ~l~-~l~~-l-~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         184 KIS-DISP-L-ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             CCC-CCGG-G-GGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             ccC-CChh-h-cCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            998 6664 3 479999999999999996543  88999999999974

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=8.9e-20  Score=177.12  Aligned_cols=162  Identities=20%  Similarity=0.252  Sum_probs=130.3

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCC-CccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCC
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSI-PSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRN   79 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N   79 (789)
                      ++|+++|+|+ .+|+.+.  +++++|+|++|+|++.+ +..|..+++|+.|+|++|++.+..+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            3789999999 8898874  68999999999998755 566899999999999999999888999999999999999999


Q ss_pred             cCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCc----------cceeecCCcccCCCchhh
Q 041249           80 QFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG----------LTILDLSRNKLSGEIPEF  149 (789)
Q Consensus        80 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~----------l~~l~ls~N~l~~~~p~~  149 (789)
                      +|++..|..|.++++|++|+|++|+|++..|++|..+.+|++|+|++|.+..          +..+.+..|.++...|..
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~  168 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK  168 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence            9997777889999999999999999998888899999999999998888753          233344444444434433


Q ss_pred             hcCcccccEEecccCCCCC
Q 041249          150 LVGLKVIENLNLSYNDLEG  168 (789)
Q Consensus       150 ~~~~~~l~~l~ls~N~~~~  168 (789)
                      +   .+++.++++.|+|.+
T Consensus       169 l---~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         169 V---RDVQIKDLPHSEFKC  184 (192)
T ss_dssp             T---TTSBGGGSCTTTCCC
T ss_pred             h---cCCEeeecCHhhCcC
Confidence            2   223344555555543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=1.6e-19  Score=177.97  Aligned_cols=187  Identities=22%  Similarity=0.342  Sum_probs=150.0

Q ss_pred             ccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEE
Q 041249          578 LSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLS  657 (789)
Q Consensus       578 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  657 (789)
                      +.++...++..+.+++.++.  ..+.+|++|++++|.|+.. + .+..+++|++|++++|+|++ ++ .+..+++|++|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred             HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccc
Confidence            44455567778888765553  3577889999999999844 3 47889999999999999985 33 367889999999


Q ss_pred             ccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccc
Q 041249          658 LGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQG  737 (789)
Q Consensus       658 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  737 (789)
                      +++|+|++ +| .+..+++|+.|++++|.+. .+ ..+.++++|+.+++++|.+++  +..+..+++|+.+++++|+++ 
T Consensus        97 l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~-  169 (210)
T d1h6ta2          97 LDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-  169 (210)
T ss_dssp             CCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC-
T ss_pred             cccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccccc-
Confidence            99999984 34 5888999999999999987 33 368889999999999999984  345778899999999999998 


Q ss_pred             cCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccC
Q 041249          738 NIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN  781 (789)
Q Consensus       738 ~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  781 (789)
                      .++. + .++++|++|+|++|+|++ ++ .+.++++|+.|+|++
T Consensus       170 ~i~~-l-~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         170 DIVP-L-AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCGG-G-TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             cccc-c-cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            5653 3 379999999999999985 44 588999999999875

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.78  E-value=4.1e-17  Score=173.53  Aligned_cols=95  Identities=25%  Similarity=0.326  Sum_probs=69.9

Q ss_pred             ccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEec
Q 041249           21 KKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTV  100 (789)
Q Consensus        21 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  100 (789)
                      .++++|||++|.|+ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++. +  .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence            35888899999988 67753   467888999999998 677653   57888899998887 5543 1  135889999


Q ss_pred             cCCCCCCcCCccccCCcccccccccCCCC
Q 041249          101 SGNILQGEIPSTLGSCIKLEILEMQGNVF  129 (789)
Q Consensus       101 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~~  129 (789)
                      ++|+++ .+|. ++.+++|++|++++|.+
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~  132 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSL  132 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCC
T ss_pred             cccccc-cccc-hhhhccceeeccccccc
Confidence            999887 5664 56777777666665554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=6.1e-19  Score=172.15  Aligned_cols=184  Identities=22%  Similarity=0.343  Sum_probs=147.0

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      +++++..+.++.+.+++.++  ...+.++++|++++|.|+. + ..++.+++|++|++++|+|++..|  +.++++|++|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            35555677888888886543  3467889999999999984 3 457889999999999999985433  8899999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++++|.+.. ++ .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|+++
T Consensus        90 ~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2          90 LMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             ECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred             ccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence            999999874 33 488899999999999998743  358889999999999999973 3 35888999999999999998


Q ss_pred             ccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCee
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVF  777 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  777 (789)
                       .++. + .++++|++|++++|+|++. + .++++++|+.|
T Consensus       164 -~l~~-l-~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         164 -DLKP-L-ANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             -CCGG-G-TTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             -CCcc-c-cCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence             5553 3 3799999999999999853 3 57888888876

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.4e-18  Score=171.04  Aligned_cols=166  Identities=23%  Similarity=0.283  Sum_probs=142.8

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      .+.+|++|++++|.+++. + .+..+++|++|+|++|+|++..  .++.+++|++|++++|+|++ ++ .+.++++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence            577899999999999954 3 3788999999999999999643  47889999999999999984 55 58899999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++++|.+.. + ..+..+++|+.+++++|.+++  +..+..+++|+++++++|++++. + .+.++++|++|+|++|+|+
T Consensus       118 ~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         118 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             ccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence            999999873 3 468889999999999999984  34688899999999999999954 3 3889999999999999998


Q ss_pred             ccCCcccccCCCCccEEEccC
Q 041249          737 GNIPLDYGFTLQNLQYFSIGT  757 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~  757 (789)
                       .+|. + .++++|++|+|++
T Consensus       192 -~l~~-l-~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         192 -DLRA-L-AGLKNLDVLELFS  209 (210)
T ss_dssp             -BCGG-G-TTCTTCSEEEEEE
T ss_pred             -CChh-h-cCCCCCCEEEccC
Confidence             7773 4 4899999999974

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.6e-18  Score=174.74  Aligned_cols=201  Identities=16%  Similarity=0.164  Sum_probs=166.7

Q ss_pred             chhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCC-CCcccCCCCCCcEEEcc-
Q 041249          582 KILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGK-IPSDFGSLSKIEVLSLG-  659 (789)
Q Consensus       582 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~-  659 (789)
                      +.++.+++.++ .+|..+.  +++++|||++|+|+.+.+.+|.++++|++|++++|.+... .+.+|.+++++++|.+. 
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            46778888888 5665543  5799999999999976677899999999999999998764 45578999999999876 


Q ss_pred             CCCCCccCCcCCCCCCCCCEEEccCCcCCccCCc-cccCCCCCCeeeccCccccccCCccccCCC-CccEEEccCCcccc
Q 041249          660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPF-TLSKLKNLVILYLGVNRLSGIVPSSIFNIS-SIAEFDVGENKIQG  737 (789)
Q Consensus       660 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~  737 (789)
                      .|++....+..|.++++|++|++++|+++...+. .+..+..+..+..+++++....+..|..++ .++.|++++|+++ 
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-  166 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-  166 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred             cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-
Confidence            4789888899999999999999999999844332 345566777778888899977778888775 7999999999999 


Q ss_pred             cCCcccccCCCCccEE-EccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249          738 NIPLDYGFTLQNLQYF-SIGTNRITGAIPPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       738 ~ip~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      .++..++ ...+++++ ++++|+|+...+..|.++++|+.|++++|+|+..
T Consensus       167 ~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l  216 (242)
T d1xwdc1         167 EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL  216 (242)
T ss_dssp             EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred             ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCcc
Confidence            8888888 56666555 6788999976677799999999999999999854

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=2.3e-18  Score=171.86  Aligned_cols=196  Identities=20%  Similarity=0.347  Sum_probs=164.7

Q ss_pred             CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249          577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL  656 (789)
Q Consensus       577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  656 (789)
                      .++++..++++.+++++..  .+..+.+|+.|++++|.|+. + ..+..+++|++|++++|+|++..|  +..+++|+++
T Consensus        17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence            4566677889999998654  46788999999999999994 4 468999999999999999985443  8999999999


Q ss_pred             EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249          657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      ++++|.++. + +.|..+++|+.+++++|+..+.  ..+...+.+..++++++.+...  ..+..+++|+.|++++|.++
T Consensus        91 ~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~  164 (227)
T d1h6ua2          91 ELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS  164 (227)
T ss_dssp             ECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred             ccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence            999999984 3 3588999999999999998743  3477888999999999999843  34788899999999999998


Q ss_pred             ccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccCC
Q 041249          737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEVP  789 (789)
Q Consensus       737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~P  789 (789)
                       ..+. + .++++|++|+|++|++++. + .+.++++|+.|++++|++++..|
T Consensus       165 -~~~~-l-~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~  212 (227)
T d1h6ua2         165 -DLTP-L-ANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP  212 (227)
T ss_dssp             -CCGG-G-TTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG
T ss_pred             -cchh-h-cccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc
Confidence             4433 3 4899999999999999964 3 38899999999999999997543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.76  E-value=2.8e-16  Score=166.92  Aligned_cols=135  Identities=28%  Similarity=0.320  Sum_probs=101.2

Q ss_pred             CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249            1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ   80 (789)
Q Consensus         1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~   80 (789)
                      +|||++|+++ .+|+.   +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++ .++. +  .+.|++|++++|.
T Consensus        42 ~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~  109 (353)
T d1jl5a_          42 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQ  109 (353)
T ss_dssp             EEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccc
Confidence            4899999998 68864   568999999999999 78865   458999999999998 4553 2  1469999999999


Q ss_pred             CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEe
Q 041249           81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLN  160 (789)
Q Consensus        81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~  160 (789)
                      +. .+|. ++.+++|++|++++|.+. ..|.....   +..+             ++..+...  .+..+..++.++.++
T Consensus       110 l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~~~---l~~l-------------~~~~~~~~--~~~~l~~l~~l~~L~  168 (353)
T d1jl5a_         110 LE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFI-------------AAGNNQLE--ELPELQNLPFLTAIY  168 (353)
T ss_dssp             CS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCCTT---CCEE-------------ECCSSCCS--SCCCCTTCTTCCEEE
T ss_pred             cc-cccc-hhhhccceeecccccccc-cccccccc---ccch-------------hhcccccc--ccccccccccceecc
Confidence            98 7774 688999999999999998 44443333   2333             33333332  233456677888898


Q ss_pred             cccCCCCC
Q 041249          161 LSYNDLEG  168 (789)
Q Consensus       161 ls~N~~~~  168 (789)
                      +++|.+..
T Consensus       169 l~~n~~~~  176 (353)
T d1jl5a_         169 ADNNSLKK  176 (353)
T ss_dssp             CCSSCCSS
T ss_pred             cccccccc
Confidence            88887653

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3.5e-18  Score=166.66  Aligned_cols=163  Identities=25%  Similarity=0.424  Sum_probs=139.8

Q ss_pred             cCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcE
Q 041249          576 GNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEV  655 (789)
Q Consensus       576 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  655 (789)
                      ..++++++|++++|.|+. + +.+..+++|++|++++|+|++..|  +.++++|++|++++|.+. .++ .+.++++|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSE
T ss_pred             HHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccc
Confidence            467889999999999995 3 348889999999999999996543  899999999999999998 444 4889999999


Q ss_pred             EEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcc
Q 041249          656 LSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI  735 (789)
Q Consensus       656 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  735 (789)
                      |++++|.+...  ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++. + .+.++++|++|++++|+|
T Consensus       111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKV  184 (199)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCC
Confidence            99999998743  45888999999999999998 344 689999999999999999954 3 489999999999999999


Q ss_pred             cccCCcccccCCCCccEE
Q 041249          736 QGNIPLDYGFTLQNLQYF  753 (789)
Q Consensus       736 ~~~ip~~~~~~l~~L~~L  753 (789)
                      + .++. + .++++|++|
T Consensus       185 ~-~i~~-l-~~L~~L~~L  199 (199)
T d2omxa2         185 S-DISV-L-AKLTNLESL  199 (199)
T ss_dssp             C-CCGG-G-GGCTTCSEE
T ss_pred             C-CCcc-c-cCCCCCCcC
Confidence            8 6763 4 379999876

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=2.9e-18  Score=189.39  Aligned_cols=108  Identities=19%  Similarity=0.228  Sum_probs=76.3

Q ss_pred             cCCeEecCCCcCCCC-CCccccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEEccCCcCCC----CCcccccC-
Q 041249           22 KLVEPYVSDNFLKGS-IPSSLGLCESLTTIGLFNNNLSG----TIPPQLMGLTSLVALDLSRNQFRG----SFPTEVGN-   91 (789)
Q Consensus        22 ~l~~L~ls~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~-   91 (789)
                      +|+.||+++|++++. +.+-++.++++++|+|++|+|+.    .++..+..+++|++|||++|.++.    .+...+.. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            578899999999742 23445678889999999998872    356667889999999999998862    12233332 


Q ss_pred             CCCCCEEeccCCCCCCc----CCccccCCcccccccccCCCC
Q 041249           92 LINLETLTVSGNILQGE----IPSTLGSCIKLEILEMQGNVF  129 (789)
Q Consensus        92 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~~  129 (789)
                      ..+|++|+|++|+++..    ++..+..+++|++|++++|++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i  124 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL  124 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence            34799999999998743    345566666666666665553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=4.5e-18  Score=187.76  Aligned_cols=115  Identities=18%  Similarity=0.133  Sum_probs=80.4

Q ss_pred             CCCCEEEccCCcCCCC-CcccccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEeccCCCCCCcCCccccCCccc
Q 041249           45 ESLTTIGLFNNNLSGT-IPPQLMGLTSLVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKL  119 (789)
Q Consensus        45 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  119 (789)
                      .+|++||+++|+|++. +...+..+++++.|+|++|.++.    .++..+..+++|++|||++|+|+..-...+..  .|
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~--~l   79 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ--GL   79 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH--TT
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHH--HH
Confidence            3589999999999853 24456678999999999999872    34566788999999999999986211111111  00


Q ss_pred             ccccccCCCCCccceeecCCcccCCC----chhhhcCcccccEEecccCCCC
Q 041249          120 EILEMQGNVFQGLTILDLSRNKLSGE----IPEFLVGLKVIENLNLSYNDLE  167 (789)
Q Consensus       120 ~~l~l~~N~~~~l~~l~ls~N~l~~~----~p~~~~~~~~l~~l~ls~N~~~  167 (789)
                      +     . .-..|+.|+|++|+++..    ++..+..+++|++|++++|+++
T Consensus        80 ~-----~-~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          80 Q-----T-PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             C-----S-TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             h-----c-CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            0     0 012356667777777543    4567788999999999999875

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=5.5e-16  Score=145.07  Aligned_cols=128  Identities=13%  Similarity=0.093  Sum_probs=64.9

Q ss_pred             CcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCC
Q 041249          623 LSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLV  702 (789)
Q Consensus       623 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  702 (789)
                      |.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|+|+...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            344445555555555555 2344444555555555555555532  2355555555555555555543343444555555


Q ss_pred             eeeccCccccccCC-ccccCCCCccEEEccCCcccccCCc---ccccCCCCccEEE
Q 041249          703 ILYLGVNRLSGIVP-SSIFNISSIAEFDVGENKIQGNIPL---DYGFTLQNLQYFS  754 (789)
Q Consensus       703 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~---~~~~~l~~L~~L~  754 (789)
                      .|++++|+|+.... ..+..+++|+.|++++|+++ ..|.   .++..+++|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            55555555552211 24555556666666666655 4442   1222455555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=6.1e-16  Score=144.76  Aligned_cols=131  Identities=18%  Similarity=0.180  Sum_probs=111.1

Q ss_pred             ccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCc
Q 041249          646 DFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI  725 (789)
Q Consensus       646 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  725 (789)
                      .|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+|+...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            4678889999999999998 457777889999999999999994 44 59999999999999999997666777889999


Q ss_pred             cEEEccCCcccccCCc-ccccCCCCccEEEccCCcccccC---cccccCCCCCCeeecc
Q 041249          726 AEFDVGENKIQGNIPL-DYGFTLQNLQYFSIGTNRITGAI---PPSISNASKLEVFQAL  780 (789)
Q Consensus       726 ~~L~Ls~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~l~  780 (789)
                      +.|++++|+|+ .++. ..+..+++|++|++++|+++...   +..+..+++|+.||-.
T Consensus        90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~~  147 (162)
T d1a9na_          90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ  147 (162)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTE
T ss_pred             ccceecccccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCCC
Confidence            99999999998 6654 44458999999999999998543   2357889999998843

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.59  E-value=2.1e-15  Score=134.10  Aligned_cols=101  Identities=23%  Similarity=0.319  Sum_probs=42.2

Q ss_pred             EEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcc
Q 041249          631 RIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR  710 (789)
Q Consensus       631 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  710 (789)
                      .|||++|+|+ .++ .+..+++|++|++++|+|+ .+|..|..+++|++|++++|+|+ .+| .+.++++|++|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence            3444444444 222 2344444444444444444 23333444444444444444444 222 24444444444444444


Q ss_pred             ccccC-CccccCCCCccEEEccCCccc
Q 041249          711 LSGIV-PSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       711 l~~~~-p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      |++.. ...+..+++|+.|++++|+++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            44221 123444444444444444444

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.58  E-value=2.9e-15  Score=133.17  Aligned_cols=118  Identities=19%  Similarity=0.249  Sum_probs=96.8

Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  733 (789)
                      +.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57999999998 444 4889999999999999998 677789999999999999999994 44 5899999999999999


Q ss_pred             cccccCCc-ccccCCCCccEEEccCCcccccC---cccccCCCCCCee
Q 041249          734 KIQGNIPL-DYGFTLQNLQYFSIGTNRITGAI---PPSISNASKLEVF  777 (789)
Q Consensus       734 ~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L  777 (789)
                      +|+ .+|. ..+..+++|+.|++++|+++...   ...+..+++|+.|
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccC-CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            998 6653 44458999999999999998532   2334457777765

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.45  E-value=1.8e-15  Score=160.68  Aligned_cols=239  Identities=14%  Similarity=0.131  Sum_probs=170.7

Q ss_pred             hhccccceeeEeccCcccccccc----cccccCccccchhcccCCccccc----------CcccccCccceeeecccCCC
Q 041249          549 RIGSKAQKVTILDLESLKLAGSI----LPHIGNLSFLKILNLENNSFTHE----------IPSEIGRLRRLQVPDLNNNS  614 (789)
Q Consensus       549 ~i~~~c~~l~~l~l~s~~~~~~~----l~~l~~l~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~Ls~N~  614 (789)
                      .....+..++.+++..+.+....    ...+...++|+.|+++++.+...          +...+...++|+.|+|++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            33445677888999888764433    23456778999999988765422          12334567889999999999


Q ss_pred             CccCC----CccCcCCCCCcEEEcccCCCCCCCCcc-------------cCCCCCCcEEEccCCCCCccC----CcCCCC
Q 041249          615 IGGEI----PVNLSSCSNLIRIGLAKNQLMGKIPSD-------------FGSLSKIEVLSLGFNNLIGSI----PPPLGN  673 (789)
Q Consensus       615 i~~~~----p~~~~~l~~L~~L~l~~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~~----~~~~~~  673 (789)
                      ++...    ...+...++|++|++++|.+.......             ....+.|+.|++++|+++...    ...+..
T Consensus       105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~  184 (344)
T d2ca6a1         105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS  184 (344)
T ss_dssp             CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred             cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence            97542    334556789999999999885211111             134678999999999986332    223456


Q ss_pred             CCCCCEEEccCCcCCcc-----CCccccCCCCCCeeeccCcccccc----CCccccCCCCccEEEccCCcccccCCccc-
Q 041249          674 LSSLRKISLAINNLAGS-----IPFTLSKLKNLVILYLGVNRLSGI----VPSSIFNISSIAEFDVGENKIQGNIPLDY-  743 (789)
Q Consensus       674 l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~-  743 (789)
                      .+.|++|+|++|+|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.-...+ 
T Consensus       185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~  264 (344)
T d2ca6a1         185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV  264 (344)
T ss_dssp             CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred             hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence            78999999999999742     344577889999999999998743    45667789999999999999974311112 


Q ss_pred             ---c-cCCCCccEEEccCCcccccC----ccccc-CCCCCCeeeccCCcCccc
Q 041249          744 ---G-FTLQNLQYFSIGTNRITGAI----PPSIS-NASKLEVFQALNNKLTGE  787 (789)
Q Consensus       744 ---~-~~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~l~~N~l~~~  787 (789)
                         . ...+.|++|++++|+|+...    ...+. +.++|+.|++++|+++..
T Consensus       265 ~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence               1 12467999999999998532    33332 577899999999999753

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=1.6e-13  Score=127.16  Aligned_cols=108  Identities=15%  Similarity=0.124  Sum_probs=72.8

Q ss_pred             CCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC-CCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeee
Q 041249          627 SNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN-NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILY  705 (789)
Q Consensus       627 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  705 (789)
                      ...+.++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34456777777776 45666777777777777655 37766666777777777777777777766667777777777777


Q ss_pred             ccCccccccCCccccCCCCccEEEccCCccc
Q 041249          706 LGVNRLSGIVPSSIFNISSIAEFDVGENKIQ  736 (789)
Q Consensus       706 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  736 (789)
                      |++|+|+...+..|. ..+|+.|+|++|++.
T Consensus        87 Ls~N~l~~l~~~~~~-~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALESLSWKTVQ-GLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred             ccCCCCcccChhhhc-cccccccccCCCccc
Confidence            777777743333443 335777777777764

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.7e-13  Score=126.86  Aligned_cols=104  Identities=13%  Similarity=0.101  Sum_probs=49.3

Q ss_pred             cEEEccCCCCCccCCcCCCCCCCCCEEEccCC-cCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccC
Q 041249          654 EVLSLGFNNLIGSIPPPLGNLSSLRKISLAIN-NLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE  732 (789)
Q Consensus       654 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  732 (789)
                      +.++.++++++ ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            34444444444 33444444445555555433 24433344455555555555555555544444455555555555555


Q ss_pred             CcccccCCcccccCCCCccEEEccCCcc
Q 041249          733 NKIQGNIPLDYGFTLQNLQYFSIGTNRI  760 (789)
Q Consensus       733 N~l~~~ip~~~~~~l~~L~~L~L~~N~l  760 (789)
                      |+|+ .+|..++ ...+|+.|+|++|++
T Consensus        90 N~l~-~l~~~~~-~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          90 NALE-SLSWKTV-QGLSLQELVLSGNPL  115 (156)
T ss_dssp             SCCS-CCCSTTT-CSCCCCEEECCSSCC
T ss_pred             CCCc-ccChhhh-ccccccccccCCCcc
Confidence            5554 4444444 223455555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.42  E-value=5.7e-16  Score=150.21  Aligned_cols=133  Identities=19%  Similarity=0.293  Sum_probs=65.7

Q ss_pred             cCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCC
Q 041249          622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNL  701 (789)
Q Consensus       622 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  701 (789)
                      .+..+++|++|+|++|+|+. ++ .+.++++|++|+|++|+|+ .+|..+..+++|++|++++|+|+. + ..+..+++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence            34444445555555555442 22 2444455555555555544 233333333445555555555552 2 235555566


Q ss_pred             CeeeccCccccccCC-ccccCCCCccEEEccCCcccccCCcc---------cccCCCCccEEEccCCccc
Q 041249          702 VILYLGVNRLSGIVP-SSIFNISSIAEFDVGENKIQGNIPLD---------YGFTLQNLQYFSIGTNRIT  761 (789)
Q Consensus       702 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~~---------~~~~l~~L~~L~L~~N~l~  761 (789)
                      +.|++++|+|+.... ..+..+++|+.|+|++|++....+..         +...+++|+.||  +..|+
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            666666666653211 34556666666666666665222221         122567777765  55554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.41  E-value=1.2e-15  Score=147.98  Aligned_cols=149  Identities=19%  Similarity=0.252  Sum_probs=117.6

Q ss_pred             CCcEEEcccC--CCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeee
Q 041249          628 NLIRIGLAKN--QLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILY  705 (789)
Q Consensus       628 ~L~~L~l~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  705 (789)
                      .++.++++++  .++ .++..+..+++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..+++|++|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence            3445555544  344 456678899999999999999984 44 5889999999999999998 5676666677899999


Q ss_pred             ccCccccccCCccccCCCCccEEEccCCcccccCCc-ccccCCCCccEEEccCCcccccCccc----------ccCCCCC
Q 041249          706 LGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL-DYGFTLQNLQYFSIGTNRITGAIPPS----------ISNASKL  774 (789)
Q Consensus       706 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L  774 (789)
                      +++|+|+..  ..+..+++|+.|+|++|+|+ .++. ..+..+++|++|+|++|+++...+..          +..+++|
T Consensus       100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L  176 (198)
T d1m9la_         100 ISYNQIASL--SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL  176 (198)
T ss_dssp             CSEEECCCH--HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred             ccccccccc--ccccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence            999999953  35888999999999999998 6653 34458999999999999998654432          5678999


Q ss_pred             CeeeccCCcCc
Q 041249          775 EVFQALNNKLT  785 (789)
Q Consensus       775 ~~L~l~~N~l~  785 (789)
                      +.||  +.+++
T Consensus       177 ~~LD--~~~I~  185 (198)
T d1m9la_         177 KKLD--GMPVD  185 (198)
T ss_dssp             CEES--SGGGT
T ss_pred             CEeC--CccCC
Confidence            9987  44444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.40  E-value=8.6e-15  Score=155.26  Aligned_cols=216  Identities=16%  Similarity=0.180  Sum_probs=160.0

Q ss_pred             cccccccCccccchhcccCCccccc----CcccccCccceeeecccCCCCccC----------CCccCcCCCCCcEEEcc
Q 041249          570 SILPHIGNLSFLKILNLENNSFTHE----IPSEIGRLRRLQVPDLNNNSIGGE----------IPVNLSSCSNLIRIGLA  635 (789)
Q Consensus       570 ~~l~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~----------~p~~~~~l~~L~~L~l~  635 (789)
                      .....+...+.|++|+|++|.|+..    +...+...++|+.|+++++.+...          +...+..+++|++|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            3455677789999999999999754    334566789999999998876422          12335668899999999


Q ss_pred             cCCCCCC----CCcccCCCCCCcEEEccCCCCCccCCcC-------------CCCCCCCCEEEccCCcCCcc----CCcc
Q 041249          636 KNQLMGK----IPSDFGSLSKIEVLSLGFNNLIGSIPPP-------------LGNLSSLRKISLAINNLAGS----IPFT  694 (789)
Q Consensus       636 ~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~----~~~~  694 (789)
                      +|.+...    +...+...++|+.|++++|.++......             ....+.|+.|.+++|+++..    +...
T Consensus       102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~  181 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  181 (344)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence            9999854    2334456789999999999885221111             13567899999999998733    2334


Q ss_pred             ccCCCCCCeeeccCcccccc-----CCccccCCCCccEEEccCCccccc----CCcccccCCCCccEEEccCCcccccCc
Q 041249          695 LSKLKNLVILYLGVNRLSGI-----VPSSIFNISSIAEFDVGENKIQGN----IPLDYGFTLQNLQYFSIGTNRITGAIP  765 (789)
Q Consensus       695 ~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~~  765 (789)
                      +..+++|+.|+|++|+|+..     +...+..+++|+.|+|++|.++..    +...+. ..++|++|+|++|.|++...
T Consensus       182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~-~~~~L~~L~Ls~n~i~~~g~  260 (344)
T d2ca6a1         182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-SWPNLRELGLNDCLLSARGA  260 (344)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG-GCTTCCEEECTTCCCCHHHH
T ss_pred             hhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccc-ccccchhhhhhcCccCchhh
Confidence            56788999999999999742     345677889999999999998632    333333 68999999999999986533


Q ss_pred             ccc----cC--CCCCCeeeccCCcCcc
Q 041249          766 PSI----SN--ASKLEVFQALNNKLTG  786 (789)
Q Consensus       766 ~~~----~~--l~~L~~L~l~~N~l~~  786 (789)
                      ..+    ..  .+.|+.|++++|+++.
T Consensus       261 ~~l~~~l~~~~~~~L~~L~ls~N~i~~  287 (344)
T d2ca6a1         261 AAVVDAFSKLENIGLQTLRLQYNEIEL  287 (344)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             HHHHHHhhhccCCCCCEEECCCCcCCh
Confidence            333    32  4679999999999874

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=1.2e-14  Score=149.64  Aligned_cols=208  Identities=16%  Similarity=0.188  Sum_probs=149.6

Q ss_pred             ccCccccchhcccCCccccc-CcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccC-CCCCC-CCcccCCCC
Q 041249          575 IGNLSFLKILNLENNSFTHE-IPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKN-QLMGK-IPSDFGSLS  651 (789)
Q Consensus       575 l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~  651 (789)
                      .....+|++|||+++.++.. ++..+..+++|++|+|++|.+++..+..+..+++|++|+++++ .++.. +...+.+++
T Consensus        42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~  121 (284)
T d2astb2          42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  121 (284)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence            34567899999999998754 3455788999999999999998877888889999999999995 56522 122245688


Q ss_pred             CCcEEEccCC-CCCcc-CCcCCC-CCCCCCEEEccCC--cCCcc-CCccccCCCCCCeeeccCc-cccccCCccccCCCC
Q 041249          652 KIEVLSLGFN-NLIGS-IPPPLG-NLSSLRKISLAIN--NLAGS-IPFTLSKLKNLVILYLGVN-RLSGIVPSSIFNISS  724 (789)
Q Consensus       652 ~L~~L~L~~N-~l~~~-~~~~~~-~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~  724 (789)
                      +|++|+++++ +++.. ....+. ..++|+.|+++++  .++.. +...+.++++|++|++++| .+++.....+..+++
T Consensus       122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~  201 (284)
T d2astb2         122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY  201 (284)
T ss_dssp             TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence            9999999986 45421 112222 3478999999975  34432 2233467899999999986 588778888999999


Q ss_pred             ccEEEccC-CcccccCCcccccCCCCccEEEccCCcccccC-cccccCCCCCCeeeccCCcCccc
Q 041249          725 IAEFDVGE-NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAI-PPSISNASKLEVFQALNNKLTGE  787 (789)
Q Consensus       725 L~~L~Ls~-N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~  787 (789)
                      |++|+|++ +.|++.....+. .+++|++|+++++ ++... +.....+++   |.+..+++++.
T Consensus       202 L~~L~L~~C~~i~~~~l~~L~-~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~  261 (284)
T d2astb2         202 LQHLSLSRCYDIIPETLLELG-EIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTI  261 (284)
T ss_dssp             CCEEECTTCTTCCGGGGGGGG-GCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCT
T ss_pred             CCEEECCCCCCCChHHHHHHh-cCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCC
Confidence            99999999 467755555555 7899999999988 44222 222233444   45677777765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=2.2e-14  Score=147.51  Aligned_cols=198  Identities=17%  Similarity=0.188  Sum_probs=146.9

Q ss_pred             hhcccCCcccccCcccccCccceeeecccCCCCccC-CCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249          583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE-IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN  661 (789)
Q Consensus       583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  661 (789)
                      .+.++...+.... .......+|++|||++|.++.. ++..+.++++|++|+|+++.+.+..+..+..+++|++|+++++
T Consensus        27 ~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c  105 (284)
T d2astb2          27 AFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC  105 (284)
T ss_dssp             EEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred             Eeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence            4445555554222 2234567899999999998744 3456788999999999999998777778889999999999995


Q ss_pred             -CCCccC-CcCCCCCCCCCEEEccCC-cCCcc-CCcccc-CCCCCCeeeccCc--ccccc-CCccccCCCCccEEEccCC
Q 041249          662 -NLIGSI-PPPLGNLSSLRKISLAIN-NLAGS-IPFTLS-KLKNLVILYLGVN--RLSGI-VPSSIFNISSIAEFDVGEN  733 (789)
Q Consensus       662 -~l~~~~-~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~-~l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~Ls~N  733 (789)
                       .++... ...+.++++|++|+|+++ .++.. ....+. ..++|+.|++++.  .++.. +...+..+++|++|+|++|
T Consensus       106 ~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~  185 (284)
T d2astb2         106 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS  185 (284)
T ss_dssp             BSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTC
T ss_pred             ccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccc
Confidence             565321 122356899999999996 45522 222233 3478999999974  45532 3334467899999999996


Q ss_pred             -cccccCCcccccCCCCccEEEccCC-cccccCcccccCCCCCCeeeccCC
Q 041249          734 -KIQGNIPLDYGFTLQNLQYFSIGTN-RITGAIPPSISNASKLEVFQALNN  782 (789)
Q Consensus       734 -~l~~~ip~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N  782 (789)
                       .+++.....+. .+++|++|+|+++ .|++.....+.++++|+.|+++++
T Consensus       186 ~~itd~~~~~l~-~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         186 VMLKNDCFQEFF-QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TTCCGGGGGGGG-GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cCCCchhhhhhc-ccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence             47766666666 7999999999995 688777778889999999999987

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.72  E-value=2.9e-10  Score=105.44  Aligned_cols=83  Identities=14%  Similarity=0.125  Sum_probs=38.9

Q ss_pred             ccCCCCCCeeeccCccccccC--CccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcc------
Q 041249          695 LSKLKNLVILYLGVNRLSGIV--PSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPP------  766 (789)
Q Consensus       695 ~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~------  766 (789)
                      +..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.|+ .++.-.+....+|+.|+|++|+++.....      
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~  139 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS  139 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence            344455555555555554321  233444555555555555555 44332222334455555555555533221      


Q ss_pred             -cccCCCCCCeee
Q 041249          767 -SISNASKLEVFQ  778 (789)
Q Consensus       767 -~~~~l~~L~~L~  778 (789)
                       .+..+|+|+.||
T Consensus       140 ~i~~~~P~L~~LD  152 (162)
T d1koha1         140 AIRERFPKLLRLD  152 (162)
T ss_dssp             HHHTTSTTCCEET
T ss_pred             HHHHHCCCCCEEC
Confidence             234455555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.60  E-value=5.9e-10  Score=103.34  Aligned_cols=12  Identities=50%  Similarity=0.504  Sum_probs=4.8

Q ss_pred             CCeeeccCcccc
Q 041249          701 LVILYLGVNRLS  712 (789)
Q Consensus       701 L~~L~Ls~N~l~  712 (789)
                      |+.|++++|.++
T Consensus       117 L~~L~L~~Npl~  128 (162)
T d1koha1         117 LEELWLDGNSLS  128 (162)
T ss_dssp             CSSCCCTTSTTS
T ss_pred             cceeecCCCCcC
Confidence            344444444433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.74  E-value=5.2e-05  Score=74.91  Aligned_cols=149  Identities=17%  Similarity=0.075  Sum_probs=95.6

Q ss_pred             HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCC
Q 041249          264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQ  342 (789)
Q Consensus       264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  342 (789)
                      |+..--..|...+..+.++.+.||+...  +++.+++|............+..|.+.+..+. +--+.++++++....  
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~--   83 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG--   83 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC--
Confidence            3444445565555544455678998864  46677888876554444455777888877663 333456666654443  


Q ss_pred             CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--------------------
Q 041249          343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--------------------  402 (789)
Q Consensus       343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------  402 (789)
                         ..++||+++++.++.+.....               .....++.++++.++.||...                    
T Consensus        84 ---~~~lv~~~l~G~~~~~~~~~~---------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  145 (263)
T d1j7la_          84 ---WSNLLMSEADGVLCSEEYEDE---------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL  145 (263)
T ss_dssp             ---EEEEEEECCSSEEHHHHTTTC---------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred             ---ceEEEEEeccccccccccccc---------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence               689999999988776544221               112334455555555555421                    


Q ss_pred             ------------------------------------CCCceecCCCCCceecCCCCceeeCccccccc
Q 041249          403 ------------------------------------QPITTHCDLKPSNILLDEEMVSHVGDFGLARF  434 (789)
Q Consensus       403 ------------------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  434 (789)
                                                          .+.++|+|+.|.||+++++...-+.||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                                22268999999999999877777999987654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.73  E-value=4.2e-06  Score=77.02  Aligned_cols=86  Identities=17%  Similarity=0.152  Sum_probs=40.2

Q ss_pred             CCCCcEEEccCC-CCCcc----CCcCCCCCCCCCEEEccCCcCCccC----CccccCCCCCCeeeccCcccccc----CC
Q 041249          650 LSKIEVLSLGFN-NLIGS----IPPPLGNLSSLRKISLAINNLAGSI----PFTLSKLKNLVILYLGVNRLSGI----VP  716 (789)
Q Consensus       650 l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~p  716 (789)
                      .++|++|+|+++ .++..    +-.++...++|++|+|++|.++...    ...+...+.|++|+|++|.|+..    +-
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            456666666653 34321    1123444455666666666654221    12233345555555555555532    11


Q ss_pred             ccccCCCCccEEEccCCcc
Q 041249          717 SSIFNISSIAEFDVGENKI  735 (789)
Q Consensus       717 ~~~~~l~~L~~L~Ls~N~l  735 (789)
                      .++...++|++|+|++|.+
T Consensus        94 ~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSS
T ss_pred             HHHHhCCcCCEEECCCCcC
Confidence            2333344455555555543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.73  E-value=3.8e-06  Score=77.33  Aligned_cols=117  Identities=11%  Similarity=0.116  Sum_probs=54.7

Q ss_pred             CCCCCEEEccCC-cCCCC----CcccccCCCCCCEEEccCCcCCC----CCcccccCCCCCCEEeccCCCCCCc----CC
Q 041249           44 CESLTTIGLFNN-NLSGT----IPPQLMGLTSLVALDLSRNQFRG----SFPTEVGNLINLETLTVSGNILQGE----IP  110 (789)
Q Consensus        44 l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p  110 (789)
                      .+.|++|+|+++ .++..    +-..+...+.|++|+|++|.+..    .+...+...+.|++|+|++|.|+..    +-
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            345555555542 34321    22334455556666666655542    1222344445566666666665521    12


Q ss_pred             ccccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEEecccCCC
Q 041249          111 STLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENLNLSYNDL  166 (789)
Q Consensus       111 ~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l~ls~N~~  166 (789)
                      .++...++|++|++++|++..+.      ......+.+.+...++|+.|+++.+..
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~~~g------~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQSVLG------NQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCCC------HHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHhCCcCCEEECCCCcCCCcc------HHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            23344444444444444322110      000012445566667777777777654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.20  E-value=4.5e-05  Score=69.73  Aligned_cols=113  Identities=18%  Similarity=0.199  Sum_probs=68.8

Q ss_pred             cCCCCCCEEEccC-CcCCC----CCcccccCCCCCCEEEccCCcCCCC----CcccccCCCCCCEEeccCCCCCCc----
Q 041249           42 GLCESLTTIGLFN-NNLSG----TIPPQLMGLTSLVALDLSRNQFRGS----FPTEVGNLINLETLTVSGNILQGE----  108 (789)
Q Consensus        42 ~~l~~L~~L~Ls~-N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----  108 (789)
                      .+.+.|++|+|++ +.|+.    .+-..+...++|++|+|++|.++..    +-..+...+.|+.+++++|.++..    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            4556777777776 45652    1444556777788888888877632    223455567788888888877632    


Q ss_pred             CCccccCCcccccccccCCCCCccceeecCCcccCC----CchhhhcCcccccEEecccCC
Q 041249          109 IPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSG----EIPEFLVGLKVIENLNLSYND  165 (789)
Q Consensus       109 ~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~----~~p~~~~~~~~l~~l~ls~N~  165 (789)
                      +-..+...++|+.++|           +++.|.+..    .+.+.+...++|+.|+++.+.
T Consensus        94 l~~~l~~~~~L~~l~L-----------~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          94 LVEALQSNTSLIELRI-----------DNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHGGGGCSSCCEEEC-----------CCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHhCccccEEee-----------ccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence            2244555555655433           233344432    244556677889999887664

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.05  E-value=3.3e-05  Score=70.71  Aligned_cols=111  Identities=15%  Similarity=0.130  Sum_probs=80.6

Q ss_pred             cCCccCCeEecCC-CcCCC----CCCccccCCCCCCEEEccCCcCCCC----CcccccCCCCCCEEEccCCcCCCC----
Q 041249           18 GNLKKLVEPYVSD-NFLKG----SIPSSLGLCESLTTIGLFNNNLSGT----IPPQLMGLTSLVALDLSRNQFRGS----   84 (789)
Q Consensus        18 ~~l~~l~~L~ls~-n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----   84 (789)
                      .+.+.|++|+|++ +.|+.    .+-.++...+.|++|+|++|.++..    +...+...++++.+++++|.++..    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            4668999999998 55752    2445567889999999999999843    445567789999999999998732    


Q ss_pred             CcccccCCCCCCEEec--cCCCCCC----cCCccccCCcccccccccCCC
Q 041249           85 FPTEVGNLINLETLTV--SGNILQG----EIPSTLGSCIKLEILEMQGNV  128 (789)
Q Consensus        85 ~p~~~~~l~~L~~L~l--~~N~l~~----~~p~~~~~l~~L~~l~l~~N~  128 (789)
                      +...+...++|+.++|  ++|.+..    .+...+..+++|+.|+++.++
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence            3356777888987555  5777863    344556667777777665543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.99  E-value=0.00096  Score=64.97  Aligned_cols=74  Identities=15%  Similarity=0.065  Sum_probs=47.7

Q ss_pred             ccccC-CccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC--CccceeeeeeccCCCCCCceEEEEeecc
Q 041249          278 IGTGS-FGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH--RNLVKVFTACSGVDYQGNDFKALVYEFM  354 (789)
Q Consensus       278 ig~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~  354 (789)
                      +..|. .+.||+.... ++..+++|......   ...+..|++.++.+..  --+.++++++.+..     ..++||+++
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~-----~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAG-----RDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----CEEEEEECC
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccccc-----ceEEEEEee
Confidence            34444 3678998876 56678889865443   3346777777776632  22455666655433     679999999


Q ss_pred             CCCChh
Q 041249          355 QNGSLE  360 (789)
Q Consensus       355 ~~g~L~  360 (789)
                      ++.++.
T Consensus        89 ~G~~~~   94 (255)
T d1nd4a_          89 PGQDLL   94 (255)
T ss_dssp             SSEETT
T ss_pred             eccccc
Confidence            875543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.93  E-value=0.001  Score=69.50  Aligned_cols=76  Identities=18%  Similarity=0.115  Sum_probs=47.9

Q ss_pred             CcccccCCccEEEEEEcCCceEEEEEEeccc----c---chhhHHHHHHHHHHhcC-CC--CccceeeeeeccCCCCCCc
Q 041249          276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH----H---HRASRSFIAECRALRSI-RH--RNLVKVFTACSGVDYQGND  345 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~~~  345 (789)
                      +.||.|....||+.....+++.|+||.-...    .   .....+...|.+.+..+ .+  ..+.+++++..+       
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~-------  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE-------  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT-------
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC-------
Confidence            4689999999999998877889999975322    1   11233456688877766 22  345566665432       


Q ss_pred             eEEEEeeccCCCC
Q 041249          346 FKALVYEFMQNGS  358 (789)
Q Consensus       346 ~~~lv~e~~~~g~  358 (789)
                      ..++|||++.+..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            3478999997643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.66  E-value=0.038  Score=57.07  Aligned_cols=72  Identities=17%  Similarity=0.234  Sum_probs=47.5

Q ss_pred             CcccccCCccEEEEEEcC-------CceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249          276 NLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK  347 (789)
Q Consensus       276 ~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  347 (789)
                      +.|+.|-.-.+|+....+       .++.|++++.- ... ......+|.++++.+. +.-..++++++.+         
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---------  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG---------  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence            457778888999998753       24667887764 222 2234567888888874 4334567777632         


Q ss_pred             EEEeeccCCCC
Q 041249          348 ALVYEFMQNGS  358 (789)
Q Consensus       348 ~lv~e~~~~g~  358 (789)
                      ++|+||+++.+
T Consensus       117 g~I~efi~g~~  127 (395)
T d1nw1a_         117 GRLEEYIPSRP  127 (395)
T ss_dssp             EEEECCCCEEE
T ss_pred             ceEEEEecccc
Confidence            57899998643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.00  E-value=0.11  Score=51.94  Aligned_cols=72  Identities=11%  Similarity=0.114  Sum_probs=43.2

Q ss_pred             ccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcc--ceeeeeeccCCCCCCceEEEEeeccCCC
Q 041249          284 GSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNL--VKVFTACSGVDYQGNDFKALVYEFMQNG  357 (789)
Q Consensus       284 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~g  357 (789)
                      -.||+.... +|..|++|+.+.... ...++..|.+.+..+....+  +..+..............+.+++++.+.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            589999886 788899999875422 34567778888877742222  1112111111111233578889988763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=89.62  E-value=1.6  Score=42.40  Aligned_cols=61  Identities=8%  Similarity=0.121  Sum_probs=37.1

Q ss_pred             ccHHHHHHhhcCCCCCCccc-----ccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC
Q 041249          260 LSYQNLHNATDGFSSANLIG-----TGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI  324 (789)
Q Consensus       260 ~~~~~~~~~~~~f~~~~~ig-----~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l  324 (789)
                      ++-+|++....+|...+...     .|---+.|+.+..  +..+++|++....  ...+...|++++..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L   68 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHL   68 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhh
Confidence            56678888888888766544     4555778998876  3458999885432  223445566666655